The	|O
products	|O
of	|O
the	|O
Saccharomyces	|O
cerevisiae	|O
CIN1	|B-PROTEIN
,	|O
CIN2	|B-PROTEIN
and	|O
CIN4	|B-PROTEIN
genes	|O
participate	|O
in	|O
a	|O
nonessential	|O
pathway	|O
required	|O
for	|O
normal	|O
microtubule	|O
function	|O
.	|O

Vitrectomy	|O
was	|O
still	|O
a	|O
significant	|O
risk	|O
factor	|O
when	|O
macular	|O
holes	|O
were	|O
excluded	|O
.	|O

Invited	|O
editorial	|O
on	|O
"	|O
Acute	|O
and	|O
chronic	|O
effects	|O
of	|O
exercise	|O
on	|O
leptin	|B-PROTEIN
levels	|O
in	|O
humans	|O
"	|O
.	|O

Both	|O
promoters	|O
lack	|O
a	|O
TATA	|O
box	|O
,	|O
and	|O
Pint	|B-PROTEIN
belongs	|O
to	|O
the	|O
MED	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
class	|O
of	|O
promoters	|O
,	|O
which	|O
initiate	|O
transcription	|O
at	|O
multiple	|O
sites	|O
.	|O

Serum	|B-PROTEIN
response	|I-PROTEIN
factor	|I-PROTEIN
(	|O
SRF	|B-PROTEIN
)	|O
,	|O
a	|O
member	|O
of	|O
an	|O
ancient	|O
family	|O
of	|O
DNA	|O
-	|O
binding	|O
proteins	|O
,	|O
is	|O
generally	|O
assumed	|O
to	|O
be	|O
a	|O
ubiquitous	|O
transcription	|O
factor	|O
involved	|O
in	|O
regulating	|O
growth	|O
factor	|O
-	|O
responsive	|O
genes	|O
.	|O

We	|O
have	|O
initiated	|O
studies	|O
to	|O
identify	|O
candidate	|O
signal	|O
transducers	|O
that	|O
associate	|O
with	|O
the	|O
cytosolic	|O
domain	|O
(	|O
cd	|O
)	|O
of	|O
the	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1R	|I-PROTEIN
.	|O

In	|O
this	|O
study	|O
,	|O
we	|O
sought	|O
to	|O
identify	|O
mechanisms	|O
that	|O
could	|O
account	|O
for	|O
the	|O
antimitogenic	|O
effects	|O
of	|O
IL	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
.	|O

Pseudomonas	|O
aeruginosa	|O
strains	|O
infecting	|O
patients	|O
with	|O
cystic	|O
fibrosis	|O
(	|O
CF	|O
)	|O
acquire	|O
a	|O
mucoid	|O
phenotype	|O
due	|O
to	|O
overproduction	|O
of	|O
alginate	|O
.	|O

Activity	|O
of	|O
palgD	|B-PROTEIN
in	|O
the	|O
cysB	|B-PROTEIN
mutant	|O
,	|O
in	|O
CHA	|O
and	|O
in	|O
the	|O
non	|O
-	|O
mucoid	|O
strain	|O
PAO	|O
was	|O
assessed	|O
by	|O
the	|O
use	|O
of	|O
a	|O
transcriptional	|O
algD	|B-PROTEIN
-	|O
xylE	|B-PROTEIN
fusion	|O
.	|O

The	|O
Man9	|B-PROTEIN
-	|I-PROTEIN
mannosidase	|I-PROTEIN
specificity	|O
of	|O
the	|O
cDNA	|O
construct	|O
was	|O
verified	|O
by	|O
the	|O
observation	|O
that	|O
all	|O
peptide	|O
sequences	|O
derived	|O
from	|O
a	|O
previously	|O
purified	|O
,	|O
catalytically	|O
active	|O
49	|O
-	|O
kDa	|O
fragment	|O
were	|O
found	|O
within	|O
the	|O
coding	|O
region	|O
.	|O

A	|O
soluble	|O
62	|O
-	|O
kDa	|O
protein	|O
was	|O
produced	|O
without	|O
the	|O
proteolytic	|O
processing	|O
by	|O
inserting	|O
the	|O
coding	|O
sequence	|O
of	|O
amino	|O
acids	|O
112	|O
to	|O
660	|O
of	|O
ORF	|O
-	|O
2	|O
in	|O
a	|O
baculovirus	|O
expression	|O
vector	|O
and	|O
using	|O
the	|O
corresponding	|O
virus	|O
to	|O
infect	|O
Sf9	|O
cells	|O
.	|O

The	|O
CPK	|B-PROTEIN
-	|I-PROTEIN
MB	|I-PROTEIN
isoenzyme	|O
showed	|O
no	|O
percentage	|O
increase	|O
of	|O
total	|O
CPK	|B-PROTEIN
higher	|O
than	|O
5%	|O
,	|O
measured	|O
at	|O
6	|O
,	|O
12	|O
,	|O
and	|O
24	|O
h	|O
after	|O
the	|O
shock	|O
,	|O
independent	|O
of	|O
the	|O
number	|O
of	|O
attempts	|O
of	|O
cardioversion	|O
.	|O

Serum	|O
and	|O
peritoneal	|O
dialysis	|O
fluid	|O
(	|O
PDF	|O
)	|O
were	|O
collected	|O
for	|O
assay	|O
throughout	|O
the	|O
course	|O
of	|O
the	|O
study	|O
and	|O
for	|O
5	|O
days	|O
thereafter	|O
.	|O

Results	|O
support	|O
the	|O
hypothesis	|O
that	|O
endogenous	|O
corticotropin	|B-PROTEIN
-	|I-PROTEIN
releasing	|I-PROTEIN
factor	|I-PROTEIN
,	|O
perhaps	|O
acting	|O
at	|O
a	|O
peripheral	|O
binding	|O
site	|O
,	|O
suppresses	|O
the	|O
active	|O
behavioral	|O
response	|O
characteristic	|O
of	|O
pups	|O
during	|O
the	|O
early	|O
phase	|O
of	|O
isolation	|O
in	|O
novel	|O
surroundings	|O
.	|O

Liver	|O
regional	|O
blood	|O
volume	|O
(	|O
LRBV	|O
)	|O
is	|O
altered	|O
by	|O
several	|O
disease	|O
states	|O
and	|O
various	|O
drugs	|O
.	|O

The	|O
gray	|O
matter	|O
NAA	|O
/	|O
mI	|O
ratio	|O
clearly	|O
separated	|O
the	|O
two	|O
groups	|O
.	|O

As	|O
with	|O
the	|O
murine	|O
and	|O
human	|O
mb	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
genes	|O
,	|O
the	|O
5'	|O
region	|O
of	|O
the	|O
bovine	|O
mb	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
gene	|O
lacked	|O
a	|O
TATA	|O
box	|O
.	|O

Chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
assays	|O
examining	|O
the	|O
ability	|O
of	|O
IE86	|B-PROTEIN
to	|O
repress	|O
activity	|O
from	|O
the	|O
HCMV	|O
major	|O
IE	|B-PROTEIN
promoter	|O
or	|O
activate	|O
the	|O
HCMV	|B-PROTEIN
early	|I-PROTEIN
promoter	|I-PROTEIN
for	|O
the	|O
2.2	|O
-	|O
kb	|O
class	|O
of	|O
RNAs	|O
demonstrated	|O
the	|O
functional	|O
integrity	|O
of	|O
the	|O
IE86	|B-PROTEIN
protein	|O
.	|O

ORF	|O
M1	|O
has	|O
striking	|O
homology	|O
to	|O
poxvirus	|O
serpins	|B-PROTEIN
,	|O
while	|O
ORF	|O
M11	|O
encodes	|O
a	|O
potential	|O
homolog	|O
of	|O
Bcl	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
-	|O
like	|O
molecules	|O
encoded	|O
by	|O
other	|O
gammaherpesviruses	|O
(	|O
gene	|B-PROTEIN
16	|I-PROTEIN
of	|O
HVS	|O
and	|O
KSHV	|O
and	|O
the	|O
BHRF1	|B-PROTEIN
gene	|O
of	|O
EBV	|O
)	|O
.	|O

Transcription	|O
factor	|O
binding	|O
sites	|O
downstream	|O
of	|O
the	|O
human	|O
immunodeficiency	|O
virus	|O
type	|O
1	|O
transcription	|O
start	|O
site	|O
are	|O
important	|O
for	|O
virus	|O
infectivity	|O
.	|O

Crystal	|O
structure	|O
of	|O
an	|O
oligomer	|O
of	|O
proteolytic	|O
zymogens	|O
:	|O
detailed	|O
conformational	|O
analysis	|O
of	|O
the	|O
bovine	|O
ternary	|O
complex	|O
and	|O
implications	|O
for	|O
their	|O
activation	|O
.	|O

Through	|O
transient	|O
transfection	|O
of	|O
NIH3T3	|O
fibroblast	|O
cells	|O
and	|O
gel	|O
mobility	|O
shift	|O
assays	|O
,	|O
the	|O
functional	|O
binding	|O
site	|O
was	|O
localized	|O
to	|O
a	|O
short	|O
region	|O
(	|O
-	|O
318	|O
to	|O
-	|O
303	|O
bp	|O
from	|O
the	|O
transcription	|O
start	|O
site	|O
)	|O
which	|O
has	|O
a	|O
CTCCC	|O
sequence	|O
.	|O

We	|O
suppose	|O
that	|O
this	|O
injection	|O
speed	|O
(	|O
0.1-0.2	|O
ml.s	|O
-	|O
1	|O
)	|O
is	|O
suitable	|O
for	|O
spinal	|O
anesthesia	|O
.	|O

Alternative	|O
splicing	|O
of	|O
ClC	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
(	|O
a	|O
member	|O
of	|O
the	|O
CIC	|B-PROTEIN
chloride	|O
-	|O
channel	|O
family	|O
)	|O
transcripts	|O
generates	|O
three	|O
truncated	|O
isoforms	|O
one	|O
of	|O
which	|O
,	|O
ClC	|B-PROTEIN
-	|I-PROTEIN
6c	|I-PROTEIN
,	|O
is	|O
kidney	|O
-	|O
specific	|O
.	|O

The	|O
current	|O
study	|O
demonstrates	|O
that	|O
T3	|O
-	|O
activated	|O
transcription	|O
of	|O
the	|O
NADPH	|B-PROTEIN
:	|I-PROTEIN
cytochrome	|I-PROTEIN
P450	|I-PROTEIN
oxidoreductase	|I-PROTEIN
(	|O
P450R	|B-PROTEIN
)	|O
gene	|O
is	|O
dependent	|O
on	|O
the	|O
thyroid	|O
hormonal	|O
status	|O
of	|O
the	|O
animal	|O
,	|O
with	|O
both	|O
transcriptional	|O
and	|O
post	|O
-	|O
transcriptional	|O
pathways	|O
being	|O
important	|O
in	|O
regulating	|O
the	|O
cellular	|O
P450R	|B-PROTEIN
mRNA	|O
level	|O
.	|O

The	|O
behavior	|O
of	|O
different	|O
types	|O
of	|O
polytetrafluoroethylene	|O
(	|O
PTFE	|O
)	|O
prostheses	|O
in	|O
the	|O
reparative	|O
scarring	|O
process	|O
of	|O
abdominal	|O
wall	|O
defects	|O
.	|O

The	|O
control	|O
group	|O
revealed	|O
significantly	|O
higher	|O
levels	|O
of	|O
coagulation	|B-PROTEIN
factors	|I-PROTEIN
II	|I-PROTEIN
,	|I-PROTEIN
V	|I-PROTEIN
and	|I-PROTEIN
VIII	|I-PROTEIN
,	|O
compared	|O
to	|O
the	|O
index	|O
group	|O
.	|O

The	|O
frequency	|O
of	|O
positive	|O
anti	|B-PROTEIN
-	|I-PROTEIN
GM1	|I-PROTEIN
antibody	|O
titers	|O
in	|O
the	|O
Guillain	|O
-	|O
Barre	|O
syndrome	|O
patients	|O
with	|O
PEN	|O
19	|O
isolates	|O
was	|O
higher	|O
than	|O
that	|O
in	|O
the	|O
Guillain	|O
-	|O
Barre	|O
syndrome	|O
and	|O
Fisher	|O
's	|O
syndrome	|O
patients	|O
without	|O
PEN	|O
19	|O
isolates	|O
.	|O

Stereotactic	|O
radiofrequency	|O
lesioning	|O
of	|O
the	|O
hamartoma	|O
resulted	|O
in	|O
seizure	|O
remission	|O
without	|O
complications	|O
20	|O
months	|O
after	|O
surgery	|O
.	|O

NF	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
/	|O
Rel	|B-PROTEIN
transcription	|O
factors	|O
participate	|O
in	|O
the	|O
activation	|O
of	|O
numerous	|O
genes	|O
involved	|O
in	|O
immune	|O
regulation	|O
/	|O
inflammation	|O
including	|O
cytokines	|O
,	|O
cell	|O
surface	|O
receptors	|O
,	|O
adhesion	|O
molecules	|O
,	|O
and	|O
acute	|O
phase	|O
proteins	|O
.	|O

If	|O
E.	|O
coli	|O
is	|O
present	|O
in	|O
any	|O
source	|O
water	|O
sample	|O
,	|O
the	|O
borehole	|O
and	|O
any	|O
directly	|O
connected	|O
borehole	|O
should	|O
be	|O
embargoed	|O
.	|O

However	|O
,	|O
mean	|O
food	|O
intake	|O
in	|O
the	|O
40%	|O
group	|O
was	|O
half	|O
that	|O
of	|O
the	|O
ACT	|O
group	|O
(	|O
p	|O
<	|O
0.001	|O
)	|O
and	|O
significantly	|O
less	|O
(	|O
p	|O
<	|O
0.01	|O
)	|O
than	|O
the	|O
SEP	|O
group	|O
,	|O
which	|O
consumed	|O
amounts	|O
equivalent	|O
to	|O
65%	|O
of	|O
daily	|O
requirement	|O
.	|O

The	|O
following	|O
technique	|O
describes	|O
a	|O
modification	|O
to	|O
a	|O
bar	|O
superstructure	|O
that	|O
provided	|O
the	|O
advantages	|O
of	|O
convenience	|O
,	|O
security	|O
,	|O
and	|O
consistent	|O
positioning	|O
even	|O
though	|O
one	|O
implant	|O
was	|O
lost	|O
and	|O
the	|O
angulation	|O
of	|O
implants	|O
limited	|O
accuracy	|O
.	|O

In	|O
summary	|O
,	|O
DDC	|O
express	|O
receptors	|O
for	|O
a	|O
broad	|O
panel	|O
of	|O
cytokines	|O
,	|O
even	|O
receptors	|O
for	|O
cytokines	|O
whose	|O
effects	|O
on	|O
DC	|O
are	|O
still	|O
unknown	|O
(	|O
i.e.	|O

Its	|O
potential	|O
as	|O
a	|O
diagnostic	|O
tool	|O
for	|O
epidemiological	|O
surveillance	|O
was	|O
assessed	|O
in	|O
comparison	|O
with	|O
three	|O
other	|O
diagnostic	|O
tests	|O
:	|O
stool	|O
examination	|O
,	|O
ELISA	|O
with	|O
soluble	|B-PROTEIN
egg	|I-PROTEIN
antigen	|I-PROTEIN
(	|O
SEA	|B-PROTEIN
)	|O
and	|O
the	|O
circumoval	|O
precipitin	|B-PROTEIN
test	|O
(	|O
COPT	|O
)	|O
.	|O

We	|O
have	|O
separated	|O
a	|O
dermatan	|O
sulfate	|O
proteoglycan	|O
,	|O
epiphycan	|O
,	|O
from	|O
decorin	|B-PROTEIN
and	|O
biglycan	|O
by	|O
using	|O
dissociative	|O
extraction	|O
of	|O
bovine	|O
fetal	|O
epiphyseal	|O
cartilage	|O
,	|O
followed	|O
by	|O
sequential	|O
ion	|O
-	|O
exchange	|O
,	|O
gel	|O
permeation	|O
,	|O
hydrophobic	|O
,	|O
and	|O
Zn2+	|O
chelate	|O
chromatographic	|O
steps	|O
.	|O

These	|O
analyses	|O
demonstrate	|O
that	|O
the	|O
dUTPase	|B-PROTEIN
isoforms	|O
are	|O
encoded	|O
by	|O
the	|O
same	|O
gene	|O
with	|O
isoform	|O
-	|O
specific	|O
transcripts	|O
arising	|O
through	|O
the	|O
use	|O
of	|O
alternative	|O
5'	|O
exons	|O
.	|O

The	|O
selective	|O
5	|B-PROTEIN
-	|I-PROTEIN
HT3	|I-PROTEIN
receptor	|I-PROTEIN
antagonists	|O
ramosetron	|O
(	|O
YM060	|O
)	|O
,	|O
YM114	|O
(	|O
KAE	|O
-	|O
393	|O
)	|O
,	|O
granisetron	|O
and	|O
ondansetron	|O
,	|O
and	|O
the	|O
substituted	|O
benzamides	|O
(	|O
5	|B-PROTEIN
-	|I-PROTEIN
HT4	|I-PROTEIN
receptor	|I-PROTEIN
agonist	|O
/	|O
5	|B-PROTEIN
-	|I-PROTEIN
HT3	|I-PROTEIN
receptor	|I-PROTEIN
antagonists	|O
)	|O
cisapride	|O
mosapride	|O
and	|O
SC	|O
-	|O
53116	|O
dose	|O
-	|O
dependently	|O
enhanced	|O
gastric	|O
emptying	|O
in	|O
normal	|O
rats	|O
.	|O

Re	|O
-	|O
evaluation	|O
of	|O
the	|O
biopsy	|O
specimen	|O
from	|O
the	|O
right	|O
hip	|O
taken	|O
at	|O
the	|O
time	|O
of	|O
the	|O
initial	|O
operation	|O
showed	|O
areas	|O
of	|O
chondrosarcoma	|O
arising	|O
in	|O
the	|O
background	|O
of	|O
synovial	|O
chondromatosis	|O
.	|O

All	|O
corneal	|O
buttons	|O
were	|O
processed	|O
for	|O
histopathologic	|O
and	|O
electron	|O
microscopic	|O
studies	|O
.	|O

3600	|O
-	|O
fold	|O
to	|O
apparent	|O
homogeneity	|O
with	|O
a	|O
41%	|O
yield	|O
by	|O
affinity	|O
chromatography	|O
utilizing	|O
DNA	|O
-	|O
cellulose	|O
;	|O
the	|O
purity	|O
of	|O
the	|O
final	|O
preparation	|O
was	|O
assessed	|O
by	|O
SDS	|O
/	|O
PAGE	|O
,	|O
lack	|O
of	|O
contamination	|O
by	|O
other	|O
nucleases	|O
and	|O
production	|O
of	|O
a	|O
monospecific	|O
antibody	|O
against	|O
the	|O
enzyme	|O
.	|O

Human	|O
thymine	|B-PROTEIN
-	|I-PROTEIN
DNA	|I-PROTEIN
glycosylase	|I-PROTEIN
maps	|O
at	|O
chromosome	|O
12q22	|O
-	|O
q24.1	|O
:	|O
a	|O
region	|O
of	|O
high	|O
loss	|O
of	|O
heterozygosity	|O
in	|O
gastric	|O
cancer	|O
.	|O

FOG	|B-PROTEIN
is	|O
coexpressed	|O
with	|O
GATA	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
during	|O
embryonic	|O
development	|O
and	|O
in	|O
erythroid	|O
and	|O
megakaryocytic	|O
cells	|O
.	|O

The	|O
mean	|O
times	|O
to	|O
detection	|O
of	|O
all	|O
mycobacteria	|O
with	|O
BACTEC	|O
9000	|O
MB	|O
and	|O
BACTEC	|O
460	|O
TB	|O
were	|O
similar	|O
(	|O
10.3	|O
and	|O
10.0	|O
days	|O
,	|O
respectively	|O
)	|O
.	|O

Though	|O
the	|O
BACTEC	|O
9000	|O
MB	|O
system	|O
is	|O
recommended	|O
for	|O
respiratory	|O
specimens	|O
,	|O
we	|O
demonstrated	|O
that	|O
it	|O
can	|O
be	|O
successfully	|O
used	|O
also	|O
for	|O
recovery	|O
of	|O
mycobacteria	|O
from	|O
clinical	|O
specimens	|O
from	|O
various	|O
extrapulmonary	|O
sites	|O
.	|O

We	|O
further	|O
found	|O
that	|O
KmMig1p	|B-PROTEIN
is	|O
fully	|O
functional	|O
when	|O
expressed	|O
in	|O
S.	|O
cerevisiae	|O
.	|O

A	|O
pre	|O
-	|O
boutonniere	|O
deformity	|O
was	|O
simulated	|O
by	|O
dividing	|O
the	|O
central	|O
slip	|O
.	|O

Autoimmune	|O
neutropenia	|O
(	|O
AIN	|O
)	|O
is	|O
a	|O
frequent	|O
cause	|O
of	|O
chronic	|O
neutropenia	|O
especially	|O
in	|O
youngest	|O
children	|O
.	|O

With	|O
regard	|O
to	|O
the	|O
characteristic	|O
expression	|O
pattern	|O
of	|O
DJ	|B-PROTEIN
protein	|O
and	|O
its	|O
conspicuous	|O
repeat	|O
units	|O
possible	|O
functional	|O
roles	|O
are	|O
discussed	|O
.	|O

Future	|O
analysis	|O
of	|O
long	|O
-	|O
term	|O
outcome	|O
measures	|O
of	|O
performance	|O
with	|O
the	|O
implant	|O
will	|O
confirm	|O
or	|O
dispute	|O
the	|O
benefit	|O
of	|O
ear	|O
selection	|O
using	|O
the	|O
Prom	|O
-	|O
EABR	|O
.	|O

This	|O
protein	|O
,	|O
designated	|O
p532	|B-PROTEIN
based	|O
on	|O
its	|O
predicted	|O
molecular	|O
weight	|O
(	|O
EMBO	|O
J	|O
15	|O
:	|O
5738	|O
,	|O
1996	|O
)	|O
,	|O
contains	|O
multiple	|O
structural	|O
domains	|O
including	|O
two	|O
regions	|O
of	|O
seven	|O
internal	|O
repeats	|O
highly	|O
related	|O
to	|O
the	|O
cell	|O
cycle	|O
regulator	|O
RCC1	|B-PROTEIN
,	|O
a	|O
guanine	|B-PROTEIN
nucleotide	|I-PROTEIN
exchange	|I-PROTEIN
factor	|I-PROTEIN
for	|O
the	|O
small	|B-PROTEIN
GTP	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
Ran	|O
,	|O
seven	|O
beta	|O
-	|O
repeat	|O
domains	|O
characteristic	|O
of	|O
the	|O
beta	|O
subunit	|O
of	|O
heterotrimeric	|O
G	|B-PROTEIN
proteins	|I-PROTEIN
,	|O
three	|O
putative	|O
SH3	|B-PROTEIN
binding	|O
sites	|O
,	|O
a	|O
putative	|O
leucine	|O
-	|O
zipper	|O
and	|O
a	|O
carboxy	|O
-	|O
terminal	|O
HECT	|B-PROTEIN
domain	|O
characteristic	|O
of	|O
E3	|B-PROTEIN
ubiquitin	|O
-	|O
protein	|O
ligases	|O
.	|O

Thus	|O
,	|O
the	|O
L45	|O
sequence	|O
between	|O
kinase	|O
subdomains	|O
IV	|O
and	|O
V	|O
specifies	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
responsiveness	|O
of	|O
the	|O
type	|B-PROTEIN
I	|I-PROTEIN
receptor	|I-PROTEIN
.	|O

The	|O
two	|O
mouse	|O
lines	|O
carrying	|O
the	|O
unfragmented	|O
Hnf3g	|B-PROTEIN
-	|O
lacZ	|B-PROTEIN
YAC	|O
showed	|O
tissue	|O
-	|O
specific	|O
,	|O
copy	|O
number	|O
-	|O
dependent	|O
and	|O
position	|O
-	|O
independent	|O
expression	|O
,	|O
proving	|O
that	|O
170	|O
kb	|O
of	|O
the	|O
Hnf3g	|B-PROTEIN
locus	|O
contain	|O
all	|O
elements	|O
important	|O
in	|O
the	|O
regulation	|O
of	|O
Hnf3g	|B-PROTEIN
.	|O

Second	|O
,	|O
plasmid	|O
-	|O
derived	|O
transgenes	|O
and	|O
gene	|O
targeting	|O
of	|O
the	|O
endogenous	|O
Hnf3g	|B-PROTEIN
gene	|O
locus	|O
were	|O
used	|O
to	|O
demonstrate	|O
that	|O
the	|O
3'	|O
-	|O
flanking	|O
region	|O
of	|O
the	|O
gene	|O
is	|O
necessary	|O
and	|O
sufficient	|O
to	|O
direct	|O
reporter	|O
gene	|O
expression	|O
in	|O
liver	|O
,	|O
pancreas	|O
,	|O
stomach	|O
and	|O
small	|O
intestine	|O
.	|O

This	|O
regulation	|O
requires	|O
two	|O
HMG	|B-PROTEIN
-	|I-PROTEIN
box	|I-PROTEIN
proteins	|O
:	|O
the	|O
ubiquitous	|O
Ste11	|B-PROTEIN
transcription	|O
factor	|O
and	|O
the	|O
M	|O
cell	|O
-	|O
controlling	|O
protein	|O
Mat1	|B-PROTEIN
-	|I-PROTEIN
Mc	|I-PROTEIN
.	|O

Here	|O
we	|O
have	|O
tested	|O
the	|O
hypothesis	|O
that	|O
the	|O
short	|O
transcripts	|O
,	|O
or	|O
proteins	|O
translated	|O
from	|O
the	|O
short	|O
transcripts	|O
,	|O
are	|O
also	|O
required	|O
for	|O
respiration	|O
.	|O

Upstream	|O
activating	|O
sequences	|O
(	|O
UASs	|O
)	|O
derived	|O
from	|O
known	|O
Ste12p	|B-PROTEIN
-	|O
dependent	|O
genes	|O
have	|O
previously	|O
been	|O
characterized	|O
to	|O
require	|O
either	|O
multiple	|O
PREs	|O
or	|O
a	|O
single	|O
PRE	|O
coupled	|O
to	|O
a	|O
binding	|O
site	|O
for	|O
a	|O
second	|O
protein	|O
.	|O

Prominent	|O
protein	|O
kinase	|O
cascades	|O
are	|O
those	|O
that	|O
activate	|O
mitogen	|O
-	|O
activated	|O
protein	|O
(	|B-PROTEIN
MAP	|I-PROTEIN
)	|I-PROTEIN
kinases	|I-PROTEIN
.	|O

JNK	|B-PROTEIN
is	|O
additionally	|O
regulated	|O
by	|O
the	|O
Ras	|B-PROTEIN
-	|O
related	|O
G	|B-PROTEIN
proteins	|I-PROTEIN
Rac	|O
and	|O
Cdc42	|B-PROTEIN
.	|O

In	|O
this	|O
study	|O
,	|O
we	|O
tested	|O
this	|O
notion	|O
by	|O
using	|O
ligation	|O
-	|O
mediated	|O
PCR	|O
to	|O
assess	|O
the	|O
formation	|O
of	|O
recombination	|B-PROTEIN
-	|I-PROTEIN
activating	|I-PROTEIN
gene	|I-PROTEIN
(	|O
RAG	|B-PROTEIN
)	|O
-	|O
dependent	|O
double	|O
-	|O
strand	|O
breaks	|O
(	|O
DSBs	|O
)	|O
at	|O
RSSs	|O
3'	|O
of	|O
Ddelta3	|B-PROTEIN
and	|O
5'	|O
of	|O
Jdelta1	|B-PROTEIN
.	|O

Recent	|O
studies	|O
have	|O
demonstrated	|O
that	|O
Cbl	|B-PROTEIN
,	|O
the	|O
120	|O
-	|O
kDa	|O
protein	|O
product	|O
of	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
cbl	|I-PROTEIN
proto	|O
-	|O
oncogene	|O
,	|O
serves	|O
as	|O
a	|O
substrate	|O
of	|O
a	|O
number	|O
of	|O
receptor	|O
-	|O
coupled	|O
tyrosine	|B-PROTEIN
kinases	|I-PROTEIN
and	|O
forms	|O
complexes	|O
with	|O
SH3	|B-PROTEIN
and	|O
SH2	|B-PROTEIN
domain	|O
-	|O
containing	|O
proteins	|O
,	|O
pointing	|O
to	|O
its	|O
role	|O
in	|O
signal	|O
transduction	|O
.	|O

Although	|O
neither	|O
constitutively	|O
activated	|O
MEK	|B-PROTEIN
(	|O
MEK	|B-PROTEIN
-	|I-PROTEIN
2E	|I-PROTEIN
)	|O
nor	|O
v	|B-PROTEIN
-	|I-PROTEIN
Src	|I-PROTEIN
was	|O
sufficient	|O
individually	|O
to	|O
differentiate	|O
the	|O
H19	|O
-	|O
7	|O
cells	|O
,	|O
coexpression	|O
of	|O
constitutively	|O
activated	|O
MEK	|B-PROTEIN
and	|O
v	|B-PROTEIN
-	|I-PROTEIN
Src	|I-PROTEIN
induced	|O
neurite	|O
outgrowth	|O
.	|O

This	|O
mechanism	|O
is	|O
in	|O
contrast	|O
to	|O
other	|O
cases	|O
of	|O
splicing	|O
regulation	|O
by	|O
PTB	|B-PROTEIN
,	|O
in	|O
which	|O
the	|O
protein	|O
represses	|O
the	|O
splice	|O
site	|O
to	|O
which	|O
it	|O
binds	|O
.	|O

While	|O
important	|O
for	|O
ligand	|O
-	|O
dependent	|O
transactivation	|O
,	|O
this	|O
interaction	|O
surface	|O
is	|O
not	|O
directly	|O
involved	|O
in	|O
transrepression	|O
of	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
activity	|O
.	|O

Gal4	|B-PROTEIN
-	|O
Eed	|B-PROTEIN
fusion	|O
protein	|O
represses	|O
transcription	|O
of	|O
a	|O
reporter	|O
gene	|O
driven	|O
by	|O
a	|O
promoter	|O
that	|O
contains	|O
Gal4	|B-PROTEIN
-	|O
binding	|O
DNA	|O
elements	|O
.	|O

In	|O
situ	|O
hybridization	|O
analysis	|O
in	|O
adult	|O
rat	|O
tissue	|O
reveals	|O
good	|O
correlation	|O
with	|O
this	|O
pattern	|O
and	|O
indicates	|O
that	|O
drm	|B-PROTEIN
mRNA	|O
is	|O
most	|O
highly	|O
expressed	|O
in	|O
nondividing	|O
and	|O
terminally	|O
differentiated	|O
cells	|O
,	|O
such	|O
as	|O
neurons	|O
,	|O
type	|O
1	|O
lung	|O
cells	|O
,	|O
and	|O
goblet	|O
cells	|O
.	|O

Neither	|O
of	|O
these	|O
proteins	|O
,	|O
individually	|O
or	|O
as	|O
a	|O
pair	|O
,	|O
can	|O
bind	|O
the	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
globin	|I-PROTEIN
3'	|O
UTR	|O
unless	|O
they	|O
are	|O
complexed	|O
with	|O
the	|O
remaining	|O
non	|O
-	|O
poly	|O
(	|O
C	|O
)	|O
binding	|O
proteins	|O
of	|O
the	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
complex	|I-PROTEIN
.	|O

A	|O
2	|O
years	|O
and	|O
9	|O
months	|O
old	|O
female	|O
patient	|O
,	|O
with	|O
the	|O
diagnosis	|O
of	|O
Weaver	|O
syndrome	|O
is	|O
reported	|O
.	|O

Confirming	|O
measures	|O
made	|O
by	|O
nurses	|O
and	|O
additionally	|O
,	|O
ABPM	|O
for	|O
women	|O
,	|O
seem	|O
to	|O
lessen	|O
this	|O
effect	|O
.	|O

In	|O
a	|O
series	|O
of	|O
patients	|O
with	|O
neuroinfection	|O
,	|O
Lyme	|O
disease	|O
,	|O
Guillain	|O
Barre	|O
syndrome	|O
,	|O
demyelinization	|O
,	|O
partial	|O
or	|O
generalized	|O
,	|O
epilepsy	|O
,	|O
we	|O
have	|O
investigated	|O
antiphospholipid	|O
antibodies	|O
of	|O
IgG	|B-PROTEIN
and	|O
IgM	|B-PROTEIN
subtypes	|O
,	|O
together	|O
with	|O
anticoagulant	|O
factors	|O
,	|O
member	|O
of	|O
thrombocytes	|O
,	|O
sedimentation	|O
rate	|O
of	|O
erythrocytes	|O
.	|O

(	|O
1996a	|O
)	|O
Biochemistry	|O
35	|O
,	|O
1589-1598	|O
]	|O
.	|O

Second	|O
,	|O
the	|O
membrane	|O
expression	|O
of	|O
alpha	|O
and	|O
beta	|O
subunits	|O
was	|O
mimicked	|O
by	|O
cholesterol	|O
and	|O
17	|O
-	|O
ketocholesterol	|O
,	|O
both	|O
of	|O
which	|O
inhibit	|O
HMG	|B-PROTEIN
-	|I-PROTEIN
CoA	|I-PROTEIN
reductase	|I-PROTEIN
.	|O

Our	|O
results	|O
suggest	|O
that	|O
Lrp	|B-PROTEIN
binds	|O
a	|O
central	|O
palindromic	|O
site	|O
,	|O
interacting	|O
predominantly	|O
with	|O
the	|O
major	|O
groove	|O
of	|O
its	|O
DNA	|O
target	|O
,	|O
and	|O
that	|O
additional	|O
dimers	|O
bind	|O
to	|O
flanking	|O
sites	|O
to	|O
form	|O
a	|O
nucleoprotein	|O
activation	|O
complex	|O
.	|O

Sustained	|O
activation	|O
of	|O
p21	|B-PROTEIN
expression	|O
is	|O
proposed	|O
to	|O
be	|O
a	|O
distinguishing	|O
feature	|O
of	|O
the	|O
activity	|O
of	|O
NGF	|B-PROTEIN
that	|O
contributes	|O
to	|O
PC12	|O
growth	|O
arrest	|O
during	|O
differentiation	|O

The	|O
remaining	|O
80	|O
patients	|O
underwent	|O
recordings	|O
of	|O
ECG	|O
,	|O
beat	|O
-	|O
to	|O
-	|O
beat	|O
arterial	|O
oxygen	|O
saturation	|O
(	|O
SaO2	|O
)	|O
,	|O
and	|O
respiration	|O
during	|O
both	|O
spontaneous	|O
and	|O
controlled	|O
breathing	|O
.	|O

The	|O
mean	|O
total	|O
white	|O
cell	|O
count	|O
increased	|O
from	|O
a	|O
baseline	|O
of	|O
11.3	|O
x	|O
10	|O
(	|O
9	|O
)	|O
/	|O
L	|O
(	|O
SD	|O
2.3	|O
)	|O
to	|O
16.2	|O
x	|O
10	|O
(	|O
9	|O
)	|O
/	|O
L	|O
(	|O
SD	|O
4.6	|O
)	|O
on	|O
day	|O
1	|O
,	|O
normalising	|O
thereafter	|O
.	|O

A	|O
prospective	|O
observational	|O
study	|O
was	|O
conducted	|O
to	|O
identify	|O
early	|O
indicators	|O
of	|O
acute	|O
dengue	|O
virus	|O
infection	|O
.	|O

In	|O
all	|O
experimental	|O
eyes	|O
,	|O
there	|O
was	|O
a	|O
marked	|O
reduction	|O
,	|O
but	|O
never	|O
a	|O
complete	|O
absence	|O
of	|O
adrenergic	|O
nerves	|O
in	|O
the	|O
iris	|O
.	|O

These	|O
lesions	|O
may	|O
be	|O
treated	|O
by	|O
propranolol	|O
or	|O
phentolamine	|O
.	|O

Furthermore	|O
,	|O
ICER	|B-PROTEIN
negatively	|O
autoregulates	|O
the	|O
alternative	|O
promoter	|O
,	|O
thus	|O
generating	|O
a	|O
feedback	|O
loop	|O
.	|O

This	|O
night	|O
-	|O
day	|O
oscillation	|O
is	|O
driven	|O
by	|O
the	|O
endogenous	|O
clock	|O
(	|O
located	|O
in	|O
the	|O
suprachiasmatic	|O
nucleus	|O
,	|O
SCN	|O
)	|O
.	|O

It	|O
is	|O
present	|O
in	|O
the	|O
nucleus	|O
of	|O
the	|O
cells	|O
in	|O
which	|O
it	|O
is	|O
expressed	|O
and	|O
can	|O
phosphorylate	|O
and	|O
activate	|O
the	|O
cyclic	|B-PROTEIN
AMP	|I-PROTEIN
response	|I-PROTEIN
element	|I-PROTEIN
binding	|I-PROTEIN
proteins	|I-PROTEIN
CREB	|O
and	|O
CREM	|B-PROTEIN
tau	|I-PROTEIN
in	|O
a	|O
manner	|O
analogous	|O
to	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
A.	|I-PROTEIN

These	|O
cells	|O
fail	|O
to	|O
generate	|O
the	|O
signals	|O
to	|O
phosphorylate	|O
CREB	|B-PROTEIN
and	|O
produce	|O
significantly	|O
less	|O
of	|O
the	|O
cytokine	|O
Interleukin	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
(	|O
IL	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
)	|O
in	|O
response	|O
to	|O
agents	|O
that	|O
either	|O
increase	|O
intracellular	|O
Ca2+	|O
and	|O
/	|O
or	|O
activate	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
C.	|I-PROTEIN

Both	|O
of	|O
these	|O
dogs	|O
had	|O
low	|O
serum	|O
IgG	|B-PROTEIN
(	|O
3.5	|O
to	|O
7.2	|O
mg	|O
/	|O
ml	|O
)	|O
and	|O
the	|O
second	|O
littermate	|O
also	|O
had	|O
reduced	|O
serum	|O
IgA	|B-PROTEIN
(	|O
<	|O
0.1	|O
to	|O
0.15	|O
mg	|O
/	|O
ml	|O
)	|O
.	|O

CONCLUSIONS	|O
:	|O
Valproate	|O
appears	|O
to	|O
inhibit	|O
the	|O
glucuronidation	|O
of	|O
carbamazepine	|O
-	|O
10,11	|O
-	|O
trans	|O
-	|O
diol	|O
,	|O
and	|O
probably	|O
also	|O
inhibits	|O
the	|O
conversion	|O
of	|O
carbamazepine	|O
-	|O
10,11	|O
-	|O
epoxide	|O
to	|O
this	|O
trans	|O
-	|O
diol	|O
derivative	|O
,	|O
rather	|O
than	|O
simply	|O
inhibiting	|O
the	|O
latter	|O
reaction	|O
only	|O
.	|O

The	|O
Ogg1	|B-PROTEIN
protein	|O
efficiently	|O
cleaves	|O
a	|O
DNA	|O
duplex	|O
where	|O
a	|O
preformed	|O
AP	|B-PROTEIN
site	|O
is	|O
placed	|O
opposite	|O
a	|O
cytosine	|O
(	|O
AP	|B-PROTEIN
/	|O
C	|O
)	|O
.	|O

A	|O
consensus	|O
sequence	|O
indicates	|O
a	|O
highly	|O
conserved	|O
lysine	|O
residue	|O
,	|O
K120	|O
of	|O
endonuclease	|B-PROTEIN
III	|I-PROTEIN
or	|O
K241	|O
of	|O
Ogg1	|B-PROTEIN
,	|O
respectively	|O
.	|O

Overall	|O
,	|O
these	|O
findings	|O
demonstrate	|O
that	|O
mutations	|O
E768D	|O
and	|O
V804L	|O
are	|O
gain	|O
-	|O
of	|O
-	|O
function	|O
mutations	|O
that	|O
confer	|O
to	|O
the	|O
long	|O
RET	|B-PROTEIN
isoform	|O
the	|O
capacity	|O
to	|O
exert	|O
a	|O
biological	|O
effect	|O
,	|O
although	|O
these	|O
mutations	|O
are	|O
more	|O
weakly	|O
activating	|O
than	|O
the	|O
MEN2A	|B-PROTEIN
and	|O
MEN2B	|B-PROTEIN
mutations	|O
.	|O

Volunteers	|O
were	|O
irradiated	|O
on	|O
their	|O
backs	|O
with	|O
suberythemal	|O
UV	|O
daily	|O
for	|O
5	|O
d	|O
after	|O
application	|O
of	|O
the	|O
sunscreens	|O
and	|O
their	|O
base	|O
lotion	|O
to	|O
different	|O
sites	|O
.	|O

E2F	|B-PROTEIN
is	|O
a	|O
heterodimeric	|O
complex	|O
consisting	|O
of	|O
E2F	|B-PROTEIN
family	|O
members	|O
(	|O
1-5	|O
)	|O
and	|O
DP	|B-PROTEIN
proteins	|O
(	|O
1-3	|O
)	|O
.	|O

EBER1	|B-PROTEIN
mRNA	|O
,	|O
a	|O
consistent	|O
marker	|O
of	|O
viral	|O
latency	|O
,	|O
was	|O
positive	|O
in	|O
all	|O
PEL	|O
cases	|O
,	|O
although	|O
at	|O
lower	|O
levels	|O
than	|O
in	|O
the	|O
non	|O
-	|O
PEL	|O
controls	|O
due	|O
to	|O
EBER1	|B-PROTEIN
expression	|O
by	|O
only	|O
a	|O
variable	|O
subset	|O
of	|O
lymphoma	|O
cells	|O
.	|O

METHODS	|O
:	|O
Four	|O
hundred	|O
fifty	|O
patients	|O
with	|O
the	|O
diagnosis	|O
of	|O
squamous	|O
cell	|O
carcinoma	|O
of	|O
the	|O
oral	|O
cavity	|O
received	|O
their	|O
primary	|O
treatment	|O
at	|O
Roswell	|O
Park	|O
Cancer	|O
Center	|O
(	|O
RPCI	|O
)	|O
from	|O
1971	|O
to	|O
1991	|O
.	|O

Therefore	|O
,	|O
use	|O
of	|O
presaturation	|O
is	|O
recommended	|O
for	|O
myocardial	|O
motion	|O
studies	|O
using	|O
cine	|O
PC	|O
velocity	|O
data	|O
.	|O

In	|O
addition	|O
,	|O
the	|O
DNA	|O
-	|O
binding	|O
experiments	|O
show	|O
that	|O
either	|O
one	|O
of	|O
the	|O
two	|O
MADS	|B-PROTEIN
domains	|O
of	|O
a	|O
dimer	|O
can	|O
be	|O
sufficient	|O
to	|O
confer	|O
a	|O
particular	|O
DNA	|O
-	|O
binding	|O
specificity	|O
to	|O
the	|O
complex	|O
and	|O
that	|O
sequences	|O
outside	|O
the	|O
amino	|O
-	|O
terminal	|O
basic	|O
region	|O
of	|O
the	|O
MADS	|B-PROTEIN
domain	|O
can	|O
,	|O
in	|O
some	|O
cases	|O
,	|O
contribute	|O
to	|O
the	|O
DNA	|O
-	|O
binding	|O
specificity	|O
of	|O
the	|O
proteins	|O
.	|O

PURPOSE	|O
/	|O
OBJECTIVES	|O
:	|O
To	|O
examine	|O
the	|O
question	|O
of	|O
whether	|O
an	|O
early	|O
first	|O
full	|O
-	|O
term	|O
pregnancy	|O
(	|O
FFTP	|O
)	|O
protects	|O
against	|O
breast	|O
cancer	|O
and	|O
whether	|O
interruption	|O
of	|O
the	|O
pregnancy	|O
with	|O
an	|O
induced	|O
abortion	|O
increases	|O
breast	|O
cancer	|O
risk	|O
.	|O

Two	|O
related	|O
studies	|O
conducted	|O
over	|O
a	|O
five	|O
week	|O
period	|O
measured	|O
and	|O
typed	|O
HLA	|B-PROTEIN
-	|I-PROTEIN
DQA1	|I-PROTEIN
from	|O
accumulated	|O
DNA	|O
on	|O
autopsy	|O
room	|O
and	|O
Forensic	|O
DNA	|O
Laboratory	|O
structures	|O
.	|O

Thirty	|O
-	|O
two	|O
rats	|O
were	|O
divided	|O
into	|O
four	|O
groups	|O
.	|O

Mutagenesis	|O
of	|O
the	|O
pecT	|B-PROTEIN
regulatory	|O
region	|O
revealed	|O
the	|O
presence	|O
of	|O
two	|O
sites	|O
in	|O
which	|O
insertions	|O
reproduced	|O
the	|O
pec	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
phenotype	|O
.	|O

BRCA1	|B-PROTEIN
,	|O
a	|O
familial	|O
breast	|O
and	|O
ovarian	|O
cancer	|O
susceptibility	|O
gene	|O
encodes	|O
nuclear	|O
phosphoproteins	|O
that	|O
function	|O
as	|O
tumor	|O
suppressors	|O
in	|O
human	|O
breast	|O
cancer	|O
cells	|O
.	|O

The	|O
alternative	|O
splice	|O
sites	|O
for	|O
the	|O
smallest	|O
adducin	|B-PROTEIN
isoform	|O
,	|O
beta	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
,	|O
are	|O
alternative	|O
donor	|O
and	|O
acceptor	|O
sites	|O
within	|O
exons	|O
7	|O
and	|O
12	|O
.	|O

Proteinuria	|O
in	|O
a	|O
young	|O
man	|O
.	|O

Neural	|O
blockade	|O
in	|O
chronic	|O
and	|O
cancer	|O
pain	|O
.	|O

Two	|O
new	|O
temperature	|O
-	|O
sensitive	|O
alleles	|O
of	|O
SEC3	|B-PROTEIN
,	|O
1	|O
of	|O
10	|O
late	|O
-	|O
acting	|O
SEC	|B-PROTEIN
genes	|O
required	|O
for	|O
targeting	|O
or	|O
fusion	|O
of	|O
post	|O
-	|O
Golgi	|O
secretory	|O
vesicles	|O
to	|O
the	|O
plasma	|O
membrane	|O
in	|O
Saccharomyces	|O
cerevisiae	|O
,	|O
were	|O
isolated	|O
in	|O
a	|O
screen	|O
for	|O
temperature	|O
-	|O
sensitive	|O
secretory	|O
mutants	|O
that	|O
are	|O
synthetically	|O
lethal	|O
with	|O
sec4	|B-PROTEIN
-	|I-PROTEIN
8	|I-PROTEIN
.	|O

Five	|O
cell	|O
strains	|O
of	|O
human	|O
dermal	|O
fibroblasts	|O
were	|O
each	|O
treated	|O
with	|O
three	|O
samples	|O
of	|O
burn	|O
blister	|O
fluid	|O
and	|O
the	|O
effect	|O
compared	|O
with	|O
the	|O
rate	|O
of	|O
contraction	|O
of	|O
free	|O
floating	|O
fibroblast	|O
populated	|O
collagen	|B-PROTEIN
lattices	|O
(	|O
FPCL	|O
)	|O
.	|O

It	|O
is	|O
thus	|O
one	|O
of	|O
the	|O
key	|O
enzymes	|O
involved	|O
in	|O
the	|O
triiodothyronine	|O
-	|O
mediated	|O
control	|O
of	|O
growth	|O
,	|O
differentiation	|O
and	|O
basal	|O
metabolism	|O
in	|O
vertebrates	|O
.	|O

Cell	|O
49	|O
,	|O
753-761	|O
]	|O
.	|O

Twenty	|O
-	|O
one	|O
ELISA	|O
-	|O
positive	|O
sera	|O
were	|O
tested	|O
and	|O
confirmed	|O
positive	|O
by	|O
plaque	|O
reduction	|O
neutralization	|O
testing	|O
.	|O

Patients	|O
received	|O
either	|O
diltiazem	|O
CD	|O
180	|O
mg	|O
or	|O
placebo	|O
once	|O
/	|O
day	|O
in	|O
combination	|O
with	|O
existing	|O
antianginal	|O
therapy	|O
.	|O

Reactive	|O
lymphoid	|O
hyperplasia	|O
was	|O
found	|O
in	|O
15	|O
cases	|O
,	|O
2	|O
cases	|O
had	|O
angiofollicular	|O
lymphoid	|O
hyperplasia	|O
or	|O
Castleman	|O
's	|O
disease	|O
,	|O
atypical	|O
lymphoid	|O
hyperplasia	|O
suggestive	|O
of	|O
malignant	|O
lymphoma	|O
was	|O
observed	|O
in	|O
3	|O
cases	|O
,	|O
and	|O
malignant	|O
lymphoma	|O
was	|O
diagnosed	|O
in	|O
the	|O
remaining	|O
4	|O
cases	|O
.	|O

We	|O
had	|O
previously	|O
analyzed	|O
repair	|O
rates	|O
of	|O
cyclobutane	|O
pyrimidine	|O
dimers	|O
at	|O
nucleotide	|O
resolution	|O
along	|O
the	|O
human	|O
JUN	|B-PROTEIN
gene	|O
in	|O
normal	|O
fibroblasts	|O
and	|O
found	|O
very	|O
efficient	|O
repair	|O
of	|O
sequences	|O
near	|O
the	|O
transcription	|O
initiation	|O
site	|O
but	|O
slow	|O
repair	|O
along	|O
the	|O
promoter	|O
.	|O

Tyrosine	|O
1356	|O
forms	|O
a	|O
multisubstrate	|O
binding	|O
site	|O
for	|O
the	|O
Grb2	|B-PROTEIN
and	|O
Shc	|B-PROTEIN
adaptor	|O
proteins	|O
,	|O
the	|O
p85	|B-PROTEIN
subunit	|O
of	|O
phosphatidylinositol	|B-PROTEIN
3'	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
,	|O
phospholipase	|B-PROTEIN
Cgamma	|I-PROTEIN
,	|O
and	|O
a	|O
phosphatase	|O
,	|O
SHP2	|B-PROTEIN
.	|O

Then	|O
we	|O
correlated	|O
HRCT	|O
findings	|O
with	|O
the	|O
clinical	|O
features	|O
,	|O
pulmonary	|O
functions	|O
and	|O
methacholine	|O
PC20	|O
(	|O
PC20M	|O
)	|O
and	|O
studied	|O
their	|O
clinical	|O
significance	|O
.	|O

Gtx	|B-PROTEIN
mRNA	|O
accumulates	|O
in	|O
parallel	|O
with	|O
the	|O
RNAs	|O
encoding	|O
the	|O
major	|O
structural	|O
proteins	|O
of	|O
myelin	|O
,	|O
myelin	|B-PROTEIN
basic	|I-PROTEIN
protein	|I-PROTEIN
(	|O
MBP	|B-PROTEIN
)	|O
,	|O
and	|O
proteolipid	|B-PROTEIN
protein	|I-PROTEIN
(	|O
PLP	|B-PROTEIN
)	|O
during	|O
postnatal	|O
brain	|O
development	|O
;	|O
Gtx	|B-PROTEIN
mRNA	|O
decreases	|O
in	|O
parallel	|O
with	|O
MBP	|B-PROTEIN
and	|O
PLP	|B-PROTEIN
mRNAs	|O
in	|O
the	|O
brains	|O
of	|O
myelin	|O
-	|O
deficient	|O
rats	|O
,	|O
which	|O
have	|O
a	|O
point	|O
mutation	|O
in	|O
the	|O
PLP	|B-PROTEIN
gene	|O
.	|O

Contacts	|O
between	|O
Bacillus	|O
subtilis	|O
catabolite	|O
regulatory	|O
protein	|O
CcpA	|B-PROTEIN
and	|O
amyO	|B-PROTEIN
target	|O
site	|O
.	|O

They	|O
also	|O
interact	|O
with	|O
GTPase	|B-PROTEIN
activating	|I-PROTEIN
proteins	|I-PROTEIN
encoded	|O
by	|O
IRA1	|B-PROTEIN
and	|O
IRA2	|B-PROTEIN
.	|O

For	|O
E2	|O
,	|O
each	|O
cat	|O
was	|O
given	|O
either	|O
5	|O
(	|O
group	|O
[	|O
G	|O
]	|O
1	|O
)	|O
or	|O
10	|O
(	|O
G2	|O
)	|O
mg	|O
of	|O
itraconazole	|O
/	|O
kg	|O
(	|O
capsules	|O
)	|O
twice	|O
daily	|O
for	|O
6	|O
weeks	|O
.	|O

RESULTS	|O
:	|O
For	|O
E1	|O
,	|O
itraconazole	|O
plasma	|O
drug	|O
concentration	|O
extrapolated	|O
to	|O
time	|O
zero	|O
(	|O
IV	|O
dose	|O
)	|O
was	|O
5.2	|O
+	|O
/	|O
-	|O
1.4	|O
micrograms	|O
/	|O
ml	|O
,	|O
and	|O
mean	|O
residence	|O
time	|O
(	|O
MRT	|O
)	|O
was	|O
37	|O
+	|O
/	|O
-	|O
16	|O
hours	|O
.	|O

The	|O
human	|O
U4	|B-PROTEIN
/	|O
U6	|B-PROTEIN
snRNP	|O
contains	|O
60	|O
and	|O
90kD	|O
proteins	|O
that	|O
are	|O
structurally	|O
homologous	|O
to	|O
the	|O
yeast	|O
splicing	|O
factors	|O
Prp4p	|B-PROTEIN
and	|O
Prp3p	|B-PROTEIN
.	|O

G	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
was	|O
started	|O
on	|O
day	|O
3	|O
of	|O
each	|O
cycle	|O
(	|O
5	|O
microg	|O
/	|O
kg	|O
/	|O
day	|O
)	|O
and	|O
was	|O
stopped	|O
the	|O
day	|O
before	|O
the	|O
last	|O
apheresis	|O
or	|O
when	|O
absolute	|O
neutrophil	|O
count	|O
was	|O
above	|O
0.5	|O
x	|O
10	|O
(	|O
9	|O
)	|O
/	|O
l	|O
.	|O

The	|O
used	|O
expression	|O
system	|O
could	|O
allow	|O
to	|O
produce	|O
mutated	|O
forms	|O
of	|O
SsEF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
obtained	|O
by	|O
mutagenesis	|O
of	|O
the	|O
corresponding	|O
gene	|O
.	|O

Crosstalk	|O
among	|O
the	|O
pathways	|O
may	|O
explain	|O
how	|O
some	|O
forms	|O
of	|O
stress	|O
can	|O
contribute	|O
to	|O
the	|O
development	|O
of	|O
a	|O
malignancy	|O
.	|O

Supershift	|O
assays	|O
,	|O
using	|O
Jun	|B-PROTEIN
and	|I-PROTEIN
Fos	|I-PROTEIN
family	|I-PROTEIN
member	|I-PROTEIN
-	|I-PROTEIN
specific	|I-PROTEIN
antibodies	|I-PROTEIN
,	|O
showed	|O
that	|O
protein	|O
complexes	|O
formed	|O
by	|O
AtT	|O
-	|O
20	|O
cell	|O
nuclear	|O
extracts	|O
bound	|O
to	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
jun	|I-PROTEIN
AP	|O
-	|O
1	|O
site	|O
were	|O
comprised	|O
of	|O
Jun	|B-PROTEIN
family	|O
members	|O
,	|O
JunD	|B-PROTEIN
,	|O
JunB	|B-PROTEIN
,	|O
and	|O
cJun	|B-PROTEIN
.	|O

The	|O
majority	|O
of	|O
PI	|B-PROTEIN
kinase	|I-PROTEIN
activity	|O
appeared	|O
to	|O
be	|O
cbl	|B-PROTEIN
-	|O
associated	|O
after	|O
PRL	|B-PROTEIN
stimulation	|O
.	|O

Mutation	|O
of	|O
Enh4	|B-PROTEIN
,	|O
an	|O
essential	|O
GT	|B-PROTEIN
-	|I-PROTEIN
IIC	|I-PROTEIN
-	|O
like	|O
enhanson	|O
in	|O
the	|O
context	|O
of	|O
the	|O
intact	|O
enhancer	|O
,	|O
abolishes	|O
silencer	|O
activity	|O
,	|O
and	|O
multimerized	|O
GT	|B-PROTEIN
-	|I-PROTEIN
IIC	|I-PROTEIN
enhansons	|O
mimic	|O
the	|O
intact	|O
CSEn	|B-PROTEIN
enhancer	|O
/	|O
silencer	|O
activities	|O
in	|O
BeWo	|O
and	|O
GC	|O
cells	|O
,	|O
respectively	|O
.	|O

Using	|O
lectin	|B-PROTEIN
-	|O
affinity	|O
chromatography	|O
,	|O
discordance	|O
between	|O
the	|O
pattern	|O
of	|O
O	|O
-	|O
glycosylation	|O
of	|O
SSBP	|B-PROTEIN
and	|O
DSBP	|B-PROTEIN
was	|O
demonstrated	|O
.	|O

Deletion	|O
mapping	|O
experiments	|O
determined	|O
that	|O
the	|O
sequences	|O
required	|O
for	|O
full	|O
activity	|O
in	|O
MSC	|O
-	|O
1	|O
cells	|O
were	|O
included	|O
within	|O
619	|O
bp	|O
of	|O
the	|O
start	|O
site	|O
and	|O
identified	|O
several	|O
regions	|O
that	|O
demonstrated	|O
increased	|O
luciferase	|B-PROTEIN
activity	|O
:	|O
the	|O
-	|O
583	|O
bp	|O
to	|O
-	|O
564	|O
bp	|O
,	|O
-	|O
503	|O
bp	|O
to	|O
-	|O
484	|O
bp	|O
,	|O
and	|O
-	|O
114	|O
bp	|O
to	|O
-	|O
65	|O
regions	|O
.	|O

Furthermore	|O
,	|O
the	|O
PH	|B-PROTEIN
and	|O
PTB	|O
domains	|O
are	|O
highly	|O
homologous	|O
(	|O
at	|O
least	|O
40%	|O
identical	|O
)	|O
to	|O
those	|O
found	|O
in	|O
insulin	|B-PROTEIN
receptor	|I-PROTEIN
substrates	|I-PROTEIN
1	|I-PROTEIN
,	|I-PROTEIN
2	|I-PROTEIN
,	|I-PROTEIN
and	|I-PROTEIN
3	|I-PROTEIN
(	|O
IRS	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
IRS	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
,	|O
and	|O
IRS	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
)	|O
.	|O

The	|O
mouse	|O
extracellular	|B-PROTEIN
signal	|I-PROTEIN
-	|I-PROTEIN
regulated	|I-PROTEIN
kinase	|I-PROTEIN
2	|I-PROTEIN
gene	|O
.	|O

As	|O
demonstrated	|O
by	|O
gel	|O
mobility	|O
shift	|O
analysis	|O
and	|O
supershift	|O
experiments	|O
,	|O
FIRE1	|B-PROTEIN
,	|O
located	|O
between	|O
-	|O
516	|O
and	|O
-	|O
498	|O
,	|O
is	|O
responsible	|O
for	|O
binding	|O
NF	|B-PROTEIN
-	|I-PROTEIN
Y.	|I-PROTEIN

MR	|O
imaging	|O
of	|O
traumatic	|O
head	|O
injuries	|O
using	|O
FLAIR	|O
technique	|O

Gag	|B-PROTEIN
protein	|O
sequence	|O
motifs	|O
of	|O
the	|O
NC	|B-PROTEIN
domain	|O
of	|O
primate	|O
foamy	|O
viruses	|O
assumed	|O
to	|O
be	|O
involved	|O
in	|O
genome	|O
encapsidation	|O
are	|O
not	|O
conserved	|O
in	|O
FeFV	|O
.	|O

Induction	|O
of	|O
B	|O
cell	|O
apoptosis	|O
by	|O
co	|O
-	|O
cross	|O
-	|O
linking	|O
CD23	|B-PROTEIN
and	|O
sIg	|B-PROTEIN
involves	|O
aberrant	|O
regulation	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
and	|O
is	|O
inhibited	|O
by	|O
bcl	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
.	|O

MEASUREMENTS	|O
AND	|O
MAIN	|O
RESULTS	|O
:	|O
Lung	|O
elastance	|O
(	|O
EL	|O
)	|O
and	|O
resistance	|O
(	|O
RL	|O
)	|O
were	|O
calculated	|O
from	|O
measurements	|O
of	|O
airway	|O
pressure	|O
,	|O
esophageal	|O
pressure	|O
,	|O
and	|O
airway	|O
flow	|O
in	|O
five	|O
anesthetized	|O
,	|O
paralyzed	|O
dogs	|O
during	|O
sinusoidal	|O
forcing	|O
at	|O
a	|O
constant	|O
mean	|O
airway	|O
pressure	|O
of	|O
10	|O
cmH2O	|O
in	|O
a	|O
wide	|O
range	|O
of	|O
breathing	|O
frequencies	|O
(	|O
0.2	|O
to	|O
1.0	|O
Hz	|O
in	|O
intervals	|O
of	|O
0.2	|O
)	|O
and	|O
tidal	|O
volumes	|O
(	|O
50	|O
,	|O
100	|O
,	|O
200	|O
,	|O
and	|O
to	|O
300	|O
mL	|O
)	|O
.	|O

Here	|O
,	|O
we	|O
report	|O
theoretical	|O
models	|O
for	|O
the	|O
Gla	|O
and	|O
EGF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
modules	|O
of	|O
human	|O
PS	|B-PROTEIN
constructed	|O
using	|O
prothrombin	|B-PROTEIN
and	|O
factor	|B-PROTEIN
X	|I-PROTEIN
experimental	|O
structures	|O
.	|O

The	|O
Cut9	|B-PROTEIN
subunit	|O
is	|O
likely	|O
to	|O
be	|O
a	|O
target	|O
for	|O
regulating	|O
APC	|B-PROTEIN
/	|O
cyclosome	|O
function	|O
through	|O
protein	|O
-	|O
protein	|O
interactions	|O
and	|O
phosphorylation	|O
.	|O

The	|O
dose	|O
was	|O
50	|O
Gy	|O
/	|O
20	|O
fractions	|O
/	|O
5	|O
weeks	|O
.	|O

Because	|O
the	|O
biosynthetic	|O
pathway	|O
to	|O
the	|O
vacuole	|O
intersects	|O
with	|O
the	|O
endocytic	|O
pathway	|O
,	|O
internalization	|O
of	|O
a	|O
bulk	|O
membrane	|O
endocytic	|O
marker	|O
FM	|O
4-64	|O
was	|O
assayed	|O
in	|O
the	|O
sop	|B-PROTEIN
mutants	|O
.	|O

All	|O
the	|O
women	|O
received	|O
13.5	|O
mg	|O
plain	|O
bupivacaine	|O
via	|O
subarachnoid	|O
injection	|O
at	|O
the	|O
L2	|O
-	|O
3	|O
interspace	|O
.	|O

Far	|O
from	|O
this	|O
being	|O
the	|O
case	|O
,	|O
however	|O
,	|O
the	|O
measurement	|O
of	|O
apo	|B-PROTEIN
B	|I-PROTEIN
has	|O
met	|O
every	|O
reasonable	|O
standard	|O
of	|O
laboratory	|O
precision	|O
and	|O
reliability	|O
to	|O
allow	|O
its	|O
widespread	|O
introduction	|O
in	|O
clinical	|O
laboratories	|O
.	|O

Two	|O
soybean	|O
cDNA	|O
clones	|O
,	|O
SPK	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
and	|O
SPK	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
,	|O
encoding	|O
putative	|O
protein	|O
kinases	|O
were	|O
isolated	|O
and	|O
characterized	|O
.	|O

Genes	|O
belonging	|O
to	|O
the	|O
ras	|B-PROTEIN
superfamily	|O
encode	|O
low	|O
-	|O
molecular	|O
-	|O
weight	|O
GTP	|B-PROTEIN
/	|I-PROTEIN
GDP	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
proteins	|I-PROTEIN
that	|O
are	|O
highly	|O
conserved	|O
in	|O
wide	|O
variety	|O
of	|O
organisms	|O
.	|O

Naltrexone	|O
has	|O
been	|O
recently	|O
approved	|O
by	|O
the	|O
Food	|O
and	|O
Drug	|O
Administration	|O
for	|O
the	|O
treatment	|O
of	|O
alcohol	|O
dependence	|O
.	|O

Ent	|B-PROTEIN
-	|I-PROTEIN
kaurene	|I-PROTEIN
synthase	|I-PROTEIN
from	|O
the	|O
fungus	|O
Phaeosphaeria	|O
sp	|O
.	|O

In	|O
this	|O
report	|O
,	|O
we	|O
identify	|O
and	|O
characterize	|O
two	|O
overlapping	|O
ELL	|B-PROTEIN
functional	|O
domains	|O
that	|O
govern	|O
its	|O
interaction	|O
with	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
II	|I-PROTEIN
and	|O
the	|O
ternary	|O
elongation	|O
complex	|O
.	|O

Eight	|O
induced	|O
cDNA	|O
sequences	|O
were	|O
identified	|O
and	|O
designated	|O
message	|B-PROTEIN
up	|I-PROTEIN
-	|I-PROTEIN
regulated	|I-PROTEIN
during	|I-PROTEIN
death	|I-PROTEIN
(	|O
mud	|O
)	|O
-	|O
1-8	|O
.	|O

The	|O
position	|O
,	|O
transcription	|O
orientation	|O
,	|O
and	|O
imprinted	|O
status	|O
of	|O
the	|O
genes	|O
immediately	|O
flanking	|O
Igf2r	|B-PROTEIN
have	|O
been	|O
assessed	|O
.	|O

Here	|O
,	|O
we	|O
describe	|O
directional	|O
chromosome	|O
walking	|O
studies	|O
starting	|O
from	|O
D8S260	|B-PROTEIN
as	|O
well	|O
as	|O
D8S285	|B-PROTEIN
.	|O

We	|O
describe	|O
a	|O
novel	|O
zinc	|B-PROTEIN
finger	|I-PROTEIN
protein	|I-PROTEIN
,	|O
dsRBP	|B-PROTEIN
-	|I-PROTEIN
ZFa	|I-PROTEIN
,	|O
isolated	|O
by	|O
screening	|O
an	|O
expression	|O
library	|O
with	|O
dsRNA	|O
.	|O

Our	|O
results	|O
indicate	|O
that	|O
the	|O
retroplasmid	|O
reverse	|B-PROTEIN
transcriptase	|I-PROTEIN
is	|O
uniquely	|O
adapted	|O
to	|O
initiate	|O
cDNA	|O
synthesis	|O
by	|O
recognizing	|O
a	|O
3'	|O
CCA	|O
sequence	|O
.	|O

Nasal	|O
absorption	|O
was	|O
rapid	|O
,	|O
nasal	|O
bioavailability	|O
was	|O
43%	|O
,	|O
and	|O
the	|O
iv	|O
and	|O
nasal	|O
elimination	|O
profiles	|O
were	|O
similar	|O
.	|O

Together	|O
,	|O
these	|O
results	|O
suggest	|O
that	|O
EGF	|B-PROTEIN
/	|O
Ras	|B-PROTEIN
/	|O
Raf	|B-PROTEIN
induces	|O
transcription	|O
via	|O
combined	|O
activation	|O
of	|O
ATF3	|B-PROTEIN
/	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
and	|O
a	|O
52	|O
-	|O
kDa	|O
nuclear	|O
factor	|O
,	|O
whereas	|O
JunD	|B-PROTEIN
acts	|O
as	|O
a	|O
repressor	|O
of	|O
this	|O
response	|O
.	|O

Together	|O
,	|O
these	|O
data	|O
support	|O
a	|O
model	|O
in	|O
which	|O
Tax	|B-PROTEIN
anchors	|O
CBP	|B-PROTEIN
to	|O
the	|O
HTLV	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
promoter	|I-PROTEIN
,	|O
with	|O
strong	|O
transcriptional	|O
activation	|O
resulting	|O
from	|O
the	|O
CBP	|B-PROTEIN
-	|O
associated	|O
activities	|O
of	|O
nucleosome	|O
remodeling	|O
and	|O
recruitment	|O
of	|O
the	|O
general	|O
transcription	|O
machinery	|O
.	|O

DNase	|B-PROTEIN
I	|I-PROTEIN
and	|O
1,10	|O
-	|O
phenanthroline	|O
-	|O
copper	|O
footprinting	|O
of	|O
MURA	|B-PROTEIN
-	|O
Mu1	|B-PROTEIN
TIR	|O
complexes	|O
indicate	|O
that	|O
MURA	|B-PROTEIN
binds	|O
to	|O
a	|O
conserved	|O
approximately	|O
32	|O
-	|O
bp	|O
region	|O
in	|O
the	|O
TIR	|O
of	|O
Mu1	|B-PROTEIN
.	|O

Consistent	|O
with	|O
this	|O
model	|O
,	|O
a	|O
synthetic	|O
construct	|O
containing	|O
three	|O
tandem	|O
copies	|O
of	|O
the	|O
native	|O
LDL	|B-PROTEIN
receptor	|I-PROTEIN
SREBP	|O
site	|O
linked	|O
to	|O
a	|O
single	|O
Sp1	|B-PROTEIN
site	|O
was	|O
also	|O
significantly	|O
activated	|O
in	|O
a	|O
buttonhead	|B-PROTEIN
-	|O
independent	|O
fashion	|O
.	|O

Various	|O
assays	|O
demonstrate	|O
promoter	|O
activity	|O
in	|O
this	|O
sequence	|O
that	|O
reproduces	|O
the	|O
normal	|O
control	|O
of	|O
E2F2	|B-PROTEIN
expression	|O
during	|O
a	|O
growth	|O
stimulation	|O
.	|O

In	|O
the	|O
adult	|O
mouse	|O
,	|O
ERR	|B-PROTEIN
alpha	|I-PROTEIN
is	|O
most	|O
highly	|O
expressed	|O
in	|O
kidney	|O
,	|O
heart	|O
,	|O
and	|O
brown	|O
adipocytes	|O
,	|O
tissues	|O
which	|O
preferentially	|O
metabolize	|O
fatty	|O
acids	|O
.	|O

The	|O
MCAD	|B-PROTEIN
nuclear	|I-PROTEIN
receptor	|I-PROTEIN
response	|I-PROTEIN
element	|I-PROTEIN
1	|I-PROTEIN
(	|O
NRRE	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
interacts	|O
in	|O
vitro	|O
with	|O
ERR	|B-PROTEIN
alpha	|I-PROTEIN
expressed	|O
in	|O
COS	|O
-	|O
7	|O
cells	|O
.	|O

Mapping	|O
features	|O
of	|O
HIV	|O
-	|O
1	|O
integrase	|B-PROTEIN
near	|O
selected	|O
sites	|O
on	|O
viral	|O
and	|O
target	|O
DNA	|O
molecules	|O
in	|O
an	|O
active	|O
enzyme	|O
-	|O
DNA	|O
complex	|O
by	|O
photo	|O
-	|O
cross	|O
-	|O
linking	|O
.	|O

Analysis	|O
of	|O
the	|O
5'	|O
flanking	|O
region	|O
of	|O
the	|O
gene	|O
also	|O
revealed	|O
the	|O
presence	|O
of	|O
multiple	|O
TATA	|O
and	|O
CAAT	|O
sequences	|O
.	|O

Analysis	|O
of	|O
the	|O
5'	|O
flanking	|O
region	|O
of	|O
the	|O
gene	|O
also	|O
revealed	|O
the	|O
presence	|O
of	|O
multiple	|O
TATA	|O
and	|O
CAAT	|O
sequences	|O
.	|O

The	|O
complete	|O
response	|O
(	|O
CR	|O
)	|O
rate	|O
was	|O
34%	|O
in	|O
the	|O
CODE	|O
with	|O
rhG	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
group	|O
and	|O
23%	|O
in	|O
the	|O
CODE	|O
alone	|O
group	|O
;	|O
the	|O
median	|O
survival	|O
was	|O
59	|O
and	|O
32	|O
weeks	|O
,	|O
respectively	|O
,	|O
in	|O
these	|O
groups	|O
(	|O
P	|O
=	|O
0.004	|O
)	|O
.	|O

Heterogeneous	|O
nuclear	|O
ribonucleoprotein	|O
A1	|B-PROTEIN
binds	|O
to	|O
the	|O
transcription	|O
-	|O
regulatory	|O
region	|O
of	|O
mouse	|O
hepatitis	|O
virus	|O
RNA	|O
.	|O

The	|O
m7GpppN	|O
cap	|O
structure	|O
of	|O
eukaryotic	|O
mRNA	|O
is	|O
formed	|O
cotranscriptionally	|O
by	|O
the	|O
sequential	|O
action	|O
of	|O
three	|O
enzymes	|O
:	|O
RNA	|B-PROTEIN
triphosphatase	|I-PROTEIN
,	|O
RNA	|B-PROTEIN
guanylyltransferase	|I-PROTEIN
,	|O
and	|O
RNA	|B-PROTEIN
(	|I-PROTEIN
guanine	|I-PROTEIN
-	|I-PROTEIN
7	|I-PROTEIN
)	|I-PROTEIN
-	|I-PROTEIN
methyltransferase	|I-PROTEIN
.	|O

In	|O
the	|O
first	|O
part	|O
of	|O
our	|O
study	|O
,	|O
the	|O
highest	|O
mutagenicity	|O
was	|O
revealed	|O
by	|O
TA98	|O
strain	|O
without	|O
enzymatic	|O
activation	|O
,	|O
suggesting	|O
a	|O
direct	|O
-	|O
acting	|O
mutagenicity	|O
prevalence	|O
in	|O
diesel	|O
particulate	|O
.	|O

The	|O
addition	|O
of	|O
culture	|O
to	|O
the	|O
CC	|O
and	|O
CC	|O
:	|O
SW	|O
by	|O
-	|O
products	|O
resulted	|O
in	|O
pH	|O
values	|O
lower	|O
(	|O
P	|O
<	|O
0.05	|O
)	|O
than	|O
those	|O
without	|O
culture	|O
on	|O
Day	|O
21	|O
,	|O
and	|O
the	|O
15%	|O
carbohydrate	|O
treatment	|O
significantly	|O
reduced	|O
pH	|O
beyond	|O
the	|O
5%	|O
carbohydrate	|O
.	|O

Myocardial	|O
interstitial	|O
edema	|O
is	|O
more	|O
likely	|O
a	|O
potential	|O
mechanism	|O
of	|O
diastolic	|O
dysfunction	|O
after	|O
DC	|O
shocks	|O
.	|O

Two	|O
experiments	|O
(	|O
N	|O
=	|O
20	|O
each	|O
)	|O
were	|O
carried	|O
out	|O
to	|O
explore	|O
the	|O
nature	|O
of	|O
ERP	|O
negativities	|O
in	|O
a	|O
visuospatial	|O
memory	|O
task	|O
and	|O
in	|O
an	|O
auditory	|O
spatial	|O
memory	|O
task	|O
,	|O
respectively	|O
.	|O

Biol.	|O

The	|O
pattern	|O
and	|O
timing	|O
of	|O
CARP	|B-PROTEIN
mRNA	|O
expression	|O
,	|O
including	|O
transient	|O
expression	|O
in	|O
the	|O
tongue	|O
at	|O
14.5	|O
days	|O
p.c	|O
.	|O
,	|O
coincides	|O
with	|O
that	|O
of	|O
Nkx2.5	|B-PROTEIN
/	|O
Csx	|B-PROTEIN
(	|O
a	|O
putative	|O
homolog	|O
of	|O
tinman	|B-PROTEIN
,	|O
the	|O
Drosophila	|O
melanogaster	|O
gene	|O
responsible	|O
for	|O
cardiac	|O
development	|O
)	|O
.	|O

Overexpression	|O
of	|O
CARP	|B-PROTEIN
in	|O
cardiomyocytes	|O
suppresses	|O
cardiac	|O
troponin	|B-PROTEIN
C	|I-PROTEIN
and	|O
atrial	|B-PROTEIN
natriuretic	|I-PROTEIN
factor	|I-PROTEIN
transcription	|O
.	|O

Substrate	|O
specificity	|O
of	|O
the	|O
RNase	|B-PROTEIN
activity	|O
of	|O
yeast	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
III	|I-PROTEIN
.	|O

Electrophoretic	|O
mobility	|O
shift	|O
assays	|O
and	|O
competition	|O
experiments	|O
showed	|O
that	|O
site	|O
A	|O
is	|O
recognized	|O
by	|O
an	|O
NF1	|B-PROTEIN
protein	|O
.	|O

Examination	|O
of	|O
the	|O
MMP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
RE1	|I-PROTEIN
sequence	|O
revealed	|O
an	|O
incomplete	|O
Y	|O
-	|O
box	|O
sequence	|O
(	|O
CTGCTGGGCAAG	|O
)	|O
,	|O
which	|O
specifically	|O
interacted	|O
with	|O
recombinant	|O
YB	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
on	|O
DMS	|O
protection	|O
footprinting	|O
analysis	|O
.	|O

Hence	|O
,	|O
scs32	|B-PROTEIN
only	|O
partially	|O
suppressed	|O
the	|O
ts	|O
phenotype	|O
and	|O
was	|O
unable	|O
to	|O
suppress	|O
the	|O
Ino	|O
-	|O
phenotype	|O
of	|O
rpo26	|B-PROTEIN
-	|I-PROTEIN
31	|I-PROTEIN
.	|O

In	|O
contrast	|O
,	|O
both	|O
Sp1	|B-PROTEIN
and	|O
ETS	|B-PROTEIN
proteins	|O
are	|O
required	|O
to	|O
bring	|O
about	|O
full	|O
promoter	|O
activity	|O
in	|O
the	|O
Surf	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
direction	|O
.	|O

CONCLUSION	|O
:	|O
Patients	|O
wit	|O
clinically	|O
palpable	|O
neck	|O
disease	|O
(	|O
N1	|O
-	|O
3	|O
)	|O
,	|O
histological	|O
evidence	|O
of	|O
metastatic	|O
nodal	|O
disease	|O
,	|O
extracapsular	|O
spread	|O
,	|O
and	|O
three	|O
or	|O
more	|O
positive	|O
lymph	|O
nodes	|O
are	|O
at	|O
greater	|O
risk	|O
of	|O
developing	|O
failure	|O
at	|O
distant	|O
sites	|O
.	|O

We	|O
have	|O
subcloned	|O
into	|O
pBR322	|O
deoxyribonucleic	|O
acid	|O
(	|O
DNA	|O
)	|O
sequences	|O
mapping	|O
either	|O
in	|O
the	|O
coding	|O
region	|O
,	|O
the	|O
5'	|O
spacer	|O
,	|O
or	|O
the	|O
3'	|O
spacer	|O
of	|O
the	|O
H2B	|B-PROTEIN
histone	|O
gene	|O
.	|O

4	|O
.	|O

Area	|O
under	|O
the	|O
drug	|O
concentration	|O
-	|O
time	|O
curves	|O
(	|O
AUC0	|O
-	|O
24	|O
hr	|O
)	|O
for	|O
MTX	|O
were	|O
2379	|O
and	|O
3534	|O
ng	|O
*	|O
hr	|O
/	|O
ml	|O
from	|O
PG	|O
-	|O
2.5%	|O
Azone	|O
and	|O
PG	|O
-	|O
7.5%	|O
Azone	|O
systems	|O
respectively	|O
.	|O

The	|O
combination	|O
of	|O
hydralazine	|O
hydrochloride	|O
and	|O
isosorbide	|O
dinitrate	|O
also	|O
improves	|O
survival	|O
,	|O
but	|O
direct	|O
comparison	|O
of	|O
both	|O
regimens	|O
provided	|O
evidence	|O
for	|O
a	|O
less	|O
favourable	|O
effect	|O
than	|O
that	|O
of	|O
the	|O
ACE	|B-PROTEIN
inhibitors	|O
.	|O

To	|O
address	|O
mechanisms	|O
that	|O
define	|O
interactions	|O
of	|O
Site	|B-PROTEIN
II	|I-PROTEIN
regulatory	|O
factors	|O
with	|O
this	|O
cell	|O
cycle	|O
control	|O
element	|O
,	|O
we	|O
have	|O
investigated	|O
these	|O
determinants	|O
of	|O
transcriptional	|O
regulation	|O
at	|O
the	|O
G1	|O
/	|O
S	|O
phase	|O
transition	|O
in	|O
FDC	|O
-	|O
P1	|O
hematopoietic	|O
progenitor	|O
cells	|O
.	|O

The	|O
goal	|O
of	|O
this	|O
study	|O
was	|O
to	|O
identify	|O
neuronal	|O
cell	|O
cultures	|O
that	|O
express	|O
RC3	|B-PROTEIN
/	|O
neurogranin	|B-PROTEIN
,	|O
to	|O
check	|O
whether	|O
they	|O
are	|O
sensitive	|O
to	|O
T3	|O
,	|O
and	|O
to	|O
examine	|O
the	|O
mechanism	|O
of	|O
regulation	|O
.	|O

There	|O
were	|O
differences	|O
between	|O
males	|O
(	|O
p	|O
<	|O
0.05	|O
)	|O
for	|O
most	|O
of	|O
the	|O
characteristics	|O
studied	|O
.	|O

Their	|O
circadian	|O
responses	|O
to	|O
both	|O
photic	|O
and	|O
non	|O
-	|O
photic	|O
cues	|O
were	|O
then	|O
tested	|O
.	|O

Although	|O
previous	|O
data	|O
have	|O
suggested	|O
that	|O
Rev	|B-PROTEIN
uses	|O
the	|O
same	|O
export	|O
pathway	|O
as	|O
uracil	|O
-	|O
rich	|O
small	|O
nuclear	|O
RNAs	|O
and	|O
5S	|B-PROTEIN
ribosomal	|O
RNA	|O
,	|O
the	|O
CTE	|O
seems	|O
to	|O
interact	|O
with	|O
evolutionarily	|O
conserved	|O
factors	|O
that	|O
are	|O
essential	|O
for	|O
cellular	|O
mRNA	|O
export	|O
.	|O

Human	|O
Duo	|B-PROTEIN
contains	|O
a	|O
guanine	|B-PROTEIN
nucleotide	|I-PROTEIN
exchange	|I-PROTEIN
factor	|I-PROTEIN
(	|O
GEF	|B-PROTEIN
)	|O
domain	|O
that	|O
is	|O
likely	|O
to	|O
be	|O
rac1	|B-PROTEIN
-	|O
specific	|O
,	|O
a	|O
pleckstrin	|B-PROTEIN
homology	|O
(	|O
PH	|B-PROTEIN
)	|O
domain	|O
and	|O
spectrin	|B-PROTEIN
-	|O
like	|O
repeat	|O
units	|O
.	|O

S2F	|B-PROTEIN
,	|O
a	|O
leaf	|O
-	|O
specific	|O
trans	|O
-	|O
acting	|O
factor	|O
,	|O
binds	|O
to	|O
a	|O
novel	|O
cis	|O
-	|O
acting	|O
element	|O
and	|O
differentially	|O
activates	|O
the	|O
RPL21	|B-PROTEIN
gene	|O
.	|O

ArgR	|B-PROTEIN
was	|O
shown	|O
to	|O
be	|O
a	|O
dimer	|O
of	|O
two	|O
equal	|O
subunits	|O
,	|O
each	|O
with	|O
a	|O
molecular	|O
mass	|O
of	|O
37,000	|O
Da	|O
.	|O

Plasma	|O
leptin	|B-PROTEIN
concentrations	|O
were	|O
higher	|O
in	|O
women	|O
than	|O
men	|O
,	|O
even	|O
after	|O
the	|O
adjustment	|O
for	|O
differences	|O
in	|O
fat	|O
mass	|O
(	|O
28	|O
+	|O
/	|O
-	|O
3	|O
ng	|O
/	|O
ml	|O
for	|O
women	|O
vs.	|O

Consistent	|O
with	|O
effects	|O
on	|O
STAT	|B-PROTEIN
activation	|O
,	|O
altered	|O
SHP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
expression	|O
also	|O
affected	|O
EGF	|B-PROTEIN
-	|O
induced	|O
activation	|O
of	|O
the	|O
mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
pathway	|O
;	|O
expression	|O
of	|O
SHP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|O
(	|O
Cys	|O
-	|O
-	|O
>	|O
Ser	|O
)	|O
inhibited	|O
activity	|O
of	|O
MEK	|B-PROTEIN
by	|O
approximately	|O
25%	|O
,	|O
whereas	|O
expression	|O
of	|O
SHP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
resulted	|O
in	|O
a	|O
approximately	|O
25%	|O
increase	|O
.	|O

This	|O
interaction	|O
involved	|O
the	|O
SH3	|B-PROTEIN
region	|O
of	|O
p50	|B-PROTEIN
(	|O
csk	|B-PROTEIN
)	|O
and	|O
a	|O
proline	|O
-	|O
rich	|O
region	|O
(	|O
PPPLPERTPESFVLADM	|O
)	|O
outside	|O
the	|O
catalytic	|O
region	|O
of	|O
PTP	|B-PROTEIN
-	|O
PEST	|O
.	|O

Following	|O
2.5	|O
Gy	|O
,	|O
HbO2	|B-PROTEIN
changes	|O
were	|O
minimal	|O
.	|O

Polarised	|O
expression	|O
of	|O
human	|O
intestinal	|O
N	|B-PROTEIN
-	|I-PROTEIN
benzoyl	|I-PROTEIN
-	|I-PROTEIN
L	|I-PROTEIN
-	|I-PROTEIN
tyrosyl	|I-PROTEIN
-	|I-PROTEIN
p	|I-PROTEIN
-	|I-PROTEIN
aminobenzoic	|I-PROTEIN
acid	|I-PROTEIN
hydrolase	|I-PROTEIN
(	|O
human	|O
meprin	|B-PROTEIN
)	|O
alpha	|O
and	|O
beta	|O
subunits	|O
in	|O
Madin	|O
-	|O
Darby	|O
canine	|O
kidney	|O
cells	|O
.	|O

Neither	|O
mutant	|O
exhibited	|O
derepression	|O
of	|O
the	|O
silent	|B-PROTEIN
mating	|I-PROTEIN
type	|O
loci	|O
.	|O

Among	|O
38	|O
patients	|O
with	|O
inducible	|O
reentrant	|O
VTs	|O
who	|O
underwent	|O
electrophysiologic	|O
study	|O
(	|O
EPS	|O
)	|O
,	|O
10	|O
VTs	|O
of	|O
six	|O
patients	|O
were	|O
selected	|O
.	|O

The	|O
cycle	|O
length	|O
of	|O
induced	|O
VT	|O
(	|O
n	|O
=	|O
10	|O
VTs	|O
)	|O
was	|O
380	|O
+	|O
/	|O
-	|O
41	|O
msec	|O
.	|O

Transient	|O
hyperammonaemia	|O
in	|O
an	|O
adult	|O
German	|O
shepherd	|O
dog	|O
.	|O

We	|O
established	|O
that	|O
the	|O
2.6	|O
kb	|O
mRNA	|O
V	|O
-	|O
1	|O
and	|O
the	|O
2.3	|O
kb	|O
GGT	|B-PROTEIN
mRNA	|O
V	|O
-	|O
2	|O
derive	|O
,	|O
by	|O
alternate	|O
splicing	|O
,	|O
from	|O
a	|O
primary	|O
transcript	|O
initiated	|O
on	|O
a	|O
distal	|O
promoter	|O
on	|O
the	|O
rat	|O
GGT	|B-PROTEIN
gene	|O
.	|O

A	|O
specific	|O
distal	|O
promoter	|O
controls	|O
gamma	|B-PROTEIN
-	|I-PROTEIN
glutamyl	|I-PROTEIN
transpeptidase	|I-PROTEIN
gene	|O
expression	|O
in	|O
undifferentiated	|O
rat	|O
transformed	|O
liver	|O
cells	|O
.	|O

These	|O
repressor	|O
sites	|O
are	|O
pyrimidine	|O
rich	|O
and	|O
bind	|O
avidly	|O
to	|O
the	|O
polypyrimidine	|B-PROTEIN
tract	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
(	|O
PTB	|B-PROTEIN
)	|O
in	|O
HeLa	|O
nuclear	|O
extracts	|O
as	|O
determined	|O
by	|O
UV	|O
crosslinking	|O
/	|O
competition	|O
assays	|O
.	|O

For	|O
higher	|O
expression	|O
of	|O
lipA	|B-PROTEIN
in	|O
S.	|O
lividans	|O
,	|O
the	|O
gene	|O
was	|O
cloned	|O
next	|O
to	|O
the	|O
strong	|O
aphII	|B-PROTEIN
promoter	|O
.	|O

Within	|O
a	|O
135	|O
-	|O
bp	|O
core	|O
homology	|O
region	|O
,	|O
the	|O
human	|O
HS12	|B-PROTEIN
enhancers	|O
are	|O
approximately	|O
90%	|O
identical	|O
to	|O
the	|O
murine	|O
homolog	|O
and	|O
include	|O
several	|O
motifs	|O
previously	|O
demonstrated	|O
to	|O
be	|O
important	|O
for	|O
function	|O
of	|O
the	|O
murine	|O
enhancer	|O
;	|O
additional	|O
segments	|O
of	|O
high	|O
sequence	|O
conservation	|O
suggest	|O
the	|O
possibility	|O
of	|O
previously	|O
unrecognized	|O
functional	|O
motifs	|O
.	|O

In	|O
contrast	|O
to	|O
the	|O
wild	|O
-	|O
type	|O
protein	|O
,	|O
expression	|O
of	|O
p45	|B-PROTEIN
NF	|O
-	|O
E2	|O
lacking	|O
this	|O
activation	|O
domain	|O
in	|O
an	|O
NF	|B-PROTEIN
-	|I-PROTEIN
E2	|I-PROTEIN
null	|O
cell	|O
line	|O
fails	|O
to	|O
support	|O
enhancer	|O
-	|O
dependent	|O
transcription	|O
in	|O
transient	|O
assays	|O
.	|O

These	|O
findings	|O
suggest	|O
one	|O
potential	|O
mechanism	|O
for	|O
direct	|O
recruitment	|O
of	|O
distal	|O
regulatory	|O
regions	|O
of	|O
the	|O
globin	|B-PROTEIN
loci	|O
to	|O
the	|O
individual	|O
promoters	|O
.	|O

The	|O
promoter	|O
region	|O
showed	|O
no	|O
consensus	|O
TATA	|O
box	|O
but	|O
it	|O
contains	|O
CCAAT	|O
and	|O
CreA	|B-PROTEIN
boxes	|O
known	|O
to	|O
be	|O
involved	|O
in	|O
both	|O
stress	|O
and	|O
carbon	|O
-	|O
catabolite	|O
regulation	|O
of	|O
fungal	|O
promoters	|O
.	|O

The	|O
two	|O
cysteine	|O
residues	|O
located	|O
in	|O
this	|O
additional	|O
region	|O
may	|O
be	|O
involved	|O
in	|O
the	|O
formation	|O
of	|O
a	|O
disulfide	|O
bridge	|O
associated	|O
with	|O
the	|O
activation	|O
process	|O
of	|O
the	|O
catalytic	|O
activity	|O
.	|O

The	|O
por	|B-PROTEIN
gene	|O
has	|O
been	|O
expressed	|O
,	|O
for	|O
the	|O
first	|O
time	|O
,	|O
in	|O
anaerobically	|O
grown	|O
Escherichia	|O
coli	|O
behind	|O
the	|O
isopropyl	|O
-	|O
beta	|O
-	|O
D	|O
-	|O
thiogalactopyranoside	|O
-	|O
inducible	|O
tac	|B-PROTEIN
promoter	|O
,	|O
resulting	|O
in	|O
the	|O
production	|O
of	|O
POR	|B-PROTEIN
in	|O
its	|O
active	|O
form	|O
.	|O

When	|O
the	|O
downstream	|O
operator	|O
was	|O
altered	|O
,	|O
there	|O
was	|O
a	|O
fourfold	|O
reduction	|O
in	|O
reporter	|O
enzyme	|O
levels	|O
.	|O

The	|O
ORF3	|O
mutant	|O
produced	|O
reduced	|O
levels	|O
of	|O
tabtoxin	|B-PROTEIN
,	|O
indicating	|O
that	|O
ORF3	|O
may	|O
have	|O
a	|O
role	|O
in	|O
T	|B-PROTEIN
beta	|I-PROTEIN
L	|I-PROTEIN
biosynthesis	|O
.	|O

Refined	|O
Cox	|O
models	|O
using	|O
a	|O
CD4	|B-PROTEIN
count	|O
of	|O
150	|O
/	|O
microL	|O
rather	|O
than	|O
200	|O
/	|O
microL	|O
to	|O
distinguish	|O
I0	|O
and	|O
I1	|O
yielded	|O
a	|O
simplified	|O
model	|O
with	|O
better	|O
fit	|O
to	|O
the	|O
observed	|O
data	|O
.	|O

However	|O
,	|O
the	|O
published	|O
reports	|O
consist	|O
of	|O
a	|O
small	|O
number	|O
of	|O
patients	|O
and	|O
limited	|O
data	|O
.	|O

These	|O
transcripts	|O
contain	|O
the	|O
5'	|O
ends	|O
of	|O
mature	|O
UbCRBP	|B-PROTEIN
mRNAs	|O
;	|O
extend	|O
through	|O
UbCRBP	|B-PROTEIN
,	|O
across	|O
the	|O
intergenic	|O
region	|O
,	|O
and	|O
a	|O
significant	|O
distance	|O
3'	|O
into	|O
the	|O
enolase	|B-PROTEIN
gene	|O
.	|O

The	|O
distribution	|O
of	|O
cryptosporidia	|O
in	|O
the	|O
intestine	|O
and	|O
number	|O
of	|O
cryptosporidia	|O
per	|O
ileal	|O
villus	|O
on	|O
different	|O
DPI	|O
were	|O
also	|O
estimated	|O
for	|O
detailed	|O
characterization	|O
of	|O
the	|O
infection	|O
in	|O
kids	|O
as	|O
a	|O
model	|O
for	|O
experimental	|O
cryptosporidiosis	|O
.	|O

As	|O
a	|O
result	|O
,	|O
the	|O
subendocardial	|O
/	|O
subepicardial	|O
blood	|O
flow	|O
ratio	|O
(	|O
ENDO	|O
/	|O
EPI	|O
)	|O
increased	|O
from	|O
0.44	|O
+	|O
/	|O
-	|O
0.09	|O
during	|O
control	|O
stenosis	|O
to	|O
0.85	|O
+	|O
/	|O
-	|O
0.13	|O
after	|O
ITF	|O
1129	|O
(	|O
10	|O
micrograms	|O
/	|O
kg	|O
/	|O
min	|O
i.v	|O
.	|O
)	|O
and	|O
to	|O
0.81	|O
+	|O
/	|O
-	|O
0.12	|O
after	|O
NTG	|O
.	|O

Proteasomes	|O
are	|O
the	|O
multisubunit	|O
protease	|O
involved	|O
in	|O
the	|O
generation	|O
of	|O
peptides	|O
presented	|O
by	|O
MHC	|B-PROTEIN
class	|I-PROTEIN
I	|I-PROTEIN
molecules	|O
.	|O

In	|O
support	|O
of	|O
this	|O
interpretation	|O
we	|O
demonstrate	|O
that	|O
MQ9b	|B-PROTEIN
binds	|O
strongly	|O
5	|O
of	|O
17	|O
motif	|O
-	|O
positive	|O
,	|O
pathogen	|O
-	|O
derived	|O
synthetic	|O
peptides	|O
.	|O

Takahashi	|O
,	|O
H.	|O

For	|O
sputum	|O
interleukin	|B-PROTEIN
-	|I-PROTEIN
8	|I-PROTEIN
there	|O
was	|O
an	|O
estimated	|O
true	|O
treatment	|O
median	|O
difference	|O
of	|O
142	|O
pg	|O
/	|O
ml	|O
(	|O
95%	|O
confidence	|O
interval	|O
(	|O
CI	|O
)	|O
8	|O
to	|O
2866	|O
pg	|O
/	|O
ml	|O
)	|O
in	|O
favour	|O
of	|O
placebo	|O
;	|O
while	|O
for	|O
maximal	|O
expiratory	|O
flow	|O
at	|O
25%	|O
(	|O
MEF25	|O
%	|O
)	|O
remaining	|O
forced	|O
vital	|O
capacity	|O
predicted	|O
for	|O
sex	|O
and	|O
height	|O
there	|O
was	|O
a	|O
15	|O
percentage	|O
points	|O
(	|O
pp	|O
)	|O
(	|O
95%	|O
CI	|O
4	|O
to	|O
26	|O
pp	|O
)	|O
mean	|O
treatment	|O
difference	|O
in	|O
favour	|O
of	|O
placebo	|O
.	|O

However	|O
,	|O
although	|O
deletion	|O
of	|O
Fp1	|B-PROTEIN
in	|O
the	|O
hCRBP1	|B-PROTEIN
gene	|O
yielded	|O
increased	|O
CAT	|B-PROTEIN
activity	|O
,	|O
pointing	|O
toward	|O
a	|O
negative	|O
regulatory	|O
function	|O
exerted	|O
by	|O
this	|O
element	|O
,	|O
its	|O
insertion	|O
upstream	|O
of	|O
the	|O
p12	|B-PROTEIN
basal	|O
promoter	|O
results	|O
in	|O
an	|O
impressive	|O
positive	|O
stimulation	|O
of	|O
CAT	|B-PROTEIN
gene	|O
expression	|O
.	|O

Gaucher	|O
's	|O
disease	|O
is	|O
a	|O
rare	|O
metabolic	|O
disorder	|O
characterized	|O
by	|O
the	|O
lack	|O
of	|O
beta	|B-PROTEIN
-	|I-PROTEIN
glucocerebrosidase	|I-PROTEIN
enzyme	|O
.	|O

These	|O
discoloration	|O
's	|O
can	|O
be	|O
treated	|O
in	|O
several	|O
ways	|O
but	|O
up	|O
to	|O
lately	|O
tooth	|O
structure	|O
had	|O
to	|O
be	|O
removed	|O
in	|O
an	|O
irreversible	|O
manner	|O
in	|O
order	|O
to	|O
provide	|O
sufficient	|O
bulk	|O
for	|O
the	|O
new	|O
restorative	|O
material	|O
.	|O

The	|O
9	|O
;	|O
22	|O
chromosomal	|O
translocation	|O
characteristic	|O
of	|O
CML	|O
results	|O
in	|O
a	|O
fused	|O
bcr	|B-PROTEIN
/	|O
abl	|B-PROTEIN
gene	|O
and	|O
an	|O
abnormal	|O
fusion	|O
protein	|O
,	|O
p210bcr	|B-PROTEIN
/	|O
abl	|B-PROTEIN
.	|O

Overexpression	|O
of	|O
BAG	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
also	|O
protected	|O
certain	|O
cell	|O
lines	|O
from	|O
heat	|O
shock	|O
-	|O
induced	|O
cell	|O
death	|O
.	|O

The	|O
5'	|O
flanking	|O
region	|O
contains	|O
potential	|O
binding	|O
sites	|O
for	|O
TATA	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
,	|O
Sp1	|B-PROTEIN
,	|O
nuclear	|B-PROTEIN
factor	|I-PROTEIN
1	|I-PROTEIN
(	|O
NF1	|B-PROTEIN
)	|O
,	|O
CAAT	|B-PROTEIN
-	|I-PROTEIN
box	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
(	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
)	|O
,	|O
hepatocyte	|B-PROTEIN
nuclear	|I-PROTEIN
factors	|I-PROTEIN
1	|I-PROTEIN
and	|I-PROTEIN
5	|I-PROTEIN
(	|O
HNF1	|B-PROTEIN
,	|O
HNF5	|B-PROTEIN
)	|O
and	|O
activator	|B-PROTEIN
proteins	|I-PROTEIN
1	|I-PROTEIN
and	|I-PROTEIN
2	|I-PROTEIN
(	|O
AP1	|B-PROTEIN
,	|O
AP2	|B-PROTEIN
)	|O
.	|O

The	|O
recognition	|O
specificity	|O
of	|O
the	|O
p55	|B-PROTEIN
PDZ	|O
domain	|O
appears	|O
to	|O
be	|O
unique	|O
,	|O
since	|O
the	|O
three	|O
PDZ	|B-PROTEIN
domains	|O
of	|O
hDlg	|B-PROTEIN
(	|O
human	|O
lymphocyte	|O
homologue	|O
of	|O
the	|O
Drosophila	|O
discs	|O
large	|B-PROTEIN
tumor	|I-PROTEIN
suppressor	|I-PROTEIN
)	|O
do	|O
not	|O
bind	|O
the	|O
cytoplasmic	|O
domain	|O
of	|O
glycophorin	|B-PROTEIN
C.	|I-PROTEIN

By	|O
analyzing	|O
the	|O
RanGAP	|B-PROTEIN
activity	|O
of	|O
a	|O
series	|O
of	|O
recombinantly	|O
expressed	|O
rna1p	|B-PROTEIN
mutant	|O
derivatives	|O
,	|O
we	|O
show	|O
that	|O
the	|O
highly	|O
acidic	|O
sequence	|O
in	|O
the	|O
C	|O
-	|O
terminal	|O
domain	|O
of	|O
both	|O
yeast	|O
proteins	|O
is	|O
indispensable	|O
for	|O
activating	|O
Ran	|B-PROTEIN
-	|O
mediated	|O
GTP	|O
hydrolysis	|O
.	|O

In	|O
the	|O
absence	|O
of	|O
MHC	|B-PROTEIN
class	|I-PROTEIN
II	|I-PROTEIN
,	|O
purified	|O
soluble	|O
D10	|B-PROTEIN
TCR	|I-PROTEIN
bound	|O
to	|O
Staphylococcus	|O
aureus	|O
enterotoxin	|O
C2	|B-PROTEIN
with	|O
an	|O
association	|O
rate	|O
of	|O
1.69	|O
+	|O
/	|O
-	|O
0.12	|O
x	|O
10	|O
(	|O
4	|O
)	|O
M	|O
(	|O
-	|O
1	|O
)	|O
sec	|O
(	|O
-	|O
1	|O
)	|O
and	|O
a	|O
dissociation	|O
rate	|O
of	|O
1.9	|O
+	|O
/	|O
-	|O
0.47	|O
x	|O
10	|O
(	|O
-	|O
2	|O
)	|O
sec	|O
(	|O
-	|O
1	|O
)	|O
,	|O
giving	|O
a	|O
dissociation	|O
constant	|O
of	|O
1.1	|O
microM	|O
.	|O

Evidence	|O
for	|O
such	|O
peak	|O
shifts	|O
has	|O
been	|O
found	|O
in	|O
the	|O
responses	|O
of	|O
auditory	|O
nerve	|O
fibers	|O
,	|O
cochlear	|O
microphonics	|O
,	|O
and	|O
the	|O
responses	|O
of	|O
outer	|O
hair	|O
cells	|O
and	|O
supporting	|O
cells	|O
in	|O
the	|O
cochlea	|O
,	|O
as	|O
well	|O
as	|O
in	|O
basilar	|O
membrane	|O
vibration	|O
measurements	|O
,	|O
and	|O
indirectly	|O
,	|O
in	|O
psychophysical	|O
data	|O
.	|O

Mnt	|B-PROTEIN
:	|O
Max	|B-PROTEIN
complexes	|O
also	|O
efficiently	|O
suppress	|O
Myc	|B-PROTEIN
-	|O
dependent	|O
activation	|O
from	|O
the	|O
same	|O
promoter	|O
.	|O

In	|O
the	|O
United	|O
States	|O
high	|O
-	|O
MW	|O
HES	|O
480	|O
which	|O
is	|O
difficult	|O
to	|O
degrade	|O
is	|O
most	|O
frequently	|O
used	|O
and	|O
results	|O
in	|O
a	|O
larger	|O
in	|O
vivo	|O
MW	|O
and	|O
subsequent	|O
decrease	|O
in	|O
factor	|B-PROTEIN
VIII	|I-PROTEIN
/	|O
von	|B-PROTEIN
Willebrand	|I-PROTEIN
factor	|I-PROTEIN
levels	|O
.	|O

Assays	|O
of	|O
total	|O
cholesterol	|O
as	|O
well	|O
as	|O
the	|O
HDL	|B-PROTEIN
,	|O
HDL2	|B-PROTEIN
,	|O
LDL	|B-PROTEIN
,	|O
triglycerides	|O
,	|O
endothelin	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
lipoprotein	|B-PROTEIN
(	|I-PROTEIN
a	|I-PROTEIN
)	|I-PROTEIN
,	|O
estradiol	|O
and	|O
FSH	|B-PROTEIN
were	|O
also	|O
obtained	|O
at	|O
baseline	|O
before	|O
receiving	|O
ERT	|O
and	|O
after	|O
3	|O
months	|O
of	|O
ERT	|O
.	|O

Six	|O
tandem	|O
repeats	|O
of	|O
the	|O
P	|B-PROTEIN
element	|I-PROTEIN
linked	|O
to	|O
the	|O
SV40	|B-PROTEIN
promoter	|I-PROTEIN
responded	|O
to	|O
phorbol	|O
12	|O
-	|O
myristate	|O
13	|O
-	|O
acetate	|O
,	|O
while	|O
that	|O
of	|O
other	|O
elements	|O
did	|O
not	|O
.	|O

The	|O
distributed	|O
current	|O
density	|O
J	|O
is	|O
calculated	|O
within	|O
the	|O
volume	|O
defined	|O
by	|O
the	|O
motor	|O
unit	|O
.	|O

The	|O
cleavage	|O
dipeptides	|O
of	|O
C1YVV	|O
NIa	|B-PROTEIN
protease	|I-PROTEIN
are	|O
Q	|O
(	|O
E	|O
)	|O
/	|O
S	|O
(	|O
A	|O
,	|O
G	|O
)	|O
.	|O

In	|O
our	|O
previous	|O
studies	|O
,	|O
transcriptional	|O
activation	|O
was	|O
shown	|O
to	|O
correlate	|O
with	|O
IEP86	|B-PROTEIN
binding	|O
to	|O
both	|O
the	|O
TATA	|B-PROTEIN
-	|I-PROTEIN
box	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
(	|O
TBP	|B-PROTEIN
)	|O
and	|O
the	|O
transcription	|O
factor	|O
bound	|O
upstream	|O
.	|O

However	|O
,	|O
we	|O
were	|O
unable	|O
to	|O
identify	|O
a	|O
p4	|B-PROTEIN
molecule	|O
.	|O

(	|O
iv	|O
)	|O
The	|O
accumulation	|O
of	|O
cyclin	|B-PROTEIN
D3	|I-PROTEIN
protein	|O
in	|O
Vero	|O
cells	|O
infected	|O
with	|O
an	|O
alpha0	|B-PROTEIN
deletion	|O
mutant	|O
was	|O
reduced	|O
relative	|O
to	|O
that	|O
of	|O
cells	|O
infected	|O
with	|O
wild	|O
-	|O
type	|O
virus	|O
or	|O
a	|O
recombinant	|O
virus	|O
in	|O
which	|O
the	|O
deleted	|O
alpha0	|B-PROTEIN
sequences	|O
were	|O
restored	|O
.	|O

We	|O
report	|O
the	|O
preliminary	|O
biochemical	|O
characterization	|O
of	|O
the	|O
T	|B-PROTEIN
antigens	|I-PROTEIN
encoded	|O
by	|O
three	|O
SV40	|O
mutants	|O
,	|O
5030	|O
,	|O
5031	|O
,	|O
and	|O
5061	|O
,	|O
each	|O
of	|O
which	|O
have	|O
altered	|O
residues	|O
within	|O
or	|O
near	|O
the	|O
ATP	|O
binding	|O
pocket	|O
.	|O

These	|O
effects	|O
were	|O
abrogated	|O
by	|O
co	|O
-	|O
expression	|O
of	|O
kinase	|O
-	|O
deficient	|O
PKC	|B-PROTEIN
zeta	|I-PROTEIN
and	|O
inhibition	|O
of	|O
phosphatidylinositol	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
p85alpha	|O
-	|O
p110	|B-PROTEIN
by	|O
wortmannin	|O
,	|O
LY294002	|O
and	|O
a	|O
dominant	|O
-	|O
negative	|O
mutant	|O
of	|O
p85alpha	|B-PROTEIN
.	|O

Protein	|B-PROTEIN
phosphatase	|I-PROTEIN
2A	|I-PROTEIN
is	|O
a	|O
critical	|O
regulator	|O
of	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
C	|I-PROTEIN
zeta	|I-PROTEIN
signaling	|O
targeted	|O
by	|O
SV40	|B-PROTEIN
small	|I-PROTEIN
t	|I-PROTEIN
to	|O
promote	|O
cell	|O
growth	|O
and	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
activation	|O
.	|O

Interestingly	|O
,	|O
the	|O
RXRalphaF318A	|B-PROTEIN
constitutive	|O
activity	|O
generated	|O
within	|O
heterodimers	|O
in	|O
the	|O
presence	|O
of	|O
BMS614	|O
requires	|O
the	|O
integrity	|O
of	|O
both	|O
RXR	|B-PROTEIN
and	|O
RAR	|B-PROTEIN
AF	|O
-	|O
2	|O
domains	|O
.	|O

These	|O
introns	|O
contain	|O
only	|O
single	|O
snoRNA	|B-PROTEIN
genes	|I-PROTEIN
and	|O
their	|O
processing	|O
involves	|O
exonucleolytic	|O
release	|O
of	|O
the	|O
snoRNA	|O
from	|O
debranched	|O
intron	|O
lariats	|O
.	|O

Recent	|O
studies	|O
have	|O
shown	|O
that	|O
the	|O
Src	|B-PROTEIN
homology	|O
-	|O
2	|O
(	|O
SH2	|B-PROTEIN
)	|O
domain	|O
-	|O
containing	|O
protein	|B-PROTEIN
-	|I-PROTEIN
tyrosine	|I-PROTEIN
phosphatase	|I-PROTEIN
,	|O
SHP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
,	|O
associates	|O
with	|O
the	|O
cytoplasmic	|O
domain	|O
of	|O
PECAM	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
as	|O
it	|O
becomes	|O
tyrosine	|O
-	|O
phosphorylated	|O
during	|O
platelet	|O
aggregation	|O
:	|O
a	|O
process	|O
that	|O
can	|O
be	|O
mimicked	|O
in	|O
part	|O
by	|O
small	|O
synthetic	|O
phosphopeptides	|O
corresponding	|O
to	|O
the	|O
cytoplasmic	|O
domain	|O
of	|O
PECAM	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
encompassing	|O
tyrosine	|O
residues	|O
Tyr	|O
-	|O
663	|O
or	|O
Tyr	|O
-	|O
686	|O
.	|O

Underlying	|O
the	|O
clustering	|O
of	|O
these	|O
risk	|O
variables	|O
were	|O
three	|O
factors	|O
.	|O

Supplementation	|O
was	|O
stopped	|O
when	|O
pl	|O
-	|O
ALB	|B-PROTEIN
reached	|O
2.0	|O
g	|O
/	|O
dL	|O
.	|O

Detection	|O
of	|O
airborne	|O
Mycobacterium	|O
tuberculosis	|O
by	|O
air	|O
filtration	|O
and	|O
polymerase	|O
chain	|O
reaction	|O
.	|O

These	|O
findings	|O
show	|O
that	|O
EBP50	|B-PROTEIN
is	|O
a	|O
physiologically	|O
relevant	|O
ezrin	|B-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
.	|O

Previously	|O
,	|O
we	|O
reported	|O
that	|O
scanthrough	|O
translation	|O
,	|O
where	|O
the	|O
initiating	|O
AUG	|O
of	|O
a	|O
primary	|O
open	|O
reading	|O
frame	|O
is	|O
bypassed	|O
,	|O
is	|O
most	|O
likely	|O
to	|O
account	|O
for	|O
the	|O
presentation	|O
of	|O
cryptic	|O
epitopes	|O
from	|O
alternative	|O
reading	|O
frames	|O
within	|O
the	|O
influenza	|O
A	|O
PR	|B-PROTEIN
/	|I-PROTEIN
8/34	|I-PROTEIN
nucleoprotein	|O
gene	|O
.	|O

This	|O
family	|O
of	|O
proteins	|O
binds	|O
GC	|O
-	|O
rich	|O
motifs	|O
widely	|O
distributed	|O
in	|O
gene	|O
promoters	|O
,	|O
resulting	|O
in	|O
distinct	|O
activation	|O
or	|O
repression	|O
of	|O
transcriptional	|O
activities	|O
.	|O

Deletion	|O
of	|O
the	|O
POR2	|B-PROTEIN
gene	|O
alone	|O
had	|O
no	|O
detectable	|O
phenotype	|O
,	|O
while	|O
yeasts	|O
with	|O
deletions	|O
of	|O
both	|O
the	|O
POR1	|B-PROTEIN
and	|O
POR2	|B-PROTEIN
genes	|O
were	|O
viable	|O
and	|O
able	|O
to	|O
grow	|O
on	|O
glycerol	|O
at	|O
30	|O
degrees	|O
C	|O
,	|O
albeit	|O
more	|O
slowly	|O
than	|O
delta	|O
por1	|B-PROTEIN
single	|O
mutants	|O
.	|O

Furthermore	|O
,	|O
our	|O
novel	|O
observation	|O
that	|O
expression	|O
of	|O
a	|O
highly	|O
activated	|O
FGFR3	|B-PROTEIN
kinase	|O
domain	|O
is	|O
able	|O
to	|O
morphologically	|O
transform	|O
fibroblasts	|O
suggests	|O
that	|O
dysregulation	|O
of	|O
FGFR3	|B-PROTEIN
has	|O
the	|O
potential	|O
to	|O
play	|O
a	|O
role	|O
in	|O
human	|O
neoplasia	|O
.	|O

The	|O
deduced	|O
amino	|O
acid	|O
sequence	|O
of	|O
the	|O
gene	|O
has	|O
significant	|O
homology	|O
to	|O
the	|O
interferon	|B-PROTEIN
regulatory	|I-PROTEIN
factors	|I-PROTEIN
(	|O
IRFs	|B-PROTEIN
)	|O
.	|O

Involvement	|O
of	|O
AP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
in	|O
regulation	|O
of	|O
the	|O
R	|B-PROTEIN
-	|I-PROTEIN
FABP	|I-PROTEIN
gene	|O
in	|O
the	|O
developing	|O
chick	|O
retina	|O
.	|O

However	|O
,	|O
Cbf5p	|B-PROTEIN
was	|O
found	|O
to	|O
be	|O
nucleolar	|O
and	|O
is	|O
highly	|O
homologous	|O
to	|O
the	|O
rat	|O
nucleolar	|O
protein	|O
NAP57	|B-PROTEIN
,	|O
which	|O
coimmunoprecipitates	|O
with	|O
Nopp140	|B-PROTEIN
and	|O
which	|O
is	|O
postulated	|O
to	|O
be	|O
involved	|O
in	|O
nucleolar	|O
-	|O
cytoplasmic	|O
shuttling	|O
(	|O
U.	|O

This	|O
newly	|O
described	|O
organism	|O
was	|O
difficult	|O
to	|O
identify	|O
due	|O
to	|O
discrepancies	|O
between	|O
the	|O
Vitek	|O
and	|O
API	|O
20E	|O
identification	|O
systems	|O
.	|O

Ig	|B-PROTEIN
heavy	|I-PROTEIN
chain	|I-PROTEIN
class	|O
switching	|O
is	|O
directed	|O
by	|O
cytokines	|O
inducing	|O
transcription	|O
from	|O
unrearranged	|O
CH	|B-PROTEIN
genes	|O
.	|O

The	|O
available	|O
data	|O
suggest	|O
that	|O
the	|O
NF	|B-PROTEIN
kappa	|I-PROTEIN
B2	|I-PROTEIN
nucleoprotein	|O
complex	|O
may	|O
cooperate	|O
with	|O
DNA	|O
-	|O
bound	|O
STAT6	|B-PROTEIN
to	|O
achieve	|O
IL	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
-	|O
dependent	|O
activation	|O
of	|O
the	|O
human	|O
IgE	|B-PROTEIN
germline	|O
gene	|O
.	|O

EXERCISE	|O
IN	|O
THE	|O
TERRESTRIAL	|O
CHRISTMAS	|O
ISLAND	|O
RED	|O
CRAB	|O
GECARCOIDEA	|O
NATALIS	|O
-	|O
ENERGETICS	|O
OF	|O
LOCOMOTION	|O

THE	|O
SCALING	|O
OF	|O
SONG	|O
FREQUENCY	|O
IN	|O
CICADAS	|O

The	|O
pheromone	|O
response	|O
pathway	|O
activates	|O
transcription	|O
of	|O
Ty5	|B-PROTEIN
retrotransposons	|O
located	|O
within	|O
silent	|O
chromatin	|O
of	|O
Saccharomyces	|O
cerevisiae	|O
.	|O

In	|O
this	|O
study	|O
we	|O
have	|O
introduced	|O
mutations	|O
into	|O
the	|O
corresponding	|O
elements	|O
of	|O
two	|O
cox3	|B-PROTEIN
promoters	|O
and	|O
show	|O
that	|O
while	|O
the	|O
core	|O
element	|O
is	|O
essential	|O
for	|O
cox3	|B-PROTEIN
promoter	|O
activity	|O
,	|O
upstream	|O
element	|O
mutations	|O
have	|O
little	|O
or	|O
no	|O
effect	|O
.	|O

We	|O
found	|O
that	|O
multiple	|O
tumor	|O
suppressor	|O
genes	|O
(	|O
e.g.	|O
,	|O
p53	|B-PROTEIN
,	|O
DCC	|B-PROTEIN
,	|O
APC	|B-PROTEIN
,	|O
MCC	|B-PROTEIN
,	|O
BRCA1	|B-PROTEIN
,	|O
and	|O
WAF1	|B-PROTEIN
/	|O
CIP1	|B-PROTEIN
)	|O
were	|O
inactivated	|O
at	|O
different	|O
frequencies	|O
via	|O
various	|O
mechanisms	|O
[	|O
e.g.	|O
,	|O
loss	|O
of	|O
heterozygosity	|O
(	|O
LOH	|O
)	|O
,	|O
loss	|O
of	|O
expression	|O
(	|O
LOE	|O
)	|O
,	|O
mutation	|O
,	|O
and	|O
inactivation	|O
by	|O
cellular	|O
binding	|O
protein	|O
]	|O
.	|O

The	|O
histidine	|O
-	|O
tagged	|O
gene	|O
,	|O
rpoCHIS	|B-PROTEIN
,	|O
was	|O
used	|O
to	|O
replace	|O
the	|O
wild	|O
-	|O
type	|O
allele	|O
in	|O
the	|O
chromosome	|O
of	|O
S.	|O
coelicolor	|O
and	|O
S.	|O
lividans	|O
.	|O

Because	|O
the	|O
deletion	|O
included	|O
the	|O
TK	|B-PROTEIN
gene	|O
,	|O
selection	|O
with	|O
gancyclovir	|O
against	|O
cells	|O
not	|O
having	|O
undergone	|O
recombination	|O
was	|O
possible	|O
.	|O

The	|O
malate	|B-PROTEIN
synthase	|I-PROTEIN
gene	|O
,	|O
MLS1	|B-PROTEIN
,	|O
of	|O
the	|O
yeast	|O
Saccharomyces	|O
cerevisiae	|O
is	|O
transcriptionally	|O
regulated	|O
by	|O
the	|O
carbon	|O
source	|O
in	|O
the	|O
growth	|O
medium	|O
.	|O

By	|O
deletion	|O
analysis	|O
of	|O
the	|O
MLS1	|B-PROTEIN
control	|O
region	|O
,	|O
we	|O
identified	|O
two	|O
sites	|O
,	|O
UAS1	|O
and	|O
UAS2	|O
,	|O
as	|O
important	|O
for	|O
efficient	|O
derepression	|O
of	|O
the	|O
gene	|O
.	|O

Lack	|O
of	|O
controlled	|O
prospective	|O
studies	|O
of	|O
sleep	|O
electroencephalograms	|O
(	|O
EEG	|O
)	|O
,	|O
and	|O
the	|O
use	|O
of	|O
medication	|O
,	|O
in	|O
children	|O
with	|O
developmental	|O
dysphasia	|O
,	|O
may	|O
deny	|O
appropriate	|O
treatment	|O
strategies	|O
to	|O
children	|O
with	|O
severe	|O
developmental	|O
speech	|O
and	|O
language	|O
disorders	|O
.	|O

Prior	|O
to	|O
meals	|O
2	|O
to	|O
3	|O
times	|O
daily	|O
,	|O
1-2	|O
tablespoons	|O
of	|O
Alzoon	|O
are	|O
recommended	|O
.	|O

Widening	|O
of	|O
the	|O
abdominal	|O
aortic	|O
wall	|O
on	|O
an	|O
ultrasound	|O
examination	|O
was	|O
the	|O
key	|O
to	|O
the	|O
incidental	|O
diagnosis	|O
of	|O
a	|O
clinically	|O
unsuspected	|O
type	|O
B	|O
dissection	|O
.	|O

Fermentation	|O
process	|O
after	|O
supplementation	|O
of	|O
nitrate	|O
,	|O
nitrite	|O
,	|O
lactic	|O
acid	|O
bacteria	|O
and	|O
formic	|O
acid	|O

Substrates	|O
include	|O
the	|O
p21	|B-PROTEIN
(	|O
ras	|B-PROTEIN
)	|O
proteins	|O
,	|O
nuclear	|O
lamins	|B-PROTEIN
,	|O
and	|O
a	|O
series	|O
of	|O
retinal	|O
proteins	|O
.	|O

Ovaries	|O
of	|O
10	|O
animals	|O
per	|O
group	|O
from	|O
16	|O
studies	|O
in	|O
CD	|O
-	|O
1	|O
mice	|O
and	|O
1	|O
study	|O
each	|O
in	|O
C3H	|O
and	|O
C57BL	|O
/	|O
6	|O
mice	|O
were	|O
sectioned	|O
serially	|O
at	|O
6	|O
microm	|O
.	|O

The	|O
Trx	|B-PROTEIN
-	|O
CT	|B-PROTEIN
fusion	|O
protein	|O
was	|O
produced	|O
less	|O
efficiently	|O
(	|O
20%	|O
of	|O
total	|O
soluble	|O
cellular	|O
protein	|O
)	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
UBP41	|B-PROTEIN
may	|O
play	|O
an	|O
important	|O
role	|O
in	|O
the	|O
recycling	|O
of	|O
ubiquitin	|B-PROTEIN
by	|O
hydrolysis	|O
of	|O
branched	|O
poly	|B-PROTEIN
-	|I-PROTEIN
ubiquitin	|I-PROTEIN
chains	|O
generated	|O
by	|O
the	|O
action	|O
of	|O
26	|B-PROTEIN
S	|I-PROTEIN
proteasome	|I-PROTEIN
on	|O
poly	|O
-	|O
ubiquitinated	|O
protein	|O
substrates	|O
,	|O
as	|O
well	|O
as	|O
in	|O
the	|O
production	|O
of	|O
free	|O
ubiquitin	|B-PROTEIN
from	|O
linear	|O
poly	|B-PROTEIN
-	|I-PROTEIN
ubiquitin	|I-PROTEIN
chains	|O
and	|O
of	|O
certain	|O
ribosomal	|O
proteins	|O
from	|O
ubiquitin	|B-PROTEIN
fusion	|O
proteins	|O
.	|O

A	|O
data	|O
base	|O
homology	|O
search	|O
revealed	|O
that	|O
the	|O
predicted	|O
ER1	|B-PROTEIN
amino	|O
acid	|O
sequence	|O
contains	|O
three	|O
regions	|O
of	|O
similarity	|O
to	|O
the	|O
rat	|O
and	|O
human	|O
proteins	|O
encoded	|O
by	|O
the	|O
metastasis	|O
-	|O
associated	|O
gene	|O
,	|O
mta1	|B-PROTEIN
,	|O
and	|O
two	|O
regions	|O
of	|O
similarity	|O
to	|O
the	|O
Caenorhabditis	|O
elegans	|O
sequence	|O
that	|O
is	|O
similar	|O
to	|O
mta1	|B-PROTEIN
.	|O

The	|O
sequenced	|O
cDNA	|O
predicts	|O
a	|O
704	|O
-	|O
amino	|O
acid	|O
protein	|O
80%	|O
identical	|O
to	|O
human	|O
progelatinase	|B-PROTEIN
B.	|I-PROTEIN

The	|O
inhibition	|O
by	|O
cytosolic	|O
Ca2+	|O
was	|O
caused	|O
by	|O
a	|O
decrease	|O
in	|O
cooperativity	|O
and	|O
by	|O
a	|O
shift	|O
in	|O
EC50	|O
toward	|O
higher	|O
InsP3	|O
concentrations	|O
.	|O

RESULTS	|O
:	|O
The	|O
standardised	|O
mortality	|O
ratio	|O
(	|O
SMR	|O
)	|O
for	|O
all	|O
malignant	|O
neoplasms	|O
was	|O
94	|O
(	|O
95%	|O
CI	|O
74	|O
to	|O
118	|O
)	|O
.	|O

Sequence	|O
analysis	|O
of	|O
this	|O
region	|O
revealed	|O
three	|O
eight	|O
-	|O
bp	|O
repetitive	|O
elements	|O
,	|O
the	|O
deletion	|O
of	|O
which	|O
restored	|O
wild	|O
-	|O
type	|O
levels	|O
of	|O
luciferase	|B-PROTEIN
activity	|O
to	|O
the	|O
-	|O
916	|O
-	|O
bp	|O
reporter	|O
plasmid	|O
.	|O

Using	|O
5'	|O
RACE	|O
and	|O
reverse	|O
transcription	|O
-	|O
PCR	|O
(	|O
RT	|O
-	|O
PCR	|O
)	|O
methodologies	|O
,	|O
we	|O
cloned	|O
these	|O
sequences	|O
from	|O
brain	|O
and	|O
placenta	|O
and	|O
found	|O
this	|O
material	|O
to	|O
be	|O
composed	|O
of	|O
alternatively	|O
spliced	|O
exons	|O
using	|O
a	|O
previously	|O
reported	|O
noncoding	|O
exon	|O
(	|O
1A	|O
)	|O
and	|O
a	|O
novel	|O
97	|O
-	|O
bp	|O
noncoding	|O
exon	|O
(	|O
1B	|O
)	|O
.	|O

This	|O
is	|O
the	|O
first	|O
study	|O
in	|O
which	|O
mutation	|O
screening	|O
has	|O
been	|O
performed	|O
for	|O
both	|O
the	|O
EXT1	|B-PROTEIN
and	|O
EXT2	|B-PROTEIN
genes	|O
prior	|O
to	|O
any	|O
linkage	|O
analysis	|O
.	|O

The	|O
regurgitation	|O
of	|O
large	|O
vitreous	|O
injections	|O
.	|O

Positron	|O
emission	|O
tomography	|O
radioligands	|O
for	|O
dopamine	|B-PROTEIN
transporters	|I-PROTEIN
and	|O
studies	|O
in	|O
human	|O
and	|O
nonhuman	|O
primates	|O
.	|O

Attenuation	|O
from	|O
the	|O
vit	|B-PROTEIN
A2	|I-PROTEIN
consensus	|O
ERE	|O
is	|O
not	|O
necessarily	|O
dependent	|O
on	|O
DNA	|O
binding	|O
as	|O
the	|O
TR	|B-PROTEIN
alpha	|I-PROTEIN
DNA	|O
binding	|O
mutant	|O
was	|O
still	|O
able	|O
to	|O
inhibit	|O
E	|O
-	|O
dependent	|O
transactivation	|O
.	|O

Expression	|O
from	|O
this	|O
element	|O
is	|O
regulated	|O
by	|O
a	|O
heteromeric	|O
protein	|O
complex	|O
containing	|O
ubiquitous	|O
(	|O
i.e.	|O
the	|O
E2A	|B-PROTEIN
-	|O
and	|O
HEB	|B-PROTEIN
-	|O
encoded	|O
proteins	|O
)	|O
and	|O
islet	|O
-	|O
enriched	|O
members	|O
of	|O
the	|O
bHLH	|B-PROTEIN
family	|I-PROTEIN
.	|O

Thus	|O
,	|O
the	|O
CCAAT	|O
box	|O
also	|O
has	|O
tissue	|O
-	|O
specific	|O
characteristics	|O
that	|O
assist	|O
in	|O
targeting	|O
expression	|O
of	|O
the	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
subunit	|I-PROTEIN
gene	|O
to	|O
trophoblasts	|O
.	|O

U4	|B-PROTEIN
/	|O
U6	|B-PROTEIN
snRNP	|O
is	|O
one	|O
of	|O
four	|O
essential	|O
small	|O
nuclear	|O
ribonucleoprotein	|O
(	|O
snRNP	|O
)	|O
particles	|O
(	|O
U1	|B-PROTEIN
,	|O
U2	|B-PROTEIN
,	|O
U5	|B-PROTEIN
and	|O
U4	|B-PROTEIN
/	|O
U6	|B-PROTEIN
)	|O
present	|O
in	|O
the	|O
spliceosome	|O
.	|O

Hprp3p	|B-PROTEIN
is	|O
a	|O
77	|O
kDa	|O
protein	|O
,	|O
which	|O
is	|O
homologous	|O
to	|O
the	|O
Saccharomyces	|O
cerevisiae	|O
splicing	|O
factor	|O
Prp3p	|B-PROTEIN
.	|O

The	|O
growth	|O
-	|O
promoting	|O
properties	|O
of	|O
the	|O
retroviral	|O
v	|B-PROTEIN
-	|I-PROTEIN
erbA	|I-PROTEIN
oncogene	|O
,	|O
a	|O
highly	|O
mutated	|O
version	|O
of	|O
the	|O
chicken	|O
thyroid	|O
hormone	|O
receptor	|O
(	|B-PROTEIN
TR	|I-PROTEIN
)	|I-PROTEIN
alpha	|I-PROTEIN
,	|O
have	|O
so	|O
far	|O
exclusively	|O
been	|O
linked	|O
to	|O
dominant	|O
repression	|O
of	|O
the	|O
antimitogenic	|O
roles	|O
of	|O
TR	|B-PROTEIN
and	|O
retinoic	|B-PROTEIN
acid	|I-PROTEIN
receptors	|I-PROTEIN
.	|O

We	|O
cloned	|O
a	|O
complete	|O
cDNA	|O
(	|O
2.9	|O
kb	|O
)	|O
for	|O
HET	|B-PROTEIN
from	|O
an	|O
MCF	|O
-	|O
7	|O
cDNA	|O
library	|O
.	|O

The	|O
most	|O
common	|O
grade	|O
3	|O
toxicity	|O
was	|O
neutropenia	|O
,	|O
thrombocytopenia	|O
,	|O
and	|O
parasthesias	|O
(	|O
observed	|O
in	|O
<	|O
10%	|O
of	|O
cycles	|O
)	|O
.	|O

Serum	|O
concentrations	|O
of	|O
E2	|O
and	|O
TBOH	|O
were	|O
measured	|O
on	|O
d	|O
0	|O
,	|O
1	|O
,	|O
3	|O
,	|O
5	|O
,	|O
7	|O
,	|O
13	|O
,	|O
21	|O
,	|O
28	|O
,	|O
42	|O
,	|O
56	|O
,	|O
84	|O
,	|O
112	|O
,	|O
and	|O
140	|O
in	|O
finishing	|O
heifers	|O
administered	|O
the	|O
following	|O
treatments	|O
:	|O
1	|O
)	|O
control	|O
;	|O
2	|O
)	|O
MGA	|O
,	|O
.5	|O
mg	|O
per	|O
heifer	|O
daily	|O
;	|O
3	|O
)	|O
Revalor	|O
-	|O
H	|O
(	|O
140	|O
mg	|O
TBA	|O
+	|O
14	|O
mg	|O
E2	|O
)	|O
;	|O
4	|O
)	|O
Revalor	|O
-	|O
H	|O
+	|O
MGA	|O
;	|O
5	|O
)	|O
Finaplix	|O
-	|O
H	|O
(	|O
200	|O
mg	|O
TBA	|O
)	|O
;	|O
and	|O
6	|O
)	|O
Finaplix	|O
-	|O
H	|O
+	|O
MGA	|O
.	|O

Serum	|O
E2	|O
concentrations	|O
increased	|O
numerically	|O
two	|O
-	|O
to	|O
threefold	|O
from	|O
d	|O
56	|O
to	|O
140	|O
in	|O
controls	|O
fed	|O
MGA	|O
,	|O
compared	|O
with	|O
controls	|O
not	|O
fed	|O
MGA	|O
.	|O

Interferon	|O
Regulatory	|O
Factor	|O
(	|B-PROTEIN
IRF	|I-PROTEIN
)	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
has	|O
been	|O
characterized	|O
as	|O
an	|O
important	|O
growth	|O
regulatory	|O
and	|O
immunomodulatory	|O
transcription	|O
factor	|O
.	|O

The	|O
genomic	|O
structure	|O
of	|O
brk	|B-PROTEIN
consists	|O
of	|O
8	|O
exons	|O
,	|O
whose	|O
boundaries	|O
are	|O
distinct	|O
from	|O
other	|O
non	|O
-	|O
receptor	|O
PTK	|B-PROTEIN
family	|O
members	|O
,	|O
again	|O
indicating	|O
a	|O
structural	|O
and	|O
functional	|O
divergence	|O
.	|O

We	|O
have	|O
previously	|O
reported	|O
that	|O
expression	|O
of	|O
a	|O
tumour	|O
derived	|O
brk	|B-PROTEIN
cDNA	|O
in	|O
mouse	|O
embryonic	|O
fibroblasts	|O
and	|O
human	|O
mammary	|O
epithelial	|O
cells	|O
supports	|O
anchorage	|O
independent	|O
growth	|O
,	|O
and	|O
in	|O
the	|O
latter	|O
potentiates	|O
the	|O
mitogenic	|O
response	|O
to	|O
epidermal	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
.	|O

Anti	|B-PROTEIN
-	|I-PROTEIN
hepatitis	|I-PROTEIN
A	|I-PROTEIN
virus	|O
(	|O
HAV	|O
)	|O
titer	|O
after	|O
vaccination	|O
was	|O
measured	|O
in	|O
83	|O
HIV	|O
-	|O
positive	|O
and	|O
39	|O
HIV	|O
-	|O
negative	|O
men	|O
.	|O

One	|O
skull	|O
does	|O
not	|O
a	|O
species	|O
make	|O
.	|O

Surprisingly	|O
,	|O
calf	|O
thymus	|O
CstF	|B-PROTEIN
contained	|O
an	|O
additional	|O
,	|O
novel	|O
form	|O
of	|O
the	|O
64	|O
-	|O
kDa	|O
subunit	|O
with	|O
a	|O
molecular	|O
mass	|O
of	|O
70	|O
kDa	|O
.	|O

Null	|O
mutations	|O
in	|O
daf	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
suppress	|O
mutations	|O
in	|O
genes	|O
encoding	|O
this	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
signal	|O
,	|O
its	|O
receptors	|O
,	|O
and	|O
associated	|O
Smad	|B-PROTEIN
signal	|O
transduction	|O
proteins	|O
.	|O
daf	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
encodes	|O
a	|O
Smad	|B-PROTEIN
protein	|O
that	|O
is	|O
most	|O
closely	|O
related	|O
to	|O
mammalian	|O
DPC4	|B-PROTEIN
,	|O
and	|O
is	|O
expressed	|O
throughout	|O
development	|O
in	|O
many	|O
of	|O
the	|O
tissues	|O
that	|O
are	|O
remodeled	|O
during	|O
dauer	|O
development	|O
.	|O

Our	|O
results	|O
favor	|O
the	|O
possibility	|O
that	|O
the	|O
Drosophila	|O
EGF	|B-PROTEIN
receptor	|I-PROTEIN
DER	|O
/	|O
Egfr	|B-PROTEIN
expressed	|O
by	|O
the	|O
EMA	|O
cells	|O
functions	|O
as	|O
a	|O
receptor	|O
for	|O
Vein	|B-PROTEIN
.	|O

PATIENTS	|O
AND	|O
METHODS	|O
:	|O
In	|O
807	|O
consecutive	|O
patients	|O
from	|O
the	|O
Chilean	|O
National	|O
Registry	|O
of	|O
Acute	|O
Myocardial	|O
Infarction	|O
we	|O
analyzed	|O
the	|O
resolution	|O
of	|O
chest	|O
pain	|O
and	|O
ST	|O
segment	|O
elevation	|O
over	|O
50%	|O
within	|O
the	|O
first	|O
90	|O
min	|O
,	|O
abrupt	|O
CK	|B-PROTEIN
rise	|O
within	|O
8	|O
h	|O
and	|O
T	|O
wave	|O
inversion	|O
in	|O
infarct	|O
related	|O
EKG	|O
leads	|O
within	|O
the	|O
first	|O
24	|O
h	|O
after	|O
thrombolysis	|O
.	|O

Because	|O
of	|O
the	|O
operon	|O
structure	|O
of	|O
this	|O
organism	|O
,	|O
traditional	|O
methods	|O
such	|O
as	|O
insertional	|O
mutagenesis	|O
run	|O
the	|O
risk	|O
of	|O
introducing	|O
polar	|O
effects	|O
on	|O
downstream	|O
genes	|O
or	|O
creating	|O
secondary	|O
mutations	|O
elsewhere	|O
in	|O
the	|O
genome	|O
.	|O

It	|O
has	|O
been	|O
proposed	|O
that	|O
the	|O
parCBA	|B-PROTEIN
operon	|O
encodes	|O
a	|O
plasmid	|O
partitioning	|O
system	|O
(	|O
M.	|O

Furthermore	|O
,	|O
the	|O
insertion	|O
of	|O
the	|O
ColE1	|O
cer	|B-PROTEIN
site	|O
into	|O
the	|O
RK2	|O
plasmid	|O
deleted	|O
for	|O
the	|O
par	|O
region	|O
failed	|O
to	|O
stabilize	|O
the	|O
plasmid	|O
in	|O
the	|O
MC1061K	|O
strain	|O
,	|O
indicating	|O
that	|O
the	|O
multimer	|O
resolution	|O
activity	|O
encoded	|O
by	|O
parCBA	|B-PROTEIN
is	|O
not	|O
by	|O
itself	|O
responsible	|O
for	|O
the	|O
stabilization	|O
activity	|O
observed	|O
for	|O
this	|O
operon	|O
.	|O

To	|O
examine	|O
the	|O
basis	|O
for	|O
the	|O
apparent	|O
differences	|O
in	|O
postsegregational	|O
killing	|O
between	|O
the	|O
two	|O
E.	|O
coli	|O
strains	|O
,	|O
transformation	|O
assays	|O
were	|O
carried	|O
out	|O
to	|O
determine	|O
the	|O
relative	|O
sensitivities	|O
of	|O
the	|O
strains	|O
to	|O
the	|O
ParE	|B-PROTEIN
toxin	|O
protein	|O
.	|O

Splice	|O
-	|O
junction	|O
elements	|O
and	|O
intronic	|O
sequences	|O
regulate	|O
alternative	|O
splicing	|O
of	|O
the	|O
Drosophila	|O
myosin	|B-PROTEIN
heavy	|I-PROTEIN
chain	|I-PROTEIN
gene	|O
transcript	|O
.	|O

Nucleotide	|O
sequence	|O
analysis	|O
of	|O
R	|O
has	|O
revealed	|O
similarities	|O
to	|O
the	|O
R1	|O
plasmid	|O
found	|O
in	|O
some	|O
South	|O
American	|O
maize	|O
races	|O
with	|O
RU	|O
cytoplasm	|O
,	|O
to	|O
the	|O
M1	|O
plasmid	|O
found	|O
in	|O
one	|O
source	|O
of	|O
Zea	|O
luxurians	|O
teosinte	|O
,	|O
to	|O
the	|O
atp9	|B-PROTEIN
mitochondrial	|O
gene	|O
and	|O
its	|O
3'	|O
flanking	|O
sequence	|O
,	|O
and	|O
also	|O
to	|O
a	|O
region	|O
3'	|O
to	|O
the	|O
orf221	|B-PROTEIN
gene	|O
.	|O

We	|O
have	|O
measured	|O
the	|O
kinetics	|O
of	|O
the	|O
recovery	|O
of	|O
mRNA	|O
synthesis	|O
in	|O
the	|O
inducible	|O
GAL10	|B-PROTEIN
and	|O
RNR3	|B-PROTEIN
genes	|O
after	|O
exposure	|O
of	|O
yeast	|O
cells	|O
to	|O
ultraviolet	|O
(	|O
UV	|O
)	|O
radiation	|O
.	|O

Cloning	|O
of	|O
a	|O
human	|O
phosphoinositide	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
with	|O
a	|O
C2	|B-PROTEIN
domain	|O
that	|O
displays	|O
reduced	|O
sensitivity	|O
to	|O
the	|O
inhibitor	|O
wortmannin	|O
.	|O

Ea	|O
value	|O
was	|O
calculated	|O
as	|O
the	|O
ratio	|O
of	|O
the	|O
steady	|O
-	|O
state	|O
end	|O
-	|O
systolic	|O
aortic	|O
pressure	|O
(	|O
ESAP	|O
)	|O
to	|O
stroke	|O
volume	|O
(	|O
thermodilution	|O
)	|O
.	|O

Functional	|O
analysis	|O
of	|O
promoter	|O
activity	|O
of	|O
the	|O
5'	|O
-	|O
flanking	|O
region	|O
of	|O
cyclin	|B-PROTEIN
D2	|I-PROTEIN
suggested	|O
that	|O
the	|O
region	|O
-	|O
1,100	|O
to	|O
-	|O
805	|O
including	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
,	|O
PEA3	|B-PROTEIN
,	|O
AP2	|B-PROTEIN
,	|O
NF	|B-PROTEIN
-	|I-PROTEIN
Y	|I-PROTEIN
,	|O
c	|B-PROTEIN
-	|I-PROTEIN
Myc	|I-PROTEIN
,	|O
and	|O
Sp1	|B-PROTEIN
may	|O
have	|O
a	|O
major	|O
positive	|O
regulatory	|O
activity	|O
for	|O
expression	|O
of	|O
cyclin	|B-PROTEIN
D2	|I-PROTEIN
.	|O

Effect	|O
of	|O
alcohol	|O
on	|O
minimal	|O
effective	|O
nCPAP	|O
pressure	|O

In	|O
contrast	|O
,	|O
resensitization	|O
of	|O
a	|O
sequestration	|O
-	|O
impaired	|O
beta2AR	|B-PROTEIN
mutant	|O
(	|O
Y326A	|O
)	|O
was	|O
reestablished	|O
following	|O
the	|O
overexpression	|O
of	|O
either	|O
GRK2	|B-PROTEIN
or	|O
beta	|B-PROTEIN
-	|I-PROTEIN
arrestin	|I-PROTEIN
1	|I-PROTEIN
.	|O

The	|O
medium	|O
chains	|O
of	|O
these	|O
complexes	|O
,	|O
mu1	|B-PROTEIN
and	|O
mu2	|B-PROTEIN
,	|O
have	|O
been	|O
implicated	|O
in	|O
two	|O
types	|O
of	|O
interaction	|O
:	|O
assembly	|O
with	|O
the	|O
beta1	|B-PROTEIN
and	|I-PROTEIN
beta2	|I-PROTEIN
chains	|I-PROTEIN
of	|O
the	|O
corresponding	|O
complexes	|O
and	|O
recognition	|O
of	|O
tyrosine	|O
-	|O
based	|O
sorting	|O
signals	|O
.	|O

We	|O
have	|O
overexpressed	|O
,	|O
purified	|O
,	|O
characterized	|O
,	|O
and	|O
crystallized	|O
the	|O
BTB	|B-PROTEIN
/	|O
POZ	|O
domain	|O
from	|O
PLZF	|B-PROTEIN
(	|O
PLZF	|B-PROTEIN
-	|O
BTB	|B-PROTEIN
/	|O
POZ	|O
)	|O
.	|O

Osmotic	|O
shock	|O
stimulates	|O
GLUT4	|B-PROTEIN
translocation	|O
in	|O
3T3L1	|O
adipocytes	|O
by	|O
a	|O
novel	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
pathway	|O
.	|O

We	|O
also	|O
identified	|O
Sp1	|B-PROTEIN
,	|O
Sp3	|B-PROTEIN
,	|O
and	|O
NGFI	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
/	|O
Egr	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
as	|O
the	|O
primary	|O
nuclear	|O
transcription	|O
factors	|O
binding	|O
to	|O
TRE1	|B-PROTEIN
which	|O
mediate	|O
Tax	|B-PROTEIN
responsiveness	|O
.	|O

Interestingly	|O
,	|O
segment	|O
nesting	|O
differentially	|O
increases	|O
the	|O
copy	|O
number	|O
of	|O
genes	|O
encoded	|O
by	|O
segment	|O
W	|O
,	|O
suggesting	|O
that	|O
the	|O
unusual	|O
genomic	|O
organization	|O
of	|O
PDVs	|O
may	|O
be	|O
directly	|O
linked	|O
to	|O
the	|O
unique	|O
functions	|O
of	|O
this	|O
virus	|O
in	|O
its	|O
obligate	|O
mutualistic	|O
association	|O
with	|O
parasitic	|O
wasps	|O
.	|O

Furthermore	|O
,	|O
deletion	|O
and	|O
mutation	|O
analyses	|O
of	|O
the	|O
VCAM	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
promoter	|O
performed	|O
with	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
constructs	|O
revealed	|O
that	|O
Tax	|B-PROTEIN
was	|O
trans	|O
activating	|O
the	|O
VCAM	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
promoter	|O
via	|O
two	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
sites	|O
present	|O
at	|O
bp	|O
-	|O
72	|O
and	|O
-	|O
57	|O
in	|O
the	|O
VCAM	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
gene	|O
promoter	|O
,	|O
with	|O
both	|O
of	|O
them	|O
being	|O
required	|O
for	|O
the	|O
Tax	|B-PROTEIN
-	|O
induced	|O
expression	|O
of	|O
this	|O
adhesion	|O
molecule	|O
.	|O

The	|O
AGM	|O
and	|O
NIH	|O
/	|O
Swiss	|O
mouse	|O
CCR5	|B-PROTEIN
proteins	|O
are	|O
97.7	|O
to	|O
98.3%	|O
and	|O
79.8%	|O
identical	|O
to	|O
the	|O
human	|O
protein	|O
,	|O
respectively	|O
.	|O

Processivity	|O
of	|O
DNA	|O
synthesis	|O
by	|O
the	|O
mutant	|O
holoenzyme	|O
containing	|O
pcna	|B-PROTEIN
-	|I-PROTEIN
79	|I-PROTEIN
was	|O
unaffected	|O
on	|O
poly	|O
(	|O
dA	|O
)	|O
x	|O
oligo	|O
(	|O
dT	|O
)	|O
but	|O
was	|O
dramatically	|O
reduced	|O
on	|O
a	|O
natural	|O
template	|O
with	|O
secondary	|O
structure	|O
.	|O

Alanine	|O
substitution	|O
mutations	|O
in	|O
the	|O
Zta	|B-PROTEIN
activation	|O
domain	|O
which	|O
eliminate	|O
the	|O
ability	|O
of	|O
Zta	|B-PROTEIN
to	|O
stimulate	|O
the	|O
D	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
complex	|I-PROTEIN
were	|O
examined	|O
.	|O

The	|O
Scm	|B-PROTEIN
and	|O
ph	|B-PROTEIN
proteins	|O
share	|O
a	|O
homology	|O
domain	|O
with	|O
38%	|O
identity	|O
over	|O
a	|O
length	|O
of	|O
65	|O
amino	|O
acids	|O
,	|O
termed	|O
the	|O
SPM	|O
domain	|O
,	|O
that	|O
is	|O
located	|O
at	|O
their	|O
respective	|O
C	|O
termini	|O
.	|O

It	|O
has	|O
been	|O
previously	|O
shown	|O
that	|O
genes	|O
transcribed	|O
by	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
II	|I-PROTEIN
(	|O
RNAP	|B-PROTEIN
II	|I-PROTEIN
)	|O
are	|O
subject	|O
to	|O
position	|O
effect	|O
variegation	|O
when	|O
located	|O
near	|O
yeast	|O
telomeres	|O
.	|O

Likewise	|O
,	|O
rad6	|B-PROTEIN
-	|I-PROTEIN
delta	|I-PROTEIN
reduces	|O
silencing	|O
of	|O
the	|O
telomere	|O
-	|O
located	|O
RNAP	|B-PROTEIN
II	|I-PROTEIN
-	|O
transcribed	|O
genes	|O
URA3	|B-PROTEIN
and	|O
ADE2	|B-PROTEIN
.	|O

The	|O
amplitude	|O
of	|O
detrusor	|O
contractions	|O
at	|O
6	|O
,	|O
12	|O
,	|O
and	|O
24	|O
hours	|O
showed	|O
no	|O
significant	|O
difference	|O
from	|O
that	|O
in	|O
the	|O
controls	|O
.	|O

In	|O
the	|O
predicted	|O
transmembrane	|O
domain	|O
,	|O
Casr	|B-PROTEIN
-	|I-PROTEIN
rs2	|I-PROTEIN
and	|O
Casr	|B-PROTEIN
-	|I-PROTEIN
rs3	|I-PROTEIN
are	|O
95%	|O
identical	|O
to	|O
Casr	|B-PROTEIN
-	|I-PROTEIN
rs1	|I-PROTEIN
.	|O

Recently	|O
,	|O
roles	|O
also	|O
have	|O
been	|O
suggested	|O
for	|O
the	|O
nuclear	|O
trans	|O
-	|O
factor	|O
GATA	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
in	|O
regulating	|O
progenitor	|O
cell	|O
proliferation	|O
.	|O

PET	|O
activation	|O
studies	|O
are	|O
performed	|O
widely	|O
to	|O
study	|O
human	|O
brain	|O
function	|O
.	|O

F	|B-PROTEIN
-	|I-PROTEIN
box	|I-PROTEIN
proteins	|I-PROTEIN
are	|O
receptors	|O
that	|O
recruit	|O
phosphorylated	|O
substrates	|O
to	|O
the	|O
SCF	|B-PROTEIN
ubiquitin	|O
-	|O
ligase	|B-PROTEIN
complex	|O
.	|O

In	|O
the	|O
context	|O
of	|O
liver	|O
allograft	|O
shortage	|O
,	|O
our	|O
results	|O
suggest	|O
that	|O
an	|O
ELT	|O
should	|O
not	|O
be	|O
performed	|O
in	|O
patients	|O
with	|O
cardiac	|O
failure	|O
,	|O
more	|O
than	|O
two	|O
OSF	|O
,	|O
or	|O
an	|O
APACHE	|O
II	|O
score	|O
higher	|O
than	|O
30	|O
.	|O

The	|O
SH3	|B-PROTEIN
domains	|O
of	|O
Grb2	|B-PROTEIN
bound	|O
in	|O
vitro	|O
to	|O
specific	|O
proline	|O
-	|O
rich	|O
motifs	|O
in	|O
the	|O
HPK1	|B-PROTEIN
tail	|O
and	|O
functioned	|O
synergistically	|O
to	|O
direct	|O
the	|O
stable	|O
binding	|O
of	|O
Grb2	|B-PROTEIN
to	|O
HPK1	|B-PROTEIN
in	|O
transfected	|O
Cos1	|O
cells	|O
.	|O

By	|O
far	|O
-	|O
Western	|O
analysis	|O
and	|O
coimmunoprecipitation	|O
studies	|O
,	|O
we	|O
demonstrate	|O
that	|O
ZNF74	|B-PROTEIN
interacts	|O
,	|O
via	|O
its	|O
zinc	|O
finger	|O
domain	|O
,	|O
with	|O
the	|O
hyperphosphorylated	|O
largest	|O
subunit	|O
of	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
II	|I-PROTEIN
(	|O
pol	|B-PROTEIN
IIo	|I-PROTEIN
)	|O
but	|O
not	|O
with	|O
the	|O
hypophosphorylated	|O
form	|O
.	|O

Thus	|O
,	|O
ZNF74	|B-PROTEIN
sublocalization	|O
in	|O
nuclear	|O
domains	|O
enriched	|O
in	|O
pre	|O
-	|O
mRNA	|O
maturating	|O
factors	|O
,	|O
its	|O
RNA	|O
binding	|O
activity	|O
,	|O
and	|O
its	|O
direct	|O
phosphodependent	|O
interaction	|O
with	|O
the	|O
pol	|B-PROTEIN
IIo	|I-PROTEIN
,	|O
a	|O
form	|O
of	|O
the	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
functionally	|O
associated	|O
with	|O
pre	|O
-	|O
mRNA	|O
processing	|O
,	|O
suggest	|O
a	|O
role	|O
for	|O
this	|O
member	|O
of	|O
the	|O
KRAB	|B-PROTEIN
multifinger	|O
protein	|O
family	|O
in	|O
RNA	|O
processing	|O
.	|O

Ki	|B-PROTEIN
-	|I-PROTEIN
ras4BVal	|I-PROTEIN
-	|I-PROTEIN
12	|I-PROTEIN
transfectant	|O
cells	|O
expressed	|O
2	|O
-	|O
fold	|O
elevated	|O
protein	|O
levels	|O
of	|O
the	|O
lysosomal	|O
cysteine	|B-PROTEIN
protease	|I-PROTEIN
cathepsin	|O
B	|O
but	|O
did	|O
not	|O
up	|O
-	|O
regulate	|O
cathepsin	|B-PROTEIN
B	|I-PROTEIN
mRNA	|O
expression	|O
.	|O

The	|O
cellular	|O
rate	|O
of	|O
anticoagulant	|B-PROTEIN
heparan	|I-PROTEIN
sulfate	|I-PROTEIN
proteoglycan	|I-PROTEIN
(	|O
HSPGact	|B-PROTEIN
)	|O
generation	|O
is	|O
determined	|O
by	|O
the	|O
level	|O
of	|O
a	|O
kinetically	|O
limiting	|O
microsomal	|O
activity	|O
,	|O
HSact	|O
conversion	|O
activity	|O
,	|O
which	|O
is	|O
predominantly	|O
composed	|O
of	|O
the	|O
long	|O
sought	|O
heparan	|B-PROTEIN
sulfate	|I-PROTEIN
D	|I-PROTEIN
-	|I-PROTEIN
glucosaminyl	|I-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
O	|I-PROTEIN
-	|I-PROTEIN
sulfotransferase	|I-PROTEIN
(	|O
3	|B-PROTEIN
-	|I-PROTEIN
OST	|I-PROTEIN
)	|O
(	|O
Shworak	|O
,	|O
N.	|O

Interestingly	|O
,	|O
EGF	|B-PROTEIN
,	|O
but	|O
not	|O
insulin	|B-PROTEIN
,	|O
stimulated	|O
tyrosine	|O
phosphorylation	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
cbl	|I-PROTEIN
and	|O
its	|O
association	|O
with	|O
Crk	|B-PROTEIN
-	|I-PROTEIN
II	|I-PROTEIN
.	|O

An	|O
end	|O
to	|O
the	|O
lottery	|O
.	|O

We	|O
previously	|O
showed	|O
that	|O
the	|O
N	|O
-	|O
terminal	|O
portion	|O
common	|O
to	|O
various	|O
chimeric	|O
MLL	|B-PROTEIN
products	|O
,	|O
as	|O
well	|O
as	|O
to	|O
MLL	|B-PROTEIN
-	|I-PROTEIN
LTG9	|I-PROTEIN
and	|O
MLL	|B-PROTEIN
-	|I-PROTEIN
LTG19	|I-PROTEIN
,	|O
localizes	|O
in	|O
the	|O
nuclei	|O
,	|O
and	|O
therefore	|O
suggested	|O
that	|O
it	|O
might	|O
play	|O
an	|O
important	|O
role	|O
in	|O
leukemogenesis	|O
.	|O

Our	|O
results	|O
suggest	|O
that	|O
the	|O
pattern	|O
of	|O
blood	|O
supply	|O
is	|O
relevant	|O
to	|O
the	|O
structural	|O
organisation	|O
of	|O
mature	|O
lamellar	|O
bone	|O
around	|O
the	|O
implant	|O
.	|O

Induction	|O
of	|O
AtP5CS1	|B-PROTEIN
mRNA	|O
accumulation	|O
in	|O
salt	|O
-	|O
treated	|O
seedlings	|O
involves	|O
an	|O
immediate	|O
early	|O
transcriptional	|O
response	|O
regulated	|O
by	|O
ABA	|O
signalling	|O
that	|O
is	|O
not	|O
inhibited	|O
by	|O
cycloheximide	|O
,	|O
but	|O
abolished	|O
by	|O
the	|O
deficiency	|O
of	|O
ABA	|O
biosynthesis	|O
in	|O
the	|O
aba1	|B-PROTEIN
Arabidopsis	|O
mutant	|O
.	|O

It	|O
thus	|O
appears	|O
that	|O
MAPK	|B-PROTEIN
functions	|O
in	|O
meiotic	|O
maturation	|O
by	|O
preventing	|O
unfertilized	|O
eggs	|O
from	|O
proceeding	|O
into	|O
parthenogenetic	|O
development	|O
.	|O

(	|O
ii	|O
)	|O
An	|O
AF	|O
G	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
level	|O
>	|O
2000	|O
pg	|O
/	|O
ml	|O
is	|O
a	|O
strong	|O
positive	|O
predictor	|O
of	|O
CAM	|O
.	|O

A	|O
positive	|O
correlation	|O
between	|O
serum	|O
myoglobin	|B-PROTEIN
and	|O
CA	|B-PROTEIN
III	|I-PROTEIN
concentrations	|O
(	|O
rs	|O
=	|O
0.933	|O
,	|O
P	|O
<	|O
0.001	|O
)	|O
was	|O
observed	|O
in	|O
hemodialyzed	|O
patients	|O
with	|O
chronic	|O
renal	|O
failure	|O
.	|O

Furthermore	|O
,	|O
the	|O
over	|O
-	|O
replication	|O
phenotype	|O
produced	|O
by	|O
this	|O
mutant	|O
p65cdc18	|B-PROTEIN
is	|O
resistant	|O
to	|O
increased	|O
mitotic	|O
cyclin	|B-PROTEIN
/	|O
CDK	|B-PROTEIN
activity	|O
,	|O
a	|O
known	|O
inhibitor	|O
of	|O
over	|O
-	|O
replication	|O
.	|O

Rip1p	|B-PROTEIN
is	|O
inessential	|O
,	|O
associated	|O
with	|O
nuclear	|O
pore	|O
complexes	|O
,	|O
and	|O
structurally	|O
related	|O
to	|O
the	|O
FG	|B-PROTEIN
-	|I-PROTEIN
nucleoporin	|I-PROTEIN
family	|O
of	|O
pore	|O
proteins	|O
.	|O

The	|O
CNXA	|O
domain	|O
is	|O
similar	|O
at	|O
the	|O
amino	|O
acid	|O
level	|O
to	|O
the	|O
Escherichia	|O
coli	|O
moaA	|B-PROTEIN
gene	|O
product	|O
,	|O
while	|O
CNXC	|O
is	|O
similar	|O
to	|O
the	|O
E.	|O
coli	|O
moaC	|B-PROTEIN
product	|O
,	|O
with	|O
both	|O
E.	|O
coli	|O
products	|O
encoded	|O
by	|O
different	|O
cistrons	|O
.	|O

Deletions	|O
in	|O
each	|O
of	|O
these	|O
regions	|O
abolish	|O
membrane	|O
localization	|O
of	|O
Tiam1	|B-PROTEIN
and	|O
membrane	|O
ruffling	|O
,	|O
suggesting	|O
that	|O
they	|O
function	|O
cooperatively	|O
.	|O

However	|O
,	|O
besides	|O
the	|O
kinase	|O
catalytic	|O
domain	|O
and	|O
double	|O
leucine	|O
/	|O
isoleucine	|O
zippers	|O
,	|O
there	|O
was	|O
no	|O
significant	|O
homology	|O
with	|O
known	|O
proteins	|O
.	|O

RNA	|B-PROTEIN
polymerase	|I-PROTEIN
II	|I-PROTEIN
inhibition	|O
increased	|O
the	|O
binding	|O
of	|O
ARE	|O
(	|O
AUBP	|O
activity	|O
)	|O
and	|O
poly	|O
(	|O
U	|O
)	|O
-	|O
Sepharose	|O
by	|O
cytoplasmic	|O
hnRNP	|O
A1	|B-PROTEIN
,	|O
while	|O
nuclear	|O
hnRNP	|O
A1	|B-PROTEIN
binding	|O
was	|O
unaffected	|O
.	|O

Modulation	|O
of	|O
AUUUA	|O
response	|O
element	|O
binding	|O
by	|O
heterogeneous	|O
nuclear	|O
ribonucleoprotein	|O
A1	|B-PROTEIN
in	|O
human	|O
T	|O
lymphocytes	|O
.	|O

Histological	|O
slides	|O
of	|O
one	|O
biopsy	|O
of	|O
each	|O
patient	|O
(	|O
formalin	|O
-	|O
fixed	|O
and	|O
paraffin	|O
-	|O
embedded	|O
)	|O
were	|O
stained	|O
with	|O
a	|O
Modified	|O
Giemsa	|O
(	|O
MG	|O
)	|O
,	|O
the	|O
Warthin	|O
-	|O
Starry	|O
(	|O
WS	|O
)	|O
,	|O
and	|O
an	|O
immunohistochemical	|O
method	|O
(	|O
IMM	|O
)	|O
using	|O
purified	|O
polyclonal	|O
H.	|O
pylori	|O
antiserum	|O
(	|O
DAKO	|O
B471	|O
)	|O
.	|O

Their	|O
biosynthesis	|O
proceeds	|O
via	|O
linear	|O
precursors	|O
that	|O
become	|O
branched	|O
by	|O
beta1	|B-PROTEIN
,	|I-PROTEIN
6	|I-PROTEIN
-	|I-PROTEIN
GlcNAc	|I-PROTEIN
transferases	|I-PROTEIN
(	|O
IGnT6	|O
,	|O
GlcNAc	|O
to	|O
Gal	|O
)	|O
.	|O

These	|O
findings	|O
indicate	|O
that	|O
the	|O
t	|O
(	|O
4	|O
;	|O
14	|O
)	|O
(	|O
p16.3	|O
;	|O
q32	|O
)	|O
represents	|O
a	|O
novel	|O
,	|O
recurrent	|O
chromosomal	|O
translocation	|O
in	|O
MM	|O
,	|O
and	|O
suggest	|O
that	|O
the	|O
FGFR3	|B-PROTEIN
gene	|O
may	|O
be	|O
the	|O
target	|O
of	|O
this	|O
abnormality	|O
and	|O
thus	|O
contribute	|O
to	|O
tumorigenesis	|O
in	|O
MM	|O
.	|O

In	|O
addition	|O
,	|O
mutation	|O
of	|O
the	|O
Sp1	|B-PROTEIN
site	|O
also	|O
significantly	|O
reduced	|O
promoter	|O
activity	|O
.	|O

Amino	|O
acid	|O
residues	|O
of	|O
beta	|O
1'	|O
,	|O
alpha	|O
A'	|O
,	|O
alpha	|O
B'	|O
,	|O
and	|O
the	|O
loop	|O
containing	|O
His539	|O
of	|O
the	|O
RNase	|B-PROTEIN
H	|I-PROTEIN
domain	|O
interact	|O
with	|O
the	|O
primer	|O
strand	|O
of	|O
the	|O
dsDNA	|O
.	|O

Moreover	|O
,	|O
in	|O
one	|O
patient	|O
with	|O
a	|O
sarcoma	|O
who	|O
underwent	|O
a	|O
leg	|O
-	|O
sparing	|O
procedure	|O
,	|O
no	|O
sciatic	|O
nerve	|O
enlargement	|O
was	|O
seen	|O
postoperatively	|O
.	|O

The	|O
full	|O
length	|O
cDNA	|O
sequence	|O
of	|O
a	|O
Type	|O
I	|O
transforming	|O
growth	|O
factor	|O
-	|O
beta	|O
(	|B-PROTEIN
TGF	|I-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
)	|I-PROTEIN
receptor	|I-PROTEIN
has	|O
been	|O
isolated	|O
from	|O
the	|O
filarial	|O
parasitic	|O
nematode	|O
Brugia	|O
pahangi	|O
.	|O

This	|O
sequence	|O
possessed	|O
homology	|O
with	|O
a	|O
methylation	|O
-	|O
sensitive	|O
promoter	|O
element	|O
,	|O
Enh2	|O
,	|O
present	|O
in	|O
the	|O
LTR	|O
of	|O
mouse	|O
intractisternal	|O
A	|O
-	|O
particles	|O
.	|O

Codon	|O
optimization	|O
for	|O
high	|O
-	|O
level	|O
expression	|O
of	|O
human	|O
erythropoietin	|B-PROTEIN
(	|O
EPO	|B-PROTEIN
)	|O
in	|O
mammalian	|O
cells	|O
.	|O

Parodoxical	|O
rise	|O
in	|O
urinary	|O
albumin	|B-PROTEIN
levels	|O
after	|O
treatment	|O
of	|O
essential	|O
hypertension	|O
.	|O

20%	|O
of	|O
total	|O
HSL	|B-PROTEIN
transcripts	|O
in	|O
human	|O
subcutaneous	|O
adipocytes	|O
.	|O

Taken	|O
together	|O
,	|O
our	|O
data	|O
suggest	|O
that	|O
Rat7p	|B-PROTEIN
/	|O
Nup159p	|B-PROTEIN
is	|O
anchored	|O
within	|O
the	|O
NPC	|O
through	|O
its	|O
coiled	|O
-	|O
coil	|O
region	|O
and	|O
adjacent	|O
sequences	|O
.	|O

In	|O
a	|O
group	|O
of	|O
13	|O
patients	|O
with	|O
obliterative	|O
arteriopathies	|O
of	|O
the	|O
lower	|O
limbs	|O
the	|O
plasma	|O
levels	|O
of	|O
thrombomodulin	|B-PROTEIN
(	|O
TM	|B-PROTEIN
)	|O
,	|O
betathromboglobulin	|B-PROTEIN
(	|O
beta	|B-PROTEIN
-	|I-PROTEIN
TG	|I-PROTEIN
)	|O
,	|O
D	|O
-	|O
dimer	|O
(	|O
DD	|O
)	|O
and	|O
plasminogen	|B-PROTEIN
activator	|I-PROTEIN
-	|I-PROTEIN
inhibitor	|I-PROTEIN
(	|O
pAI	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
were	|O
measured	|O
,	|O
and	|O
compared	|O
to	|O
the	|O
values	|O
obtained	|O
from	|O
10	|O
healthy	|O
volunteers	|O
.	|O

These	|O
residues	|O
,	|O
Ile244	|O
at	|O
the	|O
extracellular	|O
end	|O
of	|O
transmembrane	|O
helix	|O
3	|O
,	|O
and	|O
Tyr318	|O
at	|O
the	|O
COOH	|O
-	|O
terminal	|O
portion	|O
of	|O
extracellular	|O
loop	|O
2	|O
,	|O
are	|O
replaced	|O
by	|O
Leu	|O
and	|O
Ile	|O
in	|O
the	|O
PTH	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
receptor	|I-PROTEIN
,	|O
respectively	|O
.	|O

We	|O
have	|O
now	|O
shown	|O
that	|O
in	|O
vivo	|O
phosphorylation	|O
of	|O
14-3-3	|B-PROTEIN
zeta	|I-PROTEIN
at	|O
the	|O
CKIalpha	|B-PROTEIN
site	|O
(	|O
Thr	|O
-	|O
233	|O
)	|O
negatively	|O
regulates	|O
its	|O
binding	|O
to	|O
c	|B-PROTEIN
-	|I-PROTEIN
Raf	|I-PROTEIN
,	|O
and	|O
may	|O
be	|O
important	|O
in	|O
Raf	|B-PROTEIN
-	|O
mediated	|O
signal	|O
transduction	|O
.	|O

Mouse	|O
mast	|O
cell	|O
protease	|B-PROTEIN
9	|I-PROTEIN
,	|O
a	|O
novel	|O
member	|O
of	|O
the	|O
chromosome	|O
14	|O
family	|O
of	|O
serine	|B-PROTEIN
proteases	|I-PROTEIN
that	|O
is	|O
selectively	|O
expressed	|O
in	|O
uterine	|O
mast	|O
cells	|O
.	|O

A	|O
DNase	|B-PROTEIN
I	|I-PROTEIN
-	|O
hypersensitive	|O
site	|O
has	|O
also	|O
been	|O
mapped	|O
in	|O
the	|O
258	|O
-	|O
base	|O
pair	|O
enhancer	|O
region	|O
.	|O

[	|O
Pulmonary	|O
vascular	|O
resistance	|O
(	|O
PVR	|O
)	|O
during	|O
10%	|O
O2	|O
-	|O
PVR	|O
during	|O
21%	|O
O2	|O
/	|O
PVR	|O
during	|O
21%	|O
O2	|O
]	|O
x	|O
100	|O
was	|O
termed	|O
as	|O
hypoxic	|O
pulmonary	|O
vasoconstriction	|O
(	|O
HPV	|O
)	|O
.	|O

Together	|O
,	|O
our	|O
results	|O
show	|O
that	|O
tinman	|B-PROTEIN
is	|O
controlled	|O
by	|O
an	|O
array	|O
of	|O
discrete	|O
enhancer	|O
elements	|O
that	|O
are	|O
activated	|O
successively	|O
by	|O
differential	|O
genetic	|O
inputs	|O
,	|O
as	|O
well	|O
as	|O
by	|O
closely	|O
linked	|O
activator	|O
and	|O
repressor	|O
binding	|O
sites	|O
within	|O
an	|O
early	|O
-	|O
acting	|O
enhancer	|O
,	|O
which	|O
restrict	|O
twist	|B-PROTEIN
activity	|O
to	|O
specific	|O
areas	|O
within	|O
the	|O
twist	|B-PROTEIN
expression	|O
domain	|O
.	|O

An	|O
unusual	|O
cysteine	|O
triplet	|O
conserved	|O
in	|O
the	|O
sequences	|O
of	|O
TB	|B-PROTEIN
domains	|I-PROTEIN
is	|O
localized	|O
to	|O
the	|O
hydrophobic	|O
core	|O
,	|O
at	|O
the	|O
C	|O
-	|O
terminus	|O
of	|O
an	|O
alpha	|O
-	|O
helix	|O
.	|O

The	|O
Fis	|B-PROTEIN
protein	|O
regulates	|O
site	|O
-	|O
specific	|O
DNA	|O
inversion	|O
catalyzed	|O
by	|O
a	|O
family	|O
of	|O
DNA	|B-PROTEIN
invertases	|I-PROTEIN
when	|O
bound	|O
to	|O
a	|O
cis	|O
-	|O
acting	|O
recombinational	|O
enhancer	|O
.	|O

Protein	|O
phosphatases	|O
play	|O
a	|O
critical	|O
role	|O
in	|O
the	|O
regulation	|O
of	|O
the	|O
eukaryotic	|O
cell	|O
cycle	|O
and	|O
signal	|O
transduction	|O
.	|O

The	|O
cell	|O
cycle	|O
-	|O
regulated	|O
transcription	|O
factor	|O
E2F	|B-PROTEIN
is	|O
also	|O
known	|O
to	|O
bend	|O
DNA	|O
upon	|O
binding	|O
.	|O

Our	|O
study	|O
reveals	|O
that	|O
the	|O
modular	|O
structure	|O
of	|O
the	|O
FSH	|B-PROTEIN
receptor	|I-PROTEIN
gene	|O
generates	|O
motifs	|O
that	|O
allows	|O
coupling	|O
to	|O
different	|O
effectors	|O
.	|O

Transcriptional	|O
regulation	|O
of	|O
SUP35	|B-PROTEIN
and	|O
SUP45	|B-PROTEIN
in	|O
Saccharomyces	|O
cerevisiae	|O
.	|O

These	|O
studies	|O
serve	|O
as	|O
the	|O
basis	|O
for	|O
the	|O
further	|O
characterization	|O
of	|O
the	|O
regulatory	|O
mechanism	|O
of	|O
aromatase	|B-PROTEIN
expression	|O
in	|O
human	|O
breast	|O
cancer	|O
and	|O
ASCs	|O
.	|O

Xenopus	|O
Ran	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
1	|I-PROTEIN
:	|O
molecular	|O
interactions	|O
and	|O
effects	|O
on	|O
nuclear	|O
assembly	|O
in	|O
Xenopus	|O
egg	|O
extracts	|O
.	|O

She	|O
improved	|O
with	|O
a	|O
combination	|O
of	|O
benzodiazepines	|O
and	|O
the	|O
acetylcholinesterase	|B-PROTEIN
inhibitor	|O
physostigmine	|O
.	|O

METHODS	|O
:	|O
Total	|O
muscle	|O
paralysis	|O
was	|O
induced	|O
under	|O
general	|O
anesthesia	|O
in	|O
a	|O
group	|O
of	|O
obese	|O
persons	|O
(	|O
n	|O
=	|O
9	|O
;	|O
body	|O
mass	|O
index	|O
,	|O
32	|O
+	|O
/	|O
-	|O
3	|O
kg	|O
[	|O
-	|O
2	|O
]	|O
)	|O
and	|O
in	|O
a	|O
group	|O
of	|O
nonobese	|O
persons	|O
(	|O
n	|O
=	|O
9	|O
;	|O
body	|O
mas	|O
index	|O
,	|O
21	|O
+	|O
/	|O
-	|O
2	|O
kg	|O
[	|O
-	|O
2	|O
]	|O
)	|O
.	|O

PKA	|B-PROTEIN
phosphorylated	|O
WT1	|B-PROTEIN
at	|O
Ser	|O
-	|O
365	|O
and	|O
Ser	|O
-	|O
393	|O
in	|O
vitro	|O
,	|O
as	|O
well	|O
as	|O
at	|O
additional	|O
sites	|O
,	|O
and	|O
this	|O
phosphorylation	|O
abolished	|O
the	|O
DNA	|O
-	|O
binding	|O
activity	|O
of	|O
WT1	|B-PROTEIN
in	|O
vitro	|O
.	|O

Our	|O
findings	|O
provide	|O
the	|O
first	|O
evidence	|O
that	|O
the	|O
function	|O
of	|O
WT1	|B-PROTEIN
can	|O
be	|O
modulated	|O
by	|O
its	|O
phosphorylation	|O
in	|O
vivo	|O
.	|O

Re	|O
:	|O
"	|O
Assessing	|O
the	|O
direction	|O
of	|O
causality	|O
in	|O
cross	|O
-	|O
sectional	|O
studies	|O
"	|O
.	|O

A	|O
second	|O
aim	|O
was	|O
to	|O
determine	|O
whether	|O
the	|O
decrease	|O
in	|O
muscle	|O
-	|O
tendon	|O
unit	|O
rest	|O
length	|O
produced	|O
by	|O
prolonged	|O
immobilisation	|O
in	|O
a	|O
shortened	|O
position	|O
is	|O
mediated	|O
primarily	|O
by	|O
adaptations	|O
of	|O
the	|O
muscle	|O
or	|O
tendon	|O
.	|O

The	|O
presence	|O
of	|O
an	|O
additional	|O
sequence	|O
of	|O
nucleotides	|O
145-165	|O
from	|O
the	|O
3'	|O
end	|O
of	|O
RNA3	|B-PROTEIN
enhanced	|O
template	|O
recognition	|O
by	|O
RdRp	|B-PROTEIN
in	|O
vitro	|O
and	|O
accumulation	|O
of	|O
RNA3	|B-PROTEIN
in	|O
vivo	|O
to	|O
wild	|O
-	|O
type	|O
levels	|O
.	|O

We	|O
argue	|O
that	|O
the	|O
primary	|O
role	|O
of	|O
hh	|B-PROTEIN
in	|O
controlling	|O
polarity	|O
is	|O
to	|O
cause	|O
anterior	|O
compartment	|O
cells	|O
to	|O
reverse	|O
their	|O
interpretation	|O
of	|O
an	|O
underlying	|O
symmetric	|O
polarization	|O
.	|O

Restriction	|O
enzyme	|O
mapping	|O
,	|O
subcloning	|O
,	|O
and	|O
DNA	|O
sequencing	|O
analysis	|O
of	|O
recombinant	|O
phage	|O
lambda	|O
and	|O
P1	|O
clones	|O
revealed	|O
that	|O
exons	|O
encoding	|O
the	|O
1.9	|O
-	|O
kb	|O
mouse	|O
TS	|B-PROTEIN
mRNA	|O
are	|O
dispersed	|O
over	|O
>	|O
150	|O
kb	|O
genomic	|O
DNA	|O
.	|O

Transfection	|O
analyses	|O
indicated	|O
that	|O
the	|O
expression	|O
of	|O
Tbxas1	|B-PROTEIN
is	|O
controlled	|O
by	|O
a	|O
short	|O
(	|O
70	|O
-	|O
bp	|O
)	|O
positive	|O
regulatory	|O
sequence	|O
and	|O
several	|O
upstream	|O
repressive	|O
elements	|O
.	|O

The	|O
results	|O
of	|O
this	|O
study	|O
suggest	|O
that	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
activity	|O
may	|O
be	|O
regulated	|O
by	|O
its	|O
interaction	|O
with	|O
the	|O
cell	|O
cycle	|O
regulatory	|O
protein	|O
,	|O
E2F	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

The	|O
lysozyme	|B-PROTEIN
FEF	|O
site	|O
is	|O
immediately	|O
5'	|O
to	|O
a	|O
PU	|B-PROTEIN
.	|O

Osteocalcin	|B-PROTEIN
(	|O
OC	|B-PROTEIN
)	|O
is	|O
a	|O
matrix	|O
calcium	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
expressed	|O
in	|O
osteoblasts	|O
and	|O
odontoblasts	|O
undergoing	|O
mineralization	|O
.	|O

In	|O
this	|O
study	|O
,	|O
we	|O
examine	|O
the	|O
effects	|O
of	|O
Msx2	|B-PROTEIN
expression	|O
on	|O
OC	|B-PROTEIN
promoter	|O
activation	|O
(	|O
luciferase	|B-PROTEIN
reporter	|O
)	|O
by	|O
FGF2	|B-PROTEIN
/	|O
FSK	|B-PROTEIN
and	|O
calcitriol	|O
in	|O
MC3T3	|O
-	|O
E1	|O
osteoblasts	|O
.	|O

Thus	|O
,	|O
unlike	|O
other	|O
proteins	|O
reported	|O
to	|O
inhibit	|O
SRF	|B-PROTEIN
activity	|O
,	|O
the	|O
repressor	|O
activity	|O
associated	|O
with	|O
the	|O
GC	|O
-	|O
rich	|O
element	|O
does	|O
not	|O
appear	|O
to	|O
function	|O
through	|O
direct	|O
inhibition	|O
of	|O
SRF	|B-PROTEIN
binding	|O
.	|O

However	|O
,	|O
one	|O
CAK	|B-PROTEIN
-	|O
phosphorylated	|O
phosphopeptide	|O
comigrates	|O
with	|O
a	|O
Cdc2	|B-PROTEIN
-	|O
phosphorylated	|O
phosphopeptide	|O
previously	|O
shown	|O
to	|O
be	|O
mitosis	|O
-	|O
specific	|O
,	|O
suggesting	|O
that	|O
,	|O
in	|O
vitro	|O
,	|O
CAK	|B-PROTEIN
is	|O
able	|O
to	|O
phosphorylate	|O
at	|O
least	|O
one	|O
site	|O
that	|O
is	|O
also	|O
phosphorylated	|O
in	|O
vivo	|O
.	|O

The	|O
pen	|O
can	|O
heal	|O
.	|O

The	|O
mHIF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
alpha	|I-PROTEIN
structural	|O
gene	|O
is	|O
composed	|O
of	|O
15	|O
exons	|O
.	|O

However	|O
,	|O
when	|O
a	|O
second	|O
,	|O
upstream	|O
IRE	|B-PROTEIN
-	|O
like	|O
sequence	|O
was	|O
evaluated	|O
by	|O
EMSA	|O
,	|O
a	|O
DNA	|O
binding	|O
pattern	|O
distinct	|O
from	|O
that	|O
seen	|O
following	|O
exposure	|O
to	|O
IFN	|B-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
alone	|O
was	|O
observed	|O
after	|O
prolonged	|O
stimulation	|O
with	|O
both	|O
IFN	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
and	|O
IFN	|B-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
.	|O

In	|O
Arabidopsis	|O
,	|O
the	|O
induction	|O
of	|O
a	|O
dehydration	|O
-	|O
responsive	|O
gene	|O
,	|O
rd22	|B-PROTEIN
,	|O
is	|O
mediated	|O
by	|O
abscisic	|O
acid	|O
(	|O
ABA	|O
)	|O
and	|O
requires	|O
protein	|O
biosynthesis	|O
for	|O
ABA	|O
-	|O
dependent	|O
gene	|O
expression	|O
.	|O

A	|O
cDNA	|O
encoding	|O
a	|O
MYC	|B-PROTEIN
-	|O
related	|O
DNA	|O
binding	|O
protein	|O
was	|O
isolated	|O
by	|O
DNA	|O
-	|O
ligand	|O
binding	|O
screening	|O
,	|O
using	|O
the	|O
67	|O
-	|O
bp	|O
region	|O
as	|O
a	|O
probe	|O
,	|O
and	|O
designated	|O
rd22BP1	|B-PROTEIN
.	|O

Human	|O
PDK1	|B-PROTEIN
is	|O
homologous	|O
to	|O
the	|O
Drosophila	|O
protein	|O
kinase	|O
DSTPK61	|B-PROTEIN
,	|O
which	|O
has	|O
been	|O
implicated	|O
in	|O
the	|O
regulation	|O
of	|O
sex	|O
differentiation	|O
,	|O
oogenesis	|O
and	|O
spermatogenesis	|O
.	|O

Thus	|O
,	|O
the	|O
synergistic	|O
effects	|O
of	|O
HNF	|B-PROTEIN
-	|I-PROTEIN
1beta	|I-PROTEIN
and	|O
the	|O
GR	|B-PROTEIN
on	|O
dexamethasone	|O
-	|O
stimulated	|O
promoter	|O
activity	|O
require	|O
that	|O
they	|O
are	|O
bound	|O
to	|O
the	|O
HNF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
site	|O
and	|O
the	|O
GRE	|O
,	|O
respectively	|O
,	|O
and	|O
may	|O
involve	|O
protein	|O
-	|O
protein	|O
interactions	|O
between	|O
the	|O
transcription	|O
factors	|O
,	|O
or	|O
between	|O
them	|O
and	|O
the	|O
basal	|O
transcription	|O
machinery	|O
or	|O
a	|O
steroid	|B-PROTEIN
receptor	|I-PROTEIN
coactivator	|O
.	|O

Mutational	|O
analysis	|O
shows	|O
that	|O
both	|O
an	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
like	|O
sequence	|O
(	|O
-	|O
294	|O
/	|O
-	|O
285	|O
,	|O
TGAATCATCA	|O
)	|O
and	|O
an	|O
A	|O
/	|O
T	|O
-	|O
rich	|O
myocyte	|B-PROTEIN
enhancer	|I-PROTEIN
factor	|I-PROTEIN
(	|O
MEF	|B-PROTEIN
)	|O
-	|O
2	|O
like	|O
sequence	|O
(	|O
-	|O
310	|O
/	|O
-	|O
298	|O
,	|O
TTAAAAATAAAAA	|O
)	|O
in	|O
the	|O
33	|O
-	|O
bp	|O
region	|O
are	|O
necessary	|O
for	|O
the	|O
OP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
effect	|O
.	|O

Unlike	|O
most	|O
other	|O
members	|O
of	|O
the	|O
Bcl	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
family	|O
,	|O
BAD	|B-PROTEIN
(	|O
Bcl	|B-PROTEIN
-	|I-PROTEIN
xL	|I-PROTEIN
/	|I-PROTEIN
Bcl	|I-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
associated	|I-PROTEIN
death	|I-PROTEIN
promoter	|O
)	|O
,	|O
a	|O
death	|B-PROTEIN
enhancer	|I-PROTEIN
,	|O
has	|O
no	|O
C	|O
-	|O
terminal	|O
transmembrane	|O
domain	|O
for	|O
targeting	|O
to	|O
the	|O
outer	|O
mitochondrial	|O
membrane	|O
and	|O
nuclear	|O
envelope	|O
.	|O

Electromobility	|O
shift	|O
and	|O
cotransfection	|O
assays	|O
demonstrated	|O
that	|O
HNF1alpha	|B-PROTEIN
,	|O
but	|O
not	|O
HNF4	|B-PROTEIN
,	|O
bound	|O
to	|O
its	|O
cognate	|O
site	|O
and	|O
transactivated	|O
G6Pase	|B-PROTEIN
gene	|O
expression	|O
.	|O

An	|O
open	|O
reading	|O
frame	|O
of	|O
2862	|O
bp	|O
encoding	|O
a	|O
954	|O
amino	|O
acid	|O
protein	|O
was	|O
identified	|O
.	|O

One	|O
of	|O
these	|O
,	|O
an	|O
AACA	|O
motif	|O
,	|O
has	|O
been	|O
shown	|O
to	|O
be	|O
a	|O
negative	|O
regulator	|O
in	|O
non	|O
-	|O
seed	|O
tissues	|O
and	|O
has	|O
a	|O
similarity	|O
to	|O
the	|O
barley	|O
gibberellin	|O
responsive	|O
element	|O
recognized	|O
by	|O
MYB	|B-PROTEIN
-	|O
like	|O
DNA	|O
binding	|O
proteins	|O
.	|O

Strain	|O
CFN037	|O
is	|O
an	|O
R.	|O
etli	|O
mutant	|O
induced	|O
by	|O
a	|O
single	|O
Tn5mob	|B-PROTEIN
insertion	|O
in	|O
the	|O
promoter	|O
region	|O
of	|O
the	|O
thiCOGE	|B-PROTEIN
gene	|O
cluster	|O
.	|O

Expression	|O
of	|O
thiamin	|O
biosynthetic	|O
genes	|O
(	|O
thiCOGE	|B-PROTEIN
)	|O
and	|O
production	|O
of	|O
symbiotic	|O
terminal	|O
oxidase	|O
cbb3	|B-PROTEIN
in	|O
Rhizobium	|O
etli	|O
.	|O

We	|O
have	|O
cloned	|O
and	|O
sequenced	|O
a	|O
region	|O
encoding	|O
a	|O
lipase	|B-PROTEIN
operon	|O
and	|O
a	|O
putative	|O
,	|O
previously	|O
uncharacterized	|O
metalloprotease	|B-PROTEIN
of	|O
Vibrio	|O
cholerae	|O
O1	|O
.	|O

Furthermore	|O
,	|O
the	|O
amount	|O
of	|O
tRNA	|B-PROTEIN
(	|I-PROTEIN
3Lys	|I-PROTEIN
)	|I-PROTEIN
that	|O
was	|O
placed	|O
onto	|O
viral	|O
RNA	|O
in	|O
mutated	|O
viruses	|O
was	|O
significantly	|O
less	|O
than	|O
that	|O
placed	|O
in	|O
the	|O
wild	|O
-	|O
type	|O
virus	|O
.	|O

This	|O
protein	|O
is	|O
present	|O
in	|O
both	|O
HeLa	|O
nuclear	|O
extracts	|O
and	|O
S100	|B-PROTEIN
extracts	|O
but	|O
absent	|O
from	|O
SR	|B-PROTEIN
protein	|O
preparations	|O
,	|O
suggesting	|O
that	|O
it	|O
is	|O
not	|O
a	|O
classical	|O
SR	|B-PROTEIN
protein	|O
.	|O

Differential	|O
regulation	|O
of	|O
the	|O
pre	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
and	|O
pregenomic	|O
promoters	|O
of	|O
human	|O
hepatitis	|O
B	|O
virus	|O
by	|O
members	|O
of	|O
the	|O
nuclear	|B-PROTEIN
receptor	|I-PROTEIN
superfamily	|I-PROTEIN
.	|O

Acad	|O
.	|O

Chimeras	|O
containing	|O
IE1	|B-PROTEIN
peptides	|O
dramatically	|O
activated	|O
transcription	|O
of	|O
the	|O
basal	|O
promoter	|O
only	|O
when	|O
lac	|B-PROTEIN
operator	|O
sequences	|O
were	|O
present	|O
.	|O

The	|O
results	|O
of	|O
replicase	|B-PROTEIN
assays	|O
performed	|O
with	|O
mutant	|O
VP2	|B-PROTEIN
containing	|O
a	|O
deletion	|O
in	|O
its	|O
RNA	|O
-	|O
binding	|O
domain	|O
suggests	|O
that	|O
the	|O
essential	|O
role	|O
for	|O
VP2	|B-PROTEIN
in	|O
replication	|O
is	|O
linked	|O
to	|O
the	|O
protein	|O
's	|O
ability	|O
to	|O
bind	|O
the	|O
mRNA	|O
template	|O
for	|O
minus	|O
-	|O
strand	|O
synthesis	|O
.	|O

We	|O
previously	|O
described	|O
two	|O
alanine	|O
cluster	|O
mutations	|O
,	|O
R77	|O
to	|O
A	|O
(	|O
R77A	|O
)	|O
-	|O
K79A	|O
and	|O
E192A	|O
-	|O
E194A	|O
,	|O
which	|O
selectively	|O
inactivated	|O
the	|O
triphosphatase	|O
component	|O
.	|O

Transfection	|O
of	|O
HepG2	|O
and	|O
SK	|O
-	|O
N	|O
-	|O
MC	|O
cells	|O
with	|O
constructs	|O
deleted	|O
of	|O
additional	|O
5'	|O
-	|O
flanking	|O
fragments	|O
permitted	|O
the	|O
definition	|O
of	|O
a	|O
minimal	|O
200	|O
bp	|O
promoter	|O
fragment	|O
containing	|O
the	|O
pseudo	|O
-	|O
TATA	|O
box	|O
and	|O
two	|O
putative	|O
SP1	|B-PROTEIN
-	|O
binding	|O
sites	|O
.	|O

Both	|O
inserts	|O
are	|O
larger	|O
than	|O
their	|O
homologues	|O
in	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
2alpha	|I-PROTEIN
kinases	|I-PROTEIN
.	|O

Three	|O
monopolar	|O
electrodes	|O
were	|O
inserted	|O
into	|O
the	|O
left	|O
and	|O
right	|O
lateral	|O
vestibulospinal	|O
tract	|O
(	|O
LVST	|O
)	|O
and	|O
medial	|O
vestibulospinal	|O
tract	|O
(	|O
MVST	|O
)	|O
of	|O
the	|O
C1	|O
segment	|O
,	|O
to	|O
determine	|O
the	|O
pathway	|O
of	|O
axons	|O
.	|O

Epitopes	|O
of	|O
adhesion	|O
-	|O
perturbing	|O
monoclonal	|O
antibodies	|O
map	|O
within	|O
a	|O
predicted	|O
alpha	|O
-	|O
helical	|O
domain	|O
of	|O
the	|O
integrin	|B-PROTEIN
beta	|O
1	|O
subunit	|O
.	|O

Polyhomeotic	|O
and	|O
Posterior	|B-PROTEIN
Sex	|I-PROTEIN
Combs	|I-PROTEIN
may	|O
participate	|O
in	|O
a	|O
more	|O
general	|O
transcriptional	|O
mechanism	|O
that	|O
causes	|O
modulated	|O
gene	|O
repression	|O
,	|O
whereas	|O
the	|O
inclusion	|O
of	|O
Polycomb	|B-PROTEIN
protein	|O
in	|O
the	|O
complex	|O
at	|O
PREs	|B-PROTEIN
leads	|O
to	|O
stable	|O
silencing	|O
.	|O

Furthermore	|O
,	|O
both	|O
rhHR23	|B-PROTEIN
proteins	|O
function	|O
in	|O
a	|O
defined	|O
NER	|O
system	|O
reconstituted	|O
with	|O
purified	|O
proteins	|O
,	|O
indicating	|O
direct	|O
involvement	|O
of	|O
hHR23	|B-PROTEIN
proteins	|O
in	|O
the	|O
DNA	|O
repair	|O
reaction	|O
via	|O
interaction	|O
with	|O
XPC	|B-PROTEIN
.	|O

The	|O
yeast	|O
silent	|O
information	|O
regulator	|O
Sir4p	|B-PROTEIN
anchors	|O
and	|O
partitions	|O
plasmids	|O
.	|O

These	|O
results	|O
implicate	|O
a	|O
precursor	|O
-	|O
specific	|O
base	|O
-	|O
paired	|O
structure	|O
involving	|O
sequences	|O
on	|O
both	|O
sides	|O
of	|O
the	|O
mature	|O
cleavage	|O
site	|O
in	|O
the	|O
3'	|O
processing	|O
of	|O
human	|O
U2	|B-PROTEIN
RNA	|O
.	|O

Polysome	|O
analyses	|O
in	|O
a	|O
temperature	|O
-	|O
sensitive	|O
fal1	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
mutant	|O
and	|O
a	|O
Fal1p	|B-PROTEIN
-	|O
depleted	|O
strain	|O
reveal	|O
a	|O
decrease	|O
in	|O
the	|O
number	|O
of	|O
40S	|B-PROTEIN
ribosomal	|O
subunits	|O
.	|O

Sequence	|O
analysis	|O
identified	|O
some	|O
of	|O
these	|O
cDNA	|O
clones	|O
as	|O
Dlc	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
a	|O
sequence	|O
encoding	|O
a	|O
small	|O
,	|O
9	|O
-	|O
kDa	|O
human	|O
homolog	|O
of	|O
the	|O
outer	|O
-	|O
arm	|O
dynein	|B-PROTEIN
light	|O
-	|O
chain	|O
protein	|O
.	|O

Importantly	|O
,	|O
in	|O
HeLa	|O
and	|O
293	|O
cells	|O
,	|O
endogenous	|O
and	|O
transfected	|O
I	|B-PROTEIN
kappaB	|I-PROTEIN
alpha	|I-PROTEIN
coimmunoprecipitated	|O
with	|O
Myc	|B-PROTEIN
-	|O
tagged	|O
or	|O
endogenous	|O
Dlc	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

The	|O
mouse	|O
M	|B-PROTEIN
-	|I-PROTEIN
lysozyme	|I-PROTEIN
downstream	|O
enhancer	|O
has	|O
been	|O
previously	|O
characterized	|O
on	|O
several	|O
levels	|O
of	|O
gene	|O
regulation	|O
.	|O

Identification	|O
of	|O
dynein	|B-PROTEIN
heavy	|O
chain	|O
genes	|O
expressed	|O
in	|O
human	|O
and	|O
mouse	|O
testis	|O
:	|O
chromosomal	|O
localization	|O
of	|O
an	|O
axonemal	|O
dynein	|B-PROTEIN
gene	|O
.	|O

Bitter	|O
cassava	|O
contains	|O
cyanogenic	|O
glycosides	|O
;	|O
processing	|O
breaks	|O
them	|O
down	|O
to	|O
acetone	|O
cyanohydrin	|O
and	|O
hydrogen	|O
cyanide	|O
.	|O

The	|O
proposed	|O
mechanism	|O
of	|O
effect	|O
states	|O
that	|O
mono	|O
(	|O
2	|O
-	|O
ethylhexyl	|O
)	|O
phthalate	|O
(	|O
MEHP	|O
)	|O
,	|O
the	|O
primary	|O
hydrolysis	|O
product	|O
of	|O
DEHP	|O
,	|O
mimics	|O
the	|O
inducing	|O
prostaglandins	|O
(	|O
PG	|O
)	|O
PGD	|O
(	|O
2	|O
)	|O
,	|O
9alpha	|O
,	|O
11betaPGF2	|O
,	|O
and	|O
PGF2alpha	|O
,	|O
and	|O
thromboxanes	|O
in	|O
the	|O
lungs	|O
,	|O
thereby	|O
increasing	|O
the	|O
risk	|O
of	|O
inducing	|O
inflammation	|O
in	|O
the	|O
airways	|O
,	|O
which	|O
is	|O
a	|O
characteristic	|O
of	|O
asthma	|O
.	|O

We	|O
found	|O
14	|O
protein	|O
binding	|O
sites	|O
that	|O
were	|O
occupied	|O
in	|O
vivo	|O
.	|O

Constitutive	|O
protection	|O
of	|O
E2F	|B-PROTEIN
recognition	|O
sequences	|O
in	|O
the	|O
human	|O
thymidine	|B-PROTEIN
kinase	|I-PROTEIN
promoter	|O
during	|O
cell	|O
cycle	|O
progression	|O
.	|O

Comparison	|O
of	|O
genomic	|O
sequence	|O
shows	|O
that	|O
the	|O
ph	|B-PROTEIN
locus	|O
has	|O
been	|O
duplicated	|O
,	|O
and	|O
that	|O
it	|O
contains	|O
proximal	|O
and	|O
distal	|O
transcription	|O
units	|O
.	|O

Radiation	|O
decreased	|O
the	|O
levels	|O
of	|O
T4	|O
and	|O
T3	|O
6	|O
h	|O
and	|O
72	|O
h	|O
in	|O
group	|O
C	|O
,	|O
in	|O
group	|O
A	|O
at	|O
72	|O
h	|O
,	|O
in	|O
group	|O
B	|O
at	|O
24	|O
h	|O
postexposure	|O
.	|O

We	|O
have	|O
reviewed	|O
the	|O
experience	|O
of	|O
a	|O
major	|O
MMT	|O
general	|O
practice	|O
with	|O
hepatitis	|O
C	|O
virus	|O
(	|O
HCV	|O
)	|O
infection	|O
from	|O
1991	|O
to	|O
1995	|O
.	|O

The	|O
author	|O
analyzes	|O
extensive	|O
own	|O
data	|O
based	|O
on	|O
study	|O
into	|O
particular	|O
features	|O
of	|O
cardiovascular	|O
disorders	|O
in	|O
chronic	|O
renal	|O
impairement	|O
with	|O
making	|O
use	|O
of	|O
modern	|O
diagnostic	|O
tools	|O
.	|O

In	|O
this	|O
paper	|O
,	|O
characterization	|O
is	|O
given	|O
of	|O
clinical	|O
and	|O
biochemical	|O
features	|O
of	|O
VH	|O
B	|O
course	|O
against	|O
the	|O
background	|O
of	|O
narcomania	|O
.	|O

447	|O
microns	|O
for	|O
A.	|O
microcephalum	|O
and	|O
350	|O
microns	|O
for	|O
A.	|O
wedli	|O
)	|O
,	|O
and	|O
fewer	|O
testes	|O
per	|O
proglottis	|O
(	|O
44-73	|O
vs.	|O

The	|O
ZnF20	|B-PROTEIN
cDNA	|O
hybridized	|O
to	|O
multiple	|O
transcripts	|O
in	|O
a	|O
thyroid	|O
cancer	|O
cell	|O
line	|O
(	|O
8.0	|O
,	|O
4.5	|O
and	|O
2	|O
kb	|O
)	|O
that	|O
increased	|O
after	|O
cycloheximide	|O
treatment	|O
and	|O
decayed	|O
<	|O
2	|O
h	|O
after	|O
addition	|O
of	|O
actinomycin	|O
D.	|O

Glutathione	|B-PROTEIN
S	|I-PROTEIN
-	|I-PROTEIN
transferase	|I-PROTEIN
(	|O
GST	|B-PROTEIN
)	|O
-	|O
E2F	|B-PROTEIN
and	|O
GST	|B-PROTEIN
-	|O
DP	|B-PROTEIN
fusion	|O
proteins	|O
were	|O
found	|O
to	|O
cooperate	|O
in	|O
binding	|O
to	|O
the	|O
three	|O
E2F	|B-PROTEIN
sites	|O
in	|O
the	|O
DNA	|B-PROTEIN
polymerase	|I-PROTEIN
alpha	|I-PROTEIN
gene	|O
promoter	|O
in	|O
vitro	|O
.	|O

Two	|O
sterol	|O
regulatory	|O
element	|O
-	|O
like	|O
sequences	|O
mediate	|O
up	|O
-	|O
regulation	|O
of	|O
caveolin	|B-PROTEIN
gene	|O
transcription	|O
in	|O
response	|O
to	|O
low	|B-PROTEIN
density	|I-PROTEIN
lipoprotein	|I-PROTEIN
free	|O
cholesterol	|O
.	|O

Furthermore	|O
,	|O
DNA	|O
-	|O
bound	|O
LAZ3	|B-PROTEIN
/	|O
BCL6	|B-PROTEIN
recruits	|O
SMRT	|B-PROTEIN
in	|O
vivo	|O
,	|O
and	|O
both	|O
overexpressed	|O
proteins	|O
completely	|O
colocalize	|O
in	|O
nuclear	|O
dots	|O
.	|O

CONCLUSIONS	|O
:	|O
We	|O
obtained	|O
normal	|O
EPO	|B-PROTEIN
levels	|O
for	|O
mothers	|O
and	|O
newborns	|O
for	|O
our	|O
area	|O
,	|O
similarly	|O
to	|O
the	|O
previously	|O
described	|O
ones	|O
.	|O

Ischaemia	|O
was	|O
induced	|O
by	|O
a	|O
low	|O
flow	|O
rate	|O
of	|O
0.8	|O
mL	|O
min	|O
-	|O
1	|O
for	|O
30	|O
min	|O
,	|O
and	|O
was	|O
followed	|O
by	|O
a	|O
40	|O
-	|O
minute	|O
reperfusion	|O
.	|O

First	|O
,	|O
two	|O
MCTs	|O
using	|O
a	|O
long	|O
electrode	|O
,	|O
3	|O
cm	|O
in	|O
size	|O
,	|O
were	|O
performed	|O
in	|O
the	|O
central	|O
area	|O
of	|O
the	|O
tumor	|O
,	|O
and	|O
eight	|O
MCTs	|O
by	|O
a	|O
short	|O
electrode	|O
,	|O
2	|O
cm	|O
in	|O
size	|O
,	|O
were	|O
done	|O
in	|O
the	|O
peripheral	|O
and	|O
surrounding	|O
area	|O
of	|O
the	|O
tumor	|O
.	|O

BACKGROUND	|O
:	|O
Checkpoint	|O
pathways	|O
prevent	|O
cell	|O
-	|O
cycle	|O
progression	|O
in	|O
the	|O
event	|O
of	|O
DNA	|O
lesions	|O
.	|O

Direct	|O
proof	|O
that	|O
the	|O
heightened	|O
renal	|O
cellular	|O
apoptosis	|O
in	|O
PKD	|O
is	|O
not	|O
occurring	|O
through	|O
p53	|B-PROTEIN
was	|O
obtained	|O
by	|O
successive	|O
matings	|O
between	|O
SBM	|O
and	|O
p53	|B-PROTEIN
(	|O
-	|O
/	|O
-	|O
)	|O
mice	|O
.	|O

Accumulated	|O
evidence	|O
indicates	|O
that	|O
,	|O
upon	|O
stimulation	|O
with	|O
interferon	|B-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
(	|O
IFN	|B-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
)	|O
,	|O
three	|O
beta	|O
-	|O
type	|O
subunits	|O
,	|O
designated	|O
LMP2	|B-PROTEIN
,	|O
LMP7	|B-PROTEIN
,	|O
and	|O
PSMB10	|B-PROTEIN
,	|O
are	|O
incorporated	|O
into	|O
the	|O
20S	|B-PROTEIN
proteasome	|O
by	|O
displacing	|O
the	|O
housekeeping	|O
beta	|O
-	|O
type	|O
subunits	|O
designated	|O
PSMB6	|B-PROTEIN
,	|O
PSMB5	|B-PROTEIN
,	|O
and	|O
PSMB7	|B-PROTEIN
,	|O
respectively	|O
.	|O

The	|O
major	|O
RNase	|B-PROTEIN
E	|I-PROTEIN
cleavage	|O
product	|O
(	|O
denoted	|O
pSok	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
)	|O
is	|O
rapidly	|O
degraded	|O
by	|O
polynucleotide	|B-PROTEIN
phosphorylase	|I-PROTEIN
(	|O
PNPase	|B-PROTEIN
)	|O
.	|O

This	|O
difference	|O
may	|O
result	|O
from	|O
the	|O
lower	|O
match	|O
to	|O
the	|O
ARG	|O
box	|O
consensus	|O
of	|O
the	|O
O	|O
(	|O
rocD	|B-PROTEIN
)	|O
site	|O
.	|O

Ask	|O
AONE	|O
's	|O
experts	|O
...	|O
about	|O
productivity	|O
indicators	|O
.	|O

All	|O
pigs	|O
had	|O
significant	|O
regional	|O
LV	|O
dysfunction	|O
and	|O
reduced	|O
LV	|O
ejection	|O
fraction	|O
(	|O
41	|O
+	|O
/	|O
-	|O
11%	|O
)	|O
.	|O

The	|O
progress	|O
of	|O
morphological	|O
research	|O
on	|O
the	|O
parabrachial	|O
nucleus	|O

The	|O
amplitudes	|O
of	|O
DPOAE	|O
also	|O
recovered	|O
to	|O
a	|O
greater	|O
extent	|O
and	|O
outer	|O
hair	|O
cell	|O
losses	|O
were	|O
less	|O
severe	|O
in	|O
the	|O
R	|O
-	|O
PIA	|O
-	|O
treated	|O
ears	|O
.	|O

The	|O
data	|O
provide	|O
evidence	|O
both	|O
for	|O
a	|O
signal	|O
transduction	|O
pathway	|O
independent	|O
of	|O
JNK	|B-PROTEIN
,	|O
ERK	|B-PROTEIN
,	|O
and	|O
p38	|B-PROTEIN
MAP	|O
kinase	|O
to	|O
be	|O
involved	|O
in	|O
the	|O
induction	|O
of	|O
rhoB	|B-PROTEIN
by	|O
genotoxic	|O
stress	|O
,	|O
and	|O
furthermore	|O
,	|O
indicate	|O
autoregulation	|O
of	|O
rhoB	|B-PROTEIN
.	|O

In	|O
an	|O
effort	|O
to	|O
separate	|O
domains	|O
of	|O
FadR	|B-PROTEIN
required	|O
for	|O
DNA	|O
binding	|O
,	|O
dimerization	|O
,	|O
and	|O
ligand	|O
binding	|O
,	|O
chimeric	|O
protein	|O
fusions	|O
between	|O
the	|O
DNA	|O
binding	|O
domain	|O
of	|O
LexA	|B-PROTEIN
and	|O
different	|O
regions	|O
of	|O
FadR	|B-PROTEIN
were	|O
constructed	|O
.	|O

Inhibition	|O
appears	|O
to	|O
result	|O
from	|O
titration	|O
of	|O
general	|O
transcription	|O
factors	|O
because	|O
MDM2	|B-PROTEIN
overexpression	|O
inhibits	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
as	|O
well	|O
as	|O
other	|O
promoters	|O
in	|O
vivo	|O
and	|O
basal	|O
transcription	|O
in	|O
vitro	|O
.	|O

4	|O
)	|O
PU	|B-PROTEIN
and	|O
PD	|B-PROTEIN
lacked	|O
the	|O
canonical	|O
TATA	|O
or	|O
CAAT	|O
motifs	|O
,	|O
and	|O
are	|O
AT	|O
-	|O
rich	|O
.	|O

We	|O
also	|O
show	|O
by	|O
immunogold	|O
electron	|O
microscopy	|O
immunocytochemistry	|O
that	|O
amphiphysin	|B-PROTEIN
I	|I-PROTEIN
is	|O
localized	|O
in	|O
the	|O
nerve	|O
terminal	|O
cytomatrix	|O
and	|O
is	|O
partially	|O
associated	|O
with	|O
endocytic	|O
intermediates	|O
.	|O

The	|O
mobility	|O
shift	|O
of	|O
both	|O
of	|O
these	|O
proteins	|O
is	|O
abolished	|O
by	|O
treatment	|O
with	|O
inhibitors	|O
of	|O
PKC	|B-PROTEIN
or	|O
mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
/	|O
extracellular	|B-PROTEIN
signal	|I-PROTEIN
-	|I-PROTEIN
related	|I-PROTEIN
kinase	|I-PROTEIN
kinase	|I-PROTEIN
.	|O

The	|O
prescription	|O
for	|O
apoplexy	|O
includes	|O
C1	|O
-	|O
7	|O
,	|O
T1	|O
-	|O
9	|O
and	|O
L2	|O
-	|O
4	|O
.	|O

During	|O
the	|O
aftermath	|O
of	|O
excitation	|O
of	|O
the	|O
skin	|O
sympathetic	|O
nerve	|O
by	|O
mental	|O
arithmetics	|O
,	|O
3/12	|O
A	|O
delta	|O
units	|O
were	|O
turned	|O
to	|O
the	|O
active	|O
state	|O
with	|O
decreased	|O
mechanical	|O
threshold	|O
.	|O

In	|O
a	|O
similar	|O
fashion	|O
to	|O
adipose	|O
stromal	|O
cells	|O
,	|O
serum	|O
potentiated	|O
the	|O
response	|O
to	|O
dexamethasone	|O
but	|O
had	|O
no	|O
effect	|O
on	|O
phorbol	|O
ester	|O
-	|O
stimulated	|O
activity	|O
.	|O

Thus	|O
,	|O
Hex	|B-PROTEIN
expression	|O
marks	|O
the	|O
earliest	|O
unequivocal	|O
molecular	|O
anteroposterior	|O
asymmetry	|O
in	|O
the	|O
mouse	|O
embryo	|O
and	|O
indicates	|O
that	|O
the	|O
anteroposterior	|O
axis	|O
of	|O
the	|O
embryo	|O
develops	|O
from	|O
conversion	|O
of	|O
a	|O
proximodistal	|O
asymmetry	|O
established	|O
in	|O
the	|O
primitive	|O
endoderm	|O
lineage	|O
.	|O

Thus	|O
,	|O
dpp	|B-PROTEIN
and	|O
omb	|B-PROTEIN
promote	|O
both	|O
dorsal	|O
leg	|O
cell	|O
fate	|O
as	|O
well	|O
as	|O
transdetermination	|O
-	|O
competent	|O
leg	|O
disc	|O
cells	|O
.	|O

CONCLUSIONS	|O
:	|O
While	|O
INR	|O
correction	|O
may	|O
be	|O
achieved	|O
by	|O
all	|O
the	|O
above	|O
methods	|O
,	|O
that	|O
relating	|O
log	|O
reference	|O
INR	|O
to	|O
log	|O
local	|O
prothrombin	|B-PROTEIN
time	|O
by	|O
linear	|O
regression	|O
analysis	|O
is	|O
the	|O
simplest	|O
to	|O
perform	|O
.	|O

RESULTS	|O
:	|O
The	|O
overall	|O
FNF	|O
for	|O
1992	|O
was	|O
12.3%	|O
and	|O
was	|O
19.1%	|O
,	|O
22.2%	|O
,	|O
3.8%	|O
and	|O
6.1%	|O
per	|O
successive	|O
quarters	|O
in	|O
1992	|O
.	|O

Western	|O
blot	|O
analysis	|O
of	|O
various	|O
bovine	|O
tissues	|O
with	|O
human	|O
NMT	|B-PROTEIN
peptide	|O
antibody	|O
indicated	|O
a	|O
common	|O
prominent	|O
immunoreactive	|O
band	|O
with	|O
an	|O
apparent	|O
molecular	|O
mass	|O
of	|O
48.5-50	|O
kDa	|O
in	|O
all	|O
tissues	|O
.	|O

Transcription	|O
start	|O
sites	|O
of	|O
the	|O
plastid	|O
ACCase	|B-PROTEIN
genes	|O
were	|O
estimated	|O
from	|O
the	|O
longest	|O
cDNA	|O
clones	|O
obtained	|O
by	|O
5'	|O
-	|O
RACE	|O
(	|O
rapid	|O
amplification	|O
of	|O
cDNA	|O
ends	|O
)	|O
.	|O

AIDS	|O
-	|O
related	|O
disseminated	|O
histoplasmosis	|O
in	|O
San	|O
Francisco	|O
,	|O
California	|O
.	|O

Thus	|O
,	|O
Fis	|B-PROTEIN
acts	|O
as	|O
an	|O
accessory	|O
transcriptional	|O
activator	|O
at	|O
the	|O
mar	|B-PROTEIN
promoter	|O
.	|O

These	|O
observations	|O
provide	|O
strong	|O
support	|O
for	|O
the	|O
idea	|O
that	|O
expression	|O
of	|O
mutant	|O
tRNA	|O
can	|O
confer	|O
a	|O
mutator	|O
phenotype	|O
,	|O
including	|O
the	|O
UVM	|O
-	|O
constitutive	|O
phenotype	|O
observed	|O
in	|O
mutA	|B-PROTEIN
and	|O
mutC	|B-PROTEIN
cells	|O
.	|O

TNF	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
exposure	|O
markedly	|O
increased	|O
activity	|O
of	|O
several	|O
RNA	|O
-	|O
binding	|O
proteins	|O
,	|O
especially	|O
a	|O
novel	|O
Mr	|O
50,000-55,000	|O
RNA	|O
-	|O
binding	|O
protein	|O
.	|O

We	|O
speculate	|O
that	|O
the	|O
human	|O
papillomavirus	|O
late	|O
mRNAs	|O
,	|O
produced	|O
from	|O
several	|O
hundred	|O
copies	|O
of	|O
the	|O
virus	|O
genome	|O
present	|O
in	|O
infected	|O
cells	|O
,	|O
compete	|O
with	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
mRNAs	|O
for	|O
destabilizing	|O
cellular	|O
factors	|O
and	|O
that	|O
this	|O
may	|O
lead	|O
to	|O
elevated	|O
Fos	|B-PROTEIN
protein	|O
levels	|O
in	|O
human	|O
papillomavirus	|O
infected	|O
cells	|O
.	|O

Two	|O
closely	|O
related	|O
IgH	|B-PROTEIN
constant	|O
region	|O
genes	|O
,	|O
CHA	|B-PROTEIN
and	|O
CHB	|B-PROTEIN
,	|O
have	|O
been	|O
sequenced	|O
completely	|O
.	|O

The	|O
aim	|O
of	|O
this	|O
study	|O
was	|O
to	|O
find	|O
out	|O
whether	|O
it	|O
was	|O
possible	|O
to	|O
detect	|O
normal	|O
lymph	|O
nodes	|O
by	|O
high	|O
-	|O
resolution	|O
mediastinal	|O
US	|O
.	|O

To	|O
study	|O
the	|O
role	|O
of	|O
heavy	|O
chain	|O
motifs	|O
in	|O
substrate	|O
recognition	|O
,	|O
secreted	|O
variants	|O
of	|O
recombinant	|O
bovine	|O
proenteropeptidase	|B-PROTEIN
were	|O
constructed	|O
by	|O
replacing	|O
the	|O
transmembrane	|O
domain	|O
with	|O
a	|O
signal	|O
peptide	|O
.	|O

CKbeta4GT	|B-PROTEIN
-	|I-PROTEIN
II	|I-PROTEIN
is	|O
predicted	|O
to	|O
encode	|O
a	|O
type	|B-PROTEIN
II	|I-PROTEIN
transmembrane	|I-PROTEIN
glycoprotein	|I-PROTEIN
of	|O
43	|O
kDa	|O
with	|O
five	|O
potential	|O
N	|O
-	|O
linked	|O
glycosylation	|O
sites	|O
.	|O

We	|O
now	|O
demonstrate	|O
that	|O
CCAAT	|O
/	|O
enhancer	|O
-	|O
binding	|O
protein	|O
(	|B-PROTEIN
C	|I-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
)	|I-PROTEIN
delta	|I-PROTEIN
is	|O
a	|O
major	|O
component	|O
of	|O
a	|O
PGE2	|O
-	|O
stimulated	|O
DNA	|O
-	|O
protein	|O
complex	|O
involving	|O
HS3D	|B-PROTEIN
and	|O
find	|O
that	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBPdelta	|I-PROTEIN
transactivates	|O
IGF	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
promoter	|O
1	|O
through	|O
this	|O
site	|O
.	|O

PATIENTS	|O
AND	|O
METHODS	|O
:	|O
Semen	|O
analyses	|O
were	|O
performed	|O
on	|O
58	|O
patients	|O
with	|O
stages	|O
I	|O
-	|O
III	|O
HD	|O
before	|O
,	|O
during	|O
,	|O
and	|O
after	|O
chemotherapy	|O
and	|O
after	|O
the	|O
sperm	|O
count	|O
recovered	|O
from	|O
the	|O
effects	|O
of	|O
abdominal	|O
radiotherapy	|O
that	|O
was	|O
given	|O
after	|O
chemotherapy	|O
.	|O

Thus	|O
,	|O
the	|O
absence	|O
of	|O
residual	|O
infarct	|O
-	|O
zone	|O
viability	|O
discriminates	|O
patients	|O
who	|O
develop	|O
progressive	|O
left	|O
ventricular	|O
dilation	|O
after	|O
reperfused	|O
AMI	|O
from	|O
those	|O
who	|O
maintain	|O
normal	|O
left	|O
ventricular	|O
geometry	|O
.	|O

With	|O
a	|O
BMI	|O
cutoff	|O
of	|O
27	|O
,	|O
mean	|O
cardiac	|O
NE	|O
spillover	|O
was	|O
46%	|O
lower	|O
in	|O
the	|O
obese	|O
subjects	|O
when	|O
compared	|O
with	|O
the	|O
lean	|O
subjects	|O
(	|O
P	|O
=	|O
.017	|O
)	|O
.	|O

The	|O
gene	|O
(	|O
ApxII	|B-PROTEIN
)	|O
encoding	|O
both	|O
chloroplastic	|O
ascorbate	|B-PROTEIN
peroxidase	|I-PROTEIN
isoenzymes	|O
was	|O
isolated	|O
and	|O
the	|O
organization	|O
of	|O
the	|O
gene	|O
was	|O
determined	|O
.	|O

This	|O
emphasizes	|O
the	|O
conclusion	|O
that	|O
CDF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
not	|O
an	|O
E2F	|B-PROTEIN
family	|O
member	|O
and	|O
points	|O
to	|O
profound	|O
differences	|O
in	|O
the	|O
cell	|O
cycle	|O
regulation	|O
of	|O
CDF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
E2F	|B-PROTEIN
.	|O

The	|O
proofreading	|O
domain	|O
of	|O
Escherichia	|O
coli	|O
DNA	|B-PROTEIN
polymerase	|I-PROTEIN
I	|I-PROTEIN
and	|O
other	|O
DNA	|B-PROTEIN
and	|I-PROTEIN
/	|I-PROTEIN
or	|I-PROTEIN
RNA	|I-PROTEIN
exonuclease	|I-PROTEIN
domains	|O
.	|O

Interleukin	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
levels	|O
remained	|O
low	|O
throughout	|O
the	|O
course	|O
.	|O

Responsibility	|O
matters	|O
-	|O
-	|O
this	|O
is	|O
a	|O
scientific	|O
council	|O

Southern	|O
blot	|O
analysis	|O
of	|O
endonuclease	|O
-	|O
digested	|O
genomic	|O
DNA	|O
from	|O
primary	|O
chick	|O
embryo	|O
fibroblasts	|O
(	|O
CEF	|O
)	|O
suggested	|O
that	|O
MEK2	|B-PROTEIN
is	|O
a	|O
single	|O
-	|O
copy	|O
gene	|O
in	|O
this	|O
vertebrate	|O
species	|O
.	|O

Sequences	|O
required	|O
for	|O
interaction	|O
of	|O
mu2	|B-PROTEIN
and	|O
CTLA	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
were	|O
localized	|O
to	|O
residues	|O
,	|O
161TTGVY	|O
in	|O
CTLA	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
;	|O
this	|O
sequence	|O
is	|O
N	|O
-	|O
terminal	|O
to	|O
,	|O
but	|O
overlaps	|O
with	|O
,	|O
a	|O
previously	|O
identified	|O
SH2	|B-PROTEIN
binding	|O
motif	|O
,	|O
165YVKM	|O
,	|O
involved	|O
in	|O
CTLA	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
signaling	|O
.	|O

Here	|O
,	|O
we	|O
report	|O
that	|O
a	|O
transfected	|O
Chinese	|O
hamster	|O
ovary	|O
(	|O
CHO	|O
)	|O
cell	|O
line	|O
expressing	|O
a	|O
murine	|O
CD4	|B-PROTEIN
fragment	|O
containing	|O
the	|O
first	|O
two	|O
N	|O
-	|O
terminal	|O
domains	|O
secretes	|O
both	|O
monomeric	|O
molecules	|O
and	|O
disulfide	|O
-	|O
linked	|O
multimers	|O
.	|O

SCID	|O
V	|B-PROTEIN
(	|O
D	|B-PROTEIN
)	|O
J	|B-PROTEIN
recombination	|O
can	|O
be	|O
partly	|O
rescued	|O
in	|O
T	|O
-	|O
lymphocytes	|O
by	|O
either	|O
DNA	|O
-	|O
damaging	|O
agents	|O
(	|O
gamma	|O
-	|O
irradiation	|O
and	|O
bieomycin	|O
)	|O
or	|O
a	|O
null	|O
mutation	|O
of	|O
the	|O
p53	|B-PROTEIN
gene	|O
,	|O
possibly	|O
because	|O
of	|O
transiently	|O
elevated	|O
DNA	|O
repair	|O
activity	|O
in	|O
response	|O
to	|O
DNA	|O
damage	|O
or	|O
to	|O
delayed	|O
apoptosis	|O
in	|O
the	|O
absence	|O
of	|O
p53	|B-PROTEIN
.	|O

Coexpression	|O
of	|O
mouse	|O
PKR	|B-PROTEIN
(	|I-PROTEIN
1-515	|I-PROTEIN
)	|I-PROTEIN
WT	|I-PROTEIN
as	|O
a	|O
Gal4	|B-PROTEIN
DNA	|O
-	|O
binding	|O
domain	|O
fusion	|O
with	|O
either	|O
the	|O
catalytic	|O
-	|O
deficient	|O
human	|O
PKR	|B-PROTEIN
(	|O
1-551	|O
)	|O
K296R	|O
mutant	|O
,	|O
the	|O
RNA	|O
-	|O
binding	|O
-	|O
deficient	|O
human	|O
PKR	|B-PROTEIN
(	|O
1-551	|O
)	|O
K64E	|O
/	|O
K296R	|O
double	|O
mutant	|O
,	|O
or	|O
wild	|O
-	|O
type	|O
mouse	|O
PKR	|B-PROTEIN
(	|O
1-515	|O
)	|O
WT	|O
as	|O
full	|O
-	|O
length	|O
PKR	|B-PROTEIN
-	|O
Gal4	|B-PROTEIN
activation	|O
domain	|O
fusions	|O
resulted	|O
in	|O
activation	|O
of	|O
the	|O
HIS3	|B-PROTEIN
and	|O
lacZ	|B-PROTEIN
reporters	|O
.	|O

Using	|O
GST	|B-PROTEIN
-	|O
PKR	|B-PROTEIN
fusion	|O
chromatography	|O
,	|O
direct	|O
physical	|O
interaction	|O
between	|O
the	|O
mouse	|O
and	|O
human	|O
PKR	|B-PROTEIN
homologs	|O
was	|O
established	|O
.	|O

An	|O
even	|O
greater	|O
inflammatory	|O
response	|O
was	|O
observed	|O
after	|O
intratracheal	|O
instillation	|O
of	|O
ufCB	|O
,	|O
but	|O
not	|O
after	|O
CB	|O
instillation	|O
.	|O

Interestingly	|O
,	|O
the	|O
avirulent	|O
strain	|O
H37Ra	|O
showed	|O
weak	|O
hybridization	|O
with	|O
these	|O
two	|O
probes	|O
,	|O
suggesting	|O
that	|O
these	|O
genes	|O
might	|O
have	|O
been	|O
deleted	|O
in	|O
the	|O
avirulent	|O
strain	|O
or	|O
are	|O
present	|O
in	|O
limited	|O
copy	|O
numbers	|O
as	|O
opposed	|O
to	|O
those	|O
in	|O
the	|O
virulent	|O
strain	|O
H37Rv	|O
.	|O

These	|O
defects	|O
no	|O
doubt	|O
impair	|O
the	|O
folding	|O
and	|O
configuration	|O
necessary	|O
for	|O
normal	|O
processing	|O
of	|O
the	|O
AVP	|B-PROTEIN
gene	|O
precursor	|O
.	|O

Similarities	|O
between	|O
the	|O
hIGFBP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
phosphoenolpyruvate	|B-PROTEIN
kinase	|I-PROTEIN
(	|O
PEPCK	|B-PROTEIN
)	|O
promoters	|O
,	|O
including	|O
regions	|O
conferring	|O
insulin	|B-PROTEIN
,	|O
glucocorticoid	|O
,	|O
and	|O
cyclic	|O
adenosine	|O
-	|O
monophosphate	|O
responses	|O
,	|O
are	|O
consistent	|O
with	|O
our	|O
previous	|O
hypothesis	|O
that	|O
IGFBP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
involved	|O
in	|O
regulation	|O
of	|O
glucose	|O
metabolism	|O
.	|O

This	|O
binary	|O
repeat	|O
contains	|O
repetitive	|O
DNA	|O
elements	|O
that	|O
include	|O
LINES	|O
,	|O
SINES	|O
,	|O
medium	|O
reiteration	|O
frequency	|O
repeats	|O
,	|O
and	|O
a	|O
transposon	|O
-	|O
like	|O
element	|O
.	|O

At	|O
60	|O
days	|O
the	|O
amount	|O
of	|O
gangliosides	|O
was	|O
on	|O
average	|O
lower	|O
in	|O
females	|O
than	|O
in	|O
males	|O
,	|O
even	|O
if	|O
with	|O
some	|O
exception	|O
.	|O

Large	|O
genomic	|O
constructs	|O
integrate	|O
at	|O
the	|O
endogenous	|O
locus	|O
by	|O
homologous	|O
recombination	|O
,	|O
but	|O
cDNA	|O
-	|O
derived	|O
sequences	|O
lacking	|O
long	|O
stretches	|O
of	|O
contiguous	|O
genomic	|O
DNA	|O
(	|O
due	|O
to	|O
intron	|O
excision	|O
)	|O
typically	|O
integrate	|O
into	|O
chromosomal	|O
DNA	|O
by	|O
nonhomologous	|O
recombination	|O
.	|O

The	|O
existence	|O
of	|O
these	|O
two	|O
categories	|O
of	|O
strains	|O
offers	|O
a	|O
new	|O
genetic	|O
system	|O
in	|O
which	|O
the	|O
properties	|O
of	|O
a	|O
potential	|O
invertebrate	|O
retrovirus	|O
can	|O
be	|O
tested	|O
.	|O

During	|O
the	|O
conditioning	|O
procedure	|O
,	|O
the	|O
C	|O
-	|O
fiber	|O
reflex	|O
was	|O
facilitated	|O
(	|O
wind	|O
-	|O
up	|O
)	|O
in	|O
a	|O
stimulus	|O
-	|O
dependent	|O
fashion	|O
in	|O
intact	|O
,	|O
anesthetized	|O
animals	|O
during	|O
the	|O
application	|O
of	|O
the	|O
first	|O
seven	|O
conditioning	|O
stimuli	|O
;	|O
thereafter	|O
,	|O
the	|O
magnitude	|O
of	|O
the	|O
responses	|O
reached	|O
a	|O
plateau	|O
and	|O
then	|O
decreased	|O
.	|O

As	|O
a	|O
sequence	|O
-	|O
specific	|O
DNA	|O
binding	|O
transcription	|O
factor	|O
,	|O
p53	|B-PROTEIN
specifically	|O
binds	|O
to	|O
a	|O
20	|O
-	|O
bp	|O
consensus	|O
motif	|O
5'	|O
-	|O
PuPuPuC	|O
(	|O
A	|O
/	|O
T	|O
)	|O
(	|O
T	|O
/	|O
A	|O
)	|O
GPyPyPyPuPuPuC	|O
(	|O
A	|O
/	|O
T	|O
)	|O
(	|O
T	|O
/	|O
A	|O
)	|O
GPyPyPy	|O
-	|O
3'	|O
.	|O

TSA	|O
treatment	|O
,	|O
however	|O
,	|O
did	|O
not	|O
detectably	|O
alter	|O
enhancer	|O
factor	|O
binding	|O
or	|O
the	|O
positioning	|O
of	|O
nuc	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
on	|O
the	|O
majority	|O
of	|O
the	|O
chromatin	|O
templates	|O
indicating	|O
that	|O
protein	|O
acetylation	|O
and	|O
chromatin	|O
remodeling	|O
may	|O
be	|O
limiting	|O
steps	|O
that	|O
occur	|O
only	|O
on	|O
transcriptionally	|O
competent	|O
templates	|O
,	|O
or	|O
that	|O
remodeling	|O
of	|O
nuc	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
requires	|O
additional	|O
factors	|O
.	|O

Upon	|O
UV	|O
damage	|O
,	|O
Crb2	|B-PROTEIN
is	|O
transiently	|O
modified	|O
,	|O
probably	|O
phosphorylated	|O
,	|O
with	|O
a	|O
similar	|O
timing	|O
of	|O
phosphorylation	|O
in	|O
Chk1	|B-PROTEIN
kinase	|O
,	|O
which	|O
is	|O
reported	|O
to	|O
restrain	|O
Cdc2	|B-PROTEIN
activation	|O
.	|O

Moreover	|O
,	|O
moderate	|O
overexpression	|O
of	|O
Chk1	|B-PROTEIN
suppresses	|O
the	|O
phenotypes	|O
of	|O
cut5	|B-PROTEIN
and	|O
crb2	|B-PROTEIN
mutants	|O
.	|O

Tcn1p	|B-PROTEIN
/	|O
Crz1p	|B-PROTEIN
,	|O
a	|O
calcineurin	|B-PROTEIN
-	|O
dependent	|O
transcription	|O
factor	|O
that	|O
differentially	|O
regulates	|O
gene	|O
expression	|O
in	|O
Saccharomyces	|O
cerevisiae	|O
.	|O

Structure	|O
and	|O
localization	|O
of	|O
the	|O
human	|O
gene	|O
encoding	|O
SR	|B-PROTEIN
-	|I-PROTEIN
BI	|I-PROTEIN
/	|O
CLA	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

We	|O
introduced	|O
the	|O
gel	|O
technique	|O
as	|O
a	|O
routine	|O
assay	|O
for	|O
antibody	|O
detection	|O
and	|O
identification	|O
in	|O
1993	|O
.	|O

Stability	|O
of	|O
pyrimethamine	|O
in	|O
a	|O
liquid	|O
dosage	|O
formulation	|O
stored	|O
for	|O
three	|O
months	|O
.	|O

Multiple	|O
regression	|O
analyses	|O
revealed	|O
that	|O
WAIS	|O
-	|O
R	|O
factor	|O
scores	|O
Verbal	|O
Comprehension	|O
and	|O
Freedom	|O
from	|O
Distractibility	|O
accounted	|O
for	|O
up	|O
to	|O
42%	|O
of	|O
the	|O
variance	|O
in	|O
WMS	|O
-	|O
R	|O
and	|O
CVLT	|O
indices	|O
.	|O

Bilateral	|O
basal	|O
arteries	|O
were	|O
measured	|O
by	|O
the	|O
transtemporal	|O
approach	|O
with	|O
a	|O
2	|O
MHz	|O
pulsed	|O
Doppler	|O
instrument	|O
(	|O
TC	|O
-	|O
2	|O
64B	|O
EME	|O
)	|O
.	|O

At	|O
the	|O
genomic	|O
level	|O
,	|O
the	|O
sequences	|O
of	|O
two	|O
members	|O
of	|O
this	|O
family	|O
are	|O
known	|O
in	|O
the	|O
rat	|O
Rattus	|O
norvegicus	|O
:	|O
the	|O
VCSA1	|B-PROTEIN
gene	|O
,	|O
encoding	|O
the	|O
prohormone	|O
-	|O
like	|O
polypeptide	|O
SMR1	|B-PROTEIN
,	|O
and	|O
the	|O
VCSB1	|B-PROTEIN
gene	|O
,	|O
encoding	|O
a	|O
salivary	|O
Pro	|O
-	|O
rich	|O
polypeptide	|O
.	|O

The	|O
Saccharomyces	|O
cerevisiae	|O
RAD30	|B-PROTEIN
gene	|O
,	|O
a	|O
homologue	|O
of	|O
Escherichia	|O
coli	|O
dinB	|B-PROTEIN
and	|O
umuC	|B-PROTEIN
,	|O
is	|O
DNA	|O
damage	|O
inducible	|O
and	|O
functions	|O
in	|O
a	|O
novel	|O
error	|O
-	|O
free	|O
postreplication	|O
repair	|O
mechanism	|O
.	|O

However	|O
,	|O
in	|O
a	|O
new	|O
experiment	|O
in	|O
which	|O
the	|O
deletion	|O
task	|O
was	|O
presented	|O
as	|O
a	|O
puppet	|O
game	|O
,	|O
and	|O
with	|O
pretraining	|O
and	|O
selection	|O
on	|O
vowel	|O
deletion	|O
,	|O
a	|O
significantly	|O
higher	|O
level	|O
of	|O
success	|O
was	|O
achieved	|O
by	|O
the	|O
children	|O
working	|O
with	|O
the	|O
CVCC	|O
material	|O
.	|O

Diet	|O
therapy	|O
with	|O
soy	|O
proteins	|O
for	|O
chronic	|O
stomach	|O
ulcers	|O

In	|O
ICU	|O
patients	|O
,	|O
the	|O
LIS	|O
related	|O
to	|O
the	|O
postoperative	|O
rise	|O
in	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
level	|O
only	|O
,	|O
even	|O
though	|O
the	|O
rise	|O
in	|O
plasma	|O
concentrations	|O
of	|O
cytokines	|O
interrelated	|O
.	|O

Resistance	|O
training	|O
shifts	|O
the	|O
power	|O
curve	|O
in	|O
a	|O
positive	|O
direction	|O
when	|O
the	|O
measurements	|O
are	|O
determined	|O
with	|O
absolute	|O
loads	|O
,	|O
but	|O
the	|O
increased	|O
power	|O
may	|O
not	|O
be	|O
transferred	|O
to	|O
an	|O
absolute	|O
performance	|O
task	|O
like	|O
the	|O
SSP	|O
.	|O

Gel	|O
-	|O
shift	|O
assays	|O
identified	|O
two	|O
Sp1	|B-PROTEIN
binding	|O
sites	|O
within	|O
this	|O
element	|O
.	|O

Y15170	|B-PROTEIN
(	|O
Surf	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
,	|O
Surf	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
)	|O
,	|O
Y15171	|B-PROTEIN
(	|O
Surf	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
,	|O
Surf	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
Surf	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
)	|O
,	|O
and	|O
Y15172	|B-PROTEIN
(	|O
Surf	|B-PROTEIN
-	|I-PROTEIN
5	|I-PROTEIN
.	|O
)	|O
]	|O

Gel	|O
mobility	|O
shift	|O
and	|O
super	|O
-	|O
shift	|O
assays	|O
using	|O
liver	|O
nuclear	|O
extracts	|O
from	|O
either	|O
rat	|O
liver	|O
or	|O
DDT1MF	|O
-	|O
2	|O
cells	|O
demonstrated	|O
that	|O
the	|O
CRE	|O
in	|O
the	|O
alpha	|B-PROTEIN
1B	|I-PROTEIN
-	|I-PROTEIN
AR	|I-PROTEIN
gene	|O
bound	|O
CRE	|B-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
.	|O

These	|O
results	|O
suggest	|O
that	|O
,	|O
in	|O
this	|O
experimental	|O
model	|O
,	|O
ACE	|B-PROTEIN
inhibitors	|O
limit	|O
the	|O
arrhythmias	|O
following	|O
ischemia	|O
-	|O
reperfusion	|O
and	|O
free	|O
radical	|O
scavenging	|O
action	|O
of	|O
these	|O
drugs	|O
does	|O
not	|O
have	|O
a	|O
major	|O
contributory	|O
role	|O
in	|O
their	|O
protective	|O
effect	|O
.	|O

The	|O
mean	|O
values	|O
of	|O
the	|O
first	|O
three	|O
components	|O
were	|O
not	|O
significantly	|O
different	|O
in	|O
ARVD	|O
patients	|O
and	|O
control	|O
subjects	|O
.	|O

However	|O
,	|O
the	|O
signaling	|O
cascade	|O
utilized	|O
by	|O
the	|O
urokinase	|B-PROTEIN
receptor	|I-PROTEIN
is	|O
only	|O
incompletely	|O
understood	|O
.	|O

The	|O
murine	|O
Htf9	|B-PROTEIN
-	|I-PROTEIN
a	|I-PROTEIN
/	|O
RanBP1	|B-PROTEIN
and	|O
Htf9	|B-PROTEIN
-	|I-PROTEIN
c	|I-PROTEIN
genes	|O
are	|O
divergently	|O
transcribed	|O
from	|O
a	|O
shared	|O
TATA	|O
-	|O
less	|O
promoter	|O
.	|O

In	|O
accordance	|O
with	|O
clinical	|O
improvement	|O
we	|O
found	|O
a	|O
decrease	|O
of	|O
laboratory	|O
indicators	|O
of	|O
inflammation	|O
(	|O
C	|B-PROTEIN
-	|I-PROTEIN
reactive	|I-PROTEIN
protein	|I-PROTEIN
,	|O
alpha	|B-PROTEIN
2	|I-PROTEIN
-	|I-PROTEIN
globuline	|I-PROTEIN
,	|O
prostaglandin	|O
E2	|O
)	|O
.	|O

We	|O
have	|O
previously	|O
reported	|O
that	|O
depletion	|O
of	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
C	|I-PROTEIN
by	|O
long	|O
-	|O
term	|O
treatment	|O
of	|O
B16	|O
mouse	|O
melanoma	|O
cells	|O
with	|O
phorbol	|O
dibutyrate	|O
(	|O
PDBu	|O
)	|O
prevented	|O
cell	|O
density	|O
-	|O
dependent	|O
melanogenesis	|O
.	|O

Replacement	|O
of	|O
residues	|O
in	|O
positions	|O
+	|O
3	|O
(	|O
His128Asn	|O
)	|O
and	|O
+	|O
2	|O
(	|O
Gln155Lys	|O
)	|O
of	|O
the	|O
reading	|O
helices	|O
of	|O
fingers	|O
2	|O
and	|O
3	|O
,	|O
respectively	|O
,	|O
prevented	|O
binding	|O
.	|O

Two	|O
disulphide	|O
bridges	|O
,	|O
which	|O
are	|O
conserved	|O
in	|O
all	|O
spermadhesin	|O
molecules	|O
and	|O
many	|O
CUB	|O
domains	|O
,	|O
crosslink	|O
loop	|O
LA	|O
and	|O
strand	|O
beta	|O
4	|O
and	|O
loops	|O
LE	|O
and	|O
LG	|O
,	|O
respectively	|O
,	|O
at	|O
opposite	|O
edges	|O
of	|O
the	|O
same	|O
face	|O
of	|O
the	|O
domain	|O
.	|O

Mg	|B-PROTEIN
-	|I-PROTEIN
chelatase	|I-PROTEIN
of	|O
tobacco	|O
:	|O
identification	|O
of	|O
a	|O
Chl	|B-PROTEIN
D	|I-PROTEIN
cDNA	|O
sequence	|O
encoding	|O
a	|O
third	|O
subunit	|O
,	|O
analysis	|O
of	|O
the	|O
interaction	|O
of	|O
the	|O
three	|O
subunits	|O
with	|O
the	|O
yeast	|O
two	|O
-	|O
hybrid	|O
system	|O
,	|O
and	|O
reconstitution	|O
of	|O
the	|O
enzyme	|O
activity	|O
by	|O
co	|O
-	|O
expression	|O
of	|O
recombinant	|O
CHL	|B-PROTEIN
D	|I-PROTEIN
,	|O
CHL	|B-PROTEIN
H	|I-PROTEIN
and	|O
CHL	|B-PROTEIN
I.	|I-PROTEIN

One	|O
R	|O
-	|O
EST	|O
and	|O
one	|O
Pto	|B-PROTEIN
-	|O
like	|O
sequence	|O
each	|O
mapped	|O
to	|O
two	|O
locations	|O
.	|O

The	|O
multidomain	|O
structure	|O
includes	|O
a	|O
cysteine	|O
-	|O
rich	|O
motif	|O
resembling	|O
those	|O
of	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
C	|I-PROTEIN
and	|O
n	|B-PROTEIN
-	|I-PROTEIN
chimaerin	|I-PROTEIN
and	|O
a	|O
putative	|O
pleckstrin	|B-PROTEIN
homology	|O
domain	|O
.	|O

The	|O
interaction	|O
between	|O
DDB	|B-PROTEIN
and	|O
E2F1	|B-PROTEIN
can	|O
also	|O
be	|O
detected	|O
by	|O
coimmunoprecipitation	|O
experiments	|O
.	|O

271	|O
:	|O
31290-31295	|O
,	|O
1996	|O
)	|O
.	|O

Nevertheless	|O
,	|O
antibodies	|O
directed	|O
against	|O
an	|O
epitope	|O
-	|O
tagged	|O
version	|O
of	|O
Prp42p	|B-PROTEIN
specifically	|O
precipitate	|O
U1	|B-PROTEIN
snRNA	|O
from	|O
yeast	|O
extracts	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
in	|O
addition	|O
to	|O
Grb2	|B-PROTEIN
-	|O
mediated	|O
activation	|O
of	|O
Ras	|B-PROTEIN
,	|O
PLC	|B-PROTEIN
-	|I-PROTEIN
gamma1	|I-PROTEIN
-	|O
mediated	|O
DAG	|O
production	|O
is	|O
required	|O
for	|O
EGF	|B-PROTEIN
-	|O
and	|O
PDGF	|B-PROTEIN
-	|O
induced	|O
S	|O
-	|O
phase	|O
entry	|O
and	|O
gene	|O
expression	|O
,	|O
possibly	|O
through	|O
activation	|O
of	|O
PKC	|B-PROTEIN
.	|O

In	|O
this	|O
study	|O
,	|O
we	|O
investigated	|O
STAT	|B-PROTEIN
activation	|O
in	|O
a	|O
panel	|O
of	|O
rodent	|O
fibroblast	|O
cell	|O
lines	|O
stably	|O
transformed	|O
by	|O
diverse	|O
viral	|O
oncoproteins	|O
.	|O

In	|O
serum	|O
-	|O
stimulated	|O
cells	|O
,	|O
the	|O
binding	|O
of	|O
NF	|B-PROTEIN
-	|I-PROTEIN
Y	|I-PROTEIN
/	|O
CBF	|B-PROTEIN
to	|O
TKC1	|B-PROTEIN
increased	|O
gradually	|O
,	|O
reaching	|O
a	|O
plateau	|O
at	|O
the	|O
S	|O
phase	|O
.	|O

CONCLUSION	|O
:	|O
In	|O
our	|O
animal	|O
model	|O
,	|O
blood	|O
-	|O
brain	|O
barrier	|O
disruption	|O
was	|O
a	|O
reproducible	|O
,	|O
integral	|O
finding	|O
of	|O
single	|O
-	|O
fraction	|O
,	|O
high	|O
-	|O
dose	|O
irradiation	|O
injury	|O
.	|O

To	|O
facilitate	|O
the	|O
investigation	|O
of	|O
parameters	|O
that	|O
govern	|O
selective	|O
export	|O
in	|O
adenovirus	|O
-	|O
infected	|O
cells	|O
,	|O
we	|O
constructed	|O
a	|O
marked	|O
human	|O
beta	|B-PROTEIN
-	|I-PROTEIN
actin	|I-PROTEIN
minigene	|O
under	|O
the	|O
control	|O
of	|O
the	|O
glucocorticoid	|B-PROTEIN
-	|I-PROTEIN
inducible	|I-PROTEIN
enhancer	|I-PROTEIN
-	|I-PROTEIN
promoter	|I-PROTEIN
of	|O
mouse	|O
mammary	|O
tumor	|O
virus	|O
and	|O
introduced	|O
it	|O
into	|O
the	|O
left	|O
end	|O
of	|O
the	|O
adenovirus	|O
type	|O
5	|O
(	|O
Ad5	|O
)	|O
genome	|O
.	|O

Cell	|O
factor	|O
-	|O
mediated	|O
regulatory	|O
interactions	|O
are	|O
involved	|O
in	|O
regulating	|O
the	|O
restricted	|O
expression	|O
of	|O
the	|O
HCMV	|O
major	|O
immediate	|B-PROTEIN
-	|I-PROTEIN
early	|I-PROTEIN
(	|O
IE	|B-PROTEIN
)	|O
gene	|O
(	|O
J.	|O

MpB	|O
GroEL	|B-PROTEIN
has	|O
extensive	|O
sequence	|O
similarity	|O
(	|O
92%	|O
)	|O
with	|O
Escherichia	|O
coli	|O
GroEL	|B-PROTEIN
and	|O
other	|O
members	|O
of	|O
the	|O
chaperonin	|B-PROTEIN
-	|I-PROTEIN
60	|I-PROTEIN
family	|O
.	|O

The	|O
critical	|O
mutations	|O
were	|O
likely	|O
to	|O
have	|O
been	|O
multiple	|O
and	|O
dispersed	|O
,	|O
including	|O
elongation	|O
of	|O
the	|O
TM	|O
and	|O
Nef	|B-PROTEIN
coding	|O
sequences	|O
;	|O
changes	|O
in	|O
RNA	|O
splice	|O
donor	|O
and	|O
acceptor	|O
sites	|O
,	|O
TATA	|O
box	|O
sites	|O
,	|O
and	|O
Sp1	|B-PROTEIN
sites	|O
;	|O
multiple	|O
changes	|O
in	|O
the	|O
V2	|B-PROTEIN
region	|O
of	|O
SU	|B-PROTEIN
,	|O
including	|O
a	|O
consensus	|O
neutralization	|O
epitope	|O
;	|O
and	|O
five	|O
new	|O
N	|O
-	|O
linked	|O
glycosylation	|O
sites	|O
in	|O
SU	|B-PROTEIN
.	|O

C.	|O

These	|O
are	|O
the	|O
long	|O
terminal	|O
repeat	|O
(	|O
LTR	|O
)	|O
promoter	|O
,	|O
which	|O
regulates	|O
expression	|O
of	|O
the	|O
viral	|O
structural	|O
proteins	|O
,	|O
and	|O
a	|O
second	|O
internal	|O
promoter	|O
,	|O
located	|O
towards	|O
the	|O
3'	|O
end	|O
of	|O
the	|O
env	|B-PROTEIN
gene	|O
,	|O
that	|O
directs	|O
expression	|O
of	|O
the	|O
viral	|O
auxiliary	|O
proteins	|O
.	|O

The	|O
5'	|O
end	|O
of	|O
the	|O
genomic	|O
RNA	|O
of	|O
rubella	|O
virus	|O
(	|O
RUB	|O
)	|O
contains	|O
a	|O
14	|O
-	|O
nucleotide	|O
(	|O
nt	|O
)	|O
single	|O
-	|O
stranded	|O
leader	|O
(	|O
ss	|O
-	|O
leader	|O
)	|O
followed	|O
by	|O
a	|O
stem	|O
-	|O
and	|O
-	|O
loop	|O
structure	|O
[	|O
5'	|O
(	|O
+	|O
)	|O
SL	|O
]	|O
(	|O
nt	|O
15	|O
to	|O
65	|O
)	|O
,	|O
the	|O
complement	|O
of	|O
which	|O
at	|O
the	|O
3'	|O
end	|O
of	|O
the	|O
minus	|O
-	|O
strand	|O
RNA	|O
[	|O
3'	|O
(	|O
-	|O
)	|O
SL	|O
]	|O
has	|O
been	|O
proposed	|O
to	|O
function	|O
as	|O
a	|O
promoter	|O
for	|O
synthesis	|O
of	|O
genomic	|O
plus	|O
strands	|O
.	|O

To	|O
investigate	|O
the	|O
requirements	|O
for	|O
CBF2	|B-PROTEIN
binding	|O
,	|O
we	|O
synthesized	|O
a	|O
series	|O
of	|O
oligonucleotides	|O
carrying	|O
double	|O
transversion	|O
mutations	|O
spanning	|O
both	|O
the	|O
conserved	|O
core	|O
sequence	|O
and	|O
outside	|O
flanking	|O
sequences	|O
.	|O

In	|O
addition	|O
,	|O
the	|O
affinities	|O
of	|O
CBF2	|B-PROTEIN
for	|O
binding	|O
to	|O
the	|O
LMP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
LMP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
,	|O
and	|O
CD23	|B-PROTEIN
promoters	|O
were	|O
also	|O
measured	|O
.	|O

CONCLUSIONS	|O
:	|O
The	|O
myocardial	|O
uptake	|O
of	|O
99mTc	|O
sestamibi	|O
in	|O
normal	|O
subjects	|O
and	|O
patients	|O
with	|O
coronary	|O
artery	|O
disease	|O
is	|O
comparable	|O
after	|O
exercise	|O
,	|O
dipyridamole	|O
,	|O
and	|O
adenosine	|O
stress	|O
.	|O

The	|O
SR	|B-PROTEIN
protein	|O
family	|O
is	|O
involved	|O
in	|O
constitutive	|O
and	|O
regulated	|O
pre	|O
-	|O
mRNA	|O
splicing	|O
and	|O
has	|O
been	|O
found	|O
to	|O
be	|O
evolutionarily	|O
conserved	|O
in	|O
metazoan	|O
organisms	|O
.	|O

To	|O
investigate	|O
the	|O
activity	|O
of	|O
TCF11	|B-PROTEIN
through	|O
this	|O
selected	|O
site	|O
,	|O
both	|O
alone	|O
and	|O
in	|O
the	|O
presence	|O
of	|O
MafG	|B-PROTEIN
,	|O
we	|O
have	|O
used	|O
a	|O
transient	|O
transfection	|O
assay	|O
.	|O

These	|O
and	|O
other	|O
comparisons	|O
suggest	|O
that	|O
,	|O
during	|O
evolution	|O
,	|O
both	|O
the	|O
RNA	|B-PROTEIN
-	|I-PROTEIN
polymerase	|I-PROTEIN
specificity	|O
of	|O
telomerase	|B-PROTEIN
RNA	|O
-	|O
gene	|O
promoters	|O
and	|O
,	|O
more	|O
recently	|O
,	|O
the	|O
position	|O
of	|O
the	|O
template	|O
sequence	|O
in	|O
the	|O
telomerase	|B-PROTEIN
RNA	|O
changed	|O
.	|O

Deadenylation	|O
and	|O
decay	|O
of	|O
beta	|B-PROTEIN
-	|I-PROTEIN
globin	|I-PROTEIN
mRNA	|O
in	|O
K562	|O
cells	|O
is	|O
extraordinarily	|O
slow	|O
compared	|O
with	|O
NIH	|O
3T3	|O
cells	|O
,	|O
suggesting	|O
that	|O
the	|O
increased	|O
stability	|O
gained	|O
by	|O
beta	|B-PROTEIN
-	|I-PROTEIN
globin	|I-PROTEIN
mRNA	|O
in	|O
K562	|O
cells	|O
is	|O
mainly	|O
controlled	|O
at	|O
the	|O
deadenylation	|O
step	|O
.	|O

Holliday	|O
junction	|O
resolvase	|B-PROTEIN
in	|O
Schizosaccharomyces	|O
pombe	|O
has	|O
identical	|O
endonuclease	|O
activity	|O
to	|O
the	|O
CCE1	|B-PROTEIN
homologue	|O
YDC2	|B-PROTEIN
.	|O

Ca2+	|B-PROTEIN
/	|I-PROTEIN
calmodulin	|I-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
II	|I-PROTEIN
(	|O
CaMK	|B-PROTEIN
II	|I-PROTEIN
)	|O
is	|O
a	|O
multifunctional	|O
serine	|B-PROTEIN
/	|I-PROTEIN
threonine	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
that	|O
regulates	|O
ion	|O
channels	|O
,	|O
metabolic	|O
enzymes	|O
,	|O
cytoskeletal	|O
proteins	|O
,	|O
and	|O
possibly	|O
transcription	|O
factors	|O
.	|O

A	|O
cAMP	|O
-	|O
responsive	|O
element	|O
-	|O
like	|O
(	|O
CRE	|O
-	|O
like	|O
,	|O
TGACGTGA	|O
)	|O
promoter	|O
sequence	|O
and	|O
a	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
A	|I-PROTEIN
signaling	|O
pathway	|O
are	|O
involved	|O
in	|O
this	|O
induction	|O
,	|O
and	|O
activation	|O
of	|O
both	|O
CRE	|B-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
(	|O
CREB	|B-PROTEIN
)	|O
and	|O
activating	|B-PROTEIN
transcription	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
(	|O
ATF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
)	|O
is	|O
required	|O
in	|O
the	|O
above	|O
process	|O
.	|O

IVOX	|O
was	|O
named	|O
as	|O
an	|O
acronym	|O
for	|O
intravascular	|O
oxygenator	|O
.	|O

Histopathologically	|O
,	|O
a	|O
cystic	|O
lymphangioma	|O
was	|O
diagnosed	|O
because	|O
of	|O
the	|O
morphological	|O
features	|O
and	|O
the	|O
immunohistochemical	|O
stainings	|O
of	|O
CD34	|B-PROTEIN
and	|O
Factor	|B-PROTEIN
VIII	|I-PROTEIN
related	|I-PROTEIN
antigen	|I-PROTEIN
which	|O
were	|O
observed	|O
positive	|O
reactions	|O
in	|O
endothelial	|O
cells	|O
of	|O
the	|O
cysts	|O
.	|O

Protease	|O
activities	|O
in	|O
cultures	|O
of	|O
the	|O
streptococcal	|O
strains	|O
were	|O
associated	|O
with	|O
species	|O
of	|O
different	|O
molecular	|O
masses	|O
ranging	|O
from	|O
130	|O
to	|O
200	|O
kDa	|O
,	|O
suggesting	|O
posttranslational	|O
processing	|O
possibly	|O
as	|O
a	|O
result	|O
of	|O
autoproteolysis	|O
at	|O
post	|O
-	|O
proline	|O
peptide	|O
bonds	|O
in	|O
the	|O
N	|O
-	|O
terminal	|O
parts	|O
of	|O
the	|O
molecules	|O
.	|O

The	|O
mechanism	|O
underlying	|O
such	|O
analgesia	|O
has	|O
been	|O
suggested	|O
to	|O
involve	|O
the	|O
interaction	|O
between	|O
the	|O
two	|O
separate	|O
but	|O
interconnected	|O
motivational	|O
systems	|O
"	|O
defense	|O
"	|O
and	|O
"	|O
pain	|O
.	|O
"	|O
To	|O
determine	|O
the	|O
developmental	|O
course	|O
of	|O
defense	|O
and	|O
nociception	|O
,	|O
these	|O
processes	|O
were	|O
analyzed	|O
during	|O
early	|O
ontogeny	|O
in	|O
rats	|O
.	|O

Three	|O
large	|O
field	|O
placement	|O
errors	|O
(	|O
two	|O
patients	|O
with	|O
11.5	|O
and	|O
16.0	|O
mm	|O
distances	|O
of	|O
the	|O
planned	|O
versus	|O
simulated	|O
isocenter	|O
,	|O
respectively	|O
and	|O
one	|O
patient	|O
with	|O
a	|O
7	|O
degree	|O
rotational	|O
error	|O
)	|O
were	|O
detected	|O
and	|O
,	|O
as	|O
with	|O
the	|O
smaller	|O
errors	|O
,	|O
were	|O
immediately	|O
corrected	|O
.	|O

In	|O
addition	|O
,	|O
a	|O
catalytically	|O
inactive	|O
version	|O
of	|O
the	|O
Src	|B-PROTEIN
family	|O
member	|O
,	|O
Lck	|B-PROTEIN
(	|O
lymphoid	|B-PROTEIN
cell	|I-PROTEIN
kinase	|I-PROTEIN
)	|O
,	|O
was	|O
expressed	|O
,	|O
purified	|O
,	|O
and	|O
evaluated	|O
as	|O
a	|O
Csk	|B-PROTEIN
substrate	|O
.	|O

A.	|O
,	|O
Swift	|O
,	|O
A.	|O

Neuronal	|O
mechanisms	|O
underlying	|O
stimulus	|O
-	|O
response	|O
(	|O
S	|O
-	|O
R	|O
)	|O
associations	|O
in	|O
S	|O
-	|O
R	|O
compatibility	|O
tasks	|O
were	|O
identified	|O
in	|O
2	|O
experiments	|O
with	|O
monkeys	|O
.	|O

The	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
/	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
HCCs	|O
were	|O
also	|O
characterized	|O
by	|O
a	|O
particularly	|O
strong	|O
expression	|O
of	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
and	|O
very	|O
low	|O
apoptotic	|O
index	|O
in	|O
contrast	|O
to	|O
high	|O
levels	|O
of	|O
apoptosis	|O
in	|O
peritumorous	|O
tissues	|O
and	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
HCCs	|O
.	|O

Taken	|O
together	|O
,	|O
our	|O
data	|O
suggest	|O
that	|O
the	|O
antagonistic	|O
effects	|O
of	|O
CRP	|B-PROTEIN
and	|O
KdgR	|B-PROTEIN
on	|O
the	|O
expression	|O
of	|O
the	|O
pectinolysis	|B-PROTEIN
genes	|I-PROTEIN
occur	|O
by	|O
different	|O
mechanisms	|O
,	|O
including	|O
direct	|O
competition	|O
between	|O
the	|O
two	|O
regulators	|O
or	|O
between	|O
the	|O
repressor	|O
and	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
for	|O
the	|O
occupation	|O
of	|O
a	|O
common	|O
DNA	|O
region	|O
on	|O
the	|O
target	|O
genes	|O
.	|O

The	|O
well	|O
-	|O
known	|O
Rel	|B-PROTEIN
/	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
family	|O
of	|O
vertebrate	|O
transcription	|O
factors	|O
comprises	|O
a	|O
number	|O
of	|O
structurally	|O
related	|O
,	|O
interacting	|O
proteins	|O
that	|O
bind	|O
DNA	|O
as	|O
dimers	|O
and	|O
whose	|O
activity	|O
is	|O
regulated	|O
by	|O
subcellular	|O
location	|O
.	|O

The	|O
cglIM	|B-PROTEIN
gene	|O
is	|O
organized	|O
in	|O
an	|O
unusual	|O
operon	|O
which	|O
contains	|O
,	|O
in	|O
addition	|O
,	|O
two	|O
genes	|O
encoding	|O
stress	|O
-	|O
sensitive	|O
restriction	|O
enzymes	|O
.	|O

Lysine	|B-PROTEIN
-	|I-PROTEIN
ketoglutarate	|I-PROTEIN
reductase	|I-PROTEIN
and	|O
saccharopine	|B-PROTEIN
dehydrogenase	|I-PROTEIN
from	|O
Arabidopsis	|O
thaliana	|O
:	|O
nucleotide	|O
sequence	|O
and	|O
characterization	|O
.	|O

The	|O
purpose	|O
of	|O
this	|O
investigation	|O
was	|O
to	|O
describe	|O
a	|O
new	|O
formulation	|O
of	|O
silver	|O
sulfadiazine	|O
in	|O
a	|O
water	|O
soluble	|O
gel	|O
,	|O
poloxamer	|O
188	|O
.	|O

The	|O
study	|O
goals	|O
were	|O
to	|O
isolate	|O
a	|O
full	|O
-	|O
length	|O
clone	|O
encoding	|O
CO	|B-PROTEIN
-	|I-PROTEIN
Ag	|I-PROTEIN
from	|O
a	|O
bovine	|O
corneal	|O
cDNA	|O
library	|O
and	|O
to	|O
express	|O
this	|O
clone	|O
in	|O
Escherichia	|O
coli	|O
(	|O
E.	|O
coli	|O
)	|O
.	|O

The	|O
pel	|B-PROTEIN
gene	|O
from	|O
an	|O
Amycolata	|O
sp	|O
.	|O
encoding	|O
a	|O
pectate	|B-PROTEIN
lyase	|I-PROTEIN
(	|O
EC	|B-PROTEIN
4.2.2.2	|I-PROTEIN
)	|O
was	|O
isolated	|O
by	|O
activity	|O
screening	|O
a	|O
genomic	|O
DNA	|O
library	|O
in	|O
Streptomyces	|O
lividans	|O
TK24	|O
.	|O

The	|O
gene	|O
contains	|O
six	|O
exons	|O
separated	|O
by	|O
1.1-5.8	|O
kb	|O
introns	|O
and	|O
has	|O
been	|O
localized	|O
to	|O
the	|O
murine	|O
chromosome	|O
2	|O
by	|O
linkage	|O
analysis	|O
.	|O

In	|O
Xenopus	|O
embryos	|O
,	|O
the	|O
engineered	|O
PDGF	|B-PROTEIN
receptor	|I-PROTEIN
protein	|O
induced	|O
the	|O
formation	|O
of	|O
mesoderm	|O
from	|O
animal	|O
-	|O
pole	|O
explants	|O
in	|O
an	|O
FK1012	|O
-	|O
dependent	|O
manner	|O
.	|O

A	|O
cytosolic	|O
variant	|O
of	|O
the	|O
protein	|O
underwent	|O
efficient	|O
transphosphorylation	|O
,	|O
yet	|O
failed	|O
to	|O
activate	|O
appreciably	|O
either	|O
p70	|B-PROTEIN
(	|O
S6k	|B-PROTEIN
)	|O
or	|O
MAP	|B-PROTEIN
kinase	|I-PROTEIN
following	|O
treatment	|O
with	|O
FK1012	|O
.	|O

Small	|O
-	|O
molecule	|O
control	|O
of	|O
insulin	|B-PROTEIN
and	|O
PDGF	|B-PROTEIN
receptor	|I-PROTEIN
signaling	|O
and	|O
the	|O
role	|O
of	|O
membrane	|O
attachment	|O
.	|O

Conversely	|O
,	|O
the	|O
inactive	|O
dAK	|B-PROTEIN
subunit	|O
is	|O
progressively	|O
activated	|O
by	|O
1	|O
)	|O
association	|O
with	|O
a	|O
dGK	|B-PROTEIN
or	|O
dCK	|B-PROTEIN
subunit	|O
and	|O
2	|O
)	|O
the	|O
conformationally	|O
driven	|O
heterotropic	|O
affect	|O
of	|O
dGuo	|B-PROTEIN
or	|O
dCyd	|B-PROTEIN
bound	|O
to	|O
the	|O
opposing	|O
subunit	|O
.	|O

CONCLUSIONS	|O
:	|O
A	|O
50	|O
-	|O
mg	|O
daily	|O
dose	|O
of	|O
bicalutamide	|O
is	|O
sufficient	|O
when	|O
given	|O
in	|O
combination	|O
with	|O
an	|O
agent	|O
,	|O
such	|O
as	|O
a	|O
LHRH	|B-PROTEIN
-	|O
A	|O
,	|O
that	|O
lowers	|O
serum	|O
testosterone	|O
,	|O
but	|O
higher	|O
doses	|O
of	|O
bicalutamide	|O
may	|O
be	|O
needed	|O
when	|O
the	|O
drug	|O
is	|O
given	|O
as	|O
monotherapy	|O
.	|O

A	|O
genomic	|O
clone	|O
was	|O
isolated	|O
that	|O
contained	|O
12.5	|O
kb	|O
of	|O
the	|O
5'	|O
-	|O
flanking	|O
region	|O
and	|O
the	|O
first	|O
exon	|O
of	|O
the	|O
p69/71	|B-PROTEIN
2-5	|I-PROTEIN
A	|I-PROTEIN
synthetase	|I-PROTEIN
gene	|O
.	|O

Although	|O
the	|O
gene	|O
is	|O
substantially	|O
smaller	|O
than	|O
the	|O
human	|O
genes	|O
for	|O
other	|O
mitochondrial	|O
enzymes	|O
,	|O
its	|O
intron	|O
/	|O
exon	|O
organization	|O
is	|O
very	|O
similar	|O
,	|O
especially	|O
to	|O
that	|O
of	|O
P450scc	|B-PROTEIN
.	|O

RESULTS	|O
:	|O
Looking	|O
at	|O
the	|O
question	|O
of	|O
its	|O
benefits	|O
,	|O
we	|O
were	|O
unable	|O
to	|O
find	|O
any	|O
methodologically	|O
sound	|O
studies	|O
that	|O
have	|O
shown	|O
efficacy	|O
for	|O
EMDR	|O
in	|O
eating	|O
disorders	|O
,	|O
or	|O
,	|O
indeed	|O
,	|O
any	|O
psychiatric	|O
disorder	|O
.	|O

In	|O
the	|O
clinical	|O
study	|O
,	|O
the	|O
defect	|O
size	|O
shown	|O
by	|O
BMIPP	|O
imaging	|O
was	|O
greater	|O
in	|O
anterior	|O
than	|O
in	|O
inferior	|O
infarcts	|O
(	|O
p	|O
<	|O
0.001	|O
)	|O
and	|O
correlated	|O
well	|O
with	|O
the	|O
risk	|O
area	|O
revealed	|O
by	|O
contrast	|O
ventriculography	|O
(	|O
r	|O
=	|O
0.80	|O
,	|O
p	|O
<	|O
0.0001	|O
)	|O
CONCLUSION	|O
:	|O
The	|O
above	|O
preliminary	|O
data	|O
,	|O
admittedly	|O
from	|O
a	|O
small	|O
group	|O
of	|O
patients	|O
,	|O
suggest	|O
that	|O
tomographic	|O
BMIPP	|O
imaging	|O
provides	|O
an	|O
accurate	|O
quantification	|O
of	|O
defect	|O
size	|O
by	|O
means	|O
of	|O
a	|O
simple	|O
threshold	|O
technique	|O
and	|O
,	|O
in	|O
the	|O
subacute	|O
phase	|O
,	|O
permits	|O
determination	|O
of	|O
the	|O
amount	|O
of	|O
myocardium	|O
at	|O
risk	|O
after	|O
acute	|O
myocardial	|O
infarction	|O
.	|O

Transient	|O
overexpression	|O
of	|O
mutant	|O
EphB1	|B-PROTEIN
receptors	|O
(	|O
Y594F	|O
)	|O
blocked	|O
Nck	|B-PROTEIN
recruitment	|O
to	|O
EphB1	|B-PROTEIN
,	|O
attenuated	|O
downstream	|O
JNK	|B-PROTEIN
activation	|O
,	|O
and	|O
blocked	|O
cell	|O
attachment	|O
responses	|O
.	|O

The	|O
promoter	|O
for	|O
HMG	|B-PROTEIN
-	|I-PROTEIN
CoA	|I-PROTEIN
synthase	|I-PROTEIN
contains	|O
two	|O
binding	|O
sites	|O
for	|O
the	|O
sterol	|B-PROTEIN
regulatory	|I-PROTEIN
element	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
proteins	|I-PROTEIN
(	|O
SREBPs	|B-PROTEIN
)	|O
.	|O

S.	|O
,	|O
and	|O
Walter	|O
,	|O
P.	|O

Here	|O
we	|O
demonstrate	|O
that	|O
Hh	|B-PROTEIN
and	|O
Patched	|B-PROTEIN
(	|O
Ptc	|B-PROTEIN
)	|O
act	|O
through	|O
those	|O
Ci	|B-PROTEIN
binding	|O
sites	|O
to	|O
modulate	|O
the	|O
level	|O
of	|O
Ci	|B-PROTEIN
-	|O
dependent	|O
transcriptional	|O
activation	|O
in	|O
S2	|O
cells	|O
.	|O

Furthermore	|O
the	|O
median	|O
increase	|O
in	|O
cyclosporine	|O
DR	|O
/	|O
C	|O
(	|O
SS	|O
trough	|O
)	|O
was	|O
18	|O
l	|O
h	|O
-	|O
1	|O
(	|O
-	|O
3.1	|O
to	|O
42.1	|O
l	|O
h	|O
-	|O
1	|O
,	|O
interquartile	|O
range	|O
)	|O
.	|O

Patients	|O
and	|O
their	|O
relatives	|O
must	|O
be	|O
informed	|O
about	|O
the	|O
available	|O
effective	|O
treatment	|O
possibilities	|O
and	|O
about	|O
the	|O
right	|O
moment	|O
for	|O
their	|O
application	|O
in	|O
an	|O
individual	|O
patient	|O
.	|O

Several	|O
PTPases	|B-PROTEIN
were	|O
expressed	|O
abundantly	|O
in	|O
the	|O
5	|O
-	|O
FU	|O
-	|O
treated	|O
bone	|O
marrow	|O
stem	|O
cells	|O
.	|O

Expression	|O
of	|O
PTPRO	|B-PROTEIN
was	|O
also	|O
observed	|O
in	|O
human	|O
CD34+	|B-PROTEIN
bone	|O
marrow	|O
cells	|O
and	|O
5	|O
-	|O
FU	|O
-	|O
treated	|O
murine	|O
primitive	|O
stem	|O
cells	|O
.	|O

The	|O
organization	|O
of	|O
SPP1	|B-PROTEIN
genes	|O
involved	|O
in	|O
the	|O
replication	|O
,	|O
DNA	|O
packaging	|O
and	|O
phage	|O
assembly	|O
proteins	|O
resembles	|O
the	|O
organization	|O
of	|O
genes	|O
of	|O
equivalent	|O
regions	|O
of	|O
different	|O
E.	|O
coli	|O
double	|O
-	|O
stranded	|O
DNA	|O
phages	|O
.	|O

Our	|O
results	|O
showed	|O
that	|O
compared	|O
to	|O
the	|O
primary	|O
photon	|O
fluence	|O
,	|O
the	|O
extra	|O
-	|O
focal	|O
photon	|O
fluence	|O
from	|O
the	|O
primary	|O
collimator	|O
and	|O
the	|O
flattening	|O
filter	|O
was	|O
11%	|O
-	|O
16%	|O
at	|O
the	|O
isocenter	|O
,	|O
among	|O
which	|O
70%	|O
was	|O
contributed	|O
by	|O
the	|O
flattening	|O
filter	|O
.	|O

The	|O
functional	|O
mature	|O
domain	|O
of	|O
pediocin	|B-PROTEIN
AcH	|I-PROTEIN
(	|O
Lys+	|O
1	|O
to	|O
Cys+	|O
44	|O
)	|O
is	|O
targeted	|O
into	|O
the	|O
E.	|O
coli	|O
sec	|O
machinery	|O
and	|O
secreted	|O
to	|O
the	|O
periplasm	|O
in	|O
active	|O
form	|O
when	|O
fused	|O
in	|O
frame	|O
to	|O
the	|O
COOH	|O
terminus	|O
of	|O
the	|O
secretory	|O
protein	|O
maltose	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
(	|O
MBP	|B-PROTEIN
)	|O
.	|O

Isomers	|O
were	|O
differentiated	|O
based	|O
on	|O
the	|O
MS	|O
-	|O
MS	|O
data	|O
of	|O
the	|O
trofluoroacetyl	|O
-	|O
biphenylol	|O
derivatives	|O
.	|O

Although	|O
RAD17	|B-PROTEIN
,	|O
RAD24	|B-PROTEIN
and	|O
MEC3	|B-PROTEIN
are	|O
not	|O
required	|O
for	|O
cell	|O
cycle	|O
arrest	|O
when	|O
S	|O
phase	|O
is	|O
inhibited	|O
by	|O
hydroxyurea	|O
(	|O
HU	|O
)	|O
,	|O
they	|O
do	|O
contribute	|O
to	|O
the	|O
viability	|O
of	|O
yeast	|O
cells	|O
grown	|O
in	|O
the	|O
presence	|O
of	|O
HU	|O
,	|O
possibly	|O
because	|O
they	|O
are	|O
required	|O
for	|O
the	|O
repair	|O
of	|O
HU	|O
-	|O
induced	|O
DNA	|O
damage	|O
.	|O

Clinical	|O
value	|O
of	|O
the	|O
estimation	|O
of	|O
growth	|O
kinetics	|O
of	|O
primary	|O
ovarian	|O
cancer	|O
recurrences	|O
by	|O
CA125	|B-PROTEIN
doubling	|O
time	|O

This	|O
review	|O
seeks	|O
to	|O
summarize	|O
the	|O
disease	|O
,	|O
to	|O
propose	|O
pathways	|O
of	|O
carcinogenesis	|O
and	|O
to	|O
suggest	|O
ways	|O
in	|O
which	|O
the	|O
"	|O
traditional	|O
"	|O
risk	|O
factors	|O
may	|O
be	|O
interpreted	|O
on	|O
the	|O
basis	|O
of	|O
evolving	|O
knowledge	|O
.	|O

The	|O
patient	|O
underwent	|O
two	|O
intracytoplasmic	|O
sperm	|O
injection	|O
cycles	|O
with	|O
thawed	|O
epididymal	|O
spermatozoa	|O
,	|O
in	|O
which	|O
,	|O
due	|O
to	|O
a	|O
pharmacist	|O
's	|O
mistake	|O
,	|O
ovarian	|O
stimulation	|O
was	|O
carried	|O
out	|O
by	|O
a	|O
combination	|O
of	|O
long	|O
-	|O
acting	|O
gonadotrophin	|B-PROTEIN
-	|I-PROTEIN
releasing	|I-PROTEIN
hormone	|I-PROTEIN
agonist	|O
(	|O
leuprolide	|O
depot	|O
)	|O
and	|O
gonadotrophins	|B-PROTEIN
.	|O

Protein	|B-PROTEIN
C	|I-PROTEIN
deficiency	|O
or	|O
protein	|B-PROTEIN
S	|I-PROTEIN
deficiency	|O
was	|O
the	|O
only	|O
identified	|O
risk	|O
factor	|O
for	|O
5.4%	|O
(	|O
2	|O
patients	|O
)	|O
and	|O
13.5%	|O
(	|O
5	|O
patients	|O
)	|O
,	|O
respectively	|O
,	|O
of	|O
these	|O
37	|O
children	|O
.	|O

Perhaps	|O
in	|O
addition	|O
to	|O
,	|O
or	|O
as	|O
part	|O
of	|O
,	|O
its	|O
essential	|O
function	|O
in	|O
late	|O
mitosis	|O
,	|O
MOB1	|B-PROTEIN
is	|O
required	|O
for	|O
a	|O
cell	|O
cycle	|O
reset	|O
function	|O
necessary	|O
for	|O
the	|O
initiation	|O
of	|O
the	|O
spindle	|O
pole	|O
body	|O
duplication	|O
.	|O

In	|O
contrast	|O
,	|O
overproduction	|O
of	|O
Der3p	|B-PROTEIN
is	|O
lethal	|O
in	|O
a	|O
sec61	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
strain	|O
at	|O
the	|O
permissive	|O
temperature	|O
of	|O
25	|O
degrees	|O
C.	|O

Normal	|O
baseline	|O
(	|O
day	|O
-	|O
8	|O
)	|O
PC	|O
levels	|O
(	|O
86	|O
and	|O
89%	|O
)	|O
were	|O
markedly	|O
reduced	|O
in	|O
both	|O
patients	|O
at	|O
the	|O
time	|O
of	|O
VOD	|O
manifestation	|O
on	|O
day	|O
20	|O
and	|O
40	|O
,	|O
respectively	|O
(	|O
26	|O
and	|O
31%	|O
)	|O
.	|O

To	|O
examine	|O
the	|O
role	|O
of	|O
this	|O
CE2	|O
element	|O
in	|O
regulating	|O
Hoxa1	|B-PROTEIN
expression	|O
in	|O
vivo	|O
,	|O
transgenic	|O
mice	|O
were	|O
generated	|O
which	|O
express	|O
a	|O
Hoxa1	|B-PROTEIN
beta	|O
-	|O
galactosidase	|O
reporter	|O
gene	|O
that	|O
contains	|O
a	|O
mutation	|O
in	|O
the	|O
CE2	|O
element	|O
.	|O

An	|O
evolutionary	|O
conserved	|O
element	|O
is	|O
essential	|O
for	|O
somite	|O
and	|O
adjacent	|O
mesenchymal	|O
expression	|O
of	|O
the	|O
Hoxa1	|B-PROTEIN
gene	|O
.	|O

RESULTS	|O
:	|O
The	|O
bovine	|O
cDNA	|O
insert	|O
sequence	|O
was	|O
273	|O
nucleotides	|O
in	|O
length	|O
for	|O
the	|O
entire	|O
mRNA	|O
coding	|O
region	|O
,	|O
212	|O
nucleotides	|O
in	|O
the	|O
5'	|O
untranslated	|O
region	|O
,	|O
83	|O
nucleotides	|O
in	|O
the	|O
3'	|O
untranslated	|O
region	|O
and	|O
a	|O
poly	|O
(	|O
A	|O
)	|O
tail	|O
.	|O

Altogether	|O
46	|O
phase	|O
III	|O
activities	|O
were	|O
recorded	|O
.	|O

We	|O
have	|O
previously	|O
identified	|O
a	|O
liver	|O
-	|O
enriched	|O
transcription	|O
factor	|O
,	|O
HNF	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
,	|O
which	|O
is	|O
required	|O
for	|O
HNF	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
beta	|I-PROTEIN
promoter	|O
activity	|O
and	|O
also	|O
recognizes	|O
the	|O
regulatory	|O
region	|O
of	|O
numerous	|O
hepatocyte	|O
-	|O
specific	|O
genes	|O
.	|O

A	|O
cDNA	|O
clone	|O
was	|O
identified	|O
encoding	|O
a	|O
second	|O
GHS	|B-PROTEIN
-	|I-PROTEIN
R	|I-PROTEIN
-	|O
related	|O
gene	|O
(	|O
GPR39	|B-PROTEIN
)	|O
.	|O

(	|O
1997	|O
)	|O
Science	|O
275	|O
,	|O
1927-1930	|O
)	|O
.	|O

P.	|O
,	|O
Peyron	|O
,	|O
J.	|O

A	|O
hybridoma	|O
clone	|O
(	|O
7H1	|O
)	|O
resulting	|O
from	|O
the	|O
fusion	|O
between	|O
CEMLAI	|O
/	|O
NP	|O
and	|O
human	|O
embryonic	|O
fibroblasts	|O
MRC5	|O
cells	|O
produced	|O
very	|O
large	|O
amounts	|O
of	|O
P47	|B-PROTEIN
that	|O
was	|O
purified	|O
using	|O
Jacalin	|B-PROTEIN
lectin	|O
(	|O
specific	|O
for	|O
O	|O
-	|O
glycans	|O
)	|O
and	|O
microsequenced	|O
.	|O

This	|O
information	|O
,	|O
together	|O
with	|O
estimation	|O
of	|O
the	|O
size	|O
of	|O
the	|O
deglycosylated	|O
A	|O
subunit	|O
relative	|O
to	|O
a	|O
series	|O
of	|O
C	|O
-	|O
terminal	|O
truncated	|O
TSHR	|B-PROTEIN
ectodomain	|O
variants	|O
,	|O
places	|O
cleavage	|O
Site	|O
1	|O
in	|O
the	|O
vicinity	|O
of	|O
,	|O
or	|O
closely	|O
upstream	|O
to	|O
,	|O
residue	|O
317	|O
.	|O

In	|O
vitro	|O
DNase	|B-PROTEIN
I	|I-PROTEIN
footprinting	|O
of	|O
the	|O
200	|O
-	|O
bp	|O
proximal	|O
region	|O
of	|O
the	|O
promoter	|O
with	|O
a	|O
murine	|O
Hepa	|O
1-6	|O
cell	|O
nuclear	|O
extract	|O
revealed	|O
a	|O
clear	|O
footprint	|O
of	|O
a	|O
region	|O
corresponding	|O
to	|O
-	|O
80	|O
to	|O
-	|O
28	|O
bp	|O
of	|O
the	|O
murine	|O
fVII	|B-PROTEIN
gene	|O
,	|O
suggesting	|O
that	|O
liver	|O
factors	|O
interact	|O
with	|O
this	|O
region	|O
of	|O
the	|O
DNA	|O
.	|O

A	|O
reciprocal	|O
binding	|O
assay	|O
using	|O
IM	|O
-	|O
9	|O
cells	|O
as	|O
a	|O
source	|O
of	|O
SHP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
SHP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
revealed	|O
specific	|O
association	|O
of	|O
SHP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
(	|O
but	|O
not	|O
SHP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
with	|O
a	|O
glutathione	|B-PROTEIN
S	|I-PROTEIN
-	|I-PROTEIN
transferase	|I-PROTEIN
fusion	|O
incorporating	|O
GHR	|B-PROTEIN
cytoplasmic	|O
domain	|O
residues	|O
485-620	|O
,	|O
but	|O
only	|O
if	|O
the	|O
fusion	|O
was	|O
first	|O
rendered	|O
tyrosine	|O
-	|O
phosphorylated	|O
.	|O

Both	|O
increasing	|O
basal	|O
FSH	|B-PROTEIN
and	|O
age	|O
were	|O
associated	|O
significantly	|O
with	|O
increased	|O
total	|O
gonadotrophin	|B-PROTEIN
dose	|O
,	|O
and	|O
reduced	|O
number	|O
of	|O
oocytes	|O
collected	|O
and	|O
pregnancy	|O
rate	|O
.	|O

A	|O
comparative	|O
study	|O
was	|O
undertaken	|O
between	|O
an	|O
enzymatic	|O
immunohistochemical	|O
technique	|O
(	|O
EIT	|O
)	|O
developed	|O
for	|O
the	|O
diagnosis	|O
of	|O
human	|O
trichinellosis	|O
and	|O
the	|O
indirect	|O
immunofluorescence	|O
test	|O
(	|O
IIF	|O
)	|O
,	|O
analysing	|O
sera	|O
from	|O
outbreaks	|O
of	|O
human	|O
trichinellosis	|O
in	|O
Argentina	|O
.	|O

Our	|O
results	|O
establish	|O
GKLF	|B-PROTEIN
as	|O
a	|O
sequence	|O
-	|O
specific	|O
transcription	|O
factor	|O
likely	|O
involved	|O
in	|O
regulation	|O
of	|O
expression	|O
of	|O
endogenous	|O
genes	|O
.	|O

CES4	|B-PROTEIN
on	|O
a	|O
multicopy	|O
plasmid	|O
was	|O
unable	|O
to	|O
suppress	|O
tif1	|B-PROTEIN
-	|O
A79V	|O
.	|O

Here	|O
we	|O
report	|O
that	|O
in	|O
cultured	|O
cells	|O
from	|O
Drosophila	|O
melanogaster	|O
human	|O
Sp1	|B-PROTEIN
efficiently	|O
activates	|O
transcription	|O
from	|O
synthetic	|O
promoters	|O
containing	|O
TATA	|O
boxes	|O
,	|O
but	|O
not	|O
from	|O
promoters	|O
that	|O
contain	|O
an	|O
initiator	|O
instead	|O
of	|O
a	|O
TATA	|O
box	|O
.	|O

No	|O
apparent	|O
clinical	|O
signs	|O
indicative	|O
of	|O
systemic	|O
toxicity	|O
were	|O
observed	|O
in	|O
the	|O
F0	|O
and	|O
F1	|O
animals	|O
of	|O
either	|O
sex	|O
.	|O

We	|O
have	|O
used	|O
mutation	|O
-	|O
directed	|O
chemical	|O
cross	|O
-	|O
linking	|O
with	|O
bis	|O
(	|O
sulfosuccinimidyl	|O
)	|O
suberate	|O
(	|O
BS3	|O
)	|O
to	|O
investigate	|O
the	|O
architecture	|O
of	|O
the	|O
gp41	|B-PROTEIN
oligomer	|O
.	|O

In	|O
an	|O
effort	|O
to	|O
identify	|O
the	|O
USH1C	|B-PROTEIN
disease	|I-PROTEIN
gene	|I-PROTEIN
we	|O
have	|O
isolated	|O
the	|O
region	|O
between	|O
these	|O
markers	|O
in	|O
yeast	|O
artificial	|O
chromosomes	|O
(	|O
YACs	|O
)	|O
using	|O
a	|O
combination	|O
of	|O
STS	|O
content	|O
mapping	|O
and	|O
Alu	|B-PROTEIN
-	|O
PCR	|O
hybridization	|O
.	|O

PowerBLAST	|O
analysis	|O
identified	|O
six	|O
clusters	|O
of	|O
expressed	|O
sequence	|O
tags	|O
(	|O
ESTs	|O
)	|O
,	|O
two	|O
known	|O
genes	|O
(	|O
BIR	|B-PROTEIN
,	|O
SUR1	|B-PROTEIN
)	|O
mapped	|O
previously	|O
to	|O
this	|O
region	|O
,	|O
and	|O
a	|O
previously	|O
characterized	|O
but	|O
unmapped	|O
gene	|O
NEFA	|B-PROTEIN
(	|O
DNA	|B-PROTEIN
binding	|I-PROTEIN
/	|I-PROTEIN
EF	|I-PROTEIN
hand	|I-PROTEIN
/	|I-PROTEIN
acidic	|I-PROTEIN
amino	|I-PROTEIN
-	|I-PROTEIN
acid	|I-PROTEIN
-	|I-PROTEIN
rich	|I-PROTEIN
)	|O
.	|O

A	|O
fusion	|O
protein	|O
composed	|O
of	|O
beta	|B-PROTEIN
-	|I-PROTEIN
galactosidase	|I-PROTEIN
and	|O
full	|O
-	|O
length	|O
Ahr	|B-PROTEIN
translocates	|O
from	|O
the	|O
cytoplasm	|O
to	|O
the	|O
nucleus	|O
in	|O
a	|O
ligand	|O
-	|O
dependent	|O
manner	|O
.	|O

Reconstitution	|O
of	|O
Raf	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
activity	|O
was	|O
observed	|O
only	|O
with	|O
kinase	|O
active	|O
Jak1	|B-PROTEIN
in	|O
both	|O
cell	|O
lines	|O
.	|O

In	|O
addition	|O
,	|O
negatively	|O
regulatory	|O
region	|O
may	|O
exist	|O
from	|O
-	|O
1782	|O
to	|O
-	|O
1295	|O
bp	|O
.	|O

The	|O
hypothesis	|O
of	|O
Geisler	|O
(	|O
Brain	|O
Res.	|O

The	|O
second	|O
transcript	|O
,	|O
rhis4l	|B-PROTEIN
,	|O
is	|O
bicistronic	|O
.	|O

Consistent	|O
with	|O
this	|O
interpretation	|O
,	|O
a	|O
mutant	|O
form	|O
of	|O
XRN1	|B-PROTEIN
,	|O
which	|O
encodes	|O
a	|O
5'	|O
-	|O
3'	|O
exonuclease	|O
,	|O
was	|O
identified	|O
as	|O
an	|O
extragenic	|O
suppressor	|O
that	|O
increases	|O
the	|O
half	|O
-	|O
life	|O
of	|O
rhis4	|B-PROTEIN
mRNA	|O
,	|O
leading	|O
to	|O
a	|O
10	|O
-	|O
fold	|O
increase	|O
in	|O
steady	|O
-	|O
state	|O
mRNA	|O
levels	|O
compared	|O
to	|O
the	|O
wild	|O
-	|O
type	|O
HIS4	|B-PROTEIN
mRNA	|O
level	|O
.	|O

Sip1	|B-PROTEIN
was	|O
initially	|O
identified	|O
by	|O
virtue	|O
of	|O
its	|O
interaction	|O
with	|O
SC35	|B-PROTEIN
,	|O
a	|O
splicing	|O
factor	|O
of	|O
the	|O
SR	|B-PROTEIN
family	|O
.	|O

Consistent	|O
with	|O
previous	|O
reports	|O
,	|O
addition	|O
of	|O
a	|O
myristoylation	|O
signal	|O
to	|O
mSos1	|B-PROTEIN
(	|O
MyrSos1	|B-PROTEIN
)	|O
rendered	|O
it	|O
transforming	|O
for	|O
NIH	|O
3T3	|O
cells	|O
and	|O
deletion	|O
of	|O
the	|O
mSos	|B-PROTEIN
C	|O
terminus	|O
(	|O
MyrSos1	|B-PROTEIN
-	|I-PROTEIN
deltaC	|I-PROTEIN
)	|O
did	|O
not	|O
interfere	|O
with	|O
this	|O
activity	|O
.	|O

Such	|O
mutations	|O
are	|O
thought	|O
to	|O
exert	|O
their	|O
dominant	|O
phenotype	|O
by	|O
sequestration	|O
of	|O
the	|O
guanine	|B-PROTEIN
nucleotide	|I-PROTEIN
exchange	|I-PROTEIN
factor	|I-PROTEIN
(	|O
GNEF	|B-PROTEIN
)	|O
.	|O

Several	|O
studies	|O
have	|O
characterized	|O
the	|O
upstream	|O
regulatory	|O
region	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
,	|O
and	|O
identified	|O
cis	|O
-	|O
acting	|O
elements	|O
termed	|O
the	|O
cyclic	|O
AMP	|O
(	|O
cAMP	|O
)	|O
response	|O
elements	|O
(	|O
CREs	|O
)	|O
that	|O
are	|O
critical	|O
for	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
transcription	|O
in	|O
response	|O
to	|O
a	|O
variety	|O
of	|O
extracellular	|O
stimuli	|O
.	|O

We	|O
have	|O
cloned	|O
a	|O
kinase	|O
,	|O
Nlk	|B-PROTEIN
,	|O
that	|O
is	|O
a	|O
murine	|O
homolog	|O
of	|O
the	|O
Drosophila	|O
nemo	|B-PROTEIN
(	|O
nmo	|B-PROTEIN
)	|O
gene	|O
.	|O

Our	|O
findings	|O
suggest	|O
that	|O
striatal	|O
FDG	|O
and	|O
particularly	|O
RACLO	|O
are	|O
sensitive	|O
and	|O
effective	|O
measures	|O
of	|O
striatal	|O
function	|O
and	|O
may	|O
help	|O
characterizing	|O
patients	|O
with	|O
multiple	|O
system	|O
atrophy	|O
.	|O

Childhood	|O
misbehavior	|O
and	|O
the	|O
risk	|O
of	|O
injecting	|O
drug	|O
use	|O
.	|O

Genetic	|O
analysis	|O
has	|O
subsequently	|O
identified	|O
subpathways	|O
of	|O
the	|O
DNA	|O
structure	|O
checkpoints	|O
,	|O
including	|O
the	|O
reversible	|O
arrest	|O
of	|O
DNA	|O
synthesis	|O
.	|O

Thus	|O
,	|O
Esigma54	|B-PROTEIN
promoters	|O
are	|O
responsive	|O
to	|O
CRP	|B-PROTEIN
,	|O
a	|O
protein	|O
unrelated	|O
to	|O
sigma54	|B-PROTEIN
activators	|O
,	|O
and	|O
the	|O
repression	|O
exerted	|O
is	|O
the	|O
direct	|O
result	|O
of	|O
an	|O
interaction	|O
between	|O
Esigma54	|B-PROTEIN
and	|O
the	|O
CRP	|B-PROTEIN
-	|O
cAMP	|O
complex	|O
.	|O

GlcNAc	|O
-	|O
and	|O
GlcNAc2	|O
-	|O
PP	|O
-	|O
Dolichol	|O
biosynthesis	|O
could	|O
be	|O
shown	|O
with	|O
isolated	|O
S.c	|O
erevisiae	|O
membranes	|O
from	|O
cells	|O
harboring	|O
the	|O
recombinant	|O
plasmid	|O
and	|O
grown	|O
on	|O
glucose	|O
thus	|O
suppressing	|O
transcription	|O
of	|O
the	|O
endogenous	|O
gene	|O
.	|O

Demonstration	|O
of	|O
tissue	|O
lesions	|O
after	|O
intramuscular	|O
injection	|O
by	|O
determination	|O
of	|O
creatine	|B-PROTEIN
kinase	|I-PROTEIN
in	|O
blood	|O

Antibodies	|O
raised	|O
against	|O
GST	|B-PROTEIN
mSH2	|I-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
identified	|O
a	|O
cellular	|O
protein	|O
of	|O
92	|O
kDa	|O
that	|O
was	|O
not	|O
found	|O
to	|O
be	|O
phosphorylated	|O
on	|O
Tyr	|O
.	|O

Interleukin	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
(	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
)	|O
is	|O
a	|O
pleiotropic	|O
cytokine	|O
,	|O
which	|O
is	|O
involved	|O
in	|O
inflammatory	|O
and	|O
immune	|O
responses	|O
,	|O
acute	|O
phase	|O
reactions	|O
,	|O
and	|O
hematopoiesis	|O
.	|O

Upon	|O
analysis	|O
of	|O
various	|O
deletion	|O
and	|O
point	|O
-	|O
mutated	|O
variants	|O
of	|O
the	|O
human	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
gene	|O
promoter	|O
coupled	|O
to	|O
a	|O
reporter	|O
gene	|O
,	|O
we	|O
screened	|O
for	|O
possible	|O
cooperating	|O
transcription	|O
factors	|O
.	|O

This	|O
region	|O
,	|O
however	|O
,	|O
contains	|O
a	|O
CCAATC	|O
box	|O
in	|O
the	|O
reverse	|O
complement	|O
and	|O
several	|O
GC	|O
boxes	|O
that	|O
are	|O
recognition	|O
sites	|O
for	|O
SP1	|B-PROTEIN
.	|O

Our	|O
purpose	|O
was	|O
to	|O
determine	|O
if	|O
intact	|O
perianal	|O
(	|O
S4	|O
-	|O
5	|O
)	|O
pin	|O
sensation	|O
(	|O
PPS	|O
)	|O
and	|O
bulbocavernosus	|O
(	|O
S2	|O
-	|O
4	|O
)	|O
reflex	|O
(	|O
BCR	|O
)	|O
shortly	|O
after	|O
spinal	|O
cord	|O
injury	|O
(	|O
SCI	|O
)	|O
are	|O
predictive	|O
of	|O
bladder	|O
function	|O
recovery	|O
.	|O

The	|O
correct	|O
termination	|O
of	|O
retroviral	|O
transcripts	|O
at	|O
the	|O
3'	|O
LTR	|O
R	|O
/	|O
U5	|O
junction	|O
is	|O
primarily	|O
dependent	|O
on	|O
the	|O
canonical	|O
AAUAAA	|O
polyadenylation	|O
signal	|O
,	|O
so	|O
we	|O
have	|O
analyzed	|O
the	|O
effect	|O
of	|O
mutating	|O
the	|O
polyadenylation	|O
signal	|O
sequences	|O
on	|O
the	|O
properties	|O
of	|O
a	|O
selectable	|O
murine	|O
retroviral	|O
vector	|O
.	|O

Levels	|O
of	|O
the	|O
MEK	|B-PROTEIN
inhibitor	|O
PD98059	|O
that	|O
block	|O
EGF	|B-PROTEIN
-	|O
induced	|O
mitogenesis	|O
and	|O
MAP	|B-PROTEIN
kinase	|I-PROTEIN
phosphorylation	|O
also	|O
abrogate	|O
EGF	|B-PROTEIN
-	|O
induced	|O
focal	|O
adhesion	|O
disassembly	|O
and	|O
cell	|O
motility	|O
.	|O

ALT	|B-PROTEIN
levels	|O
in	|O
responders	|O
were	|O
lowered	|O
by	|O
46%	|O
and	|O
AST	|B-PROTEIN
levels	|O
were	|O
lowered	|O
by	|O
35%	|O
after	|O
12	|O
weeks	|O
of	|O
vitamin	|O
E	|O
treatment	|O
.	|O

Surprisingly	|O
,	|O
the	|O
COOH	|O
-	|O
terminal	|O
domain	|O
of	|O
RanGAP1	|B-PROTEIN
was	|O
also	|O
found	|O
to	|O
harbor	|O
a	|O
nuclear	|O
localization	|O
signal	|O
.	|O

51.9%	|O
(	|O
P	|O
=	|O
0.0006	|O
)	|O
in	|O
the	|O
MMF	|O
versus	|O
the	|O
AZA	|O
groups	|O
,	|O
respectively	|O
.	|O

Our	|O
study	|O
was	|O
designed	|O
to	|O
investigate	|O
the	|O
effect	|O
of	|O
MMF	|O
on	|O
in	|O
vivo	|O
bone	|O
mineral	|O
metabolism	|O
.	|O

Pao2	|O
increased	|O
from	|O
15.5	|O
+	|O
/	|O
-	|O
5.6	|O
kPa	|O
(	|O
116	|O
+	|O
/	|O
-	|O
42	|O
mm	|O
Hg	|O
)	|O
to	|O
17.3	|O
+	|O
/	|O
-	|O
6.3	|O
kPa	|O
(	|O
130	|O
+	|O
/	|O
-	|O
47	|O
mm	|O
Hg	|O
)	|O
(	|O
P	|O
<	|O
0.05	|O
)	|O
.	|O

Typical	|O
configurations	|O
of	|O
psychosocial	|O
stress	|O
factors	|O
of	|O
psychiatrically	|O
conspicuous	|O
children	|O
and	|O
adolescents	|O

Nine	|O
cats	|O
received	|O
PMEA	|O
at	|O
a	|O
dosage	|O
of	|O
10	|O
mg	|O
/	|O
kg	|O
body	|O
weight	|O
,	|O
nine	|O
cats	|O
received	|O
FPMPA	|O
at	|O
a	|O
dosage	|O
of	|O
25	|O
mg	|O
/	|O
kg	|O
body	|O
weight	|O
.	|O

Resistance	|O
to	|O
thyroid	|O
hormone	|O
:	|O
implications	|O
for	|O
neurodevelopmental	|O
research	|O
on	|O
the	|O
effects	|O
of	|O
thyroid	|O
hormone	|O
disruptors	|O
.	|O

Here	|O
,	|O
we	|O
present	|O
evidence	|O
that	|O
exposure	|O
of	|O
DT40	|O
lymphoma	|O
B	|O
cells	|O
to	|O
low	|O
energy	|O
electromagnetic	|O
field	|O
(	|O
EMF	|O
)	|O
results	|O
in	|O
a	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
-	|O
dependent	|O
activation	|O
of	|O
phospholipase	|B-PROTEIN
Cgamma2	|I-PROTEIN
(	|O
PLC	|B-PROTEIN
-	|I-PROTEIN
gamma2	|I-PROTEIN
)	|O
leading	|O
to	|O
increased	|O
inositol	|O
phospholipid	|O
turnover	|O
.	|O

We	|O
present	|O
the	|O
preliminary	|O
results	|O
obtained	|O
on	|O
36	|O
patients	|O
which	|O
were	|O
followed	|O
for	|O
a	|O
mean	|O
period	|O
of	|O
12	|O
months	|O
.	|O

Moreover	|O
,	|O
xTAK1KN	|B-PROTEIN
could	|O
block	|O
the	|O
expression	|O
of	|O
ventral	|O
mesoderm	|O
marker	|O
genes	|O
induced	|O
by	|O
Smad1	|B-PROTEIN
or	|O
5	|O
.	|O

PATIENTS	|O
AND	|O
METHOD	|O
:	|O
Since	|O
1986	|O
,	|O
62	|O
patients	|O
were	|O
irradiated	|O
stereotactically	|O
.	|O

The	|O
assay	|O
exhibits	|O
a	|O
dynamic	|O
range	|O
of	|O
0.1-100	|O
micrograms	|O
l	|O
-	|O
1	|O
using	|O
a	|O
monoclonal	|O
antibody	|O
or	|O
alternatively	|O
10	|O
micrograms	|O
l	|O
-	|O
1	|O
to	|O
10	|O
mg	|O
l	|O
-	|O
1	|O
using	|O
commercially	|O
available	|O
antiserum	|O
.	|O

Training	|O
for	|O
audit	|O
.	|O

A	|O
canonical	|O
TATA	|O
box	|O
was	|O
not	|O
detected	|O
.	|O

Expression	|O
and	|O
characterization	|O
of	|O
recombinant	|O
single	|O
-	|O
chain	|O
Fv	|B-PROTEIN
and	|O
Fv	|B-PROTEIN
fragments	|O
derived	|O
from	|O
a	|O
set	|O
of	|O
catalytic	|O
antibodies	|O
.	|O

A	|O
putative	|O
inhibitor	|O
(	|O
s	|O
)	|O
appears	|O
to	|O
co	|O
-	|O
elute	|O
in	|O
the	|O
inactive	|O
fraction	|O
that	|O
blocked	|O
the	|O
L	|B-PROTEIN
(	|I-PROTEIN
alpha	|I-PROTEIN
)	|I-PROTEIN
activity	|O
.	|O

Platelet	|O
aggregation	|O
in	|O
response	|O
to	|O
10	|O
micrograms	|O
collagen	|B-PROTEIN
/	|O
ml	|O
was	|O
decreased	|O
in	|O
parallel	|O
after	|O
treatment	|O
with	|O
ASA	|O
.	|O

Using	|O
himA	|B-PROTEIN
mutants	|O
,	|O
we	|O
confirmed	|O
that	|O
IHF	|B-PROTEIN
plays	|O
a	|O
role	|O
in	|O
the	|O
molybdate	|O
-	|O
dependent	|O
regulation	|O
of	|O
dmsA	|B-PROTEIN
-	|O
lacZ	|B-PROTEIN
expression	|O
in	|O
vivo	|O
.	|O

Cross	|O
-	|O
talking	|O
among	|O
Drosophila	|O
nuclear	|O
receptors	|O
at	|O
the	|O
promiscuous	|O
response	|O
element	|O
of	|O
the	|O
ng	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
ng	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
intermolt	|O
genes	|O
.	|O

The	|O
ipsilateral	|O
breast	|O
tumor	|O
relapse	|O
rate	|O
was	|O
similar	|O
between	|O
the	|O
PALP	|O
and	|O
MGDET	|O
groups	|O
.	|O

Sibling	|O
aggregation	|O
of	|O
low	|B-PROTEIN
-	|I-PROTEIN
and	|I-PROTEIN
high	|I-PROTEIN
-	|I-PROTEIN
density	|I-PROTEIN
lipoprotein	|I-PROTEIN
cholesterol	|I-PROTEIN
and	|O
apolipoproteins	|B-PROTEIN
B	|I-PROTEIN
and	|I-PROTEIN
A	|I-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
levels	|O
in	|O
black	|O
and	|O
white	|O
children	|O
:	|O
the	|O
Bogalusa	|O
Heart	|O
Study	|O
.	|O

The	|O
CAPLC1	|B-PROTEIN
protein	|O
also	|O
exhibited	|O
several	|O
unique	|O
features	|O
,	|O
including	|O
a	|O
novel	|O
stretch	|O
of	|O
18-19	|O
amino	|O
acid	|O
residues	|O
within	|O
the	|O
X	|O
domain	|O
and	|O
an	|O
unusually	|O
long	|O
N	|O
-	|O
terminus	|O
which	|O
did	|O
not	|O
contain	|O
a	|O
recognizable	|O
EF	|O
-	|O
hand	|O
Ca	|O
(	|O
2+	|O
)	|O
-	|O
binding	|O
domain	|O
.	|O

This	|O
hypothesis	|O
is	|O
consistent	|O
with	|O
the	|O
occurrence	|O
of	|O
PEA3	|B-PROTEIN
binding	|O
sites	|O
in	|O
the	|O
PEA3	|B-PROTEIN
promoter	|O
and	|O
with	|O
the	|O
ability	|O
of	|O
PEA3	|B-PROTEIN
to	|O
transactivate	|O
this	|O
promoter	|O
.	|O

Pet	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
can	|O
bind	|O
specifically	|O
to	|O
a	|O
PEA3	|B-PROTEIN
ETS	|O
DNA	|O
-	|O
binding	|O
motif	|O
and	|O
can	|O
modulate	|O
transcription	|O
of	|O
synthetic	|O
promoter	|O
constructs	|O
in	|O
a	|O
sequence	|O
-	|O
specific	|O
manner	|O
.	|O

The	|O
protein	|O
expressed	|O
by	|O
F2771	|B-PROTEIN
cDNA	|O
in	|O
transfected	|O
COS	|O
cells	|O
is	|O
localized	|O
in	|O
the	|O
cytoplasm	|O
.	|O

Northern	|O
analysis	|O
indicated	|O
differential	|O
expression	|O
by	|O
tissue	|O
with	|O
highest	|O
expression	|O
in	|O
the	|O
heart	|O
.	|O

As	|O
well	|O
,	|O
further	|O
deletion	|O
of	|O
the	|O
promoter	|O
region	|O
to	|O
nucleotide	|O
-	|O
110	|O
,	|O
which	|O
contains	|O
only	|O
one	|O
SF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
binding	|O
site	|O
,	|O
still	|O
retained	|O
the	|O
ability	|O
to	|O
respond	|O
to	|O
exogenous	|O
SF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

The	|O
observation	|O
that	|O
beta	|B-PROTEIN
2m	|I-PROTEIN
with	|O
covalently	|O
attached	|O
peptide	|O
can	|O
effectively	|O
create	|O
CTL	|O
target	|O
structures	|O
in	|O
vitro	|O
offers	|O
new	|O
possibilities	|O
for	|O
the	|O
in	|O
vivo	|O
induction	|O
of	|O
epitope	|O
-	|O
specific	|O
CTL	|O
responses	|O
by	|O
either	|O
DNA	|O
immunization	|O
or	|O
injection	|O
of	|O
the	|O
purified	|O
epitope	|O
-	|O
linked	|O
beta	|B-PROTEIN
2m	|I-PROTEIN
.	|O

The	|O
mRNAs	|O
of	|O
these	|O
genes	|O
contain	|O
respectively	|O
one	|O
(	|O
YAP1	|B-PROTEIN
uORF	|O
)	|O
and	|O
two	|O
(	|O
YAP2	|B-PROTEIN
uORF1	|O
and	|O
uORF2	|O
)	|O
upstream	|O
open	|O
reading	|O
frames	|O
.	|O
uORF	|O
-	|O
mediated	|O
modulation	|O
of	|O
post	|O
-	|O
termination	|O
events	|O
on	|O
the	|O
5'	|O
-	|O
untranslated	|O
region	|O
(	|O
5'	|O
-	|O
UTR	|O
)	|O
directs	|O
differential	|O
control	|O
not	|O
only	|O
of	|O
translation	|O
but	|O
also	|O
of	|O
mRNA	|O
decay	|O
.	|O

To	|O
further	|O
investigate	|O
the	|O
nature	|O
of	|O
the	|O
site	|O
specificity	|O
a	|O
set	|O
of	|O
deletion	|O
mutants	|O
of	|O
the	|O
160	|O
bp	|O
sequence	|O
were	|O
analysed	|O
.	|O

In	|O
the	|O
tissues	|O
tested	|O
,	|O
except	|O
brain	|O
,	|O
the	|O
message	|O
for	|O
CLIP	|B-PROTEIN
-	|I-PROTEIN
170	|I-PROTEIN
was	|O
more	|O
abundant	|O
than	|O
that	|O
for	|O
Restin	|B-PROTEIN
.	|O

BACKGROUND	|O
:	|O
Chemicals	|O
vary	|O
considerably	|O
in	|O
their	|O
intrinsic	|O
ability	|O
to	|O
cause	|O
allergic	|O
contact	|O
dermatitis	|O
.	|O

Cytoskeletal	|O
polarization	|O
of	|O
T	|O
cells	|O
is	|O
regulated	|O
by	|O
an	|O
immunoreceptor	|O
tyrosine	|O
-	|O
based	|O
activation	|O
motif	|O
-	|O
dependent	|O
mechanism	|O
.	|O

Here	|O
we	|O
have	|O
examined	|O
the	|O
ability	|O
of	|O
the	|O
cellular	|O
protein	|O
YB	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
to	|O
modulate	|O
transcription	|O
of	|O
the	|O
HIV	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
promoter	|I-PROTEIN
in	|O
a	|O
human	|O
astrocytic	|O
cell	|O
line	|O
(	|O
U	|O
-	|O
87MG	|O
)	|O
,	|O
a	|O
neuronal	|O
cell	|O
line	|O
(	|O
SK	|O
-	|O
N	|O
-	|O
MC	|O
)	|O
and	|O
lymphoid	|O
cells	|O
(	|O
Jurkat	|O
)	|O
by	|O
transfection	|O
assay	|O
.	|O

Also	|O
,	|O
the	|O
deduced	|O
amino	|O
acids	|O
of	|O
the	|O
antigenic	|O
regions	|O
A	|O
,	|O
B	|O
and	|O
C	|O
of	|O
VP7	|B-PROTEIN
were	|O
nearly	|O
conserved	|O
within	|O
the	|O
phylogenetic	|O
lineages	|O
.	|O

The	|O
cloned	|O
alcR	|B-PROTEIN
gene	|O
provided	|O
in	|O
trans	|O
restored	|O
these	|O
siderophore	|O
system	|O
activities	|O
to	|O
the	|O
mutants	|O
.	|O

The	|O
cloned	|O
alcR	|B-PROTEIN
gene	|O
provided	|O
in	|O
trans	|O
restored	|O
these	|O
siderophore	|O
system	|O
activities	|O
to	|O
the	|O
mutants	|O
.	|O

Copyright	|O
1998	|O
Academic	|O
Press	|O
.	|O

It	|O
may	|O
also	|O
be	|O
suggested	|O
that	|O
particular	|O
care	|O
should	|O
be	|O
taken	|O
when	|O
such	|O
a	|O
trans	|O
-	|O
dominant	|O
Rev	|B-PROTEIN
mutant	|O
is	|O
considered	|O
to	|O
be	|O
used	|O
as	|O
a	|O
genetic	|O
therapy	|O
against	|O
HIV	|O
-	|O
I	|O
infection	|O
,	|O
in	|O
individuals	|O
infected	|O
with	|O
both	|O
HIV	|O
-	|O
I	|O
and	|O
HTLV	|O
-	|O
1	|O
.	|O

PATIENTS	|O
AND	|O
METHODS	|O
:	|O
Between	|O
January	|O
1992	|O
and	|O
June	|O
1994	|O
at	|O
St	|O
.	|O

The	|O
frequency	|O
of	|O
SPs	|O
for	|O
both	|O
the	|O
moderate	|O
and	|O
severe	|O
groups	|O
was	|O
significantly	|O
higher	|O
than	|O
that	|O
in	|O
patients	|O
with	|O
a	|O
normal	|O
MMFCV	|O
(	|O
p	|O
<	|O
.01	|O
)	|O
;	|O
of	|O
154	|O
arms	|O
with	|O
a	|O
normal	|O
MMFCV	|O
,	|O
only	|O
9	|O
(	|O
6%	|O
)	|O
had	|O
an	|O
SP	|O
.	|O

We	|O
analyzed	|O
the	|O
P	|O
-	|O
SAECG	|O
in	|O
the	|O
time	|O
and	|O
frequency	|O
domain	|O
in	|O
23	|O
patients	|O
with	|O
Paf	|O
and	|O
19	|O
controls	|O
.	|O

Competitive	|O
reverse	|O
transcription	|O
-	|O
polymerase	|O
chain	|O
reaction	|O
and	|O
HPLC	|O
analysis	|O
showed	|O
that	|O
RUSH	|B-PROTEIN
-	|I-PROTEIN
1alpha	|I-PROTEIN
is	|O
the	|O
progesterone	|O
-	|O
dependent	|O
splice	|O
variant	|O
.	|O

TOR2	|B-PROTEIN
is	|O
part	|O
of	|O
two	|O
related	|O
signaling	|O
pathways	|O
coordinating	|O
cell	|O
growth	|O
in	|O
Saccharomyces	|O
cerevisiae	|O
.	|O

Transcervical	|O
amnioinfusion	|O
.	|O

SETTING	|O
:	|O
A	|O
division	|O
of	|O
a	|O
large	|O
tea	|O
plantation	|O
in	|O
Kandy	|O
.	|O

Simple	|O
models	|O
of	|O
bimolecular	|O
interaction	|O
did	|O
not	|O
fully	|O
account	|O
for	|O
the	|O
kinetic	|O
profiles	|O
obtained	|O
with	|O
the	|O
parental	|O
antibodies	|O
and	|O
the	|O
hybrids	|O
,	|O
and	|O
this	|O
complexity	|O
suggested	|O
the	|O
existence	|O
of	|O
a	|O
conformational	|O
heterogeneity	|O
in	|O
these	|O
molecules	|O
.	|O

In	|O
order	|O
to	|O
decipher	|O
the	|O
pathway	|O
that	|O
leads	|O
to	|O
Hox	|B-PROTEIN
gene	|O
induction	|O
,	|O
we	|O
have	|O
investigated	|O
whether	|O
a	|O
Hox	|B-PROTEIN
gene	|O
regulator	|O
,	|O
the	|O
leucine	|O
zipper	|O
transcription	|O
factor	|O
MafB	|B-PROTEIN
/	|O
Kr	|B-PROTEIN
,	|O
is	|O
itself	|O
transcriptionally	|O
regulated	|O
by	|O
the	|O
environmental	|O
signals	|O
.	|O

Substrates	|O
for	|O
p210	|B-PROTEIN
(	|O
bcr	|B-PROTEIN
-	|O
abl	|B-PROTEIN
)	|O
are	|O
likely	|O
to	|O
be	|O
involved	|O
in	|O
the	|O
pathogenesis	|O
of	|O
CML	|O
.	|O

Reporter	|O
constructs	|O
function	|O
in	|O
a	|O
parallel	|O
manner	|O
,	|O
demonstrating	|O
the	|O
key	|O
role	|O
of	|O
the	|O
AhR	|B-PROTEIN
in	|O
constitutive	|O
as	|O
well	|O
as	|O
TCDD	|O
-	|O
induced	|O
expression	|O
of	|O
Cyp1B1	|B-PROTEIN
in	|O
mouse	|O
embryo	|O
fibroblasts	|O
.	|O

Transfection	|O
studies	|O
also	|O
showed	|O
that	|O
3'	|O
-	|O
deletion	|O
of	|O
sequences	|O
downstream	|O
of	|O
the	|O
transcriptional	|O
start	|O
site	|O
(	|O
+	|O
1	|O
/	|O
+	|O
47	|O
)	|O
markedly	|O
reduced	|O
OSM	|B-PROTEIN
-	|O
fold	|O
induction	|O
.	|O

Oncostatin	|B-PROTEIN
M	|I-PROTEIN
stimulates	|O
c	|B-PROTEIN
-	|I-PROTEIN
Fos	|I-PROTEIN
to	|O
bind	|O
a	|O
transcriptionally	|O
responsive	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
element	|O
within	|O
the	|O
tissue	|O
inhibitor	|O
of	|O
metalloproteinase	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
promoter	|I-PROTEIN
.	|O

We	|O
have	|O
isolated	|O
a	|O
new	|O
human	|O
RING	|B-PROTEIN
-	|I-PROTEIN
finger	|I-PROTEIN
gene	|I-PROTEIN
(	|O
RNF4	|B-PROTEIN
)	|O
that	|O
encodes	|O
a	|O
190	|O
-	|O
amino	|O
-	|O
acid	|O
protein	|O
.	|O

To	|O
elucidate	|O
the	|O
regulatory	|O
mechanism	|O
of	|O
human	|O
AM	|B-PROTEIN
gene	|O
expression	|O
,	|O
functional	|O
elements	|O
of	|O
5'	|O
-	|O
flanking	|O
region	|O
of	|O
AM	|B-PROTEIN
gene	|O
were	|O
studied	|O
in	|O
human	|O
aortic	|O
endothelial	|O
cells	|O
(	|O
HAEC	|O
)	|O
.	|O

The	|O
COOH	|O
-	|O
terminal	|O
region	|O
of	|O
the	|O
transcripts	|O
contained	|O
fifteen	|O
triplet	|O
repeats	|O
(	|O
GCT	|O
;	|O
alanine	|O
)	|O
at	|O
nucleotide	|O
465	|O
to	|O
509	|O
,	|O
which	|O
is	|O
significantly	|O
expanded	|O
compared	|O
to	|O
the	|O
rat	|O
RL14	|B-PROTEIN
.	|O

Soluble	|O
FasR	|B-PROTEIN
ligand	|O
-	|O
binding	|O
domain	|O
:	|O
high	|O
-	|O
yield	|O
production	|O
of	|O
active	|O
fusion	|O
and	|O
non	|O
-	|O
fusion	|O
recombinant	|O
proteins	|O
using	|O
the	|O
baculovirus	|O
/	|O
insect	|O
cell	|O
system	|O
.	|O

Control	|O
of	|O
fatty	|O
liver	|O
syndrome	|O
in	|O
a	|O
Jersey	|O
herd	|O
by	|O
a	|O
change	|O
of	|O
diet	|O
and	|O
the	|O
use	|O
of	|O
recombinant	|O
bovine	|O
somatotrophin	|B-PROTEIN
.	|O

The	|O
inhibition	|O
of	|O
focus	|O
formation	|O
observed	|O
in	|O
the	|O
presence	|O
of	|O
C3G	|B-PROTEIN
was	|O
not	|O
due	|O
to	|O
toxic	|O
effects	|O
on	|O
cell	|O
viability	|O
,	|O
since	|O
transfected	|O
C3G	|B-PROTEIN
cells	|O
exhibited	|O
the	|O
same	|O
survival	|O
and	|O
growth	|O
rates	|O
as	|O
untransfected	|O
NIH3T3	|O
cells	|O
or	|O
cells	|O
transfected	|O
with	|O
plasmid	|O
vector	|O
alone	|O
.	|O

C.D	|O
2	|O
-	|O
Chr	|O
4	|O
congenic	|O
strains	|O
harboring	|O
DBA	|O
/	|O
2	|O
alleles	|O
associated	|O
with	|O
the	|O
Pctr1	|B-PROTEIN
locus	|O
contained	|O
DBA	|O
/	|O
2	|O
"	|O
resistant	|O
"	|O
alleles	|O
of	|O
the	|O
CDK4	|B-PROTEIN
/	|O
CDK6	|B-PROTEIN
inhibitors	|O
p16	|B-PROTEIN
and	|O
p15	|B-PROTEIN
.	|O

When	|O
tested	|O
with	|O
wild	|O
-	|O
type	|O
(	|O
DBA	|O
/	|O
2	|O
)	|O
p16	|B-PROTEIN
,	|O
both	|O
A134C	|O
and	|O
G232A	|O
BALB	|O
/	|O
c	|O
-	|O
specific	|O
variants	|O
of	|O
p16	|B-PROTEIN
were	|O
inefficient	|O
in	|O
their	|O
ability	|O
to	|O
inhibit	|O
the	|O
activity	|O
of	|O
cyclin	|B-PROTEIN
D2	|I-PROTEIN
/	|O
CDK4	|B-PROTEIN
in	|O
kinase	|O
assays	|O
with	|O
retinoblastoma	|B-PROTEIN
protein	|I-PROTEIN
,	|O
suggesting	|O
this	|O
defective	|O
,	|O
inherited	|O
allele	|O
plays	|O
an	|O
important	|O
role	|O
in	|O
the	|O
genetic	|O
susceptibility	|O
of	|O
BALB	|O
/	|O
c	|O
mice	|O
for	|O
plasmacytoma	|O
induction	|O
and	|O
that	|O
p16	|B-PROTEIN
(	|O
INK4a	|B-PROTEIN
)	|O
is	|O
a	|O
strong	|O
candidate	|O
for	|O
the	|O
Pctr1	|B-PROTEIN
locus	|O
.	|O

Despite	|O
this	|O
there	|O
was	|O
no	|O
difference	|O
in	|O
the	|O
intubating	|O
conditions	|O
at	|O
one	|O
minute	|O
with	|O
25	|O
excellent	|O
/	|O
5	|O
good	|O
in	|O
the	|O
suxamethonium	|O
group	|O
and	|O
27	|O
excellent	|O
/	|O
3	|O
good	|O
in	|O
the	|O
rocuronium	|O
group	|O
.	|O

Cloning	|O
and	|O
expression	|O
of	|O
two	|O
genes	|O
encoding	|O
auxin	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
proteins	|I-PROTEIN
from	|O
tobacco	|O
.	|O

Furthermore	|O
,	|O
direct	|O
association	|O
with	|O
D3	|O
phosphatidylinositides	|O
seems	|O
to	|O
be	|O
essential	|O
for	|O
activation	|O
of	|O
PKB	|B-PROTEIN
/	|O
Akt	|B-PROTEIN
.	|O

The	|O
FMN	|O
moiety	|O
but	|O
not	|O
the	|O
[	|O
3Fe	|O
-	|O
4S	|O
]	|O
cluster	|O
of	|O
the	|O
subunit	|O
appears	|O
to	|O
participate	|O
in	|O
this	|O
reaction	|O
.	|O

Alison	|O
Bell	|O
Memorial	|O
Award	|O
.	|O

METHODS	|O
:	|O
A	|O
population	|O
survey	|O
was	|O
undertaken	|O
in	|O
10,148	|O
individuals	|O
to	|O
measure	|O
the	|O
prevalence	|O
and	|O
identify	|O
the	|O
causes	|O
of	|O
blindness	|O
in	|O
Lebanon	|O
.	|O

During	|O
organogenesis	|O
,	|O
HFH	|B-PROTEIN
-	|I-PROTEIN
8	|I-PROTEIN
expression	|O
is	|O
found	|O
in	|O
the	|O
splanchnic	|O
mesoderm	|O
in	|O
close	|O
apposition	|O
of	|O
the	|O
gut	|O
endoderm	|O
,	|O
suggesting	|O
a	|O
role	|O
in	|O
mesenchymal	|O
-	|O
epithelial	|O
induction	|O
of	|O
lung	|O
and	|O
gut	|O
morphogenesis	|O
.	|O

However	|O
,	|O
laparoscopy	|O
failed	|O
to	|O
establish	|O
inoperability	|O
in	|O
any	|O
cases	|O
of	|O
carcinoma	|O
spread	|O
to	|O
areas	|O
not	|O
accessible	|O
to	|O
laparoscopic	|O
visualization	|O
.	|O

No	|O
difference	|O
in	|O
telomere	|O
length	|O
was	|O
seen	|O
in	|O
mutants	|O
affected	|O
in	|O
the	|O
regulation	|O
of	|O
Cdc2	|B-PROTEIN
,	|O
whereas	|O
some	|O
of	|O
the	|O
DNA	|O
repair	|O
mutants	|O
examined	|O
had	|O
slightly	|O
longer	|O
telomeres	|O
than	|O
did	|O
the	|O
wild	|O
type	|O
.	|O

The	|O
mean	|O
duration	|O
of	|O
pain	|O
relief	|O
was	|O
4-6	|O
weeks	|O
.	|O

The	|O
ESEM	|O
differs	|O
from	|O
conventional	|O
SEM	|O
in	|O
that	|O
no	|O
sample	|O
preparation	|O
is	|O
needed	|O
,	|O
eliminating	|O
artifactual	|O
changes	|O
.	|O

Sp1	|B-PROTEIN
can	|O
activate	|O
transcription	|O
through	|O
immunoglobulin	|B-PROTEIN
kappa	|I-PROTEIN
-	|I-PROTEIN
chain	|I-PROTEIN
enhancer	|O
or	|O
P	|B-PROTEIN
-	|I-PROTEIN
selectin	|I-PROTEIN
promoter	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
sites	|O
.	|O
p50	|B-PROTEIN
homodimers	|O
replace	|O
Sp1	|B-PROTEIN
from	|O
the	|O
P	|B-PROTEIN
-	|I-PROTEIN
selectin	|I-PROTEIN
promoter	|O
by	|O
binding	|O
site	|O
competition	|O
and	|O
thereby	|O
either	|O
inhibit	|O
basal	|O
Sp1	|B-PROTEIN
-	|O
driven	|O
expression	|O
or	|O
,	|O
in	|O
concert	|O
with	|O
Bcl	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
,	|O
stimulate	|O
expression	|O
.	|O

The	|O
3'	|O
fragment	|O
was	|O
shown	|O
to	|O
accumulate	|O
as	|O
full	|O
-	|O
length	|O
mRNA	|O
disappeared	|O
in	|O
actinomycin	|O
D	|O
-	|O
treated	|O
cells	|O
,	|O
indicating	|O
a	|O
precursor	|O
-	|O
product	|O
relationship	|O
.	|O

The	|O
TATA	|B-PROTEIN
box	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
(	|O
TBP	|B-PROTEIN
)	|O
plays	|O
an	|O
essential	|O
role	|O
in	|O
transcription	|O
by	|O
all	|O
three	|O
eukaryotic	|O
nuclear	|O
RNA	|B-PROTEIN
polymerases	|I-PROTEIN
,	|O
polymerases	|O
(	|B-PROTEIN
Pol	|I-PROTEIN
)	|I-PROTEIN
I	|I-PROTEIN
,	|I-PROTEIN
II	|I-PROTEIN
,	|I-PROTEIN
and	|I-PROTEIN
III	|I-PROTEIN
.	|O

A	|O
triple	|O
-	|O
mutant	|O
TBP	|B-PROTEIN
(	|O
R231E	|O
+	|O
R235E	|O
+	|O
R239S	|O
)	|O
had	|O
greatly	|O
reduced	|O
activity	|O
for	|O
yeast	|O
U6	|B-PROTEIN
snRNA	|O
gene	|O
transcription	|O
while	|O
remaining	|O
active	|O
for	|O
Pol	|B-PROTEIN
II	|I-PROTEIN
basal	|O
transcription	|O
.	|O

E2F	|B-PROTEIN
activity	|O
is	|O
regulated	|O
in	|O
part	|O
by	|O
the	|O
retinoblastoma	|B-PROTEIN
family	|I-PROTEIN
of	|O
tumor	|O
suppressor	|O
proteins	|O
.	|O

This	|O
resulted	|O
in	|O
a	|O
complete	|O
inhibition	|O
of	|O
Site	|O
-	|O
1	|O
cleavage	|O
that	|O
was	|O
restored	|O
by	|O
concomitant	|O
overexpression	|O
of	|O
full	|O
-	|O
length	|O
SCAP	|B-PROTEIN
.	|O

To	|O
determine	|O
the	|O
true	|O
molecular	|O
identity	|O
of	|O
SFD	|B-PROTEIN
,	|O
both	|O
the	|O
50	|O
-	|O
and	|O
57	|O
-	|O
kDa	|O
polypeptides	|O
were	|O
directly	|O
sequenced	|O
.	|O

Molecular	|O
characterization	|O
of	|O
the	|O
50	|O
-	|O
and	|O
57	|O
-	|O
kDa	|O
subunits	|O
of	|O
the	|O
bovine	|O
vacuolar	|B-PROTEIN
proton	|I-PROTEIN
pump	|I-PROTEIN
.	|O

In	|O
C.	|O
albicans	|O
,	|O
HST6	|B-PROTEIN
is	|O
expressed	|O
constitutively	|O
at	|O
high	|O
levels	|O
in	|O
the	|O
different	|O
cell	|O
types	|O
analysed	|O
(	|O
yeast	|O
,	|O
hyphae	|O
,	|O
white	|O
and	|O
opaque	|O
)	|O
,	|O
demonstrating	|O
that	|O
HST6	|B-PROTEIN
transcription	|O
is	|O
not	|O
repressed	|O
in	|O
this	|O
diploid	|O
yeast	|O
,	|O
unlike	|O
in	|O
diploid	|O
S.	|O
cerevisiae	|O
,	|O
and	|O
suggesting	|O
a	|O
basic	|O
biological	|O
function	|O
for	|O
the	|O
Hst6p	|B-PROTEIN
transporter	|O
in	|O
C.	|O
albicans	|O
.	|O

Furthermore	|O
,	|O
binding	|O
of	|O
recombinant	|O
Myb	|B-PROTEIN
and	|O
Ets	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
protein	|O
to	|O
these	|O
fragments	|O
could	|O
be	|O
competed	|O
with	|O
an	|O
excess	|O
of	|O
double	|O
stranded	|O
oligodeoxynucleotides	|O
containing	|O
canonical	|O
,	|O
but	|O
not	|O
mutated	|O
,	|O
Myb	|B-PROTEIN
-	|O
or	|O
Ets	|B-PROTEIN
-	|O
binding	|O
sites	|O
.	|O

This	|O
structure	|O
interconnects	|O
specific	|O
triplets	|O
of	|O
the	|O
basal	|O
bodies	|O
with	|O
the	|O
microtubular	|O
bundles	|O
that	|O
emerge	|O
from	|O
the	|O
basal	|O
apparatus	|O
.	|O

To	|O
understand	|O
the	|O
regulatory	|O
mechanism	|O
controlling	|O
its	|O
expression	|O
at	|O
low	|O
temperature	|O
,	|O
the	|O
promoter	|O
region	|O
has	|O
been	|O
characterized	|O
.	|O

In	|O
the	|O
current	|O
study	|O
,	|O
the	|O
roles	|O
of	|O
two	|O
putative	|O
cis	|O
-	|O
acting	|O
elements	|O
within	|O
the	|O
-	|O
73	|O
to	|O
+	|O
44	|O
region	|O
in	|O
basal	|O
exon	|O
2	|O
promoter	|O
activity	|O
were	|O
evaluated	|O
using	|O
mutagenesis	|O
and	|O
nuclear	|O
protein	|O
-	|O
DNA	|O
binding	|O
assays	|O
.	|O

For	|O
the	|O
5HT5A	|B-PROTEIN
receptor	|I-PROTEIN
the	|O
addition	|O
of	|O
yohimbine	|O
resulted	|O
in	|O
a	|O
similar	|O
but	|O
smaller	|O
effect	|O
.	|O

We	|O
have	|O
examined	|O
reporter	|O
gene	|O
(	|O
beta	|B-PROTEIN
-	|I-PROTEIN
gal	|I-PROTEIN
)	|O
expression	|O
directed	|O
by	|O
human	|O
heat	|B-PROTEIN
shock	|I-PROTEIN
transcription	|I-PROTEIN
factors	|I-PROTEIN
1	|I-PROTEIN
and	|I-PROTEIN
2	|I-PROTEIN
(	|O
HSF1	|B-PROTEIN
and	|O
HSF2	|B-PROTEIN
)	|O
in	|O
HeLa	|O
cells	|O
and	|O
in	|O
yeast	|O
(	|O
Saccharomyces	|O
cerevisiae	|O
)	|O
.	|O

Localized	|O
fluorescence	|O
was	|O
detectable	|O
only	|O
in	|O
cells	|O
containing	|O
a	|O
visible	|O
midcell	|O
constriction	|O
,	|O
suggesting	|O
that	|O
FtsK	|B-PROTEIN
targeting	|O
normally	|O
occurs	|O
only	|O
at	|O
a	|O
late	|O
stage	|O
of	|O
septation	|O
.	|O

No	|O
TATA	|O
box	|O
was	|O
found	|O
in	|O
the	|O
putative	|O
promoter	|O
region	|O
,	|O
but	|O
multiple	|O
GC	|O
boxes	|O
were	|O
found	|O
around	|O
the	|O
cap	|O
sites	|O
,	|O
supporting	|O
the	|O
previously	|O
inferred	|O
housekeeping	|O
nature	|O
of	|O
CYP51	|B-PROTEIN
gene	|O
and	|O
the	|O
existence	|O
of	|O
the	|O
multiple	|O
transcription	|O
initiation	|O
sites	|O
.	|O

Structural	|O
and	|O
evolutionary	|O
studies	|O
on	|O
sterol	|B-PROTEIN
14	|I-PROTEIN
-	|I-PROTEIN
demethylase	|I-PROTEIN
P450	|I-PROTEIN
(	|O
CYP51	|B-PROTEIN
)	|O
,	|O
the	|O
most	|O
conserved	|O
P450	|B-PROTEIN
monooxygenase	|I-PROTEIN
:	|O
I.	|O

Its	|O
expression	|O
pattern	|O
is	|O
representative	|O
of	|O
many	|O
B	|O
cell	|O
-	|O
specific	|O
proteins	|O
,	|O
which	|O
are	|O
essential	|O
for	|O
B	|O
cell	|O
development	|O
and	|O
activation	|O
but	|O
are	|O
down	|O
-	|O
regulated	|O
after	|O
B	|O
cells	|O
become	|O
terminally	|O
differentiated	|O
plasma	|O
cells	|O
.	|O

The	|O
intercistronic	|O
gene	|O
junctions	|O
of	|O
vesicular	|O
stomatitis	|O
virus	|O
(	|O
VSV	|O
)	|O
contain	|O
conserved	|O
sequence	|O
elements	|O
that	|O
are	|O
important	|O
for	|O
polyadenylation	|O
and	|O
transcription	|O
termination	|O
of	|O
upstream	|O
transcript	|O
as	|O
well	|O
as	|O
reinitiation	|O
of	|O
transcription	|O
of	|O
downstream	|O
transcript	|O
.	|O

Infectious	|O
mutant	|O
virus	|O
progeny	|O
was	|O
obtained	|O
only	|O
on	|O
complementing	|O
gK	|B-PROTEIN
-	|O
expressing	|O
cells	|O
,	|O
suggesting	|O
that	|O
gK	|B-PROTEIN
has	|O
an	|O
important	|O
function	|O
in	|O
the	|O
replication	|O
cycle	|O
.	|O

Cleavage	|O
and	|O
DNA	|O
joining	|O
reactions	|O
,	|O
carried	|O
out	|O
by	|O
human	|O
immunodeficiency	|O
virus	|O
type	|O
1	|O
(	|O
HIV	|O
-	|O
1	|O
)	|O
integrase	|B-PROTEIN
,	|O
are	|O
necessary	|O
to	|O
effect	|O
the	|O
covalent	|O
insertion	|O
of	|O
HIV	|O
-	|O
1	|O
DNA	|O
into	|O
the	|O
host	|O
genome	|O
.	|O

The	|O
DSF	|O
regimen	|O
appears	|O
to	|O
have	|O
significant	|O
activity	|O
in	|O
patients	|O
who	|O
have	|O
metastatic	|O
pancreatic	|O
islet	|O
-	|O
cell	|O
carcinoma	|O
,	|O
and	|O
patient	|O
tolerance	|O
of	|O
the	|O
regimen	|O
is	|O
excellent	|O
,	|O
thus	|O
warranting	|O
further	|O
investigation	|O
.	|O

Activation	|O
of	|O
the	|O
mitogen	|O
activated	|O
protein	|O
(	|B-PROTEIN
MAP	|I-PROTEIN
)	|I-PROTEIN
kinase	|I-PROTEIN
is	|O
a	|O
primary	|O
consequence	|O
of	|O
Ras	|B-PROTEIN
activation	|O
and	|O
plays	|O
a	|O
key	|O
role	|O
in	|O
mediating	|O
Ras	|B-PROTEIN
signal	|O
transduction	|O
.	|O

Histone	|B-PROTEIN
acetylation	|O
levels	|O
in	|O
cells	|O
result	|O
from	|O
a	|O
dynamic	|O
equilibrium	|O
between	|O
competing	|O
histone	|B-PROTEIN
acetylases	|I-PROTEIN
and	|I-PROTEIN
deacetylases	|I-PROTEIN
.	|O

CONCLUSIONS	|O
:	|O
XCoe2	|B-PROTEIN
may	|O
play	|O
a	|O
pivotal	|O
role	|O
in	|O
the	|O
transcriptional	|O
cascade	|O
that	|O
specifies	|O
primary	|O
neurons	|O
in	|O
Xenopus	|O
embryos	|O
:	|O
by	|O
maintaining	|O
Delta	|B-PROTEIN
-	|O
Notch	|B-PROTEIN
signalling	|O
,	|O
XCoe2	|B-PROTEIN
stabilises	|O
the	|O
higher	|O
neural	|O
potential	|O
of	|O
selected	|O
progenitor	|O
cells	|O
that	|O
express	|O
X	|B-PROTEIN
-	|I-PROTEIN
ngnr	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
ensuring	|O
the	|O
transition	|O
between	|O
neural	|O
competence	|O
and	|O
irreversible	|O
commitment	|O
to	|O
a	|O
neural	|O
fate	|O
;	|O
and	|O
it	|O
promotes	|O
neuronal	|O
differentiation	|O
by	|O
activating	|O
XNeuroD	|B-PROTEIN
expression	|O
,	|O
directly	|O
or	|O
indirectly	|O
.	|O

RESULTS	|O
:	|O
Patients	|O
in	|O
Group	|O
A	|O
had	|O
a	|O
higher	|O
incidence	|O
of	|O
posterolateral	|O
wall	|O
motion	|O
abnormalities	|O
(	|O
p	|O
<	|O
0.001	|O
)	|O
on	|O
radionuclide	|O
ventriculography	|O
,	|O
a	|O
larger	|O
infarct	|O
area	|O
(	|O
as	|O
evidenced	|O
by	|O
higher	|O
peak	|O
creatine	|B-PROTEIN
kinase	|I-PROTEIN
levels	|O
)	|O
(	|O
p	|O
<	|O
0.02	|O
)	|O
and	|O
a	|O
lower	|O
left	|O
ventricular	|O
ejection	|O
fraction	|O
(	|O
LVEF	|O
)	|O
at	|O
hospital	|O
discharge	|O
(	|O
p	|O
<	|O
0.008	|O
)	|O
than	|O
those	|O
in	|O
Group	|O
B.	|O

CyIIa	|B-PROTEIN
transcription	|O
follows	|O
,	|O
and	|O
is	|O
therefore	|O
downstream	|O
of	|O
,	|O
the	|O
initial	|O
specification	|O
of	|O
these	|O
embryonic	|O
domains	|O
.	|O

Cis	|O
-	|O
regulation	|O
downstream	|O
of	|O
cell	|O
type	|O
specification	|O
:	|O
a	|O
single	|O
compact	|O
element	|O
controls	|O
the	|O
complex	|O
expression	|O
of	|O
the	|O
CyIIa	|B-PROTEIN
gene	|O
in	|O
sea	|O
urchin	|O
embryos	|O
.	|O

We	|O
also	|O
present	|O
evidence	|O
that	|O
human	|O
HYAL1	|B-PROTEIN
is	|O
identical	|O
to	|O
an	|O
uncharacterized	|O
gene	|O
positionally	|O
cloned	|O
by	|O
others	|O
from	|O
chromosome	|O
3p21.3	|O
that	|O
is	|O
homozygously	|O
deleted	|O
in	|O
several	|O
small	|O
-	|O
cell	|O
lung	|O
carcinoma	|O
cell	|O
lines	|O
.	|O

In	|O
patients	|O
with	|O
myalgia	|O
,	|O
Raynaud	|O
's	|O
syndrome	|O
,	|O
skin	|O
vasculitis	|O
and	|O
vascular	|O
diseases	|O
WFAg	|B-PROTEIN
concentrations	|O
were	|O
higher	|O
than	|O
in	|O
patients	|O
without	|O
them	|O
.	|O

Although	|O
the	|O
expression	|O
of	|O
the	|O
4E	|B-PROTEIN
-	|I-PROTEIN
BP1	|I-PROTEIN
gene	|O
alone	|O
has	|O
not	|O
yet	|O
been	|O
accomplished	|O
,	|O
the	|O
gene	|O
was	|O
expressed	|O
in	|O
Escherichia	|O
coli	|O
[	|O
BL21	|O
(	|O
DE3	|O
)	|O
]	|O
as	|O
a	|O
fusion	|O
gene	|O
with	|O
the	|O
glutathione	|B-PROTEIN
-	|I-PROTEIN
S	|I-PROTEIN
-	|I-PROTEIN
transferase	|I-PROTEIN
(	|O
GST	|B-PROTEIN
)	|O
gene	|O
using	|O
a	|O
prokaryotic	|O
gene	|O
fusion	|O
vector	|O
(	|O
pGEX	|O
-	|O
4T	|O
-	|O
2	|O
)	|O
,	|O
which	|O
contains	|O
a	|O
gene	|O
sequence	|O
coding	|O
the	|O
cleavage	|O
site	|O
for	|O
a	|O
specific	|O
protease	|O
,	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
thrombin	|I-PROTEIN
.	|O

Randomised	|O
comparison	|O
of	|O
addition	|O
of	|O
autologous	|O
bone	|O
-	|O
marrow	|O
transplantation	|O
to	|O
intensive	|O
chemotherapy	|O
for	|O
acute	|O
myeloid	|O
leukaemia	|O
in	|O
first	|O
remission	|O
:	|O
results	|O
of	|O
MRC	|O
AML	|O
10	|O
trial	|O
.	|O

Therapeutic	|O
use	|O
of	|O
cannabis	|O
.	|O

Analysis	|O
of	|O
intragenic	|O
revertants	|O
shows	|O
that	|O
this	|O
function	|O
depends	|O
on	|O
the	|O
amino	|O
acid	|O
preceding	|O
the	|O
first	|O
cysteine	|O
residue	|O
of	|O
the	|O
DNA	|O
-	|O
binding	|O
domain	|O
of	|O
Hap1p	|B-PROTEIN
.	|O

Peripheral	|O
visual	|O
stimuli	|O
and	|O
monoaural	|O
auditory	|O
stimuli	|O
were	|O
used	|O
as	|O
targets	|O
.	|O

A	|O
review	|O
of	|O
studies	|O
published	|O
between	|O
1983	|O
and	|O
1995	|O
shows	|O
that	|O
there	|O
are	|O
some	|O
common	|O
factors	|O
as	|O
regards	|O
the	|O
psychological	|O
distress	|O
and	|O
social	|O
and	|O
functional	|O
limitations	|O
this	|O
group	|O
of	|O
patients	|O
has	|O
to	|O
deal	|O
with	|O
.	|O

PKC	|B-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
,	|O
which	|O
is	|O
not	|O
present	|O
in	|O
keratinocytes	|O
,	|O
also	|O
induces	|O
involucrin	|B-PROTEIN
gene	|O
expression	|O
in	|O
a	|O
TPA	|O
-	|O
independent	|O
manner	|O
,	|O
when	|O
introduced	|O
into	|O
SVHK	|O
cells	|O
.	|O

Identification	|O
and	|O
characterization	|O
of	|O
specific	|O
DNA	|O
-	|O
binding	|O
complexes	|O
containing	|O
members	|O
of	|O
the	|O
Myc	|B-PROTEIN
/	|O
Max	|B-PROTEIN
/	|O
Mad	|B-PROTEIN
network	|O
of	|O
transcriptional	|O
regulators	|O
.	|O

We	|O
further	|O
show	|O
that	|O
proteolytic	|O
targeting	|O
by	|O
calpain	|B-PROTEIN
II	|I-PROTEIN
and	|O
the	|O
proteasome	|O
involves	|O
different	|O
structural	|O
elements	|O
of	|O
YY1	|B-PROTEIN
.	|O

Primers	|O
for	|O
subsequent	|O
rounds	|O
of	|O
RACE	|O
were	|O
designed	|O
from	|O
the	|O
5'	|O
-	|O
ends	|O
of	|O
amplified	|O
RACE	|O
products	|O
.	|O

Human	|O
ZFM1	|B-PROTEIN
protein	|O
is	|O
a	|O
transcriptional	|O
repressor	|O
that	|O
interacts	|O
with	|O
the	|O
transcription	|O
activation	|O
domain	|O
of	|O
stage	|B-PROTEIN
-	|I-PROTEIN
specific	|I-PROTEIN
activator	|I-PROTEIN
protein	|I-PROTEIN
.	|O

Surprisingly	|O
,	|O
the	|O
CSF1R	|B-PROTEIN
/	|O
IRDelta960	|B-PROTEIN
was	|O
as	|O
effective	|O
as	|O
the	|O
CSF1R	|B-PROTEIN
/	|O
IR	|B-PROTEIN
in	|O
mediating	|O
CSF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
protection	|O
of	|O
cells	|O
from	|O
staurosporine	|O
-	|O
induced	|O
apoptosis	|O
.	|O

CONCLUSIONS	|O
:	|O
The	|O
special	|O
clinical	|O
presentation	|O
of	|O
our	|O
case	|O
of	|O
possible	|O
Gardner	|O
's	|O
syndrome	|O
is	|O
discussed	|O
.	|O

These	|O
results	|O
would	|O
suggest	|O
that	|O
a	|O
high	|O
UV	|O
sensitivity	|O
is	|O
associated	|O
with	|O
high	|O
phaeomelanin	|O
and	|O
low	|O
eumelanin	|O
levels	|O
,	|O
and	|O
point	|O
to	|O
the	|O
eumelanin	|O
/	|O
phaeomelanin	|O
ratio	|O
as	|O
a	|O
novel	|O
chemical	|O
parameter	|O
that	|O
could	|O
be	|O
used	|O
for	|O
predicting	|O
individuals	|O
at	|O
high	|O
risk	|O
for	|O
skin	|O
cancer	|O
and	|O
melanoma	|O
.	|O

In	|O
ferrets	|O
naturally	|O
infected	|O
with	|O
H.	|O
mustelae	|O
,	|O
a	|O
single	|O
dose	|O
(	|O
50	|O
mg	|O
/	|O
kg	|O
,	|O
per	|O
os	|O
)	|O
of	|O
fluorofamide	|O
completely	|O
inhibited	|O
bacterial	|O
urease	|B-PROTEIN
.	|O

The	|O
cAMP	|O
-	|O
dependent	|O
mitogenic	|O
pathway	|O
is	|O
unique	|O
as	|O
it	|O
is	|O
independent	|O
of	|O
mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
activation	|O
and	|O
differs	|O
from	|O
growth	|O
factor	|O
-	|O
dependent	|O
pathways	|O
at	|O
the	|O
level	|O
of	|O
the	|O
expression	|O
of	|O
several	|O
protooncogenes	|O
/	|O
transcription	|O
factors	|O
.	|O

CONCLUSIONS	|O
:	|O
Use	|O
of	|O
the	|O
first	|O
method	|O
was	|O
associated	|O
with	|O
a	|O
reduction	|O
in	|O
the	|O
time	|O
patients	|O
remained	|O
in	|O
the	|O
ICU	|O
before	|O
transfer	|O
to	|O
another	|O
unit	|O
and	|O
savings	|O
in	|O
nursing	|O
time	|O
,	|O
but	|O
the	|O
two	|O
methods	|O
did	|O
not	|O
differ	|O
according	|O
to	|O
clinical	|O
outcomes	|O
.	|O

We	|O
have	|O
elucidated	|O
the	|O
exon	|O
-	|O
intron	|O
organization	|O
of	|O
the	|O
entire	|O
human	|O
CD58	|B-PROTEIN
gene	|O
,	|O
including	|O
approximately	|O
2.5	|O
kilobases	|O
(	|O
kb	|O
)	|O
of	|O
5'	|O
-	|O
flanking	|O
DNA	|O
.	|O

The	|O
risk	|O
factors	|O
for	|O
hematuria	|O
in	|O
patients	|O
with	|O
renal	|O
hypouricemia	|O
are	|O
the	|O
elevation	|O
of	|O
urinary	|O
urate	|O
concentration	|O
and	|O
the	|O
subtypes	|O
of	|O
Post	|O
and	|O
Secretion	|O
.	|O

Two	|O
hundred	|O
sixty	|O
-	|O
four	|O
patients	|O
scheduled	|O
for	|O
DCBM	|O
were	|O
randomized	|O
to	|O
receive	|O
intravenously	|O
geG	|O
0.25	|O
mg	|O
(	|O
geG	|O
-	|O
25	|O
)	|O
,	|O
or	|O
geG	|O
0.5	|O
mg	|O
(	|O
geG	|O
-	|O
50	|O
)	|O
,	|O
or	|O
HBB	|O
20	|O
mg	|O
as	|O
hypotonic	|O
agent	|O
.	|O

If	|O
the	|O
haemoglobin	|B-PROTEIN
concentration	|O
(	|O
Hb	|B-PROTEIN
)	|O
was	|O
less	|O
than	|O
12	|O
g	|O
dL	|O
-	|O
1	|O
they	|O
were	|O
given	|O
a	|O
four	|O
week	|O
course	|O
of	|O
ferrous	|O
sulphate	|O
.	|O

In	|O
all	|O
cells	|O
,	|O
the	|O
accumulation	|O
of	|O
high	|O
Dsg	|B-PROTEIN
protein	|O
levels	|O
required	|O
calcium	|O
and	|O
was	|O
not	|O
observed	|O
in	|O
low	|O
calcium	|O
(	|O
0.05-0.07	|O
mM	|O
)	|O
media	|O
.	|O

Based	|O
on	|O
restriction	|O
enzyme	|O
analysis	|O
,	|O
Southern	|O
blots	|O
,	|O
polymerase	|O
chain	|O
reaction	|O
analysis	|O
and	|O
DNA	|O
sequencing	|O
,	|O
it	|O
was	|O
confirmed	|O
that	|O
the	|O
three	|O
overlapping	|O
clones	|O
isolated	|O
cover	|O
the	|O
entire	|O
cHO	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
gene	|O
,	|O
as	|O
well	|O
as	|O
approximately	|O
10	|O
kb	|O
of	|O
the	|O
flanking	|O
regions	|O
on	|O
both	|O
ends	|O
.	|O

RESULTS	|O
:	|O
Using	|O
information	|O
in	|O
the	|O
dbEST	|O
database	|O
of	|O
expressed	|O
sequence	|O
tags	|O
,	|O
we	|O
isolated	|O
an	|O
Arabidopsis	|O
thaliana	|O
gene	|O
(	|O
GCR1	|B-PROTEIN
)	|O
that	|O
encodes	|O
a	|O
protein	|O
with	|O
seven	|O
predicted	|O
membrane	|O
-	|O
spanning	|O
domains	|O
and	|O
other	|O
features	|O
characteristic	|O
of	|O
7TM	|B-PROTEIN
receptors	|I-PROTEIN
.	|O

E1A	|B-PROTEIN
represses	|O
apolipoprotein	|B-PROTEIN
AI	|I-PROTEIN
enhancer	|O
activity	|O
in	|O
liver	|O
cells	|O
through	|O
a	|O
pRb	|B-PROTEIN
-	|O
and	|O
CBP	|B-PROTEIN
-	|O
independent	|O
pathway	|O
.	|O

Position	|O
-	|O
independent	|O
expression	|O
of	|O
a	|O
human	|O
nerve	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
-	|O
luciferase	|B-PROTEIN
reporter	|O
gene	|O
cloned	|O
on	|O
a	|O
yeast	|O
artificial	|O
chromosome	|O
vector	|O
.	|O

Calcitriol	|O
therapy	|O
was	|O
associated	|O
with	|O
a	|O
decrease	|O
in	|O
serum	|O
iPTH	|B-PROTEIN
levels	|O
(	|O
701	|O
+	|O
/	|O
-	|O
103.9	|O
vs.	|O

Alterations	|O
in	|O
DNase	|B-PROTEIN
I	|I-PROTEIN
reactivity	|O
of	|O
the	|O
GC	|O
-	|O
response	|O
element	|O
region	|O
suggest	|O
that	|O
GC	|B-PROTEIN
receptor	|I-PROTEIN
-	|O
GC	|O
complexes	|O
may	|O
associate	|O
,	|O
in	|O
a	|O
transient	|O
manner	|O
,	|O
with	|O
the	|O
promoter	|O
in	|O
the	|O
actively	|O
transcribing	|O
control	|O
state	|O
.	|O

Most	|O
pituitary	|O
hormone	|O
-	|O
coding	|O
gene	|O
promoters	|O
are	|O
activated	|O
by	|O
Ptx1	|B-PROTEIN
.	|O

One	|O
of	|O
these	|O
small	|O
inteins	|B-PROTEIN
might	|O
be	|O
inactive	|O
or	|O
a	|O
"	|O
pseudo	|O
intein	|B-PROTEIN
.	|O
"	|O
The	|O
results	|O
suggest	|O
a	|O
modular	|O
architecture	|O
for	|O
inteins	|B-PROTEIN
,	|O
clarify	|O
their	|O
origin	|O
and	|O
relationship	|O
to	|O
other	|O
protein	|O
families	|O
,	|O
and	|O
extend	|O
recent	|O
experimental	|O
findings	|O
on	|O
the	|O
functional	|O
roles	|O
of	|O
intein	|B-PROTEIN
N	|O
,	|O
C	|O
,	|O
and	|O
EN	|O
motifs	|O
.	|O

Purification	|O
of	|O
MvaT	|B-PROTEIN
enriched	|O
for	|O
two	|O
polypeptides	|O
of	|O
approximate	|O
molecular	|O
mass	|O
15	|O
kDa	|O
and	|O
16	|O
kDa	|O
,	|O
designated	|O
P15	|B-PROTEIN
and	|O
P16	|B-PROTEIN
.	|O

M	|B-PROTEIN
-	|I-PROTEIN
66	|I-PROTEIN
identified	|O
the	|O
14	|O
-	|O
kDa	|O
protein	|O
in	|O
another	|O
MMTV	|O
bearing	|O
T	|O
-	|O
cell	|O
lymphoma	|O
,	|O
EL	|O
-	|O
4	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
betaf	|I-PROTEIN
potentiates	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
SRE	|O
activated	|O
by	|O
PKC	|B-PROTEIN
through	|O
the	|O
SRF	|B-PROTEIN
binding	|O
site	|O
.	|O

RT	|O
-	|O
PCR	|O
indicated	|O
that	|O
p21	|B-PROTEIN
mRNA	|O
was	|O
induced	|O
1.4	|O
-	|O
,	|O
2.0	|O
-	|O
,	|O
and	|O
3.1	|O
-	|O
fold	|O
in	|O
the	|O
2	|O
-	|O
day	|O
neonatal	|O
,	|O
7	|O
-	|O
day	|O
neonatal	|O
,	|O
and	|O
adult	|O
stages	|O
,	|O
respectively	|O
,	|O
compared	|O
to	|O
the	|O
17	|O
-	|O
day	|O
fetal	|O
stage	|O
.	|O

Ganciclovir	|O
and	|O
foscarnet	|O
efficacy	|O
in	|O
AIDS	|O
-	|O
related	|O
CMV	|O
polyradiculopathy	|O
.	|O

BACKGROUND	|O
:	|O
Defensins	|B-PROTEIN
,	|O
also	|O
known	|O
as	|O
human	|O
neutrophil	|B-PROTEIN
peptides	|I-PROTEIN
,	|O
are	|O
antimicrobial	|O
peptides	|O
present	|O
in	|O
the	|O
azurophil	|O
granules	|O
of	|O
neutrophils	|O
.	|O

The	|O
spontaneous	|O
mutation	|O
blocking	|O
pca	|B-PROTEIN
gene	|O
expression	|O
was	|O
located	|O
in	|O
the	|O
promoter	|O
for	|O
the	|O
pca	|B-PROTEIN
operon	|O
.	|O

From	|O
250	|O
g	|O
of	|O
cells	|O
,	|O
we	|O
isolated	|O
1	|O
mg	|O
of	|O
PDH	|B-PROTEIN
complex	|O
with	|O
a	|O
specific	|O
activity	|O
of	|O
12.6	|O
U	|O
/	|O
mg	|O
of	|O
protein	|O
.	|O

The	|O
PDH	|B-PROTEIN
complex	|O
-	|O
encoding	|O
genes	|O
were	|O
identified	|O
by	|O
hybridization	|O
experiments	|O
and	|O
sequence	|O
analysis	|O
in	|O
two	|O
separate	|O
gene	|O
regions	|O
in	|O
the	|O
genome	|O
of	|O
Z.	|O
mobilis	|O
.	|O

We	|O
have	|O
identified	|O
two	|O
functional	|O
elements	|O
,	|O
both	|O
located	|O
downstream	|O
from	|O
the	|O
TATA	|O
motif	|O
,	|O
that	|O
control	|O
Id4	|B-PROTEIN
promoter	|O
activity	|O
.	|O

Azithromycin	|O
is	|O
a	|O
new	|O
generation	|O
macrolide	|O
antibiotic	|O
with	|O
unusual	|O
and	|O
favorable	|O
pharmacokinetics	|O
,	|O
and	|O
seems	|O
to	|O
be	|O
a	|O
very	|O
promising	|O
agent	|O
for	|O
innovative	|O
anti	|O
-	|O
H.	|O
pylori	|O
regimens	|O
.	|O

The	|O
study	|O
enrolled	|O
994	|O
people	|O
co	|O
-	|O
infected	|O
with	|O
CMV	|O
and	|O
HIV	|O
,	|O
with	|O
at	|O
least	|O
one	|O
CD4	|B-PROTEIN
count	|O
recorded	|O
<	|O
100	|O
x	|O
10	|O
(	|O
6	|O
)	|O
cells	|O
/	|O
l	|O
.	|O

BACKGROUND	|O
AND	|O
OBJECTIVES	|O
:	|O
The	|O
sexually	|O
transmitted	|O
diseases	|O
(	|O
STD	|O
)	|O
control	|O
program	|O
for	|O
female	|O
sex	|O
workers	|O
(	|O
FSW	|O
)	|O
in	|O
Lima	|O
,	|O
Peru	|O
,	|O
provided	|O
periodic	|O
serological	|O
tests	|O
for	|O
syphilis	|O
and	|O
cervical	|O
smears	|O
for	|O
gonococci	|O
,	|O
but	|O
not	|O
medication	|O
for	|O
STD	|O
or	|O
condoms	|O
.	|O

National	|O
certification	|O
:	|O
a	|O
vital	|O
component	|O
of	|O
quality	|O
assurance	|O
.	|O

Two	|O
rare	|O
novel	|O
mutations	|O
,	|O
D811N	|O
in	|O
exon	|O
20	|O
and	|O
R835C	|O
in	|O
exon	|O
21	|O
,	|O
were	|O
identified	|O
in	|O
the	|O
first	|O
nucleotide	|O
-	|O
binding	|O
fold	|O
(	|O
NBF	|O
)	|O
,	|O
a	|O
functionally	|O
important	|O
region	|O
of	|O
SUR1	|B-PROTEIN
,	|O
in	|O
one	|O
patient	|O
each	|O
,	|O
both	|O
heterozygotes	|O
.	|O

Chimaeric	|O
VP16	|B-PROTEIN
-	|O
E2	|B-PROTEIN
molecules	|O
suggest	|O
that	|O
the	|O
epithelial	|O
specific	|O
transcriptional	|O
activation	|O
of	|O
the	|O
BPV	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
LCR	|I-PROTEIN
promoter	|O
is	|O
mediated	|O
by	|O
the	|O
E2	|B-PROTEIN
transactivation	|O
domain	|O
.	|O

In	|O
order	|O
to	|O
examine	|O
the	|O
potential	|O
role	|O
of	|O
transcriptional	|O
silencing	|O
during	|O
productive	|O
HSV	|O
-	|O
1	|O
infection	|O
,	|O
recombinant	|O
viruses	|O
were	|O
generated	|O
in	|O
which	|O
wild	|O
-	|O
type	|O
or	|O
mutant	|O
ICP34.5	|B-PROTEIN
promoters	|O
controlling	|O
the	|O
expression	|O
of	|O
a	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
reporter	|O
gene	|O
were	|O
inserted	|O
into	|O
the	|O
thymidine	|B-PROTEIN
kinase	|I-PROTEIN
gene	|O
of	|O
the	|O
viral	|O
genome	|O
.	|O

These	|O
changes	|O
correlate	|O
directly	|O
with	|O
an	|O
increase	|O
in	|O
the	|O
acetylation	|O
levels	|O
of	|O
all	|O
four	|O
core	|O
histones	|B-PROTEIN
in	|O
vivo	|O
.	|O

Drosophila	|O
orthodenticle	|B-PROTEIN
(	|O
otd	|B-PROTEIN
)	|O
and	|O
murine	|O
Otx	|B-PROTEIN
genes	|O
exemplify	|O
this	|O
,	|O
both	|O
in	|O
terms	|O
of	|O
expression	|O
patterns	|O
and	|O
mutant	|O
phenotypes	|O
.	|O

APETALA3	|B-PROTEIN
transcripts	|O
are	|O
first	|O
detected	|O
in	|O
a	|O
meristematic	|O
region	|O
that	|O
will	|O
give	|O
rise	|O
to	|O
the	|O
petal	|O
and	|O
stamen	|O
primordia	|O
,	|O
and	|O
expression	|O
is	|O
maintained	|O
in	|O
this	|O
region	|O
during	|O
subsequent	|O
development	|O
of	|O
these	|O
organs	|O
.	|O

We	|O
also	|O
recovered	|O
mutations	|O
in	|O
the	|O
60A	|B-PROTEIN
gene	|O
which	|O
encodes	|O
another	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
-	|O
related	|O
factor	|O
in	|O
Drosophila	|O
.	|O

Cell	|O
lines	|O
are	|O
checked	|O
to	|O
find	|O
out	|O
whether	|O
they	|O
develop	|O
tumors	|O
in	|O
nude	|O
mice	|O
followed	|O
by	|O
an	|O
analysis	|O
of	|O
the	|O
karyotype	|O
.	|O

Cervicovaginal	|O
foetal	|O
fibronectin	|B-PROTEIN
in	|O
the	|O
prediction	|O
of	|O
preterm	|O
labour	|O
in	|O
a	|O
low	|O
-	|O
risk	|O
population	|O
.	|O

In	|O
addition	|O
,	|O
IgM	|B-PROTEIN
can	|O
be	|O
absent	|O
in	|O
children	|O
with	|O
congenital	|O
toxoplasmosis	|O
or	|O
subjects	|O
with	|O
secondary	|O
reactivation	|O
.	|O

Both	|O
variants	|O
display	|O
the	|O
seven	|O
-	|O
transmembrane	|O
topology	|O
that	|O
is	|O
typical	|O
for	|O
G	|B-PROTEIN
protein	|I-PROTEIN
-	|I-PROTEIN
coupled	|I-PROTEIN
receptors	|I-PROTEIN
.	|O

A	|O
constitutive	|O
allele	|O
of	|O
GPA2	|B-PROTEIN
could	|O
stimulate	|O
growth	|O
of	|O
a	|O
strain	|O
lacking	|O
both	|O
RAS	|B-PROTEIN
genes	|O
.	|O

The	|O
COOH	|O
-	|O
terminus	|O
of	|O
this	|O
new	|O
isoform	|O
,	|O
which	|O
we	|O
designate	|O
beta	|B-PROTEIN
4	|I-PROTEIN
,	|O
lacks	|O
a	|O
22	|O
amino	|O
acid	|O
lysine	|O
-	|O
rich	|O
sequence	|O
common	|O
to	|O
both	|O
the	|O
human	|O
red	|O
cell	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
and	|I-PROTEIN
beta	|I-PROTEIN
-	|I-PROTEIN
adducin	|I-PROTEIN
subunits	|O
and	|O
homologous	|O
to	|O
a	|O
highly	|O
conserved	|O
region	|O
in	|O
MARCKS	|B-PROTEIN
,	|O
a	|O
filamentous	|O
actin	|B-PROTEIN
-	|O
cross	|O
linking	|O
protein	|O
regulated	|O
by	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
C	|I-PROTEIN
and	|O
calcium	|O
/	|O
calmodulin	|B-PROTEIN
.	|O
beta	|B-PROTEIN
4	|I-PROTEIN
-	|I-PROTEIN
adducin	|I-PROTEIN
preserves	|O
a	|O
previously	|O
identified	|O
calmodulin	|B-PROTEIN
binding	|O
domain	|O
.	|O

PCR	|O
analysis	|O
indicates	|O
that	|O
this	|O
new	|O
beta	|B-PROTEIN
-	|I-PROTEIN
adducin	|I-PROTEIN
isoform	|O
is	|O
expressed	|O
in	|O
fetal	|O
brain	|O
and	|O
liver	|O
,	|O
bone	|O
marrow	|O
,	|O
and	|O
NT	|O
-	|O
2	|O
(	|O
neuroepithelial	|O
)	|O
cells	|O
,	|O
but	|O
is	|O
not	|O
detected	|O
in	|O
several	|O
other	|O
tissues	|O
.	|O

The	|O
gene	|O
lac	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
encoding	|O
the	|O
enzyme	|O
laccase	|B-PROTEIN
,	|O
is	|O
the	|O
best	|O
characterized	|O
of	|O
a	|O
number	|O
of	|O
genes	|O
in	|O
the	|O
chestnut	|O
blight	|O
fungus	|O
,	|O
Cryphonectria	|O
parasitica	|O
,	|O
that	|O
are	|O
repressed	|O
by	|O
hypoviruses	|O
,	|O
a	|O
group	|O
of	|O
virulence	|O
-	|O
attenuating	|O
mycoviruses	|O
.	|O
lac	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
has	|O
also	|O
been	|O
shown	|O
to	|O
be	|O
transcriptionally	|O
activated	|O
by	|O
low	|O
concentrations	|O
of	|O
the	|O
translational	|O
inhibitor	|O
cycloheximide	|O
(	|O
CHX	|O
)	|O
and	|O
by	|O
the	|O
immunosuppressant	|O
cyclosporin	|O
A.	|O

Both	|O
TRE	|O
-	|O
like	|O
elements	|O
were	|O
capable	|O
of	|O
binding	|O
AP1	|B-PROTEIN
.	|O

The	|O
hp55	|B-PROTEIN
gamma	|I-PROTEIN
protein	|O
interacts	|O
strongly	|O
with	|O
the	|O
activated	|O
IGFIR	|B-PROTEIN
but	|O
not	|O
with	|O
the	|O
kinase	|O
-	|O
negative	|O
mutant	|O
receptor	|O
.	|O
hp55	|B-PROTEIN
gamma	|I-PROTEIN
also	|O
interacts	|O
with	|O
the	|O
insulin	|B-PROTEIN
receptor	|I-PROTEIN
(	|O
IR	|B-PROTEIN
)	|O
in	|O
the	|O
yeast	|O
two	|O
-	|O
hybrid	|O
system	|O
.	|O

The	|O
plant	|O
protein	|O
maintains	|O
all	|O
the	|O
functional	|O
domains	|O
found	|O
in	|O
the	|O
other	|O
proteins	|O
,	|O
including	|O
nuclear	|O
localization	|O
signal	|O
,	|O
DNA	|O
-	|O
binding	|O
domain	|O
and	|O
helicase	|B-PROTEIN
motifs	|O
,	|O
suggesting	|O
that	|O
it	|O
might	|O
also	|O
act	|O
as	|O
part	|O
of	|O
the	|O
RNA	|O
transcription	|O
apparatus	|O
,	|O
as	|O
well	|O
as	|O
nucleotide	|O
excision	|O
repair	|O
in	|O
plant	|O
cells	|O
.	|O

This	|O
paper	|O
describes	|O
the	|O
genomic	|O
organization	|O
of	|O
mouse	|O
gC1qBP	|B-PROTEIN
and	|O
the	|O
characterization	|O
of	|O
its	|O
5'	|O
flanking	|O
region	|O
.	|O

LysR	|B-PROTEIN
proteins	|O
have	|O
been	|O
shown	|O
to	|O
regulate	|O
urease	|B-PROTEIN
in	|O
Klebsiella	|O
aerogenes	|O
(	|O
NAC	|B-PROTEIN
)	|O
,	|O
and	|O
catalase	|B-PROTEIN
in	|O
Escherichia	|O
coli	|O
(	|O
OxyR	|B-PROTEIN
)	|O
,	|O
which	|O
offers	|O
the	|O
intracellular	|O
bacterium	|O
protection	|O
from	|O
phagolysosome	|O
damage	|O
.	|O

Also	|O
,	|O
the	|O
anti	|O
-	|O
inflammatory	|O
activities	|O
of	|O
an	|O
aqueous	|O
extract	|O
of	|O
Buddleia	|O
cordata	|O
and	|O
its	|O
principal	|O
glycoside	|O
linarin	|O
were	|O
evaluated	|O
.	|O

Regulation	|O
of	|O
the	|O
Raf	|B-PROTEIN
kinase	|O
in	|O
T	|O
cells	|O
differs	|O
from	|O
findings	|O
with	|O
a	|O
variety	|O
of	|O
cell	|O
lines	|O
that	|O
the	|O
catalytic	|O
domain	|O
of	|O
Raf	|B-PROTEIN
(	|O
Raf	|B-PROTEIN
(	|O
delta26	|O
-	|O
303	|O
)	|O
)	|O
shows	|O
no	|O
activity	|O
.	|O

Full	|O
-	|O
length	|O
FLAP	|B-PROTEIN
clones	|O
were	|O
isolated	|O
from	|O
a	|O
mouse	|O
skeletal	|O
muscle	|O
cDNA	|O
library	|O
.	|O

Members	|O
of	|O
the	|O
meis1	|B-PROTEIN
and	|O
pbx	|B-PROTEIN
homeodomain	|O
protein	|O
families	|O
cooperatively	|O
bind	|O
a	|O
cAMP	|O
-	|O
responsive	|O
sequence	|O
(	|O
CRS1	|O
)	|O
from	|O
bovine	|O
CYP17	|B-PROTEIN
.	|O

We	|O
have	|O
visualized	|O
DNA	|O
-	|O
protein	|O
complexes	|O
by	|O
electron	|O
microscopy	|O
and	|O
a	|O
high	|O
-	|O
affinity	|O
binding	|O
site	|O
of	|O
WDV	|O
Rep	|B-PROTEIN
protein	|O
within	|O
the	|O
core	|O
element	|O
has	|O
been	|O
mapped	|O
to	|O
approximately	|O
144	|O
+	|O
/	|O
-	|O
18	|O
bp	|O
upstream	|O
from	|O
the	|O
initiation	|O
site	|O
,	|O
between	|O
the	|O
start	|O
site	|O
for	|O
complementary	|O
-	|O
sense	|O
transcription	|O
and	|O
the	|O
TATA	|O
box	|O
.	|O

Rex	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
a	|O
gene	|O
encoding	|O
a	|O
transcription	|O
factor	|O
expressed	|O
in	|O
the	|O
early	|O
embryo	|O
,	|O
is	|O
regulated	|O
via	|O
Oct	|B-PROTEIN
-	|I-PROTEIN
3/4	|I-PROTEIN
and	|O
Oct	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
binding	|O
to	|O
an	|O
octamer	|O
site	|O
and	|O
a	|O
novel	|O
protein	|O
,	|O
Rox	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
binding	|O
to	|O
an	|O
adjacent	|O
site	|O
.	|O

However	|O
,	|O
inhibition	|O
of	|O
both	|O
the	|O
ERK	|B-PROTEIN
/	|O
RSK	|B-PROTEIN
and	|O
the	|O
p38	|B-PROTEIN
/	|O
MAPKAP	|B-PROTEIN
kinase	|I-PROTEIN
2	|I-PROTEIN
pathways	|O
completely	|O
abolished	|O
NGF	|B-PROTEIN
-	|O
induced	|O
CREB	|B-PROTEIN
Ser	|O
-	|O
133	|O
phosphorylation	|O
.	|O

Cells	|O
respond	|O
to	|O
the	|O
accumulation	|O
of	|O
unfolded	|O
proteins	|O
in	|O
the	|O
endoplasmic	|O
reticulum	|O
(	|O
ER	|O
)	|O
by	|O
increasing	|O
the	|O
transcription	|O
of	|O
the	|O
genes	|O
encoding	|O
ER	|B-PROTEIN
-	|I-PROTEIN
resident	|I-PROTEIN
chaperone	|I-PROTEIN
proteins	|O
.	|O

The	|O
RAS	|B-PROTEIN
-	|O
cyclic	|B-PROTEIN
AMP	|I-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
cAPK	|O
pathway	|O
prevents	|O
the	|O
UAS	|O
activity	|O
of	|O
IREu	|B-PROTEIN
in	|O
the	|O
presence	|O
of	|O
glucose	|O
as	|O
the	|O
sole	|O
carbon	|O
source	|O
,	|O
while	|O
the	|O
transcriptional	|O
activators	|O
Msn2p	|B-PROTEIN
and	|O
Msn4p	|B-PROTEIN
promote	|O
the	|O
UAS	|O
activity	|O
of	|O
this	|O
repeat	|O
in	|O
the	|O
presence	|O
of	|O
acetate	|O
.	|O

The	|O
mei4+	|B-PROTEIN
gene	|O
of	|O
the	|O
fission	|O
yeast	|O
Schizosaccharomyces	|O
pombe	|O
was	|O
cloned	|O
by	|O
functional	|O
complementation	|O
.	|O

Alternative	|O
splicing	|O
of	|O
fibroblast	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
receptor	|I-PROTEIN
2	|I-PROTEIN
(	|O
FGF	|B-PROTEIN
-	|I-PROTEIN
R2	|I-PROTEIN
)	|O
is	|O
an	|O
example	|O
of	|O
highly	|O
regulated	|O
alternative	|O
splicing	|O
in	|O
which	|O
exons	|O
IIIb	|O
and	|O
IIIc	|O
are	|O
utilized	|O
in	|O
a	|O
mutually	|O
exclusive	|O
manner	|O
in	|O
different	|O
cell	|O
types	|O
.	|O

In	|O
some	|O
cases	|O
,	|O
the	|O
aberrant	|O
methylation	|O
of	|O
CpGs	|O
within	|O
5'	|O
regulatory	|O
regions	|O
has	|O
led	|O
to	|O
suppression	|O
of	|O
gene	|O
activity	|O
.	|O

The	|O
genomic	|O
fragments	|O
were	|O
fused	|O
upstream	|O
of	|O
the	|O
luciferase	|B-PROTEIN
reporter	|O
gene	|O
.	|O

Cotransfection	|O
analyses	|O
of	|O
the	|O
T	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
promoter	|O
-	|O
reporter	|O
constructs	|O
with	|O
a	|O
T	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
expression	|O
vector	|O
into	|O
human	|O
HepG2	|O
cells	|O
,	|O
which	|O
do	|O
not	|O
express	|O
T	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
,	|O
suggested	|O
that	|O
autoregulation	|O
may	|O
be	|O
involved	|O
in	|O
controlling	|O
both	|O
rat	|O
and	|O
human	|O
T	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
gene	|O
expression	|O
.	|O

Deletion	|O
of	|O
the	|O
last	|O
two	|O
Ser	|O
residues	|O
,	|O
including	|O
one	|O
PKC	|B-PROTEIN
consensus	|O
site	|O
in	|O
the	|O
receptor	|O
tail	|O
,	|O
prevented	|O
only	|O
phorbol	|O
12	|O
-	|O
myristate	|O
13	|O
-	|O
acetate	|O
-	|O
induced	|O
desensitization	|O
by	|O
30%	|O
.	|O

Flap	|O
survival	|O
depends	|O
on	|O
the	|O
development	|O
of	|O
a	|O
small	|O
number	|O
of	|O
vascular	|O
connections	|O
between	|O
vessels	|O
arising	|O
from	|O
the	|O
pedicle	|O
and	|O
preexisting	|O
dermal	|O
vessels	|O
.	|O

Jean	|O
Klig	|O
reviews	|O
recent	|O
literature	|O
about	|O
lower	|O
respiratory	|O
tract	|O
infection	|O
in	|O
children	|O
.	|O

Potential	|O
indicators	|O
were	|O
assessed	|O
for	|O
the	|O
two	|O
classifications	|O
of	|O
protein	|O
-	|O
energy	|O
malnutrition	|O
in	|O
the	|O
guidelines	|O
for	|O
integrated	|O
management	|O
of	|O
childhood	|O
illness	|O
:	|O
severe	|O
malnutrition	|O
,	|O
which	|O
requires	|O
immediate	|O
referral	|O
to	|O
hospital	|O
,	|O
and	|O
very	|O
low	|O
weight	|O
,	|O
which	|O
calls	|O
for	|O
feeding	|O
assessment	|O
,	|O
nutritional	|O
counselling	|O
and	|O
follow	|O
-	|O
up	|O
.	|O

SNAC	|O
or	|O
PBS	|O
was	|O
infused	|O
for	|O
6.5	|O
h	|O
,	|O
beginning	|O
30	|O
min	|O
before	|O
ischemia	|O
and	|O
continuing	|O
throughout	|O
the	|O
duration	|O
of	|O
reperfusion	|O
.	|O

Despite	|O
its	|O
requirement	|O
for	|O
enhancer	|O
-	|O
dependent	|O
splicing	|O
activity	|O
in	|O
vitro	|O
,	|O
the	|O
dU2AF38	|B-PROTEIN
RS	|O
domain	|O
was	|O
also	|O
inessential	|O
in	|O
vivo	|O
.	|O

In	|O
vitro	|O
binding	|O
studies	|O
using	|O
GST	|B-PROTEIN
fusion	|O
proteins	|O
and	|O
yeast	|O
extracts	|O
defined	|O
distinct	|O
binding	|O
sites	|O
on	|O
yAP180A	|B-PROTEIN
for	|O
Pan1p	|B-PROTEIN
and	|O
clathrin	|B-PROTEIN
.	|O
yAP180	|B-PROTEIN
proteins	|O
and	|O
Pan1p	|B-PROTEIN
,	|O
like	|O
actin	|B-PROTEIN
,	|O
localize	|O
to	|O
peripheral	|O
patches	|O
along	|O
the	|O
plasma	|O
membrane	|O
.	|O

In	|O
vitro	|O
affinity	|O
analyses	|O
demonstrated	|O
that	|O
recombinant	|O
130	|O
-	|O
kD	|O
protein	|O
directly	|O
interacts	|O
with	|O
ZO	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
the	|O
cytoplasmic	|O
domain	|O
of	|O
occludin	|B-PROTEIN
,	|O
but	|O
not	|O
with	|O
ZO	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
.	|O

Cytochrome	|B-PROTEIN
b	|I-PROTEIN
in	|O
human	|O
complex	|B-PROTEIN
II	|I-PROTEIN
(	|O
succinate	|B-PROTEIN
-	|I-PROTEIN
ubiquinone	|I-PROTEIN
oxidoreductase	|I-PROTEIN
)	|O
:	|O
cDNA	|O
cloning	|O
of	|O
the	|O
components	|O
in	|O
liver	|O
mitochondria	|O
and	|O
chromosome	|O
assignment	|O
of	|O
the	|O
genes	|O
for	|O
the	|O
large	|O
(	|O
SDHC	|B-PROTEIN
)	|O
and	|O
small	|O
(	|O
SDHD	|B-PROTEIN
)	|O
subunits	|O
to	|O
1q21	|O
and	|O
11q23	|O
.	|O

A	|O
possible	|O
decrease	|O
in	|O
theophylline	|O
's	|O
volume	|O
of	|O
distribution	|O
at	|O
4	|O
days	|O
,	|O
but	|O
not	|O
immediately	|O
,	|O
after	|O
administration	|O
of	|O
chloroquine	|O
was	|O
suggested	|O
,	|O
although	|O
this	|O
just	|O
failed	|O
to	|O
achieve	|O
statistical	|O
significance	|O
(	|O
p	|O
=	|O
0.055	|O
)	|O
.	|O

The	|O
addition	|O
of	|O
a	|O
Paf	|B-PROTEIN
-	|O
containing	|O
extract	|O
does	|O
not	|O
lead	|O
to	|O
significant	|O
protein	|O
binding	|O
to	|O
these	|O
two	|O
hly	|B-PROTEIN
target	|O
sequences	|O
in	|O
the	|O
absence	|O
of	|O
PrfA	|B-PROTEIN
but	|O
converts	|O
the	|O
complex	|O
(	|O
CIII	|O
)	|O
consisting	|O
of	|O
PrfA	|B-PROTEIN
and	|O
the	|O
109	|O
bp	|O
hly	|B-PROTEIN
DNA	|O
fragment	|O
to	|O
a	|O
slower	|O
migrating	|O
PrfA	|B-PROTEIN
-	|O
Paf	|B-PROTEIN
-	|O
DNA	|O
complex	|O
(	|O
CI	|O
)	|O
.	|O

Moreover	|O
,	|O
it	|O
is	|O
the	|O
assumptions	|O
behind	|O
steady	|O
-	|O
state	|O
O2	|O
uptake	|O
that	|O
do	|O
not	|O
permit	|O
proper	|O
interpretation	|O
of	|O
energy	|O
expenditure	|O
during	|O
EPOC	|O
;	|O
1	|O
l	|O
O2	|O
not	|O
=	|O
20.9	|O
kJ	|O
.	|O

The	|O
predicted	|O
amino	|O
acid	|O
sequence	|O
of	|O
m	|B-PROTEIN
-	|I-PROTEIN
Staf	|I-PROTEIN
is	|O
highly	|O
homologous	|O
to	|O
that	|O
of	|O
Staf	|B-PROTEIN
,	|O
another	|O
selenocysteine	|B-PROTEIN
tRNA	|I-PROTEIN
gene	|I-PROTEIN
transcription	|I-PROTEIN
activating	|I-PROTEIN
factor	|I-PROTEIN
of	|O
Xenopus	|O
laevis	|O
.	|O

ROCK	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
,	|O
Kinectin	|B-PROTEIN
,	|O
and	|O
mDia2	|B-PROTEIN
can	|O
bind	|O
the	|O
wild	|O
type	|O
forms	|O
of	|O
both	|O
RhoA	|B-PROTEIN
and	|O
Cdc42	|B-PROTEIN
in	|O
a	|O
GTP	|O
-	|O
dependent	|O
manner	|O
in	|O
vitro	|O
.	|O

Among	|O
three	|O
isoforms	|O
,	|O
the	|O
beta	|O
isoform	|O
has	|O
the	|O
greatest	|O
Vmax	|O
value	|O
for	|O
the	|O
PtdIns	|B-PROTEIN
(	|I-PROTEIN
4	|I-PROTEIN
)	|I-PROTEIN
P	|I-PROTEIN
kinase	|I-PROTEIN
activity	|O
and	|O
the	|O
gamma	|O
isoform	|O
is	|O
most	|O
markedly	|O
stimulated	|O
by	|O
phosphatidic	|O
acid	|O
.	|O

The	|O
beta	|O
subunit	|O
of	|O
the	|O
heterotrimeric	|O
G	|B-PROTEIN
proteins	|I-PROTEIN
that	|O
transduce	|O
signals	|O
across	|O
the	|O
plasma	|O
membrane	|O
is	|O
made	|O
up	|O
of	|O
an	|O
amino	|O
-	|O
terminal	|O
alpha	|O
-	|O
helical	|O
segment	|O
followed	|O
by	|O
seven	|O
repeating	|O
units	|O
called	|O
WD	|O
(	|O
Trp	|O
-	|O
Asp	|O
)	|O
repeats	|O
that	|O
occur	|O
in	|O
about	|O
140	|O
different	|O
proteins	|O
.	|O

Two	|O
differentially	|O
expressed	|O
LNX	|B-PROTEIN
messages	|O
encode	|O
overlapping	|O
proteins	|O
with	|O
predicted	|O
molecular	|O
masses	|O
of	|O
80	|O
kDa	|O
(	|O
LNX	|B-PROTEIN
)	|O
and	|O
70	|O
kDa	|O
(	|O
LNX	|B-PROTEIN
-	|I-PROTEIN
b	|I-PROTEIN
)	|O
.	|O

In	|O
contrast	|O
,	|O
the	|O
contractile	|O
action	|O
of	|O
arachidonic	|O
acid	|O
,	|O
via	|O
a	|O
presumed	|O
cyclooxygenase	|B-PROTEIN
product	|O
that	|O
mediated	|O
the	|O
contractions	|O
caused	|O
by	|O
both	|O
TF	|B-PROTEIN
and	|O
EGF	|B-PROTEIN
,	|O
was	|O
not	|O
blocked	|O
by	|O
any	|O
of	|O
the	|O
signal	|O
pathway	|O
probe	|O
inhibitors	|O
.	|O

Recent	|O
studies	|O
have	|O
revealed	|O
unconventional	|O
myosin	|B-PROTEIN
V	|I-PROTEIN
to	|O
be	|O
an	|O
important	|O
actin	|B-PROTEIN
-	|O
based	|O
molecular	|O
motor	|O
involved	|O
in	|O
vesicular	|O
movement	|O
.	|O

On	|O
a	|O
separate	|O
occasion	|O
the	|O
T1	|O
weighted	|O
and	|O
T2	|O
weighted	|O
sagittal	|O
and	|O
T2	|O
weighted	|O
axial	|O
sequences	|O
were	|O
reported	|O
blind	|O
in	|O
relation	|O
to	|O
the	|O
initial	|O
assessment	|O
.	|O

Furthermore	|O
,	|O
a	|O
minor	|O
start	|O
site	|O
was	|O
localized	|O
179	|O
bp	|O
upstream	|O
of	|O
the	|O
major	|O
site	|O
using	|O
reverse	|B-PROTEIN
transcriptase	|I-PROTEIN
-	|O
polymerase	|O
chain	|O
reaction	|O
with	|O
various	|O
P1	|O
primers	|O
(	|O
primer	|O
walking	|O
)	|O
,	|O
primer	|O
extension	|O
,	|O
and	|O
cDNA	|O
cloning	|O
.	|O

Analysis	|O
of	|O
promoter	|O
and	|O
androgen	|O
regulatory	|O
sequences	|O
required	|O
for	|O
optimal	|O
transcription	|O
of	|O
the	|O
rat	|O
androgen	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
gene	|O
.	|O

The	|O
iron	|O
dependence	|O
of	|O
transcription	|O
and	|O
expression	|O
of	|O
cvaA	|B-PROTEIN
,	|O
which	|O
encodes	|O
a	|O
transporter	|O
accessory	|O
protein	|O
,	|O
and	|O
cvi	|B-PROTEIN
,	|O
encoding	|O
the	|O
colicin	|B-PROTEIN
V	|I-PROTEIN
immunity	|I-PROTEIN
protein	|I-PROTEIN
,	|O
was	|O
assessed	|O
under	|O
conditions	|O
of	|O
iron	|O
excess	|O
or	|O
depletion	|O
.	|O

In	|O
a	|O
gntR	|B-PROTEIN
deletion	|O
mutant	|O
,	|O
the	|O
expression	|O
of	|O
a	|O
chromosomal	|O
gntT	|B-PROTEIN
::	|O
lacZ	|B-PROTEIN
fusion	|O
is	|O
both	|O
high	|O
and	|O
constitutive	|O
,	|O
confirming	|O
that	|O
GntR	|B-PROTEIN
is	|O
the	|O
negative	|O
regulator	|O
of	|O
gntT	|B-PROTEIN
.	|O

Furthermore	|O
,	|O
the	|O
deletion	|O
of	|O
bcp	|B-PROTEIN
from	|O
the	|O
chromosome	|O
had	|O
no	|O
effect	|O
on	|O
gcv	|B-PROTEIN
-	|O
lacZ	|B-PROTEIN
expression	|O
.	|O

Of	|O
these	|O
sites	|O
,	|O
PEA3	|B-PROTEIN
and	|O
STAT	|B-PROTEIN
contributed	|O
specifically	|O
to	|O
induction	|O
by	|O
v	|B-PROTEIN
-	|I-PROTEIN
src	|I-PROTEIN
,	|O
whereas	|O
the	|O
remaining	|O
elements	|O
were	|O
also	|O
involved	|O
in	|O
induction	|O
by	|O
the	|O
phorbol	|O
ester	|O
phorbol	|O
myristate	|O
acetate	|O
(	|O
PMA	|O
)	|O
.	|O

BRCA1	|B-PROTEIN
protein	|O
contains	|O
an	|O
amino	|O
-	|O
terminal	|O
zinc	|O
finger	|O
motif	|O
and	|O
a	|O
carboxy	|O
-	|O
terminal	|O
acidic	|O
region	|O
.	|O

The	|O
mitochondrial	|B-PROTEIN
regulatory	|I-PROTEIN
region	|I-PROTEIN
(	|O
mrr	|B-PROTEIN
)	|O
located	|O
between	|O
the	|O
tRNAPhe	|B-PROTEIN
and	|O
tRNAPro	|B-PROTEIN
genes	|O
of	|O
mitochondrial	|O
DNA	|O
(	|O
mtDNA	|O
)	|O
is	|O
essential	|O
for	|O
regulation	|O
of	|O
replication	|O
and	|O
transcription	|O
of	|O
the	|O
mitochondrial	|O
genome	|O
.	|O

In	|O
this	|O
report	|O
,	|O
we	|O
investigate	|O
the	|O
mechanism	|O
underlying	|O
Ras	|B-PROTEIN
activation	|O
upon	|O
stimulation	|O
of	|O
these	|O
two	|O
types	|O
of	|O
receptors	|O
in	|O
hematopoietic	|O
cells	|O
.	|O

Thus	|O
,	|O
Sir	|B-PROTEIN
proteins	|O
from	|O
K.	|O
lactis	|O
have	|O
roles	|O
in	|O
both	|O
silencing	|O
and	|O
telomere	|O
length	|O
maintenance	|O
,	|O
reflecting	|O
conserved	|O
functional	|O
themes	|O
.	|O

Therefore	|O
,	|O
we	|O
conclude	|O
that	|O
DnaA	|B-PROTEIN
may	|O
contact	|O
the	|O
beta	|O
subunit	|O
of	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
during	|O
activation	|O
of	|O
the	|O
pR	|B-PROTEIN
promoter	|O
.	|O

Expression	|O
of	|O
Bcl	|B-PROTEIN
-	|I-PROTEIN
XL	|I-PROTEIN
inhibited	|O
the	|O
association	|O
of	|O
Apaf	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
with	|O
caspase	|B-PROTEIN
-	|I-PROTEIN
9	|I-PROTEIN
in	|O
mammalian	|O
cells	|O
.	|O

Whole	|O
-	|O
mount	|O
in	|O
situ	|O
hybridization	|O
to	|O
early	|O
mouse	|O
embryos	|O
of	|O
9.5-10.5	|O
days	|O
indicated	|O
a	|O
complex	|O
pattern	|O
of	|O
Arp1	|B-PROTEIN
expression	|O
spatially	|O
overlapping	|O
with	|O
the	|O
expression	|O
of	|O
All1	|B-PROTEIN
.	|O

These	|O
mutants	|O
were	|O
tested	|O
for	|O
ability	|O
to	|O
bind	|O
each	|O
of	|O
the	|O
Site	|B-PROTEIN
II	|I-PROTEIN
cognate	|O
proteins	|O
,	|O
and	|O
subsequently	|O
evaluated	|O
for	|O
ability	|O
to	|O
confer	|O
H4	|B-PROTEIN
transcriptional	|O
activity	|O
using	|O
chimeric	|O
H4	|B-PROTEIN
promoter	|O
/	|O
CAT	|B-PROTEIN
fusion	|O
constructs	|O
in	|O
different	|O
cell	|O
types	|O
.	|O

Increased	|O
plasma	|O
IgE	|B-PROTEIN
was	|O
also	|O
confirmed	|O
in	|O
the	|O
NC	|O
mice	|O
,	|O
and	|O
treatment	|O
with	|O
FK506	|O
ointment	|O
reduced	|O
the	|O
plasma	|O
IgE	|B-PROTEIN
level	|O
.	|O

Creatine	|B-PROTEIN
kinase	|I-PROTEIN
release	|O
after	|O
hepatic	|O
artery	|O
embolization	|O
in	|O
patients	|O
with	|O
carcinoid	|O
tumors	|O
.	|O

Furthermore	|O
,	|O
in	|O
the	|O
ischemia	|O
/	|O
angiotension	|B-PROTEIN
II	|I-PROTEIN
-	|O
induced	|O
AHF	|O
model	|O
,	|O
NIC	|O
decreased	|O
left	|O
ventricular	|O
end	|O
-	|O
diastolic	|O
pressure	|O
(	|O
LVEDP	|O
)	|O
.	|O

Group	|O
A	|O
(	|O
68.7	|O
+	|O
/	|O
-	|O
2.7	|O
years	|O
)	|O
consisted	|O
of	|O
patients	|O
with	|O
0	|O
or	|O
1	|O
risk	|O
factors	|O
;	|O
B	|O
(	|O
68.3	|O
+	|O
/	|O
-	|O
4.2	|O
years	|O
)	|O
those	|O
with	|O
2	|O
risk	|O
factors	|O
;	|O
and	|O
C	|O
(	|O
69.2	|O
+	|O
/	|O
-	|O
3.6	|O
years	|O
)	|O
those	|O
with	|O
3	|O
or	|O
more	|O
risk	|O
factors	|O
.	|O

We	|O
further	|O
demonstrate	|O
that	|O
RU486	|O
-	|O
PR	|B-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
interacts	|O
physically	|O
with	|O
NCoR	|B-PROTEIN
in	|O
vitro	|O
.	|O

PRL	|B-PROTEIN
receptor	|I-PROTEIN
also	|O
activates	|O
SHP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
,	|O
a	|O
cytosolic	|O
tyrosine	|B-PROTEIN
phosphatase	|I-PROTEIN
.	|O

The	|O
dominant	|O
negative	|O
mutant	|O
of	|O
SHP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
was	|O
found	|O
to	|O
inhibit	|O
the	|O
induction	|O
of	|O
tyrosine	|O
phosphorylation	|O
and	|O
DNA	|O
-	|O
binding	|O
activity	|O
of	|O
m	|B-PROTEIN
-	|I-PROTEIN
Stat5a	|I-PROTEIN
,	|O
m	|B-PROTEIN
-	|I-PROTEIN
Stat5b	|I-PROTEIN
,	|O
and	|O
the	|O
carboxyl	|O
-	|O
terminal	|O
deletion	|O
variant	|O
m	|B-PROTEIN
-	|I-PROTEIN
Stat5adelta749	|I-PROTEIN
,	|O
as	|O
well	|O
as	|O
the	|O
transactivation	|O
potential	|O
of	|O
m	|B-PROTEIN
-	|I-PROTEIN
Stat5a	|I-PROTEIN
and	|O
m	|B-PROTEIN
-	|I-PROTEIN
Stat5b	|I-PROTEIN
.	|O

CONCLUSIONS	|O
:	|O
These	|O
routinely	|O
collected	|O
data	|O
provided	|O
quantitative	|O
estimates	|O
of	|O
changes	|O
in	|O
CBZ	|O
Cl	|O
/	|O
F	|O
due	|O
to	|O
comedication	|O
and	|O
an	|O
age	|O
-	|O
related	|O
decrease	|O
in	|O
Cl	|O
/	|O
F	|O
The	|O
derived	|O
regression	|O
equations	|O
reasonably	|O
predicted	|O
concentrations	|O
in	|O
a	|O
separate	|O
validation	|O
set	|O
.	|O

Sites	|O
1	|O
and	|O
4	|O
in	|O
lumican	|B-PROTEIN
and	|O
keratocan	|B-PROTEIN
are	|O
in	|O
a	|O
homologous	|O
location	|O
.	|O

Our	|O
observations	|O
suggest	|O
that	|O
members	|O
of	|O
the	|O
HMG	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
family	|O
play	|O
an	|O
important	|O
role	|O
in	|O
SRF	|B-PROTEIN
-	|O
dependent	|O
transcription	|O
and	|O
that	|O
their	|O
effect	|O
is	|O
mediated	|O
primarily	|O
by	|O
a	|O
protein	|O
-	|O
protein	|O
interaction	|O
.	|O

ATP	|O
-	|O
dependent	|O
assembly	|O
of	|O
a	|O
ternary	|O
complex	|O
consisting	|O
of	|O
a	|O
DNA	|O
mismatch	|O
and	|O
the	|O
yeast	|O
MSH2	|B-PROTEIN
-	|O
MSH6	|B-PROTEIN
and	|O
MLH1	|B-PROTEIN
-	|O
PMS1	|B-PROTEIN
protein	|O
complexes	|O
.	|O

Mutation	|O
of	|O
the	|O
central	|O
Tyr497	|O
to	|O
Phe	|O
blocks	|O
the	|O
tyrosine	|O
phosphorylation	|O
of	|O
the	|O
insulin	|B-PROTEIN
receptor	|I-PROTEIN
substrate	|I-PROTEIN
1	|I-PROTEIN
(	|O
IRS1	|B-PROTEIN
)	|O
and	|O
diminishes	|O
proliferation	|O
in	|O
response	|O
to	|O
IL	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
.	|O

Instead	|O
,	|O
it	|O
contained	|O
two	|O
tandem	|O
kappaB	|B-PROTEIN
elements	|O
and	|O
a	|O
variant	|O
activating	|B-PROTEIN
transcription	|I-PROTEIN
factor	|I-PROTEIN
/	|O
cAMP	|O
response	|O
element	|O
site	|O
,	|O
which	|O
closely	|O
resembled	|O
sites	|O
in	|O
the	|O
E	|B-PROTEIN
-	|I-PROTEIN
selectin	|I-PROTEIN
gene	|O
that	|O
are	|O
required	|O
for	|O
TNF	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
-	|O
or	|O
LPS	|O
-	|O
inducible	|O
expression	|O
.	|O

We	|O
recently	|O
characterized	|O
a	|O
single	|O
yeast	|O
hnRNP	|B-PROTEIN
methyltransferase	|I-PROTEIN
(	|O
HMT1	|B-PROTEIN
)	|O
.	|O

We	|O
recently	|O
characterized	|O
a	|O
single	|O
yeast	|O
hnRNP	|B-PROTEIN
methyltransferase	|I-PROTEIN
(	|O
HMT1	|B-PROTEIN
)	|O
.	|O

Recombinant	|O
HRMT1L2	|B-PROTEIN
protein	|O
encoded	|O
by	|O
the	|O
most	|O
common	|O
5'	|O
-	|O
variant	|O
exhibited	|O
methyltransferase	|O
activity	|O
in	|O
vitro	|O
.	|O

The	|O
possible	|O
roles	|O
of	|O
HRMT1L1	|B-PROTEIN
and	|O
HRMT1L2	|B-PROTEIN
in	|O
human	|O
disease	|O
are	|O
currently	|O
unknown	|O
.	|O

Identification	|O
and	|O
characterization	|O
of	|O
two	|O
putative	|O
human	|O
arginine	|B-PROTEIN
methyltransferases	|I-PROTEIN
(	|O
HRMT1L1	|B-PROTEIN
and	|O
HRMT1L2	|B-PROTEIN
)	|O
.	|O

Interestingly	|O
,	|O
the	|O
activated	|O
PDGF	|B-PROTEIN
beta	|I-PROTEIN
-	|I-PROTEIN
receptor	|I-PROTEIN
was	|O
found	|O
not	|O
to	|O
bind	|O
Crk	|B-PROTEIN
proteins	|O
.	|O

Furthermore	|O
,	|O
interactions	|O
were	|O
identified	|O
between	|O
endogenous	|O
E	|B-PROTEIN
-	|I-PROTEIN
cadherin	|I-PROTEIN
and	|O
the	|O
chimera	|O
containing	|O
the	|O
E	|B-PROTEIN
-	|I-PROTEIN
cadherin	|I-PROTEIN
extracellular	|O
domain	|O
and	|O
the	|O
desmoglein	|B-PROTEIN
1	|I-PROTEIN
intracellular	|O
domain	|O
providing	|O
in	|O
vivo	|O
evidence	|O
for	|O
previously	|O
predicted	|O
lateral	|O
interactions	|O
of	|O
E	|B-PROTEIN
-	|I-PROTEIN
cadherin	|I-PROTEIN
extracellular	|O
domains	|O
.	|O

The	|O
ether	|O
phospholipid	|O
1	|O
-	|O
O	|O
-	|O
octadecyl	|O
-	|O
2	|O
-	|O
O	|O
-	|O
methyl	|O
-	|O
rac	|O
-	|O
glycero	|O
-	|O
3	|O
-	|O
phosphocholine	|O
(	|O
ET	|O
-	|O
18	|O
-	|O
OCH3	|O
;	|O
edelfosine	|O
)	|O
is	|O
a	|O
potent	|O
inducer	|O
of	|O
apoptosis	|O
in	|O
human	|O
tumor	|O
cells	|O
.	|O

In	|O
addition	|O
to	|O
a	|O
previously	|O
characterized	|O
promoter	|O
(	|O
P1	|O
)	|O
,	|O
we	|O
now	|O
show	|O
the	|O
existence	|O
of	|O
a	|O
second	|O
promoter	|O
for	|O
the	|O
human	|O
IL	|B-PROTEIN
-	|I-PROTEIN
5Ralpha	|I-PROTEIN
gene	|O
.	|O

Serum	|O
levels	|O
of	|O
testosterone	|O
also	|O
showed	|O
no	|O
significant	|O
changes	|O
by	|O
exposure	|O
to	|O
p	|O
,	|O
p	|O
'	|O
-	|O
DDE	|O
under	|O
the	|O
conditions	|O
of	|O
this	|O
study	|O
.	|O

Overall	|O
agreement	|O
between	|O
rest	|O
/	|O
postnitroglycerin	|O
technetium	|O
-	|O
99m	|O
tetrofosmin	|O
SPET	|O
studies	|O
and	|O
rest	|O
/	|O
redistribution	|O
or	|O
rest	|O
/	|O
reinjection	|O
thallium	|O
-	|O
201	|O
SPET	|O
studies	|O
,	|O
regarding	|O
the	|O
presence	|O
of	|O
myocardial	|O
viability	|O
,	|O
was	|O
87%	|O
and	|O
90%	|O
,	|O
respectively	|O
.	|O

Their	|O
use	|O
resulted	|O
in	|O
a	|O
sensitivity	|O
of	|O
73%	|O
and	|O
a	|O
specificity	|O
of	|O
74%	|O
with	|O
regard	|O
to	|O
predictability	|O
of	|O
ALT	|B-PROTEIN
levels	|O
increasing	|O
during	|O
the	|O
trial	|O
.	|O

One	|O
hundred	|O
replicate	|O
data	|O
sets	|O
of	|O
100	|O
subjects	|O
each	|O
were	|O
simulated	|O
for	|O
each	|O
missing	|O
data	|O
scenario	|O
.	|O

Spatial	|O
accuracy	|O
of	|O
primary	|O
and	|O
secondary	|O
memory	|O
-	|O
guided	|O
saccades	|O
in	|O
schizophrenic	|O
patients	|O
.	|O

Successful	|O
treatment	|O
with	|O
nasal	|O
continuous	|O
positive	|O
airway	|O
pressure	|O
(	|O
8.3	|O
+	|O
/	|O
-	|O
1.5	|O
cmH2O	|O
)	|O
for	|O
3	|O
days	|O
caused	|O
a	|O
significant	|O
decrease	|O
in	|O
mean	|O
blood	|O
pressure	|O
in	|O
OSAS	|O
.	|O

When	|O
data	|O
were	|O
expressed	|O
in	|O
a	|O
cumulative	|O
manner	|O
,	|O
the	|O
response	|O
to	|O
intravenous	|O
adenosine	|O
3	|O
mg	|O
,	|O
6	|O
mg	|O
,	|O
9	|O
mg	|O
and	|O
12	|O
mg	|O
in	|O
the	|O
24	|O
episodes	|O
of	|O
PSVT	|O
were	|O
5	|O
episodes	|O
(	|O
21%	|O
)	|O
,	|O
16	|O
episodes	|O
(	|O
67%	|O
)	|O
,	|O
20	|O
episodes	|O
(	|O
83%	|O
)	|O
and	|O
20	|O
episodes	|O
(	|O
83%	|O
)	|O
respectively	|O
.	|O

RNAs	|O
are	|O
not	|O
only	|O
essential	|O
components	|O
of	|O
both	|O
ribosomal	|O
subunits	|O
but	|O
also	|O
transiently	|O
interacting	|O
factors	|O
during	|O
particle	|O
formation	|O
.	|O

To	|O
study	|O
retinoid	|O
signalling	|O
in	|O
zebrafish	|O
embryos	|O
,	|O
we	|O
developed	|O
a	|O
novel	|O
method	|O
to	|O
detect	|O
endogenous	|O
retinoids	|O
in	|O
situ	|O
in	|O
embryos	|O
,	|O
using	|O
a	|O
fusion	|O
protein	|O
of	|O
the	|O
ligand	|O
inducible	|O
transactivation	|O
domain	|O
of	|O
a	|O
retinoic	|B-PROTEIN
acid	|I-PROTEIN
receptor	|I-PROTEIN
and	|O
a	|O
heterologous	|O
DNA	|O
binding	|O
domain	|O
.	|O

To	|O
identify	|O
nuclear	|O
regulatory	|O
factors	|O
,	|O
we	|O
have	|O
located	|O
and	|O
functionally	|O
characterized	|O
the	|O
CCR5	|B-PROTEIN
gene	|O
promoter	|O
.	|O

Fluorescence	|O
in	|O
situ	|O
hybridization	|O
of	|O
metaphase	|O
spreads	|O
of	|O
chromosome	|O
8	|O
,	|O
containing	|O
hybrid	|O
cell	|O
line	|O
706	|O
-	|O
B6	|O
clone	|O
17	|O
(	|O
CL	|O
-	|O
17	|O
)	|O
with	|O
cosmid	|O
c101F1	|O
,	|O
placed	|O
the	|O
9804	|B-PROTEIN
gene	|O
close	|O
to	|O
the	|O
telomere	|O
at	|O
8q24.3	|O
.	|O

The	|O
interaction	|O
between	|O
piroxicam	|O
and	|O
poloxamer	|O
was	|O
studied	|O
by	|O
x	|O
-	|O
ray	|O
diffractometry	|O
(	|O
XRD	|O
)	|O
,	|O
infrared	|O
(	|O
IR	|O
)	|O
spectroscopy	|O
and	|O
differential	|O
thermal	|O
analysis	|O
(	|O
DTA	|O
)	|O
with	|O
a	|O
solid	|O
dispersion	|O
,	|O
coprecipitate	|O
,	|O
or	|O
physical	|O
mixture	|O
.	|O

Cell	|O
survival	|O
by	|O
Epo	|B-PROTEIN
did	|O
not	|O
require	|O
activation	|O
of	|O
other	|O
known	|O
signaling	|O
pathways	|O
including	|O
PI	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
kinase	|I-PROTEIN
,	|O
PLC	|B-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
,	|O
Ras	|B-PROTEIN
or	|O
Stats	|B-PROTEIN
.	|O

The	|O
N	|O
-	|O
syndecan	|O
-	|O
dependent	|O
neurite	|O
outgrowth	|O
is	|O
inhibited	|O
by	|O
the	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
inhibitors	|O
herbimycin	|O
A	|O
and	|O
PP1	|B-PROTEIN
.	|O

An	|O
in	|O
vivo	|O
ZAP	|B-PROTEIN
-	|I-PROTEIN
70	|I-PROTEIN
substrate	|O
,	|O
SLP	|B-PROTEIN
-	|I-PROTEIN
76	|I-PROTEIN
,	|O
implicated	|O
in	|O
Erk	|B-PROTEIN
activation	|O
,	|O
also	|O
became	|O
rapidly	|O
tyrosine	|O
-	|O
phosphorylated	|O
in	|O
Jurkat	|O
cells	|O
,	|O
but	|O
not	|O
in	|O
P116	|O
cells	|O
,	|O
upon	|O
treatment	|O
with	|O
H2O2	|O
.	|O

The	|O
pharmacokinetic	|O
patterns	|O
of	|O
estradiol	|O
(	|O
CAS	|O
50-28-2	|O
)	|O
and	|O
of	|O
estrone	|O
(	|O
CAS	|O
53-16-7	|O
)	|O
were	|O
investigated	|O
in	|O
18	|O
women	|O
in	|O
natural	|O
or	|O
surgical	|O
menopause	|O
during	|O
the	|O
application	|O
of	|O
a	|O
new	|O
estradiol	|O
transdermal	|O
patch	|O
with	|O
active	|O
matrix	|O
and	|O
without	|O
absorption	|O
enhancers	|O
designed	|O
for	|O
epicutaneous	|O
applications	|O
of	|O
7	|O
days	|O
(	|O
hereinafter	|O
called	|O
"	|O
patch	|O
7D	|O
"	|O
)	|O
.	|O

The	|O
results	|O
confirm	|O
that	|O
a	|O
single	|O
base	|O
change	|O
in	|O
the	|O
branchpoint	|O
consensus	|O
sequence	|O
of	|O
an	|O
intron	|O
can	|O
cause	|O
human	|O
disease	|O
although	|O
this	|O
sequence	|O
is	|O
poorly	|O
conserved	|O
in	|O
mammals	|O
.	|O

Conversely	|O
,	|O
the	|O
central	|O
regions	|O
are	|O
highly	|O
variable	|O
.	|O

Among	|O
the	|O
H	|B-PROTEIN
/	|I-PROTEIN
ACA	|I-PROTEIN
snoRNAs	|O
associated	|O
with	|O
Gar1p	|B-PROTEIN
,	|O
one	|O
can	|O
distinguish	|O
a	|O
large	|O
group	|O
of	|O
snoRNAs	|O
that	|O
are	|O
not	|O
essential	|O
in	|O
yeast	|O
and	|O
serve	|O
as	|O
guides	|O
for	|O
pseudouridine	|O
synthesis	|O
onto	|O
the	|O
pre	|O
-	|O
rRNA	|O
molecule	|O
.	|O

It	|O
bound	|O
to	|O
vitamin	|B-PROTEIN
D	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
VDR	|B-PROTEIN
)	|O
but	|O
not	|O
retinoic	|B-PROTEIN
acid	|I-PROTEIN
Xalpha	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
RXRalpha	|B-PROTEIN
)	|O
in	|O
the	|O
human	|O
T	|O
cell	|O
line	|O
MT2	|O
cells	|O
.	|O

Further	|O
studies	|O
demonstrated	|O
that	|O
the	|O
PPARalpha	|B-PROTEIN
ligand	|O
8	|O
(	|O
S	|O
)	|O
-	|O
hydroxyeicosatetraenoic	|O
acid	|O
strongly	|O
promotes	|O
the	|O
interaction	|O
of	|O
PPARalpha	|B-PROTEIN
with	|O
the	|O
co	|O
-	|O
activator	|O
RIP	|B-PROTEIN
-	|I-PROTEIN
140	|I-PROTEIN
but	|O
decreases	|O
the	|O
interaction	|O
of	|O
PPARalpha	|B-PROTEIN
with	|O
the	|O
co	|O
-	|O
repressor	|O
SMRT	|B-PROTEIN
.	|O

Based	|O
on	|O
the	|O
current	|O
literature	|O
,	|O
the	|O
mechanisms	|O
involved	|O
in	|O
the	|O
toxicity	|O
of	|O
OA	|B-PROTEIN
indicate	|O
three	|O
major	|O
effects	|O
:	|O
(	|O
1	|O
)	|O
inhibition	|O
of	|O
mitochondrial	|O
respiration	|O
correlated	|O
with	|O
a	|O
depletion	|O
of	|O
ATP	|O
;	|O
(	|O
2	|O
)	|O
inhibition	|O
of	|O
tRNA	|B-PROTEIN
-	|I-PROTEIN
synthetase	|I-PROTEIN
accompanied	|O
by	|O
a	|O
reduced	|O
protein	|O
synthesis	|O
;	|O
and	|O
(	|O
3	|O
)	|O
enhanced	|O
lipid	|O
peroxidation	|O
.	|O

We	|O
previously	|O
demonstrated	|O
that	|O
acute	|O
expression	|O
of	|O
the	|O
bovine	|O
papillomavirus	|O
type	|O
1	|O
(	|O
BPV1	|O
)	|O
E2	|B-PROTEIN
protein	|O
in	|O
HeLa	|O
and	|O
HT	|O
-	|O
3	|O
cervical	|O
carcinoma	|O
cell	|O
lines	|O
greatly	|O
reduced	|O
cellular	|O
proliferation	|O
by	|O
imposing	|O
a	|O
specific	|O
G1	|O
/	|O
S	|O
phase	|O
growth	|O
arrest	|O
.	|O

Four	|O
possible	|O
isoforms	|O
(	|O
hGli2	|B-PROTEIN
alpha	|I-PROTEIN
,	|I-PROTEIN
beta	|I-PROTEIN
,	|I-PROTEIN
gamma	|I-PROTEIN
,	|I-PROTEIN
and	|I-PROTEIN
delta	|I-PROTEIN
)	|O
are	|O
formed	|O
by	|O
combinations	|O
of	|O
two	|O
independent	|O
alternative	|O
splicings	|O
,	|O
and	|O
all	|O
the	|O
isoforms	|O
could	|O
bind	|O
to	|O
a	|O
DNA	|O
motif	|O
,	|O
TRE2S	|O
,	|O
in	|O
the	|O
LTR	|O
.	|O

Specialized	|O
actin	|B-PROTEIN
tails	|O
that	|O
propel	|O
IEV	|O
particles	|O
to	|O
the	|O
periphery	|O
and	|O
virus	|O
-	|O
tipped	|O
microvilli	|O
(	|O
both	|O
common	|O
in	|O
wild	|O
-	|O
type	|O
-	|O
infected	|O
cells	|O
)	|O
were	|O
absent	|O
in	|O
cells	|O
infected	|O
with	|O
vA33delta	|O
.	|O

Their	|O
mean	|O
IOP	|O
was	|O
15.3	|O
(	|O
SD	|O
3.7	|O
)	|O
mmHg	|O
prior	|O
to	|O
induction	|O
of	|O
anesthesia	|O
,	|O
13.5	|O
(	|O
SD	|O
3.5	|O
)	|O
mmHg	|O
after	|O
loss	|O
of	|O
eyelash	|O
reflex	|O
following	|O
injection	|O
of	|O
methohexitone	|O
,	|O
16.1	|O
(	|O
SD	|O
2.4	|O
)	|O
mmHg	|O
after	|O
cessation	|O
of	|O
muscle	|O
fasciculations	|O
induced	|O
by	|O
suxamethonium	|O
,	|O
19.2	|O
(	|O
SD	|O
5.6	|O
)	|O
mmHg	|O
after	|O
cessation	|O
of	|O
convulsion	|O
and	|O
15.5	|O
(	|O
SD	|O
4.4	|O
)	|O
mmHg	|O
following	|O
resumption	|O
of	|O
regular	|O
spontaneous	|O
respiration	|O
.	|O

A	|O
cDNA	|O
,	|O
cak1At	|B-PROTEIN
,	|O
was	|O
isolated	|O
that	|O
suppressed	|O
the	|O
CAK	|B-PROTEIN
mutation	|O
in	|O
budding	|O
yeast	|O
,	|O
and	|O
it	|O
also	|O
complemented	|O
a	|O
fission	|O
yeast	|O
CAK	|B-PROTEIN
mutant	|O
.	|O
cak1At	|B-PROTEIN
encodes	|O
a	|O
protein	|O
related	|O
to	|O
animal	|O
CAKs	|B-PROTEIN
.	|O

Post	|O
-	|O
translational	|O
modifications	|O
such	|O
as	|O
glycosylation	|O
and	|O
phosphorylation	|O
could	|O
be	|O
excluded	|O
as	|O
potential	|O
explanations	|O
for	|O
the	|O
protein	|O
heterogeneity	|O
.	|O

In	|O
addition	|O
to	|O
restoring	|O
checkpoint	|O
control	|O
,	|O
overexpression	|O
of	|O
sum1+	|B-PROTEIN
inhibits	|O
the	|O
normal	|O
cell	|O
cycle	|O
response	|O
to	|O
osmotic	|O
stress	|O
.	|O

Ime1	|B-PROTEIN
plays	|O
a	|O
pivotal	|O
role	|O
in	|O
the	|O
initiation	|O
of	|O
meiosis	|O
in	|O
a	|O
/	|O
alpha	|O
diploid	|O
cells	|O
of	|O
Saccharomyces	|O
cerevisiae	|O
.	|O

Rhesus	|O
macaques	|O
and	|O
BALB	|O
/	|O
c	|O
mice	|O
inoculated	|O
with	|O
the	|O
Mengo	|O
virus	|O
SIV	|O
recombinants	|O
failed	|O
to	|O
develop	|O
CTL	|O
responses	|O
against	|O
the	|O
SIV	|O
gene	|O
products	|O
,	|O
while	|O
one	|O
of	|O
the	|O
HIV	|B-PROTEIN
-	|I-PROTEIN
Nef	|I-PROTEIN
recombinants	|O
induced	|O
a	|O
weak	|O
CTL	|O
response	|O
in	|O
mice	|O
directed	|O
to	|O
an	|O
HIV1	|O
Nef	|B-PROTEIN
peptide	|O
spanning	|O
positions	|O
182-198	|O
.	|O

Deltamethrin	|O
was	|O
most	|O
effective	|O
on	|O
the	|O
thatched	|O
surface	|O
and	|O
produced	|O
100%	|O
mortality	|O
of	|O
An	|O
.	|O
culicifacies	|O
adults	|O
up	|O
to	|O
12	|O
weeks	|O
,	|O
even	|O
when	|O
exposed	|O
at	|O
the	|O
lowest	|O
dose	|O
/	|O
12.5	|O
mg	|O
/	|O
m2	|O
.	|O

Trichloroethylene	|O
,	|O
in	|O
turn	|O
,	|O
increased	|O
the	|O
AUC	|O
5.0	|O
(	|O
1.9-13.4	|O
)	|O
,	|O
25.8	|O
(	|O
8.2-80.8	|O
)	|O
and	|O
2.9	|O
(	|O
1.6-5.4	|O
)	|O
,	|O
respectively	|O
,	|O
whereas	|O
the	|O
corresponding	|O
values	|O
for	|O
n	|O
-	|O
hexane	|O
were	|O
1.9	|O
(	|O
0.7-5.1	|O
)	|O
,	|O
1.5	|O
(	|O
0.5-4.6	|O
)	|O
,	|O
and	|O
3.2	|O
(	|O
1.8-5.9	|O
)	|O
.	|O

Solution	|O
structure	|O
of	|O
the	|O
IRF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
DNA	|O
-	|O
binding	|O
domain	|O
:	|O
a	|O
novel	|O
subgroup	|O
of	|O
the	|O
winged	|B-PROTEIN
helix	|I-PROTEIN
-	|I-PROTEIN
turn	|I-PROTEIN
-	|I-PROTEIN
helix	|I-PROTEIN
family	|O
.	|O

In	|O
contrast	|O
,	|O
receptor	|O
/	|O
G	|B-PROTEIN
protein	|I-PROTEIN
coupling	|O
appeared	|O
unaffected	|O
by	|O
expression	|O
of	|O
loop	|O
3i	|O
domains	|O
derived	|O
from	|O
two	|O
receptors	|O
coupled	|O
to	|O
G	|B-PROTEIN
(	|I-PROTEIN
i	|I-PROTEIN
/	|I-PROTEIN
o	|I-PROTEIN
)	|I-PROTEIN
proteins	|I-PROTEIN
(	|O
M2Ach	|O
-	|O
muscarinic	|O
and	|O
alpha2A	|B-PROTEIN
-	|I-PROTEIN
adrenergic	|I-PROTEIN
receptors	|I-PROTEIN
)	|O
.	|O

These	|O
data	|O
indicate	|O
that	|O
the	|O
third	|O
intracellular	|O
loop	|O
of	|O
the	|O
rat	|O
GnRH	|B-PROTEIN
-	|I-PROTEIN
R	|I-PROTEIN
is	|O
involved	|O
in	|O
receptor	|O
G	|B-PROTEIN
(	|I-PROTEIN
q	|I-PROTEIN
/	|I-PROTEIN
11	|I-PROTEIN
)	|I-PROTEIN
protein	|O
coupling	|O
and	|O
/	|O
or	|O
selectivity	|O
,	|O
and	|O
in	|O
the	|O
GGH	|O
(	|O
3	|O
)	|O
1'	|O
cell	|O
line	|O
,	|O
this	|O
loop	|O
is	|O
also	|O
involved	|O
in	|O
signal	|O
transduction	|O
mediated	|O
through	|O
the	|O
Gs	|B-PROTEIN
protein	|O
pathway	|O
.	|O

Decreased	|O
levels	|O
of	|O
alpha2	|B-PROTEIN
-	|I-PROTEIN
antiplasmin	|I-PROTEIN
were	|O
also	|O
observed	|O
in	|O
the	|O
mediastinum	|O
(	|O
0.50	|O
versus	|O
0.61	|O
U	|O
/	|O
mL	|O
;	|O
p	|O
<	|O
0.05	|O
)	|O
.	|O

A	|O
catalytic	|O
domain	|O
of	|O
eukaryotic	|O
DNA	|B-PROTEIN
topoisomerase	|I-PROTEIN
I.	|I-PROTEIN

A	|O
cluster	|O
of	|O
basic	|O
amino	|O
acids	|O
,	|O
KKKR	|O
,	|O
generated	|O
by	|O
joining	|O
of	|O
the	|O
sequences	|O
encoded	|O
by	|O
the	|O
constitutive	|O
exon	|O
13	|O
and	|O
the	|O
alternative	|O
exon	|O
16	|O
,	|O
is	|O
necessary	|O
for	|O
the	|O
nuclear	|O
targeting	|O
of	|O
4.1	|B-PROTEIN
H	|I-PROTEIN
,	|O
as	|O
demonstrated	|O
by	|O
site	|O
-	|O
directed	|O
mutagenesis	|O
analysis	|O
.	|O

Another	|O
stem	|O
-	|O
loop	|O
called	|O
structure	|O
III	|O
near	|O
the	|O
3'	|O
-	|O
end	|O
of	|O
repY	|B-PROTEIN
sequesters	|O
both	|O
the	|O
5'	|O
-	|O
rCGCC	|O
-	|O
3'	|O
sequence	|O
and	|O
the	|O
repZ	|B-PROTEIN
ribosome	|O
-	|O
binding	|O
site	|O
.	|O

All	|O
three	|O
genes	|O
have	|O
been	|O
mapped	|O
precisely	|O
to	|O
a	|O
small	|O
region	|O
on	|O
human	|O
chromosome	|O
16p12.1	|O
-	|O
p11.2	|O
(	|O
homologous	|O
to	|O
mouse	|O
chromosome	|O
7	|O
)	|O
,	|O
using	|O
somatic	|O
cell	|O
hybrids	|O
and	|O
cosmid	|O
clones	|O
.	|O

In	|O
fus3	|B-PROTEIN
mutants	|O
,	|O
the	|O
levels	|O
of	|O
Ty1	|B-PROTEIN
RNA	|O
,	|O
protein	|O
synthesis	|O
,	|O
and	|O
proteolytic	|O
processing	|O
were	|O
not	|O
altered	|O
relative	|O
to	|O
those	|O
in	|O
FUS3	|B-PROTEIN
strains	|O
but	|O
steady	|O
-	|O
state	|O
levels	|O
of	|O
TyA	|B-PROTEIN
,	|O
integrase	|B-PROTEIN
,	|O
and	|O
reverse	|B-PROTEIN
transcriptase	|I-PROTEIN
proteins	|O
and	|O
Ty1	|B-PROTEIN
cDNA	|O
were	|O
all	|O
increased	|O
.	|O

Posttranslational	|O
regulation	|O
of	|O
Ty1	|B-PROTEIN
retrotransposition	|O
by	|O
mitogen	|O
-	|O
activated	|O
protein	|O
kinase	|O
Fus3	|B-PROTEIN
.	|O

The	|O
general	|O
transcription	|B-PROTEIN
factor	|I-PROTEIN
IIA	|I-PROTEIN
(	|O
TFIIA	|B-PROTEIN
)	|O
interacts	|O
with	|O
the	|O
TATA	|B-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
(	|O
TBP	|B-PROTEIN
)	|O
and	|O
promoter	|O
DNA	|O
to	|O
mediate	|O
transcription	|O
activation	|O
in	|O
vitro	|O
.	|O

Their	|O
function	|O
is	|O
not	|O
only	|O
to	|O
recruit	|O
Pho2	|B-PROTEIN
to	|O
the	|O
promoter	|O
but	|O
to	|O
allow	|O
cooperative	|O
binding	|O
of	|O
Pho4	|B-PROTEIN
together	|O
with	|O
Pho2	|B-PROTEIN
.	|O

Substitution	|O
of	|O
the	|O
Ser	|O
-	|O
Thr	|O
sites	|O
with	|O
the	|O
phosphomimetic	|O
Asp	|O
generated	|O
a	|O
constitutively	|O
active	|O
form	|O
of	|O
IRF	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
that	|O
functioned	|O
as	|O
a	|O
very	|O
strong	|O
activator	|O
of	|O
promoters	|O
containing	|O
PRDI	|B-PROTEIN
-	|O
PRDIII	|B-PROTEIN
or	|O
ISRE	|B-PROTEIN
regulatory	|O
elements	|O
.	|O

New	|O
-	|O
onset	|O
angina	|O
preceding	|O
acute	|O
myocardial	|O
infarction	|O
is	|O
associated	|O
with	|O
improved	|O
contractile	|O
recovery	|O
after	|O
thrombolysis	|O
.	|O

In	|O
this	|O
study	|O
,	|O
the	|O
effect	|O
of	|O
acute	|O
administration	|O
of	|O
various	|O
doses	|O
of	|O
malathion	|O
via	|O
oral	|O
and	|O
dermal	|O
routes	|O
to	|O
mice	|O
and	|O
rats	|O
on	|O
serum	|O
levels	|O
of	|O
histamine	|O
was	|O
evaluated	|O
.	|O

Fetal	|O
growth	|O
retardation	|O
as	|O
a	|O
cause	|O
of	|O
impaired	|O
ovarian	|O
development	|O
.	|O

Similarly	|O
,	|O
PCDFs	|O
/	|O
PCDDs	|O
ratio	|O
in	|O
ESP	|O
ash	|O
was	|O
lower	|O
than	|O
that	|O
in	|O
boiler	|O
ash	|O
.	|O

In	|O
addition	|O
to	|O
DNA	|O
-	|O
protein	|O
interactions	|O
,	|O
protein	|O
-	|O
protein	|O
interactions	|O
with	|O
partner	|O
proteins	|O
often	|O
play	|O
major	|O
roles	|O
in	|O
targeting	|O
ETS	|B-PROTEIN
-	|O
domain	|O
proteins	|O
to	|O
specific	|O
promoters	|O
.	|O

Localization	|O
of	|O
67	|O
exons	|O
on	|O
a	|O
YAC	|O
contig	|O
spanning	|O
1.5	|O
Mb	|O
around	|O
the	|O
multidrug	|B-PROTEIN
resistance	|I-PROTEIN
gene	|I-PROTEIN
region	|O
of	|O
human	|O
chromosome	|O
7q21.1	|O
.	|O

The	|O
complete	|O
exon	|O
-	|O
intron	|O
organization	|O
of	|O
the	|O
murine	|O
gene	|O
encoding	|O
M	|B-PROTEIN
-	|I-PROTEIN
protein	|I-PROTEIN
,	|O
a	|O
structural	|O
protein	|O
of	|O
sarcomeric	|O
myofibrils	|O
,	|O
was	|O
determined	|O
.	|O

PURPOSE	|O
:	|O
To	|O
introduce	|O
an	|O
image	|O
analysis	|O
of	|O
the	|O
cornea	|O
in	|O
photorefractive	|O
keratectomy	|O
(	|O
PRK	|O
)	|O
for	|O
preoperative	|O
and	|O
early	|O
postoperative	|O
determination	|O
of	|O
changes	|O
in	|O
the	|O
condition	|O
of	|O
the	|O
cornea	|O
.	|O

Mean+	|O
/	|O
-	|O
SD	|O
serum	|O
VEGF	|B-PROTEIN
concentrations	|O
were	|O
significantly	|O
higher	|O
(	|O
P	|O
<	|O
0.001	|O
)	|O
in	|O
women	|O
with	|O
PCO	|O
and	|O
PCOS	|O
(	|O
3.4	|O
+	|O
/	|O
-	|O
0.7	|O
and	|O
3.2	|O
+	|O
/	|O
-	|O
0.66	|O
ng	|O
/	|O
ml	|O
respectively	|O
)	|O
compared	|O
with	|O
women	|O
with	|O
normal	|O
ovaries	|O
(	|O
2.3	|O
+	|O
/	|O
-	|O
0.5	|O
ng	|O
/	|O
ml	|O
)	|O
.	|O

Strikingly	|O
,	|O
these	|O
cells	|O
contain	|O
a	|O
missense	|O
mutation	|O
of	|O
the	|O
p53	|B-PROTEIN
gene	|O
at	|O
codon	|O
242	|O
(	|O
p53	|B-PROTEIN
(	|O
242	|O
)	|O
)	|O
,	|O
which	|O
substitutes	|O
alanine	|O
for	|O
glycine	|O
.	|O

The	|O
new	|O
algorithm	|O
,	|O
called	|O
RBI	|O
-	|O
MAP	|O
,	|O
is	|O
based	|O
on	|O
the	|O
rescaled	|O
block	|O
iterative	|O
EM	|O
(	|O
RBI	|O
-	|O
EM	|O
)	|O
algorithm	|O
.	|O

A	|O
third	|O
ORF	|O
,	|O
ORF5	|O
,	|O
shows	|O
homology	|O
with	|O
gene	|O
agrB	|B-PROTEIN
from	|O
Staphylococcus	|O
aureus	|O
,	|O
which	|O
is	|O
involved	|O
in	|O
the	|O
mechanism	|O
of	|O
regulation	|O
of	|O
the	|O
virulence	|O
phenotype	|O
in	|O
this	|O
species	|O
.	|O

An	|O
association	|O
between	|O
hSIE	|B-PROTEIN
and	|O
Stat	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
after	|O
MHC	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
ligation	|O
was	|O
directly	|O
demonstrated	|O
by	|O
precipitating	|O
Stat	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
from	|O
nuclear	|O
extracts	|O
with	|O
biotinylated	|O
hSIE	|B-PROTEIN
probe	|O
and	|O
avidin	|B-PROTEIN
-	|O
coupled	|O
agarose	|O
.	|O

Transcriptional	|O
repression	|O
mediated	|O
by	|O
LysR	|B-PROTEIN
-	|O
type	|O
regulator	|O
CatR	|B-PROTEIN
bound	|O
at	|O
multiple	|O
binding	|O
sites	|O
.	|O

Two	|O
of	|O
these	|O
resulted	|O
in	|O
increased	|O
levels	|O
of	|O
the	|O
alpha	|O
subunit	|O
,	|O
and	|O
one	|O
caused	|O
a	|O
substitution	|O
of	|O
glycine	|O
for	|O
the	|O
aspartic	|O
acid	|O
residue	|O
at	|O
position	|O
171	|O
,	|O
in	|O
the	|O
N	|O
-	|O
terminal	|O
domain	|O
.	|O

These	|O
two	|O
mRNA	|O
species	|O
are	|O
produced	|O
by	|O
differential	|O
polyadenylation	|O
site	|O
usage	|O
.	|O

Using	|O
Southern	|O
blot	|O
analysis	|O
and	|O
restriction	|O
mapping	|O
of	|O
genomic	|O
YAC	|O
(	|O
yeast	|O
artificial	|O
chromosome	|O
)	|O
and	|O
cosmid	|O
clones	|O
,	|O
we	|O
located	|O
the	|O
human	|O
RIL	|B-PROTEIN
gene	|O
240-260	|O
kb	|O
telomeric	|O
to	|O
the	|O
IRF1	|B-PROTEIN
gene	|O
and	|O
characterized	|O
its	|O
genomic	|O
structure	|O
.	|O

U73	|B-PROTEIN
contains	|O
C	|O
,	|O
D	|O
and	|O
D'	|O
boxes	|O
and	|O
a	|O
12	|O
-	|O
nucleotide	|O
antisense	|O
complementarity	|O
to	|O
the	|O
28S	|B-PROTEIN
ribosomal	|O
RNA	|O
.	|O

However	|O
,	|O
mandibular	|O
position	|O
(	|O
S	|O
-	|O
N	|O
-	|O
B	|O
and	|O
S	|O
-	|O
N	|O
-	|O
Pog	|O
)	|O
was	|O
found	|O
to	|O
be	|O
significantly	|O
more	|O
retrusive	|O
in	|O
Class	|O
II	|O
when	|O
compared	|O
with	|O
Class	|O
I	|O
subjects	|O
.	|O

Echinostomiasis	|O
is	|O
aggravated	|O
by	|O
socioeconomic	|O
factors	|O
such	|O
as	|O
poverty	|O
,	|O
malnutrition	|O
,	|O
an	|O
explosively	|O
growing	|O
free	|O
-	|O
food	|O
market	|O
,	|O
a	|O
lack	|O
of	|O
supervised	|O
food	|O
inspection	|O
,	|O
poor	|O
or	|O
insufficient	|O
sanitation	|O
,	|O
other	|O
helminthiases	|O
,	|O
and	|O
declining	|O
economic	|O
conditions	|O
.	|O

The	|O
localization	|O
of	|O
ZAP	|B-PROTEIN
-	|I-PROTEIN
70	|I-PROTEIN
to	|O
the	|O
cell	|O
cortex	|O
is	|O
,	|O
therefore	|O
,	|O
regulated	|O
by	|O
the	|O
activity	|O
of	|O
SRC	|B-PROTEIN
-	|O
family	|O
kinases	|O
,	|O
independently	|O
of	|O
their	|O
ability	|O
to	|O
phosphorylate	|O
immunoreceptor	|O
tyrosine	|O
-	|O
based	|O
activation	|O
motifs	|O
of	|O
the	|O
TCR	|B-PROTEIN
.	|O

Finally	|O
,	|O
a	|O
role	|O
for	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
in	|O
preventing	|O
apoptosis	|O
induced	|O
by	|O
ER	|O
calcium	|O
release	|O
was	|O
demonstrated	|O
by	|O
data	|O
showing	|O
that	|O
sAPPalpha	|B-PROTEIN
prevents	|O
thapsigargin	|O
-	|O
induced	|O
apoptosis	|O
,	|O
an	|O
effect	|O
blocked	|O
by	|O
kappaB	|B-PROTEIN
decoy	|O
DNA	|O
.	|O

Many	|O
cytokine	|O
receptors	|O
employ	|O
Janus	|B-PROTEIN
protein	|I-PROTEIN
tyrosine	|I-PROTEIN
kinases	|I-PROTEIN
(	|O
Jaks	|B-PROTEIN
)	|O
and	|O
signal	|B-PROTEIN
transducers	|I-PROTEIN
and	|I-PROTEIN
activators	|I-PROTEIN
of	|I-PROTEIN
transcription	|I-PROTEIN
(	|O
Stats	|B-PROTEIN
)	|O
for	|O
nuclear	|O
signaling	|O
.	|O

A	|O
site	|O
-	|O
directed	|O
R618K	|O
mutation	|O
in	|O
the	|O
Stat5	|B-PROTEIN
SH2	|O
domain	|O
abolished	|O
the	|O
phosphorylation	|O
by	|O
Jak2	|B-PROTEIN
,	|O
while	|O
deletion	|O
of	|O
the	|O
C	|O
terminus	|O
led	|O
to	|O
Stat5	|B-PROTEIN
hyperphosphorylation	|O
.	|O

The	|O
effect	|O
of	|O
nitric	|B-PROTEIN
oxide	|I-PROTEIN
synthase	|I-PROTEIN
inhibitor	|O
on	|O
reperfusion	|O
injury	|O
of	|O
the	|O
brain	|O
under	|O
hypothermic	|O
circulatory	|O
arrest	|O
.	|O

Specifically	|O
,	|O
recombination	|O
at	|O
HMR	|B-PROTEIN
was	|O
used	|O
to	|O
produce	|O
rings	|O
that	|O
lacked	|O
the	|O
E	|O
and	|O
I	|O
silencers	|O
.	|O

In	|O
angiodysplasia	|O
,	|O
ectatic	|O
vessels	|O
in	|O
the	|O
mucosa	|O
appeared	|O
to	|O
contain	|O
less	|O
collagen	|B-PROTEIN
type	|I-PROTEIN
IV	|I-PROTEIN
than	|O
similarly	|O
sized	|O
vessels	|O
in	|O
the	|O
submucosa	|O
,	|O
and	|O
perforating	|O
vessels	|O
appeared	|O
in	|O
many	|O
cases	|O
to	|O
lose	|O
staining	|O
at	|O
the	|O
level	|O
of	|O
the	|O
muscularis	|O
mucosae	|O
.	|O

We	|O
studied	|O
the	|O
human	|O
vestibulo	|O
-	|O
ocular	|O
reflex	|O
(	|O
VOR	|O
)	|O
in	|O
response	|O
to	|O
head	|O
'	|O
impulses	|O
'	|O
:	|O
brief	|O
,	|O
unpredictable	|O
,	|O
passive	|O
,	|O
high	|O
-	|O
acceleration	|O
(	|O
up	|O
to	|O
4000	|O
degrees	|O
/	|O
s2	|O
)	|O
,	|O
low	|O
-	|O
amplitude	|O
(	|O
20-30	|O
degrees	|O
)	|O
head	|O
rotations	|O
.	|O

To	|O
clarify	|O
whether	|O
seizure	|O
-	|O
offset	|O
patterns	|O
are	|O
reliable	|O
in	|O
predicting	|O
seizure	|O
outcome	|O
,	|O
we	|O
studied	|O
SEEG	|O
/	|O
ECoG	|O
in	|O
a	|O
similar	|O
group	|O
of	|O
patients	|O
with	|O
temporal	|O
lobe	|O
epilepsy	|O
(	|O
TLE	|O
)	|O
.	|O

In	|O
this	|O
study	|O
,	|O
to	|O
characterize	|O
the	|O
gene	|O
for	|O
protein	|B-PROTEIN
Z	|I-PROTEIN
,	|O
its	|O
organization	|O
and	|O
structure	|O
were	|O
determined	|O
by	|O
a	|O
combination	|O
of	|O
PCR	|O
amplification	|O
of	|O
leukocyte	|O
DNA	|O
and	|O
isolation	|O
of	|O
phage	|O
clones	|O
from	|O
a	|O
human	|O
genomic	|O
library	|O
.	|O

These	|O
modifications	|O
may	|O
improve	|O
the	|O
interlaboratory	|O
reproducibility	|O
of	|O
CD34	|B-PROTEIN
determinations	|O
due	|O
to	|O
the	|O
reduction	|O
in	|O
sample	|O
handling	|O
and	|O
calculation	|O
of	|O
results	|O
.	|O

The	|O
present	|O
results	|O
demonstrate	|O
that	|O
rats	|O
with	|O
relatively	|O
small	|O
remnants	|O
of	|O
one	|O
olfactory	|O
bulb	|O
can	|O
perform	|O
a	|O
variety	|O
of	|O
odor	|O
detection	|O
and	|O
discrimination	|O
tasks	|O
as	|O
well	|O
or	|O
nearly	|O
as	|O
well	|O
as	|O
controls	|O
.	|O

UDP	|B-PROTEIN
-	|I-PROTEIN
GlcNAc	|I-PROTEIN
:	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
-	|I-PROTEIN
D	|I-PROTEIN
-	|I-PROTEIN
mannoside	|I-PROTEIN
beta	|I-PROTEIN
-	|I-PROTEIN
1,2	|I-PROTEIN
-	|I-PROTEIN
N	|I-PROTEIN
-	|I-PROTEIN
acetylglucosaminyltransferase	|I-PROTEIN
II	|I-PROTEIN
(	|O
GnT	|B-PROTEIN
II	|I-PROTEIN
;	|O
EC	|B-PROTEIN
2.4.1.143	|I-PROTEIN
)	|O
is	|O
essential	|O
for	|O
the	|O
normal	|O
assembly	|O
of	|O
complex	|O
Asn	|O
-	|O
linked	|O
glycans	|O
.	|O

These	|O
patients	|O
failed	|O
to	|O
respond	|O
to	|O
intravenous	|O
cyclophosphamide	|O
and	|O
steroids	|O
and	|O
were	|O
then	|O
changed	|O
to	|O
receive	|O
oral	|O
cyclosporine	|O
A	|O
,	|O
at	|O
a	|O
dose	|O
of	|O
5	|O
mg	|O
/	|O
kg	|O
/	|O
day	|O
.	|O

The	|O
predicted	|O
amino	|O
acid	|O
sequence	|O
is	|O
78.0%	|O
identical	|O
to	|O
the	|O
cytoplasmic	|O
dynein	|B-PROTEIN
heavy	|O
chain	|O
of	|O
Neurospora	|O
crassa	|O
,	|O
70.2%	|O
identical	|O
to	|O
that	|O
of	|O
Aspergillus	|O
nidulans	|O
and	|O
24.8%	|O
identical	|O
to	|O
that	|O
of	|O
Saccharomyces	|O
cerevisiae	|O
.	|O

The	|O
DNA	|O
binding	|O
activities	|O
of	|O
the	|O
three	|O
repressor	|O
preparations	|O
were	|O
studied	|O
using	|O
fragments	|O
containing	|O
CIRs	|O
(	|O
CIR3	|O
-	|O
CIR6	|O
)	|O
from	|O
the	|O
essential	|O
early	|O
region	|O
as	|O
templates	|O
for	|O
DNase	|B-PROTEIN
I	|I-PROTEIN
footprinting	|O
.	|O

Molecular	|O
modelling	|O
suggested	|O
that	|O
the	|O
tetramerization	|O
domain	|O
was	|O
a	|O
four	|O
-	|O
helix	|O
bundle	|O
,	|O
stabilized	|O
by	|O
interactions	|O
of	|O
seven	|O
conserved	|O
aromatic	|O
amino	|O
acids	|O
.	|O

In	|O
the	|O
present	|O
study	|O
,	|O
we	|O
sought	|O
to	|O
investigate	|O
whether	|O
constitutive	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
activity	|O
in	|O
chronically	|O
HIV	|O
-	|O
1	|O
-	|O
infected	|O
promonocytic	|O
U937	|O
(	|O
U9	|O
-	|O
IIIB	|O
)	|O
and	|O
myeloblastic	|O
PLB	|O
-	|O
985	|O
(	|O
PLB	|O
-	|O
IIIB	|O
)	|O
cells	|O
affects	|O
apoptotic	|O
signaling	|O
.	|O

Taken	|O
together	|O
,	|O
these	|O
results	|O
suggest	|O
that	|O
silymarin	|O
may	|O
exert	|O
a	|O
strong	|O
anticarcinogenic	|O
effect	|O
against	|O
PCA	|O
and	|O
that	|O
this	|O
effect	|O
is	|O
likely	|O
to	|O
involve	|O
impairment	|O
of	|O
erbB1	|B-PROTEIN
-	|O
SHC	|B-PROTEIN
-	|O
mediated	|O
signaling	|O
pathway	|O
,	|O
induction	|O
of	|O
CDKIs	|B-PROTEIN
,	|O
and	|O
a	|O
resultant	|O
G1	|O
arrest	|O
.	|O

In	|O
connective	|O
tissue	|O
,	|O
cell	|O
structure	|O
contributes	|O
to	|O
type	|B-PROTEIN
I	|I-PROTEIN
collagen	|I-PROTEIN
expression	|O
.	|O

To	|O
explore	|O
the	|O
function	|O
of	|O
human	|O
SINA	|B-PROTEIN
-	|I-PROTEIN
homologous	|I-PROTEIN
(	|O
Siah	|B-PROTEIN
)	|O
proteins	|O
,	|O
expression	|O
plasmids	|O
encoding	|O
Siah	|B-PROTEIN
-	|I-PROTEIN
1A	|I-PROTEIN
were	|O
transiently	|O
transfected	|O
into	|O
293	|O
epithelial	|O
cells	|O
and	|O
GM701	|O
fibroblast	|O
cells	|O
,	|O
resulting	|O
in	|O
growth	|O
arrest	|O
without	|O
induction	|O
of	|O
apoptosis	|O
.	|O

A	|O
point	|O
mutation	|O
in	|O
Galphao	|B-PROTEIN
and	|O
Galphai1	|B-PROTEIN
blocks	|O
interaction	|O
with	|O
regulator	|O
of	|O
G	|B-PROTEIN
protein	|I-PROTEIN
signaling	|O
proteins	|O
.	|O

Indeed	|O
,	|O
it	|O
is	|O
shown	|O
that	|O
it	|O
mediates	|O
the	|O
formation	|O
of	|O
disulfide	|O
-	|O
linked	|O
homodimers	|O
and	|O
that	|O
the	|O
formation	|O
of	|O
homo	|O
-	|O
and	|O
heterodimers	|O
are	|O
mutually	|O
excluded	|O
.	|O

N.	|O
,	|O
and	|O
Fanning	|O
,	|O
E.	|O

We	|O
have	|O
shown	|O
previously	|O
that	|O
GH3	|O
cells	|O
transfected	|O
with	|O
the	|O
rat	|O
GnRH	|B-PROTEIN
receptor	|I-PROTEIN
cDNA	|O
(	|O
GGH3	|O
-	|O
1'	|O
cells	|O
)	|O
support	|O
the	|O
expression	|O
of	|O
a	|O
cotransfected	|O
fusion	|O
gene	|O
composed	|O
of	|O
797	|O
base	|O
pairs	|O
of	|O
rat	|O
LHbeta	|B-PROTEIN
gene	|O
5'	|O
-	|O
flanking	|O
sequence	|O
and	|O
the	|O
first	|O
5	|O
base	|O
pairs	|O
of	|O
the	|O
5'	|O
-	|O
untranslated	|O
region	|O
fused	|O
to	|O
a	|O
luciferase	|B-PROTEIN
reporter	|O
(	|O
-	|B-PROTEIN
797	|I-PROTEIN
/	|I-PROTEIN
+	|I-PROTEIN
5LHbetaLUC	|I-PROTEIN
)	|O
and	|O
respond	|O
to	|O
a	|O
GnRH	|B-PROTEIN
agonist	|O
with	|O
a	|O
10	|O
-	|O
fold	|O
stimulation	|O
of	|O
activity	|O
.	|O

The	|O
5'	|O
-	|O
flanking	|O
region	|O
,	|O
from	|O
nucleotide	|O
-	|O
837	|O
to	|O
-	|O
336	|O
,	|O
contains	|O
TATA	|O
and	|O
inverted	|O
CAAT	|O
boxes	|O
as	|O
well	|O
as	|O
GATA	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
/	|O
SP1	|B-PROTEIN
erythroid	|O
-	|O
specific	|O
cis	|O
-	|O
acting	|O
regulatory	|O
elements	|O
.	|O

We	|O
established	|O
the	|O
radiosensitive	|O
cell	|O
line	|O
SX9	|O
from	|O
mammary	|O
carcinoma	|O
cell	|O
line	|O
FM3A	|O
.	|O

In	|O
patients	|O
with	|O
type	|O
IA	|O
maple	|O
syrup	|O
urine	|O
disease	|O
,	|O
the	|O
E1alpha	|B-PROTEIN
subunit	|O
is	|O
affected	|O
,	|O
resulting	|O
in	|O
the	|O
loss	|O
of	|O
E1	|B-PROTEIN
and	|O
branched	|O
-	|O
chain	|O
ketoacid	|B-PROTEIN
dehydrogenase	|I-PROTEIN
catalytic	|O
activities	|O
.	|O

Results	|O
showed	|O
that	|O
the	|O
mean	|O
bond	|O
strength	|O
of	|O
H.T.V.	|O
specimens	|O
ranged	|O
from	|O
9.6	|O
to	|O
13.12	|O
kg	|O
/	|O
cm2	|O
,	|O
while	|O
the	|O
mean	|O
bond	|O
strength	|O
of	|O
R.T.V.	|O
specimens	|O
ranged	|O
from	|O
0.36	|O
to	|O
1.75	|O
kg	|O
/	|O
cm2	|O
.	|O

OBJECTIVES	|O
:	|O
To	|O
measure	|O
coagulation	|B-PROTEIN
factor	|I-PROTEIN
VIII	|I-PROTEIN
:	|I-PROTEIN
coagulant	|I-PROTEIN
(	|O
F.V	|B-PROTEIN
III	|I-PROTEIN
:	|I-PROTEIN
C	|I-PROTEIN
)	|O
and	|O
C1	|B-PROTEIN
-	|I-PROTEIN
esterase	|I-PROTEIN
inhibitor	|I-PROTEIN
(	|O
C1	|B-PROTEIN
-	|I-PROTEIN
INH	|I-PROTEIN
)	|O
,	|O
hemostasis	|O
-	|O
associated	|O
acute	|O
-	|O
phase	|O
reactant	|O
proteins	|O
and	|O
coagulation	|B-PROTEIN
factors	|I-PROTEIN
VII	|I-PROTEIN
(	|O
F.V	|B-PROTEIN
II	|I-PROTEIN
)	|O
,	|O
IX	|O
(	|O
F.I	|B-PROTEIN
X	|I-PROTEIN
)	|O
,	|O
and	|O
X	|O
(	|O
F.X	|B-PROTEIN
)	|O
,	|O
hemostasis	|O
proteins	|O
not	|O
associated	|O
with	|O
an	|O
acute	|O
-	|O
phase	|O
response	|O
,	|O
in	|O
a	|O
select	|O
population	|O
of	|O
horses	|O
with	|O
colic	|O
and	|O
hemostasis	|O
abnormalities	|O
,	|O
and	|O
presumed	|O
to	|O
have	|O
acute	|O
-	|O
phase	|O
changes	|O
.	|O

RESULTS	|O
:	|O
Horses	|O
with	|O
colic	|O
had	|O
significantly	|O
higher	|O
fibrinogen	|B-PROTEIN
concentration	|O
,	|O
greater	|O
alpha	|B-PROTEIN
2AP	|I-PROTEIN
and	|O
protein	|B-PROTEIN
C	|I-PROTEIN
activities	|O
,	|O
and	|O
longer	|O
PT	|O
and	|O
APTT	|O
than	|O
did	|O
healthy	|O
horses	|O
.	|O

The	|O
data	|O
suggest	|O
that	|O
plasminogen	|B-PROTEIN
,	|O
alpha	|B-PROTEIN
2AP	|I-PROTEIN
,	|O
and	|O
C1	|B-PROTEIN
-	|I-PROTEIN
INH	|I-PROTEIN
,	|O
should	|O
be	|O
considered	|O
equine	|O
acute	|O
-	|O
phase	|O
proteins	|O
.	|O

None	|O
of	|O
the	|O
patients	|O
was	|O
obese	|O
.	|O

Marked	|O
elevation	|O
of	|O
creatine	|B-PROTEIN
kinase	|I-PROTEIN
was	|O
observed	|O
while	|O
serum	|O
albumin	|B-PROTEIN
,	|O
immunoglobulin	|B-PROTEIN
,	|O
and	|O
complement	|O
were	|O
decreased	|O
.	|O

DESIGN	|O
AND	|O
METHODS	|O
:	|O
Case	|O
study	|O
.	|O

METHODS	|O
:	|O
A	|O
total	|O
of	|O
15	|O
pigs	|O
were	|O
randomised	|O
to	|O
ligation	|O
of	|O
left	|O
marginal	|O
arteries	|O
(	|O
infarction	|O
group	|O
,	|O
n	|O
=	|O
5	|O
)	|O
,	|O
to	|O
TMLR	|O
of	|O
the	|O
left	|O
lateral	|O
wall	|O
using	|O
a	|O
holmium	|O
:	|O
yttrium	|O
-	|O
aluminium	|O
garnet	|O
(	|O
Ho	|O
:	|O
YAG	|O
)	|O
laser	|O
(	|O
laser	|O
group	|O
,	|O
n	|O
=	|O
5	|O
)	|O
,	|O
and	|O
to	|O
both	|O
(	|O
laser	|O
-	|O
infarction	|O
group	|O
,	|O
n	|O
=	|O
5	|O
)	|O
.	|O

RACK1	|B-PROTEIN
,	|O
a	|O
receptor	|O
for	|O
activated	|O
C	|B-PROTEIN
kinase	|I-PROTEIN
and	|O
a	|O
homolog	|O
of	|O
the	|O
beta	|O
subunit	|O
of	|O
G	|B-PROTEIN
proteins	|I-PROTEIN
,	|O
inhibits	|O
activity	|O
of	|O
src	|B-PROTEIN
tyrosine	|O
kinases	|O
and	|O
growth	|O
of	|O
NIH	|O
3T3	|O
cells	|O
.	|O

Peptide	|O
sequences	|O
of	|O
the	|O
zinc	|O
finger	|O
protein	|O
Ttk	|B-PROTEIN
and	|O
the	|O
transcription	|O
factor	|O
Adf	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
were	|O
obtained	|O
.	|O

The	|O
same	|O
IL	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
-	|O
inducible	|O
reporter	|O
gene	|O
is	|O
also	|O
synergistically	|O
activated	|O
by	|O
the	|O
endogenous	|O
Stat6	|B-PROTEIN
and	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
proteins	|O
in	|O
IL	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
-	|O
stimulated	|O
I.2	|O
9mu	|O
B	|O
lymphoma	|O
cells	|O
.	|O

HEF1	|B-PROTEIN
,	|O
p130	|B-PROTEIN
(	|O
Cas	|B-PROTEIN
)	|O
,	|O
and	|O
Efs	|B-PROTEIN
/	|O
Sin	|B-PROTEIN
constitute	|O
a	|O
family	|O
of	|O
multidomain	|O
docking	|O
proteins	|O
that	|O
have	|O
been	|O
implicated	|O
in	|O
coordinating	|O
the	|O
regulation	|O
of	|O
cell	|O
adhesion	|O
.	|O

In	|O
support	|O
of	|O
a	|O
role	|O
at	|O
the	|O
spindle	|O
,	|O
two	|O
-	|O
hybrid	|O
library	|O
screening	|O
with	|O
HEF1	|B-PROTEIN
identifies	|O
the	|O
human	|O
homolog	|O
of	|O
the	|O
G2	|O
/	|O
M	|O
spindle	|O
-	|O
regulatory	|O
protein	|O
Dim1p	|B-PROTEIN
as	|O
a	|O
specific	|O
interactor	|O
with	|O
a	|O
region	|O
of	|O
HEF1	|B-PROTEIN
encompassed	|O
in	|O
p55	|B-PROTEIN
(	|O
HEF1	|B-PROTEIN
)	|O
.	|O

Our	|O
data	|O
showed	|O
that	|O
activation	|O
of	|O
the	|O
raf	|B-PROTEIN
-	|O
ERK	|B-PROTEIN
pathway	|O
led	|O
to	|O
activation	|O
of	|O
TF	|B-PROTEIN
expression	|O
in	|O
breast	|O
carcinoma	|O
cells	|O
and	|O
suggested	|O
that	|O
constitutive	|O
activation	|O
of	|O
this	|O
pathway	|O
leads	|O
to	|O
high	|O
TF	|B-PROTEIN
expression	|O
in	|O
MDA	|O
-	|O
MB	|O
-	|O
231	|O
cells	|O
.	|O

However	|O
,	|O
a	|O
zinc	|O
-	|O
depleted	|O
enzyme	|O
was	|O
obtained	|O
after	|O
prolonged	|O
dialysis	|O
against	|O
the	|O
specific	|O
chelating	|O
agent	|O
1,10	|O
-	|O
phenanthroline	|O
.	|O

All	|O
patients	|O
diagnosed	|O
of	|O
H.	|O
influenza	|O
type	|O
b	|O
meningitis	|O
were	|O
less	|O
than	|O
3	|O
years	|O
old	|O
.	|O

The	|O
lines	|O
also	|O
differed	|O
in	|O
postsynaptic	|O
,	|O
but	|O
not	|O
presynaptic	|O
,	|O
5	|B-PROTEIN
-	|I-PROTEIN
HT1A	|I-PROTEIN
receptors	|I-PROTEIN
.	|O

Convulsive	|O
seizure	|O
during	|O
a	|O
treatment	|O
with	|O
interferon	|B-PROTEIN
alpha	|I-PROTEIN
for	|O
chronic	|O
viral	|O
hepatitis	|O
C	|O

Immunohistochemically	|O
,	|O
anticytokeratin	|B-PROTEIN
19	|I-PROTEIN
antibody	|O
revealed	|O
strong	|O
staining	|O
in	|O
both	|O
epithelial	|O
and	|O
sarcomatous	|O
MPM	|O
tissues	|O
.	|O

Genetic	|O
studies	|O
in	|O
Drosophila	|O
have	|O
led	|O
to	|O
the	|O
identification	|O
of	|O
several	|O
components	|O
of	|O
the	|O
Notch	|B-PROTEIN
pathway	|O
.	|O

The	|O
bZP2	|B-PROTEIN
cDNA	|O
(	|O
115-1914	|O
nt	|O
,	|O
1.8	|O
kb	|O
)	|O
,	|O
excluding	|O
sequences	|O
coding	|O
for	|O
N	|O
-	|O
terminal	|O
signal	|O
sequence	|O
and	|O
C	|O
-	|O
terminal	|O
transmembranelike	|O
domain	|O
,	|O
was	|O
PCR	|O
amplified	|O
and	|O
Sac1	|B-PROTEIN
-	|O
Sal1	|B-PROTEIN
restricted	|O
fragment	|O
cloned	|O
in	|O
frame	|O
downstream	|O
of	|O
the	|O
T5	|O
promoter	|O
under	|O
the	|O
lac	|B-PROTEIN
operator	|O
control	|O
in	|O
a	|O
pQE	|O
-	|O
30	|O
vector	|O
.	|O

Control	|O
subjects	|O
'	|O
evoked	|O
potentials	|O
(	|O
EPs	|O
)	|O
were	|O
characterized	|O
by	|O
an	|O
initial	|O
positivity	|O
in	|O
the	|O
90-140	|O
ms	|O
range	|O
(	|O
P1	|O
)	|O
at	|O
the	|O
temporo	|O
-	|O
occipital	|O
site	|O
.	|O

Class	|B-PROTEIN
I	|I-PROTEIN
alpha1	|I-PROTEIN
,	|I-PROTEIN
2	|I-PROTEIN
-	|I-PROTEIN
mannosidases	|I-PROTEIN
play	|O
an	|O
essential	|O
role	|O
in	|O
the	|O
elaboration	|O
of	|O
complex	|O
and	|O
hybrid	|O
N	|O
-	|O
glycans	|O
in	|O
mammalian	|O
cells	|O
.	|O

Structural	|O
features	|O
of	|O
the	|O
minimal	|O
DNA	|O
binding	|O
domain	|O
(	|O
M98	|O
-	|O
F219	|O
)	|O
of	|O
human	|O
nucleotide	|O
excision	|O
repair	|O
protein	|O
XPA	|B-PROTEIN
.	|O

Amongst	|O
other	|O
qualities	|O
,	|O
the	|O
book	|O
's	|O
importance	|O
lies	|O
in	|O
the	|O
fact	|O
that	|O
it	|O
associates	|O
an	|O
elaborate	|O
theoretical	|O
construction	|O
with	|O
the	|O
empirical	|O
data	|O
,	|O
working	|O
within	|O
the	|O
possibilities	|O
provided	|O
by	|O
late	|O
19th	|O
-	|O
century	|O
moral	|O
statistics	|O
.	|O

The	|O
results	|O
point	|O
to	|O
the	|O
effectiveness	|O
of	|O
the	|O
educational	|O
intervention	|O
.	|O

The	|O
mechanistic	|O
implications	|O
of	|O
aromatic	|O
non	|O
-	|O
responsiveness	|O
of	|O
autonomously	|O
expressed	|O
A	|O
-	|O
domain	|O
,	|O
despite	|O
its	|O
demonstrated	|O
ability	|O
to	|O
bind	|O
phenol	|O
,	|O
are	|O
discussed	|O
.	|O

RESULTS	|O
:	|O
Acetabular	|O
index	|O
returned	|O
to	|O
normal	|O
gradually	|O
as	|O
the	|O
time	|O
went	|O
by	|O
and	|O
significantly	|O
within	|O
one	|O
year	|O
after	|O
the	|O
reduction	|O
of	|O
developmental	|O
dislocation	|O
of	|O
the	|O
hip	|O
.	|O

Recently	|O
,	|O
extremely	|O
high	|O
levels	|O
of	|O
endothelin	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
(	|O
ET	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
were	|O
detected	|O
in	|O
the	|O
pericardial	|O
fluid	|O
of	|O
patients	|O
undergoing	|O
cardiac	|O
surgery	|O
.	|O

Consequently	|O
,	|O
it	|O
is	|O
not	|O
known	|O
how	|O
knee	|O
loading	|O
changes	|O
following	|O
ACL	|O
transection	|O
,	|O
and	|O
how	|O
it	|O
contributes	|O
to	|O
cartilage	|O
degeneration	|O
.	|O

We	|O
show	|O
that	|O
the	|O
surfaces	|O
of	|O
tracheal	|O
cartilage	|O
matrix	|O
are	|O
collagen	|B-PROTEIN
-	|O
rich	|O
and	|O
surround	|O
a	|O
proteoglycan	|O
-	|O
rich	|O
core	|O
.	|O

Comparative	|O
mapping	|O
of	|O
the	|O
Brassica	|O
S	|B-PROTEIN
locus	|I-PROTEIN
region	|O
and	|O
its	|O
homeolog	|O
in	|O
Arabidopsis	|O
.	|O

Roles	|O
of	|O
the	|O
Candida	|O
albicans	|O
mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
homolog	|O
,	|O
Cek1p	|B-PROTEIN
,	|O
in	|O
hyphal	|O
development	|O
and	|O
systemic	|O
candidiasis	|O
.	|O

Neither	|O
the	|O
reaction	|O
of	|O
monosaccharides	|O
nor	|O
the	|O
disaccharides	|O
with	|O
beta	|O
-	|O
alanine	|O
resulted	|O
in	|O
the	|O
formation	|O
of	|O
maltol	|O
.	|O

In	|O
most	|O
subjects	|O
,	|O
markers	|O
of	|O
bone	|O
formation	|O
and	|O
resorption	|O
were	|O
normal	|O
.	|O

Analysis	|O
of	|O
a	|O
Mac1p	|B-PROTEIN
mutant	|O
,	|O
refractile	|O
for	|O
copper	|O
-	|O
dependent	|O
repression	|O
of	|O
the	|O
Cu	|B-PROTEIN
(	|I-PROTEIN
I	|I-PROTEIN
)	|I-PROTEIN
transport	|I-PROTEIN
genes	|I-PROTEIN
,	|O
showed	|O
an	|O
aberrant	|O
pattern	|O
of	|O
CUP1	|B-PROTEIN
expression	|O
and	|O
copper	|O
sensitivity	|O
.	|O

The	|O
DNA	|O
sequencing	|O
of	|O
the	|O
recombinant	|O
clones	|O
revealed	|O
the	|O
expression	|O
of	|O
RXR	|B-PROTEIN
alpha	|I-PROTEIN
and	|O
RXR	|B-PROTEIN
beta	|I-PROTEIN
.	|O

A	|O
stratified	|O
random	|O
sample	|O
of	|O
20	|O
active	|O
employees	|O
from	|O
a	|O
cohort	|O
of	|O
phenoxy	|O
herbicide	|O
workers	|O
was	|O
selected	|O
in	|O
1995	|O
for	|O
determining	|O
PCDD	|O
and	|O
PCDF	|O
congeners	|O
in	|O
blood	|O
lipids	|O
to	|O
assess	|O
the	|O
extent	|O
of	|O
past	|O
PCDD	|O
and	|O
PCDF	|O
exposure	|O
in	|O
this	|O
cohort	|O
and	|O
whether	|O
that	|O
exposure	|O
might	|O
explain	|O
site	|O
-	|O
specific	|O
cancer	|O
findings	|O
in	|O
the	|O
total	|O
cohort	|O
.	|O

The	|O
clinical	|O
and	|O
laboratory	|O
features	|O
of	|O
72	|O
children	|O
with	|O
Henoch	|O
-	|O
Schonlein	|O
purpura	|O
(	|O
HSP	|O
)	|O
were	|O
examined	|O
to	|O
determine	|O
if	|O
there	|O
were	|O
associations	|O
between	|O
the	|O
laboratory	|O
indices	|O
-	|O
-	|O
including	|O
white	|O
blood	|O
cell	|O
(	|O
WBC	|O
)	|O
counts	|O
,	|O
serum	|O
C	|B-PROTEIN
-	|I-PROTEIN
reactive	|I-PROTEIN
protein	|I-PROTEIN
(	|O
CRP	|B-PROTEIN
)	|O
levels	|O
,	|O
platelet	|O
(	|O
PLT	|O
)	|O
counts	|O
-	|O
-	|O
and	|O
the	|O
clinical	|O
manifestations	|O
of	|O
acute	|O
HSP	|O
.	|O

We	|O
provide	|O
community	|O
metabolic	|O
data	|O
that	|O
indicate	|O
that	|O
large	|O
changes	|O
in	|O
CO2	|O
concentration	|O
can	|O
occur	|O
in	|O
coral	|O
reef	|O
waters	|O
via	|O
biogeochemical	|O
processes	|O
not	|O
directly	|O
associated	|O
with	|O
photosynthesis	|O
,	|O
respiration	|O
,	|O
calcification	|O
,	|O
and	|O
CaCO3	|O
dissolution	|O
.	|O

In	|O
contrast	|O
to	|O
other	|O
known	|O
retroviruses	|O
,	|O
the	|O
FV	|O
pol	|B-PROTEIN
genes	|O
are	|O
expressed	|O
via	|O
spliced	|O
transcripts	|O
.	|O

Substitution	|O
of	|O
bulky	|O
hydrophobic	|O
residues	|O
with	|O
charged	|O
residues	|O
within	|O
PEP1	|B-PROTEIN
affects	|O
the	|O
fusion	|O
activity	|O
of	|O
the	|O
S	|B-PROTEIN
protein	|I-PROTEIN
without	|O
affecting	|O
processing	|O
and	|O
surface	|O
expression	|O
.	|O

Tributyltin	|O
and	|O
its	|O
breakdown	|O
products	|O
,	|O
mono	|O
-	|O
and	|O
di	|O
-	|O
butyltin	|O
,	|O
were	|O
determined	|O
in	|O
water	|O
birds	|O
collected	|O
from	|O
Lake	|O
Huron	|O
(	|O
the	|O
Great	|O
Lakes	|O
)	|O
,	|O
marine	|O
coastal	|O
United	|O
States	|O
,	|O
and	|O
the	|O
west	|O
coast	|O
of	|O
British	|O
Columbia	|O
,	|O
Canada	|O
.	|O

The	|O
5'	|O
flanking	|O
region	|O
of	|O
the	|O
CD1	|B-PROTEIN
gene	|O
contained	|O
the	|O
binding	|O
motifs	|O
for	|O
two	|O
cytokine	|O
-	|O
inducible	|O
transcription	|O
factors	|O
,	|O
NF	|B-PROTEIN
-	|I-PROTEIN
IL2	|I-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
and	|O
NF	|B-PROTEIN
-	|I-PROTEIN
IL6	|I-PROTEIN
.	|O

Fregnac	|O
,	|O
M.	|O

GLRaV	|O
-	|O
2	|O
is	|O
the	|O
only	|O
closterovirus	|O
,	|O
so	|O
far	|O
,	|O
that	|O
matches	|O
the	|O
genome	|O
organization	|O
of	|O
the	|O
type	|O
member	|O
of	|O
the	|O
group	|O
,	|O
BYV	|O
,	|O
and	|O
thus	|O
can	|O
be	|O
unambiguously	|O
classified	|O
as	|O
a	|O
definitive	|O
member	|O
of	|O
the	|O
genus	|O
Closterovirus	|O
.	|O

Demographic	|O
and	|O
clinical	|O
data	|O
were	|O
compared	|O
with	|O
a	|O
control	|O
group	|O
of	|O
339	|O
healthy	|O
age	|O
-	|O
matched	|O
women	|O
and	|O
with	|O
a	|O
sample	|O
of	|O
224	|O
women	|O
with	|O
wrist	|O
fracture	|O
.	|O

Combined	|O
expression	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
and	|O
p65	|B-PROTEIN
induced	|O
vigorous	|O
transcription	|O
of	|O
IL	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
promoter	|O
-	|O
and	|O
CD28RE	|B-PROTEIN
-	|O
driven	|O
reporter	|O
constructs	|O
in	|O
both	|O
LFA	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
-	|O
and	|O
B7	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|O
costimulated	|O
Jurkat	|O
cells	|O
.	|O

Identical	|O
results	|O
were	|O
obtained	|O
when	|O
transfections	|O
and	|O
mobility	|O
shift	|O
assays	|O
were	|O
performed	|O
in	|O
primary	|O
rat	|O
hepatocytes	|O
in	|O
which	|O
the	|O
endogenous	|O
ALS	|B-PROTEIN
gene	|O
is	|O
expressed	|O
.	|O

This	|O
E	|O
box	|O
sequence	|O
(	|O
CACGTG	|O
)	|O
is	|O
identical	|O
to	|O
the	|O
binding	|O
element	|O
for	|O
USF	|B-PROTEIN
(	|O
upstream	|B-PROTEIN
stimulatory	|I-PROTEIN
factor	|I-PROTEIN
)	|O
,	|O
a	|O
member	|O
of	|O
the	|O
helix	|B-PROTEIN
-	|I-PROTEIN
loop	|I-PROTEIN
-	|I-PROTEIN
helix	|I-PROTEIN
family	|I-PROTEIN
of	|O
transcription	|O
factors	|O
.	|O

Interferon	|B-PROTEIN
beta	|I-PROTEIN
therapy	|O
was	|O
discontinued	|O
for	|O
4	|O
weeks	|O
.	|O

Liquid	|O
chromatographic	|O
method	|O
for	|O
analysis	|O
of	|O
all	|O
-	|O
rac	|O
-	|O
alpha	|O
-	|O
tocopheryl	|O
acetate	|O
and	|O
retinyl	|O
palmitate	|O
in	|O
milk	|O
-	|O
based	|O
infant	|O
formula	|O
using	|O
matrix	|O
solid	|O
-	|O
phase	|O
dispersion	|O
.	|O

We	|O
specially	|O
devised	|O
3	|O
types	|O
of	|O
turbo	|O
pumps	|O
,	|O
a	|O
centrifugal	|O
pump	|O
(	|O
CFP	|O
)	|O
,	|O
a	|O
mixed	|O
flow	|O
pump	|O
(	|O
MFP	|O
)	|O
,	|O
and	|O
an	|O
axial	|O
flow	|O
pump	|O
(	|O
AFP	|O
)	|O
,	|O
and	|O
analyzed	|O
their	|O
in	|O
vitro	|O
performance	|O
.	|O

Examination	|O
of	|O
the	|O
mitochondrial	|O
bc1	|B-PROTEIN
complex	|O
crystal	|O
structure	|O
[	|O
Zhang	|O
,	|O
Z.	|O
,	|O
Huang	|O
,	|O
L.	|O
,	|O
Shulmeister	|O
,	|O
V.	|O

Two	|O
protease	|O
-	|O
resistant	|O
fragments	|O
spanning	|O
the	|O
N	|O
-	|O
and	|O
C	|O
-	|O
terminal	|O
halves	|O
of	|O
the	|O
nuclease	|O
were	|O
identified	|O
using	|O
different	|O
proteases	|O
which	|O
cleave	|O
the	|O
protein	|O
in	|O
the	|O
same	|O
region	|O
.	|O

The	|O
side	|O
-	|O
to	|O
-	|O
side	|O
difference	|O
was	|O
statistically	|O
significant	|O
at	|O
EXT	|O
30	|O
degrees	|O
/	|O
s	|O
and	|O
60	|O
degrees	|O
/	|O
s	|O
(	|O
p	|O
<	|O
0.05	|O
)	|O
.	|O

CONCLUSION	|O
:	|O
In	|O
women	|O
who	|O
want	|O
or	|O
require	|O
conservative	|O
management	|O
of	|O
grade	|O
4	|O
prolapse	|O
and	|O
are	|O
unable	|O
to	|O
retain	|O
a	|O
single	|O
pessary	|O
,	|O
the	|O
placement	|O
of	|O
two	|O
pessaries	|O
often	|O
will	|O
be	|O
successful	|O
.	|O

The	|O
ability	|O
to	|O
maintain	|O
expression	|O
of	|O
FAS1	|B-PROTEIN
in	|O
nmt1	|B-PROTEIN
-	|O
451Dino2	|B-PROTEIN
Delta	|O
cells	|O
suggests	|O
the	|O
existence	|O
of	|O
another	|O
transcription	|O
factor	|O
,	|O
or	|O
factors	|O
,	|O
whose	|O
expression	|O
/	|O
activity	|O
is	|O
inversely	|O
related	|O
to	|O
overall	|O
levels	|O
of	|O
cellular	|O
protein	|O
N	|O
-	|O
myristoy	|O
-	|O
lation	|O
.	|O

Rev	|B-PROTEIN
-	|O
erbAalpha	|B-PROTEIN
/	|I-PROTEIN
beta	|I-PROTEIN
)	|O
,	|O
Mxi	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
Mad	|B-PROTEIN
bHLH	|O
-	|O
zip	|O
proteins	|O
and	|O
the	|O
oncoproteins	|O
PLZF	|B-PROTEIN
and	|O
LAZ3	|B-PROTEIN
/	|O
BCL6	|B-PROTEIN
is	|O
mediated	|O
by	|O
the	|O
corepressors	|O
N	|B-PROTEIN
-	|I-PROTEIN
CoR	|I-PROTEIN
and	|O
SMRT	|B-PROTEIN
.	|O

The	|O
identified	|O
isolates	|O
of	|O
CSF	|O
(	|O
20	|O
of	|O
29	|O
)	|O
were	|O
:	|O
ECHO	|O
30	|O
(	|O
9	|O
)	|O
,	|O
ECHO	|O
11	|O
(	|O
7	|O
)	|O
,	|O
ECHO	|O
9	|O
(	|O
3	|O
)	|O
and	|O
ECHO	|O
7	|O
(	|O
1	|O
)	|O
.	|O

There	|O
was	|O
no	|O
evidence	|O
of	|O
any	|O
persistent	|O
oscillation	|O
within	|O
the	|O
ULF	|O
band	|O
.	|O

The	|O
ParaSight	|O
-	|O
F	|O
test	|O
alone	|O
was	|O
used	|O
to	|O
monitor	|O
serum	|O
antigen	|O
levels	|O
after	|O
treatment	|O
in	|O
24	|O
patients	|O
.	|O

The	|O
purified	|O
recombinant	|O
protein	|O
was	|O
assayed	|O
for	|O
its	|O
enzyme	|O
activity	|O
by	|O
monitoring	|O
transfer	|O
of	|O
[	|O
3H	|O
]	|O
methyl	|O
groups	|O
from	|O
the	|O
substrate	|O
DNA	|O
to	|O
the	|O
MGMT	|B-PROTEIN
protein	|O
;	|O
the	|O
activity	|O
was	|O
found	|O
to	|O
be	|O
stable	|O
at	|O
90	|O
degrees	|O
C	|O
for	|O
at	|O
least	|O
30	|O
min	|O
.	|O

A	|O
deproteinization	|O
procedure	|O
was	|O
coupled	|O
with	|O
a	|O
reversed	|O
-	|O
phase	|O
HPLC	|O
separation	|O
using	|O
a	|O
250x4.6	|O
mm	|O
I.D.	|O

Elimination	|O
of	|O
the	|O
inducible	|O
response	|O
requires	|O
simultaneous	|O
mutation	|O
of	|O
both	|O
sequences	|O
,	|O
however	|O
,	|O
in	|O
the	|O
presence	|O
of	|O
an	|O
intact	|O
EpRE	|O
the	|O
upstream	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
site	|O
is	|O
irrelevant	|O
to	|O
induction	|O
.	|O

Three	|O
high	|B-PROTEIN
mobility	|I-PROTEIN
group	|I-PROTEIN
-	|O
like	|O
sequences	|O
within	|O
a	|O
48	|O
-	|O
base	|O
pair	|O
enhancer	|O
of	|O
the	|O
Col2a1	|B-PROTEIN
gene	|O
are	|O
required	|O
for	|O
cartilage	|O
-	|O
specific	|O
expression	|O
in	|O
vivo	|O
.	|O

The	|O
sequence	|O
contains	|O
an	|O
open	|O
reading	|O
frame	|O
of	|O
1744	|O
nt	|O
in	|O
the	|O
virus	|O
-	|O
sense	|O
strand	|O
,	|O
a	|O
3'	|O
untranslated	|O
region	|O
of	|O
1360	|O
nt	|O
and	|O
a	|O
3'	|O
poly	|O
(	|O
A	|O
)	|O
tail	|O
.	|O

A	|O
phylogenetic	|O
analysis	|O
of	|O
the	|O
reverse	|B-PROTEIN
transcriptase	|I-PROTEIN
domain	|O
confirms	|O
our	|O
differential	|O
genetic	|O
assessment	|O
that	|O
Cyclops	|B-PROTEIN
from	|O
pea	|O
is	|O
a	|O
novel	|O
element	|O
with	|O
no	|O
specific	|O
relationship	|O
to	|O
the	|O
previously	|O
described	|O
Gypsy	|B-PROTEIN
-	|O
like	|O
elements	|O
from	|O
plants	|O
.	|O

At	|O
physiological	|O
doses	|O
,	|O
either	|O
insulin	|B-PROTEIN
-	|I-PROTEIN
like	|I-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
I	|I-PROTEIN
(	|O
IGF	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
)	|O
or	|O
insulin	|B-PROTEIN
turned	|O
out	|O
to	|O
be	|O
as	|O
potent	|O
as	|O
dibutyryl	|O
cAMP	|O
(	|O
dbcAMP	|O
)	|O
in	|O
increasing	|O
UCP1	|B-PROTEIN
gene	|O
transcription	|O
rate	|O
(	|O
1	|O
h	|O
)	|O
and	|O
also	|O
UCP1	|B-PROTEIN
mRNA	|O
accumulation	|O
(	|O
3	|O
h	|O
)	|O
,	|O
their	|O
maximal	|O
effect	|O
(	|O
15	|O
-	|O
fold	|O
increase	|O
)	|O
reached	|O
upon	|O
treatment	|O
for	|O
24	|O
h	|O
.	|O

In	|O
addition	|O
,	|O
insulin	|B-PROTEIN
induced	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
DNA	|O
binding	|O
activity	|O
,	|O
this	|O
effect	|O
being	|O
totally	|O
prevented	|O
in	|O
the	|O
presence	|O
of	|O
MEK	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
inhibitor	|O
.	|O

Essentially	|O
,	|O
2'	|O
-	|O
O	|O
-	|O
methyl	|O
oligoribonucleotides	|O
(	|O
2'	|O
OMeRNA	|O
)	|O
were	|O
delivered	|O
to	|O
the	|O
nuclei	|O
of	|O
primary	|O
mdx	|O
myoblasts	|O
in	|O
culture	|O
.	|O

A	|O
large	|O
deletion	|O
in	|O
the	|O
CTD	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
motif	|I-PROTEIN
blocks	|O
down	|O
-	|O
regulation	|O
but	|O
does	|O
not	|O
affect	|O
the	|O
essential	|O
function	|O
of	|O
Nrd1	|B-PROTEIN
.	|O

Regulation	|O
of	|O
the	|O
human	|O
p21	|B-PROTEIN
/	|O
WAF1	|B-PROTEIN
/	|O
Cip1	|B-PROTEIN
promoter	|O
in	|O
hepatic	|O
cells	|O
by	|O
functional	|O
interactions	|O
between	|O
Sp1	|B-PROTEIN
and	|O
Smad	|B-PROTEIN
family	|O
members	|O
.	|O

RESULTS	|O
:	|O
We	|O
isolated	|O
a	|O
C.	|O
elegans	|O
cDNA	|O
that	|O
encoded	|O
a	|O
protein	|O
which	|O
was	|O
similar	|O
to	|O
,	|O
but	|O
not	|O
exactly	|O
homologous	|O
with	|O
mammalian	|O
p120	|B-PROTEIN
Ras	|O
-	|O
GAP	|B-PROTEIN
.	|O

The	|O
weak	|O
base	|O
ketoconazole	|O
showed	|O
complete	|O
dissolution	|O
from	|O
a	|O
tablet	|O
formulation	|O
in	|O
Simulated	|O
Gastric	|O
Fluid	|O
without	|O
pepsin	|B-PROTEIN
(	|O
SGFsp	|O
)	|O
within	|O
30	|O
minutes	|O
,	|O
70%	|O
dissolution	|O
in	|O
2	|O
hours	|O
under	|O
fed	|O
state	|O
simulated	|O
upper	|O
jejunal	|O
conditions	|O
but	|O
only	|O
6%	|O
dissolution	|O
in	|O
2	|O
hours	|O
under	|O
fasted	|O
state	|O
conditions	|O
.	|O

In	|O
mammals	|O
,	|O
the	|O
Rb	|B-PROTEIN
protein	|O
interacts	|O
specifically	|O
with	|O
D	|B-PROTEIN
-	|I-PROTEIN
type	|I-PROTEIN
cyclins	|I-PROTEIN
and	|O
regulates	|O
cell	|O
proliferation	|O
by	|O
binding	|O
and	|O
inhibiting	|O
E2F	|B-PROTEIN
transcription	|O
factors	|O
.	|O

In	|O
addition	|O
to	|O
the	|O
signals	|O
obtained	|O
by	|O
ligation	|O
of	|O
the	|O
TCR	|B-PROTEIN
,	|O
T	|O
cells	|O
need	|O
additional	|O
,	|O
co	|O
-	|O
stimulatory	|O
signals	|O
to	|O
be	|O
activated	|O
.	|O

Moreover	|O
,	|O
the	|O
observation	|O
of	|O
enhanced	|O
luteal	|O
HSP	|B-PROTEIN
-	|I-PROTEIN
27	|I-PROTEIN
phosphorylation	|O
in	|O
vivo	|O
,	|O
in	|O
late	|O
pregnancy	|O
,	|O
when	|O
PKC	|B-PROTEIN
-	|I-PROTEIN
delta	|I-PROTEIN
is	|O
abundant	|O
and	|O
active	|O
,	|O
suggests	|O
that	|O
select	|O
PKC	|B-PROTEIN
family	|O
members	|O
contribute	|O
to	|O
sHSP	|B-PROTEIN
phosphorylation	|O
events	|O
in	|O
vivo	|O
.	|O

We	|O
characterized	|O
the	|O
structure	|O
of	|O
this	|O
leader	|O
mRNA	|O
by	|O
using	|O
the	|O
program	|O
Mfold	|O
and	|O
a	|O
combination	|O
of	|O
nested	|O
and	|O
internal	|O
deletions	|O
transcriptionally	|O
fused	|O
to	|O
a	|O
promoterless	|O
lac	|B-PROTEIN
operon	|O
.	|O

The	|O
importance	|O
of	|O
these	|O
sites	|O
for	|O
transcriptional	|O
activation	|O
was	|O
studied	|O
by	|O
site	|O
-	|O
directed	|O
mutagenesis	|O
followed	|O
by	|O
promoter	|O
function	|O
analysis	|O
of	|O
the	|O
mutants	|O
with	|O
a	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
reporter	|O
system	|O
.	|O

Routine	|O
blood	|O
examination	|O
showed	|O
leukocytosis	|O
,	|O
thrombocytopenia	|O
,	|O
positive	|O
CRP	|B-PROTEIN
,	|O
and	|O
elevated	|O
myocardial	|O
enzymes	|O
.	|O

Previous	|O
studies	|O
have	|O
suggested	|O
that	|O
moderate	|O
cooling	|O
increases	|O
the	|O
responsiveness	|O
of	|O
vascular	|O
alpha2	|B-PROTEIN
-	|I-PROTEIN
adrenoceptors	|I-PROTEIN
.	|O

Two	|O
members	|O
of	|O
the	|O
Cbl	|B-PROTEIN
family	|O
have	|O
since	|O
been	|O
defined	|O
in	|O
mammals	|O
(	|O
c	|B-PROTEIN
-	|I-PROTEIN
Cbl	|I-PROTEIN
and	|O
Cbl	|B-PROTEIN
-	|I-PROTEIN
b	|I-PROTEIN
)	|O
,	|O
one	|O
in	|O
C.	|O
elegans	|O
(	|O
Sli	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
and	|O
one	|O
in	|O
Drosophila	|O
(	|O
D	|B-PROTEIN
-	|I-PROTEIN
Cbl	|I-PROTEIN
)	|O
.	|O

Anti	|B-PROTEIN
-	|I-PROTEIN
PTB	|I-PROTEIN
antibodies	|O
did	|O
not	|O
inhibit	|O
the	|O
binding	|O
of	|O
PTB	|B-PROTEIN
to	|O
RNA	|O
because	|O
they	|O
were	|O
able	|O
to	|O
supershift	|O
RNA	|B-PROTEIN
-	|I-PROTEIN
PTB	|I-PROTEIN
complexes	|O
.	|O

The	|O
use	|O
of	|O
antibodies	|O
to	|O
the	|O
polypyrimidine	|B-PROTEIN
tract	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
(	|O
PTB	|B-PROTEIN
)	|O
to	|O
analyze	|O
the	|O
protein	|O
components	|O
that	|O
assemble	|O
on	|O
alternatively	|O
spliced	|O
pre	|O
-	|O
mRNAs	|O
that	|O
use	|O
distant	|O
branch	|O
points	|O
.	|O

The	|O
therapeutic	|O
use	|O
of	|O
botulinum	|B-PROTEIN
toxin	|I-PROTEIN
(	|O
Botox	|B-PROTEIN
)	|O
is	|O
increasing	|O
in	|O
popularity	|O
.	|O

The	|O
viral	|O
oncoprotein	|O
E1A	|B-PROTEIN
inhibits	|O
NFAT	|B-PROTEIN
-	|O
dependent	|O
transactivation	|O
in	|O
a	|O
p300	|B-PROTEIN
-	|O
dependent	|O
manner	|O
.	|O

We	|O
have	|O
applied	|O
the	|O
mRNA	|O
differential	|O
display	|O
method	|O
to	|O
compare	|O
and	|O
analyze	|O
mRNAs	|O
prepared	|O
from	|O
five	|O
normal	|O
nasopharyngeal	|O
epithelial	|O
cell	|O
cultures	|O
and	|O
five	|O
nasopharyngeal	|O
carcinoma	|O
cell	|O
lines	|O
.	|O

Similar	|O
experiments	|O
with	|O
TR	|B-PROTEIN
support	|O
the	|O
high	|O
affinity	|O
of	|O
RIP140	|B-PROTEIN
to	|O
the	|O
RXR	|B-PROTEIN
subunit	|O
and	|O
also	|O
suggest	|O
that	|O
either	|O
partner	|O
in	|O
the	|O
TR	|B-PROTEIN
/	|O
RXR	|B-PROTEIN
heterodimer	|O
can	|O
independently	|O
respond	|O
to	|O
ligand	|O
.	|O

SETTING	|O
:	|O
University	|O
hospital	|O
-	|O
based	|O
,	|O
tertiary	|O
care	|O
infertility	|O
center	|O
.	|O

RESULT	|O
(	|O
S	|O
)	|O
:	|O
In	|O
patients	|O
with	|O
elevated	|O
FSH	|B-PROTEIN
levels	|O
on	|O
cycle	|O
day	|O
3	|O
,	|O
a	|O
low	|O
oocyte	|O
yield	|O
was	|O
achieved	|O
(	|O
7	|O
versus	|O
11	|O
)	|O
and	|O
a	|O
high	|O
number	|O
of	|O
ampules	|O
of	|O
hMG	|B-PROTEIN
was	|O
necessary	|O
(	|O
56	|O
versus	|O
33	|O
)	|O
.	|O

RESULTS	|O
:	|O
Of	|O
the	|O
patients	|O
with	|O
IS	|O
,	|O
67%	|O
had	|O
significantly	|O
greater	|O
values	|O
of	|O
directional	|O
preponderance	|O
on	|O
the	|O
OVAR	|O
test	|O
(	|O
a	|O
measure	|O
of	|O
otolith	|O
system	|O
imbalance	|O
)	|O
compared	|O
with	|O
control	|O
subjects	|O
.	|O

In	|O
the	|O
ePTFE	|O
specimens	|O
,	|O
tissue	|O
coverage	|O
had	|O
increased	|O
.	|O

As	|O
predicted	|O
by	|O
the	|O
Wing	|O
and	|O
Kristofferson	|O
model	|O
,	|O
the	|O
durations	|O
of	|O
successive	|O
ISIs	|O
tended	|O
to	|O
be	|O
negatively	|O
correlated	|O
.	|O

Thus	|O
,	|O
included	|O
in	|O
the	|O
KG1a	|O
EST	|O
dataset	|O
are	|O
candidates	|O
for	|O
new	|O
human	|O
genes	|O
that	|O
may	|O
play	|O
roles	|O
in	|O
hematopoietic	|O
differentiative	|O
progression	|O
and	|O
lineage	|O
commitment	|O
.	|O

We	|O
found	|O
the	|O
following	|O
:	|O
Specific	|O
mutations	|O
affected	|O
the	|O
precise	|O
carbohydrate	|O
structure	|O
and	|O
folding	|O
of	|O
the	|O
HA	|B-PROTEIN
trimer	|O
.	|O

The	|O
results	|O
show	|O
that	|O
ROS	|O
production	|O
by	|O
viable	|O
spermatozoa	|O
is	|O
highly	|O
correlated	|O
with	|O
the	|O
concentration	|O
of	|O
PMN	|B-PROTEIN
elastase	|I-PROTEIN
and	|O
the	|O
number	|O
of	|O
both	|O
peroxidase	|B-PROTEIN
-	|O
positive	|O
and	|O
round	|O
cells	|O
.	|O

Yeast	|O
U1	|B-PROTEIN
snRNP	|O
is	|O
considerably	|O
more	|O
complex	|O
than	|O
its	|O
metazoan	|O
counterpart	|O
,	|O
which	|O
suggests	|O
possible	|O
differences	|O
between	|O
yeast	|O
and	|O
metazoa	|O
in	|O
early	|O
splicing	|O
events	|O
.	|O

Yeast	|O
U1	|B-PROTEIN
snRNP	|O
therefore	|O
contains	|O
16	|O
different	|O
proteins	|O
,	|O
including	|O
seven	|O
snRNP	|O
core	|B-PROTEIN
proteins	|O
,	|O
three	|O
homologues	|O
of	|O
the	|O
metazoan	|O
U1	|B-PROTEIN
snRNP	|O
-	|O
specific	|O
proteins	|O
,	|O
and	|O
six	|O
yeast	|O
-	|O
specific	|O
U1	|B-PROTEIN
snRNP	|O
proteins	|O
.	|O

After	|O
the	|O
first	|O
cycle	|O
,	|O
18	|O
cases	|O
were	|O
treated	|O
at	|O
dose	|O
level	|O
1	|O
,	|O
after	|O
a	|O
second	|O
cycle	|O
,	|O
13	|O
cases	|O
were	|O
treated	|O
at	|O
dose	|O
level	|O
2	|O
.	|O

The	|O
opioid	|O
antagonist	|O
naltrexone	|O
(	|O
0.01-1.0	|O
mg	|O
/	|O
kg	|O
)	|O
antagonized	|O
the	|O
discriminative	|O
stimulus	|O
effects	|O
of	|O
heroin	|O
,	|O
but	|O
naltrexone	|O
at	|O
doses	|O
up	|O
to	|O
10	|O
mg	|O
/	|O
kg	|O
had	|O
no	|O
effect	|O
on	|O
the	|O
discriminative	|O
stimulus	|O
effects	|O
of	|O
cocaine	|O
.	|O

In	|O
this	|O
study	|O
we	|O
examined	|O
hepatic	|O
stellate	|O
cell	|O
regulation	|O
of	|O
M6P	|B-PROTEIN
/	|O
IGFIIR	|B-PROTEIN
expression	|O
and	|O
found	|O
that	|O
M6P	|B-PROTEIN
/	|O
IGFIIR	|B-PROTEIN
mRNA	|O
transcript	|O
levels	|O
increased	|O
in	|O
stellate	|O
cells	|O
from	|O
rats	|O
exposed	|O
to	|O
carbon	|O
tetrachloride	|O
(	|O
CCl4	|O
)	|O
,	|O
a	|O
potent	|O
fibrogenic	|O
stimulant	|O
.	|O

One	|O
cDNA	|O
clone	|O
designated	|O
NCoA	|O
-	|O
62	|O
,	|O
encoded	|O
a	|O
62	|O
,	|O
000	|O
-	|O
Da	|O
protein	|O
that	|O
is	|O
highly	|O
related	|O
to	|O
BX42	|B-PROTEIN
,	|O
a	|O
Drosophila	|O
melanogaster	|O
nuclear	|O
protein	|O
involved	|O
in	|O
ecdysone	|O
-	|O
stimulated	|O
gene	|O
expression	|O
.	|O

These	|O
widely	|O
expressed	|O
proteins	|O
share	|O
a	|O
C	|O
-	|O
terminal	|O
region	|O
that	|O
bears	|O
significant	|O
sequence	|O
homology	|O
to	|O
a	|O
group	|O
of	|O
GDP	|B-PROTEIN
/	|I-PROTEIN
GTP	|I-PROTEIN
exchange	|I-PROTEIN
proteins	|I-PROTEIN
for	|O
the	|O
Rab3	|B-PROTEIN
family	|O
of	|O
small	|B-PROTEIN
GTP	|I-PROTEIN
binding	|I-PROTEIN
proteins	|I-PROTEIN
.	|O

Whereas	|O
p82	|B-PROTEIN
expression	|O
had	|O
no	|O
effect	|O
on	|O
ERK2	|B-PROTEIN
activation	|O
by	|O
p126	|B-PROTEIN
,	|O
p70	|B-PROTEIN
completely	|O
abrogated	|O
this	|O
activity	|O
.	|O

The	|O
pre	|O
-	|O
mRNA	|O
splicing	|O
factor	|O
U2AF	|B-PROTEIN
(	|O
U2	|B-PROTEIN
small	|I-PROTEIN
nuclear	|I-PROTEIN
ribonucleoprotein	|I-PROTEIN
particle	|I-PROTEIN
[	|I-PROTEIN
snRNP	|I-PROTEIN
]	|I-PROTEIN
auxiliary	|I-PROTEIN
factor	|I-PROTEIN
)	|O
plays	|O
a	|O
critical	|O
role	|O
in	|O
3'	|O
splice	|O
site	|O
selection	|O
.	|O

The	|O
brackets	|O
were	|O
bonded	|O
to	|O
100	|O
freshly	|O
extracted	|O
bovine	|O
incisors	|O
,	|O
and	|O
,	|O
after	|O
storage	|O
in	|O
tap	|O
water	|O
at	|O
room	|O
temperature	|O
for	|O
24	|O
hours	|O
,	|O
they	|O
were	|O
subsequently	|O
tested	|O
in	|O
a	|O
shear	|O
mode	|O
using	|O
a	|O
universal	|O
testing	|O
machine	|O
.	|O

Exercise	|O
training	|O
has	|O
become	|O
increasingly	|O
important	|O
in	|O
the	|O
treatment	|O
of	|O
heart	|O
failure	|O
patients	|O
.	|O

The	|O
growth	|O
of	|O
Aer	|O
.	|O
hydrophila	|O
in	|O
filter	|O
-	|O
sterilized	|O
lettuce	|O
extract	|O
was	|O
completely	|O
inhibited	|O
by	|O
0.1%	|O
(	|O
v	|O
/	|O
v	|O
)	|O
BMC	|O
whereas	|O
that	|O
of	|O
Ps	|O
.	|O
fluorescens	|O
was	|O
not	|O
significantly	|O
affected	|O
by	|O
1%	|O
(	|O
v	|O
/	|O
v	|O
)	|O
BMC	|O
.	|O

Despite	|O
continuous	|O
compliance	|O
,	|O
unexplained	|O
resurgence	|O
of	|O
serum	|O
ferritin	|B-PROTEIN
levels	|O
occurred	|O
in	|O
4/7	|O
patients	|O
of	|O
the	|O
'	|O
veteran	|O
'	|O
group	|O
after	|O
4-5	|O
years	|O
on	|O
L1	|O
.	|O

Hematocrit	|O
and	|O
PaO2	|O
did	|O
not	|O
change	|O
.	|O

Regulation	|O
of	|O
myosin	|B-PROTEIN
phosphatase	|I-PROTEIN
activity	|O
involves	|O
changes	|O
in	|O
subunit	|O
interactions	|O
,	|O
although	|O
molecular	|O
mechanisms	|O
are	|O
not	|O
defined	|O
.	|O

Commutative	|O
saccadic	|O
generator	|O
is	|O
sufficient	|O
to	|O
control	|O
a	|O
3	|O
-	|O
D	|O
ocular	|O
plant	|O
with	|O
pulleys	|O
.	|O

The	|O
virus	|O
-	|O
associated	|O
VAI	|B-PROTEIN
RNA	|O
of	|O
adenovirus	|O
is	|O
a	|O
small	|O
highly	|O
structured	|O
RNA	|O
that	|O
is	|O
required	|O
for	|O
the	|O
efficient	|O
translation	|O
of	|O
cellular	|O
and	|O
viral	|O
mRNAs	|O
at	|O
late	|O
times	|O
after	|O
infection	|O
.	|O

Structure	|O
of	|O
the	|O
gene	|O
encoding	|O
the	|O
human	|O
cyclin	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
kinase	|I-PROTEIN
inhibitor	|O
p18	|B-PROTEIN
and	|O
mutational	|O
analysis	|O
in	|O
breast	|O
cancer	|O
.	|O

The	|O
YccA	|B-PROTEIN
protein	|O
was	|O
found	|O
to	|O
be	|O
degraded	|O
in	|O
an	|O
FtsH	|B-PROTEIN
-	|O
dependent	|O
manner	|O
in	|O
vivo	|O
and	|O
in	|O
vitro	|O
,	|O
whereas	|O
the	|O
YccA11	|B-PROTEIN
mutant	|O
protein	|O
,	|O
lacking	|O
eight	|O
amino	|O
acid	|O
residues	|O
within	|O
the	|O
amino	|O
-	|O
terminal	|O
cytoplasmic	|O
domain	|O
,	|O
was	|O
refractory	|O
to	|O
the	|O
degradation	|O
.	|O

The	|O
major	|O
type	|O
involves	|O
activator	|O
proteins	|O
that	|O
bind	|O
to	|O
DNA	|O
adjacent	|O
to	|O
where	|O
the	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
(	|O
RNAP	|B-PROTEIN
)	|O
holoenzyme	|O
binds	|O
,	|O
usually	|O
assisting	|O
in	|O
recruitment	|O
of	|O
the	|O
RNAP	|B-PROTEIN
to	|O
the	|O
promoter	|O
.	|O

A	|O
conserved	|O
role	|O
for	|O
L1	|B-PROTEIN
as	|O
a	|O
transmembrane	|O
link	|O
between	|O
neuronal	|O
adhesion	|O
and	|O
membrane	|O
cytoskeleton	|O
assembly	|O
.	|O

Atmospheric	|O
benzene	|O
,	|O
urinary	|O
muconic	|O
acid	|O
(	|O
tt	|O
-	|O
MA	|O
)	|O
and	|O
leukocyte	|O
alkaline	|B-PROTEIN
phosphatase	|I-PROTEIN
activity	|O
(	|O
LAPA	|O
)	|O
were	|O
evaluated	|O
among	|O
66	|O
car	|O
mechanics	|O
,	|O
34	|O
road	|O
tanker	|O
drivers	|O
,	|O
and	|O
28	|O
nonexposed	|O
workers	|O
.	|O

It	|O
contains	|O
a	|O
5'	|O
-	|O
noncoding	|O
region	|O
(	|O
NCR	|O
)	|O
of	|O
73	|O
nucleotides	|O
,	|O
five	|O
open	|O
reading	|O
frames	|O
(	|O
ORFs	|O
1	|O
to	|O
5	|O
)	|O
which	|O
encode	|O
proteins	|O
with	|O
M	|O
(	|O
r	|O
)	|O
160	|O
kDa	|O
RNA	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
RNA	|I-PROTEIN
polymerase	|I-PROTEIN
(	|O
ORF1	|O
)	|O
,	|O
26	|O
kDa	|O
movement	|B-PROTEIN
protein	|I-PROTEIN
1	|I-PROTEIN
(	|O
ORF2	|O
)	|O
,	|O
13	|O
kDa	|O
movement	|B-PROTEIN
protein	|I-PROTEIN
2	|I-PROTEIN
(	|O
ORF3	|O
)	|O
,	|O
10	|O
kDa	|O
movement	|B-PROTEIN
protein	|I-PROTEIN
3	|I-PROTEIN
(	|O
ORF4	|O
)	|O
,	|O
24	|O
kDa	|O
coat	|B-PROTEIN
protein	|O
(	|O
OFR5	|O
)	|O
,	|O
and	|O
a	|O
3'	|O
NCR	|O
of	|O
76	|O
nucleotides	|O
.	|O

After	|O
profound	|O
normovolemic	|O
hemodilution	|O
(	|O
Hct	|O
9%	|O
)	|O
superiority	|O
of	|O
LV	|O
MC	|O
and	|O
LV	|O
diastolic	|O
properties	|O
was	|O
found	|O
,	|O
when	|O
myocardial	|O
oxygenation	|O
was	|O
supported	|O
by	|O
i.v	|O
.	|O
perflubron	|O
emulsion	|O
,	|O
a	|O
temporary	|O
O2	|O
carrier	|O
.	|O

Sp1	|B-PROTEIN
and	|O
two	|O
Sp3	|B-PROTEIN
isoforms	|O
were	|O
detected	|O
as	|O
the	|O
primary	|O
cellular	|O
constituents	|O
of	|O
DNA	|O
-	|O
protein	|O
complexes	|O
formed	|O
with	|O
the	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
-	|O
proximal	|O
site	|O
.	|O

These	|O
genes	|O
may	|O
represent	|O
interesting	|O
targets	|O
for	|O
new	|O
therapeutic	|O
strategies	|O
.	|O

It	|O
could	|O
also	|O
inhibit	|O
C1q	|B-PROTEIN
-	|O
dependent	|O
haemolysis	|O
of	|O
both	|O
IgG	|B-PROTEIN
-	|O
and	|O
IgM	|B-PROTEIN
-	|O
sensitized	|O
erythrocytes	|O
.	|O

3	|O
)	|O
and	|O
one	|O
distal	|O
(	|O
-	|O
11.8	|O
/	|O
-	|O
10.9	|O
)	|O
,	|O
presented	|O
an	|O
enhancer	|O
activity	|O
in	|O
pituitary	|O
cells	|O
when	|O
placed	|O
upstream	|O
of	|O
the	|O
SV40	|B-PROTEIN
promoter	|I-PROTEIN
.	|O

The	|O
second	|O
patient	|O
had	|O
received	|O
pituitary	|O
-	|O
derived	|O
growth	|B-PROTEIN
hormone	|I-PROTEIN
for	|O
treatment	|O
of	|O
growth	|B-PROTEIN
hormone	|I-PROTEIN
deficiency	|O
,	|O
secondary	|O
to	|O
a	|O
third	|O
ventricle	|O
teratoma	|O
,	|O
exised	|O
13	|O
yr	|O
earlier	|O
.	|O

3	|O
-	|O
-	|O
It	|O
is	|O
necessary	|O
to	|O
think	|O
about	|O
cosmetic	|O
consequences	|O
of	|O
the	|O
chinese	|O
flap	|O
and	|O
consider	|O
other	|O
possibilities	|O
of	|O
the	|O
flap	|O
choice	|O
.	|O

CONCLUSION	|O
:	|O
TNF	|B-PROTEIN
alpha	|I-PROTEIN
,	|O
TGF	|B-PROTEIN
beta	|I-PROTEIN
,	|O
PDGF	|B-PROTEIN
and	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1beta	|I-PROTEIN
increased	|O
LDLr	|B-PROTEIN
gene	|O
expression	|O
by	|O
increasing	|O
sterol	|O
-	|O
independent	|O
and	|O
mitogenesis	|O
-	|O
independent	|O
gene	|O
transcription	|O
.	|O

Binding	|O
affinities	|O
of	|O
different	|O
nucleotide	|O
mono	|O
-	|O
,	|O
di	|O
-	|O
and	|O
triphosphates	|O
and	|O
non	|O
-	|O
hydrolyzable	|O
analogs	|O
indicate	|O
that	|O
the	|O
beta	|O
-	|O
phosphate	|O
moiety	|O
is	|O
required	|O
for	|O
substrate	|O
binding	|O
.	|O

However	|O
,	|O
it	|O
is	|O
only	|O
one	|O
-	|O
half	|O
and	|O
one	|O
-	|O
third	|O
the	|O
size	|O
of	|O
the	|O
proteolipids	|O
from	|O
M.	|O
thermoautotrophicum	|O
and	|O
M.	|O
jannaschii	|O
,	|O
respectively	|O
.	|O
ahaK	|B-PROTEIN
is	|O
expressed	|O
in	|O
Escherichia	|O
coli	|O
,	|O
and	|O
it	|O
is	|O
incorporated	|O
into	|O
the	|O
cytoplasmic	|O
membrane	|O
despite	|O
the	|O
different	|O
chemical	|O
natures	|O
of	|O
lipids	|O
from	|O
archaea	|O
and	|O
bacteria	|O
.	|O

In	|O
this	|O
report	|O
we	|O
studied	|O
the	|O
role	|O
of	|O
protein	|B-PROTEIN
-	|I-PROTEIN
tyrosine	|I-PROTEIN
phosphatase	|I-PROTEIN
SHP	|O
-	|O
2	|O
in	|O
ErbB	|B-PROTEIN
-	|O
mediated	|O
activation	|O
of	|O
mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
MAPK	|B-PROTEIN
)	|O
by	|O
overexpressing	|O
SHP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
mutants	|O
in	|O
COS	|O
-	|O
7	|O
cells	|O
.	|O

Osteoadherin	|B-PROTEIN
is	|O
a	|O
recently	|O
described	|O
bone	|O
proteoglycan	|O
containing	|O
keratan	|O
sulfate	|O
.	|O

Intron	|O
8	|O
harbored	|O
a	|O
strong	|O
erythroid	|O
-	|O
specific	|O
enhancer	|O
activity	|O
which	|O
was	|O
orientation	|O
-	|O
dependent	|O
.	|O

The	|O
intron	|O
8	|O
enhancer	|O
region	|O
was	|O
not	|O
activated	|O
by	|O
GATA	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
together	|O
with	|O
Sp1	|B-PROTEIN
in	|O
transactivation	|O
experiments	|O
in	|O
COS	|O
-	|O
1	|O
cells	|O
indicating	|O
the	|O
involvement	|O
of	|O
a	|O
related	|O
Sp1	|B-PROTEIN
protein	|O
or	|O
of	|O
another	|O
unidentified	|O
erythroid	|O
factor	|O
.	|O

The	|O
cleavage	|O
of	|O
Fak	|B-PROTEIN
by	|O
caspases	|B-PROTEIN
may	|O
thus	|O
play	|O
an	|O
important	|O
role	|O
in	|O
the	|O
execution	|O
of	|O
the	|O
suicide	|O
program	|O
by	|O
disabling	|O
the	|O
anti	|O
-	|O
apoptotic	|O
function	|O
of	|O
Fak	|B-PROTEIN
.	|O

Moreover	|O
,	|O
the	|O
mass	|O
estimated	|O
with	|O
the	|O
QCM	|O
response	|O
through	|O
the	|O
Sauerbrey	|O
equation	|O
and	|O
the	|O
mass	|O
which	|O
can	|O
be	|O
measured	|O
thanks	|O
to	|O
other	|O
analytical	|O
techniques	|O
,	|O
in	|O
our	|O
case	|O
an	|O
enzymatic	|O
assay	|O
,	|O
are	|O
different	|O
:	|O
the	|O
deposited	|O
mass	|O
is	|O
generally	|O
overestimated	|O
by	|O
the	|O
QCM	|O
.	|O

[	|O
Treatment	|O
of	|O
early	|O
T1	|O
small	|O
T2N	|O
breast	|O
cancers	|O
.	|O

Transcription	|O
initiation	|O
occurred	|O
predominantly	|O
at	|O
the	|O
putative	|O
sigmaA	|B-PROTEIN
-	|O
dependent	|O
promoter	|O
in	|O
exponentially	|O
growing	|O
cells	|O
and	|O
was	|O
induced	|O
under	|O
stress	|O
conditions	|O
.	|O

The	|O
genes	|O
encoding	|O
(	|O
2Fe	|O
-	|O
2S	|O
)	|O
plant	|O
-	|O
like	|O
ferredoxins	|B-PROTEIN
were	|O
studied	|O
in	|O
the	|O
widely	|O
used	|O
cyanobacterium	|O
Synechocystis	|O
PCC6803	|O
.	|O

RNA	|O
of	|O
GBV	|O
-	|O
C	|O
was	|O
detected	|O
in	|O
14	|O
(	|O
18%	|O
)	|O
patients	|O
before	|O
BMT	|O
.	|O

A	|O
major	|O
pool	|O
of	|O
Dsg	|B-PROTEIN
-	|O
plakoglobin	|B-PROTEIN
complexes	|O
sedimented	|O
at	|O
8S	|O
and	|O
exhibited	|O
a	|O
1	|O
:	|O
1	|O
stoichiometry	|O
.	|O

Our	|O
results	|O
indicate	|O
that	|O
the	|O
binding	|O
of	|O
CBF	|B-PROTEIN
/	|O
NF	|B-PROTEIN
-	|I-PROTEIN
Y	|I-PROTEIN
to	|O
the	|O
inverted	|O
CCAAT	|O
box	|O
is	|O
responsible	|O
for	|O
transcriptional	|O
activation	|O
of	|O
the	|O
nTPH	|B-PROTEIN
gene	|O
.	|O

In	|O
macrophages	|O
,	|O
LPS	|O
-	|O
inducible	|O
HIV	|O
-	|O
1	|O
gene	|O
expression	|O
is	|O
mediated	|O
in	|O
part	|O
by	|O
binding	|O
of	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
to	|O
identical	|O
tandem	|O
binding	|O
sites	|O
located	|O
within	|O
the	|O
long	|O
terminal	|O
repeat	|O
(	|O
LTR	|O
)	|O
.	|O

The	|O
influence	|O
of	|O
p53	|B-PROTEIN
on	|O
cytokine	|O
-	|O
triggered	|O
Janus	|B-PROTEIN
kinase	|I-PROTEIN
-	|O
STAT	|B-PROTEIN
signaling	|O
was	|O
investigated	|O
in	|O
human	|O
hepatoma	|O
Hep3B	|O
cell	|O
lines	|O
engineered	|O
to	|O
constitutively	|O
express	|O
the	|O
temperature	|O
-	|O
sensitive	|O
Val135	|O
mutant	|O
of	|O
p53	|B-PROTEIN
.	|O

It	|O
can	|O
also	|O
be	|O
used	|O
to	|O
examine	|O
various	|O
laryngeal	|O
parameters	|O
obtained	|O
from	|O
videotaped	|O
endoscopic	|O
and	|O
stroboscopic	|O
examinations	|O
.	|O

CONCLUSIONS	|O
:	|O
Two	|O
consecutive	|O
sets	|O
of	|O
transrectal	|O
ultrasound	|O
guided	|O
sextant	|O
biopsies	|O
of	|O
the	|O
prostate	|O
performed	|O
in	|O
a	|O
single	|O
office	|O
visit	|O
represent	|O
a	|O
cost	|O
-	|O
effective	|O
biopsy	|O
strategy	|O
for	|O
men	|O
presenting	|O
with	|O
an	|O
abnormal	|O
digital	|O
rectal	|O
examination	|O
and	|O
/	|O
or	|O
elevated	|O
serum	|O
PSA	|B-PROTEIN
.	|O

Examination	|O
of	|O
nuclear	|O
magnetic	|O
resonance	|O
(	|O
NMR	|O
)	|O
spectra	|O
of	|O
a	|O
series	|O
of	|O
N	|O
-	|O
terminally	|O
truncated	|O
MIP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
beta	|I-PROTEIN
variants	|O
reveals	|O
that	|O
these	|O
proteins	|O
possess	|O
a	|O
range	|O
of	|O
ability	|O
to	|O
dimerize	|O
.	|O

Interestingly	|O
,	|O
PKA	|B-PROTEIN
activity	|O
is	|O
dispensable	|O
in	|O
a	|O
strain	|O
lacking	|O
Msn2p	|B-PROTEIN
and	|O
Msn4p	|B-PROTEIN
activity	|O
.	|O

They	|O
also	|O
indicate	|O
that	|O
direct	|O
interactions	|O
between	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBPs	|I-PROTEIN
and	|O
specific	|O
Ets	|B-PROTEIN
family	|O
members	|O
,	|O
together	|O
with	|O
GATA	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
are	|O
important	|O
for	|O
eosinophil	|O
lineage	|O
determination	|O
.	|O

Recently	|O
,	|O
a	|O
human	|O
transcription	|O
elongation	|O
factor	|O
P	|B-PROTEIN
-	|I-PROTEIN
TEFb	|I-PROTEIN
,	|O
consisting	|O
of	|O
CDK9	|B-PROTEIN
kinase	|I-PROTEIN
,	|O
cyclin	|B-PROTEIN
T	|I-PROTEIN
and	|O
other	|O
associated	|O
factors	|O
,	|O
has	|O
been	|O
shown	|O
to	|O
interact	|O
with	|O
Tat	|B-PROTEIN
to	|O
restore	|O
Tat	|B-PROTEIN
activation	|O
in	|O
HeLa	|O
nuclear	|O
extract	|O
depleted	|O
of	|O
P	|B-PROTEIN
-	|I-PROTEIN
TEFb	|I-PROTEIN
.	|O

We	|O
have	|O
used	|O
the	|O
hydrophobic	|O
repeats	|O
of	|O
the	|O
HSF1	|B-PROTEIN
trimerization	|O
domain	|O
in	|O
the	|O
yeast	|O
two	|O
-	|O
hybrid	|O
protein	|O
interaction	|O
assay	|O
to	|O
identify	|O
heat	|B-PROTEIN
shock	|I-PROTEIN
factor	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
1	|I-PROTEIN
(	|O
HSBP1	|B-PROTEIN
)	|O
,	|O
a	|O
novel	|O
,	|O
conserved	|O
,	|O
76	|O
-	|O
amino	|O
-	|O
acid	|O
protein	|O
that	|O
contains	|O
two	|O
extended	|O
arrays	|O
of	|O
hydrophobic	|O
repeats	|O
that	|O
interact	|O
with	|O
the	|O
HSF1	|B-PROTEIN
heptad	|O
repeats	|O
.	|O

Genomic	|O
and	|O
cDNA	|O
clones	|O
homologous	|O
to	|O
the	|O
yeast	|O
GCN2	|B-PROTEIN
eIF	|O
-	|O
2alpha	|O
kinase	|O
(	|O
yGCN2	|O
)	|O
were	|O
isolated	|O
from	|O
Drosophila	|O
melanogaster	|O
.	|O

The	|O
general	|O
recombination	|O
at	|O
a	|O
polarizing	|O
voltage	|O
of	|O
300	|O
V	|O
is	|O
less	|O
than	|O
2%	|O
for	|O
dose	|O
-	|O
rates	|O
up	|O
to	|O
about	|O
100	|O
mGy	|O
min	|O
-	|O
1	|O
.	|O

The	|O
low	|O
number	|O
of	|O
false	|O
positives	|O
indicates	|O
that	|O
our	|O
scheme	|O
would	|O
not	|O
confuse	|O
the	|O
radiologist	|O
by	|O
suggesting	|O
normal	|O
regions	|O
as	|O
suspicious	|O
.	|O

Strengthening	|O
the	|O
biological	|O
weapons	|O
convention	|O
and	|O
implications	|O
on	|O
the	|O
pharmaceutical	|O
and	|O
biotechnology	|O
industry	|O
.	|O

VirD2	|B-PROTEIN
is	|O
one	|O
of	|O
the	|O
key	|O
Agrobacterium	|O
tumefaciens	|O
proteins	|O
involved	|O
in	|O
T	|O
-	|O
DNA	|O
processing	|O
and	|O
transfer	|O
.	|O

Taken	|O
together	|O
,	|O
these	|O
data	|O
indicate	|O
that	|O
the	|O
VirD2	|B-PROTEIN
omega	|O
domain	|O
is	|O
important	|O
for	|O
efficient	|O
T	|O
-	|O
DNA	|O
integration	|O
.	|O

The	|O
DHEAS	|O
levels	|O
in	|O
all	|O
stages	|O
of	|O
decreased	|O
BMD	|O
were	|O
significantly	|O
lower	|O
than	|O
those	|O
in	|O
the	|O
group	|O
with	|O
normal	|O
BMD	|O
.	|O

Orientation	|O
of	|O
the	|O
nuclear	|O
spin	|O
system	|O
by	|O
optical	|O
pumping	|O
causes	|O
an	|O
Overhauser	|O
shift	|O
of	|O
the	|O
excitonic	|O
energy	|O
levels	|O
proportional	|O
to	|O
the	|O
degree	|O
of	|O
nuclear	|O
orientation	|O
.	|O

Cystatin	|B-PROTEIN
A	|I-PROTEIN
,	|O
a	|O
cysteine	|B-PROTEIN
proteinase	|I-PROTEIN
inhibitor	|O
,	|O
is	|O
one	|O
of	|O
the	|O
precursor	|O
proteins	|O
of	|O
cornified	|O
cell	|O
envelope	|B-PROTEIN
of	|O
keratinocytes	|O
and	|O
is	|O
expressed	|O
during	|O
the	|O
late	|O
stage	|O
of	|O
keratinocyte	|O
differentiation	|O
.	|O

A	|O
role	|O
for	|O
RalGDS	|B-PROTEIN
and	|O
a	|O
novel	|O
Ras	|B-PROTEIN
effector	|O
in	|O
the	|O
Ras	|B-PROTEIN
-	|O
mediated	|O
inhibition	|O
of	|O
skeletal	|O
myogenesis	|O
.	|O

GTPase	|B-PROTEIN
activating	|O
specificity	|O
of	|O
RGS12	|B-PROTEIN
and	|O
binding	|O
specificity	|O
of	|O
an	|O
alternatively	|O
spliced	|O
PDZ	|B-PROTEIN
(	|O
PSD	|B-PROTEIN
-	|I-PROTEIN
95	|I-PROTEIN
/	|O
Dlg	|B-PROTEIN
/	|O
ZO	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
domain	|O
.	|O

However	|O
,	|O
mutations	|O
in	|O
the	|O
HNF	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
binding	|O
site	|O
on	|O
element	|O
CIIB	|B-PROTEIN
and	|O
inhibition	|O
of	|O
HNF	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
synthesis	|O
in	|O
HepG2	|O
cells	|O
by	|O
antisense	|O
HNF	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
constructs	|O
decreased	|O
the	|O
apoCII	|B-PROTEIN
promoter	|O
activity	|O
to	|O
25-40%	|O
of	|O
the	|O
control	|O
,	|O
indicating	|O
that	|O
HNF	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
is	|O
a	|O
positive	|O
regulator	|O
of	|O
the	|O
apoCII	|B-PROTEIN
gene	|O
.	|O

272	|O
,	|O
19107-19110	|O
)	|O
.	|O

In	|O
addition	|O
,	|O
we	|O
find	|O
that	|O
E2F	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
can	|O
cause	|O
apoptosis	|O
in	|O
p53	|B-PROTEIN
-	|O
/	|O
-	|O
tumour	|O
cells	|O
and	|O
further	|O
p300	|B-PROTEIN
,	|O
which	|O
also	|O
functions	|O
as	|O
a	|O
co	|O
-	|O
activator	|O
for	|O
the	|O
E2F	|B-PROTEIN
/	|O
DP	|B-PROTEIN
heterodimer	|O
,	|O
enhances	|O
the	|O
apoptotic	|O
activity	|O
of	|O
E2F	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

Blocked	|O
shift	|O
/	|O
supershift	|O
analysis	|O
indicates	|O
that	|O
Fos	|B-PROTEIN
family	|O
member	|O
proteins	|O
especially	|O
Fra	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
Fra	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
are	|O
related	|O
to	|O
progression	|O
and	|O
no	|O
changes	|O
found	|O
in	|O
the	|O
Jun	|B-PROTEIN
family	|O
member	|O
proteins	|O
although	|O
they	|O
are	|O
present	|O
in	|O
the	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
/	|O
DNA	|O
binding	|O
complex	|O
.	|O

Initially	|O
,	|O
we	|O
observed	|O
that	|O
unmutated	|O
p53	|B-PROTEIN
is	|O
strongly	|O
expressed	|O
in	|O
premalignant	|O
mammary	|O
glands	|O
and	|O
in	|O
mammary	|O
tumors	|O
derived	|O
from	|O
the	|O
MMTV	|O
-	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
strain	|O
.	|O

These	|O
data	|O
show	|O
that	|O
heterologous	|O
virus	|O
RNAs	|O
(	|O
BSMV	|O
)	|O
can	|O
serve	|O
as	|O
primer	|O
donors	|O
for	|O
MStV	|O
mRNA	|O
capped	|O
RNA	|O
-	|O
primed	|O
transcription	|O
in	|O
doubly	|O
infected	|O
plants	|O
.	|O

Human	|O
isoforms	|O
,	|O
designated	|O
1	|O
to	|O
4	|O
,	|O
differ	|O
from	|O
each	|O
other	|O
by	|O
the	|O
start	|O
codon	|O
used	|O
.	|O

Comparison	|O
of	|O
cDNA	|O
and	|O
genomic	|O
sequences	|O
shows	|O
that	|O
the	|O
ZNF189	|B-PROTEIN
gene	|O
spans	|O
approximately	|O
11	|O
kb	|O
and	|O
is	|O
organized	|O
into	|O
at	|O
least	|O
four	|O
exons	|O
,	|O
the	|O
large	|O
3'	|O
-	|O
end	|O
exon	|O
coding	|O
for	|O
the	|O
complete	|O
zinc	|O
finger	|O
domain	|O
and	|O
the	|O
3'	|O
untranslated	|O
region	|O
.	|O

Malaria	|O
had	|O
diminished	|O
significantly	|O
by	|O
the	|O
early	|O
1940s	|O
,	|O
and	|O
this	|O
paper	|O
queries	|O
whether	|O
that	|O
reduction	|O
was	|O
due	|O
to	|O
the	|O
control	|O
projects	|O
of	|O
the	|O
thirties	|O
,	|O
and	|O
,	|O
if	|O
so	|O
,	|O
whether	|O
such	|O
projects	|O
should	|O
be	|O
a	|O
model	|O
for	|O
the	|O
current	|O
developing	|O
world	|O
,	|O
where	|O
malaria	|O
is	|O
a	|O
growing	|O
problem	|O
today	|O
.	|O

The	|O
gp330	|B-PROTEIN
/	|O
Megalin	|B-PROTEIN
/	|O
LRP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
protein	|O
belongs	|O
to	|O
the	|O
low	|B-PROTEIN
-	|I-PROTEIN
density	|I-PROTEIN
lipoprotein	|I-PROTEIN
receptor	|I-PROTEIN
gene	|O
family	|O
and	|O
is	|O
believed	|O
to	|O
function	|O
as	|O
an	|O
endocytic	|O
receptor	|O
for	|O
the	|O
uptake	|O
of	|O
lipoproteins	|O
and	|O
many	|O
other	|O
ligands	|O
.	|O

In	|O
the	|O
DNA	|O
recognition	|O
helix	|O
of	|O
finger	|O
II	|O
,	|O
the	|O
conserved	|O
Arg	|O
at	|O
position	|O
62	|O
(	|O
N	|O
-	|O
terminal	|O
side	|O
of	|O
the	|O
first	|O
zinc	|O
-	|O
coordinating	|O
histidine	|O
)	|O
was	|O
changed	|O
to	|O
a	|O
Leu	|O
or	|O
Gln	|O
.	|O

Dosage	|O
in	|O
both	|O
cases	|O
was	|O
0.2	|O
g	|O
/	|O
m2	|O
.	|O

Five	|O
additional	|O
copies	|O
of	|O
Lian	|B-PROTEIN
elements	|O
were	|O
isolated	|O
,	|O
mapped	|O
by	|O
restriction	|O
digestion	|O
,	|O
and	|O
partially	|O
sequenced	|O
.	|O

Evolutionary	|O
relationships	|O
among	|O
putative	|O
RNA	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
RNA	|I-PROTEIN
polymerases	|I-PROTEIN
encoded	|O
by	|O
a	|O
mitochondrial	|O
virus	|O
-	|O
like	|O
RNA	|O
in	|O
the	|O
Dutch	|O
elm	|O
disease	|O
fungus	|O
,	|O
Ophiostoma	|O
novo	|O
-	|O
ulmi	|O
,	|O
by	|O
other	|O
viruses	|O
and	|O
virus	|O
-	|O
like	|O
RNAs	|O
and	|O
by	|O
the	|O
Arabidopsis	|O
mitochondrial	|O
genome	|O
.	|O

Role	|O
of	|O
the	|O
transcription	|O
start	|O
site	|O
core	|O
region	|O
and	|O
transcription	|O
factor	|O
YY1	|B-PROTEIN
in	|O
Rous	|B-PROTEIN
sarcoma	|I-PROTEIN
virus	|I-PROTEIN
long	|I-PROTEIN
terminal	|I-PROTEIN
repeat	|I-PROTEIN
promoter	|O
activity	|O
.	|O

Fowlpox	|O
virus	|O
encodes	|O
nonessential	|O
homologs	|O
of	|O
cellular	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
SNAP	|I-PROTEIN
,	|O
PC	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
and	|O
an	|O
orphan	|O
human	|O
homolog	|O
of	|O
a	|O
secreted	|O
nematode	|O
protein	|O
.	|O

Addition	|O
of	|O
Rap	|O
or	|O
KN62	|O
after	|O
exposure	|O
of	|O
cells	|O
to	|O
progesterone	|O
agonist	|O
Org	|O
2058	|O
had	|O
no	|O
effect	|O
on	|O
induction	|O
of	|O
CAT	|B-PROTEIN
activity	|O
.	|O

The	|O
Dax	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
gene	|O
encodes	|O
a	|O
protein	|O
that	|O
is	|O
structurally	|O
related	|O
to	|O
members	|O
of	|O
the	|O
orphan	|B-PROTEIN
nuclear	|I-PROTEIN
receptor	|I-PROTEIN
superfamily	|O
.	|O

He	|O
was	|O
administered	|O
recombinant	|O
IFN	|B-PROTEIN
alpha	|I-PROTEIN
-	|I-PROTEIN
2b	|I-PROTEIN
under	|O
the	|O
diagnosis	|O
of	|O
chronic	|O
hepatitis	|O
C.	|O

Further	|O
,	|O
Ser	|O
/	|O
Thr	|O
phosphorylation	|O
of	|O
downstream	|O
molecules	|O
Akt	|B-PROTEIN
and	|O
p70	|B-PROTEIN
S6	|I-PROTEIN
kinase	|I-PROTEIN
was	|O
inhibited	|O
.	|O

Quantitative	|O
evaluation	|O
of	|O
the	|O
steady	|O
state	|O
kinetics	|O
of	|O
MEK	|B-PROTEIN
inhibition	|O
by	|O
these	|O
compounds	|O
reveals	|O
that	|O
U0126	|O
has	|O
approximately	|O
100	|O
-	|O
fold	|O
higher	|O
affinity	|O
for	|O
deltaN3	|O
-	|O
S218E	|O
/	|O
S222D	|O
MEK	|B-PROTEIN
than	|O
does	|O
PD098059	|O
.	|O

Regulation	|O
at	|O
37	|O
degrees	|O
C	|O
,	|O
therefore	|O
,	|O
involves	|O
the	|O
action	|O
of	|O
three	|O
protein	|O
kinase	|O
cascades	|O
that	|O
repress	|O
HSF1	|B-PROTEIN
through	|O
phosphorylation	|O
of	|O
serine	|O
residues	|O
303	|O
,	|O
307	|O
,	|O
and	|O
363	|O
and	|O
may	|O
promote	|O
growth	|O
by	|O
suppressing	|O
the	|O
heat	|O
shock	|O
response	|O
.	|O

Clinical	|O
implication	|O
of	|O
protein	|O
levels	|O
of	|O
IL	|B-PROTEIN
-	|I-PROTEIN
5	|I-PROTEIN
in	|O
induced	|O
sputum	|O
in	|O
asthmatic	|O
patients	|O
.	|O

In	|O
these	|O
cells	|O
,	|O
ras	|B-PROTEIN
-	|O
induced	|O
transition	|O
is	|O
accompanied	|O
by	|O
a	|O
strong	|O
induction	|O
of	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|O
binding	|O
activity	|O
along	|O
with	|O
increased	|O
expression	|O
of	|O
CD44	|B-PROTEIN
mRNA	|O
and	|O
protein	|O
.	|O

However	|O
,	|O
little	|O
is	|O
known	|O
regarding	|O
the	|O
genomic	|O
organization	|O
and	|O
developmental	|O
expression	|O
of	|O
the	|O
caveolin	|B-PROTEIN
gene	|O
family	|O
.	|O

Tensile	|O
bond	|O
strengths	|O
between	|O
resin	|O
composite	|O
and	|O
bovine	|O
dentin	|O
using	|O
dentin	|O
adhesive	|O
systems	|O
(	|O
Clearfil	|O
Liner	|O
Bond	|O
II	|O
:	|O
LB	|O
II	|O
;	|O
Scotchbond	|O
Multi	|O
-	|O
Purpose	|O
:	|O
MP	|O
)	|O
bonding	|O
systems	|O
showed	|O
a	|O
large	|O
scatter	|O
among	|O
students	|O
and	|O
dentists	|O
.	|O

This	|O
distribution	|O
implies	|O
that	|O
the	|O
polycistronic	|O
precursor	|O
is	|O
imported	|O
into	|O
the	|O
nucleolus	|O
for	|O
processing	|O
to	|O
the	|O
mature	|O
snoRNAs	|O
,	|O
and	|O
that	|O
the	|O
import	|O
or	|O
processing	|O
pathway	|O
involves	|O
coiled	|O
bodies	|O
.	|O

Suppressive	|O
therapy	|O
for	|O
thyroid	|O
nodules	|O
.	|O

Fourteen	|O
healthy	|O
male	|O
volunteers	|O
completed	|O
the	|O
study	|O
.	|O

In	|O
the	|O
absence	|O
of	|O
Mg2+	|O
,	|O
a	|O
hydrophobic	|O
exonuclease	|O
site	|O
dominates	|O
over	|O
the	|O
polymerase	|O
site	|O
for	|O
possession	|O
of	|O
the	|O
primer	|O
terminus	|O
.	|O

As	|O
the	|O
high	|O
-	|O
affinity	|O
Mg2+	|O
binding	|O
sites	|O
are	|O
filled	|O
,	|O
the	|O
primer	|O
terminus	|O
migrates	|O
from	|O
the	|O
exonuclease	|O
site	|O
to	|O
a	|O
highly	|O
based	|O
stacked	|O
polymerase	|O
active	|O
site	|O
.	|O

One	|O
missense	|O
allele	|O
(	|O
P236S	|O
)	|O
with	|O
complete	|O
loss	|O
of	|O
function	|O
at	|O
30	|O
degreesC	|O
and	|O
four	|O
missense	|O
alleles	|O
(	|O
L173F	|O
,	|O
E225K	|O
,	|O
S269L	|O
and	|O
E274K	|O
)	|O
that	|O
conferred	|O
a	|O
temperature	|O
sensitive	|O
phenotype	|O
were	|O
identified	|O
.	|O

Structural	|O
analysis	|O
of	|O
the	|O
5'	|O
-	|O
regulatory	|O
region	|O
reveals	|O
that	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
met	|I-PROTEIN
promoter	|O
lacks	|O
TATA	|O
or	|O
CAAT	|O
elements	|O
but	|O
has	|O
an	|O
extremely	|O
high	|O
G	|O
-	|O
C	|O
content	|O
and	|O
multiple	|O
Sp1	|B-PROTEIN
binding	|O
sites	|O
.	|O

The	|O
report	|O
highlights	|O
the	|O
possible	|O
contribution	|O
of	|O
stress	|O
factors	|O
in	|O
the	|O
context	|O
of	|O
therapy	|O
resistant	|O
periodontal	|O
disease	|O
,	|O
and	|O
the	|O
results	|O
seem	|O
to	|O
be	|O
understandable	|O
within	|O
the	|O
context	|O
of	|O
a	|O
stress	|O
system	|O
disorder	|O
perspective	|O
.	|O

Acute	|O
pancreatitis	|O
is	|O
a	|O
rather	|O
common	|O
abdominal	|O
disorder	|O
.	|O

To	|O
better	|O
understand	|O
the	|O
role	|O
of	|O
Ets	|B-PROTEIN
proteins	|O
in	|O
Ras	|B-PROTEIN
transformation	|O
,	|O
we	|O
have	|O
now	|O
analyzed	|O
the	|O
effects	|O
of	|O
stably	|O
expressing	|O
a	|O
variety	|O
of	|O
Ets2	|B-PROTEIN
constructs	|O
in	|O
Ras	|B-PROTEIN
-	|O
transformed	|O
NIH3T3	|O
(	|O
DT	|O
)	|O
cells	|O
.	|O

Each	|O
binding	|O
site	|O
,	|O
however	|O
,	|O
was	|O
different	|O
in	|O
its	|O
preference	|O
for	|O
binding	|O
partners	|O
.	|O

We	|O
isolated	|O
the	|O
human	|O
FGF	|B-PROTEIN
-	|I-PROTEIN
BP	|I-PROTEIN
promoter	|O
and	|O
determined	|O
by	|O
deletion	|O
analysis	|O
that	|O
TPA	|O
regulatory	|O
elements	|O
were	|O
all	|O
contained	|O
in	|O
the	|O
first	|O
118	|O
base	|O
pairs	|O
upstream	|O
of	|O
the	|O
transcription	|O
start	|O
site	|O
.	|O

Manipulation	|O
of	|O
the	|O
checkpoint	|O
regulators	|O
involved	|O
in	|O
cell	|O
cycle	|O
arrest	|O
and	|O
apoptosis	|O
may	|O
thus	|O
provide	|O
a	|O
novel	|O
strategy	|O
to	|O
cancer	|O
therapy	|O
.	|O

Electrophoretic	|O
mobility	|O
shift	|O
assays	|O
demonstrated	|O
specific	|O
nuclear	|O
protein	|O
binding	|O
to	|O
-	|O
85	|O
/	|O
-	|O
64	|O
,	|O
and	|O
single	|O
point	|O
mutations	|O
suggested	|O
important	|O
binding	|O
nucleotides	|O
between	|O
-	|O
79	|O
/	|O
-	|O
68	|O
with	|O
five	|O
critical	|O
bases	|O
between	|O
-	|O
74	|O
/	|O
-	|O
70	|O
(	|O
5'	|O
-	|O
CTCCT	|O
-	|O
3'	|O
)	|O
.	|O

The	|O
diagnostic	|O
accuracy	|O
of	|O
serum	|O
PE	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
was	|O
0.80	|O
,	|O
and	|O
that	|O
of	|O
amylase	|B-PROTEIN
0.97	|O
.	|O

We	|O
demonstrate	|O
that	|O
Ddc1p	|B-PROTEIN
interacts	|O
physically	|O
in	|O
vivo	|O
with	|O
Mec3p	|B-PROTEIN
,	|O
and	|O
this	|O
interaction	|O
requires	|O
Rad17p	|B-PROTEIN
.	|O

"	|O
Complex	|O
partial	|O
"	|O
seizures	|O
.	|O

B	|B-PROTEIN
cell	|I-PROTEIN
antigen	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
BCR	|B-PROTEIN
)	|O
-	|O
mediated	|O
formation	|O
of	|O
a	|O
SHP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
-	|O
pp120	|B-PROTEIN
complex	|O
and	|O
its	|O
inhibition	|O
by	|O
Fc	|B-PROTEIN
gamma	|I-PROTEIN
RIIB1	|I-PROTEIN
-	|O
BCR	|B-PROTEIN
coligation	|O
.	|O

Chem.	|O
,	|O
270	|O
:	|O
7117-7124	|O
,	|O
1995	|O
;	|O
and	|O
MT	|O
Hartsough	|O
et	|O
al.	|O
,	|O
J.	|O

Deleting	|O
SNF1	|B-PROTEIN
repressed	|O
meiosis	|O
at	|O
the	|O
same	|O
three	|O
steps	|O
that	|O
were	|O
inhibited	|O
by	|O
glucose	|O
,	|O
suggesting	|O
that	|O
glucose	|O
blocks	|O
meiosis	|O
by	|O
inhibiting	|O
Snf1	|B-PROTEIN
.	|O

Here	|O
we	|O
investigate	|O
the	|O
role	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
Cbl	|I-PROTEIN
in	|O
development	|O
and	|O
homeostasis	|O
in	|O
mice	|O
by	|O
targeted	|O
disruption	|O
of	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
Cbl	|I-PROTEIN
locus	|O
.	|O
c	|B-PROTEIN
-	|I-PROTEIN
Cbl	|I-PROTEIN
-	|O
deficient	|O
mice	|O
were	|O
viable	|O
,	|O
fertile	|O
,	|O
and	|O
outwardly	|O
normal	|O
in	|O
appearance	|O
.	|O

One	|O
is	|O
to	|O
act	|O
within	|O
the	|O
visceral	|O
endoderm	|O
to	|O
promote	|O
proper	|O
streak	|O
morphogenesis	|O
.	|O

We	|O
propose	|O
that	|O
noi	|B-PROTEIN
/	|O
pax2.1	|B-PROTEIN
participates	|O
in	|O
sequential	|O
signaling	|O
processes	|O
as	|O
a	|O
key	|O
integrator	|O
of	|O
midbrain	|O
-	|O
hindbrain	|O
boundary	|O
development	|O
.	|O

Ligand	|O
-	|O
independent	|O
activation	|O
of	|O
platelet	|B-PROTEIN
-	|I-PROTEIN
derived	|I-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
receptor	|I-PROTEIN
is	|O
a	|O
necessary	|O
intermediate	|O
in	|O
lysophosphatidic	|O
,	|O
acid	|O
-	|O
stimulated	|O
mitogenic	|O
activity	|O
in	|O
L	|O
cells	|O
.	|O

METHODS	|O
:	|O
Fibrotic	|O
changes	|O
involving	|O
bone	|O
marrow	|O
were	|O
evaluated	|O
histologically	|O
semiquantitatively	|O
using	|O
reticulin	|B-PROTEIN
fiber	|O
impregnation	|O
(	|O
method	|O
of	|O
Gomori	|O
)	|O
.	|O

In	|O
canrenoate	|O
-	|O
treated	|O
rats	|O
,	|O
ANP	|B-PROTEIN
infusion	|O
caused	|O
greater	|O
increases	|O
in	|O
sodium	|O
excretion	|O
(	|O
FENA	|O
from	|O
3.05	|O
+	|O
/	|O
-	|O
0.71	|O
to	|O
7.21	|O
+	|O
/	|O
-	|O
0.45%	|O
;	|O
P	|O
<	|O
0.05	|O
;	|O
n	|O
=	|O
8	|O
)	|O
than	|O
saline	|O
infusion	|O
(	|O
FENA	|O
from	|O
4.16	|O
+	|O
/	|O
-	|O
1.11	|O
to	|O
5.47	|O
+	|O
/	|O
-	|O
0.66%	|O
;	|O
n	|O
=	|O
6	|O
)	|O
,	|O
despite	|O
the	|O
hypocapnia	|O
.	|O

We	|O
then	|O
studied	|O
four	|O
unrelated	|O
Japanese	|O
families	|O
with	|O
GSD	|O
-	|O
Ib	|O
,	|O
and	|O
found	|O
three	|O
novel	|O
mutations	|O
:	|O
a	|O
four	|O
-	|O
base	|O
deletion	|O
/	|O
two	|O
-	|O
base	|O
insertion	|O
,	|O
a	|O
point	|O
mutation	|O
within	|O
a	|O
consensus	|O
splicing	|O
donor	|O
site	|O
,	|O
and	|O
a	|O
missense	|O
mutation	|O
(	|O
W118R	|O
)	|O
.	|O

Removal	|O
of	|O
the	|O
carboxyl	|O
region	|O
severely	|O
reduced	|O
transcriptional	|O
activation	|O
.	|O

A	|O
"	|O
Level	|O
A	|O
"	|O
in	|O
vitro	|O
/	|O
in	|O
vivo	|O
correlation	|O
was	|O
established	|O
for	|O
a	|O
sustained	|O
release	|O
theophylline	|O
(	|O
CAS	|O
58-55-9	|O
)	|O
preparation	|O
(	|O
Bronchoretard	|O
)	|O
under	|O
investigation	|O
.	|O

METHOD	|O
:	|O
50	|O
consecutive	|O
children	|O
aged	|O
from	|O
6	|O
months	|O
to	|O
17	|O
years	|O
were	|O
included	|O
into	|O
the	|O
study	|O
which	|O
comprised	|O
questionnaires	|O
of	|O
patient	|O
and	|O
family	|O
histories	|O
,	|O
serological	|O
screening	|O
tests	|O
for	|O
common	|O
inhalational	|O
allergens	|O
(	|O
CAP	|O
SX1	|O
)	|O
,	|O
and	|O
determination	|O
of	|O
total	|O
serum	|O
immunoglobulin	|B-PROTEIN
E	|I-PROTEIN
(	|O
IgE	|B-PROTEIN
)	|O
and	|O
of	|O
latex	|O
-	|O
specific	|O
serum	|O
IgE	|B-PROTEIN
by	|O
solid	|O
-	|O
phase	|O
immunoassays	|O
.	|O

The	|O
PDE4A	|B-PROTEIN
-	|O
subfamily	|O
-	|O
specific	|O
linker	|O
region	|O
LR1	|O
,	|O
which	|O
joins	|O
UCR1	|O
and	|O
UCR2	|O
,	|O
is	|O
encoded	|O
by	|O
two	|O
exons	|O
,	|O
whereas	|O
LR2	|O
,	|O
which	|O
joins	|O
UCR2	|O
to	|O
the	|O
catalytic	|O
unit	|O
,	|O
is	|O
encoded	|O
by	|O
a	|O
single	|O
exon	|O
.	|O

Pol32Delta	|B-PROTEIN
strains	|O
are	|O
weak	|O
antimutators	|O
and	|O
are	|O
defective	|O
for	|O
damage	|O
-	|O
induced	|O
mutagenesis	|O
.	|O

At	|O
the	|O
same	|O
time	|O
,	|O
the	|O
results	|O
indicate	|O
that	|O
p53	|B-PROTEIN
plays	|O
a	|O
defensive	|O
role	|O
against	|O
HBV	|O
by	|O
transcriptionally	|O
repressing	|O
the	|O
HBV	|B-PROTEIN
core	|I-PROTEIN
promoter	|O
through	|O
liver	|B-PROTEIN
-	|I-PROTEIN
specific	|I-PROTEIN
enhancer	|I-PROTEIN
II	|I-PROTEIN
and	|O
HBx	|B-PROTEIN
is	|O
required	|O
to	|O
counteract	|O
this	|O
inhibitory	|O
function	|O
of	|O
p53	|B-PROTEIN
.	|O

To	|O
gain	|O
insight	|O
into	|O
the	|O
expression	|O
of	|O
the	|O
AtCP1	|B-PROTEIN
gene	|O
,	|O
northern	|O
blot	|O
analysis	|O
was	|O
carried	|O
out	|O
.	|O

The	|O
aim	|O
of	|O
the	|O
study	|O
was	|O
to	|O
correlate	|O
the	|O
responsiveness	|O
to	|O
bronchoprovocation	|O
with	|O
methacholine	|O
in	|O
subjects	|O
a	|O
with	|O
allergic	|O
rhinitis	|O
during	|O
and	|O
out	|O
of	|O
the	|O
pollen	|O
season	|O
with	|O
total	|O
serum	|O
IgE	|B-PROTEIN
and	|O
blood	|O
eosinophils	|O
.	|O

These	|O
results	|O
provide	|O
the	|O
first	|O
demonstration	|O
that	|O
an	|O
SR	|B-PROTEIN
protein	|O
can	|O
influence	|O
splicing	|O
of	|O
specific	|O
pre	|O
-	|O
mRNAs	|O
in	|O
vivo	|O
.	|O

In	|O
particular	|O
,	|O
the	|O
potential	|O
for	|O
prostate	|O
cancer	|O
chemoprevention	|O
using	|O
nonsteroidal	|O
anti	|O
-	|O
inflammatory	|O
drugs	|O
(	|O
cyclo	|B-PROTEIN
-	|I-PROTEIN
oxygenase	|I-PROTEIN
inhibitors	|O
;	|O
NSAIDs	|O
)	|O
has	|O
received	|O
little	|O
attention	|O
.	|O

This	|O
study	|O
reports	|O
the	|O
isolation	|O
of	|O
a	|O
P.	|O
hybrida	|O
gene	|O
,	|O
jaf13	|B-PROTEIN
,	|O
encoding	|O
a	|O
basic	|B-PROTEIN
helix	|I-PROTEIN
-	|I-PROTEIN
loop	|I-PROTEIN
-	|I-PROTEIN
helix	|I-PROTEIN
protein	|I-PROTEIN
that	|O
,	|O
on	|O
the	|O
basis	|O
of	|O
sequence	|O
homology	|O
and	|O
intron	|O
/	|O
exon	|O
structure	|O
,	|O
represents	|O
the	|O
P.	|O
hybrida	|O
orthologue	|O
of	|O
the	|O
Z.	|O
mays	|O
r	|B-PROTEIN
genes	|O
.	|O

Identical	|O
c	|B-PROTEIN
-	|I-PROTEIN
erbB3	|I-PROTEIN
transcripts	|O
are	|O
expressed	|O
in	|O
normal	|O
human	|O
placental	|O
tissues	|O
.	|O

During	|O
the	|O
past	|O
4	|O
years	|O
,	|O
a	|O
purposeful	|O
search	|O
was	|O
made	|O
for	|O
electrocardiograms	|O
with	|O
documented	|O
reversible	|O
QRS	|O
changes	|O
associated	|O
with	|O
all	|O
acute	|O
injury	|O
pattern	|O
.	|O

Mutating	|O
a	|O
potential	|O
cleavage	|O
site	|O
located	|O
N	|O
-	|O
terminal	|O
to	|O
the	|O
protease	|O
domain	|O
,	|O
Gln2526	|O
-	|O
Asp2527	|O
,	|O
diminished	|O
processing	|O
.	|O

METHODS	|O
:	|O
Millipore	|O
ultrafiltration	|O
membranes	|O
of	|O
three	|O
different	|O
pore	|O
sizes	|O
were	|O
used	|O
as	|O
model	|O
lenticule	|O
materials.T	|O
he	|O
nominal	|O
membrane	|O
pore	|O
sizes	|O
were	|O
0.1	|O
microm	|O
,	|O
0.45	|O
microm	|O
,	|O
and	|O
3	|O
microm	|O
;	|O
the	|O
surface	|O
roughness	|O
increased	|O
in	|O
the	|O
same	|O
order	|O
The	|O
membranes	|O
were	|O
coated	|O
with	|O
a	|O
thin	|O
layer	|O
of	|O
collagen	|B-PROTEIN
I	|I-PROTEIN
and	|O
implanted	|O
in	|O
a	|O
circular	|O
pocket	|O
of	|O
the	|O
anterior	|O
cornea	|O
of	|O
adult	|O
cats	|O
,	|O
and	|O
were	|O
clinically	|O
evaluated	|O
for	|O
the	|O
extent	|O
of	|O
epithelialization	|O
and	|O
the	|O
persistence	|O
of	|O
epithelial	|O
attachment	|O
.	|O

The	|O
role	|O
of	|O
calcitonin	|B-PROTEIN
,	|O
and	|O
other	|O
agonists	|O
which	|O
activate	|O
the	|O
cAMP	|O
pathway	|O
,	|O
in	|O
regulating	|O
transcription	|O
of	|O
the	|O
human	|O
parathyroid	|B-PROTEIN
hormone	|I-PROTEIN
-	|I-PROTEIN
related	|I-PROTEIN
protein	|I-PROTEIN
(	|O
PTHrP	|B-PROTEIN
)	|O
gene	|O
was	|O
investigated	|O
in	|O
a	|O
human	|O
lung	|O
cancer	|O
cell	|O
line	|O
(	|O
BEN	|O
)	|O
.	|O

The	|O
combination	|O
of	|O
Pitx2	|B-PROTEIN
and	|O
another	|O
homeodomain	|B-PROTEIN
protein	|O
,	|O
Pit	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
yielded	|O
a	|O
synergistic	|O
55	|O
-	|O
fold	|O
activation	|O
of	|O
the	|O
prolactin	|B-PROTEIN
promoter	|O
in	|O
transfection	|O
assays	|O
.	|O

The	|O
biochemical	|O
and	|O
molecular	|O
spectrum	|O
of	|O
ornithine	|B-PROTEIN
transcarbamylase	|I-PROTEIN
deficiency	|O
.	|O

To	|O
further	|O
understand	|O
the	|O
role	|O
of	|O
cis	|O
-	|O
acting	|O
elements	|O
in	|O
these	|O
regulatory	|O
mechanisms	|O
,	|O
we	|O
have	|O
characterized	|O
a	|O
transcriptional	|O
promoter	|O
that	|O
drives	|O
germline	|O
expression	|O
of	|O
TCR	|B-PROTEIN
beta	|I-PROTEIN
gene	|O
segments	|O
in	|O
vivo	|O
.	|O

Our	|O
results	|O
suggest	|O
that	|O
the	|O
crucial	|O
role	|O
of	|O
the	|O
mutations	|O
activating	|O
v	|B-PROTEIN
-	|I-PROTEIN
erbA	|I-PROTEIN
as	|O
an	|O
oncogene	|O
is	|O
to	|O
'	|O
freeze	|O
'	|O
c	|B-PROTEIN
-	|I-PROTEIN
ErbA	|I-PROTEIN
/	|O
TRalpha	|B-PROTEIN
in	|O
its	|O
non	|O
-	|O
liganded	|O
,	|O
repressive	|O
conformation	|O
and	|O
to	|O
facilitate	|O
its	|O
overexpression	|O
.	|O

Downregulation	|O
of	|O
FUS	|B-PROTEIN
expression	|O
in	|O
BCR	|B-PROTEIN
/	|O
ABL	|B-PROTEIN
-	|O
expressing	|O
32Dcl3	|O
cells	|O
was	|O
associated	|O
with	|O
suppression	|O
of	|O
growth	|O
factor	|O
-	|O
independent	|O
colony	|O
formation	|O
,	|O
restoration	|O
of	|O
G	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
-	|O
induced	|O
granulocytic	|O
differentiation	|O
and	|O
reduced	|O
tumorigenic	|O
potential	|O
in	|O
vivo	|O
.	|O

In	|O
this	|O
study	|O
,	|O
we	|O
describe	|O
a	|O
mammalian	|O
cell	|O
-	|O
free	|O
transcription	|O
system	|O
reconstituted	|O
with	|O
only	|O
recombinant	|O
proteins	|O
and	|O
epitope	|O
-	|O
tagged	|O
multiprotein	|O
complexes	|O
.	|O

This	|O
repressor	|O
is	|O
however	|O
unlikely	|O
to	|O
mediate	|O
spi	|B-PROTEIN
2.3	|O
3'	|O
UTR	|O
silencer	|O
action	|O
since	|O
it	|O
was	|O
not	|O
detected	|O
in	|O
rat	|O
hepatocytes	|O
.	|O

A	|O
prerequisite	|O
for	|O
the	|O
synthesis	|O
of	|O
sialylated	|O
glycoconjugates	|O
is	|O
the	|O
activated	|O
sugar	|O
-	|O
nucleotide	|O
cytidine	|O
5'	|O
-	|O
monophosphate	|O
N	|O
-	|O
acetylneuraminic	|O
acid	|O
(	|O
CMP	|O
-	|O
Neu5Ac	|O
)	|O
,	|O
which	|O
provides	|O
a	|O
substrate	|O
for	|O
Golgi	|O
sialyltransferases	|B-PROTEIN
.	|O

Thus	|O
,	|O
the	|O
bovine	|O
PEDF	|B-PROTEIN
cDNA	|O
isolated	|O
here	|O
codes	|O
for	|O
a	|O
functional	|O
soluble	|O
secreted	|O
PEDF	|B-PROTEIN
glycoprotein	|O
.	|O

We	|O
propose	|O
a	|O
model	|O
in	|O
which	|O
Sro7	|B-PROTEIN
function	|O
is	|O
involved	|O
in	|O
the	|O
targeting	|O
of	|O
the	|O
myosin	|B-PROTEIN
proteins	|O
to	|O
their	|O
intrinsic	|O
pathways	|O
.	|O

We	|O
found	|O
sequences	|O
related	|O
to	|O
this	|O
insertion	|O
in	|O
wild	|O
-	|O
type	|O
strains	|O
of	|O
N.	|O
crassa	|O
and	|O
other	|O
Neurospora	|O
species	|O
.	|O

When	|O
cysteine	|O
is	|O
scanned	|O
through	|O
the	|O
helices	|O
,	|O
characteristic	|O
repeating	|O
patterns	|O
of	|O
solvent	|O
exposure	|O
and	|O
burial	|O
are	|O
observed	|O
.	|O

Human	|O
ULK1	|B-PROTEIN
,	|O
a	|O
novel	|O
serine	|B-PROTEIN
/	|I-PROTEIN
threonine	|I-PROTEIN
kinase	|I-PROTEIN
related	|O
to	|O
UNC	|B-PROTEIN
-	|I-PROTEIN
51	|I-PROTEIN
kinase	|O
of	|O
Caenorhabditis	|O
elegans	|O
:	|O
cDNA	|O
cloning	|O
,	|O
expression	|O
,	|O
and	|O
chromosomal	|O
assignment	|O
.	|O

Specifically	|O
,	|O
I	|O
use	|O
molecular	|O
markers	|O
that	|O
identify	|O
particular	|O
neuroectodermal	|O
domains	|O
,	|O
all	|O
neuroblasts	|O
or	|O
individual	|O
neuroblasts	|O
,	|O
to	|O
show	|O
that	|O
in	|O
DER	|B-PROTEIN
mutant	|O
embryos	|O
(	|O
1	|O
)	|O
intermediate	|O
column	|O
neuroblasts	|O
do	|O
not	|O
form	|O
,	|O
(	|O
2	|O
)	|O
medial	|O
column	|O
neuroblasts	|O
often	|O
acquire	|O
identities	|O
inappropriate	|O
for	|O
their	|O
position	|O
,	|O
while	|O
(	|O
3	|O
)	|O
lateral	|O
neuroblasts	|O
develop	|O
normally	|O
.	|O

Cochlear	|O
microphonic	|O
potentials	|O
in	|O
patients	|O
with	|O
vestibular	|O
schwannomas	|O
.	|O

These	|O
results	|O
with	|O
clozapine	|O
illustrate	|O
that	|O
LI	|O
is	|O
sensitive	|O
to	|O
antipsychotics	|O
which	|O
differ	|O
in	|O
their	|O
mode	|O
of	|O
action	|O
and	|O
furthermore	|O
emphasize	|O
the	|O
value	|O
of	|O
LI	|O
as	|O
a	|O
test	|O
model	|O
for	|O
detecting	|O
the	|O
antipsychotic	|O
potential	|O
of	|O
novel	|O
drugs	|O
.	|O

The	|O
complement	|O
C3a	|B-PROTEIN
anaphylatoxin	|O
receptor	|O
(	|O
C3aR	|B-PROTEIN
)	|O
is	|O
a	|O
seven	|O
-	|O
transmembrane	|O
G	|B-PROTEIN
-	|I-PROTEIN
protein	|I-PROTEIN
coupled	|I-PROTEIN
chemoattractant	|I-PROTEIN
receptor	|I-PROTEIN
that	|O
on	|O
binding	|O
the	|O
C3a	|B-PROTEIN
peptide	|O
ligand	|O
mediates	|O
numerous	|O
cellular	|O
responses	|O
,	|O
including	|O
histamine	|O
release	|O
from	|O
mast	|O
cells	|O
.	|O
smooth	|O
muscle	|O
contraction	|O
,	|O
and	|O
the	|O
directed	|O
migration	|O
of	|O
eosinophils	|O
.	|O

CONCLUSIONS	|O
:	|O
Significant	|O
elevations	|O
of	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1alpha	|I-PROTEIN
and	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1beta	|I-PROTEIN
occur	|O
in	|O
patients	|O
with	|O
bacterial	|O
cystitis	|O
and	|O
microscopic	|O
hematuria	|O
.	|O

Band	|O
-	|O
shift	|O
assays	|O
were	|O
performed	|O
using	|O
the	|O
LPS	|B-PROTEIN
-	|I-PROTEIN
and	|I-PROTEIN
IL	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|I-PROTEIN
responsive	|I-PROTEIN
element	|I-PROTEIN
(	|O
LILRE	|B-PROTEIN
)	|O
oligonucleotide	|O
,	|O
a	|O
gamma	|B-PROTEIN
interferon	|I-PROTEIN
activation	|O
site	|O
-	|O
like	|O
site	|O
that	|O
is	|O
present	|O
in	|O
the	|O
human	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1beta	|I-PROTEIN
promoter	|O
.	|O

The	|O
C	|O
-	|O
terminal	|O
region	|O
contains	|O
the	|O
PTP	|B-PROTEIN
-	|O
like	|O
domain	|O
,	|O
whereas	|O
the	|O
N	|O
-	|O
terminal	|O
region	|O
shows	|O
no	|O
homology	|O
to	|O
any	|O
known	|O
mammalian	|O
protein	|O
.	|O

In	|O
addition	|O
,	|O
and	|O
in	|O
support	|O
of	|O
a	|O
mediating	|O
role	|O
of	|O
STATs	|B-PROTEIN
in	|O
the	|O
activation	|O
of	|O
the	|O
p21	|B-PROTEIN
promoter	|O
,	|O
overexpression	|O
of	|O
Stat3	|B-PROTEIN
potentiated	|O
the	|O
cytokine	|O
effect	|O
on	|O
the	|O
p21	|B-PROTEIN
promoter	|O
;	|O
whereas	|O
a	|O
dominant	|O
negative	|O
Stat3	|B-PROTEIN
,	|O
or	|O
a	|O
mutation	|O
of	|O
the	|O
STAT	|B-PROTEIN
response	|O
element	|O
on	|O
the	|O
promoter	|O
,	|O
significantly	|O
reduced	|O
the	|O
cytokine	|O
effect	|O
.	|O

The	|O
heterogeneous	|O
nuclear	|O
ribonucleoprotein	|O
C	|B-PROTEIN
protein	|I-PROTEIN
tetramer	|O
binds	|O
U1	|B-PROTEIN
,	|O
U2	|B-PROTEIN
,	|O
and	|O
U6	|B-PROTEIN
snRNAs	|O
through	|O
its	|O
high	|O
affinity	|O
RNA	|O
binding	|O
domain	|O
(	|O
the	|O
bZIP	|O
-	|O
like	|O
motif	|O
)	|O
.	|O

On	|O
the	|O
comparison	|O
of	|O
correlated	|O
proportions	|O
for	|O
clustered	|O
data	|O
.	|O

A	|O
safe	|O
and	|O
simple	|O
system	|O
for	|O
the	|O
detection	|O
of	|O
sudden	|O
infant	|O
death	|O
syndrome	|O
(	|O
SIDS	|O
)	|O
is	|O
proposed	|O
.	|O

The	|O
resulting	|O
mutants	|O
were	|O
coexpressed	|O
with	|O
gE	|B-PROTEIN
in	|O
the	|O
vaccinia	|O
virus	|O
-	|O
based	|O
vTF7	|O
-	|O
3	|O
system	|O
,	|O
and	|O
the	|O
formation	|O
and	|O
endoplasmic	|O
reticulum	|O
(	|O
ER	|O
)	|O
-	|O
to	|O
-	|O
Golgi	|O
transport	|O
of	|O
the	|O
hetero	|O
-	|O
oligomeric	|O
complex	|O
were	|O
monitored	|O
.	|O

Homozygous	|O
mutant	|O
mice	|O
,	|O
designated	|O
Cux	|B-PROTEIN
/	|O
CDPDeltaCR1	|B-PROTEIN
,	|O
display	|O
a	|O
phenotype	|O
characterized	|O
by	|O
curly	|O
vibrissae	|O
and	|O
wavy	|O
hair	|O
.	|O

The	|O
mutant	|O
protein	|O
is	|O
present	|O
at	|O
levels	|O
slightly	|O
greater	|O
than	|O
wild	|O
-	|O
type	|O
,	|O
but	|O
exhibits	|O
the	|O
same	|O
tissue	|O
distribution	|O
as	|O
wild	|O
-	|O
type	|O
protein	|O
,	|O
and	|O
has	|O
approximately	|O
normal	|O
affinity	|O
for	|O
known	|O
target	|O
sequences	|O
(	|O
though	|O
no	|O
DNA	|O
targets	|O
identified	|O
to	|O
date	|O
require	|O
the	|O
first	|O
cut	|O
repeat	|O
for	|O
binding	|O
)	|O
.	|O

METHODS	|O
:	|O
We	|O
retrospectively	|O
reviewed	|O
242	|O
adult	|O
cadaveric	|O
renal	|O
transplant	|O
recipients	|O
treated	|O
between	|O
11/91	|O
and	|O
5/97	|O
.	|O

The	|O
spectrum	|O
of	|O
age	|O
-	|O
associated	|O
brain	|O
abnormalities	|O
:	|O
their	|O
measurement	|O
and	|O
histopathological	|O
correlates	|O
.	|O

Our	|O
laboratory	|O
has	|O
recently	|O
identified	|O
two	|O
phosducin	|B-PROTEIN
-	|I-PROTEIN
like	|I-PROTEIN
orphan	|I-PROTEIN
proteins	|I-PROTEIN
(	|O
PhLOP1	|B-PROTEIN
and	|O
PhLOP2	|B-PROTEIN
)	|O
that	|O
lack	|O
the	|O
ability	|O
to	|O
interact	|O
with	|O
Gbetagamma	|B-PROTEIN
.	|O

Reverse	|B-PROTEIN
transcriptase	|I-PROTEIN
-	|O
polymerase	|O
chain	|O
reaction	|O
(	|O
RT	|B-PROTEIN
-	|O
PCR	|O
)	|O
was	|O
performed	|O
using	|O
eyestalk	|O
complementary	|O
DNA	|O
of	|O
the	|O
sand	|O
shrimp	|O
Metapenaeus	|O
ensis	|O
.	|O

In	|O
contrast	|O
,	|O
transcription	|O
initiating	|O
from	|O
opuE	|B-PROTEIN
P	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
(	|O
sigma	|B-PROTEIN
A	|I-PROTEIN
)	|O
rose	|O
in	|O
proportion	|O
to	|O
the	|O
external	|O
osmolarity	|O
and	|O
was	|O
maintained	|O
at	|O
high	|O
levels	|O
.	|O

Randomly	|O
selected	|O
300	|O
children	|O
aged	|O
3	|O
months	|O
-	|O
3	|O
yr	|O
were	|O
analysed	|O
over	|O
a	|O
period	|O
of	|O
one	|O
year	|O
for	|O
estimating	|O
prevalence	|O
of	|O
nutritional	|O
anaemia	|O
.	|O

In	|O
insects	|O
,	|O
arylalkylamine	|B-PROTEIN
N	|I-PROTEIN
-	|I-PROTEIN
acetyltransferases	|I-PROTEIN
(	|O
AANATs	|B-PROTEIN
)	|O
have	|O
been	|O
implicated	|O
in	|O
several	|O
physiological	|O
processes	|O
,	|O
including	|O
sclerotization	|O
,	|O
inactivation	|O
of	|O
certain	|O
neurotransmitters	|O
,	|O
and	|O
,	|O
similar	|O
to	|O
the	|O
function	|O
in	|O
vertebrates	|O
,	|O
catalysis	|O
of	|O
the	|O
rate	|O
-	|O
limiting	|O
step	|O
in	|O
melatonin	|O
biosynthesis	|O
.	|O

In	|O
experiments	|O
with	|O
the	|O
D1	|O
antagonist	|O
SCH	|O
23390	|O
,	|O
buprenorphine	|O
-	|O
induced	|O
depression	|O
was	|O
consistently	|O
blocked	|O
,	|O
but	|O
facilitation	|O
was	|O
unaffected	|O
.	|O

These	|O
results	|O
establish	|O
that	|O
hydroquinones	|O
lead	|O
to	|O
mutagenicity	|O
and	|O
carcinogenicity	|O
.	|O

IA	|O
-	|O
CT	|O
with	|O
cisplatin	|O
50	|O
mg	|O
and	|O
doxorubicin	|O
30	|O
mg	|O
was	|O
administered	|O
by	|O
one	|O
shot	|O
method	|O
in	|O
bilateral	|O
internal	|O
iliac	|O
arteries	|O
.	|O

Arnt3	|B-PROTEIN
mRNA	|O
was	|O
expressed	|O
in	|O
brain	|O
,	|O
skeletal	|O
muscle	|O
,	|O
13.5	|O
-	|O
day	|O
embryos	|O
,	|O
and	|O
P19	|O
cells	|O
treated	|O
with	|O
retinoic	|O
acid	|O
.	|O

Acute	|O
idiopathic	|O
thrombocytopenic	|O
purpura	|O
presenting	|O
a	|O
high	|O
serum	|O
level	|O
of	|O
immunoglobulin	|B-PROTEIN
E	|I-PROTEIN
and	|O
eosinophilia	|O
in	|O
an	|O
elderly	|O
patient	|O
.	|O

The	|O
genomic	|O
structure	|O
and	|O
chromosomal	|O
location	|O
of	|O
the	|O
human	|O
TR2	|B-PROTEIN
orphan	|O
receptor	|O
,	|O
a	|O
member	|O
of	|O
the	|O
steroid	|B-PROTEIN
receptor	|I-PROTEIN
superfamily	|O
.	|O

Correlation	|O
of	|O
skin	|O
disorders	|O
with	|O
CD4	|B-PROTEIN
lymphocyte	|O
counts	|O
in	|O
patients	|O
with	|O
HIV	|O
/	|O
AIDS	|O
.	|O

E2F	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
shares	|O
significant	|O
homology	|O
with	|O
E2Fs	|B-PROTEIN
1-5	|I-PROTEIN
,	|O
especially	|O
within	|O
the	|O
DNA	|O
binding	|O
,	|O
heterodimerization	|O
and	|O
marked	|O
box	|O
domains	|O
.	|O

The	|O
IE13.1	|O
cell	|O
line	|O
was	|O
able	|O
to	|O
complement	|O
a	|O
recombinant	|O
virus	|O
in	|O
which	|O
both	|O
copies	|O
of	|O
the	|O
IE	|B-PROTEIN
gene	|O
were	|O
replaced	|O
by	|O
insertion	|O
of	|O
the	|O
Escherichia	|O
coli	|O
lacZ	|B-PROTEIN
gene	|O
.	|O

DNase	|B-PROTEIN
I	|I-PROTEIN
footprinting	|O
and	|O
electrophoretic	|O
mobility	|O
shift	|O
analyses	|O
revealed	|O
two	|O
hepatocyte	|B-PROTEIN
nuclear	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
(	|O
HNF1	|B-PROTEIN
)	|O
,	|O
three	|O
CCAAT	|B-PROTEIN
/	|I-PROTEIN
enhancer	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
(	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
)	|O
,	|O
and	|O
one	|O
consensus	|O
palindromic	|O
thyroid	|O
hormone	|O
response	|O
elements	|O
within	|O
the	|O
first	|O
215	|O
base	|O
pairs	|O
(	|O
bp	|O
)	|O
of	|O
the	|O
promoter	|O
sequence	|O
of	|O
rat	|O
Std	|B-PROTEIN
.	|O

Thus	|O
,	|O
these	|O
studies	|O
on	|O
rat	|O
Std	|B-PROTEIN
promoter	|O
function	|O
indicate	|O
that	|O
(	|O
i	|O
)	|O
HNF1	|B-PROTEIN
and	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
are	|O
responsible	|O
for	|O
liver	|O
specificity	|O
of	|O
the	|O
rat	|O
Std	|B-PROTEIN
gene	|O
;	|O
(	|O
ii	|O
)	|O
androgenic	|O
repression	|O
of	|O
the	|O
gene	|O
requires	|O
the	|O
presence	|O
of	|O
all	|O
of	|O
the	|O
OCT	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
elements	|O
between	|O
positions	|O
-	|O
231	|O
and	|O
-	|O
292	|O
;	|O
and	|O
(	|O
iii	|O
)	|O
AR	|B-PROTEIN
may	|O
exert	|O
its	|O
negative	|O
regulatory	|O
effect	|O
indirectly	|O
through	|O
transcriptional	|O
interference	|O
of	|O
OCT	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
rather	|O
than	|O
through	|O
a	|O
direct	|O
DNA	|B-PROTEIN
-	|I-PROTEIN
AR	|I-PROTEIN
interaction	|O
.	|O

Purified	|O
Hsk1	|B-PROTEIN
phosphorylates	|O
the	|O
Cdc19	|B-PROTEIN
(	|O
Mcm2	|B-PROTEIN
)	|O
subunit	|O
of	|O
the	|O
six	|B-PROTEIN
-	|I-PROTEIN
member	|I-PROTEIN
minichromosome	|I-PROTEIN
maintenance	|I-PROTEIN
protein	|I-PROTEIN
complex	|I-PROTEIN
purified	|O
from	|O
fission	|O
yeast	|O
.	|O

The	|O
yeast	|O
MMS2	|B-PROTEIN
gene	|O
was	|O
cloned	|O
by	|O
its	|O
ability	|O
to	|O
complement	|O
the	|O
methyl	|O
methanesulfonate	|O
sensitivity	|O
of	|O
the	|O
mms2	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
mutant	|O
and	|O
was	|O
later	|O
shown	|O
to	|O
be	|O
involved	|O
in	|O
DNA	|O
post	|O
-	|O
replication	|O
repair	|O
.	|O

Expression	|O
of	|O
the	|O
human	|O
papillomavirus	|O
type	|O
11	|O
E5A	|B-PROTEIN
protein	|O
from	|O
the	|O
E1E4	|B-PROTEIN
,	|I-PROTEIN
E5	|I-PROTEIN
transcript	|O
.	|O

Anesthesia	|O
with	|O
M	|O
/	|O
K	|O
was	|O
reversed	|O
after	|O
41.6	|O
min	|O
of	|O
immobilization	|O
with	|O
atipamezole	|O
.	|O

There	|O
was	|O
no	|O
evident	|O
inciting	|O
agent	|O
of	|O
the	|O
disease	|O
.	|O

MK	|O
-	|O
801	|O
administration	|O
resulted	|O
in	|O
a	|O
biphasic	|O
response	|O
in	|O
seizure	|O
latency	|O
.	|O

In	|O
contrast	|O
,	|O
the	|O
distribution	|O
of	|O
endocytic	|O
markers	|O
is	|O
not	|O
affected	|O
.	|O

Toxicity	|O
during	|O
the	|O
therapeutic	|O
period	|O
was	|O
not	|O
significant	|O
in	|O
the	|O
study	|O
group	|O
compared	|O
with	|O
the	|O
historical	|O
control	|O
,	|O
treated	|O
with	|O
the	|O
same	|O
regimen	|O
without	|O
G	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
.	|O

The	|O
purpose	|O
of	|O
this	|O
article	|O
is	|O
to	|O
discuss	|O
the	|O
factors	|O
involved	|O
in	|O
the	|O
selection	|O
of	|O
antibodies	|O
,	|O
radionuclides	|O
and	|O
labeling	|O
methods	|O
in	|O
the	|O
development	|O
of	|O
radioimmunotherapy	|O
(	|O
RIT	|O
)	|O
for	|O
non	|O
-	|O
Hodgkin	|O
's	|O
lymphoma	|O
(	|O
NHL	|O
)	|O
from	|O
a	|O
single	|O
clinical	|O
study	|O
site	|O
through	|O
multicenter	|O
trials	|O
and	|O
commercialization	|O
.	|O

Both	|O
methods	|O
were	|O
employed	|O
for	|O
various	|O
focal	|O
-	|O
film	|O
distances	|O
,	|O
image	|O
intensifier	|O
tube	|O
modes	|O
and	|O
laser	|O
printer	|O
formats	|O
.	|O

The	|O
effect	|O
of	|O
Rho	|B-PROTEIN
on	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
independent	|O
of	|O
the	|O
mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
pathway	|O
,	|O
as	|O
a	|O
dominant	|O
-	|O
negative	|O
MEK	|B-PROTEIN
and	|O
a	|O
MEK	|B-PROTEIN
inhibitor	|O
(	|O
PD98059	|O
)	|O
did	|O
not	|O
affect	|O
Rho	|B-PROTEIN
-	|O
induced	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
activity	|O
.	|O

Site	|O
-	|O
directed	|O
mutagenesis	|O
of	|O
residues	|O
in	|O
this	|O
domain	|O
(	|O
R82A	|O
,	|O
K85A	|O
,	|O
K88A	|O
,	|O
and	|O
V89A	|O
)	|O
resulted	|O
in	|O
proteins	|O
which	|O
failed	|O
to	|O
transactivate	|O
from	|O
the	|O
HTLV	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
LTR	|I-PROTEIN
in	|O
vivo	|O
.	|O

Mutations	|O
within	|O
the	|O
C	|O
terminus	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
at	|O
serine	|O
residues	|O
that	|O
are	|O
phosphorylation	|O
targets	|O
for	|O
growth	|O
factors	|O
and	|O
MAP	|B-PROTEIN
kinase	|I-PROTEIN
completely	|O
abrogate	|O
transactivation	|O
and	|O
block	|O
potentiation	|O
by	|O
MAP	|B-PROTEIN
kinase	|I-PROTEIN
.	|O

In	|O
the	|O
former	|O
cells	|O
,	|O
ets	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
was	|O
a	|O
CSF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
immediate	|O
-	|O
early	|O
response	|O
gene	|O
,	|O
and	|O
phosphorylated	|O
ets	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
was	|O
detected	|O
after	|O
2	|O
to	|O
4	|O
h	|O
,	|O
coincident	|O
with	|O
expression	|O
of	|O
ets	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
protein	|O
.	|O

Persistent	|O
activation	|O
of	|O
mitogen	|O
-	|O
activated	|O
protein	|O
kinases	|O
p42	|B-PROTEIN
and	|O
p44	|B-PROTEIN
and	|O
ets	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
phosphorylation	|O
in	|O
response	|O
to	|O
colony	|B-PROTEIN
-	|I-PROTEIN
stimulating	|I-PROTEIN
factor	|I-PROTEIN
1	|I-PROTEIN
/	|O
c	|B-PROTEIN
-	|I-PROTEIN
fms	|I-PROTEIN
signaling	|O
.	|O

Identification	|O
of	|O
a	|O
proline	|O
-	|O
rich	|O
sequence	|O
in	|O
the	|O
CD2	|B-PROTEIN
cytoplasmic	|O
domain	|O
critical	|O
for	|O
regulation	|O
of	|O
integrin	|B-PROTEIN
-	|O
mediated	|O
adhesion	|O
and	|O
activation	|O
of	|O
phosphoinositide	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
.	|O

Vam7p	|B-PROTEIN
,	|O
a	|O
SNAP	|B-PROTEIN
-	|I-PROTEIN
25	|I-PROTEIN
-	|O
like	|O
molecule	|O
,	|O
and	|O
Vam3p	|B-PROTEIN
,	|O
a	|O
syntaxin	|B-PROTEIN
homolog	|O
,	|O
function	|O
together	|O
in	|O
yeast	|O
vacuolar	|O
protein	|O
trafficking	|O
.	|O

We	|O
have	|O
tested	|O
this	|O
possibility	|O
by	|O
constructing	|O
a	|O
consecutive	|O
series	|O
of	|O
cysteine	|O
substitutions	|O
in	|O
the	|O
Neu	|B-PROTEIN
juxtamembrane	|O
domain	|O
in	|O
order	|O
to	|O
force	|O
dimerization	|O
along	|O
a	|O
series	|O
of	|O
interreceptor	|O
faces	|O
.	|O

It	|O
has	|O
been	|O
demonstrated	|O
previously	|O
that	|O
Pax	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
,	|O
a	|O
paired	|B-PROTEIN
domain	|I-PROTEIN
(	|O
PD	|B-PROTEIN
)	|O
/	|O
homeodomain	|B-PROTEIN
(	|O
HD	|B-PROTEIN
)	|O
transcription	|O
factor	|O
critical	|O
for	|O
eye	|O
development	|O
,	|O
contributes	|O
to	|O
the	|O
activation	|O
of	|O
the	|O
alphaB	|B-PROTEIN
-	|I-PROTEIN
,	|I-PROTEIN
alphaA	|I-PROTEIN
-	|I-PROTEIN
,	|I-PROTEIN
delta1	|I-PROTEIN
-	|I-PROTEIN
,	|I-PROTEIN
and	|I-PROTEIN
zeta	|I-PROTEIN
-	|I-PROTEIN
crystallin	|I-PROTEIN
genes	|O
in	|O
the	|O
lens	|O
.	|O

Tctex	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
binding	|O
required	|O
the	|O
first	|O
19	|O
amino	|O
acids	|O
of	|O
Fyn	|B-PROTEIN
and	|O
integrity	|O
of	|O
two	|O
lysine	|O
residues	|O
within	|O
this	|O
sequence	|O
that	|O
were	|O
previously	|O
shown	|O
to	|O
be	|O
important	|O
for	|O
Fyn	|B-PROTEIN
interactions	|O
with	|O
the	|O
immunoreceptor	|O
tyrosine	|O
-	|O
based	|O
activation	|O
motifs	|O
(	|O
ITAMs	|O
)	|O
of	|O
lymphocyte	|O
Ag	|B-PROTEIN
receptors	|I-PROTEIN
.	|O

The	|O
prothrombin	|B-PROTEIN
gene	|O
G20210A	|O
mutation	|O
is	|O
not	|O
found	|O
among	|O
Japanese	|O
patients	|O
with	|O
deep	|O
vein	|O
thrombosis	|O
and	|O
healthy	|O
individuals	|O
.	|O

Transcriptional	|O
regulation	|O
of	|O
the	|O
GluR2	|B-PROTEIN
gene	|O
:	|O
neural	|O
-	|O
specific	|O
expression	|O
,	|O
multiple	|O
promoters	|O
,	|O
and	|O
regulatory	|O
elements	|O
.	|O

The	|O
binding	|O
of	|O
NF	|B-PROTEIN
-	|I-PROTEIN
ATp	|I-PROTEIN
,	|O
although	|O
not	|O
NF	|B-PROTEIN
-	|I-PROTEIN
AT4	|I-PROTEIN
,	|O
to	|O
this	|O
enhancer	|O
also	|O
occurs	|O
along	|O
with	|O
HTLV	|O
-	|O
I	|O
-	|O
mediated	|O
infection	|O
of	|O
human	|O
peripheral	|O
blood	|O
T	|O
-	|O
cells	|O
.	|O

Thus	|O
,	|O
TRAF2	|B-PROTEIN
initiates	|O
SAPK	|B-PROTEIN
and	|O
p38	|B-PROTEIN
activation	|O
by	|O
binding	|O
two	|O
proximal	|O
protein	|O
kinases	|O
:	|O
GCK	|B-PROTEIN
and	|O
RIP	|B-PROTEIN
.	|O

Tumor	|B-PROTEIN
necrosis	|I-PROTEIN
factor	|I-PROTEIN
signaling	|O
to	|O
stress	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
SAPK	|B-PROTEIN
)	|O
/	|O
Jun	|B-PROTEIN
NH2	|I-PROTEIN
-	|I-PROTEIN
terminal	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
JNK	|B-PROTEIN
)	|O
and	|O
p38	|B-PROTEIN
.	|O

The	|O
activity	|O
of	|O
the	|O
minimal	|O
promoter	|O
was	|O
found	|O
to	|O
be	|O
controlled	|O
by	|O
a	|O
combination	|O
of	|O
the	|O
activities	|O
of	|O
the	|O
transcription	|O
factors	|O
Sp1	|B-PROTEIN
,	|O
Sp3	|B-PROTEIN
,	|O
and	|O
NF	|B-PROTEIN
-	|I-PROTEIN
Y.	|I-PROTEIN

In	|O
the	|O
studies	|O
described	|O
in	|O
this	|O
report	|O
,	|O
we	|O
have	|O
investigated	|O
the	|O
signaling	|O
pathway	|O
(	|O
s	|O
)	|O
that	|O
are	|O
responsible	|O
for	|O
CREB	|B-PROTEIN
activation	|O
in	|O
normal	|O
T	|O
cells	|O
.	|O

Respondents	|O
who	|O
lived	|O
with	|O
a	|O
spouse	|O
/	|O
partner	|O
only	|O
were	|O
less	|O
likely	|O
to	|O
have	|O
an	|O
unfavorable	|O
BMI	|O
status	|O
than	|O
people	|O
in	|O
the	|O
other	|O
two	|O
groups	|O
.	|O

Isolation	|O
of	|O
a	|O
novel	|O
TP53	|B-PROTEIN
target	|O
gene	|O
from	|O
a	|O
colon	|O
cancer	|O
cell	|O
line	|O
carrying	|O
a	|O
highly	|O
regulated	|O
wild	|O
-	|O
type	|O
TP53	|B-PROTEIN
expression	|O
system	|O
.	|O

Overexpression	|O
of	|O
MDR1	|B-PROTEIN
has	|O
been	|O
demonstrated	|O
in	|O
many	|O
cancers	|O
,	|O
both	|O
in	|O
patient	|O
tumors	|O
and	|O
in	|O
cell	|O
lines	|O
selected	|O
with	|O
a	|O
variety	|O
of	|O
chemotherapeutic	|O
agents	|O
.	|O

Cytogenetic	|O
and	|O
molecular	|O
characterization	|O
of	|O
random	|O
chromosomal	|O
rearrangements	|O
activating	|O
the	|O
drug	|O
resistance	|O
gene	|O
,	|O
MDR1	|B-PROTEIN
/	|I-PROTEIN
P	|I-PROTEIN
-	|I-PROTEIN
glycoprotein	|I-PROTEIN
,	|O
in	|O
drug	|O
-	|O
selected	|O
cell	|O
lines	|O
and	|O
patients	|O
with	|O
drug	|O
refractory	|O
ALL	|O
.	|O

BACKGROUND	|O
:	|O
It	|O
is	|O
generally	|O
accepted	|O
that	|O
smoking	|O
increases	|O
blood	|O
pressure	|O
and	|O
inhibits	|O
muscle	|O
sympathetic	|O
nerve	|O
activity	|O
(	|O
SNA	|O
)	|O
.	|O

When	|O
the	|O
blood	|O
pressure	|O
increase	|O
in	|O
response	|O
to	|O
smoking	|O
was	|O
blunted	|O
by	|O
nitroprusside	|O
infusion	|O
,	|O
there	|O
was	|O
a	|O
striking	|O
increase	|O
in	|O
muscle	|O
SNA	|O
.	|O

After	|O
that	|O
report	|O
,	|O
carboxypeptidase	|B-PROTEIN
D	|I-PROTEIN
(	|O
CPD	|B-PROTEIN
)	|O
was	|O
subsequently	|O
purified	|O
from	|O
bovine	|O
pituitary	|O
and	|O
characterized	|O
as	|O
a	|O
novel	|O
carboxypeptidase	|B-PROTEIN
E	|I-PROTEIN
(	|O
CPE	|B-PROTEIN
)	|O
-	|O
like	|O
enzyme	|O
,	|O
with	|O
many	|O
characteristics	|O
in	|O
common	|O
with	|O
duck	|O
gp180	|B-PROTEIN
(	|O
Song	|O
,	|O
L.	|O
,	|O
Fricker	|O
,	|O
L.D.	|O
,	|O
1995	|O
.	|O

RA	|O
-	|O
treatment	|O
of	|O
these	|O
transfectants	|O
induced	|O
morphologic	|O
and	|O
immunophenotypic	|O
maturation	|O
,	|O
changes	|O
in	|O
RA	|O
-	|O
regulated	|O
genes	|O
,	|O
and	|O
a	|O
G1	|O
cell	|O
cycle	|O
arrest	|O
in	|O
a	|O
manner	|O
similar	|O
to	|O
parental	|O
NT2	|O
/	|O
D1	|O
cells	|O
.	|O

The	|O
histopathology	|O
and	|O
neovascularization	|O
did	|O
not	|O
appreciably	|O
differ	|O
between	|O
xenograft	|O
tumors	|O
derived	|O
from	|O
FGF4	|B-PROTEIN
over	|O
-	|O
expressing	|O
versus	|O
control	|O
transfectants	|O
.	|O

For	|O
smaller	|O
vessels	|O
up	|O
to	|O
a	|O
diameter	|O
of	|O
0.5	|O
mm	|O
,	|O
treatments	|O
at	|O
16	|O
and	|O
18	|O
J	|O
/	|O
cm2	|O
showed	|O
good	|O
results	|O
in	|O
60	|O
and	|O
82%	|O
respectively	|O
;	|O
for	|O
vessels	|O
up	|O
to	|O
1	|O
mm	|O
in	|O
27	|O
and	|O
33%	|O
.	|O

Pressure	|O
ulcers	|O
.	|O

RXR	|B-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
expression	|O
produced	|O
significant	|O
reduction	|O
in	|O
levels	|O
of	|O
RA	|O
-	|O
responsive	|O
genes	|O
including	|O
the	|O
cyclin	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
kinase	|I-PROTEIN
inhibitors	|O
p21Cip1	|B-PROTEIN
/	|O
WAF1	|B-PROTEIN
and	|O
p27Kip1	|B-PROTEIN
,	|O
resulting	|O
in	|O
increased	|O
cdc2	|B-PROTEIN
and	|O
cdk2	|B-PROTEIN
kinase	|O
activity	|O
and	|O
RB	|B-PROTEIN
phosphorylation	|O
.	|O

TBP	|B-PROTEIN
can	|O
be	|O
phosphorylated	|O
in	|O
vitro	|O
by	|O
extracts	|O
of	|O
U937	|O
cells	|O
or	|O
by	|O
bacterially	|O
expressed	|O
activated	|O
ERK2	|B-PROTEIN
;	|O
the	|O
phosphorylation	|O
sites	|O
were	|O
mapped	|O
to	|O
ERK	|B-PROTEIN
kinase	|I-PROTEIN
consensus	|O
sites	|O
in	|O
the	|O
TBP	|B-PROTEIN
amino	|O
-	|O
terminal	|O
domain	|O
.	|O

During	|O
the	|O
CR	|O
/	|O
PP	|O
diet	|O
only	|O
the	|O
HS	|O
subjects	|O
did	|O
not	|O
show	|O
the	|O
stress	|O
-	|O
induced	|O
rise	|O
in	|O
depression	|O
,	|O
decline	|O
in	|O
vigour	|O
and	|O
cortisol	|O
elevation	|O
that	|O
they	|O
showed	|O
after	|O
the	|O
PR	|O
/	|O
CP	|O
diet	|O
.	|O

Generally	|O
ILC	|O
and	|O
ILVF	|O
values	|O
decreased	|O
with	|O
increasing	|O
exposure	|O
time	|O
with	|O
rate	|O
constants	|O
ranging	|O
from	|O
0.03	|O
to	|O
0.33	|O
day	|O
-	|O
1	|O
(	|O
wet	|O
and	|O
lipid	|O
weight	|O
)	|O
for	|O
ILC	|O
and	|O
0.03	|O
to	|O
0.31	|O
day	|O
-	|O
1	|O
for	|O
ILVF	|O
.	|O

These	|O
sequence	|O
analyses	|O
suggest	|O
that	|O
xIRS	|B-PROTEIN
-	|I-PROTEIN
u	|I-PROTEIN
is	|O
a	|O
novel	|O
member	|O
of	|O
the	|O
IRS	|B-PROTEIN
family	|O
rather	|O
than	|O
a	|O
Xenopus	|O
homolog	|O
of	|O
an	|O
existing	|O
member	|O
.	|O

The	|O
present	|O
study	|O
sought	|O
to	|O
develop	|O
an	|O
equation	|O
to	|O
estimate	|O
VO2peak	|O
in	|O
peripheral	|O
arterial	|O
occlusive	|O
disease	|O
(	|O
PAOD	|O
)	|O
patients	|O
with	|O
intermittent	|O
claudication	|O
and	|O
to	|O
determine	|O
independent	|O
predictors	|O
of	|O
VO2peak	|O
in	|O
this	|O
population	|O
.	|O

Evidence	|O
for	|O
a	|O
novel	|O
MAPKKK	|B-PROTEIN
-	|O
independent	|O
pathway	|O
controlling	|O
the	|O
stress	|O
activated	|O
Sty1	|B-PROTEIN
/	|O
Spc1	|B-PROTEIN
MAP	|O
kinase	|O
in	|O
fission	|O
yeast	|O
.	|O

The	|O
Abbreviated	|O
Injury	|O
Scale	|O
(	|O
AIS	|O
)	|O
,	|O
Injury	|O
Severity	|O
Scale	|O
and	|O
TRISS	|O
methodology	|O
comprise	|O
a	|O
mathematically	|O
sound	|O
system	|O
for	|O
the	|O
analysis	|O
of	|O
injuries	|O
and	|O
injured	|O
patients	|O
.	|O

This	|O
hypothesis	|O
was	|O
tested	|O
by	|O
introducing	|O
mutations	|O
at	|O
each	|O
of	|O
the	|O
three	|O
histidine	|O
pairs	|O
,	|O
the	|O
H382	|O
-	|O
X2	|O
-	|O
H385	|O
pair	|O
,	|O
the	|O
H411	|O
-	|O
X2	|O
-	|O
H414	|O
pair	|O
and	|O
the	|O
H430	|O
-	|O
X5	|O
-	|O
H436	|O
pair	|O
,	|O
which	|O
constitute	|O
the	|O
histidine	|O
-	|O
rich	|O
region	|O
near	|O
the	|O
C	|O
terminus	|O
of	|O
gp17	|B-PROTEIN
.	|O

Using	|O
backcross	|O
analysis	|O
,	|O
both	|O
exons	|O
1	|O
and	|O
4	|O
mapped	|O
to	|O
a	|O
proximal	|O
region	|O
of	|O
murine	|O
Chromosome	|O
4	|O
indistinguishable	|O
from	|O
the	|O
vacillans	|B-PROTEIN
gene	|O
.	|O

Seventy	|O
-	|O
five	|O
percent	|O
of	|O
children	|O
who	|O
received	|O
a	|O
second	|O
transplant	|O
for	|O
HCV	|O
hepatitis	|O
had	|O
early	|O
histologic	|O
recurrence	|O
that	|O
led	|O
to	|O
liver	|O
failure	|O
and	|O
death	|O
.	|O

However	|O
,	|O
both	|O
TPN	|O
groups	|O
showed	|O
a	|O
marked	|O
increase	|O
in	|O
activities	|O
of	|O
liver	|O
lysosomal	|B-PROTEIN
enzymes	|I-PROTEIN
.	|O

Regulation	|O
of	|O
embryonic	|O
growth	|O
and	|O
lysosomal	|O
targeting	|O
by	|O
the	|O
imprinted	|O
Igf2	|B-PROTEIN
/	|O
Mpr	|B-PROTEIN
gene	|O
.	|O

Furthermore	|O
,	|O
we	|O
demonstrated	|O
that	|O
Galpha11	|B-PROTEIN
Q209L	|I-PROTEIN
stimulated	|O
Src	|B-PROTEIN
family	|O
kinase	|O
activity	|O
and	|O
induced	|O
tyrosine	|O
phosphorylation	|O
of	|O
several	|O
proteins	|O
in	|O
HEK	|O
-	|O
293	|O
cells	|O
.	|O

The	|O
micturition	|O
pressure	|O
was	|O
significantly	|O
decreased	|O
only	|O
after	|O
injection	|O
with	|O
BUP	|O
-	|O
4	|O
in	|O
both	|O
normal	|O
and	|O
obstructed	|O
rats	|O
.	|O

Peroxisome	|B-PROTEIN
proliferator	|I-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
receptors	|I-PROTEIN
(	|O
PPAR	|B-PROTEIN
)	|O
modulate	|O
transcription	|O
by	|O
binding	|O
to	|O
specific	|O
peroxisome	|O
proliferator	|O
-	|O
response	|O
elements	|O
(	|O
PPRE	|O
)	|O
through	|O
heterodimerization	|O
with	|O
the	|O
9	|B-PROTEIN
-	|I-PROTEIN
cis	|I-PROTEIN
retinoic	|I-PROTEIN
acid	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
RXR	|B-PROTEIN
)	|O
.	|O

Furthermore	|O
,	|O
early	|O
-	|O
and	|O
late	|O
-	|O
firing	|O
origins	|O
differ	|O
not	|O
in	|O
the	|O
timing	|O
of	|O
their	|O
recruitment	|O
of	|O
an	|O
Mcm	|B-PROTEIN
protein	|O
,	|O
but	|O
in	|O
the	|O
timing	|O
of	|O
RPA	|B-PROTEIN
's	|O
recruitment	|O
.	|O

Thus	|O
,	|O
in	|O
the	|O
presence	|O
of	|O
active	|O
S	|B-PROTEIN
-	|I-PROTEIN
CDKs	|I-PROTEIN
and	|O
Dbf4	|B-PROTEIN
/	|O
Cdc7	|B-PROTEIN
,	|O
Mcms	|B-PROTEIN
may	|O
open	|O
origins	|O
and	|O
thereby	|O
facilitate	|O
the	|O
loading	|O
of	|O
RPA	|B-PROTEIN
.	|O

Tyrosine	|O
phosphorylated	|O
STATs	|B-PROTEIN
dimerize	|O
and	|O
translocate	|O
into	|O
the	|O
nucleus	|O
to	|O
activate	|O
specific	|O
genes	|O
.	|O

Nonsynonymous	|O
substitution	|O
in	|O
abalone	|O
sperm	|O
fertilization	|O
genes	|O
exceeds	|O
substitution	|O
in	|O
introns	|O
and	|O
mitochondrial	|O
DNA	|O
.	|O

Gel	|O
retardation	|O
assays	|O
detected	|O
ZiaR	|B-PROTEIN
-	|O
dependent	|O
complexes	|O
forming	|O
with	|O
the	|O
zia	|B-PROTEIN
operator	|O
-	|O
promoter	|O
and	|O
ZiaR	|B-PROTEIN
-	|O
DNA	|O
binding	|O
was	|O
enhanced	|O
by	|O
treatment	|O
with	|O
a	|O
metal	|O
-	|O
chelator	|O
in	|O
vitro	|O
.	|O

CONCLUSION	|O
:	|O
Although	|O
quantitative	|O
and	|O
qualitative	|O
criteria	|O
for	|O
diagnosing	|O
fatty	|O
liver	|O
on	|O
helical	|O
CT	|O
can	|O
be	|O
determined	|O
,	|O
they	|O
are	|O
protocol	|O
-	|O
specific	|O
.	|O

The	|O
PC	|O
-	|O
based	|O
RTPS	|O
is	|O
designed	|O
to	|O
run	|O
in	|O
the	|O
Microsoft	|O
Windows	|O
3.11	|O
environment	|O
(	|O
and	|O
later	|O
versions	|O
)	|O
,	|O
for	|O
computers	|O
equipped	|O
with	|O
486	|O
or	|O
Pentium	|O
processors	|O
.	|O

Alternatively	|O
,	|O
the	|O
similarity	|O
in	|O
apparent	|O
regulatory	|O
action	|O
of	|O
the	|O
genes	|O
may	|O
indicate	|O
allelic	|O
differences	|O
wherein	|O
the	|O
IS1112C	|B-PROTEIN
Rf3	|O
allele	|O
may	|O
differ	|O
from	|O
alleles	|O
of	|O
maintainer	|O
lines	|O
by	|O
the	|O
capability	|O
to	|O
regulate	|O
both	|O
orf107	|B-PROTEIN
and	|O
urf209	|B-PROTEIN
processing	|O
activities	|O
.	|O

JCAHO	|O
revised	|O
interpretation	|O

Molecular	|O
cloning	|O
and	|O
functional	|O
characterization	|O
of	|O
murine	|O
sphingosine	|B-PROTEIN
kinase	|I-PROTEIN
.	|O

A	|O
human	|O
SPT3	|B-PROTEIN
-	|O
TAFII31	|B-PROTEIN
-	|O
GCN5	|B-PROTEIN
-	|O
L	|B-PROTEIN
acetylase	|I-PROTEIN
complex	|O
distinct	|O
from	|O
transcription	|B-PROTEIN
factor	|I-PROTEIN
IID	|I-PROTEIN
.	|O

Oleate	|O
induced	|O
steady	|O
-	|O
state	|O
levels	|O
of	|O
M	|B-PROTEIN
-	|I-PROTEIN
CPT	|I-PROTEIN
I	|I-PROTEIN
mRNA	|O
4.5	|O
-	|O
fold	|O
.	|O

Mapping	|O
of	|O
the	|O
DNA	|O
binding	|O
domain	|O
of	|O
the	|O
copper	|O
-	|O
responsive	|O
transcription	|O
factor	|O
Mac1	|B-PROTEIN
from	|O
Saccharomyces	|O
cerevisiae	|O
.	|O

A	|O
further	|O
mechanism	|O
increasing	|O
specific	|O
activation	|O
was	|O
cooperation	|O
of	|O
receptors	|O
at	|O
multiple	|O
and	|O
weak	|O
HREs	|O
,	|O
which	|O
was	|O
accentuated	|O
in	|O
the	|O
presence	|O
of	|O
both	|O
the	|O
AR	|B-PROTEIN
N	|O
terminus	|O
and	|O
ligand	|O
binding	|O
domain	|O
.	|O

Previously	|O
,	|O
we	|O
characterized	|O
a	|O
DNA	|O
-	|O
binding	|O
protein	|O
,	|O
HS2NF5	|B-PROTEIN
,	|O
that	|O
bound	|O
tightly	|O
to	|O
a	|O
conserved	|O
region	|O
within	|O
hypersensitive	|O
site	|O
2	|O
(	|O
HS2	|O
)	|O
of	|O
the	|O
human	|O
beta	|B-PROTEIN
-	|I-PROTEIN
globin	|I-PROTEIN
locus	|O
control	|O
region	|O
(	|O
LCR	|O
)	|O
(	|O
Lam	|O
,	|O
L.	|O

The	|O
CBF1	|B-PROTEIN
site	|O
within	|O
HS2	|O
resides	|O
near	|O
sites	|O
for	|O
hematopoietic	|O
regulators	|O
such	|O
as	|O
GATA	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
NF	|B-PROTEIN
-	|I-PROTEIN
E2	|I-PROTEIN
,	|O
and	|O
TAL1	|B-PROTEIN
.	|O

The	|O
rat	|O
branched	|O
-	|O
chain	|O
-	|O
2	|O
-	|O
oxo	|O
-	|O
acid	|O
dehydrogenase	|O
(	|B-PROTEIN
BCOD	|I-PROTEIN
)	|I-PROTEIN
kinase	|I-PROTEIN
mRNA	|O
is	|O
transcribed	|O
from	|O
a	|O
TATA	|O
-	|O
less	|O
promoter	|O
that	|O
has	|O
GC	|O
-	|O
rich	|O
sequences	|O
and	|O
two	|O
putative	|O
Sp1	|B-PROTEIN
binding	|O
sites	|O
near	|O
the	|O
transcription	|O
start	|O
site	|O
.	|O

Co	|O
-	|O
transfection	|O
of	|O
the	|O
Sp1	|B-PROTEIN
expression	|O
plasmid	|O
and	|O
the	|O
-	|O
58	|O
promoter	|O
construct	|O
into	|O
Drosophila	|O
Schneider	|O
cells	|O
revealed	|O
that	|O
Sp1	|B-PROTEIN
contributed	|O
to	|O
the	|O
kinase	|O
basal	|O
promoter	|O
activity	|O
by	|O
binding	|O
to	|O
the	|O
non	|O
-	|O
consensus	|O
site	|O
in	|O
the	|O
-	|O
58	|O
region	|O
.	|O

Until	|O
such	|O
investigations	|O
are	|O
performed	|O
,	|O
we	|O
conclude	|O
that	|O
the	|O
role	|O
for	|O
adjuvant	|O
treatment	|O
is	|O
questionable	|O
and	|O
that	|O
TME	|O
surgery	|O
is	|O
preferred	|O
as	|O
the	|O
treatment	|O
option	|O
for	|O
Stage	|O
T1	|O
-	|O
T3	|O
rectal	|O
cancers	|O
.	|O

Likewise	|O
,	|O
at	|O
150	|O
degrees	|O
C	|O
with	|O
2%	|O
APS	|O
the	|O
surface	|O
density	|O
of	|O
NH2	|O
groups	|O
reached	|O
a	|O
maximum	|O
at	|O
24	|O
hr	|O
and	|O
remained	|O
relatively	|O
constant	|O
up	|O
to	|O
96	|O
hr	|O
.	|O

Taken	|O
together	|O
,	|O
these	|O
results	|O
suggest	|O
that	|O
the	|O
cooperation	|O
of	|O
transcription	|O
factors	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
and	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
essential	|O
for	|O
transactivation	|O
of	|O
IL	|B-PROTEIN
-	|I-PROTEIN
8	|I-PROTEIN
gene	|O
by	|O
HTLV	|O
-	|O
I	|O
Tax	|B-PROTEIN
.	|O

This	|O
study	|O
examines	|O
the	|O
cooperative	|O
effects	|O
of	|O
a	|O
human	|O
estrogen	|B-PROTEIN
receptor	|I-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
(	|O
ERalpha	|B-PROTEIN
)	|O
isoform	|O
on	|O
estrogen	|O
(	|O
E2	|O
)	|O
-	|O
mediated	|O
gene	|O
activation	|O
in	|O
U2	|O
-	|O
OS	|O
osteosarcoma	|O
cells	|O
.	|O

Transfection	|O
of	|O
increasing	|O
amounts	|O
of	|O
delta5ERalpha	|B-PROTEIN
expression	|O
vector	|O
into	|O
[	|O
ERalpha+	|B-PROTEIN
]	|O
OS	|O
cells	|O
resulted	|O
in	|O
potentiation	|O
of	|O
E2	|O
-	|O
stimulated	|O
ERELuc	|B-PROTEIN
activity	|O
in	|O
a	|O
synergistic	|O
,	|O
dose	|O
-	|O
dependent	|O
manner	|O
.	|O

Studies	|O
using	|O
the	|O
yeast	|O
two	|O
-	|O
hybrid	|O
system	|O
also	|O
did	|O
not	|O
provide	|O
evidence	|O
for	|O
the	|O
formation	|O
of	|O
a	|O
VDR	|B-PROTEIN
-	|O
TR	|B-PROTEIN
protein	|O
-	|O
protein	|O
interaction	|O
.	|O

Our	|O
results	|O
show	|O
that	|O
,	|O
from	|O
a	|O
thermodynamical	|O
standpoint	|O
,	|O
melatonin	|O
may	|O
directly	|O
scavenge	|O
hydroxyl	|O
radicals	|O
both	|O
in	|O
vacuum	|O
and	|O
in	|O
aqueous	|O
solution	|O
.	|O

This	|O
sequence	|O
,	|O
Thr	|O
-	|O
Gly	|O
-	|O
X	|O
-	|O
X	|O
-	|O
Gly	|O
-	|O
Asp	|O
-	|O
Gly	|O
-	|O
Lys	|O
-	|O
Ile	|O
-	|O
Phe	|O
,	|O
forms	|O
part	|O
of	|O
the	|O
B	|O
-	|O
loop	|O
and	|O
is	|O
conserved	|O
in	|O
a	|O
wide	|O
variety	|O
of	|O
organisms	|O
that	|O
include	|O
bacteria	|O
,	|O
algae	|O
and	|O
archeabacteria	|O
.	|O

We	|O
did	|O
not	|O
observe	|O
any	|O
changes	|O
in	|O
Bcl	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
or	|O
Bcl	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
-	|O
related	|O
proteins	|O
(	|O
Bcl	|B-PROTEIN
-	|I-PROTEIN
x	|I-PROTEIN
,	|O
Bax	|B-PROTEIN
,	|O
and	|O
Bad	|B-PROTEIN
)	|O
in	|O
control	|O
or	|O
KCREB	|B-PROTEIN
-	|O
transfected	|O
cells	|O
before	|O
or	|O
after	|O
treatment	|O
with	|O
Tg	|O
.	|O

Tyrosine	|O
112	|O
of	|O
latent	|B-PROTEIN
membrane	|I-PROTEIN
protein	|I-PROTEIN
2A	|I-PROTEIN
is	|O
essential	|O
for	|O
protein	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
loading	|O
and	|O
regulation	|O
of	|O
Epstein	|O
-	|O
Barr	|O
virus	|O
latency	|O
.	|O

The	|O
only	|O
abundant	|O
viral	|O
transcript	|O
expressed	|O
during	|O
latency	|O
is	|O
the	|O
latency	|B-PROTEIN
-	|I-PROTEIN
related	|I-PROTEIN
(	|O
LR	|B-PROTEIN
)	|O
RNA	|O
.	|O

To	|O
improve	|O
test	|O
efficiency	|O
,	|O
we	|O
modified	|O
our	|O
previously	|O
introduced	|O
contrast	|O
/	|O
color	|O
card	|O
test	|O
by	|O
including	|O
a	|O
patterned	|O
test	|O
stimulus	|O
and	|O
reducing	|O
the	|O
number	|O
of	|O
stimuli	|O
in	|O
both	|O
experimental	|O
phases	|O
.	|O

The	|O
defect	|O
in	|O
these	|O
proteins	|O
was	|O
also	|O
uniformly	|O
suppressed	|O
by	|O
either	|O
Mn2+	|O
,	|O
or	|O
the	|O
Mu	|O
B	|B-PROTEIN
protein	|I-PROTEIN
in	|O
the	|O
presence	|O
of	|O
ATP	|O
and	|O
target	|O
DNA	|O
.	|O

Using	|O
homology	|O
cloning	|O
techniques	|O
,	|O
we	|O
identified	|O
a	|O
mouse	|O
homologue	|O
of	|O
E	|B-PROTEIN
(	|I-PROTEIN
Pc	|I-PROTEIN
)	|I-PROTEIN
,	|O
termed	|O
Epc1	|B-PROTEIN
,	|O
a	|O
yeast	|O
protein	|O
that	|O
we	|O
name	|O
EPL1	|B-PROTEIN
,	|O
and	|O
as	|O
well	|O
as	|O
additional	|O
ESTs	|O
from	|O
Caenorhabditis	|O
elegans	|O
,	|O
mice	|O
and	|O
humans	|O
.	|O

Second	|O
,	|O
the	|O
wild	|O
-	|O
type	|O
m8	|B-PROTEIN
3'	|O
UTR	|O
strongly	|O
reduces	|O
accumulation	|O
of	|O
heterologous	|O
transcripts	|O
in	|O
vivo	|O
,	|O
an	|O
activity	|O
that	|O
requires	|O
its	|O
K	|O
box	|O
sequences	|O
.	|O

In	|O
particular	|O
,	|O
unc	|B-PROTEIN
-	|I-PROTEIN
86	|I-PROTEIN
encodes	|O
a	|O
POU	|B-PROTEIN
-	|O
type	|O
homeodomain	|B-PROTEIN
protein	|I-PROTEIN
needed	|O
for	|O
the	|O
production	|O
of	|O
the	|O
touch	|O
cells	|O
,	|O
while	|O
mec	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
encodes	|O
a	|O
LIM	|B-PROTEIN
-	|O
type	|O
homeodomain	|B-PROTEIN
protein	|I-PROTEIN
needed	|O
for	|O
the	|O
differentiation	|O
of	|O
the	|O
touch	|O
cells	|O
.	|O

During	|O
the	|O
2h	|O
resuscitation	|O
period	|O
,	|O
extracellular	|O
aspartate	|O
and	|O
glutamate	|O
concentrations	|O
in	|O
the	|O
cerebral	|O
striatum	|O
were	|O
higher	|O
during	|O
hypoxaemic	|O
resuscitation	|O
(	|O
p	|O
=	|O
0.044	|O
and	|O
p	|O
=	|O
0.055	|O
,	|O
respectively	|O
)	|O
than	|O
during	|O
resuscitation	|O
with	|O
21%	|O
O2	|O
or	|O
100%	|O
O2	|O
,	|O
suggesting	|O
an	|O
unfavourable	|O
accumulation	|O
of	|O
potent	|O
excitotoxins	|O
during	|O
hypoxaemic	|O
resuscitation	|O
.	|O

Expression	|O
of	|O
constitutively	|O
active	|O
MEK1	|B-PROTEIN
,	|O
the	|O
kinase	|O
that	|O
activates	|O
ERKs	|B-PROTEIN
,	|O
or	|O
overexpression	|O
of	|O
ERK2	|B-PROTEIN
,	|O
but	|O
not	|O
JNK1	|B-PROTEIN
,	|O
inhibited	|O
Stat3	|B-PROTEIN
activation	|O
.	|O

MEKs	|B-PROTEIN
and	|O
ERKs	|B-PROTEIN
inhibited	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
activation	|O
of	|O
Stat3	|B-PROTEIN
harboring	|O
a	|O
mutation	|O
at	|O
serine	|O
-	|O
727	|O
,	|O
the	|O
major	|O
site	|O
for	|O
serine	|O
phosphorylation	|O
,	|O
similar	|O
to	|O
inhibition	|O
of	|O
wild	|O
-	|O
type	|O
Stat3	|B-PROTEIN
,	|O
and	|O
inhibited	|O
Janus	|B-PROTEIN
kinases	|I-PROTEIN
Jak1	|O
and	|O
Jak2	|B-PROTEIN
upstream	|O
of	|O
Stat3	|B-PROTEIN
in	|O
the	|O
Jak	|B-PROTEIN
-	|O
STAT	|B-PROTEIN
-	|O
signaling	|O
pathway	|O
.	|O

Furthermore	|O
,	|O
phosphatidylinositol	|O
(	|O
3,4,5	|O
)	|O
trisphosphate	|O
specifically	|O
stimulates	|O
the	|O
activity	|O
of	|O
ILK	|B-PROTEIN
in	|O
vitro	|O
,	|O
and	|O
in	|O
addition	|O
,	|O
membrane	|O
targetted	|O
constitutively	|O
active	|O
Pi	|B-PROTEIN
(	|I-PROTEIN
3	|I-PROTEIN
)	|I-PROTEIN
K	|I-PROTEIN
activates	|O
ILK	|B-PROTEIN
in	|O
vivo	|O
.	|O

Transfection	|O
and	|O
in	|O
vitro	|O
binding	|O
studies	|O
identified	|O
within	|O
HEFT1	|B-PROTEIN
a	|I-PROTEIN
promoter	|O
whose	|O
basal	|O
activity	|O
required	|O
a	|O
GC	|O
box	|O
activated	|O
by	|O
Sp1	|B-PROTEIN
or	|O
Sp3	|B-PROTEIN
.	|O

Plasma	|O
was	|O
tested	|O
before	|O
and	|O
after	|O
(	|O
14	|O
+	|O
/	|O
-	|O
7.5	|O
[	|O
SD	|O
]	|O
days	|O
)	|O
surgery	|O
for	|O
IgG	|B-PROTEIN
antibodies	|O
to	|O
the	|O
complex	|O
of	|O
heparin	|O
/	|O
platelet	|B-PROTEIN
factor	|I-PROTEIN
4	|I-PROTEIN
,	|O
using	|O
a	|O
standardized	|O
,	|O
validated	|O
enzyme	|O
-	|O
linked	|O
immunosorbent	|O
assay	|O
(	|O
ELISA	|O
)	|O
.	|O

Genome	|O
plasticity	|O
in	|O
the	|O
distal	|O
tail	|O
fiber	|O
locus	|O
of	|O
the	|O
T	|O
-	|O
even	|O
bacteriophage	|O
:	|O
recombination	|O
between	|O
conserved	|O
motifs	|O
swaps	|O
adhesin	|B-PROTEIN
specificity	|O
.	|O

The	|O
FAS	|B-PROTEIN
promoter	|O
was	|O
up	|O
-	|O
regulated	|O
by	|O
insulin	|B-PROTEIN
through	|O
the	|O
proximal	|O
insulin	|B-PROTEIN
response	|O
sequence	|O
containing	|O
an	|O
E	|O
-	|O
box	|O
motif	|O
at	|O
the	|O
-	|O
65	|O
-	|O
base	|O
pair	|O
position	|O
.	|O

The	|O
effect	|O
of	|O
independent	|O
predictors	|O
on	|O
survival	|O
was	|O
examined	|O
in	|O
a	|O
Cox	|O
regression	|O
model	|O
with	|O
adjustment	|O
for	|O
existing	|O
illnesses	|O
.	|O

Effects	|O
of	|O
rhG	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
on	|O
neutrophil	|O
functions	|O
and	|O
survival	|O
in	|O
sepsis	|O
induced	|O
diabetic	|O
rats	|O
.	|O

OBJECTIVE	|O
:	|O
The	|O
purpose	|O
of	|O
this	|O
article	|O
is	|O
to	|O
review	|O
balance	|O
instruments	|O
developed	|O
within	|O
the	|O
past	|O
10	|O
years	|O
that	|O
can	|O
be	|O
used	|O
in	|O
the	|O
clinic	|O
or	|O
home	|O
environment	|O
.	|O

CASE	|O
REPORT	|O
:	|O
We	|O
observed	|O
a	|O
congenital	|O
skin	|O
defect	|O
located	|O
exclusively	|O
on	|O
the	|O
trunk	|O
.	|O

Whereas	|O
,	|O
in	|O
the	|O
single	|O
-	|O
chambered	|O
body	|O
box	|O
,	|O
PenH	|O
units	|O
(	|O
Enhanced	|O
Pause	|O
)	|O
reflect	|O
"	|O
effort	|O
of	|O
breathing	|O
.	|O
"	|O
This	|O
is	|O
measured	|O
as	|O
the	|O
pause	|O
between	|O
inspiration	|O
and	|O
expiration	|O
.	|O

Anastrozole	|O
is	|O
the	|O
first	|O
aromatase	|B-PROTEIN
inhibitor	|O
to	|O
show	|O
a	|O
significant	|O
survival	|O
advantage	|O
over	|O
megestrol	|O
acetate	|O
in	|O
post	|O
-	|O
menopausal	|O
women	|O
with	|O
advanced	|O
breast	|O
cancer	|O
.	|O

W.	|O

Moritta	|O
)	|O
and	|O
contains	|O
Bis	|O
-	|O
GMA	|O
.	|O

Mutation	|O
of	|O
either	|O
the	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
or	|O
the	|O
ets	|B-PROTEIN
component	|O
of	|O
this	|O
site	|O
also	|O
prevented	|O
promoter	|O
activity	|O
in	|O
SMCs	|O
.	|O

ANIMALS	|O
:	|O
Fifty	|O
dogs	|O
with	|O
naturally	|O
developing	|O
DM	|O
.	|O

Surprisingly	|O
,	|O
double	|O
mutants	|O
of	|O
the	|O
shy2	|B-PROTEIN
-	|I-PROTEIN
1D	|I-PROTEIN
mutant	|O
with	|O
the	|O
phytochrome	|B-PROTEIN
-	|O
deficient	|O
mutants	|O
hy2	|B-PROTEIN
,	|O
hy3	|B-PROTEIN
(	|O
phyB	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
and	|O
fre1	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
(	|O
phyA	|B-PROTEIN
-	|I-PROTEIN
201	|I-PROTEIN
)	|O
showed	|O
reduced	|O
photomorphogenic	|O
response	|O
in	|O
darkness	|O
with	|O
a	|O
longer	|O
hypocotyl	|O
,	|O
a	|O
longer	|O
inflorescence	|O
stem	|O
,	|O
and	|O
a	|O
lower	|O
level	|O
expression	|O
of	|O
the	|O
CAB	|B-PROTEIN
gene	|O
than	|O
the	|O
shy2	|B-PROTEIN
-	|I-PROTEIN
1D	|I-PROTEIN
single	|O
mutant	|O
.	|O

This	|O
suggests	|O
that	|O
while	|O
underpredictions	|O
of	|O
pain	|O
do	|O
not	|O
hurt	|O
more	|O
,	|O
disruption	|O
on	|O
primary	|O
tasks	|O
and	|O
physiological	|O
impact	|O
are	|O
higher	|O
.	|O

Laser	|O
ablation	|O
has	|O
been	|O
employed	|O
as	|O
a	|O
therapeutic	|O
measure	|O
for	|O
chronic	|O
pulmonary	|O
emphysema	|O
.	|O

The	|O
SH2	|O
-	|O
containing	|O
adapter	|O
protein	|O
GRB10	|B-PROTEIN
interacts	|O
with	|O
BCR	|B-PROTEIN
-	|O
ABL	|B-PROTEIN
.	|O

Saccharomyces	|O
cerevisiae	|O
contains	|O
four	|O
known	|O
acyl	|B-PROTEIN
-	|I-PROTEIN
CoA	|I-PROTEIN
synthetases	|I-PROTEIN
(	|O
fatty	|B-PROTEIN
acid	|I-PROTEIN
activation	|I-PROTEIN
proteins	|I-PROTEIN
,	|O
Faaps	|B-PROTEIN
)	|O
.	|O

We	|O
recently	|O
reported	|O
a	|O
placenta	|O
-	|O
specific	|O
enhancer	|O
in	|O
the	|O
human	|B-PROTEIN
leukemia	|I-PROTEIN
inhibitory	|I-PROTEIN
factor	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
LIFR	|B-PROTEIN
)	|O
gene	|O
and	|O
now	|O
show	|O
detailed	|O
characterization	|O
of	|O
the	|O
226	|O
-	|O
base	|O
pair	|O
enhancer	|O
(	|O
-	|O
4625	|O
/	|O
-	|O
4400	|O
nucleotides	|O
)	|O
.	|O

Copyright	|O
1998	|O
Elsevier	|O
Science	|O
B.V.	|O

It	|O
may	|O
be	|O
time	|O
to	|O
reevaluate	|O
the	|O
dichotomy	|O
between	|O
AD	|O
and	|O
VaD	|O
.	|O

Clone	|O
39	|O
was	|O
a	|O
homolog	|O
of	|O
CONSTANS	|B-PROTEIN
,	|O
which	|O
is	|O
a	|O
gene	|O
involved	|O
in	|O
controlling	|O
the	|O
flowering	|O
time	|O
in	|O
Arabidopsis	|O
.	|O

Badcock	|O
and	|O
Westheimer	|O
(	|O
Spatial	|O
Vision	|O
1	|O
(	|O
1	|O
)	|O
,	|O
3-11	|O
,	|O
1985	|O
)	|O
showed	|O
that	|O
a	|O
thin	|O
vertical	|O
line	|O
induces	|O
nearby	|O
zones	|O
of	|O
attraction	|O
and	|O
repulsion	|O
;	|O
this	|O
study	|O
extends	|O
those	|O
results	|O
by	|O
more	|O
closely	|O
examining	|O
the	|O
horizontal	|O
and	|O
vertical	|O
extents	|O
of	|O
the	|O
repulsion	|O
zone	|O
and	|O
by	|O
using	|O
an	|O
illusory	|O
contour	|O
to	|O
induce	|O
repulsion	|O
.	|O

The	|O
effects	|O
of	|O
high	|O
intensity	|O
light	|O
emissions	|O
,	|O
produced	|O
by	|O
a	|O
novel	|O
pulsed	|O
power	|O
energization	|O
technique	|O
(	|O
PPET	|O
)	|O
,	|O
on	|O
the	|O
survival	|O
of	|O
bacterial	|O
populations	|O
of	|O
verocytotoxigenic	|O
Escherichia	|O
coli	|O
(	|O
serotype	|O
0157	|O
:	|O
H7	|O
)	|O
and	|O
Listeria	|O
monocytogenes	|O
(	|O
serotype	|O
4b	|O
)	|O
were	|O
investigated	|O
.	|O

Multiple	|O
chemical	|O
sensitivity	|O
(	|O
MCS	|O
)	|O
is	|O
a	|O
syndrome	|O
in	|O
which	|O
multiple	|O
symptoms	|O
reportedly	|O
occur	|O
with	|O
low	|O
-	|O
level	|O
chemical	|O
exposure	|O
.	|O

POU	|B-PROTEIN
-	|O
domain	|O
proteins	|O
,	|O
such	|O
as	|O
the	|O
pituitary	|O
-	|O
specific	|O
factor	|O
Pit	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
are	|O
members	|O
of	|O
the	|O
homeodomain	|B-PROTEIN
family	|O
of	|O
proteins	|O
which	|O
are	|O
important	|O
in	|O
development	|O
and	|O
homeostasis	|O
,	|O
acting	|O
constitutively	|O
or	|O
in	|O
response	|O
to	|O
signal	|O
-	|O
transduction	|O
pathways	|O
to	|O
either	|O
repress	|O
or	|O
activate	|O
the	|O
expression	|O
of	|O
specific	|O
genes	|O
.	|O

Wild	|O
-	|O
type	|O
and	|O
mutant	|O
MyoD	|B-PROTEIN
were	|O
introduced	|O
into	|O
cells	|O
using	|O
an	|O
E1	|B-PROTEIN
,	|O
E3	|B-PROTEIN
-	|O
deleted	|O
adenoviral	|O
vector	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
Thr115	|O
may	|O
play	|O
an	|O
important	|O
role	|O
in	|O
the	|O
regulation	|O
of	|O
MyoD	|B-PROTEIN
function	|O
under	|O
conditions	|O
of	|O
high	|O
mitogenesis	|O
.	|O

This	|O
and	|O
previous	|O
results	|O
suggest	|O
that	|O
the	|O
CRE	|O
and	|O
Sp1	|B-PROTEIN
site	|O
may	|O
synergistically	|O
activate	|O
TH	|B-PROTEIN
transcription	|O
in	|O
a	|O
promoter	|O
context	|O
-	|O
dependent	|O
manner	|O
.	|O

desmethyltrimebutine	|O
was	|O
inactive	|O
.	|O

Endoscopic	|O
examinations	|O
,	|O
peripheral	|O
white	|O
blood	|O
cell	|O
(	|O
WBC	|O
)	|O
counts	|O
,	|O
and	|O
assays	|O
of	|O
myeloperoxidase	|B-PROTEIN
activity	|O
(	|O
MPO	|B-PROTEIN
)	|O
in	|O
homogenates	|O
of	|O
colon	|O
mucosa	|O
were	|O
performed	|O
after	|O
one	|O
week	|O
(	|O
4%	|O
DSS	|O
model	|O
)	|O
and	|O
eight	|O
weeks	|O
(	|O
1%	|O
DSS	|O
model	|O
)	|O
.	|O

T7	|O
transcription	|O
could	|O
be	|O
manipulated	|O
to	|O
achieve	|O
different	|O
levels	|O
of	|O
constitutive	|O
expression	|O
,	|O
through	|O
the	|O
use	|O
of	|O
promoter	|O
mutations	|O
.	|O

The	|O
primers	|O
were	|O
degenerate	|O
sets	|O
of	|O
oligonucleotides	|O
derived	|O
from	|O
known	|O
amino	|O
acid	|O
sequences	|O
of	|O
the	|O
PBAN	|B-PROTEIN
precursor	|O
.	|O

Plants	|O
transformed	|O
with	|O
the	|O
35S	|B-PROTEIN
-	|O
1	|B-PROTEIN
-	|I-PROTEIN
sst	|I-PROTEIN
construct	|O
accumulated	|O
the	|O
oligofructans	|O
1	|O
-	|O
kestose	|O
(	|O
GF2	|O
)	|O
,	|O
1,1	|O
-	|O
nystose	|O
(	|O
GF3	|O
)	|O
and	|O
1,1,1	|O
-	|O
fructosylnystose	|O
(	|O
GF4	|O
)	|O
.	|O

Based	|O
on	|O
the	|O
comparison	|O
of	|O
the	|O
predicted	|O
amino	|O
acid	|O
sequences	|O
of	|O
1	|B-PROTEIN
-	|I-PROTEIN
sst	|I-PROTEIN
and	|O
1	|B-PROTEIN
-	|I-PROTEIN
fft	|I-PROTEIN
with	|O
those	|O
of	|O
other	|O
plant	|O
fructosyl	|B-PROTEIN
transferase	|I-PROTEIN
genes	|O
,	|O
we	|O
postulate	|O
that	|O
both	|O
plant	|B-PROTEIN
fructan	|I-PROTEIN
genes	|O
have	|O
evolved	|O
from	|O
plant	|O
invertase	|B-PROTEIN
genes	|O
.	|O

However	|O
,	|O
ICK1	|B-PROTEIN
was	|O
induced	|O
by	|O
ABA	|O
,	|O
and	|O
along	|O
with	|O
ICK1	|B-PROTEIN
induction	|O
there	|O
was	|O
a	|O
decrease	|O
in	|O
Cdc2	|B-PROTEIN
-	|O
like	|O
histone	|O
H1	|B-PROTEIN
kinase	|O
activity	|O
.	|O

A	|O
5.0	|O
-	|O
kb	|O
transcript	|O
detected	|O
by	|O
the	|O
differential	|O
display	|O
amplicon	|O
3G1	|O
was	|O
found	|O
to	|O
correlate	|O
strongly	|O
with	|O
RAG1	|B-PROTEIN
mRNA	|O
expression	|O
in	|O
various	|O
human	|O
cell	|O
lines	|O
.	|O

The	|O
hBRAG	|B-PROTEIN
gene	|O
was	|O
localized	|O
to	|O
the	|O
long	|O
arm	|O
of	|O
chromosome	|O
10	|O
(	|O
10q26	|O
)	|O
.	|O

Here	|O
,	|O
we	|O
report	|O
that	|O
swa5	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
a	|O
new	|O
temperature	|O
-	|O
sensitive	|O
allele	|O
of	|O
the	|O
clathrin	|B-PROTEIN
heavy	|I-PROTEIN
chain	|I-PROTEIN
gene	|O
(	|O
chc1	|B-PROTEIN
-	|I-PROTEIN
5	|I-PROTEIN
)	|O
,	|O
which	|O
carries	|O
a	|O
frameshift	|O
mutation	|O
near	|O
the	|O
3'	|O
end	|O
of	|O
the	|O
CHC1	|B-PROTEIN
open	|O
reading	|O
frame	|O
.	|O

We	|O
have	|O
determined	|O
the	|O
molecular	|O
lesions	|O
of	|O
nine	|O
Scm	|B-PROTEIN
mutant	|O
alleles	|O
,	|O
which	|O
identify	|O
functional	|O
requirements	|O
for	|O
specific	|O
domains	|O
.	|O

Intriguingly	|O
,	|O
three	|O
hypomorphic	|O
Scm	|B-PROTEIN
mutations	|O
,	|O
which	|O
map	|O
within	|O
an	|O
mbt	|B-PROTEIN
repeat	|O
,	|O
interact	|O
with	|O
PcG	|B-PROTEIN
mutations	|O
more	|O
strongly	|O
than	|O
do	|O
Scm	|B-PROTEIN
null	|O
alleles	|O
.	|O

Northern	|O
analysis	|O
revealed	|O
no	|O
detectable	|O
expression	|O
of	|O
the	|O
transcript	|O
in	|O
diapause	|O
-	|O
or	|O
nondiapause	|O
-	|O
programmed	|O
wandering	|O
larvae	|O
,	|O
and	|O
only	|O
trace	|O
expression	|O
in	|O
nondiapausing	|O
pupae	|O
.	|O

Besides	|O
the	|O
characterization	|O
and	|O
discussion	|O
of	|O
the	|O
experimental	|O
setup	|O
used	|O
,	|O
the	|O
rate	|O
constants	|O
obtained	|O
are	|O
discussed	|O
and	|O
compared	|O
with	|O
estimated	|O
values	|O
.	|O

Genomic	|O
locus	|O
of	|O
chCTCF	|B-PROTEIN
contains	|O
a	|O
GC	|O
-	|O
rich	|O
untranslated	|O
exon	|O
separated	|O
from	|O
seven	|O
coding	|O
exons	|O
by	|O
a	|O
long	|O
intron	|O
.	|O

The	|O
presence	|O
of	|O
PDZ	|B-PROTEIN
and	|O
SAM	|O
domains	|O
in	|O
the	|O
KS5	|B-PROTEIN
protein	|I-PROTEIN
suggests	|O
that	|O
it	|O
may	|O
act	|O
as	|O
a	|O
molecular	|O
adaptor	|O
,	|O
promoting	|O
and	|O
relaying	|O
information	|O
in	|O
a	|O
signal	|O
transduction	|O
pathway	|O
.	|O

BACKGROUND	|O
:	|O
Fluoroquinolones	|O
(	|O
FQ	|O
)	|O
are	|O
contraindicated	|O
in	|O
children	|O
because	|O
of	|O
the	|O
risk	|O
of	|O
cartilage	|O
damage	|O
.	|O

In	|O
analyses	|O
with	|O
control	|O
for	|O
multiple	|O
variables	|O
,	|O
relative	|O
risk	|O
for	|O
microalbuminuria	|O
(	|O
urinary	|O
albumin	|B-PROTEIN
excretion	|O
,	|O
20-199	|O
microg	|O
/	|O
min	|O
)	|O
in	|O
men	|O
and	|O
women	|O
was	|O
2.51	|O
and	|O
1.62	|O
,	|O
respectively	|O
,	|O
with	|O
18	|O
mm	|O
Hg	|O
higher	|O
(	|O
1	|O
SD	|O
)	|O
systolic	|O
blood	|O
pressure	|O
;	|O
2.25	|O
and	|O
2.10	|O
,	|O
respectively	|O
,	|O
with	|O
1.0	|O
-	|O
mmol	|O
/	|O
L	|O
(	|O
40	|O
mg	|O
/	|O
dL	|O
)	|O
higher	|O
plasma	|O
cholesterol	|O
level	|O
;	|O
1.99	|O
and	|O
1.91	|O
,	|O
respectively	|O
,	|O
for	|O
smokers	|O
vs	|O
nonsmokers	|O
;	|O
and	|O
1.83	|O
and	|O
1.33	|O
,	|O
respectively	|O
,	|O
with	|O
4	|O
kg	|O
/	|O
m2	|O
higher	|O
body	|O
mass	|O
index	|O
.	|O

However	|O
,	|O
while	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1beta	|I-PROTEIN
and	|O
TNF	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
both	|O
induced	|O
nuclear	|O
binding	|O
of	|O
the	|O
Rel	|B-PROTEIN
proteins	|O
p50	|B-PROTEIN
and	|O
p65	|B-PROTEIN
to	|O
an	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
consensus	|O
oligonucleotide	|O
in	|O
gel	|O
shift	|O
assays	|O
and	|O
caused	|O
transient	|O
degradation	|O
of	|O
inhibitor	|B-PROTEIN
of	|I-PROTEIN
NF	|I-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
(	|O
IkappaB	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
)	|O
in	|O
the	|O
cytoplasm	|O
of	|O
myofibroblasts	|O
,	|O
only	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1beta	|I-PROTEIN
upregulated	|O
PDGF	|B-PROTEIN
-	|I-PROTEIN
Ralpha	|I-PROTEIN
.	|O

Cotransfections	|O
with	|O
ATF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
and	|O
HNF	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
expression	|O
plasmids	|O
resulted	|O
in	|O
additive	|O
transactivation	|O
of	|O
the	|O
apoCIII	|B-PROTEIN
promoter	|O
.	|O

Phosphocreatine	|O
hydrolysis	|O
during	|O
submaximal	|O
exercise	|O
:	|O
the	|O
effect	|O
of	|O
FIO2	|O
.	|O

Pseudocontact	|O
shifts	|O
arise	|O
from	|O
the	|O
isotropic	|O
reorientational	|O
average	|O
of	|O
the	|O
dipolar	|O
coupling	|O
between	|O
unpaired	|O
electron	|O
and	|O
nuclei	|O
,	|O
in	|O
the	|O
presence	|O
of	|O
magnetic	|O
susceptibility	|O
anisotropy	|O
.	|O

GETS	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
expressed	|O
in	|O
many	|O
tissues	|O
,	|O
but	|O
is	|O
enriched	|O
in	|O
retina	|O
and	|O
brain	|O
.	|O

The	|O
interaction	|O
of	|O
U1	|B-PROTEIN
-	|O
70K	|O
with	|O
the	|O
SRZ	|B-PROTEIN
proteins	|O
is	|O
confirmed	|O
further	|O
in	|O
vitro	|O
using	|O
a	|O
blot	|O
overlay	|O
assay	|O
.	|O

The	|O
major	|O
phenotypes	|O
resulting	|O
from	|O
Fab1p	|B-PROTEIN
kinase	|I-PROTEIN
inactivation	|O
include	|O
temperature	|O
-	|O
sensitive	|O
growth	|O
,	|O
vacuolar	|O
acidification	|O
defects	|O
,	|O
and	|O
dramatic	|O
increases	|O
in	|O
vacuolar	|O
size	|O
.	|O

Small	|B-PROTEIN
GTPases	|I-PROTEIN
of	|O
the	|O
Ypt	|B-PROTEIN
/	|O
Rab	|B-PROTEIN
family	|O
are	|O
involved	|O
in	|O
the	|O
regulation	|O
of	|O
vesicular	|O
transport	|O
.	|O

The	|O
GEF	|B-PROTEIN
and	|O
GAP	|B-PROTEIN
activities	|O
for	|O
Ypt1p	|B-PROTEIN
localize	|O
to	|O
particulate	|O
cellular	|O
fractions	|O
.	|O

Dopamine	|B-PROTEIN
beta	|I-PROTEIN
-	|I-PROTEIN
hydroxylase	|I-PROTEIN
(	|O
DBH	|B-PROTEIN
)	|O
catalyzes	|O
the	|O
conversion	|O
of	|O
dopamine	|O
to	|O
noradrenaline	|O
and	|O
is	|O
selectively	|O
expressed	|O
in	|O
noradrenergic	|O
and	|O
adrenergic	|O
neurons	|O
and	|O
neuroendocrine	|O
cells	|O
.	|O

Collectively	|O
,	|O
this	|O
study	|O
emphasizes	|O
a	|O
critical	|O
role	|O
of	|O
Phox2a	|B-PROTEIN
as	|O
well	|O
as	|O
its	|O
functional	|O
synergism	|O
with	|O
other	|O
transcription	|O
factors	|O
(	|O
e.g.	|O
,	|O
CREB	|B-PROTEIN
,	|O
AP2	|B-PROTEIN
,	|O
and	|O
Sp1	|B-PROTEIN
)	|O
in	|O
transcriptional	|O
activation	|O
of	|O
the	|O
DBH	|B-PROTEIN
gene	|O
.	|O

Interestingly	|O
,	|O
an	|O
antibody	|O
against	|O
N	|B-PROTEIN
-	|I-PROTEIN
SMase	|I-PROTEIN
can	|O
abrogate	|O
Ox	|B-PROTEIN
-	|I-PROTEIN
LDL	|I-PROTEIN
-	|O
and	|O
TNF	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
-	|O
induced	|O
apoptosis	|O
and	|O
therefore	|O
may	|O
be	|O
useful	|O
for	|O
in	|O
vivo	|O
studies	|O
of	|O
apoptosis	|O
in	|O
experimental	|O
animals	|O
.	|O

We	|O
found	|O
that	|O
virulent	|O
Ngo	|O
strains	|O
induce	|O
phosphorylation	|O
and	|O
activation	|O
of	|O
JNK	|B-PROTEIN
but	|O
not	|O
of	|O
p38	|B-PROTEIN
kinase	|O
.	|O

Focused	|O
beams	|O
of	|O
classical	|O
light	|O
ablate	|O
elements	|O
of	|O
the	|O
cell	|O
division	|O
machinery	|O
and	|O
switch	|O
the	|O
beating	|O
of	|O
hearts	|O
on	|O
a	|O
cellular	|O
basis	|O
.	|O

The	|O
human	|O
T	|O
cell	|O
lymphotropic	|O
retrovirus	|O
type	|O
I	|O
(	|O
HTLV	|O
-	|O
I	|O
)	|O
trans	|O
-	|O
activator	|O
,	|O
Tax	|B-PROTEIN
,	|O
interacts	|O
specifically	|O
with	|O
the	|O
basic	|O
-	|O
domain	|O
/	|O
leucine	|O
-	|O
zipper	|O
(	|B-PROTEIN
bZip	|I-PROTEIN
)	|I-PROTEIN
protein	|I-PROTEIN
,	|O
cAMP	|B-PROTEIN
response	|I-PROTEIN
element	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
(	|O
CREB	|B-PROTEIN
)	|O
,	|O
bound	|O
to	|O
the	|O
viral	|O
Tax	|B-PROTEIN
-	|I-PROTEIN
responsive	|I-PROTEIN
element	|I-PROTEIN
consisting	|O
of	|O
three	|O
imperfect	|O
21	|O
-	|O
base	|O
pair	|O
repeats	|O
,	|O
each	|O
with	|O
a	|O
cAMP	|O
response	|O
element	|O
core	|O
flanked	|O
by	|O
G	|O
/	|O
C	|O
-	|O
rich	|O
sequences	|O
.	|O

This	|O
sequence	|O
is	|O
very	|O
similar	|O
to	|O
the	|O
insulin	|B-PROTEIN
response	|I-PROTEIN
sequence	|I-PROTEIN
found	|O
in	|O
the	|O
regulatory	|O
region	|O
of	|O
other	|O
genes	|O
negatively	|O
regulated	|O
by	|O
insulin	|B-PROTEIN
such	|O
as	|O
those	|O
encoding	|O
phosphoenolpyruvate	|B-PROTEIN
carboxykinase	|I-PROTEIN
,	|O
tyrosine	|B-PROTEIN
aminotransferase	|I-PROTEIN
,	|O
and	|O
insulin	|B-PROTEIN
-	|I-PROTEIN
like	|I-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
1	|I-PROTEIN
.	|O

The	|O
murine	|O
facilitative	|O
glucose	|B-PROTEIN
transporter	|I-PROTEIN
isoform	|I-PROTEIN
3	|I-PROTEIN
(	|O
Glut	|B-PROTEIN
3	|I-PROTEIN
)	|O
is	|O
developmentally	|O
regulated	|O
and	|O
is	|O
predominantly	|O
expressed	|O
in	|O
neurons	|O
and	|O
trophoblasts	|O
.	|O

However	|O
,	|O
changing	|O
the	|O
half	|O
-	|O
site	|O
to	|O
the	|O
consensus	|O
sequence	|O
AGGTCA	|O
(	|O
IRper	|O
-	|O
1	|O
)	|O
increased	|O
binding	|O
of	|O
AaEcR.A	|B-PROTEIN
aUSP	|I-PROTEIN
10	|O
-	|O
fold	|O
over	|O
IRhsp	|O
-	|O
1	|O
and	|O
,	|O
at	|O
the	|O
same	|O
time	|O
,	|O
reduced	|O
the	|O
stringency	|O
of	|O
the	|O
spacer	|O
length	|O
requirement	|O
,	|O
with	|O
IRper	|O
-	|O
0	|O
to	|O
IRper	|O
-	|O
5	|O
showing	|O
detectable	|O
binding	|O
.	|O

The	|O
levels	|O
of	|O
transactivation	|O
are	|O
correlated	|O
with	|O
the	|O
respective	|O
binding	|O
affinities	|O
of	|O
the	|O
response	|O
elements	|O
(	|O
IRper	|O
-	|O
1	|O
>	|O
DR	|O
-	|O
4	|O
>	|O
IRhsp	|O
-	|O
1	|O
)	|O
.	|O

The	|O
high	|O
density	|O
of	|O
tegumental	|O
spines	|O
on	|O
posterior	|O
half	|O
of	|O
the	|O
body	|O
and	|O
the	|O
distribution	|O
of	|O
type	|O
II	|O
papillae	|O
on	|O
dorsal	|O
surface	|O
are	|O
considered	|O
to	|O
be	|O
characteristic	|O
of	|O
C.	|O
armatus	|O
.	|O

Inactivation	|O
of	|O
p53	|B-PROTEIN
but	|O
not	|O
p73	|B-PROTEIN
by	|O
adenovirus	|O
type	|O
5	|O
E1B	|B-PROTEIN
55	|O
-	|O
kilodalton	|O
and	|O
E4	|B-PROTEIN
34	|O
-	|O
kilodalton	|O
oncoproteins	|O
.	|O

The	|O
Epstein	|O
-	|O
Barr	|O
virus	|O
transactivator	|O
Zta	|B-PROTEIN
triggers	|O
lytic	|O
gene	|O
expression	|O
and	|O
is	|O
essential	|O
for	|O
replication	|O
of	|O
the	|O
lytic	|O
origin	|O
,	|O
oriLyt	|O
.	|O

Cotransfection	|O
of	|O
the	|O
helicase	|B-PROTEIN
-	|O
primase	|B-PROTEIN
proteins	|O
,	|O
one	|O
of	|O
which	|O
was	|O
fused	|O
to	|O
a	|O
heterologous	|O
activation	|O
domain	|O
,	|O
led	|O
to	|O
Zta	|B-PROTEIN
-	|O
dependent	|O
superactivation	|O
of	|O
CAT	|B-PROTEIN
expression	|O
.	|O

Sequence	|O
comparisons	|O
strongly	|O
suggest	|O
that	|O
the	|O
S27a	|B-PROTEIN
and	|O
the	|O
ubiquitin	|B-PROTEIN
coding	|O
sequences	|O
found	|O
in	|O
the	|O
genome	|O
of	|O
CP	|O
Rit	|O
were	|O
both	|O
derived	|O
from	|O
a	|O
bovine	|O
mRNA	|O
encoding	|O
a	|O
hybrid	|O
protein	|O
with	|O
the	|O
structure	|O
NH2	|O
-	|O
ubiquitin	|B-PROTEIN
-	|O
S27a	|B-PROTEIN
-	|O
COOH	|O
.	|O

J.	|O

There	|O
was	|O
a	|O
trend	|O
in	|O
all	|O
studies	|O
favouring	|O
PVI	|O
.	|O

A	|O
single	|O
rectal	|O
dose	|O
of	|O
25	|O
mg	|O
/	|O
kg	|O
will	|O
obtain	|O
this	|O
lower	|O
concentration	|O
within	|O
1	|O
h	|O
of	|O
administration	|O
and	|O
maintain	|O
it	|O
for	|O
up	|O
to	|O
6	|O
h	|O
.	|O

This	|O
domain	|O
,	|O
although	|O
adjacent	|O
to	|O
the	|O
5'	|O
edge	|O
of	|O
the	|O
SD	|O
sequence	|O
,	|O
does	|O
not	|O
inhibit	|O
ribosome	|O
binding	|O
as	|O
long	|O
as	|O
the	|O
single	|O
-	|O
stranded	|O
region	|O
of	|O
domain	|O
3	|O
is	|O
present	|O
.	|O

Although	|O
YopH	|B-PROTEIN
is	|O
a	|O
highly	|O
active	|O
PTP	|B-PROTEIN
,	|O
it	|O
preferentially	|O
targets	|O
a	|O
subset	|O
of	|O
tyrosine	|O
-	|O
phosphorylated	|O
proteins	|O
in	|O
host	|O
cells	|O
,	|O
including	|O
p130Cas	|B-PROTEIN
.	|O

Phylogenetic	|O
position	|O
of	|O
the	|O
Phacotaceae	|O
within	|O
the	|O
Chlamydophyceaeas	|O
revealed	|O
by	|O
analysis	|O
of	|O
18S	|B-PROTEIN
rDNA	|O
and	|O
rbcL	|B-PROTEIN
sequences	|O
.	|O

Previous	|O
genetic	|O
studies	|O
led	|O
to	|O
the	|O
conclusion	|O
that	|O
nitrate	|O
and	|O
nitrite	|O
induction	|O
of	|O
nasF	|B-PROTEIN
operon	|O
expression	|O
is	|O
determined	|O
by	|O
a	|O
transcriptional	|O
antitermination	|O
mechanism	|O
.	|O

The	|O
activation	|O
and	|O
injury	|O
of	|O
endothelial	|O
cells	|O
induced	|O
by	|O
TNF	|B-PROTEIN
and	|O
other	|O
proinflammatory	|O
cytokines	|O
may	|O
underlie	|O
the	|O
local	|O
effects	|O
of	|O
these	|O
mediators	|O
in	|O
vivo	|O
.	|O

A	|O
technique	|O
for	|O
thermal	|O
imaging	|O
of	|O
the	|O
animal	|O
and	|O
human	|O
brain	|O
cortex	|O
using	|O
an	|O
infrared	|O
optical	|O
system	|O
is	|O
described	|O
.	|O

EGFR	|B-PROTEIN
levels	|O
were	|O
found	|O
to	|O
be	|O
elevated	|O
5	|O
-	|O
,	|O
3	|O
.	|O

Here	|O
we	|O
demonstrate	|O
that	|O
THOV	|B-PROTEIN
NP	|I-PROTEIN
contains	|O
a	|O
motif	|O
(	|O
KRxxxxxxxxxKTKK	|O
)	|O
at	|O
amino	|O
acid	|O
positions	|O
179-193	|O
that	|O
represents	|O
a	|O
classical	|O
bipartite	|O
nuclear	|O
localization	|O
signal	|O
(	|O
NLS	|O
)	|O
.	|O

As	|O
PP2A	|B-PROTEIN
exerts	|O
a	|O
range	|O
of	|O
cellular	|O
functions	|O
including	|O
cell	|O
cycle	|O
regulation	|O
and	|O
cell	|O
fate	|O
determination	|O
,	|O
we	|O
were	|O
surprised	|O
to	|O
find	|O
that	|O
these	|O
embryos	|O
develop	|O
normally	|O
until	|O
postimplantation	|O
,	|O
around	|O
embryonic	|O
day	|O
5.5/6.0	|O
.	|O

The	|O
most	|O
frequent	|O
risk	|O
factor	|O
for	|O
ischaemic	|O
was	|O
hypertension	|O
.	|O

The	|O
results	|O
indicate	|O
that	|O
anthraquinone	|O
sennoside	|O
B	|O
and	|O
rhein	|O
are	|O
weakly	|O
genotoxic	|O
.	|O

Furthermore	|O
,	|O
LB1	|B-PROTEIN
gene	|O
mapped	|O
to	|O
chromosome	|O
13q14	|O
,	|O
a	|O
region	|O
that	|O
has	|O
been	|O
involved	|O
as	|O
a	|O
chromosomal	|O
breakpoint	|O
in	|O
DLBL	|O
.	|O

16	|O
subjects	|O
were	|O
repatch	|O
tested	|O
to	|O
ethylmercury	|O
chloride	|O
(	|O
EtHgCl	|O
)	|O
and	|O
to	|O
solutions	|O
containing	|O
EtHgCl	|O
mixed	|O
with	|O
L	|O
-	|O
cysteine	|O
and	|O
glutathione	|O
,	|O
respectively	|O
.	|O

Wild	|O
-	|O
type	|O
AT1A	|B-PROTEIN
receptors	|I-PROTEIN
,	|O
expressed	|O
in	|O
Chinese	|O
hamster	|O
ovary	|O
cells	|O
,	|O
rapidly	|O
internalized	|O
after	|O
Ang	|B-PROTEIN
II	|I-PROTEIN
stimulation	|O
[	|O
t1/2	|O
2.3	|O
min	|O
;	|O
maximal	|O
level	|O
of	|O
internalization	|O
(	|O
Ymax	|O
)	|O
78.2%	|O
]	|O
,	|O
as	|O
did	|O
mutant	|O
receptors	|O
carrying	|O
single	|O
acidic	|O
substitutions	|O
(	|O
T332E	|O
,	|O
t1/2	|O
2.7	|O
min	|O
,	|O
Ymax	|O
76.3%	|O
;	|O
S335D	|O
,	|O
t1/2	|O
2.4	|O
min	|O
,	|O
Ymax	|O
76.7%	|O
;	|O
T336E	|O
,	|O
t1/2	|O
2.5	|O
min	|O
,	|O
Ymax	|O
78.2%	|O
;	|O
S338D	|O
,	|O
t1/2	|O
2.6	|O
min	|O
,	|O
Ymax	|O
78.4%	|O
)	|O
.	|O

The	|O
activated	|O
glucocorticoid	|B-PROTEIN
receptor	|I-PROTEIN
forms	|O
a	|O
complex	|O
with	|O
Stat5	|B-PROTEIN
and	|O
enhances	|O
Stat5	|B-PROTEIN
-	|O
mediated	|O
transcriptional	|O
induction	|O
.	|O

T.	|O
,	|O
Mahasneh	|O
,	|O
A.	|O
,	|O
and	|O
Cote	|O
,	|O
G.	|O

The	|O
carboxyl	|O
-	|O
terminal	|O
portion	|O
of	|O
UKLF	|B-PROTEIN
contains	|O
three	|O
zinc	|O
fingers	|O
of	|O
the	|O
Cys2	|O
-	|O
His2	|O
type	|O
and	|O
binds	|O
in	|O
vitro	|O
to	|O
the	|O
CACCC	|O
motif	|O
of	|O
the	|O
beta	|B-PROTEIN
-	|I-PROTEIN
globin	|I-PROTEIN
promoter	|O
and	|O
to	|O
the	|O
Sp1	|B-PROTEIN
recognition	|O
sequence	|O
.	|O

We	|O
have	|O
recently	|O
identified	|O
a	|O
mouse	|O
enzyme	|O
termed	|O
gamma	|B-PROTEIN
-	|I-PROTEIN
glutamyl	|I-PROTEIN
leukotrienase	|I-PROTEIN
(	|O
GGL	|B-PROTEIN
)	|O
that	|O
converts	|O
leukotriene	|O
C4	|O
(	|O
LTC4	|O
)	|O
to	|O
leukotriene	|O
D4	|O
(	|O
LTD4	|O
)	|O
.	|O

UGA	|O
codon	|O
position	|O
affects	|O
the	|O
efficiency	|O
of	|O
selenocysteine	|O
incorporation	|O
into	|O
glutathione	|B-PROTEIN
peroxidase	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

Forskolin	|O
significantly	|O
enhanced	|O
heregulin	|B-PROTEIN
-	|O
stimulated	|O
expression	|O
of	|O
cyclin	|B-PROTEIN
D	|I-PROTEIN
and	|O
phosphorylation	|O
of	|O
the	|O
retinoblastoma	|B-PROTEIN
gene	|I-PROTEIN
product	|O
.	|O

The	|O
ARF	|B-PROTEIN
promoter	|O
was	|O
also	|O
found	|O
to	|O
be	|O
highly	|O
responsive	|O
to	|O
E2F1	|B-PROTEIN
expression	|O
,	|O
in	|O
keeping	|O
with	|O
previous	|O
results	|O
at	|O
the	|O
RNA	|O
level	|O
.	|O

RESULTS	|O
:	|O
The	|O
binding	|O
of	|O
99mTc	|O
d	|O
,	|O
1	|O
-	|O
HMPAO	|O
to	|O
human	|O
placenta	|O
ranged	|O
from	|O
2.95%	|O
+	|O
/	|O
-	|O
1.5%	|O
to	|O
5.82%	|O
+	|O
/	|O
-	|O
0.3%	|O
per	|O
1	|O
ml	|O
standard	|O
solution	|O
.	|O

CM	|O
reduced	|O
the	|O
nuclear	|O
binding	|O
activity	|O
of	|O
transcription	|O
factor	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
,	|O
which	|O
is	|O
probably	|O
important	|O
for	|O
basal	|O
activity	|O
of	|O
the	|O
human	|O
NOS	|B-PROTEIN
II	|I-PROTEIN
promoter	|O
,	|O
is	|O
unlikely	|O
to	|O
function	|O
as	|O
a	|O
major	|O
effector	|O
of	|O
CM	|O
in	|O
DLD	|O
-	|O
1	|O
cells	|O
.	|O

Observers	|O
with	|O
brain	|O
injury	|O
and	|O
control	|O
participants	|O
performed	|O
a	|O
vigilance	|O
task	|O
during	|O
which	|O
they	|O
received	|O
periodic	|O
whiffs	|O
of	|O
unscented	|O
air	|O
or	|O
air	|O
scented	|O
with	|O
peppermint	|O
.	|O

A	|O
simple	|O
analytical	|O
method	|O
for	|O
l	|O
-	|O
menthol	|O
by	|O
high	|O
-	|O
performance	|O
liquid	|O
chromatography	|O
with	|O
a	|O
polarized	|O
photometric	|O
detector	|O
was	|O
established	|O
.	|O

RESULTS	|O
:	|O
The	|O
cardiac	|O
index	|O
significantly	|O
changed	|O
with	|O
varying	|O
PaCO2	|O
levels	|O
(	|O
hypocapnia	|O
,	|O
-	|O
9%	|O
;	|O
hypercapnia	|O
,	|O
13%	|O
)	|O
.	|O

After	|O
measuring	|O
baseline	|O
Vmca	|O
at	|O
a	|O
partial	|O
pressure	|O
of	|O
carbon	|O
dioxide	|O
in	|O
arterial	|O
blood	|O
(	|O
PaCO2	|O
)	|O
of	|O
37.7	|O
+	|O
/	|O
-	|O
4.5	|O
mmHg	|O
(	|O
mean	|O
+	|O
/	|O
-	|O
SD	|O
)	|O
,	|O
measurements	|O
were	|O
repeated	|O
at	|O
a	|O
PaCO	|O
of	|O
44.2	|O
+	|O
/	|O
-	|O
3.8	|O
mmHg	|O
,	|O
and	|O
the	|O
carbon	|O
dioxide	|O
reactivity	|O
(	|O
absolute	|O
value	|O
:	|O
cm	|O
x	|O
s	|O
(	|O
-	|O
1	|O
)	|O
x	|O
mmHg	|O
(	|O
-	|O
1	|O
)	|O
;	|O
relative	|O
value	|O
:	|O
percentage	|O
of	|O
baseline	|O
Vmca	|O
/	|O
mmHg	|O
)	|O
was	|O
calculated	|O
.	|O

Multivariate	|O
Cox	|O
survival	|O
analysis	|O
identified	|O
baseline	|O
EF	|O
<	|O
or	|O
=	|O
30%	|O
,	|O
presence	|O
of	|O
significant	|O
mitral	|O
regurgitation	|O
(	|O
>	|O
2+	|O
)	|O
before	|O
ablation	|O
,	|O
and	|O
failure	|O
to	|O
exhibit	|O
improved	|O
cardiac	|O
performance	|O
by	|O
1	|O
month	|O
after	|O
ablation	|O
as	|O
the	|O
only	|O
independent	|O
predictors	|O
of	|O
death	|O
.	|O

We	|O
have	|O
developed	|O
a	|O
new	|O
method	|O
for	|O
estimation	|O
of	|O
regional	|O
CBF	|O
(	|O
rCBF	|O
)	|O
and	|O
cerebrovascular	|O
reserve	|O
capacity	|O
on	|O
a	|O
pixel	|O
-	|O
by	|O
-	|O
pixel	|O
basis	|O
by	|O
means	|O
of	|O
dynamic	|O
magnetic	|O
resonance	|O
imaging	|O
(	|O
MRI	|O
)	|O
.	|O

Cost	|O
-	|O
effectiveness	|O
analysis	|O
provides	|O
a	|O
rational	|O
means	|O
of	|O
allocating	|O
limited	|O
health	|O
care	|O
resources	|O
by	|O
allowing	|O
the	|O
comparison	|O
of	|O
the	|O
costs	|O
of	|O
lipid	|O
-	|O
lowering	|O
therapy	|O
,	|O
in	|O
particular	|O
,	|O
therapy	|O
with	|O
beta	|B-PROTEIN
-	|I-PROTEIN
hydroxy	|I-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
-	|I-PROTEIN
methylglutaryl	|I-PROTEIN
-	|I-PROTEIN
CoA	|I-PROTEIN
(	|I-PROTEIN
coenzyme	|I-PROTEIN
A	|I-PROTEIN
)	|I-PROTEIN
reductase	|I-PROTEIN
inhibitors	|O
(	|O
statins	|O
)	|O
,	|O
with	|O
the	|O
costs	|O
of	|O
atherosclerosis	|O
that	|O
could	|O
be	|O
prevented	|O
by	|O
lowering	|O
cholesterol	|O
.	|O

Although	|O
E2FBP1	|B-PROTEIN
lacks	|O
the	|O
transactivation	|O
domain	|O
,	|O
it	|O
stimulates	|O
E2F	|B-PROTEIN
site	|O
-	|O
dependent	|O
transcription	|O
in	|O
cooperation	|O
with	|O
E2F	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

Sequencing	|O
of	|O
a	|O
40	|O
-	|O
kb	|O
DNA	|O
segment	|O
of	|O
the	|O
FK506	|O
gene	|O
cluster	|O
from	|O
Streptomyces	|O
sp	|O
.	|O

The	|O
predicted	|O
domain	|O
structures	|O
of	|O
FkbB	|B-PROTEIN
and	|O
FkbC	|B-PROTEIN
are	|O
analogous	|O
to	|O
that	|O
of	|O
FkbA	|B-PROTEIN
and	|O
comprise	|O
30	|O
fatty	|B-PROTEIN
-	|I-PROTEIN
acid	|I-PROTEIN
-	|I-PROTEIN
synthase	|I-PROTEIN
(	|O
FAS	|B-PROTEIN
)	|O
-	|O
like	|O
domains	|O
arranged	|O
in	|O
6	|O
modules	|O
.	|O

Analysis	|O
of	|O
Msy2	|B-PROTEIN
mRNA	|O
expression	|O
in	|O
prepubertal	|O
and	|O
adult	|O
mouse	|O
testes	|O
,	|O
and	|O
in	|O
isolated	|O
populations	|O
of	|O
germ	|O
cells	|O
,	|O
reveals	|O
maximal	|O
expression	|O
in	|O
postmeiotic	|O
round	|O
spermatids	|O
,	|O
a	|O
cell	|O
type	|O
with	|O
abundant	|O
amounts	|O
of	|O
stored	|O
messenger	|O
ribonucleoproteins	|O
.	|O

1	|O
in	|O
Ho	|O
Chi	|O
Minh	|O
City	|O
was	|O
studied	|O
by	|O
culture	|O
and	|O
latex	|O
agglutination	|O
of	|O
blood	|O
,	|O
cerebrospinal	|O
fluid	|O
,	|O
urine	|O
and	|O
pleural	|O
fluid	|O
.	|O

Glycogen	|O
synthesis	|O
and	|O
catabolism	|O
,	|O
gluconeogenesis	|O
,	|O
glycolysis	|O
,	|O
motility	|O
,	|O
cell	|O
surface	|O
properties	|O
and	|O
adherence	|O
are	|O
modulated	|O
by	|O
csrA	|B-PROTEIN
in	|O
Escherichia	|O
coli	|O
,	|O
while	|O
the	|O
production	|O
of	|O
several	|O
secreted	|O
virulence	|O
factors	|O
,	|O
the	|O
plant	|O
hypersensitive	|O
response	|O
elicitor	|O
HrpN	|B-PROTEIN
(	|O
Ecc	|B-PROTEIN
)	|O
and	|O
,	|O
potentially	|O
,	|O
other	|O
secondary	|O
metabolites	|O
are	|O
regulated	|O
by	|O
rsmA	|B-PROTEIN
in	|O
Erwinia	|O
carotovora	|O
.	|O

The	|O
cwg2	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
mutation	|O
was	|O
identified	|O
as	|O
a	|O
guanine	|O
to	|O
adenine	|O
substitution	|O
at	|O
nucleotide	|O
604	|O
of	|O
the	|O
coding	|O
region	|O
,	|O
originating	|O
the	|O
change	|O
A202T	|O
in	|O
the	|O
cwg2p	|B-PROTEIN
.	|O

Deletion	|O
analysis	|O
revealed	|O
that	|O
the	|O
essential	|O
domain	|O
of	|O
this	|O
promoter	|O
,	|O
termed	|O
the	|O
ORF5	|B-PROTEIN
/	|I-PROTEIN
deltaX	|I-PROTEIN
transcript	|O
promoter	|O
,	|O
mapped	|O
to	|O
nucleotides	|O
1525-1625	|O
.	|O

Some	|O
of	|O
the	|O
peptide	|O
:	|O
MBP	|B-PROTEIN
fusions	|O
were	|O
also	|O
analyzed	|O
using	|O
surface	|O
plasmon	|O
resonance	|O
.	|O

Cardiac	|O
myosin	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
C	|I-PROTEIN
(	|O
MyBP	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
)	|O
:	|O
identification	|O
of	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
A	|I-PROTEIN
and	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
C	|I-PROTEIN
phosphorylation	|O
sites	|O
.	|O

Handling	|O
on	|O
PND	|O
9	|O
did	|O
not	|O
result	|O
in	|O
elevated	|O
CORT	|O
levels	|O
in	|O
any	|O
of	|O
the	|O
groups	|O
.	|O

Analysis	|O
of	|O
chromosomal	|O
DNA	|O
sequence	|O
immediately	|O
downstream	|O
of	|O
the	|O
transposon	|O
insertion	|O
identified	|O
two	|O
open	|O
reading	|O
frames	|O
,	|O
designated	|O
csrR	|B-PROTEIN
and	|O
csrS	|B-PROTEIN
,	|O
which	|O
exhibited	|O
sequence	|O
similarity	|O
to	|O
bacterial	|O
two	|O
-	|O
component	|O
regulatory	|O
systems	|O
.	|O

633	|O
+	|O
/	|O
-	|O
258	|O
aggregates	|O
/	|O
ml	|O
at	|O
0	|O
rpm	|O
;	|O
P	|O
<	|O
0.001	|O
)	|O
.	|O

We	|O
previously	|O
delineated	|O
a	|O
region	|O
in	|O
the	|O
fatty	|B-PROTEIN
-	|I-PROTEIN
acid	|I-PROTEIN
synthase	|I-PROTEIN
promoter	|O
,	|O
which	|O
was	|O
responsible	|O
for	|O
obesity	|O
-	|O
related	|O
overexpression	|O
of	|O
the	|O
fatty	|B-PROTEIN
-	|I-PROTEIN
acid	|I-PROTEIN
synthase	|I-PROTEIN
(	|O
FAS	|B-PROTEIN
)	|O
gene	|O
,	|O
by	|O
negatively	|O
regulating	|O
the	|O
activity	|O
of	|O
the	|O
downstream	|O
promoter	|O
in	|O
lean	|O
but	|O
not	|O
obese	|O
rat	|O
fat	|O
cells	|O
.	|O

Finally	|O
,	|O
using	|O
in	|O
vitro	|O
binding	|O
studies	|O
,	|O
we	|O
showed	|O
that	|O
SREBP2	|B-PROTEIN
was	|O
able	|O
to	|O
displace	|O
ADD1	|B-PROTEIN
/	|O
SREBP1	|B-PROTEIN
binding	|O
from	|O
the	|O
sterol	|O
regulatory	|O
element	|O
(	|O
SRE	|O
)	|O
site	|O
.	|O

Thus	|O
,	|O
IRF	|B-PROTEIN
-	|I-PROTEIN
7	|I-PROTEIN
exhibits	|O
functional	|O
similarity	|O
to	|O
IRF	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
;	|O
however	|O
,	|O
the	|O
preferential	|O
expression	|O
of	|O
IRF	|B-PROTEIN
-	|I-PROTEIN
7	|I-PROTEIN
in	|O
lymphoid	|O
cells	|O
(	|O
the	|O
cell	|O
type	|O
that	|O
expresses	|O
IFNA	|B-PROTEIN
)	|O
suggests	|O
that	|O
IRF	|B-PROTEIN
-	|I-PROTEIN
7	|I-PROTEIN
may	|O
play	|O
a	|O
critical	|O
role	|O
in	|O
regulating	|O
the	|O
IFNA	|B-PROTEIN
gene	|O
expression	|O
.	|O

J.	|O

PURPOSE	|O
:	|O
The	|O
role	|O
interleukin	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
(	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
)	|O
in	|O
the	|O
treatment	|O
of	|O
congenital	|O
thrombocytopenias	|O
is	|O
unknown	|O
.	|O

CKII	|B-PROTEIN
as	|O
a	|O
CD44	|B-PROTEIN
-	|O
associated	|O
serine	|B-PROTEIN
kinase	|I-PROTEIN
therefore	|O
may	|O
serve	|O
as	|O
an	|O
important	|O
molecule	|O
in	|O
a	|O
signaling	|O
cascade	|O
that	|O
produces	|O
a	|O
variety	|O
of	|O
cellular	|O
responses	|O
in	|O
MDA231	|O
breast	|O
cancer	|O
cells	|O
.	|O

Galphaq	|B-PROTEIN
,	|O
Galpha12	|B-PROTEIN
,	|O
and	|O
Galpha13	|B-PROTEIN
,	|O
but	|O
not	|O
Galphai	|B-PROTEIN
,	|O
activate	|O
SRF	|B-PROTEIN
through	|O
RhoA	|B-PROTEIN
.	|O

Additionally	|O
in	|O
seven	|O
subjects	|O
adrenaline	|O
(	|O
A	|O
)	|O
and	|O
noradrenaline	|O
(	|O
NA	|O
)	|O
concentrations	|O
were	|O
determined	|O
.	|O

Northern	|O
blot	|O
analyses	|O
show	|O
that	|O
the	|O
hBub1	|B-PROTEIN
mRNA	|O
level	|O
is	|O
abundantly	|O
expressed	|O
in	|O
tissues	|O
or	|O
cells	|O
with	|O
a	|O
high	|O
mitotic	|O
index	|O
.	|O

We	|O
mapped	|O
two	|O
overlapping	|O
expressed	|O
sequence	|O
tag	|O
clones	|O
within	|O
a	|O
genomic	|O
contig	|O
on	|O
human	|O
chromosome	|O
5	|O
,	|O
band	|O
q31	|O
.	|O

Htra2	|B-PROTEIN
-	|I-PROTEIN
beta3	|I-PROTEIN
is	|O
developmentally	|O
regulated	|O
and	|O
expressed	|O
predominantly	|O
in	|O
brain	|O
,	|O
liver	|O
testis	|O
,	|O
and	|O
weakly	|O
in	|O
kidney	|O
.	|O

Gng3lg	|B-PROTEIN
transcripts	|O
are	|O
expressed	|O
in	|O
a	|O
variety	|O
of	|O
tissues	|O
including	|O
both	|O
brain	|O
and	|O
testes	|O
.	|O

Using	|O
an	|O
interspecific	|O
backcross	|O
panel	|O
,	|O
we	|O
localized	|O
both	|O
Gng3	|B-PROTEIN
and	|O
Gng3lg	|B-PROTEIN
to	|O
the	|O
same	|O
locus	|O
on	|O
chromosome	|O
19	|O
.	|O

We	|O
also	|O
raised	|O
a	|O
polyclonal	|O
antibody	|O
against	|O
the	|O
glutathione	|B-PROTEIN
S	|I-PROTEIN
-	|I-PROTEIN
transferase	|I-PROTEIN
fusion	|O
protein	|O
containing	|O
the	|O
NH2	|O
-	|O
terminal	|O
86	|O
amino	|O
acids	|O
of	|O
human	|O
NRAMP2	|B-PROTEIN
.	|O

Inhibition	|O
of	|O
the	|O
apolipoprotein	|B-PROTEIN
B	|I-PROTEIN
mRNA	|O
editing	|O
enzyme	|O
-	|O
complex	|O
by	|O
hnRNP	|O
C1	|B-PROTEIN
protein	|O
and	|O
40S	|B-PROTEIN
hnRNP	|O
complexes	|O
.	|O

SRC	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
can	|O
relieve	|O
the	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
-	|O
mediated	|O
repression	|O
of	|O
GR	|B-PROTEIN
activity	|O
.	|O

However	|O
the	|O
sequence	|O
surrounding	|O
the	|O
transcription	|O
start	|O
site	|O
CTCA	|O
(	|O
+	|O
1	|O
)	|O
TTCC	|O
was	|O
similar	|O
to	|O
the	|O
consensus	|O
CTCA	|O
(	|O
+	|O
1	|O
)	|O
NTCT	|O
(	|O
N	|O
is	|O
any	|O
nucleoside	|O
)	|O
for	|O
an	|O
initiator	|O
element	|O
found	|O
in	|O
terminal	|B-PROTEIN
deoxynucleotidyltransferase	|I-PROTEIN
and	|O
a	|O
number	|O
of	|O
other	|O
highly	|O
regulated	|O
genes	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
the	|O
total	|O
number	|O
of	|O
subunit	|O
c	|O
in	|O
F0	|B-PROTEIN
should	|O
be	|O
a	|O
multiple	|O
of	|O
2	|O
and	|O
3	|O
.	|O

Expression	|O
of	|O
a	|O
dominant	|O
-	|O
negative	|O
mutant	|O
of	|O
JNK1	|B-PROTEIN
also	|O
suppressed	|O
glucose	|O
deprivation	|O
-	|O
induced	|O
JNK1	|B-PROTEIN
activation	|O
as	|O
well	|O
as	|O
HSP70	|B-PROTEIN
gene	|O
expression	|O
.	|O

The	|O
interaction	|O
of	|O
AF	|O
-	|O
1	|O
with	|O
proteins	|O
that	|O
regulate	|O
distinct	|O
steps	|O
of	|O
transcription	|O
may	|O
provide	|O
a	|O
mechanism	|O
for	|O
synergistic	|O
activation	|O
of	|O
gene	|O
expression	|O
by	|O
AF	|O
-	|O
1	|O
.	|O

The	|O
role	|O
of	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
C	|I-PROTEIN
signaling	|O
in	|O
activated	|O
DRA	|B-PROTEIN
transcription	|O
.	|O

Ligand	|O
binding	|O
to	|O
the	|O
receptor	|O
complex	|O
leads	|O
to	|O
tyrosine	|O
phosphorylation	|O
and	|O
activation	|O
of	|O
Janus	|B-PROTEIN
kinases	|I-PROTEIN
(	|O
Jak	|B-PROTEIN
)	|O
,	|O
phosphorylation	|O
of	|O
the	|O
signal	|O
transducing	|O
subunit	|O
gp130	|B-PROTEIN
,	|O
followed	|O
by	|O
recruitment	|O
and	|O
phosphorylation	|O
of	|O
the	|O
signal	|B-PROTEIN
transducer	|I-PROTEIN
and	|I-PROTEIN
activator	|I-PROTEIN
of	|I-PROTEIN
transcription	|I-PROTEIN
factors	|I-PROTEIN
STAT3	|O
and	|O
STAT1	|B-PROTEIN
and	|O
the	|O
src	|B-PROTEIN
homology	|I-PROTEIN
domain	|I-PROTEIN
(	|O
SH2	|B-PROTEIN
)	|O
-	|O
containing	|O
protein	|B-PROTEIN
tyrosine	|I-PROTEIN
phosphatase	|I-PROTEIN
(	|O
SHP2	|B-PROTEIN
)	|O
.	|O

Interestingly	|O
,	|O
an	|O
increase	|O
of	|O
distance	|O
per	|O
se	|O
did	|O
not	|O
have	|O
a	|O
deleterious	|O
effect	|O
on	|O
translation	|O
efficiency	|O
.	|O

We	|O
also	|O
mapped	|O
a	|O
3'	|O
-	|O
polyadenylation	|O
site	|O
504bp	|O
downstream	|O
of	|O
the	|O
TGA	|O
stop	|O
codon	|O
,	|O
consistent	|O
with	|O
the	|O
2.5	|O
kb	|O
transcript	|O
size	|O
.	|O

RBP56	|B-PROTEIN
protein	|O
turned	|O
out	|O
to	|O
be	|O
hTAFII68	|B-PROTEIN
which	|O
was	|O
isolated	|O
as	|O
a	|O
TATA	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
associated	|I-PROTEIN
factor	|I-PROTEIN
(	|O
TAF	|B-PROTEIN
)	|O
from	|O
a	|O
sub	|O
-	|O
population	|O
of	|O
TFIID	|B-PROTEIN
complexes	|O
(	|O
Bertolotti	|O
A.	|O
,	|O
Lutz	|O
,	|O
Y.	|O
,	|O
Heard	|O
,	|O
D.J.	|O
,	|O
Chambon	|O
,	|O
P.	|O
,	|O
Tora	|O
,	|O
L.	|O
,	|O
1996	|O
.	|O
hTAFII68	|B-PROTEIN
,	|O
a	|O
novel	|O
RNA	|O
/	|O
ssDNA	|O
-	|O
binding	|O
protein	|O
with	|O
homology	|O
to	|O
the	|O
proto	|O
-	|O
oncoproteins	|O
TLS	|B-PROTEIN
/	|O
FUS	|B-PROTEIN
and	|O
EWS	|B-PROTEIN
is	|O
associated	|O
with	|O
both	|O
TFIID	|B-PROTEIN
and	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
II	|I-PROTEIN
.	|O

An	|O
electrophoretic	|O
mobility	|O
shift	|O
assay	|O
was	|O
performed	|O
to	|O
characterize	|O
the	|O
binding	|O
property	|O
of	|O
TR2	|B-PROTEIN
and	|O
its	|O
truncated	|O
isoform	|O
.	|O

Gel	|O
-	|O
mobility	|O
shift	|O
analysis	|O
was	|O
also	|O
performed	|O
for	|O
the	|O
CCAAT	|O
motif	|O
at	|O
-	|O
67	|O
.	|O

BACKGROUND	|O
:	|O
The	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
proto	|O
-	|O
oncogene	|O
has	|O
been	|O
suggested	|O
to	|O
play	|O
key	|O
roles	|O
in	|O
cell	|O
proliferation	|O
,	|O
differentiation	|O
,	|O
transformation	|O
and	|O
apoptosis	|O
.	|O

AMY	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
was	|O
localized	|O
in	|O
the	|O
cytoplasm	|O
in	|O
cells	|O
expressing	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
at	|O
low	|O
levels	|O
,	|O
but	|O
in	|O
the	|O
nucleus	|O
in	|O
the	|O
cells	|O
of	|O
a	|O
high	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
expression	|O
in	|O
transiently	|O
transfected	|O
cells	|O
.	|O

RESULTS	|O
:	|O
We	|O
identified	|O
a	|O
full	|O
-	|O
length	|O
cDNA	|O
with	|O
an	|O
open	|O
reading	|O
frame	|O
of	|O
2883	|O
bp	|O
corresponding	|O
to	|O
a	|O
predicted	|O
protein	|O
of	|O
961	|O
amino	|O
acids	|O
that	|O
shares	|O
greater	|O
than	|O
95%	|O
homology	|O
with	|O
the	|O
rat	|O
gamma	|O
-	|O
aminobutyric	|O
acid	|O
B	|O
(	|B-PROTEIN
GABAB	|I-PROTEIN
)	|I-PROTEIN
receptor	|I-PROTEIN
.	|O

On	|O
Day	|O
8	|O
,	|O
the	|O
CIDR	|O
-	|O
B	|O
was	|O
removed	|O
and	|O
500	|O
micrograms	|O
cloprostenol	|O
injected	|O
,	|O
IM	|O
.	|O

Antidepressant	|O
-	|O
like	|O
properties	|O
of	|O
some	|O
serotonin	|B-PROTEIN
receptor	|I-PROTEIN
ligands	|O
and	|O
calcium	|O
channel	|O
antagonists	|O
measured	|O
with	|O
the	|O
forced	|O
swimming	|O
test	|O
in	|O
mice	|O
.	|O

Another	|O
tentative	|O
hotspot	|O
mutation	|O
in	|O
the	|O
third	|O
patient	|O
,	|O
a	|O
frame	|O
shift	|O
caused	|O
by	|O
a	|O
G	|O
nucleotide	|O
insertion	|O
in	|O
a	|O
monotonous	|O
repeat	|O
of	|O
six	|O
Gs	|O
in	|O
HPRT	|B-PROTEIN
exon	|O
3	|O
,	|O
has	|O
been	|O
reported	|O
previously	|O
in	|O
three	|O
other	|O
LN	|O
patients	|O
.	|O

SRF	|B-PROTEIN
-	|O
deficient	|O
embryos	|O
(	|O
Srf	|B-PROTEIN
-	|O
/	|O
-	|O
)	|O
have	|O
a	|O
severe	|O
gastrulation	|O
defect	|O
and	|O
do	|O
not	|O
develop	|O
to	|O
term	|O
.	|O

These	|O
characteristic	|O
structural	|O
features	|O
were	|O
used	|O
to	|O
create	|O
the	|O
abbreviation	|O
AZF1	|B-PROTEIN
(	|O
Asparagine	|B-PROTEIN
-	|I-PROTEIN
rich	|I-PROTEIN
Zinc	|I-PROTEIN
Finger	|I-PROTEIN
protein	|I-PROTEIN
)	|O
.	|O

Over	|O
-	|O
expression	|O
of	|O
Azf1p	|B-PROTEIN
in	|O
the	|O
yeast	|O
cell	|O
does	|O
not	|O
influence	|O
the	|O
expression	|O
level	|O
of	|O
the	|O
mitochondrial	|O
transcription	|O
factor	|O
Mtf1p	|B-PROTEIN
,	|O
indicating	|O
that	|O
the	|O
influence	|O
of	|O
Azf1p	|B-PROTEIN
on	|O
the	|O
suppression	|O
of	|O
the	|O
special	|O
mitochondrial	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
mutant	|O
is	|O
an	|O
indirect	|O
one	|O
.	|O

We	|O
have	|O
generated	|O
a	|O
computer	|O
model	|O
of	|O
the	|O
C	|O
-	|O
terminal	|O
domain	|O
of	|O
the	|O
434	|O
repressor	|O
based	|O
on	|O
the	|O
crystal	|O
structure	|O
of	|O
the	|O
homologous	|O
UmuD	|B-PROTEIN
'	|O
protein	|O
.	|O

Large	|O
-	|O
scale	|O
sequencing	|O
of	|O
two	|O
regions	|O
in	|O
human	|O
chromosome	|O
7q22	|O
:	|O
analysis	|O
of	|O
650	|O
kb	|O
of	|O
genomic	|O
sequence	|O
around	|O
the	|O
EPO	|B-PROTEIN
and	|O
CUTL1	|B-PROTEIN
loci	|O
reveals	|O
17	|O
genes	|O
.	|O

Because	|O
Trp53	|B-PROTEIN
(	|O
the	|O
mouse	|O
homolog	|O
of	|O
human	|O
TP53	|B-PROTEIN
)	|O
is	|O
located	|O
with	|O
Tk1	|B-PROTEIN
on	|O
chromosome	|O
11	|O
and	|O
is	|O
critical	|O
in	|O
regulating	|O
cellular	|O
responses	|O
following	|O
exposure	|O
to	|O
DNA	|O
damaging	|O
agents	|O
,	|O
we	|O
wanted	|O
to	|O
determine	|O
if	|O
these	|O
mouse	|O
lymphoma	|O
cells	|O
harbor	|O
mutations	|O
in	|O
Trp53	|B-PROTEIN
.	|O

One	|O
of	|O
these	|O
fragments	|O
shows	|O
the	|O
highest	|O
amino	|O
acid	|O
sequence	|O
homology	|O
to	|O
the	|O
insect	|O
ecdysone	|O
inducible	|O
gene	|O
E75	|B-PROTEIN
.	|O

The	|O
full	|O
-	|O
length	|O
N	|B-PROTEIN
gene	|O
,	|O
encoded	|O
by	|O
open	|O
reading	|O
frame	|O
7	|O
,	|O
was	|O
cloned	|O
from	|O
the	|O
Canadian	|O
PRRS	|O
virus	|O
,	|O
PA	|O
-	|O
8	|O
.	|O

Based	|O
on	|O
sequence	|O
homology	|O
,	|O
the	|O
genes	|O
were	|O
identified	|O
as	|O
TEF	|B-PROTEIN
,	|O
encoding	|O
translation	|B-PROTEIN
elongation	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
alpha	|I-PROTEIN
and	|O
RPS7	|B-PROTEIN
,	|O
encoding	|O
ribosomal	|O
protein	|O
S7	|B-PROTEIN
.	|O

We	|O
have	|O
previously	|O
shown	|O
that	|O
ARNO	|B-PROTEIN
localizes	|O
to	|O
the	|O
plasma	|O
membrane	|O
in	|O
vivo	|O
and	|O
efficiently	|O
catalyzes	|O
ARF6	|B-PROTEIN
nucleotide	|O
exchange	|O
in	|O
vitro	|O
.	|O

Renal	|O
pathology	|O
and	|O
long	|O
-	|O
term	|O
outcome	|O
in	|O
childhood	|O
SLE	|O
.	|O

Transcription	|O
factors	|O
of	|O
the	|O
Stat	|B-PROTEIN
family	|O
are	|O
controlled	|O
by	|O
protein	|O
kinases	|O
.	|O

We	|O
propose	|O
that	|O
two	|O
pathways	|O
regulate	|O
Stat5	|B-PROTEIN
serine	|O
phosphorylation	|O
,	|O
one	|O
that	|O
is	|O
prolactin	|B-PROTEIN
-	|O
activated	|O
and	|O
PD98059	|O
-	|O
resistant	|O
and	|O
one	|O
that	|O
is	|O
constitutively	|O
active	|O
and	|O
PD98059	|O
-	|O
sensitive	|O
and	|O
preferentially	|O
targets	|O
Stat5a	|B-PROTEIN
.	|O

An	|O
approximately	|O
37	|O
-	|O
kDa	|O
cytoplasmic	|O
protein	|O
is	|O
rapidly	|O
tyrosine	|O
-	|O
phosphorylated	|O
in	|O
the	|O
response	|O
of	|O
mouse	|O
BAC1.2	|O
F5	|O
macrophages	|O
to	|O
colony	|B-PROTEIN
stimulating	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
(	|O
CSF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
.	|O
pp37	|B-PROTEIN
was	|O
purified	|O
from	|O
the	|O
cytosolic	|O
fraction	|O
by	|O
anti	|B-PROTEIN
-	|I-PROTEIN
Tyr	|I-PROTEIN
(	|I-PROTEIN
P	|I-PROTEIN
)	|I-PROTEIN
affinity	|O
chromatography	|O
,	|O
size	|O
exclusion	|O
chromatography	|O
,	|O
and	|O
C4	|O
reverse	|O
phase	|O
high	|O
pressure	|O
liquid	|O
chromatography	|O
.	|O

Dose	|O
of	|O
20	|O
ig	|O
were	|O
administered	|O
within	|O
a	|O
scheme	|O
from	|O
0.1	|O
to	|O
6	|O
months	|O
in	|O
order	|O
to	|O
study	|O
its	|O
immunogenicity	|O
,	|O
which	|O
was	|O
evaluated	|O
at	|O
2	|O
,	|O
7	|O
,	|O
and	|O
12	|O
months	|O
after	|O
the	|O
first	|O
dose	|O
.	|O

The	|O
various	|O
available	|O
data	|O
strongly	|O
suggesting	|O
an	|O
environmental	|O
toxic	|O
origin	|O
for	|O
the	|O
"	|O
sperm	|O
fall	|O
"	|O
will	|O
be	|O
presented	|O
as	|O
well	|O
as	|O
the	|O
most	|O
frequently	|O
suspected	|O
class	|O
of	|O
substances	|O
,	|O
the	|O
xenoestrogens	|O
.	|O

This	|O
association	|O
was	|O
independently	|O
significant	|O
for	|O
patients	|O
treated	|O
primarily	|O
(	|O
not	|O
for	|O
recurrence	|O
)	|O
.	|O

CONCLUSION	|O
:	|O
Local	|O
control	|O
was	|O
highest	|O
with	|O
Preop	|O
in	|O
patients	|O
presenting	|O
primarily	|O
with	|O
gross	|O
disease	|O
,	|O
and	|O
with	|O
Postop	|O
in	|O
patients	|O
presenting	|O
primarily	|O
following	|O
gross	|O
total	|O
excision	|O
.	|O

Its	|O
interaction	|O
with	|O
RFX5	|B-PROTEIN
and	|O
RFXAP	|B-PROTEIN
is	|O
essential	|O
for	|O
binding	|O
of	|O
the	|O
RFX	|B-PROTEIN
complex	|O
to	|O
MHC	|B-PROTEIN
-	|I-PROTEIN
II	|I-PROTEIN
promoters	|O
.	|O

We	|O
have	|O
previously	|O
mapped	|O
the	|O
defect	|O
in	|O
RIIIS	|O
/	|O
J	|O
to	|O
distal	|O
mouse	|O
Chr	|O
11	|O
,	|O
distinct	|O
from	|O
the	|O
Vwf	|B-PROTEIN
locus	|O
on	|O
Chr	|O
6	|O
.	|O

These	|O
data	|O
may	|O
also	|O
aid	|O
in	|O
the	|O
localization	|O
of	|O
other	|O
disease	|O
loci	|O
mapped	|O
to	|O
this	|O
region	|O
,	|O
including	|O
the	|O
gene	|O
for	|O
tricho	|O
-	|O
dento	|O
-	|O
osseous	|O
syndrome	|O
and	|O
a	|O
murine	|O
locus	|O
for	|O
susceptibility	|O
to	|O
ozone	|O
-	|O
induced	|O
acute	|O
lung	|O
injury	|O
.	|O

Copyright	|O
1998	|O
Academic	|O
Press	|O
.	|O

An	|O
open	|O
reading	|O
frame	|O
encoding	|O
a	|O
protein	|O
which	|O
shows	|O
significant	|O
similarity	|O
to	|O
invertases	|B-PROTEIN
and	|O
resolvases	|B-PROTEIN
was	|O
located	|O
immediately	|O
upstream	|O
of	|O
the	|O
Pac25I	|B-PROTEIN
R	|O
-	|O
M	|O
operon	|O
.	|O

Identification	|O
of	|O
a	|O
new	|O
gene	|O
in	|O
the	|O
streptococcal	|O
plasmid	|O
pLS1	|O
:	|O
the	|O
rnaI	|B-PROTEIN
gene	|O
.	|O

Rather	|O
,	|O
usp	|B-PROTEIN
is	|O
required	|O
in	|O
late	|O
third	|O
instar	|O
larvae	|O
for	|O
appropriate	|O
developmental	|O
and	|O
transcriptional	|O
responses	|O
to	|O
the	|O
ecdysone	|O
pulse	|O
that	|O
triggers	|O
puparium	|O
formation	|O
.	|O

An	|O
intact	|O
neurovascular	|O
supply	|O
is	|O
essential	|O
for	|O
the	|O
viability	|O
of	|O
a	|O
muscle	|O
flap	|O
.	|O

Examination	|O
of	|O
DNA	|O
:	|O
protein	|O
binding	|O
complexes	|O
by	|O
gel	|O
-	|O
shift	|O
analysis	|O
indicated	|O
that	|O
nuclear	|O
factors	|O
from	|O
both	|O
proliferative	|O
and	|O
growth	|O
-	|O
arrested	|O
cells	|O
bound	|O
to	|O
the	|O
DNA	|O
fragment	|O
spanning	|O
-	|O
949	|O
-	|O
-	|O
722	|O
bp	|O
.	|O

BACKGROUND	|O
:	|O
Studies	|O
in	|O
lean	|O
men	|O
show	|O
poor	|O
regulation	|O
of	|O
energy	|O
(	|O
EB	|O
)	|O
and	|O
fat	|O
balance	|O
(	|O
FB	|O
)	|O
during	|O
manipulation	|O
of	|O
dietary	|O
ratios	|O
of	|O
fat	|O
to	|O
carbohydrate	|O
.	|O

Fatal	|O
apneusis	|O
was	|O
observed	|O
under	|O
following	|O
conditions	|O
:	|O
(	|O
1	|O
)	|O
Persistent	|O
apnea	|O
was	|O
produced	|O
after	|O
a	|O
single	|O
KA	|O
microinjection	|O
in	|O
one	|O
side	|O
of	|O
the	|O
VRG	|O
-	|O
Apa	|O
(	|O
5	|O
animals	|O
)	|O
.	|O

A	|O
comparative	|O
analysis	|O
of	|O
the	|O
reported	|O
MOCT	|O
-	|O
associated	|O
malignant	|O
melanomas	|O
emphasizes	|O
the	|O
singularity	|O
of	|O
our	|O
case	|O
in	|O
the	|O
amelanotic	|O
character	|O
of	|O
the	|O
melanoma	|O
,	|O
its	|O
lymphotropism	|O
and	|O
the	|O
coexistence	|O
of	|O
invasive	|O
squamous	|O
cell	|O
carcinoma	|O
.	|O

RESULTS	|O
:	|O
An	|O
herpetic	|O
seroconversion	|O
is	|O
observed	|O
with	|O
presence	|O
of	|O
type	|O
I	|O
herpes	|O
simplex	|O
virus	|O
(	|O
HSV	|O
I	|O
)	|O
nucleic	|O
acids	|O
in	|O
the	|O
recipient	|O
's	|O
aqueous	|O
humor	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
HIV	|O
-	|O
1	|O
Gag	|B-PROTEIN
sequences	|O
can	|O
influence	|O
the	|O
viral	|O
PR	|B-PROTEIN
-	|O
mediated	|O
processing	|O
of	|O
the	|O
MuLV	|O
TM	|O
Env	|B-PROTEIN
protein	|O
p15	|B-PROTEIN
(	|I-PROTEIN
E	|I-PROTEIN
)	|I-PROTEIN
.	|O

These	|O
results	|O
demonstrate	|O
a	|O
specific	|O
association	|O
of	|O
SIV	|O
and	|O
HIV	|O
-	|O
2	|O
nef	|B-PROTEIN
,	|O
but	|O
not	|O
HIV	|O
-	|O
1	|O
nef	|B-PROTEIN
,	|O
with	|O
TCRzeta	|B-PROTEIN
.	|O

Competition	|O
EMSA	|O
established	|O
that	|O
constitutively	|O
expressed	|O
nuclear	|O
proteins	|O
bound	|O
the	|O
KCS	|B-PROTEIN
element	|O
selectively	|O
;	|O
KCS	|B-PROTEIN
protein	|O
binding	|O
activity	|O
correlated	|O
with	|O
promoter	|O
activity	|O
in	|O
the	|O
transient	|O
transfection	|O
reporter	|O
assay	|O
.	|O

Mechanism	|O
of	|O
interferon	|B-PROTEIN
action	|O
:	|O
identification	|O
of	|O
essential	|O
positions	|O
within	|O
the	|O
novel	|O
15	|O
-	|O
base	|O
-	|O
pair	|O
KCS	|B-PROTEIN
element	|O
required	|O
for	|O
transcriptional	|O
activation	|O
of	|O
the	|O
RNA	|O
-	|O
dependent	|O
protein	|O
kinase	|O
pkr	|B-PROTEIN
gene	|O
.	|O

GH	|B-PROTEIN
failed	|O
to	|O
stimulate	|O
phosphorylation	|O
or	|O
activation	|O
of	|O
Jun	|B-PROTEIN
N	|O
-	|O
terminal	|O
kinase	|O
under	|O
the	|O
conditions	|O
used	|O
.	|O

Expression	|O
of	|O
a	|O
novel	|O
murine	|O
phospholipase	|B-PROTEIN
D	|I-PROTEIN
homolog	|O
coincides	|O
with	|O
late	|O
neuronal	|O
development	|O
in	|O
the	|O
forebrain	|O
.	|O

We	|O
detected	|O
no	|O
effect	|O
of	|O
deleting	|O
YCL024W	|B-PROTEIN
,	|O
either	|O
alone	|O
or	|O
in	|O
combination	|O
with	|O
deletion	|O
of	|O
GIN4	|B-PROTEIN
.	|O

Paralemmin	|B-PROTEIN
is	|O
also	|O
phosphorylated	|O
,	|O
and	|O
its	|O
mRNA	|O
is	|O
differentially	|O
spliced	|O
in	|O
a	|O
tissue	|O
-	|O
specific	|O
and	|O
developmentally	|O
regulated	|O
manner	|O
.	|O

The	|O
deduced	|O
amino	|O
acid	|O
sequence	|O
of	|O
CBP90	|B-PROTEIN
had	|O
no	|O
significant	|O
similarity	|O
to	|O
any	|O
other	|O
protein	|O
,	|O
but	|O
it	|O
had	|O
a	|O
proline	|O
-	|O
rich	|O
domain	|O
at	|O
the	|O
C	|O
-	|O
terminal	|O
region	|O
.	|O

The	|O
effect	|O
of	|O
low	|O
-	|O
profile	|O
serine	|O
substitutions	|O
in	|O
the	|O
V3	|B-PROTEIN
loop	|O
of	|O
HIV	|O
-	|O
1	|O
gp120	|B-PROTEIN
IIIB	|I-PROTEIN
/	|O
LAI	|B-PROTEIN
on	|O
the	|O
immunogenicity	|O
of	|O
the	|O
envelope	|B-PROTEIN
protein	|O
.	|O

Transcription	|O
start	|O
site	|O
mapping	|O
identified	|O
the	|O
presence	|O
of	|O
an	|O
aphidicolin	|O
-	|O
sensitive	|O
late	|O
transcript	|O
arising	|O
from	|O
a	|O
TAAG	|O
motif	|O
located	|O
at	|O
-	|O
352	|O
nucleotides	|O
and	|O
an	|O
aphidicolin	|O
-	|O
insensitive	|O
early	|O
transcript	|O
originating	|O
from	|O
a	|O
TTGT	|O
motif	|O
located	|O
35	|O
nucleotides	|O
downstream	|O
to	|O
a	|O
TATA	|O
box	|O
at	|O
-	|O
312	|O
nucleotides	|O
,	|O
with	|O
respect	|O
to	|O
the	|O
+	|O
1	|O
ATG	|O
of	|O
lef2	|B-PROTEIN
.	|O

The	|O
human	|O
2'	|B-PROTEIN
,	|I-PROTEIN
5'	|I-PROTEIN
-	|I-PROTEIN
oligoadenylate	|I-PROTEIN
(	|I-PROTEIN
2-5	|I-PROTEIN
A	|I-PROTEIN
)	|I-PROTEIN
synthetases	|I-PROTEIN
are	|O
members	|O
of	|O
a	|O
family	|O
interferon	|B-PROTEIN
(	|O
IFN	|B-PROTEIN
)	|O
-	|O
inducible	|O
anti	|B-PROTEIN
-	|I-PROTEIN
viral	|I-PROTEIN
proteins	|I-PROTEIN
.	|O

Our	|O
findings	|O
demonstrate	|O
a	|O
dose	|O
-	|O
dependent	|O
blockade	|O
of	|O
the	|O
mechanical	|O
sensitivity	|O
caused	|O
by	|O
a	|O
mild	|O
thermal	|O
injury	|O
by	|O
both	|O
GBP	|O
and	|O
IBG	|O
.	|O

These	|O
striations	|O
were	|O
caused	|O
by	|O
contact	|O
between	|O
the	|O
sharp	|O
edge	|O
of	|O
the	|O
upper	|O
canine	|O
and	|O
the	|O
P3	|O
during	|O
honing	|O
(	|O
canine	|O
/	|O
premolar	|O
complex	|O
)	|O
.	|O

Low	|O
PbrO2	|O
readings	|O
,	|O
however	|O
,	|O
could	|O
be	|O
caused	|O
by	|O
local	|O
microhemorrhages	|O
,	|O
undetectable	|O
on	|O
CT	|O
or	|O
MRI	|O
.	|O

The	|O
consequences	|O
of	|O
intensive	|O
swine	|O
production	|O
on	|O
the	|O
environment	|O
and	|O
possible	|O
solutions	|O
by	|O
means	|O
of	|O
nutrition	|O
are	|O
outlined	|O
.	|O

This	|O
study	|O
demonstrates	|O
that	|O
alteration	|O
of	|O
CDKN2	|B-PROTEIN
is	|O
one	|O
of	|O
the	|O
most	|O
frequent	|O
genetic	|O
abnormalities	|O
in	|O
prostate	|O
cancer	|O
and	|O
may	|O
contribute	|O
to	|O
prostate	|O
carcinogenesis	|O
.	|O

The	|O
pharmacokinetic	|O
parameters	|O
which	|O
helped	|O
predict	|O
these	|O
toxicities	|O
included	|O
area	|O
under	|O
the	|O
curve	|O
and	|O
peak	|O
plasma	|O
level	|O
.	|O

A	|O
Chinese	|O
(	|O
HK	|O
)	|O
SF	|O
-	|O
36	|O
survey	|O
form	|O
was	|O
developed	|O
by	|O
an	|O
iterative	|O
translation	|O
process	|O
.	|O

However	|O
,	|O
the	|O
use	|O
of	|O
cyclosporin	|O
A	|O
is	|O
associated	|O
with	|O
an	|O
increased	|O
prevalence	|O
of	|O
hypertension	|O
in	|O
kidney	|O
transplant	|O
recipients	|O
.	|O

PURPOSE	|O
:	|O
To	|O
determine	|O
the	|O
effects	|O
of	|O
hypercholesterolemia	|O
and	|O
atherosclerosis	|O
-	|O
induced	|O
chronic	|O
cavernosal	|O
arterial	|O
insufficiency	|O
on	|O
cavernosal	|O
smooth	|O
muscle	|O
tone	|O
,	|O
nitric	|B-PROTEIN
oxide	|I-PROTEIN
synthase	|I-PROTEIN
(	|O
NOS	|B-PROTEIN
)	|O
activity	|O
and	|O
cavernosal	|O
tissue	|O
synthesis	|O
of	|O
constrictor	|O
eicosanoids	|O
.	|O

Characterization	|O
of	|O
the	|O
regulatory	|O
regions	|O
of	|O
the	|O
human	|O
aromatase	|B-PROTEIN
(	|O
P450arom	|B-PROTEIN
)	|O
gene	|O
involved	|O
in	|O
placenta	|O
-	|O
specific	|O
expression	|O
.	|O

Recombinant	|O
FVIIa	|B-PROTEIN
was	|O
stable	|O
in	|O
the	|O
infusion	|O
pump	|O
for	|O
several	|O
days	|O
at	|O
room	|O
temperature	|O
and	|O
for	|O
24	|O
h	|O
at	|O
body	|O
temperature	|O
.	|O

CD4	|B-PROTEIN
lymphocyte	|O
and	|O
viral	|O
load	|O
levels	|O
suggested	|O
an	|O
optimal	|O
response	|O
to	|O
ARV	|O
therapy	|O
at	|O
the	|O
time	|O
LD	|O
developed	|O
.	|O

(	|O
1992	|O
)	|O
Biochemistry	|O
31	|O
,	|O
3351-3358	|O
]	|O
.	|O

Levels	|O
of	|O
serum	|O
IgE	|B-PROTEIN
were	|O
measured	|O
monthly	|O
,	|O
and	|O
nasal	|O
IgE	|B-PROTEIN
was	|O
measured	|O
at	|O
the	|O
height	|O
and	|O
end	|O
of	|O
the	|O
season	|O
.	|O

A	|O
mutation	|O
in	|O
the	|O
5'	|O
C2U4	|O
repeat	|O
causes	|O
underaccumulation	|O
of	|O
snR13F	|B-PROTEIN
,	|O
whereas	|O
mutations	|O
in	|O
the	|O
3'	|O
C2U4	|O
repeat	|O
cause	|O
the	|O
accumulation	|O
of	|O
two	|O
novel	|O
RNAs	|O
that	|O
migrate	|O
in	|O
the	|O
500	|O
-	|O
nt	|O
range	|O
.	|O

By	|O
directly	|O
interacting	|O
with	|O
both	|O
Arfs	|B-PROTEIN
and	|O
tyrosine	|B-PROTEIN
kinases	|I-PROTEIN
involved	|O
in	|O
regulating	|O
cell	|O
growth	|O
and	|O
cytoskeletal	|O
organization	|O
,	|O
ASAP1	|B-PROTEIN
could	|O
coordinate	|O
membrane	|O
remodeling	|O
events	|O
with	|O
these	|O
processes	|O
.	|O

By	|O
DNase	|B-PROTEIN
I	|I-PROTEIN
footprint	|O
analysis	|O
of	|O
the	|O
PNR	|O
element	|O
,	|O
a	|O
palindrome	|O
of	|O
two	|O
high	|O
-	|O
affinity	|O
Ets	|B-PROTEIN
-	|O
binding	|O
sites	|O
(	|O
CTTCCCTGGAAG	|O
)	|O
was	|O
identified	|O
.	|O

These	|O
sorting	|O
nexins	|B-PROTEIN
also	|O
associated	|O
with	|O
the	|O
long	|O
isoform	|O
of	|O
the	|O
leptin	|B-PROTEIN
receptor	|I-PROTEIN
but	|O
not	|O
with	|O
the	|O
short	|O
and	|O
medium	|O
isoforms	|O
.	|O

Cyclophilins	|B-PROTEIN
are	|O
cis	|O
-	|O
trans	|O
-	|O
peptidyl	|O
-	|O
prolyl	|O
isomerases	|B-PROTEIN
that	|O
bind	|O
to	|O
and	|O
are	|O
inhibited	|O
by	|O
the	|O
immunosuppressant	|O
cyclosporin	|O
A	|O
(	|O
CsA	|O
)	|O
.	|O

In	|O
vitro	|O
protein	|O
retention	|O
experiments	|O
in	|O
which	|O
Hsp90	|B-PROTEIN
heterocomplexes	|O
were	|O
precipitated	|O
resulted	|O
in	|O
coprecipitation	|O
of	|O
Cns1	|B-PROTEIN
.	|O

The	|O
Ras	|B-PROTEIN
-	|I-PROTEIN
related	|I-PROTEIN
GTPases	|I-PROTEIN
are	|O
small	|O
,	|O
20	|O
-	|O
to	|O
25	|O
-	|O
kDa	|O
proteins	|O
which	|O
cycle	|O
between	|O
an	|O
inactive	|O
GDP	|O
-	|O
bound	|O
form	|O
and	|O
an	|O
active	|O
GTP	|O
-	|O
bound	|O
state	|O
.	|O

To	|O
modulate	|O
transcription	|O
,	|O
regulatory	|O
factors	|O
communicate	|O
with	|O
basal	|O
transcription	|O
factors	|O
and	|O
/	|O
or	|O
RNA	|B-PROTEIN
polymerases	|I-PROTEIN
in	|O
a	|O
variety	|O
of	|O
ways	|O
.	|O

Endogenous	|O
RMP	|B-PROTEIN
was	|O
immunologically	|O
detected	|O
interacting	|O
with	|O
assembled	|O
RPB5	|B-PROTEIN
in	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
in	|O
mammalian	|O
cells	|O
.	|O

In	|O
this	|O
study	|O
,	|O
rabbits	|O
were	|O
used	|O
to	|O
evaluate	|O
the	|O
sutured	|O
wound	|O
reaction	|O
with	|O
Dexon	|O
or	|O
nylon	|O
in	|O
the	|O
conjunctival	|O
flap	|O
1	|O
,	|O
4	|O
,	|O
7	|O
,	|O
14	|O
and	|O
28	|O
days	|O
after	|O
trabeculectomy	|O
surgery	|O
with	|O
or	|O
without	|O
the	|O
use	|O
of	|O
mitomycin	|O
-	|O
C.	|O

The	|O
mapping	|O
was	|O
completed	|O
with	|O
Southern	|O
blotting	|O
and	|O
restriction	|O
analysis	|O
.	|O

The	|O
zona	|O
pellucida	|O
(	|O
ZP	|O
)	|O
,	|O
the	|O
extracellular	|O
glycocalyx	|O
that	|O
surrounds	|O
the	|O
oocyte	|O
,	|O
is	|O
well	|O
known	|O
to	|O
mediate	|O
homologous	|O
gamete	|O
interaction	|O
.	|O

Therapeutic	|O
use	|O
of	|O
continuous	|O
subcutaneous	|O
infusion	|O
of	|O
recombinant	|O
human	|O
erythropoietin	|B-PROTEIN
in	|O
malnourished	|O
predialysis	|O
anemic	|O
patients	|O
with	|O
diabetic	|O
nephropathy	|O
.	|O

Although	|O
pathological	|O
thyroid	|O
function	|O
is	|O
related	|O
to	|O
changes	|O
in	|O
energy	|O
expenditure	|O
and	|O
body	|O
composition	|O
,	|O
its	|O
possible	|O
influence	|O
on	|O
leptin	|B-PROTEIN
levels	|O
remains	|O
to	|O
be	|O
determined	|O
.	|O

These	|O
cognitive	|O
deficits	|O
were	|O
prevented	|O
in	|O
animals	|O
treated	|O
with	|O
MK	|O
-	|O
801	|O
during	|O
SE	|O
.	|O

Here	|O
we	|O
demonstrate	|O
that	|O
the	|O
mechanism	|O
of	|O
activation	|O
of	|O
HIF	|B-PROTEIN
-	|I-PROTEIN
1alpha	|I-PROTEIN
is	|O
a	|O
multi	|O
-	|O
step	|O
process	|O
which	|O
includes	|O
hypoxia	|O
-	|O
dependent	|O
nuclear	|O
import	|O
and	|O
activation	|O
(	|O
derepression	|O
)	|O
of	|O
the	|O
transactivation	|O
domain	|O
,	|O
resulting	|O
in	|O
recruitment	|O
of	|O
the	|O
CREB	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
(	|O
CBP	|B-PROTEIN
)	|O
/	|O
p300	|B-PROTEIN
coactivator	|O
.	|O

Thus	|O
,	|O
hypoxia	|O
-	|O
inducible	|O
nuclear	|O
import	|O
and	|O
transactivation	|O
by	|O
recruitment	|O
of	|O
CBP	|B-PROTEIN
can	|O
be	|O
functionally	|O
separated	|O
from	|O
one	|O
another	|O
and	|O
play	|O
critical	|O
roles	|O
in	|O
signal	|O
transduction	|O
by	|O
HIF	|B-PROTEIN
-	|I-PROTEIN
1alpha	|I-PROTEIN
.	|O

The	|O
rat	|O
aldolase	|B-PROTEIN
C	|I-PROTEIN
gene	|O
encodes	|O
a	|O
glycolytic	|O
enzyme	|O
strongly	|O
expressed	|O
in	|O
adult	|O
brain	|O
.	|O

A	|O
synergistic	|O
effect	|O
on	|O
HCK	|B-PROTEIN
promoter	|O
activity	|O
was	|O
observed	|O
at	|O
high	|O
concentrations	|O
of	|O
Sp1	|B-PROTEIN
.	|O

Quinone	|O
-	|O
binding	|O
domain	|O
and	|O
amino	|O
acid	|O
residues	|O
involved	|O
in	|O
quinone	|O
binding	|O
.	|O

Western	|O
analyses	|O
with	|O
antisera	|O
raised	|O
against	|O
Lu	|B-PROTEIN
-	|I-PROTEIN
ECAM	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
peptides	|O
show	|O
that	|O
the	|O
N	|O
-	|O
terminal	|O
region	|O
of	|O
the	|O
predicted	|O
open	|O
reading	|O
frame	|O
is	|O
present	|O
only	|O
in	|O
the	|O
larger	|O
size	|O
proteins	|O
(	|O
i.e.	|O

Mammalian	|O
sperm	|O
motility	|O
is	|O
regulated	|O
by	|O
a	|O
cascade	|O
of	|O
cAMP	|O
-	|O
dependent	|O
protein	|O
phosphorylation	|O
events	|O
mediated	|O
by	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
A.	|I-PROTEIN

In	|O
this	|O
paper	|O
,	|O
we	|O
show	|O
that	|O
,	|O
like	|O
BAP2	|B-PROTEIN
,	|O
the	|O
expression	|O
of	|O
the	|O
BAP3	|B-PROTEIN
gene	|O
in	|O
S.	|O
cerevisiae	|O
is	|O
induced	|O
by	|O
the	|O
addition	|O
of	|O
branched	|O
-	|O
chain	|O
amino	|O
acids	|O
to	|O
the	|O
medium	|O
.	|O

Effect	|O
of	|O
enteral	|O
nutritional	|O
products	|O
differing	|O
in	|O
carbohydrate	|O
and	|O
fat	|O
on	|O
indices	|O
of	|O
carbohydrate	|O
and	|O
lipid	|O
metabolism	|O
in	|O
patients	|O
with	|O
NIDDM	|O
.	|O

Low	|O
-	|O
grade	|O
gastric	|O
MALT	|O
lymphoma	|O
and	|O
helicobacter	|O
heilmannii	|O
(	|O
Gastrospirillum	|O
hominis	|O

These	|O
studies	|O
support	|O
the	|O
view	|O
that	|O
HMG	|B-PROTEIN
I	|I-PROTEIN
(	|I-PROTEIN
Y	|I-PROTEIN
)	|I-PROTEIN
is	|O
an	|O
important	|O
cofactor	|O
for	|O
HLA	|B-PROTEIN
-	|I-PROTEIN
DRA	|I-PROTEIN
gene	|O
activation	|O
by	|O
Oct	|B-PROTEIN
-	|I-PROTEIN
2A	|I-PROTEIN
and	|O
provide	|O
insights	|O
into	|O
its	|O
mechanism	|O
of	|O
action	|O
.	|O

In	|O
contrast	|O
to	|O
hemodynamic	|O
and	|O
histopathological	|O
predictors	|O
of	|O
survival	|O
,	|O
vWF	|B-PROTEIN
:	|O
Ag	|O
does	|O
not	|O
require	|O
invasive	|O
techniques	|O
to	|O
be	|O
determined	|O
.	|O

CONCLUSION	|O
:	|O
We	|O
were	|O
unable	|O
to	|O
identify	|O
features	|O
of	|O
disease	|O
likely	|O
to	|O
be	|O
associated	|O
with	|O
a	|O
clinically	|O
useful	|O
response	|O
to	|O
inhaled	|O
NO	|O
therapy	|O
using	|O
the	|O
parameters	|O
studied	|O
.	|O

We	|O
find	|O
that	|O
BCL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
POZ	|O
domain	|O
mutations	|O
that	|O
disrupt	|O
the	|O
interaction	|O
with	|O
N	|B-PROTEIN
-	|I-PROTEIN
CoR	|I-PROTEIN
and	|O
SMRT	|B-PROTEIN
no	|O
longer	|O
repress	|O
transcription	|O
.	|O

Partial	|O
characterization	|O
of	|O
the	|O
active	|O
site	|O
human	|O
platelet	|O
cAMP	|B-PROTEIN
phosphodiesterase	|I-PROTEIN
,	|O
PDE3A	|B-PROTEIN
,	|O
by	|O
site	|O
-	|O
directed	|O
mutagenesis	|O
.	|O

This	|O
core	|O
sequence	|O
,	|O
along	|O
with	|O
additional	|O
nonspecific	|O
downstream	|O
nucleotides	|O
,	|O
is	|O
sufficient	|O
for	|O
partial	|O
suppression	|O
of	|O
spliceosome	|O
assembly	|O
and	|O
splicing	|O
of	|O
BPV	|O
-	|O
1	|O
pre	|O
-	|O
mRNAs	|O
.	|O

Over	|O
-	|O
expression	|O
of	|O
the	|O
cofactor	|O
p300	|B-PROTEIN
,	|O
which	|O
functions	|O
as	|O
a	|O
coactivator	|O
of	|O
myoD	|B-PROTEIN
-	|O
mediated	|O
transcription	|O
,	|O
alleviated	|O
repression	|O
by	|O
COUP	|B-PROTEIN
-	|I-PROTEIN
TF	|I-PROTEIN
II	|I-PROTEIN
.	|O

Familial	|O
autoimmune	|O
hepatitis	|O
and	|O
C4	|B-PROTEIN
deficiency	|O

No	|O
mutations	|O
were	|O
found	|O
in	|O
follicular	|O
adenomas	|O
.	|O

Since	|O
glutathione	|B-PROTEIN
peroxidase	|I-PROTEIN
(	|O
GPX	|B-PROTEIN
)	|O
and	|O
superoxide	|B-PROTEIN
dismutase	|I-PROTEIN
(	|O
SOD	|B-PROTEIN
)	|O
play	|O
a	|O
significant	|O
role	|O
in	|O
erythrocyte	|O
antioxidative	|O
defence	|O
,	|O
it	|O
is	|O
very	|O
important	|O
to	|O
determine	|O
their	|O
activity	|O
in	|O
occupationally	|O
exposed	|O
workers	|O
.	|O

Retroviral	|O
nucleocapsid	|B-PROTEIN
proteins	|I-PROTEIN
(	|O
NCPs	|O
)	|O
are	|O
CCHC	|O
-	|O
type	|O
zinc	|B-PROTEIN
finger	|I-PROTEIN
proteins	|I-PROTEIN
that	|O
mediate	|O
virion	|O
RNA	|O
binding	|O
activities	|O
associated	|O
with	|O
retrovirus	|O
assembly	|O
and	|O
genomic	|O
RNA	|O
encapsidation	|O
.	|O

The	|O
Schizosaccharomyces	|O
pombe	|O
rad1+	|B-PROTEIN
cell	|O
cycle	|O
checkpoint	|O
control	|O
gene	|O
is	|O
required	|O
for	|O
S	|O
-	|O
phase	|O
and	|O
G2	|O
/	|O
M	|O
arrest	|O
in	|O
response	|O
to	|O
both	|O
DNA	|O
damage	|O
and	|O
incomplete	|O
DNA	|O
replication	|O
.	|O

It	|O
is	|O
now	|O
well	|O
established	|O
that	|O
progression	|O
through	|O
the	|O
eukaryotic	|O
cell	|O
cycle	|O
is	|O
controlled	|O
by	|O
oscillations	|O
in	|O
the	|O
activity	|O
of	|O
cyclin	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
kinases	|I-PROTEIN
(	|O
CDKs	|B-PROTEIN
)	|O
.	|O

Positive	|O
genetic	|O
selections	|O
for	|O
inhibition	|O
of	|O
cyclin	|B-PROTEIN
/	|O
CDK	|B-PROTEIN
function	|O
were	|O
characterized	|O
using	|O
the	|O
E.	|O
coli	|O
neo	|B-PROTEIN
and	|O
yeast	|O
LEU2	|B-PROTEIN
genes	|O
.	|O

The	|O
hematopoietic	|B-PROTEIN
colony	|I-PROTEIN
-	|I-PROTEIN
stimulating	|I-PROTEIN
factors	|I-PROTEIN
(	|O
CSF	|B-PROTEIN
)	|O
have	|O
been	|O
introduced	|O
into	|O
clinical	|O
practice	|O
as	|O
additional	|O
supportive	|O
measures	|O
that	|O
can	|O
reduce	|O
the	|O
incidence	|O
of	|O
infectious	|O
complications	|O
in	|O
patients	|O
with	|O
cancer	|O
and	|O
neutropenia	|O
.	|O

All	|O
injections	|O
of	|O
CSF	|B-PROTEIN
were	|O
given	|O
after	|O
the	|O
initiation	|O
of	|O
neutropenia	|O
and	|O
continued	|O
until	|O
the	|O
occurrence	|O
of	|O
an	|O
absolute	|O
neutrophil	|O
recovery	|O
.	|O
rHu	|B-PROTEIN
GM	|I-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
and	|O
rHu	|B-PROTEIN
G	|I-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
,	|O
administered	|O
once	|O
daily	|O
at	|O
the	|O
250	|O
microg	|O
m	|O
(	|O
-	|O
2	|O
)	|O
day	|O
(	|O
-	|O
1	|O
)	|O
and	|O
5	|O
microg	|O
kg	|O
(	|O
-	|O
1	|O
)	|O
day	|O
(	|O
-	|O
1	|O
)	|O
level	|O
,	|O
were	|O
effective	|O
in	|O
increasing	|O
the	|O
absolute	|O
neutrophil	|O
count	|O
and	|O
neutrophil	|O
function	|O
,	|O
as	|O
measured	|O
by	|O
an	|O
automated	|O
chemiluminescence	|O
system	|O
.	|O

Expression	|O
of	|O
lacZ	|B-PROTEIN
from	|O
the	|O
promoter	|O
of	|O
the	|O
Escherichia	|O
coli	|O
spc	|B-PROTEIN
operon	|O
cloned	|O
into	|O
vectors	|O
carrying	|O
the	|O
W205	|O
trp	|B-PROTEIN
-	|O
lac	|B-PROTEIN
fusion	|O
.	|O

We	|O
evaluated	|O
regional	|O
right	|O
ventricular	|O
wall	|O
motion	|O
during	|O
systole	|O
in	|O
patients	|O
with	|O
surgically	|O
repaired	|O
tetralogy	|O
of	|O
Fallot	|O
(	|O
TOF	|O
)	|O
using	|O
color	|O
kinesis	|O
imaging	|O
.	|O

RT	|O
-	|O
PCR	|O
analysis	|O
showed	|O
that	|O
PLP	|B-PROTEIN
-	|I-PROTEIN
H	|I-PROTEIN
as	|O
well	|O
as	|O
PLP	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
and	|O
PLP	|B-PROTEIN
-	|I-PROTEIN
D	|I-PROTEIN
are	|O
expressed	|O
in	|O
all	|O
rat	|O
strains	|O
examined	|O
,	|O
confirming	|O
that	|O
PLP	|B-PROTEIN
diversity	|O
is	|O
not	|O
due	|O
to	|O
strain	|O
differences	|O
.	|O

Molecular	|O
cloning	|O
and	|O
characterization	|O
of	|O
a	|O
new	|O
member	|O
of	|O
the	|O
rat	|O
placental	|O
prolactin	|B-PROTEIN
(	|O
PRL	|B-PROTEIN
)	|O
family	|O
,	|O
PRL	|B-PROTEIN
-	|O
like	|O
protein	|B-PROTEIN
H.	|I-PROTEIN

Interestingly	|O
,	|O
we	|O
find	|O
that	|O
the	|O
interaction	|O
between	|O
Tat	|B-PROTEIN
and	|O
hCycT1	|B-PROTEIN
requires	|O
zinc	|O
as	|O
well	|O
as	|O
essential	|O
cysteine	|O
residues	|O
in	|O
both	|O
proteins	|O
.	|O

Thus	|O
,	|O
we	|O
have	|O
identified	|O
an	|O
activation	|O
target	|O
of	|O
a	|O
human	|O
activator	|O
,	|O
Oct	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
within	|O
its	|O
cognate	|O
basal	|O
transcription	|O
complex	|O
.	|O

During	|O
early	|O
neurogenesis	|O
,	|O
Vnd	|B-PROTEIN
protein	|O
is	|O
restricted	|O
to	|O
ventral	|O
column	|O
neuroectoderm	|O
and	|O
neuroblasts	|O
;	|O
later	|O
it	|O
is	|O
detected	|O
in	|O
a	|O
complex	|O
pattern	|O
of	|O
neurons	|O
.	|O

The	|O
repression	|O
domain	|O
,	|O
and	|O
indeed	|O
the	|O
entire	|O
Cdc68	|B-PROTEIN
protein	|O
,	|O
is	|O
highly	|O
conserved	|O
,	|O
as	|O
shown	|O
by	|O
the	|O
sequence	|O
of	|O
the	|O
Cdc68	|B-PROTEIN
functional	|O
homolog	|O
from	|O
the	|O
yeast	|O
Kluyveromyces	|O
lactis	|O
and	|O
by	|O
database	|O
searches	|O
.	|O

The	|O
exodomain	|O
alone	|O
has	|O
the	|O
high	|O
affinity	|O
hormone	|O
binding	|O
site	|O
but	|O
is	|O
not	|O
capable	|O
of	|O
generating	|O
hormonal	|O
signal	|O
.	|O

Pyrrolidine	|O
dithiocarbamate	|O
,	|O
a	|O
potent	|O
transcriptional	|O
inhibitor	|O
of	|O
the	|O
viral	|B-PROTEIN
LTR	|I-PROTEIN
,	|O
abrogated	|O
the	|O
cytokine	|O
responses	|O
in	|O
both	|O
U1	|O
and	|O
ACH	|O
-	|O
2	|O
cells	|O
,	|O
suggesting	|O
a	|O
common	|O
TNF	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
-	|O
mediated	|O
transcriptional	|O
mechanism	|O
in	|O
these	|O
cell	|O
types	|O
despite	|O
their	|O
different	|O
modes	|O
of	|O
provirus	|O
latency	|O
.	|O

Furthermore	|O
,	|O
synergistic	|O
activation	|O
of	|O
ERK2	|B-PROTEIN
occurred	|O
in	|O
the	|O
absence	|O
of	|O
changes	|O
in	|O
intracellular	|O
Ca2+	|O
,	|O
and	|O
was	|O
not	|O
blocked	|O
by	|O
inhibition	|O
of	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
C	|I-PROTEIN
activity	|O
and	|O
represents	|O
a	|O
separate	|O
pathway	|O
by	|O
which	|O
CD19	|B-PROTEIN
regulates	|O
B	|O
cell	|O
function	|O
.	|O

The	|O
retrovesical	|O
hydatid	|O
cyst	|O
is	|O
a	|O
very	|O
rare	|O
site	|O
.	|O

Biochemical	|O
analysis	|O
reveals	|O
that	|O
KS1	|B-PROTEIN
is	|O
a	|O
nuclear	|O
protein	|O
containing	|O
two	|O
transcriptional	|O
repressor	|O
domains	|O
,	|O
R1	|O
and	|O
R2	|O
.	|O

However	|O
,	|O
the	|O
BCH	|O
group	|O
showed	|O
inferior	|O
gross	|O
motor	|O
performance	|O
on	|O
the	|O
Bruininks	|O
-	|O
Oseretsky	|O
Test	|O
of	|O
Motor	|O
Proficiency	|O
(	|O
Bruininks	|O
1978	|O
)	|O
.	|O

The	|O
results	|O
raise	|O
the	|O
possibility	|O
that	|O
pH	|O
induced	|O
post	|O
-	|O
translational	|O
modifications	|O
of	|O
DdRPA	|B-PROTEIN
are	|O
involved	|O
in	|O
events	|O
that	|O
halt	|O
cell	|O
proliferation	|O
and	|O
induce	|O
differentiation	|O
in	|O
Dictyostelium	|O
.	|O

We	|O
report	|O
here	|O
that	|O
,	|O
for	|O
a	|O
constant	|O
amount	|O
of	|O
transfected	|O
DNA	|O
,	|O
the	|O
level	|O
of	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
(	|O
CAT	|B-PROTEIN
)	|O
mRNA	|O
is	|O
increased	|O
in	|O
Vpr	|B-PROTEIN
-	|O
expressing	|O
cells	|O
using	|O
either	|O
HIV	|O
-	|O
1	|O
or	|O
a	|O
murine	|O
leukemia	|O
virus	|O
(	|O
MLV	|O
)	|O
SL3	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
LTR	|O
-	|O
CAT	|B-PROTEIN
reporter	|O
construct	|O
.	|O

We	|O
identified	|O
telSMN	|B-PROTEIN
mutations	|O
in	|O
11	|O
of	|O
these	|O
unrelated	|O
SMA	|O
-	|O
like	|O
individuals	|O
who	|O
carry	|O
a	|O
single	|O
copy	|O
of	|O
telSMN	|B-PROTEIN
:	|O
these	|O
include	|O
two	|O
frameshift	|O
mutations	|O
(	|O
800ins11	|O
and	|O
542delGT	|O
)	|O
and	|O
three	|O
missense	|O
mutations	|O
(	|O
A2G	|O
,	|O
S262I	|O
,	|O
and	|O
T274I	|O
)	|O
.	|O

The	|O
decrease	|O
of	|O
TNF	|B-PROTEIN
receptors	|I-PROTEIN
by	|O
IL	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
was	|O
accompanied	|O
by	|O
down	|O
-	|O
regulation	|O
of	|O
TNF	|B-PROTEIN
-	|O
induced	|O
activities	|O
,	|O
including	|O
cytotoxicity	|O
,	|O
caspase	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
activation	|O
,	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
and	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
activation	|O
,	|O
and	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
N	|O
-	|O
terminal	|O
kinase	|O
induction	|O
.	|O

Type	|B-PROTEIN
2	|I-PROTEIN
deiodinase	|I-PROTEIN
(	|O
D2	|B-PROTEIN
)	|O
catalyzes	|O
the	|O
5'	|O
-	|O
deiodination	|O
of	|O
thyroxine	|O
to	|O
form	|O
3,5,3	|O
'	|O
-	|O
triiodothyronine	|O
.	|O

We	|O
have	|O
identified	|O
two	|O
overlapping	|O
expressed	|O
sequence	|O
tag	|O
clones	|O
,	|O
which	|O
contain	|O
the	|O
missing	|O
4.4	|O
-	|O
kb	|O
3'	|O
-	|O
UTR	|O
of	|O
the	|O
human	|O
D2	|B-PROTEIN
(	|O
hD2	|B-PROTEIN
)	|O
cDNA	|O
.	|O

Biol.	|O

Here	|O
we	|O
have	|O
investigated	|O
the	|O
structural	|O
requirements	|O
and	|O
consequences	|O
of	|O
regulatory	|O
phosphorylation	|O
for	|O
the	|O
interaction	|O
between	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
and	|O
JNK	|B-PROTEIN
in	|O
vivo	|O
.	|O

P	|B-PROTEIN
-	|I-PROTEIN
CIP1	|I-PROTEIN
,	|O
a	|O
novel	|O
protein	|O
that	|O
interacts	|O
with	|O
the	|O
cytosolic	|O
domain	|O
of	|O
peptidylglycine	|B-PROTEIN
alpha	|I-PROTEIN
-	|I-PROTEIN
amidating	|I-PROTEIN
monooxygenase	|I-PROTEIN
,	|O
is	|O
associated	|O
with	|O
endosomes	|O
.	|O

Immunolocalization	|O
of	|O
Sop1p	|B-PROTEIN
revealed	|O
a	|O
cytoplasmic	|O
distribution	|O
and	|O
cell	|O
fractionation	|O
studies	|O
showed	|O
that	|O
a	|O
significant	|O
fraction	|O
of	|O
Sop1p	|B-PROTEIN
was	|O
recovered	|O
in	|O
a	|O
sedimentable	|O
fraction	|O
of	|O
the	|O
cytosolic	|O
material	|O
.	|O

Resultant	|O
activation	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
N	|I-PROTEIN
-	|I-PROTEIN
terminal	|I-PROTEIN
kinase	|I-PROTEIN
/	|O
stress	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
JNK	|B-PROTEIN
/	|O
SAPK	|B-PROTEIN
)	|O
.	|O

Here	|O
we	|O
report	|O
the	|O
full	|O
-	|O
length	|O
coding	|O
cDNA	|O
sequence	|O
of	|O
the	|O
mouse	|O
homologue	|O
of	|O
MPP3	|B-PROTEIN
.	|O

The	|O
method	|O
also	|O
eliminates	|O
tagging	|O
of	|O
venous	|O
spins	|O
and	|O
concern	|O
about	|O
asymmetric	|O
magnetization	|O
transfer	|O
effects	|O
.	|O

Consistent	|O
with	|O
this	|O
,	|O
purified	|O
Dlk	|B-PROTEIN
phosphorylated	|O
core	|O
histones	|B-PROTEIN
H3	|O
,	|O
H2A	|B-PROTEIN
and	|O
H4	|B-PROTEIN
as	|O
exogenous	|O
substrates	|O
and	|O
endogenous	|O
histone	|B-PROTEIN
H3	|O
in	|O
kinase	|O
assays	|O
with	|O
nuclear	|O
extracts	|O
.	|O

In	|O
this	|O
study	|O
we	|O
provide	|O
evidence	|O
that	|O
B	|B-PROTEIN
-	|I-PROTEIN
Myb	|I-PROTEIN
is	|O
a	|O
direct	|O
physiological	|O
target	|O
for	|O
cyclin	|B-PROTEIN
A	|I-PROTEIN
/	|O
Cdk2	|B-PROTEIN
.	|O

Neither	|O
Ha	|B-PROTEIN
-	|I-PROTEIN
Ras	|I-PROTEIN
(	|O
G12V	|O
,	|O
T35S	|O
)	|O
(	|O
Ha	|B-PROTEIN
-	|I-PROTEIN
RasV12S35	|I-PROTEIN
)	|O
,	|O
which	|O
activates	|O
the	|O
Rafl	|B-PROTEIN
signaling	|O
pathway	|O
,	|O
nor	|O
Ha	|B-PROTEIN
-	|I-PROTEIN
Ras	|I-PROTEIN
(	|O
G12V	|O
,	|O
E37G	|O
)	|O
(	|O
Ha	|B-PROTEIN
-	|I-PROTEIN
RasV12G37	|I-PROTEIN
)	|O
,	|O
which	|O
stimulates	|O
the	|O
RalGDS	|B-PROTEIN
pathway	|O
,	|O
did	|O
not	|O
have	|O
significant	|O
effects	|O
on	|O
factor	|O
-	|O
withdrawal	|O
apoptosis	|O
of	|O
myeloid	|O
cells	|O
.	|O

We	|O
have	|O
isolated	|O
a	|O
novel	|O
human	|O
cyclin	|B-PROTEIN
,	|O
cyclin	|B-PROTEIN
E2	|O
,	|O
that	|O
contains	|O
significant	|O
homology	|O
to	|O
cyclin	|B-PROTEIN
E.	|O

Initial	|O
experience	|O
with	|O
the	|O
new	|O
technology	|O
indicates	|O
that	|O
SieScape	|O
is	|O
an	|O
alternative	|O
to	|O
other	|O
methods	|O
such	|O
as	|O
CT	|O
and	|O
MRI	|O
.	|O

The	|O
dopamine	|O
D4	|B-PROTEIN
receptor	|I-PROTEIN
as	|O
well	|O
as	|O
many	|O
other	|O
catecholaminergic	|B-PROTEIN
receptors	|I-PROTEIN
contain	|O
several	|O
putative	|O
SH3	|B-PROTEIN
binding	|O
domains	|O
.	|O

The	|O
highly	|O
amyloidogenic	|O
42	|O
-	|O
residue	|O
form	|O
of	|O
Abeta	|B-PROTEIN
(	|O
Abeta42	|B-PROTEIN
)	|O
is	|O
the	|O
first	|O
species	|O
to	|O
be	|O
deposited	|O
in	|O
both	|O
sporadic	|O
and	|O
familial	|O
AD	|O
.	|O

This	|O
model	|O
is	|O
supported	|O
by	|O
experiments	|O
showing	|O
that	|O
Cdr2	|B-PROTEIN
associates	|O
with	|O
the	|O
N	|O
-	|O
terminal	|O
regulatory	|O
domain	|O
of	|O
Wee1	|B-PROTEIN
in	|O
cell	|O
lysates	|O
and	|O
phosphorylates	|O
Wee1	|B-PROTEIN
in	|O
vitro	|O
.	|O

Schizosaccharomyces	|O
pombe	|O
cells	|O
respond	|O
to	|O
nutrient	|O
deprivation	|O
by	|O
altering	|O
G2	|O
/	|O
M	|O
cell	|O
size	|O
control	|O
.	|O

A	|O
-	|O
tracts	|O
functioned	|O
best	|O
when	|O
positioned	|O
close	|O
to	|O
the	|O
-	|O
35	|O
hexamer	|O
rather	|O
than	|O
one	|O
helical	|O
turn	|O
farther	|O
upstream	|O
,	|O
similar	|O
to	|O
the	|O
positioning	|O
optimal	|O
for	|O
UP	|O
element	|O
function	|O
.	|O

Pyk2	|B-PROTEIN
phosphorylation	|O
increased	|O
upon	|O
adherence	|O
of	|O
FLG	|O
29.1	|O
cells	|O
to	|O
fibronectin	|B-PROTEIN
and	|O
to	|O
ST2	|O
stromal	|O
cells	|O
.	|O

Raf	|B-PROTEIN
is	|O
a	|O
key	|O
serine	|B-PROTEIN
-	|I-PROTEIN
threonine	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
which	|O
participates	|O
in	|O
the	|O
transmission	|O
of	|O
growth	|O
,	|O
anti	|O
-	|O
apoptotic	|O
and	|O
differentiation	|O
messages	|O
.	|O

The	|O
US	|O
National	|O
Institute	|O
on	|O
Alcohol	|O
Abuse	|O
and	|O
Alcoholism	|O
(	|O
NIAAA	|O
)	|O
recognizes	|O
two	|O
forms	|O
of	|O
problematic	|O
drinking	|O
:	|O
'	|O
willful	|O
alcohol	|O
abuse	|O
'	|O
,	|O
a	|O
behavioural	|O
problem	|O
,	|O
and	|O
'	|O
alcohol	|O
dependence	|O
'	|O
,	|O
a	|O
true	|O
medical	|O
disorder	|O
,	|O
which	|O
includes	|O
a	|O
genetic	|O
component	|O
,	|O
that	|O
can	|O
be	|O
scientifically	|O
understood	|O
and	|O
medically	|O
treated	|O
.	|O

Collagen	|B-PROTEIN
was	|O
extracted	|O
from	|O
the	|O
skin	|O
,	|O
and	|O
the	|O
lack	|O
of	|O
type	|B-PROTEIN
III	|I-PROTEIN
collagen	|I-PROTEIN
was	|O
determined	|O
by	|O
means	|O
of	|O
sodium	|O
dodecyl	|O
sulfate	|O
-	|O
polyacrylamide	|O
gel	|O
electrophoresis	|O
(	|O
SDS	|O
-	|O
PAGE	|O
)	|O
.	|O

RESULTS	|O
:	|O
During	|O
the	|O
7	|O
-	|O
year	|O
period	|O
,	|O
10,331	|O
symptomatic	|O
duodenal	|O
ulcer	|O
diseases	|O
were	|O
diagnosed	|O
.	|O

RESULTS	|O
:	|O
Significant	|O
changes	|O
from	|O
pretreatment	|O
to	|O
posttreatment	|O
were	|O
observed	|O
(	|O
p	|O
<	|O
0.001	|O
)	|O
.	|O

In	|O
turn	|O
,	|O
assembly	|O
of	|O
this	|O
complex	|O
mediates	|O
the	|O
enzymatic	|O
activation	|O
of	|O
the	|O
p21	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
1	|I-PROTEIN
and	|O
facilitates	|O
actin	|B-PROTEIN
polymerization	|O
.	|O

The	|O
tip	|O
of	|O
the	|O
button	|O
caused	|O
a	|O
perforation	|O
of	|O
the	|O
posterior	|O
stomach	|O
wall	|O
,	|O
leading	|O
to	|O
death	|O
.	|O

Jembrana	|O
disease	|O
virus	|O
(	|O
JDV	|O
)	|O
is	|O
a	|O
newly	|O
identified	|O
bovine	|O
lentivirus	|O
that	|O
is	|O
closely	|O
related	|O
to	|O
the	|O
bovine	|O
immunodeficiency	|O
virus	|O
(	|O
BIV	|O
)	|O
.	|O

Approximately	|O
50%	|O
of	|O
the	|O
residues	|O
are	|O
conserved	|O
among	|O
all	|O
three	|O
sequences	|O
,	|O
yet	|O
all	|O
three	|O
viruses	|O
have	|O
retained	|O
response	|O
elements	|O
for	|O
glucocorticoids	|O
,	|O
two	|O
positionally	|O
conserved	|O
CCAAT	|O
boxes	|O
,	|O
and	|O
positionally	|O
conserved	|O
TATA	|O
boxes	|O
.	|O

Nhp2p	|B-PROTEIN
is	|O
a	|O
highly	|O
basic	|O
protein	|O
that	|O
belongs	|O
to	|O
a	|O
family	|O
of	|O
putative	|O
RNA	|O
-	|O
binding	|O
proteins	|O
.	|O

This	|O
survey	|O
included	|O
3000	|O
randomly	|O
selected	|O
Norwegians	|O
above	|O
18	|O
years	|O
of	|O
age	|O
who	|O
received	|O
the	|O
European	|O
Organization	|O
for	|O
Research	|O
and	|O
Treatment	|O
of	|O
Cancer	|O
Core	|O
Quality	|O
of	|O
Life	|O
Questionnaire	|O
(	|O
EORTC	|O
QLQ	|O
-	|O
C30	|O
(	|O
+	|O
3	|O
)	|O
by	|O
mail	|O
.	|O

During	|O
presentation	|O
of	|O
happy	|O
facial	|O
expressions	|O
,	|O
we	|O
detected	|O
a	|O
signal	|O
increase	|O
predominantly	|O
in	|O
the	|O
left	|O
anterior	|O
cingulate	|O
gyrus	|O
,	|O
bilateral	|O
posterior	|O
cingulate	|O
gyri	|O
,	|O
medial	|O
frontal	|O
cortex	|O
and	|O
right	|O
supramarginal	|O
gyrus	|O
,	|O
brain	|O
regions	|O
previously	|O
implicated	|O
in	|O
visuospatial	|O
and	|O
emotion	|O
processing	|O
tasks	|O
.	|O

Down	|O
-	|O
regulation	|O
of	|O
IRS	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
linked	|O
to	|O
its	|O
serine	|O
phosphorylation	|O
dependent	|O
on	|O
PI	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
activity	|O
and	|O
appears	|O
required	|O
for	|O
differentiation	|O
to	|O
occur	|O
,	|O
as	|O
IRS	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
not	|O
modified	|O
and	|O
continues	|O
to	|O
accumulate	|O
in	|O
a	|O
nondifferentiating	|O
myoblast	|O
cell	|O
line	|O
.	|O

This	|O
study	|O
utilizes	|O
the	|O
mammalian	|O
two	|O
-	|O
hybrid	|O
system	|O
to	|O
examine	|O
the	|O
role	|O
of	|O
ligand	|O
in	|O
the	|O
dimerization	|O
of	|O
human	|B-PROTEIN
progesterone	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
hPR	|B-PROTEIN
)	|O
.	|O

One	|O
of	|O
its	|O
unique	|O
features	|O
appears	|O
to	|O
be	|O
the	|O
unusually	|O
short	|O
5'	|O
-	|O
untranslated	|O
regions	|O
(	|O
UTR	|O
)	|O
(	|O
1-6	|O
nucleotides	|O
(	|O
nts	|O
)	|O
)	|O
and	|O
the	|O
apparent	|O
absence	|O
of	|O
5'	|O
-	|O
cap	|O
structures	|O
from	|O
its	|O
mRNAs	|O
.	|O

The	|O
gene	|O
encoding	|O
human	|O
tissue	|B-PROTEIN
-	|I-PROTEIN
type	|I-PROTEIN
plasminogen	|I-PROTEIN
activator	|I-PROTEIN
(	|O
t	|B-PROTEIN
-	|I-PROTEIN
PA	|I-PROTEIN
)	|O
is	|O
regulated	|O
in	|O
a	|O
cell	|O
-	|O
type	|O
-	|O
specific	|O
manner	|O
.	|O

Both	|O
the	|O
presence	|O
of	|O
arginine	|O
and	|O
anaerobiosis	|O
are	|O
needed	|O
to	|O
trigger	|O
induction	|O
of	|O
the	|O
pathway	|O
.	|O

Competition	|O
with	|O
a	|O
putative	|O
MADS	|B-PROTEIN
box	|O
consensus	|O
binding	|O
site	|O
from	|O
the	|O
promoter	|O
of	|O
the	|O
coordinately	|O
regulated	|O
opaque	|O
-	|O
phase	|O
-	|O
specific	|O
gene	|O
PEP1	|B-PROTEIN
(	|O
SAP1	|B-PROTEIN
)	|O
and	|O
the	|O
human	|O
MADS	|B-PROTEIN
box	|O
consensus	|O
binding	|O
site	|O
for	|O
serum	|B-PROTEIN
response	|I-PROTEIN
factor	|I-PROTEIN
demonstrated	|O
that	|O
one	|O
of	|O
the	|O
three	|O
complexes	|O
formed	|O
was	|O
specific	|O
to	|O
the	|O
OP4	|B-PROTEIN
sequence	|O
.	|O

The	|O
human	|O
SHBG	|B-PROTEIN
proximal	|O
promoter	|O
was	|O
analyzed	|O
by	|O
DNase	|B-PROTEIN
I	|I-PROTEIN
footprinting	|O
,	|O
and	|O
the	|O
functional	|O
significance	|O
of	|O
6	|O
footprinted	|O
regions	|O
(	|O
FP1	|O
-	|O
FP6	|O
)	|O
within	|O
the	|O
proximal	|O
promoter	|O
was	|O
studied	|O
in	|O
human	|O
HepG2	|O
hepatoblastoma	|O
cells	|O
.	|O

In	|O
vitro	|O
translation	|O
and	|O
in	|O
vivo	|O
polysome	|O
profile	|O
analysis	|O
indicated	|O
that	|O
transcripts	|B-PROTEIN
C	|I-PROTEIN
and	|O
E	|O
were	|O
translated	|O
with	|O
similar	|O
translational	|O
efficiencies	|O
that	|O
are	|O
substantially	|O
greater	|O
than	|O
that	|O
of	|O
transcript	|B-PROTEIN
D	|I-PROTEIN
,	|O
suggesting	|O
that	|O
5'	|O
-	|O
untranslated	|O
regions	|O
play	|O
a	|O
role	|O
in	|O
translational	|O
control	|O
.	|O

We	|O
have	|O
introduced	|O
a	|O
mutation	|O
(	|O
Ser36	|O
-	|O
-	|O
>	|O
Asn	|O
)	|O
into	|O
this	|O
domain	|O
of	|O
p190	|B-PROTEIN
that	|O
decreased	|O
its	|O
ability	|O
to	|O
bind	|O
guanine	|O
nucleotide	|O
when	|O
expressed	|O
as	|O
a	|O
hemagglutinin	|B-PROTEIN
(	|O
HA	|B-PROTEIN
)	|O
-	|O
tagged	|O
protein	|O
in	|O
COS	|O
cells	|O
.	|O

Wild	|O
type	|O
HA	|B-PROTEIN
-	|O
p190	|B-PROTEIN
induced	|O
a	|O
phenotype	|O
of	|O
rounded	|O
cells	|O
with	|O
long	|O
,	|O
beaded	|O
extensions	|O
similar	|O
to	|O
that	|O
seen	|O
when	|O
Rho	|B-PROTEIN
function	|O
is	|O
disrupted	|O
by	|O
ADP	|O
-	|O
ribosylation	|O
.	|O

We	|O
emphasize	|O
that	|O
ANCA	|B-PROTEIN
-	|O
associated	|O
vasculitis	|O
is	|O
another	|O
important	|O
complication	|O
of	|O
RA	|O
.	|O

The	|O
downstream	|O
,	|O
TATA	|O
-	|O
less	|O
promoter	|O
has	|O
high	|O
G+	|O
C	|O
content	|O
,	|O
and	|O
exon	|O
1b	|O
predominates	|O
among	|O
abundantly	|O
expressed	|O
mRNA	|O
species	|O
.	|O

Although	|O
we	|O
predicted	|O
that	|O
overexpression	|O
of	|O
the	|O
COOH	|O
-	|O
terminal	|O
domains	|O
,	|O
which	|O
were	|O
thought	|O
to	|O
be	|O
involved	|O
in	|O
the	|O
regulation	|O
of	|O
SREBP	|B-PROTEIN
processing	|O
,	|O
would	|O
result	|O
in	|O
disruption	|O
of	|O
the	|O
SREBP	|B-PROTEIN
-	|O
dependent	|O
transcriptional	|O
regulation	|O
of	|O
several	|O
genes	|O
,	|O
the	|O
mRNA	|O
levels	|O
for	|O
3	|O
-	|O
hydroxy	|O
-	|O
3	|O
-	|O
methylglutaryl	|O
coenzyme	|O
A	|O
(	|B-PROTEIN
HMG	|I-PROTEIN
CoA	|I-PROTEIN
)	|I-PROTEIN
synthase	|I-PROTEIN
in	|O
these	|O
two	|O
cell	|O
lines	|O
were	|O
regulated	|O
in	|O
a	|O
sterol	|O
-	|O
dependent	|O
manner	|O
.	|O

Dry	|O
matter	|O
intake	|O
,	|O
apparent	|O
nutrient	|O
digestibilities	|O
,	|O
serum	|O
chemistry	|O
profiles	|O
,	|O
sphingolipid	|O
concentrations	|O
,	|O
and	|O
persistency	|O
of	|O
FB1	|O
in	|O
tissues	|O
were	|O
evaluated	|O
.	|O

However	|O
,	|O
no	|O
studies	|O
have	|O
been	|O
conducted	|O
to	|O
further	|O
investigate	|O
this	|O
potentially	|O
hazardous	|O
effect	|O
of	|O
lidocaine	|O
.	|O

E.	|O
,	|O
Scott	|O
,	|O
J.	|O

Yap1p	|B-PROTEIN
is	|O
constitutively	|O
nuclear	|O
in	|O
a	|O
crm1	|B-PROTEIN
mutant	|O
,	|O
and	|O
Crm1p	|B-PROTEIN
binds	|O
to	|O
a	|O
nuclear	|O
export	|O
sequence	|O
(	|O
NES	|O
)	|O
-	|O
like	|O
sequence	|O
in	|O
Yap1p	|B-PROTEIN
in	|O
the	|O
presence	|O
of	|O
RanGTP	|B-PROTEIN
.	|O

Mean	|O
intake	|O
of	|O
vitamin	|O
A	|O
amounted	|O
to	|O
1.1	|O
and	|O
0.9	|O
mg	|O
RE	|O
/	|O
day	|O
for	|O
men	|O
and	|O
women	|O
,	|O
respectively	|O
;	|O
the	|O
contributions	|O
of	|O
meat	|O
,	|O
fats	|O
and	|O
oils	|O
,	|O
vegetables	|O
and	|O
dairy	|O
products	|O
to	|O
total	|O
intake	|O
were	|O
35%	|O
,	|O
24%	|O
,	|O
16%	|O
,	|O
and	|O
16%	|O
,	|O
respectively	|O
.	|O

Also	|O
,	|O
the	|O
amplitude	|O
of	|O
the	|O
oscillatory	|O
potentials	|O
(	|O
O1+	|O
O2+	|O
O3+	|O
O4	|O
)	|O
was	|O
significantly	|O
reduced	|O
in	|O
the	|O
early	|O
postoperative	|O
period	|O
.	|O

Furthermore	|O
,	|O
RING1	|B-PROTEIN
overexpression	|O
results	|O
in	|O
enhanced	|O
expression	|O
of	|O
the	|O
proto	|O
-	|O
oncogenes	|O
c	|B-PROTEIN
-	|I-PROTEIN
jun	|I-PROTEIN
and	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
.	|O

The	|O
yeast	|O
RER2	|B-PROTEIN
gene	|O
,	|O
identified	|O
by	|O
endoplasmic	|O
reticulum	|O
protein	|O
localization	|O
mutations	|O
,	|O
encodes	|O
cis	|B-PROTEIN
-	|I-PROTEIN
prenyltransferase	|I-PROTEIN
,	|O
a	|O
key	|O
enzyme	|O
in	|O
dolichol	|O
synthesis	|O
.	|O

The	|O
yeast	|O
retrotransposon	|O
Ty5	|B-PROTEIN
preferentially	|O
integrates	|O
into	|O
regions	|O
of	|O
silent	|O
chromatin	|O
.	|O

The	|O
loss	|O
of	|O
SKO1	|B-PROTEIN
completely	|O
restored	|O
ENA1	|B-PROTEIN
expression	|O
in	|O
a	|O
hog1	|B-PROTEIN
mutant	|O
and	|O
partially	|O
suppressed	|O
the	|O
osmotic	|O
stress	|O
sensitivity	|O
,	|O
qualifying	|O
Sko1p	|B-PROTEIN
as	|O
a	|O
downstream	|O
effector	|O
of	|O
the	|O
HOG	|B-PROTEIN
pathway	|O
.	|O

Elevated	|O
expression	|O
of	|O
a	|O
previously	|O
uncharacterized	|O
gene	|O
,	|O
SPP381	|B-PROTEIN
,	|O
efficiently	|O
suppresses	|O
the	|O
growth	|O
and	|O
splicing	|O
defects	|O
of	|O
a	|O
temperature	|O
-	|O
sensitive	|O
(	|O
Ts	|O
)	|O
mutant	|O
prp38	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

The	|O
slower	|O
-	|O
electrophoretic	|O
-	|O
mobility	|O
form	|O
of	|O
p68	|B-PROTEIN
was	|O
absent	|O
in	|O
human	|O
cells	|O
in	|O
G1	|O
/	|O
S	|O
and	|O
appeared	|O
as	|O
the	|O
cells	|O
entered	|O
G2	|O
/	|O
M.	|O

We	|O
have	|O
identified	|O
amino	|O
acid	|O
sequences	|O
in	|O
mammalian	|O
and	|O
Xenopus	|O
NeuroD1	|B-PROTEIN
/	|O
BETA2	|B-PROTEIN
that	|O
are	|O
necessary	|O
for	|O
insulin	|B-PROTEIN
gene	|O
expression	|O
and	|O
ectopic	|O
neurogenesis	|O
.	|O

Both	|O
NUP98	|B-PROTEIN
-	|O
HOXA9	|B-PROTEIN
chimeras	|O
transformed	|O
NIH	|O
3T3	|O
fibroblasts	|O
,	|O
and	|O
this	|O
transformation	|O
required	|O
the	|O
HOXA9	|B-PROTEIN
domains	|O
for	|O
DNA	|O
binding	|O
and	|O
PBX	|B-PROTEIN
interaction	|O
.	|O

Recent	|O
studies	|O
have	|O
suggested	|O
that	|O
Y319	|O
also	|O
positively	|O
regulate	|O
ZAP	|B-PROTEIN
-	|I-PROTEIN
70	|I-PROTEIN
function	|O
.	|O

Genetic	|O
and	|O
molecular	|O
data	|O
indicate	|O
that	|O
wild	|O
-	|O
type	|O
Pan	|B-PROTEIN
and	|O
CiD	|B-PROTEIN
compete	|O
for	|O
binding	|O
to	|O
Arm	|B-PROTEIN
,	|O
leading	|O
to	|O
a	|O
compromised	|O
transduction	|O
of	|O
the	|O
Wg	|B-PROTEIN
signal	|O
in	|O
heterozygous	|O
ciD	|B-PROTEIN
/	|O
+	|O
animals	|O
and	|O
to	|O
a	|O
dramatic	|O
enhancement	|O
of	|O
the	|O
gain	|O
-	|O
of	|O
-	|O
function	|O
activity	|O
of	|O
CiD	|B-PROTEIN
in	|O
homozygous	|O
mutants	|O
.	|O

Another	|O
ORF	|O
,	|O
dda.2	|B-PROTEIN
located	|O
between	|O
modA	|B-PROTEIN
and	|O
dda	|B-PROTEIN
,	|O
shares	|O
sequence	|O
similarity	|O
with	|O
sigma70	|B-PROTEIN
,	|O
and	|O
we	|O
call	|O
it	|O
srd	|B-PROTEIN
.	|O

The	|O
location	|O
of	|O
the	|O
IBS	|O
within	|O
the	|O
catB	|B-PROTEIN
structural	|O
gene	|O
,	|O
the	|O
cooperativity	|O
observed	|O
in	|O
footprinting	|O
studies	|O
and	|O
phasing	|O
studies	|O
suggest	|O
that	|O
the	|O
IBS	|O
participates	|O
in	|O
the	|O
interaction	|O
of	|O
CatR	|B-PROTEIN
with	|O
the	|O
upstream	|O
binding	|O
sites	|O
by	|O
looping	|O
out	|O
the	|O
intervening	|O
DNA	|O
.	|O

In	|O
vitro	|O
transcription	|O
assays	|O
demonstrate	|O
that	|O
the	|O
TCA	|O
-	|O
cycle	|O
intermediate	|O
,	|O
fumarate	|O
,	|O
directly	|O
and	|O
specifically	|O
inhibits	|O
the	|O
formation	|O
of	|O
the	|O
clcA	|B-PROTEIN
transcript	|O
.	|O

BIAcore	|O
analysis	|O
gave	|O
a	|O
Kaff	|O
of	|O
4.4	|O
x	|O
10	|O
(	|O
10	|O
)	|O
M	|O
-	|O
1	|O
for	|O
the	|O
binding	|O
of	|O
N	|B-PROTEIN
-	|I-PROTEIN
A3	|I-PROTEIN
to	|O
T84.1	|B-PROTEIN
and	|O
2.2	|O
x	|O
10	|O
(	|O
10	|O
)	|O
M	|O
-	|O
1	|O
for	|O
the	|O
binding	|O
of	|O
N	|B-PROTEIN
-	|I-PROTEIN
A3	|I-PROTEIN
to	|O
T84.6	|B-PROTEIN
6	|I-PROTEIN
.	|O

Expression	|O
of	|O
p130	|B-PROTEIN
(	|O
Cas	|B-PROTEIN
)	|O
(	|O
Cas	|B-PROTEIN
)	|O
,	|O
a	|O
major	|O
binding	|O
protein	|O
for	|O
the	|O
Crk	|B-PROTEIN
SH2	|O
-	|O
domain	|O
,	|O
also	|O
induced	|O
JNK	|B-PROTEIN
activation	|O
,	|O
which	|O
was	|O
blocked	|O
by	|O
the	|O
SH2	|B-PROTEIN
-	|O
mutant	|O
of	|O
Crk	|B-PROTEIN
.	|O

Positive	|O
correlations	|O
were	|O
seen	|O
between	|O
the	|O
measurements	|O
for	|O
protein	|O
intake	|O
(	|O
r	|O
=	|O
.58	|O
,	|O
P	|O
=	|O
.0026	|O
)	|O
energy	|O
intake	|O
(	|O
r	|O
=	|O
.78	|O
,	|O
P	|O
<	|O
.00001	|O
)	|O
,	|O
with	|O
mean	|O
differences	|O
of.0	|O
66	|O
g	|O
/	|O
kg	|O
/	|O
d	|O
(	|O
SD.3	|O
8	|O
)	|O
2.04	|O
kcal	|O
/	|O
kg	|O
/	|O
day	|O
(	|O
SD	|O
6.67	|O
)	|O
,	|O
respectively	|O
.	|O

The	|O
Og4C3	|B-PROTEIN
enzyme	|O
-	|O
linked	|O
immunosorbent	|O
assay	|O
(	|O
ELISA	|O
)	|O
to	|O
detect	|O
circulating	|O
Wuchereria	|B-PROTEIN
bancrofti	|I-PROTEIN
antigen	|I-PROTEIN
uses	|O
50	|O
microL	|O
of	|O
serum	|O
.	|O

We	|O
now	|O
show	|O
that	|O
gp200	|B-PROTEIN
-	|O
MR6	|B-PROTEIN
ligation	|O
can	|O
also	|O
mimic	|O
IL	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
and	|O
have	|O
an	|O
anti	|O
-	|O
proliferative	|O
pro	|O
-	|O
maturational	|O
influence	|O
within	|O
the	|O
immune	|O
system	|O
,	|O
causing	|O
up	|O
-	|O
regulation	|O
of	|O
co	|O
-	|O
stimulatory	|O
molecules	|O
on	|O
B	|O
lymphocytes	|O
.	|O

The	|O
Mig1	|B-PROTEIN
repressor	|O
is	|O
a	|O
zinc	|B-PROTEIN
finger	|I-PROTEIN
protein	|I-PROTEIN
that	|O
mediates	|O
glucose	|O
repression	|O
in	|O
yeast	|O
.	|O

Ethylene	|O
is	|O
involved	|O
in	|O
endosperm	|O
rupture	|O
and	|O
high	|O
-	|O
level	|O
betaGLU	|B-PROTEIN
I	|I-PROTEIN
expression	|O
;	|O
but	|O
,	|O
it	|O
does	|O
not	|O
affect	|O
the	|O
spatial	|O
and	|O
temporal	|O
pattern	|O
of	|O
betaGLU	|B-PROTEIN
I	|I-PROTEIN
expression	|O
.	|O

The	|O
divergence	|O
in	|O
primary	|O
structure	|O
between	|O
the	|O
sheep	|O
CRF1	|B-PROTEIN
and	|O
the	|O
other	|O
mammalian	|O
CRF1s	|B-PROTEIN
is	|O
primarily	|O
localized	|O
to	|O
the	|O
extracellular	|O
amino	|O
terminal	|O
domain	|O
of	|O
the	|O
receptor	|O
(	|O
18	|O
of	|O
22	|O
divergent	|O
residues	|O
,	|O
ovine	|O
vs	|O
human	|O
CRF1	|B-PROTEIN
)	|O
.	|O

Agonist	|O
-	|O
induced	|O
receptor	|O
internalization	|O
,	|O
determined	|O
as	|O
the	|O
percent	|O
of	|O
total	|O
[	|O
125I	|O
]	|O
Tyr0	|O
-	|O
oCRF	|B-PROTEIN
bound	|O
located	|O
in	|O
the	|O
acid	|O
-	|O
resistant	|O
fraction	|O
of	|O
transfected	|O
Cos	|O
7	|O
cells	|O
,	|O
increased	|O
with	|O
time	|O
(	|O
0-60	|O
min	|O
at	|O
37	|O
degrees	|O
C	|O
)	|O
for	|O
both	|O
wild	|O
-	|O
type	|O
and	|O
variant	|O
oCRF1	|B-PROTEIN
.	|O

Recurrent	|O
arterial	|O
thrombotic	|O
disease	|O
on	|O
young	|O
onset	|O
and	|O
protein	|B-PROTEIN
S	|I-PROTEIN
deficiency	|O
.	|O

We	|O
showed	|O
that	|O
Stat3	|B-PROTEIN
and	|O
Stat3beta	|B-PROTEIN
were	|O
affinity	|O
purified	|O
using	|O
phosphopeptides	|O
containing	|O
Y704	|O
and	|O
Y744	|O
but	|O
not	|O
by	|O
nonphosphorylated	|O
peptide	|O
analogues	|O
or	|O
by	|O
phosphopeptides	|O
containing	|O
Y729	|O
and	|O
Y764	|O
.	|O

Taken	|O
together	|O
,	|O
our	|O
results	|O
indicate	|O
that	|O
the	|O
FCR1	|B-PROTEIN
gene	|O
behaves	|O
as	|O
a	|O
negative	|O
regulator	|O
of	|O
drug	|O
resistance	|O
in	|O
C.	|O
albicans	|O
and	|O
constitute	|O
the	|O
first	|O
evidence	|O
that	|O
FCZ	|O
resistance	|O
can	|O
result	|O
from	|O
the	|O
inactivation	|O
of	|O
a	|O
regulatory	|O
factor	|O
such	|O
as	|O
Fcr1p	|B-PROTEIN
.	|O

These	|O
findings	|O
suggest	|O
that	|O
late	|O
MYO	|O
/	|O
M	|O
is	|O
more	|O
useful	|O
than	|O
washout	|O
rate	|O
to	|O
assess	|O
the	|O
effect	|O
of	|O
treatment	|O
on	|O
heart	|O
failure	|O
due	|O
to	|O
DCM	|O
.	|O

This	|O
study	|O
was	|O
undertaken	|O
to	|O
evaluate	|O
how	|O
couplers	|O
and	|O
their	|O
placement	|O
affect	|O
the	|O
ALGO2	|O
click	|O
spectral	|O
properties	|O
.	|O

CONCLUSIONS	|O
:	|O
Pretreatment	|O
with	|O
OCs	|O
prior	|O
to	|O
pituitary	|O
suppression	|O
in	|O
the	|O
early	|O
follicular	|O
phase	|O
decreases	|O
ovarian	|O
cyst	|O
formation	|O
,	|O
without	|O
an	|O
apparent	|O
effect	|O
on	|O
subsequent	|O
follicular	|O
recruitment	|O
or	|O
pregnancy	|O
rates	|O
.	|O

With	|O
regard	|O
to	|O
the	|O
optimal	|O
threshold	|O
values	|O
,	|O
sensitivity	|O
and	|O
specificity	|O
were	|O
100%	|O
/	|O
97%	|O
and	|O
95%	|O
/	|O
95%	|O
with	|O
FDG	|O
PET	|O
,	|O
compared	|O
to	|O
86%	|O
/	|O
92%	|O
and	|O
77%	|O
/	|O
82%	|O
with	|O
IS	|O
,	|O
respectively	|O
.	|O

This	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
activity	|O
is	|O
inhibited	|O
by	|O
c	|B-PROTEIN
-	|I-PROTEIN
Fos	|I-PROTEIN
,	|O
another	|O
protooncoprotein	|O
that	|O
can	|O
dimerize	|O
with	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
to	|O
form	|O
the	|O
transcription	|O
factor	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

Dorsal	|O
root	|O
ganglia	|O
neuron	|O
-	|O
specific	|O
promoter	|O
activity	|O
of	|O
the	|O
rabbit	|O
beta	|B-PROTEIN
-	|I-PROTEIN
galactoside	|I-PROTEIN
alpha1	|I-PROTEIN
,	|I-PROTEIN
2	|I-PROTEIN
-	|I-PROTEIN
fucosyltransferase	|I-PROTEIN
gene	|O
.	|O

CONCLUSION	|O
:	|O
Our	|O
study	|O
shows	|O
that	|O
(	|O
1	|O
)	|O
total	|O
body	|O
BMD	|O
and	|O
femoral	|O
neck	|O
BMD	|O
were	|O
significantly	|O
higher	|O
in	|O
the	|O
study	|O
group	|O
that	|O
performed	|O
weight	|O
-	|O
bearing	|O
exercises	|O
than	|O
in	|O
control	|O
subjects	|O
,	|O
(	|O
2	|O
)	|O
swimming	|O
exercise	|O
had	|O
no	|O
effect	|O
on	|O
BMD	|O
,	|O
and	|O
(	|O
3	|O
)	|O
although	|O
swimming	|O
is	|O
not	|O
a	|O
bone	|O
-	|O
building	|O
exercise	|O
,	|O
it	|O
can	|O
significantly	|O
improve	|O
shoulder	|O
,	|O
back	|O
,	|O
and	|O
grip	|O
muscle	|O
strength	|O
.	|O

This	|O
suggests	|O
roles	|O
for	|O
both	|O
the	|O
CE1	|O
and	|O
CE2	|O
elements	|O
in	|O
regulating	|O
Hoxb1	|B-PROTEIN
gene	|O
expression	|O
during	|O
development	|O
.	|O

CAL	|O
gain	|O
amounted	|O
to	|O
4.2	|O
+	|O
/	|O
-	|O
1.3	|O
mm	|O
,	|O
60%	|O
of	|O
the	|O
defects	|O
showing	|O
CAL	|O
gain	|O
>	|O
or	|O
=	|O
4	|O
mm	|O
.	|O

Comparisons	|O
with	|O
other	|O
known	|O
germins	|B-PROTEIN
and	|O
germin	|B-PROTEIN
-	|O
like	|O
proteins	|O
indicate	|O
that	|O
these	|O
Arabidopsis	|O
GLP	|B-PROTEIN
subfamilies	|O
are	|O
unique	|O
from	|O
wheat	|O
germin	|B-PROTEIN
.	|O

Lead	|O
fixation	|O
in	|O
dogs	|O
achieved	|O
with	|O
RF	|O
energy	|O
.	|O

However	|O
,	|O
there	|O
has	|O
not	|O
been	|O
any	|O
evidence	|O
of	|O
A.	|O
salmonicida	|O
infections	|O
,	|O
specifically	|O
furunculosis	|O
,	|O
associated	|O
with	|O
the	|O
fish	|O
in	|O
this	|O
loch	|O
.	|O

Further	|O
,	|O
we	|O
show	|O
that	|O
this	|O
EIA	|B-PROTEIN
-	|O
inducible	|O
CBF	|O
/	|O
cdc2	|B-PROTEIN
is	|O
related	|O
to	|O
the	|O
CBF	|B-PROTEIN
which	|O
was	|O
shown	|O
to	|O
activate	|O
the	|O
heat	|B-PROTEIN
shock	|I-PROTEIN
protein	|I-PROTEIN
70	|I-PROTEIN
promoter	|O
.	|O

The	|O
percutaneous	|O
absorption	|O
of	|O
clindamycin	|O
was	|O
studied	|O
in	|O
healthy	|O
male	|O
volunteers	|O
,	|O
comparing	|O
two	|O
investigative	|O
clindamycin	|O
(	|O
%	|O
w	|O
/	|O
v	|O
)	|O
/	|O
tretinoin	|O
(	|O
0.025%	|O
w	|O
/	|O
v	|O
)	|O
gels	|O
,	|O
containing	|O
clindamycin	|O
phosphate	|O
ester	|O
and	|O
clindamycin	|O
HCl	|O
,	|O
respectively	|O
,	|O
relative	|O
to	|O
a	|O
clindamycin	|O
phosphate	|O
lotion	|O
(	|O
1%	|O
clindamycin	|O
;	|O
Dalacin	|O
T	|O
)	|O
.	|O

The	|O
BAL	|O
concentrations	|O
of	|O
the	|O
nine	|O
cytokines	|O
evaluated	|O
for	|O
the	|O
more	|O
and	|O
less	|O
affected	|O
lungs	|O
were	|O
compared	|O
:	|O
interleukin	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
(	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
)	|O
,	|O
IL	|B-PROTEIN
-	|I-PROTEIN
8	|I-PROTEIN
,	|O
IL	|B-PROTEIN
-	|I-PROTEIN
12	|I-PROTEIN
,	|O
tumor	|B-PROTEIN
necrosis	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
(	|O
TNF	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
)	|O
,	|O
and	|O
interferon	|B-PROTEIN
gamma	|I-PROTEIN
(	|O
IFN	|B-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
)	|O
showed	|O
significant	|O
differences	|O
(	|O
p	|O
ranged	|O
between	|O
0	|O
.	|O

Phosphorylation	|O
analyses	|O
indicated	|O
that	|O
inhibition	|O
of	|O
ERK	|B-PROTEIN
-	|I-PROTEIN
1/2	|I-PROTEIN
decreased	|O
okadaic	|O
acid	|O
-	|O
elevated	|O
phosphorylation	|O
of	|O
JunD	|B-PROTEIN
and	|O
FosB	|B-PROTEIN
.	|O

Two	|O
-	|O
way	|O
analysis	|O
of	|O
variance	|O
was	|O
used	|O
to	|O
determine	|O
whether	|O
composite	|O
knowledge	|O
score	|O
differed	|O
among	|O
patient	|O
groups	|O
.	|O

The	|O
human	|O
pathogenic	|O
bacterium	|O
group	|O
A	|O
Streptococcus	|O
produces	|O
an	|O
extracellular	|O
cysteine	|B-PROTEIN
protease	|I-PROTEIN
[	|O
streptococcal	|B-PROTEIN
pyrogenic	|I-PROTEIN
exotoxin	|I-PROTEIN
B	|I-PROTEIN
(	|O
SpeB	|B-PROTEIN
)	|O
]	|O
that	|O
is	|O
a	|O
critical	|O
virulence	|O
factor	|O
for	|O
invasive	|O
disease	|O
episodes	|O
.	|O

The	|O
orbitofrontal	|O
,	|O
cingulate	|O
,	|O
and	|O
anteromedial	|O
part	|O
of	|O
the	|O
dorsal	|O
premotor	|O
areas	|O
were	|O
preferentially	|O
activated	|O
by	|O
the	|O
self	|O
-	|O
initiated	|O
hand	|O
movement	|O
task	|O
(	|O
SELF	|O
)	|O
.	|O

Improving	|O
the	|O
evidence	|O
base	|O
for	|O
anaesthesia	|O
.	|O

Plasma	|O
CCK	|B-PROTEIN
levels	|O
were	|O
determined	|O
at	|O
regular	|O
intervals	|O
.	|O

The	|O
peroxisome	|O
biogenesis	|O
disorders	|O
(	|O
PBDs	|O
)	|O
are	|O
a	|O
set	|O
of	|O
lethal	|O
genetic	|O
diseases	|O
characterized	|O
by	|O
peroxisomal	|O
metabolic	|O
deficiencies	|O
,	|O
multisystem	|O
abnormalities	|O
,	|O
mental	|O
retardation	|O
,	|O
and	|O
premature	|O
death	|O
.	|O

The	|O
active	|O
site	|O
includes	|O
the	|O
acidic	|O
triad	|O
Asp53	|O
(	|O
the	|O
site	|O
of	|O
phosphorylation	|O
)	|O
,	|O
Asp10	|O
and	|O
Glu9	|O
.	|O

Consistent	|O
with	|O
these	|O
findings	|O
,	|O
relatively	|O
weak	|O
transcriptional	|O
silencing	|O
by	|O
the	|O
native	|O
VDR	|B-PROTEIN
was	|O
observed	|O
using	|O
the	|O
osteopontin	|B-PROTEIN
VDRE	|O
.	|O

In	|O
PAV	|O
-	|O
3	|O
,	|O
the	|O
E1A	|B-PROTEIN
region	|O
is	|O
located	|O
between	|O
1.5	|O
and	|O
3.8	|O
map	|O
units	|O
.	|O

Six	|O
putative	|O
MDV	|O
genome	|O
products	|O
,	|O
including	|O
one	|O
Rep	|B-PROTEIN
and	|O
five	|O
non	|O
-	|O
Rep	|B-PROTEIN
proteins	|O
,	|O
show	|O
high	|O
(	|O
70.4-90.9%	|O
)	|O
amino	|O
acid	|O
identity	|O
to	|O
the	|O
corresponding	|O
six	|O
FBNYV	|B-PROTEIN
proteins	|O
,	|O
whereas	|O
two	|O
other	|O
Rep	|B-PROTEIN
proteins	|O
encoded	|O
by	|O
MDV	|O
-	|O
C2	|B-PROTEIN
and	|O
C3	|B-PROTEIN
are	|O
82.3%	|O
and	|O
73.0%	|O
identical	|O
to	|O
those	|O
encoded	|O
by	|O
SCSV	|O
-	|O
C2	|B-PROTEIN
and	|O
C6	|B-PROTEIN
,	|O
respectively	|O
.	|O

MPO	|B-PROTEIN
was	|O
labeled	|O
with	|O
1	|O
mCi	|O
125I	|O
by	|O
a	|O
technique	|O
of	|O
self	|O
-	|O
labeling	|O
in	|O
the	|O
presence	|O
of	|O
10	|O
(	|O
-	|O
4	|O
)	|O
M	|O
hydrogen	|O
peroxide	|O
.	|O

It	|O
is	|O
related	|O
to	|O
a	|O
variety	|O
of	|O
mammalian	|O
Golgi	|O
-	|O
associated	|O
proteins	|O
and	|O
to	|O
the	|O
yeast	|O
Uso1p	|B-PROTEIN
,	|O
an	|O
essential	|O
protein	|O
involved	|O
in	|O
docking	|O
of	|O
endoplasmic	|O
reticulum	|O
-	|O
derived	|O
vesicles	|O
to	|O
the	|O
cis	|O
-	|O
Golgi	|O
.	|O

The	|O
data	|O
indicate	|O
that	|O
Bmp2	|B-PROTEIN
is	|O
directly	|O
regulated	|O
by	|O
retinoic	|O
acid	|O
-	|O
bound	|O
receptors	|O
and	|O
Sp1	|B-PROTEIN
.	|O

Both	|O
proteins	|O
were	|O
shown	|O
to	|O
be	|O
constitutively	|O
associated	|O
with	|O
tubulin	|B-PROTEIN
.	|O

HEED	|B-PROTEIN
was	|O
found	|O
to	|O
bind	|O
to	|O
MA	|B-PROTEIN
protein	|O
in	|O
vitro	|O
,	|O
as	|O
efficiently	|O
as	|O
in	|O
vivo	|O
in	|O
yeast	|O
cells	|O
.	|O

Fas	|B-PROTEIN
-	|O
resistant	|O
DT	|O
-	|O
40	|O
lymphoma	|O
B	|O
-	|O
cells	|O
rendered	|O
BTK	|B-PROTEIN
-	|O
deficient	|O
through	|O
targeted	|O
disruption	|O
of	|O
the	|O
btk	|B-PROTEIN
gene	|O
by	|O
homologous	|O
recombination	|O
knockout	|O
underwent	|O
apoptosis	|O
after	|O
Fas	|B-PROTEIN
ligation	|O
,	|O
but	|O
wild	|O
-	|O
type	|O
DT	|O
-	|O
40	|O
cells	|O
or	|O
BTK	|B-PROTEIN
-	|O
deficient	|O
DT	|O
-	|O
40	|O
cells	|O
reconstituted	|O
with	|O
wild	|O
-	|O
type	|O
human	|O
btk	|B-PROTEIN
gene	|O
did	|O
not	|O
.	|O

A	|O
motif	|O
(	|O
TGATGTCA	|O
)	|O
which	|O
matches	|O
a	|O
CREB	|B-PROTEIN
site	|O
and	|O
is	|O
similar	|O
to	|O
an	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
site	|O
is	|O
embedded	|O
within	|O
ER2	|B-PROTEIN
.	|O

Conventionally	|O
,	|O
four	|O
nominal	|O
allotypic	|O
variants	|O
,	|O
b4	|O
,	|O
b5	|O
,	|O
b6	|O
and	|O
b9	|O
have	|O
been	|O
shown	|O
to	|O
be	|O
co	|O
-	|O
dominantly	|O
expressed	|O
at	|O
the	|O
Ckappa1	|B-PROTEIN
gene	|O
locus	|O
.	|O

Therefore	|O
,	|O
in	|O
order	|O
to	|O
search	|O
for	|O
the	|O
latent	|O
genes	|O
,	|O
we	|O
used	|O
allotype	|O
-	|O
specific	|O
oligonucleotides	|O
for	|O
b5	|O
,	|O
b6	|O
and	|O
b9	|O
to	|O
probe	|O
DNAs	|O
from	|O
both	|O
normal	|O
and	|O
T.	|O
brucei	|O
-	|O
infected	|O
rabbits	|O
by	|O
Southern	|O
blotting	|O
.	|O

TRAF2	|B-PROTEIN
is	|O
known	|O
to	|O
associate	|O
with	|O
TRADD	|B-PROTEIN
,	|O
and	|O
expression	|O
of	|O
a	|O
dominant	|O
-	|O
negative	|O
N	|O
-	|O
terminal	|O
deletion	|O
TRAF2	|B-PROTEIN
mutant	|O
was	|O
found	|O
to	|O
partially	|O
inhibit	|O
LMP1	|B-PROTEIN
-	|O
induced	|O
JNK	|B-PROTEIN
activation	|O
in	|O
293	|O
cells	|O
.	|O

These	|O
data	|O
further	|O
define	|O
a	|O
role	|O
for	|O
TRADD	|B-PROTEIN
and	|O
TRAF2	|B-PROTEIN
in	|O
JNK	|B-PROTEIN
activation	|O
and	|O
confirm	|O
that	|O
LMP1	|B-PROTEIN
utilizes	|O
signalling	|O
mechanisms	|O
used	|O
by	|O
the	|O
TNF	|B-PROTEIN
receptor	|I-PROTEIN
/	|O
CD40	|B-PROTEIN
family	|O
to	|O
elicit	|O
its	|O
pleiotropic	|O
activities	|O
.	|O

Epstein	|O
-	|O
Barr	|O
virus	|O
-	|O
encoded	|O
latent	|B-PROTEIN
membrane	|I-PROTEIN
protein	|I-PROTEIN
1	|I-PROTEIN
activates	|O
the	|O
JNK	|B-PROTEIN
pathway	|O
through	|O
its	|O
extreme	|O
C	|O
terminus	|O
via	|O
a	|O
mechanism	|O
involving	|O
TRADD	|B-PROTEIN
and	|O
TRAF2	|B-PROTEIN
.	|O

In	|O
contrast	|O
,	|O
transiently	|O
transfected	|O
cells	|O
expressing	|O
EBNA	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
revealed	|O
a	|O
sixfold	|O
increase	|O
in	|O
EBNA	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
protein	|O
expression	|O
from	|O
the	|O
genomic	|O
EBNA	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
gene	|O
compared	|O
to	|O
EBNA	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
cDNA	|O
.	|O

However	|O
,	|O
serial	|O
passages	|O
of	|O
fetal	|O
lamb	|O
kidney	|O
(	|O
FLK	|O
)	|O
cells	|O
,	|O
which	|O
are	|O
sensitive	|O
to	|O
infection	|O
with	|O
BLV	|O
,	|O
after	|O
transient	|O
transfection	|O
revealed	|O
that	|O
mutation	|O
of	|O
a	|O
second	|O
tyrosine	|O
residue	|O
in	|O
the	|O
N	|O
-	|O
terminal	|O
motif	|O
completely	|O
prevented	|O
the	|O
propagation	|O
of	|O
the	|O
virus	|O
.	|O

Varicella	|O
-	|O
zoster	|O
virus	|O
(	|O
VZV	|O
)	|O
glycoprotein	|B-PROTEIN
gI	|I-PROTEIN
is	|O
a	|O
type	|B-PROTEIN
1	|I-PROTEIN
transmembrane	|I-PROTEIN
glycoprotein	|I-PROTEIN
which	|O
is	|O
one	|O
component	|O
of	|O
the	|O
heterodimeric	|O
gE	|B-PROTEIN
:	|O
gI	|B-PROTEIN
Fc	|O
receptor	|O
complex	|O
.	|O

To	|O
this	|O
end	|O
,	|O
we	|O
analyzed	|O
the	|O
phosphorylation	|O
status	|O
of	|O
a	|O
universal	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
substrate	|O
,	|O
the	|O
transforming	|O
Shc	|B-PROTEIN
adapter	|O
protein	|O
,	|O
in	|O
fibroblasts	|O
expressing	|O
the	|O
viral	|O
oncogene	|O
.	|O

These	|O
genes	|O
were	|O
expressed	|O
in	|O
a	|O
Saccharomyces	|O
cerevisiae	|O
mutant	|O
in	|O
which	|O
the	|O
endogenous	|O
ferrochelatase	|B-PROTEIN
gene	|O
(	|O
HEM15	|B-PROTEIN
)	|O
had	|O
been	|O
deleted	|O
,	|O
and	|O
the	|O
phenotypes	|O
of	|O
the	|O
transformants	|O
were	|O
characterized	|O
.	|O

In	|O
this	|O
study	|O
,	|O
evidence	|O
is	|O
presented	|O
that	|O
temporally	|O
and	|O
spatially	|O
specific	|O
mef2	|B-PROTEIN
expression	|O
is	|O
controlled	|O
by	|O
a	|O
complex	|O
array	|O
of	|O
cis	|O
-	|O
acting	|O
regulatory	|O
modules	|O
that	|O
are	|O
responsive	|O
to	|O
different	|O
genetic	|O
signals	|O
.	|O

Furthermore	|O
,	|O
using	|O
transgenic	|O
mouse	|O
technology	|O
we	|O
localized	|O
independent	|O
cis	|O
-	|O
regulatory	|O
elements	|O
controlling	|O
the	|O
tissue	|O
-	|O
specific	|O
expression	|O
of	|O
Pax6	|B-PROTEIN
.	|O

In	|O
the	|O
second	|O
experiment	|O
,	|O
a	|O
stable	|O
nickel	|O
isotope	|O
,	|O
61Ni	|O
,	|O
was	|O
given	|O
in	|O
drinking	|O
water	|O
to	|O
20	|O
nickel	|O
-	|O
sensitized	|O
women	|O
and	|O
20	|O
age	|O
-	|O
matched	|O
controls	|O
,	|O
both	|O
groups	|O
having	|O
vesicular	|O
hand	|O
eczema	|O
of	|O
the	|O
pompholyx	|O
type	|O
.	|O

Folded	|O
tissue	|O
and	|O
crimped	|O
collagen	|B-PROTEIN
fibers	|O
in	|O
the	|O
tunica	|O
albuginea	|O
permit	|O
its	|O
expansion	|O
during	|O
erection	|O
.	|O

Number	|O
of	|O
patients	|O
infected	|O
with	|O
nontuberculous	|O
mycobacteria	|O
(	|O
NTM	|O
)	|O
is	|O
increasing	|O
world	|O
-	|O
wide	|O
in	|O
recent	|O
years	|O
.	|O

Comparison	|O
of	|O
the	|O
sequences	|O
of	|O
attP	|B-PROTEIN
,	|O
attB	|B-PROTEIN
and	|O
bacteria	|O
-	|O
prophage	|O
junctions	|O
attL	|B-PROTEIN
and	|O
attR	|B-PROTEIN
showed	|O
a	|O
26	|O
bp	|O
common	|O
core	|O
sequence	|O
,	|O
where	|O
recombination	|O
takes	|O
place	|O
,	|O
near	|O
the	|O
5'	|O
end	|O
of	|O
the	|O
integrase	|B-PROTEIN
gene	|O
.	|O

Interferon	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
treatment	|O
of	|O
posttransplant	|O
lymphoproliferative	|O
disorder	|O
in	|O
recipients	|O
of	|O
solid	|O
organ	|O
transplants	|O
.	|O

Immunological	|O
testing	|O
was	|O
performed	|O
on	|O
all	|O
brewery	|O
workers	|O
and	|O
some	|O
control	|O
volunteers	|O
using	|O
skin	|O
prick	|O
testing	|O
with	|O
hops	|O
,	|O
barley	|O
,	|O
and	|O
yeast	|O
antigens	|O
as	|O
well	|O
as	|O
other	|O
nonoccupational	|O
allergens	|O
,	|O
and	|O
by	|O
determining	|O
total	|O
serum	|O
IgE	|B-PROTEIN
levels	|O
.	|O

OBJECTIVE	|O
:	|O
To	|O
evaluate	|O
the	|O
accuracy	|O
of	|O
working	|O
casts	|O
for	|O
crown	|O
and	|O
bridge	|O
restorations	|O
made	|O
from	|O
twin	|O
mix	|O
putty	|O
/	|O
wash	|O
silicone	|O
elastomeric	|O
impression	|O
materials	|O
using	|O
different	|O
types	|O
of	|O
stock	|O
tray	|O
.	|O

OBJECTIVES	|O
:	|O
To	|O
assess	|O
the	|O
ability	|O
of	|O
pretreatment	|O
and	|O
post	|O
-	|O
treatment	|O
prostate	|B-PROTEIN
-	|I-PROTEIN
specific	|I-PROTEIN
antigen	|I-PROTEIN
(	|O
PSA	|B-PROTEIN
)	|O
measurements	|O
,	|O
clinical	|O
tumor	|O
stage	|O
,	|O
tumor	|O
grade	|O
,	|O
Gleason	|O
sum	|O
,	|O
race	|O
,	|O
age	|O
,	|O
and	|O
radiation	|O
dose	|O
to	|O
predict	|O
the	|O
recurrence	|O
of	|O
prostate	|O
cancer	|O
following	|O
external	|O
beam	|O
radiation	|O
therapy	|O
(	|O
XRT	|O
)	|O
since	|O
the	|O
introduction	|O
of	|O
PSA	|B-PROTEIN
as	|O
a	|O
tumor	|O
marker	|O
at	|O
one	|O
tertiary	|O
care	|O
center	|O
.	|O

To	|O
evaluate	|O
whether	|O
the	|O
human	|O
gene	|O
is	|O
also	|O
a	|O
target	|O
of	|O
thyroid	|O
hormone	|O
we	|O
have	|O
searched	|O
for	|O
T3	|O
-	|O
responsive	|O
elements	|O
in	|O
NRGN	|B-PROTEIN
cloned	|O
genomic	|O
fragments	|O
spanning	|O
the	|O
whole	|O
gene	|O
.	|O

The	|O
transcriptional	|O
activity	|O
of	|O
PPARgamma	|B-PROTEIN
is	|O
positively	|O
modulated	|O
by	|O
ligand	|O
binding	|O
and	|O
negatively	|O
regulated	|O
by	|O
phosphorylation	|O
mediated	|O
by	|O
the	|O
MEK	|B-PROTEIN
/	|O
ERK	|B-PROTEIN
signaling	|O
pathway	|O
.	|O

BACKGROUND	|O
:	|O
Diazepam	|O
,	|O
one	|O
of	|O
the	|O
benzodiazepine	|O
group	|O
of	|O
tranquilizers	|O
,	|O
is	|O
used	|O
as	|O
an	|O
adjunctive	|O
drug	|O
for	|O
sedation	|O
and	|O
for	|O
relief	|O
of	|O
anxiety	|O
in	|O
the	|O
treatment	|O
of	|O
epilepsy	|O
.	|O

Bioplastique	|O
granuloma	|O
presents	|O
with	|O
irregularly	|O
shaped	|O
cystic	|O
spaces	|O
of	|O
varying	|O
size	|O
containing	|O
jagged	|O
,	|O
translucent	|O
,	|O
nonbirefringent	|O
foreign	|O
bodies	|O
whereas	|O
Artecoll	|O
granuloma	|O
shows	|O
numerous	|O
round	|O
vacuoles	|O
nearly	|O
identical	|O
in	|O
size	|O
and	|O
shape	|O
enclosing	|O
round	|O
and	|O
sharply	|O
circumscribed	|O
,	|O
translucent	|O
,	|O
nonbirefringent	|O
foreign	|O
bodies	|O
.	|O

This	|O
Tbx6	|B-PROTEIN
-	|O
subfamily	|O
gene	|O
is	|O
likely	|O
to	|O
participate	|O
in	|O
paraxial	|O
mesoderm	|O
formation	|O
and	|O
somitogenesis	|O
in	|O
human	|O
embryo	|O
.	|O

Structure	|O
-	|O
function	|O
analysis	|O
of	|O
the	|O
Z	|O
-	|O
DNA	|O
-	|O
binding	|O
domain	|O
Zalpha	|O
of	|O
dsRNA	|B-PROTEIN
adenosine	|I-PROTEIN
deaminase	|I-PROTEIN
type	|I-PROTEIN
I	|I-PROTEIN
reveals	|O
similarity	|O
to	|O
the	|O
(	|B-PROTEIN
alpha	|I-PROTEIN
+	|I-PROTEIN
beta	|I-PROTEIN
)	|I-PROTEIN
family	|O
of	|O
helix	|B-PROTEIN
-	|I-PROTEIN
turn	|I-PROTEIN
-	|I-PROTEIN
helix	|I-PROTEIN
proteins	|I-PROTEIN
.	|O

In	|O
addition	|O
,	|O
the	|O
regulation	|O
of	|O
Glvr	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
gene	|O
expression	|O
also	|O
has	|O
potential	|O
applications	|O
to	|O
gene	|O
therapy	|O
,	|O
since	|O
retroviral	|O
vectors	|O
carrying	|O
gibbon	|O
ape	|O
leukemia	|O
virus	|O
envelope	|B-PROTEIN
proteins	|O
are	|O
used	|O
for	|O
gene	|O
delivery	|O
into	|O
different	|O
cell	|O
types	|O
.	|O

Carbohydrates	|O
and	|O
glycoconjugates	|O
biophysical	|O
methods	|O
.	|O

Molecular	|O
cloning	|O
of	|O
mouse	|O
glycolate	|B-PROTEIN
oxidase	|I-PROTEIN
.	|O

In	|O
such	|O
a	|O
manner	|O
,	|O
activated	|O
PKR	|B-PROTEIN
inhibits	|O
cell	|O
growth	|O
and	|O
induces	|O
apoptosis	|O
,	|O
whereas	|O
disruption	|O
of	|O
normal	|O
PKR	|B-PROTEIN
signaling	|O
results	|O
in	|O
unregulated	|O
cell	|O
growth	|O
.	|O

We	|O
isolated	|O
a	|O
ribosomal	|O
protein	|O
L18	|B-PROTEIN
by	|O
interaction	|O
with	|O
PKR	|B-PROTEIN
.	|O

Processing	|O
of	|O
the	|O
polycistronic	|O
precursor	|O
requires	|O
nucleases	|O
also	|O
involved	|O
in	|O
rRNA	|O
processing	|O
,	|O
i.e.	|O
,	|O
Rnt1p	|B-PROTEIN
and	|O
Rat1p	|B-PROTEIN
.	|O

To	|O
search	|O
for	|O
transcriptional	|O
regulators	|O
,	|O
we	|O
used	|O
a	|O
fragment	|O
of	|O
the	|O
SpHE	|B-PROTEIN
promoter	|O
containing	|O
several	|O
individual	|O
elements	|O
instead	|O
of	|O
the	|O
conventional	|O
bait	|O
that	|O
contains	|O
a	|O
multimerized	|O
cis	|O
element	|O
.	|O

As	|O
expected	|O
for	|O
a	|O
positive	|O
SpHE	|B-PROTEIN
transcriptional	|I-PROTEIN
regulator	|I-PROTEIN
,	|O
the	|O
timing	|O
of	|O
SpEts4	|B-PROTEIN
gene	|O
expression	|O
precedes	|O
the	|O
transient	|O
expression	|O
of	|O
SpHE	|B-PROTEIN
in	|O
the	|O
very	|O
early	|O
sea	|O
urchin	|O
blastula	|O
.	|O

Furthermore	|O
,	|O
rhoA	|B-PROTEIN
-	|O
mediated	|O
SRE	|O
activation	|O
was	|O
blocked	|O
by	|O
dominant	|O
negative	|O
mutants	|O
of	|O
PKC	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
or	|O
PKC	|B-PROTEIN
-	|I-PROTEIN
epsilon	|I-PROTEIN
.	|O

Nip7p	|B-PROTEIN
-	|O
depleted	|O
cells	|O
exhibited	|O
the	|O
same	|O
defects	|O
as	|O
Nop8p	|B-PROTEIN
-	|O
depleted	|O
cells	|O
,	|O
except	|O
that	|O
they	|O
accumulated	|O
27S	|B-PROTEIN
precursors	|O
.	|O

We	|O
show	|O
that	|O
the	|O
Sm	|B-PROTEIN
-	|O
binding	|O
site	|O
and	|O
stem	|O
-	|O
loop	|O
III	|O
structures	|O
are	|O
necessary	|O
for	|O
correct	|O
3'	|O
-	|O
end	|O
formation	|O
.	|O

Five	|O
different	|O
subtypes	|O
of	|O
spondyloarthropathy	|O
(	|O
SpA	|O
)	|O
are	|O
now	|O
recognized	|O
.	|O

Further	|O
experiments	|O
will	|O
be	|O
required	|O
to	|O
highlight	|O
the	|O
in	|O
vivo	|O
role	|O
of	|O
ELE1	|B-PROTEIN
in	|O
nuclear	|O
receptor	|O
functioning	|O
.	|O

Overexpression	|O
of	|O
PTTG	|B-PROTEIN
in	|O
transfected	|O
NIH	|O
3T3	|O
cells	|O
also	|O
stimulated	|O
expression	|O
and	|O
secretion	|O
of	|O
basic	|B-PROTEIN
fibroblast	|I-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
,	|O
a	|O
human	|O
pituitary	|O
tumor	|O
growth	|B-PROTEIN
-	|I-PROTEIN
regulating	|I-PROTEIN
factor	|I-PROTEIN
.	|O

The	|O
perifascicular	|O
connective	|O
tissue	|O
sheath	|O
is	|O
important	|O
in	|O
organising	|O
the	|O
contraction	|O
of	|O
the	|O
myocardium	|O
by	|O
preventing	|O
lateral	|O
spread	|O
of	|O
conduction	|O
and	|O
by	|O
permitting	|O
transmission	|O
of	|O
the	|O
impulse	|O
only	|O
at	|O
the	|O
termination	|O
of	|O
the	|O
purkinje	|O
fibre	|O
.	|O

E1	|B-PROTEIN
,	|O
a	|O
DNA	|B-PROTEIN
helicase	|I-PROTEIN
,	|O
collaborates	|O
with	|O
the	|O
HPV	|O
E2	|B-PROTEIN
protein	|O
in	|O
ori	|O
-	|O
dependent	|O
replication	|O
.	|O

Here	|O
we	|O
describe	|O
a	|O
mutant	|O
alpha	|O
subunit	|O
designed	|O
to	|O
inhibit	|O
receptor	|O
-	|O
mediated	|O
hormonal	|O
activation	|O
of	|O
Gs	|B-PROTEIN
,	|O
the	|O
stimulatory	|O
regulator	|O
of	|O
adenylyl	|B-PROTEIN
cyclase	|I-PROTEIN
.	|O

A	|O
gapped	|O
search	|O
with	|O
the	|O
C	|O
-	|O
terminal	|O
region	|O
of	|O
CDED	|B-PROTEIN
/	|O
LIOR	|B-PROTEIN
revealed	|O
a	|O
36-41%	|O
similarity	|O
to	|O
several	|O
proteins	|O
related	|O
to	|O
signal	|O
transduction	|O
and	|O
cell	|O
replication	|O
,	|O
such	|O
as	|O
ORC1	|B-PROTEIN
and	|O
KSR	|B-PROTEIN
.	|O

Northern	|O
blot	|O
analysis	|O
demonstrated	|O
the	|O
ubiquitous	|O
expression	|O
of	|O
2.9	|O
kb	|O
and	|O
3	|O
.	|O

Additionally	|O
,	|O
a	|O
variety	|O
of	|O
regulatory	|O
schemes	|O
contribute	|O
temporal	|O
and	|O
/	|O
or	|O
spatial	|O
restriction	|O
to	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
responses	|O
.	|O

Induction	|O
of	|O
anaesthesia	|O
was	|O
standardised	|O
:	|O
fentanyl	|O
(	|O
3	|O
micrograms	|O
/	|O
kg	|O
)	|O
,	|O
thiopentone	|O
(	|O
5	|O
mg	|O
/	|O
kg	|O
)	|O
,	|O
atracurium	|O
(	|O
0.4	|O
mg	|O
/	|O
kg	|O
)	|O
.	|O

A	|O
comparison	|O
of	|O
the	|O
clinical	|O
profile	|O
of	|O
cavernous	|O
malformations	|O
with	|O
and	|O
without	|O
associated	|O
venous	|O
malformations	|O
.	|O

Conserved	|O
and	|O
distinct	|O
roles	|O
of	|O
kreisler	|B-PROTEIN
in	|O
regulation	|O
of	|O
the	|O
paralogous	|O
Hoxa3	|B-PROTEIN
and	|O
Hoxb3	|B-PROTEIN
genes	|O
.	|O

Magnetically	|O
induced	|O
optical	|O
self	|O
-	|O
pulsing	|O
in	|O
a	|O
nonlinear	|O
resonator	|O
.	|O

Wave	|O
cybernetics	|O
:	|O
A	|O
simple	|O
model	|O
of	|O
wave	|O
-	|O
controlled	|O
nonlinear	|O
and	|O
nonlocal	|O
cooperative	|O
phenomena	|O
.	|O

Autoionization	|O
rates	|O
and	|O
energy	|O
levels	|O
of	|O
triplet	|O
nf	|O
,	|O
v	|O
=	|O
1	|O
Rydberg	|O
states	|O
of	|O
H2	|O
.	|O

Unitary	|O
-	|O
group	|O
approach	|O
to	|O
spin	|O
-	|O
dependent	|O
operators	|O
.	|O

Nonlocal	|O
approach	|O
to	|O
scattering	|O
in	|O
a	|O
one	|O
-	|O
dimensional	|O
problem	|O
.	|O

Soft	|O
-	|O
x	|O
-	|O
ray	|O
lasing	|O
at	|O
32.6	|O
nm	|O
in	|O
Ne	|O
-	|O
like	|O
Ti	|O
ions	|O
driven	|O
by	|O
40	|O
J	|O
of	|O
energy	|O
from	|O
two	|O
650	|O
-	|O
ps	|O
laser	|O
pulses	|O
.	|O

Next	|O
,	|O
to	|O
identify	|O
regions	|O
of	|O
the	|O
promoter	|O
involved	|O
,	|O
we	|O
examined	|O
a	|O
series	|O
of	|O
tenascin	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
promoter	|O
constructs	|O
with	|O
5'	|O
deletions	|O
and	|O
showed	|O
that	|O
denatured	|O
collagen	|B-PROTEIN
-	|O
dependent	|O
promoter	|O
activity	|O
was	|O
retained	|O
by	|O
a	|O
122	|O
-	|O
base	|O
pair	|O
element	|O
,	|O
located	|O
-	|O
43	|O
to	|O
-	|O
165	|O
bp	|O
upstream	|O
of	|O
the	|O
RNA	|O
start	|O
site	|O
.	|O

Nuclear	|B-PROTEIN
factor	|I-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
(	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
)	|O
is	|O
an	|O
important	|O
transcription	|O
factor	|O
for	|O
the	|O
genes	|O
of	|O
many	|O
pro	|O
-	|O
inflammatory	|O
proteins	|O
and	|O
is	|O
strongly	|O
activated	|O
by	|O
the	|O
cytokines	|O
interleukin	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
tumor	|O
necrosis	|O
factor	|O
(	|B-PROTEIN
TNF	|I-PROTEIN
)	|I-PROTEIN
alpha	|I-PROTEIN
under	|O
various	|O
pathological	|O
conditions	|O
.	|O

Moreover	|O
,	|O
this	|O
enhancement	|O
of	|O
transcriptional	|O
activation	|O
by	|O
COUP	|B-PROTEIN
-	|I-PROTEIN
TFI	|I-PROTEIN
requires	|O
specifically	|O
the	|O
AF	|O
-	|O
1	|O
transactivation	|O
function	|O
of	|O
ER	|B-PROTEIN
and	|O
can	|O
be	|O
observed	|O
in	|O
the	|O
presence	|O
of	|O
E2	|O
or	|O
4	|O
-	|O
hydroxytamoxifen	|O
but	|O
not	|O
ICI	|O
164384	|O
.	|O

Recombinant	|O
Ffh	|B-PROTEIN
has	|O
a	|O
melting	|O
point	|O
of	|O
tm	|O
=	|O
89	|O
degreesC	|O
.	|O

Unilateral	|O
naris	|O
occlusion	|O
and	|O
the	|O
rat	|O
accessory	|O
olfactory	|O
bulb	|O
.	|O

This	|O
region	|O
of	|O
hsp90	|B-PROTEIN
mediates	|O
ATP	|O
-	|O
independent	|O
chaperone	|O
activity	|O
,	|O
overlaps	|O
the	|O
hsp90	|B-PROTEIN
dimerization	|O
domain	|O
,	|O
and	|O
includes	|O
structural	|O
elements	|O
important	|O
for	|O
steroid	|B-PROTEIN
receptor	|I-PROTEIN
interaction	|O
.	|O

The	|O
promoter	|O
of	|O
the	|O
rat	|O
pgp2	|B-PROTEIN
/	|O
mdr1b	|B-PROTEIN
gene	|O
has	|O
a	|O
GC	|O
-	|O
rich	|O
region	|O
(	|O
pgp2GC	|B-PROTEIN
)	|O
that	|O
is	|O
highly	|O
conserved	|O
in	|O
mdr	|B-PROTEIN
genes	|O
and	|O
contains	|O
an	|O
consensus	|O
Sp1	|B-PROTEIN
site	|O
.	|O

Sp1	|B-PROTEIN
's	|O
role	|O
in	|O
transactivation	|O
of	|O
the	|O
pgp2	|B-PROTEIN
/	|O
mdr1b	|B-PROTEIN
promoter	|O
was	|O
tested	|O
in	|O
Drosophila	|O
Schneider	|O
cells	|O
.	|O

Measurements	|O
included	|O
bone	|O
mineral	|O
density	|O
of	|O
the	|O
lumbar	|O
spine	|O
and	|O
proximal	|O
femur	|O
(	|O
by	|O
dual	|O
-	|O
energy	|O
X	|O
-	|O
ray	|O
absorptiometry	|O
)	|O
and	|O
biochemical	|O
markers	|O
of	|O
bone	|O
remodeling	|O
(	|O
serum	|O
bone	|O
-	|O
specific	|O
alkaline	|B-PROTEIN
phosphatase	|I-PROTEIN
by	|O
immunoassay	|O
and	|O
urine	|O
deoxypyridinoline	|O
by	|O
high	|O
-	|O
pressure	|O
liquid	|O
chromatography	|O
)	|O
.	|O

Human	|O
MGP	|B-PROTEIN
is	|O
a	|O
10	|O
-	|O
kD	|O
skeletal	|O
extracellular	|O
matrix	|O
(	|B-PROTEIN
ECM	|I-PROTEIN
)	|I-PROTEIN
protein	|I-PROTEIN
that	|O
consists	|O
of	|O
an	|O
84	|O
-	|O
aa	|O
mature	|O
protein	|O
and	|O
a	|O
19	|O
-	|O
aa	|O
transmembrane	|O
signal	|O
peptide	|O
.	|O

Dual	|O
roles	|O
of	|O
p82	|B-PROTEIN
,	|O
the	|O
clam	|O
CPEB	|B-PROTEIN
homolog	|O
,	|O
in	|O
cytoplasmic	|O
polyadenylation	|O
and	|O
translational	|O
masking	|O
.	|O

The	|O
RNA	|O
polymerase	|O
III	|O
-	|O
recruiting	|O
factor	|O
TFIIIB	|B-PROTEIN
induces	|O
a	|O
DNA	|O
bend	|O
between	|O
the	|O
TATA	|O
box	|O
and	|O
the	|O
transcriptional	|O
start	|O
site	|O
.	|O

The	|O
pattern	|O
of	|O
RNase	|B-PROTEIN
E	|I-PROTEIN
digestion	|O
of	|O
finP305	|B-PROTEIN
RNA	|O
differed	|O
from	|O
FinP	|B-PROTEIN
,	|O
and	|O
GST	|B-PROTEIN
-	|O
FinO	|B-PROTEIN
did	|O
not	|O
protect	|O
finP305	|B-PROTEIN
RNA	|O
from	|O
cleavage	|O
in	|O
vitro	|O
.	|O

Transcription	|O
readthrough	|O
into	|O
the	|O
inverted	|O
repeats	|O
has	|O
little	|O
effect	|O
on	|O
this	|O
event	|O
.	|O

Analysis	|O
of	|O
hematopoietic	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
prescriptions	|O
in	|O
19	|O
french	|O
cancer	|O
centers	|O

In	|O
the	|O
second	|O
case	|O
,	|O
an	|O
epidermal	|O
cyst	|O
was	|O
diagnosed	|O
.	|O

MotA	|B-PROTEIN
also	|O
binds	|O
a	|O
DNA	|O
sequence	|O
(	|O
a	|O
MotA	|B-PROTEIN
box	|O
)	|O
,	|O
centered	|O
at	|O
position	|O
-	|O
30	|O
.	|O

We	|O
suggest	|O
that	|O
MotA	|B-PROTEIN
and	|O
AsiA	|B-PROTEIN
may	|O
function	|O
like	|O
certain	|O
eukaryotic	|O
TAFs	|B-PROTEIN
(	|O
TATA	|B-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
(	|I-PROTEIN
TBP	|I-PROTEIN
)	|I-PROTEIN
associated	|I-PROTEIN
factors	|I-PROTEIN
)	|O
whose	|O
binding	|O
to	|O
TBP	|B-PROTEIN
results	|O
in	|O
transcription	|O
from	|O
new	|O
core	|O
promoter	|O
sequences	|O
.	|O

The	|O
S229A	|O
variant	|O
can	|O
better	|O
flip	|O
modified	|O
bases	|O
but	|O
does	|O
not	|O
tightly	|O
lock	|O
the	|O
flipped	|O
base	|O
into	|O
the	|O
adenine	|O
-	|O
binding	|O
pocket	|O
,	|O
suggesting	|O
that	|O
Ser229	|O
could	|O
form	|O
a	|O
contact	|O
to	|O
the	|O
flipped	|O
adenine	|O
.	|O

The	|O
high	|O
conservation	|O
of	|O
the	|O
3'	|O
terminus	|O
suggests	|O
that	|O
this	|O
region	|O
directs	|O
the	|O
assembly	|O
of	|O
proteins	|O
required	|O
for	|O
the	|O
initiation	|O
of	|O
RNA	|O
replication	|O
.	|O

All	|O
stimulations	|O
were	|O
down	|O
-	|O
regulated	|O
with	|O
GnRH	|B-PROTEIN
-	|I-PROTEIN
a	|I-PROTEIN
commenced	|O
on	|O
day	|O
21	|O
in	|O
a	|O
long	|O
protocol	|O
before	|O
gonadotropin	|B-PROTEIN
stimulation	|O
.	|O

The	|O
sequence	|O
up	|O
to	|O
-	|O
267	|O
bp	|O
relative	|O
to	|O
the	|O
transcription	|O
start	|O
site	|O
was	|O
sufficient	|O
to	|O
enhance	|O
reporter	|O
gene	|O
expression	|O
depending	|O
on	|O
the	|O
mesodermal	|O
differentiation	|O
of	|O
P19	|O
cells	|O
.	|O

Chem.	|O

No	|O
significant	|O
differences	|O
between	|O
the	|O
substituted	|O
and	|O
wild	|O
type	|O
peptides	|O
were	|O
observed	|O
,	|O
suggesting	|O
that	|O
this	|O
substitution	|O
in	|O
the	|O
intact	|O
protein	|O
may	|O
cause	|O
disruption	|O
of	|O
global	|O
rather	|O
than	|O
local	|O
structures	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
met	|I-PROTEIN
gene	|O
is	|O
also	|O
a	|O
target	|O
of	|O
p53	|B-PROTEIN
gene	|O
regulation	|O
.	|O

C3	|B-PROTEIN
toxin	|I-PROTEIN
completely	|O
inhibited	|O
RhoA	|B-PROTEIN
function	|O
,	|O
partially	|O
inhibited	|O
SRE	|O
:	|O
Luc	|B-PROTEIN
activity	|O
,	|O
but	|O
had	|O
no	|O
effect	|O
on	|O
LPA	|O
-	|O
stimulated	|O
c	|B-PROTEIN
-	|I-PROTEIN
Fos	|I-PROTEIN
expression	|O
.	|O

However	|O
,	|O
C3	|B-PROTEIN
toxin	|I-PROTEIN
alone	|O
or	|O
in	|O
combination	|O
with	|O
growth	|O
factors	|O
did	|O
not	|O
stimulate	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
:	|O
Luc	|B-PROTEIN
activity	|O
and	|O
actually	|O
antagonized	|O
the	|O
synergistic	|O
activation	|O
of	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
:	|O
Luc	|B-PROTEIN
observed	|O
in	|O
response	|O
to	|O
co	|O
-	|O
stimulation	|O
with	|O
growth	|O
factors	|O
and	|O
Ro	|O
-	|O
31-8220	|O
.	|O

The	|O
aim	|O
of	|O
the	|O
present	|O
study	|O
was	|O
to	|O
examine	|O
the	|O
antimicrobial	|O
susceptibility	|O
to	|O
10	|O
currently	|O
used	|O
antimicrobial	|O
agents	|O
of	|O
50	|O
strains	|O
of	|O
P.	|O
acnes	|O
isolated	|O
from	|O
acne	|O
lesions	|O
and	|O
identified	|O
using	|O
a	|O
Rap	|O
ID	|O
ANA	|O
II	|O
panel	|O
.	|O

The	|O
role	|O
of	|O
intraoperative	|O
echocardiography	|O
in	|O
surgery	|O
of	|O
the	|O
heart	|O
and	|O
large	|O
vessels	|O

Taken	|O
together	|O
,	|O
our	|O
results	|O
demonstrate	|O
that	|O
CAP1	|B-PROTEIN
is	|O
involved	|O
in	|O
multidrug	|O
resistance	|O
and	|O
oxidative	|O
stress	|O
response	|O
in	|O
C.	|O
albicans	|O
.	|O

Trinipatch	|O
is	|O
a	|O
small	|O
,	|O
transparent	|O
,	|O
matricial	|O
,	|O
monolayer	|O
patch	|O
with	|O
an	|O
absorption	|O
promoter	|O
,	|O
marketed	|O
in	|O
two	|O
dose	|O
-	|O
strengths	|O
(	|O
5	|O
mg	|O
/	|O
24	|O
h	|O
and	|O
10	|O
mg	|O
/	|O
24	|O
h	|O
)	|O
by	|O
Laboratoires	|O
Synthelabo	|O
.	|O

The	|O
RMRI	|O
was	|O
tested	|O
for	|O
interrater	|O
reliability	|O
using	|O
three	|O
simulated	|O
and	|O
10	|O
actual	|O
patients	|O
.	|O

The	|O
starting	|O
point	|O
is	|O
the	|O
consideration	|O
that	|O
the	|O
conceptions	|O
underlying	|O
the	|O
ICIDH	|O
are	|O
not	|O
suitable	|O
to	|O
serve	|O
as	|O
a	|O
mainstay	|O
of	|O
a	|O
model	|O
for	|O
diagnostics	|O
in	|O
rehabilitation	|O
because	|O
they	|O
do	|O
not	|O
reflect	|O
essential	|O
characteristics	|O
of	|O
the	|O
diagnostic	|O
process	|O
which	|O
is	|O
the	|O
basis	|O
for	|O
intervention	|O
.	|O

Pokeweed	|B-PROTEIN
antiviral	|I-PROTEIN
protein	|I-PROTEIN
(	|O
PAP	|B-PROTEIN
)	|O
from	|O
Phytolacca	|O
americana	|O
is	|O
a	|O
highly	|O
specific	|O
N	|B-PROTEIN
-	|I-PROTEIN
glycosidase	|I-PROTEIN
removing	|O
adenine	|O
residues	|O
(	|O
A4324	|O
in	|O
28S	|B-PROTEIN
rRNA	|O
and	|O
A2660	|O
in	|O
23S	|B-PROTEIN
rRNA	|O
)	|O
from	|O
intact	|O
ribosomes	|O
of	|O
both	|O
eukaryotes	|O
and	|O
prokaryotes	|O
.	|O

OBJECTIVE	|O
:	|O
This	|O
meta	|O
-	|O
analysis	|O
of	|O
67	|O
controlled	|O
trials	|O
was	|O
performed	|O
to	|O
quantify	|O
the	|O
cholesterol	|O
-	|O
lowering	|O
effect	|O
of	|O
major	|O
dietary	|O
fibers	|O
.	|O

Among	|O
these	|O
360	|O
ZFPs	|B-PROTEIN
,	|O
a	|O
novel	|O
ZFP	|B-PROTEIN
cDNA	|O
named	|O
HFHZ	|B-PROTEIN
(	|O
human	|O
fetal	|O
heart	|O
ZFP	|B-PROTEIN
)	|O
with	|O
sequence	|O
homology	|O
to	|O
a	|O
Kruppel	|B-PROTEIN
-	|O
associated	|O
box	|O
(	|O
KRAB	|B-PROTEIN
)	|O
was	|O
identified	|O
.	|O

The	|O
3.3	|O
-	|O
fold	|O
higher	|O
expression	|O
in	|O
the	|O
fetal	|O
heart	|O
than	|O
in	|O
the	|O
adult	|O
heart	|O
suggests	|O
that	|O
HFHZ	|B-PROTEIN
mRNA	|O
is	|O
downregulated	|O
in	|O
the	|O
process	|O
of	|O
development	|O
.	|O

When	|O
the	|O
high	|O
affinity	|O
hnRNP	|B-PROTEIN
A1	|O
binding	|O
site	|O
was	|O
inserted	|O
into	|O
the	|O
beta	|B-PROTEIN
-	|I-PROTEIN
globin	|I-PROTEIN
reporter	|O
,	|O
Rev	|B-PROTEIN
was	|O
able	|O
to	|O
increase	|O
the	|O
cytoplasmic	|O
levels	|O
of	|O
unspliced	|O
mRNAs	|O
to	|O
14%	|O
.	|O

To	|O
date	|O
,	|O
two	|O
such	|O
proteins	|O
,	|O
PLZF	|B-PROTEIN
and	|O
LAZ	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
/	|O
BCL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
,	|O
have	|O
been	|O
implicated	|O
in	|O
oncogenesis	|O
.	|O

Overexpression	|O
of	|O
POG1	|B-PROTEIN
inhibits	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
factor	|I-PROTEIN
-	|O
induced	|O
G1	|O
arrest	|O
and	|O
transcriptional	|O
repression	|O
of	|O
the	|O
CLN1	|B-PROTEIN
and	|O
CLN2	|B-PROTEIN
genes	|O
.	|O

We	|O
now	|O
show	|O
that	|O
RNU2	|B-PROTEIN
fragility	|O
can	|O
be	|O
induced	|O
by	|O
transfection	|O
with	|O
an	|O
expression	|O
vector	|O
encoding	|O
Ad12	|O
E1B	|B-PROTEIN
55	|O
kDa	|O
alone	|O
but	|O
not	|O
by	|O
an	|O
E1	|B-PROTEIN
vector	|O
encoding	|O
all	|O
E1	|B-PROTEIN
products	|O
(	|O
3	|O
E1A	|B-PROTEIN
proteins	|O
,	|O
as	|O
well	|O
as	|O
the	|O
E1B	|B-PROTEIN
19	|O
kDa	|O
and	|O
55	|O
kDa	|O
proteins	|O
)	|O
.	|O

Competitionsupershift	|O
EMSA	|O
assays	|O
revealed	|O
that	|O
multiple	|O
proteins	|O
were	|O
involved	|O
in	|O
bandshift	|O
complex	|O
formation	|O
with	|O
KCS	|B-PROTEIN
,	|O
one	|O
of	|O
which	|O
was	|O
identified	|O
as	|O
factor	|O
Sp1	|B-PROTEIN
.	|O

Similarity	|O
of	|O
DNA	|O
binding	|O
and	|O
transcriptional	|O
regulation	|O
by	|O
Caenorhabditis	|O
elegans	|O
MAB	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
and	|O
Drosophila	|O
melanogaster	|O
DSX	|B-PROTEIN
suggests	|O
conservation	|O
of	|O
sex	|O
determining	|O
mechanisms	|O
.	|O

CONTEXT	|O
:	|O
ThinPrep	|O
,	|O
AutoPap	|O
,	|O
and	|O
Papnet	|O
are	|O
3	|O
new	|O
technologies	|O
that	|O
increase	|O
the	|O
sensitivity	|O
and	|O
cost	|O
of	|O
cervical	|O
cancer	|O
screening	|O
.	|O

Experiments	|O
on	|O
narcotized	|O
cats	|O
demonstrated	|O
that	|O
the	|O
derivatives	|O
of	|O
2	|O
-	|O
mercaptobenzimidazole	|O
possessing	|O
the	|O
properties	|O
of	|O
specific	|O
bradycardic	|O
agents	|O
and	|O
coded	|O
as	|O
CM	|O
-	|O
251	|O
,	|O
CM	|O
-	|O
266	|O
,	|O
and	|O
CM	|O
-	|O
345	|O
,	|O
reduce	|O
the	|O
mean	|O
rise	|O
of	|O
segment	|O
ST	|O
on	|O
numerous	|O
leads	|O
of	|O
the	|O
epicardial	|O
electrogram	|O
during	|O
5	|O
-	|O
min	|O
occlusion	|O
of	|O
the	|O
anterior	|O
descending	|O
branch	|O
of	|O
the	|O
left	|O
coronary	|O
artery	|O
.	|O

Neither	|O
the	|O
p42/44	|B-PROTEIN
nor	|O
the	|O
JNK	|B-PROTEIN
pathway	|O
was	|O
involved	|O
in	|O
the	|O
action	|O
of	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1beta	|I-PROTEIN
.	|O

In	|O
protocol	|O
2	|O
,	|O
eight	|O
different	|O
subjects	|O
performed	|O
Con	|O
and	|O
Ecc	|O
arm	|O
curls	|O
to	|O
fatigue	|O
,	|O
followed	|O
by	|O
postexercise	|O
muscle	|O
ischemia	|O
,	|O
by	|O
using	|O
the	|O
same	|O
resistance	|O
as	|O
in	|O
protocol	|O
1	|O
.	|O

Airflow	|O
was	|O
measured	|O
with	|O
a	|O
custom	|O
-	|O
designed	|O
turbine	|O
and	|O
a	|O
45	|O
-	|O
ft	|O
.	|O
-	|O
long	|O
cable	|O
to	|O
reach	|O
the	|O
volume	|O
-	|O
measuring	|O
module	|O
.	|O

Both	|O
mutations	|O
confer	|O
amino	|O
acid	|O
substitutions	|O
in	|O
the	|O
viral	|O
coat	|B-PROTEIN
protein	|O
but	|O
differ	|O
in	|O
their	|O
relative	|O
abilities	|O
to	|O
utilize	|O
the	|O
foreign	|O
scaffolding	|B-PROTEIN
protein	|I-PROTEIN
.	|O

Complete	|O
recovery	|O
of	|O
liver	|O
function	|O
after	|O
this	|O
surgery	|O
tended	|O
to	|O
be	|O
slow	|O
.	|O

Although	|O
both	|O
transcripts	|O
share	|O
the	|O
first	|O
nine	|O
exons	|O
,	|O
exon	|O
10	|O
of	|O
ZIS	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
is	|O
lacking	|O
in	|O
ZIS	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
and	|O
instead	|O
,	|O
exon	|O
11	|O
(	|O
10th	|O
exon	|O
)	|O
of	|O
ZIS	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
larger	|O
in	|O
size	|O
,	|O
leading	|O
to	|O
the	|O
longer	|O
3'	|O
-	|O
UTR	|O
.	|O

Expression	|O
of	|O
the	|O
second	|O
gene	|O
(	|O
XT3	|B-PROTEIN
)	|O
was	|O
found	|O
to	|O
be	|O
conserved	|O
in	|O
human	|O
kidney	|O
,	|O
and	|O
partial	|O
sequence	|O
was	|O
obtained	|O
from	|O
a	|O
human	|O
cDNA	|O
library	|O
.	|O

IFN	|B-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
was	|O
elevated	|O
during	|O
active	|O
TB	|O
when	|O
compared	|O
with	|O
healthy	|O
controls	|O
,	|O
declining	|O
during	|O
and	|O
after	|O
treatment	|O
.	|O

The	|O
missing	|O
5'	|O
sequences	|O
were	|O
obtained	|O
by	|O
5'	|O
-	|O
rapid	|O
amplification	|O
of	|O
cDNA	|O
ends	|O
and	|O
by	|O
analysis	|O
of	|O
an	|O
NHE5	|B-PROTEIN
genomic	|O
clone	|O
,	|O
and	|O
the	|O
missing	|O
3'	|O
sequences	|O
were	|O
obtained	|O
by	|O
3'	|O
-	|O
rapid	|O
amplification	|O
of	|O
cDNA	|O
ends	|O
.	|O

If	|O
no	|O
alloantibodies	|O
are	|O
detected	|O
,	|O
further	|O
analysis	|O
to	|O
define	|O
a	|O
role	|O
of	|O
drug	|O
-	|O
related	|O
or	|O
autoantibodies	|O
is	|O
required	|O
.	|O

This	|O
dependence	|O
,	|O
however	|O
,	|O
can	|O
be	|O
overcome	|O
to	|O
a	|O
large	|O
extent	|O
by	|O
dividing	|O
min	|O
LVdP	|O
/	|O
dt	|O
by	|O
mean	|O
aortic	|O
pressure	|O
.	|O

Genoa	|O
,	|O
Italy	|O
,	|O
24-28	|O
August	|O
1997	|O
.	|O

Electronic	|O
structure	|O
of	|O
delta	|O
-	|O
plutonium	|O
and	|O
of	|O
single	|O
Al	|O
,	|O
Ga	|O
,	|O
and	|O
Sc	|O
impurities	|O
in	|O
delta	|O
-	|O
plutonium	|O
.	|O

Bound	|O
-	|O
exciton	|O
transfer	|O
and	|O
photoluminescence	|O
undulation	|O
spectra	|O
for	|O
acceptors	|O
in	|O
ZnTe	|O
.	|O

Unified	|O
theory	|O
of	|O
segregated	|O
-	|O
stack	|O
organic	|O
charge	|O
-	|O
transfer	|O
solids	|O
:	|O
Magnetic	|O
properties	|O
.	|O

Internal	|O
modes	|O
of	|O
a	|O
soliton	|O
.	|O

II	|O
.	|O

Envelope	|O
-	|O
function	|O
matching	|O
conditions	|O
for	|O
GaAs	|O
/	|O
(	|O
Al	|O
,	|O
Ga	|O
)	|O
As	|O
heterojunctions	|O
.	|O

Neutron	|O
scattering	|O
measurements	|O
of	|O
critical	|O
exponents	|O
in	|O
CsMnBr3	|O
:	|O
A	|O
Z2	|O
&	|O
gt	|O
;	|O
=	|O
1	|O
antiferromagnet	|O
.	|O

(	|O
2	|O
)	|O
Erythroid	|O
32D	|O
Epo1	|B-PROTEIN
cells	|O
showed	|O
a	|O
lower	|O
level	|O
of	|O
bulk	|O
PKC	|B-PROTEIN
catalytic	|O
activity	|O
,	|O
lacked	|O
the	|O
expression	|O
of	|O
epsilon	|B-PROTEIN
and	|I-PROTEIN
eta	|I-PROTEIN
PKC	|I-PROTEIN
isoforms	|I-PROTEIN
,	|O
and	|O
showed	|O
a	|O
weak	|O
or	|O
absent	|O
upregulation	|O
of	|O
the	|O
remaining	|O
isoforms	|O
,	|O
except	|O
betaI	|B-PROTEIN
,	|O
upon	|O
readdition	|O
of	|O
Epo	|B-PROTEIN
to	|O
growth	|O
factor	|O
-	|O
starved	|O
cells	|O
.	|O

We	|O
used	|O
expression	|O
cloning	|O
to	|O
identify	|O
interleukin	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
(	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
)	|O
as	|O
one	|O
factor	|O
that	|O
suppressed	|O
growth	|O
of	|O
a	|O
pre	|O
-	|O
B	|O
-	|O
cell	|O
variant	|O
line	|O
,	|O
1A9	|O
-	|O
M.	|O

Airflow	|O
through	|O
the	|O
dust	|O
trap	|O
was	|O
controlled	|O
with	|O
a	|O
vacuum	|O
pump	|O
.	|O

Thus	|O
,	|O
in	|O
normal	|O
intestinal	|O
epithelial	|O
goblet	|O
cells	|O
,	|O
TbetaRI	|B-PROTEIN
and	|O
TbetaRII	|B-PROTEIN
can	|O
respond	|O
to	|O
autocrine	|O
but	|O
not	|O
exogenous	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
without	|O
the	|O
participation	|O
of	|O
TbetaRIII	|B-PROTEIN
.	|O

The	|O
history	|O
of	|O
exposure	|O
and	|O
carboxyhemoglobin	|B-PROTEIN
levels	|O
should	|O
alert	|O
the	|O
physician	|O
to	|O
this	|O
diagnosis	|O
.	|O

The	|O
odds	|O
ratio	|O
for	|O
CHD	|O
was	|O
1.21	|O
(	|O
95%	|O
confidence	|O
interval	|O
,	|O
0.84-1.75	|O
)	|O
given	|O
a	|O
positive	|O
serostatus	|O
of	|O
specific	|O
IgG	|B-PROTEIN
antibodies	|O
after	|O
adjustment	|O
for	|O
covariates	|O
.	|O

Another	|O
group	|O
of	|O
HIPP	|O
-	|O
and	|O
HCX	|O
-	|O
lesioned	|O
animals	|O
trained	|O
on	|O
the	|O
tasks	|O
after	|O
the	|O
lesion	|O
showed	|O
reduced	|O
impairments	|O
of	|O
the	|O
type	|O
described	|O
above	|O
,	|O
suggesting	|O
that	|O
extrahippocampal	|O
structures	|O
trained	|O
after	|O
the	|O
lesion	|O
can	|O
assume	|O
the	|O
role	|O
of	|O
the	|O
hippocampus	|O
to	|O
some	|O
degree	|O
.	|O

The	|O
case	|O
for	|O
neutrinos	|O
from	|O
SN	|O
1987A	|O
.	|O

Scaling	|O
of	|O
fluctuations	|O
in	|O
one	|O
-	|O
dimensional	|O
interface	|O
and	|O
hopping	|O
models	|O
.	|O

Model	|O
of	|O
spatiotemporal	|O
dynamics	|O
of	|O
stick	|O
-	|O
slip	|O
motion	|O
.	|O

NMR	|O
of	|O
diffusing	|O
atoms	|O
in	|O
a	|O
periodic	|O
porous	|O
medium	|O
in	|O
the	|O
presence	|O
of	|O
a	|O
nonuniform	|O
magnetic	|O
field	|O
.	|O

Microstructure	|O
and	|O
conductivity	|O
of	|O
hierarchical	|O
laminate	|O
composites	|O
.	|O

Anisotropic	|O
heat	|O
transport	|O
in	|O
the	|O
octylcyanobiphenyl	|O
(	|O
8CB	|O
)	|O
liquid	|O
crystal	|O
.	|O

Direct	|O
approach	|O
to	|O
the	|O
study	|O
of	|O
soliton	|O
perturbations	|O
.	|O

Mutations	|O
affecting	|O
only	|O
CD4	|B-PROTEIN
regulation	|O
mapped	|O
to	|O
residues	|O
previously	|O
shown	|O
to	|O
mediate	|O
the	|O
binding	|O
of	|O
Nef	|B-PROTEIN
to	|O
this	|O
receptor	|O
,	|O
such	|O
as	|O
W57	|O
and	|O
L58	|O
,	|O
as	|O
well	|O
as	|O
to	|O
an	|O
AP	|B-PROTEIN
-	|O
recruiting	|O
dileucine	|O
motif	|O
and	|O
to	|O
an	|O
acidic	|O
dipeptide	|O
in	|O
the	|O
C	|O
-	|O
terminal	|O
region	|O
of	|O
the	|O
protein	|O
.	|O

Several	|O
mutations	|O
disrupted	|O
the	|O
endonuclease	|O
and	|O
helicase	|B-PROTEIN
activities	|O
;	|O
however	|O
,	|O
only	|O
one	|O
amino	|B-PROTEIN
-	|I-PROTEIN
terminal	|I-PROTEIN
-	|I-PROTEIN
charge	|I-PROTEIN
cluster	|I-PROTEIN
mutant	|I-PROTEIN
protein	|I-PROTEIN
(	|O
D40A	|O
-	|O
D42A	|O
-	|O
D44A	|O
)	|O
completely	|O
lost	|O
AAV	|O
hairpin	|O
DNA	|O
binding	|O
activity	|O
.	|O

The	|O
lytic	|O
cycle	|O
of	|O
KSHV	|O
,	|O
probably	|O
under	|O
the	|O
initial	|O
control	|O
of	|O
the	|O
KSHV	|O
/	|O
Rta	|B-PROTEIN
gene	|O
,	|O
may	|O
directly	|O
contribute	|O
to	|O
tumor	|O
pathogenesis	|O
.	|O

We	|O
conclude	|O
that	|O
(	|O
i	|O
)	|O
we	|O
have	|O
identified	|O
several	|O
candidate	|O
latency	|O
genes	|O
of	|O
murine	|O
gammaHV68	|O
,	|O
(	|O
ii	|O
)	|O
expression	|O
of	|O
genes	|O
during	|O
latency	|O
may	|O
be	|O
different	|O
in	|O
different	|O
organs	|O
,	|O
consistent	|O
with	|O
multiple	|O
latency	|O
programs	|O
and	|O
/	|O
or	|O
multiple	|O
cellular	|O
sites	|O
of	|O
latency	|O
,	|O
and	|O
(	|O
iii	|O
)	|O
regions	|O
of	|O
the	|O
viral	|O
genome	|O
(	|O
v	|B-PROTEIN
-	|I-PROTEIN
bcl	|I-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
gene	|I-PROTEIN
,	|O
v	|B-PROTEIN
-	|I-PROTEIN
GCR	|I-PROTEIN
gene	|I-PROTEIN
,	|O
and	|O
gene	|B-PROTEIN
73	|I-PROTEIN
)	|O
are	|O
transcribed	|O
during	|O
latency	|O
with	|O
both	|O
gammaHV68	|O
and	|O
primate	|O
gammaherpesviruses	|O
.	|O

These	|O
data	|O
indicate	|O
a	|O
functional	|O
role	|O
for	|O
U1	|B-PROTEIN
in	|O
NRS	|B-PROTEIN
-	|O
mediated	|O
splicing	|O
inhibition	|O
.	|O

This	|O
suggests	|O
that	|O
the	|O
DcuS	|B-PROTEIN
-	|O
DcuR	|B-PROTEIN
system	|O
responds	|O
to	|O
external	|O
substrates	|O
.	|O

Here	|O
we	|O
describe	|O
the	|O
identification	|O
and	|O
characterization	|O
of	|O
several	|O
Sp100	|B-PROTEIN
splice	|O
variant	|O
proteins	|O
and	|O
support	|O
their	|O
existence	|O
by	|O
elucidation	|O
of	|O
the	|O
3'	|O
-	|O
end	|O
of	|O
the	|O
Sp100	|B-PROTEIN
gene	|O
.	|O

Crossover	|O
in	|O
the	|O
specific	|O
heat	|O
of	|O
dilute	|O
magnets	|O
induced	|O
by	|O
critical	|O
spin	|O
-	|O
wave	|O
dynamics	|O
.	|O

Erratum	|O
:	|O
Absence	|O
of	|O
precursor	|O
effects	|O
above	|O
the	|O
martensitic	|O
transformation	|O
in	|O
a	|O
virgin	|O
crystal	|O
of	|O
Li	|O
metal	|O

Interplane	|O
coupling	|O
in	|O
the	|O
superconductor	|O
Y2Ba4Cu7O15	|O
as	|O
revealed	|O
by	|O
NQR	|O
spin	|O
-	|O
echo	|O
double	|O
resonance	|O
.	|O

Electronic	|O
structure	|O
of	|O
a	|O
buried	|O
NiSi2	|O
or	|O
CoSi2	|O
layer	|O
in	|O
bulk	|O
Si	|O
.	|O

Raman	|O
investigation	|O
of	|O
YBa2	|O
-	|O
xLaxCu3O7	|O
ceramics	|O
.	|O

Effects	|O
of	|O
point	|O
defects	|O
on	|O
lattice	|O
parameters	|O
of	|O
semiconductors	|O
.	|O

Chaotic	|O
electron	|O
dynamics	|O
around	|O
a	|O
single	|O
elliptically	|O
shaped	|O
antidot	|O
.	|O

However	|O
,	|O
deletions	|O
of	|O
the	|O
C	|O
terminal	|O
11	|O
or	|O
14	|O
amino	|O
acids	|O
had	|O
more	|O
substantial	|O
effects	|O
.	|O

Sixty	|O
months	|O
after	|O
the	|O
initial	|O
vaccination	|O
,	|O
all	|O
vaccinees	|O
who	|O
received	|O
annual	|O
follow	|O
-	|O
up	|O
still	|O
had	|O
protective	|O
levels	|O
of	|O
anti	|B-PROTEIN
-	|I-PROTEIN
HAV	|I-PROTEIN
.	|O

However	|O
,	|O
after	|O
PRK	|O
at	|O
5	|O
weeks	|O
of	|O
age	|O
,	|O
partial	|O
retreatment	|O
may	|O
be	|O
necessary	|O
due	|O
to	|O
regression	|O
of	|O
the	|O
PRK	|O
effect	|O
.	|O

Its	|O
early	|O
lesions	|O
were	|O
characterized	|O
by	|O
angiomatosis	|O
,	|O
vasculopathy	|O
,	|O
and	|O
proliferation	|O
of	|O
synoviocytes	|O
and	|O
fibroblasts	|O
.	|O

Molecular	|O
cloning	|O
of	|O
human	|O
cDNA	|O
encoding	|O
a	|O
novel	|O
beta1	|B-PROTEIN
,	|I-PROTEIN
6	|I-PROTEIN
-	|I-PROTEIN
N	|I-PROTEIN
-	|I-PROTEIN
acetylglucosaminyltransferase	|I-PROTEIN
forming	|O
core	|O
2	|O
and	|O
core	|O
4	|O
.	|O

Interspecific	|O
mouse	|O
back	|O
-	|O
cross	|O
analysis	|O
identified	|O
the	|O
loci	|O
for	|O
mouse	|O
3Ost	|B-PROTEIN
genes	|O
and	|O
syntenic	|O
assignments	|O
of	|O
corresponding	|O
human	|O
isologs	|O
were	|O
confirmed	|O
by	|O
the	|O
identification	|O
of	|O
mapped	|O
sequence	|O
-	|O
tagged	|O
site	|O
markers	|O
.	|O

The	|O
Scales	|O
of	|O
Cognitive	|O
Impairment	|O
Rated	|O
From	|O
Institutional	|O
Records	|O
(	|O
SCIRFIR	|O
)	|O
,	|O
a	|O
battery	|O
based	|O
on	|O
commonly	|O
used	|O
dementia	|O
rating	|O
instruments	|O
,	|O
was	|O
tested	|O
on	|O
the	|O
records	|O
of	|O
26	|O
chronically	|O
institutionalized	|O
,	|O
elderly	|O
schizophrenia	|O
patients	|O
,	|O
for	|O
the	|O
purpose	|O
of	|O
retrospectively	|O
evaluating	|O
the	|O
long	|O
-	|O
term	|O
course	|O
of	|O
cognitive	|O
change	|O
in	|O
schizophrenia	|O
and	|O
relating	|O
it	|O
to	|O
available	|O
autopsy	|O
materials	|O
.	|O

It	|O
was	|O
demonstrated	|O
that	|O
the	|O
processing	|O
signals	|O
in	|O
the	|O
transcript	|O
,	|O
i.e.	|O
both	|O
donor	|O
splice	|O
sites	|O
and	|O
the	|O
polyadenylation	|O
site	|O
located	|O
in	|O
the	|O
muscle	|O
-	|O
specific	|O
intron	|O
,	|O
have	|O
to	|O
be	|O
weak	|O
.	|O

Most	|O
recently	|O
,	|O
the	|O
use	|O
of	|O
the	|O
product	|O
of	|O
brain	|O
weight	|O
and	|O
clearance	|O
has	|O
been	|O
proposed	|O
.	|O

Recombination	|O
and	|O
transcription	|O
of	|O
the	|O
endogenous	|O
Ig	|B-PROTEIN
heavy	|I-PROTEIN
chain	|I-PROTEIN
locus	|O
is	|O
effected	|O
by	|O
the	|O
Ig	|B-PROTEIN
heavy	|I-PROTEIN
chain	|I-PROTEIN
intronic	|O
enhancer	|O
core	|O
region	|O
in	|O
the	|O
absence	|O
of	|O
the	|O
matrix	|O
attachment	|O
regions	|O
.	|O

Two	|O
of	|O
these	|O
motifs	|O
are	|O
part	|O
of	|O
a	|O
highly	|O
conserved	|O
and	|O
inducible	|O
dyad	|O
symmetry	|O
element	|O
shown	|O
previously	|O
to	|O
control	|O
a	|O
remote	|O
IL	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
enhancer	|O
and	|O
the	|O
CD18	|B-PROTEIN
promoter	|O
.	|O

In	|O
concert	|O
with	|O
the	|O
coactivator	|O
CREB	|B-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
/	|O
p300	|B-PROTEIN
,	|O
which	|O
interacts	|O
with	|O
GABPalpha	|B-PROTEIN
,	|O
the	|O
binding	|O
of	|O
GABPalpha	|B-PROTEIN
and	|I-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
to	|O
the	|O
dyad	|O
symmetry	|O
element	|O
controls	|O
the	|O
induction	|O
of	|O
IL	|B-PROTEIN
-	|I-PROTEIN
16	|I-PROTEIN
promoter	|O
in	|O
T	|O
cells	|O
.	|O

TPO	|B-PROTEIN
by	|O
itself	|O
did	|O
not	|O
activate	|O
ERK1	|B-PROTEIN
,	|O
ERK2	|B-PROTEIN
and	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
C	|I-PROTEIN
(	|O
PKC	|B-PROTEIN
)	|O
,	|O
whereas	|O
TPO	|B-PROTEIN
directly	|O
enhanced	|O
the	|O
PKC	|B-PROTEIN
-	|O
dependent	|O
activation	|O
of	|O
ERKs	|B-PROTEIN
induced	|O
by	|O
other	|O
agonists	|O
including	|O
thrombin	|B-PROTEIN
and	|O
phorbol	|O
esters	|O
,	|O
without	|O
affecting	|O
the	|O
PKC	|B-PROTEIN
activation	|O
by	|O
those	|O
agonists	|O
.	|O

BACKGROUND	|O
:	|O
In	|O
the	|O
ubiquitin	|B-PROTEIN
-	|O
dependent	|O
proteolysis	|O
pathway	|O
,	|O
a	|O
ubiquitin	|B-PROTEIN
ligase	|I-PROTEIN
(	|O
E3	|B-PROTEIN
)	|O
is	|O
responsible	|O
for	|O
substrate	|O
selectivity	|O
and	|O
timing	|O
of	|O
degradation	|O
.	|O

CONCLUSIONS	|O
:	|O
Fission	|O
yeast	|O
SCF	|B-PROTEIN
is	|O
composed	|O
of	|O
Pop1	|B-PROTEIN
and	|O
Pop2	|B-PROTEIN
,	|O
two	|O
structurally	|O
related	|O
but	|O
functionally	|O
independent	|O
F	|B-PROTEIN
-	|I-PROTEIN
box	|I-PROTEIN
/	|I-PROTEIN
WD	|I-PROTEIN
-	|I-PROTEIN
repeat	|I-PROTEIN
proteins	|I-PROTEIN
.	|O

19F	|O
NMR	|O
studies	|O
in	|O
ABF4	|O
-	|O
type	|O
layered	|O
antiferromagnets	|O
.	|O

Optical	|O
-	|O
absorption	|O
spectra	|O
,	|O
crystal	|O
-	|O
field	|O
energy	|O
levels	|O
,	|O
and	|O
transition	|O
line	|O
strengths	|O
of	|O
holmium	|O
in	|O
trigonal	|O
Na3	|O

Observation	|O
of	|O
dipolar	|O
interactions	|O
between	|O
Pb0	|O
defects	|O
at	|O
the	|O
(	|O
111	|O
)	|O
Si	|O
/	|O
SiO2	|O
interface	|O
.	|O

Quantum	|O
-	|O
statistical	|O
theory	|O
of	|O
high	|O
-	|O
field	|O
transport	|O
phenomena	|O
.	|O

NH3	|O
and	|O
NO	|O
interaction	|O
with	|O
Si	|O
(	|O
100	|O
)	|O
-	|O
(	|O
2	|O
x	|O
1	|O
)	|O
surfaces	|O
.	|O

Chirality	|O
-	|O
glass	|O
and	|O
spin	|O
-	|O
glass	|O
correlations	|O
in	|O
the	|O
two	|O
-	|O
dimensional	|O
random	|O
-	|O
bond	|O
XY	|O
model	|O
.	|O

Echo	|O
modulation	|O
in	|O
Pr3+	|O
:	|O
YAlO3	|O
.	|O

Mechanisms	|O
of	|O
visible	|O
-	|O
light	|O
emission	|O
from	|O
electro	|O
-	|O
oxidized	|O
porous	|O
silicon	|O
.	|O

Far	|O
-	|O
infrared	|O
hopping	|O
conductivity	|O
in	|O
the	|O
CuO	|O
chains	|O
of	|O
a	|O
single	|O
-	|O
domain	|O
YBa2Cu3O7	|O
-	|O
delta	|O
crystal	|O
.	|O

Surface	|O
spin	|O
waves	|O
in	|O
a	|O
Heisenberg	|O
ferrimagnet	|O
with	|O
a	|O
single	|O
-	|O
ion	|O
anisotropy	|O
(	|O
uniaxial	|O
and	|O
nonuniaxial	|O
)	|O
.	|O

Optically	|O
detected	|O
librons	|O
and	|O
phonons	|O
in	|O
crystalline	|O
C60	|O
.	|O

Multilayer	|O
-	|O
relaxation	|O
geometry	|O
and	|O
electronic	|O
structure	|O
of	|O
a	|O
W	|O
(	|O
111	|O
)	|O
surface	|O
.	|O

Temperature	|O
dependence	|O
of	|O
the	|O
sublattice	|O
spontaneous	|O
magnetization	|O
of	|O
YBa2Cu3O6	|O
.	|O

GW	|O
Gamma	|O
approximation	|O
for	|O
electron	|O
self	|O
-	|O
energies	|O
in	|O
semiconductors	|O
and	|O
insulators	|O
.	|O

Precision	|O
measurement	|O
of	|O
the	|O
pion	|O
mass	|O
difference	|O
m	|O
pi	|O
-	|O
-	|O
m	|O
pi	|O
0	|O
.	|O

Testing	|O
gravity	|O
to	|O
second	|O
post	|O
-	|O
Newtonian	|O
order	|O
:	|O
A	|O
field	|O
-	|O
theory	|O
approach	|O
.	|O

Genetic	|O
experiments	|O
using	|O
mutants	|O
defective	|O
in	|O
apontic	|B-PROTEIN
and	|O
bruno	|B-PROTEIN
reveal	|O
a	|O
functional	|O
interaction	|O
between	|O
these	|O
genes	|O
.	|O

In	|O
the	|O
current	|O
model	|O
,	|O
Wingless	|B-PROTEIN
/	|O
Wnt	|B-PROTEIN
signal	|O
stabilizes	|O
Armadillo	|B-PROTEIN
/	|O
beta	|B-PROTEIN
-	|I-PROTEIN
catenin	|I-PROTEIN
,	|O
which	|O
then	|O
accumulates	|O
in	|O
nuclei	|O
and	|O
binds	|O
TCF	|B-PROTEIN
/	|O
LEF	|B-PROTEIN
family	|O
proteins	|O
,	|O
forming	|O
bipartite	|O
transcription	|O
factors	|O
which	|O
activate	|O
transcription	|O
of	|O
Wingless	|B-PROTEIN
/	|O
Wnt	|B-PROTEIN
responsive	|O
genes	|O
.	|O

In	|O
support	|O
of	|O
clinical	|O
antianginal	|O
studies	|O
,	|O
the	|O
vasodilator	|O
nicorandil	|O
(	|O
NIC	|O
)	|O
was	|O
combined	|O
with	|O
the	|O
beta	|B-PROTEIN
-	|I-PROTEIN
adrenergic	|I-PROTEIN
receptor	|I-PROTEIN
antagonists	|O
propranolol	|O
(	|O
PRO	|O
)	|O
and	|O
atenolol	|O
(	|O
ATN	|O
)	|O
and	|O
with	|O
the	|O
calcium	|O
channel	|O
blocker	|O
diltiazem	|O
(	|O
DTZ	|O
)	|O
to	|O
determine	|O
their	|O
cardiovascular	|O
and	|O
pharmacokinetic	|O
interactions	|O
.	|O

Factors	|O
influencing	|O
direct	|O
-	|O
immersion	|O
(	|O
DI	|O
)	|O
-	|O
SPME	|O
process	|O
were	|O
also	|O
checked	|O
and	|O
chosen	|O
experimentally	|O
.	|O

In	|O
contrast	|O
,	|O
an	|O
amino	|O
-	|O
terminal	|O
fragment	|O
containing	|O
the	|O
C	|O
/	|O
H1	|O
domain	|O
was	|O
sufficient	|O
for	|O
coactivation	|O
of	|O
Zta	|B-PROTEIN
transcription	|O
and	|O
viral	|O
reactivation	|O
function	|O
.	|O

In	|O
addition	|O
,	|O
a	|O
potent	|O
splicing	|O
enhancer	|O
sequence	|O
isolated	|O
in	|O
the	|O
selection	|O
specifically	|O
binds	|O
a	|O
20	|O
-	|O
kDa	|O
SR	|B-PROTEIN
protein	|O
.	|O

Elimination	|O
of	|O
ETH1	|B-PROTEIN
in	|O
apn1	|B-PROTEIN
strains	|O
also	|O
increased	|O
spontaneous	|O
mutation	|O
rates	|O
9	|O
-	|O
or	|O
31	|O
-	|O
fold	|O
compared	|O
to	|O
the	|O
wild	|O
type	|O
as	|O
determined	|O
by	|O
reversion	|O
to	|O
adenine	|O
or	|O
lysine	|O
prototrophy	|O
,	|O
respectively	|O
.	|O

Elimination	|O
of	|O
ETH1	|B-PROTEIN
in	|O
apn1	|B-PROTEIN
strains	|O
also	|O
increased	|O
spontaneous	|O
mutation	|O
rates	|O
9	|O
-	|O
or	|O
31	|O
-	|O
fold	|O
compared	|O
to	|O
the	|O
wild	|O
type	|O
as	|O
determined	|O
by	|O
reversion	|O
to	|O
adenine	|O
or	|O
lysine	|O
prototrophy	|O
,	|O
respectively	|O
.	|O

These	|O
data	|O
suggest	|O
that	|O
other	|O
Ras	|B-PROTEIN
effectors	|O
can	|O
collaborate	|O
with	|O
PI	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
and	|O
with	|O
each	|O
other	|O
to	|O
activate	|O
Pak	|B-PROTEIN
.	|O

Mammalian	|O
Ras	|B-PROTEIN
GTPase	|O
-	|O
activating	|O
protein	|O
(	|O
GAP	|B-PROTEIN
)	|O
,	|O
p120	|B-PROTEIN
Ras	|O
-	|O
GAP	|B-PROTEIN
,	|O
has	|O
been	|O
implicated	|O
as	|O
both	|O
a	|O
downregulator	|O
and	|O
effector	|O
of	|O
Ras	|B-PROTEIN
proteins	|O
,	|O
but	|O
its	|O
precise	|O
role	|O
in	|O
Ras	|B-PROTEIN
-	|O
mediated	|O
signal	|O
transduction	|O
pathways	|O
is	|O
unclear	|O
.	|O

Three	|O
mog	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
alleles	|O
possess	|O
premature	|O
stop	|O
codons	|O
and	|O
are	|O
likely	|O
to	|O
be	|O
null	|O
alleles	|O
,	|O
and	|O
one	|O
is	|O
a	|O
missense	|O
mutation	|O
and	|O
is	|O
likely	|O
to	|O
retain	|O
residual	|O
activity	|O
.	|O
mog	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
mRNA	|O
is	|O
expressed	|O
in	|O
both	|O
germ	|O
line	|O
and	|O
somatic	|O
tissues	|O
and	|O
appears	|O
to	|O
be	|O
ubiquitous	|O
.	|O

However	|O
,	|O
unlike	|O
the	|O
SIN3	|B-PROTEIN
gene	|O
of	|O
Saccharomyces	|O
cerevisiae	|O
,	|O
pst1	|B-PROTEIN
(	|O
+	|O
)	|O
is	|O
essential	|O
for	|O
cell	|O
viability	|O
.	|O

The	|O
Nmd3	|B-PROTEIN
protein	|O
sequence	|O
does	|O
not	|O
contain	|O
readily	|O
recognizable	|O
motifs	|O
of	|O
known	|O
function	|O
.	|O

The	|O
distribution	|O
of	|O
the	|O
various	|O
repeats	|O
suggests	|O
its	|O
organization	|O
is	|O
similar	|O
to	|O
the	|O
beta	|O
-	|O
heterochromatic	|O
regions	|O
near	|O
the	|O
base	|O
of	|O
the	|O
major	|O
chromosome	|O
arms	|O
.	|O

Calcitonin	|B-PROTEIN
simultaneously	|O
regulates	|O
both	|O
periosteal	|O
hyperostosis	|O
and	|O
trabecular	|O
osteopenia	|O
in	|O
the	|O
spinal	|O
hyperostotic	|O
mouse	|O
(	|O
twy	|B-PROTEIN
/	|O
twy	|B-PROTEIN
)	|O
in	|O
vivo	|O
.	|O

Electrophoretic	|O
mobility	|O
-	|O
shift	|O
assays	|O
performed	|O
with	|O
the	|O
HNF	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
X	|O
and	|O
Y	|O
sites	|O
demonstrated	|O
that	|O
both	|O
sites	|O
are	|O
capable	|O
of	|O
binding	|O
HNF	|B-PROTEIN
-	|I-PROTEIN
3alpha	|I-PROTEIN
and	|O
HNF	|B-PROTEIN
-	|I-PROTEIN
3beta	|I-PROTEIN
.	|O

In	|O
addition	|O
,	|O
we	|O
also	|O
show	|O
that	|O
cdk7	|B-PROTEIN
may	|O
phosphorylate	|O
the	|O
carboxy	|O
-	|O
terminal	|O
domain	|O
(	|O
CTD	|O
)	|O
of	|O
RNA	|B-PROTEIN
pol	|I-PROTEIN
II	|I-PROTEIN
in	|O
the	|O
absence	|O
of	|O
promoter	|O
opening	|O
.	|O

The	|O
therapy	|O
with	|O
a	|O
H2	|B-PROTEIN
-	|I-PROTEIN
receptor	|I-PROTEIN
antagonist	|O
is	|O
less	|O
effective	|O
than	|O
the	|O
triple	|O
therapies	|O
with	|O
omeprazole	|O
or	|O
lansoprazole	|O
.	|O

In	|O
humans	|O
,	|O
three	|O
tissue	|O
-	|O
specific	|O
plastin	|B-PROTEIN
isoforms	|O
have	|O
been	|O
identified	|O
.	|O

No	|O
TATA	|O
or	|O
Inr	|O
sequence	|O
was	|O
found	|O
.	|O

The	|O
inhibition	|O
by	|O
the	|O
RIalpha	|B-PROTEIN
subunit	|O
is	|O
reversed	|O
by	|O
addition	|O
of	|O
nanomolar	|O
concentrations	|O
of	|O
cAMP	|O
(	|O
Ka	|O
=	|O
40	|O
nM	|O
)	|O
,	|O
thus	|O
demonstrating	|O
that	|O
PrKX	|B-PROTEIN
is	|O
a	|O
novel	|O
,	|O
type	|B-PROTEIN
I	|I-PROTEIN
cAMP	|I-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
that	|O
is	|O
activated	|O
at	|O
lower	|O
cAMP	|O
concentrations	|O
than	|O
the	|O
holoenzyme	|O
with	|O
the	|O
Calpha	|B-PROTEIN
subunit	|I-PROTEIN
of	|O
cAMP	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
.	|O

Proteins	|O
known	|O
to	|O
bind	|O
the	|O
PEPCK	|B-PROTEIN
CRE	|O
include	|O
the	|O
CRE	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
(	|O
CREB	|B-PROTEIN
)	|O
and	|O
members	|O
of	|O
the	|O
CCAAT	|B-PROTEIN
/	|I-PROTEIN
enhancer	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
(	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
)	|O
family	|O
.	|O

This	|O
construct	|O
,	|O
termed	|O
pDeltaCREC	|B-PROTEIN
/	|O
EBP	|B-PROTEIN
,	|O
binds	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBPalpha	|I-PROTEIN
and	|I-PROTEIN
beta	|I-PROTEIN
but	|O
not	|O
CREB	|B-PROTEIN
,	|O
yet	|O
it	|O
confers	|O
a	|O
nearly	|O
complete	|O
glucocorticoid	|O
response	|O
when	|O
transiently	|O
transfected	|O
into	|O
H4IIE	|O
rat	|O
hepatoma	|O
cells	|O
.	|O

In	|O
addition	|O
,	|O
in	|O
vitro	|O
mutagenesis	|O
of	|O
both	|O
Engrailed	|B-PROTEIN
and	|O
Pbx1	|B-PROTEIN
sites	|O
indicated	|O
that	|O
other	|O
unidentified	|O
sites	|O
are	|O
responsible	|O
for	|O
the	|O
transcriptional	|O
enhancement	|O
observed	|O
with	|O
the	|O
intronic	|O
fragment	|O
.	|O

Several	|O
secondary	|O
structure	|O
elements	|O
were	|O
identified	|O
.	|O

Here	|O
,	|O
we	|O
evidence	|O
that	|O
the	|O
developmental	|O
functions	|O
of	|O
the	|O
family	|O
of	|O
transcription	|O
factors	|O
characterized	|O
by	|O
the	|O
POU	|B-PROTEIN
DNA	|O
binding	|O
motif	|O
exerts	|O
roles	|O
in	|O
mammalian	|O
development	|O
.	|O

High	|O
-	|O
affinity	|O
site	|O
-	|O
specific	|O
DNA	|O
binding	|O
by	|O
POU	|B-PROTEIN
domain	|O
transcription	|O
factors	|O
requires	|O
both	|O
the	|O
POU	|B-PROTEIN
-	|O
specific	|O
and	|O
the	|O
POU	|B-PROTEIN
-	|O
homeodomain	|O
.	|O

In	|O
the	|O
Oct	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
crystal	|O
,	|O
the	|O
POU	|B-PROTEIN
-	|O
specific	|O
domain	|O
recognizes	|O
a	|O
GCAT	|O
half	|O
-	|O
site	|O
,	|O
while	|O
the	|O
corresponding	|O
sequence	|O
recognized	|O
by	|O
the	|O
Pit	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
POU	|O
-	|O
specific	|O
domain	|O
,	|O
GTAT	|O
,	|O
is	|O
on	|O
the	|O
opposing	|O
strand	|O
.	|O

Systematic	|O
functional	|O
analysis	|O
of	|O
V1a	|B-PROTEIN
/	|I-PROTEIN
V2	|I-PROTEIN
hybrid	|I-PROTEIN
receptors	|I-PROTEIN
showed	|O
that	|O
the	|O
second	|O
intracellular	|O
loop	|O
of	|O
the	|O
V1a	|B-PROTEIN
receptor	|O
is	|O
required	|O
and	|O
sufficient	|O
for	|O
efficient	|O
coupling	|O
to	|O
Gq	|B-PROTEIN
/	|I-PROTEIN
11	|I-PROTEIN
,	|O
whereas	|O
the	|O
third	|O
intracellular	|O
loop	|O
of	|O
the	|O
V2	|B-PROTEIN
receptor	|I-PROTEIN
is	|O
required	|O
and	|O
sufficient	|O
for	|O
coupling	|O
to	|O
Gs	|B-PROTEIN
.	|O

Most	|O
other	|O
end	|O
points	|O
were	|O
highly	|O
significant	|O
,	|O
and	|O
death	|O
,	|O
which	|O
was	|O
monitored	|O
across	|O
the	|O
U.S.	|O
program	|O
,	|O
was	|O
different	|O
with	|O
p	|O
<	|O
0.0001	|O
.	|O

The	|O
other	|O
is	|O
located	|O
at	|O
-	|O
1335	|O
,	|O
outside	|O
this	|O
highly	|O
conserved	|O
region	|O
.	|O

The	|O
fatigue	|O
exercise	|O
showed	|O
relatively	|O
high	|O
blood	|O
lactate	|O
concentration	|O
[	|O
12.5	|O
(	|O
SD	|O
2.6	|O
)	|O
mmol	|O
x	|O
l	|O
(	|O
-	|O
1	|O
)	|O
]	|O
and	|O
an	|O
increase	|O
of	|O
serum	|O
creatine	|B-PROTEIN
kinase	|I-PROTEIN
(	|O
CK	|B-PROTEIN
)	|O
activity	|O
delayed	|O
by	|O
2	|O
days	|O
[	|O
540	|O
(	|O
SD	|O
407	|O
)	|O
U	|O
x	|O
l	|O
(	|O
-	|O
1	|O
)	|O
]	|O
.	|O

Those	|O
radiological	|O
aspects	|O
were	|O
distributed	|O
in	|O
two	|O
categories	|O
:	|O
1	|O
)	|O
type	|O
I	|O
-	|O
presenting	|O
variable	|O
sinusoidal	|O
filling	|O
.	|O

Results	|O
demonstrated	|O
that	|O
the	|O
presence	|O
of	|O
myofibroblasts	|O
varied	|O
considerably	|O
from	|O
case	|O
to	|O
case	|O
and	|O
was	|O
always	|O
related	|O
to	|O
smooth	|O
muscle	|O
cell	|O
dispersion	|O
,	|O
which	|O
occurred	|O
around	|O
medium	|O
-	|O
sized	|O
damaged	|O
portal	|O
vein	|O
branches	|O
.	|O

New	|O
Langevin	|O
equations	|O
for	|O
a	|O
translating	|O
and	|O
simultaneously	|O
rotating	|O
asymmetric	|O
top	|O
.	|O

Radiative	|O
corrections	|O
to	|O
beta	|O
decay	|O
and	|O
the	|O
possibility	|O
of	|O
a	|O
fourth	|O
generation	|O
.	|O

Depth	|O
-	|O
controlled	|O
grazing	|O
-	|O
incidence	|O
diffraction	|O
of	|O
synchrotron	|O
x	|O
radiation	|O
.	|O

Oscillatory	|O
exchange	|O
of	|O
atoms	|O
between	|O
traps	|O
containing	|O
Bose	|O
condensates	|O
.	|O

Structure	|O
determination	|O
of	|O
an	|O
adsorbate	|O
-	|O
induced	|O
multilayer	|O
reconstruction	|O
:	|O
(	|O
1	|O
x	|O
2	|O
)	|O
-	|O
H	|O
/	|O
Ni	|O
(	|O
110	|O
)	|O
.	|O

Magnetic	|O
trapping	|O
of	|O
spin	|O
-	|O
polarized	|O
atomic	|O
hydrogen	|O
.	|O

Northern	|O
blot	|O
and	|O
in	|O
situ	|O
hybridization	|O
analyses	|O
revealed	|O
GPR34	|B-PROTEIN
mRNA	|O
transcripts	|O
in	|O
several	|O
human	|O
and	|O
rat	|O
brain	|O
regions	|O
.	|O

The	|O
microphthalmia	|B-PROTEIN
-	|I-PROTEIN
TFE	|I-PROTEIN
(	|O
MiT	|B-PROTEIN
)	|O
subfamily	|O
of	|O
basic	|O
helix	|O
-	|O
loop	|O
-	|O
helix	|O
leucine	|O
zipper	|O
(	|B-PROTEIN
bHLH	|I-PROTEIN
-	|I-PROTEIN
ZIP	|I-PROTEIN
)	|I-PROTEIN
transcription	|I-PROTEIN
factors	|I-PROTEIN
,	|O
including	|O
TFE3	|B-PROTEIN
,	|O
TFEB	|B-PROTEIN
,	|O
TFEC	|B-PROTEIN
,	|O
and	|O
Mitf	|B-PROTEIN
,	|O
has	|O
been	|O
implicated	|O
in	|O
the	|O
regulation	|O
of	|O
tissue	|O
-	|O
specific	|O
gene	|O
expression	|O
in	|O
several	|O
cell	|O
lineages	|O
.	|O

Fifty	|O
-	|O
seven	|O
patients	|O
aged	|O
<	|O
55	|O
years	|O
with	|O
acute	|O
lymphoblastic	|O
leukemia	|O
(	|O
ALL	|O
)	|O
in	|O
second	|O
or	|O
third	|O
bone	|O
marrow	|O
(	|O
BM	|O
)	|O
relapse	|O
or	|O
refractory	|O
to	|O
first	|O
-	|O
line	|O
therapy	|O
were	|O
enrolled	|O
in	|O
an	|O
Italian	|O
cooperative	|O
study	|O
.	|O

The	|O
dorsal	|O
nerves	|O
of	|O
the	|O
penis	|O
were	|O
anesthetized	|O
bilaterally	|O
with	|O
lidocaine	|O
.	|O

In	|O
the	|O
brain	|O
,	|O
muscarinic	|B-PROTEIN
receptors	|I-PROTEIN
mediate	|O
motor	|O
and	|O
memory	|O
function	|O
by	|O
interaction	|O
with	|O
their	|O
ligand	|O
acetylcholine	|O
.	|O

Early	|O
-	|O
onset	|O
scleral	|O
necrosis	|O
after	|O
iodine	|O
I	|O
125	|O
plaque	|O
radiotherapy	|O
for	|O
ciliochoroidal	|O
melanoma	|O
.	|O

Successful	|O
interaction	|O
of	|O
ARF	|B-PROTEIN
and	|O
PKC	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
with	|O
PLD1	|B-PROTEIN
was	|O
not	|O
achieved	|O
,	|O
but	|O
a	|O
C	|O
-	|O
terminal	|O
fragment	|O
of	|O
human	|O
PLD1	|B-PROTEIN
(	|O
denoted	|O
"	|O
D4	|O
"	|O
)	|O
interacted	|O
with	|O
the	|O
active	|O
mutant	|O
of	|O
RhoA	|B-PROTEIN
,	|O
RhoAVal	|B-PROTEIN
-	|I-PROTEIN
14	|I-PROTEIN
.	|O

In	|O
this	|O
study	|O
,	|O
we	|O
investigated	|O
the	|O
signal	|O
transduction	|O
pathways	|O
that	|O
are	|O
involved	|O
in	|O
OM	|B-PROTEIN
-	|O
induced	|O
LDLR	|B-PROTEIN
transcription	|O
.	|O

Vacuum	|O
Rabi	|O
splitting	|O
as	|O
a	|O
feature	|O
of	|O
linear	|O
-	|O
dispersion	|O
theory	|O
:	|O
Analysis	|O
and	|O
experimental	|O
observations	|O
.	|O

High	|O
-	|O
pressure	|O
effects	|O
on	|O
ultrafast	|O
-	|O
relaxation	|O
kinetics	|O
of	|O
excitons	|O
in	|O
polydiacetylene	|O
4BCMU	|O
.	|O

Drag	|O
reduction	|O
in	|O
turbulent	|O
flows	|O
by	|O
polymers	|O
.	|O

Large	|O
scale	|O
electronic	|O
structure	|O
calculations	|O
.	|O

Current	|O
world	|O
literature	|O
.	|O

These	|O
results	|O
show	|O
that	|O
Ski	|B-PROTEIN
is	|O
a	|O
component	|O
of	|O
the	|O
HDAC	|B-PROTEIN
complex	|O
and	|O
that	|O
Ski	|B-PROTEIN
is	|O
required	|O
for	|O
the	|O
transcriptional	|O
repression	|O
mediated	|O
by	|O
this	|O
complex	|O
.	|O

Recombinant	|O
unr	|B-PROTEIN
acts	|O
synergistically	|O
with	|O
recombinant	|O
PTB	|B-PROTEIN
to	|O
stimulate	|O
translation	|O
dependent	|O
on	|O
the	|O
rhinovirus	|O
IRES	|O
.	|O

Analysis	|O
of	|O
the	|O
consensus	|O
binding	|O
sequence	|O
and	|O
the	|O
DNA	|O
-	|O
binding	|O
domain	|O
of	|O
ZF5	|B-PROTEIN
.	|O

Mapping	|O
of	|O
the	|O
human	|O
Voltage	|B-PROTEIN
-	|I-PROTEIN
Dependent	|I-PROTEIN
Anion	|I-PROTEIN
Channel	|I-PROTEIN
isoforms	|O
1	|O
and	|O
2	|O
reconsidered	|O
.	|O

Identification	|O
of	|O
RNase	|B-PROTEIN
T	|I-PROTEIN
as	|O
a	|O
high	|O
-	|O
copy	|O
suppressor	|O
of	|O
the	|O
UV	|O
sensitivity	|O
associated	|O
with	|O
single	|O
-	|O
strand	|O
DNA	|B-PROTEIN
exonuclease	|I-PROTEIN
deficiency	|O
in	|O
Escherichia	|O
coli	|O
.	|O

Inhibition	|O
of	|O
phosphatidylinositol	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
kinase	|I-PROTEIN
did	|O
not	|O
have	|O
a	|O
significant	|O
effect	|O
on	|O
p53	|B-PROTEIN
conformation	|O
but	|O
did	|O
have	|O
a	|O
weak	|O
but	|O
significant	|O
effect	|O
on	|O
Tpo	|B-PROTEIN
-	|O
enhanced	|O
viability	|O
.	|O

No	|O
difference	|O
in	|O
percentage	|O
of	|O
males	|O
in	|O
semen	|O
production	|O
was	|O
noted	|O
between	|O
strains	|O
,	|O
CP	|O
levels	|O
,	|O
or	|O
feeding	|O
regimens	|O
.	|O

The	|O
Lp	|B-PROTEIN
mouse	|O
mutant	|O
provides	|O
a	|O
model	|O
for	|O
the	|O
severe	|O
human	|O
neural	|O
tube	|O
defect	|O
(	|O
NTD	|O
)	|O
,	|O
cranio	|O
-	|O
rachischisis	|O
.	|O

Further	|O
analysis	|O
of	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
DNA	|O
binding	|O
activities	|O
in	|O
7	|O
-	|O
to	|O
14	|O
-	|O
day	|O
culture	|O
activated	|O
HSCs	|O
led	|O
to	|O
the	|O
discovery	|O
of	|O
high	|B-PROTEIN
mobility	|I-PROTEIN
AP	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
complexes	|O
(	|O
HMAP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
.	|O

Mutations	|O
of	|O
the	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
site	|O
of	|O
the	|O
TIMP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
promoter	|O
that	|O
prevented	|O
formation	|O
of	|O
HMAP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
caused	|O
a	|O
70%	|O
loss	|O
of	|O
activity	|O
in	|O
transfected	|O
activated	|O
HSCs	|O
.	|O

STUDY	|O
DESIGN	|O
:	|O
Salivary	|O
immunoglobulin	|B-PROTEIN
A	|I-PROTEIN
levels	|O
of	|O
each	|O
of	|O
20	|O
subjects	|O
were	|O
determined	|O
on	|O
3	|O
occasions	|O
:	|O
first	|O
,	|O
while	|O
the	|O
subject	|O
was	|O
still	|O
smoking	|O
;	|O
second	|O
,	|O
7	|O
days	|O
after	|O
cessation	|O
of	|O
smoking	|O
;	|O
third	|O
,	|O
on	|O
the	|O
14th	|O
day	|O
after	|O
cessation	|O
.	|O

Therefore	|O
,	|O
high	|O
set	|O
-	|O
up	|O
accuracy	|O
and	|O
reproducibility	|O
are	|O
mandatory	|O
.	|O

Role	|O
of	|O
g2	|O
in	|O
relating	|O
the	|O
Schwinger	|O
and	|O
Gerasimov	|O
-	|O
Drell	|O
-	|O
Hearn	|O
sum	|O
rules	|O
.	|O

Spectroscopy	|O
of	|O
negative	|O
ions	|O
utilizing	|O
multiphoton	|O
detachment	|O
in	|O
a	|O
Raman	|O
coupling	|O
regime	|O
.	|O

Band	|O
structure	|O
effects	|O
of	|O
transport	|O
properties	|O
in	|O
icosahedral	|O
quasicrystals	|O
.	|O

Acoustic	|O
transmission	|O
spectra	|O
in	|O
the	|O
Penrose	|O
lattice	|O
.	|O

Two	|O
-	|O
Channel	|O
Kondo	|O
Lattice	|O
:	|O
An	|O
Incoherent	|O
Metal	|O
.	|O

Basal	|O
midexpiratory	|O
lower	|O
esophageal	|O
sphincter	|O
pressure	|O
was	|O
similar	|O
in	|O
the	|O
study	|O
group	|O
(	|O
mean	|O
[	|O
SD	|O
]	|O
20.1	|O
[	|O
9.1	|O
]	|O
mmHg	|O
)	|O
and	|O
controls	|O
(	|O
17.6	|O
[	|O
6.0	|O
]	|O
mmHg	|O
)	|O
;	|O
the	|O
pressure	|O
did	|O
not	|O
change	|O
following	|O
EVS	|O
or	|O
EVL	|O
.	|O

CPDs	|O
at	|O
these	|O
three	|O
sites	|O
may	|O
partially	|O
displace	|O
TFIIIA	|B-PROTEIN
,	|O
thereby	|O
enabling	|O
rapid	|O
repair	|O
.	|O

There	|O
was	|O
no	|O
difference	|O
in	|O
the	|O
hormone	|O
receptor	|O
status	|O
between	|O
the	|O
cases	|O
without	|O
lymph	|O
node	|O
metastases	|O
and	|O
with	|O
lymph	|O
node	|O
metastases	|O
,	|O
'	|O
clandestine	|O
'	|O
or	|O
macrometastases	|O
.	|O

On	|O
the	|O
other	|O
hand	|O
,	|O
subjects	|O
with	|O
air	|O
trapping	|O
(	|O
residual	|O
volume	|O
(	|O
RV	|O
)	|O
/	|O
total	|O
lung	|O
capacity	|O
(	|O
TLC	|O
)	|O
>	|O
37%	|O
)	|O
disclosed	|O
not	|O
only	|O
a	|O
higher	|O
n	|O
(	|O
mit	|O
)	|O
(	|O
0.63	|O
+	|O
/	|O
-	|O
0.17	|O
versus	|O
0.43	|O
+	|O
/	|O
-	|O
0.07	|O
mt	|O
x	|O
microm	|O
(	|O
-	|O
2	|O
)	|O
,	|O
p	|O
<	|O
0.05	|O
)	|O
but	|O
shorter	|O
sarcomeres	|O
(	|O
L	|O
(	|O
sar	|O
)	|O
)	|O
than	|O
subjects	|O
without	|O
this	|O
functional	|O
abnormality	|O
(	|O
2.08	|O
+	|O
/	|O
-	|O
0.16	|O
to	|O
2.27	|O
+	|O
/	|O
-	|O
0.15	|O
microm	|O
,	|O
p	|O
<	|O
0.05	|O
)	|O
.	|O

Gel	|O
filtration	|O
,	|O
sedimentation	|O
velocity	|O
,	|O
and	|O
immunoprecipitation	|O
experiments	|O
revealed	|O
that	|O
beta4	|O
is	|O
a	|O
component	|O
of	|O
a	|O
multisubunit	|O
complex	|O
(	|O
AP	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
)	|O
that	|O
also	|O
contains	|O
the	|O
sigma4	|O
polypeptide	|O
and	|O
two	|O
additional	|O
adaptor	|O
subunit	|O
homologs	|O
named	|O
mu4	|O
(	|O
mu	|O
-	|O
ARP2	|O
)	|O
and	|O
epsilon	|O
.	|O

Cyclin	|B-PROTEIN
D1	|I-PROTEIN
-	|I-PROTEIN
associated	|I-PROTEIN
kinase	|I-PROTEIN
activity	|O
and	|O
protein	|O
levels	|O
were	|O
increased	|O
in	|O
mammary	|O
tumors	|O
from	|O
murine	|O
mammary	|O
tumor	|O
virus	|O
-	|O
pp60	|B-PROTEIN
(	|O
c	|B-PROTEIN
-	|I-PROTEIN
src527F	|I-PROTEIN
)	|O
transgenic	|O
mice	|O
.	|O

The	|O
SH2	|B-PROTEIN
domain	|I-PROTEIN
-	|I-PROTEIN
containing	|I-PROTEIN
inositol	|I-PROTEIN
5'	|I-PROTEIN
-	|I-PROTEIN
phosphatase	|I-PROTEIN
(	|O
SHIP	|B-PROTEIN
)	|O
recruits	|O
the	|O
p85	|B-PROTEIN
subunit	|O
of	|O
phosphoinositide	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
during	|O
FcgammaRIIb1	|B-PROTEIN
-	|O
mediated	|O
inhibition	|O
of	|O
B	|B-PROTEIN
cell	|I-PROTEIN
receptor	|I-PROTEIN
signaling	|O
.	|O

We	|O
show	|O
that	|O
the	|O
mouse	|O
genome	|O
contains	|O
four	|O
copies	|O
of	|O
the	|O
ubc	|B-PROTEIN
-	|I-PROTEIN
9	|I-PROTEIN
gene	|O
.	|O

An	|O
increase	|O
in	|O
bone	|O
mineral	|O
density	|O
at	|O
the	|O
spine	|O
,	|O
total	|O
hip	|O
,	|O
and	|O
total	|O
body	|O
has	|O
been	|O
reported	|O
with	|O
raloxifene	|O
but	|O
seems	|O
to	|O
be	|O
less	|O
than	|O
that	|O
seen	|O
with	|O
estrogen	|O
or	|O
alendronate	|O
therapy	|O
.	|O

However	|O
,	|O
in	|O
those	|O
studies	|O
due	|O
to	|O
the	|O
presence	|O
of	|O
thiol	|O
agents	|O
in	|O
the	|O
PKC	|B-PROTEIN
preparations	|O
,	|O
the	|O
sensitive	|O
reaction	|O
of	|O
BPO	|O
with	|O
redox	|O
-	|O
active	|O
cysteine	|O
residues	|O
in	|O
PKC	|B-PROTEIN
was	|O
not	|O
observed	|O
.	|O

Interestingly	|O
,	|O
Csx	|B-PROTEIN
/	|O
Nkx2	|B-PROTEIN
.	|O

We	|O
also	|O
identified	|O
an	|O
alternative	|O
spliced	|O
form	|O
of	|O
Lyp	|B-PROTEIN
RNA	|O
,	|O
Lyp2	|B-PROTEIN
.	|O

The	|O
costs	|O
were	|O
DM	|O
11,562	|O
for	|O
a	|O
PE	|O
,	|O
DM	|O
12,477	|O
for	|O
a	|O
VR	|O
and	|O
DM	|O
7,532	|O
for	|O
a	|O
MR	|O
.	|O

We	|O
now	|O
provide	|O
evidence	|O
for	|O
physical	|O
and	|O
functional	|O
interaction	|O
between	|O
Doa4	|B-PROTEIN
and	|O
the	|O
proteasome	|O
.	|O

Independent	|O
splicing	|O
events	|O
involve	|O
three	|O
previously	|O
described	|O
cassette	|O
exons	|O
,	|O
which	|O
are	|O
predicted	|O
to	|O
encode	|O
most	|O
of	|O
the	|O
second	|O
transmembrane	|O
domain	|O
.	|O

Each	|O
of	|O
these	|O
genes	|O
contains	|O
a	|O
putative	|O
upstream	|O
ORF	|O
,	|O
while	|O
STA2	|B-PROTEIN
has	|O
two	|O
additional	|O
in	|O
-	|O
frame	|O
AUG	|O
codons	|O
5'	|O
to	|O
the	|O
major	|O
cistron	|O
.	|O

Nipponbare	|O
as	|O
well	|O
as	|O
O.	|O
australiensis	|O
.	|O

In	|O
addition	|O
,	|O
mapping	|O
of	|O
the	|O
promoter	|O
region	|O
and	|O
the	|O
identification	|O
of	|O
putative	|O
promoter	|O
regulatory	|O
sequences	|O
should	|O
give	|O
insight	|O
into	|O
the	|O
transcriptional	|O
regulation	|O
of	|O
UCP2	|B-PROTEIN
expression	|O
-	|O
-	|O
in	|O
particular	|O
by	|O
anyone	|O
of	|O
the	|O
above	|O
mentioned	|O
factors	|O
-	|O
-	|O
in	|O
vitro	|O
and	|O
in	|O
vivo	|O
.	|O

The	|O
rate	|O
of	|O
resectability	|O
is	|O
low	|O
and	|O
5	|O
-	|O
year	|O
survival	|O
is	|O
very	|O
poor	|O
.	|O

In	|O
order	|O
to	|O
better	|O
characterize	|O
the	|O
distribution	|O
of	|O
ML	|O
and	|O
MAP	|O
estimates	|O
under	|O
these	|O
conditions	|O
,	|O
we	|O
derive	|O
a	|O
point	|O
approximation	|O
to	|O
density	|O
values	|O
of	|O
the	|O
conditional	|O
distribution	|O
of	|O
such	|O
estimates	|O
.	|O

RT	|O
-	|O
PCR	|O
was	|O
performed	|O
using	|O
previously	|O
reported	|O
degenerate	|O
oligonucleotide	|O
primers	|O
to	|O
the	|O
ligand	|O
binding	|O
domain	|O
(	|O
LBD	|O
)	|O
of	|O
known	|O
beta	|B-PROTEIN
integrin	|I-PROTEIN
subunits	|O
and	|O
Bge	|B-PROTEIN
cDNA	|O
.	|O

The	|O
lowest	|O
culture	|O
failure	|O
rate	|O
of	|O
0.2	|O
per	|O
cent	|O
was	|O
found	|O
after	|O
EAF	|O
compared	|O
with	|O
0.9	|O
per	|O
cent	|O
among	|O
CVS	|O
.	|O

Ectopic	|O
expression	|O
of	|O
d	|B-PROTEIN
-	|I-PROTEIN
axin	|I-PROTEIN
inhibited	|O
Wingless	|B-PROTEIN
signaling	|O
.	|O

The	|O
corresponding	|O
differences	|O
in	|O
FVIIa	|B-PROTEIN
and	|O
PAI	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
were	|O
not	|O
statistically	|O
significant	|O
.	|O

Primary	|O
and	|O
secondary	|O
structural	|O
elements	|O
required	|O
for	|O
synthesis	|O
of	|O
barley	|O
yellow	|O
dwarf	|O
virus	|O
subgenomic	|O
RNA1	|B-PROTEIN
.	|O

On	|O
the	|O
other	|O
side	|O
,	|O
when	|O
the	|O
aortic	|O
ring	|O
was	|O
perfused	|O
with	|O
L	|O
-	|O
NNA	|O
(	|O
NO	|O
-	|O
synthesis	|O
inhibitor	|O
)	|O
or	|O
methylene	|O
blue	|O
(	|O
soluble	|O
cGMPase	|B-PROTEIN
inhibitor	|O
)	|O
,	|O
the	|O
changes	|O
could	|O
be	|O
attenuated	|O
.	|O

Nevertheless	|O
,	|O
inactivation	|O
of	|O
the	|O
cyclin	|B-PROTEIN
E	|I-PROTEIN
-	|O
Cdk2	|B-PROTEIN
complex	|O
in	|O
response	|O
to	|O
mitogen	|O
starvation	|O
occurs	|O
normally	|O
in	|O
MEFs	|O
that	|O
have	|O
a	|O
homozygous	|O
deletion	|O
of	|O
the	|O
p27	|B-PROTEIN
gene	|O
.	|O

Identification	|O
and	|O
characterization	|O
of	|O
IS2404	|B-PROTEIN
and	|O
IS2606	|B-PROTEIN
:	|O
two	|O
distinct	|O
repeated	|O
sequences	|O
for	|O
detection	|O
of	|O
Mycobacterium	|O
ulcerans	|O
by	|O
PCR	|O
.	|O

Taken	|O
together	|O
,	|O
these	|O
results	|O
are	|O
consistent	|O
with	|O
the	|O
possibility	|O
that	|O
p202	|B-PROTEIN
protein	|O
contributes	|O
to	|O
the	|O
cell	|O
growth	|O
retardation	|O
activity	|O
of	|O
the	|O
IFNs	|B-PROTEIN
,	|O
at	|O
least	|O
in	|O
part	|O
,	|O
by	|O
modulating	|O
p21	|B-PROTEIN
protein	|O
levels	|O
.	|O

Similar	|O
results	|O
were	|O
also	|O
obtained	|O
with	|O
a	|O
HepG2	|O
hepatoblastoma	|O
cell	|O
line	|O
carrying	|O
wt	|O
p53	|B-PROTEIN
.	|O

Partial	|O
sequencing	|O
of	|O
the	|O
region	|O
downstream	|O
of	|O
ORF	|O
-	|O
Pto	|B-PROTEIN
revealed	|O
homology	|O
to	|O
the	|O
ru	|B-PROTEIN
/	|I-PROTEIN
AB	|I-PROTEIN
genes	|O
,	|O
involved	|O
in	|O
UV	|O
resistance	|O
,	|O
from	|O
plasmid	|O
pPSR1	|O
.	|O

The	|O
MSY2	|B-PROTEIN
associated	|O
kinase	|O
is	|O
not	|O
casein	|B-PROTEIN
kinase	|I-PROTEIN
2	|I-PROTEIN
,	|O
the	|O
kinase	|O
believed	|O
to	|O
phosphorylate	|O
mRNP3+	|B-PROTEIN
4	|I-PROTEIN
in	|O
oocytes	|O
,	|O
but	|O
a	|O
yet	|O
unidentified	|O
kinase	|O
.	|O

This	|O
suggests	|O
that	|O
helicase	|B-PROTEIN
-	|O
like	|O
genes	|O
may	|O
be	|O
involved	|O
in	|O
the	|O
biosynthesis	|O
of	|O
nucleic	|O
acids	|O
and	|O
proteins	|O
,	|O
and	|O
that	|O
the	|O
genes	|O
can	|O
be	|O
transcriptionally	|O
activated	|O
by	|O
heat	|O
shock	|O
to	|O
compensate	|O
for	|O
the	|O
repressed	|O
synthesis	|O
of	|O
mRNA	|O
and	|O
protein	|O
.	|O

These	|O
data	|O
provide	|O
the	|O
molecular	|O
tools	|O
for	|O
the	|O
final	|O
identification	|O
of	|O
the	|O
MKS	|B-PROTEIN
and	|O
the	|O
MUL	|B-PROTEIN
genes	|O
.	|O

The	|O
H	|O
-	|O
reflex	|O
recovery	|O
curve	|O
was	|O
obtained	|O
after	|O
stimulation	|O
of	|O
the	|O
median	|O
nerve	|O
at	|O
the	|O
elbow	|O
and	|O
recording	|O
from	|O
the	|O
flexor	|O
carpi	|O
radialis	|O
.	|O

The	|O
origins	|O
of	|O
reflected	|O
light	|O
changes	|O
associated	|O
with	|O
neuronal	|O
activity	|O
(	|O
optical	|O
signals	|O
)	|O
were	|O
investigated	|O
in	|O
rat	|O
somatosensory	|O
cortex	|O
with	|O
optical	|O
imaging	|O
,	|O
microspectrophotometry	|O
,	|O
and	|O
laser	|O
-	|O
Doppler	|O
flowmetry	|O
,	|O
and	|O
dynamic	|O
changes	|O
in	|O
local	|O
hemoglobin	|B-PROTEIN
concentration	|O
and	|O
oxygenation	|O
were	|O
focused	|O
on	|O
.	|O

Human	|O
neuronal	|O
Elav	|B-PROTEIN
-	|O
like	|O
proteins	|O
contain	|O
three	|O
RNP	|O
-	|O
type	|O
RNA	|O
recognition	|O
motifs	|O
(	|O
RRMs	|O
)	|O
.	|O

Comparison	|O
of	|O
frequencies	|O
of	|O
atrial	|O
fibrillation	|O
after	|O
coronary	|O
artery	|O
bypass	|O
grafting	|O
with	|O
and	|O
without	|O
the	|O
use	|O
of	|O
cardiopulmonary	|O
bypass	|O
.	|O

The	|O
results	|O
of	|O
supershift	|O
analysis	|O
using	|O
specific	|O
antibodies	|O
against	|O
transcription	|O
factors	|O
suggested	|O
that	|O
both	|O
binding	|O
complexes	|O
contained	|O
the	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
components	|O
p50	|B-PROTEIN
and	|O
p65	|B-PROTEIN
,	|O
and	|O
did	|O
not	|O
contain	|O
other	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
proteins	|O
(	|O
p52	|B-PROTEIN
,	|O
c	|B-PROTEIN
-	|I-PROTEIN
Rel	|I-PROTEIN
,	|O
Rel	|B-PROTEIN
B	|I-PROTEIN
)	|O
,	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
proteins	|O
(	|O
c	|B-PROTEIN
-	|I-PROTEIN
Fos	|I-PROTEIN
,	|O
C	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
)	|O
,	|O
CREB	|B-PROTEIN
or	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBPbeta	|I-PROTEIN
(	|O
NF	|B-PROTEIN
-	|I-PROTEIN
IL6	|I-PROTEIN
)	|O
.	|O

A	|O
set	|O
of	|O
peptides	|O
corresponding	|O
to	|O
the	|O
individual	|O
elements	|O
of	|O
secondary	|O
structure	|O
derived	|O
from	|O
the	|O
N	|O
-	|O
terminal	|O
domain	|O
of	|O
the	|O
ribosomal	|O
protein	|O
L9	|B-PROTEIN
have	|O
been	|O
synthesized	|O
.	|O

The	|O
results	|O
showed	|O
that	|O
IFN	|B-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
stimulated	|O
the	|O
rapid	|O
accumulation	|O
of	|O
interferon	|O
regulated	|O
factor	|O
(	|B-PROTEIN
IRF	|I-PROTEIN
)	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
mRNA	|O
,	|O
followed	|O
by	|O
a	|O
delayed	|O
and	|O
dose	|O
-	|O
dependent	|O
inhibition	|O
of	|O
alpha1	|B-PROTEIN
(	|I-PROTEIN
I	|I-PROTEIN
)	|I-PROTEIN
procollagen	|I-PROTEIN
mRNA	|O
expression	|O
in	|O
skin	|O
fibroblasts	|O
from	|O
several	|O
different	|O
donors	|O
.	|O

Functional	|O
domains	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
promoter	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
1	|I-PROTEIN
involved	|O
in	|O
transcriptional	|O
repression	|O
and	|O
cell	|O
growth	|O
regulation	|O
.	|O

Therefore	|O
,	|O
we	|O
have	|O
named	|O
this	|O
gene	|O
UBP43	|B-PROTEIN
.	|O

These	|O
results	|O
continue	|O
to	|O
support	|O
the	|O
hypothesis	|O
that	|O
HS2	|O
,	|O
HS3	|O
,	|O
and	|O
HS4	|O
act	|O
as	|O
a	|O
single	|O
,	|O
integral	|O
unit	|O
to	|O
regulate	|O
human	|O
globin	|B-PROTEIN
gene	|O
transcription	|O
as	|O
a	|O
holocomplex	|O
,	|O
but	|O
they	|O
can	|O
also	|O
be	|O
interpreted	|O
to	|O
say	|O
that	|O
formation	|O
of	|O
a	|O
DNase	|B-PROTEIN
I	|I-PROTEIN
hypersensitive	|O
holocomplex	|O
alone	|O
is	|O
not	|O
sufficient	|O
for	|O
mediating	|O
high	|O
-	|O
level	|O
globin	|B-PROTEIN
gene	|O
transcription	|O
.	|O

To	|O
identify	|O
additional	|O
non	|O
-	|O
Sir	|B-PROTEIN
factors	|O
that	|O
affect	|O
rDNA	|O
silencing	|O
,	|O
we	|O
performed	|O
a	|O
genetic	|O
screen	|O
designed	|O
to	|O
isolate	|O
mutations	|O
which	|O
alter	|O
the	|O
expression	|O
of	|O
reporter	|O
genes	|O
integrated	|O
within	|O
the	|O
rDNA	|O
.	|O

Because	|O
there	|O
is	|O
great	|O
need	|O
for	|O
iron	|O
in	|O
the	|O
EPO	|B-PROTEIN
-	|O
stimulated	|O
erythroid	|O
progenitors	|O
,	|O
it	|O
is	|O
essential	|O
that	|O
serum	|O
ferritin	|B-PROTEIN
and	|O
transferrin	|B-PROTEIN
saturation	|O
levels	|O
should	|O
be	|O
maintained	|O
over	|O
300	|O
microg	|O
/	|O
liter	|O
and	|O
30%	|O
,	|O
respectively	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
the	|O
p33	|B-PROTEIN
subunit	|O
of	|O
eIF3	|B-PROTEIN
plays	|O
an	|O
important	|O
role	|O
in	|O
the	|O
initiation	|O
phase	|O
of	|O
protein	|O
synthesis	|O
and	|O
that	|O
its	|O
RNA	|O
-	|O
binding	|O
domain	|O
is	|O
required	|O
for	|O
optimal	|O
activity	|O
.	|O

In	|O
this	|O
study	|O
,	|O
we	|O
elucidate	|O
signaling	|O
pathways	|O
induced	|O
by	|O
photodynamic	|O
therapy	|O
(	|O
PDT	|O
)	|O
with	|O
hypericin	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
ATF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
plays	|O
a	|O
central	|O
role	|O
in	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
signaling	|O
by	|O
acting	|O
as	|O
a	|O
common	|O
nuclear	|O
target	|O
of	|O
both	|O
Smad	|B-PROTEIN
and	|O
TAK1	|B-PROTEIN
pathways	|O
.	|O

KEY	|O
WORDS	|O
:	|O
Melaleuca	|O
;	|O
Lake	|O
Okeechobee	|O
;	|O
Littoral	|O
zone	|O
;	|O
Water	|O
level	|O
;	|O
Regulation	|O
schedule	|O

The	|O
systolic	|O
peak	|O
of	|O
pulmonary	|O
vein	|O
was	|O
higher	|O
than	|O
the	|O
diastolic	|O
peak	|O
in	|O
45	|O
out	|O
of	|O
56	|O
cases	|O
.	|O

Specimens	|O
were	|O
assayed	|O
for	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
fetoprotein	|I-PROTEIN
,	|O
unconjugated	|O
estriol	|O
,	|O
free	|O
alpha	|B-PROTEIN
hCG	|I-PROTEIN
,	|O
and	|O
total	|O
hCG	|B-PROTEIN
.	|O

FASEB	|O
Federal	|O
Funding	|O
Consensus	|O
Conference	|O
FY	|O
2000	|O
.	|O

The	|O
following	|O
data	|O
were	|O
recorded	|O
at	|O
arrival	|O
in	|O
the	|O
intensive	|O
care	|O
unit	|O
6	|O
,	|O
12	|O
,	|O
24	|O
,	|O
and	|O
48	|O
hours	|O
after	|O
termination	|O
of	|O
CPB	|O
:	|O
heart	|O
rate	|O
,	|O
blood	|O
pressure	|O
,	|O
left	|O
atrial	|O
pressure	|O
,	|O
central	|O
-	|O
peripheral	|O
temperature	|O
difference	|O
,	|O
arterial	|O
-	|O
central	|O
venous	|O
oxygen	|O
saturation	|O
difference	|O
,	|O
urine	|O
output	|O
,	|O
serum	|O
creatinine	|O
,	|O
lactate	|O
and	|O
neutrophil	|O
elastase	|B-PROTEIN
levels	|O
,	|O
the	|O
Doppler	|O
echocardiographic	|O
factors	|O
shortening	|O
fraction	|O
and	|O
preejection	|O
period	|O
/	|O
left	|O
-	|O
ventricular	|O
ejection	|O
time	|O
,	|O
and	|O
cumulative	|O
doses	|O
of	|O
catecholamines	|O
(	|O
epinephrine	|O
)	|O
,	|O
enoximone	|O
,	|O
and	|O
furosemide	|O
.	|O

MDS1	|B-PROTEIN
/	|O
EVI1	|B-PROTEIN
,	|O
located	|O
on	|O
chromosome	|O
3	|O
band	|O
q26	|O
,	|O
encodes	|O
a	|O
zinc	|B-PROTEIN
-	|I-PROTEIN
finger	|I-PROTEIN
DNA	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
transcription	|I-PROTEIN
activator	|I-PROTEIN
not	|O
detected	|O
in	|O
normal	|O
hematopoietic	|O
cells	|O
but	|O
expressed	|O
in	|O
several	|O
normal	|O
tissues	|O
.	|O

Analysis	|O
of	|O
the	|O
protein	|O
sequences	|O
of	|O
these	|O
two	|O
replicases	|B-PROTEIN
,	|O
together	|O
with	|O
previously	|O
characterized	|O
H.	|B-PROTEIN
pylori	|I-PROTEIN
plasmid	|I-PROTEIN
replication	|I-PROTEIN
proteins	|I-PROTEIN
,	|O
supports	|O
the	|O
formation	|O
of	|O
a	|O
distinct	|O
class	|O
of	|O
H.	|B-PROTEIN
pylori	|I-PROTEIN
plasmid	|I-PROTEIN
proteins	|I-PROTEIN
.	|O

The	|O
JTc	|O
delta	|O
among	|O
the	|O
three	|O
groups	|O
did	|O
not	|O
differ	|O
as	|O
well	|O
:	|O
JTc	|O
delta	|O
of	|O
the	|O
VT	|O
group	|O
was	|O
70	|O
ms	|O
+	|O
/	|O
-	|O
30	|O
ms	|O
,	|O
the	|O
JTc	|O
delta	|O
of	|O
the	|O
PVC	|O
group	|O
was	|O
60	|O
msec	|O
+	|O
/	|O
-	|O
25	|O
msec	|O
,	|O
and	|O
the	|O
JTc	|O
delta	|O
of	|O
the	|O
control	|O
group	|O
was	|O
70	|O
ms	|O
+	|O
/	|O
-	|O
30	|O
ms	|O
.	|O

In	|O
contrast	|O
,	|O
deletion	|O
of	|O
the	|O
upstream	|O
portion	|O
of	|O
the	|O
delta	|O
promoter	|O
led	|O
to	|O
a	|O
10	|O
fold	|O
decrease	|O
in	|O
expression	|O
.	|O

Site	|O
-	|O
directed	|O
mutagenesis	|O
of	|O
binding	|O
sites	|O
for	|O
the	|O
repressor	|O
proteins	|O
BP1	|B-PROTEIN
and	|O
BP2	|B-PROTEIN
in	|O
the	|O
upstream	|O
portion	|O
of	|O
the	|O
beta	|B-PROTEIN
globin	|I-PROTEIN
gene	|O
flanking	|O
region	|O
led	|O
to	|O
a	|O
4-6	|O
fold	|O
increase	|O
in	|O
promoter	|O
activity	|O
.	|O

However	|O
,	|O
with	|O
the	|O
alpha1	|O
antagonist	|O
prazosin	|O
(	|O
5	|O
x	|O
10	|O
(	|O
-	|O
8	|O
)	|O
-	|O
5	|O
x	|O
10	|O
(	|O
-	|O
7	|O
)	|O
M	|O
)	|O
,	|O
no	|O
relaxation	|O
occurred	|O
.	|O

Differential	|O
expression	|O
of	|O
AP	|B-PROTEIN
-	|I-PROTEIN
2alpha	|I-PROTEIN
and	|O
AP	|B-PROTEIN
-	|I-PROTEIN
2beta	|I-PROTEIN
in	|O
the	|O
developing	|O
chick	|O
retina	|O
:	|O
repression	|O
of	|O
R	|B-PROTEIN
-	|I-PROTEIN
FABP	|I-PROTEIN
promoter	|O
activity	|O
by	|O
AP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
.	|O

The	|O
algorithm	|O
also	|O
limited	|O
TG	|O
to	|O
20	|O
and	|O
64%	|O
,	|O
apoB	|B-PROTEIN
to	|O
6	|O
and	|O
20%	|O
,	|O
and	|O
Lp	|B-PROTEIN
(	|I-PROTEIN
a	|I-PROTEIN
)	|I-PROTEIN
to	|O
15	|O
and	|O
56%	|O
,	|O
of	|O
low	|O
-	|O
and	|O
high	|O
-	|O
risk	|O
groups	|O
,	|O
respectively	|O
.	|O

The	|O
mean	|O
value	|O
of	|O
the	|O
CD79b	|B-PROTEIN
to	|O
the	|O
CD79b	|B-PROTEIN
internally	|O
deleted	|O
ratio	|O
was	|O
0.64	|O
+	|O
/	|O
-	|O
0.20	|O
SD	|O
in	|O
normal	|O
donors	|O
and	|O
0.44	|O
+	|O
/	|O
-	|O
0.27	|O
SD	|O
in	|O
B	|O
-	|O
CLL	|O
(	|O
P	|O
=	|O
.01	|O
)	|O
.	|O

As	|O
normal	|O
B	|O
cells	|O
also	|O
present	|O
this	|O
variant	|O
,	|O
the	|O
mechanism	|O
of	|O
CD79b	|B-PROTEIN
posttranscriptional	|O
regulation	|O
might	|O
reflect	|O
the	|O
activation	|O
stage	|O
of	|O
the	|O
normal	|O
B	|O
cell	|O
from	|O
which	|O
B	|O
-	|O
CLL	|O
derives	|O
.	|O

Conformational	|O
studies	|O
combining	|O
secondary	|O
structure	|O
predictions	|O
,	|O
CD	|O
and	|O
NMR	|O
spectroscopy	|O
together	|O
with	|O
ELISA	|O
assays	|O
,	|O
showed	|O
that	|O
the	|O
greater	|O
is	|O
the	|O
propensity	|O
of	|O
the	|O
epitope	|O
for	|O
helix	|O
formation	|O
the	|O
higher	|O
is	|O
the	|O
recognition	|O
by	|O
anti	|B-PROTEIN
-	|I-PROTEIN
K159	|I-PROTEIN
.	|O

Schwab	|O
and	|O
England	|O
ADL	|O
scores	|O
in	|O
the	|O
"	|O
off	|O
"	|O
state	|O
were	|O
improved	|O
by	|O
18%	|O
and	|O
in	|O
the	|O
"	|O
on	|O
"	|O
state	|O
the	|O
scores	|O
declined	|O
by	|O
2%	|O
.	|O

High	|O
-	|O
level	|O
gains	|O
(	|O
HLGs	|O
)	|O
indicative	|O
of	|O
gene	|O
amplifications	|O
were	|O
identified	|O
at	|O
11q13	|O
in	|O
two	|O
cases	|O
,	|O
and	|O
in	|O
one	|O
case	|O
each	|O
at	|O
2q33	|O
-	|O
34	|O
,	|O
3q25	|O
-	|O
29	|O
,	|O
5p15.1	|O
-	|O
15.2	|O
,	|O
7q21	|O
-	|O
22	|O
,	|O
11p11.2	|O
,	|O
12p11.2	|O
-	|O
12	|O
,	|O
and	|O
13q34	|O
.	|O

With	|O
respect	|O
to	|O
the	|O
distribution	|O
of	|O
active	|O
MREs	|O
over	|O
the	|O
promoter	|O
region	|O
,	|O
the	|O
hMT	|B-PROTEIN
-	|I-PROTEIN
IIA	|I-PROTEIN
gene	|O
is	|O
largely	|O
different	|O
from	|O
the	|O
mouse	|O
metallothionein	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
gene	|O
,	|O
suggesting	|O
that	|O
MRE	|O
arrangement	|O
is	|O
not	|O
an	|O
important	|O
factor	|O
for	|O
metal	|O
regulation	|O
.	|O

The	|O
cDNA	|O
was	|O
expressed	|O
in	|O
Saccharomyces	|O
cerevisiae	|O
under	|O
the	|O
control	|O
of	|O
the	|O
yeast	|O
triose	|B-PROTEIN
phosphate	|I-PROTEIN
isomerase	|I-PROTEIN
promoter	|O
.	|O

Interestingly	|O
,	|O
the	|O
RNA	|O
sequences	|O
selected	|O
by	|O
the	|O
mutated	|O
zinc	|O
knuckle	|O
9G8	|B-PROTEIN
variant	|O
are	|O
efficiently	|O
recognized	|O
by	|O
SRp20	|B-PROTEIN
,	|O
in	|O
agreement	|O
with	|O
the	|O
fact	|O
that	|O
the	|O
RBD	|O
of	|O
9G8	|B-PROTEIN
and	|O
SRp20	|B-PROTEIN
are	|O
similar	|O
.	|O

Topoisomerase	|B-PROTEIN
II	|I-PROTEIN
is	|O
a	|O
major	|O
target	|O
of	|O
the	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
casein	|I-PROTEIN
kinase	|I-PROTEIN
2	|I-PROTEIN
(	|O
PK	|B-PROTEIN
CK2	|I-PROTEIN
)	|O
in	|O
vivo	|O
.	|O

Recent	|O
work	|O
in	|O
this	|O
laboratory	|O
has	|O
shown	|O
that	|O
the	|O
gene	|O
coding	|O
for	|O
acetate	|B-PROTEIN
kinase	|I-PROTEIN
(	|O
ackA	|B-PROTEIN
)	|O
in	|O
Sinorhizobium	|O
meliloti	|O
is	|O
up	|O
-	|O
regulated	|O
in	|O
response	|O
to	|O
phosphate	|O
limitation	|O
.	|O

All	|O
numbers	|O
refer	|O
to	|O
nucleotide	|O
positions	|O
on	|O
the	|O
wild	|O
-	|O
type	|O
HIV	|O
-	|O
1	|O
transcript	|O
.	|O

Sequence	|O
analysis	|O
revealed	|O
that	|O
the	|O
MEMA	|B-PROTEIN
protein	|O
is	|O
identical	|O
with	|O
a	|O
160	|O
kDa	|O
nuclear	|O
'	|O
domain	|O
rich	|O
in	|O
serines	|O
'	|O
(	|B-PROTEIN
DRS	|I-PROTEIN
)	|I-PROTEIN
protein	|I-PROTEIN
occurring	|O
free	|O
in	|O
the	|O
nucleoplasm	|O
and	|O
in	|O
U2	|B-PROTEIN
-	|O
ribonucleoprotein	|O
structures	|O
.	|O

Here	|O
,	|O
we	|O
report	|O
the	|O
complete	|O
structure	|O
of	|O
the	|O
human	|O
topoisomerase	|B-PROTEIN
IIalpha	|I-PROTEIN
gene	|O
,	|O
which	|O
consists	|O
of	|O
35	|O
exons	|O
spanning	|O
27.5	|O
kb	|O
.	|O

Dopaminergic	|O
modulation	|O
of	|O
transcallosal	|O
activity	|O
of	|O
cat	|O
motor	|O
cortical	|O
neurons	|O
.	|O

Previous	|O
studies	|O
characterized	|O
a	|O
cytokine	|O
-	|O
inducible	|O
,	|O
functional	|O
nuclear	|O
factor	|O
(	|B-PROTEIN
NF	|I-PROTEIN
)	|I-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
consensus	|O
element	|O
in	|O
the	|O
immediate	|O
5'	|O
regulatory	|O
region	|O
of	|O
the	|O
MGSA	|B-PROTEIN
/	|O
GRO	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
gene	|O
at	|O
-	|O
78	|O
bp	|O
.	|O

An	|O
exon	|O
that	|O
prevents	|O
transport	|O
of	|O
a	|O
mature	|O
mRNA	|O
.	|O

Four	|O
CsA	|O
-	|O
treated	|O
patients	|O
developed	|O
persistently	|O
elevated	|O
UAER	|O
>	|O
30	|O
mg	|O
/	|O
24	|O
h	|O
(	|O
n	|O
=	|O
3	|O
with	|O
microalbuminuria	|O
)	|O
,	|O
whereas	|O
all	|O
the	|O
17	|O
placebo	|O
-	|O
treated	|O
patients	|O
had	|O
normal	|O
UAER	|O
(	|O
<	|O
30	|O
mg	|O
/	|O
24	|O
h	|O
)	|O
after	|O
7	|O
years	|O
of	|O
follow	|O
-	|O
up	|O
.	|O

Mutational	|O
analysis	|O
of	|O
the	|O
-	|O
84	|O
/	|O
-	|O
55	|O
DNA	|O
showed	|O
that	|O
JEG	|O
-	|O
3	|O
nuclear	|O
proteins	|O
bound	|O
to	|O
a	|O
site	|O
containing	|O
,	|O
but	|O
not	|O
identical	|O
to	|O
,	|O
the	|O
SF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
sequence	|O
.	|O

In	|O
contrast	|O
,	|O
no	|O
change	|O
was	|O
detected	|O
in	|O
the	|O
phenotype	|O
of	|O
'	|O
unstressed	|O
'	|O
clones	|O
,	|O
with	|O
respect	|O
to	|O
any	|O
of	|O
the	|O
following	|O
parameters	|O
:	|O
proliferation	|O
rate	|O
in	|O
monolayer	|O
,	|O
serum	|O
-	|O
dependence	|O
for	|O
proliferation	|O
or	|O
survival	|O
,	|O
tumorigenicity	|O
,	|O
cellular	|O
morphology	|O
,	|O
or	|O
tissue	|O
-	|O
specific	|O
differentiation	|O
markers	|O
.	|O

A	|O
high	|O
reactor	|O
pH	|O
(	|O
+	|O
/	|O
-	|O
8	|O
)	|O
,	|O
a	|O
short	|O
solid	|O
retention	|O
time	|O
(	|O
<	|O
150	|O
days	|O
)	|O
,	|O
and	|O
the	|O
presence	|O
of	|O
a	|O
substantial	|O
SRB	|O
population	|O
in	|O
the	|O
inoculum	|O
may	|O
considerably	|O
reduce	|O
the	|O
time	|O
required	|O
for	|O
acetate	|O
-	|O
utilising	|O
SRB	|O
to	|O
outcompete	|O
MB	|O
.	|O

In	|O
throttling	|O
valves	|O
,	|O
the	|O
aim	|O
is	|O
to	|O
correlate	|O
the	|O
effect	|O
of	|O
shear	|O
to	|O
a	|O
parameter	|O
related	|O
to	|O
the	|O
inner	|O
geometry	|O
of	|O
the	|O
valve	|O
and	|O
to	|O
operating	|O
conditions	|O
.	|O

The	|O
induced	|O
respiratory	|O
burst	|O
was	|O
investigated	|O
by	|O
the	|O
intracellular	|O
oxidative	|O
transformation	|O
of	|O
dihydrorhodamine	|O
123	|O
to	|O
the	|O
fluorescent	|O
dye	|O
rhodamine	|O
123	|O
via	|O
flow	|O
cytometry	|O
.	|O

A	|O
mutation	|O
linked	|O
to	|O
the	|O
SOC1	|B-PROTEIN
gene	|O
,	|O
previously	|O
defined	|O
by	|O
recessive	|O
mutations	|O
that	|O
suppress	|O
cbp1	|B-PROTEIN
ts	|O
alleles	|O
and	|O
stabilize	|O
many	|O
mitochondrial	|O
mRNAs	|O
,	|O
was	|O
also	|O
isolated	|O
.	|O

A	|O
deletion	|O
mutation	|O
analysis	|O
of	|O
the	|O
recombinant	|O
protein	|O
has	|O
shown	|O
that	|O
the	|O
N	|O
-	|O
terminal	|O
region	|O
and	|O
the	|O
two	|O
leucine	|O
zippers	|O
are	|O
necessary	|O
for	|O
the	|O
binding	|O
.	|O

A	|O
database	|O
search	|O
has	|O
revealed	|O
as	|O
the	|O
most	|O
significative	|O
homology	|O
a	|O
match	|O
with	|O
the	|O
human	|O
mitochondrial	|B-PROTEIN
transcription	|I-PROTEIN
termination	|I-PROTEIN
factor	|I-PROTEIN
(	|O
mTERF	|B-PROTEIN
)	|O
,	|O
a	|O
protein	|O
that	|O
also	|O
binds	|O
DNA	|O
as	|O
a	|O
monomer	|O
and	|O
contains	|O
three	|O
leucine	|O
zippers	|O
forming	|O
intramolecular	|O
interactions	|O
.	|O

In	|O
all	|O
trials	|O
,	|O
antigen	|O
challenge	|O
followed	|O
1	|O
h	|O
after	|O
the	|O
last	|O
treatment	|O
.	|O

31	|O
,	|O
1997	|O
,	|O
40	|O
patients	|O
had	|O
died	|O
(	|O
35	|O
in	|O
the	|O
ERA	|O
-	|O
II	|O
group	|O
and	|O
5	|O
in	|O
the	|O
ERA	|O
-	|O
III	|O
group	|O
)	|O
,	|O
for	|O
a	|O
crude	|O
mortality	|O
rate	|O
of	|O
8.0%	|O
.	|O

We	|O
found	|O
that	|O
total	|O
PSA	|B-PROTEIN
can	|O
be	|O
detected	|O
in	|O
all	|O
cyst	|O
fluids	|O
and	|O
in	|O
about	|O
75%	|O
of	|O
female	|O
sera	|O
.	|O

Type	|O
I	|O
cysts	|O
(	|O
with	|O
a	|O
high	|O
K+	|O
/	|O
Na+	|O
ratio	|O
)	|O
tend	|O
to	|O
have	|O
higher	|O
total	|O
PSA	|B-PROTEIN
than	|O
Type	|O
II	|O
cysts	|O
.	|O

Despite	|O
this	|O
DNA	|O
binding	|O
activity	|O
,	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
reporter	|O
activity	|O
was	|O
suppressed	|O
in	|O
these	|O
cells	|O
.	|O

A	|O
single	|O
N	|O
-	|O
glycosylation	|O
site	|O
present	|O
in	|O
chicken	|O
gp42	|B-PROTEIN
is	|O
conserved	|O
among	|O
all	|O
five	|O
of	|O
these	|O
proteins	|O
:	|O
carbohydrate	|O
analysis	|O
of	|O
gp42	|B-PROTEIN
revealed	|O
the	|O
presence	|O
of	|O
a	|O
complex	|O
type	|O
glycan	|O
chain	|O
at	|O
this	|O
site	|O
.	|O

Here	|O
we	|O
describe	|O
the	|O
optimization	|O
and	|O
characterization	|O
of	|O
a	|O
140	|O
-	|O
residue	|O
fragment	|O
,	|O
containing	|O
the	|O
Runt	|B-PROTEIN
domain	|O
of	|O
AML1	|B-PROTEIN
,	|O
which	|O
is	|O
suitable	|O
for	|O
structural	|O
studies	|O
.	|O

Judge	|O
OKs	|O
docs	|O
'	|O
bid	|O
for	|O
Chicago	|O
hospital	|O
.	|O

HANYS	|O
criticizes	|O
laparoscopic	|O
gall	|O
bladder	|O
guidelines	|O
.	|O

Groups	|O
dicker	|O
for	|O
price	|O
breaks	|O
as	|O
anesthetic	|O
gas	|O
goes	|O
multi	|O
-	|O
source	|O
.	|O

Troubled	|O
CareNetwork	|O
gets	|O
pact	|O
from	|O
largest	|O
teacher	|O
union	|O
in	|O
Wis	|O
.	|O

JCAHO	|O
asks	|O
for	|O
hospitals	|O
'	|O
patience	|O
.	|O

Ultrasonography	|O
provides	|O
excellent	|O
intraoperative	|O
evaluation	|O
of	|O
spinal	|O
cord	|O
injury	|O
.	|O

UPMC	|O
is	|O
not	|O
the	|O
only	|O
organization	|O
pursuing	|O
controlled	|O
NHBC	|O
organ	|O
procurement	|O
,	|O
however	|O
.	|O

Because	|O
of	|O
concerns	|O
regarding	|O
blood	|O
transfusion	|O
-	|O
related	|O
communicable	|O
disease	|O
(	|O
eg	|O
,	|O
acquired	|O
immune	|O
deficiency	|O
syndrome	|O
and	|O
non	|O
-	|O
A	|O
,	|O
non	|O
-	|O
B	|O
hepatitis	|O
)	|O
,	|O
there	|O
has	|O
been	|O
increasing	|O
research	|O
effort	|O
into	|O
postoperative	|O
hemorrhage	|O
related	|O
to	|O
cardiopulmonary	|O
bypass	|O
with	|O
extracorporeal	|O
circulation	|O
.	|O

They	|O
contrast	|O
trends	|O
in	|O
fertility	|O
,	|O
life	|O
expectancy	|O
ratios	|O
,	|O
and	|O
gender	|O
differences	|O
in	|O
these	|O
countries	|O
with	|O
the	|O
Hispanic	|O
population	|O
of	|O
the	|O
United	|O
States	|O
.	|O

Holger	|O
v	|O
.	|O

Hospital	|O
hit	|O
for	|O
hiring	|O
AHERF	|O
physicians	|O
.	|O

Overexpression	|O
of	|O
either	|O
DAP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
or	|O
sentrin	|B-PROTEIN
causes	|O
apoptosis	|O
of	|O
TNF	|B-PROTEIN
-	|O
sensitive	|O
L929	|O
fibroblast	|O
cell	|O
line	|O
,	|O
as	|O
well	|O
as	|O
TNF	|B-PROTEIN
-	|O
resistant	|O
osteosarcoma	|O
cell	|O
line	|O
,	|O
U2OS	|O
.	|O

This	|O
is	|O
in	|O
contrast	|O
to	|O
PPARgamma2	|B-PROTEIN
,	|O
which	|O
was	|O
previously	|O
shown	|O
to	|O
be	|O
phosphorylated	|O
at	|O
a	|O
single	|O
site	|O
in	|O
a	|O
motif	|O
that	|O
is	|O
not	|O
homologous	|O
to	|O
the	|O
sites	|O
now	|O
described	|O
in	|O
PPARalpha	|B-PROTEIN
.	|O

These	|O
results	|O
suggest	|O
KCC3	|B-PROTEIN
is	|O
a	|O
new	|O
member	|O
of	|O
the	|O
KCC	|B-PROTEIN
family	|O
that	|O
is	|O
under	|O
distinct	|O
regulation	|O
from	|O
KCC1	|B-PROTEIN
.	|O

We	|O
have	|O
screened	|O
the	|O
elastin	|B-PROTEIN
gene	|O
for	|O
mutations	|O
responsible	|O
for	|O
supravalvular	|O
aortic	|O
stenosis	|O
(	|O
SVAS	|O
)	|O
in	|O
two	|O
large	|O
,	|O
independently	|O
collected	|O
families	|O
with	|O
isolated	|O
(	|O
nonsyndromic	|O
)	|O
SVAS	|O
.	|O

Spatiotemporal	|O
expression	|O
of	|O
the	|O
PAX3	|B-PROTEIN
gene	|O
is	|O
tightly	|O
regulated	|O
during	|O
development	|O
.	|O

25	|O
-	|O
OH	|O
-	|O
D3	|O
did	|O
not	|O
adversely	|O
affect	|O
animal	|O
health	|O
at	|O
the	|O
proposed	|O
use	|O
level	|O
of	|O
99	|O
micrograms	|O
/	|O
kg	|O
feed	|O
when	|O
replacing	|O
vitamin	|O
D3	|O
in	|O
turkey	|O
rations	|O
.	|O

A	|O
list	|O
of	|O
12	|O
names	|O
for	|O
the	|O
disease	|O
and	|O
37	|O
diagnostic	|O
criteria	|O
were	|O
proposed	|O
to	|O
a	|O
Consensus	|O
Panel	|O
of	|O
12	|O
Italian	|O
experts	|O
who	|O
ranked	|O
them	|O
in	|O
order	|O
so	|O
as	|O
to	|O
identify	|O
a	|O
core	|O
set	|O
of	|O
criteria	|O
.	|O

Methanesulfonyl	|O
fluoride	|O
(	|O
MSF	|O
)	|O
:	|O
a	|O
double	|O
-	|O
blind	|O
,	|O
placebo	|O
-	|O
controlled	|O
study	|O
of	|O
safety	|O
and	|O
efficacy	|O
in	|O
the	|O
treatment	|O
of	|O
senile	|O
dementia	|O
of	|O
the	|O
Alzheimer	|O
type	|O
.	|O

METHODS	|O
:	|O
Between	|O
August	|O
1991	|O
and	|O
June	|O
1994	|O
,	|O
198	|O
men	|O
with	|O
clinical	|O
T2	|O
or	|O
T3	|O
classified	|O
(	|O
TNM	|O
)	|O
prostate	|O
carcinoma	|O
(	|O
bone	|O
scan	|O
negative	|O
)	|O
who	|O
were	|O
at	|O
high	|O
risk	|O
of	|O
lymph	|O
node	|O
involvement	|O
underwent	|O
a	|O
111In	|O
-	|O
capromab	|O
pendetide	|O
scan	|O
prior	|O
to	|O
staging	|O
lymphadenectomy	|O
.	|O

Voluntary	|O
wheel	|O
running	|O
did	|O
not	|O
significantly	|O
increase	|O
estimated	|O
alanine	|O
or	|O
pyruvate	|O
Gneo	|O
or	|O
absolute	|O
glycerol	|O
Ra	|O
.	|O

Immediately	|O
after	|O
surgery	|O
,	|O
dialysate	|O
PGE2	|O
and	|O
adenosine	|O
concentrations	|O
were	|O
3.7	|O
+	|O
/	|O
-	|O
0.7	|O
and	|O
296	|O
+	|O
/	|O
-	|O
127	|O
nM	|O
,	|O
respectively	|O
.	|O

Because	|O
of	|O
the	|O
probable	|O
causal	|O
relationship	|O
between	|O
constitutive	|O
p210	|B-PROTEIN
(	|O
bcr	|B-PROTEIN
/	|O
abl	|B-PROTEIN
)	|O
protein	|B-PROTEIN
tyrosine	|I-PROTEIN
kinase	|I-PROTEIN
activity	|O
and	|O
manifestations	|O
of	|O
chronic	|O
-	|O
phase	|O
chronic	|O
myelogenous	|O
leukemia	|O
(	|O
CML	|O
;	|O
myeloid	|O
expansion	|O
)	|O
,	|O
a	|O
key	|O
goal	|O
is	|O
to	|O
identify	|O
relevant	|O
p210	|B-PROTEIN
substrates	|O
in	|O
primary	|O
chronic	|O
-	|O
phase	|O
CML	|O
hematopoietic	|O
progenitor	|O
cells	|O
.	|O

In	|O
vitro	|O
precipitation	|O
with	|O
a	|O
glutathione	|B-PROTEIN
-	|I-PROTEIN
S	|I-PROTEIN
-	|I-PROTEIN
transferase	|I-PROTEIN
-	|O
fusion	|O
protein	|O
containing	|O
the	|O
C	|O
-	|O
terminal	|O
transactivation	|O
domain	|O
of	|O
STAT5a	|B-PROTEIN
showed	|O
GH	|B-PROTEIN
-	|O
regulated	|O
association	|O
of	|O
ERK1/2	|B-PROTEIN
with	|O
the	|O
fusion	|O
protein	|O
,	|O
while	|O
this	|O
was	|O
not	|O
seen	|O
when	|O
serine	|O
780	|O
in	|O
STAT5a	|B-PROTEIN
was	|O
changed	|O
to	|O
alanine	|O
.	|O

One	|O
such	|O
element	|O
,	|O
1P	|O
,	|O
was	|O
employed	|O
to	|O
clone	|O
from	|O
a	|O
rat	|O
pituitary	|O
cDNA	|O
expression	|O
library	|O
a	|O
novel	|O
417	|O
-	|O
amino	|O
acid	|O
WD	|B-PROTEIN
protein	|O
,	|O
designated	|O
PREB	|B-PROTEIN
(	|O
PRL	|O
regulatory	|O
element	|O
binding	|O
)	|O
protein	|O
.	|O

Characterization	|O
of	|O
the	|O
transcription	|O
factor	|O
MTF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
from	|O
the	|O
Japanese	|O
pufferfish	|O
(	|O
Fugu	|O
rubripes	|O
)	|O
reveals	|O
evolutionary	|O
conservation	|O
of	|O
heavy	|O
metal	|O
stress	|O
response	|O
.	|O

The	|O
peroxisome	|B-PROTEIN
proliferator	|I-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
receptors	|I-PROTEIN
(	|O
PPARs	|B-PROTEIN
)	|O
are	|O
members	|O
of	|O
the	|O
nuclear	|B-PROTEIN
hormone	|I-PROTEIN
receptor	|I-PROTEIN
superfamily	|O
.	|O

However	|O
,	|O
F	|B-PROTEIN
-	|I-PROTEIN
SRC	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
mutant	|O
lacking	|O
CBP	|B-PROTEIN
-	|O
interacting	|O
domain	|O
still	|O
preserved	|O
enhancing	|O
activity	|O
.	|O

The	|O
catalytic	|O
site	|O
has	|O
an	|O
S1	|O
pocket	|O
lined	|O
with	|O
conserved	|O
hydrophobic	|O
residues	|O
to	|O
accommodate	|O
the	|O
pyroglutamyl	|O
residue	|O
.	|O

The	|O
complete	|O
circular	|O
TTV	|O
genome	|O
contained	|O
a	|O
novel	|O
sequence	|O
of	|O
113	|O
nt	|O
(	|O
nt	|O
3740	|O
to	|O
3852	|O
[	|O
=	|O
0	|O
]	|O
)	|O
in	|O
between	|O
the	|O
known	|O
3'	|O
-	|O
and	|O
5'	|O
-	|O
end	|O
arms	|O
,	|O
forming	|O
a	|O
117	|O
-	|O
nt	|O
GC	|O
-	|O
rich	|O
stretch	|O
(	|O
GC	|O
content	|O
,	|O
90.6%	|O
at	|O
nt	|O
3736	|O
to	|O
3852	|O
)	|O
.	|O

The	|O
Asian	|O
mouse	|O
Mus	|O
castaneus	|O
is	|O
resistant	|O
to	|O
infection	|O
by	|O
the	|O
polytropic	|O
mink	|O
cell	|O
focus	|O
-	|O
inducing	|O
(	|O
MCF	|O
)	|O
subgroup	|O
of	|O
murine	|O
leukemia	|O
viruses	|O
(	|O
MuLVs	|O
)	|O
.	|O

To	|O
determine	|O
the	|O
function	|O
of	|O
VZV	|O
gK	|B-PROTEIN
in	|O
virus	|O
growth	|O
,	|O
a	|O
series	|O
of	|O
gK	|B-PROTEIN
deletion	|O
mutants	|O
were	|O
constructed	|O
with	|O
VZV	|O
cosmid	|O
DNA	|O
derived	|O
from	|O
the	|O
Oka	|O
strain	|O
.	|O

CCAAT	|B-PROTEIN
displacement	|I-PROTEIN
protein	|I-PROTEIN
binds	|O
to	|O
and	|O
negatively	|O
regulates	|O
human	|O
papillomavirus	|O
type	|O
6	|O
E6	|B-PROTEIN
,	|O
E7	|B-PROTEIN
,	|O
and	|O
E1	|B-PROTEIN
promoters	|O
.	|O

As	|O
such	|O
the	|O
findings	|O
support	|O
existing	|O
studies	|O
that	|O
have	|O
identified	|O
given	|O
social	|O
characteristics	|O
of	|O
drink	|O
drivers	|O
.	|O

Three	|O
different	|O
site	|O
-	|O
directed	|O
mutations	|O
of	|O
the	|O
cyclic	|O
AMP	|O
response	|O
element	|O
each	|O
reduced	|O
the	|O
nerve	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
effect	|O
by	|O
>	|O
90%	|O
.	|O

Using	|O
an	|O
RNase	|B-PROTEIN
H	|I-PROTEIN
protection	|O
assay	|O
and	|O
specific	|O
blocking	|O
oligonucleotides	|O
,	|O
we	|O
find	|O
that	|O
recognition	|O
of	|O
the	|O
5'	|O
splice	|O
-	|O
site	|O
(	|O
5'	|O
ss	|O
)	|O
and	|O
branchpoint	|O
sequence	|O
(	|O
BPS	|O
)	|O
elements	|O
by	|O
U11	|B-PROTEIN
and	|O
U12	|B-PROTEIN
snRNPs	|O
,	|O
respectively	|O
,	|O
displays	|O
strong	|O
cooperativity	|O
,	|O
requiring	|O
both	|O
sites	|O
in	|O
the	|O
pre	|O
-	|O
mRNA	|O
substrate	|O
for	|O
efficient	|O
complex	|O
formation	|O
.	|O

Analysis	|O
of	|O
lacZ	|B-PROTEIN
transcriptional	|O
fusions	|O
shows	|O
that	|O
the	|O
KdgR	|B-PROTEIN
-	|O
binding	|O
sites	|O
negatively	|O
affect	|O
the	|O
expression	|O
of	|O
rsmB	|B-PROTEIN
.	|O

Many	|O
eukaryotic	|O
cell	|O
surface	|O
proteins	|O
are	|O
anchored	|O
in	|O
the	|O
lipid	|O
bilayer	|O
through	|O
glycosylphosphatidylinositol	|O
(	|O
GPI	|O
)	|O
.	|O

In	|O
the	|O
cell	|O
-	|O
free	|O
import	|O
assay	|O
,	|O
beta	|B-PROTEIN
-	|I-PROTEIN
catenin	|I-PROTEIN
rapidly	|O
migrates	|O
into	|O
the	|O
nucleus	|O
without	|O
the	|O
exogenous	|O
addition	|O
of	|O
cytosol	|O
,	|O
Ran	|B-PROTEIN
,	|O
or	|O
ATP	|O
/	|O
GTP	|O
.	|O

In	|O
ischemic	|O
and	|O
hypoxic	|O
hypoxia	|O
,	|O
a	|O
strong	|O
correlation	|O
was	|O
found	|O
between	|O
cyt	|O
a	|O
,	|O
a3	|O
oxidation	|O
level	|O
and	|O
VO2	|O
in	|O
both	|O
ischemic	|O
and	|O
hypoxic	|O
hypoxia	|O
(	|O
r2	|O
=	|O
.90	|O
and	|O
.87	|O
,	|O
respectively	|O
)	|O
.	|O

An	|O
endogenous	|O
mammalian	|O
regulator	|O
of	|O
this	|O
process	|O
,	|O
named	|O
Usurpin	|B-PROTEIN
,	|O
has	|O
been	|O
identified	|O
(	|O
aliases	|O
for	|O
Usurpin	|B-PROTEIN
include	|O
CASH	|B-PROTEIN
,	|O
Casper	|B-PROTEIN
,	|O
CLARP	|B-PROTEIN
,	|O
FLAME	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
FLIP	|B-PROTEIN
,	|O
I	|B-PROTEIN
-	|I-PROTEIN
FLICE	|I-PROTEIN
and	|O
MRIT	|B-PROTEIN
)	|O
.	|O

Plasma	|O
glucose	|O
,	|O
immunoreactive	|B-PROTEIN
insulin	|I-PROTEIN
(	|O
IRI	|B-PROTEIN
)	|O
,	|O
C	|B-PROTEIN
-	|I-PROTEIN
peptide	|I-PROTEIN
,	|O
glucagon	|B-PROTEIN
,	|O
and	|O
GLP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
levels	|O
at	|O
each	|O
time	|O
point	|O
during	|O
OGTT	|O
were	|O
measured	|O
.	|O

Each	|O
recombinant	|O
product	|O
was	|O
a	|O
fusion	|O
protein	|O
with	|O
a	|O
B	|O
domain	|O
of	|O
Staphylococcal	|B-PROTEIN
protein	|I-PROTEIN
A	|I-PROTEIN
(	|O
SPA	|B-PROTEIN
)	|O
.	|O

Polypyrimidine	|O
and	|O
ssDNA	|O
binding	|O
by	|O
the	|O
isolated	|O
VH	|B-PROTEIN
domain	|O
of	|O
immunization	|O
-	|O
induced	|O
anti	|O
-	|O
Z	|O
-	|O
DNA	|O
Ab	|O
resembles	|O
the	|O
activity	|O
of	|O
natural	|O
autoantibodies	|O
and	|O
suggests	|O
that	|O
VH	|B-PROTEIN
-	|O
dependent	|O
binding	|O
to	|O
a	|O
ligand	|O
mimicked	|O
by	|O
polypyrimidines	|O
may	|O
play	|O
a	|O
role	|O
in	|O
B	|O
cell	|O
selection	|O
before	|O
immunization	|O
with	|O
Z	|O
-	|O
DNA	|O
.	|O

Technetium	|O
-	|O
99m	|O
methylene	|O
diphosphonate	|O
scintimammography	|O
for	|O
evaluation	|O
of	|O
palpable	|O
breast	|O
masses	|O
.	|O

INTERVENTIONS	|O
:	|O
Study	|O
patients	|O
were	|O
randomly	|O
divided	|O
into	|O
four	|O
parallel	|O
groups	|O
to	|O
receive	|O
either	|O
terbinafine	|O
250	|O
mg	|O
a	|O
day	|O
for	|O
12	|O
or	|O
16	|O
weeks	|O
(	|O
groups	|O
T12	|O
and	|O
T16	|O
)	|O
or	|O
itraconazole	|O
400	|O
mg	|O
a	|O
day	|O
for	|O
1	|O
week	|O
in	|O
every	|O
4	|O
weeks	|O
for	|O
12	|O
or	|O
16	|O
weeks	|O
(	|O
groups	|O
I3	|O
and	|O
I4	|O
)	|O
.	|O

Nuclear	|O
receptors	|O
(	|O
NRs	|O
)	|O
can	|O
function	|O
as	|O
ligandinducible	|O
transregulators	|O
in	|O
both	|O
mammalian	|O
and	|O
yeast	|O
cells	|O
,	|O
indicating	|O
that	|O
important	|O
features	|O
of	|O
transcriptional	|O
control	|O
have	|O
been	|O
conserved	|O
throughout	|O
evolution	|O
.	|O

When	|O
tethered	|O
to	|O
a	|O
heterologous	|O
DNA	|O
-	|O
binding	|O
domain	|O
,	|O
PSU1	|B-PROTEIN
can	|O
activate	|O
transcription	|O
on	|O
its	|O
own	|O
.	|O

OBJECTIVE	|O
:	|O
To	|O
follow	|O
-	|O
up	|O
prospectively	|O
patients	|O
with	|O
arthritis	|O
after	|O
infection	|O
with	|O
beta	|O
-	|O
haemolytic	|O
streptococci	|O
of	|O
Lancefield	|O
group	|O
A	|O
(	|O
beta	|O
HSA	|O
)	|O
,	|O
with	|O
emphasis	|O
on	|O
clinical	|O
characteristics	|O
and	|O
serological	|O
features	|O
.	|O

Bacteria	|O
can	|O
also	|O
cause	|O
a	|O
labyrinthitis	|O
acting	|O
directly	|O
on	|O
the	|O
inner	|O
ear	|O
:	|O
among	|O
these	|O
,	|O
Treponemas	|O
Pallidum	|O
,	|O
a	|O
spirochaete	|O
which	|O
causes	|O
syphilis	|O
and	|O
Borrelia	|O
Burgdorferi	|O
,	|O
a	|O
spirochaete	|O
that	|O
causes	|O
Lyme	|O
Disease	|O
,	|O
must	|O
be	|O
mentioned	|O
.	|O

We	|O
found	|O
that	|O
the	|O
expression	|O
of	|O
the	|O
protein	|O
was	|O
maximum	|O
in	|O
mitosis	|O
and	|O
minimum	|O
in	|O
G1	|O
,	|O
which	|O
correlated	|O
with	|O
the	|O
expression	|O
of	|O
its	|O
messenger	|O
RNA	|O
.	|O

These	|O
findings	|O
demonstrate	|O
that	|O
signature	|O
-	|O
tagged	|O
mutagenesis	|O
is	|O
a	|O
viable	|O
approach	|O
to	|O
identify	|O
bacterial	|O
genes	|O
associated	|O
with	|O
the	|O
ability	|O
to	|O
infect	|O
the	|O
urinary	|O
tract	|O
.	|O

Pathol	|O
.	|O

The	|O
eukaryotic	|O
cell	|O
cycle	|O
is	|O
governed	|O
in	|O
part	|O
by	|O
the	|O
periodic	|O
transcription	|O
of	|O
cyclin	|B-PROTEIN
genes	|O
,	|O
whose	|O
protein	|O
products	|O
associate	|O
with	|O
and	|O
positively	|O
regulate	|O
the	|O
cyclin	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
kinases	|I-PROTEIN
.	|O

The	|O
GAC1	|B-PROTEIN
gene	|O
encodes	|O
the	|O
regulatory	|O
subunit	|O
for	|O
a	|O
type	|B-PROTEIN
1	|I-PROTEIN
serine	|I-PROTEIN
/	|I-PROTEIN
threonine	|I-PROTEIN
phosphoprotein	|I-PROTEIN
phosphatase	|I-PROTEIN
,	|O
Glc7	|B-PROTEIN
.	|O

The	|O
results	|O
demonstrate	|O
that	|O
the	|O
Glc7	|B-PROTEIN
phosphatase	|O
and	|O
its	|O
Gac1	|B-PROTEIN
regulatory	|O
subunit	|O
play	|O
positive	|O
roles	|O
in	|O
HSF	|B-PROTEIN
activation	|O
of	|O
CUP1	|B-PROTEIN
transcription	|O
.	|O

MEF	|B-PROTEIN
and	|O
AML1B	|B-PROTEIN
synergistically	|O
transactivated	|O
an	|O
interleukin	|B-PROTEIN
3	|I-PROTEIN
promoter	|O
reporter	|O
gene	|O
construct	|O
,	|O
yet	|O
the	|O
activating	|O
activity	|O
of	|O
MEF	|B-PROTEIN
was	|O
abolished	|O
when	|O
MEF	|B-PROTEIN
was	|O
coexpressed	|O
with	|O
AML1	|B-PROTEIN
/	|O
ETO	|B-PROTEIN
.	|O

Mechanistically	|O
,	|O
the	|O
presence	|O
of	|O
the	|O
GRR	|O
appears	|O
to	|O
stop	|O
further	|O
degradation	|O
of	|O
p50	|B-PROTEIN
and	|O
to	|O
stabilize	|O
the	|O
molecule	|O
.	|O

This	|O
phosphorylation	|O
can	|O
be	|O
catalyzed	|O
by	|O
a	|O
break	|O
-	|O
ended	|O
double	|O
-	|O
stranded	|O
DNA	|O
-	|O
activated	|O
protein	|O
kinase	|O
activity	|O
from	|O
the	|O
sea	|O
urchin	|O
nucleus	|O
in	|O
vitro	|O
.	|O

Concomitantly	|O
,	|O
the	|O
total	|O
cellular	|O
level	|O
of	|O
p21	|B-PROTEIN
increased	|O
severalfold	|O
via	|O
a	|O
posttranscriptional	|O
mechanism	|O
.	|O

Moreover	|O
,	|O
when	|O
added	|O
to	|O
the	|O
osteoclast	|O
cultures	|O
,	|O
mrIhh	|B-PROTEIN
-	|I-PROTEIN
N	|I-PROTEIN
markedly	|O
stimulated	|O
the	|O
formation	|O
of	|O
resorption	|O
pits	|O
on	|O
dentine	|O
slices	|O
.	|O

Overall	|O
,	|O
our	|O
results	|O
suggest	|O
that	|O
resistant	|O
genotypes	|O
exist	|O
among	|O
the	|O
WAD	|O
goat	|O
population	|O
.	|O

The	|O
molecular	|O
mechanism	|O
by	|O
which	|O
Gle2p	|B-PROTEIN
and	|O
the	|O
Gle2p	|B-PROTEIN
-	|O
Nup116p	|B-PROTEIN
interaction	|O
function	|O
in	|O
mRNA	|O
export	|O
is	|O
unknown	|O
.	|O

The	|O
Fyn	|B-PROTEIN
NH2	|O
terminus	|O
was	|O
necessary	|O
but	|O
not	|O
sufficient	|O
for	|O
interaction	|O
with	|O
zeta	|O
and	|O
both	|O
Fyn	|B-PROTEIN
kinase	|O
and	|O
SH2	|B-PROTEIN
domains	|O
were	|O
required	|O
,	|O
directing	|O
phosphorylation	|O
of	|O
zeta	|B-PROTEIN
ITAM	|I-PROTEIN
tyrosines	|O
and	|O
binding	|O
to	|O
zeta	|B-PROTEIN
ITAM	|I-PROTEIN
phosphotyrosines	|O
.	|O

In	|O
budding	|O
yeast	|O
,	|O
the	|O
protein	|O
Skp1p	|B-PROTEIN
,	|O
the	|O
cullin	|B-PROTEIN
-	|O
family	|O
member	|O
Cdc53p	|B-PROTEIN
,	|O
and	|O
the	|O
F	|O
-	|O
box	|O
/	|O
WD	|O
-	|O
repeat	|O
protein	|O
Cdc4p	|B-PROTEIN
form	|O
the	|O
SCFCdc4p	|B-PROTEIN
ubiquitin	|O
ligase	|O
complex	|O
,	|O
which	|O
targets	|O
the	|O
cyclin	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
Cdk	|B-PROTEIN
)	|O
inhibitor	|O
Sic1p	|B-PROTEIN
for	|O
proteolysis	|O
[	|O
3	|O
]	|O
[	|O
4	|O
]	|O
[	|O
5	|O
]	|O
[	|O
6	|O
]	|O
[	|O
7	|O
]	|O
[	|O
8	|O
]	|O
.	|O

We	|O
show	|O
here	|O
that	|O
,	|O
despite	|O
their	|O
structural	|O
and	|O
functional	|O
similarities	|O
,	|O
the	|O
pop1	|B-PROTEIN
and	|O
pop2	|B-PROTEIN
genes	|O
fail	|O
to	|O
complement	|O
each	|O
other	|O
's	|O
deletion	|O
phenotypes	|O
,	|O
indicating	|O
that	|O
they	|O
perform	|O
non	|O
-	|O
redundant	|O
,	|O
but	|O
potentially	|O
interdependent	|O
,	|O
functions	|O
in	|O
proteolysis	|O
.	|O

Antithrombin	|B-PROTEIN
III	|I-PROTEIN
prevents	|O
60	|O
min	|O
warm	|O
intestinal	|O
ischemia	|O
reperfusion	|O
injury	|O
in	|O
rats	|O
.	|O

In	|O
retrospect	|O
,	|O
the	|O
diagnoses	|O
were	|O
reconsidered	|O
applying	|O
strict	|O
criteria	|O
.	|O

These	|O
observations	|O
of	|O
elevated	|O
serum	|O
lipase	|B-PROTEIN
and	|O
serum	|O
CA	|B-PROTEIN
19-9	|I-PROTEIN
in	|O
Sjogren	|O
's	|O
syndrome	|O
without	|O
evidence	|O
of	|O
malignancy	|O
may	|O
reflect	|O
pancreatic	|O
involvement	|O
in	|O
this	|O
disorder	|O
.	|O

Acute	|O
pancreatitis	|O
as	|O
a	|O
complication	|O
of	|O
polyarteritis	|O
nodosa	|O
.	|O

Significantly	|O
greater	|O
improvement	|O
(	|O
p	|O
<	|O
0.05	|O
)	|O
in	|O
the	|O
sertraline	|O
group	|O
first	|O
became	|O
apparent	|O
by	|O
the	|O
end	|O
of	|O
week	|O
3	|O
on	|O
the	|O
Y	|O
-	|O
BOCS	|O
and	|O
the	|O
CGI	|O
Improvement	|O
scale	|O
,	|O
and	|O
by	|O
the	|O
end	|O
of	|O
weeks	|O
6	|O
and	|O
8	|O
,	|O
respectively	|O
,	|O
on	|O
the	|O
NIMH	|O
and	|O
CGI	|O
Severity	|O
scale	|O
.	|O

Stress	|B-PROTEIN
-	|I-PROTEIN
inducible	|I-PROTEIN
protein	|I-PROTEIN
kinases	|I-PROTEIN
capable	|O
of	|O
activating	|O
c	|B-PROTEIN
-	|I-PROTEIN
jun	|I-PROTEIN
expression	|O
include	|O
stress	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
/	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
N	|I-PROTEIN
-	|I-PROTEIN
terminal	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
SAPK	|B-PROTEIN
/	|O
JNK	|B-PROTEIN
)	|O
and	|O
p38	|B-PROTEIN
members	|O
of	|O
the	|O
mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
MAPK	|B-PROTEIN
)	|O
superfamily	|O
of	|O
signaling	|O
molecules	|O
.	|O

Transforming	|O
growth	|O
factor	|O
(	|B-PROTEIN
TGF	|I-PROTEIN
)	|I-PROTEIN
-	|I-PROTEIN
beta1	|I-PROTEIN
induces	|O
extracellular	|O
matrix	|O
deposition	|O
and	|O
proliferation	|O
of	|O
mesenchymal	|O
cells	|O
.	|O

Chronotherapeutics	|O
in	|O
cardiovascular	|O
disease	|O
.	|O

Group	|O
psychometric	|O
functions	|O
for	|O
listeners	|O
with	|O
hearing	|O
loss	|O
do	|O
not	|O
show	|O
a	|O
decrease	|O
in	|O
performance	|O
at	|O
the	|O
largest	|O
values	|O
of	|O
delta	|O
f	|O
included	|O
in	|O
this	|O
study	|O
.	|O

Uroflowmetry	|O
can	|O
detect	|O
dysuria	|O
,	|O
which	|O
may	|O
be	|O
poorly	|O
perceived	|O
or	|O
even	|O
unknown	|O
to	|O
the	|O
subjects	|O
themselves	|O
.	|O

Marked	|O
racial	|O
variation	|O
in	|O
birthweight	|O
percentiles	|O
by	|O
gestational	|O
age	|O
was	|O
evident	|O
.	|O

Significant	|O
correlations	|O
between	|O
mental	|O
status	|O
as	|O
measured	|O
by	|O
the	|O
Mini	|O
-	|O
Mental	|O
State	|O
Examination	|O
and	|O
NA	|O
/	|O
mI	|O
,	|O
mI	|O
/	|O
Cr	|O
and	|O
NA	|O
were	|O
found	|O
.	|O

Glucagon	|B-PROTEIN
also	|O
induced	|O
LUC	|B-PROTEIN
activity	|O
very	|O
strongly	|O
when	|O
the	|O
CRE1	|O
and	|O
CRE2	|O
sites	|O
were	|O
combined	|O
;	|O
induction	|O
of	|O
the	|O
(	|O
CRE1	|O
)	|O
3	|O
(	|O
CRE2	|O
)	|O
2SV40	|O
-	|O
LUC	|B-PROTEIN
constructs	|O
was	|O
positively	|O
modulated	|O
by	|O
the	|O
pO2	|O
.	|O

In	|O
this	|O
study	|O
,	|O
we	|O
report	|O
the	|O
isolation	|O
and	|O
characterization	|O
of	|O
the	|O
entire	|O
rat	|O
GSTA3	|B-PROTEIN
(	|O
rGST	|B-PROTEIN
Yc1	|I-PROTEIN
)	|O
subunit	|O
gene	|O
.	|O

Calcinosis	|O
cutis	|O
following	|O
intravenous	|O
infusion	|O
of	|O
calcium	|O
gluconate	|O
.	|O

Initial	|O
control	|O
of	|O
bleeding	|O
is	|O
similar	|O
,	|O
but	|O
eradication	|O
is	|O
achieved	|O
in	|O
fewer	|O
sessions	|O
with	|O
EVL	|O
.	|O

Finally	|O
,	|O
we	|O
determined	|O
the	|O
genomic	|O
organization	|O
of	|O
the	|O
human	|O
TrxR2	|B-PROTEIN
gene	|O
,	|O
which	|O
consists	|O
of	|O
18	|O
exons	|O
spanning	|O
about	|O
67	|O
kb	|O
,	|O
and	|O
its	|O
chromosomal	|O
localization	|O
at	|O
position	|O
22q11.2	|O
.	|O

The	|O
aims	|O
of	|O
this	|O
study	|O
were	|O
to	|O
determine	|O
and	|O
rank	|O
the	|O
frequency	|O
of	|O
self	|O
reported	|O
visual	|O
disability	|O
in	|O
daily	|O
tasks	|O
performed	|O
by	|O
glaucoma	|O
patients	|O
;	|O
to	|O
examine	|O
the	|O
interrelation	|O
between	|O
disabilities	|O
using	|O
factor	|O
analysis	|O
;	|O
to	|O
study	|O
the	|O
relation	|O
between	|O
perceived	|O
visual	|O
difficulty	|O
and	|O
a	|O
measure	|O
of	|O
the	|O
severity	|O
of	|O
visual	|O
field	|O
loss	|O
;	|O
to	|O
develop	|O
a	|O
glaucoma	|O
specific	|O
subgroup	|O
of	|O
questions	|O
;	|O
and	|O
examine	|O
the	|O
validity	|O
and	|O
reliability	|O
of	|O
this	|O
subgroup	|O
of	|O
questions	|O
.	|O

Furthermore	|O
,	|O
the	|O
validity	|O
of	|O
this	|O
new	|O
subset	|O
of	|O
questions	|O
was	|O
shown	|O
to	|O
be	|O
significant	|O
(	|O
r	|O
=	|O
0.037	|O
,	|O
p	|O
<	|O
0.05	|O
)	|O
for	|O
the	|O
correlation	|O
between	|O
a	|O
measure	|O
of	|O
the	|O
severity	|O
of	|O
binocular	|O
visual	|O
field	|O
loss	|O
and	|O
the	|O
mean	|O
score	|O
of	|O
the	|O
variables	|O
used	|O
in	|O
the	|O
glaucoma	|O
specific	|O
subgroup	|O
of	|O
questions	|O
.	|O

Sequence	|O
comparison	|O
of	|O
cytochromes	|O
bd	|B-PROTEIN
and	|O
their	|O
homologs	|O
from	|O
various	|O
organisms	|O
demonstrates	|O
that	|O
the	|O
proteins	|O
can	|O
be	|O
classified	|O
into	|O
two	|O
subfamilies	|O
,	|O
a	|O
proteobacterial	|O
type	|O
including	|O
E.	|O
coli	|O
bd	|B-PROTEIN
and	|O
a	|O
more	|O
widely	|O
distributed	|O
type	|O
including	|O
the	|O
B.	|O
stearothermophilus	|O
enzyme	|O
,	|O
suggesting	|O
that	|O
the	|O
latter	|O
type	|O
is	|O
evolutionarily	|O
older	|O
.	|O

Canalith	|O
repositioning	|O
is	|O
the	|O
mainstay	|O
of	|O
treatment	|O
.	|O

Solution	|O
structure	|O
and	|O
mechanism	|O
of	|O
the	|O
MutT	|B-PROTEIN
pyrophosphohydrolase	|O
.	|O

In	|O
11	|O
eyes	|O
that	|O
had	|O
been	|O
selected	|O
at	|O
random	|O
10	|O
micrograms	|O
of	|O
recombinant	|O
tissue	|B-PROTEIN
plasminogen	|I-PROTEIN
activator	|I-PROTEIN
were	|O
injected	|O
midvitreally	|O
24	|O
hrs	|O
later	|O
.	|O

RESULTS	|O
AND	|O
CONCLUSIONS	|O
:	|O
Brandt	|O
's	|O
double	|O
cuff	|O
-	|O
tubes	|O
(	|O
G2	|O
)	|O
succeed	|O
in	|O
avoiding	|O
uncontrolled	|O
increase	|O
of	|O
cuff	|O
-	|O
pressure	|O
during	|O
anaesthesia	|O
with	|O
N2O	|O
.	|O

Accordingly	|O
,	|O
we	|O
designated	|O
this	|O
gene	|O
CTL1	|B-PROTEIN
(	|O
capping	|B-PROTEIN
enzyme	|I-PROTEIN
RNAtriphosphatase	|I-PROTEIN
-	|I-PROTEIN
like	|I-PROTEIN
1	|I-PROTEIN
)	|O
.	|O

The	|O
binding	|O
of	|O
PH	|B-PROTEIN
domains	|O
to	|O
Gbetagamma	|B-PROTEIN
was	|O
inhibited	|O
by	|O
preincubation	|O
of	|O
Gbetagamma	|B-PROTEIN
with	|O
the	|O
GDP	|O
-	|O
bound	|O
but	|O
not	|O
the	|O
GTP	|O
-	|O
bound	|O
form	|O
of	|O
Gialpha	|B-PROTEIN
.	|O

Their	|O
afterglows	|O
are	|O
brighter	|O
than	|O
supernovae	|O
and	|O
therefore	|O
are	|O
called	|O
hypernovae	|O
.	|O

Constrictive	|O
pericarditis	|O
and	|O
pleuropulmonary	|O
disease	|O
linked	|O
to	|O
ergot	|O
dopamine	|O
agonist	|O
therapy	|O
(	|O
cabergoline	|O
)	|O
for	|O
Parkinson	|O
's	|O
disease	|O
.	|O

An	|O
undilated	|O
type	|O
of	|O
APBD	|O
is	|O
frequently	|O
associated	|O
with	|O
AMT	|O
and	|O
we	|O
believe	|O
,	|O
therefore	|O
,	|O
that	|O
clinicians	|O
should	|O
be	|O
aware	|O
of	|O
a	|O
possible	|O
coexistence	|O
of	|O
APBD	|O
and	|O
AMT	|O
.	|O

In	|O
addition	|O
,	|O
we	|O
also	|O
constructed	|O
and	|O
expressed	|O
chimeric	|O
fusion	|O
protein	|O
that	|O
contains	|O
HIV	|O
-	|O
2	|O
gag	|B-PROTEIN
with	|O
V3	|B-PROTEIN
domains	|O
of	|O
HIV	|O
-	|O
1IIIB	|O
,	|O
HIV	|O
-	|O
1MN	|O
,	|O
HIV	|O
-	|O
1SF2	|O
and	|O
HIV	|O
-	|O
1RF	|O
.	|O

Our	|O
results	|O
indicate	|O
that	|O
V3	|B-PROTEIN
peptides	|O
from	|O
all	|O
major	|O
clades	|O
of	|O
HIV	|O
-	|O
1	|O
carried	|O
by	|O
HIV	|O
-	|O
2	|O
gag	|B-PROTEIN
can	|O
be	|O
used	|O
as	|O
a	|O
potential	|O
HIV	|O
/	|O
AIDS	|O
vaccine	|O
.	|O

Efficacy	|O
was	|O
determined	|O
by	|O
responses	|O
to	|O
question	|O
3	|O
(	|O
ability	|O
to	|O
achieve	|O
an	|O
erection	|O
)	|O
and	|O
question	|O
4	|O
(	|O
ability	|O
to	|O
maintain	|O
an	|O
erection	|O
)	|O
of	|O
the	|O
15	|O
-	|O
item	|O
International	|O
Index	|O
of	|O
Erectile	|O
Function	|O
(	|O
IIEF	|O
)	|O
.	|O

Evidence	|O
for	|O
the	|O
involvement	|O
of	|O
the	|O
Glc7	|B-PROTEIN
-	|O
Reg1	|B-PROTEIN
phosphatase	|O
and	|O
the	|O
Snf1	|B-PROTEIN
-	|O
Snf4	|B-PROTEIN
kinase	|O
in	|O
the	|O
regulation	|O
of	|O
INO1	|B-PROTEIN
transcription	|O
in	|O
Saccharomyces	|O
cerevisiae	|O
.	|O

In	|O
XO	|O
males	|O
,	|O
two	|O
her	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
mRNAs	|O
,	|O
her	|B-PROTEIN
-	|I-PROTEIN
1a	|I-PROTEIN
and	|O
her	|B-PROTEIN
-	|I-PROTEIN
1b	|I-PROTEIN
,	|O
are	|O
transcribed	|O
from	|O
two	|O
separate	|O
promoters	|O
:	|O
P1	|O
,	|O
located	|O
in	|O
the	|O
5'	|O
-	|O
flanking	|O
region	|O
,	|O
and	|O
P2	|O
,	|O
located	|O
in	|O
the	|O
large	|O
second	|O
intron	|O
.	|O

Induction	|O
of	|O
Fas	|B-PROTEIN
ligand	|O
expression	|O
by	|O
HIV	|O
involves	|O
the	|O
interaction	|O
of	|O
Nef	|B-PROTEIN
with	|O
the	|O
T	|B-PROTEIN
cell	|I-PROTEIN
receptor	|I-PROTEIN
zeta	|O
chain	|O
.	|O

Receptor	|B-PROTEIN
protein	|I-PROTEIN
tyrosine	|I-PROTEIN
phosphatases	|I-PROTEIN
(	|O
RPTPs	|B-PROTEIN
)	|O
comprise	|O
a	|O
family	|O
of	|O
proteins	|O
that	|O
feature	|O
intracellular	|O
phosphatase	|O
domains	|O
and	|O
an	|O
ectodomain	|O
with	|O
putative	|O
ligand	|O
-	|O
binding	|O
motifs	|O
.	|O

These	|O
well	|O
-	|O
characterized	|O
brain	|O
regions	|O
may	|O
provide	|O
a	|O
basis	|O
for	|O
future	|O
studies	|O
of	|O
RPTP	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
function	|O
.	|O

Commonly	|O
used	|O
stressors	|O
are	|O
mental	|O
arithmetics	|O
,	|O
speech	|O
tasks	|O
,	|O
the	|O
Stroop	|O
test	|O
,	|O
videogame	|O
playing	|O
,	|O
films	|O
or	|O
videotapes	|O
and	|O
interviews	|O
.	|O

The	|O
control	|O
group	|O
included	|O
8	|O
afterbirth	|O
samples	|O
from	|O
physiological	|O
full	|O
-	|O
term	|O
pregnancies	|O
.	|O

However	|O
,	|O
we	|O
identified	|O
a	|O
gene	|O
between	|O
the	|O
MDV2	|O
UL54	|B-PROTEIN
and	|O
UL55	|B-PROTEIN
genes	|O
with	|O
homology	|O
to	|O
the	|O
first	|O
ORF	|O
(	|B-PROTEIN
ORF	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|I-PROTEIN
of	|I-PROTEIN
equine	|I-PROTEIN
herpesvirus	|I-PROTEIN
type	|I-PROTEIN
1	|I-PROTEIN
and	|O
corresponding	|O
gene	|O
identified	|O
in	|O
pseudorabies	|O
virus	|O
.	|O

In	|O
contrast	|O
,	|O
the	|O
loss	|O
of	|O
MAD2	|B-PROTEIN
staining	|O
in	|O
meiosis	|O
was	|O
not	|O
correlated	|O
with	|O
initial	|O
microtubule	|O
attachment	|O
but	|O
was	|O
correlated	|O
with	|O
a	|O
measure	|O
of	|O
tension	|O
:	|O
the	|O
distance	|O
between	|O
homologous	|O
or	|O
sister	|O
kinetochores	|O
(	|O
in	|O
meiosis	|O
I	|O
and	|O
II	|O
,	|O
respectively	|O
)	|O
.	|O

In	|O
epithelial	|O
cells	|O
,	|O
the	|O
PH	|B-PROTEIN
domain	|O
of	|O
Akt	|B-PROTEIN
/	|O
PKB	|B-PROTEIN
localised	|O
to	|O
sites	|O
of	|O
cell	|O
-	|O
cell	|O
and	|O
cell	|O
-	|O
matrix	|O
contact	|O
,	|O
distinct	|O
from	|O
focal	|O
contacts	|O
,	|O
even	|O
in	|O
the	|O
absence	|O
of	|O
serum	|O
.	|O

The	|O
5'	|O
untranslated	|O
and	|O
coding	|O
regions	|O
are	|O
contained	|O
within	|O
12	|O
exons	|O
,	|O
with	|O
the	|O
translation	|O
start	|O
site	|O
located	|O
within	|O
the	|O
first	|O
exon	|O
.	|O

The	|O
motility	|O
of	|O
sperm	|O
,	|O
except	|O
for	|O
those	|O
adjacent	|O
to	|O
both	|O
electrodes	|O
,	|O
did	|O
not	|O
change	|O
after	|O
stimulation	|O
for	|O
60s	|O
,	|O
despite	|O
a	|O
high	|O
electrical	|O
energy	|O
.	|O

Induction	|O
of	|O
the	|O
CINC	|B-PROTEIN
promoter	|O
by	|O
IL	|B-PROTEIN
-	|I-PROTEIN
17	|I-PROTEIN
in	|O
IEC	|O
-	|O
6	|O
cells	|O
was	|O
TNF	|B-PROTEIN
receptor	|I-PROTEIN
-	|I-PROTEIN
associated	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
(	|O
TRAF6	|B-PROTEIN
)	|O
,	|O
but	|O
not	|O
TRAF2	|B-PROTEIN
,	|O
dependent	|O
.	|O

SCFFWD1	|B-PROTEIN
may	|O
be	|O
critical	|O
for	|O
tumor	|O
development	|O
and	|O
suppression	|O
through	|O
regulation	|O
of	|O
beta	|B-PROTEIN
-	|I-PROTEIN
catenin	|I-PROTEIN
protein	|O
stability	|O
.	|O

A	|O
Bub2p	|B-PROTEIN
-	|O
dependent	|O
spindle	|O
checkpoint	|O
pathway	|O
regulates	|O
the	|O
Dbf2p	|B-PROTEIN
kinase	|O
in	|O
budding	|O
yeast	|O
.	|O

We	|O
analyzed	|O
the	|O
modular	|O
organization	|O
of	|O
DNA	|B-PROTEIN
polymerase	|I-PROTEIN
beta	|I-PROTEIN
and	|O
found	|O
that	|O
residues	|O
making	|O
contact	|O
with	|O
DNA	|O
phosphates	|O
were	|O
localized	|O
to	|O
five	|O
modules	|O
.	|O

RESULTS	|O
:	|O
Cholinergic	|O
nerves	|O
are	|O
mainly	|O
involved	|O
in	|O
the	|O
regulation	|O
of	|O
enteric	|O
nerve	|O
responses	|O
to	|O
EFS	|O
in	|O
the	|O
normal	|O
IAS	|O
.	|O

Two	|O
-	|O
dimensional	|O
gel	|O
electrophoresis	|O
of	|O
anti	|B-PROTEIN
-	|I-PROTEIN
p59fyn	|I-PROTEIN
immunoprecipitates	|O
obtained	|O
from	|O
non	|O
-	|O
transformed	|O
resting	|O
human	|O
T	|O
lymphocytes	|O
resulted	|O
in	|O
the	|O
identification	|O
of	|O
an	|O
oligomeric	|O
protein	|O
complex	|O
which	|O
is	|O
constitutively	|O
formed	|O
between	|O
Fyn	|B-PROTEIN
and	|O
several	|O
additional	|O
phosphoproteins	|O
(	|O
pp43	|B-PROTEIN
,	|O
pp72	|B-PROTEIN
,	|O
pp85	|B-PROTEIN
,	|O
the	|O
protein	|B-PROTEIN
tyrosine	|I-PROTEIN
kinase	|I-PROTEIN
Pyk2	|O
,	|O
as	|O
well	|O
as	|O
the	|O
two	|O
recently	|O
cloned	|O
adaptor	|O
proteins	|O
,	|O
SKAP55	|B-PROTEIN
and	|O
SLAP	|B-PROTEIN
-	|I-PROTEIN
130	|I-PROTEIN
)	|O
.	|O

We	|O
show	|O
that	|O
other	|O
cdc33	|B-PROTEIN
mutants	|O
also	|O
arrest	|O
in	|O
G1	|O
.	|O

A	|O
cdc33	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
strain	|O
expressing	|O
either	|O
stable	|O
Cln3p	|B-PROTEIN
(	|O
Cln3	|B-PROTEIN
-	|I-PROTEIN
1p	|I-PROTEIN
)	|O
or	|O
a	|O
hybrid	|O
UBI4	|B-PROTEIN
5'	|O
-	|O
CLN3	|O
mRNA	|O
,	|O
whose	|O
translation	|O
displays	|O
decreased	|O
dependence	|O
on	|O
eIF4E	|B-PROTEIN
,	|O
arrested	|O
randomly	|O
in	|O
the	|O
cell	|O
cycle	|O
.	|O

Regulatory	|O
motifs	|O
for	|O
gene	|O
expression	|O
such	|O
as	|O
nuclear	|B-PROTEIN
-	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
-	|O
binding	|O
-	|O
site	|O
-	|O
like	|O
sequence	|O
(	|O
kappaB	|B-PROTEIN
site	|O
)	|O
and	|O
nuclear	|B-PROTEIN
-	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
interleukin	|I-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
-	|O
binding	|O
-	|O
site	|O
-	|O
like	|O
sequence	|O
(	|O
NF	|B-PROTEIN
-	|I-PROTEIN
IL	|I-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
site	|O
)	|O
were	|O
found	|O
in	|O
the	|O
5'	|O
-	|O
upstream	|O
regulatory	|O
region	|O
.	|O

The	|O
gene	|O
structure	|O
of	|O
Elk1	|B-PROTEIN
spans	|O
15.2	|O
kb	|O
and	|O
consists	|O
of	|O
seven	|O
exons	|O
and	|O
six	|O
introns	|O
.	|O

Total	|O
serum	|O
calcium	|O
was	|O
7.8	|O
+	|O
/	|O
-	|O
0.8	|O
mg	|O
/	|O
dl	|O
,	|O
whereas	|O
ionized	|O
calcium	|O
was	|O
5.7	|O
+	|O
/	|O
-	|O
0.7	|O
mg	|O
/	|O
dl	|O
,	|O
phosphorus	|O
3.2	|O
+	|O
/	|O
-	|O
1.2	|O
mg	|O
/	|O
dl	|O
,	|O
and	|O
alkaline	|B-PROTEIN
phosphatase	|I-PROTEIN
149	|O
+	|O
/	|O
-	|O
48.6	|O
U	|O
/	|O
liter	|O
.	|O

Sequence	|O
analysis	|O
suggests	|O
that	|O
TtrA	|B-PROTEIN
contains	|O
a	|O
molybdopterin	|O
guanine	|O
dinucleotide	|O
cofactor	|O
and	|O
a	|O
[	|O
4Fe	|O
-	|O
4S	|O
]	|O
cluster	|O
,	|O
that	|O
TtrB	|B-PROTEIN
binds	|O
four	|O
[	|O
4Fe	|O
-	|O
4S	|O
]	|O
clusters	|O
,	|O
and	|O
that	|O
TtrC	|B-PROTEIN
is	|O
an	|O
integral	|O
membrane	|O
protein	|O
containing	|O
a	|O
quinol	|O
oxidation	|O
site	|O
.	|O

Cranio	|O
-	|O
caudal	|O
differences	|O
in	|O
granulation	|O
tissue	|O
formation	|O
:	|O
an	|O
experimental	|O
study	|O
in	|O
the	|O
rat	|O
.	|O

Site	|O
-	|O
directed	|O
mutagenesis	|O
showed	|O
that	|O
two	|O
adjacent	|O
SP1	|B-PROTEIN
sites	|O
proximal	|O
to	|O
exon	|O
1	|O
were	|O
equally	|O
important	|O
in	|O
sustaining	|O
basal	|O
promoter	|O
activity	|O
.	|O

Breast	|O
-	|O
fed	|O
newborn	|O
infants	|O
synthesize	|O
n	|O
-	|O
6	|O
long	|O
-	|O
chain	|O
polyunsaturated	|O
fatty	|O
acids	|O
already	|O
during	|O
the	|O
first	|O
week	|O
of	|O
life	|O
,	|O
but	|O
the	|O
contribution	|O
of	|O
endogenous	|O
synthesis	|O
to	|O
the	|O
total	|O
plasma	|O
long	|O
-	|O
chain	|O
polyunsaturated	|O
pool	|O
is	|O
small	|O
.	|O

Ischemia	|O
and	|O
reperfusion	|O
markedly	|O
increased	|O
the	|O
release	|O
of	|O
6	|O
-	|O
keto	|O
-	|O
PGF1	|O
alpha	|O
and	|O
TXB2	|O
.	|O

Prostate	|B-PROTEIN
-	|I-PROTEIN
specific	|I-PROTEIN
antigen	|I-PROTEIN
(	|O
PSA	|B-PROTEIN
)	|O
promoter	|O
-	|O
driven	|O
androgen	|O
-	|O
inducible	|O
expression	|O
of	|O
sodium	|B-PROTEIN
iodide	|I-PROTEIN
symporter	|I-PROTEIN
in	|O
prostate	|O
cancer	|O
cell	|O
lines	|O
.	|O

It	|O
is	|O
clear	|O
that	|O
subclinical	|O
and	|O
silent	|O
CD	|O
exist	|O
in	|O
a	|O
large	|O
subgroup	|O
of	|O
the	|O
celiac	|O
population	|O
.	|O

Ras2p	|B-PROTEIN
activates	|O
invasive	|O
growth	|O
using	|O
either	|O
of	|O
two	|O
downstream	|O
signaling	|O
pathways	|O
,	|O
the	|O
filamentation	|O
MAPK	|B-PROTEIN
(	|O
Cdc42p	|B-PROTEIN
/	|O
Ste20p	|B-PROTEIN
/	|O
MAPK	|B-PROTEIN
)	|O
cascade	|O
or	|O
the	|O
cAMP	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
Cyr1p	|B-PROTEIN
/	|O
cAMP	|O
/	|O
PKA	|B-PROTEIN
)	|O
pathway	|O
.	|O

Consistent	|O
with	|O
this	|O
prediction	|O
,	|O
transfections	|O
into	|O
the	|O
hematopoietic	|O
cell	|O
line	|O
Jurkat	|O
showed	|O
a	|O
9.0	|O
-	|O
and	|O
2.5	|O
-	|O
fold	|O
activation	|O
of	|O
the	|O
mim	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
promoter	|O
by	|O
the	|O
p32	|B-PROTEIN
and	|O
p30	|B-PROTEIN
isoforms	|O
,	|O
respectively	|O
.	|O

Previous	|O
work	|O
has	|O
shown	|O
that	|O
spleen	|B-PROTEIN
necrosis	|I-PROTEIN
virus	|I-PROTEIN
(	|I-PROTEIN
SNV	|I-PROTEIN
)	|I-PROTEIN
long	|I-PROTEIN
terminal	|I-PROTEIN
repeats	|I-PROTEIN
(	|O
LTRs	|O
)	|O
are	|O
associated	|O
with	|O
Rex	|B-PROTEIN
/	|O
Rex	|B-PROTEIN
-	|O
responsive	|O
element	|O
-	|O
independent	|O
expression	|O
of	|O
bovine	|O
leukemia	|O
virus	|O
RNA	|O
and	|O
supports	|O
the	|O
hypothesis	|O
that	|O
SNV	|O
RNA	|O
contains	|O
a	|O
cis	|O
-	|O
acting	|O
element	|O
that	|O
interacts	|O
with	|O
cellular	|O
Rex	|B-PROTEIN
-	|O
like	|O
proteins	|O
.	|O

Despite	|O
the	|O
reported	|O
detrimental	|O
effects	|O
on	|O
CNS	|O
development	|O
,	|O
a	|O
number	|O
of	|O
animal	|O
studies	|O
have	|O
shown	|O
that	|O
pretreatment	|O
with	|O
corticosteroids	|O
nevertheless	|O
protect	|O
the	|O
brain	|O
from	|O
hypoxia	|O
-	|O
ischemic	|O
injury	|O
;	|O
however	|O
,	|O
clinically	|O
such	|O
treatment	|O
is	|O
no	|O
longer	|O
favored	|O
.	|O

In	|O
one	|O
mechanism	|O
,	|O
a	|O
specialized	|O
ubiquitin	|B-PROTEIN
-	|O
dependent	|O
proteolytic	|O
system	|O
(	|O
called	|O
the	|O
APC	|O
-	|O
dependent	|O
proteolysis	|O
machinery	|O
)	|O
degrades	|O
the	|O
mitotic	|O
(	|O
Clb	|B-PROTEIN
)	|O
cyclin	|B-PROTEIN
subunit	|O
.	|O

Predictors	|O
of	|O
success	|O
in	|O
pharmacy	|O
school	|O
:	|O
PCAT	|O
vs.	|O
other	|O
admission	|O
criteria	|O
.	|O

Canadian	|O
survey	|O
reveals	|O
widespread	|O
dissatisfaction	|O
among	|O
physicians	|O
.	|O

In	|O
a	|O
series	|O
of	|O
16	|O
full	|O
-	|O
scale	|O
fire	|O
tests	|O
,	|O
investigators	|O
at	|O
the	|O
IIT	|O
Research	|O
Institute	|O
have	|O
concluded	|O
that	|O
automatic	|O
door	|O
control	|O
in	|O
the	|O
room	|O
of	|O
fire	|O
origin	|O
can	|O
significantly	|O
reduce	|O
the	|O
spread	|O
of	|O
toxic	|O
smoke	|O
and	|O
gases	|O
.	|O

Online	|O
LATCH	|O
demonstrates	|O
a	|O
shift	|O
in	|O
identification	|O
of	|O
the	|O
library	|O
as	|O
an	|O
isolated	|O
unit	|O
to	|O
an	|O
interactive	|O
resource	|O
center	|O
.	|O

Reporting	|O
of	|O
adverse	|O
events	|O
occurring	|O
during	|O
clinical	|O
trials	|O
of	|O
investigational	|O
drugs	|O
is	|O
a	|O
complex	|O
and	|O
controversial	|O
issue	|O
.	|O

Medicare	|O
SNF	|O
benefits	|O
revised	|O
-	|O
-	|O
again	|O
.	|O

In	|O
this	|O
paper	|O
,	|O
the	|O
current	|O
status	|O
of	|O
the	|O
understanding	|O
of	|O
the	|O
interaction	|O
mechanisms	|O
of	|O
ultrasound	|O
with	|O
biological	|O
media	|O
and	|O
the	|O
factors	|O
that	|O
govern	|O
different	|O
biological	|O
effects	|O
are	|O
surveyed	|O
.	|O

Members	|O
of	|O
the	|O
mitogen	|O
activated	|O
protein	|O
(	|B-PROTEIN
MAP	|I-PROTEIN
)	|I-PROTEIN
kinase	|I-PROTEIN
family	|O
,	|O
extracellular	|B-PROTEIN
signal	|I-PROTEIN
-	|I-PROTEIN
regulated	|I-PROTEIN
kinase	|I-PROTEIN
,	|O
stress	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
/	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
NH2	|I-PROTEIN
-	|I-PROTEIN
terminal	|I-PROTEIN
kinase	|I-PROTEIN
,	|O
and	|O
p38	|B-PROTEIN
,	|O
are	|O
central	|O
elements	|O
that	|O
transduce	|O
the	|O
signal	|O
generated	|O
by	|O
growth	|O
factors	|O
,	|O
cytokines	|O
,	|O
and	|O
stressing	|O
agents	|O
.	|O

In	|O
the	|O
present	|O
study	|O
,	|O
we	|O
have	|O
investigated	|O
the	|O
functional	|O
role	|O
of	|O
the	|O
other	|O
MAP	|B-PROTEIN
kinases	|I-PROTEIN
in	|O
PDGF	|B-PROTEIN
-	|O
mediated	|O
cellular	|O
responses	|O
.	|O

Analyses	|O
of	|O
tyrosine	|O
residue	|O
-	|O
mutated	|O
PDGF	|B-PROTEIN
receptors	|O
show	|O
that	|O
Src	|B-PROTEIN
homology	|O
2	|O
domain	|O
-	|O
containing	|O
proteins	|O
including	|O
Src	|B-PROTEIN
family	|O
kinases	|O
,	|O
phosphatidylinositol	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
,	|O
the	|O
GTPase	|B-PROTEIN
-	|I-PROTEIN
activating	|I-PROTEIN
protein	|I-PROTEIN
of	|O
Ras	|B-PROTEIN
,	|O
the	|O
Src	|B-PROTEIN
homology	|O
2	|O
domain	|O
-	|O
containing	|O
phosphatase	|O
SHP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
,	|O
phospholipase	|B-PROTEIN
C	|I-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
,	|O
and	|O
Crk	|B-PROTEIN
do	|O
not	|O
play	|O
a	|O
major	|O
role	|O
in	|O
mediating	|O
the	|O
PDGF	|B-PROTEIN
-	|O
induced	|O
activation	|O
of	|O
p38	|B-PROTEIN
.	|O

Here	|O
we	|O
show	|O
that	|O
calpeptin	|B-PROTEIN
inhibits	|O
tyrosine	|B-PROTEIN
phosphatases	|I-PROTEIN
,	|O
enhancing	|O
tyrosine	|O
phosphorylation	|O
particularly	|O
of	|O
paxillin	|B-PROTEIN
.	|O

Three	|O
-	|O
dimensional	|O
structural	|O
studies	|O
using	|O
electron	|O
cryomicroscopy	|O
showed	|O
that	|O
the	|O
binding	|O
of	|O
one	|O
Fab	|B-PROTEIN
(	|O
8H2	|O
/	|O
G5	|O
)	|O
does	|O
not	|O
affect	|O
the	|O
conformation	|O
of	|O
the	|O
capsid	|O
,	|O
and	|O
the	|O
efficiency	|O
of	|O
mRNA	|O
production	|O
is	|O
similar	|O
to	|O
that	|O
of	|O
the	|O
native	|O
subviral	|O
particle	|O
.	|O

Further	|O
,	|O
mutational	|O
analysis	|O
of	|O
NS5A	|B-PROTEIN
assigned	|O
the	|O
SH3	|B-PROTEIN
-	|O
binding	|O
region	|O
to	|O
a	|O
proline	|O
-	|O
rich	|O
motif	|O
that	|O
is	|O
highly	|O
conserved	|O
among	|O
HCV	|O
genotypes	|O
.	|O

Taken	|O
together	|O
,	|O
these	|O
findings	|O
show	|O
that	|O
16K	|O
hPRL	|B-PROTEIN
inhibits	|O
the	|O
VEGF	|B-PROTEIN
-	|O
induced	|O
Ras	|B-PROTEIN
activation	|O
;	|O
this	|O
antagonism	|O
represents	|O
a	|O
novel	|O
and	|O
potentially	|O
important	|O
mechanism	|O
for	|O
the	|O
control	|O
of	|O
angiogenesis	|O
.	|O

Analysis	|O
of	|O
SRE	|O
oligonucleotide	|O
gel	|O
mobility	|O
shift	|O
assays	|O
with	|O
nuclear	|O
extracts	|O
from	|O
Sertoli	|O
cells	|O
demonstrated	|O
the	|O
presence	|O
of	|O
both	|O
the	|O
SRF	|B-PROTEIN
and	|O
the	|O
ubiquitously	|O
expressed	|O
bHLH	|O
protein	|O
E12	|B-PROTEIN
/	|O
E47	|B-PROTEIN
.	|O

We	|O
calculated	|O
differences	|O
in	|O
late	|O
occlusion	|O
rates	|O
by	|O
the	|O
chi2	|O
(	|O
chi	|O
-	|O
square	|O
)	|O
test	|O
,	|O
and	|O
found	|O
these	|O
differences	|O
were	|O
significant	|O
(	|O
P	|O
=	|O
.04	|O
)	|O
.	|O

Baseline	|O
electrocorticography	|O
over	|O
the	|O
surface	|O
of	|O
the	|O
temporal	|O
lobe	|O
and	|O
depth	|O
electrode	|O
recordings	|O
in	|O
the	|O
amygdala	|O
and	|O
hippocampus	|O
were	|O
obtained	|O
,	|O
followed	|O
by	|O
10	|O
min	|O
of	|O
recording	|O
before	|O
and	|O
after	|O
the	|O
i.v	|O
.	|O
administration	|O
of	|O
both	|O
alfentanil	|O
50	|O
microg	|O
/	|O
kg	|O
and	|O
fentanyl	|O
10	|O
microg	|O
/	|O
kg	|O
.	|O

We	|O
describe	|O
a	|O
genetic	|O
system	|O
for	|O
further	|O
characterizing	|O
the	|O
role	|O
of	|O
the	|O
extreme	|O
C	|O
-	|O
terminus	|O
of	|O
the	|O
beta	|O
subunit	|O
of	|O
E.	|O
coli	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
.	|O

We	|O
suggest	|O
that	|O
FlgN	|B-PROTEIN
and	|O
FliT	|B-PROTEIN
are	|O
substrate	|O
-	|O
specific	|O
flagellar	|O
chaperones	|O
that	|O
prevent	|O
oligomerization	|O
of	|O
the	|O
HAPs	|B-PROTEIN
by	|O
binding	|O
to	|O
their	|O
helical	|O
domains	|O
before	|O
export	|O
.	|O

Post	|O
and	|O
core	|O
fabrication	|O
for	|O
divergent	|O
canals	|O
with	|O
a	|O
cast	|O
post	|O
and	|O
core	|O
and	|O
a	|O
prefabricated	|O
dowel	|O
.	|O

Rep63A	|B-PROTEIN
(	|O
513	|O
amino	|O
acids	|O
[	|O
aa	|O
]	|O
)	|O
,	|O
encoded	|O
by	|O
the	|O
largest	|O
ORF	|O
,	|O
displayed	|O
strong	|O
similarity	|O
(	|O
40%	|O
identity	|O
)	|O
to	|O
the	|O
replication	|O
proteins	|O
from	|O
plasmids	|O
pAMbeta1	|O
,	|O
pIP501	|O
,	|O
and	|O
pSM19035	|O
,	|O
indicating	|O
that	|O
the	|O
pAW63	|O
replicon	|O
belongs	|O
to	|O
the	|O
pAMbeta1	|O
family	|O
of	|O
gram	|O
-	|O
positive	|O
theta	|O
-	|O
replicating	|O
plasmids	|O
.	|O

Here	|O
we	|O
report	|O
the	|O
cloning	|O
and	|O
characterization	|O
of	|O
Xenopus	|O
Pax	|B-PROTEIN
-	|I-PROTEIN
5	|I-PROTEIN
and	|O
Pax	|B-PROTEIN
-	|I-PROTEIN
8	|I-PROTEIN
,	|O
two	|O
orthologues	|O
of	|O
the	|O
Pax	|B-PROTEIN
-	|I-PROTEIN
2/5/8	|I-PROTEIN
gene	|O
family	|O
.	|O

Km	|O
values	|O
for	|O
ammonium	|O
,	|O
2	|O
-	|O
oxoglutarate	|O
,	|O
NADH	|O
,	|O
glutamate	|O
and	|O
NAD+	|O
were	|O
6.5	|O
,	|O
3.5	|O
,	|O
0.06	|O
,	|O
37.1	|O
and	|O
0.046	|O
mM	|O
,	|O
respectively	|O
.	|O

Interferon	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
may	|O
exacerbate	|O
cryoblobulinemia	|O
-	|O
related	|O
ischemic	|O
manifestations	|O
:	|O
an	|O
adverse	|O
effect	|O
potentially	|O
related	|O
to	|O
its	|O
anti	|O
-	|O
angiogenic	|O
activity	|O
.	|O

Interferon	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
may	|O
exacerbate	|O
cryoblobulinemia	|O
-	|O
related	|O
ischemic	|O
manifestations	|O
:	|O
an	|O
adverse	|O
effect	|O
potentially	|O
related	|O
to	|O
its	|O
anti	|O
-	|O
angiogenic	|O
activity	|O
.	|O

In	|O
addition	|O
,	|O
we	|O
demonstrate	|O
that	|O
the	|O
production	|O
of	|O
active	|O
recombinant	|O
telomerase	|B-PROTEIN
requires	|O
a	|O
factor	|O
in	|O
rabbit	|O
reticulocyte	|O
lysate	|O
that	|O
promotes	|O
ribonucleoprotein	|O
assembly	|O
.	|O

The	|O
enhanced	|O
binding	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
Abl	|I-PROTEIN
to	|O
DNA	|O
containing	|O
5	|O
-	|O
methylcytosine	|O
residues	|O
may	|O
result	|O
from	|O
an	|O
increased	|O
propensity	|O
of	|O
the	|O
double	|O
helix	|O
to	|O
denature	|O
locally	|O
coupled	|O
with	|O
a	|O
protein	|O
-	|O
induced	|O
reduction	|O
in	|O
the	|O
base	|O
stacking	|O
interaction	|O
.	|O

Homozygous	|O
mutation	|O
in	|O
two	|O
children	|O
led	|O
to	|O
amputation	|O
of	|O
legs	|O
due	|O
to	|O
purpura	|O
fulminans	|O
.	|O

According	|O
to	|O
pilot	|O
experiments	|O
which	|O
considered	|O
various	|O
durations	|O
of	|O
global	|O
no	|O
-	|O
flow	|O
ischemia	|O
ranging	|O
from	|O
10	|O
to	|O
20	|O
minutes	|O
,	|O
two	|O
durations	|O
were	|O
chosen	|O
for	|O
the	|O
present	|O
study	|O
:	|O
20	|O
minutes	|O
(	|O
group	|O
20	|O
)	|O
in	|O
which	|O
ventricular	|O
fibrillation	|O
(	|O
VF	|O
)	|O
was	|O
the	|O
predominant	|O
form	|O
of	|O
arrhythmias	|O
,	|O
and	|O
18	|O
minutes	|O
(	|O
group	|O
18	|O
)	|O
in	|O
which	|O
the	|O
prevalence	|O
of	|O
VF	|O
was	|O
markedly	|O
lower	|O
despite	|O
the	|O
small	|O
difference	|O
in	|O
the	|O
duration	|O
of	|O
ischemia	|O
.	|O

An	|O
end	|O
-	|O
to	|O
-	|O
end	|O
pancreaticojejunostomy	|O
using	|O
a	|O
mechanical	|O
purse	|O
-	|O
string	|O
device	|O
.	|O

We	|O
further	|O
demonstrate	|O
that	|O
the	|O
Stress	|B-PROTEIN
-	|I-PROTEIN
Activated	|I-PROTEIN
-	|I-PROTEIN
Protein	|I-PROTEIN
-	|I-PROTEIN
Kinase	|I-PROTEIN
(	|O
SAPK	|B-PROTEIN
)	|O
target	|O
sites	|O
of	|O
ATF2	|B-PROTEIN
,	|O
Thr69	|O
and	|O
Thr71	|O
are	|O
not	|O
required	|O
for	|O
the	|O
formation	|O
of	|O
the	|O
p300	|B-PROTEIN
/	|O
CBP	|B-PROTEIN
-	|O
ATF2	|B-PROTEIN
multiprotein	|O
complex	|O
.	|O

Blood	|O
samples	|O
were	|O
obtained	|O
daily	|O
during	|O
this	|O
supplementation	|O
period	|O
and	|O
5	|O
d	|O
thereafter	|O
(	|O
d	|O
11	|O
to	|O
15	|O
)	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
mitochondrial	|O
presequences	|O
interact	|O
with	|O
the	|O
mt	|B-PROTEIN
-	|I-PROTEIN
hsp70	|I-PROTEIN
during	|O
or	|O
after	|O
mitochondrial	|O
protein	|O
import	|O
.	|O

The	|O
3'	|O
terminus	|O
of	|O
the	|O
genome	|O
can	|O
be	|O
folded	|O
into	|O
a	|O
tRNA	|O
-	|O
like	|O
secondary	|O
structure	|O
that	|O
has	|O
a	|O
valine	|O
anticodon	|O
;	|O
the	|O
tRNA	|O
-	|O
like	|O
structure	|O
lacks	|O
a	|O
pseudoknot	|O
in	|O
the	|O
aminoacyl	|O
stem	|O
,	|O
a	|O
feature	|O
common	|O
to	|O
both	|O
genera	|O
of	|O
tetraviruses	|O
.	|O

O.	|O
novo	|O
-	|O
ulmi	|O
RNA	|B-PROTEIN
-	|I-PROTEIN
7	|I-PROTEIN
,	|O
previously	|O
believed	|O
to	|O
be	|O
a	|O
satellite	|O
-	|O
like	|O
RNA	|O
,	|O
is	|O
shown	|O
to	|O
be	|O
a	|O
defective	|O
RNA	|O
,	|O
derived	|O
from	|O
OnuMV4	|B-PROTEIN
-	|I-PROTEIN
Ld	|I-PROTEIN
RNA	|O
by	|O
multiple	|O
internal	|O
deletions	|O
.	|O

Only	|O
one	|O
gene	|O
,	|O
fibronectin	|B-PROTEIN
(	|O
FN	|B-PROTEIN
)	|O
,	|O
was	|O
highly	|O
overexpressed	|O
(	|O
>	|O
60	|O
-	|O
fold	|O
)	|O
in	|O
LNCaP	|O
-	|O
r	|O
cells	|O
,	|O
consistent	|O
with	|O
previously	|O
reported	|O
overexpression	|O
of	|O
FN	|B-PROTEIN
in	|O
prostate	|O
cancer	|O
.	|O

We	|O
also	|O
observed	|O
that	|O
cell	|O
surface	|O
CD4	|B-PROTEIN
(	|O
-	|O
)	|O
CD8	|B-PROTEIN
(	|O
-	|O
)	|O
CD3	|B-PROTEIN
(	|O
-	|O
)	|O
cells	|O
with	|O
rearranged	|O
TCR	|B-PROTEIN
genes	|O
developed	|O
from	|O
Id3	|B-PROTEIN
-	|O
transduced	|O
but	|O
not	|O
from	|O
control	|O
-	|O
transduced	|O
pre	|O
-	|O
T	|O
cells	|O
in	|O
an	|O
FTOC	|O
.	|O

As	|O
determined	|O
in	|O
a	|O
modified	|O
yeast	|O
two	|O
-	|O
hybrid	|O
system	|O
,	|O
mIRS3	|B-PROTEIN
bound	|O
strongly	|O
to	|O
the	|O
p85	|B-PROTEIN
subunit	|O
of	|O
phosphatidylinositol	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
.	|O

Insulin	|B-PROTEIN
stimulation	|O
promoted	|O
the	|O
association	|O
of	|O
mIRS3	|B-PROTEIN
with	|O
p85	|B-PROTEIN
,	|O
SHP2	|B-PROTEIN
,	|O
Nck	|B-PROTEIN
,	|O
and	|O
Shc	|B-PROTEIN
.	|O

The	|O
mRNA	|O
expression	|O
of	|O
RFX1	|B-PROTEIN
,	|O
RFX2	|B-PROTEIN
,	|O
and	|O
RFX3	|B-PROTEIN
was	|O
detected	|O
ubiquitously	|O
,	|O
but	|O
in	|O
transient	|O
-	|O
transfection	|O
assays	|O
,	|O
multimerized	|O
RFX	|B-PROTEIN
binding	|O
sites	|O
in	|O
front	|O
of	|O
a	|O
basal	|O
promoter	|O
efficiently	|O
functioned	|O
in	|O
a	|O
tissue	|O
-	|O
and	|O
lineage	|O
-	|O
specific	|O
manner	|O
.	|O

In	|O
the	|O
case	|O
of	|O
the	|O
unspliceable	|O
intron	|O
,	|O
repression	|O
of	|O
luciferase	|B-PROTEIN
expression	|O
likely	|O
involved	|O
two	|O
AUF1	|B-PROTEIN
-	|O
binding	|O
sequences	|O
,	|O
since	|O
luciferase	|B-PROTEIN
expression	|O
was	|O
increased	|O
by	|O
deletion	|O
of	|O
these	|O
sites	|O
.	|O

Thus	|O
,	|O
VDR	|B-PROTEIN
acts	|O
selectively	|O
on	|O
the	|O
two	|O
components	|O
required	|O
for	|O
activation	|O
of	|O
this	|O
promoter	|O
/	|O
enhancer	|O
:	|O
it	|O
competes	|O
with	|O
NFAT1	|B-PROTEIN
for	|O
binding	|O
to	|O
the	|O
composite	|O
site	|O
,	|O
positioning	|O
itself	|O
adjacent	|O
to	|O
Jun	|B-PROTEIN
-	|O
Fos	|B-PROTEIN
on	|O
the	|O
DNA	|O
.	|O

Two	|O
evolutionarily	|O
conserved	|O
kinases	|O
,	|O
the	|O
cyclin	|B-PROTEIN
B	|I-PROTEIN
(	|O
Clb	|B-PROTEIN
)	|O
/	|O
cyclin	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
Cdk	|B-PROTEIN
/	|O
Cdc28p	|B-PROTEIN
)	|O
and	|O
Cdc7p	|B-PROTEIN
along	|O
with	|O
its	|O
interacting	|O
factor	|O
Dbf4p	|B-PROTEIN
,	|O
are	|O
required	|O
late	|O
in	|O
G1	|O
to	|O
initiate	|O
DNA	|O
replication	|O
.	|O

The	|O
RanQ69L	|B-PROTEIN
preincubation	|O
leads	|O
to	|O
accumulation	|O
of	|O
CRM1	|B-PROTEIN
at	|O
the	|O
cytoplasmic	|O
periphery	|O
of	|O
the	|O
nuclear	|O
pore	|O
complex	|O
(	|O
NPC	|O
)	|O
in	|O
association	|O
with	|O
the	|O
p62	|B-PROTEIN
complex	|O
and	|O
Can	|B-PROTEIN
/	|O
Nup214	|B-PROTEIN
.	|O

All	|O
of	|O
the	|O
elements	|O
exhibited	|O
a	|O
uniform	|O
structure	|O
.	|O

In	|O
contrast	|O
,	|O
the	|O
deduced	|O
amino	|O
acid	|O
sequence	|O
of	|O
a	|O
second	|O
family	|O
(	|O
ART5	|B-PROTEIN
)	|O
of	|O
transferases	|O
,	|O
cloned	|O
from	|O
murine	|O
lymphoma	|O
cells	|O
and	|O
expressed	|O
in	|O
high	|O
abundance	|O
in	|O
testis	|O
,	|O
displays	|O
a	|O
hydrophobic	|O
amino	|O
terminus	|O
,	|O
consistent	|O
with	|O
a	|O
signal	|O
sequence	|O
,	|O
but	|O
lacks	|O
a	|O
hydrophobic	|O
signal	|O
sequence	|O
at	|O
its	|O
carboxyl	|O
terminus	|O
,	|O
suggesting	|O
that	|O
the	|O
protein	|O
is	|O
destined	|O
for	|O
export	|O
.	|O

RESULTS	|O
:	|O
Each	|O
year	|O
,	|O
on	|O
average	|O
39%	|O
of	|O
cases	|O
seen	|O
in	|O
Sardinia	|O
are	|O
notified	|O
;	|O
646	|O
(	|O
40%	|O
)	|O
of	|O
the	|O
1591	|O
patients	|O
notified	|O
during	|O
the	|O
study	|O
period	|O
were	|O
never	|O
seen	|O
by	|O
regional	|O
medical	|O
centres	|O
.	|O

This	|O
dimer	|O
interface	|O
is	|O
likely	|O
important	|O
for	|O
increasing	|O
the	|O
DNA	|O
-	|O
binding	|O
specificity	|O
and	|O
affinity	|O
of	|O
the	|O
trimeric	|O
form	|O
of	|O
HSF	|B-PROTEIN
,	|O
as	|O
well	|O
as	|O
for	|O
increasing	|O
cooperativity	|O
between	|O
adjacent	|O
trimers	|O
.	|O

The	|O
paramyxovirus	|O
fusion	|O
(	|B-PROTEIN
F	|I-PROTEIN
)	|I-PROTEIN
protein	|I-PROTEIN
mediates	|O
membrane	|O
fusion	|O
.	|O

Additionally	|O
,	|O
deletion	|O
analysis	|O
of	|O
the	|O
UCP2	|B-PROTEIN
promoter	|O
-	|O
PLAP	|B-PROTEIN
constructs	|O
indicated	|O
that	|O
the	|O
minimal	|O
region	|O
exhibiting	|O
the	|O
promoter	|O
activity	|O
was	|O
located	|O
between	|O
nt	|O
-	|O
33	|O
and	|O
+	|O
100	|O
,	|O
and	|O
that	|O
a	|O
strong	|O
enhancer	|O
was	|O
present	|O
within	|O
601	|O
bp	|O
of	|O
the	|O
5'	|O
-	|O
promoter	|O
region	|O
.	|O

The	|O
hTERT	|B-PROTEIN
gene	|O
encompasses	|O
more	|O
than	|O
37kb	|O
and	|O
consists	|O
of	|O
16	|O
exons	|O
.	|O

Both	|O
betaAPP	|B-PROTEIN
mRNA	|O
and	|O
Abeta	|B-PROTEIN
levels	|O
are	|O
increased	|O
in	|O
trisomy	|O
21	|O
.	|O

In	|O
reperfusion	|O
B	|O
,	|O
only	|O
the	|O
diabetic	|O
group	|O
demonstrated	|O
a	|O
significant	|O
increase	|O
in	|O
IL	|B-PROTEIN
-	|I-PROTEIN
8	|I-PROTEIN
concentrations	|O
at	|O
1	|O
and	|O
15	|O
min	|O
compared	|O
to	|O
nondiabetics	|O
.	|O

This	|O
repression	|O
was	|O
reversed	|O
agonists	|O
of	|O
either	|O
receptor	|O
demonstrating	|O
a	|O
functional	|O
interaction	|O
between	|O
NCoR	|B-PROTEIN
and	|O
PPARalpha.R	|B-PROTEIN
XRalpha	|O
heterodimeric	|O
complexes	|O
in	|O
mammalian	|O
cells	|O
.	|O

In	|O
the	|O
present	|O
study	|O
,	|O
we	|O
show	|O
that	|O
SRm160/300	|B-PROTEIN
is	|O
required	|O
for	|O
a	|O
purine	|O
-	|O
rich	|O
ESE	|B-PROTEIN
to	|O
promote	|O
the	|O
splicing	|O
of	|O
a	|O
pre	|O
-	|O
mRNA	|O
derived	|O
from	|O
the	|O
Drosophila	|O
doublesex	|B-PROTEIN
gene	|O
.	|O

Spc42p	|B-PROTEIN
also	|O
was	|O
identified	|O
as	|O
a	|O
component	|O
of	|O
a	|O
cytoplasmic	|O
SPB	|O
subcomplex	|O
containing	|O
Spc94p	|B-PROTEIN
/	|O
Nud1p	|B-PROTEIN
,	|O
Cnm67p	|B-PROTEIN
,	|O
and	|O
Spc42p	|B-PROTEIN
.	|O

The	|O
average	|O
coefficients	|O
of	|O
correlation	|O
were	|O
0.9998	|O
and	|O
0.9993	|O
for	|O
the	|O
QMF	|O
and	|O
the	|O
QIT	|O
system	|O
,	|O
respectively	|O
.	|O

The	|O
5	|O
-	|O
year	|O
OS	|O
for	|O
stage	|O
IIIB	|O
was	|O
30.9%	|O
,	|O
compared	|O
to	|O
7.8%	|O
for	|O
stage	|O
IV	|O
.	|O

Furthermore	|O
,	|O
heparin	|B-PROTEIN
lyase	|I-PROTEIN
treatment	|O
of	|O
extracts	|O
of	|O
cells	|O
expressing	|O
recombinant	|O
YD	|B-PROTEIN
-	|I-PROTEIN
repeat	|I-PROTEIN
protein	|O
releases	|O
this	|O
protein	|O
from	|O
high	|O
molecular	|O
mass	|O
aggregates	|O
.	|O

The	|O
coefficient	|O
of	|O
determination	|O
,	|O
r2	|O
,	|O
of	|O
the	|O
other	|O
scores	|O
ranged	|O
from	|O
0.56	|O
to	|O
0.61	|O
.	|O

While	|O
determination	|O
of	|O
the	|O
protein	|O
content	|O
of	|O
the	|O
formulae	|O
gave	|O
no	|O
valid	|O
information	|O
,	|O
RAST	|O
/	|O
EAST	|O
inhibition	|O
was	|O
highest	|O
for	|O
cow	|O
's	|O
milk	|O
,	|O
followed	|O
by	|O
the	|O
partially	|O
hydrolysed	|O
whey	|O
formula	|O
,	|O
partially	|O
hydrolysed	|O
whey	|O
/	|O
casein	|B-PROTEIN
formula	|O
,	|O
soy	|O
/	|O
pork	|O
collagen	|B-PROTEIN
formula	|O
,	|O
and	|O
the	|O
amino	|O
acid	|O
formula	|O
.	|O

In	|O
light	|O
of	|O
the	|O
importance	|O
of	|O
GnRHR	|B-PROTEIN
,	|O
the	|O
molecular	|O
mechanisms	|O
underlying	|O
the	|O
transcriptional	|O
regulation	|O
of	|O
the	|O
human	|O
GnRHR	|B-PROTEIN
(	|O
hGnRHR	|B-PROTEIN
)	|O
gene	|O
become	|O
a	|O
key	|O
issue	|O
in	|O
understanding	|O
human	|O
reproduction	|O
.	|O

Competitive	|O
mobility	|O
shift	|O
assays	|O
using	|O
either	|O
alphaT3	|O
-	|O
1	|O
nuclear	|O
extract	|O
or	|O
recombinant	|O
SF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
protein	|O
clearly	|O
indicated	|O
that	|O
SF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
able	|O
to	|O
interact	|O
specifically	|O
with	|O
this	|O
GSE	|B-PROTEIN
element	|O
positioned	|O
at	|O
-	|O
134	|O
.	|O

Grade	|O
3	|O
mucositis	|O
was	|O
reported	|O
in	|O
1	|O
patient	|O
.	|O

CDK4	|B-PROTEIN
kinase	|O
activities	|O
were	|O
unaffected	|O
,	|O
as	|O
were	|O
the	|O
levels	|O
of	|O
the	|O
CDK	|B-PROTEIN
inhibitor	|O
p21Cip1	|B-PROTEIN
present	|O
in	|O
cyclin	|B-PROTEIN
E	|I-PROTEIN
immunocomplexes	|O
.	|O

The	|O
recombinant	|O
purified	|O
protein	|O
expressed	|O
in	|O
the	|O
baculovirus	|O
system	|O
had	|O
an	|O
approximate	|O
molecular	|O
size	|O
20	|O
kDa	|O
with	|O
amino	|O
-	|O
terminal	|O
sequence	|O
of	|O
AVQGP	|O
.	|O

Induction	|O
of	|O
the	|O
urokinase	|B-PROTEIN
promoter	|O
by	|O
HGF	|B-PROTEIN
/	|O
SF	|B-PROTEIN
via	|O
the	|O
Met	|B-PROTEIN
receptor	|I-PROTEIN
was	|O
blocked	|O
by	|O
co	|O
-	|O
expression	|O
of	|O
a	|O
dominant	|O
-	|O
negative	|O
Grb2	|B-PROTEIN
and	|O
Sos1	|B-PROTEIN
expression	|O
construct	|O
.	|O

Serine	|O
phosphorylation	|O
of	|O
STAT3	|B-PROTEIN
was	|O
only	|O
apparent	|O
after	|O
somatostatin	|B-PROTEIN
treatment	|O
and	|O
was	|O
abolished	|O
by	|O
pertussis	|B-PROTEIN
toxin	|I-PROTEIN
or	|O
PD	|O
98059	|O
,	|O
together	|O
with	|O
the	|O
associated	|O
increases	|O
in	|O
proliferation	|O
.	|O

Nevertheless	|O
,	|O
we	|O
demonstrate	|O
that	|O
the	|O
entire	|O
three	|O
-	|O
component	|O
yeast	|O
capping	|O
apparatus	|O
,	|O
consisting	|O
of	|O
RNA	|B-PROTEIN
5'	|I-PROTEIN
-	|I-PROTEIN
triphosphatase	|I-PROTEIN
(	|O
Cet1p	|B-PROTEIN
)	|O
,	|O
RNA	|B-PROTEIN
guanylyltransferase	|I-PROTEIN
(	|O
Ceg1p	|B-PROTEIN
)	|O
,	|O
and	|O
Abd1p	|B-PROTEIN
could	|O
be	|O
replaced	|O
in	|O
vivo	|O
by	|O
the	|O
two	|O
-	|O
component	|O
mammalian	|O
apparatus	|O
consisting	|O
of	|O
a	|O
bifunctional	|O
triphosphatase	|O
-	|O
guanylyltransferase	|O
Mce1p	|B-PROTEIN
and	|O
the	|O
methyltransferase	|O
Hcm1	|B-PROTEIN
(	|I-PROTEIN
121-476	|I-PROTEIN
)	|I-PROTEIN
p	|I-PROTEIN
.	|O

The	|O
IC50	|O
values	|O
for	|O
rat	|O
and	|O
dog	|O
urinary	|O
bladder	|O
were	|O
3.9	|O
x	|O
10	|O
(	|O
-	|O
6	|O
)	|O
M	|O
and	|O
3.8	|O
x	|O
10	|O
(	|O
-	|O
6	|O
)	|O
M	|O
,	|O
respectively	|O
.	|O

Although	|O
it	|O
has	|O
two	|O
potential	|O
binding	|O
sites	|O
,	|O
the	|O
purified	|O
MerR	|B-PROTEIN
homodimer	|O
binds	|O
only	|O
one	|O
Hg	|O
(	|O
II	|O
)	|O
ion	|O
,	|O
employing	|O
Cys82	|O
from	|O
one	|O
monomer	|O
and	|O
Cys117	|O
and	|O
Cys126	|O
from	|O
the	|O
other	|O
.	|O

The	|O
influence	|O
of	|O
Epstein	|O
-	|O
Barr	|O
virus	|O
seropositivity	|O
on	|O
the	|O
efficacy	|O
of	|O
intravenous	|O
immune	|B-PROTEIN
globulin	|I-PROTEIN
in	|O
children	|O
with	|O
immune	|O
thrombocytopenic	|O
purpura	|O
.	|O

The	|O
results	|O
of	|O
the	|O
lab	|O
and	|O
field	|O
tests	|O
yielded	|O
high	|O
levels	|O
of	|O
infestation	|O
in	|O
larvae	|O
with	|O
values	|O
ranging	|O
from	|O
90	|O
to	|O
100%	|O
and	|O
from	|O
85	|O
to	|O
95%	|O
,	|O
respectively	|O
.	|O

Amisulpride	|O
400	|O
mg	|O
had	|O
several	|O
adverse	|O
effects	|O
on	|O
psychomotor	|O
and	|O
,	|O
although	|O
less	|O
severe	|O
,	|O
on	|O
cognitive	|O
performance	|O
on	|O
the	|O
fifth	|O
day	|O
only	|O
.	|O

MutY	|B-PROTEIN
is	|O
an	|O
adenine	|B-PROTEIN
-	|I-PROTEIN
DNA	|I-PROTEIN
glycosylase	|I-PROTEIN
with	|O
specificity	|O
for	|O
mismatches	|O
involving	|O
8	|O
-	|O
oxoguanine	|O
(	|O
oG.A	|O
)	|O
or	|O
guanine	|O
(	|O
G.A	|O
)	|O
.	|O

The	|O
kinetics	|O
of	|O
kinase	|O
activity	|O
within	|O
these	|O
complexes	|O
compared	|O
to	|O
CheA	|B-PROTEIN
alone	|O
indicate	|O
approximately	|O
a	|O
50%	|O
decrease	|O
in	|O
the	|O
KM	|O
for	|O
ATP	|O
and	|O
a	|O
100	|O
-	|O
fold	|O
increase	|O
in	|O
the	|O
Vmax	|O
.	|O

Latexin	|B-PROTEIN
,	|O
a	|O
carboxypeptidase	|B-PROTEIN
A	|I-PROTEIN
inhibitor	|O
,	|O
is	|O
expressed	|O
in	|O
a	|O
cell	|O
type	|O
-	|O
specific	|O
manner	|O
in	|O
both	|O
central	|O
and	|O
peripheral	|O
nervous	|O
systems	|O
in	|O
the	|O
rat	|O
.	|O

Regression	|O
analyses	|O
identified	|O
7	|O
risk	|O
and	|O
7	|O
protective	|O
factors	|O
with	|O
minimal	|O
overlap	|O
.	|O

During	|O
1985	|O
,	|O
1990	|O
,	|O
and	|O
1995	|O
,	|O
respectively	|O
,	|O
11.7	|O
,	|O
11.3	|O
,	|O
and	|O
11.4	|O
infants	|O
per	|O
100,000	|O
live	|O
births	|O
had	|O
a	|O
diagnosis	|O
of	|O
HSV	|O
(	|O
P	|O
=	|O
.98	|O
)	|O
.	|O

Subsets	|O
of	|O
patients	|O
were	|O
performed	|O
according	|O
to	|O
the	|O
severity	|O
of	|O
trauma	|O
(	|O
ISS	|O
<	|O
9	|O
;	|O
9-17	|O
;	|O
18-31	|O
;	|O
>	|O
32	|O
)	|O
,	|O
based	|O
on	|O
the	|O
different	|O
injury	|O
pattern	|O
,	|O
and	|O
survivors	|O
versus	|O
nonsurvivors	|O
as	|O
well	|O
.	|O

The	|O
median	|O
age	|O
was	|O
33	|O
years	|O
(	|O
range	|O
17-56	|O
years	|O
)	|O
.	|O

Developmental	|O
follow	|O
-	|O
up	|O
at	|O
age	|O
2	|O
years	|O
was	|O
performed	|O
.	|O

In	|O
the	|O
whole	|O
group	|O
of	|O
infected	|O
children	|O
,	|O
an	|O
age	|O
-	|O
specific	|O
z	|O
score	|O
<	|O
-	|O
2	|O
for	|O
weight	|O
and	|O
for	|O
FFM	|O
was	|O
significantly	|O
associated	|O
with	|O
an	|O
increased	|O
risk	|O
of	|O
death	|O
[	|O
relative	|O
risk	|O
(	|O
95%	|O
CI	|O
)	|O
=	|O
11.4	|O
(	|O
3.1	|O
,	|O
41.0	|O
)	|O
and	|O
5.1	|O
(	|O
1.5	|O
,	|O
18.2	|O
)	|O
,	|O
respectively	|O
]	|O
;	|O
when	|O
only	|O
children	|O
with	|O
more	|O
severe	|O
disease	|O
were	|O
considered	|O
,	|O
only	|O
z	|O
score	|O
for	|O
weight	|O
was	|O
significantly	|O
associated	|O
with	|O
an	|O
increased	|O
risk	|O
[	|O
4.6	|O
(	|O
1.4	|O
,	|O
14.9	|O
)	|O
]	|O
.	|O

In	|O
addition	|O
,	|O
these	|O
cells	|O
contained	|O
one	|O
,	|O
two	|O
,	|O
or	|O
multiple	|O
nuclei	|O
indicative	|O
of	|O
a	|O
G2	|O
/	|O
M	|O
delay	|O
in	|O
nuclear	|O
division	|O
and	|O
also	|O
a	|O
defect	|O
in	|O
cytokinesis	|O
and	|O
/	|O
or	|O
cell	|O
separation	|O
.	|O

DAF16	|B-PROTEIN
is	|O
known	|O
to	|O
be	|O
a	|O
component	|O
of	|O
a	|O
signaling	|O
pathway	|O
that	|O
has	|O
been	|O
partially	|O
dissected	|O
genetically	|O
and	|O
includes	|O
homologues	|O
of	|O
the	|O
insulin	|B-PROTEIN
/	|O
IGF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
receptor	|I-PROTEIN
,	|O
PtdIns	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
and	|O
PKB	|B-PROTEIN
.	|O

However	|O
,	|O
neu	|B-PROTEIN
differentiation	|O
factor	|O
-	|O
induced	|O
heterodimers	|O
of	|O
ErbB2	|B-PROTEIN
and	|O
ErbB4	|B-PROTEIN
activated	|O
Stat5	|B-PROTEIN
.	|O

Although	|O
linker	|O
regions	|O
in	|O
transcription	|O
factors	|O
are	|O
known	|O
to	|O
modulate	|O
DNA	|O
binding	|O
specificity	|O
,	|O
our	|O
studies	|O
suggest	|O
that	|O
the	|O
human	|O
HSF1	|B-PROTEIN
linker	|O
plays	|O
no	|O
role	|O
in	|O
determining	|O
HSF1	|B-PROTEIN
binding	|O
preferences	|O
in	|O
vivo	|O
but	|O
is	|O
a	|O
critical	|O
determinant	|O
in	|O
regulating	|O
the	|O
HSF1	|B-PROTEIN
monomer	|O
-	|O
trimer	|O
equilibrium	|O
.	|O

Modulation	|O
of	|O
human	|O
heat	|B-PROTEIN
shock	|I-PROTEIN
factor	|I-PROTEIN
trimerization	|O
by	|O
the	|O
linker	|O
domain	|O
.	|O

Both	|O
functional	|O
analyses	|O
in	|O
undifferentiated	|O
and	|O
differentiated	|O
F9	|O
cells	|O
and	|O
characterization	|O
of	|O
DNA	|O
-	|O
protein	|O
complexes	|O
in	|O
vitro	|O
have	|O
identified	|O
the	|O
sequence	|O
motifs	|O
GTGACT	|O
(	|O
C	|O
)	|O
,	|O
ATTGT	|O
,	|O
and	|O
GATA	|O
as	|O
the	|O
key	|O
transcription	|O
factor	|O
binding	|O
sites	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
the	|O
phenotype	|O
of	|O
XLP	|O
may	|O
result	|O
from	|O
perturbed	|O
signaling	|O
not	|O
only	|O
through	|O
SLAM	|B-PROTEIN
,	|O
but	|O
also	|O
other	|O
cell	|O
surface	|O
molecules	|O
that	|O
utilize	|O
SAP	|B-PROTEIN
as	|O
a	|O
signaling	|O
adaptor	|O
protein	|O
.	|O

We	|O
also	|O
localized	|O
the	|O
Fra	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
phosphorylation	|O
sites	|O
by	|O
MAPK	|B-PROTEIN
to	|O
three	|O
threonine	|O
and	|O
three	|O
serine	|O
residues	|O
in	|O
the	|O
COOH	|O
-	|O
terminal	|O
region	|O
by	|O
means	|O
of	|O
site	|O
-	|O
directed	|O
mutagenesis	|O
and	|O
showed	|O
that	|O
the	|O
threonine	|O
residues	|O
were	|O
more	|O
susceptible	|O
to	|O
MAPK	|B-PROTEIN
.	|O

Nevertheless	|O
,	|O
they	|O
are	|O
functionally	|O
distinct	|O
in	|O
that	|O
FcalphaRI	|B-PROTEIN
binds	|O
human	|O
IgA	|B-PROTEIN
(	|O
hIgA	|B-PROTEIN
)	|O
but	|O
not	|O
bovine	|O
IgG2	|B-PROTEIN
(	|O
bIgG2	|B-PROTEIN
)	|O
,	|O
whereas	|O
bFcgamma2R	|B-PROTEIN
binds	|O
bIgG2	|B-PROTEIN
but	|O
not	|O
hIgA	|B-PROTEIN
.	|O

Vac1p	|B-PROTEIN
was	|O
found	|O
to	|O
bind	|O
the	|O
Sec1p	|B-PROTEIN
homologue	|O
Vps45p	|B-PROTEIN
.	|O

In	|O
a	|O
heterologous	|O
transcriptional	|O
system	|O
in	|O
which	|O
the	|O
upstream	|O
regions	|O
of	|O
oIFNtau	|B-PROTEIN
were	|O
inserted	|O
in	|O
front	|O
of	|O
simian	|O
virus	|O
40	|O
(	|B-PROTEIN
SV40	|I-PROTEIN
)	|I-PROTEIN
promoter	|I-PROTEIN
,	|O
the	|O
regions	|O
between	|O
bases	|O
-	|O
654	|O
and	|O
-	|O
555	|O
were	|O
determined	|O
as	|O
being	|O
the	|O
enhancer	|O
region	|O
required	|O
for	|O
oIFNtau	|B-PROTEIN
-	|O
SV40	|O
-	|O
CAT	|B-PROTEIN
transactivation	|O
.	|O

In	|O
co	|O
-	|O
transfection	|O
studies	|O
,	|O
the	|O
expression	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
plus	|O
c	|B-PROTEIN
-	|I-PROTEIN
Fos	|I-PROTEIN
enhanced	|O
the	|O
transactivation	|O
of	|O
oIFNtau	|B-PROTEIN
-	|O
CAT	|B-PROTEIN
but	|O
the	|O
expression	|O
of	|O
GATA	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
GATA	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
or	|O
GATA	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
did	|O
not	|O
.	|O

To	|O
identify	|O
these	|O
sites	|O
,	|O
Cdk2	|B-PROTEIN
-	|O
phosphorylated	|O
MARCKS	|B-PROTEIN
was	|O
digested	|O
with	|O
lysyl	|B-PROTEIN
endoprotease	|I-PROTEIN
and	|O
analysed	|O
by	|O
electrospray	|O
MS	|O
.	|O

The	|O
yeast	|O
LPD1	|B-PROTEIN
gene	|O
encoding	|O
lipoamide	|B-PROTEIN
dehydrogenase	|I-PROTEIN
is	|O
subject	|O
to	|O
the	|O
general	|O
control	|O
of	|O
amino	|O
acid	|O
biosynthesis	|O
mediated	|O
by	|O
the	|O
GCN4	|B-PROTEIN
transcription	|O
factor	|O
.	|O

The	|O
relatively	|O
mild	|O
defects	|O
observed	|O
in	|O
Rpd3	|B-PROTEIN
mutants	|O
suggest	|O
that	|O
the	|O
recently	|O
identified	|O
Groucho	|B-PROTEIN
and	|O
dCtBP	|B-PROTEIN
corepressor	|O
proteins	|O
do	|O
not	|O
function	|O
solely	|O
through	|O
the	|O
recruitment	|O
of	|O
histone	|B-PROTEIN
deacetylases	|I-PROTEIN
.	|O

However	|O
,	|O
the	|O
serum	|O
TNF	|B-PROTEIN
-	|I-PROTEIN
a	|I-PROTEIN
concentration	|O
decreased	|O
significantly	|O
in	|O
patients	|O
receiving	|O
pentoxifylline	|O
(	|O
basal	|O
623	|O
+	|O
/	|O
-	|O
366	|O
pg	|O
/	|O
ml	|O
;	|O
6th	|O
month	|O
562	|O
+	|O
/	|O
-	|O
358	|O
pg	|O
/	|O
ml	|O
,	|O
p	|O
<	|O
0.01	|O
)	|O
,	|O
but	|O
not	|O
in	|O
the	|O
control	|O
group	|O
.	|O

In	|O
addition	|O
,	|O
we	|O
show	|O
that	|O
the	|O
expression	|O
of	|O
individual	|O
members	|O
of	|O
one	|O
subfamily	|O
of	|O
KRAB	|B-PROTEIN
zinc	|O
finger	|O
genes	|O
is	|O
restricted	|O
to	|O
specific	|O
hematopoietic	|O
cell	|O
lineages	|O
.	|O

Employing	|O
fluorescence	|O
spectroscopy	|O
and	|O
circular	|O
dichroism	|O
,	|O
we	|O
showed	|O
that	|O
the	|O
binding	|O
of	|O
Ca2+	|O
to	|O
ALG	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
induced	|O
significant	|O
conformational	|O
changes	|O
in	|O
both	|O
the	|O
N	|O
-	|O
terminal	|O
and	|O
C	|O
-	|O
terminal	|O
domains	|O
of	|O
the	|O
protein	|O
.	|O

They	|O
also	|O
occur	|O
in	|O
similar	|O
locations	|O
in	|O
the	|O
promoters	|O
of	|O
several	|O
other	|O
ribosomal	|B-PROTEIN
protein	|I-PROTEIN
genes	|O
.	|O

Both	|O
carbachol	|O
(	|O
100	|O
microM	|O
)	|O
and	|O
EGF	|B-PROTEIN
(	|O
10	|O
nM	|O
)	|O
induced	|O
Ras	|B-PROTEIN
activation	|O
.	|O

Dominant	|O
negative	|O
Sos	|B-PROTEIN
did	|O
not	|O
affect	|O
carbachol	|O
stimulation	|O
of	|O
HA	|B-PROTEIN
-	|O
ERK2	|B-PROTEIN
but	|O
inhibited	|O
the	|O
stimulatory	|O
effect	|O
of	|O
EGF	|B-PROTEIN
by	|O
60%	|O
.	|O

RESULTS	|O
:	|O
Transpulmonary	|O
passage	|O
of	|O
contrast	|O
occurred	|O
in	|O
sufficient	|O
amounts	|O
to	|O
enhance	|O
the	|O
intensity	|O
of	|O
the	|O
Doppler	|O
signal	|O
significantly	|O
,	|O
but	|O
the	|O
duration	|O
of	|O
this	|O
effect	|O
was	|O
short	|O
.	|O

In	|O
this	|O
paper	|O
,	|O
such	|O
lesions	|O
in	|O
two	|O
cases	|O
were	|O
evaluated	|O
by	|O
ultrasonography	|O
.	|O

These	|O
regions	|O
contain	|O
inverted	|O
E	|O
-	|O
box	|O
palindromic	|O
or	|O
direct	|O
repeat	|O
motifs	|O
and	|O
bind	|O
SREBP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
with	|O
different	|O
affinities	|O
.	|O

To	|O
address	|O
these	|O
questions	|O
,	|O
a	|O
recombinant	|O
FRAP	|B-PROTEIN
/	|O
mTOR	|B-PROTEIN
protein	|O
and	|O
a	|O
FRAP	|B-PROTEIN
/	|O
mTOR	|B-PROTEIN
immunoprecipitate	|O
were	|O
utilized	|O
in	|O
in	|O
vitro	|O
kinase	|O
assays	|O
to	|O
phosphorylate	|O
4E	|B-PROTEIN
-	|I-PROTEIN
BP1	|I-PROTEIN
.	|O

Hrs	|B-PROTEIN
has	|O
a	|O
FYVE	|O
double	|O
zinc	|O
finger	|O
domain	|O
,	|O
which	|O
specifically	|O
binds	|O
phosphatidylinositol	|O
(	|O
3	|O
)	|O
-	|O
phosphate	|O
and	|O
is	|O
conserved	|O
in	|O
several	|O
proteins	|O
involved	|O
in	|O
vesicular	|O
traffic	|O
.	|O

The	|O
coexpression	|O
of	|O
full	|O
-	|O
length	|O
expression	|O
constructs	|O
for	|O
both	|O
DBP	|B-PROTEIN
and	|O
hepatic	|B-PROTEIN
leukemia	|I-PROTEIN
factor	|I-PROTEIN
resulted	|O
in	|O
a	|O
dramatic	|O
increase	|O
in	|O
activation	|O
mediated	|O
by	|O
the	|O
GAL4	|B-PROTEIN
-	|O
DBP	|B-PROTEIN
fusion	|O
proteins	|O
,	|O
suggesting	|O
the	|O
involvement	|O
of	|O
a	|O
regulated	|O
coactivator	|O
in	|O
this	|O
process	|O
.	|O

Three	|O
subgenomes	|O
also	|O
comprised	|O
15	|O
to	|O
75	|O
nucleotides	|O
derived	|O
from	|O
the	|O
5'	|O
part	|O
of	|O
the	|O
NS2	|B-PROTEIN
gene	|O
.	|O

Cp	|B-PROTEIN
is	|O
normally	|O
the	|O
main	|O
promoter	|O
for	|O
EBNA	|B-PROTEIN
mRNA	|O
initiation	|O
,	|O
so	|O
it	|O
appears	|O
that	|O
EBNA3C	|B-PROTEIN
contributes	|O
to	|O
a	|O
negative	|O
autoregulatory	|O
control	|O
loop	|O
.	|O

These	|O
indications	|O
of	|O
deregulated	|O
signalling	|O
in	|O
the	|O
absence	|O
of	|O
tyrosine	|O
118	|O
were	|O
substantiated	|O
by	|O
sustained	|O
activation	|O
of	|O
STAT3	|B-PROTEIN
.	|O

With	|O
exon	|O
trapping	|O
,	|O
we	|O
could	|O
isolate	|O
five	|O
potential	|O
exons	|O
from	|O
the	|O
YAC	|O
946E12	|O
that	|O
spans	|O
the	|O
region	|O
,	|O
four	|O
of	|O
which	|O
could	|O
be	|O
placed	|O
in	|O
the	|O
contig	|O
in	|O
the	|O
vicinity	|O
of	|O
the	|O
breakpoints	|O
.	|O

Campomelic	|O
dysplasia	|O
translocation	|O
breakpoints	|O
are	|O
scattered	|O
over	|O
1	|O
Mb	|O
proximal	|O
to	|O
SOX9	|B-PROTEIN
:	|O
evidence	|O
for	|O
an	|O
extended	|O
control	|O
region	|O
.	|O

The	|O
most	|O
common	|O
characteristics	|O
of	|O
VRE	|O
patients	|O
were	|O
recent	|O
prior	|O
vancomycin	|O
use	|O
,	|O
recent	|O
prior	|O
susceptible	|O
enterococcal	|O
infection	|O
,	|O
coinfection	|O
with	|O
other	|O
microbial	|O
pathogens	|O
,	|O
and	|O
concurrent	|O
fungal	|O
infection	|O
.	|O

A	|O
coiled	|O
-	|O
coil	|O
domain	|O
,	|O
conserved	|O
within	|O
each	|O
encoded	|O
protein	|O
,	|O
serves	|O
as	|O
a	|O
potential	|O
interaction	|O
motif	|O
for	|O
FLI	|B-PROTEIN
LRR	|O
.	|O

Binding	|O
affinities	|O
of	|O
these	|O
recombinant	|O
phages	|O
as	|O
determined	|O
by	|O
the	|O
retention	|O
of	|O
these	|O
phages	|O
by	|O
a	|O
His	|O
-	|O
tag	|O
immobilized	|O
gp17	|B-PROTEIN
column	|O
,	|O
and	|O
by	|O
co	|O
-	|O
immunoprecipitation	|O
with	|O
purified	|O
terminase	|B-PROTEIN
supported	|O
the	|O
specific	|O
nature	|O
of	|O
the	|O
portal	|B-PROTEIN
protein	|I-PROTEIN
and	|O
terminase	|B-PROTEIN
interaction	|O
sites	|O
.	|O

Although	|O
the	|O
terminase	|B-PROTEIN
apparently	|O
interacts	|O
with	|O
this	|O
gp20	|B-PROTEIN
portal	|O
peptide	|O
,	|O
polyclonal	|O
antibody	|O
against	|O
the	|O
portal	|O
peptide	|O
appears	|O
unable	|O
to	|O
access	|O
it	|O
in	|O
the	|O
native	|O
structure	|O
,	|O
suggesting	|O
intimate	|O
association	|O
of	|O
gp20	|B-PROTEIN
and	|O
gp17	|B-PROTEIN
possibly	|O
internalizes	|O
terminase	|B-PROTEIN
regions	|O
within	|O
the	|O
portal	|O
in	|O
the	|O
packasome	|O
complex	|O
.	|O

The	|O
hybrid	|O
viruses	|O
were	|O
found	|O
to	|O
accumulate	|O
to	|O
high	|O
levels	|O
in	|O
infected	|O
plants	|O
,	|O
to	|O
form	|O
stable	|O
virions	|O
,	|O
and	|O
to	|O
be	|O
mechanically	|O
transmissible	|O
.	|O

cDNA	|O
and	|O
structural	|O
organization	|O
of	|O
the	|O
gene	|O
Pole1	|B-PROTEIN
for	|O
the	|O
mouse	|O
DNA	|B-PROTEIN
polymerase	|I-PROTEIN
epsilon	|I-PROTEIN
catalytic	|O
subunit	|O
.	|O

Nevertheless	|O
cryopreservation	|O
of	|O
spermatozoa	|O
in	|O
a	|O
medium	|O
containing	|O
neither	|O
SP	|O
nor	|O
biological	|O
substances	|O
could	|O
offer	|O
an	|O
acceptable	|O
cryoprotection	|O
of	|O
spermatozoa	|O
to	|O
be	|O
used	|O
in	|O
assisted	|O
fertilization	|O
procedures	|O
,	|O
especially	|O
for	|O
intracytoplasmic	|O
sperm	|O
injection	|O
.	|O

A	|O
liquid	|O
chromatographic	|O
method	|O
is	|O
described	|O
for	|O
analysis	|O
of	|O
beta	|O
-	|O
carotene	|O
in	|O
medical	|O
food	|O
.	|O

The	|O
FCMS	|O
conditions	|O
were	|O
as	|O
follows	|O
:	|O
2	|O
kW	|O
maximum	|O
electrical	|O
power	|O
consumption	|O
,	|O
800	|O
V	|O
maximum	|O
capacitor	|O
voltage	|O
,	|O
720	|O
microseconds	|O
pulsewidth	|O
(	|O
180	|O
microseconds	|O
rise	|O
time	|O
)	|O
,	|O
and	|O
5-30	|O
Hz	|O
frequency	|O
.	|O

Severe	|O
hemolysis	|O
resulted	|O
in	|O
statistically	|O
significant	|O
changes	|O
in	|O
the	|O
mean	|O
values	|O
of	|O
the	|O
above	|O
analytes	|O
in	|O
addition	|O
to	|O
the	|O
following	|O
increases	|O
:	|O
alanine	|B-PROTEIN
aminotransferase	|I-PROTEIN
,	|O
calcium	|O
,	|O
and	|O
serum	|O
globulins	|B-PROTEIN
(	|O
P	|O
<	|O
0.001	|O
)	|O
and	|O
albumin	|B-PROTEIN
and	|O
total	|O
protein	|O
(	|O
P	|O
<	|O
0.01	|O
)	|O
.	|O

EMSA	|O
with	|O
crude	|O
nuclear	|O
extracts	|O
demonstrated	|O
that	|O
stimulation	|O
with	|O
CD40L	|B-PROTEIN
results	|O
in	|O
the	|O
induction	|O
of	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
complexes	|O
that	|O
bind	|O
to	|O
each	|O
of	|O
the	|O
three	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
sites	|O
and	|O
are	|O
composed	|O
mainly	|O
of	|O
p50	|B-PROTEIN
and	|O
RelB	|B-PROTEIN
,	|O
but	|O
also	|O
include	|O
c	|B-PROTEIN
-	|I-PROTEIN
Rel	|I-PROTEIN
and	|O
p65	|B-PROTEIN
.	|O

Optimal	|O
monitoring	|O
of	|O
ODA	|O
remains	|O
undefined	|O
.	|O

The	|O
major	|O
transcription	|O
factors	|O
controlling	|O
arginine	|O
metabolism	|O
in	|O
Escherichia	|O
coli	|O
and	|O
Bacillus	|O
subtilis	|O
,	|O
ArgR	|B-PROTEIN
and	|O
AhrC	|B-PROTEIN
,	|O
respectively	|O
,	|O
are	|O
homologous	|O
multimeric	|O
proteins	|O
that	|O
form	|O
l	|O
-	|O
arginine	|O
-	|O
dependent	|O
DNA	|O
-	|O
binding	|O
complexes	|O
capable	|O
of	|O
repressing	|O
transcription	|O
of	|O
the	|O
biosynthetic	|O
genes	|O
(	|O
both	|O
)	|O
,	|O
activating	|O
transcription	|O
of	|O
catabolic	|O
genes	|O
(	|O
AhrC	|B-PROTEIN
only	|O
)	|O
or	|O
facilitating	|O
plasmid	|O
dimer	|O
resolution	|O
(	|O
both	|O
)	|O
.	|O

The	|O
studied	|O
protein	|O
fragments	|O
consist	|O
of	|O
residues	|O
Arg183	|O
-	|O
His267	|O
of	|O
the	|O
human	|O
ER	|B-PROTEIN
and	|O
residues	|O
Lys438	|O
-	|O
Gln520	|O
of	|O
the	|O
rat	|O
GR	|B-PROTEIN
.	|O

The	|O
exon	|O
:	|O
intron	|O
structure	|O
of	|O
chicken	|O
IL8	|B-PROTEIN
corresponds	|O
almost	|O
exactly	|O
to	|O
that	|O
of	|O
human	|O
IL8	|B-PROTEIN
and	|O
differs	|O
from	|O
those	|O
of	|O
other	|O
known	|O
mammalian	|O
CXC	|B-PROTEIN
chemokine	|I-PROTEIN
genes	|I-PROTEIN
.	|O

The	|O
Aa	|B-PROTEIN
-	|I-PROTEIN
Pri2	|I-PROTEIN
gene	|O
,	|O
specifically	|O
expressed	|O
during	|O
basidiocarp	|O
differentiation	|O
of	|O
the	|O
mushroom	|O
Agrocybe	|O
aegerita	|O
,	|O
was	|O
cloned	|O
.	|O

The	|O
main	|O
causes	|O
of	|O
liver	|O
disease	|O
in	|O
the	|O
patients	|O
with	|O
HCC	|O
were	|O
hepatitis	|O
C	|O
virus	|O
(	|O
HCV	|O
)	|O
(	|O
77%	|O
)	|O
,	|O
alcohol	|O
abuse	|O
(	|O
73%	|O
)	|O
,	|O
and	|O
the	|O
combination	|O
of	|O
HCV	|O
and	|O
alcohol	|O
abuse	|O
(	|O
50%	|O
)	|O
.	|O

Three	|O
new	|O
aromatase	|B-PROTEIN
inhibitors	|O
have	|O
recently	|O
completed	|O
phase	|O
III	|O
evaluation	|O
as	|O
treatment	|O
of	|O
metastatic	|O
breast	|O
cancer	|O
in	|O
post	|O
-	|O
menopausal	|O
women	|O
whose	|O
disease	|O
has	|O
progressed	|O
despite	|O
tamoxifen	|O
therapy	|O
:	|O
anastrozole	|O
(	|O
ARIMIDEX	|O
,	|O
Zeneca	|O
)	|O
,	|O
letrozole	|O
(	|O
FEMARA	|O
,	|O
Novartis	|O
)	|O
and	|O
vorozole	|O
(	|O
RIVIZOR	|O
,	|O
Janssen	|O
)	|O
.	|O

CONCLUSIONS	|O
:	|O
Turbutest	|O
is	|O
a	|O
valuable	|O
tool	|O
in	|O
asthmatic	|O
patients	|O
'	|O
training	|O
,	|O
allowing	|O
identification	|O
and	|O
improvement	|O
of	|O
an	|O
inadequate	|O
inhalation	|O
technique	|O
with	|O
Turbuhaler	|O
.	|O

Of	|O
those	|O
injuries	|O
,	|O
143	|O
cases	|O
were	|O
snowboard	|O
related	|O
and	|O
158	|O
cases	|O
were	|O
ski	|O
related	|O
.	|O

The	|O
femoral	|O
artery	|O
/	|O
vein	|O
and	|O
the	|O
soleus	|O
and	|O
gastrocnemius	|O
muscles	|O
were	|O
examined	|O
in	|O
healthy	|O
human	|O
male	|O
volunteers	|O
.	|O

SRFDelta5	|B-PROTEIN
acts	|O
as	|O
a	|O
naturally	|O
occurring	|O
dominant	|O
negative	|O
regulatory	|O
mutant	|O
that	|O
blocks	|O
SRF	|B-PROTEIN
-	|O
dependent	|O
skeletal	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
actin	|I-PROTEIN
,	|O
cardiac	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
actin	|I-PROTEIN
,	|O
smooth	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
actin	|I-PROTEIN
,	|O
SM22alpha	|B-PROTEIN
,	|O
and	|O
SRF	|B-PROTEIN
promoter	|O
-	|O
luciferase	|B-PROTEIN
reporter	|O
activities	|O
.	|O

In	|O
serum	|O
-	|O
free	|O
media	|O
,	|O
p50E4F	|B-PROTEIN
accelerated	|O
E1A	|B-PROTEIN
-	|O
induced	|O
apoptosis	|O
.	|O

The	|O
potency	|O
of	|O
the	|O
effect	|O
of	|O
Nim	|O
(	|O
0.5	|O
mg.k	|O
g	|O
-	|O
1	|O
i.p	|O
.	|O
)	|O
was	|O
similar	|O
to	|O
that	|O
of	|O
NBP	|O
(	|O
10	|O
mg.k	|O
g	|O
-	|O
1	|O
i.p	|O
.	|O
)	|O
.	|O

CONCLUSION	|O
:	|O
NBP	|O
pre	|O
-	|O
treatment	|O
or	|O
post	|O
-	|O
treatment	|O
markedly	|O
enhanced	|O
the	|O
rCBF	|O
to	|O
striatum	|O
in	|O
RMCAO	|O
rats	|O
.	|O

Progression	|O
after	|O
first	|O
-	|O
line	|O
chemotherapy	|O
was	|O
associated	|O
with	|O
significantly	|O
worse	|O
survival	|O
for	|O
patients	|O
with	|O
metastasis	|O
.	|O

Mutations	|O
within	|O
human	|O
UTR1	|O
modulate	|O
NRF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
expression	|O
by	|O
interfering	|O
with	|O
mRNA	|O
translational	|O
efficiency	|O
in	|O
transfected	|O
cells	|O
and	|O
in	|O
an	|O
in	|O
vitro	|O
translation	|O
system	|O
.	|O

As	|O
is	|O
deduced	|O
from	|O
the	|O
nucleotide	|O
sequence	|O
of	|O
the	|O
cDNA	|O
,	|O
CBS	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
contains	|O
an	|O
open	|O
reading	|O
frame	|O
consisting	|O
of	|O
182	|O
amino	|O
acids	|O
,	|O
with	|O
a	|O
molecular	|O
weight	|O
of	|O
19.5	|O
kDa	|O
.	|O

Corticostriatal	|O
and	|O
corticosubthalamic	|O
input	|O
zones	|O
from	|O
the	|O
presupplementary	|O
motor	|O
area	|O
in	|O
the	|O
macaque	|O
monkey	|O
:	|O
comparison	|O
with	|O
the	|O
input	|O
zones	|O
from	|O
the	|O
supplementary	|O
motor	|O
area	|O
.	|O

Basic	|B-PROTEIN
fibroblast	|I-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
(	|O
bFGF	|B-PROTEIN
)	|O
has	|O
been	|O
shown	|O
to	|O
induce	|O
angiogenesis	|O
in	|O
various	|O
animal	|O
models	|O
,	|O
but	|O
the	|O
methods	|O
of	|O
administration	|O
used	|O
experimentally	|O
are	|O
not	|O
clinically	|O
feasible	|O
.	|O

Both	|O
filters	|O
equally	|O
contributed	|O
to	|O
elevation	|O
of	|O
iliac	|O
venous	|O
pressure	|O
(	|O
median	|O
,	|O
9.3	|O
and	|O
7.2	|O
mm	|O
Hg	|O
[	|O
n	|O
=	|O
9	|O
]	|O
with	|O
the	|O
spring	|O
filter	|O
and	|O
RF02	|O
filter	|O
,	|O
respectively	|O
)	|O
.	|O

12	|O
healthy	|O
women	|O
(	|O
age	|O
18-38	|O
years	|O
)	|O
were	|O
examined	|O
using	|O
the	|O
2	|O
-	|O
hour	|O
's	|O
method	|O
of	|O
passive	|O
leg	|O
rising	|O
(	|O
PLR	|O
)	|O
in	|O
follicular	|O
(	|O
FP	|O
)	|O
and	|O
luteal	|O
(	|O
LP	|O
)	|O
phases	|O
of	|O
normal	|O
ovulatory	|O
cycle	|O
.	|O

Thus	|O
,	|O
sgRNA2	|B-PROTEIN
has	|O
the	|O
3'	|O
TE	|O
in	|O
its	|O
5'	|O
UTR	|O
.	|O

These	|O
single	|O
mutational	|O
defects	|O
in	|O
the	|O
eRF1	|B-PROTEIN
-	|O
eRF3	|B-PROTEIN
interaction	|O
became	|O
evident	|O
when	|O
either	|O
truncated	|O
protein	|O
eRF3C	|B-PROTEIN
or	|O
C	|O
-	|O
terminally	|O
altered	|O
eRF1	|B-PROTEIN
proteins	|O
were	|O
used	|O
for	|O
the	|O
authentic	|O
protein	|O
,	|O
providing	|O
further	|O
support	|O
for	|O
the	|O
presence	|O
of	|O
a	|O
C	|O
-	|O
terminal	|O
interaction	|O
.	|O

Removal	|O
of	|O
each	|O
of	|O
three	|O
contiguous	|O
segments	|O
from	|O
the	|O
N	|O
-	|O
terminal	|O
half	|O
specifically	|O
inhibits	|O
the	|O
formation	|O
of	|O
5.8	|B-PROTEIN
Ss	|I-PROTEIN
rRNA	|O
,	|O
whereas	|O
deleting	|O
part	|O
of	|O
the	|O
C	|O
-	|O
terminal	|O
region	|O
of	|O
the	|O
protein	|O
only	|O
blocks	|O
the	|O
production	|O
of	|O
18S	|B-PROTEIN
rRNA	|O
.	|O

Ras	|B-PROTEIN
is	|O
not	|O
associated	|O
with	|O
the	|O
tegument	|O
.	|O

Green	|O
fluorescent	|O
protein	|O
-	|O
tagged	|O
UNC	|B-PROTEIN
-	|I-PROTEIN
49B	|I-PROTEIN
and	|O
UNC	|B-PROTEIN
-	|I-PROTEIN
49C	|I-PROTEIN
subunits	|O
are	|O
coexpressed	|O
in	|O
muscle	|O
cells	|O
and	|O
are	|O
colocalized	|O
to	|O
synaptic	|O
regions	|O
.	|O

We	|O
show	|O
that	|O
a	|O
protein	|O
,	|O
UBC9	|B-PROTEIN
,	|O
interacts	|O
specifically	|O
with	|O
TEL	|B-PROTEIN
in	|O
vitro	|O
and	|O
in	|O
vivo	|O
.	|O

The	|O
aim	|O
of	|O
this	|O
study	|O
was	|O
to	|O
investigate	|O
the	|O
spontaneous	|O
reports	|O
of	|O
suspected	|O
adverse	|O
drug	|O
reactions	|O
,	|O
observed	|O
in	|O
elderly	|O
patients	|O
(	|O
over	|O
65	|O
years	|O
of	|O
age	|O
)	|O
in	|O
Sicily	|O
(	|O
Italy	|O
)	|O
during	|O
the	|O
period	|O
from	|O
1	|O
January	|O
1995	|O
to	|O
31	|O
December	|O
1997	|O
.	|O

Molecules	|O
of	|O
NH3	|O
are	|O
capable	|O
of	|O
emitting	|O
stimulated	|O
radiation	|O
(	|O
MASER	|O
)	|O
.	|O

The	|O
major	|O
findings	|O
of	|O
our	|O
studies	|O
are	|O
as	|O
follows	|O
:	|O
1	|O
)	|O
There	|O
are	|O
no	|O
detectable	|O
signals	|O
around	|O
GDF	|B-PROTEIN
-	|I-PROTEIN
9	|I-PROTEIN
-	|O
deficient	|O
follicles	|O
for	|O
several	|O
theca	|O
cell	|O
layer	|O
markers	|O
[	|O
i.e.	|O

Interestingly	|O
,	|O
highly	|O
charged	|O
residues	|O
were	|O
abundantly	|O
possessed	|O
in	|O
the	|O
carboxy	|O
-	|O
terminal	|O
part	|O
of	|O
the	|O
MDV2	|O
UL10	|B-PROTEIN
protein	|O
.	|O

Identification	|O
and	|O
structure	|O
of	|O
the	|O
Marek	|O
's	|O
disease	|O
virus	|O
serotype	|O
2	|O
glycoprotein	|O
M	|B-PROTEIN
gene	|I-PROTEIN
:	|O
comparison	|O
with	|O
glycoprotein	|O
M	|B-PROTEIN
genes	|I-PROTEIN
of	|O
Herpesviridae	|O
family	|O
.	|O

OBJECTIVE	|O
:	|O
To	|O
perform	|O
a	|O
cost	|O
-	|O
effectiveness	|O
analysis	|O
(	|O
CEA	|O
)	|O
between	|O
a	|O
standard	|O
antiemetic	|O
regimen	|O
-	|O
chlorpromazine	|O
+	|O
dexamethasone	|O
(	|O
CPM	|O
-	|O
DEX	|O
)	|O
-	|O
and	|O
a	|O
5	|B-PROTEIN
-	|I-PROTEIN
HT3	|I-PROTEIN
receptor	|I-PROTEIN
antagonist	|O
-	|O
tropisetron	|O
(	|O
TROP	|O
)	|O
-	|O
-	|O
in	|O
the	|O
control	|O
of	|O
acute	|O
emesis	|O
induced	|O
by	|O
highly	|O
emetogenic	|O
chemotherapy	|O
in	|O
children	|O
,	|O
considering	|O
two	|O
analytic	|O
perspectives	|O
:	|O
hospital	|O
and	|O
patients	|O
.	|O

Baseline	|O
data	|O
were	|O
obtained	|O
from	|O
10	|O
adults	|O
.	|O

A	|O
comparison	|O
of	|O
the	|O
nucleotide	|O
and	|O
deduced	|O
amino	|O
acid	|O
sequences	|O
of	|O
the	|O
core	|O
regions	|O
of	|O
the	|O
RNA	|O
-	|O
dependent	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
domains	|O
found	|O
in	|O
these	|O
three	|O
dsRNAs	|O
suggested	|O
that	|O
these	|O
dsRNAs	|O
probably	|O
evolved	|O
independently	|O
within	|O
each	|O
host	|O
plant	|O
from	|O
a	|O
common	|O
ancestor	|O
.	|O

Consistent	|O
with	|O
this	|O
possibility	|O
,	|O
a	|O
non	|O
-	|O
MBD	|B-PROTEIN
region	|O
of	|O
Bin1	|B-PROTEIN
was	|O
sufficient	|O
to	|O
recruit	|O
a	|O
repression	|O
function	|O
to	|O
DNA	|O
that	|O
was	|O
unrelated	|O
to	|O
histone	|B-PROTEIN
deacetylase	|I-PROTEIN
.	|O

Forty	|O
-	|O
eight	|O
sequences	|O
,	|O
30	|O
not	|O
previously	|O
identified	|O
as	|O
IR	|O
-	|O
responsive	|O
,	|O
were	|O
significantly	|O
regulated	|O
by	|O
IR	|O
.	|O

A	|O
recently	|O
described	|O
protein	|O
,	|O
metaxin	|B-PROTEIN
1	|I-PROTEIN
,	|O
serves	|O
as	|O
a	|O
component	|O
of	|O
a	|O
preprotein	|O
import	|O
complex	|O
in	|O
the	|O
outer	|O
membrane	|O
of	|O
the	|O
mammalian	|O
mitochondrion	|O
.	|O

Molecular	|O
cloning	|O
of	|O
rat	|O
SH2	|B-PROTEIN
-	|I-PROTEIN
containing	|I-PROTEIN
inositol	|I-PROTEIN
phosphatase	|I-PROTEIN
2	|I-PROTEIN
(	|O
SHIP2	|B-PROTEIN
)	|O
and	|O
its	|O
role	|O
in	|O
the	|O
regulation	|O
of	|O
insulin	|B-PROTEIN
signaling	|O
.	|O

Slp1	|B-PROTEIN
represses	|O
transcription	|O
via	|O
this	|O
binding	|O
site	|O
in	|O
yeast	|O
cells	|O
,	|O
consistent	|O
with	|O
its	|O
role	|O
as	|O
a	|O
direct	|O
repressor	|O
of	|O
ftz	|B-PROTEIN
stripes	|O
in	|O
interstripe	|O
regions	|O
during	|O
late	|O
stages	|O
of	|O
embryogenesis	|O
.	|O

The	|O
results	|O
of	|O
these	|O
studies	|O
support	|O
a	|O
model	|O
in	|O
which	|O
VirB4	|B-PROTEIN
dimers	|O
or	|O
homomultimers	|O
contribute	|O
structural	|O
information	|O
for	|O
the	|O
assembly	|O
of	|O
a	|O
transenvelope	|O
channel	|O
competent	|O
for	|O
bidirectional	|O
DNA	|O
transfer	|O
,	|O
whereas	|O
an	|O
ATP	|O
-	|O
dependent	|O
activity	|O
is	|O
required	|O
for	|O
configuring	|O
this	|O
channel	|O
as	|O
a	|O
dedicated	|O
export	|O
machine	|O
.	|O

The	|O
penicillin	|B-PROTEIN
binding	|I-PROTEIN
proteins	|I-PROTEIN
(	|O
PBPs	|B-PROTEIN
)	|O
synthesize	|O
and	|O
remodel	|O
peptidoglycan	|O
,	|O
the	|O
structural	|O
component	|O
of	|O
the	|O
bacterial	|O
cell	|O
wall	|O
.	|O

TCR	|B-PROTEIN
alpha	|I-PROTEIN
(	|O
TCRA	|B-PROTEIN
)	|O
expression	|O
was	|O
examined	|O
in	|O
RNA	|O
samples	|O
from	|O
PBMC	|O
and	|O
isolated	|O
populations	|O
of	|O
CD4+	|B-PROTEIN
,	|O
CD8+	|B-PROTEIN
,	|O
and	|O
DN	|O
T	|O
cells	|O
from	|O
15	|O
healthy	|O
individuals	|O
.	|O

Similar	|O
results	|O
were	|O
obtained	|O
with	|O
xylitol	|O
,	|O
an	|O
activator	|O
of	|O
the	|O
pentose	|O
phosphate	|O
pathway	|O
.	|O

The	|O
high	|O
density	|O
lipoprotein	|O
(	|B-PROTEIN
HDL	|I-PROTEIN
)	|I-PROTEIN
receptor	|I-PROTEIN
mediates	|O
the	|O
uptake	|O
of	|O
cholesterol	|O
and	|O
cholesteryl	|O
esters	|O
,	|O
substrates	|O
for	|O
steroidogenesis	|O
,	|O
from	|O
an	|O
HDL	|B-PROTEIN
particle	|O
in	|O
the	|O
adrenal	|O
gland	|O
and	|O
gonads	|O
.	|O

D3S1261	|B-PROTEIN
is	|O
physically	|O
located	|O
at	|O
or	|O
near	|O
the	|O
MITF	|B-PROTEIN
locus	|O
,	|O
while	|O
D3S2465	|B-PROTEIN
and	|O
D3S1766	|B-PROTEIN
are	|O
flanking	|O
the	|O
locus	|O
at	|O
about	|O
17.5	|O
cM	|O
genetic	|O
distance	|O
each	|O
side	|O
.	|O

The	|O
percentages	|O
of	|O
recovery	|O
decreased	|O
with	|O
storage	|O
time	|O
,	|O
although	|O
the	|O
addition	|O
of	|O
dispersant	|O
(	|O
Tris	|O
-	|O
Tween	|O
80	|O
)	|O
before	|O
storage	|O
appeared	|O
to	|O
partially	|O
prevent	|O
adhesion	|O
.	|O

Point	|O
mutations	|O
of	|O
the	|O
site	|O
that	|O
suppressed	|O
Pit	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
binding	|O
in	|O
vitro	|O
restored	|O
full	|O
tiGH	|B-PROTEIN
promoter	|O
activity	|O
.	|O

A	|O
human	|O
Raf	|B-PROTEIN
-	|O
responsive	|O
zinc	|O
-	|O
finger	|O
protein	|O
that	|O
binds	|O
to	|O
divergent	|O
sequences	|O
.	|O

We	|O
are	|O
reporting	|O
an	|O
autopsy	|O
case	|O
of	|O
so	|O
-	|O
called	|O
"	|O
acute	|O
multiple	|O
sclerosis	|O
"	|O
that	|O
was	|O
difficult	|O
to	|O
differentiate	|O
from	|O
a	|O
brain	|O
tumor	|O
on	|O
MRI	|O
findings	|O
.	|O

Furthermore	|O
,	|O
MOM	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
and	|O
TAK1	|B-PROTEIN
bind	|O
related	|O
proteins	|O
that	|O
promote	|O
their	|O
kinase	|O
activities	|O
.	|O

BACKGROUND	|O
:	|O
The	|O
MAZE	|O
-	|O
III	|O
is	|O
the	|O
surgical	|O
treatment	|O
of	|O
choice	|O
for	|O
medically	|O
refractory	|O
atrial	|O
fibrillation	|O
.	|O

Gab2	|B-PROTEIN
,	|O
a	|O
new	|O
pleckstrin	|B-PROTEIN
homology	|O
domain	|O
-	|O
containing	|O
adapter	|O
protein	|O
,	|O
acts	|O
to	|O
uncouple	|O
signaling	|O
from	|O
ERK	|B-PROTEIN
kinase	|I-PROTEIN
to	|O
Elk	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

The	|O
presence	|O
of	|O
cutaneous	|O
xanthomas	|O
with	|O
normal	|O
serum	|O
lipid	|O
levels	|O
is	|O
due	|O
to	|O
the	|O
antibetalipoproteic	|O
activity	|O
of	|O
the	|O
monoclonal	|O
immunoglobulin	|B-PROTEIN
.	|O

In	|O
an	|O
attempt	|O
to	|O
reduce	|O
the	|O
incidence	|O
of	|O
NSAID	|O
-	|O
induced	|O
gastrointestinal	|O
lesions	|O
,	|O
the	|O
following	|O
approaches	|O
have	|O
been	|O
proposed	|O
:	|O
(	|O
i	|O
)	|O
use	|O
of	|O
the	|O
prostaglandin	|O
analogue	|O
misoprostol	|O
,	|O
which	|O
is	|O
an	|O
antiulcer	|O
drug	|O
which	|O
has	|O
been	|O
proven	|O
to	|O
be	|O
as	|O
effective	|O
in	|O
the	|O
prevention	|O
of	|O
NSAID	|O
-	|O
induced	|O
gastric	|O
and	|O
duodenal	|O
ulcers	|O
as	|O
in	|O
the	|O
reduction	|O
of	|O
serious	|O
upper	|O
gastrointestinal	|O
complications	|O
;	|O
(	|O
ii	|O
)	|O
histamine	|B-PROTEIN
H2	|I-PROTEIN
receptor	|I-PROTEIN
antagonists	|O
(	|O
H2	|O
antagonists	|O
)	|O
,	|O
e.g.	|O
ranitidine	|O
,	|O
cimetidine	|O
and	|O
famotidine	|O
,	|O
which	|O
are	|O
useful	|O
in	|O
the	|O
prevention	|O
of	|O
NSAID	|O
-	|O
induced	|O
duodenal	|O
ulcers	|O
during	|O
long	|O
term	|O
treatment	|O
,	|O
but	|O
not	|O
in	|O
the	|O
prevention	|O
of	|O
NSAID	|O
-	|O
induced	|O
gastric	|O
ulcers	|O
;	|O
(	|O
iii	|O
)	|O
proton	|O
pump	|O
inhibitors	|O
,	|O
e.g	|O
omeprazole	|O
,	|O
and	|O
pantoprazole	|O
,	|O
whose	|O
efficacy	|O
in	|O
preventing	|O
NSAID	|O
-	|O
associated	|O
ulcers	|O
has	|O
been	|O
recently	|O
demonstrated	|O
;	|O
and	|O
(	|O
iv	|O
)	|O
barrier	|O
agents	|O
,	|O
e.g.	|O
sucralfate	|O
,	|O
which	|O
cannot	|O
be	|O
recommended	|O
as	|O
prophylactic	|O
agents	|O
to	|O
prevent	|O
NSAID	|O
-	|O
induced	|O
gastropathy	|O
.	|O

Lung	|O
mesenchyme	|O
serves	|O
as	|O
a	|O
'	|O
compleat	|O
'	|O
inducer	|O
of	|O
lung	|O
morphogenesis	|O
by	|O
secreting	|O
soluble	|O
peptide	|O
growth	|O
factors	|O
.	|O

The	|O
activation	|O
of	|O
the	|O
HIV	|O
promoter	|O
required	|O
the	|O
nuclear	|O
localization	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
Abl	|I-PROTEIN
and	|O
could	|O
be	|O
correlated	|O
with	|O
increased	|O
tyrosine	|O
phosphorylation	|O
of	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
II	|I-PROTEIN
.	|O

The	|O
bovine	|O
papillomavirus	|O
E2	|B-PROTEIN
protein	|O
can	|O
inhibit	|O
the	|O
proliferation	|O
of	|O
HT	|O
-	|O
3	|O
cells	|O
,	|O
a	|O
p53	|B-PROTEIN
-	|O
negative	|O
cervical	|O
carcinoma	|O
cell	|O
line	|O
containing	|O
integrated	|O
human	|O
papillomavirus	|O
type	|O
30	|O
DNA	|O
.	|O

E2	|B-PROTEIN
point	|O
mutants	|O
unable	|O
to	|O
inhibit	|O
cell	|O
growth	|O
did	|O
not	|O
repress	|O
cdc25A	|B-PROTEIN
and	|O
cdc25B	|B-PROTEIN
expression	|O
,	|O
nor	|O
did	|O
the	|O
cell	|O
cycle	|O
inhibitors	|O
hydroxyurea	|O
and	|O
mimosine	|O
.	|O

BACKGROUND	|O
/	|O
PURPOSE	|O
:	|O
Anomalous	|O
arrangement	|O
of	|O
the	|O
pancreaticobiliary	|O
duct	|O
(	|O
AAPBD	|O
)	|O
is	|O
closely	|O
related	|O
to	|O
congenital	|O
biliary	|O
dilatation	|O
and	|O
frequently	|O
associated	|O
with	|O
biliary	|O
tract	|O
malignancy	|O
.	|O

Neurospora	|O
crassa	|O
CYT	|B-PROTEIN
-	|I-PROTEIN
18	|I-PROTEIN
,	|O
can	|O
rescue	|O
the	|O
exonic	|O
trap	|O
and	|O
intron	|O
mutants	|O
which	|O
cause	|O
a	|O
structural	|O
defect	|O
.	|O

DDP1	|B-PROTEIN
also	|O
localizes	|O
to	|O
heterochromatin	|O
in	|O
interphase	|O
nuclei	|O
of	|O
larval	|O
neuroblasts	|O
.	|O

In	|O
a	|O
reconstituted	|O
human	|O
DNA	|O
repair	|O
system	|O
containing	|O
DNA	|B-PROTEIN
polymerase	|I-PROTEIN
beta	|I-PROTEIN
and	|O
DNA	|B-PROTEIN
ligase	|I-PROTEIN
III	|I-PROTEIN
-	|O
XRCC1	|B-PROTEIN
,	|O
accurate	|O
rejoining	|O
of	|O
a	|O
3'	|O
mismatched	|O
base	|O
residue	|O
at	|O
a	|O
single	|O
-	|O
strand	|O
break	|O
is	|O
dependent	|O
on	|O
addition	|O
of	|O
the	|O
exonuclease	|O
.	|O

The	|O
PAC	|O
clone	|O
with	|O
an	|O
insert	|O
size	|O
of	|O
120kb	|O
was	|O
isolated	|O
and	|O
mapped	|O
by	|O
restriction	|O
analysis	|O
.	|O

Sequence	|O
of	|O
10q24	|B-PROTEIN
locus	|O
surrounding	|O
the	|O
HOX11	|B-PROTEIN
oncogene	|O
reveals	|O
a	|O
new	|O
gene	|O
HUG1	|B-PROTEIN
expressed	|O
in	|O
a	|O
T	|O
-	|O
ALL	|O
cell	|O
line	|O
.	|O

About	|O
20	|O
kb	|O
upstream	|O
of	|O
LAMB2	|B-PROTEIN
we	|O
found	|O
a	|O
gene	|O
encoding	|O
a	|O
transcribed	|O
,	|O
non	|O
-	|O
processed	|O
LAMB2	|B-PROTEIN
-	|O
like	|O
pseudogene	|O
(	|O
LAMB2L	|B-PROTEIN
)	|O
.	|O

Site	|O
-	|O
directed	|O
mutagenesis	|O
of	|O
the	|O
R2	|B-PROTEIN
protein	|O
was	|O
used	|O
to	|O
provide	|O
evidence	|O
that	|O
this	|O
motif	|O
is	|O
also	|O
part	|O
of	|O
the	|O
active	|O
site	|O
of	|O
the	|O
endonuclease	|O
encoded	|O
by	|O
this	|O
element	|O
.	|O

The	|O
infected	|B-PROTEIN
cell	|I-PROTEIN
protein	|I-PROTEIN
no	|I-PROTEIN
.	|I-PROTEIN
0	|I-PROTEIN
(	|O
ICP0	|B-PROTEIN
)	|O
of	|O
herpes	|O
simplex	|O
virus	|O
1	|O
is	|O
a	|O
promiscuous	|O
transactivator	|O
shown	|O
to	|O
enhance	|O
the	|O
expression	|O
of	|O
genes	|O
introducted	|O
into	|O
cells	|O
by	|O
infection	|O
or	|O
transfection	|O
.	|O

Wrist	|O
measurement	|O
of	|O
blood	|O
pressure	|O
:	|O
some	|O
critical	|O
remarks	|O
to	|O
oscillometry	|O
.	|O

G	|O
-	|O
box	|O
-	|O
directed	|O
expression	|O
in	|O
leaves	|O
required	|O
the	|O
presence	|O
of	|O
an	|O
enhancer	|O
region	|O
from	|O
the	|O
cauliflower	|O
mosaic	|O
virus	|O
(	|O
CaMV	|O
)	|O
35S	|B-PROTEIN
promoter	|O
.	|O

Another	|O
element	|O
necessary	|O
for	|O
augmenting	|O
the	|O
amplitude	|O
of	|O
the	|O
oscillation	|O
lies	|O
between	|O
-	|O
178	|O
and	|O
-	|O
264	|O
.	|O

This	|O
scFv	|O
was	|O
therefore	|O
used	|O
as	|O
control	|O
in	|O
experiments	|O
where	|O
another	|O
anti	|B-PROTEIN
-	|I-PROTEIN
Ras	|I-PROTEIN
scFv	|O
(	|O
Y259	|B-PROTEIN
scFv	|I-PROTEIN
,	|O
derived	|O
from	|O
the	|O
neutralizing	|O
anti	|B-PROTEIN
-	|I-PROTEIN
Ras	|I-PROTEIN
mAb	|O
Y13	|O
-	|O
259	|O
)	|O
blocked	|O
the	|O
Ras	|B-PROTEIN
pathway	|O
in	|O
vitro	|O
and	|O
led	|O
to	|O
tumor	|O
regression	|O
in	|O
a	|O
nude	|O
mouse	|O
model	|O
[	|O
Cochet	|O
,	|O
O.	|O
,	|O
Kenigsberg	|O
,	|O
M.	|O
,	|O
Delumeau	|O
,	|O
I.	|O
,	|O
Virone	|O
-	|O
Oddos	|O
,	|O
A.	|O
,	|O
Multon	|O
,	|O
M.C.	|O
,	|O
Fridman	|O
,	|O
W.H.	|O
,	|O
Schweighoffer	|O
,	|O
F.	|O
,	|O
Teillaud	|O
,	|O
J.L.	|O
,	|O
Tocque	|O
,	|O
B.	|O
,	|O
1998	|O
.	|O

There	|O
was	|O
no	|O
competition	|O
between	|O
activin	|B-PROTEIN
A	|I-PROTEIN
and	|O
OP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
for	|O
availability	|O
of	|O
Smad4	|B-PROTEIN
,	|O
indicating	|O
that	|O
the	|O
concentration	|O
of	|O
this	|O
common	|O
signal	|O
transducer	|O
is	|O
not	|O
limiting	|O
for	|O
generating	|O
the	|O
observed	|O
biological	|O
responses	|O
.	|O

Our	|O
data	|O
therefore	|O
indicate	|O
that	|O
it	|O
is	|O
possible	|O
to	|O
engineer	|O
the	|O
HA	|B-PROTEIN
envelope	|O
glycoprotein	|O
by	|O
fusing	|O
ligands	|O
to	|O
its	|O
amino	|O
-	|O
terminal	|O
end	|O
without	|O
affecting	|O
its	|O
fusion	|O
activity	|O
.	|O

However	|O
,	|O
the	|O
favored	|O
,	|O
parallel	|O
beta	|O
helix	|O
model	|O
is	|O
a	|O
compact	|O
coil	|O
of	|O
ten	|O
helically	|O
arranged	|O
beta	|O
strands	|O
forming	|O
two	|O
parallel	|O
beta	|O
sheet	|O
faces	|O
.	|O

This	|O
is	|O
predicted	|O
to	|O
encode	|O
a	|O
315	|O
-	|O
residue	|O
protein	|O
containing	|O
seven	|O
hydrophobic	|O
helical	|O
regions	|O
and	|O
a	|O
17	|O
amino	|O
acid	|O
motif	|O
characteristic	|O
of	|O
the	|O
R7G	|B-PROTEIN
family	|O
of	|O
G	|B-PROTEIN
-	|I-PROTEIN
protein	|I-PROTEIN
coupled	|I-PROTEIN
membrane	|I-PROTEIN
-	|I-PROTEIN
bound	|I-PROTEIN
receptors	|I-PROTEIN
.	|O

Characterisation	|O
of	|O
the	|O
chicken	|O
apolipoprotein	|B-PROTEIN
A	|I-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
gene	|O
5'	|O
-	|O
flanking	|O
region	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
members	|O
of	|O
the	|O
ATF	|B-PROTEIN
family	|O
are	|O
involved	|O
in	|O
mediating	|O
the	|O
transcriptional	|O
regulation	|O
of	|O
the	|O
KGF	|B-PROTEIN
gene	|O
in	|O
response	|O
to	|O
extracellular	|O
stimuli	|O
via	|O
a	|O
novel	|O
CRE	|O
regulatory	|O
element	|O
.	|O

Moreover	|O
,	|O
a	|O
high	|O
proportion	|O
of	|O
blood	|O
samples	|O
from	|O
a	|O
random	|O
sample	|O
of	|O
the	|O
rest	|O
of	|O
the	|O
suspects	|O
tested	|O
positive	|O
for	|O
trypanosome	|O
-	|O
specific	|O
DNA	|O
by	|O
PCR	|O
(	|O
79.9%	|O
for	|O
T.	|O
b	|O
.	|O
gambiense	|O
and	|O
13.9%	|O
for	|O
T.	|O
b	|O
.	|O
rhodesiense	|O
)	|O
.	|O

A	|O
multi	|O
-	|O
centre	|O
evaluation	|O
of	|O
the	|O
card	|O
indirect	|O
agglutination	|O
test	|O
for	|O
trypanosomiasis	|O
(	|O
TrypTect	|O
CIATT	|O
)	|O
.	|O

Results	|O
for	|O
men	|O
who	|O
drank	|O
up	|O
to	|O
two	|O
drinks	|O
per	|O
day	|O
suggest	|O
that	|O
if	|O
the	|O
dependence	|O
criteria	|O
were	|O
invalid	|O
,	|O
reductions	|O
in	|O
the	|O
prevalence	|O
of	|O
specific	|O
indicators	|O
of	|O
alcohol	|O
dependence	|O
would	|O
range	|O
from	|O
0.3%	|O
to	|O
5.2%	|O
.	|O

Mutagenesis	|O
of	|O
the	|O
CDE	|O
/	|O
CHR	|O
elements	|O
and	|O
Sp1	|B-PROTEIN
sites	|O
in	|O
this	|O
region	|O
,	|O
alone	|O
or	|O
in	|O
combination	|O
,	|O
reduced	|O
transcriptional	|O
activity	|O
by	|O
40-60%	|O
in	|O
asynchronously	|O
growing	|O
cells	|O
and	|O
abolished	|O
cell	|O
cycle	|O
periodicity	|O
in	|O
G2	|O
-	|O
M	|O
-	|O
synchronized	|O
cells	|O
.	|O

Using	|O
Scheffe	|O
's	|O
procedure	|O
as	|O
an	|O
illustration	|O
,	|O
comparisons	|O
are	|O
made	|O
to	|O
usual	|O
sample	|O
size	|O
methods	|O
that	|O
incorrectly	|O
ignore	|O
the	|O
stochastic	|O
nature	|O
of	|O
S2p	|O
.	|O

The	|O
crystal	|O
structure	|O
of	|O
the	|O
VP16	|B-PROTEIN
core	|O
has	|O
been	|O
determined	|O
at	|O
2.1	|O
A	|O
resolution	|O
.	|O

Ozagrel	|O
,	|O
ifenprodil	|O
,	|O
cinnarizine	|O
and	|O
dilazep	|O
were	|O
more	|O
effective	|O
than	|O
pentoxifylline	|O
in	|O
increasing	|O
rCBF	|O
at	|O
the	|O
HPC	|O
.	|O

The	|O
latter	|O
method	|O
adds	|O
clamping	|O
of	|O
the	|O
inferior	|O
vena	|O
cava	|O
,	|O
which	|O
results	|O
in	|O
hypotension	|O
,	|O
requiring	|O
invasive	|O
anesthetic	|O
management	|O
.	|O

By	|O
contrast	|O
,	|O
PvirE	|B-PROTEIN
or	|O
Plac	|B-PROTEIN
promoter	|O
constructs	|O
yielded	|O
functional	|O
VirE2	|B-PROTEIN
only	|O
if	|O
virE1	|B-PROTEIN
was	|O
coexpressed	|O
with	|O
virE2	|B-PROTEIN
.	|O

Simian	|O
parainfluenza	|O
virus	|O
5	|O
(	|O
SV5	|O
)	|O
is	|O
a	|O
prototype	|O
of	|O
the	|O
Paramyxoviridae	|O
family	|O
of	|O
nonsegmented	|O
negative	|O
-	|O
sense	|O
RNA	|O
viruses	|O
.	|O

To	|O
investigate	|O
the	|O
functions	|O
of	|O
GE	|O
,	|O
IG	|O
,	|O
and	|O
GS	|O
sequences	|O
in	|O
transcription	|O
,	|O
we	|O
constructed	|O
plasmids	|O
containing	|O
cDNAs	|O
of	|O
the	|O
full	|O
-	|O
length	|O
SV5	|O
genome	|O
in	|O
which	|O
the	|O
gene	|O
junction	|O
sequences	|O
(	|O
GE	|O
,	|O
IG	|O
,	|O
and	|O
GS	|O
sequences	|O
)	|O
located	|O
between	|O
the	|O
hemagglutinin	|B-PROTEIN
-	|I-PROTEIN
neuraminidase	|I-PROTEIN
(	|O
HN	|B-PROTEIN
)	|O
and	|O
the	|O
polymerase	|B-PROTEIN
(	|I-PROTEIN
L	|I-PROTEIN
)	|I-PROTEIN
genes	|O
were	|O
replaced	|O
with	|O
the	|O
counterpart	|O
sequences	|O
from	|O
other	|O
gene	|O
junctions	|O
.	|O

CXCR4	|B-PROTEIN
is	|O
a	|O
chemokine	|O
receptor	|O
and	|O
a	|O
coreceptor	|O
for	|O
T	|O
-	|O
cell	|O
-	|O
line	|O
-	|O
tropic	|O
(	|O
X4	|O
)	|O
and	|O
dual	|O
-	|O
tropic	|O
(	|O
R5X4	|O
)	|O
human	|O
immunodeficiency	|O
virus	|O
type	|O
1	|O
(	|O
HIV	|O
-	|O
1	|O
)	|O
isolates	|O
.	|O

These	|O
data	|O
will	|O
help	|O
us	|O
to	|O
better	|O
detail	|O
the	|O
CXCR4	|B-PROTEIN
structural	|O
requirements	|O
exhibited	|O
by	|O
different	|O
HIV	|O
-	|O
1	|O
strains	|O
and	|O
will	|O
direct	|O
further	|O
mutagenesis	|O
efforts	|O
aimed	|O
at	|O
better	|O
defining	|O
the	|O
domains	|O
in	|O
CXCR4	|B-PROTEIN
involved	|O
in	|O
the	|O
HIV	|O
-	|O
1	|O
Env	|B-PROTEIN
-	|O
mediated	|O
fusion	|O
process	|O
.	|O

The	|O
results	|O
of	|O
these	|O
analyses	|O
indicate	|O
that	|O
the	|O
proteinase	|O
cleaves	|O
at	|O
amino	|O
acid	|O
residues	|O
E960	|O
-	|O
A961	|O
,	|O
E1071	|O
-	|O
S1072	|O
,	|O
E1345	|O
-	|O
T1346	|O
,	|O
and	|O
E1419	|O
-	|O
G1420	|O
;	|O
however	|O
,	|O
the	|O
cleavage	|O
efficiency	|O
is	|O
varied	|O
.	|O

y	|O
.	|O

SM	|B-PROTEIN
is	|O
also	|O
shown	|O
to	|O
be	|O
associated	|O
in	|O
vivo	|O
with	|O
other	|O
components	|O
of	|O
the	|O
CRM	|B-PROTEIN
1	|I-PROTEIN
export	|O
pathway	|O
,	|O
including	|O
the	|O
small	|O
GTPase	|O
Ran	|B-PROTEIN
and	|O
the	|O
nucleoporin	|O
CAN	|B-PROTEIN
/	|O
Nup214	|B-PROTEIN
.	|O

Identification	|O
of	|O
a	|O
spliced	|O
gene	|O
from	|O
Kaposi	|O
's	|O
sarcoma	|O
-	|O
associated	|O
herpesvirus	|O
encoding	|O
a	|O
protein	|O
with	|O
similarities	|O
to	|O
latent	|B-PROTEIN
membrane	|I-PROTEIN
proteins	|I-PROTEIN
1	|I-PROTEIN
and	|I-PROTEIN
2A	|I-PROTEIN
of	|O
Epstein	|O
-	|O
Barr	|O
virus	|O
.	|O

Auditory	|O
clicks	|O
were	|O
given	|O
at	|O
a	|O
rate	|O
of	|O
20	|O
s	|O
(	|O
-	|O
1	|O
)	|O
.	|O

Myosin	|B-PROTEIN
light	|I-PROTEIN
chain	|I-PROTEIN
kinase	|I-PROTEIN
functions	|O
downstream	|O
of	|O
Ras	|B-PROTEIN
/	|O
ERK	|B-PROTEIN
to	|O
promote	|O
migration	|O
of	|O
urokinase	|B-PROTEIN
-	|I-PROTEIN
type	|I-PROTEIN
plasminogen	|I-PROTEIN
activator	|I-PROTEIN
-	|O
stimulated	|O
cells	|O
in	|O
an	|O
integrin	|B-PROTEIN
-	|O
selective	|O
manner	|O
.	|O

The	|O
inhibition	|O
of	|O
StAR	|B-PROTEIN
gene	|O
transcription	|O
by	|O
DAX	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
was	|O
dose	|O
-	|O
dependent	|O
reducing	|O
transcription	|O
to	|O
6%	|O
of	|O
control	|O
levels	|O
.	|O

In	|O
a	|O
prospective	|O
randomized	|O
study	|O
,	|O
287	|O
patients	|O
with	|O
advanced	|O
non	|O
-	|O
small	|O
cell	|O
lung	|O
cancer	|O
(	|O
NSCLC	|O
)	|O
stage	|O
IIIb	|O
or	|O
IV	|O
with	|O
ECOG	|O
performance	|O
status	|O
(	|O
PS	|O
)	|O
0-1	|O
or	|O
2	|O
were	|O
randomly	|O
assigned	|O
to	|O
receive	|O
either	|O
best	|O
supportive	|O
care	|O
(	|O
BSC	|O
)	|O
or	|O
supportive	|O
care	|O
plus	|O
combination	|O
chemotherapy	|O
(	|O
IEP	|O
regimen	|O
:	|O
ifosfamide	|O
3	|O
gm	|O
/	|O
m2	|O
IV	|O
with	|O
mesna	|O
uroprotection	|O
,	|O
epirubicin	|O
60	|O
mg	|O
/	|O
m2	|O
IV	|O
on	|O
day	|O
1	|O
and	|O
cisplatin	|O
60	|O
mg	|O
/	|O
m2	|O
IV	|O
on	|O
day	|O
2	|O
;	|O
or	|O
MVP	|O
regimen	|O
:	|O
mitomycin	|O
-	|O
C	|O
8	|O
mg	|O
/	|O
m2	|O
,	|O
cisplatin	|O
100	|O
mg	|O
/	|O
m2	|O
IV	|O
on	|O
day	|O
1	|O
,	|O
vinblastine	|O
4	|O
mg	|O
/	|O
m2	|O
IV	|O
on	|O
days	|O
1	|O
and	|O
15	|O
)	|O
.	|O

Using	|O
sequence	|O
information	|O
from	|O
human	|B-PROTEIN
BMAL1	|I-PROTEIN
(	|O
hBMAL1	|B-PROTEIN
)	|O
cDNAs	|O
previously	|O
reported	|O
by	|O
our	|O
laboratory	|O
,	|O
we	|O
have	|O
isolated	|O
and	|O
characterized	|O
cDNAs	|O
encoding	|O
three	|O
splice	|O
variants	|O
of	|O
the	|O
mouse	|O
BMAL1	|B-PROTEIN
(	|O
mBMAL1	|B-PROTEIN
)	|O
gene	|O
.	|O

Comparison	|O
with	|O
the	|O
bHLH	|B-PROTEIN
/	|O
PAS	|B-PROTEIN
family	|O
genes	|O
revealed	|O
that	|O
the	|O
intron	|O
/	|O
exon	|O
splice	|O
pattern	|O
of	|O
mBMAL1	|B-PROTEIN
most	|O
closely	|O
matches	|O
that	|O
of	|O
the	|O
mAhr	|B-PROTEIN
,	|O
which	|O
suggests	|O
that	|O
BMAL1	|B-PROTEIN
and	|O
Ahr	|B-PROTEIN
belong	|O
to	|O
the	|O
same	|O
subclass	|O
and	|O
may	|O
be	|O
derived	|O
from	|O
a	|O
common	|O
primordial	|O
gene	|O
.	|O

The	|O
transcriptional	|O
activities	|O
of	|O
the	|O
full	|O
-	|O
length	|O
promoter	|O
(	|O
-	|O
295	|O
to	|O
+	|O
85	|O
)	|O
and	|O
of	|O
three	|O
deletion	|O
constructs	|O
(	|O
-	|O
197	|O
,	|O
-	|O
154	|O
and	|O
-	|O
74	|O
to	|O
+	|O
85	|O
)	|O
were	|O
significantly	|O
down	|O
-	|O
regulated	|O
in	|O
resistant	|O
cells	|O
.	|O

We	|O
were	|O
able	|O
to	|O
detect	|O
significant	|O
differences	|O
in	|O
functional	|O
residual	|O
capacity	|O
adjusted	|O
for	|O
weight	|O
or	|O
height	|O
,	|O
and	|O
compliance	|O
of	|O
the	|O
respiratory	|O
system	|O
adjusted	|O
for	|O
weight	|O
or	|O
lung	|O
volume	|O
in	|O
the	|O
ILD	|O
infants	|O
compared	|O
to	|O
the	|O
healthy	|O
controls	|O
or	|O
infants	|O
who	|O
had	|O
PPHN	|O
,	|O
indicating	|O
that	|O
these	|O
PFTs	|O
were	|O
sensitive	|O
enough	|O
to	|O
determine	|O
abnormal	|O
lung	|O
function	|O
in	|O
this	|O
age	|O
group	|O
.	|O

A	|O
13	|O
-	|O
bp	|O
cis	|O
-	|O
regulatory	|O
element	|O
in	|O
the	|O
LTR	|O
promoter	|O
of	|O
the	|O
tobacco	|O
retrotransposon	|O
Tto1	|B-PROTEIN
is	|O
involved	|O
in	|O
responsiveness	|O
to	|O
tissue	|O
culture	|O
,	|O
wounding	|O
,	|O
methyl	|O
jasmonate	|O
and	|O
fungal	|O
elicitors	|O
.	|O

In	|O
this	|O
study	|O
we	|O
describe	|O
that	|O
platelet	|B-PROTEIN
-	|I-PROTEIN
derived	|I-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
(	|O
PDGF	|B-PROTEIN
)	|O
,	|O
12	|O
-	|O
O	|O
-	|O
tetradecanoyl	|O
-	|O
phorbol	|O
-	|O
acetate	|O
(	|O
TPA	|O
)	|O
,	|O
and	|O
forskolin	|O
induced	|O
CREB	|B-PROTEIN
(	|O
cAMP	|B-PROTEIN
-	|I-PROTEIN
responsive	|I-PROTEIN
element	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
)	|O
Ser	|O
-	|O
133	|O
phosphorylation	|O
with	|O
comparable	|O
magnitude	|O
and	|O
kinetics	|O
in	|O
NIH	|O
3T3	|O
cells	|O
.	|O

This	|O
constitutes	|O
evidence	|O
for	|O
an	|O
in	|O
vivo	|O
role	|O
of	|O
SRC	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
in	|O
dimerization	|O
-	|O
induced	|O
activation	|O
by	|O
OR1	|B-PROTEIN
/	|O
RXRalpha	|B-PROTEIN
.	|O

By	|O
contrast	|O
,	|O
mTRAP100	|B-PROTEIN
coprecipitates	|O
in	|O
vivo	|O
with	|O
another	|O
component	|O
of	|O
the	|O
TRAP	|B-PROTEIN
complex	|O
(	|O
TRAP220	|B-PROTEIN
)	|O
,	|O
which	|O
directly	|O
contacts	|O
TR	|B-PROTEIN
and	|O
the	|O
vitamin	|B-PROTEIN
D	|I-PROTEIN
receptor	|I-PROTEIN
in	|O
a	|O
ligand	|O
-	|O
dependent	|O
manner	|O
.	|O

This	|O
sequence	|O
also	|O
confers	|O
VDR	|B-PROTEIN
and	|O
vitamin	|O
D	|O
responsiveness	|O
to	|O
a	|O
heterologous	|O
promoter	|O
.	|O

Classical	|O
ligand	|O
-	|O
activated	|O
nuclear	|O
receptors	|O
(	|O
e.g.	|O
thyroid	|B-PROTEIN
hormone	|I-PROTEIN
receptor	|I-PROTEIN
,	|O
retinoic	|B-PROTEIN
acid	|I-PROTEIN
receptor	|I-PROTEIN
)	|O
,	|O
orphan	|B-PROTEIN
nuclear	|I-PROTEIN
receptors	|I-PROTEIN
(	|O
e.g.	|O

Expression	|O
of	|O
GlcNAc	|B-PROTEIN
-	|I-PROTEIN
TI	|I-PROTEIN
mRNA	|O
in	|O
tobacco	|O
leaves	|O
was	|O
detected	|O
using	|O
RT	|O
-	|O
PCR	|O
.	|O

Chemical	|O
stability	|O
tests	|O
and	|O
site	|O
-	|O
specific	|O
mutagenesis	|O
identified	|O
amino	|O
acids	|O
H219	|O
and	|O
D63	|O
of	|O
RegS	|B-PROTEIN
and	|O
RegR	|B-PROTEIN
,	|O
respectively	|O
,	|O
as	|O
the	|O
phosphorylated	|O
residues	|O
.	|O

An	|O
overexpression	|O
of	|O
the	|O
betaAPP	|B-PROTEIN
gene	|O
in	|O
certain	|O
areas	|O
of	|O
the	|O
AD	|O
brain	|O
has	|O
been	|O
suggested	|O
to	|O
be	|O
an	|O
important	|O
factor	|O
in	|O
the	|O
neuropathology	|O
of	|O
AD	|O
.	|O

For	|O
functional	|O
studies	|O
,	|O
two	|O
promoter	|O
regions	|O
were	|O
cloned	|O
upstream	|O
of	|O
the	|O
reporter	|O
gene	|O
,	|O
chloramphenicol	|B-PROTEIN
acetyl	|I-PROTEIN
transferase	|I-PROTEIN
(	|O
CAT	|B-PROTEIN
)	|O
:	|O
(	|O
i	|O
)	|O
phbetaE	|O
-	|O
B	|O
-	|O
the	|O
plasmid	|O
that	|O
contains	|O
the	|O
human	|O
(	|O
h	|O
)	|O
promoter	|O
region	|O
(	|O
-	|O
2832	|O
to	|O
+	|O
101	|O
)	|O
including	|O
URE	|O
,	|O
and	|O
(	|O
ii	|O
)	|O
prhbetaE	|O
-	|O
B	|O
-	|O
the	|O
plasmid	|O
that	|O
contains	|O
the	|O
rhesus	|O
(	|O
rh	|O
)	|O
promoter	|O
region	|O
excluding	|O
URE	|O
as	|O
it	|O
lacks	|O
a	|O
270	|O
bp	|O
region	|O
of	|O
the	|O
hbetaAPP	|B-PROTEIN
promoter	|O
(	|O
-	|O
2435	|O
to	|O
-	|O
2165	|O
)	|O
.	|O

67	|O
393	|O
bp	|O
of	|O
contiguous	|O
DNA	|O
located	|O
between	|O
markers	|O
cdc18	|B-PROTEIN
and	|O
cdc14	|B-PROTEIN
on	|O
the	|O
right	|O
arm	|O
of	|O
fission	|O
yeast	|O
chromosome	|O
II	|O
has	|O
been	|O
sequenced	|O
as	|O
part	|O
of	|O
the	|O
European	|O
Union	|O
Schizosaccharomyces	|O
pombe	|O
genome	|O
sequencing	|O
project	|O
.	|O

67	|O
393	|O
bp	|O
of	|O
contiguous	|O
DNA	|O
located	|O
between	|O
markers	|O
cdc18	|B-PROTEIN
and	|O
cdc14	|B-PROTEIN
on	|O
the	|O
right	|O
arm	|O
of	|O
fission	|O
yeast	|O
chromosome	|O
II	|O
has	|O
been	|O
sequenced	|O
as	|O
part	|O
of	|O
the	|O
European	|O
Union	|O
Schizosaccharomyces	|O
pombe	|O
genome	|O
sequencing	|O
project	|O
.	|O

G	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
(	|O
480	|O
micrograms	|O
subcutaneously	|O
(	|O
s.c	|O
.	|O
)	|O
)	|O
were	|O
used	|O
in	|O
55	|O
and	|O
GM	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
(	|O
400	|O
micrograms	|O
s.c	|O
.	|O
)	|O
in	|O
28	|O
chemotherapeutic	|O
cycles	|O
.	|O

Overexpression	|O
of	|O
H411	|B-PROTEIN
cDNA	|O
in	|O
the	|O
RAW	|O
264.7	|O
macrophage	|O
cell	|O
line	|O
promoted	|O
an	|O
increased	|O
growth	|O
rate	|O
,	|O
suggesting	|O
that	|O
expression	|O
of	|O
H411	|B-PROTEIN
is	|O
part	|O
of	|O
the	|O
proliferative	|O
cell	|O
response	|O
to	|O
LPS	|O
.	|O

Human	|O
expressed	|O
sequence	|O
tag	|O
clones	|O
were	|O
identified	|O
by	|O
sequence	|O
similarity	|O
to	|O
mammalian	|O
and	|O
yeast	|O
oligosaccharide	|O
-	|O
processing	|O
mannosidases	|B-PROTEIN
,	|O
and	|O
the	|O
full	|O
-	|O
length	|O
coding	|O
region	|O
of	|O
the	|O
putative	|O
mannosidase	|B-PROTEIN
homolog	|O
was	|O
isolated	|O
by	|O
a	|O
combination	|O
of	|O
5'	|O
-	|O
rapid	|O
amplification	|O
of	|O
cDNA	|O
ends	|O
and	|O
direct	|O
polymerase	|O
chain	|O
reaction	|O
from	|O
human	|O
placental	|O
cDNA	|O
.	|O

Activation	|O
of	|O
ERK1/2	|B-PROTEIN
is	|O
correlated	|O
with	|O
induction	|O
of	|O
the	|O
immediate	|B-PROTEIN
-	|I-PROTEIN
early	|I-PROTEIN
response	|I-PROTEIN
genes	|I-PROTEIN
.	|O

The	|O
transcription	|O
of	|O
most	|O
RP	|B-PROTEIN
genes	|O
is	|O
activated	|O
by	|O
two	|O
Rap1p	|B-PROTEIN
binding	|O
sites	|O
,	|O
250	|O
to	|O
400	|O
bp	|O
upstream	|O
from	|O
the	|O
initiation	|O
of	|O
transcription	|O
.	|O

We	|O
have	|O
isolated	|O
three	|O
mutant	|O
alleles	|O
of	|O
CDC4	|B-PROTEIN
(	|O
cdc4	|B-PROTEIN
-	|I-PROTEIN
10	|I-PROTEIN
,	|O
cdc4	|B-PROTEIN
-	|I-PROTEIN
11	|I-PROTEIN
,	|O
and	|O
cdc4	|B-PROTEIN
-	|I-PROTEIN
16	|I-PROTEIN
)	|O
which	|O
suppress	|O
the	|O
nuclear	|O
division	|O
defect	|O
of	|O
cdc20	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
cells	|O
.	|O

Role	|O
of	|O
secondary	|O
structure	|O
in	|O
discrimination	|O
between	|O
constitutive	|O
and	|O
inducible	|O
activators	|O
.	|O

In	|O
summary	|O
,	|O
Ca	|O
(	|O
2+	|O
)	|O
-	|O
dependent	|O
activation	|O
of	|O
NO	|O
production	|O
mediates	|O
apoptosis	|O
after	|O
TG	|B-PROTEIN
exposure	|O
in	|O
JT	|O
/	|O
Neo	|O
cells	|O
.	|O

Accumulation	|O
of	|O
the	|O
U4	|B-PROTEIN
/	|O
U6	|B-PROTEIN
duplex	|O
was	|O
relieved	|O
by	|O
overexpression	|O
of	|O
wild	|O
-	|O
type	|O
Prp44p	|B-PROTEIN
.	|O

Our	|O
results	|O
,	|O
when	|O
combined	|O
with	|O
previously	|O
published	|O
in	|O
vitro	|O
results	|O
,	|O
support	|O
a	|O
direct	|O
role	|O
for	|O
Prp44p	|B-PROTEIN
in	|O
unwinding	|O
of	|O
the	|O
U4	|B-PROTEIN
/	|O
U6	|B-PROTEIN
helix	|O
.	|O

This	|O
approximately	|O
125	|O
-	|O
nt	|O
RNA	|O
proved	|O
to	|O
arise	|O
via	|O
RNase	|B-PROTEIN
E	|I-PROTEIN
cleavage	|O
from	|O
the	|O
3'	|O
-	|O
terminal	|O
region	|O
of	|O
the	|O
mRNAs	|O
bearing	|O
the	|O
terminator	|O
.	|O

The	|O
mysteries	|O
of	|O
geographic	|O
variability	|O
in	|O
nonmelanoma	|O
skin	|O
cancer	|O
incidence	|O
.	|O

In	|O
Saccharomyces	|O
cerevisiae	|O
the	|O
cAMP	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
kinases	|I-PROTEIN
(	|O
PKAs	|B-PROTEIN
)	|O
promote	|O
cytoplasmic	|O
growth	|O
and	|O
modulate	|O
the	|O
growth	|O
-	|O
regulated	|O
mechanism	|O
triggering	|O
the	|O
begin	|O
of	|O
DNA	|O
synthesis	|O
.	|O

We	|O
have	|O
shown	|O
previously	|O
that	|O
in	|O
contrast	|O
to	|O
other	|O
extracellular	|O
matrix	|O
molecules	|O
pepsin	|B-PROTEIN
-	|O
solubilized	|O
collagen	|B-PROTEIN
VI	|I-PROTEIN
(	|O
CVI	|B-PROTEIN
)	|O
can	|O
stimulate	|O
DNA	|O
synthesis	|O
of	|O
various	|O
mesenchymal	|O
cell	|O
types	|O
,	|O
apparently	|O
independent	|O
of	|O
integrin	|B-PROTEIN
-	|O
mediated	|O
signal	|O
transduction	|O
.	|O

A	|O
recombinant	|O
derivative	|O
harboring	|O
the	|O
pMJ101	|O
replication	|O
region	|O
proved	|O
to	|O
be	|O
compatible	|O
with	|O
pJM1	|O
,	|O
a	|O
plasmid	|O
containing	|O
the	|O
iron	|O
acquisition	|O
system	|O
required	|O
for	|O
the	|O
virulence	|O
of	|O
V.	|O
anguillarum	|O
775	|O
,	|O
another	|O
important	|O
pathogen	|O
that	|O
causes	|O
vibriosis	|O
.	|O

FAK	|B-PROTEIN
localizes	|O
to	|O
sites	|O
of	|O
transmembrane	|O
integrin	|B-PROTEIN
receptor	|I-PROTEIN
clustering	|O
and	|O
facilitates	|O
intracellular	|O
signaling	|O
events	|O
.	|O

Expression	|O
of	|O
various	|O
FAK	|B-PROTEIN
mutants	|O
in	|O
the	|O
FAK	|B-PROTEIN
-	|O
cells	|O
showed	|O
that	|O
FAK	|B-PROTEIN
kinase	|O
activity	|O
,	|O
the	|O
Tyr	|B-PROTEIN
-	|I-PROTEIN
397	|I-PROTEIN
/	|I-PROTEIN
SH2	|I-PROTEIN
domain	|O
binding	|O
site	|O
,	|O
and	|O
the	|O
first	|O
proline	|O
-	|O
rich	|O
SH3	|B-PROTEIN
binding	|O
region	|O
in	|O
the	|O
FAK	|B-PROTEIN
C	|O
-	|O
terminal	|O
domain	|O
were	|O
individually	|O
needed	|O
to	|O
promote	|O
full	|O
FAK	|B-PROTEIN
-	|O
mediated	|O
FAK	|B-PROTEIN
-	|O
cell	|O
migration	|O
to	|O
FN	|B-PROTEIN
whereas	|O
direct	|O
paxillin	|B-PROTEIN
binding	|O
to	|O
FAK	|B-PROTEIN
was	|O
not	|O
required	|O
.	|O

This	|O
dominant	|O
-	|O
negative	|O
effect	|O
of	|O
FRNK	|B-PROTEIN
was	|O
reversed	|O
by	|O
a	|O
point	|O
mutation	|O
(	|O
Leu	|O
-	|O
1034	|O
to	|O
Ser	|O
)	|O
which	|O
prevented	|O
FRNK	|B-PROTEIN
localization	|O
to	|O
focal	|O
contact	|O
sites	|O
.	|O

Fifty	|O
six	|O
young	|O
patients	|O
(	|O
age	|O
<	|O
45	|O
yr	|O
)	|O
with	|O
doppler	|O
-	|O
proven	|O
DVT	|O
were	|O
investigated	|O
for	|O
the	|O
presence	|O
of	|O
resistance	|O
to	|O
activated	|B-PROTEIN
protein	|I-PROTEIN
C	|I-PROTEIN
(	|O
APC	|B-PROTEIN
-	|I-PROTEIN
R	|I-PROTEIN
)	|O
,	|O
lupus	|O
anticoagulant	|O
(	|O
LA	|O
)	|O
,	|O
anticardiolipin	|B-PROTEIN
antibodies	|I-PROTEIN
and	|O
deficiencies	|O
of	|O
protein	|B-PROTEIN
C	|I-PROTEIN
,	|O
protein	|B-PROTEIN
S	|I-PROTEIN
,	|O
ATIII	|B-PROTEIN
activities	|O
.	|O

DESIGN	|O
:	|O
Comparison	|O
of	|O
number	|O
of	|O
women	|O
with	|O
PKU	|O
aged	|O
15-44	|O
years	|O
on	|O
the	|O
NSW	|O
PKU	|O
database	|O
(	|O
observed	|O
number	|O
)	|O
with	|O
expected	|O
number	|O
derived	|O
from	|O
population	|O
data	|O
.	|O

PURPOSE	|O
:	|O
The	|O
purposes	|O
of	|O
the	|O
present	|O
study	|O
were	|O
to	|O
assess	|O
the	|O
effects	|O
of	|O
a	|O
12	|O
-	|O
wk	|O
laboratory	|O
based	|O
aerobic	|O
exercise	|O
program	|O
on	|O
cardiopulmonary	|O
function	|O
,	|O
CD4	|B-PROTEIN
cell	|O
count	|O
,	|O
and	|O
physician	|O
-	|O
assessed	|O
health	|O
status	|O
among	|O
symptomatic	|O
pre	|O
-	|O
AIDS	|O
HIV	|O
-	|O
infected	|O
individuals	|O
(	|O
N	|O
=	|O
28	|O
)	|O
and	|O
to	|O
assess	|O
the	|O
degree	|O
to	|O
which	|O
ill	|O
health	|O
was	|O
associated	|O
with	|O
exercise	|O
relapse	|O
.	|O

The	|O
enzyme	|O
displays	|O
optimal	|O
activity	|O
at	|O
about	|O
0.5	|O
mM	|O
pantoate	|O
(	|O
k	|O
(	|O
cat	|O
)	|O
0.63	|O
s	|O
(	|O
-	|O
1	|O
)	|O
)	|O
and	|O
at	|O
pH	|O
7.8	|O
.	|O

Taken	|O
together	|O
,	|O
these	|O
results	|O
demonstrate	|O
that	|O
the	|O
RP	|B-PROTEIN
,	|O
like	|O
the	|O
20S	|B-PROTEIN
proteasome	|O
,	|O
is	|O
functionally	|O
and	|O
structurally	|O
conserved	|O
among	|O
eukaryotes	|O
and	|O
indicate	|O
that	|O
the	|O
plant	|O
RPT	|B-PROTEIN
subunits	|O
,	|O
like	|O
their	|O
yeast	|O
counterparts	|O
,	|O
have	|O
non	|O
-	|O
redundant	|O
functions	|O
.	|O

Epidemiologic	|O
evidence	|O
indicates	|O
that	|O
estrogen	|O
replacement	|O
therapy	|O
after	|O
menopause	|O
increases	|O
breast	|O
cancer	|O
risk	|O
.	|O

In	|O
addition	|O
to	|O
its	|O
elongation	|O
activity	|O
,	|O
ELL	|B-PROTEIN
contains	|O
a	|O
novel	|O
type	|O
of	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
II	|I-PROTEIN
interaction	|O
domain	|O
that	|O
is	|O
capable	|O
of	|O
repressing	|O
polymerase	|O
activity	|O
in	|O
promoter	|O
-	|O
specific	|O
transcription	|O
.	|O

A	|O
diagnosis	|O
of	|O
IgA	|B-PROTEIN
lambda	|I-PROTEIN
multiple	|O
myeloma	|O
with	|O
peritoneal	|O
involvement	|O
was	|O
made	|O
.	|O

The	|O
radiation	|O
burden	|O
associated	|O
with	|O
the	|O
majority	|O
of	|O
examinations	|O
in	|O
nuclear	|O
medicine	|O
expressed	|O
as	|O
the	|O
effective	|O
dose	|O
is	|O
comparable	|O
with	|O
the	|O
radiation	|O
burden	|O
of	|O
radiodiagnostic	|O
examinations	|O
,	|O
only	|O
after	|O
administration	|O
of	|O
preparations	|O
with	|O
131I	|O
,	|O
201Tl	|O
,	|O
67Ga	|O
and	|O
111In	|O
it	|O
is	|O
markedly	|O
higher	|O
.	|O

Although	|O
the	|O
risk	|O
of	|O
malformation	|O
in	|O
children	|O
born	|O
after	|O
ICSI	|O
is	|O
not	|O
increased	|O
there	|O
is	|O
an	|O
increased	|O
risk	|O
to	|O
transmit	|O
genetic	|O
abnormalities	|O
in	|O
case	|O
of	|O
NOA	|O
(	|O
such	|O
as	|O
the	|O
rate	|O
of	|O
sex	|O
chromosome	|O
,	|O
or	|O
microdeletions	|O
of	|O
the	|O
Y	|O
chromosome	|O
)	|O
and	|O
in	|O
case	|O
of	|O
congenital	|O
OA	|O
(	|O
mutations	|O
of	|O
the	|O
cystic	|B-PROTEIN
fibrosis	|I-PROTEIN
gene	|I-PROTEIN
)	|O
.	|O

TaV	|O
particles	|O
have	|O
a	|O
buoyant	|O
density	|O
of	|O
1.296	|O
g	|O
/	|O
cm3	|O
in	|O
CsCl	|O
and	|O
consist	|O
of	|O
two	|O
capsid	|B-PROTEIN
proteins	|I-PROTEIN
of	|O
56	|O
and	|O
6	|O
kDa	|O
.	|O

CONCLUSION	|O
:	|O
These	|O
results	|O
suggest	|O
that	|O
vibration	|O
-	|O
induced	|O
neural	|O
involvement	|O
can	|O
be	|O
considered	|O
neither	|O
pure	|O
digital	|O
neuropathy	|O
,	|O
nor	|O
definite	|O
CTS	|O
,	|O
as	|O
previously	|O
described	|O
.	|O

In	|O
about	|O
770	|O
bp	|O
upstream	|O
region	|O
of	|O
Spam1	|B-PROTEIN
that	|O
has	|O
been	|O
cloned	|O
and	|O
sequenced	|O
,	|O
multiple	|O
transcription	|O
factor	|O
binding	|O
sites	|O
including	|O
a	|O
CRE	|O
(	|O
cAMP	|O
-	|O
responsive	|O
element	|O
)	|O
were	|O
found	|O
.	|O

The	|O
in	|O
vitro	|O
relaxivity	|O
of	|O
the	|O
complex	|O
is	|O
16.24	|O
s	|O
(	|O
-	|O
1	|O
)	|O
mM	|O
(	|O
-	|O
1	|O
)	|O
.	|O

Structure	|O
and	|O
expression	|O
of	|O
the	|O
mouse	|O
growth	|B-PROTEIN
hormone	|I-PROTEIN
receptor	|I-PROTEIN
/	|O
growth	|B-PROTEIN
hormone	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
gene	|O
.	|O

Bacterial	|O
recovery	|O
of	|O
SA	|O
from	|O
the	|O
liver	|O
/	|O
spleen	|O
and	|O
the	|O
cecal	|O
tonsil	|O
in	|O
contact	|O
poults	|O
and	|O
SG	|O
from	|O
contact	|O
chicks	|O
treated	|O
with	|O
ILK	|B-PROTEIN
was	|O
dramatically	|O
reduced	|O
when	|O
compared	|O
to	|O
non	|O
-	|O
treated	|O
contact	|O
poults	|O
and	|O
chicks	|O
.	|O

The	|O
results	|O
of	|O
the	|O
ISIS	|O
-	|O
2	|O
trial	|O
and	|O
the	|O
data	|O
from	|O
the	|O
Antiplatelet	|O
Trialists	|O
'	|O
Collaboration	|O
indicated	|O
that	|O
aspirin	|O
is	|O
mandatory	|O
in	|O
patients	|O
with	|O
acute	|O
myocardial	|O
infarction	|O
and	|O
for	|O
secondary	|O
prevention	|O
.	|O

This	|O
study	|O
was	|O
performed	|O
to	|O
assess	|O
the	|O
role	|O
of	|O
additional	|O
diagnostic	|O
laparoscopy	|O
in	|O
the	|O
preoperative	|O
staging	|O
of	|O
patients	|O
with	|O
adenocarcinoma	|O
of	|O
the	|O
esophagus	|O
,	|O
gastric	|O
cancer	|O
and	|O
pancreatic	|O
cancer	|O
prior	|O
to	|O
intended	|O
curative	|O
surgery	|O
.	|O

This	|O
report	|O
presents	|O
state	|O
-	|O
specific	|O
MMRs	|O
for	|O
1987-1996	|O
,	|O
focusing	|O
on	|O
persistent	|O
disparities	|O
in	|O
maternal	|O
mortality	|O
between	|O
black	|O
and	|O
white	|O
women	|O
.	|O

Preheparin	|O
LPL	|B-PROTEIN
mass	|O
level	|O
did	|O
not	|O
significantly	|O
differ	|O
in	|O
individuals	|O
from	|O
19	|O
to	|O
70	|O
years	|O
old	|O
,	|O
for	|O
both	|O
men	|O
and	|O
women	|O
.	|O

A	|O
decrease	|O
in	|O
insulin	|B-PROTEIN
-	|O
induced	|O
receptor	|O
kinase	|O
activity	|O
was	|O
observed	|O
for	|O
solubilized	|O
chimeric	|O
receptors	|O
.	|O

Cat	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
identical	|O
to	|O
the	|O
recently	|O
identified	|O
binding	|O
partner	|O
for	|O
the	|O
beta	|B-PROTEIN
-	|I-PROTEIN
adrenergic	|I-PROTEIN
receptor	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
betaARK	|B-PROTEIN
or	|O
GRK	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
)	|O
,	|O
which	|O
was	|O
shown	|O
to	|O
have	|O
Arf	|B-PROTEIN
-	|O
GAP	|B-PROTEIN
activity	|O
.	|O

Cat	|B-PROTEIN
proteins	|O
are	|O
tyrosine	|O
-	|O
phosphorylated	|O
when	|O
co	|O
-	|O
expressed	|O
in	|O
cells	|O
with	|O
the	|O
focal	|B-PROTEIN
adhesion	|I-PROTEIN
kinase	|I-PROTEIN
Fak	|O
and	|O
Src	|B-PROTEIN
.	|O

Immunoprecipitation	|O
experiments	|O
using	|O
DokR	|B-PROTEIN
-	|O
specific	|O
antibodies	|O
revealed	|O
an	|O
interaction	|O
between	|O
endogenous	|O
DokR	|B-PROTEIN
and	|O
a	|O
150	|O
-	|O
kDa	|O
protein	|O
that	|O
is	|O
tyrosine	|O
-	|O
phosphorylated	|O
in	|O
EGF	|B-PROTEIN
-	|O
stimulated	|O
BaF	|O
/	|O
3	|O
cells	|O
.	|O

Expansins	|B-PROTEIN
are	|O
a	|O
family	|O
of	|O
proteins	|O
that	|O
catalyse	|O
long	|O
-	|O
term	|O
extension	|O
of	|O
isolated	|O
plant	|O
cell	|O
walls	|O
due	|O
to	|O
an	|O
as	|O
yet	|O
unknown	|O
biochemical	|O
mechanism	|O
.	|O

This	|O
review	|O
summarizes	|O
the	|O
clinical	|O
evidence	|O
to	|O
support	|O
current	|O
therapies	|O
in	|O
irritable	|O
bowel	|O
syndrome	|O
(	|O
IBS	|O
)	|O
.	|O

The	|O
responsive	|O
region	|O
of	|O
the	|O
alpha	|B-PROTEIN
2	|I-PROTEIN
(	|I-PROTEIN
V	|I-PROTEIN
)	|I-PROTEIN
collagen	|I-PROTEIN
gene	|O
was	|O
localized	|O
to	|O
a	|O
fragment	|O
including	|O
100	|O
bp	|O
of	|O
basal	|O
promoter	|O
and	|O
150	|O
bp	|O
of	|O
exon	|O
1	|O
sequences	|O
,	|O
which	|O
contained	|O
two	|O
CRE	|O
-	|O
like	|O
elements	|O
.	|O

Furthermore	|O
,	|O
addition	|O
of	|O
B	|B-PROTEIN
-	|I-PROTEIN
Myb	|I-PROTEIN
-	|O
glutathionine	|B-PROTEIN
S	|I-PROTEIN
-	|I-PROTEIN
transferase	|I-PROTEIN
fusion	|O
protein	|O
inhibited	|O
complex	|O
formation	|O
.	|O

APOE	|B-PROTEIN
-	|O
epsilon4	|O
count	|O
predicts	|O
age	|O
when	|O
prevalence	|O
of	|O
AD	|O
increases	|O
,	|O
then	|O
declines	|O
:	|O
the	|O
Cache	|O
County	|O
Study	|O
.	|O

Repair	|O
of	|O
double	|O
-	|O
strand	|O
breaks	|O
(	|O
DSBs	|O
)	|O
in	|O
chromosomal	|O
DNA	|O
by	|O
nonhomologous	|O
end	|O
-	|O
joining	|O
(	|O
NHEJ	|O
)	|O
is	|O
not	|O
well	|O
characterized	|O
in	|O
the	|O
yeast	|O
Saccharomyces	|O
cerevisiae	|O
.	|O

A	|O
new	|O
DNA	|B-PROTEIN
repair	|I-PROTEIN
gene	|I-PROTEIN
from	|O
Schizosaccharomyces	|O
pombe	|O
with	|O
homology	|O
to	|O
RecA	|B-PROTEIN
was	|O
identified	|O
and	|O
characterized	|O
.	|O

Among	|O
mucus	|O
-	|O
secreting	|O
cells	|O
,	|O
the	|O
gastric	|O
gland	|O
mucous	|O
cells	|O
,	|O
Brunner	|O
's	|O
glands	|O
,	|O
accessory	|O
glands	|O
of	|O
pancreaticobiliary	|O
tract	|O
,	|O
and	|O
pancreatic	|O
ducts	|O
exhibiting	|O
gastric	|O
metaplasia	|O
are	|O
unique	|O
in	|O
that	|O
they	|O
express	|O
class	|B-PROTEIN
III	|I-PROTEIN
mucin	|I-PROTEIN
identified	|O
by	|O
paradoxical	|O
Con	|B-PROTEIN
A	|I-PROTEIN
staining	|O
composed	|O
of	|O
periodate	|O
oxidation	|O
,	|O
sodium	|O
borohydride	|O
reduction	|O
,	|O
Con	|B-PROTEIN
A	|I-PROTEIN
,	|O
and	|O
horseradish	|B-PROTEIN
peroxidase	|I-PROTEIN
reaction	|O
.	|O

The	|O
C	|O
-	|O
terminal	|O
mutants	|O
were	|O
strongly	|O
dominant	|O
over	|O
TraR	|B-PROTEIN
,	|O
suggesting	|O
that	|O
they	|O
can	|O
form	|O
heteromultimers	|O
with	|O
the	|O
wild	|O
-	|O
type	|O
activator	|O
.	|O

Thus	|O
,	|O
elongin	|B-PROTEIN
C	|I-PROTEIN
is	|O
found	|O
to	|O
oligomerize	|O
in	|O
solution	|O
and	|O
to	|O
undergo	|O
significant	|O
structural	|O
rearrangements	|O
upon	|O
binding	|O
of	|O
two	|O
different	|O
partner	|O
proteins	|O
.	|O

The	|O
data	|O
imply	|O
that	|O
JAK	|B-PROTEIN
/	|O
STAT	|B-PROTEIN
signaling	|O
has	|O
a	|O
role	|O
in	|O
EBV	|O
-	|O
associated	|O
malignancies	|O
.	|O

There	|O
were	|O
27	|O
men	|O
and	|O
156	|O
women	|O
.	|O

A.	|O
,	|O
Bowers	|O
,	|O
K.E	|O
,	|O
and	|O
Matthews	|O
,	|O
C.	|O

Spfkh1	|B-PROTEIN
is	|O
transcribed	|O
in	|O
one	|O
open	|O
reading	|O
frame	|O
that	|O
contains	|O
the	|O
DNA	|O
binding	|O
domain	|O
,	|O
nuclear	|O
localization	|O
signal	|O
and	|O
transactivation	|O
domain	|O
.	|O

The	|O
molecular	|O
mechanism	|O
of	|O
Tax	|B-PROTEIN
-	|O
mediated	|O
trans	|O
-	|O
activation	|O
has	|O
been	|O
well	|O
investigated	|O
.	|O

Gel	|O
filtration	|O
and	|O
co	|O
-	|O
immunoprecipitation	|O
analyses	|O
reveal	|O
that	|O
Mad2p	|B-PROTEIN
tightly	|O
associates	|O
with	|O
another	|O
spindle	|O
checkpoint	|O
component	|O
,	|O
Mad1p	|B-PROTEIN
.	|O

METHODS	|O
:	|O
109	|O
suspected	|O
cases	|O
with	|O
SS	|O
underwent	|O
the	|O
biopsies	|O
.	|O

We	|O
also	|O
identify	|O
several	|O
regulatory	|O
domain	|O
mutants	|O
in	|O
which	|O
Cd	|O
(	|O
2+	|O
)	|O
tolerance	|O
of	|O
the	|O
mutant	|O
strain	|O
and	|O
transport	|O
activity	|O
of	|O
the	|O
protein	|O
are	|O
dissociated	|O
.	|O

The	|O
human	|O
immunodeficiency	|O
virus	|O
type	|O
-	|O
1	|O
(	|O
HIV	|O
-	|O
1	|O
)	|O
Tat	|B-PROTEIN
protein	|O
regulates	|O
transcription	|O
by	|O
stimulating	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
processivity	|O
.	|O

One	|O
of	|O
these	|O
SEBPs	|B-PROTEIN
,	|O
SEBP2	|B-PROTEIN
,	|O
was	|O
shown	|O
to	|O
be	|O
the	|O
product	|O
of	|O
the	|O
homeotic	|B-PROTEIN
gene	|I-PROTEIN
fork	|O
head	|O
.	|O

Identity	|O
elements	|O
in	|O
tRNA	|O
for	|O
mono	|O
-	|O
and	|O
dimethylation	|O
reactions	|O
by	|O
the	|O
recombinant	|O
pfTrm1p	|B-PROTEIN
were	|O
identified	|O
using	|O
in	|O
vitro	|O
T7	|O
transcripts	|O
of	|O
33	|O
variants	|O
of	|O
tRNA	|B-PROTEIN
(	|I-PROTEIN
Asp	|I-PROTEIN
)	|I-PROTEIN
and	|O
tRNA	|B-PROTEIN
(	|I-PROTEIN
Phe	|I-PROTEIN
)	|I-PROTEIN
from	|O
yeast	|O
.	|O

In	|O
insulin	|B-PROTEIN
-	|O
responsive	|O
cells	|O
,	|O
Akt	|B-PROTEIN
phosphorylates	|O
and	|O
inactivates	|O
the	|O
serine	|B-PROTEIN
/	|I-PROTEIN
threonine	|I-PROTEIN
kinase	|I-PROTEIN
glycogen	|O
synthase	|O
kinase	|O
-	|O
3	|O
(	|O
GSK	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
)	|O
.	|O

The	|O
B	|B-PROTEIN
cell	|I-PROTEIN
antigen	|I-PROTEIN
receptor	|I-PROTEIN
activates	|O
the	|O
Akt	|B-PROTEIN
(	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
B	|I-PROTEIN
)	|O
/	|O
glycogen	|B-PROTEIN
synthase	|I-PROTEIN
kinase	|I-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
signaling	|O
pathway	|O
via	|O
phosphatidylinositol	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
.	|O

Fewer	|O
recombination	|O
events	|O
are	|O
detected	|O
in	|O
four	|O
different	|O
B	|O
and	|O
T	|O
cell	|O
lines	|O
that	|O
do	|O
not	|O
undergo	|O
switch	|O
recombination	|O
of	|O
their	|O
endogenous	|O
genes	|O
.	|O

IL	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
TNF	|B-PROTEIN
increase	|O
AND	|B-PROTEIN
-	|I-PROTEIN
34	|I-PROTEIN
transcript	|O
levels	|O
in	|O
thymic	|O
cortical	|O
reticular	|O
,	|O
thymic	|O
nurse	|O
,	|O
and	|O
fibroblast	|O
cell	|O
lines	|O
.	|O

To	|O
determine	|O
what	|O
role	|O
eIF4E	|B-PROTEIN
might	|O
play	|O
in	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
expression	|O
,	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
5'	|O
untranslated	|O
region	|O
(	|O
UTR	|O
)	|O
was	|O
fused	|O
in	|O
-	|O
frame	|O
to	|O
CAT	|B-PROTEIN
reporters	|O
,	|O
and	|O
several	|O
more	|O
derivative	|O
constructs	|O
were	|O
made	|O
.	|O

Analysis	|O
of	|O
cell	|O
cycle	|O
proteins	|O
showed	|O
that	|O
24	|O
h	|O
of	|O
lovastatin	|O
treatment	|O
in	|O
the	|O
control	|O
cells	|O
caused	|O
an	|O
elevation	|O
in	|O
the	|O
levels	|O
of	|O
the	|O
cyclin	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
kinase	|I-PROTEIN
inhibitor	|O
p27	|B-PROTEIN
(	|O
kip1	|B-PROTEIN
)	|O
,	|O
inhibition	|O
of	|O
both	|O
cyclin	|B-PROTEIN
E	|I-PROTEIN
-	|I-PROTEIN
and	|I-PROTEIN
cyclin	|I-PROTEIN
A	|I-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
kinase	|I-PROTEIN
activity	|O
,	|O
and	|O
decreased	|O
levels	|O
of	|O
hyperphosphorylated	|O
retinoblastoma	|B-PROTEIN
protein	|I-PROTEIN
(	|O
pRb	|B-PROTEIN
)	|O
.	|O

RESULTS	|O
:	|O
Circulating	|O
leptin	|B-PROTEIN
concentrations	|O
in	|O
AN	|O
were	|O
3.5	|O
+	|O
/	|O
-	|O
0.5	|O
versus	|O
7.6	|O
+	|O
/	|O
-	|O
1.2	|O
ng	|O
/	|O
ml	|O
in	|O
control	|O
subjects	|O
.	|O

Copyright	|O
1999	|O
Academic	|O
Press	|O
.	|O

Oligonucleotide	|O
probes	|O
corresponding	|O
to	|O
wild	|O
-	|O
type	|O
and	|O
mutant	|O
EpRE	|O
sequences	|O
were	|O
used	|O
in	|O
gel	|O
-	|O
shift	|O
and	|O
super	|O
-	|O
shift	|O
analyses	|O
to	|O
identify	|O
proteins	|O
binding	|O
.	|O

PKNbeta	|B-PROTEIN
had	|O
high	|O
sequence	|O
homology	|O
with	|O
PKNalpha	|B-PROTEIN
,	|O
originally	|O
isolated	|O
PKN	|B-PROTEIN
,	|O
especially	|O
in	|O
the	|O
repeats	|O
of	|O
charged	|O
amino	|O
acid	|O
-	|O
rich	|O
region	|O
with	|O
leucine	|O
-	|O
zipper	|O
like	|O
sequences	|O
(	|O
CZ	|O
region	|O
/	|O
HR1	|O
)	|O
,	|O
in	|O
the	|O
carboxyl	|O
-	|O
terminal	|O
catalytic	|O
domain	|O
,	|O
and	|O
in	|O
approximately	|O
130	|O
amino	|O
acid	|O
stretch	|O
(	|O
D	|O
region	|O
/	|O
HR2	|O
)	|O
,	|O
located	|O
between	|O
CZ	|O
region	|O
/	|O
HR1	|O
and	|O
the	|O
catalytic	|O
domain	|O
.	|O

At	|O
baseline	|O
,	|O
serum	|O
levels	|O
of	|O
lycopene	|O
and	|O
FLOP	|O
were	|O
abnormally	|O
high	|O
and	|O
serum	|O
FLOP	|O
was	|O
correlated	|O
significantly	|O
with	|O
plasma	|O
cyclosporine	|O
levels	|O
(	|O
r	|O
=	|O
0.646	|O
,	|O
p	|O
=	|O
0.016	|O
)	|O
.	|O

BACKGROUND	|O
:	|O
Chronic	|O
alcohol	|O
consumption	|O
has	|O
been	|O
demonstrated	|O
to	|O
be	|O
deleterious	|O
to	|O
bone	|O
health	|O
.	|O

Interestingly	|O
,	|O
following	|O
induction	|O
of	|O
stress	|O
by	|O
heat	|O
shock	|O
,	|O
high	|O
salt	|O
,	|O
or	|O
ethanol	|O
,	|O
conditions	|O
under	|O
which	|O
most	|O
mRNA	|O
export	|O
is	|O
blocked	|O
,	|O
Npl3p	|B-PROTEIN
is	|O
still	|O
exported	|O
from	|O
the	|O
nucleus	|O
.	|O

For	|O
symptomatic	|O
relief	|O
and	|O
inhibition	|O
of	|O
the	|O
growth	|O
of	|O
the	|O
metastases	|O
interferon	|B-PROTEIN
-	|I-PROTEIN
a	|I-PROTEIN
and	|O
somatostatin	|B-PROTEIN
analogues	|O
can	|O
be	|O
employed	|O
.	|O

In	|O
summary	|O
,	|O
the	|O
no	|O
-	|O
adverse	|O
-	|O
effect	|O
-	|O
level	|O
for	|O
this	|O
study	|O
was	|O
determined	|O
to	|O
be	|O
1000	|O
ppm	|O
,	|O
based	|O
on	|O
decreased	|O
weight	|O
gain	|O
in	|O
female	|O
rats	|O
,	|O
and	|O
on	|O
slight	|O
organ	|O
weight	|O
changes	|O
in	|O
both	|O
sexes	|O
at	|O
3000	|O
ppm	|O
.	|O

Some	|O
of	|O
them	|O
produce	|O
gigantic	|O
sperm	|O
several	|O
times	|O
the	|O
total	|O
male	|O
body	|O
length	|O
.	|O

John	|O
leonard	|O
dawson	|O

PDGF	|B-PROTEIN
A	|O
-	|O
chain	|O
levels	|O
increase	|O
in	|O
cultured	|O
vascular	|O
smooth	|O
muscle	|O
cells	|O
(	|O
SMCs	|O
)	|O
exposed	|O
to	|O
ATII	|B-PROTEIN
.	|O

M	|B-PROTEIN
-	|I-PROTEIN
Ras	|I-PROTEIN
interacted	|O
poorly	|O
in	|O
a	|O
yeast	|O
two	|O
-	|O
hybrid	|O
assay	|O
with	|O
multiple	|O
Ras	|B-PROTEIN
effectors	|O
,	|O
including	|O
c	|B-PROTEIN
-	|I-PROTEIN
Raf	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
A	|B-PROTEIN
-	|I-PROTEIN
Raf	|I-PROTEIN
,	|O
B	|B-PROTEIN
-	|I-PROTEIN
Raf	|I-PROTEIN
,	|O
phosphoinositol	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
kinase	|I-PROTEIN
delta	|I-PROTEIN
,	|O
RalGDS	|B-PROTEIN
,	|O
and	|O
Rin1	|B-PROTEIN
.	|O

Deletion	|O
mapping	|O
of	|O
the	|O
human	|O
presenilin	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
(	|O
PS1	|B-PROTEIN
)	|O
promoter	|O
delineated	|O
the	|O
most	|O
active	|O
fragment	|O
from	|O
-	|O
118	|O
to	|O
+	|O
178	|O
in	|O
relation	|O
to	|O
the	|O
transcription	|O
start	|O
site	|O
mapped	|O
in	|O
this	|O
study	|O
,	|O
in	|O
both	|O
human	|O
neuroblastoma	|O
SK	|O
-	|O
N	|O
-	|O
SH	|O
and	|O
hepatoma	|O
HepG2	|O
cells	|O
.	|O

Microcirculatory	|O
oxygenation	|O
and	|O
shunting	|O
in	|O
sepsis	|O
and	|O
shock	|O
.	|O

Analysis	|O
of	|O
the	|O
E2F1	|B-PROTEIN
gene	|O
promoter	|O
showed	|O
that	|O
the	|O
-	|O
146	|O
to	|O
-	|O
54	|O
region	|O
was	|O
required	|O
for	|O
E2	|B-PROTEIN
-	|O
responsiveness	|O
in	|O
transient	|O
transfection	|O
assays	|O
,	|O
and	|O
subsequent	|O
deletion	|O
/	|O
mutation	|O
analysis	|O
showed	|O
that	|O
a	|O
single	|O
upstream	|O
GC	|O
-	|O
rich	|O
and	|O
two	|O
downstream	|O
CCAAT	|O
-	|O
binding	|O
sites	|O
were	|O
required	|O
for	|O
transactivation	|O
by	|O
E2	|B-PROTEIN
.	|O

In	|O
the	|O
course	|O
of	|O
investigating	|O
the	|O
mechanisms	|O
by	|O
which	|O
OF5	|B-PROTEIN
and	|O
OF3	|B-PROTEIN
regulated	|O
CYP11A1	|B-PROTEIN
transcription	|O
,	|O
we	|O
found	|O
that	|O
OF5	|B-PROTEIN
and	|O
OF3	|B-PROTEIN
bound	|O
Sp1	|B-PROTEIN
and	|O
Sp3	|B-PROTEIN
in	|O
JEG	|O
-	|O
3	|O
cells	|O
.	|O

In	|O
contrast	|O
,	|O
the	|O
differentiation	|O
of	|O
neoplastically	|O
transformed	|O
cells	|O
does	|O
not	|O
repress	|O
mitogenic	|O
responsiveness	|O
or	|O
junB	|B-PROTEIN
or	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
inducibility	|O
.	|O

Adipocyte	|O
differentiation	|O
of	|O
nontransformed	|O
cells	|O
also	|O
markedly	|O
represses	|O
the	|O
ability	|O
of	|O
SRF	|B-PROTEIN
to	|O
bind	|O
to	|O
the	|O
junB	|B-PROTEIN
SRE	|O
,	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
SRE	|O
,	|O
and	|O
other	|O
SREs	|O
,	|O
as	|O
determined	|O
by	|O
mobility	|O
shift	|O
and	|O
gel	|O
supershift	|O
assays	|O
,	|O
without	|O
affecting	|O
the	|O
DNA	|O
binding	|O
characteristics	|O
of	|O
the	|O
nuclear	|O
protein	|O
SP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

Transformation	|O
blocks	|O
differentiation	|O
-	|O
induced	|O
inhibition	|O
of	|O
serum	|B-PROTEIN
response	|I-PROTEIN
factor	|I-PROTEIN
interactions	|O
with	|O
serum	|O
response	|O
elements	|O
.	|O

The	|O
core	|B-PROTEIN
enzyme	|O
is	|O
homologous	|O
to	|O
those	|O
of	|O
bacteriophages	|O
T3	|O
,	|O
T7	|O
and	|O
SP6	|O
whereas	|O
the	|O
specificity	|O
factor	|O
shows	|O
similarities	|O
with	|O
bacterial	|O
sigma	|B-PROTEIN
factors	|I-PROTEIN
.	|O

The	|O
Cr.p	|B-PROTEIN
sbA	|I-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
ORF	|O
contains	|O
an	|O
H	|O
-	|O
N	|O
-	|O
H	|O
motif	|O
,	|O
and	|O
possibly	|O
a	|O
GIY	|O
-	|O
YIG	|O
motif	|O
.	|O

The	|O
interaction	|O
of	|O
zf4	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
with	|O
full	|O
-	|O
length	|O
5	|B-PROTEIN
S	|I-PROTEIN
RNA	|O
was	|O
far	|O
more	|O
sensitive	|O
to	|O
non	|O
-	|O
specific	|O
competitor	|O
concentration	|O
than	|O
was	|O
the	|O
zf4	|B-PROTEIN
-	|I-PROTEIN
7	|I-PROTEIN
:	|O
5	|B-PROTEIN
S	|I-PROTEIN
RNA	|O
interaction	|O
,	|O
suggesting	|O
that	|O
finger	|O
seven	|O
contributes	|O
to	|O
both	|O
affinity	|O
and	|O
specificity	|O
in	|O
this	|O
protein	|O
:	|O
RNA	|O
interaction	|O
.	|O

The	|O
STAT	|B-PROTEIN
protein	|O
accumulation	|O
resulting	|O
from	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
expression	|O
was	|O
tightly	|O
coupled	|O
to	|O
the	|O
morphological	|O
conversion	|O
of	|O
fibroblasts	|O
to	|O
adipocytes	|O
and	|O
represents	|O
an	|O
expression	|O
profile	|O
identical	|O
to	|O
that	|O
reported	|O
for	|O
mature	|O
adipocytes	|O
in	|O
vivo	|O
.	|O

The	|O
median	|O
durations	|O
for	|O
response	|O
and	|O
survival	|O
time	|O
in	|O
the	|O
late	|O
phase	|O
II	|O
trial	|O
were	|O
2.3	|O
months	|O
and	|O
5.8	|O
months	|O
,	|O
respectively	|O
.	|O

The	|O
role	|O
of	|O
's	|O
cientific	|O
psychiatry	|O
'	|O
in	|O
understanding	|O
patients	|O
with	|O
chronic	|O
schizophrenia	|O
or	|O
severe	|O
personality	|O
disorder	|O
.	|O

Myocardial	|O
antioxidant	|O
enzymes	|O
,	|O
catalase	|B-PROTEIN
,	|O
glutathione	|B-PROTEIN
peroxidase	|I-PROTEIN
and	|O
superoxide	|B-PROTEIN
dismutase	|I-PROTEIN
,	|O
in	|O
the	|O
MCT	|O
-	|O
treated	|O
rats	|O
were	|O
not	|O
different	|O
compared	|O
to	|O
control	|O
rats	|O
.	|O

The	|O
second	|O
goal	|O
was	|O
to	|O
ascertain	|O
the	|O
somatotopic	|O
arrangement	|O
of	|O
the	|O
GPi	|O
in	|O
PD	|O
.	|O

These	|O
overall	|O
results	|O
indicate	|O
that	|O
there	|O
is	|O
generally	|O
one	|O
PERV	|O
copy	|O
per	|O
integration	|O
site	|O
.	|O

The	|O
present	|O
investigation	|O
conducted	|O
in	|O
a	|O
population	|O
of	|O
258	|O
dentally	|O
aware	|O
individuals	|O
in	|O
the	|O
age	|O
range	|O
20-69	|O
years	|O
,	|O
was	|O
initiated	|O
to	|O
elucidate	|O
the	|O
relationship	|O
between	|O
tobacco	|O
smoking	|O
and	|O
supragingival	|O
calculus	|O
,	|O
taking	|O
into	|O
account	|O
possible	|O
confounding	|O
factors	|O
such	|O
as	|O
age	|O
,	|O
gender	|O
,	|O
oral	|O
hygiene	|O
and	|O
gingival	|O
inflammation	|O
.	|O

OBJECTIVE	|O
:	|O
To	|O
determine	|O
whether	|O
administration	|O
of	|O
misoprostol	|O
prevents	|O
gastric	|O
hemorrhage	|O
in	|O
healthy	|O
dogs	|O
treated	|O
with	|O
high	|O
doses	|O
of	|O
methylprednisolone	|O
sodium	|O
succinate	|O
(	|O
MPSS	|O
)	|O
.	|O

Patients	|O
were	|O
assessed	|O
for	|O
cardiac	|O
MIBG	|O
uptake	|O
,	|O
circulating	|O
norepinephrine	|O
concentration	|O
,	|O
LVEF	|O
,	|O
peak	|O
Vo2	|O
,	|O
x	|O
-	|O
ray	|O
cardiothoracic	|O
ratio	|O
,	|O
M	|O
-	|O
mode	|O
echographic	|O
end	|O
-	|O
diastolic	|O
diameter	|O
and	|O
right	|O
-	|O
sided	|O
heart	|O
catheterization	|O
parameters	|O
.	|O

Nuclear	|O
hormone	|O
receptors	|O
(	|O
NRs	|O
)	|O
are	|O
ligand	|O
-	|O
inducible	|O
transcription	|O
factors	|O
that	|O
mediate	|O
critical	|O
functions	|O
in	|O
many	|O
species	|O
.	|O

These	|O
cells	|O
were	|O
able	|O
to	|O
present	|O
influenza	|O
virus	|O
particles	|O
to	|O
HLA	|B-PROTEIN
-	|I-PROTEIN
DR1	|I-PROTEIN
-	|O
restricted	|O
T	|O
cell	|O
clones	|O
.	|O

Sequencing	|O
of	|O
zebrafish	|O
(	|O
Danio	|O
rerio	|O
)	|O
bacterial	|O
artificial	|O
chromosome	|O
and	|O
P1	|O
artificial	|O
chromosome	|O
genomic	|O
clone	|O
fragments	|O
and	|O
of	|O
cDNA	|O
clones	|O
has	|O
led	|O
to	|O
the	|O
identification	|O
of	|O
five	|O
new	|O
loci	|O
coding	|O
for	|O
beta	|B-PROTEIN
subunits	|I-PROTEIN
of	|I-PROTEIN
proteasomes	|I-PROTEIN
(	|O
PSMB	|B-PROTEIN
)	|O
.	|O

In	|O
addition	|O
to	|O
homologues	|O
of	|O
the	|O
human	|O
genes	|O
PSMB5	|B-PROTEIN
through	|O
PSMB9	|B-PROTEIN
,	|O
two	|O
new	|O
genes	|O
,	|O
PSMB11	|B-PROTEIN
and	|O
PSMB12	|B-PROTEIN
,	|O
have	|O
been	|O
found	|O
for	|O
which	|O
there	|O
are	|O
no	|O
known	|O
corresponding	|O
genes	|O
in	|O
humans	|O
.	|O

It	|O
applies	|O
Udry	|O
's	|O
biosocial	|O
perspective	|O
,	|O
which	|O
attempts	|O
to	|O
reconcile	|O
the	|O
biological	|O
and	|O
sociological	|O
models	|O
of	|O
premarital	|O
sexual	|O
and	|O
reproductive	|O
behaviour	|O
.	|O

Weight	|O
and	|O
height	|O
z	|O
-	|O
scores	|O
were	|O
significantly	|O
associated	|O
with	|O
BMD	|O
z	|O
-	|O
scores	|O
.	|O

A	|O
limited	|O
sampling	|O
strategy	|O
was	|O
used	|O
based	|O
on	|O
a	|O
bayesian	|O
parameter	|O
estimation	|O
algorithm	|O
that	|O
is	|O
part	|O
of	|O
the	|O
ADAPT	|O
II	|O
software	|O
package	|O
.	|O

Interaction	|O
of	|O
HRI	|B-PROTEIN
with	|O
Hsc70	|B-PROTEIN
was	|O
required	|O
for	|O
the	|O
transformation	|O
of	|O
HRI	|B-PROTEIN
,	|O
as	|O
the	|O
Hsc70	|B-PROTEIN
antagonist	|O
clofibric	|O
acid	|O
inhibited	|O
the	|O
folding	|O
of	|O
HRI	|B-PROTEIN
into	|O
a	|O
mature	|O
-	|O
competent	|O
conformation	|O
.	|O

The	|O
amino	|O
acid	|O
changes	|O
D206A	|O
and	|O
D208A	|O
abolish	|O
singly	|O
or	|O
in	|O
combination	|O
the	|O
exonuclease	|O
activity	|O
in	|O
vivo	|O
.	|O

Previous	|O
experimental	|O
evidence	|O
had	|O
indicated	|O
that	|O
Reg1	|B-PROTEIN
might	|O
target	|O
Glc7	|B-PROTEIN
to	|O
nuclear	|O
substrates	|O
such	|O
as	|O
the	|O
Snf1	|B-PROTEIN
kinase	|O
complex	|O
.	|O

In	|O
the	|O
budding	|O
yeast	|O
,	|O
Saccharomyces	|O
cerevisiae	|O
,	|O
replicators	|O
can	|O
function	|O
outside	|O
the	|O
chromosome	|O
as	|O
autonomously	|O
replicating	|O
sequence	|O
(	|O
ARS	|O
)	|O
elements	|O
;	|O
however	|O
,	|O
within	|O
chromosome	|O
III	|O
,	|O
certain	|O
ARSs	|O
near	|O
the	|O
transcriptionally	|O
silent	|O
HML	|B-PROTEIN
locus	|O
show	|O
no	|O
replication	|O
origin	|O
activity	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
,	|O
for	|O
the	|O
HML	|B-PROTEIN
ARS	|O
cluster	|O
(	|O
ARS303	|B-PROTEIN
,	|O
ARS320	|B-PROTEIN
,	|O
and	|O
ARS302	|B-PROTEIN
)	|O
,	|O
inactivity	|O
of	|O
origins	|O
is	|O
independent	|O
of	|O
local	|O
transcriptional	|O
silencing	|O
,	|O
even	|O
though	|O
origins	|O
and	|O
silencers	|O
share	|O
key	|O
cis	|O
-	|O
and	|O
trans	|O
-	|O
acting	|O
components	|O
.	|O

In	|O
the	|O
present	|O
study	|O
,	|O
we	|O
demonstrate	|O
that	|O
expression	|O
of	|O
TD	|B-PROTEIN
-	|I-PROTEIN
IkappaBalpha	|I-PROTEIN
blocked	|O
phorbol	|O
myristate	|O
acetate	|O
-	|O
phytohemagglutinin	|B-PROTEIN
or	|O
tumor	|B-PROTEIN
necrosis	|I-PROTEIN
factor	|I-PROTEIN
alpha	|I-PROTEIN
-	|O
induced	|O
IkappaBalpha	|B-PROTEIN
gene	|O
transcription	|O
and	|O
abolished	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
DNA	|O
binding	|O
activity	|O
,	|O
due	|O
to	|O
the	|O
continued	|O
cytoplasmic	|O
sequestration	|O
of	|O
RelA	|B-PROTEIN
(	|O
p65	|B-PROTEIN
)	|O
by	|O
TD	|B-PROTEIN
-	|I-PROTEIN
IkappaBalpha	|I-PROTEIN
.	|O

(	|O
i	|O
)	|O
Complete	|O
Grb10	|B-PROTEIN
expression	|O
from	|O
cDNA	|O
with	|O
an	|O
ecdysone	|O
-	|O
regulated	|O
transient	|O
expression	|O
system	|O
stimulated	|O
PDGF	|B-PROTEIN
-	|I-PROTEIN
BB	|I-PROTEIN
-	|O
,	|O
IGF	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
,	|O
and	|O
insulin	|B-PROTEIN
-	|O
but	|O
not	|O
epidermal	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
(	|O
EGF	|B-PROTEIN
)	|O
-	|O
induced	|O
DNA	|O
synthesis	|O
in	|O
an	|O
ecdysone	|O
dose	|O
-	|O
responsive	|O
fashion	|O
.	|O

The	|O
analysis	|O
of	|O
two	|O
distinct	|O
mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
pathways	|O
shows	|O
that	|O
stress	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
-	|O
Jun	|B-PROTEIN
N	|I-PROTEIN
-	|I-PROTEIN
terminal	|I-PROTEIN
kinase	|I-PROTEIN
activation	|O
,	|O
resulting	|O
in	|O
the	|O
phosphorylation	|O
of	|O
ATF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
,	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
,	|O
and	|O
JunD	|B-PROTEIN
,	|O
is	|O
required	|O
not	|O
only	|O
for	|O
the	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|O
but	|O
also	|O
for	|O
the	|O
TPA	|O
-	|O
dependent	|O
induction	|O
,	|O
while	|O
the	|O
extracellular	|B-PROTEIN
signal	|I-PROTEIN
-	|I-PROTEIN
related	|I-PROTEIN
kinase	|I-PROTEIN
1	|I-PROTEIN
(	|O
ERK	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
and	|O
ERK	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
activation	|O
is	|O
involved	|O
in	|O
the	|O
TPA	|O
-	|O
but	|O
not	|O
in	|O
the	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|O
dependent	|O
stimulation	|O
of	|O
the	|O
uPA	|B-PROTEIN
enhancer	|O
.	|O

CONCLUSIONS	|O
:	|O
In	|O
healthy	|O
individuals	|O
,	|O
whole	|O
body	|O
insulin	|B-PROTEIN
sensitivity	|O
is	|O
related	|O
,	|O
or	|O
"	|O
coupled	|O
,	|O
"	|O
to	|O
the	|O
anaerobic	|O
threshold	|O
.	|O

Interdomain	|O
signaling	|O
in	|O
a	|O
two	|O
-	|O
domain	|O
fragment	|O
of	|O
the	|O
human	|O
glucocorticoid	|B-PROTEIN
receptor	|I-PROTEIN
.	|O

In	|O
contrast	|O
,	|O
the	|O
xtRNA	|B-PROTEIN
(	|O
Sec	|B-PROTEIN
)	|O
gene	|O
needs	|O
the	|O
binding	|O
of	|O
the	|O
seven	|O
Staf	|B-PROTEIN
zinc	|O
fingers	|O
,	|O
but	|O
not	|O
Oct	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
for	|O
optimal	|O
transcriptional	|O
capacity	|O
.	|O

Collectively	|O
,	|O
these	|O
results	|O
show	|O
that	|O
the	|O
differential	|O
utilization	|O
of	|O
Staf	|B-PROTEIN
zinc	|I-PROTEIN
finger	|I-PROTEIN
1	|I-PROTEIN
represents	|O
a	|O
new	|O
,	|O
critical	|O
determinant	|O
of	|O
the	|O
transcriptional	|O
activation	|O
mechanism	|O
for	|O
the	|O
Xenopus	|B-PROTEIN
tRNA	|I-PROTEIN
(	|O
Sec	|B-PROTEIN
)	|O
and	|O
human	|O
U6	|B-PROTEIN
snRNA	|O
genes	|O
.	|O

In	|O
B	|O
cells	|O
,	|O
HEF1	|B-PROTEIN
is	|O
phosphorylated	|O
by	|O
a	|O
cytoskeleton	|O
-	|O
dependent	|O
mechanism	|O
that	|O
is	|O
triggered	|O
by	|O
integrin	|B-PROTEIN
ligation	|O
.	|O

The	|O
calcitonin	|B-PROTEIN
-	|O
induced	|O
tyrosine	|O
phosphorylation	|O
of	|O
HEF1	|B-PROTEIN
increased	|O
in	|O
a	|O
time	|O
-	|O
and	|O
dose	|O
-	|O
dependent	|O
manner	|O
.	|O

Independent	|O
protrudor	|O
muscle	|O
stimulation	|O
increased	|O
VI	|O
,	|O
max	|O
(	|O
peak	|O
increase	|O
61	|O
%	|O
,	|O
P	|O
<	|O
0.05	|O
)	|O
,	|O
did	|O
not	|O
change	|O
Pcrit	|O
,	|O
and	|O
decreased	|O
Rn	|O
(	|O
peak	|O
decrease	|O
of	|O
41	|O
%	|O
,	|O
P	|O
<	|O
0.05	|O
)	|O
.	|O

We	|O
report	|O
the	|O
construction	|O
of	|O
an	|O
approximately	|O
1.7	|O
-	|O
Mb	|O
sequence	|O
-	|O
ready	|O
YAC	|O
/	|O
BAC	|O
clone	|O
contig	|O
of	|O
8p22	|O
-	|O
p23	|O
.	|O

The	|O
human	|O
RAD30B	|B-PROTEIN
and	|O
mouse	|O
Rad30b	|B-PROTEIN
mRNA	|O
transcripts	|O
,	|O
like	|O
many	|O
repair	|O
proteins	|O
,	|O
are	|O
highly	|O
expressed	|O
in	|O
the	|O
testis	|O
.	|O

Analysis	|O
of	|O
the	|O
mouse	|O
STAP	|B-PROTEIN
gene	|O
isolated	|O
from	|O
the	|O
genomic	|O
library	|O
revealed	|O
that	|O
the	|O
STAP	|B-PROTEIN
gene	|O
spans	|O
a	|O
region	|O
of	|O
over	|O
11	|O
kb	|O
and	|O
comprises	|O
eight	|O
exons	|O
.	|O

A	|O
reduced	|O
matrix	|O
distribution	|O
and	|O
enhanced	|O
cell	|O
density	|O
were	|O
observed	|O
as	|O
the	|O
biofilm	|O
aged	|O
.	|O

After	|O
10	|O
months	|O
of	|O
treatment	|O
with	|O
the	|O
conjugated	|O
estrogen	|O
,	|O
both	|O
his	|O
height	|O
and	|O
weight	|O
showed	|O
improvement	|O
,	|O
while	|O
his	|O
bone	|O
mineral	|O
density	|O
and	|O
bone	|O
age	|O
were	|O
increased	|O
.	|O

Viscosity	|O
experiments	|O
on	|O
the	|O
catalytic	|O
fragment	|O
kinase	|O
reaction	|O
demonstrated	|O
that	|O
the	|O
chemical	|O
(	|O
phosphoryl	|O
transfer	|O
)	|O
step	|O
had	|O
a	|O
reduced	|O
rate	|O
.	|O

Velocity	|O
sedimentation	|O
,	|O
cross	|O
-	|O
linking	|O
,	|O
and	|O
immunoprecipitation	|O
analyses	|O
of	|O
detergent	|O
-	|O
solubilized	|O
rat	|O
brain	|O
revealed	|O
that	|O
the	|O
32	|O
and	|O
34	|O
kDa	|O
polypeptides	|O
reside	|O
within	|O
heterotetramers	|O
.	|O

In	|O
vitro	|O
expression	|O
levels	|O
of	|O
the	|O
different	|O
plasmids	|O
differed	|O
by	|O
as	|O
much	|O
as	|O
tenfold	|O
.	|O

In	|O
EEG	|O
only	|O
single	|O
slow	|O
waves	|O
above	|O
left	|O
temporal	|O
region	|O
were	|O
revealed	|O
.	|O

Molecular	|O
characterization	|O
of	|O
type	|O
-	|O
specific	|O
capsular	|O
polysaccharide	|O
biosynthesis	|O
genes	|O
of	|O
Streptococcus	|O
agalactiae	|O
type	|O
Ia	|O
.	|O

(	|O
1998	|O
)	|O
FASEB	|O
J.	|O

IL	|B-PROTEIN
-	|I-PROTEIN
1beta	|I-PROTEIN
(	|O
10	|O
ng	|O
/	|O
ml	|O
)	|O
drastically	|O
increased	|O
both	|O
PDGFalphaR	|B-PROTEIN
and	|O
CCAAT	|B-PROTEIN
/	|I-PROTEIN
enhancer	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
delta	|I-PROTEIN
(	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBPdelta	|I-PROTEIN
)	|O
mRNA	|O
levels	|O
in	|O
a	|O
time	|O
dependent	|O
manner	|O
.	|O

The	|O
recruitment	|O
of	|O
constitutively	|O
phosphorylated	|O
p185	|B-PROTEIN
(	|O
neu	|B-PROTEIN
)	|O
and	|O
the	|O
activated	|O
mitogenic	|O
pathway	|O
proteins	|O
to	|O
this	|O
membrane	|O
-	|O
microfilament	|O
interaction	|O
site	|O
provides	|O
a	|O
physical	|O
model	|O
for	|O
integrating	|O
the	|O
assembly	|O
of	|O
the	|O
mitogenic	|O
pathway	|O
with	|O
the	|O
transmission	|O
of	|O
growth	|O
factor	|O
signal	|O
to	|O
the	|O
cytoskeleton	|O
.	|O

Transient	|O
tyrosine	|O
phosphorylation	|O
of	|O
Crk	|B-PROTEIN
in	|O
fibroblast	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
-	|O
stimulated	|O
endothelial	|O
cells	|O
was	|O
dependent	|O
on	|O
the	|O
juxtamembrane	|O
tyrosine	|O
residue	|O
463	|O
in	|O
FGFR	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
and	|O
a	|O
Crk	|B-PROTEIN
SH2	|O
domain	|O
precipitated	|O
FGFR	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
via	|O
phosphorylated	|O
Tyr	|O
-	|O
463	|O
,	|O
indicating	|O
direct	|O
complex	|O
formation	|O
between	|O
Crk	|B-PROTEIN
and	|O
FGFR	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

ECG	|O
-	|O
gated	|O
myocardial	|O
Technetium	|O
-	|O
99m	|O
sestamibi	|O
SPECT	|O
is	|O
a	|O
useful	|O
technique	|O
to	|O
measure	|O
myocardial	|O
perfusion	|O
and	|O
function	|O
simultaneously	|O
.	|O

Role	|O
of	|O
the	|O
3'	|O
untranslated	|O
region	|O
of	|O
baculovirus	|O
p10	|B-PROTEIN
mRNA	|O
in	|O
high	|O
-	|O
level	|O
expression	|O
of	|O
foreign	|O
genes	|O
.	|O

The	|O
intron	|O
RNA	|O
consists	|O
of	|O
2492	|O
nucleotides	|O
which	|O
can	|O
be	|O
folded	|O
into	|O
a	|O
secondary	|O
structure	|O
with	|O
all	|O
the	|O
expected	|O
sequence	|O
motifs	|O
of	|O
subgroup	|O
-	|O
IIA1	|O
introns	|O
(	|O
Michel	|O
et	|O
al.	|O

The	|O
intron	|O
is	|O
capable	|O
of	|O
splicing	|O
despite	|O
the	|O
fact	|O
that	|O
both	|O
the	|O
EBS1	|B-PROTEIN
/	|O
IBS1	|B-PROTEIN
and	|O
the	|O
EBS2	|B-PROTEIN
/	|O
IBS2	|B-PROTEIN
sequence	|O
motifs	|O
,	|O
thought	|O
to	|O
be	|O
necessary	|O
for	|O
correct	|O
splicing	|O
,	|O
extend	|O
over	|O
5	|O
instead	|O
of	|O
6	|O
bp	|O
.	|O

The	|O
Trk	|B-PROTEIN
/	|I-PROTEIN
Nerve	|I-PROTEIN
Growth	|I-PROTEIN
Factor	|I-PROTEIN
receptor	|I-PROTEIN
mediates	|O
the	|O
rapid	|O
activation	|O
of	|O
a	|O
number	|O
of	|O
intracellular	|O
signaling	|O
proteins	|O
,	|O
including	|O
phosphatidylinositol	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
PI	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
)	|O
.	|O

The	|O
controversy	|O
of	|O
significance	|O
testing	|O
:	|O
misconceptions	|O
and	|O
alternatives	|O
.	|O

Chemical	|O
uptake	|O
into	|O
human	|O
stratum	|O
corneum	|O
in	|O
vivo	|O
from	|O
volatile	|O
and	|O
non	|O
-	|O
volatile	|O
solvents	|O
.	|O

Like	|O
DNA	|O
binding	|O
,	|O
transcriptional	|O
enhancement	|O
required	|O
amino	|O
-	|O
terminally	|O
located	|O
basic	|O
amino	|O
acid	|O
residues	|O
but	|O
not	|O
the	|O
carboxyl	|O
-	|O
terminal	|O
portion	|O
of	|O
Hap46	|B-PROTEIN
known	|O
to	|O
participate	|O
in	|O
hsp70	|B-PROTEIN
interaction	|O
.	|O

We	|O
have	|O
tested	|O
the	|O
function	|O
of	|O
two	|O
potential	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
-	|O
like	|O
sites	|O
present	|O
in	|O
the	|O
PAI	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
proximal	|O
promoter	|O
for	|O
responsiveness	|O
to	|O
TNFalpha	|B-PROTEIN
using	|O
chloramphenicol	|B-PROTEIN
acetyl	|I-PROTEIN
transferase	|I-PROTEIN
reporter	|O
gene	|O
deletion	|O
and	|O
mutation	|O
analyses	|O
.	|O

N	|O
-	|O
terminal	|O
sequence	|O
analysis	|O
and	|O
NMR	|O
measurements	|O
revealed	|O
that	|O
this	|O
fragment	|O
originates	|O
from	|O
the	|O
C	|O
-	|O
terminal	|O
80	|O
residues	|O
of	|O
MBF1	|B-PROTEIN
and	|O
form	|O
a	|O
well	|O
structured	|O
C	|O
-	|O
terminal	|O
domain	|O
of	|O
MBF1	|B-PROTEIN
,	|O
MBF1CTD	|B-PROTEIN
.	|O

The	|O
nucleosomal	|O
response	|O
associated	|O
with	|O
immediate	|B-PROTEIN
-	|I-PROTEIN
early	|I-PROTEIN
gene	|I-PROTEIN
induction	|O
is	|O
mediated	|O
via	|O
alternative	|O
MAP	|B-PROTEIN
kinase	|I-PROTEIN
cascades	|O
:	|O
MSK1	|B-PROTEIN
as	|O
a	|O
potential	|O
histone	|O
H3	|B-PROTEIN
/	|O
HMG	|B-PROTEIN
-	|I-PROTEIN
14	|I-PROTEIN
kinase	|O
.	|O

The	|O
arrangement	|O
of	|O
these	|O
cutoff	|O
-	|O
levels	|O
leads	|O
to	|O
a	|O
sensitivity	|O
of	|O
85%	|O
at	|O
a	|O
specificity	|O
of	|O
55%	|O
for	|O
Protein	|O
S100	|B-PROTEIN
when	|O
measured	|O
by	|O
RIA	|O
,	|O
and	|O
to	|O
a	|O
sensitivity	|O
of	|O
77%	|O
at	|O
a	|O
specificity	|O
of	|O
61%	|O
when	|O
measured	|O
by	|O
LIA	|O
.	|O

272	|O
,	|O
1904	|O
]	|O
.	|O

Using	|O
16	|O
strains	|O
of	|O
C.	|O
trachomatis	|O
in	|O
triplicate	|O
assays	|O
,	|O
we	|O
found	|O
the	|O
RT	|O
-	|O
PCR	|O
method	|O
consistently	|O
more	|O
sensitive	|O
than	|O
the	|O
conventional	|O
technique	|O
for	|O
all	|O
eight	|O
antimicrobials	|O
tested	|O
,	|O
with	|O
resultant	|O
MICs	|O
determined	|O
by	|O
RT	|O
-	|O
PCR	|O
ranging	|O
from	|O
1.6	|O
-	|O
fold	|O
higher	|O
(	|O
erythromycin	|O
)	|O
to	|O
>	|O
/	|O
=	|O
195	|O
-	|O
fold	|O
higher	|O
(	|O
amoxicillin	|O
)	|O
.	|O

Null	|O
alleles	|O
of	|O
SAS4	|B-PROTEIN
and	|O
SAS5	|B-PROTEIN
bypassed	|O
the	|O
role	|O
of	|O
the	|O
Abf1p	|B-PROTEIN
binding	|O
site	|O
of	|O
the	|O
HMR	|B-PROTEIN
-	|I-PROTEIN
E	|I-PROTEIN
silencer	|O
but	|O
not	|O
the	|O
role	|O
of	|O
the	|O
ACS	|B-PROTEIN
or	|O
Rap1p	|B-PROTEIN
binding	|O
site	|O
.	|O

Recent	|O
molecular	|O
analysis	|O
has	|O
revealed	|O
that	|O
the	|O
S	|B-PROTEIN
locus	|O
is	|O
highly	|O
polymorphic	|O
and	|O
contains	|O
several	|O
genes	|O
,	|O
i.e.	|O
,	|O
SLG	|B-PROTEIN
,	|O
SRK	|B-PROTEIN
,	|O
the	|O
as	|O
-	|O
yet	|O
-	|O
unidentified	|O
pollen	|O
S	|B-PROTEIN
gene	|O
(	|O
s	|O
)	|O
,	|O
and	|O
other	|O
linked	|O
genes	|O
.	|O

A	|O
cDNA	|O
encoding	|O
a	|O
putative	|O
RNA	|B-PROTEIN
and	|I-PROTEIN
/	|I-PROTEIN
or	|I-PROTEIN
DNA	|I-PROTEIN
helicase	|I-PROTEIN
has	|O
been	|O
isolated	|O
from	|O
Arabidopsis	|O
thaliana	|O
cDNA	|O
libraries	|O
.	|O

In	|O
vivo	|O
,	|O
MyoD	|B-PROTEIN
requires	|O
this	|O
tryptophan	|O
motif	|O
to	|O
evoke	|O
chromatin	|O
remodeling	|O
in	|O
the	|O
Myogenin	|B-PROTEIN
promoter	|O
and	|O
to	|O
activate	|O
Myogenin	|B-PROTEIN
transcription	|O
.	|O

RESULTS	|O
:	|O
256	|O
Periods	|O
of	|O
TTP	|O
or	|O
PUNP	|O
were	|O
reported	|O
by	|O
men	|O
and	|O
174	|O
by	|O
women	|O
.	|O

Feed	|O
intake	|O
and	|O
BW	|O
gains	|O
were	|O
decreased	|O
(	|O
P	|O
<	|O
0.05	|O
)	|O
by	|O
dietary	|O
treatments	|O
containing	|O
M.	|O

The	|O
N	|O
terminus	|O
of	|O
beta	|O
(	|O
95	|O
kDa	|O
)	|O
corresponds	|O
to	|O
alpha	|O
with	|O
the	|O
integrase	|B-PROTEIN
domain	|O
attached	|O
to	|O
the	|O
C	|O
terminus	|O
(	|O
32	|O
kDa	|O
)	|O
.	|O

Skn	|B-PROTEIN
-	|I-PROTEIN
1a	|I-PROTEIN
lacking	|O
the	|O
C	|O
-	|O
terminal	|O
region	|O
completely	|O
lost	|O
transactivation	|O
ability	|O
,	|O
irrespective	|O
of	|O
the	|O
promoter	|O
tested	|O
,	|O
and	|O
was	|O
able	|O
to	|O
block	|O
transactivation	|O
by	|O
normal	|O
Skn	|B-PROTEIN
-	|I-PROTEIN
1a	|I-PROTEIN
in	|O
competition	|O
assays	|O
.	|O

In	|O
early	|O
Xenopus	|O
embryos	|O
,	|O
the	|O
transforming	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
member	|O
activin	|B-PROTEIN
induces	|O
the	|O
gene	|O
Mix.2	|B-PROTEIN
by	|O
stimulating	|O
the	|O
formation	|O
of	|O
a	|O
multiprotein	|O
complex	|O
,	|O
activin	|B-PROTEIN
-	|I-PROTEIN
responsive	|I-PROTEIN
factor	|I-PROTEIN
(	|O
ARF	|B-PROTEIN
)	|O
.	|O

To	|O
further	|O
characterize	|O
the	|O
structure	|O
and	|O
evolutionary	|O
synthesis	|O
of	|O
the	|O
CMT1A	|O
-	|O
REP	|O
repeat	|O
,	|O
fluorescent	|O
in	|O
situ	|O
hybridization	|O
(	|O
FISH	|O
)	|O
analysis	|O
and	|O
heterologous	|O
PCR	|O
-	|O
based	|O
assays	|O
were	|O
carried	|O
out	|O
for	|O
a	|O
series	|O
of	|O
primates	|O
.	|O

Natl	|O
.	|O

In	|O
the	|O
face	|O
of	|O
the	|O
outbreak	|O
,	|O
there	|O
was	|O
a	|O
delay	|O
before	|O
vaccination	|O
was	|O
able	|O
to	|O
stop	|O
deaths	|O
.	|O

Here	|O
we	|O
show	|O
that	|O
a	|O
novel	|O
isoform	|O
of	|O
Rapl	|B-PROTEIN
GTPase	|O
-	|O
activating	|O
protein	|O
,	|O
called	|O
rap1GAPII	|B-PROTEIN
,	|O
binds	|O
specifically	|O
to	|O
the	|O
alpha	|O
-	|O
subunits	|O
of	|O
the	|O
G	|B-PROTEIN
(	|I-PROTEIN
i	|I-PROTEIN
)	|I-PROTEIN
family	|O
of	|O
heterotrimeric	|O
G	|B-PROTEIN
-	|I-PROTEIN
proteins	|I-PROTEIN
.	|O

The	|O
B	|O
-	|O
oligomer	|O
of	|O
pertussis	|B-PROTEIN
toxin	|I-PROTEIN
deactivates	|O
CC	|O
chemokine	|B-PROTEIN
receptor	|I-PROTEIN
5	|I-PROTEIN
and	|O
blocks	|O
entry	|O
of	|O
M	|O
-	|O
tropic	|O
HIV	|O
-	|O
1	|O
strains	|O
.	|O

Cross	|O
-	|O
linking	|O
the	|O
B	|B-PROTEIN
cell	|I-PROTEIN
Ag	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
BCR	|B-PROTEIN
)	|O
to	|O
surface	|O
Fc	|B-PROTEIN
receptors	|I-PROTEIN
for	|O
IgG	|B-PROTEIN
(	|O
Fc	|B-PROTEIN
gamma	|I-PROTEIN
R	|I-PROTEIN
)	|O
inhibits	|O
G1	|O
-	|O
to	|O
-	|O
S	|O
progression	|O
;	|O
the	|O
mechanism	|O
by	|O
which	|O
this	|O
occurs	|O
is	|O
not	|O
completely	|O
known	|O
.	|O

Cross	|O
-	|O
linking	|O
the	|O
B	|B-PROTEIN
cell	|I-PROTEIN
Ag	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
BCR	|B-PROTEIN
)	|O
to	|O
surface	|O
Fc	|B-PROTEIN
receptors	|I-PROTEIN
for	|O
IgG	|B-PROTEIN
(	|O
Fc	|B-PROTEIN
gamma	|I-PROTEIN
R	|I-PROTEIN
)	|O
inhibits	|O
G1	|O
-	|O
to	|O
-	|O
S	|O
progression	|O
;	|O
the	|O
mechanism	|O
by	|O
which	|O
this	|O
occurs	|O
is	|O
not	|O
completely	|O
known	|O
.	|O

TRAF2	|B-PROTEIN
is	|O
a	|O
potent	|O
activator	|O
of	|O
a	|O
95	|O
-	|O
kDa	|O
serine	|B-PROTEIN
/	|I-PROTEIN
threonine	|I-PROTEIN
kinase	|I-PROTEIN
termed	|O
germinal	|B-PROTEIN
center	|I-PROTEIN
kinase	|I-PROTEIN
related	|I-PROTEIN
(	|O
GCKR	|B-PROTEIN
,	|O
also	|O
referred	|O
to	|O
as	|O
KHS1	|B-PROTEIN
)	|O
,	|O
which	|O
signals	|O
activation	|O
of	|O
the	|O
SAPK	|B-PROTEIN
pathway	|O
.	|O

An	|O
activation	|O
-	|O
responsive	|O
element	|O
in	|O
single	|B-PROTEIN
C	|I-PROTEIN
motif	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
/	|O
lymphotactin	|B-PROTEIN
promoter	|O
is	|O
a	|O
site	|O
of	|O
constitutive	|O
and	|O
inducible	|O
DNA	|O
-	|O
protein	|O
interactions	|O
involving	|O
nuclear	|O
factor	|O
of	|O
activated	|O
T	|O
cell	|O
.	|O

Cytokine	|O
-	|O
induced	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
DNA	|O
binding	|O
activity	|O
,	|O
RelA	|B-PROTEIN
nuclear	|O
translocation	|O
,	|O
I	|B-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
alpha	|I-PROTEIN
degradation	|O
,	|O
I	|B-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
serine	|O
32	|O
phosphorylation	|O
,	|O
and	|O
I	|B-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
IKK	|B-PROTEIN
)	|O
activity	|O
were	|O
blocked	|O
by	|O
curcumin	|O
treatment	|O
.	|O

A	|O
portion	|O
of	|O
p193	|B-PROTEIN
is	|O
nuclear	|O
and	|O
localizes	|O
to	|O
the	|O
mitotic	|O
spindle	|O
.	|O

The	|O
main	|O
issues	|O
are	|O
the	|O
need	|O
to	|O
explain	|O
a	|O
number	|O
of	|O
still	|O
unknown	|O
mechanisms	|O
,	|O
to	|O
determine	|O
which	|O
"	|O
natural	|O
diet	|O
"	|O
carries	|O
the	|O
minimum	|O
coronary	|O
risk	|O
and	|O
whether	|O
"	|O
new	|O
"	|O
foods	|O
produced	|O
by	|O
modern	|O
technology	|O
are	|O
really	|O
needed	|O
to	|O
contrast	|O
this	|O
epidemic	|O
.	|O

Cotransfection	|O
of	|O
the	|O
coactivator	|O
CREB	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
relieved	|O
the	|O
transcriptional	|O
repression	|O
of	|O
PPARalphawt	|B-PROTEIN
by	|O
PPARalphatr	|B-PROTEIN
,	|O
suggesting	|O
that	|O
the	|O
dominant	|O
negative	|O
effect	|O
of	|O
PPARalphatr	|B-PROTEIN
might	|O
occur	|O
through	|O
competition	|O
for	|O
essential	|O
coactivators	|O
.	|O

SF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
does	|O
not	|O
have	|O
an	|O
N	|O
-	|O
terminal	|O
AF1	|O
domain	|O
.	|O

To	|O
estimate	|O
the	|O
locations	|O
of	|O
sources	|O
with	|O
the	|O
TF	|O
-	|O
MUSIC	|O
algorithm	|O
,	|O
we	|O
first	|O
set	|O
the	|O
target	|O
region	|O
on	|O
the	|O
spectrogram	|O
of	|O
the	|O
somatosensory	|O
responses	|O
.	|O

We	|O
discuss	|O
these	|O
results	|O
in	|O
terms	|O
of	|O
the	|O
influence	|O
that	|O
time	|O
and	|O
nutritional	|O
constraints	|O
have	|O
on	|O
odonate	|O
development	|O
patterns	|O
and	|O
fitness	|O
.	|O

OBJECTIVE	|O
:	|O
1998	|O
Surveillance	|O
,	|O
Epidemiology	|O
,	|O
and	|O
End	|O
Results	|O
(	|O
SEER	|O
)	|O
data	|O
estimate	|O
an	|O
83.1%	|O
5	|O
-	|O
year	|O
survival	|O
rate	|O
for	|O
corpus	|O
uteri	|O
adenocarcinoma	|O
FIGO	|O
stage	|O
II	|O
.	|O

A	|O
novel	|O
Drosophila	|O
A	|O
kinase	|B-PROTEIN
anchor	|I-PROTEIN
protein	|I-PROTEIN
,	|O
Drosophila	|O
A	|O
kinase	|B-PROTEIN
anchor	|I-PROTEIN
protein	|I-PROTEIN
200	|O
(	|O
DAKAP200	|B-PROTEIN
)	|O
,	|O
is	|O
predicted	|O
to	|O
be	|O
involved	|O
in	|O
routing	|O
,	|O
mediating	|O
,	|O
and	|O
integrating	|O
signals	|O
carried	|O
by	|O
cAMP	|O
,	|O
Ca	|O
(	|O
2+	|O
)	|O
,	|O
and	|O
diacylglycerol	|O
(	|O
Li	|O
,	|O
Z.	|O
,	|O
Rossi	|O
,	|O
E.	|O

In	|O
vitro	|O
transcription	|O
results	|O
indicate	|O
that	|O
this	|O
5'	|O
structure	|O
functions	|O
in	|O
the	|O
attenuation	|O
mechanism	|O
,	|O
since	|O
deletion	|O
of	|O
the	|O
stem	|O
-	|O
loop	|O
caused	|O
an	|O
increase	|O
in	|O
transcription	|O
readthrough	|O
.	|O

A	|O
5'	|O
RNA	|O
stem	|O
-	|O
loop	|O
participates	|O
in	|O
the	|O
transcription	|O
attenuation	|O
mechanism	|O
that	|O
controls	|O
expression	|O
of	|O
the	|O
Bacillus	|O
subtilis	|O
trpEDCFBA	|B-PROTEIN
operon	|O
.	|O

Single	|O
-	|O
alanine	|O
-	|O
substitution	|O
mutations	|O
had	|O
minimal	|O
,	|O
if	|O
any	|O
,	|O
effects	|O
on	|O
S	|O
-	|O
induced	|O
cell	|O
-	|O
to	|O
-	|O
cell	|O
fusion	|O
.	|O

Furthermore	|O
,	|O
we	|O
demonstrate	|O
that	|O
transcription	|O
from	|O
the	|O
MMTV	|B-PROTEIN
5'	|I-PROTEIN
LTR	|I-PROTEIN
is	|O
highly	|O
active	|O
in	|O
the	|O
absence	|O
of	|O
Stat5a	|B-PROTEIN
,	|O
a	|O
transcription	|O
factor	|O
that	|O
had	|O
been	|O
shown	|O
previously	|O
to	|O
be	|O
required	|O
for	|O
transcription	|O
from	|O
the	|O
MMTV	|B-PROTEIN
LTR	|I-PROTEIN
.	|O

Regional	|O
insertional	|O
mutagenesis	|O
of	|O
specific	|O
genes	|O
on	|O
the	|O
CIC5F11	|B-PROTEIN
/	|O
CIC2B9	|B-PROTEIN
locus	|O
of	|O
Arabidopsis	|O
thaliana	|O
chromosome	|O
5	|O
using	|O
the	|O
Ac	|B-PROTEIN
/	|O
Ds	|B-PROTEIN
transposon	|O
in	|O
combination	|O
with	|O
the	|O
cDNA	|O
scanning	|O
method	|O
.	|O

RESULTS	|O
:	|O
CK	|B-PROTEIN
-	|O
MB	|B-PROTEIN
elevation	|O
was	|O
detected	|O
in	|O
313	|O
patients	|O
(	|O
18.7%	|O
)	|O
,	|O
with	|O
1-3	|O
x	|O
in	|O
12.8%	|O
,	|O
3-5	|O
x	|O
in	|O
3.5%	|O
and	|O
>	|O
5x	|O
normal	|O
in	|O
2.4%	|O
of	|O
patients	|O
.	|O

Thus	|O
,	|O
NART	|O
-	|O
R	|O
performance	|O
may	|O
not	|O
be	|O
a	|O
valid	|O
estimate	|O
of	|O
baseline	|O
IQ	|O
for	|O
patients	|O
with	|O
neurologic	|O
disorders	|O
with	|O
suspected	|O
language	|O
impairment	|O
.	|O

Activated	|O
areas	|O
have	|O
been	|O
identified	|O
by	|O
means	|O
of	|O
cross	|O
-	|O
correlation	|O
analysis	|O
.	|O

Natural	|O
Haemophilus	|O
influenzae	|O
type	|O
b	|O
capsular	|O
polysaccharide	|O
antibodies	|O
in	|O
412	|O
infants	|O
and	|O
children	|O
from	|O
West	|O
Africa	|O
(	|O
Burkina	|O
-	|O
Faso	|O
)	|O
and	|O
France	|O
:	|O
a	|O
cross	|O
-	|O
sectional	|O
serosurvey	|O
.	|O

In	|O
this	|O
study	|O
,	|O
we	|O
identified	|O
Sp1	|B-PROTEIN
and	|O
Sp3	|B-PROTEIN
as	|O
major	|O
factors	|O
binding	|O
to	|O
the	|O
Sp1	|B-PROTEIN
sites	|O
of	|O
the	|O
p21	|B-PROTEIN
/	|O
WAF1	|B-PROTEIN
/	|O
Cip1	|B-PROTEIN
promoter	|O
in	|O
MG63	|O
cells	|O
through	|O
electrophoretic	|O
mobility	|O
shift	|O
assays	|O
and	|O
showed	|O
that	|O
TSA	|O
treatment	|O
did	|O
not	|O
change	|O
their	|O
binding	|O
activities	|O
.	|O

Galoyan	|O
has	|O
summarized	|O
the	|O
results	|O
of	|O
his	|O
discovery	|O
of	|O
cardioactive	|O
neurohormones	|O
.	|O

To	|O
study	|O
the	|O
regulation	|O
of	|O
its	|O
expression	|O
,	|O
the	|O
human	|O
aldehyde	|B-PROTEIN
reductase	|I-PROTEIN
gene	|O
and	|O
promoter	|O
were	|O
cloned	|O
and	|O
characterized	|O
.	|O

Immunohistochemical	|O
staining	|O
with	|O
MIB	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
p53	|B-PROTEIN
antibodies	|O
showed	|O
low	|O
(	|O
<	|O
1%	|O
)	|O
and	|O
negative	|O
reaction	|O
.	|O

The	|O
C2C	|B-PROTEIN
-	|O
Prx	|B-PROTEIN
is	|O
encoded	|O
as	|O
a	|O
preprotein	|O
of	|O
273	|O
amino	|O
acids	|O
containing	|O
a	|O
putative	|O
chloroplast	|O
-	|O
targeting	|O
signal	|O
of	|O
65	|O
amino	|O
acids	|O
at	|O
its	|O
N	|O
-	|O
terminus	|O
.	|O

Immediately	|O
before	|O
surgery	|O
patients	|O
received	|O
either	|O
intravenous	|O
hydrocortisone	|O
100	|O
mg	|O
or	|O
placebo	|O
in	|O
random	|O
,	|O
double	|O
-	|O
blind	|O
order	|O
.	|O

A	|O
tyrosine	|O
-	|O
based	|O
sorting	|O
signal	|O
in	|O
the	|O
beta2	|B-PROTEIN
integrin	|I-PROTEIN
cytoplasmic	|O
domain	|O
mediates	|O
its	|O
recycling	|O
to	|O
the	|O
plasma	|O
membrane	|O
and	|O
is	|O
required	|O
for	|O
ligand	|O
-	|O
supported	|O
migration	|O
.	|O

The	|O
injection	|O
of	|O
XDRP1	|B-PROTEIN
protein	|O
into	|O
fertilized	|O
Xenopus	|O
eggs	|O
blocked	|O
embryonic	|O
cell	|O
division	|O
.	|O

Using	|O
transgenic	|O
Xenopus	|O
embryos	|O
,	|O
we	|O
demonstrate	|O
that	|O
the	|O
integrity	|O
of	|O
these	|O
two	|O
sequences	|O
is	|O
necessary	|O
for	|O
correct	|O
spatial	|O
expression	|O
of	|O
a	|O
Xbra2	|B-PROTEIN
promoter	|O
-	|O
driven	|O
reporter	|O
gene	|O
.	|O

In	|O
order	|O
to	|O
screen	|O
for	|O
such	|O
cofactors	|O
,	|O
we	|O
have	|O
used	|O
a	|O
transcriptionally	|O
inactive	|O
mutant	|O
of	|O
Xenopus	|O
MEF2D	|B-PROTEIN
in	|O
a	|O
yeast	|O
two	|O
-	|O
hybrid	|O
screen	|O
.	|O

NuA4	|B-PROTEIN
has	|O
an	|O
apparent	|O
molecular	|O
mass	|O
of	|O
1.3	|O
MDa	|O
.	|O

ATF1	|B-PROTEIN
transcription	|O
is	|O
negatively	|O
regulated	|O
by	|O
unsaturated	|O
fatty	|O
acids	|O
and	|O
oxygen	|O
.	|O

Two	|O
patients	|O
with	|O
recurrent	|O
tumors	|O
had	|O
high	|O
S	|O
-	|O
phase	|O
fractions	|O
both	|O
on	|O
the	|O
first	|O
resected	|O
specimens	|O
and	|O
at	|O
the	|O
time	|O
of	|O
the	|O
second	|O
operation	|O
.	|O

Mutation	|O
of	|O
TTF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
sites	|I-PROTEIN
(	|I-PROTEIN
TBE	|I-PROTEIN
)	|I-PROTEIN
1	|I-PROTEIN
,	|I-PROTEIN
3	|I-PROTEIN
,	|I-PROTEIN
and	|I-PROTEIN
4	|I-PROTEIN
in	|O
combination	|O
markedly	|O
decreased	|O
transcriptional	|O
activity	|O
of	|O
SP	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
promoter	|O
-	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
constructs	|O
containing	|O
SP	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
gene	|O
sequences	|O
from	|O
-	|O
256	|O
to	|O
+	|O
45	|O
.	|O

Insulin	|B-PROTEIN
-	|I-PROTEIN
like	|I-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
induces	|O
bcl	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
promoter	|O
through	|O
the	|O
transcription	|O
factor	|O
cAMP	|B-PROTEIN
-	|I-PROTEIN
response	|I-PROTEIN
element	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
.	|O

Synthesis	|O
of	|O
antisense	|O
RNA	|O
and	|O
S	|O
phase	|O
-	|O
dependent	|O
binding	|O
of	|O
E2F	|B-PROTEIN
complexes	|O
in	|O
intron	|O
1	|O
.	|O

Identification	|O
of	|O
eotaxin	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
will	|O
further	|O
promote	|O
our	|O
understanding	|O
of	|O
the	|O
control	|O
of	|O
eosinophil	|O
trafficking	|O
and	|O
other	|O
CCR3	|B-PROTEIN
-	|O
mediated	|O
biological	|O
phenomena	|O
.	|O

NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
plays	|O
a	|O
critical	|O
role	|O
in	|O
activation	|O
of	|O
HIV	|O
-	|O
1	|O
gene	|O
expression	|O
by	|O
cytokines	|O
and	|O
other	|O
stimuli	|O
,	|O
but	|O
the	|O
signal	|O
transduction	|O
pathways	|O
that	|O
regulate	|O
the	|O
switch	|O
from	|O
latent	|O
to	|O
productive	|O
infection	|O
have	|O
not	|O
been	|O
defined	|O
.	|O

These	|O
studies	|O
suggest	|O
that	|O
MAPK	|B-PROTEIN
acts	|O
by	|O
stimulating	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
a	|O
subsequent	|O
physical	|O
and	|O
functional	|O
interaction	|O
of	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
with	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
,	|O
resulting	|O
in	|O
a	|O
complex	|O
that	|O
synergistically	|O
transactivates	|O
the	|O
HIV	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
LTR	|I-PROTEIN
.	|O

ERK	|B-PROTEIN
MAP	|O
kinase	|O
links	|O
cytokine	|O
signals	|O
to	|O
activation	|O
of	|O
latent	|O
HIV	|O
-	|O
1	|O
infection	|O
by	|O
stimulating	|O
a	|O
cooperative	|O
interaction	|O
of	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
.	|O

A	|O
human	|O
nuclear	|O
-	|O
localized	|O
chaperone	|O
that	|O
regulates	|O
dimerization	|O
,	|O
DNA	|O
binding	|O
,	|O
and	|O
transcriptional	|O
activity	|O
of	|O
bZIP	|B-PROTEIN
proteins	|I-PROTEIN
.	|O

Clinical	|O
differentiation	|O
of	|O
patients	|O
with	|O
mild	|O
diplegic	|O
cerebral	|O
palsy	|O
(	|O
CP	|O
)	|O
and	|O
idiopathic	|O
toe	|O
walking	|O
(	|O
ITW	|O
)	|O
can	|O
be	|O
difficult	|O
.	|O

Sputum	|O
IL	|B-PROTEIN
-	|I-PROTEIN
8	|I-PROTEIN
and	|O
MPO	|B-PROTEIN
were	|O
significantly	|O
increased	|O
after	|O
BPT	|O
in	|O
both	|O
TDI	|O
-	|O
and	|O
grain	|O
dust	|O
-	|O
asthma	|O
(	|O
P	|O
<	|O
0.05	|O
)	|O
.	|O

Montelukast	|O
reduces	|O
airway	|O
eosinophilic	|O
inflammation	|O
in	|O
asthma	|O
:	|O
a	|O
randomized	|O
,	|O
controlled	|O
trial	|O
.	|O

Treatment	|O
of	|O
unstable	|O
angina	|O
:	|O
role	|O
of	|O
antithrombotic	|O
therapy	|O
.	|O

Here	|O
,	|O
we	|O
demonstrate	|O
that	|O
kinase	|O
-	|O
dead	|O
but	|O
not	|O
wild	|O
-	|O
type	|O
forms	|O
of	|O
Fyn	|B-PROTEIN
,	|O
Lck	|B-PROTEIN
,	|O
and	|O
ZAP	|B-PROTEIN
-	|I-PROTEIN
70	|I-PROTEIN
block	|O
70Z	|O
Cbl	|B-PROTEIN
-	|O
mediated	|O
NFAT	|B-PROTEIN
activation	|O
.	|O

Substitutions	|O
of	|O
region	|O
I	|O
with	|O
synthetic	|O
sequences	|O
showed	|O
that	|O
no	|O
specific	|O
sequence	|O
but	|O
rather	|O
repeats	|O
of	|O
three	|O
or	|O
more	|O
consecutive	|O
adenines	|O
or	|O
thymines	|O
,	|O
without	|O
interruption	|O
by	|O
guanine	|O
or	|O
cytosine	|O
,	|O
are	|O
required	|O
for	|O
the	|O
ARS	|O
activity	|O
.	|O

In	|O
Saccharomyces	|O
cerevisiae	|O
,	|O
PHO85	|B-PROTEIN
encodes	|O
a	|O
cyclin	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
Cdk	|B-PROTEIN
)	|O
catalytic	|O
subunit	|O
with	|O
multiple	|O
regulatory	|O
roles	|O
thought	|O
to	|O
be	|O
specified	|O
by	|O
association	|O
with	|O
different	|O
cyclin	|B-PROTEIN
partners	|O
(	|O
Pcls	|B-PROTEIN
)	|O
.	|O

Mutants	|O
with	|O
mild	|O
lace	|B-PROTEIN
alleles	|O
grow	|O
to	|O
become	|O
adults	|O
with	|O
multiple	|O
aberrant	|O
morphologies	|O
in	|O
the	|O
appendages	|O
,	|O
compound	|O
eye	|O
,	|O
and	|O
bristles	|O
.	|O

In	|O
fact	|O
,	|O
SPT	|B-PROTEIN
activity	|O
in	|O
the	|O
fly	|O
expressing	|O
epitope	|O
-	|O
tagged	|O
Lace	|B-PROTEIN
was	|O
absorbed	|O
by	|O
epitope	|O
-	|O
specific	|O
antibody	|O
.	|O

Mutations	|O
of	|O
the	|O
RET	|B-PROTEIN
gene	|O
,	|O
encoding	|O
a	|O
receptor	|B-PROTEIN
tyrosine	|I-PROTEIN
kinase	|I-PROTEIN
,	|O
have	|O
been	|O
associated	|O
with	|O
the	|O
inherited	|O
cancer	|O
syndromes	|O
MEN	|O
2A	|O
and	|O
MEN	|O
2B	|O
.	|O

These	|O
results	|O
show	|O
that	|O
targeting	|O
of	|O
Ras	|B-PROTEIN
-	|O
GAP	|B-PROTEIN
could	|O
represent	|O
a	|O
novel	|O
anticancer	|O
approach	|O
.	|O

EB	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
a	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
signal	|O
transduction	|O
gene	|O
,	|O
is	|O
transcriptionally	|O
activated	|O
in	|O
the	|O
t	|O
(	|O
1	|O
;	|O
19	|O
)	|O
subset	|O
of	|O
pre	|O
-	|O
B	|O
ALL	|O
,	|O
which	|O
express	|O
oncoprotein	|O
E2a	|B-PROTEIN
-	|O
Pbx1	|B-PROTEIN
.	|O

Protein	|B-PROTEIN
kinase	|I-PROTEIN
A	|I-PROTEIN
-	|O
Ialpha	|O
subunit	|O
-	|O
directed	|O
antisense	|O
inhibition	|O
of	|O
ovarian	|O
cancer	|O
cell	|O
growth	|O
:	|O
crosstalk	|O
with	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
signaling	|O
pathway	|O
.	|O

BCL6	|B-PROTEIN
encodes	|O
a	|O
POZ	|B-PROTEIN
/	|I-PROTEIN
Zn	|I-PROTEIN
finger	|I-PROTEIN
protein	|I-PROTEIN
,	|O
a	|O
structure	|O
similar	|O
to	|O
that	|O
of	|O
many	|O
Drosophila	|O
developmental	|O
regulators	|O
and	|O
to	|O
another	|O
protein	|O
involved	|O
in	|O
a	|O
human	|O
hematopoietic	|O
malignancy	|O
,	|O
PLZF	|B-PROTEIN
.	|O

Beta	|B-PROTEIN
1	|I-PROTEIN
integrin	|I-PROTEIN
-	|O
and	|O
proteoglycan	|O
-	|O
mediated	|O
stimulation	|O
of	|O
T	|O
lymphoma	|O
cell	|O
adhesion	|O
and	|O
mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
signaling	|O
by	|O
thrombospondin	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
thrombospondin	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
peptides	|O
.	|O

Optical	|O
CD	|O
,	|O
and	|O
spectral	|O
and	|O
activity	|O
analyses	|O
were	|O
used	|O
to	|O
examine	|O
reactivity	|O
of	|O
HO	|B-PROTEIN
isozymes	|O
with	|O
NO	|O
species	|O
produced	|O
by	|O
NO	|O
donors	|O
.	|O

The	|O
phosphotransferase	|O
system	|O
(	|O
PTS	|O
)	|O
of	|O
Streptomyces	|O
coelicolor	|O
identification	|O
and	|O
biochemical	|O
analysis	|O
of	|O
a	|O
histidine	|B-PROTEIN
phosphocarrier	|I-PROTEIN
protein	|I-PROTEIN
HPr	|O
encoded	|O
by	|O
the	|O
gene	|O
ptsH	|B-PROTEIN
.	|O

Serum	|O
concentrations	|O
of	|O
bone	|O
specific	|O
alkaline	|B-PROTEIN
phosphatase	|I-PROTEIN
(	|O
BALP	|B-PROTEIN
)	|O
and	|O
osteocalcin	|B-PROTEIN
(	|O
bone	|B-PROTEIN
Gla	|I-PROTEIN
protein	|I-PROTEIN
,	|O
BGP	|B-PROTEIN
)	|O
,	|O
urinary	|O
levels	|O
of	|O
pyridinoline	|O
(	|O
Pyr	|O
)	|O
and	|O
deoxypyridinoline	|O
(	|O
Dpyr	|O
)	|O
and	|O
computed	|O
tomography	|O
(	|O
CT	|O
)	|O
measurements	|O
of	|O
the	|O
cross	|O
-	|O
sectional	|O
areas	|O
of	|O
the	|O
vertebrae	|O
and	|O
the	|O
femurs	|O
,	|O
the	|O
apparent	|O
density	|O
of	|O
cancellous	|O
bone	|O
in	|O
the	|O
vertebrae	|O
,	|O
and	|O
the	|O
volume	|O
and	|O
the	|O
material	|O
density	|O
of	|O
cortical	|O
bone	|O
in	|O
the	|O
femurs	|O
were	|O
determined	|O
in	|O
126	|O
boys	|O
and	|O
143	|O
girls	|O
,	|O
ages	|O
7-18	|O
years	|O
.	|O

In	|O
another	|O
study	|O
,	|O
intravenous	|O
administration	|O
of	|O
devazepide	|O
,	|O
a	|O
specific	|O
cholecystokinin	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
receptor	|I-PROTEIN
antagonist	|O
,	|O
at	|O
a	|O
dose	|O
of	|O
0.1	|O
mg	|O
/	|O
kg	|O
/	|O
hr	|O
was	|O
begun	|O
15	|O
min	|O
before	|O
postprandial	|O
saline	|O
intake	|O
and	|O
continued	|O
for	|O
1	|O
hr	|O
.	|O

This	|O
cluster	|O
consisted	|O
of	|O
four	|O
apparently	|O
unrelated	|O
ESTs	|O
and	|O
two	|O
genes	|O
,	|O
pregnancy	|B-PROTEIN
-	|I-PROTEIN
associated	|I-PROTEIN
plasma	|I-PROTEIN
protein	|I-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
(	|O
PAPP	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
)	|O
and	|O
a	|O
novel	|O
gene	|O
(	|O
tentatively	|O
named	|O
EST	|B-PROTEIN
-	|I-PROTEIN
YD1	|I-PROTEIN
)	|O
.	|O

Prognostic	|O
value	|O
of	|O
a	|O
treadmill	|O
exercise	|O
score	|O
in	|O
symptomatic	|O
patients	|O
with	|O
nonspecific	|O
ST	|O
-	|O
T	|O
abnormalities	|O
on	|O
resting	|O
ECG	|O
.	|O

Structural	|O
changes	|O
in	|O
the	|O
C	|O
-	|O
terminus	|O
of	|O
Ca2+	|O
-	|O
bound	|O
rat	|O
S100B	|B-PROTEIN
(	|O
beta	|B-PROTEIN
beta	|I-PROTEIN
)	|O
upon	|O
binding	|O
to	|O
a	|O
peptide	|O
derived	|O
from	|O
the	|O
C	|O
-	|O
terminal	|O
regulatory	|O
domain	|O
of	|O
p53	|B-PROTEIN
.	|O

We	|O
propose	|O
that	|O
Gly84	|O
is	|O
part	|O
of	|O
a	|O
putative	|O
"	|O
oxyanion	|O
hole	|O
"	|O
involved	|O
in	|O
the	|O
stabilization	|O
of	|O
the	|O
transition	|O
state	|O
similar	|O
to	|O
the	|O
C	|B-PROTEIN
group	|I-PROTEIN
of	|O
the	|O
esterase	|B-PROTEIN
/	|O
lipase	|B-PROTEIN
family	|O
.	|O

The	|O
solution	|O
structure	|O
of	|O
the	|O
adduct	|O
derived	|O
from	|O
the	|O
covalent	|O
bonding	|O
of	|O
the	|O
fjord	|O
region	|O
(	|O
+	|O
)	|O
-	|O
(	|O
11S	|O
,	|O
12R	|O
,	|O
13R	|O
,	|O
14S	|O
)	|O
stereoisomer	|O
of	|O
anti	|O
-	|O
11,12	|O
-	|O
dihydroxy	|O
-	|O
13,14	|O
-	|O
epoxy	|O
-	|O
11,12,13	|O
,	|O
14	|O
-	|O
tetrahydrobenzo	|O
[	|O
g	|O
]	|O
chrysene	|O
,	|O
(	|O
+	|O
)	|O
-	|O
anti	|O
-	|O
B	|O
[	|O
g	|O
]	|O
CDE	|O
,	|O
to	|O
the	|O
exocyclic	|O
N	|O
(	|O
6	|O
)	|O
amino	|O
group	|O
of	|O
the	|O
adenine	|O
residue	|O
dA6	|O
,	|O
(	|O
designated	|O
(	|O
+	|O
)	|O
-	|O
trans	|O
-	|O
anti	|O
-	|O
(	|O
B	|O
[	|O
g	|O
]	|O
C	|O
)	|O
dA6	|O
)	|O
,	|O
positioned	|O
opposite	|O
a	|O
thymine	|O
residue	|O
dT17	|O
in	|O
the	|O
DNA	|O
sequence	|O
context	|O
d	|O
(	|O
C1	|O
-	|O
T2	|O
-	|O
C3	|O
-	|O
T4	|O
-	|O
C5	|O
-	|O
(	|O
B	|O
[	|O
g	|O
]	|O
C	|O
)	|O
A6	|O
-	|O
C7	|O
-	|O
T8	|O
-	|O
T9	|O
-	|O
C10	|O
-	|O
C11	|O
)	|O
.	|O
d	|O
(	|O
G12	|O
-	|O
G13	|O
-	|O
A14	|O
-	|O
A15	|O
-	|O
G16	|O
-	|O
T17	|O
-	|O
G18	|O
-	|O
A19	|O
-	|O
G20+	|O
+	|O
+	|O
-	|O
A21	|O
-	|O
G22	|O
)	|O
(	|O
designated	|O
(	|O
B	|O
[	|O
g	|O
]	|O
C	|O
)	|O
dA	|O
.	|O
dT	|O
11	|O
-	|O
mer	|O
duplex	|O
)	|O
,	|O
has	|O
been	|O
studied	|O
using	|O
structural	|O
information	|O
derived	|O
from	|O
NMR	|O
data	|O
in	|O
combination	|O
with	|O
molecular	|O
dynamics	|O
(	|O
MD	|O
)	|O
calculations	|O
.	|O

Since	|O
sildenafil	|O
came	|O
on	|O
the	|O
market	|O
,	|O
it	|O
seems	|O
that	|O
the	|O
place	|O
of	|O
MUSE	|O
is	|O
reduced	|O
because	|O
comparative	|O
studies	|O
give	|O
better	|O
results	|O
for	|O
sildenafil	|O
than	|O
MUSE	|O
(	|O
70%	|O
vs	|O
40%	|O
)	|O
and	|O
of	|O
course	|O
with	|O
a	|O
better	|O
acceptance	|O
.	|O

Serum	|O
antibodies	|O
were	|O
detected	|O
in	|O
at	|O
least	|O
95%	|O
of	|O
the	|O
infected	|O
guinea	|O
pigs	|O
between	|O
4-30	|O
WPI	|O
and	|O
rats	|O
between	|O
3-16	|O
WPI	|O
.	|O

During	|O
both	|O
encephalopathy	|O
episodes	|O
,	|O
CSF	|O
protein	|O
and	|O
immunoglobulin	|B-PROTEIN
G	|I-PROTEIN
(	|O
IgG	|B-PROTEIN
)	|O
levels	|O
were	|O
elevated	|O
without	|O
an	|O
increased	|O
IgG	|B-PROTEIN
index	|O
or	|O
IgG	|B-PROTEIN
synthesis	|O
rate	|O
.	|O

CONCLUSIONS	|O
:	|O
These	|O
results	|O
show	|O
that	|O
once	|O
daily	|O
oral	|O
valganciclovir	|O
can	|O
produce	|O
exposures	|O
of	|O
ganciclovir	|O
(	|O
AUC24	|O
)	|O
exceeding	|O
those	|O
attained	|O
using	|O
intravenous	|O
ganciclovir	|O
10	|O
mg	|O
/	|O
kg	|O
.	|O

Except	|O
for	|O
nonperfusion	|O
of	|O
neurosensory	|O
retinal	|O
vessels	|O
at	|O
a	|O
light	|O
dose	|O
of	|O
150	|O
J	|O
/	|O
cm2	|O
,	|O
no	|O
other	|O
adverse	|O
events	|O
were	|O
of	|O
concern	|O
.	|O

Except	|O
for	|O
nonperfusion	|O
of	|O
neurosensory	|O
retinal	|O
vessels	|O
at	|O
a	|O
light	|O
dose	|O
of	|O
150	|O
J	|O
/	|O
cm2	|O
,	|O
no	|O
other	|O
adverse	|O
events	|O
were	|O
of	|O
concern	|O
.	|O

The	|O
healing	|O
rate	|O
in	|O
HIV	|O
-	|O
positive	|O
patients	|O
was	|O
66	|O
percent	|O
after	|O
14	|O
weeks	|O
and	|O
100	|O
percent	|O
after	|O
32	|O
weeks	|O
;	|O
the	|O
corresponding	|O
figures	|O
for	|O
patients	|O
with	|O
acquired	|O
immunodeficiency	|O
syndrome	|O
were	|O
0	|O
and	|O
50	|O
percent	|O
.	|O

The	|O
P	|B-PROTEIN
mRNA	|O
also	|O
contains	|O
a	|O
third	|O
ORF	|O
for	|O
the	|O
V	|B-PROTEIN
protein	|O
,	|O
although	|O
it	|O
is	|O
unclear	|O
how	|O
or	|O
whether	|O
this	|O
ORF	|O
is	|O
accessed	|O
.	|O

A	|O
genetic	|O
screen	|O
in	|O
yeast	|O
has	|O
allowed	|O
us	|O
to	|O
identify	|O
a	|O
novel	|O
transcriptional	|O
factor	|O
binding	|O
to	|O
the	|O
GlRE	|O
,	|O
i.e.	|O
the	|O
chicken	|B-PROTEIN
ovalbumin	|I-PROTEIN
upstream	|I-PROTEIN
promoter	|I-PROTEIN
-	|I-PROTEIN
transcription	|I-PROTEIN
factor	|I-PROTEIN
II	|I-PROTEIN
(	|O
COUP	|B-PROTEIN
-	|I-PROTEIN
TFII	|I-PROTEIN
)	|O
.	|O

We	|O
have	|O
cloned	|O
the	|O
single	|O
-	|O
copy	|O
gene	|O
for	|O
the	|O
trans	|O
-	|O
spliceosomal	|O
U5	|B-PROTEIN
snRNA	|O
from	|O
the	|O
trypanosomatid	|O
species	|O
Leptomonas	|O
seymouri	|O
,	|O
using	|O
U5	|B-PROTEIN
RNA	|O
affinity	|O
selection	|O
and	|O
cDNA	|O
cloning	|O
.	|O

The	|O
MMPI	|O
-	|O
A	|O
(	|O
Butcher	|O
et	|O
al.	|O
,	|O
1992	|O
)	|O
,	|O
like	|O
the	|O
older	|O
MMPI	|O
(	|O
Hathaway	|O
&	|O
McKinley	|O
,	|O
1983	|O
)	|O
,	|O
distinguishes	|O
between	|O
anorexia	|O
and	|O
bulimia	|O
.	|O

On	|O
the	|O
other	|O
hand	|O
,	|O
phosphatidyl	|O
inositol	|O
4,5	|O
bisphosphate	|O
(	|O
PIP2	|O
)	|O
hydrolysis	|O
requires	|O
direct	|O
phosphorylation	|O
at	|O
tyrosine	|O
residue	|O
of	|O
the	|O
PLC	|B-PROTEIN
-	|I-PROTEIN
gamma1	|I-PROTEIN
isozyme	|O
.	|O

A	|O
G22V	|B-PROTEIN
mutant	|O
of	|O
M	|B-PROTEIN
-	|I-PROTEIN
Ras	|I-PROTEIN
was	|O
constitutively	|O
active	|O
and	|O
its	|O
expression	|O
in	|O
an	|O
interleukin	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
(	|O
IL	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
)	|O
-	|O
dependent	|O
mast	|O
cell	|O
/	|O
megakaryocyte	|O
cell	|O
line	|O
resulted	|O
in	|O
increased	|O
survival	|O
in	|O
the	|O
absence	|O
of	|O
IL	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
,	|O
increased	|O
growth	|O
in	|O
IL	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
,	|O
and	|O
,	|O
at	|O
high	|O
expression	|O
levels	|O
,	|O
in	|O
factor	|O
-	|O
independent	|O
growth	|O
.	|O

Mammalian	|O
M	|B-PROTEIN
-	|I-PROTEIN
Ras	|I-PROTEIN
and	|O
a	|O
Caenorhabditis	|O
elegans	|O
orthologue	|O
exhibit	|O
conserved	|O
structural	|O
features	|O
,	|O
and	|O
these	|O
are	|O
likely	|O
to	|O
mediate	|O
activation	|O
of	|O
distinctive	|O
signaling	|O
paths	|O
that	|O
function	|O
in	|O
parallel	|O
to	|O
those	|O
downstream	|O
of	|O
p21	|B-PROTEIN
Ras	|I-PROTEIN
.	|O

Taken	|O
together	|O
,	|O
our	|O
data	|O
suggest	|O
that	|O
PecS	|B-PROTEIN
attenuates	|O
pelD	|B-PROTEIN
and	|O
pelE	|B-PROTEIN
expression	|O
rather	|O
than	|O
acting	|O
as	|O
a	|O
true	|O
repressor	|O
like	|O
KdgR	|B-PROTEIN
.	|O

These	|O
observations	|O
establish	|O
that	|O
RsmC	|B-PROTEIN
negatively	|O
regulates	|O
rsmB	|B-PROTEIN
transcription	|O
but	|O
positively	|O
affects	|O
RsmA	|B-PROTEIN
production	|O
.	|O

All	|O
were	|O
experienced	|O
hearing	|O
aid	|O
users	|O
who	|O
wore	|O
linear	|O
Class	|O
D	|O
instruments	|O
with	|O
input	|O
compression	|O
limiting	|O
at	|O
the	|O
time	|O
of	|O
their	|O
enrollment	|O
in	|O
this	|O
study	|O
.	|O

SCOB	|O
testing	|O
of	|O
food	|O
-	|O
restricted	|O
animals	|O
,	|O
using	|O
a	|O
multiple	|O
fixed	|O
ratio	|O
(	|O
FR	|O
)	|O
/	|O
fixed	|O
interval	|O
(	|O
FI	|O
)	|O
schedule	|O
(	|O
FR20	|O
:	|O
FI120	|O
)	|O
,	|O
was	|O
conducted	|O
prior	|O
to	|O
each	|O
exposure	|O
to	|O
maintain	|O
the	|O
operant	|O
behavior	|O
;	|O
the	|O
data	|O
from	|O
Weeks	|O
-	|O
1	|O
,	|O
4	|O
,	|O
8	|O
,	|O
and	|O
13	|O
were	|O
evaluated	|O
for	|O
evidence	|O
of	|O
neurotoxicity	|O
.	|O

Ribonuclease	|O
protection	|O
assays	|O
revealed	|O
that	|O
hmg1	|B-PROTEIN
and	|O
hmg2	|B-PROTEIN
are	|O
differentially	|O
expressed	|O
in	|O
a	|O
developmentally	|O
-	|O
and	|O
spatially	|O
-	|O
modulated	|O
manner	|O
during	|O
morphogenesis	|O
of	|O
specialized	|O
terpenoid	|O
-	|O
containing	|O
pigment	|O
glands	|O
in	|O
embryos	|O
.	|O

Differential	|O
expression	|O
was	|O
confirmed	|O
by	|O
Northern	|O
blot	|O
analysis	|O
employing	|O
multiple	|O
normal	|O
and	|O
tumor	|O
cell	|O
lines	|O
.	|O

Inactivation	|O
of	|O
the	|O
Neurospora	|O
crassa	|O
mitochondrial	|O
outer	|O
membrane	|O
protein	|O
TOM70	|B-PROTEIN
by	|O
repeat	|O
-	|O
induced	|O
point	|O
mutation	|O
(	|O
RIP	|O
)	|O
causes	|O
defects	|O
in	|O
mitochondrial	|O
protein	|O
import	|O
and	|O
morphology	|O
.	|O

Several	|O
genes	|O
or	|O
transcriptional	|O
units	|O
were	|O
identified	|O
,	|O
including	|O
the	|O
3'	|O
end	|O
of	|O
ribosomal	|B-PROTEIN
s6	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
Rsk3	|B-PROTEIN
)	|O
;	|O
two	|O
apparently	|O
intronless	|O
and	|O
ORF	|O
-	|O
less	|O
genes	|O
;	|O
and	|O
Gpr31	|B-PROTEIN
,	|O
an	|O
intronless	|O
,	|O
putative	|O
G	|B-PROTEIN
-	|I-PROTEIN
protein	|I-PROTEIN
coupled	|I-PROTEIN
receptor	|I-PROTEIN
.	|O

The	|O
results	|O
suggest	|O
that	|O
GATA	|B-PROTEIN
-	|I-PROTEIN
5	|I-PROTEIN
may	|O
have	|O
specific	|O
downstream	|O
targets	|O
and	|O
that	|O
GATA	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
,	|I-PROTEIN
-	|I-PROTEIN
5	|I-PROTEIN
,	|I-PROTEIN
and	|I-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
can	|O
only	|O
partially	|O
substitute	|O
for	|O
each	|O
other	|O
in	|O
cardiogenesis	|O
.	|O

This	|O
study	|O
was	|O
designed	|O
to	|O
compare	|O
the	|O
efficacy	|O
of	|O
efegatran	|O
plus	|O
streptokinase	|B-PROTEIN
versus	|O
heparin	|O
plus	|O
accelerated	|O
tissue	|B-PROTEIN
plasminogen	|I-PROTEIN
activator	|I-PROTEIN
(	|O
TPA	|B-PROTEIN
)	|O
in	|O
coronary	|O
reperfusion	|O
in	|O
acute	|O
MI	|O
.	|O

Recently	|O
,	|O
cell	|O
-	|O
surface	|O
TRAIL	|B-PROTEIN
has	|O
been	|O
shown	|O
to	|O
be	|O
expressed	|O
by	|O
activated	|O
human	|O
and	|O
mouse	|O
T	|O
lymphocytes	|O
,	|O
raising	|O
the	|O
possibility	|O
that	|O
TRAIL	|B-PROTEIN
might	|O
be	|O
involved	|O
in	|O
T	|O
cell	|O
-	|O
mediated	|O
cytotoxicity	|O
and	|O
/	|O
or	|O
immune	|O
regulation	|O
.	|O

A	|O
panel	|O
of	|O
pharmacologic	|O
inhibitors	|O
was	|O
used	|O
to	|O
investigate	|O
the	|O
signal	|O
transduction	|O
pathways	|O
involved	|O
in	|O
TRAIL	|B-PROTEIN
gene	|O
induction	|O
following	|O
T	|O
lymphocyte	|O
activation	|O
.	|O

From	|O
February	|O
1991	|O
to	|O
August	|O
1997	|O
,	|O
124	|O
patients	|O
with	|O
endometrial	|O
carcinoma	|O
were	|O
treated	|O
postoperatively	|O
with	|O
high	|O
-	|O
dose	|O
-	|O
rate	|O
vaginal	|O
vault	|O
brachytherapy	|O
as	|O
the	|O
only	|O
adjuvant	|O
treatment	|O
.	|O

Twelve	|O
patients	|O
had	|O
stage	|O
IBG3	|O
,	|O
14	|O
had	|O
ICG1	|O
,	|O
9	|O
had	|O
ICG2	|O
,	|O
and	|O
3	|O
had	|O
ICG3	|O
disease	|O
.	|O

Defective	|O
provirus	|O
genomes	|O
of	|O
human	|O
T	|O
-	|O
cell	|O
leukemia	|O
virus	|O
type	|O
I	|O
are	|O
frequently	|O
detected	|O
in	|O
lymphocytes	|O
from	|O
infected	|O
individuals	|O
and	|O
in	|O
infected	|O
cell	|O
lines	|O
.	|O

A	|O
total	|O
of	|O
174	|O
primer	|O
pairs	|O
gave	|O
interpretable	|O
banding	|O
patterns	|O
,	|O
137	|O
(	|O
79%	|O
)	|O
of	|O
which	|O
revealed	|O
at	|O
least	|O
two	|O
alleles	|O
on	|O
native	|O
polyacrylamide	|O
gels	|O
.	|O

A	|O
population	|O
pharmacokinetic	|O
study	|O
of	|O
cyclosporin	|O
in	|O
organ	|O
transplant	|O
patients	|O
,	|O
including	|O
elderly	|O
allograft	|O
recipients	|O
up	|O
to	|O
75	|O
years	|O
of	|O
age	|O
,	|O
did	|O
not	|O
identify	|O
age	|O
as	|O
a	|O
covariable	|O
influencing	|O
cyclosporin	|O
pharmacokinetics	|O
.	|O

Immunofluoresence	|O
data	|O
indicated	|O
that	|O
once	|O
bound	|O
to	|O
the	|O
mutant	|O
receptor	|O
,	|O
fluorescent	|O
-	|O
labeled	|O
RAP	|B-PROTEIN
co	|O
-	|O
localized	|O
with	|O
markers	|O
of	|O
the	|O
endosomal	|O
pathway	|O
,	|O
whereas	|O
,	|O
in	|O
cells	|O
expressing	|O
the	|O
wild	|O
-	|O
type	|O
receptor	|O
,	|O
RAP	|B-PROTEIN
fluorescence	|O
co	|O
-	|O
localized	|O
with	|O
lysosomal	|O
markers	|O
.	|O

Interleukin	|B-PROTEIN
-	|I-PROTEIN
12	|I-PROTEIN
(	|O
IL	|B-PROTEIN
-	|I-PROTEIN
12	|I-PROTEIN
)	|O
is	|O
a	|O
cytokine	|O
produced	|O
by	|O
peripheral	|O
blood	|O
mononuclear	|O
cells	|O
(	|O
PBMC	|O
)	|O
that	|O
causes	|O
interferon	|B-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
(	|O
IFN	|B-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
)	|O
production	|O
and	|O
enhancement	|O
of	|O
cell	|O
-	|O
mediated	|O
cytotoxicity	|O
.	|O

IL	|B-PROTEIN
-	|I-PROTEIN
12	|I-PROTEIN
production	|O
was	|O
correlated	|O
with	|O
C3a	|O
concentration	|O
measured	|O
at	|O
the	|O
outlet	|O
of	|O
hemodialyzer	|O
after	|O
15	|O
min	|O
of	|O
dialysis	|O
(	|O
r	|O
=	|O
0.69	|O
,	|O
P	|O
<	|O
0.01	|O
)	|O
.	|O

In	|O
HeLa	|O
cells	|O
,	|O
the	|O
JNKK2	|B-PROTEIN
-	|O
JNK1	|B-PROTEIN
fusion	|O
protein	|O
showed	|O
significant	|O
JNK	|B-PROTEIN
activity	|O
,	|O
which	|O
was	|O
comparable	|O
with	|O
that	|O
of	|O
JNK1	|B-PROTEIN
activated	|O
by	|O
many	|O
stimuli	|O
and	|O
activators	|O
,	|O
including	|O
EGF	|B-PROTEIN
,	|O
TNF	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
,	|O
anisomycin	|O
,	|O
UV	|O
irradiation	|O
,	|O
MEKK1	|B-PROTEIN
,	|O
and	|O
small	|O
GTP	|O
binding	|O
proteins	|O
Rac1	|B-PROTEIN
and	|O
Cdc42Hs	|B-PROTEIN
.	|O

J.	|O

Our	|O
results	|O
implicate	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
RII	|I-PROTEIN
as	|O
a	|O
direct	|O
target	|O
of	|O
EWS	|B-PROTEIN
-	|O
FLI1	|B-PROTEIN
.	|O

The	|O
reduction	|O
in	|O
saturated	|O
fatty	|O
acids	|O
intake	|O
led	|O
to	|O
modest	|O
(	|O
but	|O
in	|O
group	|O
1	|O
significant	|O
)	|O
0.15	|O
mmol	|O
/	|O
l	|O
(	|O
2.5%	|O
)	|O
reduction	|O
in	|O
total	|O
serum	|O
cholesterol	|O
level	|O
.	|O

Secondly	|O
,	|O
an	|O
ethanol	|O
repression	|O
autoregulation	|O
(	|O
ERA	|O
)	|O
/	|O
twelve	|O
-	|O
fold	|O
TA	|O
repeat	|O
(	|O
TAB	|O
)	|O
repressor	|O
element	|O
was	|O
identified	|O
within	|O
the	|O
promoter	|O
region	|O
of	|O
the	|O
GLK1	|B-PROTEIN
gene	|O
.	|O

A	|O
crucial	|O
transcription	|O
factor	|O
in	|O
this	|O
process	|O
is	|O
STAT6	|B-PROTEIN
,	|O
which	|O
binds	|O
to	|O
a	|O
specific	|O
DNA	|O
element	|O
upon	|O
cytokine	|O
activation	|O
.	|O

CONCLUSIONS	|O
:	|O
Congenital	|O
horizontal	|O
tarsal	|O
kink	|O
is	|O
rare	|O
and	|O
its	|O
cause	|O
is	|O
unknown	|O
.	|O

A	|O
local	|O
,	|O
high	|O
-	|O
density	|O
,	|O
single	|O
-	|O
nucleotide	|O
polymorphism	|O
map	|O
used	|O
to	|O
clone	|O
Caenorhabditis	|O
elegans	|O
cdf	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

This	|O
machinery	|O
involves	|O
a	|O
secondary	|O
structure	|O
,	|O
SECIS	|O
element	|O
,	|O
in	|O
the	|O
selenoprotein	|B-PROTEIN
-	|O
encoding	|O
mRNA	|O
,	|O
directing	|O
selenocysteine	|O
insertion	|O
at	|O
the	|O
position	|O
of	|O
an	|O
opal	|O
(	|O
UGA	|O
)	|O
codon	|O
,	|O
normally	|O
conferring	|O
termination	|O
of	|O
translation	|O
.	|O

High	|O
-	|O
level	|O
expression	|O
in	|O
Escherichia	|O
coli	|O
of	|O
selenocysteine	|O
-	|O
containing	|O
rat	|O
thioredoxin	|B-PROTEIN
reductase	|I-PROTEIN
utilizing	|O
gene	|O
fusions	|O
with	|O
engineered	|O
bacterial	|O
-	|O
type	|O
SECIS	|O
elements	|O
and	|O
co	|O
-	|O
expression	|O
with	|O
the	|O
selA	|B-PROTEIN
,	|O
selB	|B-PROTEIN
and	|O
selC	|B-PROTEIN
genes	|O
.	|O

In	|O
Wnt	|B-PROTEIN
signaling	|O
,	|O
beta	|B-PROTEIN
-	|I-PROTEIN
catenin	|I-PROTEIN
and	|O
plakoglobin	|B-PROTEIN
transduce	|O
signals	|O
to	|O
the	|O
nucleus	|O
through	|O
interactions	|O
with	|O
TCF	|B-PROTEIN
-	|O
type	|O
transcription	|O
factors	|O
.	|O

Assembly	|O
of	|O
a	|O
complex	|O
between	|O
FAK	|B-PROTEIN
and	|O
Src	|B-PROTEIN
kinases	|O
may	|O
serve	|O
to	|O
regulate	|O
the	|O
subcellular	|O
localization	|O
and	|O
the	|O
enzymatic	|O
activity	|O
of	|O
members	|O
of	|O
the	|O
Src	|B-PROTEIN
family	|O
of	|O
kinases	|O
.	|O

For	|O
EPV	|O
3	|O
,	|O
10	|O
,	|O
or	|O
40	|O
,	|O
the	|O
bias	|O
exceeded	|O
25%	|O
for	|O
7	|O
,	|O
3	|O
,	|O
and	|O
1	|O
in	|O
the	|O
8	|O
-	|O
predictor	|O
model	|O
respectively	|O
,	|O
when	|O
a	|O
conventional	|O
selection	|O
criterion	|O
was	|O
used	|O
(	|O
alpha	|O
=	|O
0.05	|O
)	|O
.	|O

Our	|O
study	|O
also	|O
demonstrated	|O
significant	|O
increases	|O
in	|O
the	|O
number	|O
of	|O
larger	|O
myelinated	|O
fibers	|O
crossing	|O
the	|O
repair	|O
site	|O
in	|O
comparison	|O
with	|O
the	|O
neonatal	|O
and	|O
adult	|O
groups	|O
(	|O
p	|O
<	|O
0.04	|O
)	|O
.	|O

Me	|O
(	|O
2	|O
)	|O
SO	|O
-	|O
induced	|O
neuronal	|O
differentiation	|O
of	|O
N1E	|O
-	|O
115	|O
neuroblastoma	|O
cells	|O
increased	|O
both	|O
the	|O
expression	|O
of	|O
the	|O
endogenous	|O
Ntr	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
gene	|O
and	|O
reporter	|O
genes	|O
driven	|O
by	|O
NTR	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
promoter	|O
sequences	|O
by	|O
3-4	|O
-	|O
fold	|O
.	|O

Cortical	|O
dysplasias	|O
,	|O
genetics	|O
,	|O
and	|O
epileptogenesis	|O
.	|O

In	|O
the	|O
work	|O
reported	|O
here	|O
,	|O
we	|O
used	|O
peptide	|O
mapping	|O
,	|O
mass	|O
spectrometry	|O
,	|O
and	|O
site	|O
-	|O
directed	|O
mutagenesis	|O
to	|O
identify	|O
two	|O
sets	|O
of	|O
pAP	|B-PROTEIN
phosphorylation	|O
sites	|O
.	|O

Both	|O
HERV	|O
-	|O
K	|O
type	|O
1	|O
and	|O
2	|O
clones	|O
were	|O
isolated	|O
.	|O

Duch	|O
,	|O
and	|O
F.	|O

At	|O
all	|O
time	|O
-	|O
points	|O
,	|O
most	|O
patients	|O
(	|O
>	|O
/	|O
=	|O
87%	|O
)	|O
were	|O
receiving	|O
irbesartan	|O
/	|O
HCTZ	|O
alone	|O
.	|O

Modification	|O
of	|O
dopamine	|O
D2	|B-PROTEIN
receptor	|I-PROTEIN
activity	|O
by	|O
pergolide	|O
in	|O
Parkinson	|O
's	|O
disease	|O
:	|O
an	|O
in	|O
vivo	|O
study	|O
by	|O
PET	|O
.	|O

High	|O
-	|O
affinity	|O
binding	|O
sites	|O
for	|O
both	|O
GR	|B-PROTEIN
and	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
nucleoproteins	|O
were	|O
identified	|O
at	|O
adjacent	|O
elements	|O
within	|O
the	|O
nGRE	|O
.	|O

When	|O
the	|O
73	|O
-	|O
bp	|O
fragment	|O
was	|O
fused	|O
to	|O
an	|O
alpha1	|B-PROTEIN
-	|I-PROTEIN
globin	|I-PROTEIN
promoter	|O
-	|O
CAT	|B-PROTEIN
construct	|O
and	|O
cotransfected	|O
with	|O
CCAAT	|B-PROTEIN
transcription	|I-PROTEIN
factor	|I-PROTEIN
1	|I-PROTEIN
(	|O
CTF1	|B-PROTEIN
)	|O
/	|O
NF1	|B-PROTEIN
into	|O
Drosophila	|O
Schneider	|O
SL2	|O
insect	|O
cells	|O
(	|O
which	|O
lack	|O
NF1	|B-PROTEIN
-	|O
like	|O
proteins	|O
)	|O
trans	|O
-	|O
activation	|O
of	|O
CAT	|B-PROTEIN
activity	|O
was	|O
observed	|O
.	|O

Western	|O
blot	|O
analysis	|O
showed	|O
a	|O
rapid	|O
corresponding	|O
increase	|O
in	|O
p21WAF1	|B-PROTEIN
/	|O
CIP1	|B-PROTEIN
protein	|O
,	|O
whereas	|O
protein	|O
levels	|O
of	|O
another	|O
member	|O
of	|O
the	|O
cyclin	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
kinase	|I-PROTEIN
inhibitor	|I-PROTEIN
family	|O
,	|O
p27kip1	|B-PROTEIN
,	|O
were	|O
unchanged	|O
.	|O

Aggregation	|O
of	|O
vHnf1	|B-PROTEIN
-	|O
deficient	|O
embryonic	|O
stem	|O
cells	|O
with	|O
wild	|O
-	|O
type	|O
tetraploid	|O
embryos	|O
,	|O
which	|O
contribute	|O
exclusively	|O
to	|O
extraembryonic	|O
tissues	|O
,	|O
rescues	|O
periimplantation	|O
lethality	|O
and	|O
allows	|O
development	|O
to	|O
progress	|O
to	|O
early	|O
organogenesis	|O
.	|O

nos	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
nos	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
,	|O
two	|O
genes	|O
related	|O
to	|O
Drosophila	|O
nanos	|B-PROTEIN
,	|O
regulate	|O
primordial	|O
germ	|O
cell	|O
development	|O
and	|O
survival	|O
in	|O
Caenorhabditis	|O
elegans	|O
.	|O

Although	|O
upstream	|O
regulators	|O
of	|O
Tec	|B-PROTEIN
family	|O
kinases	|O
are	|O
relatively	|O
well	|O
characterized	|O
,	|O
little	|O
is	|O
known	|O
of	|O
the	|O
downstream	|O
effectors	|O
of	|O
these	|O
enzymes	|O
.	|O

Efficient	|O
phosphorylation	|O
of	|O
BRDG1	|B-PROTEIN
by	|O
Tec	|B-PROTEIN
required	|O
the	|O
PH	|B-PROTEIN
and	|O
SH2	|B-PROTEIN
domains	|O
as	|O
well	|O
as	|O
the	|O
kinase	|O
domain	|O
of	|O
the	|O
latter	|O
.	|O

CONCLUSION	|O
:	|O
These	|O
findings	|O
imply	|O
that	|O
eotaxin	|O
either	|O
is	|O
mechanistically	|O
involved	|O
in	|O
acute	|O
asthma	|O
or	|O
serves	|O
as	|O
a	|O
biomarker	|O
for	|O
activity	|O
of	|O
the	|O
CCR3	|B-PROTEIN
receptor	|I-PROTEIN
ligand	|O
system	|O
,	|O
which	|O
is	|O
functionally	|O
linked	|O
to	|O
asthma	|O
.	|O

The	|O
expression	|O
analysis	|O
of	|O
the	|O
KlHIS4	|B-PROTEIN
gene	|O
under	|O
phosphate	|O
starvation	|O
or	|O
high	|O
adenine	|O
supply	|O
shows	|O
that	|O
factors	|O
,	|O
such	|O
as	|O
Bas1	|B-PROTEIN
or	|O
Bas2	|B-PROTEIN
,	|O
involved	|O
in	|O
the	|O
basal	|O
control	|O
may	|O
also	|O
operate	|O
in	|O
a	|O
different	|O
way	|O
in	|O
K.	|O
lactis	|O
.	|O

These	|O
thyroid	|O
hormone	|O
changes	|O
may	|O
be	|O
mediated	|O
in	|O
part	|O
by	|O
cytokines	|O
or	|O
other	|O
inflammatory	|O
mediators	|O
,	|O
acting	|O
at	|O
the	|O
level	|O
of	|O
the	|O
hypothalamus	|O
and	|O
pituitary	|O
gland	|O
,	|O
the	|O
thyroid	|O
gland	|O
,	|O
and	|O
the	|O
hepatic	|O
deiodinase	|B-PROTEIN
system	|O
.	|O

ESS	|O
type	|O
1	|O
,	|O
with	|O
FT3	|O
low	|O
and	|O
FT4	|O
and	|O
TSH	|B-PROTEIN
normal	|O
,	|O
is	|O
the	|O
most	|O
frequent	|O
form	|O
.	|O

METHODS	|O
:	|O
We	|O
studied	|O
20	|O
symptomatic	|O
patients	|O
with	|O
HOCM	|O
(	|O
12	|O
men	|O
)	|O
,	|O
mean	|O
age	|O
52	|O
+	|O
/	|O
-	|O
17	|O
years	|O
,	|O
before	|O
and	|O
after	|O
septal	|O
reduction	|O
using	|O
echocardiography	|O
and	|O
electrocardiogram	|O
(	|O
ECG	|O
)	|O
.	|O

Paleoceanographic	|O
data	|O
from	|O
the	|O
Laurentian	|O
Fan	|O
,	|O
used	|O
as	|O
a	|O
proxy	|O
for	|O
sea	|O
surface	|O
temperature	|O
,	|O
reveal	|O
that	|O
surface	|O
slope	|O
waters	|O
north	|O
of	|O
the	|O
Gulf	|O
Stream	|O
experienced	|O
warming	|O
during	|O
the	|O
Little	|O
Ice	|O
Age	|O
of	|O
the	|O
16th	|O
to	|O
19th	|O
centuries	|O
and	|O
support	|O
the	|O
notion	|O
of	|O
an	|O
NAO	|O
-	|O
driven	|O
coupled	|O
system	|O
.	|O

This	|O
effect	|O
required	|O
(	|O
i	|O
)	|O
IR	|B-PROTEIN
activation	|O
since	|O
it	|O
was	|O
abrogated	|O
by	|O
IR	|B-PROTEIN
mutation	|O
at	|O
tyrosines	|O
1162	|O
and	|O
1163	|O
and	|O
(	|O
ii	|O
)	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
activation	|O
since	|O
it	|O
was	|O
abolished	|O
by	|O
overexpression	|O
of	|O
dominant	|O
-	|O
negative	|O
IkappaB	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
(	|O
A32/36	|O
)	|O
and	|O
mimicked	|O
by	|O
overexpression	|O
of	|O
the	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
c	|O
-	|O
Rel	|O
subunit	|O
.	|O

The	|O
factor	|O
designated	|O
B	|O
formed	|O
a	|O
complex	|O
centered	|O
on	|O
the	|O
sequence	|O
TGTGGT	|O
,	|O
a	|O
core	|O
motif	|O
recognized	|O
by	|O
members	|O
of	|O
the	|O
AML	|B-PROTEIN
/	|I-PROTEIN
CBFalpha	|I-PROTEIN
transcription	|O
factor	|O
family	|O
.	|O

Furthermore	|O
,	|O
overexpression	|O
of	|O
AML3	|B-PROTEIN
/	|O
CBFalpha1	|B-PROTEIN
could	|O
rescue	|O
the	|O
AML1	|B-PROTEIN
-	|O
ETO	|B-PROTEIN
repression	|O
.	|O

We	|O
examined	|O
Akt	|B-PROTEIN
activation	|O
in	|O
Lyn	|B-PROTEIN
-	|O
,	|O
Syk	|B-PROTEIN
-	|O
and	|O
Btk	|B-PROTEIN
-	|O
deficient	|O
DT40	|O
cells	|O
and	|O
B	|O
cells	|O
from	|O
Lyn	|B-PROTEIN
(	|O
-	|O
/	|O
-	|O
)	|O
mice	|O
.	|O

Regulators	|O
of	|O
G	|O
protein	|O
signaling	|O
(	|O
RGS	|B-PROTEIN
)	|O
proteins	|O
that	|O
contain	|O
DEP	|B-PROTEIN
(	|O
disheveled	|B-PROTEIN
,	|O
EGL	|B-PROTEIN
-	|I-PROTEIN
10	|I-PROTEIN
,	|O
pleckstrin	|B-PROTEIN
)	|O
and	|O
GGL	|B-PROTEIN
(	|O
G	|B-PROTEIN
protein	|I-PROTEIN
gamma	|I-PROTEIN
subunit	|I-PROTEIN
-	|I-PROTEIN
like	|I-PROTEIN
)	|O
domains	|O
form	|O
a	|O
subfamily	|O
that	|O
includes	|O
the	|O
mammalian	|O
RGS	|B-PROTEIN
proteins	|O
RGS6	|B-PROTEIN
,	|O
RGS7	|B-PROTEIN
,	|O
RGS9	|B-PROTEIN
,	|O
and	|O
RGS11	|B-PROTEIN
.	|O

Cloning	|O
and	|O
expression	|O
of	|O
a	|O
specific	|O
human	|O
alpha	|B-PROTEIN
1,2	|I-PROTEIN
-	|I-PROTEIN
mannosidase	|I-PROTEIN
that	|O
trims	|O
Man9GlcNAc2	|O
to	|O
Man8GlcNAc2	|O
isomer	|O
B	|O
during	|O
N	|O
-	|O
glycan	|O
biosynthesis	|O
.	|O

The	|O
ORs	|O
of	|O
GC	|O
,	|O
adjusted	|O
for	|O
age	|O
and	|O
sex	|O
,	|O
varied	|O
from	|O
17.1	|O
,	|O
for	|O
those	|O
with	|O
baseline	|O
diagnoses	|O
of	|O
superficial	|O
intestinal	|O
metaplasia	|O
(	|O
IM	|O
)	|O
,	|O
to	|O
29.3	|O
,	|O
for	|O
those	|O
with	|O
deep	|O
IM	|O
or	|O
mild	|O
dysplasia	|O
(	|O
DYS	|O
)	|O
or	|O
IM	|O
with	|O
glandular	|O
atrophy	|O
and	|O
neck	|O
hyperplasia	|O
,	|O
to	|O
104.2	|O
,	|O
for	|O
those	|O
with	|O
moderate	|O
or	|O
severe	|O
DYS	|O
,	|O
as	|O
compared	|O
with	|O
subjects	|O
with	|O
superficial	|O
gastritis	|O
(	|O
SG	|O
)	|O
or	|O
chronic	|O
atrophic	|O
gastritis	|O
(	|O
CAG	|O
)	|O
at	|O
baseline	|O
.	|O

Here	|O
we	|O
report	|O
that	|O
Dbp5p	|B-PROTEIN
and	|O
Rat7p	|B-PROTEIN
interact	|O
through	|O
their	|O
Nterminal	|O
domains	|O
.	|O

Thus	|O
,	|O
the	|O
nematode	|O
genes	|O
could	|O
be	|O
the	|O
homologs	|O
of	|O
Hh	|B-PROTEIN
molecules	|O
in	|O
other	|O
phyla	|O
.	|O

A	|O
subset	|O
of	|O
mutations	|O
in	|O
the	|O
Psi	|B-PROTEIN
synthase	|I-PROTEIN
domain	|O
impairs	|O
association	|O
of	|O
the	|O
altered	|O
Cbf5p	|B-PROTEIN
proteins	|O
with	|O
selected	|O
box	|O
H	|B-PROTEIN
/	|I-PROTEIN
ACA	|I-PROTEIN
snoRNAs	|O
,	|O
suggesting	|O
that	|O
the	|O
functional	|O
catalytic	|O
domain	|O
is	|O
essential	|O
for	|O
that	|O
interaction	|O
.	|O

Although	|O
the	|O
Src	|B-PROTEIN
tyrosine	|O
kinase	|O
induces	|O
constitutive	|O
Stat3	|B-PROTEIN
phosphorylation	|O
on	|O
tyrosine	|O
,	|O
activation	|O
of	|O
Stat3	|B-PROTEIN
-	|O
mediated	|O
gene	|O
regulation	|O
requires	|O
both	|O
tyrosine	|O
and	|O
serine	|O
phosphorylation	|O
of	|O
Stat3	|B-PROTEIN
.	|O

The	|O
transcription	|O
factor	|O
CHOP	|B-PROTEIN
(	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
homologous	|I-PROTEIN
protein	|I-PROTEIN
10	|I-PROTEIN
)	|O
is	|O
a	|O
bZIP	|B-PROTEIN
protein	|I-PROTEIN
induced	|O
by	|O
a	|O
variety	|O
of	|O
stimuli	|O
that	|O
evoke	|O
cellular	|O
stress	|O
responses	|O
and	|O
has	|O
been	|O
shown	|O
to	|O
arrest	|O
cell	|O
growth	|O
and	|O
to	|O
promote	|O
programmed	|O
cell	|O
death	|O
.	|O

Thus	|O
,	|O
CHOP	|B-PROTEIN
not	|O
only	|O
is	|O
a	|O
negative	|O
or	|O
a	|O
positive	|O
regulator	|O
of	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
target	|O
genes	|O
but	|O
also	|O
,	|O
when	|O
tethered	|O
to	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
factors	|O
,	|O
can	|O
activate	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
target	|O
genes	|O
.	|O

This	|O
motif	|O
,	|O
first	|O
described	|O
for	|O
the	|O
Drosophila	|O
homeobox	|O
activator	|O
DEAF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
identifies	|O
an	|O
emerging	|O
group	|O
of	|O
metazoan	|O
transcriptional	|O
modulators	|O
.	|O

RNase	|O
MRP	|B-PROTEIN
is	|O
a	|O
ribonucleoprotein	|O
endoribonuclease	|O
that	|O
has	|O
been	|O
shown	|O
to	|O
have	|O
roles	|O
in	|O
both	|O
mitochondrial	|O
DNA	|O
replication	|O
and	|O
nuclear	|O
5.8	|B-PROTEIN
S	|I-PROTEIN
rRNA	|O
processing	|O
.	|O

We	|O
have	|O
examined	|O
the	|O
regulation	|O
of	|O
the	|O
FGFR	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
gene	|O
(	|O
cek	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
in	|O
avian	|O
myogenic	|O
cultures	|O
by	|O
immunocytochemistry	|O
and	|O
Northern	|O
blot	|O
analysis	|O
.	|O

Regulation	|O
of	|O
avian	|O
fibroblast	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
receptor	|I-PROTEIN
1	|I-PROTEIN
(	|O
FGFR	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
gene	|O
expression	|O
during	|O
skeletal	|O
muscle	|O
differentiation	|O
.	|O

The	|O
backbone	|O
dynamics	|O
of	|O
residues	|O
located	|O
in	|O
the	|O
folded	|O
part	|O
of	|O
CRP2	|B-PROTEIN
(	|O
LIM2	|B-PROTEIN
)	|O
R122A	|B-PROTEIN
have	|O
been	|O
characterized	|O
by	|O
proton	|O
-	|O
detected	|O
(	|O
15	|O
)	|O
N	|O
NMR	|O
spectroscopy	|O
.	|O

Rac	|B-PROTEIN
causes	|O
uncapping	|O
of	|O
actin	|B-PROTEIN
filaments	|O
(	|O
F	|B-PROTEIN
-	|I-PROTEIN
actin	|I-PROTEIN
)	|O
at	|O
the	|O
plus	|O
-	|O
ends	|O
,	|O
through	|O
phosphatidylinositol	|O
4,5	|O
bisphosphate	|O
(	|O
PIP2	|O
)	|O
,	|O
and	|O
eventually	|O
induces	|O
membrane	|O
ruffling	|O
.	|O

However	|O
,	|O
a	|O
specific	|O
ICE	|B-PROTEIN
/	|O
caspase	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
inhibitor	|O
called	|O
N1445	|O
completely	|O
abolished	|O
the	|O
CK	|B-PROTEIN
-	|O
induced	|O
apoptosis	|O
by	|O
reactivating	|O
PKB	|B-PROTEIN
,	|O
but	|O
without	|O
affecting	|O
the	|O
CK	|B-PROTEIN
-	|O
induced	|O
suppression	|O
of	|O
Ras	|B-PROTEIN
transformation	|O
.	|O

OBJECTIVE	|O
:	|O
Although	|O
the	|O
preponderance	|O
of	|O
findings	|O
offer	|O
support	|O
for	|O
transient	|O
(	|O
where	|O
is	|O
it	|O
?	|O
)	|O
as	|O
opposed	|O
to	|O
sustained	|O
(	|O
what	|O
is	|O
it	|O
?	|O
)	|O
deficit	|O
,	|O
a	|O
need	|O
remains	|O
for	|O
specific	|O
depiction	|O
of	|O
the	|O
deficit	|O
.	|O

The	|O
AL	|O
-	|O
R8	|O
SI	|O
:	|O
the	|O
next	|O
generation	|O
staging	|O
container	|O
for	|O
plutonium	|O
pits	|O
at	|O
the	|O
USDOE	|O
Pantex	|O
Plant	|O
.	|O

RESULTS	|O
:	|O
Factors	|O
associated	|O
with	|O
significantly	|O
(	|O
P	|O
<	|O
.05	|O
)	|O
increased	|O
risk	|O
of	|O
treatment	|O
failure	|O
in	|O
a	|O
Cox	|O
multivariate	|O
analysis	|O
included	|O
age	|O
older	|O
than	|O
45	|O
years	|O
(	|O
relative	|O
hazard	|O
,	|O
1.17	|O
;	|O
95%	|O
confidence	|O
interval	|O
[	|O
CI	|O
]	|O
,	|O
1.02-1.33	|O
)	|O
,	|O
Karnofsky	|O
performance	|O
score	|O
less	|O
than	|O
90%	|O
(	|O
1.27	|O
;	|O
95%	|O
CI	|O
,	|O
1.07-1.51	|O
)	|O
,	|O
absence	|O
of	|O
hormone	|O
receptors	|O
(	|O
1.31	|O
;	|O
95%	|O
CI	|O
,	|O
1.15-1.51	|O
)	|O
,	|O
prior	|O
use	|O
of	|O
adjuvant	|O
chemotherapy	|O
(	|O
1.31	|O
;	|O
95%	|O
CI	|O
,	|O
1.10-1.56	|O
)	|O
,	|O
initial	|O
disease	|O
-	|O
free	|O
survival	|O
interval	|O
after	|O
adjuvant	|O
treatment	|O
of	|O
no	|O
more	|O
than	|O
18	|O
months	|O
(	|O
1.99	|O
;	|O
95%	|O
CI	|O
,	|O
1.62-2.43	|O
)	|O
,	|O
metastases	|O
in	|O
the	|O
liver	|O
(	|O
1.47	|O
;	|O
95%	|O
CI	|O
,	|O
1.20-1.80	|O
)	|O
or	|O
central	|O
nervous	|O
system	|O
(	|O
1.56	|O
;	|O
95%	|O
CI	|O
,	|O
0.99-2.46	|O
[	|O
approaches	|O
significance	|O
]	|O
)	|O
vs	|O
soft	|O
tissue	|O
,	|O
bone	|O
,	|O
or	|O
lung	|O
,	|O
3	|O
or	|O
more	|O
sites	|O
of	|O
metastatic	|O
disease	|O
(	|O
1.32	|O
;	|O
95%	|O
CI	|O
,	|O
1.13-1.54	|O
)	|O
,	|O
and	|O
incomplete	|O
response	|O
vs	|O
complete	|O
response	|O
to	|O
standard	|O
-	|O
dose	|O
chemotherapy	|O
(	|O
1.65	|O
;	|O
95%	|O
CI	|O
,	|O
1.36-1.99	|O
)	|O
.	|O

One	|O
form	|O
of	|O
the	|O
SBEI	|B-PROTEIN
gene	|O
transcript	|O
in	|O
12	|O
-	|O
day	|O
old	|O
kernels	|O
contained	|O
the	|O
exon	|O
I+	|O
II+	|O
III	|O
combination	|O
at	|O
the	|O
5'	|O
end	|O
,	|O
whereas	|O
other	|O
forms	|O
differed	|O
by	|O
inclusion	|O
of	|O
intron	|O
1	|O
or	|O
exclusion	|O
of	|O
exon	|O
II	|O
sequences	|O
.	|O

In	|O
PC	|O
,	|O
rare	|O
MNGCs	|O
had	|O
intranuclear	|O
inclusions	|O
and	|O
grooves	|O
.	|O

16	|O
percent	|O
,	|O
P	|O
<	|O
0.001	|O
)	|O
,	|O
and	|O
sustained	|O
normalization	|O
of	|O
serum	|O
alanine	|B-PROTEIN
aminotransferase	|I-PROTEIN
levels	|O
(	|O
41	|O
percent	|O
vs.	|O

Its	|O
C	|O
-	|O
terminal	|O
catalytic	|O
domain	|O
was	|O
found	|O
to	|O
be	|O
highly	|O
conserved	|O
in	|O
the	|O
homologues	|O
p140	|B-PROTEIN
(	|O
ras	|B-PROTEIN
-	|O
GRF	|B-PROTEIN
)	|O
and	|O
Sos	|B-PROTEIN
.	|O

356	|O
,	|O
93-98	|O
]	|O
.	|O

The	|O
proteasome	|O
is	|O
a	|O
large	|O
complex	|O
consisting	|O
of	|O
two	|O
multisubunit	|O
structures	|O
,	|O
the	|O
20S	|B-PROTEIN
and	|O
19S	|B-PROTEIN
(	|O
PA700	|B-PROTEIN
)	|O
or	|O
P28	|B-PROTEIN
complexes	|O
,	|O
that	|O
combine	|O
to	|O
form	|O
the	|O
26S	|B-PROTEIN
particles	|O
.	|O

In	|O
assays	|O
with	|O
purified	|O
enzymes	|O
,	|O
wild	|O
-	|O
type	|O
but	|O
not	|O
PTPS	|B-PROTEIN
-	|O
S19A	|B-PROTEIN
was	|O
a	|O
specific	|O
substrate	|O
for	|O
the	|O
cGMP	|O
-	|O
dependent	|O
protein	|O
kinase	|O
(	|B-PROTEIN
cGK	|I-PROTEIN
)	|I-PROTEIN
type	|I-PROTEIN
I	|I-PROTEIN
and	|I-PROTEIN
II	|I-PROTEIN
.	|O

R.	|O
,	|O
Fleischmann	|O
,	|O
R.	|O
,	|O
Venter	|O
,	|O
J.	|O

The	|O
N	|O
-	|O
terminal	|O
domain	|O
of	|O
approximately	|O
70	|O
kDa	|O
exhibits	|O
11	|O
imperfect	|O
amino	|O
acid	|O
repeats	|O
that	|O
show	|O
some	|O
homology	|O
to	|O
promastigote	|O
surface	|O
glycoproteins	|O
of	|O
the	|O
psa2	|B-PROTEIN
/	|O
gp46	|B-PROTEIN
complex	|O
.	|O

In	|O
contrast	|O
to	|O
previously	|O
characterized	|O
proteophosphoglycans	|O
,	|O
the	|O
ppg1	|B-PROTEIN
gene	|O
product	|O
is	|O
predominantly	|O
membrane	|O
-	|O
associated	|O
and	|O
it	|O
is	|O
expressed	|O
on	|O
the	|O
promastigote	|O
cell	|O
surface	|O
.	|O

Most	|O
important	|O
,	|O
infection	|O
of	|O
the	|O
cells	|O
with	|O
an	|O
adenoviral	|O
construct	|O
expressing	|O
this	|O
mutant	|O
inhibited	|O
the	|O
induction	|O
of	|O
VEGF	|B-PROTEIN
mRNA	|O
under	|O
conditions	|O
that	|O
mimic	|O
hypoxia	|O
.	|O

Neuregulin	|B-PROTEIN
stimulates	|O
ErbB2	|B-PROTEIN
,	|O
ErbB3	|B-PROTEIN
,	|O
and	|O
ErbB4	|B-PROTEIN
,	|O
members	|O
of	|O
the	|O
ErbB	|B-PROTEIN
family	|O
of	|O
receptor	|B-PROTEIN
tyrosine	|I-PROTEIN
kinases	|I-PROTEIN
.	|O

Our	|O
results	|O
suggest	|O
that	|O
Anu2p	|B-PROTEIN
is	|O
the	|O
yeast	|O
homologue	|O
of	|O
mammalian	|O
epsilon	|B-PROTEIN
-	|I-PROTEIN
COP	|I-PROTEIN
and	|O
the	|O
abrupt	|O
accumulation	|O
of	|O
the	|O
ER	|O
membrane	|O
caused	|O
by	|O
a	|O
blockage	|O
of	|O
the	|O
early	|O
protein	|O
transport	|O
pathway	|O
leads	|O
to	|O
alteration	|O
of	|O
nuclear	|O
morphology	|O
of	|O
the	|O
budding	|O
yeast	|O
cells	|O
.	|O

In	|O
PC12	|O
cells	|O
,	|O
nerve	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
induces	|O
neuronal	|O
differentiation	|O
and	|O
repressed	|O
expression	|O
of	|O
nrg	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

In	|O
a	|O
PC12	|O
cell	|O
mutant	|O
that	|O
is	|O
deficient	|O
in	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
A	|I-PROTEIN
activity	|O
(	|O
AB.1	|O
1	|O
)	|O
,	|O
all	|O
three	|O
differentiating	|O
agents	|O
were	|O
unable	|O
to	|O
down	|O
-	|O
regulate	|O
nrg	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
mRNA	|O
.	|O

TSC1	|B-PROTEIN
mutations	|O
include	|O
two	|O
nonsense	|O
mutations	|O
,	|O
four	|O
insertions	|O
,	|O
and	|O
three	|O
splice	|O
mutations	|O
.	|O

Twelve	|O
patients	|O
without	|O
abnormalities	|O
in	|O
the	|O
PTT	|O
are	|O
assumed	|O
to	|O
harbor	|O
missense	|O
mutations	|O
,	|O
probably	|O
in	|O
TSC2	|B-PROTEIN
.	|O

The	|O
first	|O
algorithm	|O
,	|O
FOREPROJ	|O
,	|O
is	|O
a	|O
fast	|O
-	|O
forward	|O
projection	|O
algorithm	|O
that	|O
allows	|O
calculation	|O
of	|O
the	|O
3	|O
-	|O
D	|O
attenuation	|O
correction	|O
factors	|O
(	|O
ACF	|O
's	|O
)	|O
directly	|O
from	|O
a	|O
two	|O
-	|O
dimensional	|O
(	|O
2	|O
-	|O
D	|O
)	|O
transmission	|O
scan	|O
,	|O
without	|O
first	|O
reconstructing	|O
the	|O
attenuation	|O
map	|O
and	|O
then	|O
performing	|O
a	|O
3	|O
-	|O
D	|O
forward	|O
projection	|O
.	|O

We	|O
have	|O
cloned	|O
cDNA	|O
and	|O
genomic	|O
DNA	|O
for	|O
a	|O
mouse	|O
gene	|O
encoding	|O
a	|O
protein	|O
with	|O
significant	|O
sequence	|O
similarity	|O
to	|O
conserved	|O
domains	|O
found	|O
in	|O
proteins	|O
of	|O
the	|O
Spo11p	|B-PROTEIN
family	|O
.	|O

RT	|O
-	|O
PCR	|O
and	|O
in	|O
situ	|O
hybridization	|O
analyses	|O
of	|O
a	|O
time	|O
course	|O
of	|O
juvenile	|O
testis	|O
development	|O
indicate	|O
that	|O
Spo11	|B-PROTEIN
expression	|O
begins	|O
in	|O
early	|O
meiotic	|O
Prophase	|O
I	|O
,	|O
prior	|O
to	|O
the	|O
pachytene	|O
stage	|O
,	|O
with	|O
increasing	|O
accumulation	|O
of	|O
mRNA	|O
through	|O
the	|O
pachytene	|O
stage	|O
.	|O

Animals	|O
were	|O
put	|O
to	|O
death	|O
8	|O
weeks	|O
later	|O
and	|O
the	|O
grafts	|O
were	|O
sterilely	|O
explanted	|O
and	|O
analyzed	|O
via	|O
microbiologic	|O
culture	|O
and	|O
standard	|O
histologic	|O
procedures	|O
for	|O
evidence	|O
of	|O
infection	|O
.	|O

The	|O
RMR	|O
was	|O
measured	|O
twice	|O
in	|O
each	|O
phase	|O
and	|O
found	|O
to	|O
be	|O
similar	|O
(	|O
F	|O
(	|O
1,18	|O
)	|O
=	|O
0.863	|O
)	|O
across	|O
the	|O
follicular	|O
(	|O
5018	|O
kJ	|O
/	|O
24	|O
h	|O
)	|O
and	|O
the	|O
luteal	|O
(	|O
5098	|O
kJ	|O
/	|O
24	|O
h	|O
)	|O
phases	|O
.	|O

Oseltamivir	|O
(	|O
GS4104	|O
)	|O
,	|O
which	|O
can	|O
be	|O
administered	|O
orally	|O
,	|O
is	|O
the	|O
prodrug	|O
of	|O
GS4071	|O
,	|O
a	|O
potent	|O
and	|O
selective	|O
inhibitor	|O
of	|O
influenzavirus	|O
neuraminidases	|B-PROTEIN
.	|O

In	|O
gel	|O
mobility	|O
shift	|O
assays	|O
,	|O
we	|O
found	|O
no	|O
evidence	|O
for	|O
VDR	|B-PROTEIN
-	|O
TR	|B-PROTEIN
heterodimer	|O
interaction	|O
with	|O
any	|O
tested	|O
element	|O
.	|O

The	|O
relative	|O
importance	|O
of	|O
these	|O
two	|O
mechanisms	|O
differed	|O
in	|O
a	|O
response	|O
element	|O
-	|O
specific	|O
manner	|O
.	|O

After	|O
14	|O
d	|O
of	|O
overfeeding	|O
,	|O
hepatic	|O
PL	|O
profiles	|O
were	|O
identical	|O
in	|O
the	|O
two	|O
breeds	|O
and	|O
similar	|O
to	|O
that	|O
in	|O
control	|O
livers	|O
;	|O
choline	|O
-	|O
containing	|O
PL	|O
accounted	|O
for	|O
95%	|O
of	|O
total	|O
PL	|O
.	|O

C	|O
-	|O
SP	|O
duration	|O
was	|O
significantly	|O
reduced	|O
in	|O
ALS	|O
patients	|O
compared	|O
to	|O
controls	|O
at	|O
low	|O
stimulation	|O
intensity	|O
corresponding	|O
to	|O
an	|O
MEP	|O
threshold	|O
increased	|O
by	|O
15%	|O
.	|O

These	|O
data	|O
show	|O
that	|O
the	|O
spv	|B-PROTEIN
virulence	|O
genes	|O
belong	|O
simultaneously	|O
to	|O
several	|O
regulons	|O
in	|O
the	|O
cell	|O
,	|O
raising	|O
the	|O
possibility	|O
that	|O
spv	|B-PROTEIN
expression	|O
can	|O
be	|O
fine	|O
-	|O
tuned	|O
in	|O
response	|O
to	|O
multiple	|O
environmental	|O
inputs	|O
.	|O

Intensive	|O
synthesis	|O
of	|O
PNA	|B-PROTEIN
in	|O
the	|O
cells	|O
of	|O
microvascular	|O
wall	|O
evidenced	|O
of	|O
their	|O
high	|O
functional	|O
activity	|O
,	|O
and	|O
the	|O
synthesis	|O
of	|O
DNA	|O
in	|O
them	|O
showed	|O
their	|O
ability	|O
for	|O
proliferation	|O
,	|O
i.g	|O
.	|O
-	|O
-	|O
for	|O
growth	|O
.	|O

Tracheal	|O
transsection	|O
combined	|O
with	|O
hilar	|O
ligation	|O
(	|O
TL	|O
&	|O
PL	|O
)	|O
effected	|O
a	|O
reduction	|O
of	|O
19.9%	|O
(	|O
n.s	|O
.	|O
)	|O
.	|O

Kinase	|O
-	|O
deficient	|O
erbB	|B-PROTEIN
proteins	|O
reduced	|O
epidermal	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
(	|O
EGF	|B-PROTEIN
)	|O
-	|O
induced	|O
tyrosine	|O
phosphorylation	|O
of	|O
endogenous	|O
Shc	|B-PROTEIN
proteins	|O
and	|O
also	|O
reduced	|O
immediate	|O
and	|O
sustained	|O
EGF	|B-PROTEIN
-	|O
induced	|O
ERK	|B-PROTEIN
MAPK	|O
activities	|O
in	|O
human	|O
glioblastoma	|O
cells	|O
,	|O
although	|O
basal	|O
ERK	|B-PROTEIN
MAPK	|O
activities	|O
were	|O
unaffected	|O
.	|O

Using	|O
immunolocalization	|O
,	|O
we	|O
observe	|O
that	|O
ACE3	|B-PROTEIN
,	|O
a	|O
440	|O
-	|O
bp	|O
chorion	|O
element	|O
that	|O
contains	|O
information	|O
sufficient	|O
to	|O
drive	|O
amplification	|O
,	|O
directs	|O
DmORC	|B-PROTEIN
localization	|O
in	|O
follicle	|O
cells	|O
.	|O

Therefore	|O
,	|O
homozygous	|O
co	|O
-	|O
deletions	|O
of	|O
CDKN2A	|B-PROTEIN
and	|O
CDKN2B	|B-PROTEIN
rather	|O
than	|O
mutations	|O
targeting	|O
individual	|O
transcripts	|O
are	|O
frequently	|O
selected	|O
for	|O
in	|O
these	|O
tumors	|O
.	|O

Here	|O
,	|O
we	|O
show	|O
that	|O
aortic	|O
explants	|O
isolated	|O
from	|O
PPARalpha	|B-PROTEIN
-	|O
null	|O
mice	|O
display	|O
an	|O
exacerbated	|O
response	|O
to	|O
inflammatory	|O
stimuli	|O
,	|O
such	|O
as	|O
lipopolysaccharide	|O
(	|O
LPS	|O
)	|O
,	|O
as	|O
demonstrated	|O
by	|O
increased	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
secretion	|O
.	|O

Albumin	|O
expression	|O
is	|O
maintained	|O
in	|O
the	|O
liver	|O
by	|O
a	|O
combination	|O
of	|O
liver	|O
-	|O
enriched	|O
transcription	|O
factors	|O
such	|O
as	|O
CAAT	|B-PROTEIN
enhancer	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
(	|I-PROTEIN
C	|I-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
)	|I-PROTEIN
alpha	|I-PROTEIN
and	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBPbeta	|I-PROTEIN
.	|O

The	|O
requirement	|O
for	|O
proteolytic	|O
activity	|O
of	|O
both	|O
FVIIa	|B-PROTEIN
and	|O
FXa	|B-PROTEIN
suggests	|O
that	|O
protease	|O
-	|O
activated	|O
receptors	|O
may	|O
be	|O
involved	|O
.	|O

Amyloid	|B-PROTEIN
beta	|I-PROTEIN
-	|I-PROTEIN
protein	|I-PROTEIN
(	|O
Abeta	|B-PROTEIN
)	|O
is	|O
the	|O
main	|O
constituent	|O
of	|O
amyloid	|O
fibrils	|O
found	|O
in	|O
senile	|O
plaques	|O
and	|O
cerebral	|O
vessels	|O
in	|O
Alzheimer	|O
's	|O
disease	|O
(	|O
AD	|O
)	|O
and	|O
is	|O
derived	|O
by	|O
proteolysis	|O
from	|O
the	|O
beta	|B-PROTEIN
-	|I-PROTEIN
amyloid	|I-PROTEIN
precursor	|I-PROTEIN
protein	|O
(	|O
APP	|B-PROTEIN
)	|O
.	|O

We	|O
also	|O
show	|O
that	|O
activation	|O
of	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
A	|I-PROTEIN
(	|O
PKA	|B-PROTEIN
)	|O
signaling	|O
is	|O
sufficient	|O
to	|O
down	|O
-	|O
regulate	|O
caveolin	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
protein	|O
expression	|O
and	|O
promoter	|O
activity	|O
.	|O

The	|O
importin	|B-PROTEIN
alpha.b	|O
eta	|O
heterodimer	|O
mediates	|O
nuclear	|O
import	|O
of	|O
proteins	|O
containing	|O
classical	|O
nuclear	|O
localization	|O
signals	|O
.	|O

The	|O
expressed	|O
G1	|B-PROTEIN
-	|O
G2	|B-PROTEIN
bound	|O
to	|O
both	|O
hyaluronan	|O
and	|O
link	|B-PROTEIN
protein	|O
indicating	|O
that	|O
the	|O
immunoglobulin	|B-PROTEIN
-	|O
fold	|O
motif	|O
and	|O
proteoglycan	|O
tandem	|O
repeat	|O
loops	|O
of	|O
the	|O
G1	|B-PROTEIN
domain	|O
were	|O
correctly	|O
folded	|O
.	|O

The	|O
results	|O
suggest	|O
that	|O
the	|O
presence	|O
or	|O
absence	|O
per	|O
se	|O
of	|O
keratan	|O
sulfate	|O
on	|O
native	|O
G1	|O
-	|O
G2	|O
does	|O
not	|O
affect	|O
the	|O
activity	|O
of	|O
atrolysin	|O
C	|O
toward	|O
the	|O
two	|O
sites	|O
.	|O

Despite	|O
i.v	|O
.	|O
steroid	|O
therapy	|O
,	|O
[	|O
NOexh	|O
]	|O
remained	|O
elevated	|O
throughout	|O
recovery	|O
(	|O
37.9	|O
+	|O
/	|O
-	|O
4.8	|O
ppb	|O
,	|O
p	|O
<	|O
0.001	|O
)	|O
until	|O
discharge	|O
(	|O
40.9	|O
+	|O
/	|O
-	|O
4.3	|O
ppb	|O
,	|O
p	|O
<	|O
0.001	|O
)	|O
.	|O

It	|O
contains	|O
binding	|O
sites	|O
for	|O
several	|O
transcription	|O
factors	|O
,	|O
for	|O
example	|O
:	|O
(	|O
i	|O
)	|O
a	|O
well	|O
-	|O
characterized	|O
binding	|O
site	|O
for	|O
rel	|B-PROTEIN
/	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
transcription	|O
factors	|O
in	|O
its	|O
3'	|O
-	|O
end	|O
(	|O
the	|O
H2TF1	|B-PROTEIN
or	|O
kappaB1	|B-PROTEIN
element	|O
)	|O
,	|O
(	|O
ii	|O
)	|O
a	|O
second	|O
kappaB	|B-PROTEIN
site	|O
(	|O
the	|O
kappaB2	|B-PROTEIN
element	|O
)	|O
,	|O
which	|O
is	|O
located	|O
immediately	|O
adjacent	|O
5'	|O
to	|O
the	|O
H2TF1	|B-PROTEIN
element	|O
and	|O
which	|O
is	|O
recognized	|O
by	|O
p65	|B-PROTEIN
/	|O
relA	|B-PROTEIN
in	|O
the	|O
human	|B-PROTEIN
HLA	|I-PROTEIN
system	|O
,	|O
and	|O
(	|O
iii	|O
)	|O
an	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
/	|O
ATF	|B-PROTEIN
recognition	|O
sequence	|O
in	|O
the	|O
5'	|O
end	|O
(	|O
EnA	|B-PROTEIN
-	|O
TRE	|O
)	|O
.	|O

The	|O
tumorigenic	|O
E1A	|B-PROTEIN
+	|O
cHa	|B-PROTEIN
-	|I-PROTEIN
ras	|I-PROTEIN
cells	|O
are	|O
characterized	|O
by	|O
high	|O
and	|O
constitutive	|O
DNA	|O
binding	|O
activities	|O
of	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
in	|O
contrast	|O
to	|O
nontransformed	|O
cells	|O
and	|O
the	|O
E1A	|B-PROTEIN
cells	|O
.	|O

The	|O
yeast	|O
C	|B-PROTEIN
-	|I-PROTEIN
type	|I-PROTEIN
cyclin	|I-PROTEIN
Ume3p	|O
/	|O
Srb11p	|B-PROTEIN
and	|O
its	|O
cyclin	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
Cdk	|B-PROTEIN
)	|O
Ume5p	|B-PROTEIN
are	|O
required	|O
for	|O
the	|O
full	|O
repression	|O
of	|O
genes	|O
involved	|O
in	|O
the	|O
stress	|O
response	|O
or	|O
meiosis	|O
.	|O

In	|O
particular	|O
,	|O
the	|O
S1	|B-PROTEIN
'	|I-PROTEIN
specificity	|O
site	|O
is	|O
a	|O
deep	|O
and	|O
highly	|O
hydrophobic	|O
cavity	|O
.	|O

FZD4	|B-PROTEIN
is	|O
homologous	|O
to	|O
FZD9	|B-PROTEIN
and	|O
FZD10	|B-PROTEIN
,	|O
and	|O
overall	|O
amino	|O
acid	|O
identity	|O
is	|O
as	|O
follows	|O
:	|O
FZD4	|B-PROTEIN
vs	|O
FZD9	|B-PROTEIN
,	|O
51.6%	|O
;	|O
FZD4	|B-PROTEIN
vs	|O
FZD10	|B-PROTEIN
,	|O
51.2%	|O
;	|O
FZD9	|B-PROTEIN
vs	|O
FZD10	|B-PROTEIN
,	|O
65.7%	|O
.	|O

The	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
responsive	|O
reporter	|O
construct	|O
,	|O
(	|B-PROTEIN
PRDII	|I-PROTEIN
)	|I-PROTEIN
(	|I-PROTEIN
4	|I-PROTEIN
)	|I-PROTEIN
-	|O
CAT	|B-PROTEIN
,	|O
was	|O
used	|O
to	|O
explore	|O
transcription	|O
resulting	|O
from	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
activated	|O
by	|O
Tat	|B-PROTEIN
.	|O

The	|O
RNA	|O
transcripts	|O
structurally	|O
equivalent	|O
to	|O
I	|B-PROTEIN
(	|I-PROTEIN
2	|I-PROTEIN
)	|I-PROTEIN
sgRNAs	|O
of	|O
TMV	|O
U1	|B-PROTEIN
and	|O
crTMV	|O
,	|O
but	|O
containing	|O
a	|O
hairpin	|O
structure	|O
(	|O
H	|O
)	|O
immediately	|O
upstream	|O
of	|O
IRES	|O
(	|O
MP	|B-PROTEIN
,	|O
75	|O
)	|O
(	|O
HIRES	|O
(	|O
MP	|B-PROTEIN
)	|O
,	|O
(	|O
75	|O
)	|O
(	|O
CR	|O
)	|O
-	|O
MP	|O
-	|O
CP	|O
-	|O
3'	|O
UTR	|O
;	|O
HIRES	|O
(	|O
MP	|B-PROTEIN
,	|O
75	|O
)	|O
(	|O
U1	|O
)	|O
-	|O
MP	|O
-	|O
CP	|O
-	|O
3'	|O
UTR	|O
)	|O
,	|O
were	|O
able	|O
to	|O
express	|O
the	|O
MP	|B-PROTEIN
gene	|O
in	|O
vitro	|O
.	|O

EIAV	|B-PROTEIN
LTR	|I-PROTEIN
sequence	|O
variability	|O
is	|O
confined	|O
mostly	|O
to	|O
a	|O
small	|O
portion	|O
of	|O
the	|O
enhancer	|O
within	|O
the	|O
U3	|O
segment	|O
of	|O
the	|O
LTR	|O
.	|O

Phosphatidylinositol	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
requirement	|O
in	|O
activation	|O
of	|O
the	|O
ras	|B-PROTEIN
/	|O
C	|B-PROTEIN
-	|I-PROTEIN
raf	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
/	|O
MEK	|B-PROTEIN
/	|O
ERK	|B-PROTEIN
and	|O
p70	|B-PROTEIN
(	|O
s6k	|B-PROTEIN
)	|O
signaling	|O
cascade	|O
by	|O
the	|O
insulinomimetic	|O
agent	|O
vanadyl	|O
sulfate	|O
.	|O

The	|O
core	|O
of	|O
this	|O
enhancer	|O
contains	|O
two	|O
evolutionarily	|O
conserved	|O
binding	|O
sites	|O
for	|O
the	|O
homeodomain	|B-PROTEIN
protein	|O
Tinman	|B-PROTEIN
(	|O
Tin	|B-PROTEIN
)	|O
,	|O
expressed	|O
in	|O
developing	|O
cardiac	|O
,	|O
somatic	|O
,	|O
and	|O
visceral	|O
muscle	|O
lineages	|O
.	|O

For	|O
example	|O
,	|O
introduction	|O
of	|O
immunogenic	|O
and	|O
purification	|O
tag	|O
sequences	|O
into	|O
the	|O
C	|O
-	|O
terminal	|O
coding	|O
region	|O
significantly	|O
decreased	|O
bop	|B-PROTEIN
gene	|O
mRNA	|O
and	|O
protein	|O
accumulation	|O
.	|O

Furthermore	|O
,	|O
the	|O
striking	|O
ability	|O
of	|O
polyoma	|O
middle	|B-PROTEIN
T	|I-PROTEIN
antigens	|O
to	|O
promote	|O
retinoic	|O
acid	|O
-	|O
induced	|O
differentiation	|O
appears	|O
to	|O
utilize	|O
ERK	|B-PROTEIN
,	|O
but	|O
not	|O
JNK	|B-PROTEIN
/	|O
SPK	|B-PROTEIN
or	|O
p38	|B-PROTEIN
signaling	|O
.	|O

We	|O
recommend	|O
that	|O
paracervical	|O
block	|O
with	|O
lignocaine	|O
should	|O
be	|O
used	|O
in	|O
conjunction	|O
with	|O
i.v	|O
.	|O
sedation	|O
/	|O
analgesia	|O
during	|O
egg	|O
collection	|O
performed	|O
through	|O
the	|O
transvaginal	|O
route	|O
under	|O
ultrasound	|O
guidance	|O
(	|O
TUGOR	|O
)	|O
to	|O
reduce	|O
the	|O
pain	|O
of	|O
the	|O
procedure	|O
.	|O

All	|O
loci	|O
have	|O
a	|O
similar	|O
organization	|O
,	|O
except	|O
for	|O
H1.8	|B-PROTEIN
that	|O
harbors	|O
two	|O
TcP2beta	|B-PROTEIN
genes	|O
arranged	|O
in	|O
tandem	|O
and	|O
separated	|O
by	|O
a	|O
short	|O
repetitive	|O
sequence	|O
,	|O
named	|O
SIRE	|O
(	|O
short	|O
interspersed	|O
repetitive	|O
element	|O
)	|O
,	|O
which	|O
is	|O
also	|O
found	|O
upstream	|O
of	|O
the	|O
first	|O
gene	|O
of	|O
the	|O
tandem	|O
and	|O
downstream	|O
of	|O
the	|O
second	|O
.	|O

A	|O
proportion	|O
of	|O
APC	|B-PROTEIN
wild	|O
-	|O
type	|O
colon	|O
carcinomas	|O
and	|O
melanomas	|O
also	|O
contains	|O
constitutive	|O
nuclear	|O
Tcf	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
/	|O
beta	|B-PROTEIN
-	|I-PROTEIN
catenin	|I-PROTEIN
complexes	|O
as	|O
a	|O
result	|O
of	|O
dominant	|O
mutations	|O
in	|O
the	|O
N	|O
terminus	|O
of	|O
beta	|B-PROTEIN
-	|I-PROTEIN
catenin	|I-PROTEIN
that	|O
render	|O
it	|O
insensitive	|O
to	|O
downregulation	|O
by	|O
APC	|B-PROTEIN
,	|O
GSK3	|B-PROTEIN
beta	|I-PROTEIN
,	|O
and	|O
Axin	|B-PROTEIN
/	|O
Conductin	|B-PROTEIN
.	|O

Similar	|O
mechanisms	|O
leading	|O
to	|O
deregulation	|O
of	|O
Tcf	|B-PROTEIN
target	|O
gene	|O
activity	|O
are	|O
likely	|O
to	|O
be	|O
involved	|O
in	|O
melanoma	|O
and	|O
other	|O
forms	|O
of	|O
cancer	|O
.	|O

This	|O
report	|O
describes	|O
a	|O
patient	|O
with	|O
a	|O
previous	|O
inferior	|O
acute	|O
myocardial	|O
infarction	|O
who	|O
developed	|O
right	|O
ventricular	|O
infarction	|O
with	|O
significant	|O
anterior	|O
lead	|O
ST	|O
segment	|O
elevation	|O
(	|O
V1	|O
-	|O
V4	|O
)	|O
caused	|O
by	|O
the	|O
loss	|O
of	|O
two	|O
large	|O
right	|O
ventricular	|O
branches	|O
during	|O
a	|O
coronary	|O
angioplasty	|O
of	|O
the	|O
right	|O
coronary	|O
artery	|O
.	|O

PATIENTS	|O
AND	|O
METHODS	|O
:	|O
Immediately	|O
before	|O
radical	|O
prostatectomy	|O
,	|O
bone	|O
marrow	|O
aspirates	|O
from	|O
both	|O
sides	|O
of	|O
the	|O
iliac	|O
crest	|O
were	|O
taken	|O
from	|O
287	|O
patients	|O
.	|O

PURPOSE	|O
:	|O
Previous	|O
WR	|O
-	|O
2721	|O
human	|O
pharmacokinetic	|O
studies	|O
were	|O
limited	|O
to	|O
plasma	|O
levels	|O
in	|O
patients	|O
receiving	|O
platinum	|O
-	|O
based	|O
compounds	|O
,	|O
and	|O
none	|O
includes	|O
the	|O
effects	|O
of	|O
WR	|O
-	|O
2721	|O
on	|O
endogenous	|O
thiols	|O
.	|O

With	|O
regard	|O
to	|O
nonhematologic	|O
toxicities	|O
,	|O
diarrhea	|O
,	|O
infection	|O
and	|O
elevated	|O
serum	|O
alkaline	|B-PROTEIN
phosphatase	|I-PROTEIN
of	|O
grade	|O
3	|O
or	|O
over	|O
were	|O
observed	|O
in	|O
2%	|O
of	|O
cycles	|O
,	|O
but	|O
were	|O
tolerable	|O
and	|O
reversible	|O
.	|O

LHbeta	|B-PROTEIN
is	|O
expressed	|O
in	|O
pituitary	|O
gonadotrope	|O
cells	|O
and	|O
CGbeta	|B-PROTEIN
is	|O
expressed	|O
in	|O
placental	|O
trophoblast	|O
cells	|O
.	|O

Regulation	|O
of	|O
HIV	|O
-	|O
1	|O
transcription	|O
.	|O

Human	|O
LTBP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
known	|O
to	|O
exist	|O
in	|O
different	|O
forms	|O
.	|O

In	|O
an	|O
earlier	|O
study	|O
(	|O
Kimura	|O
,	|O
Y.	|O
,	|O
Kurzydlowski	|O
,	|O
K.	|O
,	|O
Tada	|O
,	|O
M.	|O
,	|O
and	|O
MacLennan	|O
,	|O
D.	|O

It	|O
consists	|O
of	|O
2185	|O
amino	|O
acid	|O
residues	|O
encoded	|O
by	|O
a	|O
9	|O
-	|O
kilobase	|O
pair	|O
mRNA	|O
;	|O
several	|O
splice	|O
variants	|O
have	|O
been	|O
detected	|O
in	|O
human	|O
and	|O
rat	|O
cDNA	|O
libraries	|O
.	|O

Cyclic	|B-PROTEIN
AMP	|I-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
binding	|O
to	|O
A	|B-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
anchoring	|O
proteins	|O
in	|O
living	|O
cells	|O
by	|O
fluorescence	|O
resonance	|O
energy	|O
transfer	|O
of	|O
green	|B-PROTEIN
fluorescent	|I-PROTEIN
protein	|I-PROTEIN
fusion	|O
proteins	|O
.	|O

CONCLUSIONS	|O
:	|O
In	|O
addition	|O
to	|O
the	|O
superiority	|O
of	|O
octafluoropropane	|O
-	|O
filled	|O
microspheres	|O
to	|O
air	|O
-	|O
filled	|O
microspheres	|O
for	|O
LV	|O
opacification	|O
,	|O
the	|O
efficacy	|O
of	|O
OCTA	|O
is	|O
relatively	|O
unaffected	|O
by	|O
impaired	|O
LV	|O
function	|O
and	|O
is	|O
less	|O
susceptible	|O
to	|O
the	|O
effects	|O
of	|O
poor	|O
echogenicity	|O
than	|O
AIR	|O
.	|O

Factor	|B-PROTEIN
XI	|I-PROTEIN
deficiency	|O
is	|O
a	|O
rare	|O
hereditary	|O
bleeding	|O
disorder	|O
affecting	|O
the	|O
intrinsic	|O
pathway	|O
.	|O

The	|O
Ishasha	|O
samples	|O
show	|O
a	|O
range	|O
encompassing	|O
three	|O
trophic	|O
levels	|O
.	|O

The	|O
more	|O
traditional	|O
SERMS	|O
,	|O
clomiphene	|O
citrate	|O
and	|O
tamoxifen	|O
,	|O
will	|O
be	|O
reviewed	|O
along	|O
with	|O
such	|O
modern	|O
drugs	|O
as	|O
raloxifene	|O
and	|O
faslodex	|O
,	|O
with	|O
emphasis	|O
upon	|O
their	|O
actions	|O
on	|O
breast	|O
,	|O
uterus	|O
,	|O
bone	|O
and	|O
lipids	|O
.	|O

Ti	|O
exhibited	|O
a	|O
feather	|O
-	|O
like	|O
morphology	|O
.	|O

This	|O
organization	|O
suggests	|O
that	|O
duplication	|O
events	|O
that	|O
have	|O
generated	|O
the	|O
primate	|O
FUT3	|B-PROTEIN
-	|O
FUT5	|B-PROTEIN
-	|O
FUT6	|B-PROTEIN
cluster	|O
might	|O
have	|O
occurred	|O
through	|O
a	|O
long	|O
-	|O
interspersed	|O
-	|O
nuclear	|O
-	|O
element	|O
-	|O
based	|O
mechanism	|O
of	|O
unequal	|O
crossing	|O
over	|O
,	|O
as	|O
described	|O
for	|O
the	|O
globin	|B-PROTEIN
cluster	|O
.	|O

S.	|O
,	|O
Kim	|O
,	|O
S.	|O

The	|O
cop	|B-PROTEIN
region	|O
also	|O
harbors	|O
a	|O
region	|O
of	|O
plasmid	|O
incompatibility	|O
,	|O
inc	|B-PROTEIN
,	|O
encompassing	|O
a	|O
stem	|O
-	|O
loop	|O
structure	|O
,	|O
the	|O
repA	|B-PROTEIN
promoter	|O
,	|O
Prep	|B-PROTEIN
,	|O
as	|O
well	|O
as	|O
two	|O
distinct	|O
RepA	|B-PROTEIN
binding	|O
sites	|O
,	|O
BD	|O
-	|O
1	|O
and	|O
BD	|O
-	|O
2	|O
.	|O

WA	|O
constructs	|O
afforded	|O
relaxed	|O
and	|O
positive	|O
topoisomers	|O
,	|O
and	|O
cyclization	|O
kinetics	|O
indicated	|O
slow	|O
interconversion	|O
of	|O
precursors	|O
to	|O
the	|O
two	|O
topoisomers	|O
.	|O

The	|O
RFX	|B-PROTEIN
protein	|O
family	|O
includes	|O
members	|O
from	|O
yeast	|O
to	|O
humans	|O
,	|O
which	|O
function	|O
in	|O
various	|O
biological	|O
systems	|O
,	|O
and	|O
share	|O
a	|O
DNA	|O
-	|O
binding	|O
domain	|O
and	|O
a	|O
conserved	|O
C	|O
-	|O
terminal	|O
region	|O
.	|O

Binding	|O
to	|O
sulphatides	|O
and	|O
the	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
dystroglycan	|I-PROTEIN
receptor	|I-PROTEIN
was	|O
much	|O
stronger	|O
and	|O
required	|O
at	|O
least	|O
two	|O
LG	|B-PROTEIN
modules	|O
.	|O

Here	|O
,	|O
we	|O
propose	|O
that	|O
an	|O
antagonistic	|O
,	|O
BMP	|B-PROTEIN
/	|O
ALK2	|B-PROTEIN
/	|O
Smad	|B-PROTEIN
-	|O
mediated	|O
signaling	|O
pathway	|O
is	|O
active	|O
on	|O
the	|O
right	|O
side	|O
of	|O
the	|O
Xenopus	|O
embryo	|O
.	|O

These	|O
kinases	|O
belong	|O
to	|O
a	|O
new	|O
subfamily	|O
related	|O
to	|O
the	|O
Trk	|B-PROTEIN
subfamily	|O
.	|O

The	|O
data	|O
indicate	|O
that	|O
etr	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
essential	|O
for	|O
muscle	|O
development	|O
in	|O
C.	|O
elegans	|O
,	|O
perhaps	|O
by	|O
playing	|O
a	|O
role	|O
in	|O
post	|O
-	|O
transcriptional	|O
processing	|O
of	|O
some	|O
muscle	|O
component	|O
,	|O
and	|O
thus	|O
suggesting	|O
a	|O
possible	|O
conservation	|O
of	|O
gene	|O
function	|O
with	|O
human	|O
CUG	|B-PROTEIN
-	|I-PROTEIN
bp	|I-PROTEIN
.	|O

Gentamicin	|O
given	|O
by	|O
DPI	|O
and	|O
SVN	|O
significantly	|O
decreased	|O
the	|O
sputum	|O
Psa	|O
density	|O
(	|O
p	|O
<	|O
0.05	|O
)	|O
,	|O
by	|O
almost	|O
one	|O
order	|O
of	|O
magnitude	|O
.	|O

CONCLUSIONS	|O
:	|O
The	|O
largest	|O
value	|O
of	|O
the	|O
joint	|O
space	|O
may	|O
be	|O
used	|O
when	|O
evaluating	|O
rheumatoid	|O
AC	|O
joint	|O
space	|O
.	|O

An	|O
analysis	|O
of	|O
sequence	|O
of	|O
the	|O
mutant	|O
recN	|B-PROTEIN
gene	|O
revealed	|O
a	|O
G	|O
:	|O
C	|O
to	|O
T	|O
:	|O
A	|O
transversion	|O
near	|O
the	|O
3'	|O
end	|O
of	|O
the	|O
coding	|O
region	|O
.	|O

Nevertheless	|O
,	|O
in	|O
view	|O
of	|O
the	|O
potential	|O
transmission	|O
rates	|O
of	|O
HGV	|O
and	|O
the	|O
lack	|O
of	|O
effective	|O
immunization	|O
,	|O
HGV	|O
should	|O
be	|O
regarded	|O
as	|O
a	|O
potential	|O
occupational	|O
hazard	|O
for	|O
medical	|O
and	|O
dental	|O
staff	|O
.	|O

Detection	|O
of	|O
poisoning	|O
by	|O
Impila	|O
(	|O
Callilepis	|O
laureola	|O
)	|O
in	|O
a	|O
mother	|O
and	|O
child	|O
.	|O

We	|O
have	|O
previously	|O
identified	|O
mouse	|O
and	|O
human	|O
cDNAs	|O
encoding	|O
UNC	|B-PROTEIN
-	|I-PROTEIN
51	|I-PROTEIN
-	|O
like	|O
kinase	|O
(	|O
ULK1	|B-PROTEIN
)	|O
.	|O

ULKs	|B-PROTEIN
and	|O
UNC	|B-PROTEIN
-	|I-PROTEIN
51	|I-PROTEIN
share	|O
a	|O
typical	|O
domain	|O
structure	|O
of	|O
an	|O
amino	|O
-	|O
terminal	|O
kinase	|O
domain	|O
,	|O
a	|O
central	|O
proline	|O
/	|O
serine	|O
rich	|O
(	|O
PS	|O
)	|O
domain	|O
,	|O
and	|O
a	|O
carboxy	|O
-	|O
terminal	|O
(	|O
C	|O
)	|O
domain	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
ULK2	|B-PROTEIN
is	|O
involved	|O
in	|O
a	|O
previously	|O
uncharacterized	|O
signaling	|O
pathway	|O
in	|O
mammalian	|O
cells	|O
.	|O

Connector	|B-PROTEIN
enhancer	|I-PROTEIN
of	|I-PROTEIN
KSR	|I-PROTEIN
(	|O
CNK	|B-PROTEIN
)	|O
is	|O
a	|O
multidomain	|O
protein	|O
required	|O
for	|O
RAS	|B-PROTEIN
signaling	|O
.	|O

In	|O
simpler	|O
organisms	|O
,	|O
the	|O
ATP	|B-PROTEIN
sulfurylase	|I-PROTEIN
and	|O
APS	|B-PROTEIN
kinase	|I-PROTEIN
reactions	|O
are	|O
catalyzed	|O
by	|O
separate	|O
enzymes	|O
encoded	|O
by	|O
two	|O
or	|O
three	|O
genes	|O
,	|O
suggesting	|O
that	|O
a	|O
fusion	|O
of	|O
separate	|O
genes	|O
during	|O
the	|O
course	|O
of	|O
evolution	|O
generated	|O
the	|O
bifunctional	|O
enzyme	|O
.	|O

Epstein	|O
-	|O
Barr	|O
virus	|O
(	|O
EBV	|O
)	|O
latent	|B-PROTEIN
membrane	|I-PROTEIN
protein	|I-PROTEIN
1	|I-PROTEIN
(	|O
LMP1	|B-PROTEIN
)	|O
is	|O
essential	|O
for	|O
EBV	|O
-	|O
mediated	|O
transformation	|O
of	|O
primary	|O
B	|O
lymphocytes	|O
.	|O

The	|O
amino	|O
-	|O
terminal	|O
half	|O
of	|O
1a	|B-PROTEIN
is	|O
a	|O
distant	|O
homolog	|O
of	|O
alphavirus	|O
nonstructural	|O
protein	|O
nsP1	|B-PROTEIN
,	|O
which	|O
has	|O
been	|O
implicated	|O
in	|O
capping	|O
viral	|O
RNAs	|O
.	|O

Moreover	|O
,	|O
a	|O
recombinant	|O
Ad	|O
expressing	|O
Ad5	|O
E4orf6	|B-PROTEIN
/	|I-PROTEIN
7	|I-PROTEIN
induced	|O
apoptosis	|O
in	|O
rat	|O
cells	|O
when	|O
coinfected	|O
with	|O
wild	|O
-	|O
type	|O
p53	|B-PROTEIN
-	|O
expressing	|O
Ad	|O
.	|O

In	|O
HCMV	|O
(	|O
Towne	|O
)	|O
-	|O
infected	|O
HF	|O
cells	|O
at	|O
24	|O
to	|O
48	|O
h	|O
,	|O
IE2	|B-PROTEIN
also	|O
accumulated	|O
in	|O
newly	|O
formed	|O
viral	|O
DNA	|O
replication	|O
compartments	|O
containing	|O
the	|O
polymerase	|B-PROTEIN
processivity	|I-PROTEIN
factor	|I-PROTEIN
(	|O
UL44	|B-PROTEIN
)	|O
,	|O
the	|O
single	|B-PROTEIN
-	|I-PROTEIN
stranded	|I-PROTEIN
DNA	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
(	|O
SSB	|B-PROTEIN
;	|O
UL57	|B-PROTEIN
)	|O
,	|O
the	|O
UL112	|B-PROTEIN
-	|I-PROTEIN
113	|I-PROTEIN
accessory	|I-PROTEIN
protein	|I-PROTEIN
,	|O
and	|O
newly	|O
incorporated	|O
bromodeoxyuridine	|O
(	|O
BrdU	|O
)	|O
.	|O

Macroscopic	|O
researches	|O
on	|O
heart	|O
vascularization	|O
have	|O
indicated	|O
that	|O
the	|O
angioarchitecture	|O
of	|O
the	|O
conducting	|O
system	|O
differs	|O
from	|O
that	|O
of	|O
the	|O
normal	|O
myocardium	|O
.	|O

CONCLUSION	|O
(	|O
S	|O
)	|O
:	|O
Measuring	|O
urinary	|O
LH	|B-PROTEIN
levels	|O
is	|O
an	|O
excellent	|O
method	|O
for	|O
determining	|O
ovulation	|O
.	|O

However	|O
,	|O
reoperation	|O
for	|O
bulky	|O
cervical	|O
disease	|O
(	|O
group	|O
3	|O
)	|O
rarely	|O
results	|O
in	|O
normal	|O
calcitonin	|B-PROTEIN
levels	|O
and	|O
is	|O
associated	|O
with	|O
a	|O
high	|O
incidence	|O
of	|O
permanent	|O
hypoparathyroidism	|O
.	|O

We	|O
present	|O
a	|O
case	|O
of	|O
carcinoma	|O
of	|O
the	|O
breast	|O
presenting	|O
concurrently	|O
with	|O
SSc	|O
that	|O
subsequently	|O
progressed	|O
to	|O
dialysis	|O
-	|O
dependent	|O
renal	|O
failure	|O
in	|O
just	|O
1	|O
month	|O
.	|O

PURPOSE	|O
:	|O
To	|O
evaluate	|O
the	|O
disease	|O
-	|O
free	|O
survival	|O
(	|O
DFS	|O
)	|O
and	|O
overall	|O
survival	|O
(	|O
OS	|O
)	|O
,	|O
prognostic	|O
factors	|O
,	|O
and	|O
treatment	|O
-	|O
related	|O
mortality	|O
of	|O
women	|O
with	|O
stage	|O
IIIB	|O
inflammatory	|O
breast	|O
cancer	|O
(	|O
IBC	|O
)	|O
treated	|O
with	|O
combined	|O
modality	|O
therapy	|O
(	|O
CMT	|O
)	|O
and	|O
high	|O
-	|O
dose	|O
chemotherapy	|O
(	|O
HDCT	|O
)	|O
with	|O
autologous	|O
stem	|O
-	|O
cell	|O
transplantation	|O
.	|O

The	|O
GPI	|O
anchor	|O
moiety	|O
is	|O
either	|O
absent	|O
or	|O
present	|O
at	|O
a	|O
very	|O
low	|O
level	|O
in	|O
the	|O
polypeptide	|O
expressed	|O
from	|O
the	|O
cDNA	|O
that	|O
contained	|O
both	|O
the	|O
signal	|O
peptide	|O
and	|O
GPI	|O
signal	|O
sequences	|O
.	|O

We	|O
have	|O
cloned	|O
a	|O
novel	|O
100	|O
-	|O
kDa	|O
mammalian	|O
protein	|O
,	|O
which	|O
was	|O
recognized	|O
by	|O
an	|O
anti	|O
-	|O
peptide	|O
antibody	|O
against	|O
an	|O
epitope	|O
-	|O
containing	|O
nuclear	|O
localization	|O
signal	|O
of	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
p65	|O
subunit	|O
.	|O

Insulin	|B-PROTEIN
-	|O
regulated	|O
events	|O
,	|O
however	|O
,	|O
occur	|O
in	|O
all	|O
cells	|O
.	|O

Regulatory	|O
regions	|O
in	|O
the	|O
promoter	|O
and	|O
third	|O
intron	|O
of	|O
the	|O
growth	|B-PROTEIN
hormone	|I-PROTEIN
gene	|O
in	|O
rainbow	|O
trout	|O
,	|O
Oncorhynchus	|O
mykiss	|O
walbaum	|O
.	|O

Although	|O
most	|O
SFV	|O
genes	|O
have	|O
homologs	|O
encoded	|O
by	|O
other	|O
Chordopoxvirinae	|O
,	|O
the	|O
SFV	|O
genome	|O
lacks	|O
a	|O
key	|O
gene	|O
required	|O
for	|O
the	|O
production	|O
of	|O
extracellular	|O
enveloped	|O
virus	|O
.	|O

They	|O
self	|O
-	|O
completed	|O
the	|O
SF	|O
-	|O
36	|O
questionnaire	|O
and	|O
their	|O
QoL	|O
was	|O
described	|O
and	|O
retrospectively	|O
compared	|O
to	|O
that	|O
of	|O
historical	|O
controls	|O
.	|O

There	|O
was	|O
a	|O
trend	|O
toward	|O
an	|O
association	|O
between	|O
IENF	|O
and	|O
sural	|O
nerve	|O
unmyelinated	|O
fiber	|O
densities	|O
(	|O
r	|O
=	|O
0.32	|O
,	|O
p	|O
=	|O
0.054	|O
)	|O
.	|O

In	|O
addition	|O
,	|O
media	|O
containing	|O
F	|B-PROTEIN
beta	|I-PROTEIN
alpha	|I-PROTEIN
/	|O
CG	|B-PROTEIN
beta	|I-PROTEIN
displayed	|O
high	|O
-	|O
affinity	|O
binding	|O
to	|O
both	|O
CG	|B-PROTEIN
and	|I-PROTEIN
FSH	|I-PROTEIN
receptors	|I-PROTEIN
.	|O

In	|O
contrast	|O
,	|O
AP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
binding	|O
activity	|O
was	|O
significantly	|O
greater	|O
in	|O
T47D	|O
cells	|O
,	|O
and	|O
Western	|O
blots	|O
confirmed	|O
increased	|O
AP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
protein	|O
levels	|O
in	|O
these	|O
cells	|O
.	|O

N.	|O
van	|O
Hoek	|O
,	|O
and	|O
M.	|O

Here	|O
,	|O
we	|O
describe	|O
a	|O
tyrosine	|O
-	|O
phosphorylated	|O
nuclear	|O
protein	|O
,	|O
YT521	|B-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
,	|O
and	|O
show	|O
that	|O
it	|O
interacts	|O
with	|O
the	|O
nuclear	|O
transcriptosomal	|O
component	|O
scaffold	|O
attachment	|B-PROTEIN
factor	|I-PROTEIN
B	|I-PROTEIN
,	|O
and	|O
the	|O
68	|O
-	|O
kDa	|O
Src	|B-PROTEIN
substrate	|O
associated	|O
during	|O
mitosis	|O
,	|O
Sam68	|B-PROTEIN
.	|O

These	|O
mutants	|O
all	|O
failed	|O
to	|O
interact	|O
with	|O
the	|O
TraR	|B-PROTEIN
fusion	|O
in	|O
the	|O
two	|O
-	|O
hybrid	|O
system	|O
.	|O

PhoP	|B-PROTEIN
-	|O
PhoQ	|B-PROTEIN
homologues	|O
in	|O
Pseudomonas	|O
aeruginosa	|O
regulate	|O
expression	|O
of	|O
the	|O
outer	|O
-	|O
membrane	|O
protein	|O
OprH	|B-PROTEIN
and	|O
polymyxin	|O
B	|O
resistance	|O
.	|O

Deletion	|O
of	|O
fdsR	|B-PROTEIN
revealed	|O
a	|O
dual	|O
regulatory	|O
effect	|O
of	|O
FdsR	|B-PROTEIN
on	|O
the	|O
fds	|B-PROTEIN
operon	|O
by	|O
acting	|O
as	|O
transcriptional	|O
activator	|O
in	|O
the	|O
presence	|O
of	|O
formate	|O
or	|O
as	|O
repressor	|O
in	|O
the	|O
absence	|O
of	|O
formate	|O
.	|O

With	|O
constructs	|O
containing	|O
the	|O
binding	|O
site	|O
of	|O
one	|O
gene	|O
fused	|O
to	|O
the	|O
promoter	|O
of	|O
the	|O
other	|O
,	|O
we	|O
demonstrated	|O
that	|O
the	|O
positional	|O
requirements	|O
are	|O
a	|O
function	|O
of	|O
the	|O
specific	|O
binding	|O
site	|O
,	|O
not	|O
the	|O
promoter	|O
.	|O

In	|O
addition	|O
,	|O
all	|O
three	|O
Opa	|B-PROTEIN
proteins	|O
of	|O
C751	|O
bind	|O
equally	|O
well	|O
to	|O
HeLa	|O
cells	|O
transfected	|O
with	|O
cDNA	|O
encoding	|O
the	|O
carcinoembryonic	|B-PROTEIN
antigen	|I-PROTEIN
[	|O
CEA	|B-PROTEIN
(	|O
CD66e	|B-PROTEIN
)	|O
]	|O
subgroup	|O
of	|O
the	|O
CD66	|B-PROTEIN
family	|O
,	|O
but	|O
show	|O
distinct	|O
tropism	|O
for	|O
CGM1	|B-PROTEIN
-	|O
(	|O
CD66d	|B-PROTEIN
)	|O
and	|O
NCA	|B-PROTEIN
(	|O
CD66c	|B-PROTEIN
)	|O
-	|O
expressing	|O
cells	|O
.	|O

FISH	|O
using	|O
a	|O
whole	|O
chromosome	|O
4	|O
paint	|O
demonstrated	|O
multiple	|O
rearrangements	|O
involving	|O
chromosome	|O
4	|O
in	|O
MCF	|O
-	|O
7	|O
AdVp3000	|O
and	|O
MCF	|O
-	|O
7	|O
MX	|O
,	|O
while	|O
S1	|O
-	|O
M1	|O
-	|O
80	|O
contained	|O
only	|O
a	|O
simple	|O
reciprocal	|O
translocation	|O
.	|O

The	|O
MXR	|B-PROTEIN
gene	|O
encodes	|O
a	|O
half	|O
-	|O
transporter	|O
and	|O
the	|O
absence	|O
of	|O
cytogenetic	|O
evidence	|O
of	|O
coamplification	|O
of	|O
other	|O
regions	|O
suggests	|O
that	|O
a	|O
partner	|O
may	|O
not	|O
be	|O
overexpressed	|O
,	|O
and	|O
instead	|O
the	|O
MXR	|B-PROTEIN
half	|O
-	|O
transporter	|O
homodimerizes	|O
to	|O
mediate	|O
drug	|O
transport	|O
.	|O

The	|O
effect	|O
of	|O
smoking	|O
was	|O
not	|O
examined	|O
in	|O
this	|O
study	|O
,	|O
as	|O
such	|O
data	|O
were	|O
not	|O
available	|O
.	|O

Serum	|O
insulin	|B-PROTEIN
-	|I-PROTEIN
like	|I-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
I	|I-PROTEIN
(	|O
IGF	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
)	|O
SD	|O
score	|O
increased	|O
from	|O
-	|O
2.2	|O
and	|O
-	|O
4.2	|O
in	|O
men	|O
and	|O
women	|O
,	|O
respectively	|O
,	|O
to	|O
1.8	|O
and	|O
-	|O
0.9	|O
at	|O
6	|O
months	|O
and	|O
0.8	|O
and	|O
-	|O
0.7	|O
at	|O
12	|O
months	|O
.	|O

BACKGROUND	|O
:	|O
Measurement	|O
of	|O
stereoacuity	|O
at	|O
varying	|O
distances	|O
,	|O
by	|O
real	|O
or	|O
simulated	|O
depth	|O
stereoacuity	|O
tests	|O
,	|O
is	|O
helpful	|O
in	|O
the	|O
evaluation	|O
of	|O
patients	|O
with	|O
binocular	|O
imbalance	|O
or	|O
strabismus	|O
.	|O

Additional	|O
studies	|O
revealed	|O
that	|O
bovine	|O
brain	|O
Galpha	|B-PROTEIN
(	|I-PROTEIN
q	|I-PROTEIN
/	|I-PROTEIN
11	|I-PROTEIN
)	|I-PROTEIN
could	|O
also	|O
bind	|O
to	|O
an	|O
N	|O
-	|O
terminal	|O
construct	|O
of	|O
GRK2	|B-PROTEIN
,	|O
while	|O
no	|O
binding	|O
of	|O
Galpha	|B-PROTEIN
(	|I-PROTEIN
q	|I-PROTEIN
/	|I-PROTEIN
11	|I-PROTEIN
)	|I-PROTEIN
,	|O
Galpha	|B-PROTEIN
(	|I-PROTEIN
s	|I-PROTEIN
)	|I-PROTEIN
,	|O
Galpha	|B-PROTEIN
(	|I-PROTEIN
i	|I-PROTEIN
)	|I-PROTEIN
,	|O
or	|O
Galpha	|B-PROTEIN
(	|I-PROTEIN
12/13	|I-PROTEIN
)	|I-PROTEIN
to	|O
comparable	|O
constructs	|O
of	|O
GRK5	|B-PROTEIN
or	|O
GRK6	|B-PROTEIN
was	|O
observed	|O
.	|O

The	|O
elm1	|B-PROTEIN
kinase	|O
functions	|O
in	|O
a	|O
mitotic	|O
signaling	|O
network	|O
in	|O
budding	|O
yeast	|O
.	|O

Reverse	|O
transcription	|O
(	|O
RT	|O
)	|O
-	|O
PCR	|O
products	|O
were	|O
synthesized	|O
with	|O
two	|O
degenerate	|O
primers	|O
derived	|O
from	|O
the	|O
conserved	|O
motifs	|O
of	|O
various	|O
tyrosine	|B-PROTEIN
kinases	|I-PROTEIN
.	|O

In	|O
addition	|O
,	|O
the	|O
acetyltransferase	|O
activity	|O
of	|O
p300	|B-PROTEIN
was	|O
observed	|O
to	|O
be	|O
distinct	|O
from	|O
the	|O
broadly	|O
essential	|O
activation	|O
function	|O
of	|O
the	|O
CH3	|B-PROTEIN
domain	|O
/	|O
E1A	|B-PROTEIN
-	|O
binding	|O
region	|O
.	|O

The	|O
proliferation	|O
-	|O
specific	|O
HNF	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
/	|O
fork	|B-PROTEIN
head	|I-PROTEIN
homolog	|I-PROTEIN
-	|I-PROTEIN
11B	|I-PROTEIN
protein	|O
(	|O
HFH	|B-PROTEIN
-	|I-PROTEIN
11B	|I-PROTEIN
;	|O
also	|O
known	|O
as	|O
Trident	|B-PROTEIN
and	|O
Win	|B-PROTEIN
)	|O
is	|O
a	|O
family	|O
member	|O
of	|O
the	|O
winged	|B-PROTEIN
helix	|I-PROTEIN
/	|O
fork	|B-PROTEIN
head	|I-PROTEIN
transcription	|O
factors	|O
and	|O
in	|O
regenerating	|O
liver	|O
its	|O
expression	|O
is	|O
reactivated	|O
prior	|O
to	|O
hepatocyte	|O
entry	|O
into	|O
DNA	|O
replication	|O
(	|O
S	|O
phase	|O
)	|O
.	|O

In	|O
the	|O
mouse	|O
,	|O
CtBP1	|B-PROTEIN
is	|O
expressed	|O
from	|O
embryo	|O
to	|O
adult	|O
,	|O
but	|O
CtBP2	|B-PROTEIN
is	|O
mainly	|O
expressed	|O
during	|O
embryogenesis	|O
.	|O

The	|O
multiple	|O
functions	|O
of	|O
Pmt3p	|B-PROTEIN
described	|O
here	|O
suggest	|O
that	|O
several	|O
nuclear	|O
proteins	|O
are	|O
regulated	|O
by	|O
Pmt3p	|B-PROTEIN
conjugation	|O
.	|O

The	|O
role	|O
of	|O
transport	|O
by	|O
sea	|O
ice	|O
from	|O
the	|O
Kara	|O
Sea	|O
into	|O
the	|O
Arctic	|O
Ocean	|O
was	|O
assessed	|O
by	|O
a	|O
small	|O
subgroup	|O
at	|O
GEOMAR	|O
.	|O

We	|O
determined	|O
whether	|O
a	|O
single	|O
injection	|O
of	|O
slow	|O
-	|O
release	|O
estradiol	|O
-	|O
17beta	|O
(	|O
SRE2	|O
)	|O
would	|O
induce	|O
pseudopregnancy	|O
in	|O
gilts	|O
and	|O
whether	|O
PGF2alpha	|O
would	|O
regress	|O
the	|O
corpora	|O
lutea	|O
(	|O
CL	|O
)	|O
of	|O
pseudopregnancy	|O
.	|O

The	|O
level	|O
of	|O
serum	|O
creatine	|B-PROTEIN
kinase	|I-PROTEIN
was	|O
significantly	|O
high	|O
2	|O
days	|O
after	|O
ESWIB	|O
,	|O
but	|O
it	|O
recovered	|O
in	|O
a	|O
week	|O
.	|O

Among	|O
the	|O
remaining	|O
22	|O
sites	|O
,	|O
six	|O
are	|O
in	|O
the	|O
promoters	|O
of	|O
known	|O
alpha	|O
-	|O
specific	|O
genes	|O
and	|O
two	|O
other	|O
sites	|O
have	|O
an	|O
alpha2	|B-PROTEIN
-	|O
Mcm1	|B-PROTEIN
-	|O
dependent	|O
role	|O
in	|O
determining	|O
the	|O
direction	|O
of	|O
mating	|O
type	|O
switching	|O
.	|O

Activation	|O
of	|O
T	|O
cells	|O
via	|O
the	|O
TCR	|B-PROTEIN
and	|O
other	|O
costimulatory	|O
receptors	|O
triggers	|O
a	|O
number	|O
of	|O
signaling	|O
cascades	|O
.	|O

A	|O
phylogenetic	|O
analysis	|O
with	|O
the	|O
TK	|B-PROTEIN
domains	|O
from	|O
these	|O
sequences	|O
and	|O
a	|O
fourth	|O
,	|O
from	|O
a	|O
novel	|O
scavenger	|O
RTK	|B-PROTEIN
(	|O
all	|O
domains	|O
comprise	|O
the	|O
signature	|O
for	|O
the	|O
TK	|B-PROTEIN
class	|O
II	|O
receptors	|O
)	|O
,	|O
showed	|O
that	|O
they	|O
are	|O
distantly	|O
related	|O
to	|O
the	|O
insulin	|B-PROTEIN
and	|O
insulin	|B-PROTEIN
-	|I-PROTEIN
like	|I-PROTEIN
receptors	|I-PROTEIN
.	|O

Several	|O
7SL	|B-PROTEIN
RNA	|O
-	|O
encoding	|O
sequences	|O
and	|O
various	|O
intergenic	|O
spacers	|O
were	|O
amplified	|O
from	|O
the	|O
individual	|O
HindIII	|B-PROTEIN
fragments	|O
of	|O
about	|O
1.3	|O
and	|O
2.8	|O
kb	|O
.	|O

Results	|O
confirmed	|O
that	|O
stress	|O
produced	|O
CA3	|O
dendritic	|O
atrophy	|O
and	|O
tianeptine	|O
prevented	|O
it	|O
.	|O

We	|O
have	|O
isolated	|O
a	|O
binding	|O
partner	|O
for	|O
the	|O
Fanconi	|B-PROTEIN
anemia	|I-PROTEIN
group	|I-PROTEIN
C	|I-PROTEIN
protein	|O
(	|O
FANCC	|B-PROTEIN
)	|O
by	|O
yeast	|O
two	|O
-	|O
hybrid	|O
screening	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
both	|O
transcription	|O
activators	|O
depend	|O
on	|O
or	|O
interact	|O
with	|O
different	|O
subunits	|O
of	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
,	|O
although	|O
their	|O
role	|O
in	|O
formation	|O
of	|O
proper	|O
DNA	|O
geometry	|O
may	|O
also	|O
be	|O
crucial	|O
.	|O

Klebsiella	|O
oxytoca	|O
can	|O
assimilate	|O
nitrate	|O
and	|O
nitrite	|O
by	|O
using	|O
enzymes	|O
encoded	|O
by	|O
the	|O
nasFEDCBA	|B-PROTEIN
operon	|O
.	|O

Marked	|O
hemolysis	|O
significantly	|O
increased	|O
plasma	|O
values	|O
of	|O
potassium	|O
,	|O
phosphorus	|O
,	|O
total	|O
protein	|O
,	|O
and	|O
aspartate	|B-PROTEIN
aminotransferase	|I-PROTEIN
.	|O

Studies	|O
have	|O
substantiated	|O
the	|O
involvement	|O
of	|O
numerous	|O
loci	|O
on	|O
certain	|O
chromosomes	|O
;	|O
in	|O
excess	|O
of	|O
10	|O
chromosomes	|O
are	|O
thought	|O
to	|O
be	|O
involved	|O
.	|O

By	|O
negatively	|O
regulating	|O
GRK	|B-PROTEIN
-	|O
mediated	|O
receptor	|O
phosphorylation	|O
,	|O
beta	|B-PROTEIN
-	|I-PROTEIN
arrestin	|I-PROTEIN
-	|O
mediated	|O
processes	|O
such	|O
as	|O
Src	|B-PROTEIN
recruitment	|O
and	|O
clathrin	|B-PROTEIN
-	|O
mediated	|O
internalization	|O
,	|O
which	|O
are	|O
required	|O
for	|O
GPCR	|B-PROTEIN
-	|O
mediated	|O
ERK	|B-PROTEIN
activation	|O
,	|O
are	|O
inhibited	|O
,	|O
thus	|O
dampening	|O
further	|O
ERK	|B-PROTEIN
activation	|O
.	|O

Based	|O
on	|O
subcellular	|O
fractionation	|O
,	|O
the	|O
47	|O
-	|O
kDa	|O
P	|B-PROTEIN
-	|I-PROTEIN
CIP2	|I-PROTEIN
protein	|O
is	|O
mostly	|O
cytosolic	|O
.	|O

Supershift	|O
EMSAs	|O
identified	|O
that	|O
upstream	|B-PROTEIN
stimulatory	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|I-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
(	|O
USF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|I-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
)	|O
were	|O
part	|O
of	|O
these	|O
complexes	|O
.	|O

Conversely	|O
,	|O
E1A	|B-PROTEIN
binding	|O
to	|O
only	|O
p300	|B-PROTEIN
/	|O
CBP	|B-PROTEIN
results	|O
in	|O
an	|O
increase	|O
in	|O
PARP	|B-PROTEIN
enzyme	|O
activity	|O
and	|O
consequently	|O
in	|O
cell	|O
death	|O
susceptibility	|O
to	|O
irradiation	|O
,	|O
which	|O
is	|O
effectively	|O
counteracted	|O
by	|O
the	|O
PARP	|B-PROTEIN
chemical	|O
inhibitor	|O
3	|O
-	|O
aminobenzamide	|O
.	|O

Analysis	|O
of	|O
its	|O
genomic	|O
region	|O
revealed	|O
that	|O
the	|O
13	|O
-	|O
kb	|O
Cdc6	|B-PROTEIN
gene	|O
is	|O
divided	|O
into	|O
12	|O
exons	|O
by	|O
11	|O
introns	|O
.	|O

These	|O
include	|O
the	|O
CACCC	|O
and	|O
CAAT	|O
motifs	|O
.	|O

Skin	|O
pH	|O
changes	|O
associated	|O
with	|O
iontophoresis	|O
.	|O

This	|O
distinction	|O
was	|O
based	|O
upon	|O
whether	|O
the	|O
diagnosis	|O
provided	|O
a	|O
straightforward	|O
range	|O
of	|O
prognoses	|O
or	|O
an	|O
ambiguous	|O
clinical	|O
implication	|O
.	|O

The	|O
availability	|O
of	|O
potent	|O
regulatory	|O
DNA	|O
cassettes	|O
harboring	|O
the	|O
murine	|O
D1A	|B-PROTEIN
gene	|O
promoter	|O
could	|O
aid	|O
testing	|O
the	|O
neuronal	|O
-	|O
specific	|O
expression	|O
of	|O
transgenes	|O
in	|O
vivo	|O
.	|O

It	|O
may	|O
be	|O
dependent	|O
on	|O
location	|O
of	|O
a	|O
focus	|O
(	|O
according	|O
to	|O
EEG	|O
)	|O
as	|O
well	|O
as	|O
on	|O
the	|O
character	|O
and	|O
manifestation	|O
of	|O
the	|O
accompanying	|O
neuropsychologic	|O
symptomatology	|O
.	|O

The	|O
results	|O
of	|O
these	|O
studies	|O
demonstrate	|O
that	|O
the	|O
rat	|O
HDL	|O
receptor	|O
SR	|B-PROTEIN
-	|I-PROTEIN
BI	|I-PROTEIN
promoter	|O
contains	|O
two	|O
sterol	|O
response	|O
elements	|O
(	|O
pSRE	|O
and	|O
dSRE	|O
)	|O
through	|O
which	|O
SREBP	|B-PROTEIN
-	|I-PROTEIN
1a	|I-PROTEIN
can	|O
bind	|O
and	|O
activate	|O
transcription	|O
of	|O
this	|O
gene	|O
.	|O

Phosphorylation	|O
of	|O
myosin	|B-PROTEIN
-	|O
binding	|O
subunit	|O
(	|O
MBS	|B-PROTEIN
)	|O
of	|O
myosin	|B-PROTEIN
phosphatase	|I-PROTEIN
by	|O
Rho	|B-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
in	|O
vivo	|O
.	|O

Of	|O
these	|O
patients	|O
,	|O
46,164	|O
were	|O
placed	|O
on	|O
a	|O
waiting	|O
list	|O
for	|O
transplantation	|O
,	|O
23,275	|O
of	|O
whom	|O
received	|O
a	|O
first	|O
cadaveric	|O
transplant	|O
between	|O
1991	|O
and	|O
1997	|O
.	|O

In	|O
electrophoretic	|O
mobility	|O
shift	|O
assay	|O
(	|O
EMSA	|O
)	|O
,	|O
this	|O
GLUT4	|B-PROTEIN
repressor	|I-PROTEIN
element	|O
(	|O
G4RE	|B-PROTEIN
)	|O
generated	|O
specific	|O
bands	|O
with	|O
nuclear	|O
extracts	|O
from	|O
preadipocytes	|O
,	|O
but	|O
not	|O
from	|O
adipocytes	|O
.	|O

Syndromes	|O
of	|O
abnormal	|O
fat	|O
redistribution	|O
and	|O
metabolic	|O
complications	|O
in	|O
HIV	|O
-	|O
infected	|O
patients	|O
.	|O

Cytoprotection	|O
with	|O
amifostine	|O
in	|O
radiotherapy	|O
or	|O
radio	|O
-	|O
chemotherapy	|O
of	|O
head	|O
and	|O
neck	|O
tumors	|O

Immunohistochemical	|O
staining	|O
was	|O
positive	|O
for	|O
S	|B-PROTEIN
-	|I-PROTEIN
100	|I-PROTEIN
in	|O
all	|O
9	|O
cases	|O
stained	|O
,	|O
positive	|O
for	|O
HMB	|B-PROTEIN
-	|I-PROTEIN
45	|I-PROTEIN
in	|O
9	|O
(	|O
90%	|O
)	|O
of	|O
10	|O
,	|O
and	|O
negative	|O
for	|O
cytokeratin	|B-PROTEIN
in	|O
all	|O
9	|O
cases	|O
in	|O
which	|O
myxoid	|O
melanoma	|O
remained	|O
in	|O
the	|O
block	|O
after	|O
previous	|O
sections	|O
.	|O

Patients	|O
with	|O
types	|O
I	|O
and	|O
III	|O
MPGN	|O
did	|O
not	|O
differ	|O
in	|O
age	|O
at	|O
apparent	|O
onset	|O
,	|O
age	|O
at	|O
diagnosis	|O
,	|O
or	|O
interval	|O
from	|O
apparent	|O
onset	|O
of	|O
symptoms	|O
to	|O
diagnosis	|O
(	|O
biopsy	|O
)	|O
.	|O

Residual	|O
urinary	|O
abnormalities	|O
were	|O
significantly	|O
more	|O
frequent	|O
in	|O
patients	|O
with	|O
type	|O
III	|O
than	|O
type	|O
I	|O
MPGN	|O
.	|O

Taken	|O
together	|O
,	|O
differences	|O
in	|O
signaling	|O
and	|O
tissue	|O
expression	|O
suggest	|O
that	|O
the	|O
human	|O
intermediate	|O
PRLr	|B-PROTEIN
differs	|O
from	|O
the	|O
long	|O
PRLr	|B-PROTEIN
in	|O
physiological	|O
function	|O
.	|O

We	|O
describe	|O
here	|O
a	|O
Drosophila	|O
melanogaster	|O
FAK	|B-PROTEIN
homologue	|O
,	|O
DFak56	|B-PROTEIN
,	|O
which	|O
maps	|O
to	|O
band	|O
56D	|O
on	|O
the	|O
right	|O
arm	|O
of	|O
the	|O
second	|O
chromosome	|O
.	|O

Because	|O
the	|O
Pit	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
sites	|O
in	|O
the	|O
hGH	|B-PROTEIN
-	|I-PROTEIN
N	|I-PROTEIN
gene	|O
promoter	|O
are	|O
insufficient	|O
for	|O
such	|O
gene	|O
activation	|O
in	|O
vivo	|O
,	|O
these	|O
data	|O
suggested	|O
a	|O
unique	|O
chromatin	|O
-	|O
mediated	|O
developmental	|O
role	|O
for	|O
Pit	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
in	|O
the	|O
hGH	|B-PROTEIN
LCR	|O
.	|O

Recombinant	|O
prenylcysteine	|B-PROTEIN
lyase	|I-PROTEIN
was	|O
produced	|O
in	|O
a	|O
baculovirus	|O
-	|O
Sf9	|O
expression	|O
system	|O
.	|O

We	|O
show	|O
here	|O
that	|O
the	|O
third	|O
SH3	|B-PROTEIN
domain	|O
binds	|O
to	|O
Sos	|B-PROTEIN
,	|O
a	|O
guanine	|B-PROTEIN
nucleotide	|I-PROTEIN
exchange	|I-PROTEIN
factor	|I-PROTEIN
for	|O
Ras	|B-PROTEIN
and	|O
Rac	|B-PROTEIN
,	|O
both	|O
in	|O
vitro	|O
and	|O
in	|O
vivo	|O
.	|O

Point	|O
mutations	|O
in	|O
the	|O
third	|O
SH3	|B-PROTEIN
domain	|O
abolished	|O
the	|O
vinexin	|B-PROTEIN
-	|O
Sos	|B-PROTEIN
interaction	|O
.	|O

In	|O
gel	|O
mobility	|O
shift	|O
assays	|O
,	|O
low	|O
binding	|O
activity	|O
of	|O
CBF	|B-PROTEIN
to	|O
the	|O
wild	|O
-	|O
type	|O
AtpC	|B-PROTEIN
promoter	|O
sequence	|O
was	|O
observed	|O
with	|O
nuclear	|O
extracts	|O
from	|O
tissue	|O
with	|O
low	|O
AtpC	|B-PROTEIN
expression	|O
levels	|O
,	|O
i.e.	|O
extracts	|O
from	|O
etiolated	|O
and	|O
photobleached	|O
seedlings	|O
,	|O
whereas	|O
high	|O
binding	|O
activity	|O
was	|O
detectable	|O
with	|O
extracts	|O
from	|O
tissues	|O
with	|O
high	|O
AtpC	|B-PROTEIN
expression	|O
levels	|O
,	|O
i.e.	|O
extracts	|O
from	|O
light	|O
-	|O
grown	|O
seedlings	|O
and	|O
etiolated	|O
seedlings	|O
treated	|O
with	|O
cytokinin	|B-PROTEIN
.	|O

Mycoplasma	|O
hominis	|O
infections	|O
are	|O
easily	|O
missed	|O
because	|O
conventional	|O
methods	|O
for	|O
bacterial	|O
detection	|O
may	|O
fail	|O
.	|O

For	|O
this	|O
purpose	|O
,	|O
we	|O
used	|O
a	|O
series	|O
of	|O
plasmid	|O
constructs	|O
encoding	|O
different	|O
forms	|O
of	|O
the	|O
envelope	|O
glycoprotein	|B-PROTEIN
E	|I-PROTEIN
of	|O
the	|O
flavivirus	|O
tick	|O
-	|O
borne	|O
encephalitis	|O
virus	|O
.	|O

They	|O
are	|O
subdivided	|O
into	|O
two	|O
types	|O
that	|O
activate	|O
transduction	|O
pathways	|O
via	|O
different	|O
cell	|O
surface	|O
receptors	|O
.	|O

We	|O
report	|O
here	|O
that	|O
out	|O
of	|O
the	|O
major	|O
pro	|O
-	|O
inflammatory	|O
cytokines	|O
examined	|O
,	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1alpha	|I-PROTEIN
,	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1beta	|I-PROTEIN
,	|O
TNF	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
and	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
,	|O
only	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
was	|O
generated	|O
and	|O
secreted	|O
in	|O
PKCeta	|B-PROTEIN
-	|O
expressing	|O
cells	|O
without	|O
any	|O
additional	|O
inducer	|O
in	|O
serum	|O
-	|O
supplemented	|O
cultures	|O
(	|O
10%	|O
FCS	|O
)	|O
.	|O

Demyelinating	|O
diseases	|O
involving	|O
the	|O
grey	|O
matter	|O
were	|O
very	|O
rare	|O
,	|O
but	|O
we	|O
must	|O
consider	|O
the	|O
presence	|O
of	|O
symmetrical	|O
thalamic	|O
involvement	|O
in	|O
patients	|O
with	|O
ADEM	|O
.	|O

To	|O
define	|O
the	|O
minimal	|O
VDRE	|O
binding	|O
domain	|O
for	|O
human	|B-PROTEIN
VDR	|I-PROTEIN
(	|O
hVDR	|B-PROTEIN
)	|O
,	|O
a	|O
series	|O
of	|O
C	|O
-	|O
terminally	|O
truncated	|O
hVDR	|B-PROTEIN
mutants	|O
(	|O
Delta134	|O
,	|O
Delta113	|O
,	|O
Delta102	|O
,	|O
Delta90	|O
,	|O
Delta84	|O
,	|O
Delta80	|O
,	|O
and	|O
Delta60	|O
)	|O
was	|O
generated	|O
and	|O
expressed	|O
in	|O
bacteria	|O
.	|O

By	|O
an	|O
induced	|O
-	|O
fit	|O
mechanism	|O
,	|O
contacts	|O
with	|O
the	|O
anticodon	|O
can	|O
activate	|O
formation	|O
of	|O
a	|O
robust	|O
transition	|O
state	|O
at	|O
a	|O
site	|O
over	|O
70	|O
A	|O
away	|O
.	|O

These	|O
REPs	|O
,	|O
or	|O
clusters	|O
of	|O
paralogous	|O
loci	|O
,	|O
are	|O
15-100	|O
kb	|O
and	|O
harbor	|O
at	|O
least	|O
four	|O
ESTs	|O
and	|O
an	|O
expressed	|O
SH3GL	|B-PROTEIN
pseudogene	|O
.	|O

This	|O
revealed	|O
a	|O
minimum	|O
of	|O
six	|O
novel	|O
OSBP	|B-PROTEIN
-	|O
related	|O
proteins	|O
,	|O
designated	|O
ORP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
to	|O
ORP	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
.	|O

In	|O
part	|O
as	|O
a	|O
result	|O
of	|O
its	|O
inability	|O
to	|O
sustain	|O
radiative	|O
loses	|O
,	|O
the	|O
BB	|O
resonator	|O
has	|O
extremely	|O
low	|O
RF	|O
power	|O
requirements	|O
.	|O

In	|O
addition	|O
,	|O
narZ	|B-PROTEIN
expression	|O
was	|O
induced	|O
approximately	|O
20	|O
-	|O
fold	|O
intracellularly	|O
in	|O
Madin	|O
-	|O
Darby	|O
canine	|O
kidney	|O
epithelial	|O
cells	|O
and	|O
16	|O
-	|O
fold	|O
in	|O
intracellular	|O
salts	|O
medium	|O
,	|O
which	|O
is	|O
believed	|O
to	|O
mimic	|O
the	|O
intracellular	|O
milieu	|O
.	|O

However	|O
,	|O
mechanisms	|O
underlying	|O
HIV	|O
-	|O
1	|O
gene	|O
expression	|O
in	|O
the	|O
CNS	|O
are	|O
poorly	|O
understood	|O
.	|O

Is	|O
radical	|O
trachelectomy	|O
a	|O
safe	|O
alternative	|O
to	|O
radical	|O
hysterectomy	|O
for	|O
patients	|O
with	|O
stage	|O
IA	|O
-	|O
B	|O
carcinoma	|O
of	|O
the	|O
cervix	|O
?	|O
BACKGROUND	|O
:	|O
The	|O
prognosis	|O
associated	|O
with	|O
lymph	|O
node	|O
negative	|O
,	|O
early	|O
stage	|O
carcinoma	|O
of	|O
the	|O
cervix	|O
is	|O
excellent	|O
,	|O
with	|O
5	|O
-	|O
year	|O
survival	|O
rates	|O
greater	|O
than	|O
90%	|O
.	|O

A	|O
key	|O
event	|O
in	|O
this	|O
process	|O
is	|O
the	|O
selective	|O
recognition	|O
of	|O
the	|O
target	|O
membrane	|O
by	|O
the	|O
vesicle	|O
and	|O
the	|O
current	|O
view	|O
is	|O
that	|O
SNARE	|B-PROTEIN
protein	|O
interactions	|O
likely	|O
play	|O
a	|O
central	|O
role	|O
in	|O
vesicle	|O
-	|O
target	|O
recognition	|O
and	|O
or	|O
membrane	|O
fusion	|O
.	|O

Scapulae	|O
with	|O
a	|O
Type	|O
I	|O
configuration	|O
were	|O
found	|O
to	|O
have	|O
low	|O
values	|O
for	|O
the	|O
coraco	|O
-	|O
glenoid	|O
angle	|O
and	|O
coracoid	|O
overlap	|O
,	|O
which	|O
are	|O
known	|O
to	|O
be	|O
associated	|O
with	|O
a	|O
short	|O
coraco	|O
-	|O
humeral	|O
distance	|O
.	|O

Measurements	|O
in	|O
the	|O
LWS	|O
p.a	|O
.	|O
,	|O
LWS	|O
lat	|O
.	|O
and	|O
at	|O
Ward	|O
's	|O
triangle	|O
were	|O
made	|O
in	|O
a	|O
total	|O
of	|O
100	|O
patients	|O
.	|O

A	|O
group	|O
of	|O
66	|O
DSM	|O
-	|O
IV	|O
paranoid	|O
schizophrenic	|O
in	|O
-	|O
patients	|O
were	|O
assessed	|O
three	|O
times	|O
using	|O
the	|O
SAPS	|O
,	|O
SANS	|O
,	|O
BPRS	|O
and	|O
PAS	|O
.	|O

In	|O
conclusion	|O
:	|O
(	|O
i	|O
)	|O
TECRA	|O
kit	|O
is	|O
suggested	|O
to	|O
be	|O
used	|O
for	|O
screening	|O
SE	|O
producing	|O
strains	|O
;	|O
(	|O
ii	|O
)	|O
SET	|O
-	|O
RPLA	|O
and	|O
RIDASCREEN	|O
kits	|O
are	|O
suitable	|O
for	|O
epidemiological	|O
investigation	|O
of	|O
SE	|O
types	|O
,	|O
but	|O
the	|O
lack	|O
of	|O
ability	|O
for	|O
detecting	|O
SEE	|O
,	|O
long	|O
time	|O
required	|O
for	|O
testing	|O
with	|O
SET	|O
-	|O
RPLA	|O
kit	|O
and	|O
high	|O
background	|O
when	|O
using	|O
RIDASCREEN	|O
kit	|O
must	|O
be	|O
overcome	|O
;	|O
and	|O
(	|O
iii	|O
)	|O
because	|O
of	|O
the	|O
complicated	|O
test	|O
procedures	|O
and	|O
the	|O
lack	|O
of	|O
ability	|O
for	|O
detecting	|O
SEE	|O
,	|O
the	|O
practicality	|O
of	|O
SET	|O
-	|O
EIA	|O
kit	|O
in	|O
screening	|O
and	|O
epidemiological	|O
research	|O
purposes	|O
is	|O
low	|O
.	|O

Comparison	|O
of	|O
immunoassay	|O
kits	|O
for	|O
detection	|O
of	|O
staphylococcal	|B-PROTEIN
enterotoxins	|I-PROTEIN
produced	|O
by	|O
Staphylococcus	|O
aureus	|O

Despite	|O
the	|O
high	|O
frequency	|O
of	|O
natural	|O
infection	|O
,	|O
the	|O
seropositive	|O
rates	|O
of	|O
JEV	|O
antibody	|O
still	|O
correlated	|O
well	|O
with	|O
the	|O
dose	|O
of	|O
vaccine	|O
received	|O
,	|O
i.e.	|O
,	|O
67%	|O
(	|O
1122/1664	|O
)	|O
,	|O
66%	|O
(	|O
65/97	|O
)	|O
,	|O
33%	|O
(	|O
4/12	|O
)	|O
and	|O
40%	|O
(	|O
19/47	|O
)	|O
for	|O
children	|O
receiving	|O
3	|O
,	|O
2	|O
,	|O
1	|O
,	|O
and	|O
0	|O
dose	|O
of	|O
JE	|O
vaccines	|O
,	|O
respectively	|O
(	|O
P	|O
<	|O
0.0001	|O
Chi	|O
-	|O
square	|O
for	|O
trend	|O
test	|O
)	|O
.	|O

Furthermore	|O
,	|O
in	|O
vivo	|O
and	|O
in	|O
vitro	|O
protein	|O
-	|O
protein	|O
interaction	|O
experiments	|O
have	|O
shown	|O
that	|O
SR33	|B-PROTEIN
protein	|O
interacts	|O
with	|O
itself	|O
and	|O
with	|O
SR45	|B-PROTEIN
protein	|O
but	|O
not	|O
with	|O
two	|O
other	|O
members	|O
(	|O
SRZ21	|B-PROTEIN
and	|O
SRZ22	|B-PROTEIN
)	|O
of	|O
the	|O
SR	|B-PROTEIN
family	|O
that	|O
are	|O
known	|O
to	|O
interact	|O
with	|O
the	|O
Arabidopsis	|O
full	|O
-	|O
length	|O
U	|B-PROTEIN
-	|I-PROTEIN
70K	|I-PROTEIN
only	|O
.	|O

In	|O
summary	|O
,	|O
WT1	|B-PROTEIN
is	|O
enriched	|O
by	|O
oligo	|O
(	|O
dT	|O
)	|O
chromatography	|O
,	|O
as	|O
are	|O
U2AF65	|B-PROTEIN
,	|O
the	|O
U5	|B-PROTEIN
small	|I-PROTEIN
nuclear	|I-PROTEIN
RNP	|I-PROTEIN
-	|I-PROTEIN
associated	|I-PROTEIN
protein	|I-PROTEIN
p116	|O
and	|O
hnRNP	|O
A1	|B-PROTEIN
.	|O

Six	|O
out	|O
of	|O
ten	|O
hearts	|O
from	|O
macerated	|O
stillborn	|O
infants	|O
showed	|O
varying	|O
degrees	|O
of	|O
positive	|O
staining	|O
.	|O

Tih1	|B-PROTEIN
maps	|O
to	|O
distal	|O
mouse	|O
Chr	|O
1	|O
and	|O
human	|O
Chr	|O
1q31	|O
,	|O
chromosomal	|O
regions	|O
that	|O
have	|O
not	|O
shown	|O
evidence	|O
for	|O
imprinting	|O
and	|O
,	|O
in	|O
contrast	|O
to	|O
Ipl	|B-PROTEIN
,	|O
Tih1	|B-PROTEIN
is	|O
expressed	|O
equally	|O
from	|O
both	|O
parental	|O
alleles	|O
.	|O

A	|O
novel	|O
pleckstrin	|B-PROTEIN
homology	|O
-	|O
related	|O
gene	|O
family	|O
defined	|O
by	|O
Ipl	|B-PROTEIN
/	|O
Tssc3	|B-PROTEIN
,	|O
TDAG51	|B-PROTEIN
,	|O
and	|O
Tih1	|B-PROTEIN
:	|O
tissue	|O
-	|O
specific	|O
expression	|O
,	|O
chromosomal	|O
location	|O
,	|O
and	|O
parental	|O
imprinting	|O
.	|O

The	|O
potential	|O
for	|O
highly	|O
reactive	|O
nanoparticles	|O
(	|O
RNP	|O
)	|O
to	|O
absorb	|O
destructively	|O
,	|O
i.e.	|O
to	|O
neutralize	|O
highly	|O
toxic	|O
substances	|O
such	|O
as	|O
the	|O
warfare	|O
agents	|O
GA	|O
,	|O
GB	|O
,	|O
HD	|O
and	|O
VX	|O
,	|O
has	|O
been	|O
demonstrated	|O
in	|O
the	|O
laboratory	|O
.	|O

There	|O
were	|O
minimal	|O
negative	|O
effects	|O
on	|O
hematological	|O
parameters	|O
,	|O
acid	|O
-	|O
base	|O
status	|O
,	|O
and	|O
blood	|O
gases	|O
.	|O

Twelve	|O
out	|O
of	|O
43	|O
renal	|O
failure	|O
patients	|O
had	|O
troponin	|B-PROTEIN
I	|I-PROTEIN
0.13-0.9	|O
microg	|O
/	|O
l	|O
using	|O
Axsym	|O
method	|O
and	|O
4	|O
had	|O
levels	|O
of	|O
0.07-0.13	|O
microg	|O
/	|O
l	|O
using	|O
Immuno	|O
1	|O
.	|O

Therefore	|O
,	|O
we	|O
propose	|O
that	|O
p27	|B-PROTEIN
represents	|O
a	|O
crucial	|O
molecule	|O
in	|O
HMBA	|O
signaling	|O
that	|O
cannot	|O
be	|O
replaced	|O
by	|O
p21	|B-PROTEIN
.	|O

Transient	|O
,	|O
high	|O
-	|O
level	|O
Ras	|B-PROTEIN
-	|O
expression	|O
induces	|O
transcriptional	|O
activation	|O
of	|O
p21	|B-PROTEIN
mediated	|O
by	|O
a	|O
GC	|O
-	|O
rich	|O
region	|O
in	|O
p21	|B-PROTEIN
promoter	|O
-	|O
83-54	|O
bp	|O
relative	|O
to	|O
the	|O
transcription	|O
initiation	|O
site	|O
containing	|O
binding	|O
sites	|O
for	|O
Sp1	|B-PROTEIN
-	|O
family	|O
transcription	|O
factors	|O
.	|O

The	|O
RET	|B-PROTEIN
/	|O
PTC3	|B-PROTEIN
rearrangement	|O
is	|O
formed	|O
by	|O
fusion	|O
of	|O
the	|O
ELE1	|B-PROTEIN
and	|O
RET	|B-PROTEIN
genes	|O
,	|O
and	|O
is	|O
highly	|O
prevalent	|O
in	|O
radiation	|O
-	|O
induced	|O
post	|O
-	|O
Chernobyl	|O
papillary	|O
thyroid	|O
carcinomas	|O
.	|O

Apoptosis	|O
of	|O
small	|O
cells	|O
is	|O
still	|O
observed	|O
after	|O
co	|O
-	|O
transfection	|O
of	|O
JBD	|B-PROTEIN
and	|O
LMP1	|B-PROTEIN
but	|O
in	|O
addition	|O
a	|O
few	|O
apoptotic	|O
HD	|O
-	|O
MyZ	|O
cells	|O
with	|O
large	|O
fused	|O
nuclear	|O
masses	|O
are	|O
identified	|O
suggesting	|O
that	|O
specific	|O
inhibition	|O
of	|O
JNK	|B-PROTEIN
leads	|O
also	|O
to	|O
apoptosis	|O
of	|O
LMP1	|B-PROTEIN
induced	|O
RS	|O
cells	|O
.	|O

In	|O
addition	|O
to	|O
the	|O
bZIP	|O
protein	|O
Opaque2	|B-PROTEIN
(	|O
O2	|B-PROTEIN
)	|O
,	|O
there	|O
are	|O
other	|O
maize	|O
endosperm	|O
nuclear	|O
proteins	|O
that	|O
recognize	|O
the	|O
O2	|B-PROTEIN
box	|O
in	|O
22	|O
kDa	|O
zein	|B-PROTEIN
gene	|O
promoters	|O
.	|O

The	|O
mEmBP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
protein	|O
can	|O
activate	|O
transcription	|O
from	|O
a	|O
truncated	|O
promoter	|O
containing	|O
a	|O
pentamer	|O
of	|O
the	|O
O2	|B-PROTEIN
site	|O
in	|O
yeast	|O
cells	|O
;	|O
however	|O
,	|O
it	|O
inhibited	|O
regulated	|O
transcription	|O
of	|O
a	|O
22	|O
kDa	|O
zein	|B-PROTEIN
promoter	|O
in	|O
a	|O
transient	|O
expression	|O
assay	|O
using	|O
cultured	|O
maize	|O
endosperm	|O
cells	|O
.	|O

GHB	|O
,	|O
2	|O
CB	|O
,	|O
HMB	|O
,	|O
are	|O
some	|O
of	|O
these	|O
recent	|O
substances	|O
.	|O

There	|O
were	|O
15	|O
deaths	|O
,	|O
seven	|O
of	|O
which	|O
were	|O
felt	|O
to	|O
be	|O
avoidable	|O
.	|O

With	|O
this	|O
GH	|B-PROTEIN
and	|O
estrogen	|O
treatment	|O
regimen	|O
,	|O
most	|O
girls	|O
with	|O
TS	|O
can	|O
grow	|O
and	|O
develop	|O
much	|O
more	|O
in	|O
conformity	|O
with	|O
their	|O
healthy	|O
peers	|O
.	|O

We	|O
propose	|O
that	|O
the	|O
reduced	|O
responsiveness	|O
of	|O
CYP3A2	|B-PROTEIN
is	|O
the	|O
result	|O
of	|O
preferential	|O
binding	|O
of	|O
COUP	|B-PROTEIN
-	|I-PROTEIN
TF	|I-PROTEIN
at	|O
the	|O
CYP3A2	|B-PROTEIN
DexRE	|O
-	|O
1	|O
site	|O
.	|O

Higher	|O
CYP3A23	|B-PROTEIN
basal	|O
activity	|O
appears	|O
to	|O
be	|O
due	|O
to	|O
an	|O
E	|O
-	|O
box	|O
in	|O
3A23SiteA	|B-PROTEIN
that	|O
interacts	|O
with	|O
USF1	|B-PROTEIN
,	|O
a	|O
ubiquitous	|O
bHLH	|B-PROTEIN
/	|I-PROTEIN
leucine	|I-PROTEIN
zipper	|I-PROTEIN
transcription	|I-PROTEIN
factor	|I-PROTEIN
.	|O

The	|O
first	|O
one	|O
is	|O
a	|O
TPA	|O
-	|O
responsive	|O
element	|O
that	|O
controls	|O
the	|O
base	|O
-	|O
line	|O
ST3	|B-PROTEIN
promoter	|O
activity	|O
but	|O
is	|O
not	|O
required	|O
for	|O
its	|O
activation	|O
.	|O

To	|O
understand	|O
the	|O
basis	|O
for	|O
the	|O
increased	|O
cell	|O
surface	|O
stability	|O
compared	|O
with	|O
wild	|O
-	|O
type	|O
peptide	|O
and	|O
to	|O
understand	|O
the	|O
differences	|O
in	|O
T	|O
cell	|O
recognition	|O
between	|O
I1Y	|B-PROTEIN
and	|O
I1F	|B-PROTEIN
,	|O
we	|O
determined	|O
the	|O
x	|O
-	|O
ray	|O
crystal	|O
structures	|O
of	|O
the	|O
two	|O
class	|B-PROTEIN
I	|I-PROTEIN
MHC	|I-PROTEIN
-	|O
peptide	|O
complexes	|O
.	|O

Redistribution	|O
of	|O
mannosidase	|B-PROTEIN
I	|I-PROTEIN
was	|O
also	|O
observed	|O
in	|O
cells	|O
incubated	|O
at	|O
15	|O
degrees	|O
C.	|O

In	|O
addition	|O
,	|O
using	|O
biochemical	|O
activity	|O
assays	|O
for	|O
Rho	|B-PROTEIN
-	|O
like	|O
GTPases	|B-PROTEIN
,	|O
we	|O
show	|O
that	|O
the	|O
expression	|O
of	|O
beta1A	|B-PROTEIN
,	|O
beta1D	|B-PROTEIN
,	|O
or	|O
IL2R	|B-PROTEIN
-	|O
beta1A	|B-PROTEIN
in	|O
GE11	|O
or	|O
GD25	|O
cells	|O
triggers	|O
activation	|O
of	|O
both	|O
RhoA	|B-PROTEIN
and	|O
Rac1	|B-PROTEIN
,	|O
but	|O
not	|O
of	|O
Cdc42	|B-PROTEIN
.	|O

In	|O
conclusion	|O
,	|O
our	|O
data	|O
do	|O
not	|O
support	|O
a	|O
role	|O
for	|O
IVIg	|B-PROTEIN
in	|O
the	|O
remyelination	|O
of	|O
stable	|O
multiple	|O
sclerosis	|O
lesions	|O
as	|O
measured	|O
by	|O
central	|O
conduction	|O
time	|O
.	|O

The	|O
rhabdomyosarcoma	|O
R1H	|O
growing	|O
on	|O
the	|O
right	|O
flank	|O
of	|O
male	|O
WAG	|O
/	|O
Rij	|O
rats	|O
was	|O
clamped	|O
for	|O
2	|O
or	|O
4	|O
h	|O
at	|O
20	|O
degrees	|O
C	|O
or	|O
37	|O
degrees	|O
C.	|O

Relative	|O
to	|O
coherent	|O
control	|O
words	|O
(	|O
e.g.	|O
,	|O
quick	|O
)	|O
,	|O
these	|O
discourse	|O
-	|O
dependent	|O
semantic	|O
anomalies	|O
elicited	|O
a	|O
large	|O
N400	|O
effect	|O
that	|O
began	|O
at	|O
about	|O
200	|O
to	|O
250	|O
msec	|O
after	|O
word	|O
onset	|O
.	|O

These	|O
synergistic	|O
effects	|O
were	|O
strongly	|O
Jem	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
dose	|O
-	|O
dependent	|O
.	|O

Like	|O
the	|O
Tob	|B-PROTEIN
protein	|O
,	|O
Tob2	|B-PROTEIN
inhibited	|O
cell	|O
cycle	|O
progression	|O
from	|O
the	|O
G0	|O
/	|O
G1	|O
to	|O
S	|O
phases	|O
.	|O

The	|O
coordinate	|O
increase	|O
in	|O
cyclin	|B-PROTEIN
D1	|I-PROTEIN
and	|O
p21	|B-PROTEIN
had	|O
the	|O
effect	|O
of	|O
decreasing	|O
the	|O
specific	|O
but	|O
not	|O
absolute	|O
activity	|O
of	|O
cyclin	|B-PROTEIN
D1	|I-PROTEIN
/	|O
cdk4	|B-PROTEIN
.	|O
p53	|B-PROTEIN
was	|O
not	|O
involved	|O
since	|O
CSF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
induction	|O
of	|O
p21	|B-PROTEIN
was	|O
unaffected	|O
by	|O
dominant	|O
-	|O
negative	|O
p53	|B-PROTEIN
expression	|O
.	|O

In	|O
addition	|O
,	|O
SLK	|B-PROTEIN
displays	|O
high	|O
homology	|O
to	|O
microtubule	|B-PROTEIN
and	|I-PROTEIN
nuclear	|I-PROTEIN
associated	|I-PROTEIN
protein	|I-PROTEIN
(	|O
M	|B-PROTEIN
-	|I-PROTEIN
NAP	|I-PROTEIN
)	|O
and	|O
AT1	|B-PROTEIN
-	|I-PROTEIN
46	|I-PROTEIN
,	|O
both	|O
of	|O
unknown	|O
function	|O
.	|O

In	|O
this	|O
study	|O
26	|O
patients	|O
(	|O
20	|O
females	|O
and	|O
6	|O
males	|O
)	|O
were	|O
evaluated	|O
.	|O

The	|O
signalling	|O
molecules	|O
Wnt1	|B-PROTEIN
and	|O
Sonic	|B-PROTEIN
hedgehog	|I-PROTEIN
,	|O
implicated	|O
in	|O
the	|O
activation	|O
of	|O
Myf5	|B-PROTEIN
in	|O
myogenic	|O
progenitor	|O
cells	|O
in	|O
the	|O
somite	|O
,	|O
are	|O
also	|O
produced	|O
in	|O
the	|O
viscinity	|O
of	|O
the	|O
Myf5	|B-PROTEIN
expression	|O
domain	|O
in	|O
the	|O
mesencephalon	|O
.	|O

STUDY	|O
DESIGN	|O
AND	|O
METHODS	|O
:	|O
A	|O
study	|O
was	|O
initiated	|O
to	|O
compare	|O
the	|O
collection	|O
of	|O
PBPCs	|O
with	|O
the	|O
new	|O
device	|O
,	|O
the	|O
AutoPBSC	|O
(	|O
version	|O
[	|O
V	|O
]	|O
6.0	|O
with	|O
AutoPBSC	|O
tubing	|O
set	|O
)	|O
,	|O
and	|O
that	|O
with	|O
the	|O
MNC	|O
(	|O
mononuclear	|O
cell	|O
)	|O
procedure	|O
(	|O
V4.7	|O
with	|O
white	|O
cell	|O
tubing	|O
set	|O
)	|O
,	|O
for	|O
patients	|O
and	|O
healthy	|O
donors	|O
.	|O

Albumin	|B-PROTEIN
dialysis	|O
:	|O
effective	|O
removal	|O
of	|O
copper	|O
in	|O
a	|O
patient	|O
with	|O
fulminant	|O
Wilson	|O
disease	|O
and	|O
successful	|O
bridging	|O
to	|O
liver	|O
transplantation	|O
:	|O
a	|O
new	|O
possibility	|O
for	|O
the	|O
elimination	|O
of	|O
protein	|O
-	|O
bound	|O
toxins	|O
.	|O

Some	|O
artificial	|O
promoter	|O
constructs	|O
containing	|O
multiple	|O
Sp1	|B-PROTEIN
sites	|O
were	|O
highly	|O
responsive	|O
to	|O
ethanol	|O
,	|O
but	|O
others	|O
were	|O
not	|O
,	|O
suggesting	|O
that	|O
the	|O
organization	|O
of	|O
the	|O
proximal	|O
promoter	|O
region	|O
was	|O
an	|O
additional	|O
factor	|O
that	|O
affected	|O
the	|O
ethanol	|O
response	|O
.	|O

Overexpression	|O
of	|O
CDP	|B-PROTEIN
/	|O
cut	|B-PROTEIN
in	|O
ROS	|O
17/2.8	|O
osteosarcoma	|O
cells	|O
results	|O
in	|O
repression	|O
of	|O
OC	|B-PROTEIN
promoter	|O
activity	|O
;	|O
this	|O
repression	|O
is	|O
abrogated	|O
by	|O
mutating	|O
OC	|B-PROTEIN
box	|O
I.	|O

Injection	|O
of	|O
double	|O
-	|O
stranded	|O
RNA	|O
into	|O
C.	|O
elegans	|O
results	|O
in	|O
embryonic	|O
lethality	|O
;	|O
thus	|O
,	|O
the	|O
SF1	|B-PROTEIN
gene	|O
is	|O
essential	|O
not	|O
only	|O
in	|O
yeast	|O
but	|O
also	|O
in	|O
at	|O
least	|O
one	|O
metazoan	|O
.	|O

Both	|O
domains	|O
were	|O
required	|O
for	|O
specific	|O
DNA	|O
binding	|O
to	|O
the	|O
beta	|B-PROTEIN
-	|I-PROTEIN
retinoic	|I-PROTEIN
acid	|I-PROTEIN
receptor	|I-PROTEIN
element	|O
,	|O
producing	|O
a	|O
DNase	|B-PROTEIN
I	|I-PROTEIN
footprint	|O
covering	|O
predominantly	|O
one	|O
strand	|O
.	|O

Snail	|B-PROTEIN
family	|O
proteins	|O
are	|O
zinc	|O
finger	|O
transcriptional	|O
regulators	|O
first	|O
identified	|O
in	|O
Drosophila	|O
which	|O
play	|O
critical	|O
roles	|O
in	|O
cell	|O
fate	|O
determination	|O
.	|O

Consistent	|O
with	|O
this	|O
finding	|O
,	|O
beta	|B-PROTEIN
-	|I-PROTEIN
catenin	|I-PROTEIN
interacted	|O
directly	|O
with	|O
the	|O
RA	|B-PROTEIN
receptor	|I-PROTEIN
(	|O
RAR	|B-PROTEIN
)	|O
in	|O
a	|O
retinoid	|O
-	|O
dependent	|O
manner	|O
,	|O
but	|O
not	|O
with	|O
the	|O
retinoid	|B-PROTEIN
X	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
RXR	|B-PROTEIN
)	|O
,	|O
and	|O
RAR	|B-PROTEIN
competed	|O
with	|O
TCF	|B-PROTEIN
for	|O
beta	|B-PROTEIN
-	|I-PROTEIN
catenin	|I-PROTEIN
binding	|O
.	|O

Sequence	|O
analysis	|O
of	|O
the	|O
promoter	|O
region	|O
showed	|O
no	|O
TATA	|O
box	|O
but	|O
identified	|O
consensus	|O
binding	|O
motifs	|O
for	|O
Sp1	|B-PROTEIN
,	|O
CREB	|B-PROTEIN
,	|O
and	|O
half	|O
sites	|O
of	|O
the	|O
estrogen	|B-PROTEIN
receptor	|I-PROTEIN
binding	|O
site	|O
.	|O

Sak	|B-PROTEIN
kinase	|O
gene	|O
structure	|O
and	|O
transcriptional	|O
regulation	|O
.	|O

Thrombolysis	|O
was	|O
followed	|O
by	|O
a	|O
similar	|O
increase	|O
of	|O
platelet	|O
activity	|O
with	|O
maximal	|O
values	|O
reached	|O
at	|O
the	|O
3rd	|O
hour	|O
in	|O
both	|O
groups	|O
(	|O
196	|O
+	|O
/	|O
-	|O
43	|O
IU	|O
/	|O
ml	|O
in	|O
Group	|O
1	|O
and	|O
192	|O
+	|O
/	|O
-	|O
39	|O
in	|O
Group	|O
2	|O
:	|O
p	|O
&	|O
lt	|O
;	|O
001versus	|O
baseline	|O
and	|O
p	|O
NS	|O
between	|O
the	|O
groups	|O
)	|O
.	|O

Similar	|O
to	|O
Hp140	|B-PROTEIN
,	|O
isolated	|O
Hp55	|B-PROTEIN
binds	|O
DNA	|O
with	|O
moderate	|O
strength	|O
and	|O
was	|O
a	|O
specificity	|O
for	|O
double	|O
-	|O
stranded	|O
primer	|O
-	|O
template	|O
DNA	|O
.	|O

Finally	|O
,	|O
three	|O
new	|O
missense	|O
mutations	|O
,	|O
E138V	|O
,	|O
R254G	|O
,	|O
and	|O
P362R	|O
,	|O
were	|O
identified	|O
in	|O
the	|O
human	|O
AC	|B-PROTEIN
gene	|O
from	|O
FD	|O
patients	|O
.	|O

These	|O
data	|O
indicate	|O
that	|O
the	|O
interaction	|O
of	|O
eIF4A	|B-PROTEIN
with	|O
the	|O
middle	|O
region	|O
of	|O
eIF4GI	|B-PROTEIN
is	|O
necessary	|O
for	|O
translation	|O
,	|O
whereas	|O
the	|O
interaction	|O
of	|O
eIF4A	|B-PROTEIN
with	|O
the	|O
C	|O
-	|O
terminal	|O
region	|O
plays	|O
a	|O
modulatory	|O
role	|O
.	|O

The	|O
DAP5	|B-PROTEIN
/	|O
p86	|B-PROTEIN
apoptotic	|O
form	|O
was	|O
more	|O
potent	|O
than	|O
DAP5	|B-PROTEIN
/	|O
p97	|B-PROTEIN
in	|O
these	|O
functional	|O
assays	|O
.	|O

12	|O
:	|O
2684-2697	|O
,	|O
1998	|O
)	|O
:	|O
a	|O
key	|O
step	|O
of	|O
this	|O
model	|O
is	|O
the	|O
activation	|O
of	|O
the	|O
MAPK	|O
Fus3p	|B-PROTEIN
through	|O
the	|O
G	|B-PROTEIN
(	|I-PROTEIN
betagamma	|I-PROTEIN
)	|I-PROTEIN
-	|O
dependent	|O
relocalization	|O
of	|O
the	|O
Ste5p	|B-PROTEIN
-	|O
MAPK	|B-PROTEIN
cascade	|O
to	|O
the	|O
plasma	|O
membrane	|O
.	|O

Consistent	|O
with	|O
this	|O
finding	|O
,	|O
wild	|O
-	|O
type	|O
SAGA	|B-PROTEIN
inhibits	|O
TBP	|B-PROTEIN
binding	|O
to	|O
the	|O
HIS3	|B-PROTEIN
promoter	|O
in	|O
vitro	|O
,	|O
while	|O
SAGA	|B-PROTEIN
lacking	|O
Spt3	|B-PROTEIN
or	|O
Spt8	|B-PROTEIN
is	|O
not	|O
inhibitory	|O
.	|O

Saccharomyces	|O
cerevisiae	|O
contains	|O
a	|O
genetically	|O
and	|O
biochemically	|O
proven	|O
CAK	|B-PROTEIN
gene	|O
,	|O
CAK1	|B-PROTEIN
,	|O
that	|O
encodes	|O
a	|O
monomeric	|O
44	|O
-	|O
kDa	|O
Cak1p	|B-PROTEIN
protein	|O
unrelated	|O
to	|O
Cdk7	|B-PROTEIN
.	|O

Northern	|O
blot	|O
and	|O
reverse	|O
transcription	|O
-	|O
PCR	|O
analyses	|O
of	|O
human	|O
mRNA	|O
samples	|O
demonstrate	|O
that	|O
RNR	|B-PROTEIN
is	|O
expressed	|O
exclusively	|O
in	|O
the	|O
retina	|O
,	|O
with	|O
transcripts	|O
of	|O
approximately	|O
7.5	|O
kb	|O
,	|O
approximately	|O
3.0	|O
kb	|O
,	|O
and	|O
approximately	|O
2.3	|O
kb	|O
by	|O
Northern	|O
blot	|O
analysis	|O
.	|O

Particularly	|O
striking	|O
was	|O
the	|O
conservation	|O
of	|O
an	|O
AP	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
binding	|O
site	|O
within	|O
100	|O
nucleotides	|O
upstream	|O
of	|O
the	|O
transcription	|O
initiation	|O
site	|O
in	|O
both	|O
Aal	|B-PROTEIN
-	|O
rpL34	|B-PROTEIN
and	|O
Aal	|B-PROTEIN
-	|O
rpL8	|B-PROTEIN
genes	|O
.	|O

Based	|O
on	|O
a	|O
type	|O
I	|O
error	|O
of	|O
0.05	|O
,	|O
our	|O
study	|O
had	|O
a	|O
power	|O
greater	|O
than	|O
or	|O
equal	|O
to	|O
75%	|O
to	|O
detect	|O
group	|O
differences	|O
in	|O
treatment	|O
effect	|O
of	|O
greater	|O
than	|O
or	|O
equal	|O
to	|O
15%	|O
to	|O
20%	|O
.	|O

CONCLUSIONS	|O
:	|O
Serum	|O
levels	|O
of	|O
S	|B-PROTEIN
-	|I-PROTEIN
100beta	|I-PROTEIN
are	|O
reliable	|O
markers	|O
for	|O
adverse	|O
neurologic	|O
outcomes	|O
after	|O
cardiac	|O
surgery	|O
.	|O

However	|O
,	|O
no	|O
genetic	|O
alteration	|O
was	|O
detected	|O
in	|O
any	|O
of	|O
the	|O
cancers	|O
examined	|O
.	|O

All	|O
problems	|O
were	|O
associated	|O
with	|O
fractured	|O
or	|O
lost	|O
screws	|O
.	|O

Statins	|B-PROTEIN
:	|O
lower	|O
lipids	|O
and	|O
better	|O
bones	|O
?	|O
Although	|O
statins	|O
are	|O
widely	|O
used	|O
as	|O
cholesterol	|O
-	|O
lowering	|O
drugs	|O
,	|O
a	|O
recent	|O
study	|O
suggests	|O
that	|O
these	|O
compounds	|O
have	|O
anabolic	|O
effects	|O
on	|O
bone	|O
and	|O
could	|O
be	|O
developed	|O
into	|O
new	|O
treatments	|O
for	|O
common	|O
metabolic	|O
bone	|O
diseases	|O
such	|O
as	|O
osteoporosis	|O

The	|O
accumulated	|O
products	|O
of	|O
ancient	|O
duplication	|O
events	|O
can	|O
be	|O
readily	|O
observed	|O
among	|O
the	|O
genes	|O
encoding	|O
voltage	|O
-	|O
dependent	|O
Ca	|O
(	|O
2+	|O
)	|O
ion	|O
channels	|O
.	|O

The	|O
VirR	|B-PROTEIN
response	|O
regulator	|O
from	|O
Clostridium	|O
perfringens	|O
binds	|O
independently	|O
to	|O
two	|O
imperfect	|O
direct	|O
repeats	|O
located	|O
upstream	|O
of	|O
the	|O
pfoA	|B-PROTEIN
promoter	|O
.	|O

Cloning	|O
and	|O
sequencing	|O
of	|O
the	|O
upstream	|O
region	|O
of	|O
pepX	|B-PROTEIN
revealed	|O
the	|O
presence	|O
of	|O
two	|O
ORFs	|O
of	|O
360	|O
and	|O
1,338	|O
bp	|O
that	|O
were	|O
shown	|O
to	|O
be	|O
able	|O
to	|O
encode	|O
proteins	|O
with	|O
high	|O
homology	|O
to	|O
GlnR	|B-PROTEIN
and	|O
GlnA	|B-PROTEIN
proteins	|O
,	|O
respectively	|O
.	|O

Objective	|O
:	|O
To	|O
evaluate	|O
endometrial	|O
thickness	|O
and	|O
the	|O
incidence	|O
of	|O
uterine	|O
bleeding	|O
in	|O
postmenopausal	|O
women	|O
using	|O
either	|O
tibolone	|O
2.5	|O
mg	|O
or	|O
continuous	|O
combined	|O
2	|O
mg	|O
estradiol	|O
and	|O
1	|O
mg	|O
norethisterone	|O
acetate	|O
(	|O
E+	|O
NETA	|O
)	|O
daily	|O
as	|O
hormone	|O
replacement	|O
therapy	|O
.	|O

Leukocyte	|O
cultures	|O
,	|O
prepared	|O
from	|O
blood	|O
drawn	|O
from	|O
these	|O
18	|O
children	|O
at	|O
6	|O
months	|O
of	|O
age	|O
,	|O
produced	|O
lower	|O
yields	|O
of	|O
IFN	|B-PROTEIN
than	|O
those	|O
of	|O
the	|O
remaining	|O
53	|O
children	|O
,	|O
when	|O
stimulated	|O
with	|O
adenovirus	|O
(	|O
P	|O
<	|O
0.001	|O
)	|O
,	|O
coronavirus	|O
(	|O
P	|O
<	|O
0.001	|O
)	|O
or	|O
rhinovirus	|O
(	|O
P	|O
=	|O
0.002	|O
)	|O
.	|O

In	|O
the	|O
BF	|O
ECT	|O
group	|O
the	|O
-	|O
age	|O
based	|O
dose	|O
would	|O
have	|O
been	|O
similarly	|O
dependent	|O
on	|O
the	|O
initial	|O
seizure	|O
threshold	|O
level	|O
.	|O

Histological	|O
analysis	|O
showed	|O
that	|O
the	|O
neuronal	|O
loss	|O
in	|O
the	|O
DHED	|O
-	|O
treated	|O
group	|O
was	|O
notably	|O
reduced	|O
in	|O
the	|O
hippocampal	|O
area	|O
(	|O
CA1	|O
)	|O
of	|O
ischemic	|O
rats	|O
and	|O
in	|O
the	|O
dentate	|O
gyrus	|O
and	|O
hippocampal	|O
area	|O
(	|O
CA1	|O
and	|O
CA3	|O
)	|O
of	|O
EC	|O
-	|O
lesioned	|O
rats	|O
compared	|O
with	|O
the	|O
nontreated	|O
group	|O
.	|O

The	|O
extents	|O
of	|O
phosphorylation	|O
of	|O
Ser44	|O
and	|O
Ser64	|O
were	|O
1	|O
:	|O
1	|O
,	|O
whereas	|O
those	|O
of	|O
the	|O
four	|O
minor	|O
sites	|O
all	|O
together	|O
were	|O
<	|O
30%	|O
of	|O
the	|O
major	|O
one	|O
.	|O

Serum	|O
HBV	|O
-	|O
DNA	|O
,	|O
viral	|O
serology	|O
,	|O
and	|O
liver	|O
enzymes	|O
were	|O
measured	|O
sequentially	|O
;	|O
liver	|O
histology	|O
was	|O
taken	|O
before	|O
and	|O
during	|O
treatment	|O
in	|O
12	|O
patients	|O
.	|O

Chem.	|O

Maximum	|O
induction	|O
of	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
was	|O
reached	|O
at	|O
a	|O
concentration	|O
of	|O
250	|O
nmol	|O
/	|O
L	|O
of	|O
CalC	|O
.	|O

Haycocknema	|O
perplexum	|O
n	|O
.	|O
g	|O
.	|O
,	|O
n	|O
.	|O
sp	|O
.	|O

Rams	|O
were	|O
weighed	|O
and	|O
testis	|O
size	|O
was	|O
estimated	|O
by	|O
orchimetry	|O
at	|O
each	|O
time	|O
period	|O
.	|O

Animal	|O
studies	|O
showed	|O
that	|O
beam	|O
equalization	|O
significantly	|O
improved	|O
fluoroscopic	|O
and	|O
angiographic	|O
image	|O
quality	|O
.	|O

Role	|O
of	|O
estrogen	|B-PROTEIN
receptor	|I-PROTEIN
ligand	|O
and	|O
estrogen	|O
response	|O
element	|O
sequence	|O
on	|O
interaction	|O
with	|O
chicken	|B-PROTEIN
ovalbumin	|I-PROTEIN
upstream	|I-PROTEIN
promoter	|I-PROTEIN
transcription	|I-PROTEIN
factor	|I-PROTEIN
(	|O
COUP	|B-PROTEIN
-	|I-PROTEIN
TF	|I-PROTEIN
)	|O
.	|O

CONCLUSION	|O
:	|O
In	|O
Cdks	|B-PROTEIN
functioning	|O
throughout	|O
the	|O
cell	|O
cycle	|O
,	|O
tyrosine	|O
phosphorylation	|O
is	|O
inhibitory	|O
to	|O
the	|O
activation	|O
of	|O
kinase	|O
,	|O
whereas	|O
the	|O
phosphorylation	|O
of	|O
threonine	|O
in	|O
the	|O
T	|O
-	|O
loop	|O
is	|O
essential	|O
for	|O
activation	|O
.	|O

We	|O
also	|O
report	|O
that	|O
AHR	|B-PROTEIN
interacts	|O
with	|O
COUP	|B-PROTEIN
-	|I-PROTEIN
TF	|I-PROTEIN
in	|O
transfected	|O
CV	|O
-	|O
1	|O
cells	|O
.	|O

AB004534	|B-PROTEIN
.	|O

The	|O
prevalence	|O
of	|O
hepatitis	|O
C	|O
virus	|O
(	|O
HCV	|O
)	|O
infection	|O
is	|O
relatively	|O
low	|O
in	|O
childhood	|O
,	|O
with	|O
anti	|B-PROTEIN
-	|I-PROTEIN
HCV	|I-PROTEIN
prevalence	|O
rates	|O
of	|O
0.1-0.4%	|O
in	|O
the	|O
Western	|O
world	|O
.	|O

Clear	|O
and	|O
evidenced	|O
-	|O
based	|O
information	|O
should	|O
be	|O
provided	|O
to	|O
patients	|O
as	|O
to	|O
the	|O
means	|O
of	|O
prevention	|O
with	|O
special	|O
attention	|O
to	|O
individual	|O
risk	|O
groups	|O
such	|O
as	|O
IV	|O
drug	|O
abusers	|O
.	|O

During	|O
latency	|O
,	|O
more	|O
than	|O
1%	|O
of	|O
neurons	|O
in	|O
ganglia	|O
that	|O
innervate	|O
the	|O
footpad	|O
expressed	|O
beta	|B-PROTEIN
-	|I-PROTEIN
galactosidase	|I-PROTEIN
,	|O
with	|O
the	|O
number	|O
of	|O
positive	|O
cells	|O
remaining	|O
constant	|O
for	|O
at	|O
least	|O
5	|O
months	|O
.	|O

As	|O
an	|O
alternative	|O
approach	|O
to	|O
this	|O
question	|O
,	|O
we	|O
have	|O
studied	|O
the	|O
effects	|O
of	|O
ectopically	|O
expressed	|O
SHIP	|B-PROTEIN
,	|O
SHP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
or	|O
SHP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
SH2	|O
-	|O
containing	|O
decoy	|O
proteins	|O
on	|O
Fc	|B-PROTEIN
gamma	|I-PROTEIN
RIIB1	|I-PROTEIN
signaling	|O
.	|O

Compared	|O
to	|O
those	|O
with	|O
normal	|O
renal	|O
functions	|O
,	|O
these	|O
patients	|O
were	|O
older	|O
(	|O
P	|O
<	|O
or	|O
=	|O
0.01	|O
)	|O
,	|O
had	|O
significantly	|O
elevated	|O
blood	|O
pressures	|O
(	|O
P	|O
<	|O
0.01	|O
or	|O
P	|O
=	|O
0.0001	|O
)	|O
,	|O
and	|O
in	|O
the	|O
case	|O
of	|O
Type	|O
1	|O
DM	|O
,	|O
with	|O
a	|O
higher	|O
body	|O
mass	|O
index	|O
(	|O
P	|O
=	|O
0.0001	|O
)	|O
and	|O
waist	|O
-	|O
hip	|O
ratio	|O
(	|O
P	|O
<	|O
0.01	|O
)	|O
.	|O

In	|O
all	|O
tissues	|O
examined	|O
only	|O
transcripts	|O
positive	|O
for	|O
insert	|O
3	|O
,	|O
an	|O
18	|O
bp	|O
insertion	|O
in	|O
repeat	|O
21	|O
,	|O
were	|O
amplified	|O
,	|O
even	|O
under	|O
conditions	|O
in	|O
which	|O
a	|O
30%	|O
level	|O
of	|O
insert	|O
3	|O
negative	|O
transcript	|O
could	|O
be	|O
easily	|O
detected	|O
in	|O
artificially	|O
prepared	|O
control	|O
samples	|O
.	|O

These	|O
results	|O
show	|O
that	|O
the	|O
CAAT	|O
-	|O
region	|O
is	|O
involved	|O
in	|O
upregulating	|O
the	|O
MDR1	|B-PROTEIN
promoter	|O
in	|O
HL60	|O
/	|O
VCR	|O
cells	|O
.	|O

Both	|O
receptors	|O
utilize	|O
protein	|B-PROTEIN
tyrosine	|I-PROTEIN
kinases	|I-PROTEIN
(	|O
PTKs	|B-PROTEIN
)	|O
for	|O
the	|O
phosphorylation	|O
of	|O
various	|O
signaling	|O
molecules	|O
,	|O
a	|O
process	|O
that	|O
is	|O
critical	|O
for	|O
the	|O
function	|O
of	|O
both	|O
receptors	|O
.	|O

Hypothermia	|O
After	|O
Cardiac	|O
Arrest	|O
(	|O
HACA	|O
)	|O
Study	|O
Group	|O
.	|O

The	|O
synergistic	|O
effect	|O
due	|O
to	|O
the	|O
5'	|O
-	|O
3'	|O
cooperation	|O
was	|O
at	|O
least	|O
fourfold	|O
greater	|O
than	|O
the	|O
sum	|O
of	|O
the	|O
contributions	|O
of	|O
the	|O
individual	|O
UTRs	|O
.	|O

We	|O
demonstrate	|O
that	|O
both	|O
R	|B-PROTEIN
and	|O
Z	|B-PROTEIN
activate	|O
the	|O
cellular	|O
stress	|O
mitogen	|O
-	|O
activated	|O
protein	|O
(	|B-PROTEIN
MAP	|I-PROTEIN
)	|I-PROTEIN
kinases	|I-PROTEIN
,	|O
p38	|B-PROTEIN
and	|O
JNK	|B-PROTEIN
,	|O
resulting	|O
in	|O
phosphorylation	|O
(	|O
and	|O
activation	|O
)	|O
of	|O
the	|O
cellular	|O
transcription	|O
factor	|O
ATF2	|B-PROTEIN
.	|O

Two	|O
US	|O
commercial	|O
cultivars	|O
(	|O
Tehama	|O
and	|O
Vina	|O
)	|O
,	|O
three	|O
European	|O
commercial	|O
cultivars	|O
(	|O
Esterhazy	|O
,	|O
139	|O
,	|O
G120	|O
)	|O
and	|O
five	|O
New	|O
Zealand	|O
selections	|O
(	|O
Rex	|O
,	|O
Dublin	|O
's	|O
Glory	|O
,	|O
Meyric	|O
,	|O
McKinster	|O
,	|O
Stanley	|O
)	|O
were	|O
evaluated	|O
.	|O

Anatomy	|O
of	|O
the	|O
uterine	|O
artery	|O
.	|O

However	|O
,	|O
activation	|O
of	|O
the	|O
cAMP	|O
pathway	|O
,	|O
which	|O
is	|O
known	|O
to	|O
regulate	|O
inhibin	|B-PROTEIN
alpha	|I-PROTEIN
expression	|O
,	|O
greatly	|O
enhanced	|O
the	|O
actions	|O
of	|O
SF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

Deletion	|O
and	|O
site	|O
-	|O
directed	|O
mutagenesis	|O
localized	|O
a	|O
novel	|O
SF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
regulatory	|O
element	|O
(	|O
TCA	|O
GGGCCA	|O
;	|O
-	|O
137	|O
to	|O
-	|O
129	|O
)	|O
adjacent	|O
to	|O
a	|O
variant	|O
cAMP	|O
-	|O
response	|O
element	|O
(	|O
CRE	|O
;	|O
-	|O
120	|O
to	|O
-	|O
114	|O
)	|O
.	|O

Previously	|O
,	|O
we	|O
showed	|O
that	|O
the	|O
APRE	|O
is	|O
a	|O
cytokine	|O
[	|O
tumor	|B-PROTEIN
necrosis	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
(	|O
TNFalpha	|B-PROTEIN
)	|O
]	|O
-	|O
inducible	|O
enhancer	|O
by	|O
binding	|O
the	|O
heterodimeric	|O
nuclear	|B-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
(	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
)	|O
complex	|O
Rel	|B-PROTEIN
A	|I-PROTEIN
x	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB1	|I-PROTEIN
.	|O

Angiotensin	|B-PROTEIN
II	|I-PROTEIN
induces	|O
nuclear	|O
factor	|O
(	|B-PROTEIN
NF	|I-PROTEIN
)	|I-PROTEIN
-	|I-PROTEIN
kappaB1	|I-PROTEIN
isoforms	|O
to	|O
bind	|O
the	|O
angiotensinogen	|B-PROTEIN
gene	|O
acute	|O
-	|O
phase	|O
response	|O
element	|O
:	|O
a	|O
stimulus	|O
-	|O
specific	|O
pathway	|O
for	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
activation	|O
.	|O

Synthetic	|O
ligands	|O
have	|O
been	|O
identified	|O
that	|O
reset	|O
and	|O
amplify	|O
the	|O
cycle	|O
of	|O
pulsatile	|O
GH	|B-PROTEIN
secretion	|O
by	|O
interacting	|O
with	|O
the	|O
orphan	|O
GH	|B-PROTEIN
-	|I-PROTEIN
secretagogue	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
GHS	|B-PROTEIN
-	|I-PROTEIN
R	|I-PROTEIN
)	|O
.	|O

The	|O
collection	|O
of	|O
mutants	|O
displaying	|O
TGN	|O
sorting	|O
defects	|O
includes	|O
members	|O
with	|O
mutations	|O
in	|O
previously	|O
identified	|O
vacuolar	|B-PROTEIN
protein	|I-PROTEIN
sorting	|I-PROTEIN
genes	|I-PROTEIN
(	|O
VPS	|B-PROTEIN
)	|O
,	|O
including	|O
the	|O
dynamin	|B-PROTEIN
family	|O
member	|O
VPS1	|B-PROTEIN
.	|O

Also	|O
in	|O
the	|O
spectrum	|O
of	|O
mutants	|O
with	|O
TGN	|O
sorting	|O
defects	|O
are	|O
isolates	|O
with	|O
mutations	|O
in	|O
the	|O
following	|O
:	|O
RIC1	|B-PROTEIN
,	|O
encoding	|O
a	|O
product	|O
originally	|O
proposed	|O
to	|O
participate	|O
in	|O
ribosome	|O
biogenesis	|O
;	|O
LUV1	|B-PROTEIN
,	|O
encoding	|O
a	|O
product	|O
potentially	|O
involved	|O
in	|O
vacuole	|O
and	|O
microtubule	|O
organization	|O
;	|O
and	|O
INP53	|B-PROTEIN
,	|O
encoding	|O
a	|O
synaptojanin	|B-PROTEIN
-	|O
like	|O
inositol	|B-PROTEIN
polyphosphate	|I-PROTEIN
5	|I-PROTEIN
-	|I-PROTEIN
phosphatase	|I-PROTEIN
.	|O

The	|O
single	|O
strandedness	|O
is	|O
manifested	|O
as	|O
a	|O
terminal	|O
extension	|O
of	|O
the	|O
G	|O
-	|O
rich	|O
strand	|O
(	|O
G	|O
tails	|O
)	|O
that	|O
can	|O
occur	|O
independently	|O
of	|O
telomerase	|B-PROTEIN
,	|O
suggesting	|O
that	|O
cdc17	|B-PROTEIN
/	|O
pol1	|B-PROTEIN
mutants	|O
exhibit	|O
defects	|O
in	|O
telomeric	|O
lagging	|O
-	|O
strand	|O
synthesis	|O
.	|O

In	|O
addition	|O
,	|O
CaMig1	|B-PROTEIN
formed	|O
specific	|O
complexes	|O
with	|O
the	|O
URS1	|O
region	|O
of	|O
the	|O
S.	|O
cerevisiae	|O
FBP1	|B-PROTEIN
gene	|O
.	|O

Furthermore	|O
,	|O
the	|O
wide	|O
distribution	|O
of	|O
the	|O
GFP	|B-PROTEIN
-	|O
POLO	|B-PROTEIN
protein	|O
to	|O
all	|O
compartments	|O
of	|O
the	|O
mitotic	|O
apparatus	|O
provides	|O
a	|O
valuable	|O
tool	|O
for	|O
future	|O
studies	|O
on	|O
cell	|O
cycle	|O
during	|O
development	|O
.	|O

An	|O
ASIC	|O
-	|O
chip	|O
for	|O
stereoscopic	|O
depth	|O
analysis	|O
in	|O
video	|O
-	|O
real	|O
-	|O
time	|O
based	|O
on	|O
visual	|O
cortical	|O
cell	|O
behavior	|O
.	|O

However	|O
,	|O
calphostin	|O
C	|O
,	|O
a	|O
specific	|O
inhibitor	|O
of	|O
PKC	|B-PROTEIN
,	|O
abolished	|O
the	|O
TPA	|O
-	|O
induced	|O
increase	|O
in	|O
CFI	|B-PROTEIN
mRNA	|O
levels	|O
.	|O

Preimmune	|O
IgG	|B-PROTEIN
,	|O
anti	|B-PROTEIN
-	|I-PROTEIN
GalT	|I-PROTEIN
Fab	|O
fragments	|O
,	|O
irrelevant	|O
polymers	|O
and	|O
monomeric	|O
N	|O
-	|O
acetylglucosamine	|O
had	|O
no	|O
effect	|O
.	|O

Arhythmacanthus	|O
Yamaguti	|O
,	|O
1935	|O
is	|O
maintained	|O
as	|O
a	|O
synonym	|O
of	|O
Heterosentis	|O
because	|O
the	|O
distinction	|O
between	|O
two	|O
and	|O
three	|O
hook	|O
types	|O
is	|O
made	|O
equivocal	|O
when	|O
the	|O
transition	|O
between	|O
the	|O
apical	|O
and	|O
subapical	|O
hooks	|O
is	|O
gradual	|O
.	|O

We	|O
describe	|O
a	|O
case	|O
of	|O
acetaminophen	|O
overdose	|O
that	|O
was	|O
treated	|O
with	|O
both	|O
hemodialysis	|O
(	|O
HD	|O
)	|O
and	|O
NAC	|O
due	|O
to	|O
severe	|O
intoxication	|O
and	|O
slow	|O
drug	|O
clearance	|O
.	|O

Following	|O
conditioning	|O
,	|O
a	|O
single	|O
coat	|O
of	|O
adhesive	|O
was	|O
applied	|O
and	|O
light	|O
-	|O
cured	|O
.	|O

Downstream	|O
of	|O
the	|O
G	|O
-	|O
A	|O
anastomosis	|O
,	|O
the	|O
RD	|O
,	|O
CC	|O
,	|O
E	|O
(	|O
p	|O
)	|O
and	|O
loop	|O
areas	|O
were	|O
significantly	|O
different	|O
from	|O
REF	|O
,	|O
but	|O
significantly	|O
different	|O
from	|O
A	|O
-	|O
A.	|O

Induced	|O
expression	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
myc	|I-PROTEIN
is	|O
likely	|O
to	|O
contribute	|O
to	|O
the	|O
proliferation	|O
of	|O
Stat1	|B-PROTEIN
-	|O
null	|O
cells	|O
in	|O
response	|O
to	|O
IFNs	|B-PROTEIN
.	|O

Eastern	|O
Cooperative	|O
Oncology	|O
Group	|O
trial	|O
E3186	|O
was	|O
initiated	|O
to	|O
explore	|O
this	|O
question	|O
.	|O

We	|O
determined	|O
how	|O
DNA	|O
repair	|O
is	|O
affected	|O
by	|O
TFA1	|B-PROTEIN
conditional	|O
mutations	|O
.	|O

These	|O
articles	|O
both	|O
report	|O
the	|O
results	|O
of	|O
multi	|O
-	|O
institutional	|O
,	|O
randomized	|O
,	|O
phase	|O
3	|O
trials	|O
for	|O
the	|O
treatment	|O
of	|O
patients	|O
with	|O
localized	|O
(	|O
T1	|O
-	|O
3	|O
N0	|O
-	|O
1	|O
M0	|O
)	|O
esophageal	|O
squamous	|O
cell	|O
carcinoma	|O
(	|O
SCC	|O
)	|O
or	|O
esophageal	|O
adenocarcinoma	|O
.	|O

Studies	|O
of	|O
MPO	|B-PROTEIN
gene	|O
regulation	|O
can	|O
help	|O
to	|O
elucidate	|O
the	|O
mechanism	|O
of	|O
normal	|O
and	|O
abnormal	|O
myeloid	|O
differentiation	|O
.	|O

NDRF	|B-PROTEIN
/	|O
NeuroD2	|B-PROTEIN
was	|O
co	|O
-	|O
precipitated	|O
with	|O
PKN	|B-PROTEIN
from	|O
the	|O
lysate	|O
of	|O
COS	|O
-	|O
7	|O
cells	|O
transfected	|O
with	|O
both	|O
expression	|O
constructs	|O
for	|O
NDRF	|B-PROTEIN
/	|O
NeuroD2	|B-PROTEIN
and	|O
PKN	|B-PROTEIN
.	|O

Transient	|O
transfection	|O
assays	|O
using	|O
P19	|O
cells	|O
revealed	|O
that	|O
expression	|O
of	|O
NDRF	|B-PROTEIN
/	|O
NeuroD2	|B-PROTEIN
increased	|O
the	|O
transactivation	|O
of	|O
the	|O
rat	|B-PROTEIN
insulin	|I-PROTEIN
promoter	|I-PROTEIN
element	|I-PROTEIN
3	|I-PROTEIN
(	|O
RIPE3	|B-PROTEIN
)	|O
enhancer	|O
up	|O
to	|O
approximately	|O
12	|O
-	|O
fold	|O
and	|O
that	|O
co	|O
-	|O
expression	|O
of	|O
catalytically	|O
active	|O
form	|O
of	|O
PKN	|B-PROTEIN
,	|O
but	|O
not	|O
kinase	|O
-	|O
deficient	|O
derivative	|O
,	|O
resulted	|O
in	|O
a	|O
further	|O
threefold	|O
increase	|O
of	|O
NDRF	|B-PROTEIN
/	|O
NeuroD2	|B-PROTEIN
-	|O
mediated	|O
transcription	|O
.	|O

Two	|O
Pax2/5	|B-PROTEIN
/	|I-PROTEIN
8	|I-PROTEIN
-	|O
binding	|O
sites	|O
in	|O
Engrailed2	|B-PROTEIN
are	|O
required	|O
for	|O
proper	|O
initiation	|O
of	|O
endogenous	|O
mid	|O
-	|O
hindbrain	|O
expression	|O
.	|O

Upon	|O
tyrosine	|O
phosphorylation	|O
at	|O
the	|O
ITIMs	|O
,	|O
these	|O
molecules	|O
recruit	|O
SH2	|B-PROTEIN
domain	|O
-	|O
containing	|O
phosphatases	|O
such	|O
as	|O
SH2	|B-PROTEIN
-	|O
containing	|O
tyrosine	|B-PROTEIN
phosphatase	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
negatively	|O
regulate	|O
cell	|O
activity	|O
.	|O

AF154055	|B-PROTEIN
.	|O

Alignment	|O
of	|O
the	|O
cervical	|O
spine	|O
,	|O
vertebral	|O
abnormalities	|O
,	|O
and	|O
disc	|O
changes	|O
also	|O
were	|O
evaluated	|O
.	|O

The	|O
concomitant	|O
interaction	|O
of	|O
mSTI1	|B-PROTEIN
with	|O
hsp70	|B-PROTEIN
and	|O
hsp90	|B-PROTEIN
at	|O
its	|O
N	|O
-	|O
and	|O
C	|O
-	|O
termini	|O
respectively	|O
is	|O
mediated	|O
by	|O
the	|O
tetratricopeptide	|O
repeat	|O
(	|O
TPR	|O
)	|O
motifs	|O
in	|O
these	|O
regions	|O
.	|O

Competition	|O
experiments	|O
demonstrate	|O
a	|O
negative	|O
allosteric	|O
relationship	|O
between	|O
these	|O
RGD	|O
recognition	|O
sites	|O
.	|O

Sequence	|O
analysis	|O
showed	|O
that	|O
the	|O
5'	|O
-	|O
flanking	|O
region	|O
upstream	|O
to	|O
the	|O
ATG	|O
codon	|O
did	|O
not	|O
contain	|O
a	|O
conventional	|O
TATA	|O
box	|O
.	|O

After	|O
i.v	|O
.	|O
administration	|O
of	|O
500	|O
mg	|O
acetazolamide	|O
and	|O
disinfection	|O
of	|O
the	|O
conjunctiva	|O
,	|O
50	|O
micrograms	|O
rt	|B-PROTEIN
-	|I-PROTEIN
PA	|I-PROTEIN
in	|O
0.1	|O
ml	|O
(	|O
BSS	|O
)	|O
and	|O
0.5	|O
ml	|O
SF6	|O
were	|O
injected	|O
intravitreally	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
VP1	|B-PROTEIN
was	|O
efficiently	|O
transported	|O
to	|O
the	|O
nucleus	|O
and	|O
localized	|O
in	|O
the	|O
discrete	|O
subnuclear	|O
regions	|O
,	|O
possibly	|O
with	|O
VP2	|B-PROTEIN
and	|O
VP3	|B-PROTEIN
.	|O

Differential	|O
expression	|O
and	|O
regulation	|O
by	|O
20	|O
-	|O
hydroxyecdysone	|O
of	|O
mosquito	|O
ultraspiracle	|O
isoforms	|O
.	|O

The	|O
three	|O
isoforms	|O
purified	|O
with	|O
anti	|B-PROTEIN
-	|I-PROTEIN
FLAG	|I-PROTEIN
antibody	|O
affinity	|O
column	|O
transferred	|O
sulfate	|O
to	|O
heparan	|O
sulfate	|O
and	|O
heparin	|O
but	|O
not	|O
to	|O
other	|O
glycosaminoglycans	|O
.	|O

The	|O
differentiation	|O
and	|O
maintenance	|O
of	|O
a	|O
neurotransmitter	|O
phenotype	|O
is	|O
guided	|O
by	|O
the	|O
interaction	|O
of	|O
exogenous	|O
cues	|O
with	|O
intrinsic	|O
genetic	|O
machinery	|O
.	|O

Analysis	|O
of	|O
functional	|O
domains	|O
of	|O
Arix	|B-PROTEIN
reveals	|O
an	|O
N	|O
-	|O
terminal	|O
activation	|O
domain	|O
and	|O
a	|O
C	|O
-	|O
terminal	|O
repression	|O
domain	|O
.	|O

BACKGROUND	|O
:	|O
Left	|O
ventricular	|O
hypertrophy	|O
is	|O
a	|O
heterogeneous	|O
disorder	|O
with	|O
distinct	|O
morphologies	|O
.	|O

Multivariate	|O
predictors	|O
were	|O
concentric	|O
remodeling	|O
(	|O
P	|O
<	|O
0.0001	|O
;	|O
odds	|O
ratio	|O
,	|O
13.5	|O
)	|O
,	|O
left	|O
ventricular	|O
ejection	|O
fraction	|O
>	|O
2	|O
SD	|O
above	|O
normal	|O
(	|O
P	|O
<	|O
0.0001	|O
)	|O
,	|O
and	|O
single	|O
-	|O
vessel	|O
left	|O
circumflex	|O
disease	|O
(	|O
P	|O
<	|O
0.0007	|O
;	|O
odds	|O
ratio	|O
,	|O
7.6	|O
)	|O
.	|O

The	|O
case	|O
for	|O
completing	|O
the	|O
lymphadenectomy	|O
when	|O
positive	|O
lymph	|O
nodes	|O
are	|O
found	|O
during	|O
radical	|O
hysterectomy	|O
for	|O
cervical	|O
carcinoma	|O
.	|O

Overexpression	|O
of	|O
ICBP90	|B-PROTEIN
in	|O
COS	|O
-	|O
1	|O
-	|O
transfected	|O
cells	|O
induced	|O
an	|O
enhanced	|O
expression	|O
of	|O
endogenous	|O
topoisomerase	|B-PROTEIN
IIalpha	|I-PROTEIN
.	|O

The	|O
RNA	|O
aptamer	|O
contains	|O
three	|O
stems	|O
separated	|O
by	|O
a	|O
pair	|O
of	|O
two	|O
-	|O
base	|O
bulges	|O
,	|O
and	|O
adopts	|O
an	|O
unanticipated	|O
fold	|O
in	|O
which	|O
both	|O
junctional	|O
sites	|O
are	|O
anchored	|O
through	|O
base	|O
triple	|O
formation	|O
.	|O

The	|O
study	|O
suggests	|O
the	|O
presence	|O
of	|O
an	|O
anatomical	|O
sphincter	|O
at	|O
the	|O
RSJ	|O
which	|O
seems	|O
to	|O
regulate	|O
the	|O
passage	|O
of	|O
stools	|O
from	|O
the	|O
sigmoid	|O
colon	|O
to	|O
the	|O
rectum	|O
.	|O

Isolation	|O
of	|O
cDNAs	|O
encoding	|O
gibbon	|O
and	|O
monkey	|O
platelet	|B-PROTEIN
and	|I-PROTEIN
T	|I-PROTEIN
cell	|I-PROTEIN
activation	|I-PROTEIN
antigen	|I-PROTEIN
1	|I-PROTEIN
(	|O
PTA1	|O
)	|O
.	|O

To	|O
quantify	|O
any	|O
mechanical	|O
inhibitory	|O
effect	|O
of	|O
nasal	|O
intermittent	|O
positive	|O
pressure	|O
ventilation	|O
(	|O
IPPV	|O
)	|O
on	|O
inspiratory	|O
activity	|O
of	|O
the	|O
diaphragm	|O
we	|O
ventilated	|O
five	|O
conscious	|O
relaxed	|O
subjects	|O
on	|O
two	|O
occasions	|O
at	|O
respiratory	|O
rates	|O
similar	|O
to	|O
quiet	|O
breathing	|O
(	|O
QB	|O
)	|O
and	|O
at	|O
three	|O
levels	|O
of	|O
applied	|O
pressure	|O
(	|O
Pappl	|O
)	|O
-	|O
-	|O
6	|O
,	|O
9	|O
and	|O
12	|O
cmH2O	|O
,	|O
each	|O
during	|O
hypocapnia	|O
(	|O
P	|O
(	|O
CO2	|O
)	|O
allowed	|O
to	|O
decrease	|O
)	|O
and	|O
eucapnia	|O
(	|O
CO2	|O
added	|O
to	|O
inspired	|O
gas	|O
)	|O
.	|O

METHODS	|O
:	|O
Von	|B-PROTEIN
Willebrand	|I-PROTEIN
factor	|I-PROTEIN
(	|O
vWF	|B-PROTEIN
)	|O
and	|O
the	|O
fibrinolytic	|O
factors	|O
tissue	|B-PROTEIN
plasminogen	|I-PROTEIN
activator	|I-PROTEIN
(	|O
tPA	|B-PROTEIN
)	|O
,	|O
measured	|O
as	|O
tPA	|B-PROTEIN
capacity	|O
,	|O
and	|O
plasminogen	|B-PROTEIN
activator	|I-PROTEIN
inhibitor	|I-PROTEIN
1	|I-PROTEIN
(	|O
PAI	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
,	|O
platelets	|O
,	|O
fibrinogen	|B-PROTEIN
,	|O
and	|O
inflammatory	|O
markers	|O
were	|O
measured	|O
in	|O
74	|O
patients	|O
with	|O
active	|O
seropositive	|O
RA	|O
.	|O

Neuronal	|O
signaling	|O
properties	|O
are	|O
largely	|O
determined	|O
by	|O
the	|O
quantity	|O
and	|O
combination	|O
of	|O
ion	|O
channels	|O
expressed	|O
.	|O

Treatment	|O
also	|O
led	|O
to	|O
a	|O
significant	|O
dose	|O
dependent	|O
reduction	|O
in	|O
the	|O
sum	|O
of	|O
ST	|O
segment	|O
depression	|O
at	|O
both	|O
trough	|O
and	|O
peak	|O
concentrations	|O
.	|O

We	|O
have	|O
investigated	|O
the	|O
contribution	|O
of	|O
specific	|O
TATA	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
(	|O
TBP	|B-PROTEIN
)	|O
-	|O
TATA	|O
interactions	|O
to	|O
the	|O
promoter	|O
activity	|O
of	|O
a	|O
constitutively	|O
expressed	|O
silkworm	|O
tRNA	|B-PROTEIN
(	|I-PROTEIN
C	|I-PROTEIN
)	|I-PROTEIN
(	|I-PROTEIN
Ala	|I-PROTEIN
)	|I-PROTEIN
gene	|O
and	|O
have	|O
also	|O
asked	|O
whether	|O
the	|O
lack	|O
of	|O
similar	|O
interactions	|O
accounts	|O
for	|O
the	|O
low	|O
promoter	|O
activity	|O
of	|O
a	|O
silk	|O
gland	|O
-	|O
specific	|O
tRNA	|B-PROTEIN
(	|I-PROTEIN
SG	|I-PROTEIN
)	|I-PROTEIN
(	|I-PROTEIN
Ala	|I-PROTEIN
)	|I-PROTEIN
gene	|O
.	|O

The	|O
sequences	|O
showed	|O
extensive	|O
homologies	|O
with	|O
squalene	|B-PROTEIN
synthase	|I-PROTEIN
genes	|O
and	|O
enzymes	|O
from	|O
a	|O
number	|O
of	|O
other	|O
organisms	|O
and	|O
extreme	|O
amino	|O
acid	|O
conservation	|O
within	|O
the	|O
binding	|O
and	|O
catalytic	|O
domains	|O
.	|O

All	|O
clones	|O
and	|O
strains	|O
produced	|O
have	|O
been	|O
deposited	|O
in	|O
the	|O
EUROFAN	|O
genetic	|O
stock	|O
centre	|O
(	|O
EUROSCARF	|O
,	|O
Frankfurt	|O
)	|O
.	|O

Two	|O
episodes	|O
of	|O
peritonitis	|O
occurred	|O
while	|O
the	|O
patient	|O
received	|O
CAPD	|O
(	|O
1	|O
episode	|O
/	|O
3.5	|O
patient	|O
-	|O
months	|O
)	|O
.	|O

Copyright	|O
2000	|O
The	|O
Royal	|O
College	|O
of	|O
Radiologists	|O
.	|O

Two	|O
estrogen	|B-PROTEIN
receptor	|I-PROTEIN
(	|O
ER	|B-PROTEIN
)	|O
isoforms	|O
with	|O
different	|O
estrogen	|O
dependencies	|O
are	|O
generated	|O
from	|O
the	|O
trout	|O
ER	|B-PROTEIN
gene	|O
.	|O

Induction	|O
was	|O
reversed	|O
by	|O
coexpression	|O
of	|O
A	|B-PROTEIN
-	|I-PROTEIN
Fos	|I-PROTEIN
,	|O
a	|O
dominant	|O
negative	|O
to	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

In	|O
myometrial	|O
SMC	|O
,	|O
both	|O
isoforms	|O
of	|O
the	|O
progesterone	|B-PROTEIN
receptor	|I-PROTEIN
,	|O
PR	|B-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
and	|O
PR	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
,	|O
caused	|O
a	|O
ligand	|O
-	|O
dependent	|O
activation	|O
of	|O
PGDH	|B-PROTEIN
-	|I-PROTEIN
2368	|I-PROTEIN
/	|O
luc3	|B-PROTEIN
.	|O

Element	|O
B	|O
(	|O
-	|O
249	|O
/	|O
-	|O
229	|O
)	|O
shows	|O
more	|O
than	|O
80%	|O
homology	|O
to	|O
a	|O
consensus	|O
c	|B-PROTEIN
-	|I-PROTEIN
myb	|I-PROTEIN
element	|O
,	|O
but	|O
formed	|O
two	|O
specific	|O
complexes	|O
that	|O
differed	|O
from	|O
that	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
myb	|I-PROTEIN
in	|O
the	|O
electrophoretic	|O
mobility	|O
shift	|O
assay	|O
.	|O

High	|O
resolution	|O
computed	|O
tomography	|O
of	|O
the	|O
lungs	|O
in	|O
patients	|O
with	|O
rheumatoid	|O
arthritis	|O
.	|O

Stable	|O
transfection	|O
of	|O
the	|O
truncated	|O
reduced	|B-PROTEIN
folate	|I-PROTEIN
carrier	|I-PROTEIN
cDNA	|O
into	|O
mouse	|O
L1210	|O
leukemia	|O
cells	|O
:	|O
increased	|O
folate	|O
accumulation	|O
,	|O
decreased	|O
their	|O
leucovorin	|O
and	|O
folic	|O
acid	|O
growth	|O
requirements	|O
,	|O
and	|O
increased	|O
their	|O
sensitivity	|O
to	|O
methotrexate	|O
.	|O

Characterization	|O
of	|O
a	|O
human	|O
alternatively	|O
spliced	|O
truncated	|O
reduced	|B-PROTEIN
folate	|I-PROTEIN
carrier	|I-PROTEIN
increasing	|O
folate	|O
accumulation	|O
in	|O
parental	|O
leukemia	|O
cells	|O
.	|O

Electron	|O
microscopic	|O
and	|O
enzymatic	|O
analyses	|O
revealed	|O
that	|O
the	|O
A118	|O
genome	|O
is	|O
a	|O
linear	|O
,	|O
circularly	|O
permuted	|O
,	|O
terminally	|O
redundant	|O
collection	|O
of	|O
double	|O
-	|O
stranded	|O
DNA	|O
molecules	|O
.	|O

Moreover	|O
,	|O
increasing	|O
the	|O
dosage	|O
of	|O
wild	|O
-	|O
type	|O
Fus3	|B-PROTEIN
intensifies	|O
the	|O
inhibition	|O
of	|O
both	|O
Ty1	|B-PROTEIN
transposition	|O
and	|O
invasive	|O
growth	|O
.	|O

Consistently	|O
,	|O
activation	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
N	|O
-	|O
terminal	|O
kinase	|O
downstream	|O
of	|O
Rho	|B-PROTEIN
family	|O
GTP	|O
-	|O
binding	|O
proteins	|O
was	|O
also	|O
enhanced	|O
when	|O
Dbl	|B-PROTEIN
was	|O
tyrosine	|O
-	|O
phosphorylated	|O
.	|O

However	|O
,	|O
its	|O
participation	|O
in	|O
collagen	|B-PROTEIN
binding	|O
has	|O
not	|O
been	|O
shown	|O
.	|O

Together	|O
,	|O
these	|O
data	|O
suggest	|O
that	|O
the	|O
carboxyl	|O
terminus	|O
of	|O
CFTR	|B-PROTEIN
contains	|O
a	|O
tyrosine	|O
-	|O
based	|O
internalization	|O
signal	|O
that	|O
interacts	|O
with	|O
the	|O
endocytic	|O
adaptor	|O
complex	|O
AP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
to	|O
facilitate	|O
efficient	|O
entry	|O
of	|O
CFTR	|B-PROTEIN
into	|O
clathrin	|B-PROTEIN
-	|O
coated	|O
vesicles	|O
.	|O

The	|O
insulin	|B-PROTEIN
therapy	|O
regimen	|O
did	|O
not	|O
affect	|O
the	|O
evolution	|O
of	|O
the	|O
patients	|O
and	|O
no	|O
significant	|O
relationship	|O
existed	|O
between	|O
the	|O
age	|O
at	|O
diagnosis	|O
,	|O
duration	|O
of	|O
diabetes	|O
,	|O
daily	|O
insulin	|B-PROTEIN
dosage	|O
or	|O
metabolic	|O
control	|O
and	|O
height	|O
or	|O
BMI	|O
.	|O

Scmh1	|B-PROTEIN
maps	|O
to	|O
4D1	|O
-	|O
D2.1	|O
in	|O
mice	|O
.	|O

The	|O
applicability	|O
of	|O
laparoscopic	|O
donor	|O
nephrectomy	|O
(	|O
LDN	|O
)	|O
has	|O
not	|O
been	|O
assessed	|O
in	|O
the	|O
obese	|O
donor	|O
.	|O

Hyaluronan	|O
treatment	|O
stimulated	|O
collagen	|B-PROTEIN
remodeling	|O
in	|O
the	|O
peripheral	|O
region	|O
and	|O
inhibited	|O
swelling	|O
of	|O
the	|O
meniscus	|O
repaired	|O
in	|O
the	|O
inner	|O
region	|O
.	|O

We	|O
have	|O
addressed	|O
these	|O
issues	|O
by	|O
reconstituting	|O
and	|O
characterizing	|O
the	|O
KRAB	|B-PROTEIN
:	|O
KAP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|O
RBCC	|B-PROTEIN
interaction	|O
using	|O
purified	|O
components	|O
.	|O

The	|O
RING	|O
finger	|O
,	|O
B2	|O
box	|O
,	|O
and	|O
coiled	|O
-	|O
coil	|O
region	|O
are	|O
required	|O
for	|O
oligomerization	|O
of	|O
KAP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|O
RBCC	|B-PROTEIN
and	|O
KRAB	|B-PROTEIN
binding	|O
,	|O
as	|O
mutations	|O
in	|O
these	|O
domains	|O
concomitantly	|O
abolished	|O
these	|O
functions	|O
.	|O

Actins	|B-PROTEIN
show	|O
two	|O
different	|O
forms	|O
of	|O
N	|O
-	|O
terminal	|O
processing	|O
dependent	|O
on	|O
their	|O
N	|O
-	|O
terminal	|O
sequence	|O
.	|O

All	|O
four	|O
domains	|O
were	|O
linked	|O
via	|O
proline	|O
-	|O
threonine	|O
-	|O
rich	|O
peptides	|O
.	|O

JPEG	|O
53	|O
,	|O
resulting	|O
in	|O
a	|O
compression	|O
ratio	|O
of	|O
1	|O
:	|O
21	|O
,	|O
does	|O
not	|O
compromise	|O
the	|O
diagnostic	|O
performance	|O
in	|O
general	|O
.	|O

We	|O
critically	|O
assess	|O
current	|O
systematic	|O
uncertainties	|O
and	|O
determine	|O
the	|O
primordial	|O
Li	|O
abundance	|O
within	|O
new	|O
,	|O
much	|O
tighter	|O
limits	|O
:	|O
&	|O
amp	|O
;	|O
parl0	|O
;	|O
Li	|O
&	|O
amp	|O
;	|O
solm0	|O
;	|O
H	|O
&	|O
amp	|O
;	|O
parr0	|O
;	|O
p	|O
=	|O
1.23	|O
+	|O
0.68-0.32	|O
x10	|O
-	|O
10	|O
.	|O

Like	|O
their	|O
yeast	|O
counterpart	|O
,	|O
the	|O
mouse	|O
GCN2	|B-PROTEIN
isoforms	|O
contain	|O
HisRS	|B-PROTEIN
-	|O
related	|O
sequences	|O
juxtaposed	|O
to	|O
the	|O
kinase	|O
catalytic	|O
domain	|O
.	|O

Five	|O
women	|O
(	|O
15.6%	|O
)	|O
met	|O
criteria	|O
for	|O
PMS	|O
.	|O

MBI	|O
and	|O
MMBI	|O
showed	|O
similar	|O
Cmax	|O
values	|O
,	|O
but	|O
the	|O
former	|O
disappeared	|O
slower	|O
in	|O
the	|O
serum	|O
than	|O
the	|O
latter	|O
and	|O
resulted	|O
in	|O
its	|O
larger	|O
AUC	|O
values	|O
.	|O

Another	|O
long	|O
insertion	|O
in	|O
the	|O
cathepsin	|B-PROTEIN
X	|I-PROTEIN
amino	|O
acid	|O
sequence	|O
forms	|O
a	|O
beta	|O
-	|O
hairpin	|O
pointing	|O
away	|O
from	|O
the	|O
active	|O
site	|O
.	|O

Transfection	|O
experiments	|O
demonstrated	|O
that	|O
the	|O
5'	|O
-	|O
flanking	|O
region	|O
(	|O
-	|O
1894	|O
to	|O
+	|O
37	|O
)	|O
of	|O
the	|O
mStaf	|B-PROTEIN
gene	|O
drives	|O
transcription	|O
in	|O
mouse	|O
NMuMG	|O
cells	|O
and	|O
that	|O
a	|O
construct	|O
containing	|O
a	|O
fragment	|O
from	|O
-	|O
387	|O
to	|O
+	|O
37	|O
showed	|O
the	|O
highest	|O
transcriptional	|O
activity	|O
.	|O

Further	|O
studies	|O
in	|O
T	|O
-	|O
24	|O
cells	|O
demonstrated	|O
that	|O
HA	|O
fragments	|O
also	|O
induced	|O
I	|B-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
alpha	|I-PROTEIN
phosphorylation	|O
and	|O
degradation	|O
,	|O
kappa	|B-PROTEIN
B	|I-PROTEIN
-	|O
linked	|O
reporter	|O
gene	|O
expression	|O
,	|O
and	|O
ICAM	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
promoter	|O
activity	|O
in	|O
an	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
-	|O
dependent	|O
manner	|O
.	|O

Pretreatment	|O
of	|O
cells	|O
or	|O
mouse	|O
skin	|O
with	|O
antisense	|O
oligonucleotides	|O
of	|O
PKCzeta	|B-PROTEIN
impaired	|O
UV	|O
-	|O
induced	|O
activation	|O
of	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
in	|O
JB6	|O
cells	|O
as	|O
well	|O
as	|O
in	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|O
luciferase	|B-PROTEIN
transgenic	|O
mice	|O
.	|O

The	|O
level	|O
of	|O
subclinical	|O
infection	|O
was	|O
75%	|O
among	|O
seropositive	|O
dogs	|O
.	|O

METHODS	|O
:	|O
The	|O
former	|O
group	|O
included	|O
patients	|O
who	|O
had	|O
been	|O
treated	|O
with	|O
at	|O
least	|O
four	|O
PGE1	|O
alpha	|O
-	|O
ciclodestrina	|O
,	|O
short	|O
-	|O
term	|O
treatment	|O
cycles	|O
per	|O
year	|O
while	|O
the	|O
latter	|O
was	|O
a	|O
historical	|O
reference	|O
group	|O
managed	|O
without	|O
prostaglandins	|O
.	|O

Desmethylferrochloroquine	|O
1a	|O
and	|O
didesmethylferrochloroquine	|O
2	|O
would	|O
be	|O
more	|O
potent	|O
against	|O
schizontocides	|O
than	|O
CQ	|O
in	|O
vitro	|O
against	|O
two	|O
strains	|O
(	|O
HB3	|O
and	|O
Dd2	|O
)	|O
of	|O
Plasmodium	|O
falciparum	|O
.	|O

The	|O
rrd1	|B-PROTEIN
,	|I-PROTEIN
2delta	|I-PROTEIN
mutant	|O
was	|O
partially	|O
rescued	|O
by	|O
inactivation	|O
of	|O
HOG1	|B-PROTEIN
or	|O
PBS2	|B-PROTEIN
,	|O
suggesting	|O
an	|O
interaction	|O
between	|O
the	|O
RRD	|B-PROTEIN
genes	|O
and	|O
the	|O
Hog1p	|B-PROTEIN
signal	|O
transduction	|O
pathway	|O
.	|O

Members	|O
of	|O
the	|O
JAK	|B-PROTEIN
/	|O
Tyk	|B-PROTEIN
family	|O
of	|O
tyrosine	|B-PROTEIN
kinases	|I-PROTEIN
mediate	|O
phosphorylation	|O
of	|O
STAT3	|B-PROTEIN
at	|O
Tyr705	|O
during	|O
CNTF	|B-PROTEIN
signaling	|O
;	|O
however	|O
,	|O
the	|O
kinase	|O
responsible	|O
for	|O
phosphorylation	|O
at	|O
STAT3	|B-PROTEIN
Tyr727	|O
appears	|O
to	|O
depend	|O
on	|O
both	|O
the	|O
extracellular	|O
stimulus	|O
and	|O
the	|O
cellular	|O
context	|O
.	|O

In	|O
vivo	|O
,	|O
CARbeta	|B-PROTEIN
/	|O
RXRalpha	|B-PROTEIN
activated	|O
transcription	|O
from	|O
an	|O
HD	|B-PROTEIN
-	|O
PPRE	|O
luciferase	|B-PROTEIN
reporter	|O
construct	|O
.	|O

Zebrafish	|O
cyclops	|B-PROTEIN
(	|O
cyc	|B-PROTEIN
)	|O
encodes	|O
a	|O
Transforming	|B-PROTEIN
Growth	|I-PROTEIN
Factor	|I-PROTEIN
beta	|I-PROTEIN
(	|O
TGFbeta	|B-PROTEIN
)	|O
signaling	|O
factor	|O
closely	|O
related	|O
to	|O
mouse	|O
Nodal	|B-PROTEIN
.	|O

Thus	|O
,	|O
SOX8	|B-PROTEIN
is	|O
a	|O
good	|O
candidate	|O
gene	|O
contributing	|O
to	|O
the	|O
mental	|O
retardation	|O
phenotype	|O
seen	|O
in	|O
ATR	|O
-	|O
16	|O
patients	|O
.	|O

The	|O
genome	|O
organization	|O
of	|O
the	|O
mite	|O
-	|O
transmitted	|O
wheat	|O
streak	|O
mosaic	|O
virus	|O
(	|O
WSMV	|O
)	|O
appears	|O
to	|O
parallel	|O
that	|O
of	|O
members	|O
of	|O
the	|O
Potyviridae	|O
with	|O
monopartite	|O
genomes	|O
,	|O
but	|O
there	|O
are	|O
substantial	|O
amino	|O
acid	|O
dissimilarities	|O
with	|O
other	|O
potyviral	|O
polyproteins	|O
.	|O

The	|O
two	|O
-	|O
hybrid	|O
assay	|O
was	|O
then	|O
performed	|O
using	|O
full	|O
-	|O
length	|O
genes	|O
of	|O
CI	|B-PROTEIN
,	|O
HC	|B-PROTEIN
-	|I-PROTEIN
Pro	|I-PROTEIN
,	|O
P1	|B-PROTEIN
,	|O
P3	|B-PROTEIN
,	|O
and	|O
CP	|B-PROTEIN
,	|O
but	|O
no	|O
heterologous	|O
interactions	|O
were	|O
detected	|O
.	|O

Diverse	|O
endogenous	|O
light	|O
chains	|O
contribute	|O
to	|O
basement	|O
membrane	|O
reactivity	|O
in	|O
nonautoimmune	|O
mice	|O
transgenic	|O
for	|O
an	|O
anti	|B-PROTEIN
-	|I-PROTEIN
laminin	|I-PROTEIN
Ig	|O
heavy	|O
chain	|O
.	|O

Patch	|O
test	|O
results	|O
obtained	|O
with	|O
corticosteroid	|O
allergic	|O
patients	|O
tested	|O
with	|O
a	|O
large	|O
corticosteroid	|O
series	|O
validated	|O
the	|O
earlier	|O
classification	|O
of	|O
corticosteroid	|O
molecules	|O
in	|O
four	|O
groups	|O
of	|O
cross	|O
-	|O
reacting	|O
molecules	|O
:	|O
i.e.	|O
,	|O
group	|O
A	|O
(	|O
hydrocortisone	|O
type	|O
)	|O
,	|O
group	|O
B	|O
(	|O
acetonides	|O
)	|O
,	|O
group	|O
C	|O
(	|O
betamethasone	|O
type	|O
-	|O
non	|O
esterified	|O
)	|O
and	|O
group	|O
D	|O
(	|O
esters	|O
)	|O
.	|O

Mechanisms	|O
of	|O
tachyphylaxis	|O
in	|O
regional	|O
anesthesia	|O
of	|O
long	|O
duration	|O

An	|O
increase	|O
in	|O
the	|O
level	|O
of	|O
serum	|O
enzymes	|O
,	|O
such	|O
as	|O
aspartate	|B-PROTEIN
transaminase	|I-PROTEIN
,	|O
alkaline	|B-PROTEIN
phosphatase	|I-PROTEIN
,	|O
creatine	|B-PROTEIN
phosphokinase	|I-PROTEIN
,	|O
lactate	|B-PROTEIN
dehydrogenase	|I-PROTEIN
after	|O
D.	|O
russelli	|O
venom	|O
injection	|O
in	|O
albino	|O
rats	|O
is	|O
indicative	|O
of	|O
cell	|O
or	|O
tissue	|O
damage	|O
.	|O

The	|O
partial	|O
farm	|O
budget	|O
highlighted	|O
the	|O
importance	|O
of	|O
reducing	|O
sub	|O
-	|O
clinical	|O
lesions	|O
in	|O
a	|O
feedlot	|O
.	|O

Surprisingly	|O
,	|O
3	|O
full	|O
-	|O
length	|O
murine	|O
survivin	|B-PROTEIN
cDNA	|O
clones	|O
were	|O
isolated	|O
,	|O
predicting	|O
the	|O
existence	|O
of	|O
3	|O
distinct	|O
survivin	|B-PROTEIN
proteins	|O
.	|O

Thus	|O
,	|O
the	|O
induction	|O
of	|O
E2F	|B-PROTEIN
binding	|O
to	|O
the	|O
E2F	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
promoter	|O
by	|O
the	|O
E4	|B-PROTEIN
-	|I-PROTEIN
6/7	|I-PROTEIN
protein	|O
observed	|O
in	|O
vitro	|O
correlates	|O
with	|O
transactivation	|O
of	|O
E2F	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
promoter	|O
activity	|O
in	|O
vivo	|O
.	|O

We	|O
show	|O
that	|O
stabilization	|O
of	|O
the	|O
hairpin	|O
reduced	|O
the	|O
amount	|O
of	|O
tRNA	|O
primer	|O
that	|O
is	|O
annealed	|O
to	|O
the	|O
PBS	|O
.	|O

Ischemia	|O
-	|O
induced	|O
biphasic	|O
arrhythmias	|O
were	|O
suppressed	|O
in	|O
both	|O
zatebradine	|O
and	|O
propranolol	|O
groups	|O
.	|O

ZK7	|B-PROTEIN
and	|O
HZF16	|B-PROTEIN
genes	|O
appear	|O
to	|O
be	|O
the	|O
splice	|O
variants	|O
transcribed	|O
from	|O
the	|O
same	|O
gene	|O
.	|O

CONCLUSION	|O
:	|O
Presence	|O
of	|O
APOE	|B-PROTEIN
epsilon4	|O
/	|O
*	|O
seems	|O
to	|O
increase	|O
the	|O
risk	|O
for	|O
dementia	|O
and	|O
AD	|O
independently	|O
of	|O
its	|O
effect	|O
on	|O
dyslipidemia	|O
and	|O
atherogenesis	|O
.	|O

No	|O
definite	|O
conclusions	|O
are	|O
possible	|O
because	|O
of	|O
the	|O
small	|O
number	|O
of	|O
patients	|O
involved	|O
in	|O
this	|O
phase	|O
II	|O
trial	|O
.	|O

Two	|O
distinct	|O
Salmonella	|O
fimbrins	|B-PROTEIN
,	|O
AgfA	|B-PROTEIN
and	|O
SefA	|B-PROTEIN
,	|O
comprising	|O
thin	|O
aggregative	|O
fimbriae	|O
SEF17	|B-PROTEIN
and	|O
SEF14	|B-PROTEIN
,	|O
respectively	|O
,	|O
were	|O
each	|O
genetically	|O
engineered	|O
to	|O
carry	|O
PT3	|B-PROTEIN
,	|O
an	|O
alpha	|O
-	|O
helical	|O
16	|O
-	|O
amino	|O
acid	|O
Leishmania	|O
T	|O
-	|O
cell	|O
epitope	|O
derived	|O
from	|O
the	|O
metalloprotease	|B-PROTEIN
gp63	|O
.	|O

In	|O
marked	|O
contrast	|O
to	|O
AgfA	|B-PROTEIN
,	|O
none	|O
of	|O
the	|O
chimeric	|O
SefA	|B-PROTEIN
proteins	|O
were	|O
expressed	|O
or	|O
assembled	|O
into	|O
fimbriae	|O
.	|O

Productive	|O
growth	|O
of	|O
phage	|O
P22	|O
in	|O
wild	|O
-	|O
type	|O
Salmonella	|O
typhimurium	|O
correlates	|O
with	|O
the	|O
presence	|O
of	|O
Abc2	|B-PROTEIN
,	|O
but	|O
is	|O
independent	|O
of	|O
the	|O
absolute	|O
level	|O
of	|O
ATP	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
nuclease	|I-PROTEIN
activity	|O
,	|O
suggesting	|O
a	|O
qualitative	|O
change	|O
in	|O
the	|O
nature	|O
of	|O
Abc2	|B-PROTEIN
-	|O
modified	|O
RecBCD	|B-PROTEIN
nuclease	|I-PROTEIN
activity	|O
relative	|O
to	|O
the	|O
native	|O
enzyme	|O
.	|O

In	|O
this	|O
study	|O
,	|O
we	|O
investigated	|O
the	|O
molecular	|O
mechanisms	|O
underlying	|O
the	|O
inducible	|O
expression	|O
of	|O
the	|O
flt	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
gene	|O
during	|O
the	|O
activation	|O
of	|O
THP	|O
-	|O
1	|O
cells	|O
.	|O

There	|O
was	|O
a	|O
2.4	|O
-	|O
fold	|O
difference	|O
in	|O
CAT	|B-PROTEIN
produced	|O
from	|O
these	|O
transcripts	|O
in	|O
HeLa	|O
cells	|O
,	|O
which	|O
contain	|O
a	|O
greater	|O
natural	|O
abundance	|O
of	|O
PTB	|B-PROTEIN
.	|O

Multiple	|O
mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
signaling	|O
pathways	|O
connect	|O
the	|O
cot	|B-PROTEIN
oncoprotein	|O
to	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
jun	|I-PROTEIN
promoter	|O
and	|O
to	|O
cellular	|O
transformation	|O
.	|O

Dermatology	|O
is	|O
no	|O
exception	|O
.	|O

4	|O
.	|O

In	|O
the	|O
present	|O
study	|O
we	|O
have	|O
investigated	|O
the	|O
regulatory	|O
mechanism	|O
for	|O
CD95L	|B-PROTEIN
expression	|O
.	|O

Protein	|O
sequence	|O
analysis	|O
reveals	|O
that	|O
MAN1	|B-PROTEIN
shares	|O
a	|O
conserved	|O
globular	|O
domain	|O
of	|O
approximately	|O
40	|O
amino	|O
acids	|O
,	|O
which	|O
we	|O
term	|O
the	|O
LEM	|B-PROTEIN
module	|O
,	|O
with	|O
inner	|O
nuclear	|O
membrane	|O
proteins	|O
lamina	|B-PROTEIN
-	|I-PROTEIN
associated	|I-PROTEIN
polypeptide	|I-PROTEIN
2	|I-PROTEIN
and	|O
emerin	|B-PROTEIN
.	|O

Molecular	|O
cloning	|O
of	|O
a	|O
novel	|O
human	|O
I	|B-PROTEIN
-	|I-PROTEIN
mfa	|I-PROTEIN
domain	|O
-	|O
containing	|O
protein	|O
that	|O
differently	|O
regulates	|O
human	|O
T	|O
-	|O
cell	|O
leukemia	|O
virus	|O
type	|O
I	|O
and	|O
HIV	|O
-	|O
1	|O
expression	|O
.	|O

The	|O
encoded	|O
amino	|O
acid	|O
sequences	|O
in	|O
the	|O
full	|O
-	|O
length	|O
bovine	|O
and	|O
porcine	|O
cDNAs	|O
were	|O
identical	|O
,	|O
consisting	|O
of	|O
209	|O
amino	|O
acid	|O
residues	|O
,	|O
and	|O
were	|O
nearly	|O
the	|O
same	|O
as	|O
the	|O
published	|O
sequence	|O
determined	|O
by	|O
Edman	|O
degradation	|O
.	|O

With	|O
chemical	|O
shift	|O
imaging	|O
,	|O
the	|O
signal	|O
intensity	|O
decreased	|O
on	|O
the	|O
out	|O
-	|O
of	|O
-	|O
phase	|O
images	|O
in	|O
six	|O
of	|O
seven	|O
(	|O
86%	|O
)	|O
patients	|O
with	|O
APA	|O
and	|O
in	|O
eight	|O
of	|O
nine	|O
(	|O
89%	|O
)	|O
patients	|O
with	|O
BAH	|O
.	|O

For	|O
each	|O
night	|O
,	|O
the	|O
diary	|O
allowed	|O
the	|O
subjective	|O
measurement	|O
of	|O
bedtime	|O
,	|O
wake	|O
time	|O
,	|O
time	|O
in	|O
bed	|O
(	|O
TIB	|O
)	|O
,	|O
sleep	|O
efficiency	|O
,	|O
number	|O
of	|O
minutes	|O
of	|O
wake	|O
after	|O
sleep	|O
onset	|O
(	|O
WASO	|O
)	|O
,	|O
alertness	|O
on	|O
awakening	|O
,	|O
and	|O
percentage	|O
of	|O
morning	|O
needing	|O
an	|O
alarm	|O
(	|O
or	|O
a	|O
person	|O
functioning	|O
as	|O
one	|O
)	|O
.	|O

Acad	|O
.	|O

Copyright	|O
2000	|O
Academic	|O
Press	|O
.	|O

The	|O
central	|O
(	|O
R	|O
)	|O
domain	|O
is	|O
responsible	|O
for	|O
receptor	|O
-	|O
binding	|O
activity	|O
whereas	|O
the	|O
N	|O
-	|O
terminal	|O
(	|O
T	|O
)	|O
domain	|O
mediates	|O
translocation	|O
,	|O
the	|O
process	|O
by	|O
which	|O
the	|O
C	|O
-	|O
terminal	|O
cytotoxic	|O
domain	|O
is	|O
transported	|O
from	|O
the	|O
receptor	|O
to	|O
the	|O
site	|O
of	|O
its	|O
cytotoxicity	|O
.	|O

We	|O
have	|O
previously	|O
demonstrated	|O
that	|O
expression	|O
of	|O
the	|O
gene	|O
for	|O
the	|O
reproductive	|O
neuropeptide	|O
,	|O
GnRH	|B-PROTEIN
,	|O
is	|O
repressed	|O
by	|O
the	|O
glutamate	|O
/	|O
NO	|O
/	|O
cyclic	|O
GMP	|O
(	|O
cGMP	|O
)	|O
signal	|O
transduction	|O
pathway	|O
through	|O
cGMP	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
in	|O
the	|O
hypothalamic	|O
GnRH	|B-PROTEIN
-	|O
secreting	|O
neuronal	|O
cell	|O
line	|O
GT1	|O
-	|O
7	|O
.	|O

These	|O
data	|O
suggest	|O
that	|O
combined	|O
lesions	|O
of	|O
cholinergic	|O
and	|O
serotonergic	|O
neurons	|O
in	|O
the	|O
rat	|O
brain	|O
do	|O
not	|O
alter	|O
olfactory	|O
perception	|O
or	|O
olfactory	|O
short	|O
-	|O
term	|O
memory	|O
.	|O

Extreme	|O
potency	|O
of	|O
botulinum	|B-PROTEIN
toxin	|I-PROTEIN
.	|O

In	|O
contrast	|O
,	|O
c	|B-PROTEIN
-	|I-PROTEIN
Src	|I-PROTEIN
activated	|O
by	|O
isoproterenol	|O
led	|O
to	|O
tyrosine	|O
phosphorylation	|O
of	|O
Shc	|B-PROTEIN
and	|O
subsequent	|O
Erk	|B-PROTEIN
activation	|O
,	|O
but	|O
not	|O
tyrosine	|O
phosphorylation	|O
of	|O
cortactin	|B-PROTEIN
or	|O
Stat3	|B-PROTEIN
.	|O

MSSPs	|B-PROTEIN
are	|O
believed	|O
to	|O
regulate	|O
DNA	|O
replication	|O
,	|O
transcription	|O
,	|O
apopotosis	|O
and	|O
cell	|O
cycle	|O
progression	|O
by	|O
interacting	|O
with	|O
the	|O
C	|B-PROTEIN
-	|I-PROTEIN
MYC	|I-PROTEIN
protein	|O
.	|O

For	|O
wild	|O
type	|O
MutT	|B-PROTEIN
and	|O
its	|O
E53D	|B-PROTEIN
and	|O
E44D	|B-PROTEIN
mutants	|O
,	|O
plots	|O
of	|O
log	|O
(	|O
k	|O
(	|O
cat	|O
)	|O
)	|O
versus	|O
pH	|O
exhibited	|O
a	|O
limiting	|O
slope	|O
of	|O
1	|O
on	|O
the	|O
ascending	|O
limb	|O
and	|O
then	|O
a	|O
hump	|O
,	|O
i.e.	|O
,	|O
a	|O
sharply	|O
defined	|O
maximum	|O
near	|O
pH	|O
8	|O
followed	|O
by	|O
a	|O
plateau	|O
,	|O
yielding	|O
apparent	|O
pK	|O
(	|O
a	|O
)	|O
values	|O
of	|O
7.6	|O
+	|O
/	|O
-	|O
0.3	|O
and	|O
8.4	|O
+	|O
/	|O
-	|O
0.4	|O
for	|O
an	|O
essential	|O
base	|O
and	|O
a	|O
nonessential	|O
acid	|O
catalyst	|O
,	|O
respectively	|O
,	|O
in	|O
the	|O
active	|O
quaternary	|O
MutT	|B-PROTEIN
-	|O
Mg	|O
(	|O
2+	|O
)	|O
-	|O
dGTP	|O
-	|O
Mg	|O
(	|O
2+	|O
)	|O
complex	|O
.	|O

Structural	|O
changes	|O
in	|O
the	|O
kinetically	|O
more	|O
damaged	|O
E44D	|O
mutant	|O
detected	|O
in	|O
(	|O
1	|O
)	|O
H	|O
-	|O
(	|O
15	|O
)	|O
N	|O
HSQC	|O
spectra	|O
were	|O
largely	|O
limited	|O
to	|O
the	|O
loop	|O
I	|O
-	|O
helix	|O
I	|O
motif	|O
,	|O
suggesting	|O
that	|O
Glu	|O
-	|O
44	|O
stabilizes	|O
the	|O
active	|O
site	|O
region	|O
.	|O

In	|O
vitro	|O
expression	|O
of	|O
four	|O
different	|O
naturally	|O
occurring	|O
nonsense	|O
and	|O
missense	|O
mutations	|O
revealed	|O
a	|O
dramatically	|O
altered	|O
subcellular	|O
location	|O
of	|O
the	|O
protein	|O
in	|O
cultured	|O
cells	|O
.	|O

After	|O
i.v	|O
.	|O

Immunity	|O
acquired	|O
by	|O
mice	|O
during	|O
I.	|O
scapularis	|O
nymphal	|O
activity	|O
in	|O
early	|O
summer	|O
may	|O
exclude	|O
a	|O
large	|O
proportion	|O
of	|O
the	|O
mouse	|O
population	|O
from	|O
maintaining	|O
E.	|O
phagocytophila	|O
during	|O
the	|O
period	|O
of	|O
larval	|O
activity	|O
later	|O
in	|O
the	|O
season	|O
.	|O

The	|O
emerging	|O
view	|O
based	|O
on	|O
studies	|O
in	|O
yeast	|O
is	|O
that	|O
each	|O
class	|O
of	|O
snoRNPs	|O
is	|O
composed	|O
of	|O
a	|O
unique	|O
set	|O
of	|O
proteins	|O
.	|O

BCR	|B-PROTEIN
cross	|O
-	|O
linking	|O
also	|O
led	|O
to	|O
increased	|O
MAPK	|B-PROTEIN
-	|O
activated	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
activity	|O
,	|O
an	|O
enzyme	|O
that	|O
lies	|O
immediately	|O
downstream	|O
from	|O
p38	|B-PROTEIN
MAPK	|O
;	|O
MAPK	|B-PROTEIN
-	|O
activated	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
immune	|O
complexes	|O
phosphorylated	|O
a	|O
peptide	|O
substrate	|O
containing	|O
the	|O
CREB	|B-PROTEIN
serine	|O
133	|O
phosphoacceptor	|O
motif	|O
.	|O

Activation	|O
of	|O
a	|O
CRE	|O
-	|O
dependent	|O
junB	|B-PROTEIN
promoter	|O
/	|O
chloramphenicol	|B-PROTEIN
acetyltransferase	|I-PROTEIN
(	|O
CAT	|B-PROTEIN
)	|O
reporter	|O
gene	|O
by	|O
the	|O
BCR	|B-PROTEIN
was	|O
also	|O
blocked	|O
by	|O
SB203580	|O
.	|O

We	|O
present	|O
evidence	|O
that	|O
the	|O
upstream	|O
open	|O
reading	|O
frame	|O
(	|O
uORF	|O
)	|O
represses	|O
the	|O
translation	|O
of	|O
the	|O
downstream	|O
major	|O
open	|O
reading	|O
frame	|O
(	|O
mORF	|O
)	|O
.	|O

METHODS	|O
:	|O
TBN	|O
measurements	|O
were	|O
performed	|O
in	|O
31	|O
female	|O
outpatients	|O
with	|O
breast	|O
carcinoma	|O
who	|O
were	|O
undergoing	|O
standard	|O
cyclophosphamide	|O
,	|O
methotrexate	|O
,	|O
and	|O
5	|O
-	|O
fluorouracil	|O
(	|O
CMF	|O
)	|O
-	|O
based	|O
chemotherapy	|O
(	|O
median	|O
age	|O
,	|O
48	|O
years	|O
;	|O
range	|O
,	|O
26	|O
-	|O
77	|O
years	|O
)	|O
.	|O

A	|O
385	|O
bp	|O
Glucocorticoid	|O
Response	|O
Unit	|O
(	|O
GRU	|O
)	|O
was	|O
identified	|O
whose	|O
glucocorticoid	|O
induction	|O
was	|O
enhanced	|O
by	|O
dibutyryl	|O
-	|O
cAMP	|O
and	|O
reduced	|O
by	|O
phorbol	|O
esters	|O
.	|O

No	|O
somatic	|O
mutations	|O
were	|O
found	|O
in	|O
any	|O
of	|O
the	|O
samples	|O
,	|O
suggesting	|O
that	|O
ING1	|B-PROTEIN
is	|O
not	|O
a	|O
tumor	|O
suppressor	|O
gene	|O
target	|O
in	|O
head	|O
and	|O
neck	|O
cancer	|O
.	|O

Ras	|B-PROTEIN
-	|O
GRF1	|B-PROTEIN
transiently	|O
expressed	|O
with	|O
v	|B-PROTEIN
-	|I-PROTEIN
Src	|I-PROTEIN
was	|O
tyrosine	|O
-	|O
phosphorylated	|O
and	|O
showed	|O
significant	|O
GEF	|B-PROTEIN
activity	|O
toward	|O
Rac	|B-PROTEIN
,	|O
but	|O
not	|O
Rho	|B-PROTEIN
and	|O
Cdc42	|B-PROTEIN
,	|O
which	|O
was	|O
comparable	|O
with	|O
that	|O
induced	|O
by	|O
Gbetagamma	|B-PROTEIN
.	|O

As	|O
no	|O
complete	|O
PPARgamma	|B-PROTEIN
antagonists	|O
have	|O
been	|O
described	|O
hitherto	|O
,	|O
we	|O
have	|O
constructed	|O
a	|O
dominant	|O
-	|O
negative	|O
mutant	|O
receptor	|O
to	|O
inhibit	|O
wild	|O
-	|O
type	|O
PPARgamma	|B-PROTEIN
action	|O
.	|O

EMSA	|O
showed	|O
that	|O
nuclear	|O
proteins	|O
from	|O
PC12	|O
but	|O
not	|O
C6	|O
or	|O
Rat2	|O
cells	|O
bind	|O
the	|O
CRE	|O
as	|O
a	|O
complex	|O
containing	|O
activating	|O
transcription	|O
factor	|O
(	|B-PROTEIN
ATF	|I-PROTEIN
)	|I-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
and	|O
CCAAT	|B-PROTEIN
enhancer	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
beta	|I-PROTEIN
,	|O
while	|O
both	|O
PC12	|O
and	|O
C6	|O
cell	|O
nuclear	|O
extracts	|O
were	|O
recruited	|O
by	|O
the	|O
CCAAT	|O
-	|O
box	|O
as	|O
a	|O
complex	|O
containing	|O
nuclear	|B-PROTEIN
factor	|I-PROTEIN
Y.	|I-PROTEIN

EMSA	|O
showed	|O
that	|O
nuclear	|O
proteins	|O
from	|O
PC12	|O
but	|O
not	|O
C6	|O
or	|O
Rat2	|O
cells	|O
bind	|O
the	|O
CRE	|O
as	|O
a	|O
complex	|O
containing	|O
activating	|O
transcription	|O
factor	|O
(	|B-PROTEIN
ATF	|I-PROTEIN
)	|I-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
and	|O
CCAAT	|B-PROTEIN
enhancer	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
beta	|I-PROTEIN
,	|O
while	|O
both	|O
PC12	|O
and	|O
C6	|O
cell	|O
nuclear	|O
extracts	|O
were	|O
recruited	|O
by	|O
the	|O
CCAAT	|O
-	|O
box	|O
as	|O
a	|O
complex	|O
containing	|O
nuclear	|B-PROTEIN
factor	|I-PROTEIN
Y.	|I-PROTEIN

Despite	|O
resolution	|O
of	|O
the	|O
solid	|O
portion	|O
of	|O
the	|O
tumor	|O
,	|O
serial	|O
MRI	|O
showed	|O
enlargement	|O
of	|O
a	|O
bilobar	|O
tumor	|O
cyst	|O
3	|O
years	|O
after	|O
the	|O
original	|O
diagnosis	|O
.	|O

LPO	|O
and	|O
SOD	|B-PROTEIN
levels	|O
were	|O
measured	|O
at	|O
five	|O
points	|O
before	|O
and	|O
during	|O
the	|O
operation	|O
.	|O

Sustained	|O
ventricular	|O
tachycardia	|O
and	|O
its	|O
successful	|O
prophylaxis	|O
during	|O
high	|O
-	|O
dose	|O
bolus	|O
interleukin	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
therapy	|O
for	|O
metastatic	|O
renal	|O
cell	|O
carcinoma	|O
.	|O

Second	|O
,	|O
when	|O
the	|O
NBF1+	|B-PROTEIN
R	|I-PROTEIN
protein	|O
,	|O
the	|O
NBF2	|B-PROTEIN
protein	|O
,	|O
and	|O
a	|O
mixture	|O
of	|O
the	|O
two	|O
proteins	|O
were	|O
folded	|O
separately	|O
and	|O
analyzed	|O
by	|O
molecular	|O
sieve	|O
chomatography	|O
,	|O
the	|O
mixture	|O
was	|O
found	|O
to	|O
elute	|O
prior	|O
to	|O
either	|O
NBF1+	|B-PROTEIN
R	|I-PROTEIN
or	|O
NBF2	|B-PROTEIN
.	|O

Collectively	|O
,	|O
these	|O
experiments	|O
demonstrate	|O
that	|O
CFTR	|B-PROTEIN
's	|O
NBF1+	|B-PROTEIN
R	|I-PROTEIN
region	|I-PROTEIN
and	|O
its	|O
NBF2	|B-PROTEIN
domain	|O
,	|O
after	|O
folding	|O
separately	|O
as	|O
distinct	|O
units	|O
,	|O
have	|O
a	|O
strong	|O
propensity	|O
to	|O
interact	|O
and	|O
that	|O
this	|O
interaction	|O
is	|O
stable	|O
in	|O
the	|O
absence	|O
of	|O
added	|O
nucleotides	|O
or	|O
exogenously	|O
induced	|O
phosphorylation	|O
.	|O

Copyright	|O
2000	|O
Academic	|O
Press	|O
.	|O

Sulfhydryl	|O
titration	|O
with	|O
iodoacetamide	|O
,	|O
monitored	|O
by	|O
quantitating	|O
the	|O
residual	|O
thiols	|O
after	|O
reaction	|O
with	|O
a	|O
maleimide	|O
derivative	|O
of	|O
biotin	|O
,	|O
revealed	|O
a	|O
striking	|O
difference	|O
in	|O
the	|O
apparent	|O
pK	|O
(	|O
a	|O
)	|O
values	|O
of	|O
the	|O
cysteines	|O
at	|O
the	|O
two	|O
splice	|O
junctions	|O
.	|O

After	|O
nitric	|O
oxide	|O
inhalation	|O
,	|O
the	|O
results	|O
showed	|O
moderate	|O
increases	|O
in	|O
PaO2	|O
and	|O
SaO2	|O
(	|O
P	|O
>	|O
0.05	|O
)	|O
and	|O
a	|O
significant	|O
decrease	|O
in	|O
Qs	|O
/	|O
Q	|O
tau	|O
ratio	|O
(	|O
P	|O
<	|O
0.01	|O
)	|O
.	|O

The	|O
results	|O
showed	|O
that	|O
MIP	|O
,	|O
MMIF	|O
,	|O
FIC	|O
,	|O
Wimax	|O
,	|O
P0.1	|O
and	|O
minute	|O
ventilation	|O
(	|O
Vr	|O
)	|O
were	|O
significantly	|O
increased	|O
after	|O
administration	|O
of	|O
methylphenidatum	|O
and	|O
aminophylline	|O
.	|O

Forty	|O
4	|O
-	|O
month	|O
old	|O
SD	|O
female	|O
rats	|O
were	|O
randomly	|O
divided	|O
into	|O
four	|O
groups	|O
,	|O
namely	|O
sham	|O
operation	|O
,	|O
bilateral	|O
ovariectomy	|O
,	|O
ovariectomy	|O
plus	|O
supplementary	|O
ethinyl	|O
estradiol	|O
(	|O
0.2	|O
microgram	|O
/	|O
100	|O
g	|O
B.	|O

It	|O
has	|O
also	|O
been	|O
shown	|O
that	|O
a	|O
variety	|O
of	|O
extracellular	|O
factors	|O
stimulate	|O
a	|O
pair	|O
of	|O
MAPK	|O
p44	|B-PROTEIN
and	|O
MAPK	|O
p42	|B-PROTEIN
of	|O
MAPK	|B-PROTEIN
family	|O
members	|O
.	|O

Covalent	|O
modification	|O
of	|O
the	|O
transactivator	|O
protein	|O
IE2	|B-PROTEIN
-	|O
p86	|B-PROTEIN
of	|O
human	|O
cytomegalovirus	|O
by	|O
conjugation	|O
to	|O
the	|O
ubiquitin	|B-PROTEIN
-	|O
homologous	|O
proteins	|O
SUMO	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
hSMT3b	|B-PROTEIN
.	|O

73	|O
:	|O
658-666	|O
,	|O
1999	|O
)	|O
.	|O

The	|O
interaction	|O
between	|O
U	|O
(	|O
L	|O
)	|O
3	|O
.	|O

Protamine	|B-PROTEIN
and	|O
heparin	|O
doses	|O
,	|O
their	|O
sum	|O
(	|O
Sigma	|O
-	|O
dose	|O
)	|O
and	|O
differential	|O
(	|O
Delta	|O
-	|O
dose	|O
)	|O
doses	|O
,	|O
and	|O
activated	|O
clotting	|O
times	|O
were	|O
tabulated	|O
.	|O

In	|O
this	|O
study	|O
,	|O
a	|O
common	|O
mechanism	|O
has	|O
been	|O
identified	|O
to	|O
coordinate	|O
the	|O
growth	|O
-	|O
and	|O
FC	|O
-	|O
dependent	|O
expression	|O
of	|O
caveolin	|B-PROTEIN
.	|O

Comparison	|O
of	|O
the	|O
plant	|O
nuclear	|O
tRNA	|O
3'	|O
processing	|O
enzyme	|O
with	|O
the	|O
plant	|O
mitochondrial	|O
one	|O
suggests	|O
that	|O
both	|O
activities	|O
are	|O
different	|O
enzymes	|O
.	|O

The	|O
requirement	|O
of	|O
3'	|O
complementarity	|O
for	|O
a	|O
ligation	|O
reaction	|O
is	|O
reaffirmed	|O
by	|O
results	|O
from	|O
1	|O
nt	|O
insertions	|O
on	|O
either	|O
the	|O
3'	|O
-	|O
or	|O
5'	|O
-	|O
side	|O
of	|O
the	|O
nick	|O
.	|O

NKX2.1	|B-PROTEIN
is	|O
a	|O
member	|O
of	|O
the	|O
NK2	|B-PROTEIN
family	|O
of	|O
homeodomain	|B-PROTEIN
-	|O
containing	|O
transcription	|O
factors	|O
whose	|O
targeted	|O
disruption	|O
in	|O
mouse	|O
results	|O
in	|O
the	|O
absence	|O
of	|O
thyroid	|O
tissue	|O
and	|O
a	|O
severely	|O
abnormal	|O
lung	|O
phenotype	|O
.	|O

National	|O
abortion	|O
laws	|O
usually	|O
do	|O
not	|O
allow	|O
abortion	|O
when	|O
a	|O
foetus	|O
is	|O
independently	|O
viable	|O
,	|O
i.e.	|O
from	|O
a	|O
gestational	|O
age	|O
of	|O
about	|O
24	|O
weeks	|O
.	|O

Expression	|O
in	|O
early	|O
postnatal	|O
pituitary	|O
and	|O
in	|O
pre	|O
-	|O
somatotrophic	|O
cells	|O
suggests	|O
that	|O
Zn	|B-PROTEIN
-	|I-PROTEIN
16	|I-PROTEIN
could	|O
play	|O
a	|O
role	|O
in	|O
pituitary	|O
development	|O
prior	|O
to	|O
somatotroph	|O
differentiation	|O
.	|O

Mouse	|O
growth	|O
hormone	|O
transcription	|O
factor	|O
Zn	|B-PROTEIN
-	|I-PROTEIN
16	|I-PROTEIN
:	|O
unique	|O
bipartite	|O
structure	|O
containing	|O
tandemly	|O
repeated	|O
zinc	|O
finger	|O
domains	|O
not	|O
reported	|O
in	|O
rat	|O
Zn	|B-PROTEIN
-	|I-PROTEIN
15	|I-PROTEIN
.	|O

The	|O
CCAAT	|O
core	|O
sequence	|O
mutants	|O
in	|O
which	|O
both	|O
CIII	|O
and	|O
CI	|O
/	|O
CII	|O
were	|O
abolished	|O
,	|O
also	|O
increased	|O
the	|O
promoter	|O
activity	|O
.	|O

Deglutition	|O
is	|O
considered	|O
to	|O
be	|O
immature	|O
in	|O
infants	|O
and	|O
to	|O
mature	|O
postnatally	|O
.	|O

This	|O
repression	|O
does	|O
not	|O
require	|O
the	|O
PU.1	|B-PROTEIN
transactivation	|O
or	|O
PEST	|O
domains	|O
and	|O
cannot	|O
be	|O
reversed	|O
by	|O
p300	|B-PROTEIN
expression	|O
.	|O

First	|O
,	|O
human	|O
erythroid	|O
K562	|O
cells	|O
stably	|O
integrated	|O
with	|O
various	|O
HS	|B-PROTEIN
-	|I-PROTEIN
40	|I-PROTEIN
mutants	|O
cis	|O
linked	|O
to	|O
a	|O
human	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
globin	|I-PROTEIN
promoter	|O
-	|O
growth	|B-PROTEIN
hormone	|I-PROTEIN
hybrid	|O
gene	|O
were	|O
analyzed	|O
by	|O
genomic	|O
footprinting	|O
and	|O
expression	|O
analysis	|O
.	|O

Interestingly	|O
,	|O
addition	|O
of	|O
purified	|O
CBP	|B-PROTEIN
to	|O
the	|O
nuclear	|O
extracts	|O
of	|O
T47D	|O
cells	|O
markedly	|O
stimulated	|O
progesterone	|O
-	|O
and	|O
PR	|B-PROTEIN
-	|O
dependent	|O
transcription	|O
from	|O
a	|O
nucleosome	|O
-	|O
free	|O
,	|O
progesterone	|O
response	|O
element	|O
(	|O
PRE	|O
)	|O
-	|O
linked	|O
reporter	|O
DNA	|O
template	|O
.	|O

Its	|O
cognate	|O
binding	|O
protein	|O
,	|O
REST	|B-PROTEIN
/	|O
NRSF	|B-PROTEIN
,	|O
is	|O
an	|O
essential	|O
transcription	|O
factor	|O
;	|O
its	|O
null	|O
mutations	|O
result	|O
in	|O
embryonic	|O
lethality	|O
,	|O
and	|O
its	|O
dominant	|O
negative	|O
mutants	|O
produce	|O
aberrant	|O
expression	|O
of	|O
neuron	|O
-	|O
specific	|O
genes	|O
.	|O

Removal	|O
of	|O
all	|O
core	|O
histone	|B-PROTEIN
tail	|O
domains	|O
by	|O
limited	|O
trypsin	|B-PROTEIN
proteolysis	|O
or	|O
acetylation	|O
of	|O
the	|O
core	|O
histone	|B-PROTEIN
tails	|O
significantly	|O
relieves	|O
this	|O
inhibition	|O
and	|O
allows	|O
TFIIIA	|B-PROTEIN
to	|O
exhibit	|O
high	|O
-	|O
affinity	|O
binding	|O
to	|O
nucleosomal	|O
DNA	|O
.	|O

Finally	|O
,	|O
the	|O
mechanism	|O
of	|O
ASK1	|B-PROTEIN
activation	|O
involves	|O
,	|O
in	|O
part	|O
,	|O
homo	|O
-	|O
oligomerization	|O
.	|O

OUTCOME	|O
:	|O
Acetylcholine	|B-PROTEIN
receptor	|I-PROTEIN
antibodies	|O
and	|O
single	|O
-	|O
fibre	|O
electromyogram	|O
were	|O
useful	|O
in	|O
the	|O
diagnosis	|O
of	|O
myasthenia	|O
gravis	|O
.	|O

Two	|O
other	|O
patients	|O
underwent	|O
PRFR	|O
.	|O

The	|O
variations	|O
were	|O
caused	|O
by	|O
opposite	|O
shifts	|O
in	|O
TSH	|B-PROTEIN
frequency	|O
distribution	|O
in	|O
mothers	|O
and	|O
neonates	|O
.	|O

Characterization	|O
of	|O
the	|O
5'	|O
-	|O
flanking	|O
region	|O
of	|O
the	|O
human	|O
multidrug	|B-PROTEIN
resistance	|I-PROTEIN
protein	|I-PROTEIN
2	|I-PROTEIN
(	|O
MRP2	|B-PROTEIN
)	|O
gene	|O
and	|O
its	|O
regulation	|O
in	|O
comparison	|O
withthe	|O
multidrug	|B-PROTEIN
resistance	|I-PROTEIN
protein	|I-PROTEIN
3	|I-PROTEIN
(	|O
MRP3	|B-PROTEIN
)	|O
gene	|O
.	|O

However	|O
,	|O
such	|O
a	|O
mechanism	|O
was	|O
not	|O
detected	|O
in	|O
preliminary	|O
observations	|O
on	|O
M.	|O
synoviae	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
the	|O
M.	|O
jannaschii	|O
as	|O
well	|O
as	|O
related	|O
archaeal	|O
20S	|B-PROTEIN
proteasomes	|O
require	|O
a	|O
nucleotidase	|O
complex	|O
such	|O
as	|O
PAN	|B-PROTEIN
to	|O
mediate	|O
the	|O
energy	|O
-	|O
dependent	|O
hydrolysis	|O
of	|O
folded	|O
-	|O
substrate	|O
proteins	|O
and	|O
that	|O
the	|O
N	|O
-	|O
terminal	|O
73	|O
amino	|O
acid	|O
residues	|O
of	|O
PAN	|B-PROTEIN
are	|O
not	|O
absolutely	|O
required	|O
for	|O
this	|O
reaction	|O
.	|O

The	|O
transcription	|O
factor	|O
E2F	|B-PROTEIN
plays	|O
an	|O
important	|O
role	|O
in	|O
G	|O
(	|O
1	|O
)	|O
to	|O
S	|O
phase	|O
transition	|O
in	|O
the	|O
higher	|O
eukaryotic	|O
cell	|O
cycle	|O
.	|O

In	|O
two	|O
-	|O
field	|O
nodal	|O
dissection	|O
,	|O
two	|O
components	|O
are	|O
included	|O
with	|O
(	|O
modern	|O
two	|O
-	|O
field	|O
)	|O
or	|O
without	|O
(	|O
traditional	|O
two	|O
-	|O
field	|O
)	|O
nodal	|O
dissection	|O
around	|O
both	|O
recurrent	|O
laryngeal	|O
nerve	|O
chains	|O
in	|O
the	|O
upper	|O
mediastinum	|O
.	|O

Of	|O
the	|O
153	|O
patients	|O
studied	|O
,	|O
CK	|B-PROTEIN
-	|I-PROTEIN
MB	|I-PROTEIN
results	|O
were	|O
positive	|O
in	|O
91	|O
(	|O
59%	|O
)	|O
patients	|O
;	|O
ECG	|O
revealed	|O
AMI	|O
in	|O
72	|O
(	|O
47%	|O
)	|O
patients	|O
.	|O

The	|O
effect	|O
of	|O
MIB	|O
on	|O
the	|O
dose	|O
-	|O
response	|O
curve	|O
of	|O
externally	|O
applied	|O
noradrenaline	|O
was	|O
also	|O
studied	|O
.	|O

The	|O
regional	|O
blockade	|O
of	|O
H1R	|B-PROTEIN
was	|O
observed	|O
mainly	|O
in	|O
the	|O
frontal	|O
,	|O
temporal	|O
and	|O
anterior	|O
cingulate	|O
cortices	|O
,	|O
and	|O
the	|O
intravenous	|O
administration	|O
of	|O
d	|O
-	|O
chlorpheniramine	|O
as	|O
a	|O
therapeutic	|O
dose	|O
(	|O
2	|O
mg	|O
)	|O
blocked	|O
over	|O
60%	|O
of	|O
H1R	|B-PROTEIN
in	|O
the	|O
frontal	|O
cortices	|O
.	|O

The	|O
expression	|O
of	|O
the	|O
yam8	|B-PROTEIN
(	|O
+	|O
)	|O
cDNA	|O
in	|O
the	|O
mid1	|B-PROTEIN
mutant	|O
cells	|O
partially	|O
remediated	|O
the	|O
mid	|O
phenotype	|O
and	|O
resulted	|O
in	|O
a	|O
slight	|O
increase	|O
in	|O
Ca	|O
(	|O
2+	|O
)	|O
uptake	|O
activity	|O
.	|O

Linearized	|O
overall	|O
infection	|O
rates	|O
(	|O
events	|O
/	|O
100	|O
patient	|O
-	|O
days	|O
)	|O
were	|O
2.05	|O
+	|O
/	|O
-	|O
0.33	|O
(	|O
heart	|O
-	|O
lung	|O
)	|O
and	|O
2.34	|O
+	|O
/	|O
-	|O
0.34	|O
(	|O
double	|O
-	|O
lung	|O
;	|O
P	|O
=	|O
NS	|O
)	|O
at	|O
3	|O
months	|O
.	|O

Static	|O
and	|O
dynamic	|O
compliance	|O
was	|O
measured	|O
after	|O
induction	|O
of	|O
anesthesia	|O
,	|O
before	|O
and	|O
immediately	|O
after	|O
filtration	|O
in	|O
the	|O
operating	|O
theater	|O
,	|O
1	|O
hour	|O
after	|O
return	|O
to	|O
the	|O
pediatric	|O
intensive	|O
care	|O
unit	|O
,	|O
and	|O
24	|O
hours	|O
after	|O
the	|O
operation	|O
.	|O

Antipyretic	|O
therapy	|O
:	|O
physiologic	|O
rationale	|O
,	|O
diagnostic	|O
implications	|O
,	|O
and	|O
clinical	|O
consequences	|O
.	|O

There	|O
is	|O
no	|O
correlation	|O
between	|O
C2	|O
-	|O
C3	|O
disk	|O
morphology	|O
and	|O
the	|O
diskographically	|O
provoked	|O
response	|O
.	|O

KFC	|B-PROTEIN
,	|O
a	|O
Ste20	|B-PROTEIN
-	|O
like	|O
kinase	|O
with	|O
mitogenic	|O
potential	|O
and	|O
capability	|O
to	|O
activate	|O
the	|O
SAPK	|B-PROTEIN
/	|O
JNK	|B-PROTEIN
pathway	|O
.	|O

TIP30	|B-PROTEIN
has	|O
an	|O
intrinsic	|O
kinase	|O
activity	|O
required	|O
for	|O
up	|O
-	|O
regulation	|O
of	|O
a	|O
subset	|O
of	|O
apoptotic	|O
genes	|O
.	|O

We	|O
have	|O
mapped	|O
the	|O
human	|O
STAG3	|B-PROTEIN
gene	|O
to	|O
the	|O
7q22	|O
region	|O
of	|O
chromosome	|O
7	|O
;	|O
six	|O
human	|O
STAG3	|B-PROTEIN
-	|O
related	|O
genes	|O
have	|O
also	|O
been	|O
mapped	|O
:	|O
two	|O
at	|O
7q22	|O
near	|O
the	|O
functional	|O
gene	|O
,	|O
one	|O
at	|O
7q11.2	|O
2	|O
,	|O
and	|O
three	|O
at	|O
7q11.2	|O
3	|O
,	|O
two	|O
of	|O
them	|O
flanking	|O
the	|O
breakpoints	|O
commonly	|O
associated	|O
with	|O
the	|O
Williams	|O
-	|O
Beuren	|O
syndrome	|O
(	|B-PROTEIN
WBS	|I-PROTEIN
)	|I-PROTEIN
deletion	|I-PROTEIN
.	|O

Reaction	|O
time	|O
(	|O
RT	|O
)	|O
and	|O
P300	|O
were	|O
collected	|O
simultaneously	|O
.	|O

In	|O
experiment	|O
2	|O
the	|O
rats	|O
had	|O
free	|O
access	|O
to	|O
two	|O
bottles	|O
,	|O
one	|O
of	|O
which	|O
contained	|O
tap	|O
water	|O
,	|O
and	|O
the	|O
other	|O
contained	|O
either	|O
an	|O
ethanol	|O
(	|O
6%	|O
)	|O
or	|O
a	|O
sucrose	|O
(	|O
5%	|O
)	|O
solution	|O
.	|O

Furthermore	|O
,	|O
Zelen	|O
's	|O
method	|O
is	|O
used	|O
to	|O
balance	|O
the	|O
number	|O
of	|O
patients	|O
allocated	|O
to	|O
the	|O
two	|O
groups	|O
within	|O
each	|O
institution	|O
(	|O
M.	|O

RESULTS	|O
:	|O
In	|O
this	|O
group	|O
of	|O
patients	|O
,	|O
male	|O
gender	|O
(	|O
P	|O
=	|O
0	|O
.	|O

Selective	|O
visual	|O
attention	|O
involves	|O
dynamic	|O
interplay	|O
between	|O
attentional	|O
control	|O
systems	|O
and	|O
sensory	|O
brain	|O
structures	|O
.	|O

The	|O
patient	|O
had	|O
developed	|O
left	|O
-	|O
sided	|O
low	|O
-	|O
frequency	|O
tremor	|O
and	|O
hemidystonia	|O
after	|O
a	|O
severe	|O
head	|O
trauma	|O
sustained	|O
at	|O
15	|O
years	|O
of	|O
age	|O
.	|O

However	|O
,	|O
the	|O
a1	|O
isoform	|O
is	|O
expressed	|O
most	|O
heavily	|O
in	|O
brain	|O
and	|O
heart	|O
,	|O
a2	|O
in	|O
liver	|O
and	|O
kidney	|O
,	|O
and	|O
a3	|O
in	|O
liver	|O
,	|O
lung	|O
,	|O
heart	|O
,	|O
brain	|O
,	|O
spleen	|O
,	|O
and	|O
kidney	|O
.	|O

During	|O
the	|O
cloning	|O
by	|O
reverse	|B-PROTEIN
transcriptase	|I-PROTEIN
-	|O
polymerase	|O
chain	|O
reaction	|O
of	|O
the	|O
human	|O
HIF	|B-PROTEIN
-	|I-PROTEIN
1alpha	|I-PROTEIN
subunit	|O
,	|O
we	|O
isolated	|O
two	|O
cDNA	|O
clones	|O
which	|O
corresponded	|O
to	|O
alternative	|O
splicing	|O
of	|O
the	|O
HIF	|B-PROTEIN
-	|I-PROTEIN
1alpha	|I-PROTEIN
gene	|O
.	|O

To	|O
assess	|O
the	|O
relationship	|O
between	|O
G	|B-PROTEIN
(	|I-PROTEIN
q	|I-PROTEIN
)	|I-PROTEIN
/	|O
G	|B-PROTEIN
(	|I-PROTEIN
11	|I-PROTEIN
)	|I-PROTEIN
function	|O
with	|O
the	|O
phosphatidylinositol	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
dependent	|O
pathway	|O
,	|O
expression	|O
of	|O
a	|O
dominant	|O
-	|O
interfering	|O
p85	|B-PROTEIN
regulatory	|O
subunit	|O
,	|O
as	|O
well	|O
as	|O
wortmannin	|O
treatment	|O
inhibited	|O
insulin	|B-PROTEIN
-	|O
stimulated	|O
but	|O
not	|O
G	|B-PROTEIN
(	|I-PROTEIN
q	|I-PROTEIN
)	|I-PROTEIN
/	|I-PROTEIN
Q209L	|I-PROTEIN
-	|O
stimulated	|O
GLUT4	|B-PROTEIN
-	|O
EGFP	|B-PROTEIN
translocation	|O
.	|O

In	|O
endemic	|O
BL	|O
,	|O
the	|O
RB2	|B-PROTEIN
/	|O
p130	|B-PROTEIN
gene	|O
is	|O
mutated	|O
in	|O
most	|O
of	|O
the	|O
cases	|O
,	|O
and	|O
the	|O
protein	|O
is	|O
restricted	|O
to	|O
the	|O
cytoplasm	|O
.	|O

Together	|O
,	|O
these	|O
data	|O
identify	|O
ERK2	|B-PROTEIN
as	|O
a	|O
specific	|O
and	|O
direct	|O
target	|O
of	|O
HePTP	|B-PROTEIN
and	|O
are	|O
consistent	|O
with	|O
a	|O
model	|O
in	|O
which	|O
HePTP	|B-PROTEIN
negatively	|O
regulates	|O
ERK2	|B-PROTEIN
activity	|O
as	|O
part	|O
of	|O
a	|O
feedback	|O
mechanism	|O
.	|O

Cross	|O
-	|O
reaction	|O
between	|O
a	|O
monoclonal	|O
antibody	|O
and	|O
two	|O
alpha	|O
beta	|O
T	|B-PROTEIN
cell	|I-PROTEIN
receptors	|I-PROTEIN
.	|O

Strontium	|O
nitrate	|O
mixed	|O
with	|O
glycolic	|O
acid	|O
,	|O
in	|O
comparison	|O
with	|O
glycolic	|O
acid	|O
alone	|O
,	|O
markedly	|O
(	|O
p	|O
<	|O
0.01	|O
)	|O
shortened	|O
the	|O
duration	|O
of	|O
the	|O
irritation	|O
sensation	|O
from	|O
24.4	|O
+	|O
/	|O
-	|O
4.1	|O
(	|O
mean+	|O
/	|O
-	|O
SEM	|O
)	|O
min	|O
to	|O
8.9	|O
+	|O
/	|O
-	|O
3.7	|O
(	|O
mean+	|O
/	|O
-	|O
SEM	|O
)	|O
min	|O
,	|O
and	|O
significantly	|O
(	|O
p	|O
<	|O
0.05	|O
)	|O
reduced	|O
the	|O
mean	|O
magnitude	|O
of	|O
the	|O
irritation	|O
sensation	|O
at	|O
all	|O
time	|O
points	|O
(	|O
overall	|O
)	|O
.	|O

The	|O
pCMBS	|O
-	|O
reactive	|O
sulfhydryl	|O
groups	|O
were	|O
located	|O
exclusively	|O
in	|O
the	|O
exofacial	|O
half	|O
of	|O
the	|O
plasma	|O
membrane	|O
and	|O
,	|O
when	|O
presented	|O
in	|O
a	|O
helical	|O
model	|O
,	|O
lie	|O
along	|O
one	|O
side	|O
of	|O
the	|O
helices	|O
.	|O

Analysis	|O
of	|O
1	|O
Mb	|O
of	|O
published	|O
sequence	|O
from	|O
the	|O
region	|O
of	|O
conserved	|O
synteny	|O
on	|O
human	|O
chromosome	|O
5q31	|O
-	|O
q33	|O
identified	|O
45	|O
gene	|O
candidates	|O
,	|O
including	|O
35	|O
expressed	|O
genes	|O
in	|O
the	|O
human	|O
IL	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
cytokine	|O
gene	|O
cluster	|O
.	|O

Human	|O
AP	|B-PROTEIN
-	|I-PROTEIN
2rep	|I-PROTEIN
repressed	|O
both	|O
reporter	|O
expression	|O
from	|O
a	|O
transiently	|O
transfected	|O
AP	|B-PROTEIN
-	|I-PROTEIN
2alpha	|I-PROTEIN
promoter	|O
and	|O
the	|O
endogenous	|O
AP	|B-PROTEIN
-	|I-PROTEIN
2alpha	|I-PROTEIN
gene	|O
and	|O
inversely	|O
was	|O
negatively	|O
regulated	|O
by	|O
AP	|B-PROTEIN
-	|I-PROTEIN
2alpha	|I-PROTEIN
.	|O

In	|O
order	|O
to	|O
gain	|O
deeper	|O
insight	|O
into	|O
the	|O
role	|O
of	|O
the	|O
amino	|O
-	|O
terminal	|O
domain	|O
of	|O
the	|O
p24	|B-PROTEIN
(	|O
CA	|B-PROTEIN
)	|O
protein	|O
during	|O
viral	|O
replication	|O
,	|O
eight	|O
highly	|O
conserved	|O
proline	|O
residues	|O
known	|O
to	|O
promote	|O
turns	|O
and	|O
to	|O
terminate	|O
alpha	|O
-	|O
helices	|O
within	|O
the	|O
p24	|B-PROTEIN
tertiary	|O
structure	|O
were	|O
replaced	|O
by	|O
a	|O
leucine	|O
residue	|O
(	|O
P	|O
-	|O
position	|O
-	|O
L	|O
)	|O
.	|O

Clb	|B-PROTEIN
/	|O
Cdc28	|B-PROTEIN
kinases	|O
promote	|O
nuclear	|O
export	|O
of	|O
the	|O
replication	|O
initiator	|O
proteins	|O
Mcm2	|B-PROTEIN
-	|I-PROTEIN
7	|I-PROTEIN
.	|O

Alternatively	|O
,	|O
PC12	|O
-	|O
E2	|O
cells	|O
were	|O
submitted	|O
to	|O
treatment	|O
with	|O
antibodies	|O
to	|O
the	|O
fibroblast	|O
growth	|O
factor	|O
(	|B-PROTEIN
FGF	|I-PROTEIN
)	|I-PROTEIN
receptor	|I-PROTEIN
,	|O
inhibitors	|O
of	|O
the	|O
nonreceptor	|B-PROTEIN
tyrosine	|I-PROTEIN
kinase	|I-PROTEIN
p59	|O
(	|O
fyn	|B-PROTEIN
)	|O
,	|O
PLC	|B-PROTEIN
,	|O
PKC	|B-PROTEIN
and	|O
MEK	|B-PROTEIN
and	|O
an	|O
activator	|O
of	|O
PKC	|B-PROTEIN
,	|O
phorbol	|O
-	|O
12	|O
-	|O
myristate	|O
-	|O
13	|O
-	|O
acetate	|O
(	|O
PMA	|O
)	|O
.	|O

Cooperative	|O
roles	|O
of	|O
Bozozok	|B-PROTEIN
/	|O
Dharma	|B-PROTEIN
and	|O
Nodal	|B-PROTEIN
-	|O
related	|O
proteins	|O
in	|O
the	|O
formation	|O
of	|O
the	|O
dorsal	|O
organizer	|O
in	|O
zebrafish	|O
.	|O

Thiopentone	|O
sodium	|O
administered	|O
at	|O
30	|O
and	|O
10	|O
min	|O
before	|O
or	|O
5	|O
,	|O
10	|O
and	|O
15	|O
min	|O
after	|O
exposure	|O
to	|O
NOC	|O
-	|O
5	|O
,	|O
but	|O
not	|O
thereafter	|O
,	|O
significantly	|O
attenuated	|O
NO	|O
-	|O
induced	|O
neurotoxicity	|O
compared	|O
with	|O
controls	|O
.	|O

We	|O
also	|O
show	|O
that	|O
zygotically	|O
activated	|O
Xretpos	|O
transcripts	|O
are	|O
restricted	|O
to	|O
ventro	|O
-	|O
posterior	|O
specific	|O
regions	|O
and	|O
induced	|O
by	|O
UV	|O
-	|O
irradiation	|O
and	|O
BMP	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
overexpression	|O
in	|O
cycloheximide	|O
-	|O
dependent	|O
way	|O
.	|O
genesis	|O
26	|O
:	|O
198-207	|O
,	|O
2000	|O
.	|O

In	|O
all	|O
other	|O
cases	|O
,	|O
vestibular	|O
neurectomy	|O
or	|O
chemical	|O
vestibular	|O
labyrinthectomy	|O
,	|O
by	|O
means	|O
of	|O
intratympanic	|O
low	|O
concentration	|O
gentamicin	|O
(	|O
20	|O
mg	|O
/	|O
mL	|O
)	|O
,	|O
are	|O
indicated	|O
.	|O

However	|O
,	|O
when	|O
,	|O
where	|O
and	|O
how	|O
the	|O
DSPP	|B-PROTEIN
is	|O
cleaved	|O
into	|O
DSP	|B-PROTEIN
and	|O
DPP	|B-PROTEIN
is	|O
not	|O
clear	|O
.	|O

It	|O
has	|O
a	|O
grave	|O
prognosis	|O
with	|O
>	|O
70%	|O
mortality	|O
in	|O
3	|O
months	|O
,	|O
despite	|O
mechanical	|O
ventilation	|O
.	|O

We	|O
found	|O
that	|O
TCR	|B-PROTEIN
signaling	|O
induces	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
binding	|O
to	|O
this	|O
site	|O
and	|O
regulates	|O
the	|O
fasl	|B-PROTEIN
promoter	|O
function	|O
in	|O
a	|O
fashion	|O
dependent	|O
on	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
binding	|O
.	|O

Thus	|O
,	|O
patients	|O
with	|O
metastatic	|O
melanoma	|O
are	|O
not	|O
tolerant	|O
to	|O
gp100	|B-PROTEIN
Ag	|O
based	|O
on	|O
the	|O
detection	|O
of	|O
CD8+	|B-PROTEIN
T	|O
cells	|O
specific	|O
for	|O
multiple	|O
HLA	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
*	|I-PROTEIN
0201	|I-PROTEIN
-	|O
restricted	|O
,	|O
gp100	|B-PROTEIN
-	|O
derived	|O
epitopes	|O
.	|O

Approximately	|O
20%	|O
of	|O
ALCLs	|O
that	|O
express	|O
ALK	|B-PROTEIN
do	|O
not	|O
contain	|O
the	|O
t	|O
(	|O
2	|O
;	|O
5	|O
)	|O
,	|O
suggesting	|O
that	|O
other	|O
genetic	|O
abnormalities	|O
can	|O
result	|O
in	|O
aberrant	|O
ALK	|B-PROTEIN
expression	|O
.	|O

In	|O
addition	|O
,	|O
expected	|O
decreases	|O
in	|O
ATIC	|B-PROTEIN
enzymatic	|O
function	|O
in	|O
ATIC	|B-PROTEIN
-	|O
ALK	|B-PROTEIN
-	|O
containing	|O
lymphomas	|O
may	|O
render	|O
these	|O
tumors	|O
more	|O
sensitive	|O
to	|O
antifolate	|O
drugs	|O
such	|O
as	|O
methotrexate	|O
.	|O

Following	|O
the	|O
observation	|O
that	|O
non	|O
-	|O
organ	|O
-	|O
specific	|O
antibodies	|O
are	|O
related	|O
with	|O
pregnancy	|O
loss	|O
and	|O
preeclampsia	|O
,	|O
the	|O
role	|O
of	|O
organ	|O
-	|O
specific	|O
antibodies	|O
is	|O
currently	|O
being	|O
extensively	|O
investigated	|O
.	|O

Manganese	|O
ions	|O
were	|O
found	|O
to	|O
be	|O
essential	|O
for	|O
autophosphorylation	|O
of	|O
BGLF4	|B-PROTEIN
,	|O
and	|O
magnesium	|O
can	|O
stimulate	|O
the	|O
activity	|O
.	|O

The	|O
Mif1	|B-PROTEIN
5'	|O
flanking	|O
region	|O
contains	|O
a	|O
functional	|O
ER	|O
stress	|O
-	|O
responsive	|O
element	|O
which	|O
is	|O
sufficient	|O
for	|O
induction	|O
by	|O
tunicamycin	|O
.	|O

Rigid	|O
point	|O
feature	|O
registration	|O
using	|O
mutual	|O
information	|O
.	|O

Methysergide	|O
is	|O
a	|O
serotonin	|O
antagonist	|O
and	|O
has	|O
been	|O
demonstrated	|O
to	|O
reduce	|O
wound	|O
blood	|O
flow	|O
and	|O
edema	|O
formation	|O
.	|O

Serum	|O
leptin	|B-PROTEIN
concentrations	|O
in	|O
women	|O
during	|O
gonadotropin	|B-PROTEIN
stimulation	|O
cycles	|O
.	|O

Valuing	|O
families	|O
:	|O
social	|O
work	|O
practice	|O
with	|O
families	|O
from	|O
a	|O
strengths	|O
perspective	|O
.	|O

PURPOSE	|O
:	|O
A	|O
two	|O
-	|O
generation	|O
consanguineous	|O
Pakistani	|O
family	|O
with	|O
autosomal	|O
recessive	|O
Leber	|O
congenital	|O
amaurosis	|O
(	|O
LCA	|O
,	|O
MIM	|O
204,000	|O
)	|O
and	|O
keratoconus	|O
was	|O
identified	|O
.	|O

Ste18p	|B-PROTEIN
was	|O
targeted	|O
to	|O
the	|O
plasma	|O
membrane	|O
even	|O
in	|O
the	|O
absence	|O
of	|O
prenylation	|O
or	|O
thioacylation	|O
.	|O

Here	|O
,	|O
we	|O
show	|O
that	|O
IRF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
degraded	|O
via	|O
the	|O
ubiquitin	|B-PROTEIN
-	|O
proteasome	|O
pathway	|O
.	|O

An	|O
amino	|O
-	|O
acid	|O
sequence	|O
comparison	|O
revealed	|O
that	|O
Bacillus	|O
YM55	|O
-	|O
1	|O
aspartase	|B-PROTEIN
shared	|O
71%	|O
homology	|O
with	|O
Bacillus	|O
subtilis	|O
aspartase	|B-PROTEIN
and	|O
49%	|O
with	|O
Escherichia	|O
coli	|O
and	|O
Pseudomonas	|O
fluorescens	|O
aspartases	|B-PROTEIN
.	|O

Unique	|O
to	|O
this	|O
system	|O
,	|O
the	|O
activity	|O
of	|O
TraR	|B-PROTEIN
is	|O
negatively	|O
modulated	|O
by	|O
an	|O
antiactivator	|O
called	|O
TraM	|B-PROTEIN
.	|O

As	|O
assessed	|O
by	|O
a	|O
genetic	|O
assay	|O
that	|O
measures	|O
AAI	|O
-	|O
dependent	|O
DNA	|O
binding	|O
,	|O
TraM	|B-PROTEIN
inhibited	|O
TraR	|B-PROTEIN
function	|O
before	|O
and	|O
after	|O
the	|O
transcription	|O
factor	|O
had	|O
bound	|O
to	|O
its	|O
DNA	|O
recognition	|O
site	|O
.	|O

Here	|O
we	|O
show	|O
that	|O
IIIa	|O
pre	|O
-	|O
mRNA	|O
splicing	|O
is	|O
activated	|O
more	|O
than	|O
200	|O
-	|O
fold	|O
in	|O
nuclear	|O
extracts	|O
prepared	|O
from	|O
late	|O
adenovirus	|O
-	|O
infected	|O
cells	|O
(	|O
Ad	|O
-	|O
NE	|O
)	|O
compared	|O
to	|O
uninfected	|O
HeLa	|O
cell	|O
nuclear	|O
extracts	|O
(	|O
HeLa	|O
-	|O
NE	|O
)	|O
.	|O

Inactivation	|O
of	|O
Ulp2	|B-PROTEIN
also	|O
suppresses	|O
several	|O
ulp1	|B-PROTEIN
(	|O
ts	|O
)	|O
defects	|O
,	|O
and	|O
the	|O
double	|O
mutant	|O
accumulates	|O
far	|O
fewer	|O
Smt3	|B-PROTEIN
-	|O
protein	|O
conjugates	|O
than	|O
either	|O
single	|O
mutant	|O
.	|O

Collectively	|O
,	|O
the	|O
results	|O
suggest	|O
that	|O
ARF	|B-PROTEIN
binding	|O
to	|O
Mdm2	|B-PROTEIN
induces	|O
a	|O
conformational	|O
change	|O
that	|O
facilitates	|O
nucleolar	|O
import	|O
of	|O
the	|O
ARF	|B-PROTEIN
-	|O
Mdm2	|B-PROTEIN
complex	|O
and	|O
p53	|B-PROTEIN
-	|O
dependent	|O
cell	|O
cycle	|O
arrest	|O
.	|O

Cyclin	|B-PROTEIN
A	|I-PROTEIN
expression	|O
is	|O
repressed	|O
in	|O
quiescent	|O
cells	|O
by	|O
E2F	|B-PROTEIN
acting	|O
in	|O
conjunction	|O
with	|O
its	|O
pocket	|O
protein	|O
partners	|O
Rb	|B-PROTEIN
,	|O
p107	|B-PROTEIN
,	|O
and	|O
p130	|B-PROTEIN
;	|O
however	|O
,	|O
v	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
overrides	|O
this	|O
control	|O
,	|O
causing	|O
phosphorylated	|O
Rb	|B-PROTEIN
and	|O
proliferation	|O
-	|O
specific	|O
E2F	|B-PROTEIN
-	|O
p107	|B-PROTEIN
complexes	|O
to	|O
persist	|O
after	|O
mitogen	|O
withdrawal	|O
.	|O

D	|B-PROTEIN
-	|I-PROTEIN
cyclin	|I-PROTEIN
-	|O
cdk	|B-PROTEIN
activity	|O
is	|O
required	|O
for	|O
Rb	|B-PROTEIN
phosphorylation	|O
in	|O
v	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
-	|O
transformed	|O
cells	|O
,	|O
since	|O
ectopic	|O
expression	|O
of	|O
the	|O
cdk4	|B-PROTEIN
-	|O
and	|O
cdk6	|B-PROTEIN
-	|O
specific	|O
inhibitor	|O
p16	|B-PROTEIN
(	|O
INK4A	|B-PROTEIN
)	|O
inhibits	|O
both	|O
DNA	|O
synthesis	|O
and	|O
cell	|O
proliferation	|O
.	|O

CONCLUSION	|O
:	|O
A	|O
valve	|O
-	|O
like	|O
mechanism	|O
formed	|O
by	|O
the	|O
capsulorhexis	|O
rim	|O
partially	|O
adhered	|O
to	|O
the	|O
IOL	|O
optic	|O
can	|O
occur	|O
postoperatively	|O
.	|O

The	|O
protein	|O
first	|O
identified	|O
by	|O
the	|O
monoclonal	|O
antibody	|O
Q18	|B-PROTEIN
is	|O
encoded	|O
by	|O
a	|O
gene	|O
located	|O
in	|O
57A	|O
on	|O
polytene	|O
chromosomes	|O
and	|O
has	|O
been	|O
consequently	|O
named	|O
Hrb57A	|B-PROTEIN
.	|O

3'	|O
RNA	|O
boundary	|O
experiments	|O
indicate	|O
that	|O
the	|O
5'	|O
structure	|O
reduces	|O
the	|O
number	|O
of	|O
(	|O
G	|O
/	|O
U	|O
)	|O
AG	|O
repeats	|O
required	|O
for	|O
stable	|O
TRAP	|B-PROTEIN
-	|O
trp	|B-PROTEIN
leader	|O
RNA	|O
association	|O
.	|O

Gene	|O
silencing	|O
associated	|O
with	|O
repeated	|O
DNA	|O
sequences	|O
has	|O
been	|O
reported	|O
for	|O
many	|O
eukaryotes	|O
,	|O
including	|O
plants	|O
.	|O

The	|O
AtERF	|B-PROTEIN
genes	|O
were	|O
differentially	|O
regulated	|O
by	|O
ethylene	|O
and	|O
by	|O
abiotic	|O
stress	|O
conditions	|O
,	|O
such	|O
as	|O
wounding	|O
,	|O
cold	|O
,	|O
high	|O
salinity	|O
,	|O
or	|O
drought	|O
,	|O
via	|O
ETHYLENE	|B-PROTEIN
-	|I-PROTEIN
INSENSITIVE2	|I-PROTEIN
(	|O
EIN2	|B-PROTEIN
)	|O
-	|O
dependent	|O
or	|O
-	|O
independent	|O
pathways	|O
.	|O

Animals	|O
received	|O
a	|O
dose	|O
of	|O
dexamethasone	|O
(	|O
10	|O
mg	|O
/	|O
kg	|O
i.p	|O
.	|O
)	|O
prior	|O
to	|O
the	|O
protein	|O
-	|O
free	|O
surfactant	|O
preparation	|O
Exosurf	|O
(	|O
pure	|O
phospholipids	|O
containing	|O
surfactant	|O
,	|O
Wellcome	|O
GmbH	|O
,	|O
Burgwedel	|O
,	|O
Germany	|O
)	|O
and	|O
a	|O
rSP	|O
-	|O
C	|O
based	|O
surfactant	|O
,	|O
respectively	|O
.	|O

BACKGROUND	|O
:	|O
The	|O
aim	|O
of	|O
this	|O
study	|O
was	|O
to	|O
determine	|O
the	|O
response	|O
rates	|O
and	|O
toxicity	|O
of	|O
two	|O
regimens	|O
containing	|O
granulocyte	|B-PROTEIN
-	|I-PROTEIN
macrophage	|I-PROTEIN
-	|I-PROTEIN
colony	|I-PROTEIN
stimulating	|I-PROTEIN
factor	|I-PROTEIN
(	|O
GM	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
)	|O
in	|O
combination	|O
with	|O
interleukin	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
(	|O
IL	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
)	|O
in	|O
the	|O
treatment	|O
of	|O
patients	|O
with	|O
metastatic	|O
renal	|O
cell	|O
carcinoma	|O
.	|O

We	|O
show	|O
,	|O
by	|O
injection	|O
of	|O
synthetic	|O
mRNAs	|O
,	|O
that	|O
the	|O
cis	|O
-	|O
acting	|O
sequences	|O
responsible	|O
for	|O
repression	|O
of	|O
cyclin	|B-PROTEIN
B1	|I-PROTEIN
mRNA	|O
reside	|O
within	|O
its	|O
3'	|O
UTR	|O
.	|O

These	|O
data	|O
indicate	|O
that	|O
expansion	|O
of	|O
the	|O
dodecamer	|O
repeat	|O
located	|O
in	|O
the	|O
proximal	|O
promoter	|O
of	|O
CSTB	|B-PROTEIN
severely	|O
disrupts	|O
the	|O
function	|O
of	|O
the	|O
promoter	|O
and	|O
thereby	|O
reduces	|O
transcription	|O
of	|O
CSTB	|B-PROTEIN
.	|O

Thus	|O
,	|O
while	|O
the	|O
genomic	|O
organization	|O
of	|O
mHuA	|B-PROTEIN
is	|O
similar	|O
to	|O
the	|O
neural	|O
-	|O
restricted	|O
members	|O
of	|O
the	|O
Elav	|B-PROTEIN
family	|O
,	|O
the	|O
promoter	|O
element	|O
differs	|O
substantially	|O
both	|O
by	|O
sequence	|O
analysis	|O
and	|O
transcriptional	|O
activity	|O
in	|O
non	|O
-	|O
neural	|O
cell	|O
types	|O
.	|O

Analysis	|O
of	|O
the	|O
5'	|O
end	|O
of	|O
the	|O
mouse	|O
Elavl1	|B-PROTEIN
(	|O
mHuA	|B-PROTEIN
)	|O
gene	|O
reveals	|O
a	|O
transcriptional	|O
regulatory	|O
element	|O
and	|O
evidence	|O
for	|O
conserved	|O
genomic	|O
organization	|O
.	|O
mHuA	|B-PROTEIN
(	|O
Elavl1	|B-PROTEIN
)	|O
belongs	|O
to	|O
a	|O
highly	|O
conserved	|O
family	|O
of	|O
genes	|O
encoding	|O
RNA	|O
-	|O
binding	|O
proteins	|O
and	|O
has	|O
been	|O
linked	|O
to	|O
cell	|O
growth	|O
and	|O
proliferation	|O
through	|O
its	|O
regulation	|O
of	|O
mRNA	|O
stability	|O
.	|O

Electrophoretic	|O
mobility	|O
shift	|O
assays	|O
revealed	|O
that	|O
Sp1	|B-PROTEIN
binds	|O
to	|O
two	|O
different	|O
regions	|O
in	|O
the	|O
proximal	|O
promoter	|O
,	|O
a	|O
typical	|O
Sp1	|B-PROTEIN
site	|O
located	|O
at	|O
(	|O
-	|O
38	|O
;	|O
-	|O
33	|O
)	|O
and	|O
a	|O
G	|O
/	|O
C	|O
-	|O
rich	|O
region	|O
between	|O
(	|O
-	|O
67	|O
;	|O
-	|O
62	|O
)	|O
.	|O

Fgd3	|B-PROTEIN
and	|O
FGD1	|B-PROTEIN
share	|O
a	|O
high	|O
degree	|O
of	|O
sequence	|O
identity	|O
that	|O
spans	|O
>	|O
560	|O
contiguous	|O
amino	|O
acid	|O
residues	|O
.	|O

Molecular	|O
cloning	|O
of	|O
mouse	|O
thioredoxin	|B-PROTEIN
reductases	|I-PROTEIN
.	|O

The	|O
HPLC	|O
method	|O
involves	|O
an	|O
octadecylsilane	|O
column	|O
at	|O
55	|O
degrees	|O
C	|O
,	|O
a	|O
mixture	|O
of	|O
water	|O
-	|O
acetonitrile	|O
-	|O
orthophosphoric	|O
acid	|O
(	|O
779	|O
:	|O
220	|O
:	|O
1	|O
,	|O
v	|O
/	|O
v	|O
)	|O
as	|O
mobile	|O
phase	|O
and	|O
detection	|O
at	|O
226	|O
nm	|O
.	|O

Eight	|O
patients	|O
received	|O
1.5	|O
mg	|O
of	|O
adefovir	|O
dipivoxil	|O
per	|O
kg	|O
of	|O
body	|O
weight	|O
,	|O
and	|O
six	|O
patients	|O
received	|O
3.0	|O
mg	|O
of	|O
adefovir	|O
dipivoxil	|O
per	|O
kg	|O
.	|O

CYC2	|B-PROTEIN
encodes	|O
a	|O
24	|O
-	|O
kDa	|O
protein	|O
that	|O
has	|O
sequence	|O
identity	|O
to	|O
the	|O
Neurospora	|O
crassa	|O
PREG1	|B-PROTEIN
and	|O
the	|O
S.	|O
cerevisiae	|O
PHO80	|B-PROTEIN
cyclin	|I-PROTEIN
.	|O

To	|O
determine	|O
if	|O
CYC2	|B-PROTEIN
is	|O
found	|O
in	|O
a	|O
complex	|O
with	|O
previously	|O
identified	|O
trypanosome	|O
cdc2	|B-PROTEIN
-	|I-PROTEIN
related	|I-PROTEIN
kinases	|I-PROTEIN
(	|O
CRKs	|B-PROTEIN
)	|O
,	|O
the	|O
CYC2	|B-PROTEIN
gene	|O
was	|O
fused	|O
to	|O
the	|O
TY	|B-PROTEIN
epitope	|O
tag	|O
,	|O
integrated	|O
into	|O
the	|O
trypanosome	|O
genome	|O
,	|O
and	|O
expressed	|O
under	|O
inducible	|O
control	|O
.	|O

These	|O
findings	|O
indicate	|O
the	|O
involvement	|O
of	|O
Sp1	|B-PROTEIN
and	|O
an	|O
Inr	|O
in	|O
non	|O
-	|O
cell	|O
-	|O
specific	|O
regulation	|O
and	|O
a	|O
Kruppel	|B-PROTEIN
-	|O
like	|O
transcription	|O
factor	|O
and	|O
Sp1	|B-PROTEIN
in	|O
the	|O
cell	|O
-	|O
specific	|O
regulation	|O
of	|O
the	|O
LTC	|B-PROTEIN
(	|I-PROTEIN
4	|I-PROTEIN
)	|I-PROTEIN
S	|I-PROTEIN
gene	|O
.	|O

Here	|O
we	|O
review	|O
progress	|O
to	|O
date	|O
in	|O
this	|O
area	|O
.	|O

Additionally	|O
,	|O
the	|O
mouse	|O
promoter	|O
contains	|O
22	|O
copies	|O
of	|O
a	|O
CT	|O
dinucleotide	|O
repeat	|O
sequence	|O
located	|O
approximately	|O
155	|O
bp	|O
5'	|O
to	|O
exon	|O
1	|O
.	|O

The	|O
newly	|O
defined	|O
region	|O
contains	|O
an	|O
intron	|O
that	|O
may	|O
be	|O
alternatively	|O
spliced	|O
and	|O
seven	|O
polyadenylation	|O
signal	|O
sequences	|O
.	|O

Depleted	|O
and	|O
enriched	|O
U3O8	|O
standard	|O
reference	|O
materials	|O
were	|O
used	|O
to	|O
calibrate	|O
the	|O
system	|O
.	|O

Therefore	|O
,	|O
the	|O
positive	|O
cAMP	|O
control	|O
of	|O
the	|O
hypoxic	|O
SRP1	|B-PROTEIN
and	|O
HEM13	|B-PROTEIN
genes	|O
was	|O
uncoupled	|O
from	|O
the	|O
HOG	|B-PROTEIN
pathway	|O
.	|O

Most	|O
likely	|O
they	|O
might	|O
represent	|O
regulatory	|O
RNAs	|O
or	|O
transcribed	|O
transposable	|O
elements	|O
.	|O

This	|O
paper	|O
reviews	|O
the	|O
middleware	|O
-	|O
based	|O
approach	|O
adopted	|O
by	|O
CEN	|O
ENV	|O
12967-1	|O
and	|O
the	|O
specialisation	|O
necessary	|O
for	|O
the	|O
healthcare	|O
record	|O
based	|O
on	|O
CEN	|O
ENV	|O
12265	|O
'	|O
Electronic	|O
Healthcare	|O
Record	|O
Architecture	|O
'	|O
.	|O

Sequence	|O
analyses	|O
of	|O
sos2	|B-PROTEIN
mutant	|O
alleles	|O
reveal	|O
that	|O
both	|O
the	|O
N	|O
-	|O
terminal	|O
catalytic	|O
domain	|O
and	|O
the	|O
C	|O
-	|O
terminal	|O
regulatory	|O
domain	|O
of	|O
SOS2	|B-PROTEIN
are	|O
functionally	|O
essential	|O
.	|O

A	|O
mutation	|O
which	|O
abrogates	|O
the	|O
binding	|O
of	|O
these	|O
factors	|O
reduces	|O
Wp	|B-PROTEIN
reporter	|O
activity	|O
specifically	|O
in	|O
B	|O
cell	|O
lines	|O
,	|O
whereas	|O
a	|O
mutation	|O
which	|O
converts	|O
the	|O
site	|O
to	|O
a	|O
consensus	|O
CREB	|B-PROTEIN
-	|O
binding	|O
sequence	|O
maintains	|O
wild	|O
-	|O
type	|O
promoter	|O
function	|O
.	|O

Here	|O
we	|O
describe	|O
the	|O
cloning	|O
,	|O
tissue	|O
-	|O
specific	|O
expression	|O
pattern	|O
,	|O
and	|O
functional	|O
characterization	|O
of	|O
two	|O
novel	|O
TEF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
isoforms	|O
,	|O
TEF	|B-PROTEIN
-	|I-PROTEIN
1beta	|I-PROTEIN
and	|O
TEF	|B-PROTEIN
-	|I-PROTEIN
1gamma	|I-PROTEIN
.	|O

Therefore	|O
the	|O
binding	|O
sites	|O
for	|O
liver	|O
-	|O
enriched	|O
factors	|O
,	|O
present	|O
in	|O
the	|O
hamster	|O
CYP7A1	|B-PROTEIN
proximal	|O
promoter	|O
in	|O
close	|O
vicinity	|O
and	|O
conserved	|O
between	|O
species	|O
,	|O
constitute	|O
a	|O
regulatory	|O
unit	|O
important	|O
for	|O
basal	|O
hepatic	|O
expression	|O
and	|O
tissue	|O
restriction	|O
of	|O
the	|O
action	|O
of	|O
hormones	|O
such	|O
as	|O
insulin	|B-PROTEIN
.	|O

The	|O
kinase	|O
activity	|O
of	|O
PfPK6	|B-PROTEIN
is	|O
sensitive	|O
to	|O
CDK	|B-PROTEIN
inhibitors	|O
such	|O
as	|O
olomoucine	|O
and	|O
roscovitine	|O
.	|O

Although	|O
MAP	|O
(	|B-PROTEIN
mitogen	|I-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
)	|I-PROTEIN
kinases	|I-PROTEIN
are	|O
implicated	|O
in	|O
cell	|O
proliferation	|O
and	|O
differentiation	|O
in	|O
many	|O
cell	|O
types	|O
,	|O
the	|O
role	|O
of	|O
MAP	|B-PROTEIN
kinases	|I-PROTEIN
in	|O
cardiac	|O
hypertrophy	|O
remains	|O
unclear	|O
.	|O

Transfection	|O
with	|O
a	|O
CSF	|B-PROTEIN
-	|I-PROTEIN
1R	|I-PROTEIN
expression	|O
plasmid	|O
permitted	|O
CSF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|O
dependent	|O
activation	|O
of	|O
the	|O
signalling	|O
pathway	|O
targeting	|O
an	|O
Ets	|B-PROTEIN
/	|O
AP1	|B-PROTEIN
(	|O
activator	|B-PROTEIN
protein	|I-PROTEIN
1	|I-PROTEIN
)	|O
element	|O
in	|O
the	|O
uPA	|B-PROTEIN
promoter	|O
that	|O
has	|O
been	|O
shown	|O
previously	|O
to	|O
be	|O
a	|O
target	|O
of	|O
oncogenic	|O
ras	|B-PROTEIN
and	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
C	|I-PROTEIN
pathways	|O
.	|O

Regulation	|O
of	|O
urokinase	|B-PROTEIN
plasminogen	|I-PROTEIN
activator	|I-PROTEIN
gene	|O
transcription	|O
in	|O
the	|O
RAW264	|O
murine	|O
macrophage	|O
cell	|O
line	|O
by	|O
macrophage	|B-PROTEIN
colony	|I-PROTEIN
-	|I-PROTEIN
stimulating	|I-PROTEIN
factor	|I-PROTEIN
(	|O
CSF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
is	|O
dependent	|O
upon	|O
the	|O
level	|O
of	|O
cell	|O
-	|O
surface	|O
receptor	|O
.	|O

Molecule	|O
(	|O
s	|O
)	|O
secreted	|O
by	|O
neuronal	|O
cultures	|O
contribute	|O
to	|O
this	|O
induction	|O
of	|O
GLT	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
but	|O
little	|O
is	|O
known	|O
about	|O
the	|O
signaling	|O
pathways	|O
mediating	|O
this	|O
regulation	|O
.	|O

Coactivation	|O
of	|O
endogenous	|O
or	|O
exogenous	|O
G	|B-PROTEIN
(	|I-PROTEIN
q	|I-PROTEIN
)	|I-PROTEIN
-	|I-PROTEIN
coupled	|I-PROTEIN
receptors	|I-PROTEIN
with	|O
the	|O
delta	|B-PROTEIN
-	|I-PROTEIN
opioid	|I-PROTEIN
receptor	|I-PROTEIN
produced	|O
strong	|O
stimulations	|O
of	|O
PLCbeta	|B-PROTEIN
and	|O
such	|O
responses	|O
could	|O
be	|O
partially	|O
blocked	|O
by	|O
pertussis	|B-PROTEIN
toxin	|I-PROTEIN
.	|O

Patients	|O
enrolled	|O
in	|O
the	|O
Integrilin	|O
to	|O
Minimize	|O
Platelet	|O
Aggregation	|O
and	|O
Coronary	|O
Thrombosis	|O
-	|O
II	|O
(	|O
IMPACT	|O
-	|O
II	|O
)	|O
trial	|O
were	|O
analyzed	|O
.	|O

The	|O
Wnt	|B-PROTEIN
signaling	|O
pathway	|O
functions	|O
reiteratively	|O
during	|O
animal	|O
development	|O
to	|O
control	|O
cell	|O
fate	|O
decisions	|O
.	|O

This	|O
mutation	|O
no	|O
longer	|O
repressed	|O
the	|O
HPV	|O
-	|O
11	|O
upstream	|O
regulatory	|O
region	|O
-	|O
controlled	|O
reporter	|O
expression	|O
.	|O

In	|O
the	|O
icosahaedral	|O
MVMi	|O
capsid	|O
,	|O
this	|O
sequence	|O
forms	|O
the	|O
carboxy	|O
end	|O
of	|O
the	|O
amphipathic	|O
beta	|O
-	|O
strand	|O
I	|O
(	|O
betaI	|O
)	|O
,	|O
and	|O
all	|O
its	|O
basic	|O
residues	|O
are	|O
contiguously	|O
positioned	|O
at	|O
the	|O
face	|O
that	|O
in	|O
the	|O
unassembled	|O
subunit	|O
would	|O
be	|O
exposed	|O
to	|O
solvent	|O
.	|O

The	|O
two	|O
contiguous	|O
IGF2	|B-PROTEIN
(	|O
human	|O
insulin	|B-PROTEIN
-	|I-PROTEIN
like	|I-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
II	|I-PROTEIN
)	|O
and	|O
H19	|B-PROTEIN
genes	|O
are	|O
reciprocally	|O
imprinted	|O
in	|O
both	|O
human	|O
and	|O
mouse	|O
.	|O

The	|O
asymmetric	|O
methylation	|O
was	|O
associated	|O
with	|O
tissue	|O
-	|O
specific	|O
disruption	|O
of	|O
H19	|B-PROTEIN
genomic	|O
imprinting	|O
in	|O
fetal	|O
brain	|O
.	|O

The	|O
comparison	|O
of	|O
the	|O
expression	|O
patterns	|O
of	|O
the	|O
known	|O
Kv4	|B-PROTEIN
family	|O
members	|O
shows	|O
subtype	|O
specificity	|O
with	|O
significant	|O
overlaps	|O
.	|O

Early	|O
treatment	|O
mechanics	|O
of	|O
the	|O
Class	|O
II	|O
division	|O
2	|O
malocclusion	|O
.	|O

Preliminary	|O
use	|O
of	|O
the	|O
Nottingham	|O
Eczema	|O
Severity	|O
Score	|O
would	|O
support	|O
further	|O
development	|O
as	|O
a	|O
research	|O
tool	|O
for	|O
a	|O
simple	|O
assessment	|O
of	|O
disease	|O
severity	|O
that	|O
could	|O
be	|O
used	|O
in	|O
epidemiological	|O
studies	|O
.	|O

The	|O
consensus	|O
highlights	|O
the	|O
importance	|O
of	|O
residues	|O
other	|O
than	|O
the	|O
eight	|O
motifs	|O
that	|O
are	|O
often	|O
associated	|O
with	|O
DEAD	|O
-	|O
box	|O
RNA	|B-PROTEIN
helicases	|I-PROTEIN
,	|O
as	|O
well	|O
as	|O
de	|O
-	|O
emphasising	|O
the	|O
importance	|O
of	|O
the	|O
"	|O
A	|O
"	|O
residue	|O
within	|O
the	|O
"	|O
DEAD	|O
"	|O
motif	|O
.	|O

Advanced	|O
adenoma	|O
was	|O
defined	|O
as	|O
an	|O
adenoma	|O
larger	|O
than	|O
10	|O
mm	|O
or	|O
an	|O
adenoma	|O
of	|O
any	|O
size	|O
with	|O
villous	|O
component	|O
,	|O
high	|O
-	|O
grade	|O
dysplasia	|O
or	|O
invasive	|O
carcinoma	|O
.	|O

In	|O
transient	|O
assays	|O
,	|O
using	|O
rice	|O
suspension	|O
-	|O
cultured	|O
cells	|O
transformed	|O
by	|O
particle	|O
bombardment	|O
,	|O
we	|O
showed	|O
previously	|O
that	|O
Oshox1	|B-PROTEIN
can	|O
transcriptionally	|O
repress	|O
the	|O
activity	|O
of	|O
reporter	|O
gene	|O
constructs	|O
with	|O
upstream	|O
HD	|B-PROTEIN
-	|I-PROTEIN
Zip	|I-PROTEIN
binding	|O
sites	|O
.	|O

Results	|O
of	|O
two	|O
-	|O
hybrid	|O
assays	|O
and	|O
electrophoretic	|O
mobility	|O
shift	|O
assays	|O
strongly	|O
suggest	|O
that	|O
all	|O
HD	|B-PROTEIN
-	|I-PROTEIN
Zip	|I-PROTEIN
proteins	|O
of	|O
families	|O
I	|O
and	|O
II	|O
can	|O
form	|O
homodimers	|O
and	|O
also	|O
heterodimers	|O
with	|O
all	|O
HD	|B-PROTEIN
-	|I-PROTEIN
Zip	|I-PROTEIN
proteins	|O
of	|O
the	|O
same	|O
family	|O
.	|O

Among	|O
mammalian	|O
HSFs	|B-PROTEIN
,	|O
HSF1	|B-PROTEIN
has	|O
been	|O
shown	|O
to	|O
be	|O
important	|O
for	|O
regulation	|O
of	|O
the	|O
heat	|O
-	|O
induced	|O
stress	|O
gene	|O
expression	|O
,	|O
whereas	|O
the	|O
function	|O
of	|O
HSF2	|B-PROTEIN
in	|O
stress	|O
response	|O
is	|O
unclear	|O
.	|O

Importantly	|O
,	|O
concomitant	|O
expression	|O
of	|O
constitutive	|O
activated	|O
Raf	|B-PROTEIN
and	|O
V12N38	|B-PROTEIN
Ras	|I-PROTEIN
results	|O
in	|O
almost	|O
complete	|O
loss	|O
of	|O
TTF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
activity	|O
.	|O

They	|O
share	|O
many	|O
downstream	|O
targets	|O
,	|O
including	|O
remodeling	|O
of	|O
the	|O
actin	|B-PROTEIN
cytoskeleton	|O
,	|O
activation	|O
of	|O
p70	|B-PROTEIN
(	|I-PROTEIN
S6	|I-PROTEIN
)	|I-PROTEIN
kinase	|O
and	|O
c	|B-PROTEIN
-	|I-PROTEIN
jun	|I-PROTEIN
N	|I-PROTEIN
-	|I-PROTEIN
terminal	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
JNK	|B-PROTEIN
)	|O
,	|O
and	|O
regulation	|O
of	|O
transcription	|O
and	|O
cell	|O
proliferation	|O
.	|O

Expression	|O
of	|O
activated	|O
Cdc42	|B-PROTEIN
results	|O
in	|O
the	|O
translocation	|O
of	|O
PKClambda	|B-PROTEIN
from	|O
the	|O
nucleus	|O
into	|O
the	|O
cytosol	|O
,	|O
and	|O
Cdc42	|B-PROTEIN
and	|O
PKClambda	|B-PROTEIN
colocalize	|O
at	|O
the	|O
plasma	|O
membrane	|O
and	|O
in	|O
the	|O
cytoplasm	|O
.	|O

Copyright	|O
2000	|O
Academic	|O
Press	|O
.	|O

To	|O
understand	|O
whether	|O
Shc	|B-PROTEIN
localization	|O
in	|O
membrane	|O
rafts	|O
is	|O
sufficient	|O
to	|O
regulate	|O
Shc	|B-PROTEIN
function	|O
,	|O
we	|O
constructed	|O
a	|O
Shc	|B-PROTEIN
chimera	|O
containing	|O
the	|O
Ras	|B-PROTEIN
membrane	|O
localization	|O
motif	|O
at	|O
the	|O
C	|O
-	|O
terminus	|O
.	|O

Southern	|O
blotting	|O
and	|O
single	|O
strand	|O
conformation	|O
polymorphism	|O
analyses	|O
did	|O
not	|O
show	|O
tumor	|O
-	|O
specific	|O
alterations	|O
of	|O
this	|O
gene	|O
in	|O
gliomas	|O
and	|O
RT	|O
-	|O
PCR	|O
studies	|O
showed	|O
expression	|O
in	|O
glioma	|O
cell	|O
lines	|O
,	|O
suggesting	|O
that	|O
ANOVA	|B-PROTEIN
is	|O
not	|O
the	|O
chromosome	|O
19q	|O
glioma	|O
tumor	|O
suppressor	|O
gene	|O
.	|O

RegA	|B-PROTEIN
is	|O
a	|O
positive	|O
yet	|O
nonessential	|O
regulator	|O
of	|O
tol	|B-PROTEIN
-	|O
oprL	|B-PROTEIN
expression	|O
.	|O

Enzyme	|B-PROTEIN
I	|I-PROTEIN
of	|O
the	|O
phosphoenolpyruvate	|B-PROTEIN
:	|I-PROTEIN
sugar	|I-PROTEIN
phosphotransferase	|I-PROTEIN
system	|O
.	|O

Based	|O
on	|O
these	|O
data	|O
,	|O
we	|O
conclude	|O
that	|O
transcription	|O
of	|O
prgX	|B-PROTEIN
is	|O
initiated	|O
from	|O
the	|O
Qa	|B-PROTEIN
promoter	|O
in	|O
prgQ	|B-PROTEIN
,	|O
and	|O
PrgX	|B-PROTEIN
autoregulates	|O
its	|O
transcription	|O
either	|O
by	|O
mediating	|O
transcriptional	|O
readthrough	|O
or	|O
increasing	|O
mRNA	|O
stability	|O
.	|O

It	|O
was	|O
established	|O
that	|O
intrathecal	|O
or	|O
intraperitoneal	|O
PTFL	|O
,	|O
elevated	|O
the	|O
nociceptive	|O
threshold	|O
for	|O
mechanical	|O
stimuli	|O
in	|O
the	|O
formalin	|O
test	|O
in	|O
rats	|O
.	|O

Molecular	|O
mimicry	|O
of	|O
human	|O
cytokine	|O
and	|O
cytokine	|O
response	|O
pathway	|O
genes	|O
by	|O
KSHV	|O
.	|O

Family	|O
environment	|O
was	|O
an	|O
important	|O
influence	|O
on	|O
interpersonal	|O
relationships	|O
,	|O
substance	|O
use	|O
,	|O
and	|O
social	|O
support	|O
.	|O

By	|O
electrophoresis	|O
mobility	|O
shift	|O
assays	|O
using	|O
probes	|O
corresponding	|O
to	|O
different	|O
segments	|O
of	|O
the	|O
putative	|O
human	|O
c	|B-PROTEIN
-	|I-PROTEIN
myb	|I-PROTEIN
intron	|O
1	|O
transcription	|O
pause	|O
region	|O
and	|O
nuclear	|O
extracts	|O
from	|O
myeloid	|O
leukemia	|O
HL	|O
60	|O
and	|O
fibroblast	|O
WI	|O
38	|O
cells	|O
,	|O
we	|O
detected	|O
a	|O
HL	|O
-	|O
60	|O
-	|O
specific	|O
DNA	|O
-	|O
protein	|O
complex	|O
with	|O
a	|O
123	|O
-	|O
bp	|O
fragment	|O
containing	|O
binding	|O
sites	|O
for	|O
the	|O
interferon	|B-PROTEIN
regulatory	|I-PROTEIN
factors	|I-PROTEIN
(	|O
IRFs	|B-PROTEIN
)	|O
nuclear	|O
proteins	|O
.	|O

STUDY	|O
DESIGN	|O
:	|O
Fine	|O
needle	|O
aspiration	|O
cytologic	|O
smears	|O
from	|O
21	|O
cases	|O
of	|O
invasive	|O
lobular	|O
carcinoma	|O
(	|O
ILC	|O
)	|O
of	|O
breast	|O
were	|O
subjected	|O
to	|O
detailed	|O
cytomorphologic	|O
analysis	|O
.	|O

Electrophile	|O
Response	|O
Elements	|O
(	|O
EpREs	|O
)	|O
,	|O
located	|O
in	|O
5'	|O
-	|O
flanking	|O
sequences	|O
of	|O
both	|O
the	|O
GCSh	|B-PROTEIN
and	|O
GCSl	|B-PROTEIN
subunit	|O
genes	|O
,	|O
are	|O
hypothesized	|O
to	|O
at	|O
least	|O
partially	|O
mediate	|O
gene	|O
induction	|O
following	|O
xenobiotic	|O
exposure	|O
.	|O

A	|O
new	|O
technique	|O
to	|O
create	|O
an	|O
artificial	|O
stenosis	|O
in	|O
the	|O
native	|O
LAD	|O
using	|O
a	|O
hemoclip	|O
.	|O

Dll3	|B-PROTEIN
is	|O
mutated	|O
in	|O
the	|O
X	|O
-	|O
ray	|O
-	|O
induced	|O
mouse	|O
mutant	|O
pudgy	|B-PROTEIN
(	|O
pu	|B-PROTEIN
)	|O
,	|O
causing	|O
a	|O
variety	|O
of	|O
vertebrocostal	|O
defects	|O
similar	|O
to	|O
SD	|O
phenotypes	|O
.	|O

Schlegel	|O
,	|O
J.	|O

TbRAB31	|B-PROTEIN
behaviour	|O
was	|O
also	|O
studied	|O
during	|O
the	|O
cell	|O
cycle	|O
;	|O
TbRAB31	|B-PROTEIN
always	|O
localised	|O
to	|O
a	|O
discrete	|O
structure	|O
that	|O
duplicated	|O
very	|O
early	|O
in	|O
mitosis	|O
and	|O
relocated	|O
to	|O
daughter	|O
cells	|O
in	|O
a	|O
coordinate	|O
manner	|O
with	|O
the	|O
basal	|O
body	|O
and	|O
kinetoplast	|O
,	|O
suggesting	|O
the	|O
involvement	|O
of	|O
microtubules	|O
.	|O

The	|O
early	|O
dg	|O
.	|O
of	|O
rejection	|O
and	|O
especially	|O
acute	|O
rejection	|O
,	|O
it	|O
's	|O
adequate	|O
management	|O
,	|O
decreased	|O
risk	|O
for	|O
the	|O
future	|O
chronic	|O
rejection	|O
nephropathy	|O
.	|O

Invertases	|B-PROTEIN
are	|O
responsible	|O
for	|O
the	|O
breakdown	|O
of	|O
sucrose	|O
to	|O
fructose	|O
and	|O
glucose	|O
.	|O

To	|O
investigate	|O
the	|O
molecular	|O
mechanisms	|O
of	|O
this	|O
Tax	|B-PROTEIN
-	|O
mediated	|O
inhibition	|O
,	|O
we	|O
analyzed	|O
its	|O
effect	|O
on	|O
the	|O
transcriptional	|O
activity	|O
of	|O
the	|O
myogenic	|O
MyoD	|B-PROTEIN
protein	|O
,	|O
which	|O
was	|O
used	|O
as	|O
a	|O
paradigm	|O
of	|O
bHLH	|B-PROTEIN
factors	|I-PROTEIN
.	|O

The	|O
human	|O
T	|O
cell	|O
leukemia	|O
/	|O
lymphotropic	|O
virus	|O
type	|O
1	|O
Tax	|B-PROTEIN
protein	|O
represses	|O
MyoD	|B-PROTEIN
-	|O
dependent	|O
transcription	|O
by	|O
inhibiting	|O
MyoD	|B-PROTEIN
-	|O
binding	|O
to	|O
the	|O
KIX	|B-PROTEIN
domain	|O
of	|O
p300	|B-PROTEIN
.	|O

Phosphorylation	|O
and	|O
spindle	|O
pole	|O
body	|O
localization	|O
of	|O
the	|O
Cdc15p	|B-PROTEIN
mitotic	|O
regulatory	|O
protein	|O
kinase	|O
in	|O
budding	|O
yeast	|O
.	|O

Thus	|O
,	|O
both	|O
the	|O
hyperplasia	|O
and	|O
thrombotic	|O
complications	|O
which	|O
often	|O
follow	|O
stenting	|O
might	|O
be	|O
minimized	|O
by	|O
employing	|O
gold	|O
stents	|O
,	|O
which	|O
have	|O
a	|O
greater	|O
capacity	|O
than	|O
steel	|O
in	|O
supporting	|O
a	|O
functional	|O
neo	|O
-	|O
endothelium	|O
.	|O

The	|O
cell	|O
cycle	|O
and	|O
transcriptional	|O
defects	|O
caused	|O
by	|O
taf17	|B-PROTEIN
(	|O
slm7	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
are	|O
consistent	|O
with	|O
the	|O
role	|O
of	|O
TAF	|B-PROTEIN
(	|I-PROTEIN
II	|I-PROTEIN
)	|I-PROTEIN
s	|I-PROTEIN
as	|O
modulators	|O
of	|O
transcriptional	|O
activation	|O
and	|O
may	|O
reflect	|O
a	|O
role	|O
for	|O
TAF17	|B-PROTEIN
in	|O
regulating	|O
activation	|O
by	|O
SBF	|B-PROTEIN
and	|O
MBF	|B-PROTEIN
.	|O

Extracellular	|B-PROTEIN
-	|I-PROTEIN
regulated	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
ERK	|B-PROTEIN
)	|O
activation	|O
and	|O
molecular	|O
coupling	|O
of	|O
the	|O
adaptor	|O
proteins	|O
p130	|B-PROTEIN
Crk	|O
-	|O
associated	|O
substrate	|O
(	|O
CAS	|B-PROTEIN
)	|O
and	|O
c	|B-PROTEIN
-	|I-PROTEIN
CrkII	|I-PROTEIN
(	|O
Crk	|B-PROTEIN
)	|O
represent	|O
two	|O
distinct	|O
pathways	|O
that	|O
induce	|O
cell	|O
invasion	|O
and	|O
protect	|O
cells	|O
from	|O
apoptosis	|O
in	|O
a	|O
three	|O
-	|O
dimensional	|O
collagen	|B-PROTEIN
matrix	|O
.	|O

Proteolysis	|O
of	|O
Mbp1	|B-PROTEIN
and	|O
Swi4	|B-PROTEIN
DNA	|O
-	|O
protein	|O
complexes	|O
has	|O
revealed	|O
the	|O
extent	|O
of	|O
these	|O
sequences	|O
,	|O
and	|O
C	|O
-	|O
terminally	|O
extended	|O
molecules	|O
with	|O
substantially	|O
enhanced	|O
DNA	|O
binding	|O
activity	|O
compared	|O
to	|O
the	|O
core	|O
domains	|O
alone	|O
have	|O
been	|O
produced	|O
.	|O

The	|O
evolution	|O
of	|O
the	|O
CCR5	|B-PROTEIN
cis	|O
-	|O
regulatory	|O
region	|O
versus	|O
the	|O
open	|O
reading	|O
frame	|O
as	|O
well	|O
as	|O
among	|O
different	|O
domains	|O
of	|O
the	|O
open	|O
reading	|O
frame	|O
differed	|O
from	|O
one	|O
another	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
residue	|O
266	|O
serves	|O
as	|O
a	|O
"	|O
protein	|O
sensor	|O
"	|O
of	|O
altered	|O
minor	|O
groove	|O
interactions	|O
and	|O
identifies	|O
which	|O
base	|O
pair	|O
interactions	|O
are	|O
altered	|O
by	|O
these	|O
lesions	|O
.	|O

The	|O
recombinant	|O
enzymes	|O
exist	|O
as	|O
monomers	|O
.	|O

A	|O
pathway	|O
for	|O
regulation	|O
of	|O
B	|B-PROTEIN
lymphocyte	|I-PROTEIN
antigen	|I-PROTEIN
receptor	|I-PROTEIN
-	|O
induced	|O
calcium	|O
flux	|O
.	|O

We	|O
now	|O
describe	|O
a	|O
second	|O
RIM	|B-PROTEIN
protein	|O
,	|O
called	|O
RIM2	|B-PROTEIN
,	|O
that	|O
is	|O
highly	|O
homologous	|O
to	|O
RIM1	|B-PROTEIN
and	|O
also	|O
expressed	|O
primarily	|O
in	|O
brain	|O
.	|O

Inhibitor	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
(	|O
I	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
and	|O
inhibitor	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
(	|O
I	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
)	|O
selectively	|O
inhibit	|O
type	|B-PROTEIN
1	|I-PROTEIN
protein	|I-PROTEIN
serine	|I-PROTEIN
/	|I-PROTEIN
threonine	|I-PROTEIN
phosphatases	|I-PROTEIN
(	|O
PP1	|B-PROTEIN
)	|O
.	|O

Scanning	|O
mutations	|O
throughout	|O
the	|O
AC	|O
element	|O
interfered	|O
with	|O
induction	|O
but	|O
allowed	|O
us	|O
to	|O
define	|O
five	|O
overlapping	|O
sites	|O
for	|O
regulatory	|O
factors	|O
in	|O
AC	|O
and	|O
to	|O
design	|O
probes	|O
binding	|O
just	|O
one	|O
or	|O
two	|O
factors	|O
.	|O

The	|O
substrates	|O
for	|O
glycan	|O
synthesis	|O
in	|O
the	|O
lumen	|O
of	|O
the	|O
Golgi	|O
are	|O
nucleotide	|O
sugars	|O
that	|O
must	|O
be	|O
transported	|O
from	|O
the	|O
cytosol	|O
by	|O
specific	|O
membrane	|O
-	|O
bound	|O
transporters	|O
.	|O

Synaptic	|O
targeting	|O
of	|O
the	|O
postsynaptic	|O
density	|O
protein	|O
PSD	|B-PROTEIN
-	|I-PROTEIN
95	|I-PROTEIN
mediated	|O
by	|O
a	|O
tyrosine	|O
-	|O
based	|O
trafficking	|O
signal	|O
.	|O

(	|O
1998	|O
)	|O
J.	|O

Bites	|O
by	|O
two	|O
species	|O
of	|O
adders	|O
(	|O
Vipera	|O
aspis	|O
and	|O
Vipera	|O
berus	|O
)	|O
can	|O
lead	|O
to	|O
extensive	|O
swelling	|O
with	|O
multiorgan	|O
failure	|O
.	|O

Both	|O
normal	|O
and	|O
transforming	|O
PCPH	|B-PROTEIN
proteins	|O
have	|O
guanosine	|B-PROTEIN
diphosphatase	|I-PROTEIN
activity	|O
but	|O
only	|O
the	|O
oncoprotein	|O
cooperates	|O
with	|O
Ras	|B-PROTEIN
in	|O
activating	|O
extracellular	|B-PROTEIN
signal	|I-PROTEIN
-	|I-PROTEIN
regulated	|I-PROTEIN
kinase	|I-PROTEIN
ERK1	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
virulence	|O
-	|O
associated	|O
genes	|O
and	|O
their	|O
overall	|O
chromosomal	|O
arrangement	|O
are	|O
relatively	|O
well	|O
conserved	|O
between	|O
B.	|O
henselae	|O
and	|O
other	|O
gram	|O
-	|O
negative	|O
bacteria	|O
such	|O
as	|O
A.	|O
tumefaciens	|O
.	|O

An	|O
important	|O
mechanism	|O
by	|O
which	|O
the	|O
tumor	|O
suppressor	|O
p53	|B-PROTEIN
maintains	|O
genomic	|O
stability	|O
is	|O
to	|O
induce	|O
cell	|O
cycle	|O
arrest	|O
through	|O
activation	|O
of	|O
the	|O
cyclin	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
kinase	|I-PROTEIN
inhibitor	|O
p21	|B-PROTEIN
(	|O
WAF1	|B-PROTEIN
/	|O
Cip1	|B-PROTEIN
)	|O
gene	|O
.	|O

Paxillin	|B-PROTEIN
acts	|O
as	|O
an	|O
adaptor	|O
molecule	|O
in	|O
integrin	|B-PROTEIN
signaling	|O
.	|O

Thus	|O
,	|O
growth	|O
factor	|O
activation	|O
of	|O
ER	|B-PROTEIN
can	|O
mediate	|O
transactivation	|O
vs	|O
ER	|B-PROTEIN
/	|O
Sp1	|B-PROTEIN
binding	|O
to	|O
GC	|O
-	|O
rich	|O
sites	|O
and	|O
represents	|O
a	|O
novel	|O
pathway	|O
for	|O
ligand	|O
-	|O
independent	|O
ER	|B-PROTEIN
action	|O
.	|O

Furthermore	|O
,	|O
analysis	|O
of	|O
deletion	|O
promoter	|O
-	|O
reporter	|O
constructs	|O
found	|O
that	|O
the	|O
basal	|O
activity	|O
of	|O
P2	|O
resided	|O
in	|O
the	|O
proximal	|O
region	|O
of	|O
P2	|O
.	|O

RESULTS	|O
:	|O
Auditory	|O
thresholds	|O
collected	|O
during	|O
audiometric	|O
tests	|O
increased	|O
gradually	|O
in	|O
proportion	|O
with	|O
age	|O
,	|O
especially	|O
in	|O
the	|O
hypertensive	|O
group	|O
(	|O
p	|O
<	|O
0.05	|O
)	|O
.	|O

In	|O
addition	|O
,	|O
the	|O
transcription	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
IAP2	|I-PROTEIN
promoter	|O
was	|O
strongly	|O
up	|O
-	|O
regulated	|O
when	|O
CD40	|B-PROTEIN
or	|O
Epstein	|O
-	|O
Barr	|O
virus	|O
latent	|B-PROTEIN
membrane	|I-PROTEIN
protein	|I-PROTEIN
1	|I-PROTEIN
was	|O
overexpressed	|O
.	|O

A	|O
variety	|O
of	|O
professional	|O
and	|O
self	|O
-	|O
applied	|O
fluoride	|O
products	|O
are	|O
available	|O
and	|O
new	|O
fluoride	|O
delivery	|O
systems	|O
have	|O
recently	|O
entered	|O
the	|O
market	|O
.	|O

These	|O
studies	|O
identify	|O
several	|O
of	|O
the	|O
signal	|O
-	|O
transduction	|O
events	|O
involved	|O
in	|O
the	|O
apoptosis	|O
of	|O
malignant	|O
B	|O
cells	|O
that	|O
transpire	|O
following	|O
ligation	|O
of	|O
CD20	|B-PROTEIN
by	|O
anti	|B-PROTEIN
-	|I-PROTEIN
CD20	|I-PROTEIN
antibodies	|O
in	|O
the	|O
presence	|O
of	|O
Fc	|B-PROTEIN
-	|I-PROTEIN
receptor	|I-PROTEIN
-	|O
expressing	|O
cells	|O
or	|O
secondary	|O
goat	|O
anti	|B-PROTEIN
-	|I-PROTEIN
(	|I-PROTEIN
mouse	|I-PROTEIN
Ig	|I-PROTEIN
)	|I-PROTEIN
antibodies	|O
and	|O
which	|O
may	|O
contribute	|O
to	|O
the	|O
tumor	|O
regressions	|O
observed	|O
in	|O
mouse	|O
models	|O
and	|O
clinical	|O
trials	|O
.	|O

CONCLUSION	|O
:	|O
Treatment	|O
of	|O
sepsis	|O
with	|O
the	|O
platelet	|B-PROTEIN
-	|I-PROTEIN
activating	|I-PROTEIN
factor	|I-PROTEIN
antagonist	|O
BB	|O
-	|O
882	|O
offers	|O
no	|O
advantage	|O
over	|O
placebo	|O
on	|O
survival	|O
,	|O
hemodynamic	|O
status	|O
,	|O
respiratory	|O
function	|O
,	|O
or	|O
organ	|O
failure	|O
scores	|O
.	|O

Phenazone	|O
potentiates	|O
the	|O
local	|O
anaesthetic	|O
effect	|O
of	|O
lidocaine	|O
in	|O
mice	|O
.	|O

The	|O
solubility	|O
of	|O
all	|O
the	|O
mutated	|O
proteins	|O
was	|O
remarkably	|O
reduced	|O
.	|O

Recently	|O
,	|O
identical	|O
RBE	|B-PROTEIN
sequences	|O
have	|O
been	|O
identified	|O
at	|O
other	|O
locations	|O
in	|O
the	|O
human	|O
genome	|O
.	|O

EM	|O
analysis	|O
demonstrated	|O
that	|O
only	|O
one	|O
Rep	|B-PROTEIN
-	|O
DNA	|O
complex	|O
was	|O
formed	|O
on	|O
ch	|O
-	|O
19	|O
target	|O
DNA	|O
.	|O

The	|O
protein	|O
was	|O
associated	|O
with	|O
purified	|O
vaccinia	|O
virus	|O
particles	|O
and	|O
with	|O
membranes	|O
of	|O
immature	|O
and	|O
mature	|O
virions	|O
that	|O
were	|O
visualized	|O
by	|O
electron	|O
microscopy	|O
of	|O
infected	|O
cells	|O
.	|O

In	|O
vivo	|O
dimethyl	|O
sulfate	|O
footprinting	|O
of	|O
the	|O
cyclin	|B-PROTEIN
E	|I-PROTEIN
promoter	|O
revealed	|O
several	|O
regions	|O
of	|O
protection	|O
and	|O
hypersensitivity	|O
that	|O
were	|O
unique	|O
to	|O
infected	|O
cells	|O
.	|O

A	|O
total	|O
of	|O
194	|O
STSs	|O
map	|O
to	|O
this	|O
interval	|O
of	|O
3	|O
Mb	|O
,	|O
giving	|O
an	|O
average	|O
marker	|O
resolution	|O
of	|O
approximately	|O
one	|O
per	|O
15	|O
kb	|O
.	|O

Recently	|O
,	|O
a	|O
mutation	|O
in	|O
the	|O
amino	|O
-	|O
terminus	|O
of	|O
IB1	|B-PROTEIN
was	|O
associated	|O
with	|O
diabetes	|O
.	|O

CONCLUSION	|O
:	|O
More	|O
than	|O
50%	|O
of	|O
patients	|O
with	|O
perennial	|O
rhinitis	|O
and	|O
CRS	|O
do	|O
not	|O
improve	|O
after	|O
surgery	|O
,	|O
a	|O
response	|O
that	|O
may	|O
be	|O
predicted	|O
by	|O
more	|O
cells	|O
expressing	|O
IL	|B-PROTEIN
-	|I-PROTEIN
5	|I-PROTEIN
mRNA	|O
in	|O
the	|O
ethmoid	|O
sinuses	|O
.	|O

Biol.	|O

On	|O
the	|O
basis	|O
of	|O
size	|O
,	|O
the	|O
CRS	|O
sequence	|O
to	|O
which	|O
it	|O
binds	|O
,	|O
and	|O
its	|O
tentative	|O
identification	|O
as	|O
a	|O
zinc	|B-PROTEIN
finger	|I-PROTEIN
protein	|I-PROTEIN
,	|O
Adx	|B-PROTEIN
factor	|O
has	|O
been	|O
identified	|O
as	|O
a	|O
Kruppel	|B-PROTEIN
-	|O
like	|O
zinc	|O
finger	|O
protein	|O
(	|O
a	|O
mouse	|O
ZBP	|B-PROTEIN
-	|I-PROTEIN
89	|I-PROTEIN
homologue	|O
)	|O
.	|O

METHODS	|O
:	|O
The	|O
most	|O
distal	|O
muscle	|O
fibres	|O
from	|O
the	|O
deep	|O
and	|O
superficial	|O
finger	|O
flexors	|O
were	|O
measured	|O
relative	|O
to	|O
the	|O
pisiform	|O
bone	|O
in	|O
18	|O
cadaveric	|O
specimens	|O
.	|O

Here	|O
we	|O
report	|O
on	|O
the	|O
isolation	|O
of	|O
ICK2	|B-PROTEIN
,	|O
and	|O
show	|O
that	|O
it	|O
interacts	|O
with	|O
Cdc2aAt	|B-PROTEIN
,	|O
but	|O
not	|O
with	|O
a	|O
second	|O
CDK	|B-PROTEIN
from	|O
Arabidopsis	|O
,	|O
Cdc2bAt	|B-PROTEIN
.	|O

Systemic	|O
impact	|O
of	|O
risk	|O
-	|O
sharing	|O
arrangements	|O
.	|O

METHODS	|O
:	|O
We	|O
determined	|O
an	|O
odds	|O
ratio	|O
(	|O
OR	|O
)	|O
,	|O
as	|O
a	|O
measure	|O
of	|O
the	|O
relative	|O
risk	|O
of	|O
being	|O
exposed	|O
to	|O
a	|O
potential	|O
interaction	|O
,	|O
comparing	|O
the	|O
use	|O
of	|O
the	|O
H2	|B-PROTEIN
-	|I-PROTEIN
receptor	|I-PROTEIN
antagonist	|O
,	|O
cimetidine	|O
,	|O
with	|O
that	|O
of	|O
the	|O
noninteracting	|O
agents	|O
ranitidine	|O
,	|O
famotidine	|O
and	|O
nizatidine	|O
in	|O
users	|O
and	|O
nonusers	|O
of	|O
warfarin	|O
,	|O
phenytoin	|O
and	|O
theophylline	|O
.	|O

The	|O
prevalence	|O
of	|O
malnutrition	|O
was	|O
30%	|O
in	|O
the	|O
47	|O
patients	|O
without	|O
CVD	|O
and	|O
was	|O
significantly	|O
higher	|O
(	|O
70%	|O
,	|O
P	|O
<	|O
0.001	|O
)	|O
in	|O
the	|O
70	|O
patients	|O
with	|O
CVD	|O
,	|O
who	|O
also	|O
had	|O
lower	|O
tHcy	|O
,	|O
SAlb	|O
,	|O
plasma	|O
IGF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
serum	|O
creatinine	|O
(	|O
SCr	|O
)	|O
,	|O
and	|O
blood	|O
hemoglobin	|B-PROTEIN
.	|O

Our	|O
data	|O
suggest	|O
that	|O
,	|O
at	|O
least	|O
at	|O
high	|O
temperature	|O
,	|O
a	|O
critical	|O
minimal	|O
level	|O
of	|O
Ypt	|B-PROTEIN
protein	|O
prenylation	|O
is	|O
required	|O
for	|O
maintaining	|O
vesicle	|O
polarization	|O
.	|O

The	|O
second	|O
functional	|O
pair	|O
of	|O
CreA	|B-PROTEIN
sites	|O
is	|O
located	|O
between	|O
the	|O
two	|O
transcription	|O
initiation	|O
sites	|O
.	|O

A	|O
distinct	|O
staining	|O
pattern	|O
for	|O
the	|O
N	|B-PROTEIN
-	|I-PROTEIN
utrophin	|I-PROTEIN
was	|O
not	|O
detectable	|O
,	|O
although	|O
it	|O
was	|O
expected	|O
to	|O
localise	|O
at	|O
the	|O
actin	|B-PROTEIN
stress	|O
fibers	|O
.	|O

The	|O
'	|O
Newcastle	|O
'	|O
model	|O
,	|O
which	|O
is	|O
based	|O
on	|O
Hotelling	|O
's	|O
T2	|O
statistic	|O
,	|O
proved	|O
to	|O
be	|O
more	|O
sensitive	|O
and	|O
diagnosed	|O
a	|O
systematic	|O
displacement	|O
for	|O
three	|O
prostate	|O
patients	|O
.	|O

The	|O
MMA	|O
,	|O
DMA	|O
,	|O
and	|O
TMA	|B-PROTEIN
methyltransferases	|I-PROTEIN
are	|O
not	|O
homologs	|O
;	|O
however	|O
,	|O
like	|O
the	|O
MMA	|B-PROTEIN
methyltransferase	|I-PROTEIN
gene	|O
,	|O
the	|O
genes	|O
encoding	|O
the	|O
DMA	|O
and	|O
TMA	|B-PROTEIN
methyltransferases	|I-PROTEIN
each	|O
contain	|O
a	|O
single	|O
in	|O
-	|O
frame	|O
amber	|O
codon	|O
.	|O

After	|O
phosphorylation	|O
,	|O
STAT	|B-PROTEIN
proteins	|O
are	|O
transported	|O
into	|O
the	|O
nucleus	|O
and	|O
exhibit	|O
transcriptional	|O
activity	|O
.	|O

Overexpression	|O
of	|O
mcl	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
sufficient	|O
to	|O
protect	|O
against	|O
apoptosis	|O
,	|O
while	|O
transfection	|O
of	|O
a	|O
mcl	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
antisense	|O
plasmid	|O
causes	|O
cell	|O
death	|O
.	|O

Thus	|O
,	|O
although	|O
multiple	|O
senescence	|O
pathways	|O
are	|O
activated	|O
in	|O
response	|O
to	|O
a	|O
ras	|B-PROTEIN
oncogene	|O
,	|O
inactivation	|O
of	|O
TGFbeta1	|B-PROTEIN
secretion	|O
or	|O
response	|O
is	|O
sufficient	|O
to	|O
block	|O
the	|O
senescence	|O
program	|O
.	|O

In	|O
this	|O
study	|O
,	|O
the	|O
abilities	|O
of	|O
constitutive	|O
and	|O
conditional	|O
forms	|O
of	|O
the	|O
three	|O
Raf	|B-PROTEIN
kinases	|I-PROTEIN
to	|O
abrogate	|O
the	|O
cytokine	|O
dependency	|O
of	|O
FDC	|O
-	|O
P1	|O
cells	|O
were	|O
examined	|O
.	|O

Application	|O
of	|O
the	|O
method	|O
to	|O
a	|O
representative	|O
set	|O
of	|O
50	|O
known	|O
genes	|O
from	|O
Arabidopsis	|O
thaliana	|O
showed	|O
significant	|O
improvement	|O
in	|O
prediction	|O
accuracy	|O
compared	|O
to	|O
previous	|O
spliced	|O
alignment	|O
methods	|O
.	|O

The	|O
complete	|O
cDNA	|O
sequence	|O
of	|O
human	|O
betaV	|B-PROTEIN
spectrin	|I-PROTEIN
is	|O
available	|O
from	|O
GenBank	|O
(	|O
TM	|O
)	|O
as	|O
accession	|O
number	|O
.	|O

Transactivation	|O
of	|O
naturally	|O
occurring	|O
HIV	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
long	|I-PROTEIN
terminal	|I-PROTEIN
repeats	|I-PROTEIN
by	|O
the	|O
JNK	|B-PROTEIN
signaling	|O
pathway	|O
.	|O

These	|O
data	|O
show	|O
that	|O
the	|O
alpha	|O
-	|O
helix	|O
domain	|O
of	|O
p57	|B-PROTEIN
(	|O
Kip2	|B-PROTEIN
)	|O
,	|O
which	|O
is	|O
conserved	|O
in	|O
the	|O
Cip	|B-PROTEIN
/	|O
Kip	|B-PROTEIN
proteins	|O
,	|O
is	|O
implicated	|O
in	|O
protein	|O
-	|O
protein	|O
interaction	|O
and	|O
confers	|O
a	|O
specific	|O
regulatory	|O
mechanism	|O
,	|O
outside	|O
of	|O
their	|O
Cdk	|B-PROTEIN
-	|O
inhibitory	|O
activity	|O
,	|O
by	|O
which	|O
the	|O
p57	|B-PROTEIN
(	|O
Kip2	|B-PROTEIN
)	|O
family	|O
members	|O
positively	|O
act	|O
on	|O
myogenic	|O
differentiation	|O
.	|O

The	|O
mode	|O
of	|O
resistance	|O
to	|O
quinupristin	|O
/	|O
dalfopristin	|O
was	|O
not	|O
evident	|O
(	|O
sat	|O
A	|O
-	|O
negative	|O
by	|O
PCR	|O
)	|O
;	|O
and	|O
these	|O
cases	|O
illustrate	|O
the	|O
existence	|O
of	|O
streptogramin	|O
-	|O
resistant	|O
isolates	|O
before	|O
the	|O
introduction	|O
of	|O
this	|O
antimicrobial	|O
class	|O
into	|O
human	|O
clinical	|O
practice	|O
.	|O

This	|O
study	|O
was	|O
carried	|O
out	|O
to	|O
analyze	|O
PRL	|B-PROTEIN
secretion	|O
in	|O
metastatic	|O
prostate	|O
cancer	|O
patients	|O
both	|O
at	|O
basal	|O
conditions	|O
and	|O
in	|O
response	|O
to	|O
L	|O
-	|O
Dopa	|O
and	|O
metoclopramide	|O
,	|O
which	|O
represents	|O
the	|O
most	|O
classical	|O
inhibitory	|O
and	|O
stimulatory	|O
tests	|O
for	|O
PRL	|B-PROTEIN
secretion	|O
,	|O
respectively	|O
.	|O

Integrin	|B-PROTEIN
adhesion	|I-PROTEIN
receptors	|I-PROTEIN
transduce	|O
signals	|O
that	|O
control	|O
complex	|O
cell	|O
functions	|O
which	|O
require	|O
the	|O
regulation	|O
of	|O
gene	|O
expression	|O
,	|O
such	|O
as	|O
proliferation	|O
,	|O
differentiation	|O
and	|O
survival	|O
.	|O

Recombination	|O
,	|O
replication	|O
,	|O
repair	|O
:	|O
from	|O
complexity	|O
to	|O
harmony	|O
.	|O

The	|O
somatoform	|O
conundrum	|O
:	|O
a	|O
question	|O
of	|O
nosological	|O
valves	|O
.	|O

Intra	|O
-	|O
operative	|O
ultrasound	|O
(	|O
IOUS	|O
)	|O
has	|O
been	|O
widely	|O
used	|O
in	|O
an	|O
attempt	|O
to	|O
overcome	|O
these	|O
difficulties	|O
,	|O
but	|O
is	|O
limited	|O
by	|O
its	|O
two	|O
-	|O
dimensional	|O
nature	|O
,	|O
inter	|O
-	|O
user	|O
variability	|O
,	|O
and	|O
image	|O
obliteration	|O
with	|O
ablative	|O
or	|O
resectional	|O
techniques	|O
.	|O

CONCLUSIONS	|O
:	|O
This	|O
randomized	|O
study	|O
shows	|O
that	|O
Vivostat	|O
fibrin	|B-PROTEIN
sealant	|O
is	|O
effective	|O
in	|O
preventing	|O
air	|O
leakage	|O
after	|O
small	|O
lung	|O
resections	|O
in	|O
pigs	|O
,	|O
even	|O
at	|O
high	|O
inspiratory	|O
pressures	|O
.	|O

Hailey	|O
-	|O
Hailey	|O
disease	|O
is	|O
caused	|O
by	|O
mutations	|O
in	|O
ATP2C1	|B-PROTEIN
encoding	|O
a	|O
novel	|O
Ca	|O
(	|O
2+	|O
)	|O
pump	|O
.	|O

Hex	|B-PROTEIN
is	|O
expressed	|O
in	|O
the	|O
developing	|O
liver	|O
coincident	|O
with	|O
the	|O
forkhead	|B-PROTEIN
/	|O
winged	|B-PROTEIN
helix	|I-PROTEIN
transcription	|O
factor	|O
,	|O
Hepatocyte	|B-PROTEIN
Nuclear	|I-PROTEIN
Factor	|I-PROTEIN
3beta	|I-PROTEIN
(	|O
HNF3beta	|B-PROTEIN
)	|O
.	|O

As	|O
an	|O
extension	|O
of	|O
our	|O
structural	|O
characterization	|O
of	|O
the	|O
exon	|O
-	|O
intron	|O
organization	|O
of	|O
the	|O
mouse	|O
Pkr	|B-PROTEIN
gene	|O
,	|O
we	|O
now	|O
have	|O
isolated	|O
and	|O
characterized	|O
the	|O
mouse	|O
Pkr	|B-PROTEIN
promoter	|O
region	|O
required	|O
for	|O
IFN	|B-PROTEIN
-	|O
inducible	|O
transcription	|O
.	|O

The	|O
CRE	|O
,	|O
5'	|O
-	|O
TGACGTCA	|O
-	|O
3'	|O
,	|O
has	|O
been	|O
described	|O
as	|O
the	|O
consensus	|O
sequence	|O
for	|O
the	|O
cis	|O
-	|O
element	|O
that	|O
directs	|O
cAMP	|O
-	|O
regulated	|O
gene	|O
expression	|O
.	|O

Kidney	|O
length	|O
did	|O
not	|O
significantly	|O
differ	|O
between	|O
right	|O
and	|O
left	|O
,	|O
however	|O
,	|O
kidney	|O
width	|O
,	|O
cortical	|O
thickness	|O
and	|O
size	|O
did	|O
(	|O
p	|O
<	|O
0.05	|O
)	|O
.	|O

The	|O
clinical	|O
stage	|O
was	|O
I	|O
(	|O
T1N0M0	|O
)	|O
,	|O
and	|O
S2	|O
sleeve	|O
segmentectomy	|O
with	|O
lymph	|O
node	|O
dissection	|O
(	|O
R	|O
2	|O
b	|O
)	|O
was	|O
performed	|O
.	|O

Benztropine	|O
for	|O
venlafaxine	|O
-	|O
induced	|O
night	|O
sweats	|O
.	|O

A	|O
cause	|O
of	|O
increase	|O
of	|O
alkaline	|B-PROTEIN
phosphatase	|I-PROTEIN
in	|O
children	|O

The	|O
physicians	|O
in	|O
charge	|O
of	|O
all	|O
patients	|O
with	|O
evidence	|O
of	|O
acute	|O
Q	|O
fever	|O
(	|O
seroconversion	|O
and	|O
/	|O
or	|O
presence	|O
of	|O
IgM	|B-PROTEIN
)	|O
or	|O
chronic	|O
Q	|O
fever	|O
(	|O
prolonged	|O
disease	|O
and	|O
/	|O
or	|O
IgG	|B-PROTEIN
antibody	|O
titer	|O
to	|O
phase	|O
I	|O
of	|O
Coxiella	|O
burnetii	|O
>	|O
or	|O
=	|O
800	|O
)	|O
were	|O
asked	|O
to	|O
complete	|O
a	|O
questionnaire	|O
,	|O
which	|O
was	|O
computerized	|O
.	|O

Copyright	|O
2000	|O
Academic	|O
Press	|O
.	|O

Viral	|O
cell	|O
-	|O
to	|O
-	|O
cell	|O
movement	|O
of	|O
PVX	|O
CP	|B-PROTEIN
mutant	|O
was	|O
complemented	|O
in	|O
Nicotiana	|O
tabacum	|O
cv	|O
.	|O

Induction	|O
of	|O
CD86	|B-PROTEIN
expression	|O
by	|O
stimulation	|O
of	|O
U937	|O
cells	|O
with	|O
IFN	|B-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
revealed	|O
the	|O
presence	|O
of	|O
two	|O
functional	|O
GAS	|B-PROTEIN
(	|O
gamma	|B-PROTEIN
-	|I-PROTEIN
interferon	|I-PROTEIN
activation	|O
site	|O
)	|O
elements	|O
.	|O

Significantly	|O
,	|O
two	|O
proximal	|O
GATA	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|O
binding	|O
sites	|O
(	|O
-	|O
118	|O
/	|O
-	|O
113	|O
and	|O
-	|O
98	|O
/	|O
-	|O
93	|O
)	|O
and	|O
a	|O
region	|O
located	|O
within	|O
-	|O
518	|O
to	|O
-	|O
315bp	|O
of	|O
the	|O
mouse	|O
ALAS2	|B-PROTEIN
promoter	|O
were	|O
essential	|O
for	|O
transcriptional	|O
activation	|O
during	|O
chemically	|O
induced	|O
differentiation	|O
of	|O
MEL	|O
cells	|O
,	|O
implying	|O
their	|O
importance	|O
in	|O
conferring	|O
erythroid	|O
specificity	|O
to	|O
the	|O
ALAS2	|B-PROTEIN
transcriptional	|O
activation	|O
.	|O

SNAP	|B-PROTEIN
-	|I-PROTEIN
23	|I-PROTEIN
plays	|O
an	|O
important	|O
role	|O
in	|O
the	|O
regulation	|O
of	|O
vesicle	|O
trafficking	|O
in	|O
mammalian	|O
cells	|O
.	|O

The	|O
HMG	|B-PROTEIN
domain	|O
of	|O
both	|O
HMG20	|B-PROTEIN
proteins	|O
is	|O
most	|O
similar	|O
to	|O
that	|O
of	|O
yeast	|O
NHP6A	|B-PROTEIN
(	|O
38%	|O
to	|O
42%	|O
)	|O
.	|O

IgM	|B-PROTEIN
and	|O
IgG	|B-PROTEIN
anti	|I-PROTEIN
A	|I-PROTEIN
and	|O
anti	|B-PROTEIN
B	|I-PROTEIN
antibody	|I-PROTEIN
status	|O
of	|O
100	|O
antenatal	|O
O	|O
group	|O
mothers	|O
(	|O
who	|O
had	|O
non	|O
O	|O
group	|O
husbands	|O
)	|O
were	|O
studied	|O
.	|O

In	|O
an	|O
attempt	|O
to	|O
understand	|O
Wee1	|B-PROTEIN
regulation	|O
during	|O
cell	|O
cycle	|O
,	|O
yeast	|O
two	|O
-	|O
hybrid	|O
screening	|O
was	|O
used	|O
to	|O
identify	|O
Wee1	|B-PROTEIN
-	|O
binding	|O
protein	|O
(	|O
s	|O
)	|O
.	|O

Retroviral	|O
transduction	|O
of	|O
T	|B-PROTEIN
/	|I-PROTEIN
T	|I-PROTEIN
(	|I-PROTEIN
L	|I-PROTEIN
)	|I-PROTEIN
causes	|O
a	|O
rapidly	|O
fatal	|O
myeloproliferative	|O
disease	|O
in	|O
a	|O
murine	|O
bone	|O
marrow	|O
transplant	|O
(	|O
BMT	|O
)	|O
model	|O
,	|O
whereas	|O
T	|B-PROTEIN
/	|I-PROTEIN
T	|I-PROTEIN
(	|I-PROTEIN
F	|I-PROTEIN
)	|I-PROTEIN
causes	|O
a	|O
long	|O
-	|O
latency	|O
,	|O
pre	|O
-	|O
B	|O
-	|O
cell	|O
lymphoblastic	|O
lymphoma	|O
.	|O

Ab	|O
-	|O
MLV	|O
strains	|O
expressing	|O
P70	|B-PROTEIN
/	|O
S2	|B-PROTEIN
failed	|O
to	|O
transform	|O
NIH	|O
3T3	|O
cells	|O
and	|O
demonstrated	|O
a	|O
greatly	|O
reduced	|O
capacity	|O
to	|O
mediate	|O
signaling	|O
events	|O
associated	|O
with	|O
the	|O
Ras	|B-PROTEIN
-	|O
dependent	|O
mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
(	|I-PROTEIN
MAP	|I-PROTEIN
)	|I-PROTEIN
kinase	|I-PROTEIN
pathway	|O
.	|O

The	|O
codon	|O
usage	|O
is	|O
particularly	|O
marked	|O
for	|O
the	|O
gag	|B-PROTEIN
,	|O
pol	|B-PROTEIN
,	|O
and	|O
env	|B-PROTEIN
genes	|O
.	|O

The	|O
p53	|B-PROTEIN
-	|O
homolog	|O
p73beta	|B-PROTEIN
also	|O
activated	|O
the	|O
PIG3	|B-PROTEIN
promoter	|O
,	|O
but	|O
in	|O
contrast	|O
to	|O
p53	|B-PROTEIN
,	|O
the	|O
proline	|O
-	|O
rich	|O
domain	|O
of	|O
p73beta	|B-PROTEIN
(	|O
residues	|O
81-113	|O
)	|O
was	|O
dispensable	|O
to	|O
induce	|O
the	|O
PIG3	|B-PROTEIN
promoter	|O
.	|O

Results	|O
from	|O
transient	|O
assays	|O
using	|O
these	|O
mutants	|O
showed	|O
that	|O
the	|O
DE1	|O
received	|O
signals	|O
from	|O
phytochromes	|B-PROTEIN
A	|I-PROTEIN
and	|I-PROTEIN
B	|I-PROTEIN
,	|O
demonstrating	|O
that	|O
this	|O
element	|O
is	|O
indeed	|O
a	|O
light	|O
-	|O
responsive	|O
element	|O
.	|O

Co	|O
-	|O
immunoprecipitation	|O
and	|O
DNA	|O
affinity	|O
chromatography	|O
prove	|O
that	|O
Sp1	|B-PROTEIN
heterodimerizes	|O
with	|O
ZBP	|B-PROTEIN
-	|I-PROTEIN
89	|I-PROTEIN
when	|O
bound	|O
to	|O
the	|O
silencer	|O
element	|O
to	|O
yield	|O
a	|O
DNA	|O
-	|O
protein	|O
complex	|O
whose	|O
mobility	|O
is	|O
indistinguishable	|O
from	|O
that	|O
displayed	|O
by	|O
HeLa	|O
nuclear	|O
extract	|O
in	|O
band	|O
shift	|O
assays	|O
.	|O

The	|O
ZNF274	|B-PROTEIN
gene	|O
is	|O
mapped	|O
distal	|O
to	|O
marker	|O
RP	|O
S28	|O
1	|O
in	|O
the	|O
human	|O
chromosome	|O
19qter	|O
region	|O
,	|O
by	|O
RH	|O
mapping	|O
.	|O

The	|O
C	|O
-	|O
terminal	|O
Cdk2	|B-PROTEIN
truncations	|O
,	|O
however	|O
,	|O
were	|O
non	|O
-	|O
functional	|O
in	|O
these	|O
strains	|O
and	|O
thus	|O
dependent	|O
for	|O
activity	|O
on	|O
the	|O
pho85	|B-PROTEIN
coding	|O
region	|O
which	|O
remained	|O
in	|O
the	|O
mutant	|O
pho85	|B-PROTEIN
::	|O
HIS3	|B-PROTEIN
chromosomal	|O
locus	|O
.	|O

We	|O
report	|O
here	|O
on	|O
the	|O
molecular	|O
nature	|O
of	|O
an	|O
EMS	|O
-	|O
induced	|O
mutant	|O
,	|O
mn1	|B-PROTEIN
-	|I-PROTEIN
89	|I-PROTEIN
,	|O
a	|O
leaky	|O
semidominant	|O
allele	|O
of	|O
the	|O
Miniature1	|B-PROTEIN
(	|O
Mn1	|B-PROTEIN
)	|O
seed	|O
locus	|O
that	|O
encodes	|O
a	|O
seed	|O
-	|O
specific	|O
cell	|O
wall	|O
invertase	|B-PROTEIN
,	|O
INCW2	|B-PROTEIN
.	|O

We	|O
conclude	|O
that	|O
,	|O
both	|O
in	|O
atrial	|O
myocytes	|O
and	|O
in	|O
Xenopus	|O
oocytes	|O
,	|O
beta	|O
-	|O
adrenergic	|O
stimulation	|O
potentiates	|O
the	|O
ACh	|O
-	|O
evoked	|O
GIRK	|B-PROTEIN
channels	|O
via	|O
a	|O
pathway	|O
that	|O
involves	|O
PKA	|B-PROTEIN
-	|O
catalyzed	|O
phosphorylation	|O
downstream	|O
from	|O
beta	|B-PROTEIN
(	|I-PROTEIN
2	|I-PROTEIN
)	|I-PROTEIN
AR	|I-PROTEIN
.	|O

Slap	|B-PROTEIN
negatively	|O
regulates	|O
Src	|B-PROTEIN
mitogenic	|O
function	|O
but	|O
does	|O
not	|O
revert	|O
Src	|B-PROTEIN
-	|O
induced	|O
cell	|O
morphology	|O
changes	|O
.	|O

Identification	|O
of	|O
a	|O
novel	|O
E2F3	|B-PROTEIN
product	|O
suggests	|O
a	|O
mechanism	|O
for	|O
determining	|O
specificity	|O
of	|O
repression	|O
by	|O
Rb	|B-PROTEIN
proteins	|O
.	|O

In	|O
DNase	|B-PROTEIN
I	|I-PROTEIN
footprinting	|O
protection	|O
analysis	|O
,	|O
both	|O
SFRE	|B-PROTEIN
and	|O
ERE	|O
regions	|O
were	|O
protected	|O
by	|O
glutathione	|B-PROTEIN
S	|I-PROTEIN
-	|I-PROTEIN
transferase	|I-PROTEIN
-	|O
ERRalpha1	|B-PROTEIN
fusion	|O
protein	|O
.	|O

Overexpressing	|O
the	|O
coactivator	|O
,	|O
SRC1a	|B-PROTEIN
or	|O
GRIP1	|B-PROTEIN
,	|O
further	|O
enhances	|O
ERRalpha1	|B-PROTEIN
-	|O
induced	|O
transcriptional	|O
activity	|O
.	|O

Estrogen	|O
receptor	|O
-	|O
related	|O
receptor	|O
alpha	|B-PROTEIN
1	|I-PROTEIN
interacts	|O
with	|O
coactivator	|O
and	|O
constitutively	|O
activates	|O
the	|O
estrogen	|O
response	|O
elements	|O
of	|O
the	|O
human	|O
lactoferrin	|B-PROTEIN
gene	|O
.	|O

We	|O
examine	|O
current	|O
models	|O
of	|O
the	|O
effects	|O
of	|O
aging	|O
on	|O
mean	|O
response	|O
time	|O
and	|O
show	|O
how	|O
they	|O
might	|O
be	|O
reinterpreted	|O
.	|O

The	|O
effects	|O
of	|O
these	|O
mutations	|O
on	|O
protein	|O
function	|O
require	|O
further	|O
examination	|O
.	|O

The	|O
median	|O
levels	|O
of	|O
particles	|O
with	|O
50%	|O
cut	|O
-	|O
off	|O
aerodynamic	|O
diameters	|O
of	|O
10	|O
(	|O
PM10	|O
)	|O
and	|O
2.5	|O
microm	|O
(	|O
PM2.5	|O
)	|O
were	|O
170	|O
(	|O
range	|O
103-613	|O
)	|O
and	|O
95	|O
(	|O
range	|O
61-218	|O
)	|O
micro	|O
x	|O
m	|O
-	|O
3	|O
,	|O
respectively	|O
.	|O

Kaposi	|O
's	|O
sarcoma	|O
-	|O
associated	|O
herpesvirus	|O
viral	|O
interferon	|B-PROTEIN
regulatory	|I-PROTEIN
factor	|I-PROTEIN
confers	|O
resistance	|O
to	|O
the	|O
antiproliferative	|O
effect	|O
of	|O
interferon	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
.	|O

Specific	|O
and	|O
heritable	|O
genetic	|O
interference	|O
by	|O
double	|O
-	|O
stranded	|O
RNA	|O
in	|O
Arabidopsis	|O
thaliana	|O
.	|O

Comparison	|O
of	|O
sequences	|O
from	|O
-	|O
215	|O
to	|O
+	|O
1	|O
bp	|O
identified	|O
consensus	|O
binding	|O
sites	|O
for	|O
the	|O
homeodomain	|B-PROTEIN
transcription	|O
factor	|O
thyroid	|B-PROTEIN
transcription	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
(	|O
TTF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
.	|O

Two	|O
additional	|O
cis	|O
-	|O
acting	|O
sequences	|O
,	|O
conserved	|O
in	|O
both	|O
the	|O
region	|O
1	|O
and	|O
3	|O
promoters	|O
,	|O
were	|O
identified	|O
,	|O
suggesting	|O
a	|O
role	|O
for	|O
these	|O
sequences	|O
in	|O
the	|O
coordinate	|O
regulation	|O
of	|O
transcription	|O
from	|O
these	|O
promoters	|O
.	|O

Purple	|O
photosynthetic	|O
bacteria	|O
are	|O
capable	|O
of	|O
generating	|O
cellular	|O
energy	|O
from	|O
several	|O
sources	|O
,	|O
including	|O
photosynthesis	|O
,	|O
respiration	|O
,	|O
and	|O
H	|O
(	|O
2	|O
)	|O
oxidation	|O
.	|O

An	|O
analysis	|O
of	|O
synthetic	|O
peptides	|O
revealed	|O
a	|O
minimal	|O
CTD	|O
sequence	|O
that	|O
is	|O
sufficient	|O
to	|O
bind	|O
to	|O
the	|O
second	|O
Rsp5	|B-PROTEIN
WW	|O
domain	|O
(	|O
Rsp5	|B-PROTEIN
WW2	|O
)	|O
in	|O
vitro	|O
and	|O
in	|O
yeast	|O
two	|O
-	|O
hybrid	|O
assays	|O
.	|O

Furthermore	|O
,	|O
bone	|O
marrow	|O
-	|O
derived	|O
macrophages	|O
from	|O
LAT	|B-PROTEIN
-	|O
deficient	|O
mice	|O
displayed	|O
reduced	|O
phagocytic	|O
efficiency	|O
in	|O
comparison	|O
to	|O
the	|O
macrophages	|O
from	|O
wild	|O
-	|O
type	|O
mice	|O
.	|O

T1	|O
-	|O
weighted	|O
MRI	|O
on	|O
the	|O
49th	|O
postoperative	|O
day	|O
demonstrated	|O
bilateral	|O
and	|O
symmetrical	|O
hyperintense	|O
lesions	|O
in	|O
the	|O
globus	|O
pallidus	|O
.	|O

The	|O
method	|O
is	|O
applied	|O
to	|O
determine	|O
aberration	|O
constants	|O
of	|O
a	|O
CM300	|O
FEG	|O
/	|O
UT	|O
microscope	|O
with	|O
correction	|O
of	|O
the	|O
three	|O
-	|O
fold	|O
astigmatism	|O
.	|O

The	|O
interaction	|O
does	|O
not	|O
depend	|O
on	|O
the	|O
presence	|O
of	|O
the	|O
correct	|O
amino	|O
-	|O
terminal	|O
DNA	|O
binding	|O
domain	|O
or	|O
the	|O
amino	|O
acid	|O
sequences	|O
between	|O
the	|O
DNA	|O
binding	|O
domain	|O
and	|O
the	|O
last	|O
ten	|O
amino	|O
acids	|O
.	|O

METHOD	|O
:	|O
The	|O
sample	|O
of	|O
subjects	|O
was	|O
drawn	|O
from	|O
the	|O
Suffolk	|O
County	|O
Mental	|O
Health	|O
Project	|O
,	|O
a	|O
longitudinal	|O
epidemiologic	|O
study	|O
of	|O
first	|O
-	|O
hospitalized	|O
subjects	|O
with	|O
psychotic	|O
disorders	|O
;	|O
the	|O
present	|O
study	|O
focused	|O
on	|O
patients	|O
with	|O
schizophrenic	|O
disorders	|O
.	|O

Marrow	|O
dysplasia	|O
is	|O
a	|O
major	|O
characteristic	|O
of	|O
patients	|O
with	|O
myelodysplastic	|O
syndrome	|O
(	|O
MDS	|O
)	|O
,	|O
along	|O
with	|O
marrow	|O
blastosis	|O
,	|O
cytopenia	|O
and	|O
cytogenetic	|O
anomalies	|O
.	|O

Eight	|O
of	|O
the	|O
non	|O
-	|O
acceptable	|O
inlays	|O
/	|O
onlays	|O
and	|O
five	|O
of	|O
the	|O
direct	|O
restorations	|O
were	|O
replaced	|O
,	|O
while	|O
the	|O
other	|O
ones	|O
were	|O
repaired	|O
with	|O
resin	|O
composite	|O
.	|O

How	|O
plants	|O
respond	|O
to	|O
attack	|O
by	|O
the	|O
range	|O
of	|O
herbivores	|O
and	|O
pathogens	|O
that	|O
confront	|O
them	|O
in	|O
the	|O
field	|O
is	|O
the	|O
subject	|O
of	|O
considerable	|O
research	|O
by	|O
both	|O
molecular	|O
biologists	|O
and	|O
ecologists	|O
.	|O

CONCLUSION	|O
:	|O
The	|O
probability	|O
of	|O
cardiopulmonary	|O
complications	|O
increases	|O
significantly	|O
when	|O
patients	|O
develop	|O
class	|O
1	|O
HELLP	|O
syndrome	|O
.	|O

The	|O
rate	|O
-	|O
limiting	|O
step	|O
for	|O
telomerase	|B-PROTEIN
activity	|O
seems	|O
to	|O
be	|O
the	|O
expression	|O
of	|O
the	|O
catalytic	|O
subunit	|O
of	|O
the	|O
enzyme	|O
,	|O
encoded	|O
by	|O
the	|O
human	|B-PROTEIN
telomerase	|I-PROTEIN
reverse	|I-PROTEIN
transcriptase	|I-PROTEIN
(	|O
hTERT	|B-PROTEIN
)	|O
gene	|O
.	|O

In	|O
the	|O
control	|O
group	|O
,	|O
platelet	|O
markers	|O
increased	|O
1	|O
h	|O
after	|O
surgery	|O
.	|O

However	|O
,	|O
the	|O
element	|O
proximal	|O
to	|O
the	|O
transcription	|O
start	|O
site	|O
is	|O
dependent	|O
on	|O
the	|O
SRE	|O
-	|O
1	|O
.	|O

AMDA	|O
white	|O
paper	|O
identifies	|O
ways	|O
to	|O
improve	|O
pharmaceutical	|O
care	|O
in	|O
SNFs	|O
.	|O

Since	|O
proteins	|O
containing	|O
TPR	|O
elements	|O
are	|O
typically	|O
involved	|O
in	|O
multiple	|O
protein	|O
-	|O
protein	|O
interactions	|O
,	|O
we	|O
suggest	|O
that	|O
the	|O
102kD	|O
protein	|O
interacts	|O
within	|O
the	|O
tri	|O
-	|O
snRNP	|O
with	|O
both	|O
the	|O
U5	|B-PROTEIN
and	|O
U4	|B-PROTEIN
/	|O
U6	|B-PROTEIN
snRNPs	|O
,	|O
thus	|O
bridging	|O
the	|O
two	|O
particles	|O
.	|O

Antibodies	|O
raised	|O
against	|O
a	|O
C	|O
-	|O
terminal	|O
portion	|O
of	|O
Sec31A	|B-PROTEIN
co	|O
-	|O
precipitate	|O
Sec13	|B-PROTEIN
and	|O
inhibit	|O
ER	|O
-	|O
Golgi	|O
transport	|O
of	|O
temperature	|O
-	|O
arrested	|O
vesicular	|O
stomatitis	|O
G	|B-PROTEIN
protein	|I-PROTEIN
in	|O
a	|O
semi	|O
-	|O
intact	|O
cell	|O
assay	|O
.	|O

Regulation	|O
of	|O
mitochondrial	|O
single	|O
-	|O
stranded	|O
DNA	|O
-	|O
binding	|O
protein	|O
gene	|O
expression	|O
links	|O
nuclear	|O
and	|O
mitochondrial	|O
DNA	|O
replication	|O
in	|O
drosophila	|O
.	|O

Genetic	|O
and	|O
molecular	|O
complexity	|O
of	|O
the	|O
position	|O
effect	|O
variegation	|O
modifier	|O
mod	|B-PROTEIN
(	|O
mdg4	|B-PROTEIN
)	|O
in	|O
Drosophila	|O
.	|O
mod	|B-PROTEIN
(	|O
mdg4	|B-PROTEIN
)	|O
,	|O
also	|O
known	|O
as	|O
E	|B-PROTEIN
(	|I-PROTEIN
var	|I-PROTEIN
)	|I-PROTEIN
3-93	|I-PROTEIN
D	|I-PROTEIN
,	|O
is	|O
involved	|O
in	|O
a	|O
variety	|O
of	|O
processes	|O
,	|O
such	|O
as	|O
gene	|O
silencing	|O
in	|O
position	|O
effect	|O
variegation	|O
(	|O
PEV	|O
)	|O
,	|O
the	|O
control	|O
of	|O
gypsy	|B-PROTEIN
insulator	|O
sequences	|O
,	|O
regulation	|O
of	|O
homeotic	|B-PROTEIN
gene	|I-PROTEIN
expression	|O
,	|O
and	|O
programmed	|O
cell	|O
death	|O
.	|O

They	|O
are	|O
present	|O
in	|O
many	|O
kinds	|O
of	|O
living	|O
things	|O
,	|O
but	|O
their	|O
functions	|O
,	|O
especially	|O
those	|O
in	|O
humans	|O
,	|O
are	|O
unclear	|O
.	|O

This	|O
tendency	|O
is	|O
likely	|O
due	|O
to	|O
the	|O
biased	|O
nucleotide	|O
composition	|O
of	|O
the	|O
asparagus	|O
genome	|O
,	|O
rather	|O
than	|O
to	|O
the	|O
translational	|O
selection	|O
for	|O
specific	|O
codons	|O
.	|O

Transduction	|O
of	|O
the	|O
human	|O
leukemic	|O
cell	|O
line	|O
K562	|O
showed	|O
that	|O
viral	|O
MRP1	|B-PROTEIN
-	|O
PG13	|O
supernatants	|O
routinely	|O
transfer	|O
the	|O
MRP1	|B-PROTEIN
gene	|O
to	|O
approximately	|O
35%	|O
of	|O
target	|O
K562	|O
cells	|O
,	|O
of	|O
which	|O
at	|O
least	|O
one	|O
third	|O
are	|O
capable	|O
of	|O
proliferating	|O
in	|O
the	|O
presence	|O
of	|O
otherwise	|O
toxic	|O
concentrations	|O
of	|O
etoposide	|O
.	|O

Regulation	|O
of	|O
pituitary	|O
vasopressin	|B-PROTEIN
V1b	|I-PROTEIN
receptors	|I-PROTEIN
plays	|O
a	|O
critical	|O
role	|O
in	|O
regulating	|O
pituitary	|B-PROTEIN
adrenocorticotropic	|I-PROTEIN
hormone	|I-PROTEIN
(	|O
ACTH	|B-PROTEIN
)	|O
secretion	|O
during	|O
adaptation	|O
to	|O
stress	|O
.	|O

Identification	|O
of	|O
an	|O
AfsA	|B-PROTEIN
homologue	|O
(	|O
BarX	|B-PROTEIN
)	|O
from	|O
Streptomyces	|O
virginiae	|O
as	|O
a	|O
pleiotropic	|O
regulator	|O
controlling	|O
autoregulator	|O
biosynthesis	|O
,	|O
virginiamycin	|O
biosynthesis	|O
and	|O
virginiamycin	|O
M1	|O
resistance	|O
.	|O

Because	|O
the	|O
mutant	|O
defective	|O
in	|O
DNA	|O
binding	|O
also	|O
fails	|O
to	|O
stimulate	|O
Abf1	|B-PROTEIN
ARS1	|O
DNA	|O
-	|O
binding	|O
activity	|O
,	|O
our	|O
results	|O
suggest	|O
that	|O
Cdc6	|B-PROTEIN
DNA	|O
-	|O
binding	|O
activity	|O
may	|O
play	|O
a	|O
pivotal	|O
role	|O
in	|O
the	|O
initiation	|O
of	|O
DNA	|O
replication	|O
.	|O

Given	|O
its	|O
relative	|O
longevity	|O
on	|O
the	|O
Web	|O
,	|O
TIE	|O
researchers	|O
have	|O
been	|O
in	|O
a	|O
unique	|O
position	|O
to	|O
observe	|O
trends	|O
in	|O
telemedicine	|O
.	|O

The	|O
structural	|O
study	|O
of	|O
peptides	|O
belonging	|O
to	|O
the	|O
terminal	|O
domains	|O
of	|O
histone	|O
H1	|B-PROTEIN
can	|O
be	|O
considered	|O
as	|O
a	|O
step	|O
toward	|O
the	|O
understanding	|O
of	|O
the	|O
function	|O
of	|O
H1	|B-PROTEIN
in	|O
chromatin	|O
.	|O

The	|O
recovery	|O
rates	|O
for	|O
the	|O
MB	|O
/	|O
BacT	|O
,	|O
MGIT	|O
960	|O
,	|O
and	|O
solid	|O
media	|O
were	|O
91.6	|O
,	|O
87.4	|O
,	|O
and	|O
54.7%	|O
,	|O
respectively	|O
,	|O
for	|O
all	|O
mycobacteria	|O
;	|O
the	|O
recovery	|O
rates	|O
were	|O
93.6	|O
,	|O
88.9	|O
,	|O
and	|O
63.4%	|O
,	|O
respectively	|O
,	|O
for	|O
M.	|O
tuberculosis	|O
complex	|O
alone	|O
,	|O
and	|O
87.5	|O
,	|O
84.4	|O
,	|O
and	|O
37.5%	|O
,	|O
respectively	|O
,	|O
for	|O
all	|O
nontuberculous	|O
mycobacteria	|O
.	|O

Cerebral	|O
vasculitis	|O
secondary	|O
to	|O
Crohn	|O
's	|O
disease	|O
seems	|O
to	|O
be	|O
a	|O
very	|O
rare	|O
phenomenon	|O
.	|O

SELECTION	|O
CRITERIA	|O
:	|O
Randomised	|O
and	|O
possibly	|O
randomised	|O
trials	|O
using	|O
acupuncture	|O
to	|O
treat	|O
asthma	|O
and	|O
asthma	|O
-	|O
like	|O
symptoms	|O
.	|O

SELECTION	|O
CRITERIA	|O
:	|O
Randomised	|O
trials	|O
comparing	|O
children	|O
undergoing	|O
systematic	|O
therapy	|O
focusing	|O
on	|O
the	|O
family	|O
in	|O
conjunction	|O
with	|O
asthma	|O
medication	|O
,	|O
with	|O
children	|O
taking	|O
asthma	|O
medication	|O
only	|O
.	|O

To	|O
test	|O
the	|O
hypothesis	|O
that	|O
progestin	|O
-	|O
mediated	|O
increases	|O
in	|O
resting	|O
core	|O
temperature	|O
and	|O
the	|O
core	|O
temperature	|O
threshold	|O
for	|O
sweating	|O
onset	|O
are	|O
counteracted	|O
by	|O
estrogen	|O
,	|O
we	|O
studied	|O
eight	|O
women	|O
(	|O
24	|O
+	|O
/	|O
-	|O
2	|O
yr	|O
)	|O
at	|O
27	|O
degrees	|O
C	|O
rest	|O
,	|O
during	|O
20	|O
min	|O
of	|O
passive	|O
heating	|O
(	|O
35	|O
degrees	|O
C	|O
)	|O
,	|O
and	|O
during	|O
40	|O
min	|O
of	|O
exercise	|O
at	|O
35	|O
degrees	|O
C.	|O

The	|O
models	|O
were	|O
tested	|O
by	|O
studying	|O
their	|O
response	|O
to	|O
disturbances	|O
of	|O
the	|O
afferent	|O
signal	|O
from	|O
the	|O
bladder	|O
.	|O

Our	|O
data	|O
show	|O
also	|O
that	|O
phagocytic	|O
killing	|O
of	|O
meningococci	|O
is	|O
probably	|O
a	|O
more	|O
consistent	|O
assay	|O
than	|O
antibody	|O
titer	|O
levels	|O
for	|O
antimeningococcal	|O
immunity	|O
,	|O
especially	|O
in	|O
LCC	|O
-	|O
deficient	|O
patients	|O
.	|O

These	|O
studies	|O
suggest	|O
an	|O
additional	|O
component	|O
or	|O
cellular	|O
environment	|O
is	|O
required	|O
for	|O
SPRK	|B-PROTEIN
activation	|O
by	|O
Cdc42	|B-PROTEIN
.	|O

M.	|O

Jkappa	|B-PROTEIN
DNA	|O
-	|O
binding	|O
sites	|O
were	|O
not	|O
required	|O
for	|O
this	|O
activation	|O
,	|O
and	|O
a	|O
mutant	|O
EBNA	|B-PROTEIN
-	|I-PROTEIN
3C	|I-PROTEIN
protein	|O
unable	|O
to	|O
bind	|O
Jkappa	|B-PROTEIN
activated	|O
transcription	|O
as	|O
efficiently	|O
as	|O
wild	|O
-	|O
type	|O
EBNA	|B-PROTEIN
-	|I-PROTEIN
3C	|I-PROTEIN
,	|O
indicating	|O
that	|O
EBNA	|B-PROTEIN
-	|I-PROTEIN
3C	|I-PROTEIN
can	|O
regulate	|O
transcription	|O
through	|O
a	|O
mechanism	|O
that	|O
is	|O
independent	|O
of	|O
Jkappa	|B-PROTEIN
.	|O

Thus	|O
,	|O
both	|O
YY1	|B-PROTEIN
and	|O
CDP	|B-PROTEIN
appear	|O
to	|O
be	|O
negative	|O
regulators	|O
of	|O
the	|O
differentiation	|O
-	|O
induced	|O
HPV	|O
-	|O
6	|O
E1	|B-PROTEIN
promoter	|O
and	|O
thereby	|O
the	|O
HPV	|O
life	|O
cycle	|O
.	|O

Sequential	|O
cleavage	|O
by	|O
metallopeptidases	|B-PROTEIN
and	|O
proteasomes	|O
is	|O
involved	|O
in	|O
processing	|O
HIV	|O
-	|O
1	|O
ENV	|B-PROTEIN
epitope	|O
for	|O
endogenous	|O
MHC	|B-PROTEIN
class	|I-PROTEIN
I	|I-PROTEIN
antigen	|O
presentation	|O
.	|O

Cloning	|O
and	|O
characterization	|O
of	|O
human	|O
Lnk	|B-PROTEIN
,	|O
an	|O
adaptor	|O
protein	|O
with	|O
pleckstrin	|B-PROTEIN
homology	|O
and	|O
Src	|B-PROTEIN
homology	|I-PROTEIN
2	|I-PROTEIN
domains	|O
that	|O
can	|O
inhibit	|O
T	|O
cell	|O
activation	|O
.	|O

Vancomycin	|O
data	|O
were	|O
analyzed	|O
according	|O
to	|O
a	|O
one	|O
-	|O
compartment	|O
open	|O
model	|O
with	|O
use	|O
of	|O
NONMEM	|O
population	|O
pharmacokinetic	|O
software	|O
.	|O

Finally	|O
,	|O
Cas	|B-PROTEIN
existed	|O
mainly	|O
in	|O
cytosol	|O
and	|O
membrane	|O
cytoskeleton	|O
fractions	|O
in	|O
the	|O
resting	|O
state	|O
,	|O
and	|O
remained	|O
unchanged	|O
during	|O
platelet	|O
aggregation	|O
,	|O
when	|O
FAK	|B-PROTEIN
translocated	|O
to	|O
the	|O
cytoskeletal	|O
fraction	|O
.	|O

We	|O
also	|O
show	|O
that	|O
p65	|B-PROTEIN
binds	|O
to	|O
these	|O
targets	|O
with	|O
almost	|O
equal	|O
affinity	|O
and	|O
that	|O
different	|O
residues	|O
have	|O
variable	|O
roles	|O
in	|O
binding	|O
different	|O
kappaB	|B-PROTEIN
targets	|O
.	|O

Transcriptional	|O
regulation	|O
of	|O
the	|O
yeast	|O
PHO8	|B-PROTEIN
promoter	|O
in	|O
comparison	|O
to	|O
the	|O
coregulated	|O
PHO5	|B-PROTEIN
promoter	|O
.	|O

The	|O
Siglecs	|B-PROTEIN
are	|O
a	|O
subfamily	|O
of	|O
I	|B-PROTEIN
-	|I-PROTEIN
type	|I-PROTEIN
lectins	|I-PROTEIN
(	|O
immunoglobulin	|B-PROTEIN
superfamily	|O
proteins	|O
that	|O
bind	|O
sugars	|O
)	|O
that	|O
specifically	|O
recognize	|O
sialic	|O
acids	|O
.	|O

Our	|O
data	|O
provide	|O
a	|O
biochemical	|O
explanation	|O
for	|O
the	|O
similarity	|O
in	|O
phenotype	|O
between	|O
A	|O
-	|O
T	|O
and	|O
NBS	|O
.	|O

PATIENTS	|O
OR	|O
OTHER	|O
PARTICIPANTS	|O
:	|O
Twenty	|O
children	|O
met	|O
the	|O
criteria	|O
for	|O
being	|O
learning	|O
disabled	|O
.	|O

Update	|O
on	|O
maternal	|O
-	|O
fetal	|O
infections	|O
by	|O
hepatitis	|O
C	|O
,	|O
HIV	|O
and	|O
cytomegalovirus	|O

In	|O
the	|O
present	|O
study	|O
,	|O
we	|O
characterized	|O
cis	|O
-	|O
elements	|O
of	|O
the	|O
human	|O
PCI	|B-PROTEIN
gene	|O
required	|O
for	|O
expression	|O
in	|O
the	|O
hepatoma	|O
-	|O
derived	|O
cell	|O
line	|O
,	|O
HepG2	|O
cells	|O
,	|O
and	|O
also	|O
evaluated	|O
rat	|O
PCI	|B-PROTEIN
mRNA	|O
expression	|O
,	|O
particularly	|O
on	|O
the	|O
effect	|O
of	|O
androgen	|O
in	|O
rat	|O
reproductive	|O
tissues	|O
.	|O

In	|O
the	|O
study	|O
on	|O
PCI	|B-PROTEIN
mRNA	|O
expression	|O
in	|O
the	|O
reproductive	|O
organs	|O
,	|O
we	|O
first	|O
cloned	|O
rat	|O
PCI	|B-PROTEIN
cDNA	|O
and	|O
then	|O
evaluated	|O
the	|O
effect	|O
of	|O
androgen	|O
on	|O
the	|O
PCI	|B-PROTEIN
mRNA	|O
expression	|O
.	|O

To	|O
illustrate	|O
its	|O
performance	|O
,	|O
measurements	|O
of	|O
photoluminescence	|O
in	|O
GaAs	|O
/	|O
AlGaAs	|O
heterostructures	|O
are	|O
presented	|O
.	|O

The	|O
stoichiometry	|O
of	|O
the	|O
complexes	|O
formed	|O
with	|O
the	|O
dodeca	|O
-	|O
satellite	|O
C	|O
strand	|O
suggests	|O
that	|O
,	|O
in	|O
DDP1	|B-PROTEIN
,	|O
the	|O
15	|O
consecutive	|O
KH	|O
domains	|O
are	|O
organized	|O
such	|O
that	|O
they	|O
define	|O
two	|O
nucleic	|O
acid	|O
binding	|O
surfaces	|O
.	|O

Mutational	|O
analysis	|O
of	|O
mammalian	|O
translation	|B-PROTEIN
initiation	|I-PROTEIN
factor	|I-PROTEIN
5	|I-PROTEIN
(	|O
eIF5	|B-PROTEIN
)	|O
:	|O
role	|O
of	|O
interaction	|O
between	|O
the	|O
beta	|O
subunit	|O
of	|O
eIF2	|B-PROTEIN
and	|O
eIF5	|B-PROTEIN
in	|O
eIF5	|B-PROTEIN
function	|O
in	|O
vitro	|O
and	|O
in	|O
vivo	|O
.	|O

Much	|O
evidence	|O
indicates	|O
that	|O
p38	|B-PROTEIN
is	|O
an	|O
activator	|O
of	|O
MyoD	|B-PROTEIN
:	|O
(	|O
i	|O
)	|O
p38	|B-PROTEIN
kinase	|O
activity	|O
is	|O
required	|O
for	|O
the	|O
expression	|O
of	|O
MyoD	|B-PROTEIN
-	|O
responsive	|O
genes	|O
,	|O
(	|O
ii	|O
)	|O
enforced	|O
induction	|O
of	|O
p38	|B-PROTEIN
stimulates	|O
the	|O
transcriptional	|O
activity	|O
of	|O
a	|O
Gal4	|B-PROTEIN
-	|O
MyoD	|B-PROTEIN
fusion	|O
protein	|O
and	|O
allows	|O
efficient	|O
activation	|O
of	|O
chromatin	|O
-	|O
integrated	|O
reporters	|O
by	|O
MyoD	|B-PROTEIN
,	|O
and	|O
(	|O
iii	|O
)	|O
MyoD	|B-PROTEIN
-	|O
dependent	|O
myogenic	|O
conversion	|O
is	|O
reduced	|O
in	|O
mouse	|O
embryonic	|O
fibroblasts	|O
derived	|O
from	|O
p38alpha	|B-PROTEIN
(	|O
-	|O
/	|O
-	|O
)	|O
embryos	|O
.	|O

This	|O
activity	|O
is	|O
stimulated	|O
by	|O
complex	|O
formation	|O
with	|O
the	|O
other	|O
eIF2B	|B-PROTEIN
subunits	|O
.	|O

Our	|O
analysis	|O
of	|O
nonsense	|O
mutations	|O
indicates	|O
that	|O
the	|O
C	|O
terminus	|O
of	|O
eIF2Bepsilon	|B-PROTEIN
(	|O
residues	|O
518	|O
to	|O
712	|O
)	|O
is	|O
required	|O
for	|O
both	|O
catalytic	|O
activity	|O
and	|O
interaction	|O
with	|O
eIF2	|B-PROTEIN
.	|O

In	|O
contrast	|O
,	|O
mutations	|O
affecting	|O
the	|O
other	|O
two	|O
Nim1p	|B-PROTEIN
-	|O
related	|O
kinases	|O
in	|O
S.	|O
cerevisiae	|O
,	|O
Hsl1p	|B-PROTEIN
and	|O
Kcc4p	|B-PROTEIN
,	|O
produce	|O
no	|O
detectable	|O
effect	|O
on	|O
septin	|B-PROTEIN
organization	|O
.	|O

CONCLUSIONS	|O
:	|O
Physiologic	|O
pacing	|O
provides	|O
little	|O
benefit	|O
over	|O
ventricular	|O
pacing	|O
for	|O
the	|O
prevention	|O
of	|O
stroke	|O
or	|O
death	|O
due	|O
to	|O
cardiovascular	|O
causes	|O
.	|O

Among	|O
non	|O
-	|O
cirrhotics	|O
,	|O
lack	|O
of	|O
portal	|O
vein	|O
visualisation	|O
had	|O
a	|O
90%	|O
sensitivity	|O
,	|O
88%	|O
specificity	|O
,	|O
94%	|O
negative	|O
predictive	|O
value	|O
,	|O
and	|O
83%	|O
positive	|O
predictive	|O
value	|O
in	|O
the	|O
diagnosis	|O
of	|O
pre	|O
-	|O
sinusoidal	|O
portal	|O
hypertension	|O
.	|O

D5	|B-PROTEIN
/	|I-PROTEIN
D1	|I-PROTEIN
(	|I-PROTEIN
CT	|I-PROTEIN
)	|I-PROTEIN
or	|O
D5	|B-PROTEIN
/	|I-PROTEIN
D1D	|I-PROTEIN
(	|I-PROTEIN
CT	|I-PROTEIN
)	|I-PROTEIN
tail	|O
substitution	|O
mutants	|O
displayed	|O
a	|O
rank	|O
order	|O
of	|O
potency	|O
and	|O
agonist	|O
affinities	|O
virtually	|O
mimicking	|O
wild	|O
-	|O
type	|O
(	|O
wt	|O
)	|O
D1	|B-PROTEIN
receptors	|I-PROTEIN
,	|O
as	|O
indexed	|O
by	|O
both	|O
ligand	|O
binding	|O
and	|O
dopamine	|O
-	|O
stimulated	|O
cAMP	|O
accumulation	|O
assays	|O
,	|O
and	|O
,	|O
similar	|O
to	|O
wt	|O
D1	|B-PROTEIN
receptors	|I-PROTEIN
,	|O
did	|O
not	|O
exhibit	|O
receptor	|O
constitutive	|O
activity	|O
or	|O
responsiveness	|O
to	|O
inverse	|O
agonists	|O
.	|O

Modeling	|O
also	|O
revealed	|O
a	|O
very	|O
hydrophobic	|O
surface	|O
due	|O
to	|O
the	|O
absence	|O
of	|O
H12	|O
,	|O
exposing	|O
residues	|O
from	|O
H3	|O
,	|O
loop	|O
3-4	|O
,	|O
H4	|O
,	|O
and	|O
H11	|O
.	|O

The	|O
serine	|B-PROTEIN
-	|I-PROTEIN
threonine	|I-PROTEIN
kinase	|I-PROTEIN
gene	|O
is	|O
likely	|O
functional	|O
,	|O
whereas	|O
the	|O
zinc	|O
finger	|O
motif	|O
is	|O
likely	|O
nonfunctional	|O
.	|O

Stat	|B-PROTEIN
activation	|O
in	|O
response	|O
to	|O
GH	|B-PROTEIN
and	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
was	|O
determined	|O
by	|O
reporter	|O
gene	|O
induction	|O
.	|O

HFA	|O
134a	|O
had	|O
a	|O
greater	|O
tendency	|O
to	|O
take	|O
up	|O
moisture	|O
from	|O
the	|O
environment	|O
than	|O
did	|O
HFA	|O
227	|O
.	|O

RESULTS	|O
:	|O
Abnormal	|O
color	|O
perception	|O
was	|O
found	|O
in	|O
32%	|O
of	|O
the	|O
epilepsy	|O
patients	|O
treated	|O
with	|O
vigabatrin	|O
monotherapy	|O
and	|O
28%	|O
of	|O
the	|O
epilepsy	|O
patients	|O
treated	|O
with	|O
carbamazepine	|O
monotherapy	|O
.	|O

In	|O
the	|O
SPP2	|O
screening	|O
test	|O
,	|O
a	|O
few	|O
plates	|O
were	|O
not	|O
seen	|O
in	|O
both	|O
groups	|O
.	|O

Mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
(	|I-PROTEIN
MAP	|I-PROTEIN
)	|I-PROTEIN
kinase	|I-PROTEIN
phosphatase	|I-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
(	|O
MKP	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
)	|O
is	|O
a	|O
dual	|O
specificity	|O
phosphatase	|O
that	|O
inactivates	|O
extracellular	|B-PROTEIN
signal	|I-PROTEIN
-	|I-PROTEIN
regulated	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
ERK	|B-PROTEIN
)	|O
MAP	|B-PROTEIN
kinases	|I-PROTEIN
.	|O

Consistent	|O
with	|O
this	|O
,	|O
we	|O
show	|O
that	|O
peptides	|O
representing	|O
docking	|O
sites	|O
within	|O
the	|O
target	|O
substrates	|O
Elk	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
p90	|B-PROTEIN
(	|O
rsk	|B-PROTEIN
)	|O
inhibit	|O
ERK	|B-PROTEIN
-	|O
dependent	|O
activation	|O
of	|O
MKP	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
.	|O

HPLC	|O
phosphopeptide	|O
mapping	|O
,	|O
amino	|O
acid	|O
sequencing	|O
,	|O
and	|O
site	|O
-	|O
directed	|O
mutagenesis	|O
determined	|O
that	|O
NCLK	|B-PROTEIN
phosphorylates	|O
Ser	|O
(	|O
67	|O
)	|O
of	|O
I	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

When	|O
the	|O
entire	|O
diet	|O
consisted	|O
of	|O
SBF	|O
,	|O
voluntary	|O
feed	|O
intake	|O
was	|O
reduced	|O
,	|O
indicating	|O
that	|O
SBF	|O
should	|O
not	|O
be	|O
fed	|O
to	|O
ponies	|O
as	|O
the	|O
sole	|O
dietary	|O
ingredient	|O
.	|O

Hepatitis	|O
C	|O
virus	|O
infection	|O
and	|O
lymphoproliferative	|O
diseases	|O
in	|O
France	|O
:	|O
a	|O
national	|O
study	|O
.	|O

The	|O
immune	|O
system	|O
is	|O
closely	|O
integrated	|O
with	|O
the	|O
neuroendocrine	|O
system	|O
,	|O
and	|O
infection	|O
-	|O
induced	|O
increases	|O
in	|O
cytokines	|O
such	|O
as	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
and	|O
TNF	|B-PROTEIN
have	|O
numerous	|O
effects	|O
on	|O
the	|O
central	|O
nervous	|O
system	|O
.	|O

Interestingly	|O
,	|O
a	|O
decreased	|O
transcription	|O
from	|O
the	|O
endogenous	|O
c	|B-PROTEIN
-	|I-PROTEIN
Myb	|I-PROTEIN
promoter	|O
was	|O
observed	|O
in	|O
several	|O
HTLV	|O
-	|O
I	|O
transformed	|O
T	|O
-	|O
cell	|O
lines	|O
.	|O

H19	|B-PROTEIN
and	|O
Igf2	|B-PROTEIN
monoallelic	|O
expression	|O
is	|O
regulated	|O
in	|O
two	|O
distinct	|O
ways	|O
by	|O
a	|O
shared	|O
cis	|O
acting	|O
regulatory	|O
region	|O
upstream	|O
of	|O
H19	|B-PROTEIN
.	|O

C.	|O
elegans	|O
KLP	|B-PROTEIN
-	|I-PROTEIN
11	|I-PROTEIN
/	|O
OSM	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
/	|O
KAP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
:	|O
orthologs	|O
of	|O
the	|O
sea	|O
urchin	|O
kinesin	|B-PROTEIN
-	|I-PROTEIN
II	|I-PROTEIN
,	|O
and	|O
mouse	|O
KIF3A	|B-PROTEIN
/	|O
KIFB	|B-PROTEIN
/	|O
KAP3	|B-PROTEIN
kinesin	|O
complexes	|O
.	|O

Flavonoids	|O
from	|O
Brosimum	|O
acutifolium	|O
.	|O

BACKGROUND	|O
:	|O
Hepatic	|O
encephalopathy	|O
is	|O
a	|O
neuropsychiatric	|O
syndrome	|O
associated	|O
with	|O
acute	|O
liver	|O
failure	|O
,	|O
chronic	|O
parenchymal	|O
liver	|O
disease	|O
or	|O
portal	|O
systemic	|O
anastomosis	|O
.	|O

These	|O
natural	|O
antisense	|O
S	|B-PROTEIN
transcripts	|O
co	|O
-	|O
exist	|O
with	|O
several	|O
less	|O
abundant	|O
sense	|O
S	|B-PROTEIN
transcripts	|O
.	|O

Nor	|O
is	|O
such	|O
adjustment	|O
possible	|O
unless	|O
one	|O
posits	|O
a	|O
model	|O
that	|O
relates	|O
the	|O
missing	|O
observations	|O
to	|O
other	|O
observed	|O
information	|O
for	|O
each	|O
subject	|O
-	|O
models	|O
that	|O
are	|O
inherently	|O
untestable	|O
.	|O

However	|O
,	|O
the	|O
presence	|O
of	|O
effacement	|O
seems	|O
to	|O
be	|O
a	|O
more	|O
reliable	|O
and	|O
practical	|O
parameter	|O
that	|O
will	|O
be	|O
preferred	|O
in	|O
that	|O
prediction	|O
.	|O

The	|O
data	|O
are	|O
compatible	|O
with	|O
the	|O
idea	|O
that	|O
YLL031c	|B-PROTEIN
transfers	|O
the	|O
ethanolaminephosphate	|O
to	|O
the	|O
inner	|O
alpha1	|O
-	|O
2	|O
-	|O
linked	|O
mannose	|O
,	|O
i.e.	|O
the	|O
group	|O
that	|O
links	|O
the	|O
GPI	|O
lipid	|O
anchor	|O
to	|O
proteins	|O
,	|O
whereas	|O
Mcd4p	|B-PROTEIN
and	|O
Gpi7p	|B-PROTEIN
transfer	|O
ethanolaminephosphate	|O
onto	|O
the	|O
alpha1	|O
-	|O
4	|O
-	|O
and	|O
alpha1	|O
-	|O
6	|O
-	|O
linked	|O
mannoses	|O
of	|O
the	|O
GPI	|O
anchor	|O
,	|O
respectively	|O
.	|O

The	|O
C	|O
terminus	|O
of	|O
TRBP	|B-PROTEIN
binds	|O
to	|O
CBP	|B-PROTEIN
/	|O
p300	|B-PROTEIN
and	|O
DRIP130	|B-PROTEIN
,	|O
a	|O
component	|O
of	|O
the	|O
DRIP	|B-PROTEIN
/	|O
TRAP	|B-PROTEIN
/	|O
ARC	|B-PROTEIN
complex	|O
,	|O
which	|O
suggests	|O
that	|O
TRBP	|B-PROTEIN
may	|O
activate	|O
transcription	|O
by	|O
means	|O
of	|O
such	|O
interactions	|O
.	|O

The	|O
patients	|O
who	|O
presented	|O
with	|O
mucocutaneous	|O
disease	|O
also	|O
had	|O
low	|O
CD4+	|B-PROTEIN
T	|O
lymphocyte	|O
counts	|O
,	|O
and	|O
most	|O
of	|O
them	|O
had	|O
AIDS	|O
defining	|O
illnesses	|O
.	|O

Increased	|O
dietary	|O
energy	|O
decreased	|O
PAB	|O
and	|O
the	|O
use	|O
of	|O
added	|O
dietary	|O
CO	|O
rather	|O
than	|O
PF	|O
decreased	|O
PSHL	|O
in	|O
broiler	|O
breeders	|O
between	|O
26	|O
and	|O
47	|O
wk	|O
of	|O
age	|O
.	|O

The	|O
gene	|O
amplification	|O
model	|O
of	|O
Coquelle	|O
et	|O
al.	|O

Hierarchy	|O
of	|O
protein	|O
tyrosine	|B-PROTEIN
kinases	|I-PROTEIN
in	|O
interleukin	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
(	|O
IL	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
)	|O
signaling	|O
:	|O
activation	|O
of	|O
syk	|B-PROTEIN
depends	|O
on	|O
Jak3	|B-PROTEIN
;	|O
however	|O
,	|O
neither	|O
Syk	|B-PROTEIN
nor	|O
Lck	|B-PROTEIN
is	|O
required	|O
for	|O
IL	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
-	|O
mediated	|O
STAT	|B-PROTEIN
activation	|O
.	|O

Immobilized	|O
dimers	|O
of	|O
N	|B-PROTEIN
-	|I-PROTEIN
cadherin	|I-PROTEIN
-	|O
Fc	|B-PROTEIN
chimera	|O
mimic	|O
cadherin	|B-PROTEIN
-	|O
mediated	|O
cell	|O
contact	|O
formation	|O
:	|O
contribution	|O
of	|O
both	|O
outside	|O
-	|O
in	|O
and	|O
inside	|O
-	|O
out	|O
signals	|O
.	|O

Although	|O
the	|O
OC	|B-PROTEIN
promoter	|O
is	|O
activated	|O
in	|O
a	|O
C	|O
terminus	|O
dependent	|O
manner	|O
,	|O
the	|O
MDR	|B-PROTEIN
,	|O
LTR	|O
and	|O
BSP	|B-PROTEIN
promoters	|O
are	|O
repressed	|O
by	|O
three	|O
distinct	|O
mechanisms	|O
,	|O
either	|O
independent	|O
of	|O
or	|O
involving	|O
the	|O
AML	|B-PROTEIN
C	|O
terminus	|O
,	|O
or	|O
requiring	|O
only	|O
the	|O
conserved	|O
C	|O
-	|O
terminal	|O
pentapeptide	|O
VWRPY	|O
.	|O

The	|O
monoclonal	|O
immunoglobulin	|B-PROTEIN
products	|O
of	|O
plasma	|O
cell	|O
neoplasm	|O
can	|O
give	|O
rise	|O
to	|O
a	|O
variety	|O
of	|O
manifestations	|O
including	|O
hyperviscosity	|O
,	|O
amyloidosis	|O
,	|O
cryoglobulinemia	|O
,	|O
neuropathy	|O
,	|O
and	|O
renal	|O
failure	|O
.	|O

Investigation	|O
of	|O
the	|O
structural	|O
basis	|O
of	|O
the	|O
interaction	|O
between	|O
human	|O
Igs	|B-PROTEIN
and	|O
gp120	|B-PROTEIN
shows	|O
that	|O
the	|O
viral	|O
gp120	|B-PROTEIN
SAg	|O
can	|O
interact	|O
only	|O
with	|O
a	|O
subset	|O
of	|O
human	|O
V	|B-PROTEIN
(	|I-PROTEIN
H	|I-PROTEIN
)	|I-PROTEIN
3+	|I-PROTEIN
Igs	|I-PROTEIN
.	|O

Double	|O
-	|O
blind	|O
,	|O
placebo	|O
-	|O
controlled	|O
trial	|O
.	|O

Here	|O
,	|O
it	|O
is	|O
shown	|O
that	|O
TAFII250	|B-PROTEIN
,	|O
the	|O
largest	|O
subunit	|O
of	|O
TFIID	|B-PROTEIN
,	|O
contains	|O
two	|O
tandem	|O
bromodomain	|O
modules	|O
that	|O
bind	|O
selectively	|O
to	|O
multiply	|O
acetylated	|O
histone	|O
H4	|B-PROTEIN
peptides	|O
.	|O

Endostatin	|O
treatment	|O
for	|O
10	|O
minutes	|O
or	|O
24	|O
hours	|O
induced	|O
tyrosine	|O
phosphorylation	|O
of	|O
Shb	|B-PROTEIN
and	|O
formation	|O
of	|O
multiprotein	|O
complexes	|O
.	|O

Therefore	|O
,	|O
analogs	|O
of	|O
vitamin	|O
D3	|O
have	|O
been	|O
investigated	|O
in	|O
a	|O
number	|O
of	|O
trials	|O
showing	|O
improvement	|O
of	|O
psoriasis	|O
.	|O

The	|O
transcript	|O
was	|O
initially	|O
identified	|O
as	|O
a	|O
partial	|O
cDNA	|O
sequence	|O
in	|O
the	|O
course	|O
of	|O
constructing	|O
a	|O
transcript	|O
map	|O
of	|O
the	|O
region	|O
between	|O
markers	|O
D11S1765	|B-PROTEIN
and	|O
uteroglobin	|B-PROTEIN
known	|O
to	|O
encompass	|O
the	|O
gene	|O
causing	|O
Best	|O
disease	|O
.	|O

The	|O
real	|O
challenge	|O
for	|O
the	|O
future	|O
will	|O
be	|O
the	|O
management	|O
of	|O
patients	|O
who	|O
do	|O
not	|O
respond	|O
to	|O
first	|O
-	|O
line	|O
treatment	|O
.	|O

Iodine	|O
deficiency	|O
disorders	|O
in	|O
Bangladesh	|O
.	|O

The	|O
network	|O
evolution	|O
was	|O
interpreted	|O
by	|O
an	|O
approach	|O
based	|O
on	|O
the	|O
Flory	|O
model	|O
.	|O

RESULTS	|O
:	|O
Soluble	|O
CD23	|B-PROTEIN
levels	|O
were	|O
significantly	|O
higher	|O
in	|O
women	|O
with	|O
endometriosis	|O
before	|O
treatment	|O
than	|O
in	|O
ten	|O
normal	|O
controls	|O
.	|O

CONCLUSION	|O
:	|O
Our	|O
findings	|O
suggest	|O
that	|O
endometriosis	|O
increases	|O
soluble	|O
CD23	|B-PROTEIN
levels	|O
,	|O
which	|O
can	|O
be	|O
suppressed	|O
with	|O
either	|O
danazol	|O
or	|O
leuprolide	|O
acetate	|O
injection	|O
.	|O

To	|O
isolate	|O
this	|O
gene	|O
,	|O
a	|O
P	|O
-	|O
1	|O
artificial	|O
chromosome	|O
(	|O
PAC	|O
)	|O
library	|O
was	|O
screened	|O
with	|O
a	|O
full	|O
length	|O
UGT2B7	|B-PROTEIN
probe	|O
and	|O
a	|O
clone	|O
of	|O
approximately	|O
100	|O
kb	|O
in	|O
length	|O
was	|O
isolated	|O
.	|O

Age	|O
>	|O
/	|O
=	|O
50	|O
years	|O
(	|O
odds	|O
ratio	|O
[	|O
OR	|O
]	|O
,	|O
14.1	|O
)	|O
,	|O
BMI	|O
>	|O
/	|O
=	|O
28	|O
kg	|O
/	|O
m	|O
(	|O
2	|O
)	|O
(	|O
OR	|O
,	|O
5.7	|O
)	|O
,	|O
triglycerides	|O
>	|O
/	|O
=	|O
1.7	|O
mmol	|O
/	|O
L	|O
(	|O
OR	|O
,	|O
5	|O
)	|O
,	|O
and	|O
alanine	|B-PROTEIN
aminotransferase	|I-PROTEIN
(	|O
ALT	|B-PROTEIN
)	|O
>	|O
/	|O
=	|O
2N	|O
(	|O
OR	|O
,	|O
4.6	|O
)	|O
were	|O
independently	|O
associated	|O
with	|O
septal	|O
fibrosis	|O
.	|O

Biologically	|O
significant	|O
amounts	|O
of	|O
platelet	|B-PROTEIN
activating	|I-PROTEIN
factor	|I-PROTEIN
were	|O
eluted	|O
from	|O
the	|O
sorbent	|O
during	|O
the	|O
entire	|O
treatment	|O
time	|O
.	|O

However	|O
,	|O
the	|O
elderly	|O
group	|O
showed	|O
significantly	|O
longer	|O
mean	|O
residence	|O
times	|O
(	|O
MRTs	|O
)	|O
and	|O
lower	|O
plasma	|O
clearance	|O
of	|O
lidocaine	|O
during	|O
the	|O
period	|O
compared	|O
with	|O
the	|O
adult	|O
group	|O
(	|O
P	|O
<	|O
.05	|O
)	|O
.	|O

Here	|O
,	|O
we	|O
show	|O
that	|O
the	|O
zinc	|O
finger	|O
protein	|O
Gis1	|B-PROTEIN
acts	|O
as	|O
a	|O
dosage	|O
-	|O
dependent	|O
suppressor	|O
of	|O
the	|O
rim15Delta	|B-PROTEIN
defect	|O
in	|O
nutrient	|O
limitation	|O
-	|O
induced	|O
transcriptional	|O
derepression	|O
of	|O
SSA3	|B-PROTEIN
.	|O

The	|O
so	|O
-	|O
called	|O
"	|O
SH3	|B-PROTEIN
"	|O
segment	|O
of	|O
the	|O
linker	|O
domain	|O
,	|O
in	|O
contrast	|O
,	|O
shows	|O
species	|O
-	|O
specific	|O
sequence	|O
identity	|O
in	|O
all	|O
but	|O
one	|O
amino	|O
acid	|O
residues	|O
in	|O
both	|O
factors	|O
,	|O
in	|O
cattle	|O
,	|O
human	|O
,	|O
and	|O
mouse	|O
.	|O

No	|O
differences	|O
in	|O
total	|O
cholesterol	|O
levels	|O
were	|O
observed	|O
between	|O
mapuches	|O
and	|O
aymaras	|O
.	|O

Up	|O
to	|O
95%	|O
of	|O
the	|O
total	|O
UV	|O
exposure	|O
received	|O
is	|O
in	|O
the	|O
UV	|O
-	|O
A	|O
waveband	|O
(	|O
320-400	|O
nm	|O
)	|O
.	|O

To	|O
begin	|O
to	|O
characterize	|O
the	|O
role	|O
of	|O
the	|O
RNA	|O
subunits	|O
in	|O
enzyme	|O
function	|O
and	|O
substrate	|O
specificity	|O
,	|O
we	|O
swapped	|O
two	|O
hairpin	|O
structures	|O
(	|O
MRP3	|O
and	|O
P3	|O
)	|O
between	|O
RNase	|O
MRP	|B-PROTEIN
RNA	|O
and	|O
RNase	|O
P	|B-PROTEIN
RNA	|O
of	|O
S.	|O
cerevisiae	|O
.	|O

Among	|O
genes	|O
induced	|O
by	|O
added	|O
pMesogenin1	|B-PROTEIN
is	|O
Xwnt	|B-PROTEIN
-	|I-PROTEIN
8	|I-PROTEIN
,	|O
a	|O
signaling	|O
factor	|O
that	|O
induces	|O
a	|O
similar	|O
repertoire	|O
of	|O
marker	|O
genes	|O
and	|O
a	|O
similar	|O
cellular	|O
phenotype	|O
.	|O

Accordingly	|O
,	|O
no	|O
Ha	|B-PROTEIN
-	|I-PROTEIN
ras	|I-PROTEIN
codon	|O
12	|O
mutations	|O
are	|O
found	|O
in	|O
the	|O
EtNU	|O
-	|O
induced	|O
mammary	|O
tumors	|O
.	|O

False	|O
positive	|O
PET	|O
FDG	|O
corresponded	|O
to	|O
lung	|O
infection	|O
,	|O
degenerative	|O
bone	|O
disease	|O
,	|O
and	|O
reconstruction	|O
artifact	|O
.	|O

Tumor	|O
stages	|O
were	|O
IIB	|O
(	|O
T3	|O
N0	|O
)	|O
in	|O
52%	|O
,	|O
IIIA	|O
in	|O
15%	|O
,	|O
and	|O
IIIB	|O
in	|O
27%	|O
of	|O
patients	|O
.	|O

Similarly	|O
,	|O
comparison	|O
of	|O
percentage	|O
reductions	|O
of	|O
heart	|O
rate	|O
at	|O
supine	|O
,	|O
sitting	|O
and	|O
exercise	|O
by	|O
repeated	|O
measure	|O
analysis	|O
showed	|O
the	|O
Malays	|O
to	|O
have	|O
significantly	|O
higher	|O
change	|O
compared	|O
to	|O
the	|O
Chinese	|O
(	|O
p	|O
=	|O
0.040	|O
)	|O
.	|O

Consistent	|O
with	|O
our	|O
model	|O
,	|O
CTCF	|B-PROTEIN
binding	|O
is	|O
abolished	|O
by	|O
DNA	|O
methylation	|O
.	|O

OBJECTIVE	|O
:	|O
To	|O
determine	|O
the	|O
efficacy	|O
and	|O
safety	|O
of	|O
amphotericin	|O
B	|O
oral	|O
suspension	|O
(	|O
ABOS	|O
)	|O
for	|O
the	|O
treatment	|O
of	|O
fluconazole	|O
refractory	|O
oral	|O
candidiasis	|O
in	|O
persons	|O
with	|O
HIV	|O
infection	|O
.	|O

Mucin	|B-PROTEIN
gene	|O
expression	|O
has	|O
been	|O
shown	|O
to	|O
be	|O
altered	|O
in	|O
many	|O
intestinal	|O
diseases	|O
and	|O
especially	|O
cancers	|O
of	|O
the	|O
gastrointestinal	|O
tract	|O
.	|O

The	|O
experimentally	|O
mapped	|O
regions	|O
of	|O
RPB5	|B-PROTEIN
involved	|O
in	|O
these	|O
interactions	|O
correspond	|O
to	|O
distinct	|O
and	|O
surface	|O
-	|O
exposed	|O
alpha	|O
-	|O
helical	|O
structures	|O
.	|O

The	|O
model	|O
indicates	|O
that	|O
a	|O
0.076%	|O
reduction	|O
in	|O
cigarette	|O
consumption	|O
is	|O
associated	|O
with	|O
the	|O
availability	|O
of	|O
nicotine	|O
patches	|O
after	|O
1992	|O
.	|O

Paper	|O
alert	|O
.	|O

The	|O
tryptase	|B-PROTEIN
locus	|O
also	|O
contains	|O
at	|O
least	|O
four	|O
tryptase	|B-PROTEIN
-	|O
like	|O
pseudogenes	|O
,	|O
including	|O
mastin	|B-PROTEIN
,	|O
a	|O
gene	|O
expressed	|O
in	|O
dogs	|O
but	|O
not	|O
in	|O
humans	|O
.	|O

The	|O
cellular	|O
part	|O
of	|O
the	|O
third	|O
chimeric	|O
clone	|O
shows	|O
significant	|O
homology	|O
to	|O
an	|O
exon	|O
of	|O
the	|O
human	|O
tyrosine	|B-PROTEIN
phosphatase	|I-PROTEIN
1	|I-PROTEIN
gene	|O
,	|O
although	|O
oriented	|O
in	|O
the	|O
antisense	|O
direction	|O
compared	|O
to	|O
the	|O
adjacent	|O
LTR	|O
.	|O

OBJECTIVE	|O
:	|O
This	|O
study	|O
was	|O
conducted	|O
to	|O
assess	|O
the	|O
relative	|O
roles	|O
of	|O
99mTc	|O
-	|O
sestamibi	|O
scintimammography	|O
and	|O
sonography	|O
in	|O
the	|O
evaluation	|O
of	|O
breast	|O
lesions	|O
that	|O
are	|O
indeterminate	|O
or	|O
suspicious	|O
on	|O
mammography	|O
or	|O
clinical	|O
examination	|O
.	|O

Mutational	|O
analyses	|O
showed	|O
that	|O
in	|O
-	|O
frame	|O
stop	|O
codons	|O
introduced	|O
into	|O
five	|O
of	|O
seven	|O
RNA	|B-PROTEIN
2	|I-PROTEIN
ORFs	|O
did	|O
not	|O
affect	|O
accumulation	|O
of	|O
progeny	|O
LIYV	|O
RNA	|B-PROTEIN
1	|I-PROTEIN
or	|O
RNA	|B-PROTEIN
2	|I-PROTEIN
,	|O
confirming	|O
that	|O
RNA	|B-PROTEIN
2	|I-PROTEIN
does	|O
not	|O
encode	|O
proteins	|O
necessary	|O
for	|O
LIYV	|O
RNA	|O
replication	|O
.	|O

Role	|O
of	|O
NH	|O
(	|O
2	|O
)	|O
-	|O
and	|O
COOH	|O
-	|O
terminal	|O
domains	|O
of	|O
the	|O
P	|B-PROTEIN
protein	|I-PROTEIN
of	|O
human	|O
parainfluenza	|O
virus	|O
type	|O
3	|O
in	|O
transcription	|O
and	|O
replication	|O
.	|O

Phosphorylation	|O
of	|O
tyrosine	|O
residues	|O
in	|O
the	|O
kinase	|O
domain	|O
and	|O
juxtamembrane	|O
region	|O
regulates	|O
the	|O
biological	|O
and	|O
catalytic	|O
activities	|O
of	|O
Eph	|B-PROTEIN
receptors	|I-PROTEIN
.	|O

RESULTS	|O
:	|O
Fournier	|O
's	|O
gangrene	|O
occurs	|O
worldwide	|O
.	|O

Genomic	|O
DNA	|O
sequencing	|O
in	|O
the	|O
vicinity	|O
of	|O
methylmalonyl	|B-PROTEIN
-	|I-PROTEIN
CoA	|I-PROTEIN
mutase	|I-PROTEIN
gene	|I-PROTEIN
(	|O
mutAB	|B-PROTEIN
)	|O
from	|O
a	|O
rifamycin	|O
SV	|O
-	|O
producing	|O
Amycolatopsis	|O
mediterranei	|O
U32	|O
allowed	|O
us	|O
to	|O
clone	|O
,	|O
sequence	|O
,	|O
and	|O
identify	|O
a	|O
gene	|O
encoding	|O
a	|O
novel	|O
serine	|B-PROTEIN
/	|I-PROTEIN
threonine	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
amk	|B-PROTEIN
)	|O
.	|O

IL	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
is	|O
accepted	|O
as	|O
a	|O
standard	|O
treatment	|O
used	|O
alone	|O
,	|O
or	|O
in	|O
combination	|O
with	|O
chemotherapy	|O
or	|O
biotherapy	|O
in	|O
the	|O
management	|O
of	|O
metastatic	|O
melanoma	|O
and	|O
metastatic	|O
renal	|O
cell	|O
carcinoma	|O
.	|O

Moreover	|O
,	|O
expression	|O
of	|O
antisense	|O
Ha	|B-PROTEIN
-	|I-PROTEIN
Ras	|I-PROTEIN
or	|O
dominant	|O
negative	|O
Raf	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
abrogated	|O
the	|O
mitogenic	|O
effect	|O
of	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta1	|I-PROTEIN
in	|O
TSU	|O
-	|O
Pr1	|O
,	|O
and	|O
the	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta1	|I-PROTEIN
inhibition	|O
of	|O
DU145	|O
was	|O
switched	|O
to	|O
stimulation	|O
by	|O
V12Ha	|B-PROTEIN
-	|I-PROTEIN
Ras	|I-PROTEIN
transfection	|O
.	|O

Taken	|O
together	|O
,	|O
our	|O
data	|O
suggest	|O
that	|O
prostate	|O
carcinomas	|O
with	|O
the	|O
Ras	|B-PROTEIN
/	|O
MAPK	|B-PROTEIN
pathway	|O
activation	|O
might	|O
have	|O
a	|O
selective	|O
growth	|O
advantage	|O
by	|O
autocrine	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta1	|I-PROTEIN
production	|O
.	|O

Vbeta	|B-PROTEIN
segments	|O
are	|O
appended	|O
to	|O
DJbeta	|B-PROTEIN
rearrangements	|O
,	|O
with	|O
little	|O
or	|O
no	|O
direct	|O
Vbeta	|B-PROTEIN
to	|O
Jbeta	|B-PROTEIN
joining	|O
,	|O
despite	|O
12/23	|O
compatibility	|O
of	|O
Vbeta	|B-PROTEIN
23	|I-PROTEIN
-	|I-PROTEIN
RSSs	|I-PROTEIN
and	|O
Jbeta12	|B-PROTEIN
-	|I-PROTEIN
RSSs	|I-PROTEIN
.	|O

For	|O
oral	|O
administration	|O
,	|O
AUC0	|O
-	|O
infinity	|O
was	|O
58.47	|O
+	|O
/	|O
-	|O
16.37	|O
microg	|O
x	|O
h	|O
/	|O
ml	|O
,	|O
t1/2	|O
beta	|O
was	|O
18.39	|O
+	|O
/	|O
-	|O
0.06	|O
hours	|O
,	|O
maximum	|O
concentration	|O
(	|O
Cmax	|O
)	|O
was	|O
2.12	|O
+	|O
/	|O
-	|O
00.51	|O
microg	|O
/	|O
ml	|O
,	|O
time	|O
to	|O
Cmax	|O
was	|O
2.20	|O
+	|O
/	|O
-	|O
2.17	|O
hours	|O
,	|O
mean	|O
absorption	|O
time	|O
was	|O
2.09	|O
+	|O
/	|O
-	|O
0.51	|O
hours	|O
,	|O
and	|O
bioavailability	|O
was	|O
42	|O
+	|O
/	|O
-	|O
0.42%	|O
.	|O

In	|O
experiment	|O
2	|O
,	|O
no	|O
difference	|O
in	|O
gastric	|O
emptying	|O
of	|O
40%	|O
peptone	|O
or	|O
25%	|O
glucose	|O
was	|O
found	|O
between	|O
rats	|O
receiving	|O
TPN	|O
and	|O
those	|O
receiving	|O
intragastric	|O
nutrition	|O
for	|O
10	|O
to	|O
12	|O
days	|O
.	|O

In	|O
contrast	|O
,	|O
H	|B-PROTEIN
-	|I-PROTEIN
NS	|I-PROTEIN
negative	|O
regulation	|O
operated	|O
only	|O
in	|O
the	|O
absence	|O
of	|O
Fur	|B-PROTEIN
.	|O

Thus	|O
,	|O
SAG	|B-PROTEIN
appears	|O
to	|O
control	|O
cell	|O
cycle	|O
progression	|O
in	|O
yeast	|O
by	|O
promoting	|O
ubiquitination	|O
and	|O
degradation	|O
of	|O
cell	|O
cycle	|O
regulatory	|O
proteins	|O
.	|O

E2F	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
a	|O
transcription	|O
factor	|O
that	|O
regulates	|O
cell	|O
cycle	|O
progression	|O
into	|O
S	|O
-	|O
phase	|O
.	|O

It	|O
brings	|O
about	|O
fatigue	|O
,	|O
negative	|O
moods	|O
,	|O
and	|O
impaired	|O
health	|O
,	|O
sleep	|O
,	|O
safety	|O
,	|O
and	|O
working	|O
capacity	|O
.	|O

This	|O
demonstrates	|O
that	|O
treatment	|O
of	|O
the	|O
graft	|O
recipient	|O
for	|O
a	|O
relatively	|O
short	|O
period	|O
during	|O
and	|O
after	|O
surgery	|O
has	|O
a	|O
favorable	|O
effect	|O
on	|O
the	|O
survival	|O
of	|O
grafted	|O
dopaminergic	|O
neurons	|O
.	|O

The	|O
relationships	|O
among	|O
blood	|O
concentrations	|O
of	|O
thyroid	|O
hormones	|O
and	|O
selenium	|O
,	|O
zinc	|O
,	|O
retinol	|O
,	|O
and	|O
alpha	|O
-	|O
tocopherol	|O
were	|O
studied	|O
in	|O
44	|O
healthy	|O
Northern	|O
Italian	|O
oldest	|O
-	|O
old	|O
subjects	|O
(	|O
age	|O
range	|O
,	|O
90-107	|O
yr	|O
)	|O
,	|O
selected	|O
by	|O
the	|O
criteria	|O
of	|O
the	|O
SENIEUR	|O
protocol	|O
.	|O

Chinese	|O
Spring	|O
(	|O
CS	|O
)	|O
carrying	|O
the	|O
Q	|B-PROTEIN
gene	|O
to	|O
those	|O
of	|O
a	|O
chromosome	|O
deletion	|O
line	|O
of	|O
CS	|O
,	|O
namely	|O
,	|O
q5	|O
,	|O
which	|O
lacks	|O
15%	|O
of	|O
5AL	|O
including	|O
the	|O
Q	|B-PROTEIN
gene	|O
.	|O

Investigations	|O
using	|O
hippocampal	|O
slices	|O
maintained	|O
in	|O
vitro	|O
have	|O
demonstrated	|O
that	|O
bursts	|O
of	|O
oscillatory	|O
field	|O
potentials	|O
in	|O
the	|O
gamma	|O
frequency	|O
range	|O
(	|O
30-80	|O
Hz	|O
)	|O
are	|O
followed	|O
by	|O
a	|O
slower	|O
oscillation	|O
in	|O
the	|O
beta	|O
1	|O
range	|O
(	|O
12-20	|O
Hz	|O
)	|O
.	|O

Karger	|O
AG	|O
,	|O
Basel	|O

During	|O
surgery	|O
bone	|O
cysts	|O
were	|O
excised	|O
and	|O
filled	|O
by	|O
bone	|O
grafts	|O
.	|O

Urinary	|O
LTE4	|O
increased	|O
after	|O
both	|O
challenges	|O
the	|O
rise	|O
being	|O
higher	|O
following	|O
oral	|O
as	|O
compared	|O
to	|O
inhalation	|O
provocation	|O
(	|O
p	|O
=	|O
0.0001	|O
)	|O
.	|O

Basal	|O
FVR	|O
was	|O
reduced	|O
by	|O
approximately	|O
18%	|O
by	|O
ERT	|O
and	|O
HRT	|O
,	|O
but	|O
FVR	|O
responses	|O
to	|O
noradrenaline	|O
,	|O
angiotensin	|B-PROTEIN
II	|I-PROTEIN
,	|O
acetylcholine	|O
and	|O
nitroprusside	|O
were	|O
unaffected	|O
.	|O

Three	|O
FGF	|B-PROTEIN
-	|O
AS	|O
cDNAs	|O
were	|O
isolated	|O
;	|O
the	|O
full	|O
-	|O
length	|O
FGF	|B-PROTEIN
-	|O
AS	|O
mRNA	|O
and	|O
two	|O
alternative	|O
splice	|O
variants	|O
lacking	|O
exon	|O
2	|O
or	|O
exons	|O
2	|O
and	|O
3	|O
of	|O
the	|O
FGF	|B-PROTEIN
-	|O
AS	|O
sequence	|O
.	|O

Taken	|O
together	|O
,	|O
these	|O
results	|O
indicate	|O
that	|O
MAP	|B-PROTEIN
kinase	|I-PROTEIN
stimulates	|O
the	|O
hPL	|B-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
enhancer	|O
by	|O
an	|O
NF	|B-PROTEIN
-	|I-PROTEIN
IL	|I-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
-	|O
dependent	|O
pathway	|O
.	|O

Characterization	|O
of	|O
polymorphic	|O
TNRs	|O
in	|O
novel	|O
and	|O
even	|O
known	|O
genes	|O
expressed	|O
in	|O
human	|O
spinal	|O
cord	|O
is	|O
likely	|O
to	|O
help	|O
in	|O
the	|O
identification	|O
of	|O
new	|O
candidates	|O
for	|O
genes	|O
involved	|O
in	|O
neurodegenerative	|O
disorders	|O
.	|O

Finally	|O
,	|O
in	|O
situ	|O
RNA	|O
hybridization	|O
studies	|O
revealed	|O
a	|O
very	|O
specific	|O
pattern	|O
of	|O
EphA8	|B-PROTEIN
gene	|O
expression	|O
restricted	|O
to	|O
the	|O
rostral	|O
region	|O
of	|O
midbrain	|O
tectum	|O
during	|O
embryonic	|O
development	|O
.	|O

Transfection	|O
of	|O
cDNAs	|O
for	|O
three	|O
mutant	|O
enzymes	|O
into	|O
FPGS	|B-PROTEIN
-	|O
null	|O
Chinese	|O
hamster	|O
ovary	|O
cells	|O
restored	|O
a	|O
reduced	|O
level	|O
of	|O
clonal	|O
growth	|O
,	|O
whereas	|O
a	|O
T339I	|O
mutant	|O
supported	|O
growth	|O
at	|O
a	|O
level	|O
comparable	|O
to	|O
that	|O
of	|O
the	|O
wild	|O
-	|O
type	|O
enzyme	|O
.	|O

SETTING	|O
:	|O
University	|O
of	|O
Paris	|O
VII	|O
hospital.P	|O
atient	|O
(	|O
s	|O
)	|O
:	|O
Nine	|O
women	|O
had	|O
embolization	|O
for	|O
symptomatic	|O
myoma	|O
,	|O
with	|O
12	|O
pregnancies	|O
observed	|O
.	|O

Improving	|O
fissure	|O
sealant	|O
quality	|O
:	|O
mechanical	|O
preparation	|O
and	|O
filling	|O
level	|O
.	|O

The	|O
Menopause	|O
-	|O
Rating	|O
-	|O
Scale	|O
(	|O
MRS	|O
I	|O
)	|O
was	|O
used	|O
in	|O
clinical	|O
practice	|O
since	|O
1992	|O
.	|O

The	|O
MRS	|O
II	|O
meets	|O
a	|O
high	|O
methodological	|O
standard	|O
as	|O
an	|O
instrument	|O
standardized	|O
in	|O
the	|O
population	|O
.	|O

The	|O
protein	|O
encoded	|O
by	|O
the	|O
fruA	|B-PROTEIN
transcript	|O
is	|O
well	|O
conserved	|O
with	|O
the	|O
D.	|O
melanogaster	|O
type	|B-PROTEIN
A	|I-PROTEIN
protein	|I-PROTEIN
,	|O
particularly	|O
the	|O
BTB	|B-PROTEIN
protein	|O
-	|O
protein	|O
-	|O
binding	|O
domain	|O
,	|O
which	|O
is	|O
encoded	|O
by	|O
exons	|O
I	|O
and	|O
II	|O
and	|O
is	|O
100%	|O
conserved	|O
.	|O

In	|O
addition	|O
,	|O
the	|O
mouse	|O
ortholog	|O
(	|O
Mharp	|B-PROTEIN
/	|O
Smarcal1	|B-PROTEIN
)	|O
was	|O
cloned	|O
,	|O
and	|O
the	|O
Caenorhabditis	|O
elegans	|O
ortholog	|O
(	|O
CEHARP	|B-PROTEIN
)	|O
was	|O
identified	|O
in	|O
the	|O
GenBank	|O
database	|O
.	|O

Sparfloxacin	|O
and	|O
clinafloxacin	|O
were	|O
evaluated	|O
against	|O
Enterococcus	|O
faecium	|O
SF2149	|O
and	|O
Enterococcus	|O
faecalis	|O
WH245	|O
,	|O
respectively	|O
.	|O

ECP	|B-PROTEIN
and	|O
tryptase	|B-PROTEIN
levels	|O
in	|O
serum	|O
were	|O
measured	|O
before	|O
and	|O
after	|O
the	|O
last	|O
oral	|O
challenge	|O
.	|O

Tolterodine	|O
users	|O
were	|O
7.5	|O
times	|O
more	|O
likely	|O
to	|O
have	|O
received	|O
another	|O
spasmolytic	|O
drug	|O
(	|O
RR	|O
7.5	|O
,	|O
95%	|O
CI	|O
4.8	|O
to	|O
11.9	|O
)	|O
.	|O

For	|O
an	|O
unsupervised	|O
program	|O
,	|O
the	|O
costs	|O
were	|O
estimated	|O
at	|O
$	|O
311	|O
for	|O
the	|O
first	|O
year	|O
and	|O
$	|O
73	|O
for	|O
all	|O
additional	|O
years	|O
.	|O

The	|O
presence	|O
of	|O
such	|O
a	|O
putative	|O
RNA	|O
-	|O
binding	|O
domain	|O
suggests	|O
a	|O
mechanism	|O
for	|O
the	|O
observed	|O
autoregulation	|O
of	|O
bacteriophage	|O
T4	|O
DNA	|B-PROTEIN
polymerase	|I-PROTEIN
synthesis	|O
by	|O
binding	|O
to	|O
its	|O
own	|O
mRNA	|O
.	|O

Deletion	|O
and	|O
mutational	|O
analyses	|O
revealed	|O
two	|O
positive	|O
cis	|O
-	|O
regulatory	|O
elements	|O
in	|O
this	|O
region	|O
that	|O
are	|O
essential	|O
for	|O
CSX1	|B-PROTEIN
expression	|O
in	|O
cardiomyocytes	|O
.	|O

Functional	|O
studies	|O
which	|O
introduced	|O
a	|O
mutation	|O
in	|O
the	|O
AP2	|B-PROTEIN
core	|O
binding	|O
region	|O
as	|O
well	|O
as	|O
cotransfection	|O
experiments	|O
using	|O
an	|O
AP2	|B-PROTEIN
expression	|O
vector	|O
revealed	|O
that	|O
AP2	|B-PROTEIN
exerts	|O
a	|O
repressive	|O
role	|O
on	|O
the	|O
HGF	|B-PROTEIN
gene	|O
promoter	|O
activity	|O
.	|O

Using	|O
adenoviral	|O
transfer	|O
of	|O
IkappaBalpha	|B-PROTEIN
(	|O
IkappaBalpha	|B-PROTEIN
overexpression	|O
)	|O
,	|O
the	|O
production	|O
of	|O
TNF	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
induced	|O
by	|O
whole	|O
GBS	|O
was	|O
inhibited	|O
by	|O
only	|O
20%	|O
.	|O

In	|O
reconstitution	|O
experiments	|O
,	|O
we	|O
first	|O
showed	|O
that	|O
expression	|O
in	|O
the	|O
RAW	|O
264.7	|O
cell	|O
line	|O
of	|O
C	|B-PROTEIN
-	|I-PROTEIN
terminal	|I-PROTEIN
Src	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
Csk	|B-PROTEIN
)	|O
inhibited	|O
and	|O
that	|O
of	|O
a	|O
membrane	|O
-	|O
anchored	|O
,	|O
gain	|O
-	|O
of	|O
-	|O
function	|O
Csk	|B-PROTEIN
abolished	|O
the	|O
Fc	|B-PROTEIN
gamma	|I-PROTEIN
R	|I-PROTEIN
-	|O
mediated	|O
signaling	|O
that	|O
leads	|O
to	|O
phagocytosis	|O
in	|O
a	|O
kinase	|O
-	|O
dependent	|O
manner	|O
.	|O

In	|O
contrast	|O
,	|O
c	|B-PROTEIN
-	|I-PROTEIN
Src	|I-PROTEIN
-	|O
derived	|O
construct	|O
(	|O
a	|B-PROTEIN
-	|I-PROTEIN
Src	|I-PROTEIN
)	|O
,	|O
that	|O
was	|O
excluded	|O
from	|O
detergent	|O
-	|O
resistant	|O
membranes	|O
,	|O
could	|O
not	|O
restore	|O
the	|O
series	|O
of	|O
phagocytosis	|O
signaling	|O
.	|O

The	|O
delta	|B-PROTEIN
srb10	|I-PROTEIN
mutation	|O
also	|O
influenced	|O
on	|O
the	|O
transcript	|O
levels	|O
of	|O
meiosis	|O
-	|O
inducing	|O
genes	|O
called	|O
IME1	|B-PROTEIN
and	|O
IME2	|B-PROTEIN
:	|O
the	|O
mutation	|O
elevated	|O
the	|O
transcript	|O
level	|O
of	|O
IME1	|B-PROTEIN
but	|O
reduced	|O
that	|O
of	|O
IME2	|B-PROTEIN
,	|O
resulting	|O
in	|O
partial	|O
defects	|O
in	|O
premeiotic	|O
DNA	|O
synthesis	|O
and	|O
meiosis	|O
.	|O

We	|O
also	|O
found	|O
that	|O
environmental	|O
conditions	|O
for	|O
meiosis	|O
finely	|O
regulate	|O
the	|O
transcript	|O
levels	|O
of	|O
KIN28	|B-PROTEIN
and	|O
CCL1	|B-PROTEIN
,	|O
such	|O
that	|O
nitrogen	|O
starvation	|O
first	|O
elevates	|O
them	|O
but	|O
subsequent	|O
alkalization	|O
of	|O
medium	|O
decreases	|O
them	|O
.	|O

The	|O
pJR	|O
vectors	|O
differ	|O
among	|O
them	|O
in	|O
:	|O
(	|O
a	|O
)	|O
the	|O
selectable	|O
marker	|O
(	|O
Saccharomyces	|O
cerevisiae	|O
LEU	|B-PROTEIN
2	|I-PROTEIN
gene	|O
,	|O
which	|O
complements	|O
S.	|O
pombe	|O
leu1	|B-PROTEIN
-	|O
gene	|O
and	|O
S.	|O
pombe	|O
ura4+	|B-PROTEIN
and	|O
his3+	|B-PROTEIN
genes	|O
)	|O
;	|O
(	|O
b	|O
)	|O
the	|O
thiamine	|O
-	|O
repressible	|O
nmt1	|B-PROTEIN
promoter	|O
(	|O
3X	|O
,	|O
41X	|O
and	|O
81X	|O
with	|O
extremely	|O
high	|O
,	|O
moderate	|O
or	|O
low	|O
transcription	|O
efficiency	|O
,	|O
respectively	|O
)	|O
;	|O
and	|O
(	|O
c	|O
)	|O
the	|O
multiple	|O
cloning	|O
site	|O
(	|O
two	|O
multiple	|O
cloning	|O
sites	|O
,	|O
with	|O
12	|O
restriction	|O
sites	|O
each	|O
)	|O
.	|O

(	|O
GUT	|O
)	|O
Sera	|O
of	|O
30	|O
montoux	|O
negative	|O
healthy	|O
adults	|O
(	|O
age	|O
/	|O
sex	|O
matched	|O
)	|O
were	|O
taken	|O
as	|O
control	|O
by	|O
detecting	|O
IgG	|B-PROTEIN
anti	|O
bodies	|O
to	|O
A60	|B-PROTEIN
antigen	|O
.	|O

The	|O
effect	|O
of	|O
acute	|O
,	|O
mid	|O
-	|O
cervical	|O
spinal	|O
cord	|O
lesions	|O
on	|O
neuronal	|O
and	|O
reflex	|O
activity	|O
evoked	|O
by	|O
the	|O
noxious	|O
visceral	|O
stimulus	|O
,	|O
colorectal	|O
distension	|O
(	|O
CRD	|O
;	|O
80	|O
mmHg	|O
,	|O
20	|O
s	|O
)	|O
,	|O
was	|O
determined	|O
in	|O
halothane	|O
-	|O
anesthetized	|O
rats	|O
.	|O

Franz	|O
Schubert	|O
-	|O
-	|O
his	|O
life	|O
,	|O
music	|O
and	|O
diseases	|O

The	|O
results	|O
suggest	|O
that	|O
the	|O
role	|O
of	|O
S.	|O
argyrostoma	|O
in	|O
the	|O
dissemination	|O
of	|O
Trichinella	|O
larvae	|O
in	|O
nature	|O
is	|O
limited	|O
in	|O
comparison	|O
to	|O
the	|O
role	|O
played	|O
by	|O
mammals	|O
with	|O
scavenger	|O
and	|O
cannibalistic	|O
behavior	|O
.	|O

The	|O
equilibrium	|O
dissociation	|O
binding	|O
constant	|O
for	|O
the	|O
interaction	|O
of	|O
TnrA	|B-PROTEIN
with	|O
the	|O
nrgAB	|B-PROTEIN
promoter	|O
fragment	|O
was	|O
7.7	|O
nM	|O
under	|O
the	|O
conditions	|O
used	|O
here	|O
.	|O

These	|O
results	|O
demonstrate	|O
that	|O
N	|O
-	|O
glycans	|O
flanking	|O
the	|O
receptor	|O
-	|O
binding	|O
site	|O
of	|O
the	|O
HA	|B-PROTEIN
molecule	|O
are	|O
potent	|O
regulators	|O
of	|O
influenza	|O
virus	|O
growth	|O
,	|O
with	|O
the	|O
glycan	|O
at	|O
Asn149	|O
being	|O
dominant	|O
and	|O
that	|O
at	|O
Asn123	|O
being	|O
less	|O
effective	|O
.	|O

RESULTS	|O
:	|O
The	|O
introduction	|O
of	|O
the	|O
PAIP	|O
resulted	|O
in	|O
a	|O
significant	|O
(	|O
p	|O
<	|O
0.001	|O
)	|O
reduction	|O
in	|O
contaminating	|O
WBCs	|O
(	|O
median	|O
,	|O
30,000	|O
)	|O
from	|O
the	|O
numbers	|O
seen	|O
with	|O
FIP	|O
(	|O
median	|O
,	|O
2,300,000	|O
)	|O
while	|O
maintaining	|O
the	|O
separation	|O
efficacy	|O
(	|O
47%	|O
)	|O
and	|O
separation	|O
time	|O
.	|O

All	|O
were	|O
tested	|O
for	|O
serum	|O
ferritin	|B-PROTEIN
(	|O
SF	|B-PROTEIN
)	|O
,	|O
hemoglobin	|B-PROTEIN
(	|O
Hb	|B-PROTEIN
)	|O
level	|O
and	|O
asked	|O
for	|O
detailed	|O
histories	|O
of	|O
donations	|O
and	|O
iron	|O
supplementation	|O
.	|O

Vascular	|B-PROTEIN
endothelial	|I-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
(	|O
VEGF	|B-PROTEIN
)	|O
,	|O
a	|O
potent	|O
agonist	|O
secreted	|O
by	|O
virtually	|O
all	|O
cells	|O
,	|O
controls	|O
migration	|O
and	|O
division	|O
of	|O
vascular	|O
endothelial	|O
cells	|O
.	|O

The	|O
antioxidant	|O
agent	|O
pyrrolidine	|O
dithiocarbamate	|O
(	|O
PDTC	|O
)	|O
has	|O
been	|O
shown	|O
to	|O
protect	|O
endothelial	|O
cells	|O
(	|O
EC	|O
)	|O
from	|O
pro	|O
-	|O
inflammatory	|O
-	|O
induced	|O
and	|O
pro	|O
-	|O
oxidant	|O
-	|O
induced	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
activation	|O
.	|O

We	|O
further	|O
studied	|O
the	|O
effects	|O
of	|O
SIE	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
hypermethylation	|O
on	|O
p21WAF1	|B-PROTEIN
induction	|O
by	|O
STAT	|B-PROTEIN
activation	|O
.	|O

Phd	|B-PROTEIN
antibody	|O
-	|O
immunoreactive	|O
peptides	|O
are	|O
seen	|O
in	|O
light	|O
-	|O
adapted	|O
mouse	|O
retinal	|O
cytosolic	|O
and	|O
nuclear	|O
extracts	|O
.	|O

In	|O
the	|O
pRb	|B-PROTEIN
(	|O
-	|O
)	|O
SAOS	|O
-	|O
2	|O
cell	|O
line	|O
transiently	|O
transfected	|O
with	|O
a	|O
reporter	|O
plasmid	|O
containing	|O
six	|O
tal	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
binding	|O
site	|O
,	|O
pRb	|B-PROTEIN
enhances	|O
the	|O
transcriptional	|O
activity	|O
of	|O
tal	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|O
E12	|B-PROTEIN
-	|O
Lmo2	|B-PROTEIN
and	|O
tal	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|O
E12	|B-PROTEIN
-	|O
Lmo2	|B-PROTEIN
-	|O
Ldb1	|B-PROTEIN
complexes	|O
but	|O
not	|O
that	|O
of	|O
a	|O
tal	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|O
E12	|B-PROTEIN
heterodimer	|O
.	|O

This	|O
effect	|O
was	|O
not	|O
seen	|O
in	|O
conjunction	|O
with	|O
oxycodone	|O
,	|O
a	|O
morphine	|O
-	|O
like	|O
mu	|B-PROTEIN
-	|I-PROTEIN
receptor	|I-PROTEIN
agonist	|O
.	|O

In	|O
contrast	|O
to	|O
the	|O
morphological	|O
criteria	|O
,	|O
the	|O
few	|O
data	|O
available	|O
from	|O
recent	|O
studies	|O
at	|O
the	|O
genetic	|O
level	|O
have	|O
suggested	|O
that	|O
EPVs	|O
infecting	|O
different	|O
insect	|O
orders	|O
are	|O
phylogenetically	|O
distant	|O
.	|O

Neurofibromatosis	|O
of	|O
the	|O
breast	|O
in	|O
a	|O
patient	|O
with	|O
Morbus	|O
von	|O
Recklinghausen	|O

In	|O
the	|O
premating	|O
period	|O
male	|O
rate	|O
of	|O
aggression	|O
was	|O
not	|O
significantly	|O
correlated	|O
with	|O
testosterone	|O
level	|O
.	|O

These	|O
results	|O
support	|O
the	|O
hypothesis	|O
that	|O
in	|O
the	|O
presence	|O
of	|O
tryptophan	|O
the	|O
ribosome	|O
translating	|O
tnaC	|B-PROTEIN
blocks	|O
Rho	|B-PROTEIN
's	|O
access	|O
to	|O
the	|O
boxA	|B-PROTEIN
and	|O
rut	|B-PROTEIN
sites	|O
,	|O
thereby	|O
preventing	|O
transcription	|O
termination	|O
.	|O

In	|O
situ	|O
hybridization	|O
with	|O
the	|O
antisense	|O
RNA	|O
probes	|O
further	|O
supported	|O
the	|O
expression	|O
changes	|O
of	|O
these	|O
six	|O
clones	|O
and	|O
localized	|O
the	|O
changes	|O
in	|O
multiple	|O
germ	|O
cell	|O
stages	|O
as	|O
well	|O
as	|O
other	|O
cell	|O
types	|O
(	|O
Sertoli	|O
,	|O
interstitial	|O
and	|O
peritubular	|O
cells	|O
)	|O
.	|O

The	|O
administration	|O
of	|O
the	|O
GnRH	|B-PROTEIN
agonist	|O
reduced	|O
the	|O
bone	|O
mineral	|O
density	|O
in	|O
the	|O
whole	|O
femur	|O
to	|O
91.0%	|O
of	|O
that	|O
in	|O
the	|O
control	|O
group	|O
.	|O

Prevention	|O
,	|O
differential	|O
diagnosis	|O
and	|O
therapy	|O
of	|O
travel	|O
diarrhea	|O

This	|O
study	|O
shows	|O
that	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBPbeta	|I-PROTEIN
is	|O
the	|O
predominant	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
isoform	|O
found	|O
in	|O
activated	|O
stellate	|O
cells	|O
and	|O
that	|O
increased	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBPbeta	|I-PROTEIN
protein	|O
and	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBPbeta	|I-PROTEIN
binding	|O
to	|O
a	|O
proximal	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
binding	|O
site	|O
in	|O
the	|O
promoter	|O
mediates	|O
the	|O
activating	|O
effect	|O
of	|O
acetaldehyde	|O
.	|O

Mutation	|O
analysis	|O
demonstrates	|O
that	|O
the	|O
motif	|O
TCCCCT	|O
is	|O
critical	|O
for	|O
PyRo1	|B-PROTEIN
interaction	|O
.	|O

As	|O
with	|O
VP16	|B-PROTEIN
,	|O
the	|O
transactivation	|O
function	|O
of	|O
Luman	|B-PROTEIN
is	|O
also	|O
regulated	|O
by	|O
HCF	|B-PROTEIN
.	|O

After	|O
two	|O
successive	|O
rounds	|O
of	|O
selection	|O
by	|O
focus	|O
formation	|O
assay	|O
,	|O
a	|O
transforming	|O
ribozyme	|O
(	|O
Rz007	|B-PROTEIN
)	|O
was	|O
identified	|O
.	|O

G.	|O
,	|O
and	|O
Hyde	|O
,	|O
C.	|O

Our	|O
results	|O
suggest	|O
that	|O
proteasome	|O
inhibition	|O
leads	|O
to	|O
upregulation	|O
of	|O
specific	|O
members	|O
of	|O
transcription	|O
factor	|O
families	|O
controlling	|O
cellular	|O
stress	|O
response	|O
and	|O
proliferation	|O
.	|O

The	|O
ATR	|O
-	|O
X	|O
syndrome	|O
results	|O
from	|O
mutations	|O
of	|O
the	|O
XH2	|B-PROTEIN
gene	|O
,	|O
located	|O
on	|O
the	|O
X	|O
chromosome	|O
(	|O
Xq13.3	|O
)	|O
and	|O
coding	|O
for	|O
a	|O
transacting	|O
factor	|O
which	|O
regulates	|O
gene	|O
expression	|O
.	|O

AIMS	|O
:	|O
To	|O
evaluate	|O
the	|O
role	|O
of	|O
environmental	|O
intra	|O
-	|O
uterine	|O
factors	|O
in	|O
determining	|O
the	|O
birthweights	|O
of	|O
twins	|O
with	|O
increased	|O
susceptibility	|O
to	|O
diabetes	|O
and	|O
discordant	|O
for	|O
abnormal	|O
responses	|O
to	|O
the	|O
oral	|O
glucose	|O
tolerance	|O
test	|O
(	|O
OGTT	|O
)	|O
and	|O
verify	|O
the	|O
possible	|O
association	|O
of	|O
within	|O
-	|O
pair	|O
birthweight	|O
differences	|O
and	|O
metabolic	|O
abnormalities	|O
in	|O
adult	|O
life	|O
.	|O

In	|O
NASCIS	|O
III	|O
,	|O
a	|O
randomization	|O
imbalance	|O
occurred	|O
that	|O
allocated	|O
a	|O
disproportionate	|O
number	|O
of	|O
patients	|O
with	|O
no	|O
motor	|O
deficit	|O
(	|O
and	|O
therefore	|O
no	|O
chance	|O
for	|O
recovery	|O
)	|O
to	|O
the	|O
lower	|O
dose	|O
control	|O
group	|O
.	|O

Penicillin	|B-PROTEIN
acylase	|I-PROTEIN
(	|O
PA	|B-PROTEIN
)	|O
from	|O
Escherichia	|O
coli	|O
ATCC11105	|O
is	|O
a	|O
periplasmic	|O
heterodimer	|O
consisting	|O
of	|O
a	|O
24	|O
kDa	|O
small	|O
subunit	|O
and	|O
a	|O
65	|O
kDa	|O
large	|O
subunit	|O
.	|O

A	|O
murine	|O
expressed	|O
sequence	|O
tag	|O
(	|O
EST	|O
)	|O
showing	|O
homology	|O
with	|O
erythropoietin	|B-PROTEIN
receptor	|I-PROTEIN
(	|O
EPOR	|B-PROTEIN
)	|O
was	|O
identified	|O
in	|O
the	|O
EST	|O
database	|O
.	|O

When	|O
the	|O
LCx	|O
was	|O
partially	|O
occluded	|O
,	|O
mild	|O
PM	|O
-	|O
induced	|O
tachycardia	|O
resulted	|O
in	|O
decreased	|O
AoP	|O
(	|O
P	|O
=	|O
0.045	|O
)	|O
as	|O
well	|O
as	|O
in	|O
decreased	|O
SV	|O
(	|O
P	|O
=	|O
0.048	|O
)	|O
;	|O
the	|O
LVEDP	|O
remained	|O
high	|O
(	|O
P	|O
=	|O
0.002	|O
)	|O
.	|O

Activation	|O
of	|O
nuclear	|O
factor	|O
(	|B-PROTEIN
NF	|I-PROTEIN
)	|I-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
and	|O
subsequent	|O
proinflammatory	|O
gene	|O
expression	|O
in	|O
human	|O
airway	|O
epithelial	|O
cells	|O
can	|O
be	|O
evoked	|O
by	|O
oxidative	|O
stress	|O
.	|O

GAP	|O
JUNCTIONS	|O
IN	|O
THE	|O
BRAIN	|O
:	|O
PREFACE	|O
.	|O

We	|O
have	|O
isolated	|O
and	|O
functionally	|O
characterized	|O
the	|O
mouse	|O
gene	|O
for	|O
the	|O
C2	|O
subunit	|O
of	|O
the	|O
20S	|B-PROTEIN
proteasome	|O
.	|O

Furthermore	|O
,	|O
as	|O
in	|O
the	|O
human	|O
gene	|O
,	|O
the	|O
3'	|O
end	|O
of	|O
the	|O
Cacna1f	|B-PROTEIN
gene	|O
maps	|O
within	|O
5	|O
kb	|O
of	|O
the	|O
5'	|O
end	|O
of	|O
the	|O
mouse	|O
synaptophysin	|B-PROTEIN
gene	|O
in	|O
a	|O
region	|O
orthologous	|O
to	|O
Xp11.2	|O
3	|O
.	|O

With	|O
the	|O
human	|O
Rhotekin	|B-PROTEIN
cDNA	|O
as	|O
a	|O
probe	|O
,	|O
Northern	|O
hybridization	|O
revealed	|O
that	|O
a	|O
4.0	|O
-	|O
kb	|O
transcript	|O
was	|O
expressed	|O
at	|O
a	|O
high	|O
level	|O
in	|O
prostate	|O
and	|O
at	|O
a	|O
middle	|O
level	|O
in	|O
13	|O
of	|O
16	|O
tissues	|O
examined	|O
,	|O
but	|O
it	|O
cannot	|O
be	|O
detected	|O
in	|O
liver	|O
and	|O
lung	|O
tissues	|O
.	|O

Similarly	|O
,	|O
co	|O
-	|O
expression	|O
of	|O
a	|O
dominant	|O
-	|O
negative	|O
mutant	|O
of	|O
p38alpha	|B-PROTEIN
,	|O
but	|O
not	|O
of	|O
ERK1	|B-PROTEIN
,	|O
ERK2	|B-PROTEIN
,	|O
JNK1	|B-PROTEIN
,	|O
or	|O
JNK2	|B-PROTEIN
,	|O
reduces	|O
basal	|O
and	|O
cadmium	|O
-	|O
induced	|O
pE1	|B-PROTEIN
-	|I-PROTEIN
luc	|I-PROTEIN
activity	|O
.	|O

BACKGROUND	|O
:	|O
Gamma	|O
knife	|O
radiosurgery	|O
(	|O
GKR	|O
)	|O
is	|O
a	|O
safe	|O
and	|O
effective	|O
alternative	|O
to	|O
surgery	|O
for	|O
intracranial	|O
lesions	|O
.	|O

In	|O
hemodialyzed	|O
patients	|O
(	|O
Epo	|B-PROTEIN
and	|O
Non	|O
-	|O
Epo	|B-PROTEIN
group	|O
)	|O
leptin	|B-PROTEIN
levels	|O
were	|O
significantly	|O
higher	|O
when	|O
compared	|O
to	|O
CAPD	|O
patients	|O
(	|O
Epo	|B-PROTEIN
and	|O
Non	|O
-	|O
Epo	|B-PROTEIN
group	|O
,	|O
respectively	|O
)	|O
.	|O

It	|O
is	|O
mainly	|O
transcribed	|O
in	|O
neural	|O
structures	|O
and	|O
in	|O
developing	|O
organs	|O
characterized	|O
by	|O
epithelial	|O
-	|O
mesenchymal	|O
interactions	|O
.	|O

CONCLUSION	|O
:	|O
The	|O
alpha2	|O
-	|O
adrenergic	|O
antagonist	|O
idazoxan	|O
increases	|O
glucose	|O
-	|O
induced	|O
sympathetic	|O
activity	|O
but	|O
not	|O
energy	|O
expenditure	|O
in	|O
obese	|O
subjects	|O
.	|O

ID	|O
-	|O
PaGIA	|O
diphtheria	|B-PROTEIN
toxin	|I-PROTEIN
polymer	|O
particle	|O
diagnostic	|O
agent	|O
manufactured	|O
by	|O
DiaMed	|O
AG	|O
,	|O
Switzerland	|O
,	|O
was	|O
tried	|O
at	|O
bacteriological	|O
laboratory	|O
of	|O
Institute	|O
of	|O
Childhood	|O
Infections	|O
in	|O
St	|O
.	|O

Next	|O
,	|O
we	|O
show	|O
that	|O
two	|O
EMS	|O
-	|O
induced	|O
mutations	|O
,	|O
previously	|O
shown	|O
to	|O
interact	|O
genetically	|O
with	|O
zipper	|O
(	|O
Ebr	|B-PROTEIN
)	|O
,	|O
disrupt	|O
the	|O
RhoA	|B-PROTEIN
locus	|O
.	|O

Therefore	|O
,	|O
the	|O
results	|O
indicate	|O
that	|O
repeated	|O
exposure	|O
to	|O
amphetamine	|O
or	|O
apomorphine	|O
overcomes	|O
the	|O
context	|O
-	|O
dependent	|O
component	|O
of	|O
sensitization	|O
of	|O
amphetamine	|O
-	|O
or	|O
apomorphine	|O
-	|O
induced	|O
stereotyped	|O
behavior	|O
.	|O

Testing	|O
for	|O
serum	|O
IgM	|B-PROTEIN
binding	|O
to	|O
GM1	|O
ganglioside	|O
in	|O
clinical	|O
practice	|O
.	|O

Objective	|O
responses	|O
also	|O
occurred	|O
in	|O
studies	|O
that	|O
explored	|O
sequential	|O
use	|O
of	|O
exemestane	|O
after	|O
failure	|O
of	|O
aminoglutethimide	|O
(	|O
26%	|O
with	|O
exemestane	|O
200	|O
mg	|O
/	|O
day	|O
)	|O
or	|O
other	|O
nonsteroidal	|O
aromatase	|B-PROTEIN
inhibitors	|O
(	|O
6.6%	|O
with	|O
exemestane	|O
25	|O
mg	|O
/	|O
day	|O
)	|O
.	|O

Topics	|O
reviewed	|O
here	|O
include	|O
:	|O
data	|O
supporting	|O
the	|O
association	|O
of	|O
myositis	|O
with	|O
cancer	|O
and	|O
the	|O
appropriate	|O
evaluations	|O
for	|O
malignancy	|O
in	|O
a	|O
myositis	|O
patient	|O
;	|O
an	|O
approach	|O
to	|O
the	|O
assessment	|O
of	|O
patients	|O
with	|O
dermatomyositis	|O
sine	|O
myositis	|O
;	|O
the	|O
usefulness	|O
of	|O
the	|O
clinicopathological	|O
and	|O
serological	|O
classifications	|O
;	|O
a	|O
discussion	|O
of	|O
whether	|O
childhood	|O
and	|O
adult	|O
myositis	|O
are	|O
the	|O
same	|O
or	|O
different	|O
entities	|O
;	|O
a	|O
review	|O
of	|O
those	|O
prognostic	|O
factors	|O
to	|O
consider	|O
in	|O
the	|O
clinical	|O
management	|O
of	|O
myositis	|O
patients	|O
;	|O
current	|O
approaches	|O
and	|O
their	|O
limitations	|O
for	|O
assessing	|O
disease	|O
activity	|O
and	|O
damage	|O
.	|O

The	|O
science	|O
of	|O
tissue	|O
engineering	|O
.	|O

Endonuclease	|B-PROTEIN
III	|I-PROTEIN
(	|O
Nth	|B-PROTEIN
)	|O
of	|O
Escherichia	|O
coli	|O
is	|O
a	|O
DNA	|B-PROTEIN
glycosylase	|I-PROTEIN
essential	|O
for	|O
the	|O
removal	|O
of	|O
oxidised	|O
pyrimidine	|O
base	|O
residues	|O
from	|O
DNA	|O
.	|O

The	|O
duration	|O
of	|O
reactive	|O
hyperemia	|O
decreased	|O
with	|O
aging	|O
,	|O
but	|O
the	|O
difference	|O
between	|O
males	|O
and	|O
females	|O
was	|O
not	|O
significant	|O
at	|O
any	|O
age	|O
.	|O

Acquired	|O
bile	|O
duct	|O
blockage	|O
:	|O
entry	|O
of	|O
hepatobiliary	|O
agent	|O
into	|O
an	|O
intrahepatic	|O
abscess	|O
.	|O

Furthermore	|O
,	|O
this	|O
study	|O
looks	|O
at	|O
the	|O
impact	|O
of	|O
synthesis	|O
conditions	|O
on	|O
block	|O
length	|O
and	|O
crystallinity	|O
,	|O
and	|O
the	|O
impact	|O
of	|O
the	|O
blocking	|O
on	|O
both	|O
,	|O
crystallinity	|O
and	|O
solubility	|O
of	|O
the	|O
polymers	|O
.	|O

However	|O
,	|O
little	|O
was	|O
understood	|O
about	|O
the	|O
normal	|O
function	|O
of	|O
CREB	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
in	|O
mammalian	|O
development	|O
or	|O
organ	|O
physiology	|O
.	|O

The	|O
outer	|O
diameter	|O
and	|O
the	|O
thickness	|O
of	|O
the	|O
rotor	|O
are	|O
60	|O
mm	|O
and	|O
8	|O
mm	|O
,	|O
respectively	|O
.	|O

Both	|O
the	|O
MVBF	|O
and	|O
the	|O
maximum	|O
EMG	|O
activity	|O
in	|O
the	|O
right	|O
masseter	|O
and	|O
the	|O
left	|O
anterior	|O
temporalis	|O
muscles	|O
were	|O
significantly	|O
decreased	|O
during	|O
muscle	|O
pain	|O
when	|O
the	|O
subjects	|O
bit	|O
on	|O
the	|O
painful	|O
side	|O
.	|O

CONCLUSIONS	|O
:	|O
There	|O
is	|O
a	|O
relation	|O
in	|O
the	|O
topography	|O
of	|O
some	|O
visual	|O
field	|O
areas	|O
assessed	|O
by	|O
SWAP	|O
and	|O
the	|O
inferotemporal	|O
neuroretinal	|O
rim	|O
area	|O
,	|O
which	|O
may	|O
play	|O
a	|O
role	|O
in	|O
the	|O
diagnosis	|O
and	|O
follow	|O
-	|O
up	|O
of	|O
suspected	|O
glaucoma	|O
.	|O

The	|O
total	|O
alkaloids	|O
contained	|O
in	|O
the	|O
peel	|O
of	|O
Atzimba	|O
,	|O
Lopez	|O
,	|O
Marciana	|O
,	|O
Montsama	|O
,	|O
Murca	|O
,	|O
and	|O
Puebla	|O
was	|O
lower	|O
than	|O
the	|O
limits	|O
recommended	|O
for	|O
food	|O
safety	|O
.	|O

The	|O
detection	|O
success	|O
rate	|O
was	|O
determined	|O
for	|O
different	|O
markers	|O
using	|O
this	|O
MEK	|B-PROTEIN
.	|O

Herein	|O
,	|O
we	|O
show	|O
that	|O
Smad3	|B-PROTEIN
physically	|O
interacts	|O
with	|O
the	|O
HMG	|B-PROTEIN
box	|O
domain	|O
of	|O
LEF1	|B-PROTEIN
and	|O
that	|O
TGFbeta	|B-PROTEIN
and	|O
Wnt	|B-PROTEIN
pathways	|O
synergize	|O
to	|O
activate	|O
transcription	|O
of	|O
the	|O
Xenopus	|O
homeobox	|O
gene	|O
twin	|B-PROTEIN
(	|O
Xtwn	|B-PROTEIN
)	|O
.	|O

The	|O
transmembrane	|O
topology	|O
of	|O
Na	|O
(	|O
+	|O
)	|O
/	|O
H	|O
(	|O
+	|O
)	|O
exchanger	|O
NHE3	|B-PROTEIN
has	|O
been	|O
studied	|O
using	|O
in	|O
vitro	|O
transcription	|O
/	|O
translation	|O
of	|O
two	|O
types	|O
of	|O
fusion	|O
vectors	|O
designed	|O
to	|O
test	|O
membrane	|O
insertion	|O
properties	|O
of	|O
cDNA	|O
sequences	|O
encoding	|O
putative	|O
NHE3	|B-PROTEIN
membrane	|O
spanning	|O
domains	|O
(	|O
msds	|O
)	|O
.	|O

ACE	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
has	|O
a	|O
hydrophobic	|O
C	|O
terminus	|O
of	|O
H	|O
type	|O
.	|O

Members	|O
of	|O
the	|O
titin	|B-PROTEIN
/	|O
myosin	|B-PROTEIN
light	|I-PROTEIN
chain	|I-PROTEIN
kinase	|I-PROTEIN
family	|O
play	|O
an	|O
essential	|O
role	|O
in	|O
the	|O
organization	|O
of	|O
the	|O
actin	|B-PROTEIN
/	|O
myosin	|B-PROTEIN
cytoskeleton	|O
,	|O
especially	|O
in	|O
sarcomere	|O
assembly	|O
and	|O
function	|O
.	|O

We	|O
concluded	|O
that	|O
activation	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
fosER	|I-PROTEIN
mediated	|O
transcriptional	|O
inhibition	|O
of	|O
p21	|B-PROTEIN
(	|O
Cip1	|B-PROTEIN
/	|O
WAF1	|B-PROTEIN
)	|O
through	|O
a	|O
previously	|O
uncharacterized	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
site	|O
,	|O
revealing	|O
an	|O
important	|O
role	|O
for	|O
c	|B-PROTEIN
-	|I-PROTEIN
fos	|I-PROTEIN
in	|O
negative	|O
control	|O
of	|O
cell	|O
cycle	|O
regulatory	|O
genes	|O
.	|O

Furthermore	|O
,	|O
a	|O
pTyr317	|O
Shc	|B-PROTEIN
phosphopeptide	|O
selectively	|O
recognized	|O
Grb2	|B-PROTEIN
,	|O
Sos1	|B-PROTEIN
,	|O
SHIP	|B-PROTEIN
,	|O
and	|O
the	|O
p85	|B-PROTEIN
subunit	|O
of	|O
phosphatidylinositol	|B-PROTEIN
3'	|I-PROTEIN
kinase	|I-PROTEIN
from	|O
mast	|O
cells	|O
,	|O
as	|O
characterized	|O
by	|O
mass	|O
spectrometry	|O
.	|O

Although	|O
increased	|O
expression	|O
of	|O
the	|O
HMG	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
/	|I-PROTEIN
Y	|I-PROTEIN
proteins	|O
is	|O
associated	|O
with	|O
cellular	|O
proliferation	|O
,	|O
neoplastic	|O
transformation	|O
,	|O
and	|O
several	|O
human	|O
cancers	|O
,	|O
the	|O
role	|O
of	|O
these	|O
proteins	|O
in	|O
the	|O
pathogenesis	|O
of	|O
malignancy	|O
remains	|O
unclear	|O
.	|O

The	|O
naltrexone	|O
/	|O
lofexidine	|O
combination	|O
was	|O
associated	|O
with	|O
a	|O
more	|O
rapid	|O
resolution	|O
of	|O
the	|O
opiate	|O
withdrawal	|O
syndrome	|O
than	|O
a	|O
7	|O
-	|O
day	|O
lofexidine	|O
-	|O
only	|O
treatment	|O
schedule	|O
,	|O
without	|O
substantial	|O
increases	|O
in	|O
withdrawal	|O
symptoms	|O
or	|O
hypotensive	|O
side	|O
-	|O
effects	|O
.	|O

The	|O
first	|O
symptoms	|O
of	|O
enzootic	|O
calcinosis	|O
were	|O
noted	|O
in	|O
March	|O
1998	|O
,	|O
when	|O
some	|O
of	|O
the	|O
cows	|O
developed	|O
locomotor	|O
abnormalities	|O
.	|O

Screening	|O
,	|O
counseling	|O
,	|O
and	|O
treatment	|O
for	|O
alcohol	|O
and	|O
illicit	|O
drug	|O
use	|O
should	|O
be	|O
essential	|O
components	|O
in	|O
comprehensive	|O
HBP	|O
care	|O
.	|O

Transcriptional	|O
regulation	|O
of	|O
the	|O
mouse	|O
cytosolic	|O
chaperonin	|B-PROTEIN
subunit	|O
gene	|O
Ccta	|B-PROTEIN
/	|I-PROTEIN
t	|I-PROTEIN
-	|I-PROTEIN
complex	|I-PROTEIN
polypeptide	|I-PROTEIN
1	|I-PROTEIN
by	|O
selenocysteine	|B-PROTEIN
tRNA	|I-PROTEIN
gene	|I-PROTEIN
transcription	|I-PROTEIN
activating	|I-PROTEIN
factor	|I-PROTEIN
family	|O
zinc	|O
finger	|O
proteins	|O
.	|O

The	|O
unfolded	|O
protein	|O
response	|O
regulates	|O
multiple	|O
aspects	|O
of	|O
secretory	|O
and	|O
membrane	|O
protein	|O
biogenesis	|O
and	|O
endoplasmic	|O
reticulum	|O
quality	|O
control	|O
.	|O

PNRC	|B-PROTEIN
:	|O
a	|O
proline	|O
-	|O
rich	|O
nuclear	|O
receptor	|O
coregulatory	|O
protein	|O
that	|O
modulates	|O
transcriptional	|O
activation	|O
of	|O
multiple	|O
nuclear	|O
receptors	|O
including	|O
orphan	|O
receptors	|O
SF1	|B-PROTEIN
(	|O
steroidogenic	|B-PROTEIN
factor	|I-PROTEIN
1	|I-PROTEIN
)	|O
and	|O
ERRalpha1	|B-PROTEIN
(	|O
estrogen	|B-PROTEIN
related	|I-PROTEIN
receptor	|I-PROTEIN
alpha	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
.	|O

Studies	|O
using	|O
a	|O
reporter	|O
plasmid	|O
with	|O
a	|O
functionally	|O
disrupted	|O
sterol	|O
-	|O
responsive	|O
element	|O
(	|O
SRE	|O
)	|O
-	|O
1	|O
revealed	|O
a	|O
reduced	|O
stimulatory	|O
response	|O
to	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
.	|O

However	|O
,	|O
there	|O
is	|O
still	|O
a	|O
subset	|O
of	|O
tumors	|O
that	|O
displayed	|O
no	|O
changes	|O
in	|O
these	|O
genes	|O
.	|O

We	|O
have	|O
shown	|O
that	|O
the	|O
epidural	|O
(	|O
EPI	|O
)	|O
delivery	|O
of	|O
morphine	|O
encapsulated	|O
in	|O
multivesicular	|O
liposomes	|O
(	|O
DepoFoam	|O
drug	|O
delivery	|O
system	|O
)	|O
produces	|O
a	|O
sustained	|O
clearance	|O
of	|O
morphine	|O
and	|O
a	|O
prolonged	|O
analgesia	|O
.	|O

Following	|O
EPI	|O
-	|O
C0401	|O
,	|O
but	|O
not	|O
saline	|O
or	|O
DepoFoam	|O
vehicle	|O
,	|O
there	|O
were	|O
transient	|O
(	|O
<	|O
72	|O
hr	|O
)	|O
decreases	|O
in	|O
food	|O
consumption	|O
,	|O
arousal	|O
,	|O
hindlimb	|O
muscle	|O
tone	|O
,	|O
and	|O
body	|O
temperature	|O
.	|O

Bailey	|O
Instruments	|O
and	|O
Owen	|O
Mumford	|O
filaments	|O
were	|O
the	|O
most	|O
accurate	|O
with	|O
100%	|O
buckling	|O
within	|O
+	|O
/	|O
-	|O
1.0	|O
g	|O
of	|O
10	|O
g	|O
.	|O

PARTICIPANTS	|O
:	|O
Convenience	|O
sample	|O
of	|O
ambulatory	|O
outpatients	|O
with	|O
hereditary	|O
motor	|O
and	|O
sensory	|O
neuropathy	|O
,	|O
type	|O
I	|O
(	|O
n	|O
=	|O
9	|O
)	|O
,	|O
myotonic	|O
muscular	|O
dystrophy	|O
(	|O
n	|O
=	|O
10	|O
)	|O
,	|O
and	|O
able	|O
-	|O
bodied	|O
controls	|O
(	|O
n	|O
=	|O
11	|O
)	|O
.	|O

The	|O
effect	|O
of	|O
water	|O
deprivation	|O
for	|O
19	|O
h	|O
on	|O
renal	|O
Na	|O
excretion	|O
of	|O
conscious	|O
adrenalectomized	|O
(	|O
ADX	|O
)	|O
sheep	|O
maintained	|O
on	|O
a	|O
constant	|O
intravenous	|O
infusion	|O
of	|O
aldosterone	|O
and	|O
cortisol	|O
(	|O
ADX	|O
-	|O
constant	|O
steroid	|O
sheep	|O
)	|O
was	|O
investigated	|O
.	|O

Neither	|O
is	|O
it	|O
a	|O
major	|O
cause	|O
of	|O
rehydration	|O
-	|O
induced	|O
renal	|O
Na	|O
retention	|O
.	|O

CONCLUSION	|O
:	|O
Rheumatic	|O
fever	|O
in	|O
the	|O
Nazareth	|O
area	|O
is	|O
still	|O
manifest	|O
.	|O

Antithrombin	|B-PROTEIN
III	|I-PROTEIN
deficiency	|O
:	|O
when	|O
substitute	|O
,	|O
when	|O
heparin	|O
?	|O
Thrombosis	|O
ABC	|O
,	|O
3	|O
:	|O
The	|O
role	|O
of	|O
antithrombin	|B-PROTEIN
III	|I-PROTEIN

Specific	|O
class	|O
I	|O
and	|O
II	|O
histone	|B-PROTEIN
deacetylases	|I-PROTEIN
(	|O
HDACs	|B-PROTEIN
)	|O
interact	|O
in	|O
vivo	|O
with	|O
BCoR	|B-PROTEIN
,	|O
suggesting	|O
that	|O
BCoR	|B-PROTEIN
may	|O
functionally	|O
link	|O
these	|O
two	|O
classes	|O
of	|O
HDACs	|B-PROTEIN
.	|O

This	|O
is	|O
the	|O
first	|O
example	|O
of	|O
a	|O
eukaryotic	|O
transcription	|O
factor	|O
complex	|O
containing	|O
both	|O
a	|O
MADS	|B-PROTEIN
-	|O
box	|O
and	|O
a	|O
forkhead	|B-PROTEIN
protein	|O
,	|O
and	|O
it	|O
has	|O
important	|O
implications	|O
for	|O
the	|O
regulation	|O
of	|O
mammalian	|O
gene	|O
expression	|O
.	|O

After	|O
screening	|O
the	|O
Berkeley	|O
Drosophila	|O
Genome	|O
Project	|O
database	|O
with	|O
sequences	|O
from	|O
a	|O
recently	|O
characterized	|O
Leu	|B-PROTEIN
-	|I-PROTEIN
rich	|I-PROTEIN
repeats	|I-PROTEIN
-	|I-PROTEIN
containing	|I-PROTEIN
G	|I-PROTEIN
protein	|I-PROTEIN
-	|I-PROTEIN
coupled	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
LGR	|B-PROTEIN
)	|O
from	|O
Drosophila	|O
(	|O
DLGR	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
,	|O
we	|O
identified	|O
a	|O
second	|O
gene	|O
for	|O
a	|O
different	|O
LGR	|B-PROTEIN
(	|O
DLGR	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
)	|O
and	|O
cloned	|O
its	|O
cDNA	|O
.	|O

Degenerate	|O
primers	|O
homologous	|O
to	|O
highly	|O
conserved	|O
regions	|O
of	|O
known	|O
CYP3A	|B-PROTEIN
sequences	|O
were	|O
used	|O
for	|O
initial	|O
RT	|O
-	|O
PCRs	|O
.	|O

When	|O
cells	|O
were	|O
microinjected	|O
with	|O
TFOs	|O
designed	|O
to	|O
bind	|O
to	|O
a	|O
30	|O
-	|O
bp	|O
polypurine	|O
site	|O
situated	|O
between	|O
the	|O
two	|O
TK	|B-PROTEIN
genes	|O
,	|O
recombination	|O
was	|O
observed	|O
at	|O
frequencies	|O
in	|O
the	|O
range	|O
of	|O
1%	|O
,	|O
2,500	|O
-	|O
fold	|O
above	|O
the	|O
background	|O
.	|O

Methyllevamisole	|O
was	|O
used	|O
as	|O
the	|O
internal	|O
standard	|O
.	|O

Resistance	|O
ratios	|O
for	|O
the	|O
other	|O
field	|O
strains	|O
obtained	|O
by	|O
comparison	|O
with	|O
the	|O
R5	|O
strain	|O
ranged	|O
from	|O
24.5	|O
to	|O
239	|O
for	|O
topical	|O
application	|O
and	|O
from	|O
1.2	|O
to	|O
9.8	|O
for	|O
the	|O
glass	|O
jar	|O
method	|O
.	|O

Only	|O
transcripts	|O
specific	|O
for	|O
TSGF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
are	|O
detected	|O
in	|O
ovary	|O
and	|O
testes	|O
tissues	|O
of	|O
adults	|O
as	|O
well	|O
as	|O
in	|O
puparia	|O
,	|O
while	|O
neither	|O
gene	|O
is	|O
expressed	|O
during	|O
the	|O
larval	|O
developmental	|O
stages	|O
.	|O

In	|O
a	|O
gel	|O
retardation	|O
assay	|O
using	|O
HepG2	|O
nuclear	|O
extracts	|O
,	|O
the	|O
5'	|O
flanking	|O
sequence	|O
from	|O
-	|O
74	|O
to	|O
-	|O
46	|O
showed	|O
a	|O
shifted	|O
band	|O
.	|O

Reliability	|O
of	|O
cervical	|O
range	|O
of	|O
motion	|O
using	|O
the	|O
OSI	|O
CA	|O
6000	|O
spine	|O
motion	|O
analyser	|O
on	|O
asymptomatic	|O
and	|O
symptomatic	|O
subjects	|O
.	|O

Coimmunoprecipitation	|O
experiments	|O
performed	|O
in	|O
transfected	|O
cells	|O
showed	|O
that	|O
BCMA	|B-PROTEIN
associates	|O
with	|O
TNFR	|O
-	|O
associated	|O
factor	|O
(	|B-PROTEIN
TRAF	|I-PROTEIN
)	|I-PROTEIN
1	|I-PROTEIN
,	|O
TRAF2	|B-PROTEIN
,	|O
and	|O
TRAF3	|B-PROTEIN
adaptor	|O
proteins	|O
.	|O

Since	|O
the	|O
RINX	|B-PROTEIN
gene	|O
is	|O
likely	|O
an	|O
ortholog	|O
of	|O
the	|O
goldfish	|O
Vsx1	|B-PROTEIN
gene	|O
,	|O
it	|O
has	|O
been	|O
named	|O
VSX1	|B-PROTEIN
by	|O
the	|O
Human	|O
Gene	|O
Nomenclature	|O
Committee	|O
.	|O

The	|O
chromosomal	|O
localization	|O
on	|O
distal	|O
chromosome	|O
7	|O
places	|O
it	|O
in	|O
a	|O
cluster	|O
of	|O
imprinted	|O
genes	|O
,	|O
flanked	|O
by	|O
the	|O
previously	|O
described	|O
Tapa1	|B-PROTEIN
and	|O
Kcnq1	|B-PROTEIN
genes	|O
.	|O

Activation	|O
of	|O
PKA	|B-PROTEIN
by	|O
8	|O
-	|O
bromo	|O
-	|O
cyclic	|O
AMP	|O
or	|O
forskolin	|O
,	|O
and	|O
inhibition	|O
of	|O
PKC	|B-PROTEIN
by	|O
calphostin	|O
C	|O
,	|O
resulted	|O
in	|O
a	|O
significant	|O
decrease	|O
in	|O
3TP	|B-PROTEIN
activity	|O
as	|O
well	|O
as	|O
in	|O
vitro	|O
ERK	|B-PROTEIN
kinase	|O
activity	|O
in	|O
CRAC	|O
.	|O

The	|O
present	|O
study	|O
was	|O
designed	|O
to	|O
evaluate	|O
the	|O
sensitivity	|O
and	|O
specificity	|O
of	|O
AMP	|O
CT	|O
(	|O
Gen	|O
-	|O
Probe	|O
Incorporated	|O
,	|O
San	|O
Diego	|O
,	|O
CA	|O
,	|O
USA	|O
)	|O
on	|O
urogenital	|O
specimens	|O
taken	|O
from	|O
symptomatic	|O
patients	|O
and	|O
on	|O
first	|O
void	|O
urine	|O
(	|O
FVU	|O
)	|O
specimens	|O
from	|O
asymptomatic	|O
patients	|O
.	|O

Mus81p	|B-PROTEIN
also	|O
shares	|O
homology	|O
with	|O
motifs	|O
found	|O
in	|O
the	|O
XPF	|B-PROTEIN
endonuclease	|O
superfamily	|O
.	|O

Double	|O
mutant	|O
analysis	|O
suggests	|O
that	|O
Rad54p	|B-PROTEIN
and	|O
Mus81p	|B-PROTEIN
act	|O
in	|O
one	|O
pathway	|O
for	|O
the	|O
repair	|O
of	|O
,	|O
or	|O
tolerance	|O
to	|O
,	|O
UV	|O
-	|O
induced	|O
DNA	|O
damage	|O
.	|O

The	|O
linear	|O
plasmid	|O
pCLU1	|O
from	|O
the	|O
yeast	|O
Kluyveromyces	|O
lactis	|O
normally	|O
replicates	|O
in	|O
the	|O
cytoplasm	|O
,	|O
with	|O
the	|O
aid	|O
of	|O
the	|O
helper	|O
linear	|O
plasmid	|O
pGKL2	|O
,	|O
using	|O
terminal	|B-PROTEIN
protein	|I-PROTEIN
(	|O
TP	|B-PROTEIN
)	|O
as	|O
a	|O
primer	|O
.	|O

The	|O
repetitive	|O
ETn	|B-PROTEIN
(	|O
early	|B-PROTEIN
transposon	|I-PROTEIN
)	|O
family	|O
of	|O
sequences	|O
represents	|O
an	|O
active	|O
"	|O
mobile	|O
mutagen	|O
"	|O
in	|O
the	|O
mouse	|O
genome	|O
.	|O

The	|O
two	|O
main	|O
experimental	|O
variables	|O
were	|O
the	|O
attended	|O
hemifield	|O
(	|O
left	|O
or	|O
right	|O
)	|O
and	|O
the	|O
proportion	|O
of	|O
trials	|O
requiring	|O
a	|O
shift	|O
within	|O
that	|O
hemifield	|O
(	|O
20%	|O
or	|O
80%	|O
)	|O
.	|O

The	|O
measurement	|O
of	|O
NO	|O
in	|O
biological	|O
systems	|O
using	|O
chemiluminescence	|O
.	|O

Biochemical	|O
examinations	|O
of	|O
calcium	|O
-	|O
phosphorus	|O
metabolism	|O
included	|O
ions	|O
and	|O
PTH	|B-PROTEIN
concentrations	|O
in	|O
blood	|O
serum	|O
,	|O
and	|O
the	|O
activity	|O
of	|O
bone	|O
isoenzyme	|O
of	|O
AP	|B-PROTEIN
.	|O

Atorvastatin	|O
was	|O
the	|O
most	|O
cost	|O
-	|O
effective	|O
HMG	|B-PROTEIN
-	|I-PROTEIN
CoA	|I-PROTEIN
reductase	|I-PROTEIN
inhibitor	|O
.	|O

Pharmacoeconomic	|O
assessment	|O
of	|O
HMG	|B-PROTEIN
-	|I-PROTEIN
CoA	|I-PROTEIN
reductase	|I-PROTEIN
inhibitor	|O
therapy	|O
:	|O
an	|O
analysis	|O
based	|O
on	|O
the	|O
CURVES	|O
study	|O
.	|O

Interestingly	|O
,	|O
although	|O
E	|O
domains	|O
of	|O
these	|O
two	|O
receptors	|O
are	|O
much	|O
less	|O
conserved	|O
,	|O
replacement	|O
of	|O
this	|O
domain	|O
in	|O
rtER	|B-PROTEIN
by	|O
its	|O
human	|O
counterpart	|O
resulted	|O
in	|O
higher	|O
estradiol	|O
sensitivity	|O
but	|O
no	|O
increase	|O
in	|O
the	|O
magnitude	|O
of	|O
transactivation	|O
.	|O

G	|O
-	|O
DNA	|O
is	|O
a	|O
four	|O
-	|O
stranded	|O
DNA	|O
structure	|O
with	|O
diverse	|O
putative	|O
biological	|O
roles	|O
.	|O

The	|O
effectiveness	|O
of	|O
NRT	|O
appears	|O
to	|O
be	|O
largely	|O
independent	|O
of	|O
the	|O
intensity	|O
of	|O
additional	|O
support	|O
provided	|O
to	|O
the	|O
smoker	|O
.	|O

SELECTION	|O
CRITERIA	|O
:	|O
All	|O
controlled	|O
trials	|O
where	|O
adults	|O
with	|O
schizophrenia	|O
or	|O
similar	|O
illnesses	|O
were	|O
randomised	|O
to	|O
quetiapine	|O
,	|O
placebo	|O
or	|O
other	|O
neuroleptic	|O
drugs	|O
and	|O
where	|O
clinically	|O
relevant	|O
outcomes	|O
were	|O
reported	|O
.	|O

8%	|O
(	|O
95%	|O
CI	|O
,	|O
21.3-44.3%	|O
)	|O
.	|O

In	|O
contrast	|O
,	|O
the	|O
action	|O
of	|O
GLP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
at	|O
the	|O
CRE	|O
was	|O
not	|O
blocked	|O
by	|O
cotransfection	|O
with	|O
M1	|B-PROTEIN
-	|I-PROTEIN
CREB	|I-PROTEIN
,	|O
an	|O
isoform	|O
that	|O
lacks	|O
a	|O
consensus	|O
serine	|O
residue	|O
serving	|O
as	|O
substrate	|O
for	|O
PKA	|B-PROTEIN
-	|O
mediated	|O
phosphorylation	|O
.	|O

Because	|O
all	|O
PDGFbetaR	|B-PROTEIN
fusions	|O
described	|O
thus	|O
far	|O
result	|O
in	|O
splicing	|O
to	|O
a	|O
common	|O
exon	|O
of	|O
this	|O
gene	|O
,	|O
we	|O
performed	|O
5'	|O
-	|O
rapid	|O
amplification	|O
of	|O
cDNA	|O
ends	|O
PCR	|O
on	|O
patient	|O
RNA	|O
.	|O

CONCLUSIONS	|O
:	|O
In	|O
essential	|O
hypertension	|O
an	|O
acute	|O
protein	|O
load	|O
induces	|O
a	|O
decrease	|O
in	|O
GFR	|O
that	|O
may	|O
normalize	|O
under	|O
antihypertensive	|O
treatment	|O
.	|O

This	|O
finding	|O
suggested	|O
that	|O
the	|O
PI3K	|B-PROTEIN
-	|O
Akt	|B-PROTEIN
activation	|O
pathway	|O
plays	|O
some	|O
role	|O
in	|O
the	|O
antiapoptotic	|O
effect	|O
of	|O
EPO	|B-PROTEIN
.	|O

Nine	|O
DNA	|O
fragments	|O
that	|O
were	|O
specifically	|O
recognized	|O
and	|O
bound	|O
by	|O
histidine	|O
-	|O
tagged	|O
AdpA	|B-PROTEIN
were	|O
isolated	|O
by	|O
cycles	|O
of	|O
a	|O
gel	|O
mobility	|O
shift	|O
-	|O
PCR	|O
method	|O
.	|O

To	|O
determine	|O
whether	|O
the	|O
NTP	|O
-	|O
binding	|O
motif	|O
is	|O
important	|O
for	|O
Rad24	|B-PROTEIN
function	|O
,	|O
we	|O
mutated	|O
the	|O
conserved	|O
lysine	|O
(	|O
115	|O
)	|O
residue	|O
in	|O
this	|O
motif	|O
.	|O

The	|O
carboxyl	|O
-	|O
terminal	|O
proline	|O
-	|O
rich	|O
domain	|O
of	|O
SOS1	|B-PROTEIN
is	|O
involved	|O
in	|O
the	|O
interaction	|O
with	|O
the	|O
PLC	|B-PROTEIN
-	|I-PROTEIN
gamma1	|I-PROTEIN
SH3	|O
domain	|O
.	|O

From	|O
transient	|O
expression	|O
studies	|O
,	|O
we	|O
could	|O
demonstrate	|O
that	|O
the	|O
SH3	|B-PROTEIN
domain	|O
of	|O
PLC	|B-PROTEIN
-	|I-PROTEIN
gamma1	|I-PROTEIN
is	|O
necessary	|O
for	|O
the	|O
association	|O
with	|O
SOS1	|B-PROTEIN
in	|O
vivo	|O
.	|O

Six	|O
distinct	|O
Ets	|B-PROTEIN
mRNAs	|O
were	|O
identified	|O
:	|O
Ets2	|B-PROTEIN
,	|O
Fli1	|B-PROTEIN
,	|O
GABPalpha	|B-PROTEIN
,	|O
SAP1	|B-PROTEIN
,	|O
Elk1	|B-PROTEIN
,	|O
and	|O
PE1	|B-PROTEIN
.	|O

A	|O
2	|O
kb	|O
transcript	|O
was	|O
isolated	|O
from	|O
brain	|O
that	|O
encodes	|O
a	|O
approximately	|O
57	|O
kDa	|O
protein	|O
;	|O
the	|O
predicted	|O
protein	|O
contains	|O
the	|O
known	|O
N	|O
-	|O
terminal	|O
Ets	|B-PROTEIN
domain	|O
of	|O
PE1	|B-PROTEIN
and	|O
a	|O
novel	|O
C	|O
-	|O
terminal	|O
domain	|O
with	|O
signficant	|O
homology	|O
to	|O
murine	|O
ERF	|B-PROTEIN
.	|O

Twenty	|O
eligible	|O
patients	|O
with	|O
cirrhosis	|O
were	|O
randomized	|O
into	|O
two	|O
groups	|O
:	|O
10	|O
patients	|O
treated	|O
with	|O
6	|O
million	|O
units	|O
of	|O
natural	|O
IFN	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
twice	|O
a	|O
week	|O
for	|O
36	|O
months	|O
and	|O
10	|O
patients	|O
without	|O
IFN	|B-PROTEIN
therapy	|O
.	|O

Wnt	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
overexpression	|O
in	|O
mammary	|O
epithelial	|O
cells	|O
induced	|O
cyclin	|B-PROTEIN
D1	|I-PROTEIN
mRNA	|O
and	|O
targeted	|O
overexpression	|O
of	|O
Wnt	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
in	|O
the	|O
mammary	|O
gland	|O
of	|O
transgenic	|O
mice	|O
increased	|O
both	|O
ILK	|B-PROTEIN
activity	|O
and	|O
cyclin	|B-PROTEIN
D1	|I-PROTEIN
levels	|O
.	|O

Intravenous	|O
versus	|O
oral	|O
administration	|O
of	|O
amitriptyline	|O
in	|O
patients	|O
with	|O
major	|O
depression	|O
.	|O

Deletion	|O
of	|O
the	|O
RVH	|B-PROTEIN
domain	|O
resulted	|O
in	|O
loss	|O
of	|O
Ca	|O
(	|O
2+	|O
)	|O
-	|O
dependent	|O
activation	|O
.	|O

Logistic	|O
regression	|O
analysis	|O
revealed	|O
that	|O
physicians	|O
were	|O
3.6	|O
times	|O
more	|O
likely	|O
to	|O
detect	|O
thin	|O
lesions	|O
(	|O
<	|O
/	|O
=	|O
0.75	|O
mm	|O
)	|O
compared	|O
with	|O
nonphysician	|O
detectors	|O
(	|O
95%	|O
confidence	|O
interval	|O
[	|O
95%	|O
CI	|O
]	|O
,	|O
2.1	|O
,	|O
6.5	|O
;	|O
P	|O
=	|O
0.0001	|O
)	|O
.	|O

Erythema	|O
exsudativum	|O
multiforme	|O
induced	|O
by	|O
granulocyte	|B-PROTEIN
colony	|I-PROTEIN
-	|I-PROTEIN
stimulating	|I-PROTEIN
factor	|I-PROTEIN
in	|O
an	|O
allogeneic	|O
peripheral	|O
blood	|O
stem	|O
cell	|O
donor	|O
.	|O

VaI	|O
and	|O
VaII	|O
co	|O
-	|O
immunoprecipitated	|O
with	|O
ErbB2	|B-PROTEIN
,	|O
but	|O
not	|O
with	|O
ErbB1	|B-PROTEIN
,	|O
ErbB3	|B-PROTEIN
,	|O
or	|O
ErbB4	|B-PROTEIN
.	|O

While	|O
interactions	|O
of	|O
WT	|O
and	|O
variant	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
with	|O
the	|O
ErbBs	|B-PROTEIN
all	|O
result	|O
in	|O
ErbB2	|B-PROTEIN
activation	|O
,	|O
they	|O
produce	|O
different	|O
biological	|O
consequences	|O
,	|O
suggesting	|O
that	|O
the	|O
various	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
precursors	|O
differentially	|O
modulate	|O
ErbB	|B-PROTEIN
signaling	|O
.	|O

It	|O
is	|O
now	|O
well	|O
accepted	|O
that	|O
the	|O
p53	|B-PROTEIN
C	|O
-	|O
terminus	|O
plays	|O
a	|O
central	|O
role	|O
in	|O
controlling	|O
the	|O
activity	|O
of	|O
the	|O
wild	|O
-	|O
type	|O
molecule	|O
.	|O

In	|O
contrast	|O
to	|O
full	|O
-	|O
length	|O
E2F	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
,	|O
which	|O
is	|O
expressed	|O
only	|O
at	|O
the	|O
G1	|O
/	|O
S	|O
boundary	|O
,	|O
E2F	|B-PROTEIN
-	|I-PROTEIN
3B	|I-PROTEIN
is	|O
detected	|O
throughout	|O
the	|O
cell	|O
cycle	|O
with	|O
peak	|O
levels	|O
in	|O
GO	|O
where	|O
it	|O
is	|O
associated	|O
with	|O
Rb	|B-PROTEIN
.	|O

The	|O
transcription	|O
factor	|O
Jun	|B-PROTEIN
(	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
)	|O
functions	|O
as	|O
a	|O
recipient	|O
of	|O
extracellular	|O
growth	|O
signals	|O
and	|O
converts	|O
them	|O
into	|O
patterns	|O
of	|O
gene	|O
expression	|O
.	|O

Developmental	|O
toxicity	|O
of	|O
the	|O
class	|O
III	|O
antiarrhythmic	|O
agent	|O
almokalant	|O
in	|O
mice	|O
.	|O

This	|O
compound	|O
is	|O
the	|O
main	|O
bioactive	|O
metabolite	|O
of	|O
trimebutine	|O
II	|O
(	|O
Debridat	|O
,	|O
CAS	|O
39133-31-8	|O
)	|O
,	|O
an	|O
antispasmodic	|O
widely	|O
used	|O
for	|O
intestinal	|O
diseases	|O
since	|O
1969	|O
.	|O

In	|O
addition	|O
to	|O
its	|O
effect	|O
in	|O
augmenting	|O
the	|O
neutrophil	|O
response	|O
to	|O
eccentric	|O
exercise	|O
,	|O
vitamin	|O
E	|O
causes	|O
a	|O
greater	|O
increase	|O
in	|O
circulating	|O
creatine	|B-PROTEIN
kinase	|I-PROTEIN
activity	|O
,	|O
perhaps	|O
indicating	|O
increased	|O
skeletal	|O
muscle	|O
repair	|O
.	|O

This	|O
enabled	|O
the	|O
formation	|O
of	|O
stem	|O
-	|O
loop	|O
templates	|O
with	|O
the	|O
fusion	|O
point	|O
of	|O
the	|O
chimeric	|O
transcript	|O
in	|O
the	|O
loop	|O
and	|O
the	|O
use	|O
of	|O
MLL	|B-PROTEIN
primers	|O
in	|O
two	|O
-	|O
sided	|O
PCR	|O
.	|O

CONCLUSION	|O
:	|O
The	|O
authors	|O
emphasize	|O
that	|O
the	|O
initial	|O
management	|O
of	|O
primary	|O
STS	|O
should	|O
be	|O
adequate	|O
and	|O
suggest	|O
that	|O
safty	|O
margin	|O
of	|O
>	|O
or	|O
=	|O
2	|O
cm	|O
should	|O
be	|O
adhered	|O
to	|O
.	|O

Measurements	|O
were	|O
compared	|O
with	|O
two	|O
computerised	|O
treatment	|O
planning	|O
systems	|O
-	|O
-	|O
Theraplan	|O
VO5B	|O
and	|O
ADAC	|O
Pinnacle3	|O
V4.0	|O
b	|O
.	|O

Activation	|O
was	|O
biphasic	|O
;	|O
peaking	|O
at	|O
5-10	|O
min	|O
and	|O
24	|O
h	|O
after	|O
treatment	|O
.	|O

Whereas	|O
MARTA1	|B-PROTEIN
is	|O
clearly	|O
detectable	|O
in	|O
crude	|O
lysates	|O
,	|O
cytosolic	|O
and	|O
ribosomal	|O
salt	|O
-	|O
wash	|O
fractions	|O
,	|O
and	|O
in	|O
nuclear	|O
extracts	|O
,	|O
MARTA2	|B-PROTEIN
is	|O
preferentially	|O
found	|O
in	|O
the	|O
ribosomal	|O
salt	|O
-	|O
wash	|O
preparation	|O
.	|O

It	|O
contains	|O
25	|O
exons	|O
coding	|O
for	|O
a	|O
4.7	|O
kb	|O
transcript	|O
including	|O
large	|O
5'	|O
-	|O
and	|O
3'	|O
-	|O
(	|O
1218bp	|O
and	|O
701bp	|O
,	|O
respectively	|O
)	|O
untranslated	|O
regions	|O
(	|O
UTRs	|O
)	|O
.	|O

Five	|O
of	|O
the	|O
PDP1	|B-PROTEIN
isoforms	|O
differ	|O
by	|O
the	|O
substitution	|O
or	|O
insertion	|O
of	|O
amino	|O
acids	|O
at	|O
or	|O
near	|O
the	|O
N	|O
-	|O
terminal	|O
of	|O
the	|O
protein	|O
.	|O

The	|O
optimum	|O
technique	|O
for	|O
the	|O
pathological	|O
examination	|O
of	|O
sentinel	|O
lymph	|O
nodes	|O
(	|O
SLNs	|O
)	|O
is	|O
still	|O
under	|O
debate	|O
.	|O

Partial	|O
correction	|O
of	|O
anemia	|O
with	|O
recombinant	|O
human	|O
erythropoietin	|B-PROTEIN
likely	|O
reduces	|O
left	|O
ventricular	|O
mass	|O
and	|O
volume	|O
.	|O

This	|O
study	|O
demonstrated	|O
that	|O
the	|O
PFA	|O
-	|O
100	|O
analyzer	|O
can	|O
accurately	|O
assess	|O
vWF	|B-PROTEIN
-	|O
dependent	|O
platelet	|O
function	|O
and	|O
detect	|O
other	|O
platelet	|O
defects	|O
under	|O
high	|O
shear	|O
stress	|O
in	|O
complex	|O
patient	|O
populations	|O
.	|O

We	|O
recently	|O
reported	|O
the	|O
molecular	|O
cloning	|O
of	|O
a	|O
PL	|B-PROTEIN
scramblase	|I-PROTEIN
of	|O
human	|O
(	|O
HuPLSCR1	|B-PROTEIN
)	|O
and	|O
mouse	|O
origin	|O
,	|O
respectively	|O
.	|O

To	|O
analyze	|O
the	|O
regulatory	|O
activity	|O
of	|O
Gtx	|B-PROTEIN
,	|O
we	|O
first	|O
identified	|O
the	|O
optimal	|O
Gtx	|B-PROTEIN
-	|O
binding	|O
sequence	|O
using	|O
an	|O
in	|O
vitro	|O
DNA	|O
-	|O
binding	|O
assay	|O
.	|O

Using	|O
an	|O
oligomer	|O
duplex	|O
5'	|O
-	|O
A	|O
(	|O
GGGTTA	|O
)	|O
(	|O
5	|O
)	|O
-	|O
3'	|O
/	|O
5'	|O
-	|O
(	|O
TAACCC	|O
)	|O
(	|O
5	|O
)	|O
T	|O
-	|O
3'	|O
as	|O
a	|O
template	|O
-	|O
primer	|O
,	|O
we	|O
show	|O
that	|O
both	|O
the	|O
Klenow	|O
fragment	|O
of	|O
Escherichia	|O
coli	|O
DNA	|B-PROTEIN
polymerase	|I-PROTEIN
I	|I-PROTEIN
and	|O
HIV	|O
reverse	|B-PROTEIN
transcriptase	|I-PROTEIN
could	|O
expand	|O
telomere	|O
DNA	|O
sequences	|O
as	|O
well	|O
,	|O
giving	|O
products	|O
greater	|O
than	|O
the	|O
size	|O
of	|O
the	|O
template	|O
DNA	|O
.	|O

Cdk2	|B-PROTEIN
and	|O
MAPK	|B-PROTEIN
precipitates	|O
from	|O
untreated	|O
tumor	|O
lysates	|O
phosphorylated	|O
recombinant	|O
wild	|O
-	|O
type	|O
p27	|B-PROTEIN
but	|O
not	|O
the	|O
T187A	|O
mutant	|O
in	|O
vitro	|O
.	|O

The	|O
loss	|O
of	|O
avirulence	|O
activity	|O
because	|O
of	|O
mutations	|O
in	|O
the	|O
acidic	|O
transcriptional	|O
activation	|O
domain	|O
was	|O
restored	|O
by	|O
addition	|O
of	|O
the	|O
activation	|O
domain	|O
from	|O
the	|O
herpes	|O
simplex	|O
viral	|O
protein	|O
VP16	|B-PROTEIN
.	|O

Mutations	|O
in	|O
the	|O
RP2	|B-PROTEIN
locus	|O
at	|O
Xp11.3	|O
were	|O
found	|O
in	|O
a	|O
further	|O
10-20%	|O
of	|O
XLRP	|O
patients	|O
,	|O
as	|O
predicted	|O
from	|O
linkage	|O
studies	|O
.	|O

The	|O
limit	|O
between	|O
the	|O
cecum	|O
and	|O
the	|O
ascending	|O
colon	|O
was	|O
externally	|O
marked	|O
by	|O
the	|O
sulcus	|O
cecocolicus	|O
dorsalis	|O
and	|O
ventralis	|O
.	|O

Subsequently	|O
,	|O
HD	|O
inhibited	|O
healing	|O
because	|O
it	|O
significantly	|O
delayed	|O
epithelialization	|O
and	|O
caused	|O
protracted	|O
inflammation	|O
.	|O

The	|O
effectiveness	|O
of	|O
the	|O
haemodialysate	|O
Solcoseryl	|O
for	|O
second	|O
-	|O
intention	|O
wound	|O
healing	|O
in	|O
horses	|O
and	|O
ponies	|O
.	|O

Although	|O
there	|O
is	|O
little	|O
evidence	|O
that	|O
diet	|O
composition	|O
plays	|O
a	|O
clinically	|O
important	|O
role	|O
in	|O
the	|O
absorption	|O
or	|O
expenditure	|O
of	|O
energy	|O
,	|O
it	|O
does	|O
appear	|O
to	|O
play	|O
a	|O
role	|O
in	|O
food	|O
intake	|O
.	|O

These	|O
findings	|O
were	|O
reinforced	|O
by	|O
an	|O
analysis	|O
that	|O
was	|O
restricted	|O
to	|O
living	|O
donor	|O
transplants	|O
without	|O
acute	|O
rejection	|O
.	|O

These	|O
results	|O
further	|O
support	|O
an	|O
important	|O
role	|O
for	|O
CBF2	|B-PROTEIN
in	|O
mediating	|O
EBNA2	|B-PROTEIN
transactivation	|O
;	|O
they	|O
identify	|O
the	|O
hnRNP	|O
protein	|O
AUF1	|B-PROTEIN
as	|O
a	|O
major	|O
component	|O
of	|O
CBF2	|B-PROTEIN
and	|O
are	|O
also	|O
the	|O
first	|O
evidence	|O
of	|O
a	|O
cis	|O
-	|O
acting	|O
sequence	|O
other	|O
than	|O
a	|O
CBF1	|B-PROTEIN
binding	|O
element	|O
that	|O
is	|O
able	|O
to	|O
confer	|O
responsiveness	|O
to	|O
EBNA2	|B-PROTEIN
.	|O

The	|O
genome	|O
of	|O
the	|O
human	|O
herpesvirus	|O
8	|O
(	|O
HHV	|O
-	|O
8	|O
)	|O
contains	|O
a	|O
cluster	|O
of	|O
open	|O
reading	|O
frames	|O
(	|O
ORFs	|O
)	|O
encoding	|O
proteins	|O
with	|O
homology	|O
to	|O
the	|O
cellular	|O
transcription	|O
factors	|O
of	|O
the	|O
interferon	|B-PROTEIN
regulatory	|I-PROTEIN
factor	|I-PROTEIN
(	|O
IRF	|B-PROTEIN
)	|O
family	|O
.	|O

Despite	|O
these	|O
limitations	|O
the	|O
CHIME	|O
monitor	|O
provides	|O
an	|O
opportunity	|O
to	|O
record	|O
physiological	|O
data	|O
previously	|O
unavailable	|O
in	|O
the	|O
home	|O
.	|O

DATA	|O
SYNTHESIS	|O
:	|O
Intracoronary	|O
ultrasound	|O
has	|O
been	|O
shown	|O
to	|O
improve	|O
upon	|O
demonstrated	|O
weaknesses	|O
of	|O
coronary	|O
angiography	|O
.	|O

TB	|O
bone	|O
area	|O
(	|O
p	|O
<	|O
0.001	|O
)	|O
,	|O
height	|O
(	|O
p	|O
<	|O
0.01	|O
)	|O
,	|O
years	|O
in	|O
present	|O
colony	|O
(	|O
p	|O
=	|O
0.03	|O
)	|O
,	|O
and	|O
menses	|O
(	|O
p	|O
<	|O
0.01	|O
)	|O
predicted	|O
TB	|O
BMC	|O
.	|O

CREST	|O
syndrome	|O
;	|O
a	|O
changing	|O
clinical	|O
significance	|O

Troglitazone	|O
also	|O
induced	|O
an	|O
endogenous	|O
PPARgamma	|B-PROTEIN
target	|O
gene	|O
in	|O
T24	|O
cells	|O
,	|O
adipocyte	|B-PROTEIN
-	|I-PROTEIN
type	|I-PROTEIN
fatty	|I-PROTEIN
acid	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
(	|O
A	|B-PROTEIN
-	|I-PROTEIN
FABP	|I-PROTEIN
)	|O
,	|O
the	|O
expression	|O
of	|O
which	|O
correlates	|O
with	|O
bladder	|O
cancer	|O
differentiation	|O
.	|O

Viruses	|O
were	|O
isolated	|O
from	|O
9	|O
lungs	|O
:	|O
7	|O
with	|O
PI	|O
-	|O
3V	|O
,	|O
1	|O
with	|O
NCP	|O
BVDV	|O
type	|O
1	|O
,	|O
and	|O
1	|O
with	|O
both	|O
BVHV	|O
-	|O
1	|O
and	|O
BVDV	|O
.	|O

The	|O
RS447	|B-PROTEIN
human	|O
megasatellite	|B-PROTEIN
tandem	|I-PROTEIN
repetitive	|I-PROTEIN
sequence	|I-PROTEIN
encodes	|O
a	|O
novel	|O
deubiquitinating	|O
enzyme	|O
with	|O
a	|O
functional	|O
promoter	|O
.	|O

Previous	|O
experience	|O
and	|O
contextual	|O
cues	|O
are	|O
essential	|O
elements	|O
in	|O
the	|O
generation	|O
of	|O
a	|O
subjective	|O
prediction	|O
.	|O

To	|O
characterize	|O
this	|O
effect	|O
,	|O
we	|O
looked	|O
for	|O
targets	|O
of	|O
NS1	|B-PROTEIN
influenza	|O
virus	|O
protein	|O
among	|O
cellular	|O
translation	|O
factors	|O
.	|O

Collectively	|O
,	|O
these	|O
and	|O
previously	|O
published	|O
data	|O
suggest	|O
a	|O
model	|O
where	|O
NS1	|B-PROTEIN
recruits	|O
eIF4GI	|B-PROTEIN
specifically	|O
to	|O
the	|O
5'	|O
untranslated	|O
region	|O
(	|O
5'	|O
UTR	|O
)	|O
of	|O
the	|O
viral	|O
mRNA	|O
,	|O
allowing	|O
for	|O
the	|O
preferential	|O
translation	|O
of	|O
the	|O
influenza	|O
virus	|O
messengers	|O
.	|O

Eukaryotic	|O
translation	|O
initiation	|O
factor	|O
4GI	|B-PROTEIN
is	|O
a	|O
cellular	|O
target	|O
for	|O
NS1	|B-PROTEIN
protein	|O
,	|O
a	|O
translational	|O
activator	|O
of	|O
influenza	|O
virus	|O
.	|O

Splicing	|O
of	|O
the	|O
K	|B-PROTEIN
-	|I-PROTEIN
SAM	|I-PROTEIN
alternative	|O
exon	|O
of	|O
the	|O
fibroblast	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
receptor	|I-PROTEIN
2	|I-PROTEIN
gene	|O
is	|O
heavily	|O
dependent	|O
on	|O
the	|O
U	|O
-	|O
rich	|O
sequence	|O
IAS1	|B-PROTEIN
lying	|O
immediately	|O
downstream	|O
from	|O
its	|O
5'	|O
splice	|O
site	|O
.	|O

(	|O
iii	|O
)	|O
In	|O
these	|O
cells	|O
,	|O
PKCbeta	|B-PROTEIN
plays	|O
a	|O
unique	|O
Ras	|B-PROTEIN
-	|O
independent	|O
role	|O
in	|O
mediating	|O
insulin	|B-PROTEIN
but	|O
not	|O
EGF	|B-PROTEIN
or	|O
other	|O
growth	|O
factor	|O
mitogenic	|O
signals	|O
.	|O

However	|O
,	|O
it	|O
is	|O
not	|O
known	|O
whether	|O
the	|O
recently	|O
identified	|O
isoforms	|O
Vav2	|B-PROTEIN
and	|O
Vav3	|B-PROTEIN
,	|O
which	|O
are	|O
broadly	|O
expressed	|O
,	|O
can	|O
couple	|O
with	|O
similar	|O
classes	|O
of	|O
receptors	|O
,	|O
nor	|O
is	|O
it	|O
known	|O
whether	|O
all	|O
Vav	|B-PROTEIN
isoforms	|O
possess	|O
identical	|O
functional	|O
activities	|O
.	|O

Transcriptional	|O
regulation	|O
of	|O
fbp1	|B-PROTEIN
promoter	|O
constructs	|O
containing	|O
only	|O
UAS1	|O
or	|O
UAS2	|O
confirms	|O
that	|O
the	|O
PKA	|B-PROTEIN
and	|O
MAPK	|B-PROTEIN
regulation	|O
is	|O
targeted	|O
to	|O
both	|O
sites	|O
.	|O

X	|O
-	|O
ray	|O
crystallographic	|O
data	|O
show	|O
that	|O
the	|O
PLZF	|B-PROTEIN
BTB	|O
/	|O
POZ	|O
domain	|O
forms	|O
an	|O
obligate	|O
homodimer	|O
via	|O
an	|O
extensive	|O
interface	|O
.	|O

The	|O
ability	|O
of	|O
SMRT	|B-PROTEIN
to	|O
associate	|O
with	|O
these	|O
transcription	|O
factors	|O
and	|O
thereby	|O
to	|O
mediate	|O
repression	|O
is	|O
strongly	|O
inhibited	|O
by	|O
activation	|O
of	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
signaling	|O
pathways	|O
,	|O
such	|O
as	|O
that	|O
represented	|O
by	|O
the	|O
epidermal	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
receptor	|I-PROTEIN
.	|O

In	|O
addition	|O
,	|O
the	|O
ketamine	|O
-	|O
treated	|O
rats	|O
had	|O
more	|O
neurons	|O
and	|O
glial	|O
cells	|O
surrounding	|O
the	|O
ventricles	|O
.	|O

The	|O
differences	|O
were	|O
as	|O
follows	|O
:	|O
for	|O
overall	|O
response	|O
rate	|O
p	|O
=	|O
0.004	|O
;	|O
power	|O
(	|O
for	|O
p	|O
=	|O
0.05	|O
)	|O
85%	|O
;	|O
for	|O
survival	|O
p	|O
=	|O
0.09	|O
;	|O
for	|O
grade	|O
IV	|O
granulocytopenia	|O
p	|O
=	|O
0.3	|O
;	|O
and	|O
for	|O
febrile	|O
neutropenia	|O
p	|O
=	|O
0.61	|O
.	|O

Patients	|O
were	|O
randomly	|O
assigned	|O
to	|O
treatment	|O
with	|O
the	|O
ACE	|B-PROTEIN
inhibitor	|O
perindopril	|O
(	|O
and	|O
the	|O
diuretic	|O
indapamide	|O
for	|O
those	|O
with	|O
no	|O
definite	|O
indication	|O
for	|O
or	|O
contraindication	|O
to	|O
treatment	|O
with	|O
a	|O
diuretic	|O
)	|O
or	|O
matching	|O
placebo	|O
(	|O
s	|O
)	|O
.	|O

The	|O
results	|O
indicate	|O
that	|O
the	|O
open	|O
-	|O
section	|O
effect	|O
decreases	|O
the	|O
torsional	|O
stiffness	|O
and	|O
stress	|O
concentration	|O
effects	|O
decrease	|O
the	|O
torsional	|O
strength	|O
of	|O
a	|O
long	|O
bone	|O
with	|O
a	|O
longitudinal	|O
defect	|O
.	|O

These	|O
regions	|O
may	|O
be	|O
differentially	|O
involved	|O
in	|O
tissue	|O
-	|O
specificity	|O
,	|O
and	|O
/	|O
or	|O
circadian	|O
regulation	|O
,	|O
of	|O
the	|O
human	|O
hPer1	|B-PROTEIN
gene	|O
transcription	|O
.	|O

Additionally	|O
,	|O
putative	|O
CF1	|B-PROTEIN
/	|O
USP	|B-PROTEIN
and	|O
Broad	|B-PROTEIN
Complex	|I-PROTEIN
Z2	|I-PROTEIN
transcription	|O
factor	|O
elements	|O
were	|O
found	|O
in	|O
the	|O
upstream	|O
regions	|O
of	|O
MIH	|B-PROTEIN
and	|O
MO	|B-PROTEIN
-	|I-PROTEIN
IH	|I-PROTEIN
genes	|O
respectively	|O
.	|O

Sequence	|O
analysis	|O
reveals	|O
that	|O
the	|O
newly	|O
discovered	|O
oasA2	|B-PROTEIN
gene	|O
represents	|O
a	|O
pseudogene	|O
that	|O
is	|O
still	|O
transcribed	|O
,	|O
but	|O
is	|O
not	|O
functionally	|O
translated	|O
.	|O

Genomic	|O
and	|O
functional	|O
characterization	|O
of	|O
the	|O
oas	|B-PROTEIN
gene	|O
family	|O
encoding	|O
O	|B-PROTEIN
-	|I-PROTEIN
acetylserine	|I-PROTEIN
(	|I-PROTEIN
thiol	|I-PROTEIN
)	|I-PROTEIN
lyases	|I-PROTEIN
,	|O
enzymes	|O
catalyzing	|O
the	|O
final	|O
step	|O
in	|O
cysteine	|O
biosynthesis	|O
in	|O
Arabidopsis	|O
thaliana	|O
.	|O

Two	|O
distinct	|O
recessive	|O
susceptibility	|O
loci	|O
for	|O
vasculitis	|O
were	|O
mapped	|O
on	|O
chromosome	|O
(	|O
Chr	|O
)	|O
4	|O
at	|O
D4Mit89	|B-PROTEIN
and	|O
D4Mit147	|B-PROTEIN
in	|O
both	|O
progenies	|O
.	|O

During	|O
treatment	|O
,	|O
the	|O
phosphorylation	|O
state	|O
of	|O
Rb	|B-PROTEIN
shifted	|O
to	|O
a	|O
hypophosphorylated	|O
form	|O
.	|O
mRNA	|O
for	|O
the	|O
HPV	|O
E6	|B-PROTEIN
/	|O
E7	|B-PROTEIN
genes	|O
decreased	|O
;	|O
however	|O
,	|O
significant	|O
changes	|O
in	|O
the	|O
E7	|B-PROTEIN
protein	|O
were	|O
not	|O
observed	|O
,	|O
while	|O
increased	|O
levels	|O
of	|O
Rb	|B-PROTEIN
immunoprecipitated	|O
with	|O
anti	|B-PROTEIN
-	|I-PROTEIN
E7	|I-PROTEIN
antibodies	|O
were	|O
observed	|O
.	|O

Further	|O
characterization	|O
of	|O
these	|O
putative	|O
Hoxa	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
target	|O
genes	|O
will	|O
aid	|O
in	|O
delineating	|O
the	|O
functions	|O
of	|O
the	|O
Hoxa	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
protein	|O
in	|O
the	|O
differentiation	|O
processes	|O
which	|O
occur	|O
during	|O
embryogenesis	|O
.	|O

The	|O
ability	|O
of	|O
U6	|B-PROTEIN
-	|O
U57	|B-PROTEIN
mutants	|O
to	|O
influence	|O
the	|O
fidelity	|O
of	|O
both	|O
branch	|O
site	|O
and	|O
3'	|O
splice	|O
site	|O
recognition	|O
suggests	|O
that	|O
this	|O
nucleotide	|O
may	|O
participate	|O
in	|O
the	|O
formation	|O
of	|O
the	|O
active	|O
site	|O
(	|O
s	|O
)	|O
of	|O
the	|O
spliceosome	|O
.	|O

We	|O
have	|O
determined	|O
the	|O
structure	|O
of	|O
the	|O
WNT	|B-PROTEIN
-	|I-PROTEIN
2B	|I-PROTEIN
gene	|O
.	|O

The	|O
role	|O
of	|O
daunorubicin	|O
in	|O
induction	|O
therapy	|O
for	|O
adult	|O
acute	|O
myeloid	|O
leukemia	|O

Five	|O
of	|O
the	|O
Aeromonas	|O
strains	|O
and	|O
one	|O
of	|O
V	|O
cholerae	|O
non	|O
-	|O
O1	|O
were	|O
positive	|O
for	|O
enterotoxin	|O
activity	|O
.	|O

TNF	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
induced	|O
a	|O
dose	|O
-	|O
and	|O
time	|O
-	|O
dependent	|O
increase	|O
in	|O
cyclooxygenase	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
(	|O
COX	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
)	|O
expression	|O
and	|O
PGE2	|O
formation	|O
in	|O
human	|O
NCI	|O
-	|O
H292	|O
epithelial	|O
cells	|O
.	|O

The	|O
therapy	|O
time	|O
to	|O
deliver	|O
the	|O
NCS	|O
therapeutic	|O
dose	|O
of	|O
10000	|O
RBE	|O
-	|O
cGy	|O
,	|O
is	|O
27	|O
times	|O
longer	|O
when	|O
157Gd	|O
is	|O
used	|O
instead	|O
of	|O
10B	|O
.	|O

Mis3	|B-PROTEIN
is	|O
needed	|O
for	|O
the	|O
formation	|O
of	|O
18S	|B-PROTEIN
ribosome	|O
RNA	|O
,	|O
and	|O
may	|O
hence	|O
direct	|O
the	|O
level	|O
of	|O
proteins	|O
required	|O
for	|O
the	|O
coupling	|O
.	|O

Losartan	|O
Intervention	|O
For	|O
Endpoint	|O
.	|O

CONCLUSION	|O
:	|O
Vitrectomy	|O
for	|O
vitreous	|O
hemorrhage	|O
in	|O
Terson	|O
syndrome	|O
is	|O
a	|O
safe	|O
and	|O
effective	|O
procedure	|O
,	|O
offering	|O
a	|O
rapid	|O
and	|O
prolonged	|O
improvement	|O
in	|O
vision	|O
.	|O

RNA	|O
in	|O
situ	|O
hybridization	|O
on	|O
brain	|O
sections	|O
of	|O
normal	|O
human	|O
embryos	|O
revealed	|O
a	|O
strong	|O
labeling	|O
in	|O
restricted	|O
areas	|O
of	|O
the	|O
cerebral	|O
cortex	|O
.	|O

To	|O
facilitate	|O
manipulation	|O
of	|O
large	|O
genomic	|O
sequences	|O
,	|O
we	|O
developed	|O
a	|O
method	|O
of	|O
converting	|O
Escherichia	|O
coli	|O
P1	|O
artificial	|O
chromosomes	|O
(	|O
PACs	|O
)	|O
into	|O
yeast	|O
artificial	|O
chromosomes	|O
(	|O
YACs	|O
)	|O
.	|O

After	|O
gamma	|O
-	|O
irradiation	|O
,	|O
the	|O
majority	|O
of	|O
F9	|O
cells	|O
undergo	|O
apoptosis	|O
implying	|O
that	|O
wt	|O
-	|O
p53	|B-PROTEIN
likely	|O
triggers	|O
pro	|O
-	|O
apoptotic	|O
gene	|O
expression	|O
in	|O
DNA	|O
damaged	|O
cells	|O
.	|O

Mobilization	|O
with	|O
cyclophosphamide	|O
and	|O
granulocyte	|B-PROTEIN
-	|I-PROTEIN
colony	|I-PROTEIN
stimulating	|I-PROTEIN
factor	|I-PROTEIN
was	|O
effective	|O
in	|O
terms	|O
of	|O
CD34+	|B-PROTEIN
cell	|O
shift	|O
to	|O
peripheral	|O
blood	|O
and	|O
the	|O
good	|O
quality	|O
autograft	|O
reliably	|O
led	|O
to	|O
haematopoetic	|O
recovery	|O
after	|O
megachemotherapy	|O
.	|O

This	|O
suggests	|O
that	|O
cardiovascular	|O
magnetic	|O
resonance	|O
is	|O
the	|O
preferred	|O
technique	|O
for	|O
volume	|O
and	|O
ejection	|O
fraction	|O
estimation	|O
in	|O
heart	|O
failure	|O
patients	|O
,	|O
because	|O
of	|O
its	|O
3D	|O
approach	|O
for	|O
non	|O
-	|O
symmetric	|O
ventricles	|O
and	|O
superior	|O
image	|O
quality	|O
.	|O

A	|O
degenerate	|O
DNA	|O
transposon	|O
,	|O
Pat	|B-PROTEIN
,	|O
was	|O
identified	|O
in	|O
the	|O
genomes	|O
of	|O
various	|O
wild	|O
-	|O
type	|O
strains	|O
of	|O
the	|O
filamentous	|O
fungus	|O
Podospora	|O
anserina	|O
.	|O

However	|O
,	|O
the	|O
presence	|O
of	|O
Tax	|B-PROTEIN
I	|I-PROTEIN
increased	|O
the	|O
extent	|O
and	|O
altered	|O
the	|O
profile	|O
of	|O
proteins	|O
binding	|O
TRE	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
in	|O
vivo	|O
.	|O

We	|O
have	|O
also	|O
identified	|O
a	|O
functional	|O
domain	|O
in	|O
the	|O
ORF	|O
50	|O
protein	|O
,	|O
an	|O
immediate	|B-PROTEIN
-	|I-PROTEIN
early	|I-PROTEIN
gene	|I-PROTEIN
product	|O
that	|O
is	|O
mainly	|O
encoded	|O
by	|O
ORF	|O
50	|O
.	|O

A	|O
2.3	|O
-	|O
kb	|O
full	|O
-	|O
length	|O
cDNA	|O
clone	|O
of	|O
an	|O
Atlantic	|O
halibut	|O
Mx	|B-PROTEIN
gene	|O
was	|O
isolated	|O
from	|O
a	|O
liver	|O
cDNA	|O
library	|O
.	|O

PLUS	|O
-	|O
3	|O
is	|O
a	|O
new	|O
Swedish	|O
protocol	|O
of	|O
natural	|O
speech	|O
in	|O
3	|O
-	|O
year	|O
-	|O
old	|O
children	|O
.	|O

Once	|O
HIT	|O
II	|O
is	|O
suspected	|O
,	|O
heparin	|O
(	|O
and	|O
low	|O
-	|O
molecular	|O
-	|O
weight	|O
heparins	|O
)	|O
should	|O
be	|O
stopped	|O
immediately	|O
.	|O

The	|O
reduced	|O
efficiency	|O
in	|O
the	|O
glycosylase	|B-PROTEIN
activity	|O
is	|O
also	|O
reflected	|O
in	|O
a	|O
reduced	|O
ability	|O
of	|O
S120K	|O
MutY	|B-PROTEIN
to	|O
prevent	|O
DNA	|O
mutations	|O
in	|O
vivo	|O
.	|O

METHODS	|O
AND	|O
RESULTS	|O
:	|O
We	|O
prospectively	|O
compared	|O
the	|O
automated	|O
measurements	|O
of	|O
left	|O
ventricular	|O
ejection	|O
fraction	|O
(	|O
LVEF	|O
)	|O
and	|O
volumes	|O
from	|O
rest	|O
-	|O
injected	|O
gated	|O
Technetium	|O
99m	|O
(	|O
Tc99m	|O
)	|O
perfusion	|O
SPECT	|O
with	|O
equilibrium	|O
radionuclide	|O
angiocardiography	|O
(	|O
ERNA	|O
)	|O
in	|O
62	|O
patients	|O
and	|O
the	|O
assessment	|O
of	|O
regional	|O
function	|O
with	|O
echocardiography	|O
in	|O
22	|O
patients	|O
.	|O

The	|O
2	|O
cDNAs	|O
differed	|O
in	|O
the	|O
length	|O
of	|O
their	|O
respective	|O
3'	|O
untranslated	|O
regions	|O
,	|O
of	|O
577	|O
bp	|O
in	|O
Cp.F	|B-PROTEIN
6	|I-PROTEIN
and	|O
72	|O
bp	|O
in	|O
Cp.F	|B-PROTEIN
10	|I-PROTEIN
,	|O
in	|O
both	|O
of	|O
which	|O
a	|O
putative	|O
polyadenylation	|O
signal	|O
was	|O
identified	|O
.	|O

This	|O
intracellular	|O
signaling	|O
,	|O
known	|O
as	|O
the	|O
unfolded	|O
protein	|O
response	|O
(	|O
UPR	|O
)	|O
,	|O
is	|O
mediated	|O
by	|O
the	|O
cis	|O
-	|O
acting	|O
ER	|O
stress	|O
response	|O
element	|O
(	|O
ERSE	|O
)	|O
in	|O
mammals	|O
.	|O

A	|O
Y.	|O
lipolytica	|O
Kar2p	|B-PROTEIN
mutant	|O
was	|O
isolated	|O
that	|O
restored	|O
interaction	|O
with	|O
an	|O
Sls1p	|B-PROTEIN
mutant	|O
,	|O
suggesting	|O
that	|O
the	|O
interaction	|O
with	|O
Sls1p	|B-PROTEIN
could	|O
be	|O
nucleotide	|O
and	|O
/	|O
or	|O
conformation	|O
dependent	|O
.	|O

We	|O
have	|O
carried	|O
out	|O
a	|O
comprehensive	|O
and	|O
systematic	|O
mutagenesis	|O
of	|O
the	|O
Cse4p	|B-PROTEIN
N	|O
terminus	|O
to	|O
analyze	|O
its	|O
function	|O
.	|O

The	|O
spacing	|O
of	|O
the	|O
essential	|O
N	|O
-	|O
terminal	|O
domain	|O
(	|O
END	|O
)	|O
relative	|O
to	|O
the	|O
HFD	|B-PROTEIN
can	|O
be	|O
changed	|O
significantly	|O
without	|O
an	|O
apparent	|O
effect	|O
on	|O
Cse4p	|B-PROTEIN
function	|O
.	|O

The	|O
bases	|O
of	|O
this	|O
comparison	|O
are	|O
reviewed	|O
and	|O
discussed	|O
.	|O

In	|O
invertebrates	|O
,	|O
Fhit	|B-PROTEIN
is	|O
encoded	|O
as	|O
a	|O
fusion	|O
protein	|O
with	|O
Nit	|B-PROTEIN
,	|O
a	|O
member	|O
of	|O
the	|O
nitrilase	|B-PROTEIN
superfamily	|O
.	|O

Platelet	|O
counts	|O
and	|O
function	|O
as	|O
well	|O
as	|O
fibrinogen	|B-PROTEIN
and	|O
von	|B-PROTEIN
Willebrand	|I-PROTEIN
factor	|I-PROTEIN
(	|O
vWF	|B-PROTEIN
)	|O
levels	|O
were	|O
determined	|O
in	|O
each	|O
sample	|O
.	|O

The	|O
manifestations	|O
often	|O
include	|O
a	|O
moderate	|O
thrombocytopenia	|O
and	|O
,	|O
less	|O
commonly	|O
,	|O
hemolysis	|O
.	|O

A	|O
beta2	|B-PROTEIN
RARE	|I-PROTEIN
reporter	|O
construct	|O
in	|O
which	|O
the	|O
methylation	|O
-	|O
susceptible	|O
cytosines	|O
in	|O
the	|O
sense	|O
strand	|O
were	|O
replaced	|O
by	|O
thymine	|O
displayed	|O
marked	|O
loss	|O
of	|O
activity	|O
in	|O
a	|O
replicated	|O
chromatin	|O
-	|O
dependent	|O
manner	|O
.	|O

Non	|O
-	|O
poliomyelitis	|O
AFP	|O
rate	|O
had	|O
increased	|O
from	|O
0.9	|O
in	|O
1997	|O
to	|O
2.8	|O
in	|O
1998	|O
.	|O

Consciousness	|O
is	|O
connected	|O
with	|O
attention	|O
,	|O
working	|O
memory	|O
and	|O
perception	|O
.	|O

Multiparity	|O
had	|O
a	|O
protective	|O
effect	|O
with	|O
0.66	|O
less	|O
risk	|O
(	|O
95%	|O
CI	|O
0.44-0.99	|O
)	|O
.	|O

Picture	|O
the	|O
smell	|O
.	|O

The	|O
aim	|O
of	|O
our	|O
study	|O
was	|O
to	|O
evaluate	|O
the	|O
level	|O
of	|O
oxidative	|O
stress	|O
in	|O
healthy	|O
controls	|O
(	|O
CTL	|O
)	|O
compared	|O
with	|O
CRF	|O
and	|O
HD	|O
patients	|O
before	|O
(	|O
pre	|O
-	|O
HD	|O
)	|O
and	|O
after	|O
(	|O
post	|O
-	|O
HD	|O
)	|O
the	|O
dialysis	|O
session	|O
,	|O
carried	|O
out	|O
on	|O
a	|O
high	|O
biocompatible	|O
polyacrylonitrile	|O
membrane	|O
AN69	|O
.	|O

Indirect	|O
plasma	|O
parameters	|O
such	|O
as	|O
vitamin	|O
E	|O
,	|O
thiol	|O
and	|O
uric	|O
acid	|O
levels	|O
were	|O
also	|O
quantified	|O
.	|O

Only	|O
two	|O
of	|O
27	|O
participants	|O
(	|O
7.4%	|O
)	|O
with	|O
definite	|O
POAG	|O
had	|O
been	|O
previously	|O
diagnosed	|O
and	|O
treated	|O
,	|O
and	|O
66.7%	|O
of	|O
the	|O
previously	|O
undiagnosed	|O
had	|O
IOP	|O
less	|O
than	|O
22	|O
mmHg	|O
.	|O

Taken	|O
together	|O
,	|O
they	|O
uphold	|O
the	|O
emerging	|O
concern	|O
that	|O
women	|O
with	|O
ER	|B-PROTEIN
(	|O
+	|O
)	|O
cancers	|O
may	|O
not	|O
benefit	|O
significantly	|O
from	|O
endocrine	|O
treatment	|O
if	|O
the	|O
tumors	|O
also	|O
overexpress	|O
HER	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
.	|O

Promoter	|O
activity	|O
was	|O
dose	|O
-	|O
dependently	|O
inhibited	|O
by	|O
cotransfection	|O
with	|O
either	|O
ras	|B-PROTEIN
or	|O
mos	|B-PROTEIN
oncogenes	|O
,	|O
but	|O
oncogene	|O
inhibition	|O
was	|O
reversed	|O
and	|O
the	|O
overall	|O
activity	|O
increased	|O
when	|O
cells	|O
were	|O
treated	|O
with	|O
the	|O
MAP	|B-PROTEIN
kinase	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
MKK	|B-PROTEIN
)	|O
inhibitor	|O
PD98059	|O
.	|O

Our	|O
results	|O
indicate	|O
that	|O
the	|O
expression	|O
of	|O
Cktsf1b1	|B-PROTEIN
,	|O
a	|O
gene	|O
associated	|O
with	|O
early	|O
development	|O
and	|O
cell	|O
transformation	|O
,	|O
is	|O
sensitive	|O
to	|O
MKK	|B-PROTEIN
levels	|O
and	|O
may	|O
be	|O
regulated	|O
via	|O
multiple	|O
transcription	|O
factor	|O
complexes	|O
.	|O

INTERVENTIONS	|O
:	|O
Subcutaneous	|O
tissue	|O
PO2	|O
and	|O
PCO2	|O
tensions	|O
were	|O
measured	|O
directly	|O
in	|O
patients	|O
with	|O
necrotising	|O
fasciitis	|O
and	|O
in	|O
healthy	|O
volunteers	|O
during	|O
normobaric	|O
and	|O
hyperbaric	|O
conditions	|O
.	|O

Because	|O
GH	|B-PROTEIN
-	|O
induced	|O
Akt	|B-PROTEIN
activation	|O
was	|O
completely	|O
inhibited	|O
in	|O
both	|O
cells	|O
by	|O
the	|O
same	|O
concentration	|O
of	|O
LY294002	|O
,	|O
these	|O
findings	|O
indicate	|O
that	|O
the	|O
wortmannin	|O
sensitivity	|O
of	|O
both	|O
the	|O
IRS	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|O
independent	|O
and	|O
-	|O
dependent	|O
GH	|B-PROTEIN
-	|O
induced	|O
MAP	|B-PROTEIN
kinase	|I-PROTEIN
activation	|O
may	|O
reflect	|O
the	|O
activity	|O
of	|O
another	|O
wortmannin	|O
-	|O
sensitive	|O
target	|O
(	|O
s	|O
)	|O
in	|O
addition	|O
to	|O
PI3K	|B-PROTEIN
in	|O
mediation	|O
of	|O
GH	|B-PROTEIN
-	|O
induced	|O
MAP	|B-PROTEIN
kinase	|I-PROTEIN
activation	|O
in	|O
these	|O
cells	|O
.	|O

Insulin	|B-PROTEIN
receptor	|I-PROTEIN
substrate	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|O
mediated	|O
enhancement	|O
of	|O
growth	|B-PROTEIN
hormone	|I-PROTEIN
-	|O
induced	|O
mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
activation	|O
.	|O

Functional	|O
magnetic	|O
resonance	|O
imaging	|O
(	|O
fMRI	|O
)	|O
has	|O
been	|O
increasingly	|O
used	|O
in	|O
studying	|O
human	|O
brain	|O
function	|O
given	|O
its	|O
non	|O
-	|O
invasive	|O
feature	|O
and	|O
good	|O
spatial	|O
resolution	|O
.	|O

After	|O
declamping	|O
of	|O
the	|O
aorta	|O
,	|O
there	|O
were	|O
also	|O
severe	|O
edema	|O
,	|O
local	|O
fibre	|O
necrosis	|O
,	|O
and	|O
adhesion	|O
of	|O
leucocytes	|O
,	|O
whereas	|O
muscle	|O
fibre	|O
areas	|O
became	|O
3,935.18	|O
micro	|O
531	|O
microm	|O
(	|O
2	|O
)	|O
for	|O
type	|O
I	|O
and	|O
5,804	|O
+	|O
/	|O
-	|O
1,075	|O
microm	|O
(	|O
2	|O
)	|O
for	|O
type	|O
II	|O
.	|O

The	|O
results	|O
indicate	|O
that	|O
the	|O
relationship	|O
between	|O
comprehension	|O
and	|O
production	|O
is	|O
different	|O
at	|O
different	|O
stages	|O
in	|O
development	|O
.	|O

It	|O
was	|O
found	|O
that	|O
increase	|O
in	|O
the	|O
RH	|O
level	|O
boosts	|O
the	|O
current	|O
values	|O
by	|O
2-3	|O
orders	|O
of	|O
magnitude	|O
;	|O
contrariwise	|O
,	|O
the	|O
voltage	|O
values	|O
rise	|O
by	|O
about	|O
three	|O
times	|O
with	|O
drop	|O
in	|O
the	|O
RH	|O
.	|O

On	|O
long	|O
-	|O
term	|O
follow	|O
-	|O
up	|O
,	|O
there	|O
was	|O
no	|O
significant	|O
difference	|O
in	|O
the	|O
incidence	|O
of	|O
hospitalizations	|O
(	|O
1	|O
per	|O
2.1	|O
vs.	|O

Genomic	|O
libraries	|O
were	|O
stored	|O
as	|O
frozen	|O
cultures	|O
in	|O
a	|O
96	|O
-	|O
well	|O
format	|O
,	|O
each	|O
well	|O
containing	|O
approximately	|O
300-600	|O
colonies	|O
(	|O
12	|O
plates	|O
for	|O
small	|O
library	|O
,	|O
four	|O
for	|O
medium	|O
-	|O
size	|O
library	|O
and	|O
four	|O
for	|O
large	|O
library	|O
)	|O
.	|O

In	|O
several	|O
cell	|O
lines	|O
,	|O
mTOR	|B-PROTEIN
or	|O
its	|O
downstream	|O
targets	|O
can	|O
be	|O
regulated	|O
by	|O
phosphatidylinositol	|O
(	|B-PROTEIN
PI	|I-PROTEIN
)	|I-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
;	|O
protein	|B-PROTEIN
kinases	|I-PROTEIN
A	|I-PROTEIN
,	|I-PROTEIN
B	|I-PROTEIN
,	|I-PROTEIN
and	|I-PROTEIN
C	|I-PROTEIN
;	|O
heterotrimeric	|O
G	|B-PROTEIN
-	|I-PROTEIN
proteins	|I-PROTEIN
;	|O
a	|O
PD98059	|O
-	|O
sensitive	|O
kinase	|O
or	|O
calcium	|O
;	|O
as	|O
well	|O
as	|O
by	|O
amino	|O
acids	|O
.	|O

The	|O
tumor	|O
-	|O
suppressor	|O
protein	|O
p53	|B-PROTEIN
is	|O
involved	|O
in	|O
maintaining	|O
genomic	|O
stability	|O
.	|O

Abrogation	|O
of	|O
p53	|B-PROTEIN
function	|O
by	|O
E6	|B-PROTEIN
resulted	|O
in	|O
an	|O
increase	|O
in	|O
the	|O
spontaneous	|O
mutation	|O
frequencies	|O
at	|O
the	|O
heterozygous	|O
thymidine	|B-PROTEIN
kinase	|I-PROTEIN
(	|O
TK	|B-PROTEIN
)	|O
locus	|O
but	|O
not	|O
at	|O
the	|O
hemizygous	|O
hypoxanthine	|B-PROTEIN
phosphoribosyl	|I-PROTEIN
transferase	|I-PROTEIN
(	|O
HPRT	|B-PROTEIN
)	|O
locus	|O
.	|O

Cytogenetic	|O
analysis	|O
of	|O
LOH	|O
mutants	|O
by	|O
chromosome	|O
painting	|O
indicated	|O
a	|O
mosaic	|O
of	|O
chromosomal	|O
aberrations	|O
involving	|O
chromosome	|O
17	|O
,	|O
in	|O
which	|O
partial	|O
chromosome	|O
deletions	|O
,	|O
amplifications	|O
,	|O
and	|O
multiple	|O
translocations	|O
appeared	|O
heterogeneously	|O
in	|O
a	|O
single	|O
mutant	|O
.	|O

These	|O
results	|O
support	|O
a	|O
model	|O
in	|O
which	|O
p53	|B-PROTEIN
protein	|O
contributes	|O
to	|O
the	|O
maintenance	|O
of	|O
genomic	|O
integrity	|O
through	|O
recombinational	|O
repair	|O
.	|O

The	|O
importance	|O
of	|O
this	|O
new	|O
epidemiological	|O
profile	|O
of	|O
schistosomiasis	|O
in	|O
the	|O
State	|O
of	|O
Pernambuco	|O
relies	|O
on	|O
the	|O
fact	|O
that	|O
it	|O
can	|O
be	|O
related	|O
with	|O
the	|O
drastic	|O
human	|O
interference	|O
on	|O
the	|O
environment	|O
.	|O

In	|O
patients	|O
with	|O
type	|O
II	|O
tumors	|O
,	|O
the	|O
pattern	|O
of	|O
lymphatic	|O
spread	|O
was	|O
primarily	|O
directed	|O
toward	|O
the	|O
paracardial	|O
,	|O
lesser	|O
curvature	|O
,	|O
and	|O
left	|O
gastric	|O
artery	|O
nodes	|O
;	|O
esophagectomy	|O
offered	|O
no	|O
survival	|O
benefit	|O
over	|O
extended	|O
gastrectomy	|O
in	|O
these	|O
patients	|O
.	|O

RESULTS	|O
:	|O
No	|O
significant	|O
deformation	|O
in	|O
vertebral	|O
artery	|O
flow	|O
was	|O
noted	|O
in	|O
the	|O
flexion	|O
-	|O
distraction	|O
Stage	|O
I	|O
injuries	|O
within	|O
the	|O
physiologic	|O
range	|O
of	|O
cervical	|O
flexion	|O
.	|O

We	|O
screened	|O
a	|O
K562	|O
cDNA	|O
library	|O
and	|O
identified	|O
novel	|O
transcripts	|O
,	|O
MZF1B	|B-PROTEIN
and	|O
MZF1C	|B-PROTEIN
.	|O

The	|O
human	|O
cDNA	|O
clone	|O
NFBD1	|B-PROTEIN
(	|O
previously	|O
designated	|O
KIAA0170	|B-PROTEIN
)	|O
encodes	|O
a	|O
novel	|O
protein	|O
(	|O
2089	|O
amino	|O
acids	|O
in	|O
length	|O
;	|O
calculated	|O
molecular	|O
mass	|O
226,440	|O
D	|O
)	|O
with	|O
possible	|O
BRCT	|B-PROTEIN
domains	|O
at	|O
its	|O
carboxy	|O
terminus	|O
(	|O
amino	|O
acid	|O
residues	|O
1894-2089	|O
)	|O
.	|O

RESULTS	|O
:	|O
Neither	|O
basal	|O
FSH	|B-PROTEIN
level	|O
nor	|O
stimulated	|O
FSH	|B-PROTEIN
level	|O
alone	|O
were	|O
statistically	|O
significant	|O
predictors	|O
of	|O
IVF	|O
success	|O
;	|O
however	|O
,	|O
no	|O
patient	|O
with	|O
a	|O
day	|O
3	|O
FSH	|B-PROTEIN
level	|O
>	|O
11.1	|O
mIU	|O
/	|O
ml	|O
or	|O
a	|O
stimulated	|O
day	|O
10	|O
FSH	|B-PROTEIN
level	|O
>	|O
13.5	|O
mIU	|O
/	|O
ml	|O
conceived	|O
and	|O
carried	|O
a	|O
pregnancy	|O
.	|O

Parathyroid	|B-PROTEIN
hormone	|I-PROTEIN
regulation	|O
of	|O
bone	|B-PROTEIN
sialoprotein	|I-PROTEIN
(	|O
BSP	|B-PROTEIN
)	|O
gene	|O
transcription	|O
is	|O
mediated	|O
through	|O
a	|O
pituitary	|B-PROTEIN
-	|I-PROTEIN
specific	|I-PROTEIN
transcription	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
(	|O
Pit	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
motif	|O
in	|O
the	|O
rat	|O
BSP	|B-PROTEIN
gene	|O
promoter	|O
.	|O

Recent	|O
target	|O
BP	|O
goals	|O
promulgated	|O
by	|O
the	|O
Sixth	|O
Report	|O
from	|O
the	|O
Joint	|O
National	|O
Committee	|O
(	|O
JNC	|O
VI	|O
)	|O
are	|O
based	|O
on	|O
the	|O
premise	|O
that	|O
the	|O
intensity	|O
of	|O
treatment	|O
directly	|O
corresponds	|O
to	|O
the	|O
magnitude	|O
of	|O
pretreatment	|O
risk	|O
.	|O

Linking	|O
continuous	|O
community	|O
-	|O
based	|O
morbidity	|O
recording	|O
of	|O
influenza	|O
-	|O
like	|O
illness	|O
(	|O
ILI	|O
)	|O
with	|O
virological	|O
sampling	|O
has	|O
consistently	|O
proved	|O
its	|O
value	|O
as	|O
one	|O
of	|O
the	|O
earliest	|O
indicators	|O
of	|O
circulating	|O
influenza	|O
activity	|O
.	|O

The	|O
muskox	|O
is	|O
a	|O
new	|O
host	|O
record	|O
for	|O
T.	|O
gondii	|O
.	|O

These	|O
include	|O
NPF	|O
repeats	|O
,	|O
a	|O
leucine	|O
heptad	|O
repeat	|O
enriched	|O
in	|O
charged	|O
residues	|O
,	|O
and	|O
a	|O
proline	|O
-	|O
rich	|O
SH3	|B-PROTEIN
-	|O
like	|O
and	|O
/	|O
or	|O
WW	|O
domain	|O
-	|O
binding	|O
site	|O
in	|O
the	|O
N	|O
-	|O
terminal	|O
domain	|O
,	|O
which	|O
is	|O
followed	|O
by	|O
a	|O
membrane	|O
core	|O
containing	|O
four	|O
putative	|O
transmembrane	|O
spans	|O
and	|O
three	|O
amphiphilic	|O
segments	|O
that	|O
are	|O
the	|O
most	|O
highly	|O
conserved	|O
structural	|O
elements	|O
.	|O

We	|O
show	|O
here	|O
that	|O
this	|O
difference	|O
is	|O
due	|O
to	|O
the	|O
presence	|O
of	|O
a	|O
Mot3	|B-PROTEIN
binding	|O
site	|O
in	|O
OpA	|B-PROTEIN
.	|O

The	|O
article	|O
deals	|O
with	|O
the	|O
diagnosing	|O
and	|O
correction	|O
of	|O
reversible	|O
ischemia	|O
of	|O
the	|O
intestine	|O
.	|O

Mucosal	|O
application	|O
of	|O
NCX	|O
-	|O
4016	|O
,	|O
however	|O
,	|O
did	|O
not	|O
cause	|O
PD	|O
reduction	|O
and	|O
luminal	|O
H+	|O
loss	|O
,	|O
but	|O
produced	|O
a	|O
marked	|O
hyperemia	|O
,	|O
resulting	|O
in	|O
no	|O
damage	|O
in	|O
the	|O
stomach	|O
of	|O
both	|O
normal	|O
and	|O
STZ	|O
-	|O
diabetic	|O
rats	|O
.	|O

Functional	|O
recognition	|O
of	|O
5'	|O
splice	|O
site	|O
by	|O
U4	|B-PROTEIN
/	|O
U6.U	|B-PROTEIN
5	|O
tri	|O
-	|O
snRNP	|O
defines	|O
a	|O
novel	|O
ATP	|O
-	|O
dependent	|O
step	|O
in	|O
early	|O
spliceosome	|O
assembly	|O
.	|O

As	|O
control	|O
,	|O
the	|O
cells	|O
were	|O
transfected	|O
with	|O
DNA	|O
mixtures	|O
containing	|O
vector	|O
mU6	|O
-	|O
C1	|O
or	|O
mU6	|O
-	|O
C2	|O
.	|O

The	|O
amino	|O
acid	|O
sequence	|O
of	|O
matrilysin	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
also	|O
contains	|O
a	|O
threonine	|O
residue	|O
adjacent	|O
to	|O
the	|O
Zn	|O
-	|O
binding	|O
site	|O
that	|O
has	|O
been	|O
defined	|O
as	|O
a	|O
specific	|O
feature	|O
of	|O
matrilysin	|B-PROTEIN
.	|O

In	|O
this	|O
regard	|O
,	|O
we	|O
have	|O
recently	|O
observed	|O
that	|O
a	|O
constitutively	|O
active	|O
G	|B-PROTEIN
protein	|I-PROTEIN
-	|I-PROTEIN
coupled	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
GPCR	|B-PROTEIN
)	|O
encoded	|O
by	|O
the	|O
Kaposi	|O
's	|O
sarcoma	|O
-	|O
associated	|O
herpes	|O
virus	|O
(	|O
KSHV	|O
)	|O
/	|O
human	|O
herpes	|O
virus	|O
8	|O
is	|O
oncogenic	|O
and	|O
stimulates	|O
angiogenesis	|O
by	|O
increasing	|O
the	|O
secretion	|O
of	|O
vascular	|B-PROTEIN
endothelial	|I-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
(	|O
VEGF	|B-PROTEIN
)	|O
,	|O
which	|O
is	|O
a	|O
key	|O
angiogenic	|O
stimulator	|O
and	|O
a	|O
critical	|O
mitogen	|O
for	|O
the	|O
development	|O
of	|O
Kaposi	|O
's	|O
sarcoma	|O
.	|O

No	|O
specific	|O
subgroup	|O
of	|O
clients	|O
benefited	|O
more	|O
from	|O
URD	|O
,	|O
although	|O
a	|O
prospective	|O
study	|O
employing	|O
random	|O
assignment	|O
might	|O
be	|O
more	|O
successful	|O
in	|O
identifying	|O
such	|O
a	|O
group	|O
.	|O

In	|O
the	|O
lattice	|O
,	|O
23%	|O
of	|O
the	|O
sites	|O
are	|O
occupied	|O
,	|O
95%	|O
of	|O
the	|O
atoms	|O
are	|O
in	|O
the	|O
lowest	|O
energy	|O
magnetic	|O
sublevel	|O
,	|O
and	|O
37%	|O
are	|O
in	|O
the	|O
lowest	|O
3D	|O
vibrational	|O
state	|O
.	|O

Coexisting	|O
vertical	|O
and	|O
horizontal	|O
one	|O
and	|O
a	|O
half	|O
syndromes	|O
.	|O

As	|O
in	|O
the	|O
other	|O
three	|O
members	|O
whose	|O
gene	|O
expression	|O
is	|O
altered	|O
during	|O
tumorigenesis	|O
,	|O
PI12	|B-PROTEIN
expression	|O
was	|O
found	|O
to	|O
be	|O
down	|O
-	|O
regulated	|O
in	|O
tumor	|O
brain	|O
tissues	|O
and	|O
in	|O
two	|O
brain	|O
cancer	|O
cell	|O
lines	|O
:	|O
U	|O
-	|O
87	|O
MG	|O
and	|O
H4	|O
.	|O

Regarding	|O
"	|O
the	|O
relation	|O
between	|O
sexual	|O
orientation	|O
and	|O
penile	|O
size	|O
,	|O
"	|O
by	|O
A.	|O

This	|O
slope	|O
was	|O
further	|O
significantly	|O
decreased	|O
at	|O
5	|O
min	|O
ischemia	|O
(	|O
-	|O
26.5	|O
+	|O
/	|O
-	|O
8.8	|O
microm	|O
/	|O
mmHg	|O
)	|O
but	|O
returned	|O
toward	|O
control	|O
values	|O
in	|O
short	|O
-	|O
term	|O
hibernating	|O
myocardium	|O
at	|O
90	|O
min	|O
ischemia	|O
(	|O
-	|O
17.2	|O
+	|O
/	|O
-	|O
6.6	|O
microm	|O
/	|O
mmHg	|O
)	|O
.	|O

Whereas	|O
both	|O
MAP	|O
and	|O
MSNA	|O
increase	|O
during	|O
SHG	|O
,	|O
the	|O
transition	|O
from	|O
SHG	|O
to	|O
PHI	|O
is	|O
characterized	|O
by	|O
a	|O
transient	|O
reduction	|O
in	|O
MAP	|O
but	|O
sustained	|O
elevation	|O
in	|O
MSNA	|O
,	|O
facilitating	|O
separation	|O
of	|O
these	|O
factors	|O
in	|O
vivo	|O
.	|O

Analysis	|O
of	|O
Standard	|O
Reference	|O
Material	|O
1846	|O
,	|O
Infant	|O
Formula	|O
,	|O
gave	|O
a	|O
mean	|O
value	|O
of	|O
0.95	|O
+	|O
/	|O
-	|O
0.088	|O
mg	|O
vitamin	|O
K	|O
/	|O
kg	|O
(	|O
K	|O
or	|O
K1	|O
?	|O
)	|O
(	|O
n	|O
=	|O
31	|O
)	|O
with	|O
a	|O
coefficient	|O
of	|O
variation	|O
of	|O
9.26	|O
.	|O

We	|O
have	|O
recently	|O
discovered	|O
that	|O
CCAAAT	|B-PROTEIN
/	|I-PROTEIN
enhancer	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
(	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
)	|O
induces	|O
gene	|O
transcription	|O
through	|O
a	|O
novel	|O
IFN	|B-PROTEIN
response	|O
element	|O
called	|O
the	|O
gamma	|B-PROTEIN
-	|I-PROTEIN
IFN	|I-PROTEIN
-	|O
activated	|O
transcriptional	|O
element	|O

Northern	|O
blot	|O
analysis	|O
demonstrated	|O
that	|O
the	|O
STORP	|B-PROTEIN
gene	|O
has	|O
a	|O
ubiquitous	|O
pattern	|O
of	|O
expression	|O
similar	|O
to	|O
that	|O
of	|O
the	|O
PML	|B-PROTEIN
gene	|O
.	|O

In	|O
the	|O
TLE	|O
patients	|O
the	|O
NAA	|O
:	|O
Cr	|O
ratios	|O
were	|O
reduced	|O
in	|O
the	|O
seizure	|O
focus	|O
,	|O
while	|O
in	|O
the	|O
FLE	|O
patients	|O
they	|O
were	|O
not	|O
always	|O
reduced	|O
in	|O
the	|O
seizure	|O
focus	|O
.	|O

The	|O
Spo0F	|B-PROTEIN
residues	|O
making	|O
up	|O
the	|O
hydrophobic	|O
patch	|O
are	|O
very	|O
similar	|O
in	|O
all	|O
response	|O
regulators	|O
suggesting	|O
that	|O
the	|O
binding	|O
is	|O
initiated	|O
through	|O
the	|O
same	|O
residues	|O
in	|O
all	|O
interacting	|O
response	|O
regulator	|O
-	|O
kinase	|O
pairs	|O
.	|O

The	|O
psychologic	|O
factors	|O
associated	|O
wth	|O
serious	|O
illness	|O
,	|O
terminal	|O
prognoses	|O
,	|O
and	|O
dying	|O
complicate	|O
the	|O
scenario	|O
even	|O
more	|O
as	|O
compared	|O
with	|O
that	|O
of	|O
nonmalignant	|O
pain	|O
.	|O

However	|O
,	|O
if	|O
the	|O
spatial	|O
resolution	|O
is	|O
not	|O
critical	|O
and	|O
interest	|O
is	|O
to	|O
compare	|O
a	|O
pathologic	|O
area	|O
with	|O
a	|O
contralateral	|O
VOI	|O
,	|O
then	|O
the	|O
acquisition	|O
of	|O
two	|O
single	|O
-	|O
voxel	|O
spectra	|O
may	|O
be	|O
preferred	|O
.	|O

Quantitative	|O
evaluation	|O
of	|O
magneto	|O
-	|O
optical	|O
parameters	|O
is	|O
necessary	|O
in	|O
order	|O
to	|O
apply	|O
scanning	|O
near	|O
-	|O
field	|O
optical	|O
microscope	|O
(	|O
SNOM	|O
)	|O
technology	|O
to	|O
the	|O
study	|O
of	|O
magnetism	|O
on	|O
the	|O
mesoscopic	|O
scale	|O
.	|O

We	|O
found	|O
that	|O
the	|O
amplitude	|O
of	|O
the	|O
cortical	|O
evoked	|O
potentials	|O
(	|O
amplitude	|O
of	|O
the	|O
N2	|O
/	|O
P2	|O
peak	|O
)	|O
increased	|O
from	|O
5.1	|O
+	|O
/	|O
-	|O
0.7	|O
microV	|O
at	|O
5	|O
mA	|O
to	|O
16.3	|O
+	|O
/	|O
-	|O
1.1	|O
microV	|O
at	|O
20	|O
mA	|O
.	|O

While	|O
mutations	|O
in	|O
K	|B-PROTEIN
-	|I-PROTEIN
Rev	|I-PROTEIN
that	|O
inactivate	|O
any	|O
one	|O
of	|O
these	|O
properties	|O
also	|O
blocked	|O
K	|B-PROTEIN
-	|I-PROTEIN
Rev	|I-PROTEIN
-	|O
dependent	|O
nuclear	|O
RNA	|O
export	|O
,	|O
several	|O
K	|B-PROTEIN
-	|I-PROTEIN
Rev	|I-PROTEIN
mutants	|O
were	|O
comparable	|O
to	|O
wild	|O
type	|O
when	|O
assayed	|O
for	|O
any	|O
of	|O
these	|O
individual	|O
activities	|O
yet	|O
nevertheless	|O
defective	|O
for	|O
RNA	|O
export	|O
.	|O

LMP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
is	|O
targeted	|O
to	|O
the	|O
plasma	|O
membrane	|O
,	|O
where	|O
it	|O
binds	|O
TRAF	|B-PROTEIN
,	|O
TRADD	|B-PROTEIN
,	|O
and	|O
JAK	|B-PROTEIN
molecules	|O
to	|O
activate	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
-	|O
,	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|O
,	|O
and	|O
STAT	|B-PROTEIN
-	|O
dependent	|O
pathways	|O
as	|O
does	|O
CD40	|B-PROTEIN
.	|O

Identification	|O
of	|O
an	|O
enhancer	|O
and	|O
an	|O
alternative	|O
promoter	|O
in	|O
the	|O
first	|O
intron	|O
of	|O
the	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
fetoprotein	|I-PROTEIN
gene	|O
.	|O

Studying	|O
intracellular	|O
signaling	|O
pathways	|O
,	|O
which	|O
may	|O
be	|O
involved	|O
in	|O
malignant	|O
transformation	|O
of	|O
Ret	|B-PROTEIN
-	|I-PROTEIN
9bp	|I-PROTEIN
expressing	|O
NIH3T3	|O
cells	|O
,	|O
we	|O
could	|O
demonstrate	|O
Ret	|B-PROTEIN
-	|I-PROTEIN
9bp	|I-PROTEIN
dependent	|O
phosphorylation	|O
of	|O
insulin	|B-PROTEIN
receptor	|I-PROTEIN
substrate	|I-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
(	|O
IRS	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
)	|O
with	|O
consecutive	|O
activation	|O
of	|O
phosphatidylinositol	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
PI	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
)	|O
and	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
B	|I-PROTEIN
(	|O
PKB	|B-PROTEIN
/	|O
AKT	|B-PROTEIN
)	|O
.	|O

METHODS	|O
:	|O
In	|O
the	|O
current	|O
study	|O
the	|O
authors	|O
reported	|O
on	|O
PPB	|O
cases	|O
from	|O
a	|O
national	|O
retrospective	|O
search	|O
performed	|O
in	|O
18	|O
Italian	|O
Associations	|O
for	|O
Pediatric	|O
Hematology	|O
and	|O
Oncology	|O
centers	|O
.	|O

Phylogenetic	|O
analysis	|O
showed	|O
that	|O
the	|O
ToLCV	|O
isolates	|O
from	|O
Bangalore	|O
constitute	|O
a	|O
group	|O
of	|O
viruses	|O
separated	|O
from	|O
those	|O
of	|O
Northern	|O
India	|O
.	|O

Mutating	|O
the	|O
Fcp1p	|B-PROTEIN
-	|O
binding	|O
motif	|O
KEFGK	|O
in	|O
the	|O
RAP74	|B-PROTEIN
(	|O
Tfg1p	|B-PROTEIN
)	|O
subunit	|O
of	|O
TFIIF	|B-PROTEIN
to	|O
EEFGE	|O
led	|O
to	|O
both	|O
synthetic	|O
phenotypes	|O
in	|O
certain	|O
fcp1	|B-PROTEIN
tfg1	|O
double	|O
mutants	|O
and	|O
a	|O
reduced	|O
ability	|O
of	|O
Fcp1p	|B-PROTEIN
to	|O
activate	|O
transcription	|O
when	|O
it	|O
is	|O
artificially	|O
tethered	|O
to	|O
a	|O
promoter	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
Cdc42p	|B-PROTEIN
is	|O
in	|O
fact	|O
required	|O
for	|O
pheromone	|O
response	|O
and	|O
that	|O
interaction	|O
with	|O
the	|O
PAK	|B-PROTEIN
Ste20p	|O
is	|O
critical	|O
for	|O
that	|O
role	|O
.	|O

Deletion	|O
of	|O
an	|O
intergenic	|O
DNA	|O
-	|O
binding	|O
site	|O
for	|O
this	|O
complex	|O
from	|O
a	|O
human	|O
beta	|B-PROTEIN
-	|I-PROTEIN
globin	|I-PROTEIN
locus	|O
construct	|O
results	|O
in	|O
delayed	|O
human	|O
gamma	|B-PROTEIN
-	|I-PROTEIN
to	|I-PROTEIN
beta	|I-PROTEIN
-	|I-PROTEIN
globin	|I-PROTEIN
switching	|O
in	|O
transgenic	|O
mice	|O
,	|O
suggesting	|O
that	|O
the	|O
PYR	|B-PROTEIN
complex	|O
acts	|O
to	|O
facilitate	|O
the	|O
switch	|O
.	|O

The	|O
product	|O
of	|O
rat	|O
gene	|B-PROTEIN
33	|I-PROTEIN
was	|O
identified	|O
as	|O
an	|O
ErbB	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
-	|O
interacting	|O
protein	|O
in	|O
a	|O
two	|O
-	|O
hybrid	|O
screen	|O
employing	|O
the	|O
ErbB	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
juxtamembrane	|O
and	|O
kinase	|O
domains	|O
as	|O
bait	|O
.	|O

Studies	|O
suggest	|O
that	|O
the	|O
DGOR	|O
without	|O
acid	|O
reflux	|O
may	|O
result	|O
in	|O
symptoms	|O
but	|O
unless	|O
acid	|O
reflux	|O
is	|O
present	|O
simultaneously	|O
,	|O
it	|O
does	|O
not	|O
cause	|O
oesophagitis	|O
.	|O

Symptoms	|O
,	|O
however	|O
,	|O
appear	|O
to	|O
correlate	|O
poorly	|O
with	|O
oesophagitis	|O
;	|O
hence	|O
,	|O
severe	|O
symptoms	|O
do	|O
not	|O
indicate	|O
there	|O
is	|O
greater	|O
oesophageal	|O
damage	|O
.	|O

OBJECTIVE	|O
:	|O
To	|O
evaluate	|O
the	|O
relationship	|O
between	|O
blood	|O
flow	|O
in	|O
the	|O
tumor	|O
assessed	|O
by	|O
color	|O
Doppler	|O
ultrasound	|O
,	|O
microvessel	|O
density	|O
,	|O
and	|O
vascular	|B-PROTEIN
endothelial	|I-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
levels	|O
in	|O
endometrial	|O
carcinoma	|O
.	|O

These	|O
results	|O
demonstrate	|O
Ras	|B-PROTEIN
-	|O
and	|O
Raf	|B-PROTEIN
-	|O
independent	|O
ERK	|B-PROTEIN
MAPK	|O
activation	|O
maintains	|O
cell	|O
viability	|O
following	|O
heat	|O
shock	|O
.	|O

Three	|O
cDNAs	|O
encoding	|O
basic	|O
leucine	|O
zipper	|O
(	|O
bZIP	|O
)	|O
-	|O
type	|O
ABRE	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
proteins	|I-PROTEIN
were	|O
isolated	|O
by	|O
using	|O
the	|O
yeast	|O
one	|O
-	|O
hybrid	|O
system	|O
and	|O
were	|O
designated	|O
AREB1	|B-PROTEIN
,	|O
AREB2	|B-PROTEIN
,	|O
and	|O
AREB3	|B-PROTEIN
(	|O
ABA	|B-PROTEIN
-	|I-PROTEIN
responsive	|I-PROTEIN
element	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
)	|O
.	|O

Recombinant	|O
AROM	|B-PROTEIN
-	|O
p64	|B-PROTEIN
displayed	|O
high	|O
binding	|O
to	|O
single	|O
-	|O
stranded	|O
DNA	|O
and	|O
poly	|O
(	|O
A	|O
)	|O
homopolymers	|O
suggesting	|O
that	|O
this	|O
protein	|O
could	|O
play	|O
a	|O
role	|O
in	|O
mRNA	|O
maturation	|O
/	|O
metabolism	|O
.	|O

The	|O
protein	|B-PROTEIN
-	|I-PROTEIN
tyrosine	|I-PROTEIN
kinase	|I-PROTEIN
fer	|O
associates	|O
with	|O
signaling	|O
complexes	|O
containing	|O
insulin	|B-PROTEIN
receptor	|I-PROTEIN
substrate	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
phosphatidylinositol	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
.	|O

The	|O
variable	|O
phenotype	|O
of	|O
the	|O
allotetraploids	|O
could	|O
not	|O
be	|O
explained	|O
by	|O
cytological	|O
abnormalities	|O
.	|O

In	|O
the	|O
PMR	|O
target	|O
area	|O
but	|O
not	|O
in	|O
the	|O
nontreated	|O
area	|O
an	|O
improvement	|O
in	|O
regional	|O
myocardial	|O
flow	|O
reserve	|O
occurs	|O
in	|O
wall	|O
segments	|O
with	|O
initially	|O
severely	|O
or	|O
moderately	|O
reduced	|O
stress	|O
perfusion	|O
.	|O

Analysis	|O
of	|O
intron	|O
/	|O
exon	|O
boundaries	|O
of	|O
the	|O
genomic	|O
BAC	|O
clones	|O
demonstrate	|O
that	|O
junctin	|B-PROTEIN
,	|O
junctate	|B-PROTEIN
,	|O
and	|O
aspartyl	|B-PROTEIN
beta	|I-PROTEIN
-	|I-PROTEIN
hydroxylase	|I-PROTEIN
result	|O
from	|O
alternative	|O
splicing	|O
of	|O
the	|O
same	|O
gene	|O
.	|O

It	|O
is	|O
now	|O
estimated	|O
that	|O
inactivation	|O
mutants	|O
of	|O
PTEN	|B-PROTEIN
exist	|O
in	|O
60%	|O
of	|O
all	|O
forms	|O
of	|O
solid	|O
tumors	|O
.	|O

We	|O
have	|O
demonstrated	|O
that	|O
the	|O
activity	|O
of	|O
ILK	|B-PROTEIN
is	|O
constitutively	|O
elevated	|O
in	|O
PTEN	|B-PROTEIN
mutant	|O
cells	|O
.	|O

The	|O
growth	|B-PROTEIN
factor	|I-PROTEIN
receptor	|I-PROTEIN
-	|I-PROTEIN
bound	|I-PROTEIN
protein	|I-PROTEIN
2	|I-PROTEIN
(	|O
Grb2	|B-PROTEIN
)	|O
adaptor	|O
when	|O
complexed	|O
with	|O
Sos	|B-PROTEIN
(	|O
Son	|B-PROTEIN
of	|I-PROTEIN
sevenless	|I-PROTEIN
)	|O
,	|O
the	|O
exchange	|O
factor	|O
of	|O
Ras	|B-PROTEIN
,	|O
conveys	|O
the	|O
signal	|O
induced	|O
by	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
-	|O
activated	|O
receptor	|O
to	|O
Ras	|B-PROTEIN
by	|O
recruiting	|O
Sos	|B-PROTEIN
to	|O
the	|O
membrane	|O
,	|O
allowing	|O
activation	|O
of	|O
Ras	|B-PROTEIN
.	|O

Mutations	|O
in	|O
genes	|O
encoding	|O
PR65	|B-PROTEIN
/	|I-PROTEIN
A	|I-PROTEIN
subunits	|O
have	|O
been	|O
identified	|O
in	|O
several	|O
different	|O
human	|O
cancers	|O
and	|O
the	|O
PP2A	|B-PROTEIN
inhibitor	|O
,	|O
termed	|O
fostriecin	|O
,	|O
is	|O
being	|O
tested	|O
as	|O
an	|O
anticancer	|O
drug	|O
.	|O

For	|O
this	|O
purpose	|O
,	|O
a	|O
segment	|O
of	|O
dxr	|B-PROTEIN
was	|O
amplified	|O
from	|O
Synechococcus	|O
leopoliensis	|O
SAUG	|O
1402-1	|O
DNA	|O
via	|O
PCR	|O
using	|O
oligonucleotides	|O
for	|O
conserved	|O
regions	|O
.	|O

Perceptual	|O
learning	|O
for	|O
a	|O
pattern	|O
discrimination	|O
task	|O
.	|O

The	|O
detector	|O
has	|O
the	|O
advantage	|O
of	|O
finding	|O
both	|O
ST	|O
segment	|O
deviations	|O
and	|O
entire	|O
ST	|O
-	|O
T	|O
complex	|O
changes	|O
thereby	|O
providing	|O
a	|O
wider	|O
characterization	|O
of	|O
the	|O
potential	|O
ischemic	|O
events	|O
.	|O

While	|O
this	|O
Saccharomyces	|O
cerevisiae	|O
SIN4	|B-PROTEIN
gene	|O
product	|O
is	|O
a	|O
component	|O
of	|O
a	|O
mediator	|O
complex	|O
associated	|O
with	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
II	|I-PROTEIN
,	|O
various	|O
studies	|O
suggest	|O
the	|O
involvement	|O
of	|O
Sin4	|B-PROTEIN
in	|O
the	|O
alteration	|O
of	|O
higher	|O
-	|O
order	|O
chromatin	|O
structure	|O
.	|O

Primary	|O
adrenal	|O
hypersensitivity	|O
to	|O
ACTH	|B-PROTEIN
drive	|O
in	|O
obesity	|O
has	|O
also	|O
been	|O
suggested	|O
.	|O

In	|O
addition	|O
,	|O
a	|O
noncanonical	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
-	|O
binding	|O
site	|O
within	|O
the	|O
Gadd45gamma	|B-PROTEIN
promoter	|O
where	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBPbeta	|I-PROTEIN
and	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBPdelta	|I-PROTEIN
could	|O
bind	|O
,	|O
was	|O
identified	|O
by	|O
electrophoretic	|O
mobility	|O
shift	|O
assay	|O
(	|O
EMSA	|O
)	|O
and	|O
reporter	|O
gene	|O
analysis	|O
.	|O

Src	|B-PROTEIN
activation	|O
induced	|O
by	|O
FGF1	|B-PROTEIN
was	|O
blocked	|O
by	|O
the	|O
SH2	|B-PROTEIN
domain	|O
of	|O
Src	|B-PROTEIN
and	|O
PP2	|B-PROTEIN
,	|O
a	|O
specific	|O
inhibitor	|O
of	|O
Src	|B-PROTEIN
.	|O

The	|O
use	|O
of	|O
the	|O
PLCgamma	|B-PROTEIN
inhibitory	|O
peptide	|O
,	|O
neomycin	|O
and	|O
the	|O
calcium	|O
chelator	|O
BAPTA	|O
-	|O
AM	|O
on	|O
oocytes	|O
expressing	|O
FGFR1	|B-PROTEIN
or	|O
the	|O
stimulation	|O
by	|O
PDGF	|B-PROTEIN
-	|I-PROTEIN
BB	|I-PROTEIN
of	|O
oocytes	|O
expressing	|O
PDGFR	|B-PROTEIN
-	|O
FGFR1	|B-PROTEIN
mutated	|O
on	|O
the	|O
PLCgamma	|B-PROTEIN
binding	|O
site	|O
,	|O
prevented	|O
GVBD	|O
and	|O
ERK2	|B-PROTEIN
phosphorylation	|O
.	|O

Multiple	|O
transcription	|O
start	|O
sites	|O
were	|O
revealed	|O
by	|O
primer	|O
extension	|O
analysis	|O
of	|O
the	|O
mouse	|O
gene	|O
,	|O
and	|O
transfection	|O
constructs	|O
containing	|O
the	|O
prospective	|O
promoter	|O
generated	|O
transcriptional	|O
activity	|O
comparable	|O
to	|O
that	|O
of	|O
the	|O
SV40	|B-PROTEIN
promoter	|I-PROTEIN
.	|O

From	|O
two	|O
inhibitor	|O
scaffolds	|O
,	|O
we	|O
have	|O
identified	|O
potent	|O
and	|O
selective	|O
inhibitors	|O
for	|O
sensitized	|O
kinases	|O
from	|O
five	|O
distinct	|O
subfamilies	|O
.	|O

To	|O
determine	|O
whether	|O
interaction	|O
of	|O
arsenite	|O
with	|O
the	|O
hormone	|O
-	|O
binding	|O
domain	|O
results	|O
in	|O
receptor	|O
activation	|O
,	|O
COS	|O
-	|O
1	|O
cells	|O
were	|O
transiently	|O
cotransfected	|O
with	|O
the	|O
chimeric	|O
receptors	|O
GAL	|B-PROTEIN
-	|I-PROTEIN
ER	|I-PROTEIN
,	|O
which	|O
contains	|O
the	|O
hormone	|O
-	|O
binding	|O
domain	|O
of	|O
ERalpha	|B-PROTEIN
and	|O
the	|O
DNA	|O
-	|O
binding	|O
domain	|O
of	|O
the	|O
transcription	|O
factor	|O
GAL4	|B-PROTEIN
,	|O
and	|O
a	|O
GAL4	|B-PROTEIN
-	|O
responsive	|O
CAT	|B-PROTEIN
reporter	|O
gene	|O
.	|O

By	|O
progressive	|O
5'	|O
-	|O
deletion	|O
studies	|O
,	|O
we	|O
have	|O
identified	|O
a	|O
248	|O
-	|O
bp	|O
DNA	|O
fragment	|O
(	|O
-	|O
1018	|O
to	|O
-	|O
771	|O
,	|O
relative	|O
to	|O
the	|O
translation	|O
start	|O
site	|O
)	|O
at	|O
the	|O
5'	|O
-	|O
flanking	|O
region	|O
of	|O
the	|O
human	|O
GnRHR	|B-PROTEIN
gene	|O
that	|O
is	|O
responsible	|O
for	|O
the	|O
GnRHa	|O
-	|O
mediated	|O
down	|O
-	|O
regulation	|O
of	|O
human	|O
GnRHR	|B-PROTEIN
promoter	|O
activity	|O
.	|O

The	|O
mean	|O
day	|O
of	|O
diagnosis	|O
of	|O
periventricular	|O
echodensities	|O
was	|O
3	|O
+	|O
/	|O
-	|O
2	|O
days	|O
(	|O
range	|O
1-11	|O
days	|O
)	|O
,	|O
and	|O
of	|O
cystic	|O
PVL	|O
21	|O
+	|O
/	|O
-	|O
8	|O
days	|O
(	|O
range	|O
2-47	|O
days	|O
)	|O
.	|O

The	|O
LAMMER	|B-PROTEIN
protein	|O
kinase	|O
encoded	|O
by	|O
the	|O
Doa	|B-PROTEIN
locus	|O
of	|O
Drosophila	|O
is	|O
required	|O
in	|O
both	|O
somatic	|O
and	|O
germline	|O
cells	|O
and	|O
is	|O
expressed	|O
as	|O
both	|O
nuclear	|O
and	|O
cytoplasmic	|O
isoforms	|O
throughout	|O
development	|O
.	|O

We	|O
have	|O
mutated	|O
to	|O
cysteine	|O
,	|O
one	|O
at	|O
a	|O
time	|O
,	|O
21	|O
consecutive	|O
residues	|O
in	|O
the	|O
fourth	|O
TMS	|O
(	|O
TM4	|O
)	|O
.	|O

(	|O
1995	|O
)	|O
J.	|O

HYPOTHESIS	|O
:	|O
The	|O
aim	|O
of	|O
this	|O
study	|O
was	|O
to	|O
investigate	|O
the	|O
oxidative	|O
susceptibility	|O
of	|O
apolipoprotein	|B-PROTEIN
B	|I-PROTEIN
-	|O
containing	|O
lipoproteins	|O
and	|O
antioxidant	|O
status	|O
in	|O
patients	|O
with	|O
acute	|O
coronary	|O
syndromes	|O
and	|O
chronic	|O
stable	|O
angina	|O
pectoris	|O
.	|O

In	|O
group	|O
B	|O
37	|O
MBq	|O
in	|O
150	|O
microL	|O
of	|O
99mTc	|O
-	|O
HSA	|O
nanocolloid	|O
was	|O
additionally	|O
injected	|O
intradermally	|O
18	|O
h	|O
before	|O
surgery	|O
(	|O
3-6	|O
aliquots	|O
injected	|O
perilesionally	|O
)	|O
.	|O

Post	|O
-	|O
operative	|O
functional	|O
outcome	|O
is	|O
related	|O
to	|O
pre	|O
-	|O
operative	|O
functional	|O
status	|O
.	|O

We	|O
cloned	|O
a	|O
DNA	|O
fragment	|O
encoding	|O
the	|O
N	|O
-	|O
terminal	|O
part	|O
of	|O
a	|O
protein	|O
with	|O
significant	|O
similarity	|O
to	|O
members	|O
of	|O
the	|O
LysR	|B-PROTEIN
family	|O
of	|O
transcriptional	|O
regulators	|O
(	|O
LTTRs	|B-PROTEIN
)	|O
.	|O

AGO1	|B-PROTEIN
is	|O
similar	|O
to	|O
QDE	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
required	|O
for	|O
quelling	|O
and	|O
RDE	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
required	|O
for	|O
RNAi	|O
.	|O

Intracellular	|O
localization	|O
studies	|O
using	|O
the	|O
mDAP	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
/	|O
EGFP	|B-PROTEIN
fusion	|O
protein	|O
,	|O
cell	|O
fractionation	|O
and	|O
protease	|O
protection	|O
experiments	|O
localized	|O
mDAP	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
to	|O
the	|O
mitochondrial	|O
matrix	|O
.	|O

We	|O
could	|O
demonstrate	|O
the	|O
involvement	|O
of	|O
cAMP	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
PKA	|B-PROTEIN
)	|O
in	|O
the	|O
phosphorylation	|O
of	|O
CDC25Mm	|B-PROTEIN
in	|O
fibroblasts	|O
overexpressing	|O
this	|O
RasGEF	|B-PROTEIN
as	|O
well	|O
as	|O
in	|O
mouse	|O
brain	|O
synaptosomal	|O
membranes	|O
.	|O

Reporter	|O
gene	|O
expression	|O
analyses	|O
indicate	|O
that	|O
both	|O
WASP	|B-PROTEIN
promoters	|O
show	|O
high	|O
levels	|O
of	|O
expression	|O
in	|O
different	|O
hematopoietic	|O
cell	|O
lines	|O
.	|O

We	|O
find	|O
that	|O
3T1	|O
-	|O
3T2	|O
mixing	|O
has	|O
a	|O
pronounced	|O
effect	|O
on	|O
the	|O
line	|O
shape	|O
and	|O
radiative	|O
decay	|O
rate	|O
of	|O
emission	|O
from	|O
the	|O
3T2	|O
state	|O
and	|O
that	|O
the	|O
extent	|O
of	|O
mixing	|O
depends	|O
critically	|O
on	|O
the	|O
magnitude	|O
of	|O
nontetrahedral	|O
distortions	|O
.	|O

A	|O
total	|O
of	|O
576	|O
1	|O
-	|O
day	|O
-	|O
old	|O
Ross	|O
broiler	|O
chicks	|O
were	|O
housed	|O
in	|O
six	|O
treatment	|O
groups	|O
[	|O
six	|O
replicates	|O
of	|O
16	|O
each	|O
;	|O
control	|O
,	|O
CLI	|O
(	|O
15	|O
g	|O
kg	|O
(	|O
-	|O
1	|O
)	|O
diet	|O
)	|O
,	|O
50	|O
parts	|O
per	|O
billion	|O
(	|O
ppb	|O
)	|O
AF	|B-PROTEIN
,	|O
50	|O
ppb	|O
AF	|B-PROTEIN
plus	|O
CLI	|O
,	|O
100	|O
ppb	|O
AF	|B-PROTEIN
,	|O
100	|O
ppb	|O
AF	|B-PROTEIN
plus	|O
CLI	|O
]	|O
for	|O
42	|O
days	|O
.	|O

The	|O
cost	|O
per	|O
test	|O
is	|O
less	|O
than	|O
those	|O
for	|O
CC	|O
,	|O
kEIA	|O
and	|O
PACE2	|O
.	|O

Altogether	|O
these	|O
results	|O
suggest	|O
that	|O
,	|O
in	|O
KG1a	|O
cells	|O
,	|O
TNFalpha	|B-PROTEIN
can	|O
stimulate	|O
in	|O
parallel	|O
PC	|B-PROTEIN
-	|I-PROTEIN
PLC	|I-PROTEIN
and	|O
PLD	|B-PROTEIN
,	|O
whose	|O
lipid	|O
products	|O
activate	|O
in	|O
turn	|O
mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
MAP	|B-PROTEIN
kinase	|I-PROTEIN
)	|O
and	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
signalling	|O
respectively	|O
.	|O

Concurrently	|O
,	|O
we	|O
monitored	|O
weather	|O
conditions	|O
and	|O
used	|O
time	|O
-	|O
activity	|O
budget	|O
data	|O
of	|O
free	|O
-	|O
living	|O
birds	|O
and	|O
laboratory	|O
data	|O
on	|O
resting	|O
metabolic	|O
rate	|O
to	|O
construct	|O
time	|O
-	|O
activity	|O
laboratory	|O
(	|O
TAL	|O
)	|O
estimates	|O
of	|O
daily	|O
energy	|O
expenditure	|O
(	|O
DEE	|O
)	|O
and	|O
to	|O
partition	|O
the	|O
verdins	|O
'	|O
energy	|O
budget	|O
into	|O
thermoregulatory	|O
,	|O
activity	|O
and	|O
basal	|O
components	|O
.	|O

L	|O
/	|O
H	|O
>	|O
0.61	|O
(	|O
chi	|O
(	|O
2	|O
)	|O
=	|O
10.8	|O
;	|O
P	|O
:	|O
<	|O
0.001	|O
)	|O
and	|O
a	|O
restrictive	|O
filling	|O
pattern	|O
(	|O
chi	|O
(	|O
2	|O
)	|O
=	|O
3.6	|O
;	|O
P	|O
:	|O
<	|O
0.05	|O
)	|O
were	|O
independent	|O
predictors	|O
of	|O
events	|O
.	|O

The	|O
high	|O
selectivity	|O
of	|O
arrestins	|B-PROTEIN
for	|O
this	|O
particular	|O
functional	|O
form	|O
of	|O
receptor	|O
ensures	|O
their	|O
timely	|O
binding	|O
and	|O
dissociation	|O
.	|O

When	|O
cotransfected	|O
in	|O
fibroblasts	|O
with	|O
a	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
alpha	|I-PROTEIN
expression	|O
vector	|O
,	|O
reporter	|O
gene	|O
expression	|O
increased	|O
3	|O
-	|O
fold	|O
only	|O
in	|O
the	|O
wild	|O
-	|O
type	|O
constructs	|O
.	|O

Expression	|O
of	|O
a	|O
dominant	|O
negative	|O
Smad2	|B-PROTEIN
significantly	|O
reduces	|O
the	|O
level	|O
of	|O
luciferase	|B-PROTEIN
reporter	|O
activity	|O
induced	|O
by	|O
nodal	|O
treatment	|O
.	|O

Normal	|O
alpha1	|B-PROTEIN
(	|I-PROTEIN
I	|I-PROTEIN
)	|I-PROTEIN
collagen	|I-PROTEIN
mRNA	|O
showed	|O
no	|O
significant	|O
reduction	|O
when	|O
AR	|O
or	|O
IR	|O
was	|O
expressed	|O
from	|O
the	|O
pHbetaAPr	|O
-	|O
1	|O
-	|O
neo	|O
vector	|O
and	|O
a	|O
small	|O
(	|O
10-20%	|O
)	|O
but	|O
significant	|O
reduction	|O
when	|O
either	|O
ribozyme	|O
was	|O
expressed	|O
from	|O
the	|O
pCI.n	|O
eo	|O
vector	|O
.	|O

Nature	|O
398	|O
,	|O
828-830	|O
)	|O
that	|O
the	|O
amino	|O
acid	|O
sequences	|O
of	|O
peptide	|O
fragments	|O
obtained	|O
from	|O
a	|O
polypeptide	|O
found	|O
in	|O
a	|O
complex	|O
of	|O
proteins	|O
that	|O
alters	|O
chromatin	|O
structure	|O
(	|O
ARC	|B-PROTEIN
)	|O
are	|O
identical	|O
to	|O
portions	|O
of	|O
the	|O
deduced	|O
open	|O
reading	|O
frame	|O
of	|O
TIG	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
mRNA	|O
.	|O

Abnormalities	|O
of	|O
plasma	|O
cholecystokinin	|B-PROTEIN
were	|O
observed	|O
only	|O
in	|O
patients	|O
with	|O
delayed	|O
gastric	|O
emptying	|O
.	|O

5	|O
(	|O
Sunset	|O
Yellow	|O
FCF	|O
)	|O
were	|O
determined	|O
using	|O
liquid	|O
chromatography	|O
/	|O
mass	|O
spectrometry	|O
(	|O
LC	|O
/	|O
MS	|O
)	|O
with	|O
electrospray	|O
ionization	|O
.	|O

Polysome	|O
and	|O
40S	|B-PROTEIN
ribosome	|O
fractions	|O
were	|O
severely	|O
decreased	|O
in	|O
the	|O
krr1	|B-PROTEIN
mutant	|O
and	|O
Kri1p	|B-PROTEIN
-	|O
depleted	|O
cells	|O
.	|O

They	|O
also	|O
negatively	|O
modulate	|O
the	|O
PI	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
catalytic	|O
activity	|O
but	|O
to	|O
different	|O
extents	|O
,	|O
dependent	|O
on	|O
the	|O
unique	|O
N	|O
-	|O
terminal	|O
structure	|O
of	|O
each	|O
isoform	|O
.	|O

Cam	|B-PROTEIN
kinase	|I-PROTEIN
II	|I-PROTEIN
induces	|O
in	|O
vivo	|O
phosphorylation	|O
of	|O
Smad2	|B-PROTEIN
and	|O
Smad4	|B-PROTEIN
and	|O
,	|O
to	|O
a	|O
lesser	|O
extent	|O
,	|O
Smad3	|B-PROTEIN
.	|O

The	|O
Drosophila	|O
melanogaster	|O
suppressor	|B-PROTEIN
of	|I-PROTEIN
sable	|I-PROTEIN
gene	|O
,	|O
su	|B-PROTEIN
(	|I-PROTEIN
s	|I-PROTEIN
)	|I-PROTEIN
,	|O
encodes	|O
a	|O
novel	|O
,	|O
150	|O
-	|O
kDa	|O
nuclear	|O
RNA	|O
binding	|O
protein	|O
,	|O
SU	|B-PROTEIN
(	|I-PROTEIN
S	|I-PROTEIN
)	|I-PROTEIN
,	|O
that	|O
negatively	|O
regulates	|O
RNA	|O
accumulation	|O
from	|O
mutant	|O
alleles	|O
of	|O
other	|O
genes	|O
that	|O
have	|O
transposon	|O
insertions	|O
in	|O
the	|O
5'	|O
transcribed	|O
region	|O
.	|O

As	|O
a	|O
result	|O
,	|O
we	|O
have	|O
defined	|O
two	|O
arginine	|O
-	|O
rich	|O
motifs	|O
(	|O
ARM1	|O
and	|O
ARM2	|O
)	|O
that	|O
mediate	|O
the	|O
RNA	|O
binding	|O
activity	|O
of	|O
SU	|B-PROTEIN
(	|I-PROTEIN
S	|I-PROTEIN
)	|I-PROTEIN
.	|O

This	|O
interaction	|O
inhibits	|O
the	|O
histone	|B-PROTEIN
acetyltransferase	|I-PROTEIN
activity	|O
of	|O
p300	|B-PROTEIN
,	|O
resulting	|O
in	|O
drastic	|O
reduction	|O
of	|O
nucleosomal	|O
histone	|B-PROTEIN
acetylation	|O
and	|O
alteration	|O
of	|O
chromatin	|O
structure	|O
.	|O

Recombinant	|O
BRI1	|B-PROTEIN
-	|I-PROTEIN
KD	|I-PROTEIN
autophosphorylated	|O
on	|O
serine	|O
(	|O
Ser	|O
)	|O
and	|O
threonine	|O
(	|O
Thr	|O
)	|O
residues	|O
with	|O
p	|O
-	|O
Ser	|O
predominating	|O
.	|O

Flow	|O
cytomery	|O
was	|O
used	|O
for	|O
cell	|O
cycle	|O
analysis	|O
.	|O

Further	|O
research	|O
is	|O
required	|O
to	|O
better	|O
measure	|O
treatment	|O
effects	|O
,	|O
modification	|O
of	|O
MS	|O
natural	|O
history	|O
,	|O
and	|O
net	|O
societal	|O
costs	|O
of	|O
IFN	|B-PROTEIN
beta	|I-PROTEIN
-	|I-PROTEIN
1b	|I-PROTEIN
in	|O
RRMS	|O
.	|O

Cost	|O
-	|O
effectiveness	|O
of	|O
interferon	|B-PROTEIN
beta	|I-PROTEIN
-	|I-PROTEIN
1b	|I-PROTEIN
in	|O
slowing	|O
multiple	|O
sclerosis	|O
disability	|O
progression	|O
.	|O

Both	|O
the	|O
Cmax	|O
and	|O
AUC	|O
values	|O
were	|O
almost	|O
doubled	|O
with	|O
doubling	|O
the	|O
dose	|O
.	|O

Hyperactivation	|O
of	|O
Cdc2	|B-PROTEIN
in	|O
fission	|O
yeast	|O
causes	|O
cells	|O
to	|O
undergo	|O
a	|O
lethal	|O
premature	|O
mitosis	|O
called	|O
mitotic	|O
catastrophe	|O
.	|O

Diary	|O
.	|O

Cells	|O
differentiate	|O
in	|O
response	|O
to	|O
various	|O
extracellular	|O
stimuli	|O
.	|O

Transforming	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
beta1	|I-PROTEIN
(	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta1	|I-PROTEIN
)	|O
can	|O
act	|O
as	|O
a	|O
tumor	|O
suppressor	|O
or	|O
a	|O
tumor	|O
promoter	|O
depending	|O
on	|O
the	|O
characteristics	|O
of	|O
the	|O
malignant	|O
cell	|O
.	|O

Vasoactive	|B-PROTEIN
intestinal	|I-PROTEIN
peptide	|I-PROTEIN
and	|O
pituitary	|B-PROTEIN
adenylate	|I-PROTEIN
cyclase	|I-PROTEIN
-	|I-PROTEIN
activating	|I-PROTEIN
polypeptide	|I-PROTEIN
inhibit	|O
nuclear	|B-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
-	|O
dependent	|O
gene	|O
activation	|O
at	|O
multiple	|O
levels	|O
in	|O
the	|O
human	|O
monocytic	|O
cell	|O
line	|O
THP	|O
-	|O
1	|O
.	|O

Mn2+	|O
increased	|O
both	|O
the	|O
junction	|O
binding	|O
and	|O
cleaving	|O
activities	|O
of	|O
the	|O
mutant	|O
proteins	|O
.	|O

While	|O
Pt	|B-PROTEIN
;	|I-PROTEIN
cycH	|I-PROTEIN
;	|I-PROTEIN
1	|I-PROTEIN
and	|O
Os	|B-PROTEIN
;	|I-PROTEIN
cycH	|I-PROTEIN
;	|I-PROTEIN
1	|I-PROTEIN
were	|O
expressed	|O
in	|O
all	|O
tissues	|O
examined	|O
,	|O
the	|O
transcripts	|O
accumulated	|O
abundantly	|O
in	|O
dividing	|O
cells	|O
.	|O

Moreover	|O
,	|O
an	|O
in	|O
vitro	|O
pull	|O
-	|O
down	|O
assay	|O
showed	|O
that	|O
Os	|B-PROTEIN
;	|I-PROTEIN
CycH	|I-PROTEIN
;	|I-PROTEIN
1	|I-PROTEIN
specifically	|O
bound	|O
to	|O
R2	|B-PROTEIN
but	|O
not	|O
to	|O
other	|O
rice	|O
CDKs	|B-PROTEIN
.	|O

In	|O
transient	|O
analysis	|O
using	|O
particle	|O
bombardment	|O
of	|O
tobacco	|O
leaf	|O
sections	|O
,	|O
a	|O
tetramer	|O
of	|O
the	|O
distB	|O
ABRE	|O
(	|O
abscisic	|O
acid	|O
-	|O
responsive	|O
element	|O
)	|O
mediated	|O
transactivation	|O
by	|O
ABI3	|B-PROTEIN
and	|O
ABI3	|B-PROTEIN
-	|O
dependent	|O
response	|O
to	|O
ABA	|O
,	|O
whereas	|O
a	|O
tetramer	|O
of	|O
the	|O
composite	|O
RY	|O
/	|O
G	|O
complex	|O
,	|O
containing	|O
RY	|O
repeats	|O
and	|O
a	|O
G	|O
-	|O
box	|O
,	|O
mediated	|O
only	|O
ABA	|O
-	|O
independent	|O
transactivation	|O
by	|O
ABI3	|B-PROTEIN
.	|O

The	|O
major	|O
neurological	|O
manifestations	|O
of	|O
brain	|O
injury	|O
in	|O
these	|O
babies	|O
are	|O
spastic	|O
motor	|O
deficits	|O
.	|O

Spores	|O
from	|O
Rhizopus	|O
stolonifer	|O
were	|O
suspended	|O
in	|O
distilled	|O
water	|O
(	|O
1	|O
x	|O
10	|O
(	|O
6	|O
)	|O
spores	|O
/	|O
mL	|O
)	|O
and	|O
used	|O
as	|O
starter	|O
.	|O

Overexpression	|O
of	|O
Trdpm1	|B-PROTEIN
in	|O
a	|O
dpm1	|B-PROTEIN
(	|O
+	|O
)	|O
::	|O
his7	|B-PROTEIN
/	|I-PROTEIN
dpm1	|I-PROTEIN
(	|O
+	|O
)	|O
S.p	|O
ombe	|O
diploid	|O
resulted	|O
in	|O
a	|O
4	|O
-	|O
fold	|O
increase	|O
in	|O
specific	|O
DPM	|B-PROTEIN
synthase	|I-PROTEIN
activity	|O
.	|O

The	|O
LMW	|O
FGF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
up	|O
-	|O
regulated	|O
the	|O
PKC	|B-PROTEIN
epsilon	|O
levels	|O
by	|O
1.6	|O
-	|O
fold	|O
;	|O
by	|O
contrast	|O
the	|O
HMW	|B-PROTEIN
isoform	|O
down	|O
-	|O
regulated	|O
the	|O
level	|O
of	|O
this	|O
PKC	|B-PROTEIN
isotype	|O
by	|O
about	|O
3	|O
-	|O
fold	|O
and	|O
increased	|O
the	|O
amount	|O
of	|O
PKC	|B-PROTEIN
delta	|O
by	|O
1.7	|O
-	|O
fold	|O
.	|O

Helicobacter	|O
pylori	|O
and	|O
stomach	|O
diseases	|O
:	|O
from	|O
clinical	|O
point	|O
of	|O
view	|O

For	|O
this	|O
purpose	|O
,	|O
the	|O
writhing	|O
test	|O
,	|O
capsaicin	|O
and	|O
formalin	|O
induced	|O
-	|O
pain	|O
in	|O
mice	|O
were	|O
used	|O
.	|O

2000	|O
update	|O
of	|O
recommendations	|O
for	|O
the	|O
use	|O
of	|O
hematopoietic	|B-PROTEIN
colony	|I-PROTEIN
-	|I-PROTEIN
stimulating	|I-PROTEIN
factors	|I-PROTEIN
:	|O
evidence	|O
-	|O
based	|O
,	|O
clinical	|O
practice	|O
guidelines	|O
.	|O

Prominent	|O
findings	|O
were	|O
chronic	|O
pancreatitis	|O
with	|O
acinar	|O
and	|O
ductal	|O
plugs	|O
,	|O
granulomatous	|O
and	|O
necrotizing	|O
peripancreatic	|O
steatitis	|O
,	|O
degenerative	|O
myopathy	|O
,	|O
testicular	|O
atrophy	|O
,	|O
candidiasis	|O
and	|O
bacterial	|O
necrotizing	|O
glossitis	|O
.	|O

Taken	|O
together	|O
,	|O
our	|O
data	|O
indicate	|O
that	|O
multiple	|O
survival	|O
pathways	|O
are	|O
triggered	|O
via	|O
this	|O
receptor	|O
,	|O
whereas	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
/	|O
Rel	|B-PROTEIN
and	|O
PI	|B-PROTEIN
-	|I-PROTEIN
3K	|I-PROTEIN
are	|O
crucial	|O
for	|O
CD40	|B-PROTEIN
-	|O
induced	|O
proliferation	|O
.	|O

In	|O
vitro	|O
,	|O
Arix	|B-PROTEIN
and	|O
NBPhox	|B-PROTEIN
form	|O
DNA	|O
-	|O
independent	|O
multimers	|O
and	|O
exhibit	|O
cooperative	|O
binding	|O
to	|O
the	|O
DB1	|B-PROTEIN
regulatory	|O
element	|O
,	|O
which	|O
contains	|O
two	|O
homeodomain	|B-PROTEIN
recognition	|O
sites	|O
.	|O

We	|O
conclude	|O
from	|O
this	|O
study	|O
that	|O
Arix	|B-PROTEIN
and	|O
NBPhox	|B-PROTEIN
exhibit	|O
indistinguishable	|O
and	|O
independent	|O
transcriptional	|O
regulatory	|O
properties	|O
on	|O
the	|O
DBH	|B-PROTEIN
promoter	|O
.	|O

METHODS	|O
AND	|O
RESULTS	|O
:	|O
Studies	|O
were	|O
undertaken	|O
in	|O
9	|O
isolated	|O
guinea	|O
pig	|O
hearts	|O
,	|O
which	|O
demonstrated	|O
reverse	|O
use	|O
-	|O
dependent	|O
prolongation	|O
of	|O
cardiac	|O
repolarization	|O
by	|O
100	|O
nmol	|O
/	|O
L	|O
domperidone	|O
.	|O

The	|O
N	|O
-	|O
terminal	|O
small	|O
segment	|O
of	|O
yeast	|O
TAF145	|B-PROTEIN
(	|O
yTAF145	|B-PROTEIN
)	|O
binds	|O
to	|O
TBP	|B-PROTEIN
and	|O
thereby	|O
inhibits	|O
TBP	|B-PROTEIN
function	|O
.	|O

OBJECTIVE	|O
:	|O
To	|O
evaluate	|O
the	|O
overall	|O
performance	|O
of	|O
a	|O
new	|O
oscillometric	|O
wrist	|O
blood	|O
pressure	|O
monitor	|O
(	|O
Braun	|O
PrecisionSensor	|O
,	|O
Braun	|O
GmbH	|O
,	|O
Kronberg	|O
,	|O
Germany	|O
)	|O
as	|O
defined	|O
by	|O
the	|O
ANSI	|O
/	|O
AAMI	|O
SP10	|O
-	|O
1992	|O
guidelines	|O
,	|O
and	|O
to	|O
analyze	|O
the	|O
data	|O
for	|O
the	|O
optimized	|O
selection	|O
of	|O
the	|O
algorithm	|O
that	|O
derives	|O
the	|O
blood	|O
pressure	|O
values	|O
from	|O
the	|O
oscillometric	|O
blood	|O
pressure	|O
curves	|O
.	|O

Following	|O
the	|O
results	|O
of	|O
toxicological	|O
experiments	|O
in	|O
the	|O
target	|O
animals	|O
"	|O
Toxicological	|O
Drinking	|O
Water	|O
Standards	|O
for	|O
Animals	|O
"	|O
can	|O
be	|O
established	|O
.	|O

An	|O
increase	|O
in	|O
hypothalamic	|O
expression	|O
of	|O
at	|O
least	|O
two	|O
of	|O
the	|O
erbB	|B-PROTEIN
receptors	|I-PROTEIN
is	|O
initiated	|O
before	|O
the	|O
pubertal	|O
augmentation	|O
of	|O
gonadal	|O
steroid	|O
secretion	|O
and	|O
is	|O
completed	|O
on	|O
the	|O
day	|O
of	|O
the	|O
first	|O
preovulatory	|O
surge	|O
of	|O
gonadotropins	|B-PROTEIN
.	|O

Dsh	|B-PROTEIN
is	|O
required	|O
for	|O
two	|O
different	|O
pathways	|O
,	|O
the	|O
Wnt	|B-PROTEIN
pathway	|O
and	|O
planar	|O
polarity	|O
pathway	|O
in	|O
Drosophila	|O
.	|O

Catch	|O
-	|O
up	|O
growth	|O
and	|O
craniofacial	|O
dimensions	|O
following	|O
administration	|O
of	|O
the	|O
antineoplastic	|O
agent	|O
vincristine	|O
to	|O
young	|O
rats	|O
.	|O

CONCLUSIONS	|O
:	|O
LSCC	|O
malformation	|O
,	|O
like	|O
other	|O
inner	|O
ear	|O
malformations	|O
such	|O
as	|O
large	|O
vestibular	|O
aqueduct	|O
and	|O
X	|O
-	|O
linked	|O
mixed	|O
deafness	|O
with	|O
perilymph	|O
gusher	|O
,	|O
can	|O
be	|O
associated	|O
with	|O
CHL	|O
,	|O
SNHL	|O
,	|O
or	|O
normal	|O
hearing	|O
.	|O

Escalation	|O
to	|O
180	|O
mg	|O
/	|O
m2	|O
was	|O
to	|O
be	|O
carried	|O
out	|O
if	|O
white	|O
blood	|O
cell	|O
nadir	|O
count	|O
was	|O
>	|O
2.0	|O
x	|O
10	|O
(	|O
9	|O
)	|O
/	|O
l	|O
and	|O
platelet	|O
nadir	|O
count	|O
was	|O
>	|O
75	|O
x	|O
10	|O
(	|O
9	|O
)	|O
/	|O
l	|O
.	|O

Methyl	|O
formate	|O
was	|O
used	|O
as	|O
the	|O
solvent	|O
of	|O
biodegradable	|O
oligoesters	|O
for	|O
the	|O
fabrication	|O
of	|O
microspheres	|O
with	|O
encapsulated	|O
bovine	|B-PROTEIN
serum	|I-PROTEIN
albumin	|I-PROTEIN
(	|O
BSA	|B-PROTEIN
)	|O
.	|O

The	|O
small	|O
monomeric	|O
GTP	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
proteins	|I-PROTEIN
of	|O
the	|O
RAB	|B-PROTEIN
subfamily	|O
are	|O
key	|O
regulatory	|O
elements	|O
of	|O
the	|O
machinery	|O
that	|O
controls	|O
membrane	|O
traffic	|O
in	|O
eukaryotic	|O
cells	|O
.	|O

Furthermore	|O
,	|O
loss	|O
of	|O
methylation	|O
also	|O
greatly	|O
reduced	|O
the	|O
association	|O
of	|O
another	|O
yeast	|O
B	|O
-	|O
type	|O
subunit	|O
,	|O
Rts1p	|B-PROTEIN
.	|O

Thus	|O
,	|O
methylation	|O
of	|O
Pph21p	|B-PROTEIN
is	|O
important	|O
for	|O
formation	|O
of	|O
PP2A	|B-PROTEIN
trimeric	|O
and	|O
dimeric	|O
complexes	|O
,	|O
and	|O
consequently	|O
,	|O
for	|O
PP2A	|B-PROTEIN
function	|O
.	|O

The	|O
purpose	|O
of	|O
this	|O
study	|O
was	|O
to	|O
analyze	|O
the	|O
temporal	|O
characteristics	|O
and	|O
the	|O
spatial	|O
mapping	|O
of	|O
the	|O
independent	|O
components	|O
identified	|O
by	|O
ICA	|O
when	|O
the	|O
subject	|O
performs	|O
a	|O
finger	|O
-	|O
tapping	|O
task	|O
.	|O

The	|O
authors	|O
present	|O
the	|O
only	|O
two	|O
studies	|O
that	|O
have	|O
proved	|O
successful	|O
in	|O
treating	|O
animal	|O
models	|O
of	|O
osteoarthritis	|O
using	|O
gene	|O
therapy	|O
,	|O
and	|O
propose	|O
an	|O
overview	|O
of	|O
several	|O
strategies	|O
for	|O
the	|O
development	|O
of	|O
gene	|O
therapy	|O
in	|O
osteoarthritis	|O
treatment	|O
in	|O
the	|O
future	|O
.	|O

Together	|O
,	|O
these	|O
results	|O
indicate	|O
that	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
beta	|I-PROTEIN
induces	|O
VEGF	|B-PROTEIN
gene	|O
expression	|O
at	|O
both	|O
transcriptional	|O
and	|O
post	|O
-	|O
transcriptional	|O
levels	|O
,	|O
and	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
beta	|I-PROTEIN
evokes	|O
p38	|B-PROTEIN
MAPK	|O
and	|O
JNK	|B-PROTEIN
signalings	|O
,	|O
which	|O
in	|O
turn	|O
stimulate	|O
the	|O
transcription	|O
of	|O
the	|O
VEGF	|B-PROTEIN
gene	|O
through	|O
Sp1	|B-PROTEIN
-	|O
binding	|O
sites	|O
.	|O

Binding	|O
of	|O
NusA	|B-PROTEIN
to	|O
RNA	|O
in	|O
the	|O
presence	|O
of	|O
alpha	|O
or	|O
N	|O
involves	|O
an	|O
amino	|O
-	|O
terminal	|O
S1	|B-PROTEIN
homology	|O
region	|O
that	|O
is	|O
otherwise	|O
inactive	|O
in	|O
full	|O
-	|O
length	|O
NusA	|B-PROTEIN
.	|O

The	|O
subjects	|O
were	|O
diagnosed	|O
on	|O
the	|O
basis	|O
of	|O
DSM	|O
-	|O
IV	|O
pathological	|O
gambling	|O
criteria	|O
and	|O
completed	|O
the	|O
Turkish	|O
Version	|O
of	|O
South	|O
Oaks	|O
Gambling	|O
Screen	|O
(	|O
SOGS	|O
)	|O
.	|O

Lys	|O
(	|O
193	|O
)	|O
and	|O
Arg	|O
(	|O
194	|O
)	|O
,	|O
located	|O
at	|O
the	|O
COOH	|O
-	|O
terminal	|O
end	|O
of	|O
HD	|B-PROTEIN
,	|O
are	|O
essential	|O
for	|O
dimerization	|O
.	|O

Elevation	|O
of	|O
intracellular	|O
Ca	|O
(	|O
2+	|O
)	|O
levels	|O
are	|O
also	|O
involved	|O
because	|O
treatment	|O
with	|O
receptor	|O
-	|O
associated	|O
protein	|O
,	|O
nifedipine	|O
,	|O
MK801	|O
,	|O
removal	|O
of	|O
Ca	|O
(	|O
2+	|O
)	|O
from	|O
the	|O
medium	|O
and	|O
dantrolene	|O
all	|O
served	|O
to	|O
inhibit	|O
calcium	|O
elevation	|O
and	|O
attenuate	|O
the	|O
activation	|O
of	|O
CREB	|B-PROTEIN
.	|O

The	|O
present	|O
study	|O
shows	|O
that	|O
phosphatidylinositol	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
-	|O
dependent	|O
p38	|B-PROTEIN
kinase	|O
activation	|O
regulates	|O
Akt	|B-PROTEIN
phosphorylation	|O
and	|O
activity	|O
in	|O
human	|O
neutrophils	|O
.	|O

When	|O
BFDS	|O
was	|O
taken	|O
as	|O
the	|O
reference	|O
,	|O
W	|O
/	|O
A	|O
Z	|O
scores	|O
showed	|O
consistent	|O
positive	|O
increments	|O
,	|O
from	|O
birth	|O
in	|O
girls	|O
and	|O
1	|O
mo	|O
in	|O
boys	|O
.	|O

These	|O
probable	|O
border	|O
sequences	|O
are	|O
closely	|O
related	|O
to	|O
those	|O
of	|O
other	|O
known	|O
T	|O
-	|O
regions	|O
and	|O
define	|O
a	|O
second	|O
T	|O
-	|O
region	|O
of	|O
pTiChry5	|O
,	|O
called	|O
T	|O
-	|O
right	|O
(	|O
TR	|O
)	|O
,	|O
that	|O
confers	|O
production	|O
of	|O
the	|O
Amadoriopines	|O
.	|O

Using	|O
purified	|O
recombinant	|O
HMG	|B-PROTEIN
I	|I-PROTEIN
,	|O
we	|O
have	|O
identified	|O
several	|O
high	|O
-	|O
affinity	|O
binding	|O
sites	|O
which	|O
overlap	|O
important	|O
transcription	|O
factor	|O
binding	|O
sites	|O
.	|O

High	|B-PROTEIN
-	|I-PROTEIN
mobility	|I-PROTEIN
-	|I-PROTEIN
group	|I-PROTEIN
protein	|I-PROTEIN
I	|I-PROTEIN
can	|O
modulate	|O
binding	|O
of	|O
transcription	|O
factors	|O
to	|O
the	|O
U5	|B-PROTEIN
region	|O
of	|O
the	|O
human	|B-PROTEIN
immunodeficiency	|I-PROTEIN
virus	|I-PROTEIN
type	|I-PROTEIN
1	|I-PROTEIN
proviral	|I-PROTEIN
promoter	|I-PROTEIN
.	|O

Another	|O
cis	|O
-	|O
acting	|O
element	|O
,	|O
exonic	|O
splicing	|O
suppressor	|O
1	|O
(	|O
ESS1	|O
)	|O
,	|O
represses	|O
use	|O
of	|O
the	|O
nt	|O
3225	|O
3'	|O
splice	|O
site	|O
.	|O

Leptinaemia	|O
does	|O
not	|O
correlate	|O
with	|O
the	|O
actual	|O
or	|O
mean	|O
blood	|O
pressure	|O
reading	|O
nor	|O
with	|O
stage	|O
of	|O
hypertension	|O
according	|O
to	|O
the	|O
WHO	|O
classification	|O
.	|O

5'	|O
-	|O
RACE	|O
analysis	|O
suggested	|O
a	|O
single	|O
transcription	|O
initiation	|O
site	|O
187	|O
bp	|O
upstream	|O
from	|O
the	|O
translational	|O
start	|O
site	|O
.	|O

Thus	|O
,	|O
diamide	|O
treatment	|O
of	|O
nuclear	|O
extracts	|O
strongly	|O
reduces	|O
the	|O
binding	|O
of	|O
NFI	|B-PROTEIN
proteins	|O
,	|O
and	|O
the	|O
addition	|O
of	|O
higher	|O
concentrations	|O
of	|O
dithiothreitol	|O
to	|O
nuclear	|O
extracts	|O
from	|O
TG	|B-PROTEIN
-	|O
treated	|O
cells	|O
restores	|O
NFI	|B-PROTEIN
-	|I-PROTEIN
DNA	|I-PROTEIN
binding	|O
to	|O
levels	|O
in	|O
extracts	|O
from	|O
untreated	|O
cells	|O
.	|O

LMP2A	|B-PROTEIN
enhances	|O
Lyn	|B-PROTEIN
and	|O
Syk	|B-PROTEIN
ubiquitination	|O
in	|O
vivo	|O
in	|O
a	|O
fashion	|O
that	|O
depends	|O
on	|O
the	|O
activity	|O
of	|O
Nedd4	|B-PROTEIN
family	|O
members	|O
and	|O
correlates	|O
with	|O
destabilization	|O
of	|O
the	|O
Lyn	|B-PROTEIN
tyrosine	|I-PROTEIN
kinase	|I-PROTEIN
.	|O

Further	|O
,	|O
Tax	|B-PROTEIN
-	|O
mediated	|O
apoptosis	|O
was	|O
effectively	|O
prevented	|O
by	|O
ectopic	|O
expression	|O
of	|O
the	|O
p300	|B-PROTEIN
coactivator	|O
.	|O

Our	|O
results	|O
,	|O
however	|O
,	|O
were	|O
obtained	|O
for	|O
Z	|O
itself	|O
and	|O
not	|O
for	|O
[	|O
Z	|O
]	|O
.	|O

Fisher	|O
's	|O
exact	|O
test	|O
or	|O
Pearson	|O
's	|O
chi2	|O
test	|O
were	|O
used	|O
for	|O
statistical	|O
analysis	|O
.	|O

RESULTS	|O
:	|O
In	|O
the	|O
pregnant	|O
group	|O
,	|O
serum	|O
PP14	|B-PROTEIN
concentrations	|O
were	|O
markedly	|O
increased	|O
after	|O
ET	|O
,	|O
and	|O
a	|O
significant	|O
difference	|O
between	|O
the	|O
pregnant	|O
group	|O
and	|O
the	|O
nonpregnant	|O
group	|O
was	|O
observed	|O
8	|O
days	|O
following	|O
ET	|O
(	|O
p	|O
<	|O
0.01	|O
)	|O
.	|O

Thromboelastography	|O
is	|O
a	|O
test	|O
that	|O
could	|O
potentially	|O
correlate	|O
with	|O
the	|O
degree	|O
of	|O
anticoagulation	|O
produced	|O
by	|O
low	|O
molecular	|O
weight	|O
heparin	|O
.	|O

High	|O
expression	|O
of	|O
the	|O
peroxisome	|B-PROTEIN
proliferator	|I-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
receptor	|I-PROTEIN
alpha	|I-PROTEIN
(	|O
PPARalpha	|B-PROTEIN
)	|O
differentiates	|O
brown	|O
fat	|O
from	|O
white	|O
,	|O
and	|O
is	|O
related	|O
to	|O
its	|O
high	|O
capacity	|O
of	|O
lipid	|O
oxidation	|O
.	|O

This	|O
-	|O
2485	|O
/	|O
-	|O
2458	|O
element	|O
bound	|O
PPARalpha	|B-PROTEIN
and	|O
PPARgamma	|B-PROTEIN
from	|O
brown	|O
fat	|O
nuclei	|O
.	|O

These	|O
results	|O
provide	|O
direct	|O
evidence	|O
for	|O
differential	|O
susceptibility	|O
to	|O
endonuclease	|O
-	|O
mediated	|O
mRNA	|O
decay	|O
resulting	|O
from	|O
the	|O
differential	|O
affinity	|O
of	|O
a	|O
RNA	|O
-	|O
binding	|O
protein	|O
for	|O
cis	|O
-	|O
acting	|O
stability	|O
determinants	|O
.	|O

RESULTS	|O
:	|O
Twenty	|O
-	|O
two	|O
(	|O
26%	|O
)	|O
patients	|O
had	|O
PHG	|O
before	|O
(	|O
group	|O
A	|O
)	|O
and	|O
64	|O
(	|O
74%	|O
)	|O
developed	|O
PHG	|O
after	|O
variceal	|O
eradication	|O
(	|O
group	|O
B	|O
)	|O
.	|O

Response	|O
was	|O
extremely	|O
poor	|O
in	|O
African	|O
Americans	|O
and	|O
those	|O
with	|O
HCV	|O
genotype	|O
1	|O
.	|O

Aspirin	|O
causes	|O
peptic	|O
ulcers	|O
predominately	|O
by	|O
reducing	|O
gastric	|O
mucosal	|O
cyclooxygenase	|B-PROTEIN
(	|O
COX	|B-PROTEIN
)	|O
activity	|O
and	|O
prostaglandin	|O
synthesis	|O
.	|O

A	|O
total	|O
of	|O
1060	|O
clones	|O
were	|O
randomly	|O
selected	|O
for	|O
sequencing	|O
of	|O
one	|O
end	|O
.	|O

Expression	|O
of	|O
a	|O
hybrid	|O
protein	|O
containing	|O
the	|O
cytoplasmic	|O
C	|O
-	|O
terminal	|O
half	|O
of	|O
UhpB	|B-PROTEIN
fused	|O
to	|O
glutathione	|B-PROTEIN
S	|I-PROTEIN
-	|I-PROTEIN
transferase	|I-PROTEIN
(	|O
GST	|B-PROTEIN
)	|O
also	|O
interfered	|O
with	|O
Uhp	|B-PROTEIN
signaling	|O
.	|O

CONCLUSIONS	|O
:	|O
The	|O
surgical	|O
or	|O
multimodality	|O
treatment	|O
of	|O
MSGT	|O
has	|O
provided	|O
a	|O
good	|O
locoregional	|O
control	|O
(	|O
78%	|O
)	|O
and	|O
68%	|O
10	|O
-	|O
year	|O
survival	|O
in	|O
a	|O
series	|O
of	|O
patients	|O
treated	|O
at	|O
the	|O
oncology	|O
department	|O
of	|O
a	|O
general	|O
hospital	|O
in	|O
Quito	|O
,	|O
Ecuador	|O
.	|O

RESULTS	|O
:	|O
Glaucoma	|O
suspects	|O
were	|O
divided	|O
into	|O
two	|O
groups	|O
according	|O
to	|O
their	|O
SWAP	|O
results	|O
:	|O
high	|O
risk	|O
(	|O
with	|O
SWAP	|O
abnormalities	|O
)	|O
and	|O
low	|O
risk	|O
(	|O
with	|O
normal	|O
SWAP	|O
result	|O
)	|O
.	|O

The	|O
gene	|O
is	|O
separated	|O
into	|O
four	|O
exons	|O
by	|O
three	|O
short	|O
introns	|O
,	|O
and	|O
the	|O
open	|O
reading	|O
frame	|O
consists	|O
of	|O
6660	|O
base	|O
pairs	|O
(	|O
bp	|O
)	|O
capable	|O
of	|O
encoding	|O
a	|O
polypeptide	|O
of	|O
2220	|O
amino	|O
acid	|O
residues	|O
.	|O

Like	|O
the	|O
p190	|B-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
exon	|O
,	|O
the	|O
first	|O
exon	|O
of	|O
p190	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
is	|O
extremely	|O
large	|O
(	|O
3.7	|O
kb	|O
in	|O
length	|O
)	|O
,	|O
encoding	|O
both	|O
the	|O
GTPase	|B-PROTEIN
and	|O
middle	|O
domains	|O
(	|O
residues	|O
1-1228	|O
)	|O
,	|O
but	|O
not	|O
the	|O
remaining	|O
GAP	|B-PROTEIN
domain	|O
,	|O
suggesting	|O
a	|O
high	|O
conservation	|O
of	|O
genomic	|O
structure	|O
between	|O
two	|O
p190	|B-PROTEIN
genes	|O
.	|O

The	|O
entire	|O
human	|O
teneurin	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
(	|O
TEN1	|B-PROTEIN
)	|O
gene	|O
is	|O
contained	|O
in	|O
eight	|O
PAC	|O
clones	|O
representing	|O
part	|O
of	|O
the	|O
chromosomal	|O
locus	|O
Xq25	|O
.	|O

The	|O
plexiform	|O
neurofibroma	|O
and	|O
multiple	|O
localized	|O
neurofibromas	|O
are	|O
characteristic	|O
of	|O
NF1	|B-PROTEIN
.	|O

In	|O
general	|O
lookback	|O
,	|O
all	|O
patients	|O
who	|O
received	|O
blood	|O
before	|O
being	|O
tested	|O
for	|O
hepatitis	|O
C	|O
are	|O
advised	|O
to	|O
undergo	|O
testing	|O
.	|O

The	|O
proposed	|O
algorithm	|O
consists	|O
of	|O
several	|O
steps	|O
.	|O

It	|O
contained	|O
seven	|O
extra	|O
amino	|O
acids	|O
of	|O
FVVLNLQ	|O
;	|O
this	|O
short	|O
stretch	|O
of	|O
extra	|O
sequence	|O
was	|O
found	|O
between	|O
Gln	|O
(	|O
421	|O
)	|O
and	|O
Phe	|O
(	|O
422	|O
)	|O
within	|O
the	|O
SET	|B-PROTEIN
(	|O
Suvar3	|B-PROTEIN
-	|I-PROTEIN
9	|I-PROTEIN
,	|O
Enhancer	|B-PROTEIN
-	|I-PROTEIN
of	|I-PROTEIN
-	|I-PROTEIN
zeste	|I-PROTEIN
,	|O
Trithorax	|B-PROTEIN
)	|O
interacting	|O
domain	|O
(	|O
SID	|O
)	|O
of	|O
rMTM	|B-PROTEIN
.	|O

MED1	|B-PROTEIN
has	|O
a	|O
weak	|O
glycosylase	|B-PROTEIN
activity	|O
on	|O
the	|O
mutagenic	|O
adduct	|O
3	|O
,	|O
N	|O
(	|O
4	|O
)	|O
-	|O
ethenocytosine	|O
,	|O
a	|O
metabolite	|O
of	|O
vinyl	|O
chloride	|O
and	|O
ethyl	|O
carbamate	|O
.	|O

There	|O
were	|O
no	|O
instances	|O
of	|O
major	|O
flap	|O
necrosis	|O
although	|O
two	|O
flaps	|O
showed	|O
tip	|O
ischaemia	|O
.	|O

These	|O
results	|O
suggest	|O
that	|O
XAB1	|B-PROTEIN
is	|O
a	|O
novel	|O
cytoplasmic	|O
GTPase	|B-PROTEIN
involved	|O
in	|O
nuclear	|O
localization	|O
of	|O
XPA	|B-PROTEIN
.	|O

One	|O
of	|O
these	|O
factors	|O
,	|O
IRF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
,	|O
was	|O
initially	|O
cloned	|O
as	|O
an	|O
antagonistic	|O
counterpart	|O
to	|O
IRF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
with	|O
oncogenic	|O
potential	|O
.	|O

Among	|O
the	|O
total	|O
CDSs	|O
,	|O
8.8%	|O
match	|O
sequences	|O
of	|O
proteins	|O
found	|O
only	|O
in	|O
Bacillus	|O
subtilis	|O
and	|O
66.7%	|O
are	|O
widely	|O
conserved	|O
in	|O
comparison	|O
with	|O
the	|O
proteins	|O
of	|O
various	|O
organisms	|O
,	|O
including	|O
B.s	|O
ubtilis	|O
.	|O

Tobramycin	|O
-	|O
loaded	|O
SLN	|O
administered	|O
i.v	|O
.	|O
showed	|O
a	|O
prolonged	|O
circulation	|O
time	|O
compared	|O
to	|O
the	|O
i.v	|O
.	|O
administered	|O
tobramycin	|O
solution	|O
.	|O

Bacteriol	|O
.	|O

Terminal	|B-PROTEIN
deoxynucleotidyl	|I-PROTEIN
transferase	|I-PROTEIN
-	|O
mediated	|O
nick	|O
end	|O
labeling	|O
assays	|O
revealed	|O
that	|O
hormonal	|O
activation	|O
of	|O
the	|O
PAX3	|B-PROTEIN
repressors	|O
induced	|O
extensive	|O
apoptosis	|O
that	|O
correlated	|O
with	|O
down	|O
-	|O
regulation	|O
of	|O
BCL	|B-PROTEIN
-	|I-PROTEIN
X	|I-PROTEIN
(	|I-PROTEIN
L	|I-PROTEIN
)	|I-PROTEIN
expression	|O
.	|O

VEGF	|B-PROTEIN
promoter	|O
activity	|O
in	|O
transient	|O
transfections	|O
was	|O
decreased	|O
by	|O
either	|O
pharmacological	|O
or	|O
genetic	|O
inhibition	|O
of	|O
EGFR	|B-PROTEIN
,	|O
Ras	|B-PROTEIN
,	|O
or	|O
phosphatidylinositol	|B-PROTEIN
3'	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
[	|O
PI	|B-PROTEIN
(	|I-PROTEIN
3	|I-PROTEIN
)	|I-PROTEIN
kinase	|I-PROTEIN
]	|O
.	|O

Epidermal	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
receptor	|I-PROTEIN
transcriptionally	|O
up	|O
-	|O
regulates	|O
vascular	|B-PROTEIN
endothelial	|I-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
expression	|O
in	|O
human	|O
glioblastoma	|O
cells	|O
via	|O
a	|O
pathway	|O
involving	|O
phosphatidylinositol	|B-PROTEIN
3'	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
and	|O
distinct	|O
from	|O
that	|O
induced	|O
by	|O
hypoxia	|O
.	|O

Thus	|O
,	|O
IHHNV	|O
is	|O
closely	|O
related	|O
to	|O
densoviruses	|O
of	|O
the	|O
genus	|O
Brevidensovirus	|O
in	|O
the	|O
family	|O
Parvoviridae	|O
,	|O
and	|O
we	|O
therefore	|O
propose	|O
to	|O
rename	|O
this	|O
virus	|O
Penaeus	|O
stylirostris	|O
densovirus	|O
(	|O
PstDNV	|O
)	|O
.	|O

Stress	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
1	|I-PROTEIN
(	|O
SAPK1	|B-PROTEIN
)	|O
,	|O
also	|O
called	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
N	|I-PROTEIN
-	|I-PROTEIN
terminal	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
JNK	|B-PROTEIN
)	|O
,	|O
becomes	|O
activated	|O
in	|O
vivo	|O
in	|O
response	|O
to	|O
pro	|O
-	|O
inflammatory	|O
cytokines	|O
or	|O
cellular	|O
stresses	|O
.	|O

Catalytic	|O
activation	|O
of	|O
mitogen	|O
-	|O
activated	|O
protein	|O
(	|B-PROTEIN
MAP	|I-PROTEIN
)	|I-PROTEIN
kinase	|I-PROTEIN
phosphatase	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
by	|O
binding	|O
to	|O
p38	|B-PROTEIN
MAP	|O
kinase	|O
:	|O
critical	|O
role	|O
of	|O
the	|O
p38	|B-PROTEIN
C	|O
-	|O
terminal	|O
domain	|O
in	|O
its	|O
negative	|O
regulation	|O
.	|O

Thus	|O
,	|O
the	|O
class	|B-PROTEIN
C	|I-PROTEIN
-	|O
Vps	|B-PROTEIN
complex	|O
directs	|O
multiple	|O
reactions	|O
during	|O
the	|O
docking	|O
and	|O
fusion	|O
of	|O
vesicles	|O
with	|O
the	|O
vacuole	|O
,	|O
each	|O
of	|O
which	|O
contributes	|O
to	|O
the	|O
overall	|O
specificity	|O
and	|O
efficiency	|O
of	|O
this	|O
transport	|O
process	|O
.	|O

Combined	|O
intravenous	|O
and	|O
intra	|O
-	|O
arterial	|O
recombinant	|O
tissue	|B-PROTEIN
plasminogen	|I-PROTEIN
activator	|I-PROTEIN
in	|O
acute	|O
ischemic	|O
stroke	|O
.	|O

To	|O
begin	|O
to	|O
understand	|O
this	|O
role	|O
,	|O
we	|O
overexpressed	|O
ATF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
in	|O
a	|O
human	|O
cancer	|O
cell	|O
line	|O
.	|O

Signal	|O
transduction	|O
via	|O
modulation	|O
of	|O
phosphorylation	|O
after	|O
selective	|O
inhibition	|O
of	|O
protein	|O
phosphatase	|O
(	|B-PROTEIN
PP	|I-PROTEIN
)	|I-PROTEIN
1	|I-PROTEIN
and	|O
/	|O
or	|O
PP2A	|B-PROTEIN
appears	|O
to	|O
play	|O
a	|O
role	|O
in	|O
okadaic	|O
acid	|O
(	|O
OA	|O
)	|O
-	|O
mediated	|O
effects	|O
.	|O

Botulinum	|B-PROTEIN
toxin	|I-PROTEIN
A	|I-PROTEIN
in	|O
the	|O
treatment	|O
of	|O
hemiplegic	|O
spastic	|O
foot	|O
drop	|O
-	|O
-	|O
clinical	|O
and	|O
functional	|O
outcomes	|O
.	|O

Exon	|O
A	|O
is	|O
located	|O
approximately	|O
7	|O
kb	|O
5'	|O
to	|O
the	|O
HSL	|B-PROTEIN
translation	|O
start	|O
site	|O
.	|O

NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
is	|O
a	|O
redox	|O
-	|O
sensitive	|O
transcription	|O
factor	|O
known	|O
to	|O
be	|O
activated	|O
by	|O
oxidative	|O
stress	|O
as	|O
well	|O
as	|O
chemical	|O
and	|O
biological	|O
reductants	|O
.	|O

Cardiovascular	|O
risk	|O
factors	|O
and	|O
antihypertensive	|O
treatment	|O
.	|O

What	|O
to	|O
look	|O
for	|O
during	|O
a	|O
compliance	|O
review	|O
:	|O
10	|O
common	|O
mistakes	|O
made	|O
by	|O
SNFs	|O
.	|O

CONCLUSIONS	|O
:	|O
EBCT	|O
technology	|O
allows	|O
minimally	|O
invasive	|O
evaluation	|O
of	|O
intramyocardial	|O
microcirculatory	|O
function	|O
and	|O
permits	|O
assessment	|O
of	|O
microvascular	|O
BV	|O
distribution	|O
in	|O
different	|O
functional	|O
components	|O
.	|O

These	|O
two	|O
mAbs	|O
used	|O
the	|O
same	|O
V	|O
(	|O
H	|O
)	|O
and	|O
J	|O
(	|O
H	|O
)	|O
gene	|O
segments	|O
,	|O
but	|O
different	|O
D	|O
,	|O
Vkappa	|O
,	|O
and	|O
Jkappa	|O
genes	|O
.	|O

SSF	|O
experiments	|O
were	|O
carried	|O
out	|O
in	|O
bench	|O
-	|O
scale	|O
bioreactors	|O
(	|O
equipped	|O
with	|O
CO2	|O
and	|O
volatile	|O
organic	|O
traps	|O
)	|O
containing	|O
a	|O
mixture	|O
of	|O
lignocellulosic	|O
materials	|O
and	|O
a	|O
radiolabeled	|O
pesticide	|O
.	|O

Characterization	|O
of	|O
a	|O
Xenopus	|O
laevis	|O
CXC	|B-PROTEIN
chemokine	|I-PROTEIN
receptor	|I-PROTEIN
4	|I-PROTEIN
:	|O
implications	|O
for	|O
hematopoietic	|O
cell	|O
development	|O
in	|O
the	|O
vertebrate	|O
embryo	|O
.	|O

Patients	|O
had	|O
to	|O
have	|O
adequate	|O
liver	|O
,	|O
renal	|O
,	|O
and	|O
marrow	|O
functions	|O
.	|O

Inhibition	|O
of	|O
RNA2	|B-PROTEIN
translation	|O
was	|O
selective	|O
,	|O
with	|O
no	|O
effect	|O
on	|O
general	|O
cellular	|O
translation	|O
or	|O
translation	|O
of	|O
BMV	|O
RNA1	|B-PROTEIN
-	|O
encoded	|O
replication	|O
factor	|O
1a	|B-PROTEIN
,	|O
and	|O
was	|O
independent	|O
of	|O
p20	|B-PROTEIN
,	|O
a	|O
cellular	|O
antagonist	|O
of	|O
DED1	|B-PROTEIN
function	|O
in	|O
translation	|O
.	|O

Abbreviations	|O
:	|O
CAS	|B-PROTEIN
,	|O
CRK	|B-PROTEIN
-	|O
associated	|O
substrate	|O
;	|O
CH	|B-PROTEIN
,	|O
calponin	|B-PROTEIN
-	|O
homology	|O
domain	|O
;	|O
CSK	|B-PROTEIN
,	|O
C	|O
-	|O
terminal	|O
SRC	|B-PROTEIN
kinase	|I-PROTEIN
;	|O
E6	|B-PROTEIN
,	|O
Papillomavirus	|O
E6	|B-PROTEIN
protein	|O
;	|O
FAK	|B-PROTEIN
,	|O
focal	|B-PROTEIN
adhesion	|I-PROTEIN
kinase	|I-PROTEIN
;	|O
GIT	|B-PROTEIN
,	|O
GRK	|B-PROTEIN
interacter	|I-PROTEIN
;	|O
GPCR	|B-PROTEIN
,	|O
heterotrimeric	|B-PROTEIN
-	|I-PROTEIN
G	|I-PROTEIN
-	|I-PROTEIN
protein	|I-PROTEIN
-	|I-PROTEIN
coupled	|I-PROTEIN
receptor	|I-PROTEIN
;	|O
GRK	|B-PROTEIN
,	|O
G	|B-PROTEIN
-	|I-PROTEIN
protein	|I-PROTEIN
-	|I-PROTEIN
coupled	|I-PROTEIN
-	|I-PROTEIN
receptor	|I-PROTEIN
kinase	|I-PROTEIN
;	|O
MAPK	|B-PROTEIN
,	|O
mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
ERK	|B-PROTEIN
,	|O
p38	|B-PROTEIN
,	|O
JNK	|B-PROTEIN
)	|O
;	|O
PAK	|B-PROTEIN
,	|O
p21	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
kinase	|I-PROTEIN
;	|O
PBS	|B-PROTEIN
,	|O
paxillin	|B-PROTEIN
-	|O
binding	|O
subdomain	|O
;	|O
PIX	|B-PROTEIN
,	|O
PAK	|B-PROTEIN
-	|I-PROTEIN
interacting	|I-PROTEIN
exchange	|I-PROTEIN
factor	|I-PROTEIN
;	|O
PKL	|B-PROTEIN
,	|O
paxillin	|B-PROTEIN
kinase	|I-PROTEIN
linker	|I-PROTEIN
;	|O
POR1	|B-PROTEIN
,	|O
partner	|B-PROTEIN
of	|I-PROTEIN
Rac	|I-PROTEIN
;	|O
PS	|O
,	|O
phosphoserine	|O
;	|O
PT	|O
,	|O
phosphothreonine	|O
;	|O
PY	|O
,	|O
phosphotyrosine	|O
;	|O
RTK	|B-PROTEIN
,	|O
growth	|B-PROTEIN
factor	|I-PROTEIN
receptor	|I-PROTEIN
tyrosine	|I-PROTEIN
kinase	|I-PROTEIN
;	|O
SH	|B-PROTEIN
,	|O
SRC	|B-PROTEIN
-	|O
homology	|O
domain	|O
.	|O

In	|O
15	|O
ventilator	|O
-	|O
dependent	|O
,	|O
SB	|O
,	|O
and	|O
actively	|O
expiring	|O
patients	|O
,	|O
we	|O
found	|O
that	|O
the	|O
difference	|O
PEEP	|O
(	|O
i	|O
)	|O
,	|O
dyn	|O
-	|O
Pga	|O
,	|O
total	|O
decay	|O
(	|O
mean	|O
+	|O
/	|O
-	|O
SD	|O
,	|O
5.7	|O
+	|O
/	|O
-	|O
1.9	|O
cm	|O
H	|O
(	|O
2	|O
)	|O
O	|O
)	|O
was	|O
quite	|O
similar	|O
to	|O
PEEP	|O
(	|O
i	|O
)	|O
,	|O
dyn	|O
ref	|O
(	|O
5.3	|O
+	|O
/	|O
-	|O
1.9	|O
cm	|O
H	|O
(	|O
2	|O
)	|O
O	|O
)	|O
.	|O

Of	|O
208	|O
eligible	|O
subjects	|O
,	|O
82	|O
received	|O
supervised	|O
IPT	|O
at	|O
a	|O
dose	|O
of	|O
900	|O
mg	|O
twice	|O
weekly	|O
for	|O
6	|O
mo	|O
(	|O
Regimen	|O
A	|O
)	|O
,	|O
73	|O
received	|O
unsupervised	|O
IPT	|O
900	|O
mg	|O
twice	|O
weekly	|O
for	|O
6	|O
mo	|O
(	|O
Regimen	|O
B	|O
)	|O
,	|O
and	|O
53	|O
received	|O
unsupervised	|O
IPT	|O
300	|O
mg	|O
daily	|O
for	|O
6	|O
mo	|O
(	|O
Regimen	|O
C	|O
)	|O
.	|O

There	|O
were	|O
122	|O
cases	|O
of	|O
tuberculosis	|O
over	|O
an	|O
average	|O
10.3	|O
yr	|O
of	|O
follow	|O
-	|O
up	|O
(	|O
crude	|O
annual	|O
incidence	|O
,	|O
76.2/100,000	|O
)	|O
.	|O

These	|O
results	|O
suggested	|O
that	|O
BACH1t	|B-PROTEIN
recruits	|O
BACH1	|B-PROTEIN
to	|O
the	|O
nucleus	|O
through	|O
BTB	|B-PROTEIN
domain	|O
-	|O
mediated	|O
interaction	|O
.	|O

The	|O
U17	|B-PROTEIN
/	|O
U16	|B-PROTEIN
and	|O
the	|O
U16+	|B-PROTEIN
gene	|O
products	|O
transactivated	|O
the	|O
HIV	|B-PROTEIN
LTR	|I-PROTEIN
.	|O

Transcription	|O
of	|O
the	|O
six	|O
EBNA	|B-PROTEIN
genes	|O
,	|O
which	|O
are	|O
expressed	|O
in	|O
EBV	|O
-	|O
immortalized	|O
primary	|O
B	|O
cells	|O
,	|O
arises	|O
from	|O
one	|O
of	|O
two	|O
promoters	|O
,	|O
Cp	|B-PROTEIN
and	|O
Wp	|B-PROTEIN
,	|O
located	|O
near	|O
the	|O
left	|O
end	|O
of	|O
the	|O
viral	|O
genome	|O
.	|O

The	|O
Cili	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
sequences	|O
possess	|O
similarity	|O
to	|O
the	|O
RNaseH	|B-PROTEIN
domain	|O
of	|O
Lian	|B-PROTEIN
-	|O
Aa1	|B-PROTEIN
,	|O
a	|O
mosquito	|B-PROTEIN
non	|I-PROTEIN
-	|I-PROTEIN
LTR	|I-PROTEIN
retrotransposon	|O
.	|O

This	|O
dynamic	|O
response	|O
strongly	|O
suggests	|O
that	|O
the	|O
p53	|B-PROTEIN
and	|O
Rb	|B-PROTEIN
tumor	|O
suppressor	|O
pathways	|O
are	|O
intact	|O
in	|O
HeLa	|O
cells	|O
and	|O
that	|O
repression	|O
of	|O
HPV	|O
E6	|B-PROTEIN
and	|O
E7	|B-PROTEIN
mobilizes	|O
these	|O
pathways	|O
in	|O
an	|O
orderly	|O
fashion	|O
to	|O
deliver	|O
growth	|O
inhibitory	|O
signals	|O
to	|O
the	|O
cells	|O
.	|O

Thus	|O
,	|O
blocks	|O
in	|O
the	|O
RARalpha	|B-PROTEIN
-	|O
specific	|O
pathway	|O
of	|O
retinoid	|O
-	|O
induced	|O
differentiation	|O
may	|O
be	|O
bypassed	|O
during	|O
retinoid	|O
induction	|O
of	|O
FR	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
expression	|O
.	|O

Is	|O
more	|O
better	|O
?	|O
About	|O
dose	|O
levels	|O
of	|O
ACE	|B-PROTEIN
inhibitors	|O
in	|O
chronic	|O
heart	|O
failure	|O
.	|O

To	|O
test	|O
whether	|O
or	|O
not	|O
SOCS	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
also	|O
binds	|O
to	|O
the	|O
IGFIR	|B-PROTEIN
,	|O
we	|O
cloned	|O
human	|O
SOCS	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
by	|O
reverse	|O
transcription	|O
-	|O
polymerase	|O
chain	|O
reaction	|O
from	|O
human	|O
skeletal	|O
muscle	|O
mRNA	|O
.	|O

A	|O
protein	|O
lacking	|O
the	|O
SH2	|B-PROTEIN
and	|O
RING	|O
finger	|O
domains	|O
has	|O
no	|O
activity	|O
,	|O
but	|O
a	|O
chimeric	|O
protein	|O
with	|O
the	|O
SH2	|B-PROTEIN
and	|O
RING	|O
finger	|O
domains	|O
of	|O
SLI	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
replaced	|O
by	|O
the	|O
equivalent	|O
domains	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
Cbl	|I-PROTEIN
has	|O
activity	|O
.	|O

To	|O
evaluate	|O
the	|O
effects	|O
of	|O
HRT	|O
on	|O
those	|O
factors	|O
in	|O
end	|O
-	|O
stage	|O
renal	|O
disease	|O
(	|O
ESRD	|O
)	|O
patients	|O
,	|O
we	|O
evaluated	|O
the	|O
changes	|O
of	|O
lipid	|O
profile	|O
,	|O
coagulation	|O
and	|O
fibrinolysis	|O
markers	|O
,	|O
and	|O
plasma	|O
homocysteine	|O
levels	|O
after	|O
treatment	|O
.	|O

There	|O
was	|O
a	|O
weak	|O
significant	|O
correlation	|O
between	|O
TGF	|B-PROTEIN
beta	|I-PROTEIN
1	|I-PROTEIN
levels	|O
and	|O
normal	|O
cell	|O
radiosensitivity	|O
(	|O
lymphocyte	|O
SF2	|O
)	|O
.	|O

Acute	|O
feasibility	|O
and	|O
safety	|O
of	|O
a	|O
smoking	|O
reduction	|O
strategy	|O
for	|O
smokers	|O
with	|O
schizophrenia	|O
.	|O

Tightly	|O
ordered	|O
proteasomal	|O
degradation	|O
of	|O
proteins	|O
critical	|O
for	|O
cell	|O
cycle	|O
control	|O
implies	|O
a	|O
role	|O
of	|O
the	|O
proteasome	|O
in	|O
maintaining	|O
cell	|O
proliferation	|O
and	|O
cell	|O
survival	|O
.	|O

The	|O
sixth	|O
nucleotide	|O
was	|O
bulged	|O
out	|O
to	|O
allow	|O
stacking	|O
of	|O
this	|O
U.G	|O
pair	|O
on	|O
the	|O
adjacent	|O
helical	|O
region	|O
.	|O

Functional	|O
analysis	|O
of	|O
the	|O
mutant	|O
desmin	|B-PROTEIN
in	|O
SW13	|O
(	|O
vim	|B-PROTEIN
-	|O
)	|O
cells	|O
showed	|O
aggregation	|O
of	|O
abnormal	|O
coarse	|O
clumps	|O
of	|O
desmin	|B-PROTEIN
positive	|O
material	|O
dispersed	|O
throughout	|O
the	|O
cytoplasm	|O
.	|O

Patients	|O
with	|O
lesions	|O
affecting	|O
the	|O
PRC	|O
but	|O
sparing	|O
the	|O
PHC	|O
,	|O
and	|O
patients	|O
with	|O
lesions	|O
affecting	|O
both	|O
PRC	|O
and	|O
PHC	|O
,	|O
performed	|O
an	|O
oculomotor	|O
delayed	|O
response	|O
task	|O
with	|O
unpredictably	|O
varied	|O
memory	|O
delays	|O
of	|O
up	|O
to	|O
30	|O
s	|O
.	|O

In	|O
addition	|O
,	|O
26	|O
amino	|O
acid	|O
residues	|O
,	|O
K69	|O
,	|O
D88	|O
,	|O
E94	|O
,	|O
D134	|O
,	|O
R154	|O
,	|O
K169	|O
,	|O
H197	|O
,	|O
D233	|O
,	|O
G235	|O
,	|O
G236	|O
,	|O
G237	|O
,	|O
F238	|O
,	|O
E274	|O
,	|O
G276	|O
,	|O
R277	|O
,	|O
Y278	|O
,	|O
K294	|O
,	|O
Y323	|O
,	|O
Y331	|O
,	|O
D332	|O
,	|O
C360	|O
,	|O
D361	|O
,	|O
D364	|O
,	|O
G387	|O
,	|O
Y389	|O
,	|O
and	|O
F397	|O
(	|O
mouse	|O
ODC	|B-PROTEIN
numbering	|O
)	|O
,	|O
all	|O
of	|O
which	|O
are	|O
implicated	|O
in	|O
the	|O
formation	|O
of	|O
the	|O
pyridoxal	|O
phosphate	|O
-	|O
binding	|O
domain	|O
and	|O
the	|O
substrate	|O
-	|O
binding	|O
domain	|O
and	|O
in	|O
dimer	|O
stabilization	|O
with	|O
the	|O
eukaryotic	|O
ODCs	|B-PROTEIN
,	|O
were	|O
also	|O
conserved	|O
in	|O
S.	|O
ruminantium	|O
LDC	|B-PROTEIN
.	|O

The	|O
Psc2	|B-PROTEIN
cDNA	|O
contained	|O
an	|O
open	|O
reading	|O
frame	|O
homologous	|O
to	|O
CP2	|B-PROTEIN
family	|O
proteins	|O
.	|O

Our	|O
results	|O
indicate	|O
that	|O
Shh	|B-PROTEIN
can	|O
drive	|O
continued	|O
cycling	|O
in	|O
immature	|O
,	|O
proliferating	|O
CGNPs	|O
.	|O

The	|O
QT	|O
interval	|O
was	|O
related	|O
to	|O
various	|O
components	|O
of	|O
the	|O
insulin	|B-PROTEIN
resistance	|O
syndrome	|O
,	|O
including	|O
BP	|O
and	|O
insulin	|B-PROTEIN
sensitivity	|O
.	|O

The	|O
wavenumbers	|O
corresponding	|O
to	|O
the	|O
normal	|O
modes	|O
of	|O
vibration	|O
were	|O
calculated	|O
using	|O
the	|O
DFT	|O
(	|O
B3LYP	|O
/	|O
6-31	|O
G	|O
*	|O
*	|O
)	|O
approximation	|O
and	|O
their	|O
agreement	|O
with	|O
the	|O
measured	|O
values	|O
improved	|O
after	|O
scaling	|O
of	|O
the	|O
associated	|O
force	|O
field	|O
.	|O

The	|O
data	|O
provide	|O
strong	|O
evidence	|O
that	|O
ThlA	|B-PROTEIN
is	|O
involved	|O
in	|O
the	|O
metabolism	|O
of	|O
both	|O
acid	|O
and	|O
solvent	|O
formation	|O
,	|O
whereas	|O
the	|O
physiological	|O
function	|O
of	|O
ThlB	|B-PROTEIN
has	|O
yet	|O
to	|O
be	|O
elucidated	|O
.	|O

In	|O
addition	|O
,	|O
npm3	|B-PROTEIN
,	|O
which	|O
is	|O
usually	|O
coactivated	|O
with	|O
fgf8	|B-PROTEIN
by	|O
MMTV	|O
insertion	|O
,	|O
was	|O
not	|O
up	|O
-	|O
regulated	|O
by	|O
androgens	|O
in	|O
SC	|O
-	|O
3	|O
cells	|O
.	|O

Experiments	|O
with	|O
epitope	|O
-	|O
tagged	|O
proteins	|O
show	|O
that	|O
UEV1A	|B-PROTEIN
is	|O
a	|O
nuclear	|O
protein	|O
,	|O
whereas	|O
both	|O
Kua	|B-PROTEIN
and	|O
Kua	|B-PROTEIN
-	|O
UEV	|B-PROTEIN
localize	|O
to	|O
cytoplasmic	|O
structures	|O
,	|O
indicating	|O
that	|O
the	|O
Kua	|B-PROTEIN
domain	|O
determines	|O
the	|O
cytoplasmic	|O
localization	|O
of	|O
Kua	|B-PROTEIN
-	|O
UEV	|B-PROTEIN
.	|O

Stoichiometric	|O
phosphorylation	|O
of	|O
human	|O
p53	|B-PROTEIN
at	|O
Ser315	|O
stimulates	|O
p53	|B-PROTEIN
-	|O
dependent	|O
transcription	|O
.	|O
p53	|B-PROTEIN
protein	|O
activity	|O
as	|O
a	|O
transcription	|O
factor	|O
can	|O
be	|O
activated	|O
in	|O
vivo	|O
by	|O
antibodies	|O
that	|O
target	|O
its	|O
C	|O
-	|O
terminal	|O
negative	|O
regulatory	|O
domain	|O
suggesting	|O
that	|O
cellular	|O
enzymes	|O
that	|O
target	|O
this	|O
domain	|O
may	|O
play	|O
a	|O
role	|O
in	|O
stimulating	|O
p53	|B-PROTEIN
-	|O
dependent	|O
gene	|O
expression	|O
.	|O

Interestingly	|O
,	|O
this	|O
mutant	|O
cell	|O
line	|O
lacks	|O
expression	|O
of	|O
the	|O
IKK	|B-PROTEIN
regulatory	|O
protein	|O
,	|O
IKKgamma	|B-PROTEIN
.	|O

The	|O
Tax	|B-PROTEIN
/	|O
IKKgamma	|B-PROTEIN
interaction	|O
serves	|O
to	|O
recruit	|O
Tax	|B-PROTEIN
to	|O
the	|O
IKK	|B-PROTEIN
catalytic	|O
subunits	|O
,	|O
IKKalpha	|B-PROTEIN
and	|O
IKKbeta	|B-PROTEIN
,	|O
and	|O
this	|O
recruitment	|O
appears	|O
to	|O
be	|O
an	|O
essential	|O
mechanism	|O
by	|O
which	|O
Tax	|B-PROTEIN
stimulates	|O
the	|O
activity	|O
of	|O
IKK	|B-PROTEIN
.	|O

An	|O
anchored	|O
AFLP	|O
-	|O
and	|O
retrotransposon	|O
-	|O
based	|O
map	|O
of	|O
diploid	|O
Avena	|O
.	|O

In	|O
addition	|O
,	|O
we	|O
identified	|O
a	|O
novel	|O
type	|O
of	|O
inhibitory	|O
domain	|O
in	|O
the	|O
N	|O
-	|O
terminal	|O
60	|O
amino	|O
acids	|O
of	|O
IRF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
which	|O
strongly	|O
inhibits	|O
its	|O
transcriptional	|O
activity	|O
.	|O

Effects	|O
of	|O
spatial	|O
and	|O
temporal	|O
smoothing	|O
on	|O
stimulated	|O
brillouin	|O
scattering	|O
in	|O
the	|O
independent	|O
-	|O
hot	|O
-	|O
spot	|O
model	|O
limit	|O
The	|O
influence	|O
of	|O
laser	|O
beam	|O
smoothing	|O
on	|O
stimulated	|O
Brillouin	|O
backscattering	|O
(	|O
SBBS	|O
)	|O
is	|O
studied	|O
analytically	|O
in	|O
the	|O
limit	|O
of	|O
the	|O
independent	|O
hot	|O
spot	|O
model	|O
.	|O

Simultaneous	|O
determination	|O
of	|O
theophylline	|O
and	|O
its	|O
metabolites	|O
by	|O
HPLC	|O
]	|O
A	|O
high	|O
performance	|O
liquid	|O
chromatography	|O
(	|O
HPLC	|O
)	|O
method	|O
has	|O
been	|O
developed	|O
for	|O
the	|O
simultaneous	|O
determination	|O
of	|O
theophylline	|O
and	|O
its	|O
metabolites	|O
,	|O
with	|O
caffeine	|O
and	|O
its	|O
metabolites	|O
.	|O

Ten	|O
males	|O
performed	|O
both	|O
test	|O
conditions	|O
and	|O
oxygen	|O
uptake	|O
VO2	|O
,	|O
heart	|O
rate	|O
,	|O
minute	|O
ventilation	|O
VE	|O
,	|O
perceived	|O
exertion	|O
and	|O
spinal	|O
shrinkage	|O
were	|O
recorded	|O
.	|O

CONCLUSION	|O
:	|O
SPT	|O
is	|O
more	|O
useful	|O
than	|O
WST	|O
in	|O
differentiating	|O
patients	|O
predisposed	|O
to	|O
aspiration	|O
.	|O

Studied	|O
groups	|O
were	|O
(	|O
1	|O
)	|O
untreated	|O
control	|O
,	|O
n	|O
=	|O
12	|O
;	|O
(	|O
2	|O
)	|O
FK	|O
-	|O
1	|O
,	|O
n	|O
=	|O
8	|O
;	|O
(	|O
3	|O
)	|O
FK	|O
-	|O
3	|O
,	|O
n	|O
=	|O
8	|O
.	|O

DNA	|O
binding	|O
and	|O
glutathione	|B-PROTEIN
S	|I-PROTEIN
-	|I-PROTEIN
transferase	|I-PROTEIN
pull	|O
-	|O
down	|O
assays	|O
demonstrate	|O
that	|O
binding	|O
requires	|O
Elk	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
(	|O
1-212	|O
)	|O
but	|O
not	|O
the	|O
C	|O
-	|O
terminal	|O
transactivation	|O
domain	|O
.	|O

Unexpectedly	|O
,	|O
ALK7	|B-PROTEIN
signaling	|O
produced	|O
a	|O
remarkable	|O
change	|O
in	|O
cell	|O
morphology	|O
characterized	|O
by	|O
cell	|O
flattening	|O
and	|O
elaboration	|O
of	|O
blunt	|O
,	|O
short	|O
cell	|O
processes	|O
.	|O

The	|O
swa2	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
allele	|O
recovered	|O
from	|O
the	|O
original	|O
screen	|O
carries	|O
a	|O
point	|O
mutation	|O
in	|O
its	|O
tetratricopeptide	|O
repeat	|O
(	|O
TPR	|O
)	|O
domain	|O
,	|O
a	|O
motif	|O
not	|O
found	|O
in	|O
auxilin	|B-PROTEIN
but	|O
known	|O
in	|O
other	|O
proteins	|O
to	|O
mediate	|O
interaction	|O
with	|O
heat	|B-PROTEIN
-	|I-PROTEIN
shock	|I-PROTEIN
proteins	|I-PROTEIN
.	|O

Association	|O
of	|O
stress	|O
during	|O
delivery	|O
with	|O
increased	|O
numbers	|O
of	|O
nucleated	|O
cells	|O
and	|O
hematopoietic	|O
progenitor	|O
cells	|O
in	|O
umbilical	|O
cord	|O
blood	|O
.	|O

In	|O
slightly	|O
older	|O
embryos	|O
,	|O
the	|O
expression	|O
was	|O
skewed	|O
to	|O
one	|O
side	|O
of	|O
the	|O
embryo	|O
and	|O
by	|O
E6.5	|O
,	|O
at	|O
the	|O
onset	|O
of	|O
gastrulation	|O
,	|O
expression	|O
was	|O
seen	|O
in	|O
the	|O
epiblast	|O
,	|O
visceral	|O
endoderm	|O
,	|O
nascent	|O
mesoderm	|O
,	|O
and	|O
the	|O
primitive	|O
streak	|O
.	|O

Transformation	|O
of	|O
the	|O
sconC3	|B-PROTEIN
mutant	|O
with	|O
sconB+	|B-PROTEIN
restores	|O
the	|O
wild	|O
-	|O
type	|O
phenotype	|O
.	|O

The	|O
authors	|O
proposed	|O
that	|O
the	|O
highly	|O
convergent	|O
inputs	|O
to	|O
the	|O
entorhinal	|O
cortex	|O
indicate	|O
this	|O
region	|O
may	|O
be	|O
particularly	|O
important	|O
for	|O
selecting	|O
or	|O
compressing	|O
information	|O
.	|O

Influence	|O
of	|O
oil	|O
emulsions	|O
and	|O
diphenyl	|O
on	|O
post	|O
-	|O
harvest	|O
physiconutritional	|O
changes	|O
in	|O
Kagzi	|O
limes	|O
(	|O
Citrus	|O
aurantifolia	|O
)	|O
was	|O
studied	|O
.	|O

Detailed	|O
analysis	|O
of	|O
alpha1	|B-PROTEIN
,	|I-PROTEIN
3GT	|I-PROTEIN
transcripts	|O
revealed	|O
two	|O
major	|O
alternative	|O
splicing	|O
patterns	|O
in	|O
the	|O
5'	|O
-	|O
untranslated	|O
region	|O
(	|O
5'	|O
-	|O
UTR	|O
)	|O
and	|O
evidence	|O
for	|O
minor	|O
splicing	|O
activity	|O
that	|O
occurs	|O
in	|O
a	|O
tissue	|O
-	|O
specific	|O
manner	|O
.	|O

A	|O
thermal	|O
Kubo	|O
-	|O
Martin	|O
-	|O
Schwinger	|O
condition	|O
arises	|O
due	|O
to	|O
the	|O
coupling	|O
of	|O
a	|O
computer	|O
to	|O
a	|O
strong	|O
periodic	|O
source	|O
,	|O
namely	|O
,	|O
the	|O
daily	|O
and	|O
weekly	|O
usage	|O
patterns	|O
of	|O
the	|O
system	|O
.	|O

The	|O
non	|O
-	|O
homologous	|O
sequences	|O
in	|O
the	|O
5'	|O
untranslated	|O
regions	|O
might	|O
be	|O
acquired	|O
at	|O
or	|O
after	|O
transcription	|O
during	|O
retrotransposition	|O
of	|O
the	|O
ATLN	|O
elements	|O
.	|O

The	|O
time	|O
course	|O
of	|O
RNA1	|B-PROTEIN
replication	|O
and	|O
RNA3	|B-PROTEIN
synthesis	|O
in	|O
induced	|O
yeast	|O
paralleled	|O
that	|O
in	|O
yeast	|O
transfected	|O
with	|O
natural	|O
FHV	|O
virion	|O
RNA	|O
.	|O

The	|O
transcription	|O
and	|O
alternative	|O
splicing	|O
of	|O
human	|O
ORL1	|B-PROTEIN
and	|O
GAIP	|B-PROTEIN
are	|O
cell	|O
-	|O
type	|O
specific	|O
.	|O

RESULTS	|O
:	|O
The	|O
main	|O
effect	|O
of	|O
muscle	|O
pain	|O
,	|O
compared	|O
to	|O
non	|O
-	|O
painful	|O
stimulation	|O
,	|O
was	|O
a	|O
significant	|O
and	|O
long	|O
-	|O
lasting	|O
increase	|O
of	|O
delta	|O
(	|O
1-3	|O
Hz	|O
)	|O
power	|O
and	|O
an	|O
alpha	|O
-	|O
1	|O
(	|O
9-11	|O
Hz	|O
)	|O
power	|O
increase	|O
over	|O
the	|O
contralateral	|O
parietal	|O
locus	|O
.	|O

The	|O
extraction	|O
was	|O
subsequently	|O
rated	|O
as	|O
'	|O
easy	|O
'	|O
or	|O
'	|O
difficult	|O
'	|O
.	|O
Taking	|O
Pell	|O
-	|O
Gregory	|O
class	|O
C	|O
as	|O
a	|O
predictor	|O
of	|O
a	|O
'	|O
difficult	|O
'	|O
extraction	|O
,	|O
specificity	|O
was	|O
88%	|O
but	|O
sensitivity	|O
was	|O
low	|O
at	|O
15%	|O
.	|O

In	|O
addition	|O
,	|O
our	|O
results	|O
show	|O
that	|O
ERKs	|B-PROTEIN
and	|O
PI3Ks	|B-PROTEIN
can	|O
synergise	|O
to	|O
convert	|O
ectoderm	|O
into	|O
mesoderm	|O
.	|O

Based	|O
on	|O
16S	|B-PROTEIN
rRNA	|O
gene	|O
sequence	|O
analysis	|O
,	|O
the	|O
11	|O
species	|O
having	|O
two	|O
tuf	|B-PROTEIN
genes	|O
all	|O
have	|O
a	|O
common	|O
ancestor	|O
,	|O
while	|O
the	|O
six	|O
species	|O
having	|O
only	|O
one	|O
copy	|O
diverged	|O
from	|O
the	|O
enterococcal	|O
lineage	|O
before	|O
that	|O
common	|O
ancestor	|O
.	|O

Nevertheless	|O
,	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
A	|I-PROTEIN
stimulation	|O
induces	|O
CREMalpha	|B-PROTEIN
to	|O
activate	|O
the	|O
complex	|O
native	|O
promoter	|O
in	|O
the	|O
phosphoenolpyruvate	|B-PROTEIN
carboxykinase	|I-PROTEIN
(	|O
PEPCK	|B-PROTEIN
)	|O
gene	|O
.	|O

Another	|O
putative	|O
HNF3	|B-PROTEIN
site	|O
in	|O
close	|O
apposition	|O
to	|O
a	|O
NF1	|B-PROTEIN
/	|O
CTF	|B-PROTEIN
site	|O
was	|O
localized	|O
upstream	|O
of	|O
the	|O
silencer	|O
-	|O
like	|O
element	|O
.	|O

This	|O
transcriptional	|O
regulation	|O
occurs	|O
through	|O
modulation	|O
of	|O
the	|O
forkhead	|B-PROTEIN
transcription	|O
factor	|O
FKHR	|B-PROTEIN
-	|I-PROTEIN
L1	|I-PROTEIN
,	|O
and	|O
IL	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
inhibited	|O
FKHR	|B-PROTEIN
-	|I-PROTEIN
L1	|I-PROTEIN
activity	|O
in	|O
a	|O
PI3K	|B-PROTEIN
-	|O
dependent	|O
manner	|O
.	|O

Taken	|O
together	|O
,	|O
these	|O
observations	|O
indicate	|O
that	|O
inhibition	|O
of	|O
p27	|B-PROTEIN
(	|O
KIP1	|B-PROTEIN
)	|O
transcription	|O
through	|O
PI3K	|B-PROTEIN
-	|O
induced	|O
FKHR	|B-PROTEIN
-	|I-PROTEIN
L1	|I-PROTEIN
phosphorylation	|O
provides	|O
a	|O
novel	|O
mechanism	|O
of	|O
regulating	|O
cytokine	|O
-	|O
mediated	|O
survival	|O
and	|O
proliferation	|O
.	|O

DNase	|B-PROTEIN
I	|I-PROTEIN
genomic	|O
footprinting	|O
revealed	|O
that	|O
the	|O
c	|B-PROTEIN
-	|I-PROTEIN
Myb	|I-PROTEIN
site	|O
is	|O
occupied	|O
in	|O
a	|O
tissue	|O
-	|O
specific	|O
fashion	|O
in	|O
vivo	|O
.	|O

We	|O
conclude	|O
that	|O
c	|B-PROTEIN
-	|I-PROTEIN
Myb	|I-PROTEIN
regulates	|O
the	|O
RAG	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
promoter	|O
in	|O
T	|O
cells	|O
by	|O
binding	|O
to	|O
this	|O
consensus	|O
c	|B-PROTEIN
-	|I-PROTEIN
Myb	|I-PROTEIN
binding	|O
site	|O
.	|O

A	|O
recently	|O
reported	|O
new	|O
member	|O
of	|O
the	|O
Vav	|B-PROTEIN
family	|O
proteins	|O
,	|O
Vav3	|B-PROTEIN
has	|O
been	|O
identified	|O
as	|O
a	|O
Ros	|B-PROTEIN
receptor	|O
protein	|O
tyrosine	|O
kinase	|O
(	|O
RPTK	|B-PROTEIN
)	|O
interacting	|O
protein	|O
by	|O
yeast	|O
two	|O
-	|O
hybrid	|O
screening	|O
.	|O

Subsequently	|O
,	|O
we	|O
show	|O
that	|O
the	|O
reexpression	|O
of	|O
the	|O
r	|B-PROTEIN
-	|I-PROTEIN
PTPeta	|I-PROTEIN
gene	|O
in	|O
highly	|O
malignant	|O
rat	|O
thyroid	|O
cells	|O
transformed	|O
by	|O
retroviruses	|O
carrying	|O
the	|O
v	|B-PROTEIN
-	|I-PROTEIN
mos	|I-PROTEIN
and	|O
v	|B-PROTEIN
-	|I-PROTEIN
ras	|I-PROTEIN
-	|I-PROTEIN
Ki	|I-PROTEIN
oncogenes	|O
suppresses	|O
their	|O
malignant	|O
phenotype	|O
.	|O

Induced	|O
expression	|O
of	|O
Rnd3	|B-PROTEIN
is	|O
associated	|O
with	|O
transformation	|O
of	|O
polarized	|O
epithelial	|O
cells	|O
by	|O
the	|O
Raf	|B-PROTEIN
-	|O
MEK	|B-PROTEIN
-	|O
extracellular	|O
signal	|O
-	|O
regulated	|O
kinase	|O
pathway	|O
.	|O

The	|O
activity	|O
of	|O
the	|O
transcription	|O
factor	|O
CREB	|B-PROTEIN
is	|O
regulated	|O
by	|O
extracellular	|O
stimuli	|O
that	|O
result	|O
in	|O
its	|O
phosphorylation	|O
at	|O
a	|O
critical	|O
serine	|O
residue	|O
,	|O
Ser133	|O
.	|O

RESULTS	|O
:	|O
Average	|O
age	|O
at	|O
symptom	|O
onset	|O
was	|O
41.2	|O
years	|O
.	|O

When	|O
10	|O
fields	|O
were	|O
analysed	|O
,	|O
a	|O
strong	|O
relationship	|O
was	|O
found	|O
between	|O
the	|O
presence	|O
of	|O
bacteria	|O
on	|O
Gram	|O
staining	|O
and	|O
the	|O
final	|O
diagnosis	|O
of	|O
VAP	|O
(	|O
for	|O
PSB	|O
and	|O
PTC	|O
respectively	|O
:	|O
sensitivity	|O
74	|O
and	|O
81%	|O
,	|O
specificity	|O
94	|O
and	|O
100%	|O
,	|O
positive	|O
predictive	|O
value	|O
91	|O
and	|O
100%	|O
,	|O
negative	|O
predictive	|O
value	|O
82	|O
and	|O
88%	|O
)	|O
.	|O

Unlike	|O
the	|O
mammalian	|O
proteins	|O
,	|O
XFGF3	|B-PROTEIN
is	|O
efficiently	|O
secreted	|O
as	|O
a	|O
Mr	|O
31,000	|O
glycoprotein	|O
,	|O
gp31	|B-PROTEIN
,	|O
which	|O
undergoes	|O
proteolytic	|O
cleavage	|O
to	|O
produce	|O
an	|O
NH2	|O
-	|O
terminally	|O
truncated	|O
product	|O
,	|O
gp27	|B-PROTEIN
.	|O

NH2	|O
-	|O
terminal	|O
trimming	|O
of	|O
Xenopus	|O
and	|O
mammalian	|O
FGF3s	|B-PROTEIN
may	|O
therefore	|O
be	|O
a	|O
prerequisite	|O
of	|O
optimal	|O
biological	|O
activity	|O
.	|O

Here	|O
,	|O
we	|O
identified	|O
three	|O
cis	|O
-	|O
elements	|O
required	|O
for	|O
replication	|O
within	|O
the	|O
200	|O
bp	|O
promoter	|O
,	|O
using	|O
autonomously	|O
replicating	|O
plasmids	|O
carrying	|O
various	|O
mutations	|O
and	|O
deletions	|O
.	|O

Tranilast	|O
in	|O
the	|O
Therapy	|O
of	|O
Coronary	|O
Artery	|O
Disease	|O
.	|O

The	|O
objectives	|O
of	|O
the	|O
present	|O
study	|O
were	|O
to	|O
evaluate	|O
the	|O
effects	|O
of	|O
adding	|O
Equex	|O
to	|O
a	|O
TRIS	|O
-	|O
extender	|O
,	|O
diluting	|O
the	|O
semen	|O
in	|O
1	|O
or	|O
2	|O
steps	|O
,	|O
freezing	|O
according	|O
to	|O
2	|O
methods	|O
,	|O
thawing	|O
at	|O
2	|O
rates	|O
,	|O
and	|O
the	|O
interactions	|O
between	|O
these	|O
treatments	|O
,	|O
on	|O
the	|O
post	|O
-	|O
thaw	|O
survival	|O
of	|O
dog	|O
spermatozoa	|O
at	|O
38	|O
degrees	|O
C.	|O

This	|O
study	|O
is	|O
a	|O
further	|O
and	|O
more	|O
extensive	|O
validation	|O
of	|O
the	|O
clinician	|O
rated	|O
NIMH	|O
-	|O
LCM	|O
-	|O
p	|O
.	|O

The	|O
Aie1	|B-PROTEIN
locus	|O
was	|O
mapped	|O
to	|O
mouse	|O
chromosome	|O
7A2	|O
-	|O
A3	|O
by	|O
fluorescent	|O
in	|O
situ	|O
hybridization	|O
.	|O

Psychiatric	|O
disorders	|O
in	|O
children	|O
and	|O
adolescents	|O
carry	|O
considerable	|O
morbidity	|O
,	|O
impede	|O
development	|O
,	|O
and	|O
carry	|O
a	|O
significant	|O
mortality	|O
by	|O
suicide	|O
.	|O

Molecular	|O
cloning	|O
and	|O
expression	|O
of	|O
human	|B-PROTEIN
UDP	|I-PROTEIN
-	|I-PROTEIN
d	|I-PROTEIN
-	|I-PROTEIN
Xylose	|I-PROTEIN
:	|I-PROTEIN
proteoglycan	|I-PROTEIN
core	|I-PROTEIN
protein	|I-PROTEIN
beta	|O
-	|O
d	|O
-	|O
xylosyltransferase	|O
and	|O
its	|O
first	|O
isoform	|O
XT	|B-PROTEIN
-	|I-PROTEIN
II	|I-PROTEIN
.	|O

Thyrotoxicosis	|O
due	|O
to	|O
amiodarone	|O
is	|O
difficult	|O
to	|O
treat	|O
and	|O
is	|O
further	|O
complicated	|O
by	|O
the	|O
pro	|O
-	|O
arrhythmic	|O
potential	|O
of	|O
thyrotoxicosis	|O
and	|O
the	|O
fading	|O
antiarrhythmic	|O
effect	|O
after	|O
amiodarone	|O
withdrawal	|O
.	|O

Chaperones	|O
/	|O
HSPs	|B-PROTEIN
thus	|O
play	|O
important	|O
roles	|O
within	|O
cell	|O
cycle	|O
processes	|O
.	|O

Oncogenic	|O
signalling	|O
by	|O
E2F1	|B-PROTEIN
has	|O
recently	|O
been	|O
linked	|O
to	|O
stabilization	|O
and	|O
activation	|O
of	|O
the	|O
tumour	|O
suppressor	|O
p53	|B-PROTEIN
(	|O
refs	|O
1,3,4	|O
)	|O
.	|O

This	|O
study	|O
allows	|O
us	|O
to	|O
draw	|O
conclusions	|O
about	|O
the	|O
identity	|O
of	|O
proteins	|O
required	|O
for	|O
the	|O
development	|O
of	|O
the	|O
nervous	|O
system	|O
in	|O
Drosophila	|O
and	|O
provides	|O
an	|O
example	|O
of	|O
a	|O
molecular	|O
approach	|O
to	|O
characterize	|O
en	|O
masse	|O
transposon	|O
-	|O
tagged	|O
mutations	|O
identified	|O
in	|O
genetic	|O
screens	|O
.	|O

We	|O
describe	|O
the	|O
identification	|O
and	|O
initial	|O
characterization	|O
of	|O
neurobeachin	|B-PROTEIN
,	|O
a	|O
neuron	|O
-	|O
specific	|O
multidomain	|O
protein	|O
of	|O
327	|O
kDa	|O
with	|O
a	|O
high	|O
-	|O
affinity	|O
binding	|O
site	|O
(	|O
K	|O
(	|O
d	|O
)	|O
,	|O
10	|O
nm	|O
)	|O
for	|O
the	|O
type	|O
II	|O
regulatory	|O
subunit	|O
of	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
A	|I-PROTEIN
(	|O
PKA	|B-PROTEIN
RII	|I-PROTEIN
)	|O
.	|O

Children	|O
with	|O
ADD	|O
showed	|O
an	|O
attenuated	|O
frontal	|O
CNV	|O
-	|O
1	|O
amplitude	|O
and	|O
a	|O
trend	|O
towards	|O
increased	|O
CNV	|O
-	|O
1	|O
and	|O
CNV	|O
-	|O
2	|O
occipital	|O
amplitudes	|O
.	|O

Where	|O
UMDNJ	|O
is	|O
headed	|O
.	|O

Overexpression	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
Myc	|I-PROTEIN
in	|O
serum	|O
-	|O
starved	|O
human	|O
or	|O
mouse	|O
embryonic	|O
cells	|O
leads	|O
to	|O
apoptosis	|O
which	|O
is	|O
significantly	|O
reduced	|O
in	|O
the	|O
presence	|O
of	|O
growth	|O
factor	|O
-	|O
containing	|O
serum	|O
.	|O
c	|B-PROTEIN
-	|I-PROTEIN
Myc	|I-PROTEIN
-	|O
induced	|O
apoptosis	|O
appears	|O
to	|O
be	|O
deficient	|O
in	|O
bax	|B-PROTEIN
-	|O
null	|O
as	|O
compared	|O
with	|O
bax	|B-PROTEIN
-	|O
wild	|O
-	|O
type	|O
mouse	|O
embryonic	|O
fibroblasts	|O
.	|O

Antimicrobial	|O
Susceptibility	|O
of	|O
Klebsiella	|O
pneumoniae	|O
Producing	|O
Extended	|B-PROTEIN
-	|I-PROTEIN
Spectrum	|I-PROTEIN
beta	|I-PROTEIN
-	|I-PROTEIN
lactamase	|I-PROTEIN
(	|O
ESBL	|B-PROTEIN
)	|O
Isolated	|O
in	|O
Hospitals	|O
in	|O
Brazil	|O
.	|O

CONCLUSION	|O
:	|O
Our	|O
results	|O
suggest	|O
that	|O
AIF	|O
peak	|O
saturation	|O
leads	|O
to	|O
a	|O
significant	|O
systematic	|O
error	|O
in	|O
the	|O
determination	|O
of	|O
CBV	|O
and	|O
CBF	|O
values	|O
and	|O
has	|O
necessarily	|O
to	|O
be	|O
taken	|O
into	|O
account	|O
for	|O
dynamic	|O
contrast	|O
-	|O
enhanced	|O
MR	|O
perfusion	|O
studies	|O
.	|O

METHODS	|O
:	|O
T2	|O
*	|O
-	|O
weighted	|O
,	|O
three	|O
-	|O
dimensional	|O
gradient	|O
-	|O
echo	|O
images	|O
were	|O
acquired	|O
by	|O
exploiting	|O
the	|O
magnetic	|O
susceptibility	|O
difference	|O
between	|O
oxygenated	|O
and	|O
deoxygenated	|O
hemoglobin	|B-PROTEIN
in	|O
the	|O
vasculature	|O
and	|O
microvasculature	|O
.	|O

In	|O
the	|O
COPD	|O
patients	|O
,	|O
the	|O
variability	|O
of	|O
Delta	|O
-	|O
inst	|O
Rrs	|O
(	|O
30%	|O
)	|O
was	|O
greater	|O
than	|O
that	|O
of	|O
FOT	|O
Rrs	|O
(	|O
21%	|O
)	|O
.	|O

Toward	|O
this	|O
end	|O
,	|O
we	|O
prepared	|O
synthetic	|O
proteins	|O
with	|O
either	|O
the	|O
catalytic	|O
domain	|O
of	|O
FAP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
(	|O
C	|O
-	|O
terminal	|O
399	|O
amino	|O
acids	|O
)	|O
or	|O
its	|O
inactive	|O
form	|O
(	|O
Cys2408	|O
-	|O
-	|O
>	|O
Ser	|O
)	|O
fused	|O
to	|O
glutathione	|B-PROTEIN
-	|I-PROTEIN
S	|I-PROTEIN
-	|I-PROTEIN
transferase	|I-PROTEIN
(	|O
GST	|B-PROTEIN
)	|O
.	|O

Thus	|O
,	|O
Pet111p	|B-PROTEIN
could	|O
play	|O
dual	|O
roles	|O
in	|O
both	|O
membrane	|O
localization	|O
and	|O
regulation	|O
of	|O
Cox2p	|B-PROTEIN
synthesis	|O
within	|O
mitochondria	|O
.	|O

Furthermore	|O
,	|O
transfection	|O
of	|O
cells	|O
with	|O
the	|O
spacer	|O
-	|O
RING	|O
domain	|O
alone	|O
suppressed	|O
the	|O
antiapoptotic	|O
function	|O
of	|O
the	|O
N	|O
-	|O
terminal	|O
BIR	|B-PROTEIN
domain	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
IAP1	|I-PROTEIN
and	|O
induced	|O
apoptosis	|O
.	|O

The	|O
determination	|O
of	|O
the	|O
double	|O
bounds	|O
in	|O
blood	|O
serum	|O
lipids	|O
by	|O
titration	|O
with	|O
ozone	|O
:	|O
the	|O
pathophysiology	|O
and	|O
diagnostic	|O
significance	|O
]	|O
In	|O
this	|O
article	|O
the	|O
method	|O
of	|O
definition	|O
of	|O
double	|O
binders	|O
in	|O
lipids	|O
of	|O
blood	|O
serum	|O
in	|O
patients	|O
with	|O
different	|O
diseases	|O
basically	|O
atherosclerosis	|O
and	|O
ischemic	|O
heart	|O
disease	|O
,	|O
with	|O
use	|O
titration	|O
by	|O
ozone	|O
is	|O
given	|O
.	|O

Ang	|B-PROTEIN
II	|I-PROTEIN
-	|O
induced	|O
fibronectin	|B-PROTEIN
mRNA	|O
was	|O
not	|O
affected	|O
by	|O
PKC	|B-PROTEIN
inhibitors	|O
or	|O
PKC	|B-PROTEIN
depletion	|O
,	|O
whereas	|O
specific	|O
inhibition	|O
of	|O
EGF	|B-PROTEIN
-	|I-PROTEIN
R	|I-PROTEIN
function	|O
by	|O
a	|O
dominant	|O
negative	|O
EGF	|B-PROTEIN
-	|I-PROTEIN
R	|I-PROTEIN
mutant	|O
and	|O
tyrphostin	|O
AG1478	|O
abolished	|O
induction	|O
of	|O
fibronectin	|B-PROTEIN
mRNA	|O
.	|O

Acoust	|O
.	|O

Video	|O
images	|O
of	|O
the	|O
nostrils	|O
were	|O
captured	|O
and	|O
then	|O
analyzed	|O
for	|O
area	|O
,	|O
perimeter	|O
,	|O
centroid	|O
,	|O
principal	|O
axis	|O
,	|O
moments	|O
about	|O
the	|O
major	|O
and	|O
minor	|O
axes	|O
(	|O
I11	|O
,	|O
I22	|O
)	|O
,	|O
anisometry	|O
,	|O
bulkiness	|O
,	|O
lateral	|O
offset	|O
,	|O
internostril	|O
angle	|O
,	|O
and	|O
rotational	|O
angle	|O
.	|O

MS	|O
characteristics	|O
of	|O
coumarins	|O
,	|O
psoralens	|O
and	|O
polymethoxylated	|O
flavones	|O
with	|O
different	|O
substitution	|O
patterns	|O
were	|O
determined	|O
on	|O
the	|O
basis	|O
of	|O
the	|O
response	|O
obtained	|O
with	|O
the	|O
APcI	|O
interface	|O
.	|O

Young	|O
fish	|O
(	|O
Oreochromis	|O
mossambicus	|O
)	|O
were	|O
exposed	|O
to	|O
microgravity	|O
(	|O
micro	|O
g	|O
)	|O
for	|O
9	|O
to	|O
10	|O
days	|O
during	|O
space	|O
missions	|O
STS	|O
-	|O
55	|O
and	|O
STS	|O
-	|O
84	|O
,	|O
or	|O
to	|O
hypergravity	|O
(	|O
hg	|O
)	|O
for	|O
9	|O
days	|O
.	|O

S6K2	|B-PROTEIN
is	|O
highly	|O
homologous	|O
to	|O
S6K1	|B-PROTEIN
in	|O
the	|O
core	|O
kinase	|O
and	|O
linker	|O
regulatory	|O
domains	|O
but	|O
differs	|O
from	|O
S6K1	|B-PROTEIN
in	|O
the	|O
N	|O
-	|O
and	|O
C	|O
-	|O
terminal	|O
regions	|O
and	|O
is	|O
differently	|O
localized	|O
primarily	|O
to	|O
the	|O
nucleus	|O
because	|O
of	|O
a	|O
C	|O
-	|O
terminal	|O
nuclear	|O
localization	|O
signal	|O
unique	|O
to	|O
S6K2	|B-PROTEIN
.	|O

Pretreatment	|O
of	|O
cells	|O
with	|O
the	|O
mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
-	|I-PROTEIN
extracellular	|I-PROTEIN
signal	|I-PROTEIN
-	|I-PROTEIN
regulated	|I-PROTEIN
kinase	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
MEK	|B-PROTEIN
)	|O
inhibitor	|O
U0126	|O
inhibited	|O
S6K2	|B-PROTEIN
activation	|O
to	|O
a	|O
greater	|O
extent	|O
than	|O
S6K1	|B-PROTEIN
.	|O

T	|O
cells	|O
express	|O
two	|O
isoforms	|O
of	|O
S6k1	|B-PROTEIN
:	|O
a	|O
70	|O
kDa	|O
cytoplasmic	|O
kinase	|O
and	|O
an	|O
85	|O
kDa	|O
isoform	|O
that	|O
has	|O
a	|O
classic	|O
nuclear	|O
localisation	|O
.	|O

Ketanserin	|O
,	|O
a	|O
hypotensive	|O
drug	|O
with	|O
5	|B-PROTEIN
-	|I-PROTEIN
HT2	|I-PROTEIN
receptor	|I-PROTEIN
antagonism	|O
,	|O
when	|O
administered	|O
by	|O
topical	|O
infusion	|O
of	|O
a	|O
0.25%	|O
w	|O
/	|O
v	|O
solution	|O
by	|O
corneal	|O
and	|O
scleral	|O
applications	|O
,	|O
was	|O
found	|O
to	|O
lower	|O
intraocular	|O
pressure	|O
with	|O
four	|O
times	|O
more	|O
activity	|O
than	|O
its	|O
metabolite	|O
,	|O
ketanserinol	|O
.	|O

A	|O
prospectively	|O
gated	|O
2D	|O
axial	|O
sequence	|O
with	|O
velocity	|O
encoding	|O
in	|O
the	|O
craniocaudal	|O
direction	|O
in	|O
the	|O
cervical	|O
region	|O
was	|O
set	|O
at	|O
a	|O
velocity	|O
of	|O
+	|O
/	|O
-	|O
10	|O
cm	|O
/	|O
s	|O
.	|O

It	|O
was	|O
subsequently	|O
shown	|O
that	|O
Tip60	|B-PROTEIN
had	|O
histone	|B-PROTEIN
acetyltransferase	|I-PROTEIN
(	|O
HAT	|B-PROTEIN
)	|O
activity	|O
.	|O

Our	|O
data	|O
show	|O
that	|O
multiple	|O
MLSN1	|B-PROTEIN
transcripts	|O
,	|O
both	|O
constitutively	|O
expressed	|O
and	|O
inducible	|O
,	|O
are	|O
present	|O
in	|O
cultured	|O
pigmented	|O
melanoma	|O
cells	|O
,	|O
and	|O
suggest	|O
that	|O
MLSN1	|B-PROTEIN
expression	|O
can	|O
be	|O
regulated	|O
at	|O
the	|O
level	|O
of	|O
both	|O
transcription	|O
and	|O
mRNA	|O
processing	|O
.	|O

Copyright	|O
2000	|O
Academic	|O
Press	|O
.	|O

Plectin	|B-PROTEIN
and	|O
desmoplakin	|B-PROTEIN
have	|O
GSR	|O
-	|O
containing	|O
domains	|O
at	|O
their	|O
C	|O
-	|O
termini	|O
and	|O
we	|O
further	|O
demonstrate	|O
that	|O
the	|O
GSR	|O
-	|O
containing	|O
domain	|O
of	|O
plectin	|B-PROTEIN
,	|O
but	|O
not	|O
desmoplakin	|B-PROTEIN
,	|O
can	|O
bind	|O
to	|O
MTs	|O
in	|O
vivo	|O
.	|O

Characterization	|O
of	|O
the	|O
microtubule	|O
binding	|O
domain	|O
of	|O
microtubule	|B-PROTEIN
actin	|I-PROTEIN
crosslinking	|I-PROTEIN
factor	|I-PROTEIN
(	|O
MACF	|B-PROTEIN
)	|O
:	|O
identification	|O
of	|O
a	|O
novel	|O
group	|O
of	|O
microtubule	|B-PROTEIN
associated	|I-PROTEIN
proteins	|I-PROTEIN
.	|O

These	|O
results	|O
also	|O
suggest	|O
the	|O
involvement	|O
of	|O
additional	|O
elements	|O
in	|O
the	|O
UPR	|O
.	|O

We	|O
show	|O
that	|O
in	|O
contrast	|O
to	|O
SRC1	|B-PROTEIN
,	|O
direct	|O
binding	|O
of	|O
CBP	|B-PROTEIN
to	|O
the	|O
estrogen	|B-PROTEIN
receptor	|I-PROTEIN
is	|O
weak	|O
,	|O
suggesting	|O
that	|O
SRC1	|B-PROTEIN
functions	|O
primarily	|O
as	|O
an	|O
adaptor	|O
to	|O
recruit	|O
CBP	|B-PROTEIN
and	|O
p300	|B-PROTEIN
.	|O

Remarkably	|O
,	|O
a	|O
construct	|O
corresponding	|O
to	|O
residues	|O
631	|O
to	|O
970	|O
,	|O
which	|O
contains	|O
only	|O
the	|O
LXXLL	|O
motifs	|O
and	|O
the	|O
AD1	|O
region	|O
of	|O
SRC1	|B-PROTEIN
,	|O
retained	|O
strong	|O
coactivator	|O
activity	|O
in	|O
our	|O
assays	|O
.	|O

Since	|O
MEK	|B-PROTEIN
acts	|O
as	|O
a	|O
cytoplasmic	|O
anchor	|O
for	|O
the	|O
ERKs	|B-PROTEIN
,	|O
the	|O
lack	|O
of	|O
a	|O
MEK	|B-PROTEIN
interaction	|O
resulted	|O
in	|O
the	|O
aberrant	|O
nuclear	|O
localization	|O
of	|O
ERK2	|B-PROTEIN
-	|O
Delta19	|B-PROTEIN
-	|I-PROTEIN
25	|I-PROTEIN
mutants	|O
in	|O
serum	|O
-	|O
starved	|O
cells	|O
.	|O

Pmt2	|B-PROTEIN
is	|O
a	|O
member	|O
of	|O
a	|O
six	|O
-	|O
protein	|O
family	|O
in	|O
yeast	|O
that	|O
catalyzes	|O
the	|O
first	|O
step	|O
in	|O
O	|O
mannosylation	|O
of	|O
target	|O
proteins	|O
.	|O

Fecal	|O
samples	|O
were	|O
collected	|O
at	|O
the	|O
beginning	|O
and	|O
end	|O
of	|O
each	|O
trial	|O
period	|O
and	|O
were	|O
analyzed	|O
for	|O
gastrointestinal	|O
nematode	|O
eggs	|O
and	|O
Giardia	|O
cyst	|O
.	|O

The	|O
aim	|O
of	|O
this	|O
study	|O
was	|O
to	|O
determine	|O
the	|O
risk	|O
factors	|O
for	|O
background	|O
diabetic	|O
retinopathy	|O
(	|O
BDR	|O
)	|O
and	|O
PDR	|O
by	|O
following	|O
394	|O
Japanese	|O
patients	|O
with	|O
early	|O
-	|O
onset	|O
type	|O
2	|O
diabetes	|O
diagnosed	|O
before	|O
30	|O
years	|O
of	|O
age	|O
(	|O
mean	|O
age	|O
27	|O
,	|O
mean	|O
blood	|O
pressure	|O
at	|O
entry	|O
116/73	|O
mm	|O
Hg	|O
)	|O
.	|O

Of	|O
the	|O
21	|O
quadrants	|O
positive	|O
in	|O
the	|O
controls	|O
,	|O
17	|O
were	|O
correlated	|O
with	|O
previously	|O
detected	|O
jaw	|O
pathoses	|O
.	|O

Four	|O
cases	|O
of	|O
synovial	|O
chondromatosis	|O
are	|O
presented	|O
.	|O

Previous	|O
studies	|O
have	|O
shown	|O
that	|O
the	|O
pro	|O
-	|O
inflammatory	|O
cytokines	|O
tumor	|B-PROTEIN
necrosis	|I-PROTEIN
factor	|I-PROTEIN
alpha	|I-PROTEIN
and	|O
interferon	|B-PROTEIN
gamma	|I-PROTEIN
reduce	|O
the	|O
expression	|O
of	|O
the	|O
cystic	|B-PROTEIN
fibrosis	|I-PROTEIN
transmembrane	|I-PROTEIN
conductance	|I-PROTEIN
regulator	|I-PROTEIN
(	|O
CFTR	|B-PROTEIN
)	|O
gene	|O
(	|O
CFTR	|B-PROTEIN
)	|O
in	|O
HT	|O
-	|O
29	|O
and	|O
T84	|O
cells	|O
by	|O
acting	|O
post	|O
-	|O
transcriptionally	|O
.	|O

Regulation	|O
of	|O
RhoA	|B-PROTEIN
is	|O
required	|O
to	|O
maintain	|O
adhesion	|O
in	|O
stationary	|O
cells	|O
,	|O
but	|O
is	|O
also	|O
critical	|O
for	|O
cell	|O
spreading	|O
and	|O
migration	|O
[	|O
3	|O
]	|O
.	|O

Here	|O
we	|O
show	|O
in	|O
mouse	|O
fibroblasts	|O
stably	|O
transformed	|O
by	|O
v	|B-PROTEIN
-	|I-PROTEIN
Src	|I-PROTEIN
that	|O
mRNA	|O
and	|O
protein	|O
levels	|O
of	|O
p21	|B-PROTEIN
(	|O
WAF1	|B-PROTEIN
/	|O
CIP1	|B-PROTEIN
)	|O
,	|O
cyclin	|B-PROTEIN
D1	|I-PROTEIN
,	|O
and	|O
cyclin	|B-PROTEIN
E	|I-PROTEIN
are	|O
elevated	|O
.	|O

ORFA	|O
and	|O
ccdA	|B-PROTEIN
were	|O
constitutively	|O
cotranscribed	|O
as	|O
determined	|O
by	|O
primer	|O
extension	|O
analysis	|O
.	|O

Mouse	|O
Impact	|B-PROTEIN
is	|O
a	|O
paternally	|O
expressed	|O
gene	|O
encoding	|O
an	|O
evolutionarily	|O
conserved	|O
protein	|O
of	|O
unknown	|O
function	|O
.	|O

These	|O
cells	|O
produced	|O
P2Y	|B-PROTEIN
(	|I-PROTEIN
11	|I-PROTEIN
)	|I-PROTEIN
mRNA	|O
during	|O
culture	|O
.	|O

Coexpression	|O
studies	|O
indicate	|O
that	|O
insulin	|B-PROTEIN
and	|O
PKB	|B-PROTEIN
suppress	|O
transactivation	|O
by	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBPbeta	|I-PROTEIN
,	|O
but	|O
not	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBPalpha	|I-PROTEIN
,	|O
and	|O
that	|O
N	|O
-	|O
terminal	|O
transactivation	|O
domains	|O
in	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBPbeta	|I-PROTEIN
are	|O
required	|O
.	|O

Among	|O
eight	|O
graminaceous	|O
species	|O
tested	|O
,	|O
Ids3	|B-PROTEIN
expression	|O
was	|O
observed	|O
only	|O
in	|O
Fe	|O
-	|O
deficient	|O
roots	|O
of	|O
H.	|O
vulgare	|O
and	|O
Secale	|O
cereale	|O
.	|O
which	|O
not	|O
only	|O
secrete	|O
2'	|O
-	|O
deoxymugineic	|O
acid	|O
(	|O
DMA	|O
)	|O
,	|O
but	|O
also	|O
mugineic	|O
acid	|O
(	|O
MA	|O
)	|O
and	|O
3	|O
-	|O
epihydroxymugineic	|O
acid	|O
(	|O
epiHMA	|O
,	|O
H.	|O
vulgare	|O
)	|O
,	|O
and	|O
3	|O
-	|O
hydroxymugineic	|O
acid	|O
(	|O
HMA	|O
,	|O
S.	|O
cereale	|O
)	|O
.	|O

In	|O
contrast	|O
,	|O
high	|O
COUP	|B-PROTEIN
-	|I-PROTEIN
TFI	|I-PROTEIN
expression	|O
impeded	|O
the	|O
neuronal	|O
differentiation	|O
of	|O
P19	|O
cells	|O
induced	|O
with	|O
RA	|O
,	|O
resulting	|O
in	|O
cell	|O
cultures	|O
lacking	|O
neurons	|O
.	|O

Because	|O
PET	|O
is	|O
also	|O
useful	|O
for	|O
the	|O
pretreatment	|O
and	|O
follow	|O
-	|O
up	|O
evaluation	|O
,	|O
the	|O
use	|O
of	|O
stereotactic	|O
PET	|O
in	|O
these	|O
patients	|O
can	|O
enable	|O
an	|O
accurate	|O
comparison	|O
of	|O
PET	|O
-	|O
based	|O
metabolic	|O
data	|O
with	|O
MR	|O
-	|O
based	|O
anatomical	|O
data	|O
.	|O

Therefore	|O
,	|O
in	|O
our	|O
in	|O
vitro	|O
model	|O
,	|O
the	|O
localization	|O
of	|O
the	|O
mutation	|O
in	|O
the	|O
K	|B-PROTEIN
-	|I-PROTEIN
ras	|I-PROTEIN
gene	|O
predisposes	|O
to	|O
a	|O
different	|O
level	|O
of	|O
aggressiveness	|O
in	|O
the	|O
transforming	|O
phenotype	|O
.	|O

Here	|O
,	|O
we	|O
describe	|O
the	|O
isolation	|O
of	|O
MdPin1	|B-PROTEIN
,	|O
a	|O
Pin1	|B-PROTEIN
homologue	|O
from	|O
the	|O
plant	|O
species	|O
apple	|O
(	|O
Malus	|O
domestica	|O
)	|O
and	|O
show	|O
that	|O
it	|O
has	|O
the	|O
same	|O
phosphorylation	|O
-	|O
specific	|O
substrate	|O
specificity	|O
and	|O
can	|O
be	|O
inhibited	|O
by	|O
juglone	|O
in	|O
vitro	|O
,	|O
as	|O
is	|O
the	|O
case	|O
for	|O
Pin1	|B-PROTEIN
.	|O

Differential	|O
association	|O
of	|O
products	|O
of	|O
alternative	|O
transcripts	|O
of	|O
the	|O
candidate	|O
tumor	|O
suppressor	|O
ING1	|B-PROTEIN
with	|O
the	|O
mSin3	|B-PROTEIN
/	|O
HDAC1	|B-PROTEIN
transcriptional	|O
corepressor	|O
complex	|O
.	|O

These	|O
and	|O
other	|O
data	|O
presented	|O
suggest	|O
that	|O
TAg	|B-PROTEIN
're	|O
-	|O
models	|O
'	|O
host	|O
cell	|O
transcription	|O
factors	|O
that	|O
are	|O
used	|O
early	|O
in	|O
viral	|O
infection	|O
,	|O
and	|O
thereby	|O
mimics	|O
an	|O
event	|O
that	|O
naturally	|O
occurs	|O
during	|O
transformation	|O
.	|O

This	|O
sensitivity	|O
analysis	|O
showed	|O
that	|O
the	|O
practical	|O
limits	|O
of	|O
the	|O
accuracy	|O
of	|O
the	|O
used	|O
screening	|O
test	|O
jeopardize	|O
the	|O
estimation	|O
of	|O
the	|O
true	|O
herd	|O
prevalence	|O
within	|O
reasonable	|O
confidence	|O
limits	|O
,	|O
because	|O
the	|O
within	|O
-	|O
herd	|O
PTB	|O
true	|O
prevalence	|O
was	|O
low.F	|O
or	|O
this	|O
reason	|O
we	|O
augmented	|O
the	|O
herd	|O
specificity	|O
for	|O
herds	|O
with	|O
larger	|O
adult	|O
herd	|O
size	|O
(	|O
>	|O
5	|O
)	|O
.	|O

ORFK10.5	|B-PROTEIN
encodes	|O
a	|O
protein	|O
,	|O
latency	|B-PROTEIN
-	|I-PROTEIN
associated	|I-PROTEIN
nuclear	|I-PROTEIN
antigen	|I-PROTEIN
2	|I-PROTEIN
(	|O
LANA2	|B-PROTEIN
)	|O
,	|O
which	|O
is	|O
expressed	|O
in	|O
KSHV	|O
-	|O
infected	|O
hematopoietic	|O
tissues	|O
,	|O
including	|O
PEL	|O
and	|O
CD	|O
but	|O
not	|O
KS	|O
lesions	|O
.	|O

As	|O
hypothesized	|O
,	|O
believers	|O
showed	|O
relatively	|O
higher	|O
right	|O
hemispheric	|O
activation	|O
and	|O
reduced	|O
hemispheric	|O
asymmetry	|O
of	|O
functional	|O
complexity	|O
.	|O

In	|O
Xenopus	|O
,	|O
BMPs	|B-PROTEIN
act	|O
as	|O
epidermal	|O
inducers	|O
and	|O
also	|O
as	|O
negative	|O
regulators	|O
of	|O
neurogenesis	|O
.	|O

Presently	|O
four	|O
unique	|O
variants	|O
carrying	|O
distinct	|O
GAF	|B-PROTEIN
sequences	|O
in	|O
the	|O
N	|O
-	|O
terminal	|O
region	|O
have	|O
been	|O
identified	|O
.	|O

Genomic	|O
organization	|O
of	|O
the	|O
human	|O
phosphodiesterase	|O
PDE11A	|B-PROTEIN
gene	|O
.	|O

The	|O
present	|O
findings	|O
revealed	|O
that	|O
the	|O
rib	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
protein	|O
was	|O
a	|O
unique	|O
alpha1	|B-PROTEIN
,	|I-PROTEIN
4	|I-PROTEIN
-	|I-PROTEIN
N	|I-PROTEIN
-	|I-PROTEIN
acetylglucosaminyltransferase	|I-PROTEIN
involved	|O
in	|O
the	|O
biosynthetic	|O
initiation	|O
and	|O
elongation	|O
of	|O
heparan	|O
sulfate	|O
.	|O

Inhibition	|O
of	|O
the	|O
Mek	|B-PROTEIN
/	|O
Erk	|B-PROTEIN
pathway	|O
in	|O
Rat1	|O
/	|O
ras	|B-PROTEIN
cells	|O
,	|O
using	|O
the	|O
Mek	|B-PROTEIN
inhibitor	|O
,	|O
PD98059	|O
,	|O
resulted	|O
in	|O
complete	|O
cytoskeletal	|O
recovery	|O
,	|O
indistinguishable	|O
from	|O
that	|O
induced	|O
by	|O
HR12	|O
.	|O

The	|O
transcription	|O
factor	|O
CHOP	|B-PROTEIN
/	|O
GADD153	|B-PROTEIN
gene	|O
is	|O
induced	|O
by	|O
cellular	|O
stress	|O
and	|O
is	|O
involved	|O
in	|O
mediating	|O
apoptosis	|O
.	|O

Addition	|O
of	|O
synthetic	|O
tyrosine	|O
-	|O
phosphorylated	|O
peptides	|O
derived	|O
from	|O
betac	|O
cytoplasmic	|O
tyrosines	|O
prior	|O
to	|O
GM	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
stimulation	|O
inhibited	|O
the	|O
in	|O
vitro	|O
activation	|O
of	|O
STAT5	|B-PROTEIN
.	|O

MAIN	|O
OUTCOME	|O
MEASURES	|O
:	|O
Percentage	|O
change	|O
in	|O
the	|O
apnea	|O
-	|O
hypopnea	|O
index	|O
(	|O
AHI	|O
;	|O
apnea	|O
events	|O
+	|O
hypopnea	|O
events	|O
per	|O
hour	|O
of	|O
sleep	|O
)	|O
and	|O
odds	|O
of	|O
developing	|O
moderate	|O
-	|O
to	|O
-	|O
severe	|O
SDB	|O
(	|O
defined	|O
by	|O
an	|O
AHI	|O
>	|O
or	|O
=	|O
15	|O
events	|O
per	|O
hour	|O
of	|O
sleep	|O
)	|O
,	|O
with	|O
respect	|O
to	|O
change	|O
in	|O
weight	|O
.	|O

Paraneoplastic	|O
rheumatic	|O
syndromes	|O
.	|O

This	|O
article	|O
reviews	|O
recent	|O
information	|O
on	|O
the	|O
frequency	|O
,	|O
characteristics	|O
,	|O
and	|O
possible	|O
pathogenic	|O
mechanisms	|O
of	|O
the	|O
vasculitides	|O
occurring	|O
in	|O
patients	|O
with	|O
the	|O
main	|O
connective	|O
tissue	|O
diseases	|O
.	|O

Tec	|B-PROTEIN
kinase	|I-PROTEIN
signaling	|O
in	|O
T	|O
cells	|O
is	|O
regulated	|O
by	|O
phosphatidylinositol	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
and	|O
the	|O
Tec	|B-PROTEIN
pleckstrin	|O
homology	|O
domain	|O
.	|O

Current	|O
evidence	|O
for	|O
this	|O
type	|O
of	|O
DNA	|O
supercoiling	|O
-	|O
dependent	|O
transcriptional	|O
coupling	|O
,	|O
based	|O
largely	|O
on	|O
the	|O
in	|O
vivo	|O
activities	|O
of	|O
promoters	|O
contained	|O
in	|O
engineered	|O
DNA	|O
constructs	|O
,	|O
suggests	|O
that	|O
the	|O
transcription	|O
complex	|O
must	|O
be	|O
physically	|O
hindered	|O
to	|O
generate	|O
DNA	|O
supercoils	|O
and	|O
to	|O
prevent	|O
their	|O
diffusion	|O
throughout	|O
the	|O
DNA	|O
duplex	|O
.	|O

The	|O
structure	|O
of	|O
the	|O
free	|O
SH2	|B-PROTEIN
domain	|O
has	|O
been	|O
compared	|O
to	|O
that	|O
of	|O
the	|O
SH2	|B-PROTEIN
complexed	|O
with	|O
a	|O
doubly	|O
phosphorylated	|O
peptide	|O
derived	|O
from	|O
polyomavirus	|O
middle	|B-PROTEIN
T	|I-PROTEIN
antigen	|I-PROTEIN
(	|O
MT	|B-PROTEIN
)	|O
.	|O

We	|O
have	|O
identified	|O
three	|O
binding	|O
sites	|O
for	|O
protein	|O
complexes	|O
:	|O
a	|O
palindrome	|O
,	|O
a	|O
direct	|O
repeat	|O
,	|O
and	|O
a	|O
C+	|O
T	|O
sequence	|O
that	|O
corresponds	|O
to	|O
seven	|O
GAGA	|O
motifs	|O
on	|O
the	|O
transcribed	|O
strand	|O
.	|O

Copyright	|O
2000	|O
Academic	|O
Press	|O
.	|O

Nucleotide	|O
sequence	|O
,	|O
genome	|O
organization	|O
and	|O
phylogenetic	|O
analysis	|O
of	|O
pineapple	|O
mealybug	|O
wilt	|O
-	|O
associated	|O
virus	|O
-	|O
2	|O
.	|O

Patients	|O
underwent	|O
pretreatment	|O
cystoscopy	|O
and	|O
detailed	|O
tumor	|O
mapping	|O
,	|O
and	|O
were	|O
treated	|O
with	|O
75	|O
mg	|O
.	|O
/	|O
m.2	|O
cisplatin	|O
on	|O
day	|O
1	|O
and	|O
1	|O
gm	|O
.	|O
/	|O
m.2	|O
daily	|O
,	|O
5	|O
-	|O
fluorouracil	|O
on	|O
days	|O
1	|O
to	|O
4	|O
and	|O
definitive	|O
radiotherapy	|O
.	|O

All	|O
9	|O
untreated	|O
patients	|O
underwent	|O
laparoscopy	|O
,	|O
which	|O
identified	|O
3	|O
intra	|O
-	|O
abdominal	|O
,	|O
3	|O
vanished	|O
and	|O
2	|O
peeping	|O
testes	|O
,	|O
and	|O
1	|O
atrophic	|O
testis	|O
in	|O
the	|O
inguinal	|O
canal	|O
.	|O

This	|O
philosophy	|O
was	|O
instituted	|O
for	|O
the	|O
compound	|O
RP	|O
73401	|O
,	|O
a	|O
specific	|O
phosphodiesterase	|B-PROTEIN
IV	|I-PROTEIN
inhibitor	|O
,	|O
that	|O
was	|O
being	|O
developed	|O
simultaneously	|O
for	|O
delivery	|O
by	|O
both	|O
oral	|O
and	|O
pulmonary	|O
routes	|O
of	|O
administration	|O
.	|O

Increased	|O
levels	|O
of	|O
anticardiolipin	|O
immunoglobulin	|B-PROTEIN
G	|I-PROTEIN
may	|O
also	|O
cause	|O
bleeding	|O
.	|O

RESULTS	|O
:	|O
Prevalence	|O
of	|O
obesity	|O
(	|O
BMI	|O
SDS	|O
>	|O
2.0	|O
)	|O
was	|O
<	|O
2%	|O
at	|O
diagnosis	|O
,	|O
but	|O
increased	|O
to	|O
16%	|O
at	|O
3y	|O
.	|O

One	|O
of	|O
the	|O
sequelae	|O
of	|O
the	|O
antiphospholipid	|O
-	|O
antibodies	|O
is	|O
an	|O
impaired	|O
uteroplacental	|O
circulation	|O
.	|O

Bupropion	|O
to	|O
aid	|O
smoking	|O
cessation	|O
.	|O

Using	|O
a	|O
natural	|O
dominant	|O
negative	|O
for	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
transcriptional	|O
activity	|O
in	|O
ROS	|O
17/2.8	|O
cells	|O
,	|O
we	|O
then	|O
showed	|O
that	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
transcription	|O
factors	|O
mediated	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta1	|I-PROTEIN
-	|O
and	|O
BMP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
-	|O
regulated	|O
expression	|O
of	|O
the	|O
(	|B-PROTEIN
alpha1	|I-PROTEIN
)	|I-PROTEIN
collagen	|I-PROTEIN
I	|I-PROTEIN
gene	|O
as	|O
well	|O
as	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta1	|I-PROTEIN
-	|O
regulated	|O
expression	|O
of	|O
the	|O
parathyroid	|B-PROTEIN
hormone	|I-PROTEIN
(	|O
PTH	|B-PROTEIN
)	|O
/	|O
PTH	|B-PROTEIN
-	|I-PROTEIN
related	|I-PROTEIN
peptide	|I-PROTEIN
(	|I-PROTEIN
PTHrP	|I-PROTEIN
)	|I-PROTEIN
receptor	|I-PROTEIN
.	|O

PM	|O
12	|O
or	|O
18	|O
mg	|O
/	|O
kg	|O
daily	|O
plus	|O
a	|O
standard	|O
dose	|O
of	|O
SB	|O
for	|O
21	|O
days	|O
was	|O
statistically	|O
more	|O
effective	|O
than	|O
SB	|O
in	|O
producing	|O
a	|O
final	|O
cure	|O
for	|O
patients	|O
with	|O
VL	|O
in	|O
Bihar	|O
,	|O
India	|O
.	|O

Adjuvant	|O
therapy	|O
for	|O
colon	|O
cancer	|O
]	|O
Surgery	|O
alone	|O
may	|O
fail	|O
to	|O
cure	|O
a	|O
considerable	|O
number	|O
of	|O
locally	|O
advanced	|O
colon	|O
cancers	|O
.	|O

There	|O
were	|O
significant	|O
differences	|O
(	|O
p	|O
<	|O
0.05	|O
)	|O
between	|O
the	|O
fracture	|O
and	|O
nonfracture	|O
groups	|O
in	|O
the	|O
total	|O
femur	|O
BMD	|O
(	|O
13%	|O
)	|O
,	|O
trabecular	|O
BMD	|O
in	|O
the	|O
distal	|O
radius	|O
(	|O
4%	|O
)	|O
,	|O
and	|O
the	|O
fractal	|O
dimension	|O
in	|O
the	|O
radiographs	|O
(	|O
FD2	|O
)	|O
(	|O
3%	|O
)	|O
.	|O

BACKGROUND	|O
:	|O
The	|O
aim	|O
of	|O
this	|O
study	|O
was	|O
to	|O
determine	|O
and	|O
compare	|O
interleukin	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
(	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
)	|O
levels	|O
in	|O
gingival	|O
crevicular	|O
fluid	|O
(	|O
GCF	|O
)	|O
and	|O
clinical	|O
periodontal	|O
findings	|O
in	|O
patients	|O
with	|O
rheumatoid	|O
arthritis	|O
(	|O
RA	|O
)	|O
and	|O
adult	|O
periodontitis	|O
(	|O
AP	|O
)	|O
.	|O

In	|O
a	|O
prospective	|O
,	|O
multicentre	|O
trial	|O
the	|O
efficacy	|O
of	|O
an	|O
Vitex	|O
agnus	|O
castus	|O
L	|O
extract	|O
Ze	|O
440	|O
was	|O
investigated	|O
in	|O
50	|O
patients	|O
with	|O
pre	|O
-	|O
menstrual	|O
syndrome	|O
(	|O
PMS	|O
)	|O
.	|O

Studies	|O
are	|O
necessary	|O
to	|O
assess	|O
the	|O
source	|O
of	|O
contamination	|O
and	|O
potential	|O
role	|O
of	|O
MRSA	|O
-	|O
contaminated	|O
milk	|O
in	|O
the	|O
transmission	|O
of	|O
MRSA	|O
to	|O
neonates	|O
.	|O

Effects	|O
of	|O
Trypanosoma	|O
vivax	|O
on	|O
pregnancy	|O
of	|O
Yankasa	|O
sheep	|O
and	|O
the	|O
results	|O
of	|O
homidum	|O
chloride	|O
chemotherapy	|O
.	|O

NF	|B-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
was	|O
activated	|O
to	|O
a	|O
much	|O
greater	|O
extent	|O
by	|O
roscovitine	|O
in	|O
the	|O
WT	|O
cells	|O
than	|O
in	|O
Y8	|O
cells	|O
.	|O

Depending	|O
on	|O
treatment	|O
exposures	|O
,	|O
this	|O
at	|O
-	|O
risk	|O
population	|O
may	|O
experience	|O
life	|O
-	|O
threatening	|O
late	|O
effects	|O
,	|O
such	|O
as	|O
cirrhosis	|O
secondary	|O
to	|O
hepatitis	|O
C	|O
or	|O
late	|O
-	|O
onset	|O
anthracycline	|O
-	|O
induced	|O
cardiomyopathy	|O
,	|O
or	|O
life	|O
-	|O
changing	|O
late	|O
effects	|O
,	|O
such	|O
as	|O
cognitive	|O
dysfunction	|O
.	|O

The	|O
presence	|O
of	|O
locus	|O
-	|O
specific	|O
residues	|O
throughout	|O
the	|O
entire	|O
promoter	|O
region	|O
strongly	|O
suggests	|O
that	|O
the	|O
various	|O
HLA	|B-PROTEIN
class	|I-PROTEIN
I	|I-PROTEIN
loci	|O
are	|O
differentially	|O
regulated	|O
.	|O

Because	|O
the	|O
number	|O
of	|O
parameters	|O
required	|O
by	|O
a	|O
Volterra	|O
series	|O
grows	|O
rapidly	|O
with	|O
both	|O
the	|O
length	|O
of	|O
its	|O
memory	|O
and	|O
the	|O
order	|O
of	|O
its	|O
nonlinearity	|O
,	|O
methods	|O
for	|O
identifying	|O
these	|O
models	|O
from	|O
measurements	|O
of	|O
input	|O
/	|O
output	|O
data	|O
are	|O
limited	|O
to	|O
low	|O
-	|O
order	|O
systems	|O
with	|O
relatively	|O
short	|O
memories	|O
.	|O

The	|O
standard	|O
method	|O
for	|O
calculating	|O
the	|O
composite	|O
score	|O
on	|O
the	|O
S	|O
-	|O
B	|O
IV	|O
excludes	|O
subtests	|O
with	|O
a	|O
raw	|O
score	|O
of	|O
0	|O
,	|O
which	|O
overestimates	|O
cognitive	|O
functioning	|O
in	|O
young	|O
biologically	|O
high	|O
risk	|O
children	|O
.	|O

NiCl	|O
(	|O
2	|O
)	|O
-	|O
induced	|O
MCP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
synthesis	|O
required	|O
activation	|O
of	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
since	|O
mutation	|O
of	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
-	|O
binding	|O
sites	|O
in	|O
the	|O
promoter	|O
resulted	|O
in	|O
complete	|O
loss	|O
of	|O
inducible	|O
promoter	|O
activity	|O
.	|O

Engagement	|O
of	|O
human	|O
CD2	|B-PROTEIN
by	|O
mitogenic	|O
pairs	|O
of	|O
anti	|O
-	|O
CD2	|B-PROTEIN
mAb	|I-PROTEIN
induces	|O
tyrosine	|O
phosphorylation	|O
of	|O
a	|O
number	|O
of	|O
intracellular	|O
proteins	|O
including	|O
a	|O
120	|O
kDa	|O
phosphoprotein	|O
that	|O
we	|O
identify	|O
as	|O
the	|O
proto	|O
-	|O
oncogene	|O
c	|B-PROTEIN
-	|I-PROTEIN
Cbl	|I-PROTEIN
.	|O

Validity	|O
of	|O
NIR	|O
spectroscopy	|O
for	|O
quantitatively	|O
measuring	|O
muscle	|O
oxidative	|O
metabolic	|O
rate	|O
in	|O
exercise	|O
.	|O

Previous	|O
studies	|O
have	|O
demonstrated	|O
that	|O
tissue	|O
-	|O
restricted	|O
transcription	|O
factors	|O
including	|O
PU.1	|B-PROTEIN
and	|O
PU.1	|B-PROTEIN
interaction	|I-PROTEIN
partner	|I-PROTEIN
(	|O
PIP	|B-PROTEIN
)	|O
function	|O
synergistically	|O
with	|O
c	|B-PROTEIN
-	|I-PROTEIN
Fos	|I-PROTEIN
plus	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
to	|O
stimulate	|O
the	|O
kappaE3	|B-PROTEIN
'	|I-PROTEIN
-	|O
enhancer	|O
in	|O
3T3	|O
cells	|O
.	|O

The	|O
murine	|O
int	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
locus	|O
,	|O
identified	|O
as	|O
a	|O
frequent	|O
integration	|O
site	|O
of	|O
mouse	|O
mammary	|O
tumor	|O
viruses	|O
,	|O
encodes	|O
the	|O
48	|O
-	|O
kDa	|O
eIF3e	|O
subunit	|O
of	|O
translation	|O
initiation	|O
factor	|O
eIF3	|B-PROTEIN
.	|O

An	|O
int6	|B-PROTEIN
deletion	|O
(	|O
int6Delta	|B-PROTEIN
)	|O
mutant	|O
was	|O
viable	|O
but	|O
grew	|O
slowly	|O
in	|O
minimal	|O
medium	|O
.	|O

Additionally	|O
,	|O
MIP	|B-PROTEIN
-	|I-PROTEIN
2A	|I-PROTEIN
antagonizes	|O
cell	|O
growth	|O
regulatory	|O
role	|O
of	|O
MBP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

We	|O
produced	|O
transgenic	|O
plants	|O
expressing	|O
the	|O
antisense	|O
Arabidopsis	|B-PROTEIN
HD	|I-PROTEIN
(	|O
AtHD1	|B-PROTEIN
)	|O
gene	|O
.	|O

3.04	|O
+	|O
/	|O
-	|O
1.2	|O
,	|O
P	|O
<	|O
0.0001	|O
)	|O
,	|O
large	|O
accelerations	|O
/	|O
30	|O
min	|O
(	|O
1.46	|O
+	|O
/	|O
-	|O
1.96	|O
vs.	|O

Four	|O
transcription	|O
initiation	|O
sites	|O
have	|O
been	|O
identified	|O
by	|O
full	|O
-	|O
length	|O
RNA	|B-PROTEIN
ligase	|I-PROTEIN
-	|O
mediated	|O
rapid	|O
amplification	|O
of	|O
cDNA	|O
ends	|O
(	|O
RLM	|O
-	|O
RACE	|O
)	|O
between	|O
-	|O
61	|O
and	|O
-	|O
32	|O
bp	|O
from	|O
the	|O
translation	|O
initiation	|O
codon.R	|O
everse	|O
transcription	|O
-	|O
PCR	|O
analysis	|O
revealed	|O
that	|O
PFK	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
,	|O
PFK	|B-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
and	|O
PFK	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
genes	|O
were	|O
expressed	|O
,	|O
in	|O
all	|O
mouse	|O
tissues	|O
tested	|O
,	|O
at	|O
varying	|O
levels	|O
.	|O

PFK	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
mRNA	|O
was	|O
more	|O
abundantly	|O
expressed	|O
in	|O
all	|O
tissues	|O
than	|O
were	|O
the	|O
PFK	|B-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
and	|O
PFK	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
genes	|O
.	|O

We	|O
used	|O
the	|O
Toshiba	|O
IIDR	|O
system	|O
,	|O
which	|O
is	|O
composed	|O
of	|O
an	|O
X	|O
-	|O
ray	|O
TV	|O
system	|O
and	|O
a	|O
digital	|O
image	|O
managing	|O
circuit	|O
.	|O

In	|O
whole	|O
sardine	|O
,	|O
domoic	|O
acid	|O
was	|O
detected	|O
in	|O
levels	|O
exceeding	|O
sometimes	|O
the	|O
regulatory	|O
limit	|O
.	|O

In	|O
addition	|O
,	|O
we	|O
identified	|O
two	|O
mutations	|O
,	|O
Delta	|O
M1281	|O
and	|O
IVS51+	|O
5G	|O
-	|O
-	|O
>	|O
A	|O
,	|O
in	|O
a	|O
German	|O
USH1	|B-PROTEIN
patient	|O
.	|O

Closeup	|O
:	|O
a	|O
resource	|O
for	|O
nurses	|O
who	|O
smoke	|O
.	|O

[	|O
18F	|O
]	|O
(	|O
+	|O
)	|O
-	|O
4	|O
-	|O
fluorobenzyltrozamicol	|O
(	|O
FBT	|O
)	|O
,	|O
which	|O
selectively	|O
binds	|O
to	|O
the	|O
vesicular	|O
acetylcholine	|B-PROTEIN
transporter	|I-PROTEIN
in	|O
the	|O
presynaptic	|O
cholinergic	|O
neuron	|O
,	|O
has	|O
previously	|O
been	|O
shown	|O
to	|O
be	|O
a	|O
useful	|O
ligand	|O
for	|O
the	|O
study	|O
of	|O
cholinergic	|O
terminal	|O
density	|O
in	|O
the	|O
basal	|O
ganglia	|O
with	|O
PET	|O
.	|O

We	|O
demonstrate	|O
that	|O
the	|O
protein	|O
is	|O
a	|O
murine	|O
homologue	|O
of	|O
SAF	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
which	|O
has	|O
been	|O
shown	|O
to	|O
bind	|O
selectively	|O
to	|O
MARs	|O
and	|O
is	|O
responsible	|O
for	|O
the	|O
satMa	|B-PROTEIN
-	|O
binding	|O
activity	|O
in	|O
the	|O
chromatographic	|O
fractions	|O
.	|O

The	|O
molecular	|O
associations	|O
dictating	|O
INCENP	|B-PROTEIN
behavior	|O
during	|O
mitosis	|O
are	|O
currently	|O
unknown	|O
.	|O

Ang	|B-PROTEIN
II	|I-PROTEIN
significantly	|O
induced	|O
Ang2	|B-PROTEIN
mRNA	|O
accumulations	|O
without	|O
affecting	|O
Ang1	|B-PROTEIN
or	|O
Tie2	|B-PROTEIN
expression	|O
,	|O
which	|O
was	|O
inhibited	|O
by	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
C	|I-PROTEIN
inhibitors	|O
and	|O
by	|O
intracellular	|O
Ca	|O
(	|O
2+	|O
)	|O
chelating	|O
agents	|O
.	|O

Promoter	|O
analysis	|O
demonstrated	|O
that	|O
the	|O
sequence	|O
identical	|O
to	|O
consensus	|O
cAMP	|O
-	|O
responsive	|O
element	|O
(	|O
CRE	|O
)	|O
located	|O
at	|O
-	|O
481	|O
of	|O
the	|O
SMemb	|B-PROTEIN
promoter	|O
was	|O
critical	|O
for	|O
Hex	|B-PROTEIN
responsiveness	|O
.	|O

LH	|B-PROTEIN
/	|I-PROTEIN
CG	|I-PROTEIN
receptor	|I-PROTEIN
activation	|O
of	|O
ARNO	|B-PROTEIN
is	|O
not	|O
mediated	|O
by	|O
activation	|O
of	|O
phosphatidylinositol	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
PI	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
)	|O
or	|O
by	|O
G	|B-PROTEIN
protein	|I-PROTEIN
beta	|O
gamma	|O
subunits	|O
.	|O

Deletion	|O
analysis	|O
showed	|O
that	|O
the	|O
-	|O
321	|O
/	|O
+	|O
41	|O
sequence	|O
was	|O
sufficient	|O
for	|O
both	|O
the	|O
constitutive	|O
promoter	|O
activity	|O
and	|O
auto	|O
-	|O
activation	|O
and	|O
electrophoretic	|O
mobility	|O
shift	|O
assays	|O
identified	|O
the	|O
interaction	|O
of	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBPs	|I-PROTEIN
and	|O
Sp1	|B-PROTEIN
to	|O
this	|O
region	|O
.	|O

Termination	|O
of	|O
induced	|O
VT	|O
on	|O
the	|O
first	|O
attempt	|O
was	|O
comparable	|O
with	|O
BV	|O
pacing	|O
(	|O
87.4%	|O
)	|O
versus	|O
RV	|O
pacing	|O
(	|O
89.6%	|O
)	|O
.	|O

We	|O
compare	|O
the	|O
results	|O
of	|O
this	|O
algorithm	|O
with	|O
the	|O
results	|O
obtained	|O
with	|O
two	|O
other	|O
algorithms	|O
,	|O
the	|O
optimal	|O
algorithm	|O
for	|O
monochannel	|O
nonoverlapping	|O
noise	|O
and	|O
the	|O
optimal	|O
algorithm	|O
for	|O
multichannel	|O
additive	|O
noise	|O
,	|O
and	|O
we	|O
show	|O
that	|O
in	|O
both	|O
cases	|O
improvement	|O
can	|O
be	|O
obtained	|O
.	|O

Changes	|O
in	|O
stimulation	|O
levels	|O
over	|O
time	|O
in	|O
nucleus	|O
22	|O
cochlear	|O
implant	|O
users	|O
.	|O

Nuclease	|O
probing	|O
and	|O
structure	|O
-	|O
directed	|O
mutagenesis	|O
revealed	|O
that	|O
the	|O
105	|O
-	|O
nt	|O
TE	|O
(	|O
TE105	|O
)	|O
forms	|O
a	|O
cruciform	|O
secondary	|O
structure	|O
containing	|O
four	|O
helices	|O
connected	|O
by	|O
single	|O
-	|O
stranded	|O
regions	|O
.	|O

Tele	|O
-	|O
Talk	|O
has	|O
the	|O
extra	|O
capability	|O
of	|O
operating	|O
in	|O
live	|O
conference	|O
situations	|O
using	|O
microphone	|O
input	|O
.	|O

A	|O
marked	|O
decrease	|O
in	|O
the	|O
type	|O
1	|O
insulin	|O
-	|O
like	|O
growth	|O
factor	|O
(	|B-PROTEIN
IGF	|I-PROTEIN
)	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
IGF	|B-PROTEIN
-	|I-PROTEIN
IR	|I-PROTEIN
)	|O
occurs	|O
in	|O
prostate	|O
epithelial	|O
cells	|O
during	|O
transformation	|O
from	|O
the	|O
benign	|O
to	|O
the	|O
metastatic	|O
state	|O
.	|O

The	|O
P69	|O
cell	|O
line	|O
was	|O
derived	|O
by	|O
immortalization	|O
of	|O
human	|O
primary	|O
prostate	|O
epithelial	|O
cells	|O
with	|O
simian	|O
virus	|O
-	|O
40	|O
T	|B-PROTEIN
antigen	|I-PROTEIN
and	|O
is	|O
rarely	|O
tumorigenic	|O
.	|O

We	|O
determined	|O
whether	|O
the	|O
human	|O
StAR	|B-PROTEIN
promoter	|O
is	|O
responsive	|O
to	|O
sterol	|B-PROTEIN
regulatory	|I-PROTEIN
element	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
proteins	|I-PROTEIN
(	|O
SREBPs	|B-PROTEIN
)	|O
.	|O

Expression	|O
of	|O
SREBP	|B-PROTEIN
-	|I-PROTEIN
1a	|I-PROTEIN
stimulated	|O
StAR	|B-PROTEIN
promoter	|O
activity	|O
in	|O
the	|O
context	|O
of	|O
COS	|O
-	|O
1	|O
cells	|O
and	|O
human	|O
granulosa	|O
-	|O
lutein	|O
cells	|O
.	|O

Because	|O
the	|O
high	|B-PROTEIN
-	|I-PROTEIN
density	|I-PROTEIN
lipoprotein	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
HDL	|B-PROTEIN
-	|I-PROTEIN
R	|I-PROTEIN
)	|O
is	|O
a	|O
key	|O
element	|O
in	|O
cholesterol	|O
homeostasis	|O
and	|O
a	|O
potential	|O
therapeutic	|O
target	|O
for	|O
hypercholesterolemic	|O
drugs	|O
,	|O
an	|O
understanding	|O
of	|O
HDL	|B-PROTEIN
-	|I-PROTEIN
R	|I-PROTEIN
regulation	|O
is	|O
essential	|O
.	|O

IFN	|B-PROTEIN
-	|I-PROTEIN
stimulated	|I-PROTEIN
gene	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
and	|O
STAT1	|B-PROTEIN
homodimers	|O
formed	|O
and	|O
bound	|O
an	|O
IFN	|B-PROTEIN
-	|I-PROTEIN
stimulated	|I-PROTEIN
response	|I-PROTEIN
element	|I-PROTEIN
(	|O
ISRE	|B-PROTEIN
)	|O
and	|O
gamma	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
sequence	|I-PROTEIN
(	|O
GAS	|B-PROTEIN
)	|O
element	|O
,	|O
respectively	|O
.	|O

We	|O
have	|O
therefore	|O
studied	|O
the	|O
molecular	|O
mechanisms	|O
of	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta1	|I-PROTEIN
action	|O
on	|O
thyroglobulin	|B-PROTEIN
(	|O
TG	|B-PROTEIN
)	|O
gene	|O
expression	|O
by	|O
focusing	|O
our	|O
attention	|O
on	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta1	|I-PROTEIN
regulation	|O
of	|O
thyroid	|O
-	|O
specific	|O
transcription	|O
factors	|O
.	|O

The	|O
epitope	|O
-	|O
protected	|O
lysine	|O
(	|O
K	|O
)	|O
was	|O
present	|O
in	|O
a	|O
30	|O
-	|O
aa	|O
TPO	|B-PROTEIN
fragment	|O
that	|O
,	|O
by	|O
N	|O
-	|O
terminal	|O
sequencing	|O
,	|O
was	|O
found	|O
to	|O
be	|O
K713	|O
.	|O

To	|O
understand	|O
the	|O
molecular	|O
regulation	|O
of	|O
these	|O
genes	|O
in	|O
thyroid	|O
cells	|O
,	|O
the	|O
effect	|O
of	|O
thyroid	|B-PROTEIN
transcription	|I-PROTEIN
factor	|I-PROTEIN
1	|I-PROTEIN
(	|O
TTF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
and	|O
the	|O
paired	|B-PROTEIN
domain	|I-PROTEIN
-	|I-PROTEIN
containing	|I-PROTEIN
protein	|I-PROTEIN
8	|I-PROTEIN
(	|O
Pax	|B-PROTEIN
-	|I-PROTEIN
8	|I-PROTEIN
)	|O
on	|O
the	|O
transcriptional	|O
activity	|O
of	|O
the	|O
deiodinase	|B-PROTEIN
promoters	|O
were	|O
studied	|O
.	|O

Regional	|O
blood	|O
blow	|O
was	|O
measured	|O
by	|O
means	|O
of	|O
microspheres	|O
in	|O
predefined	|O
regions	|O
of	|O
the	|O
C6	|O
,	|O
T11	|O
,	|O
and	|O
L6	|O
vertebrae	|O
.	|O

Activation	|O
of	|O
transcription	|O
through	|O
the	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
site	|O
in	|O
Jurkat	|O
cells	|O
by	|O
JunD	|B-PROTEIN
and	|O
/	|O
or	|O
Fra	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
was	|O
weak	|O
.	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
,	|O
JunB	|B-PROTEIN
,	|O
and	|O
c	|B-PROTEIN
-	|I-PROTEIN
Fos	|I-PROTEIN
activation	|O
was	|O
greater	|O
,	|O
although	|O
the	|O
level	|O
was	|O
still	|O
less	|O
than	|O
that	|O
with	|O
Tax	|B-PROTEIN
.	|O

The	|O
mechanism	|O
of	|O
ligand	|O
-	|O
activated	|O
estrogen	|B-PROTEIN
receptor	|I-PROTEIN
alpha	|I-PROTEIN
(	|O
ERalpha	|B-PROTEIN
)	|O
-	|O
dependent	|O
activation	|O
of	|O
gene	|O
expression	|O
through	|O
the	|O
SRE	|O
was	|O
determined	|O
by	|O
mutational	|O
analysis	|O
of	|O
the	|O
promoter	|O
,	|O
analysis	|O
of	|O
mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
MAPK	|B-PROTEIN
)	|O
pathway	|O
activation	|O
by	|O
E2	|O
,	|O
and	|O
transforming	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
alpha	|I-PROTEIN
(	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
)	|O
as	|O
a	|O
positive	|O
control	|O
.	|O

Perfusion	|O
technique	|O
for	|O
perfusion	|O
-	|O
assisted	|O
direct	|O
coronary	|O
artery	|O
bypass	|O
(	|O
PADCAB	|O
)	|O
.	|O

As	|O
well	|O
,	|O
mixtures	|O
of	|O
(	|O
LA	|O
)	|O
(	|O
12	|O
)	|O
with	|O
the	|O
longer	|O
chain	|O
PEs	|O
exhibit	|O
unusual	|O
biomodal	|O
enthalpy	|O
variations	|O
,	|O
suggesting	|O
peptide	|O
immiscibility	|O
in	|O
thicker	|O
gel	|O
state	|O
bilayers	|O
.	|O

CONCLUSIONS	|O
:	|O
Under	|O
current	|O
immunization	|O
practices	|O
,	|O
the	|O
authors	|O
estimate	|O
that	|O
nearly	|O
13,000	|O
Asian	|O
and	|O
Pacific	|O
Islander	|O
children	|O
living	|O
in	|O
the	|O
United	|O
States	|O
today	|O
will	|O
become	|O
infected	|O
with	|O
HBV	|O
in	|O
the	|O
future	|O
,	|O
resulting	|O
in	|O
more	|O
than	|O
600	|O
liver	|O
carcinoma	|O
deaths	|O
.	|O

We	|O
observed	|O
NP	|B-PROTEIN
/	|O
NMP4	|B-PROTEIN
/	|O
CIZ	|B-PROTEIN
expression	|O
in	|O
osteocytes	|O
,	|O
osteoblasts	|O
,	|O
and	|O
chondrocytes	|O
in	|O
rat	|O
bone	|O
.	|O

Chlamydia	|O
and	|O
cervical	|O
cancer	|O
:	|O
a	|O
real	|O
association	|O
?	|O

A	|O
novel	|O
approach	|O
was	|O
developed	|O
for	|O
identifying	|O
transcription	|O
factor	|O
activities	|O
associated	|O
with	|O
NGF	|B-PROTEIN
-	|O
activated	|O
,	|O
but	|O
not	|O
EGF	|B-PROTEIN
-	|O
activated	|O
,	|O
signaling	|O
,	|O
using	|O
random	|O
oligonucleotide	|O
clones	|O
from	|O
a	|O
DNA	|O
recognition	|O
library	|O
to	|O
isolate	|O
specific	|O
DNA	|O
binding	|O
proteins	|O
from	|O
PC12	|O
nuclear	|O
extracts	|O
.	|O

NGF	|B-PROTEIN
elicits	|O
a	|O
more	|O
delayed	|O
and	|O
sustained	|O
ERK	|B-PROTEIN
phosphorylation	|O
than	|O
EGF	|B-PROTEIN
,	|O
consistent	|O
with	|O
previous	|O
reports	|O
.	|O

NGF	|B-PROTEIN
,	|O
but	|O
not	|O
EGF	|B-PROTEIN
,	|O
enhances	|O
the	|O
upper	|O
bands	|O
,	|O
corresponding	|O
to	|O
phosphorylated	|O
Fra	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
.	|O

Energy	|O
expenditure	|O
was	|O
obtained	|O
using	|O
a	|O
primed	|O
,	|O
3	|O
-	|O
hour	|O
infusion	|O
of	|O
NaH	|O
(	|O
13	|O
)	|O
CO	|O
(	|O
3'	|O
)	|O
,	|O
breath	|O
(	|O
13	|O
)	|O
CO	|O
(	|O
2	|O
)	|O
enrichment	|O
determination	|O
by	|O
isotope	|O
ratio	|O
mass	|O
spectroscopy	|O
,	|O
and	|O
the	|O
application	|O
of	|O
a	|O
standard	|O
regression	|O
equation	|O
.	|O

Workload	|O
,	|O
UAPs	|O
,	|O
and	|O
you	|O
.	|O

The	|O
actA	|B-PROTEIN
gene	|O
is	|O
present	|O
as	|O
a	|O
single	|O
copy	|O
in	|O
the	|O
genome	|O
of	|O
A.	|O
chrysogenum	|O
;	|O
and	|O
its	|O
expression	|O
level	|O
,	|O
opposite	|O
to	|O
pcbC	|B-PROTEIN
and	|O
cefEF	|B-PROTEIN
cephalosporin	|O
biosynthetic	|O
genes	|O
,	|O
was	|O
steady	|O
during	|O
cephalosporin	|O
fermentation	|O
,	|O
showing	|O
a	|O
single	|O
1.4	|O
-	|O
kb	|O
transcript	|O
.	|O

Adding	|O
10	|O
mmol	|O
SDS	|O
/	|O
l	|O
led	|O
to	|O
transient	|O
inhibition	|O
of	|O
acidification	|O
,	|O
metal	|O
solubilization	|O
and	|O
sulfur	|O
oxidation	|O
.	|O

We	|O
have	|O
investigated	|O
the	|O
role	|O
of	|O
NGF	|B-PROTEIN
in	|O
regulating	|O
gene	|O
transcription	|O
in	|O
PC12	|O
and	|O
INS	|O
-	|O
1	|O
cells	|O
,	|O
in	|O
order	|O
to	|O
define	|O
if	|O
there	|O
are	|O
NGF	|B-PROTEIN
-	|O
regulated	|O
genes	|O
per	|O
se	|O
.	|O

Nine	|O
animals	|O
served	|O
as	|O
control	|O
animals	|O
,	|O
whereas	|O
20	|O
animals	|O
received	|O
a	|O
focal	|O
arachnoid	|O
scar	|O
at	|O
C1	|O
-	|O
C2	|O
,	|O
which	|O
was	|O
produced	|O
by	|O
placement	|O
of	|O
a	|O
kaolin	|O
-	|O
soaked	|O
fibrin	|B-PROTEIN
sponge	|O
on	|O
the	|O
posterior	|O
surface	|O
of	|O
the	|O
spinal	|O
cord	|O
.	|O

The	|O
Schistosoma	|B-PROTEIN
mansoni	|I-PROTEIN
homologue	|I-PROTEIN
(	|O
SmSmad2	|B-PROTEIN
)	|O
was	|O
overexpressed	|O
in	|O
bacteria	|O
as	|O
a	|O
Sj26	|B-PROTEIN
-	|O
GST	|B-PROTEIN
fusion	|O
protein	|O
and	|O
used	|O
to	|O
raise	|O
specific	|O
antibodies	|O
.	|O

These	|O
data	|O
indicate	|O
that	|O
the	|O
SmSmad2	|B-PROTEIN
responds	|O
to	|O
the	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
signals	|O
by	|O
interaction	|O
with	|O
receptor	|B-PROTEIN
I	|I-PROTEIN
,	|O
which	|O
phosphorylates	|O
it	|O
,	|O
whereupon	|O
it	|O
translocates	|O
into	|O
the	|O
nucleus	|O
presumably	|O
to	|O
regulate	|O
target	|O
gene	|O
transcription	|O
and	|O
consequently	|O
elicit	|O
a	|O
specific	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
effect	|O
.	|O

Intact	|O
Flag	|O
-	|O
tagged	|O
protein	|O
products	|O
from	|O
all	|O
six	|O
were	|O
produced	|O
from	|O
genomic	|O
expression	|O
vectors	|O
,	|O
although	|O
the	|O
ORF40/41	|O
transcript	|O
encoding	|O
a	|O
primase	|B-PROTEIN
-	|O
helicase	|B-PROTEIN
component	|O
proved	|O
to	|O
be	|O
spliced	|O
with	|O
a	|O
127	|O
-	|O
bp	|O
intron	|O
.	|O

Expression	|O
of	|O
the	|O
src	|B-PROTEIN
homology	|I-PROTEIN
3	|I-PROTEIN
(	|O
SH3	|B-PROTEIN
)	|O
-	|O
encoding	|O
,	|O
expressed	|O
in	|O
tumorigenic	|O
astrocytes	|O
(	|O
SETA	|B-PROTEIN
)	|O
gene	|O
is	|O
associated	|O
with	|O
astrocyte	|O
transformation	|O
in	|O
culture	|O
and	|O
tumors	|O
in	|O
the	|O
adult	|O
brain	|O
.	|O

Naltrexone	|O
hydrochloride	|O
is	|O
a	|O
synthetic	|O
opioid	|B-PROTEIN
receptor	|I-PROTEIN
antagonist	|O
recently	|O
used	|O
in	|O
efforts	|O
to	|O
provide	|O
rapid	|O
opioid	|O
detoxification	|O
.	|O

METHODS	|O
:	|O
One	|O
hundred	|O
fourteen	|O
consecutive	|O
patients	|O
(	|O
mean	|O
age	|O
61	|O
years	|O
)	|O
with	|O
focal	|O
pancreatic	|O
masses	|O
,	|O
detected	|O
on	|O
CT	|O
,	|O
underwent	|O
EUS	|O
-	|O
FNA	|O
by	|O
using	|O
a	|O
linear	|O
-	|O
array	|O
echoendoscope	|O
and	|O
22	|O
-	|O
gauge	|O
needles	|O
.	|O

METHODS	|O
:	|O
Thyroid	|O
status	|O
was	|O
measured	|O
at	|O
baseline	|O
(	|O
1990-93	|O
)	|O
,	|O
through	|O
assessment	|O
of	|O
serum	|O
antibodies	|O
to	|O
thyroid	|B-PROTEIN
peroxidase	|I-PROTEIN
(	|O
TPO	|B-PROTEIN
-	|O
Abs	|O
,	|O
positive	|O
:	|O
>	|O
10	|O
IU	|O
/	|O
ml	|O
)	|O
,	|O
serum	|O
TSH	|B-PROTEIN
levels	|O
,	|O
and	|O
when	|O
TSH	|B-PROTEIN
was	|O
abnormal	|O
(	|O
<	|O
0.4	|O
or	|O
>	|O
4.0	|O
mU	|O
/	|O
l	|O
)	|O
,	|O
serum	|O
thyroxin	|B-PROTEIN
levels	|O
(	|O
T4	|O
)	|O
.	|O

We	|O
suggest	|O
that	|O
ventriculopleural	|O
shunting	|O
should	|O
be	|O
considered	|O
as	|O
the	|O
preferred	|O
alternative	|O
to	|O
peritoneal	|O
drainage	|O
in	|O
children	|O
with	|O
intra	|O
-	|O
abdominal	|O
adhesions	|O
or	|O
with	|O
a	|O
history	|O
of	|O
recent	|O
peritoneal	|O
infection	|O
.	|O

Derivation	|O
and	|O
initial	|O
characterization	|O
of	|O
a	|O
mouse	|O
mammary	|O
tumor	|O
cell	|O
line	|O
carrying	|O
the	|O
polyomavirus	|O
middle	|B-PROTEIN
T	|I-PROTEIN
antigen	|O
:	|O
utility	|O
in	|O
the	|O
development	|O
of	|O
novel	|O
cancer	|O
therapeutics	|O
.	|O

TBARS	|O
levels	|O
,	|O
oxygen	|O
-	|O
radical	|O
absorbing	|O
capacity	|O
assay	|O
and	|O
AFR	|O
release	|O
assessed	|O
by	|O
electron	|O
paramagnetic	|O
resonance	|O
(	|O
EPR	|O
)	|O
were	|O
used	|O
to	|O
explore	|O
the	|O
existence	|O
of	|O
oxidative	|O
stress	|O
in	|O
diabetes	|O
.	|O

Long	|O
-	|O
range	|O
comparison	|O
of	|O
human	|O
and	|O
mouse	|O
SCL	|B-PROTEIN
loci	|O
:	|O
localized	|O
regions	|O
of	|O
sensitivity	|O
to	|O
restriction	|O
endonucleases	|O
correspond	|O
precisely	|O
with	|O
peaks	|O
of	|O
conserved	|O
noncoding	|O
sequences	|O
.	|O

To	|O
account	|O
for	|O
this	|O
observation	|O
,	|O
other	|O
possible	|O
causes	|O
include	|O
increased	|O
CSF	|O
pulsation	|O
in	|O
children	|O
creating	|O
motion	|O
artifact	|O
,	|O
changes	|O
in	|O
arterial	|O
oxygen	|O
concentration	|O
intrinsic	|O
to	|O
propofol	|O
or	|O
related	|O
to	|O
the	|O
supplemental	|O
oxygen	|O
normally	|O
administered	|O
,	|O
or	|O
changes	|O
in	|O
CSF	|O
protein	|O
levels	|O
related	|O
to	|O
propofol	|O
binding	|O
to	|O
proteins	|O
for	|O
uptake	|O
into	|O
CSF	|O
.	|O

The	|O
utilities	|O
measured	|O
in	|O
our	|O
study	|O
can	|O
be	|O
applied	|O
directly	|O
to	|O
quality	|O
-	|O
of	|O
-	|O
life	|O
determinations	|O
in	|O
clinical	|O
trials	|O
of	|O
adjuvant	|O
IFN	|B-PROTEIN
alpha	|I-PROTEIN
-	|I-PROTEIN
2b	|I-PROTEIN
to	|O
measure	|O
the	|O
net	|O
benefit	|O
of	|O
therapy	|O
.	|O

Serum	|O
PTH	|B-PROTEIN
tended	|O
to	|O
increase	|O
in	|O
the	|O
WL	|O
group	|O
but	|O
not	|O
in	|O
the	|O
WM	|O
group	|O
(	|O
P	|O
<	|O
0.06	|O
)	|O
.	|O

Structure	|O
of	|O
the	|O
EMAPII	|B-PROTEIN
domain	|O
of	|O
human	|O
aminoacyl	|B-PROTEIN
-	|I-PROTEIN
tRNA	|I-PROTEIN
synthetase	|I-PROTEIN
complex	|O
reveals	|O
evolutionary	|O
dimer	|O
mimicry	|O
.	|O

Hypomorphic	|O
dSLBP	|B-PROTEIN
alleles	|O
support	|O
zygotic	|O
development	|O
but	|O
cause	|O
female	|O
sterility	|O
.	|O

We	|O
mapped	|O
the	|O
DGCR6	|B-PROTEIN
gene	|O
to	|O
chromosome	|O
22q11	|O
within	|O
a	|O
low	|O
copy	|O
repeat	|O
,	|O
termed	|O
sc11.1	|O
a	|O
,	|O
and	|O
identified	|O
a	|O
second	|O
copy	|O
of	|O
the	|O
gene	|O
,	|O
DGCR6L	|B-PROTEIN
,	|O
within	|O
the	|O
duplicate	|O
locus	|O
,	|O
termed	|O
sc11.1	|O
b	|O
.	|O

METHODS	|O
:	|O
The	|O
passive	|O
and	|O
active	|O
transport	|O
of	|O
fluorescein	|O
through	|O
the	|O
BRB	|O
was	|O
quantitated	|O
by	|O
vitreous	|O
fluorometry	|O
.	|O

Nerve	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
(	|O
NGF	|B-PROTEIN
)	|O
and	|O
retinoic	|O
acid	|O
(	|O
RA	|O
)	|O
exert	|O
important	|O
actions	|O
on	|O
PC12	|O
cells	|O
.	|O

Recruitment	|O
of	|O
an	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
II	|I-PROTEIN
complex	|O
is	|O
mediated	|O
by	|O
the	|O
constitutive	|O
activation	|O
domain	|O
in	|O
CREB	|B-PROTEIN
,	|O
independently	|O
of	|O
CREB	|B-PROTEIN
phosphorylation	|O
.	|O

The	|O
region	|O
containing	|O
both	|O
serines	|O
is	|O
homologous	|O
to	|O
the	|O
N	|O
-	|O
terminal	|O
destruction	|O
box	|O
of	|O
IkappaBalpha	|B-PROTEIN
,	|I-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
,	|I-PROTEIN
and	|I-PROTEIN
-	|I-PROTEIN
epsilon	|I-PROTEIN
.	|O

This	|O
function	|O
requires	|O
not	|O
only	|O
the	|O
kinase	|O
domain	|O
of	|O
Csk	|B-PROTEIN
,	|O
but	|O
also	|O
its	|O
Src	|B-PROTEIN
homology	|I-PROTEIN
3	|I-PROTEIN
(	|O
SH3	|B-PROTEIN
)	|O
and	|O
SH2	|B-PROTEIN
regions	|O
.	|O

Furthermore	|O
,	|O
we	|O
showed	|O
that	|O
ERSF	|B-PROTEIN
including	|O
NF	|B-PROTEIN
-	|I-PROTEIN
Y	|I-PROTEIN
and	|O
ATF6alpha	|B-PROTEIN
and	|I-PROTEIN
/	|I-PROTEIN
or	|I-PROTEIN
beta	|I-PROTEIN
and	|O
capable	|O
of	|O
binding	|O
to	|O
ERSE	|O
is	|O
indeed	|O
formed	|O
when	|O
the	|O
cellular	|O
UPR	|O
is	|O
activated	|O
.	|O

The	|O
observed	|O
phenotypes	|O
may	|O
be	|O
explained	|O
by	|O
(	|O
i	|O
)	|O
a	|O
selective	|O
disruption	|O
of	|O
very	|B-PROTEIN
-	|I-PROTEIN
low	|I-PROTEIN
-	|I-PROTEIN
density	|I-PROTEIN
lipoprotein	|I-PROTEIN
secretion	|O
due	|O
to	|O
decreased	|O
expression	|O
of	|O
genes	|O
encoding	|O
apolipoprotein	|B-PROTEIN
B	|I-PROTEIN
and	|O
microsomal	|O
triglyceride	|B-PROTEIN
transfer	|I-PROTEIN
protein	|I-PROTEIN
,	|O
(	|O
ii	|O
)	|O
an	|O
increase	|O
in	|O
hepatic	|O
cholesterol	|O
uptake	|O
due	|O
to	|O
increased	|O
expression	|O
of	|O
the	|O
major	|O
high	|B-PROTEIN
-	|I-PROTEIN
density	|I-PROTEIN
lipoprotein	|I-PROTEIN
receptor	|I-PROTEIN
,	|O
scavenger	|B-PROTEIN
receptor	|I-PROTEIN
BI	|I-PROTEIN
,	|O
and	|O
(	|O
iii	|O
)	|O
a	|O
decrease	|O
in	|O
bile	|O
acid	|O
uptake	|O
to	|O
the	|O
liver	|O
due	|O
to	|O
down	|O
-	|O
regulation	|O
of	|O
the	|O
major	|O
basolateral	|O
bile	|B-PROTEIN
acid	|I-PROTEIN
transporters	|I-PROTEIN
sodium	|I-PROTEIN
taurocholate	|I-PROTEIN
cotransporter	|I-PROTEIN
protein	|O
and	|O
organic	|B-PROTEIN
anion	|I-PROTEIN
transporter	|I-PROTEIN
protein	|I-PROTEIN
1	|I-PROTEIN
.	|O

These	|O
effects	|O
were	|O
not	|O
seen	|O
with	|O
SHIP2	|B-PROTEIN
possessing	|O
a	|O
mutation	|O
in	|O
the	|O
SH2	|B-PROTEIN
domain	|O
(	|O
R47G	|B-PROTEIN
)	|O
.	|O

The	|O
gonadotrope	|O
-	|O
specific	|O
and	|O
regulated	|O
expression	|O
of	|O
the	|O
GnRH	|B-PROTEIN
receptor	|I-PROTEIN
(	|O
GnRH	|B-PROTEIN
-	|I-PROTEIN
R	|I-PROTEIN
)	|O
gene	|O
is	|O
dependent	|O
on	|O
multiple	|O
transcription	|O
factors	|O
that	|O
interact	|O
with	|O
the	|O
noncanonical	|O
GnRH	|B-PROTEIN
-	|I-PROTEIN
R	|I-PROTEIN
activating	|I-PROTEIN
sequence	|I-PROTEIN
(	|O
GRAS	|B-PROTEIN
)	|O
,	|O
the	|O
activator	|B-PROTEIN
protein	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
(	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
element	|O
,	|O
and	|O
the	|O
steroidogenic	|B-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
(	|O
SF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
binding	|O
site	|O
.	|O

METHODS	|O
:	|O
A	|O
structured	|O
interview	|O
was	|O
undertaken	|O
at	|O
the	|O
time	|O
of	|O
initial	|O
consultation	|O
and	|O
at	|O
subsequent	|O
1	|O
-	|O
year	|O
intervals	|O
regarding	|O
type	|O
of	|O
BHS	|O
,	|O
frequency	|O
of	|O
spells	|O
,	|O
associated	|O
phenomenon	|O
,	|O
sequelae	|O
,	|O
family	|O
history	|O
,	|O
and	|O
age	|O
at	|O
termination	|O
of	|O
spells	|O
.	|O

In	|O
three	|O
cases	|O
(	|O
21.4%	|O
)	|O
,	|O
the	|O
MR	|O
imaging	|O
was	|O
interpreted	|O
as	|O
negative	|O
,	|O
but	|O
microscopic	|O
tumor	|O
was	|O
shown	|O
around	|O
seroma	|O
on	|O
reexcision	|O
.	|O

Methylation	|O
at	|O
both	|O
cytosine	|O
residues	|O
in	|O
the	|O
E2F	|B-PROTEIN
element	|O
(	|O
(	|O
m	|O
)	|O
CG	|O
(	|O
m	|O
)	|O
CG	|O
)	|O
generated	|O
a	|O
new	|O
methylcytosine	|O
-	|O
specific	|O
DNA	|O
-	|O
protein	|O
complex	|O
.	|O

These	|O
mutations	|O
,	|O
when	|O
placed	|O
in	|O
a	|O
wild	|O
-	|O
type	|O
fliF	|B-PROTEIN
background	|O
,	|O
had	|O
no	|O
mutant	|O
phenotype	|O
.	|O

As	|O
well	|O
,	|O
IFN	|B-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
-	|O
induced	|O
expression	|O
of	|O
IRF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
its	|O
binding	|O
to	|O
the	|O
IRF	|B-PROTEIN
element	|O
is	|O
inhibited	|O
.	|O

This	|O
molecule	|O
,	|O
wH22xeGFP	|B-PROTEIN
,	|O
consists	|O
of	|O
the	|O
entire	|O
humanized	|O
anti	|B-PROTEIN
-	|I-PROTEIN
FcgammaRI	|I-PROTEIN
mAb	|O
H22	|B-PROTEIN
with	|O
eGFP	|B-PROTEIN
genetically	|O
fused	|O
to	|O
the	|O
C	|O
-	|O
terminal	|O
end	|O
of	|O
each	|O
CH3	|B-PROTEIN
domain	|O
.	|O
wH22xeGFP	|B-PROTEIN
binds	|O
within	|O
the	|O
ligand	|O
-	|O
binding	|O
region	|O
by	|O
its	|O
Fc	|B-PROTEIN
end	|O
,	|O
as	|O
well	|O
as	|O
outside	|O
the	|O
ligand	|O
-	|O
binding	|O
region	|O
by	|O
its	|O
Fab	|B-PROTEIN
ends	|O
,	|O
thereby	|O
cross	|O
-	|O
linking	|O
FcgammaRI	|B-PROTEIN
.	|O

Inactivity	|O
of	|O
the	|O
human	|O
cytomegalovirus	|O
(	|O
HCMV	|O
)	|O
major	|B-PROTEIN
immediate	|I-PROTEIN
-	|I-PROTEIN
early	|I-PROTEIN
regulatory	|I-PROTEIN
region	|I-PROTEIN
(	|O
MIERR	|B-PROTEIN
)	|O
,	|O
which	|O
is	|O
composed	|O
of	|O
promoter	|O
,	|O
enhancer	|O
,	|O
unique	|O
region	|O
,	|O
and	|O
modulator	|O
,	|O
is	|O
linked	|O
to	|O
lack	|O
of	|O
HCMV	|O
replication	|O
in	|O
latently	|O
infected	|O
cells	|O
and	|O
in	|O
other	|O
nonpermissive	|O
cell	|O
types	|O
,	|O
including	|O
human	|O
embryonal	|O
NTera2	|O
carcinoma	|O
(	|O
NT2	|O
)	|O
cells	|O
.	|O

This	|O
interaction	|O
is	|O
reciprocal	|O
,	|O
since	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
dimer	|O
binding	|O
to	|O
a	|O
strong	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
site	|O
leads	|O
to	|O
enhanced	|O
CREB	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
recruitment	|O
to	|O
ATF	|B-PROTEIN
/	|O
CREB	|B-PROTEIN
sites	|O
that	|O
are	|O
weakly	|O
bound	|O
by	|O
CREB	|B-PROTEIN
.	|O

The	|O
metabolic	|O
events	|O
occurring	|O
at	|O
or	|O
near	|O
that	|O
structure	|O
and	|O
involving	|O
cyclin	|B-PROTEIN
D3	|I-PROTEIN
cause	|O
the	|O
translocation	|O
of	|O
ICP0	|B-PROTEIN
to	|O
the	|O
cytoplasm	|O
.	|O

Transient	|O
transfections	|O
showed	|O
that	|O
a	|O
single	|O
mutation	|O
(	|O
556M	|O
)	|O
decreased	|O
TBLV	|B-PROTEIN
enhancer	|I-PROTEIN
activity	|O
at	|O
least	|O
20	|O
-	|O
fold	|O
in	|O
two	|O
different	|O
T	|O
-	|O
cell	|O
lines	|O
.	|O

Vector	|O
stocks	|O
containing	|O
envelope	|B-PROTEIN
proteins	|O
from	|O
three	|O
different	|O
SIVmac	|O
clones	|O
,	|O
namely	|O
,	|O
SIVmac239	|O
(	|O
T	|O
-	|O
lymphocyte	|O
tropic	|O
[	|O
T	|O
-	|O
tropic	|O
]	|O
)	|O
,	|O
SIVmac316	|O
(	|O
macrophage	|O
tropic	|O
[	|O
M	|O
-	|O
tropic	|O
]	|O
)	|O
,	|O
and	|O
SIVmac1A11	|O
(	|O
dualtropic	|O
)	|O
,	|O
were	|O
tested	|O
.	|O

Quantitative	|O
PCR	|O
studies	|O
indicated	|O
that	|O
synthesis	|O
and	|O
transport	|O
of	|O
vector	|O
DNA	|O
into	|O
the	|O
nucleus	|O
were	|O
similar	|O
for	|O
macrophages	|O
infected	|O
with	|O
the	|O
clone	|O
239	|O
and	|O
316	|O
pseudotypes	|O
,	|O
suggesting	|O
that	|O
the	|O
restriction	|O
for	|O
SIVmac239	|O
infection	|O
is	|O
after	|O
reverse	|O
transcription	|O
and	|O
nuclear	|O
import	|O
of	|O
viral	|O
DNA	|O
.	|O

Thus	|O
,	|O
the	|O
anti	|B-PROTEIN
-	|I-PROTEIN
interferon	|I-PROTEIN
functions	|O
of	|O
vIRF	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
may	|O
contribute	|O
to	|O
the	|O
establishment	|O
of	|O
a	|O
chronic	|O
or	|O
latent	|O
infection	|O
.	|O

Both	|O
Z	|B-PROTEIN
and	|O
R	|B-PROTEIN
expression	|O
resulted	|O
in	|O
PML	|O
dispersion	|O
in	|O
EBV	|O
-	|O
positive	|O
cells	|O
.	|O

Interestingly	|O
,	|O
the	|O
activity	|O
of	|O
IkappaB	|B-PROTEIN
kinase	|I-PROTEIN
(	|O
IKK	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
)	|O
,	|O
which	|O
plays	|O
an	|O
essential	|O
role	|O
in	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
activation	|O
through	|O
IkappaB	|B-PROTEIN
phosphorylation	|O
,	|O
was	|O
largely	|O
enhanced	|O
in	|O
paclitaxel	|O
-	|O
treated	|O
cells	|O
,	|O
detected	|O
as	|O
IkappaBalpha	|B-PROTEIN
phosphorylation	|O
.	|O

Immunofluorescence	|O
studies	|O
in	|O
C2C12	|O
myotubes	|O
show	|O
that	|O
Smad2	|B-PROTEIN
and	|O
MEF2A	|B-PROTEIN
co	|O
-	|O
localise	|O
in	|O
the	|O
nucleus	|O
of	|O
multinuclear	|O
myotubes	|O
during	|O
differentiation	|O
.	|O

We	|O
propose	|O
that	|O
TFOs	|O
represent	|O
a	|O
therapeutic	|O
potential	|O
to	|O
specifically	|O
diminish	|O
the	|O
expression	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
sis	|I-PROTEIN
/	|O
PDGF	|B-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
proto	|O
-	|O
oncogene	|O
in	|O
various	|O
pathologic	|O
settings	|O
where	|O
constitutive	|O
expression	|O
of	|O
this	|O
gene	|O
has	|O
been	|O
observed	|O
.	|O

Rapid	|O
evolution	|O
of	|O
the	|O
DNA	|O
-	|O
binding	|O
site	|O
in	|O
LAGLIDADG	|O
homing	|B-PROTEIN
endonucleases	|I-PROTEIN
.	|O

Southern	|O
blot	|O
analysis	|O
of	|O
genomic	|O
DNA	|O
from	|O
somatic	|O
cell	|O
hybrids	|O
showed	|O
that	|O
endothelial	|B-PROTEIN
-	|I-PROTEIN
TACC	|I-PROTEIN
-	|I-PROTEIN
related	|I-PROTEIN
cDNA	|O
maps	|O
to	|O
chromosome	|O
10	|O
.	|O

Copyright	|O
2001	|O
Academic	|O
Press	|O
.	|O

The	|O
presence	|O
of	|O
truncated	|O
receptor	|O
isoforms	|O
in	|O
diverse	|O
species	|O
suggests	|O
that	|O
these	|O
proteins	|O
may	|O
have	|O
important	|O
functional	|O
roles	|O
in	|O
regulating	|O
EGFR	|B-PROTEIN
activity	|O
.	|O

Interestingly	|O
,	|O
the	|O
similarities	|O
with	|O
the	|O
endophilin	|B-PROTEIN
proteins	|O
cover	|O
the	|O
entire	|O
sequence	|O
of	|O
the	|O
SH3GLB	|B-PROTEIN
family	|O
,	|O
suggesting	|O
a	|O
common	|O
fold	|O
and	|O
presumably	|O
a	|O
common	|O
mode	|O
of	|O
action	|O
.	|O

Mental	|O
rotation	|O
of	|O
paired	|O
figures	|O
engendered	|O
activation	|O
in	|O
the	|O
left	|O
superior	|O
parietal	|O
lobule	|O
and	|O
the	|O
right	|O
frontal	|O
medial	|O
gyrus	|O
.	|O

We	|O
also	|O
reported	|O
the	|O
identification	|O
of	|O
three	|O
corresponding	|O
alternative	|O
first	|O
exons	|O
and	|O
an	|O
intronic	|O
promoter	|O
in	|O
the	|O
human	|O
PDE5A	|B-PROTEIN
gene	|O
.	|O

The	|O
glucose	|O
/	|O
insulin	|B-PROTEIN
stimulation	|O
was	|O
inhibited	|O
by	|O
the	|O
addition	|O
of	|O
polyunsaturated	|O
fatty	|O
acids	|O
.	|O

The	|O
continuing	|O
development	|O
of	|O
ligands	|O
that	|O
function	|O
as	|O
selective	|O
estrogens	|O
or	|O
antiestrogens	|O
for	|O
ERalpha	|B-PROTEIN
or	|O
ERbeta	|B-PROTEIN
should	|O
allow	|O
optimized	|O
tissue	|O
selectivity	|O
of	|O
these	|O
agents	|O
for	|O
menopausal	|O
hormone	|O
replacement	|O
therapy	|O
and	|O
the	|O
treatment	|O
and	|O
prevention	|O
of	|O
breast	|O
cancer	|O
.	|O

Behavioural	|O
tests	|O
with	|O
192	|O
specimen	|O
of	|O
the	|O
roman	|O
garden	|O
snail	|O
Helix	|O
pomatia	|O
L.	|O
were	|O
performed	|O
in	|O
order	|O
to	|O
clarify	|O
whether	|O
the	|O
thermopreferendum	|O
of	|O
this	|O
pulmonate	|O
is	|O
influenced	|O
not	|O
only	|O
by	|O
the	|O
temperature	|O
of	|O
the	|O
substratum	|O
but	|O
also	|O
by	|O
air	|O
temperature	|O
.	|O

In	|O
the	|O
present	|O
work	|O
,	|O
the	|O
complete	|O
genome	|O
sequences	|O
of	|O
Pyrococcus	|O
horikoshii	|O
and	|O
Pyrococcus	|O
abyssi	|O
,	|O
two	|O
species	|O
in	|O
a	|O
genus	|O
of	|O
hyperthermophilic	|O
archaeon	|O
(	|O
archaebacterium	|O
)	|O
,	|O
were	|O
compared	|O
to	|O
detect	|O
large	|O
genome	|O
polymorphisms	|O
linked	|O
with	|O
restriction	|O
-	|O
modification	|O
gene	|O
homologs	|O
.	|O

This	|O
animal	|O
model	|O
of	|O
dystonia	|O
appears	|O
to	|O
be	|O
a	|O
model	|O
of	|O
NAD	|O
in	|O
man	|O
from	|O
the	|O
viewpoint	|O
of	|O
treatment	|O
-	|O
response	|O
.	|O

Peripheral	|O
and	|O
preemptive	|O
opioid	|O
antinociception	|O
in	|O
a	|O
mouse	|O
visceral	|O
pain	|O
model	|O
.	|O

Twenty	|O
-	|O
six	|O
(	|O
55%	|O
)	|O
(	|O
95%	|O
CI	|O
,	|O
41-69%	|O
)	|O
patients	|O
experienced	|O
>	|O
or	|O
=	|O
grade	|O
3	|O
acute	|O
toxicity	|O
(	|O
RTOG	|O
)	|O
.	|O

No	|O
'	|O
TATA	|O
'	|O
motif	|O
was	|O
identified	|O
near	|O
either	|O
the	|O
GABPalpha	|B-PROTEIN
or	|O
ATPsynCF6	|B-PROTEIN
transcription	|O
start	|O
sites	|O
.	|O

Significantly	|O
higher	|O
lung	|O
function	|O
parameters	|O
were	|O
obtained	|O
in	|O
extubated	|O
recipients	|O
of	|O
LPD	|O
preserved	|O
grafts	|O
2	|O
weeks	|O
after	|O
TX	|O
.	|O

Acquired	|O
antithrombin	|B-PROTEIN
deficiency	|O
in	|O
sepsis	|O
.	|O

In	|O
addition	|O
,	|O
we	|O
have	|O
isolated	|O
a	|O
genomic	|O
fragment	|O
containing	|O
the	|O
most	|O
distal	|O
5'	|O
sequences	|O
of	|O
the	|O
major	|O
GGT	|B-PROTEIN
mRNA	|O
in	|O
HepG2	|O
cells	|O
.	|O

(	|O
1997	|O
)	|O
Nature	|O
387	|O
,	|O
370-376	|O
)	|O
]	|O
,	|O
we	|O
suggest	|O
that	|O
the	|O
metal	|O
fluoride	|O
ions	|O
replaced	|O
phosphate	|O
at	|O
the	|O
two	|O
ATP	|O
-	|O
binding	|O
sites	|O
of	|O
the	|O
iron	|O
protein	|O
,	|O
Kp2	|B-PROTEIN
.	|O

Increased	|O
erythropoietin	|B-PROTEIN
synthesis	|O
in	|O
patients	|O
with	|O
COLD	|O
or	|O
left	|O
heart	|O
failure	|O
is	|O
related	|O
to	|O
alterations	|O
in	|O
renal	|O
haemodynamics	|O
.	|O

Expression	|O
of	|O
herpes	|O
simplex	|O
virus	|O
type	|O
2	|O
US3	|B-PROTEIN
affects	|O
the	|O
Cdc42	|B-PROTEIN
/	|O
Rac	|B-PROTEIN
pathway	|O
and	|O
attenuates	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
N	|I-PROTEIN
-	|I-PROTEIN
terminal	|I-PROTEIN
kinase	|I-PROTEIN
activation	|O
.	|O

If	|O
you	|O
think	|O
education	|O
is	|O
expensive	|O
-	|O
-	|O
try	|O
ignorance	|O
-	|O
-	|O
Bok	|O
's	|O
Law	|O
.	|O

To	|O
study	|O
the	|O
in	|O
vivo	|O
role	|O
of	|O
p16.7	|B-PROTEIN
,	|O
a	|O
phi29	|O
mutant	|O
containing	|O
a	|O
suppressible	|O
mutation	|O
in	|O
gene	|B-PROTEIN
16.7	|I-PROTEIN
was	|O
constructed	|O
.	|O

To	|O
the	|O
best	|O
of	|O
our	|O
knowledge	|O
,	|O
SNTCS	|O
is	|O
highly	|O
malignant	|O
.	|O

The	|O
extraordinary	|O
stability	|O
of	|O
peptide	|O
-	|O
-	|O
gp96	|B-PROTEIN
complexes	|O
and	|O
the	|O
plasticity	|O
of	|O
the	|O
peptide	|O
-	|O
binding	|O
pocket	|O
support	|O
the	|O
proposed	|O
relay	|O
of	|O
diverse	|O
peptides	|O
to	|O
MHC	|B-PROTEIN
and	|O
/	|O
or	|O
other	|O
molecules	|O
via	|O
molecular	|O
recognition	|O
.	|O

High	|O
-	|O
affinity	|O
binding	|O
of	|O
NF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
to	|O
PSE	|B-PROTEIN
-	|I-PROTEIN
B	|I-PROTEIN
,	|O
but	|O
not	|O
to	|O
PSE	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
,	|O
was	|O
confirmed	|O
by	|O
competition	|O
of	|O
DNA	|O
-	|O
protein	|O
interactions	|O
by	|O
using	|O
NF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
DNA	|O
elements	|O
and	|O
antibodies	|O
.	|O

Coexpression	|O
of	|O
the	|O
p120	|B-PROTEIN
(	|O
ctn	|B-PROTEIN
)	|O
protein	|O
with	|O
an	|O
N	|O
-	|O
terminal	|O
deletion	|O
,	|O
which	|O
eliminates	|O
some	|O
potential	|O
tyrosine	|O
phosphorylation	|O
sites	|O
,	|O
or	|O
the	|O
protein	|O
with	|O
a	|O
single	|O
amino	|O
acid	|O
substitution	|O
(	|O
tyrosine	|O
at	|O
217	|O
to	|O
phenylalanine	|O
)	|O
resulted	|O
in	|O
an	|O
increase	|O
in	|O
the	|O
aggregation	|O
of	|O
v	|B-PROTEIN
-	|I-PROTEIN
Src	|I-PROTEIN
-	|O
transformed	|O
EL	|O
and	|O
EalphaCL	|O
cells	|O
.	|O

We	|O
show	|O
that	|O
p73	|B-PROTEIN
can	|O
transcriptionally	|O
inhibit	|O
a	|O
number	|O
of	|O
cellular	|O
and	|O
viral	|O
promoters	|O
.	|O

RESULTS	|O
:	|O
Of	|O
the	|O
24	|O
patients	|O
,	|O
6	|O
had	|O
Grade	|O
1	|O
pneumonitis	|O
,	|O
and	|O
13	|O
had	|O
Grade	|O
2	|O
pneumonitis	|O
.	|O

In	|O
contrast	|O
,	|O
we	|O
did	|O
not	|O
detect	|O
a	|O
significant	|O
correlation	|O
between	|O
plasma	|O
TNFalpha	|B-PROTEIN
and	|O
radiation	|O
pneumonitis	|O
.	|O

Using	|O
immunochemical	|O
co	|O
-	|O
precipitation	|O
methods	|O
,	|O
we	|O
also	|O
found	|O
that	|O
the	|O
two	|O
proteins	|O
are	|O
bound	|O
in	|O
vivo	|O
.	|O

METHODS	|O
:	|O
Sixteen	|O
pigs	|O
were	|O
assigned	|O
randomly	|O
to	|O
control	|O
and	|O
shock	|O
groups	|O
.	|O

Identification	|O
of	|O
pulmonary	|O
vein	|O
stenosis	|O
after	|O
radiofrequency	|O
ablation	|O
for	|O
atrial	|O
fibrillation	|O
using	|O
MRI	|O
.	|O

Tumor	|O
cell	|O
lines	|O
transduced	|O
at	|O
an	|O
MOI	|O
of	|O
8	|O
for	|O
3	|O
days	|O
led	|O
to	|O
>	|O
90%	|O
gene	|O
transfer	|O
efficiency	|O
.	|O

Treatment	|O
includes	|O
both	|O
medical	|O
and	|O
surgical	|O
options	|O
,	|O
with	|O
medical	|O
therapy	|O
further	|O
subclassified	|O
into	|O
pharmacologic	|O
and	|O
pneumatic	|O
dilation	|O
.	|O

Finally	|O
,	|O
we	|O
compared	|O
the	|O
differential	|O
screening	|O
techniques	|O
in	|O
terms	|O
of	|O
sensitivity	|O
,	|O
efficiency	|O
and	|O
occurrence	|O
of	|O
false	|O
positives	|O
.	|O

Serial	|O
US	|O
images	|O
were	|O
obtained	|O
before	|O
and	|O
20	|O
,	|O
30	|O
,	|O
40	|O
,	|O
50	|O
,	|O
60	|O
,	|O
90	|O
,	|O
120	|O
,	|O
150	|O
,	|O
180	|O
,	|O
240	|O
,	|O
and	|O
300	|O
s	|O
after	|O
intravenous	|O
injection	|O
of	|O
2	|O
g	|O
of	|O
contrast	|O
agent	|O
using	|O
conventional	|O
and	|O
harmonic	|O
PD	|O
US	|O
.	|O

To	|O
investigate	|O
the	|O
effects	|O
of	|O
exogenous	|O
hyaluronic	|O
acid	|O
,	|O
the	|O
development	|O
of	|O
port	|O
-	|O
site	|O
metastasis	|O
was	|O
examined	|O
using	|O
mouse	|O
adenocarcinoma	|O
cell	|O
-	|O
line	|O
colon	|O
26	|O
cells	|O
.	|O

Cytomegalovirus	|O
,	|O
Chlamydia	|O
pneumoniae	|O
,	|O
and	|O
Helicobacter	|O
pylori	|O
IgG	|B-PROTEIN
antibodies	|O
and	|O
restenosis	|O
after	|O
stent	|O
implantation	|O
:	|O
an	|O
angiographic	|O
and	|O
intravascular	|O
ultrasound	|O
study	|O
.	|O

Responses	|O
of	|O
single	|O
-	|O
unit	|O
carotid	|O
body	|O
chemoreceptors	|O
in	|O
adult	|O
rats	|O
.	|O

Architecture	|O
and	|O
anatomy	|O
of	|O
the	|O
genomic	|O
locus	|O
encoding	|O
the	|O
human	|O
leukemia	|O
-	|O
associated	|O
transcription	|O
factor	|O
RUNX1	|B-PROTEIN
/	|O
AML1	|B-PROTEIN
.	|O

Therefore	|O
,	|O
we	|O
suggested	|O
that	|O
both	|O
proteins	|O
might	|O
belong	|O
to	|O
the	|O
PLTP	|B-PROTEIN
family	|O
.	|O

In	|O
this	|O
paper	|O
the	|O
tyrosine	|O
dephosphorylating	|O
enzymes	|O
,	|O
the	|O
protein	|B-PROTEIN
-	|I-PROTEIN
tyrosine	|I-PROTEIN
phosphatases	|I-PROTEIN
(	|O
PTPs	|B-PROTEIN
)	|O
,	|O
are	|O
studied	|O
which	|O
can	|O
be	|O
grouped	|O
into	|O
two	|O
subfamilies	|O
,	|O
the	|O
soluble	|O
PTPs	|B-PROTEIN
and	|O
the	|O
receptor	|O
PTPs	|B-PROTEIN
(	|O
RPTPs	|B-PROTEIN
)	|O
.	|O

The	|O
Ig	|B-PROTEIN
-	|O
related	|O
,	|O
typical	|O
metazoan	|O
,	|O
module	|O
is	|O
classified	|O
to	|O
the	|O
disulphide	|O
lacking	|O
Ig	|B-PROTEIN
members	|O
and	|O
represents	|O
the	|O
phylogenetic	|O
earliest	|O
member	|O
of	|O
this	|O
group	|O
.	|O

The	|O
Sox	|B-PROTEIN
gene	|O
family	|O
(	|O
Sry	|B-PROTEIN
like	|I-PROTEIN
HMG	|I-PROTEIN
box	|I-PROTEIN
gene	|O
)	|O
is	|O
characterised	|O
by	|O
a	|O
conserved	|O
DNA	|O
sequence	|O
encoding	|O
a	|O
domain	|O
of	|O
approximately	|O
80	|O
amino	|O
acids	|O
which	|O
is	|O
responsible	|O
for	|O
sequence	|O
specific	|O
DNA	|O
binding	|O
.	|O

While	|O
these	|O
results	|O
are	|O
consistent	|O
with	|O
previously	|O
reported	|O
effects	|O
of	|O
the	|O
C	|O
-	|O
terminal	|O
domain	|O
on	|O
nucleotide	|O
binding	|O
,	|O
they	|O
also	|O
demonstrate	|O
that	|O
interactions	|O
with	|O
the	|O
N	|O
-	|O
terminal	|O
domains	|O
are	|O
necessary	|O
to	|O
inhibit	|O
proton	|O
transport	|O
.	|O

Respiratory	|O
parameters	|O
suggested	|O
that	|O
M6G	|O
produced	|O
less	|O
respiratory	|O
depression	|O
than	|O
morphine	|O
.	|O

This	|O
supports	|O
previous	|O
arguments	|O
for	|O
the	|O
improbability	|O
of	|O
biological	|O
effects	|O
at	|O
UHF	|O
frequencies	|O
unless	|O
a	|O
mechanism	|O
can	|O
be	|O
found	|O
for	|O
accumulating	|O
energy	|O
over	|O
time	|O
and	|O
space	|O
and	|O
focussing	|O
it	|O
.	|O

To	|O
assess	|O
the	|O
maximum	|O
oxygen	|O
uptake	|O
(	|O
V'	|O
O2	|O
max	|O
)	|O
of	|O
Hong	|O
Kong	|O
Chinese	|O
children	|O
and	|O
to	|O
explore	|O
its	|O
association	|O
with	|O
respiratory	|O
illnesses	|O
,	|O
we	|O
conducted	|O
the	|O
Multistage	|O
Fitness	|O
Test	|O
(	|O
MFT	|O
)	|O
,	|O
a	|O
20	|O
-	|O
m	|O
shuttle	|O
run	|O
test	|O
,	|O
in	|O
1,427	|O
schoolchildren	|O
aged	|O
between	|O
8-12	|O
years	|O
.	|O

By	|O
analyzing	|O
5'	|O
-	|O
deletion	|O
insulin	|B-PROTEIN
promoter	|O
-	|O
reporter	|O
constructs	|O
in	|O
transient	|O
transfections	|O
of	|O
clonal	|O
INS	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
beta	|I-PROTEIN
-	|O
cells	|O
,	|O
we	|O
located	|O
activating	|O
Hh	|B-PROTEIN
-	|O
responsive	|O
regions	|O
within	|O
the	|O
rat	|O
insulin	|B-PROTEIN
I	|O
promoter	|O
that	|O
include	|O
the	|O
glucose	|O
-	|O
response	|O
elements	|O
Far	|O
(	|O
E2	|O
)	|O
and	|O
Flat	|O
(	|O
A2	|O
/	|O
A3	|O
)	|O
.	|O

The	|O
androgen	|B-PROTEIN
receptor	|I-PROTEIN
(	|O
AR	|B-PROTEIN
)	|O
amino	|O
-	|O
terminus	|O
imposes	|O
androgen	|O
-	|O
specific	|O
regulation	|O
of	|O
AR	|B-PROTEIN
gene	|O
expression	|O
via	|O
an	|O
exonic	|O
enhancer	|O
.	|O

A	|O
major	|O
mechanism	|O
by	|O
which	|O
estrogens	|O
prevent	|O
osteoporosis	|O
seems	|O
to	|O
be	|O
repression	|O
of	|O
transcription	|O
of	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappa	|I-PROTEIN
B	|I-PROTEIN
target	|O
genes	|O
,	|O
such	|O
as	|O
the	|O
osteoclast	|O
-	|O
activating	|O
cytokines	|O
interleukin	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
and	|O
interleukin	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
.	|O

To	|O
identify	|O
the	|O
important	|O
cis	|O
-	|O
DNA	|O
regulatory	|O
element	|O
(	|O
s	|O
)	|O
involved	|O
in	|O
the	|O
tissue	|O
-	|O
,	|O
region	|O
-	|O
,	|O
and	|O
cell	|O
-	|O
specific	|O
expression	|O
of	|O
the	|O
mE	|B-PROTEIN
-	|I-PROTEIN
RABP	|I-PROTEIN
gene	|I-PROTEIN
,	|O
the	|O
5	|O
-	|O
kb	|O
DNA	|O
fragment	|O
was	|O
sequenced	|O
.	|O

In	|O
the	|O
mouse	|O
,	|O
both	|O
genes	|O
reside	|O
in	|O
the	|O
syntenic	|O
region	|O
8E1	|O
on	|O
chromosome	|O
8	|O
.	|O

Analysis	|O
of	|O
the	|O
genome	|O
sequence	|O
revealed	|O
26,588	|O
protein	|O
-	|O
encoding	|O
transcripts	|O
for	|O
which	|O
there	|O
was	|O
strong	|O
corroborating	|O
evidence	|O
and	|O
an	|O
additional	|O
approximately	|O
12,000	|O
computationally	|O
derived	|O
genes	|O
with	|O
mouse	|O
matches	|O
or	|O
other	|O
weak	|O
supporting	|O
evidence	|O
.	|O

The	|O
corresponding	|O
genotype	|O
was	|O
determined	|O
with	|O
a	|O
restriction	|O
enzyme	|O
-	|O
based	|O
assay	|O
.	|O

An	|O
additional	|O
9	|O
patients	|O
achieved	|O
normal	|O
levels	|O
with	|O
adjunctive	|O
drug	|O
therapy	|O
.	|O

By	|O
Caveman	|O
.	|O

Multistage	|O
models	|O
and	|O
the	|O
A	|O
-	|O
bomb	|O
survivor	|O
data	|O
:	|O
implications	|O
for	|O
carcinogenic	|O
mechanisms	|O
?	|O

The	|O
revitalization	|O
of	|O
surgery	|O
for	|O
Parkinson	|O
's	|O
disease	|O
(	|O
PD	|O
)	|O
has	|O
fueled	|O
discussion	|O
about	|O
the	|O
best	|O
methodology	|O
to	|O
define	|O
the	|O
target	|O
.	|O

Corneal	|O
scrapping	|O
and	|O
deep	|O
stromal	|O
biopsy	|O
were	|O
obtained	|O
and	|O
stained	|O
for	|O
microscopic	|O
evaluation	|O
with	|O
periodic	|O
acid	|O
-	|O
Schiff	|O
,	|O
Giemsa	|O
,	|O
and	|O
Gomori	|O
's	|O
methenamine	|O
silver	|O
stains	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
BACM	|O
has	|O
antiplaque	|O
and	|O
stronger	|O
antidegradation	|O
effects	|O
than	|O
GLCM	|O
.	|O

Multidrug	|O
resistance	|O
in	|O
Saccharomyces	|O
cerevisiae	|O
mainly	|O
results	|O
from	|O
the	|O
overexpression	|O
of	|O
genes	|O
coding	|O
for	|O
the	|O
membrane	|O
efflux	|O
pumps	|O
,	|O
the	|O
major	|O
facilitators	|O
and	|O
the	|O
ABC	|B-PROTEIN
binding	|I-PROTEIN
cassette	|I-PROTEIN
transporters	|I-PROTEIN
,	|O
under	|O
the	|O
control	|O
of	|O
key	|O
transcription	|O
regulators	|O
encoded	|O
by	|O
the	|O
PDR1	|B-PROTEIN
and	|O
PDR3	|B-PROTEIN
genes	|O
.	|O

Susceptibility	|O
to	|O
ischemia	|O
-	|O
induced	|O
arrhythmias	|O
was	|O
lower	|O
in	|O
1	|O
-	|O
week	|O
diabetics	|O
:	|O
only	|O
42	|O
%	|O
of	|O
diabetic	|O
hearts	|O
exhibited	|O
ventricular	|O
tachycardia	|O
(	|O
VT	|O
)	|O
and	|O
16	|O
%	|O
had	|O
short	|O
episodes	|O
of	|O
ventricular	|O
fibrillation	|O
(	|O
VF	|O
)	|O
as	|O
compared	|O
to	|O
VT	|O
100	|O
%	|O
and	|O
VF	|O
70	|O
%	|O
(	|O
including	|O
sustained	|O
VF	|O
36	|O
%	|O
)	|O
in	|O
the	|O
non	|O
-	|O
diabetics	|O
(	|O
P	|O
<	|O
0.05	|O
)	|O
.	|O

A	|O
picture	|O
is	|O
emerging	|O
showing	|O
a	|O
gradient	|O
of	|O
function	|O
among	|O
p53	|B-PROTEIN
,	|O
p73	|B-PROTEIN
,	|O
p63	|B-PROTEIN
ranging	|O
from	|O
tumor	|O
suppression	|O
to	|O
development	|O
.	|O

This	|O
could	|O
lead	|O
to	|O
subsequent	|O
outbreaks	|O
if	|O
Babesia	|O
carrier	|O
animals	|O
were	|O
to	|O
be	|O
introduced	|O
into	|O
the	|O
herd	|O
.	|O

Contagious	|O
bovine	|O
pleuropneumonia	|O
is	|O
a	|O
major	|O
threat	|O
for	|O
cattle	|O
in	|O
Africa	|O
.	|O

Baseline	|O
BMD	|O
values	|O
were	|O
significantly	|O
lower	|O
in	|O
the	|O
oligo	|O
-	|O
amenorrheic	|O
group	|O
than	|O
in	|O
the	|O
two	|O
others	|O
at	|O
the	|O
level	|O
of	|O
lumbar	|O
spine	|O
(	|O
anteroposterior	|O
view	|O
:	|O
0.941	|O
+	|O
/	|O
-	|O
0.039	|O
in	|O
oligo	|O
-	|O
amenorrheic	|O
vs	|O
1.077	|O
+	|O
/	|O
-	|O
0.029	|O
or	|O
1.051	|O
+	|O
/	|O
-	|O
0.017	|O
g	|O
x	|O
cm	|O
(	|O
-	|O
2	|O
)	|O
,	|O
P	|O
<	|O
0.005	|O
,	|O
in	|O
the	|O
eumenorrheic	|O
and	|O
contraceptive	|O
user	|O
groups	|O
,	|O
respectively	|O
)	|O
but	|O
not	|O
in	|O
weight	|O
-	|O
bearing	|O
bone	|O
such	|O
as	|O
proximal	|O
and	|O
midshaft	|O
femur	|O
.	|O

The	|O
distribution	|O
of	|O
red	|O
rice	|O
cultivation	|O
in	|O
Sri	|O
Lanka	|O
is	|O
coincident	|O
with	|O
the	|O
HIDD	|O
villages	|O
.	|O

The	|O
increase	|O
in	|O
number	|O
of	|O
terminal	|O
hairs	|O
,	|O
which	|O
are	|O
defined	|O
as	|O
hairs	|O
more	|O
than	|O
60	|O
microm	|O
in	|O
diameter	|O
,	|O
in	|O
the	|O
designated	|O
area	|O
(	|O
0.5	|O
cm	|O
square	|O
=	|O
0.25	|O
cm2	|O
area	|O
)	|O
of	|O
the	|O
procyanidin	|O
B	|O
-	|O
2	|O
group	|O
subjects	|O
after	|O
the	|O
6	|O
-	|O
month	|O
trial	|O
was	|O
significantly	|O
greater	|O
than	|O
that	|O
of	|O
the	|O
placebo	|O
control	|O
group	|O
subjects	|O
(	|O
procyanidin	|O
B	|O
-	|O
2	|O
,	|O
1.99	|O
+	|O
/	|O
-	|O
2.58	|O
(	|O
mean	|O
+	|O
/	|O
-	|O
SD	|O
)	|O
/	|O
0.25	|O
cm2	|O
;	|O
placebo	|O
,	|O
-	|O
0.82	|O
+	|O
/	|O
-	|O
3.40	|O
(	|O
mean	|O
+	|O
/	|O
-	|O
SD	|O
)	|O
/	|O
0.25	|O
cm2	|O
;	|O
P	|O
<	|O
0.02	|O
,	|O
two	|O
-	|O
sample	|O
t	|O
test	|O
)	|O
.	|O

Ectopic	|O
expression	|O
of	|O
the	|O
dominant	|O
mutant	|O
Lg3	|B-PROTEIN
allele	|O
is	|O
believed	|O
to	|O
cause	|O
the	|O
phenotype	|O
.	|O

High	|O
plasma	|O
AVP	|B-PROTEIN
levels	|O
observed	|O
in	|O
the	|O
two	|O
cases	|O
suggest	|O
that	|O
SSRIs	|O
stimulate	|O
AVP	|B-PROTEIN
secretion	|O
,	|O
thereby	|O
causing	|O
SIADH	|O
.	|O

Thus	|O
,	|O
in	|O
T47D	|O
breast	|O
carcinoma	|O
cells	|O
,	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
acts	|O
in	|O
synergy	|O
with	|O
EGF	|B-PROTEIN
receptor	|I-PROTEIN
autocrine	|O
activity	|O
to	|O
signal	|O
through	|O
the	|O
MAPK	|B-PROTEIN
/	|O
PI3K	|B-PROTEIN
pathways	|O
.	|O

Human	|O
homologue	|O
of	|O
yeast	|O
Rad23	|B-PROTEIN
protein	|I-PROTEIN
A	|I-PROTEIN
interacts	|O
with	|O
p300	|B-PROTEIN
/	|O
cyclic	|O
AMP	|O
-	|O
responsive	|O
element	|O
binding	|O
(	|B-PROTEIN
CREB	|I-PROTEIN
)	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
to	|O
down	|O
-	|O
regulate	|O
transcriptional	|O
activity	|O
of	|O
p53	|B-PROTEIN
.	|O

For	|O
immunological	|O
methods	|O
,	|O
identification	|O
of	|O
such	|O
antigens	|O
with	|O
intermolecular	|O
variability	|O
,	|O
e.g.	|O
,	|O
the	|O
structural	|O
aescin	|O
analogs	|O
,	|O
is	|O
of	|O
unknown	|O
validity	|O
.	|O

Most	|O
patients	|O
harboring	|O
metronidazole	|O
-	|O
and	|O
clarithromycin	|O
-	|O
resistant	|O
strains	|O
were	|O
eradicated	|O
at	|O
an	|O
equal	|O
rate	|O
by	|O
each	|O
of	|O
the	|O
three	|O
regimens	|O
.	|O

Binding	|O
of	|O
cell	|O
type	|O
-	|O
specific	|O
nuclear	|O
proteins	|O
to	|O
the	|O
5'	|O
-	|O
flanking	|O
region	|O
of	|O
maize	|O
C4	|B-PROTEIN
phosphoenolpyruvate	|I-PROTEIN
carboxylase	|I-PROTEIN
gene	|O
confers	|O
its	|O
differential	|O
transcription	|O
in	|O
mesophyll	|O
cells	|O
.	|O

RESULTS	|O
:	|O
During	|O
the	|O
stabilization	|O
period	|O
,	|O
PaCO2	|O
(	|O
mean	|O
+	|O
/	|O
-	|O
SD	|O
)	|O
was	|O
33	|O
+	|O
/	|O
-	|O
5	|O
mm	|O
Hg	|O
,	|O
and	|O
arrhythmias	|O
were	|O
not	|O
detected	|O
.	|O

BACKGROUND	|O
:	|O
Previous	|O
studies	|O
have	|O
indicated	|O
that	|O
the	|O
60	|O
-	|O
,	|O
30	|O
-	|O
,	|O
28	|O
-	|O
and	|O
12	|O
-	|O
item	|O
versions	|O
of	|O
the	|O
General	|O
Health	|O
Questionnaire	|O
(	|O
GHQ	|O
)	|O
are	|O
liable	|O
to	|O
retest	|O
effects	|O
,	|O
especially	|O
when	|O
administered	|O
multiple	|O
times	|O
with	|O
short	|O
intervals	|O
.	|O

Acute	|O
effects	|O
of	|O
LI	|O
160	|O
(	|O
extract	|O
of	|O
Hypericum	|O
perforatum	|O
,	|O
St	|O
John	|O
's	|O
wort	|O
)	|O
and	|O
two	|O
of	|O
its	|O
constituents	|O
on	|O
neuroendocrine	|O
responses	|O
in	|O
the	|O
rat	|O
.	|O

Decreased	|O
serum	|O
ceruloplasmin	|B-PROTEIN
and	|O
copper	|O
levels	|O
in	|O
cervical	|O
dystonia	|O
.	|O

A	|O
microsporidian	|O
,	|O
Nosema	|O
algerae	|O
Vavra	|O
and	|O
undeen	|O
,	|O
was	|O
found	|O
parasitizing	|O
larvae	|O
and	|O
adults	|O
of	|O
a	|O
laboratory	|O
colony	|O
of	|O
Culex	|O
pipiens	|O
L.	|O
originated	|O
from	|O
Gharbia	|O
Governorate	|O
.	|O

Molecular	|O
cloning	|O
and	|O
characterization	|O
of	|O
OsPSK	|B-PROTEIN
,	|O
a	|O
gene	|O
encoding	|O
a	|O
precursor	|O
for	|O
phytosulfokine	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
,	|O
required	|O
for	|O
rice	|O
cell	|O
proliferation	|O
.	|O

Blood	|O
from	|O
dams	|O
was	|O
collected	|O
prior	|O
to	|O
inoculation	|O
and	|O
at	|O
time	|O
of	|O
necropsy	|O
for	|O
measurement	|O
of	|O
IgM	|B-PROTEIN
and	|O
IgG	|B-PROTEIN
antibodies	|O
to	|O
M.	|O
pulmonis	|O
.	|O

Plasma	|O
DHE	|O
concentration	|O
rose	|O
promptly	|O
above	|O
5	|O
ng	|O
/	|O
ml	|O
after	|O
the	|O
application	|O
of	|O
the	|O
PSA	|O
tape	|O
onto	|O
the	|O
damaged	|O
skin	|O
in	|O
hairless	|O
rat	|O
.	|O

Single	|O
amino	|O
acid	|O
substitutions	|O
at	|O
the	|O
acyl	|O
-	|O
CoA	|O
-	|O
binding	|O
domain	|O
interrupt	|O
14	|O
[	|O
C	|O
]	|O
palmitoyl	|O
-	|O
CoA	|O
binding	|O
of	|O
ACBP2	|B-PROTEIN
,	|O
an	|O
Arabidopsis	|O
acyl	|B-PROTEIN
-	|I-PROTEIN
CoA	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
with	|O
ankyrin	|B-PROTEIN
repeats	|O
.	|O

Implications	|O
in	|O
biomonitoring	|O
of	|O
the	|O
observed	|O
accumulation	|O
patterns	|O
,	|O
especially	|O
in	|O
the	|O
different	|O
tissues	|O
of	|O
Posidonia	|O
oceanica	|O
,	|O
are	|O
discussed	|O
.	|O

Thus	|O
,	|O
Xlim	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
not	|O
only	|O
contains	|O
a	|O
unique	|O
tyrosine	|O
-	|O
rich	|O
activation	|O
domain	|O
but	|O
also	|O
contains	|O
a	|O
negative	|O
regulatory	|O
domain	|O
in	|O
CT239	|O
-	|O
403	|O
,	|O
suggesting	|O
a	|O
complex	|O
regulatory	|O
mechanism	|O
underlying	|O
the	|O
transcriptional	|O
activity	|O
of	|O
Xlim	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
in	|O
the	|O
organizer	|O
.	|O

After	|O
allowing	|O
time	|O
for	|O
absorption	|O
,	|O
participants	|O
completed	|O
a	|O
bridge	|O
simulator	|O
task	|O
.	|O

The	|O
bovine	|O
PGHS	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
cDNA	|O
was	|O
cloned	|O
by	|O
a	|O
combination	|O
of	|O
reverse	|O
transcription	|O
-	|O
polymerase	|O
chain	|O
reaction	|O
and	|O
cDNA	|O
library	|O
screening	|O
.	|O

The	|O
regulation	|O
of	|O
PGHS	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
mRNA	|O
and	|O
protein	|O
was	|O
studied	|O
in	|O
primary	|O
cultures	|O
of	|O
bovine	|O
uterine	|O
stromal	|O
cells	|O
stimulated	|O
with	|O
phorbol	|O
12	|O
-	|O
myristate	|O
13	|O
-	|O
acetate	|O
(	|O
PMA	|O
;	|O
100	|O
nM	|O
)	|O
.	|O

Functional	|O
analysis	|O
of	|O
various	|O
PTP	|B-PROTEIN
-	|O
deficient	|O
DT40	|O
B	|O
cell	|O
lines	|O
stably	|O
expressing	|O
wild	|O
-	|O
type	|O
chimeric	|O
Fc	|B-PROTEIN
gamma	|I-PROTEIN
RIIB1	|I-PROTEIN
-	|I-PROTEIN
PECAM	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
receptor	|I-PROTEIN
indicated	|O
that	|O
cytoplasmic	|O
Src	|B-PROTEIN
homology	|I-PROTEIN
2	|I-PROTEIN
-	|O
domain	|O
-	|O
containing	|O
phosphatases	|O
,	|O
SHP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
SHP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
,	|O
were	|O
both	|O
necessary	|O
and	|O
sufficient	|O
to	|O
deliver	|O
inhibitory	|O
negative	|O
regulation	|O
upon	|O
coligation	|O
of	|O
BCR	|B-PROTEIN
complex	|O
with	|O
inhibitory	|O
receptor	|O
.	|O

Anti	|B-PROTEIN
-	|I-PROTEIN
nucleolin	|I-PROTEIN
mAb	|O
was	|O
used	|O
to	|O
confirm	|O
the	|O
antigenic	|O
properties	|O
of	|O
this	|O
p95	|B-PROTEIN
component	|O
.	|O

Furthermore	|O
,	|O
stable	|O
expression	|O
of	|O
a	|O
constitutively	|O
active	|O
form	|O
of	|O
chicken	|O
Notch1	|B-PROTEIN
or	|O
Notch2	|B-PROTEIN
in	|O
a	|O
B	|O
cell	|O
line	|O
results	|O
in	|O
a	|O
down	|O
-	|O
regulation	|O
of	|O
surface	|O
IgM	|B-PROTEIN
expression	|O
,	|O
which	|O
is	|O
accompanied	|O
by	|O
the	|O
reduction	|O
of	|O
IgH	|B-PROTEIN
gene	|O
transcripts	|O
.	|O

Substitutions	|O
in	|O
the	|O
YFV	|B-PROTEIN
Ag	|O
-	|O
binding	|O
region	|O
(	|O
ABR	|B-PROTEIN
)	|O
occur	|O
at	|O
four	|O
of	|O
the	|O
eight	|O
highly	|O
conserved	|O
residues	|O
that	|O
are	|O
essential	|O
for	|O
binding	|O
of	|O
peptide	|O
-	|O
Ag	|O
in	|O
the	|O
class	|O
Ia	|O
molecules	|O
.	|O

Similarly	|O
,	|O
curcumin	|O
(	|O
diferuloylmethane	|O
)	|O
,	|O
an	|O
anti	|O
-	|O
inflammatory	|O
agent	|O
,	|O
suppressed	|O
OSM	|B-PROTEIN
-	|O
stimulated	|O
STAT1	|B-PROTEIN
phosphorylation	|O
,	|O
DNA	|O
-	|O
binding	|O
activity	|O
of	|O
STAT1	|B-PROTEIN
,	|O
and	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
N	|I-PROTEIN
-	|I-PROTEIN
terminal	|I-PROTEIN
kinase	|I-PROTEIN
activation	|O
without	|O
affecting	|O
JAK1	|B-PROTEIN
,	|O
JAK2	|B-PROTEIN
,	|O
JAK3	|B-PROTEIN
,	|O
ERK1/2	|B-PROTEIN
,	|O
and	|O
p38	|B-PROTEIN
phosphorylation	|O
.	|O

In	|O
contrast	|O
,	|O
the	|O
failure	|O
of	|O
the	|O
QKTT	|O
motif	|O
and	|O
TGN46	|O
cytoplasmic	|O
tail	|O
to	|O
induce	|O
steady	|O
-	|O
state	|O
ER	|O
localization	|O
of	|O
vesicular	|B-PROTEIN
stomatitis	|I-PROTEIN
virus	|I-PROTEIN
glycoprotein	|I-PROTEIN
(	|O
VSVG	|B-PROTEIN
)	|O
chimeras	|O
in	|O
HeLa	|O
and	|O
NRK	|O
cells	|O
indicates	|O
that	|O
significant	|O
differences	|O
in	|O
early	|O
secretory	|O
trafficking	|O
also	|O
exist	|O
.	|O

A	|O
cDNA	|O
clone	|O
encoding	|O
C2H2	|B-PROTEIN
-	|I-PROTEIN
type	|I-PROTEIN
zinc	|I-PROTEIN
finger	|I-PROTEIN
protein	|I-PROTEIN
,	|O
SCOF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
was	|O
isolated	|O
from	|O
soybean	|O
.	|O

Consistent	|O
with	|O
the	|O
specificity	|O
observed	|O
for	|O
the	|O
interaction	|O
of	|O
DmCKIIalpha	|B-PROTEIN
with	|O
these	|O
bHLH	|B-PROTEIN
proteins	|I-PROTEIN
,	|O
sequence	|O
alignment	|O
suggests	|O
that	|O
only	|O
m5	|B-PROTEIN
,	|O
m7	|B-PROTEIN
,	|O
and	|O
m8	|B-PROTEIN
contain	|O
a	|O
consensus	|O
site	|O
for	|O
phosphorylation	|O
by	|O
CKII	|B-PROTEIN
within	|O
a	|O
subdomain	|O
unique	|O
to	|O
these	|O
three	|O
proteins	|O
.	|O

Apart	|O
from	|O
antimicrobial	|O
properties	|O
,	|O
recent	|O
data	|O
indicate	|O
that	|O
PMN	|O
also	|O
exert	|O
anti	|O
-	|O
inflammatory	|O
effects	|O
by	|O
stimulation	|O
and	|O
release	|O
of	|O
cytokine	|O
antagonists	|O
such	|O
as	|O
interleukin	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
receptor	|I-PROTEIN
antagonist	|I-PROTEIN
(	|O
IL	|B-PROTEIN
-	|I-PROTEIN
1ra	|I-PROTEIN
)	|O
.	|O

The	|O
purpose	|O
of	|O
this	|O
investigation	|O
was	|O
to	|O
study	|O
the	|O
morphological	|O
characteristics	|O
of	|O
the	|O
fibrous	|O
tissue	|O
capsule	|O
resulting	|O
from	|O
the	|O
implantation	|O
of	|O
aluminum	|O
calcium	|O
phosphate	|O
(	|O
ALCAP	|O
)	|O
and	|O
hydroxyapetite	|O
(	|O
HA	|O
)	|O
bioceramics	|O
.	|O

Sevelamer	|O
hydrochloride	|O
(	|O
Renagel	|O
)	|O
is	|O
a	|O
nonabsorbed	|O
phosphate	|O
-	|O
binding	|O
polymer	|O
marketed	|O
for	|O
the	|O
treatment	|O
of	|O
hyperphosphatemia	|O
in	|O
adult	|O
patients	|O
receiving	|O
hemodialysis	|O
.	|O

The	|O
pharmacokinetic	|O
profiles	|O
of	|O
digoxin	|O
and	|O
warfarin	|O
were	|O
not	|O
altered	|O
by	|O
the	|O
simultaneous	|O
and	|O
continued	|O
administration	|O
of	|O
sevelamer	|O
.	|O

Before	|O
PO3	|O
administration	|O
,	|O
more	|O
than	|O
half	|O
(	|O
57.4%	|O
)	|O
of	|O
the	|O
patients	|O
received	|O
only	|O
1	|O
or	|O
2	|O
antituberculous	|O
drugs	|O
(	|O
ethambutole	|O
and	|O
ethionamide	|O
or	|O
ethambutole	|O
and	|O
oprofloxacin	|O
)	|O
.	|O

Can	|O
survival	|O
be	|O
prolonged	|O
for	|O
patients	|O
with	|O
hormone	|O
-	|O
resistant	|O
prostate	|O
cancer	|O
?	|O

Patients	|O
were	|O
divided	|O
into	|O
two	|O
group	|O
;	|O
Control	|O
group	|O
A	|O
in	|O
which	|O
a	|O
hot	|O
-	|O
water	|O
circulating	|O
system	|O
was	|O
used	|O
and	|O
group	|O
B	|O
in	|O
which	|O
a	|O
transtracheal	|O
heating	|O
and	|O
humidification	|O
system	|O
by	|O
ANAMED	|O
HUMITUBE	|O
was	|O
used	|O
,	|O
during	|O
gastric	|O
cancer	|O
operation	|O
.	|O

The	|O
present	|O
data	|O
also	|O
demonstrate	|O
that	|O
ectopic	|O
expression	|O
of	|O
blr1	|B-PROTEIN
increased	|O
JNK	|B-PROTEIN
/	|O
SAPK	|B-PROTEIN
activity	|O
,	|O
but	|O
JNK	|B-PROTEIN
/	|O
SAPK	|B-PROTEIN
activation	|O
was	|O
not	|O
needed	|O
for	|O
accelerated	|O
RA	|O
-	|O
induced	|O
differentiation	|O
and	|O
growth	|O
arrest	|O
.	|O

The	|O
effects	|O
of	|O
the	|O
transfected	|O
receptors	|O
were	|O
associated	|O
with	|O
antagonism	|O
of	|O
activator	|B-PROTEIN
protein	|I-PROTEIN
1	|I-PROTEIN
(	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
activity	|O
.	|O

Recent	|O
studies	|O
using	|O
isolated	|O
rat	|O
adipocytes	|O
and	|O
chemically	|O
synthesized	|O
PIG	|O
compounds	|O
point	|O
to	|O
IRS1/3	|B-PROTEIN
tyrosine	|O
phosphorylation	|O
by	|O
p59Lyn	|B-PROTEIN
kinase	|I-PROTEIN
as	|O
the	|O
site	|O
of	|O
cross	|O
-	|O
talk	|O
,	|O
the	|O
negative	|O
regulation	|O
of	|O
which	|O
by	|O
interaction	|O
with	|O
caveolin	|B-PROTEIN
is	|O
apparently	|O
abrogated	|O
by	|O
PIG	|O
.	|O

RESULTS	|O
:	|O
The	|O
parameters	|O
SF2	|O
and	|O
plating	|O
efficiency	|O
were	|O
stable	|O
throughout	|O
the	|O
4	|O
-	|O
year	|O
test	|O
period	|O
.	|O

Also	|O
,	|O
small	|O
,	|O
sense	|O
and	|O
antisense	|O
approximately	|O
22	|O
nt	|O
RNAs	|O
,	|O
derived	|O
from	|O
the	|O
satRNA	|O
,	|O
were	|O
associated	|O
with	|O
the	|O
replicating	|O
satellite	|O
.	|O

VE	|O
-	|O
DEF	|O
animals	|O
had	|O
significantly	|O
higher	|O
(	|O
p	|O
<	|O
0.05	|O
)	|O
levels	|O
of	|O
myocardial	|O
lipid	|O
peroxidation	|O
and	|O
lower	|O
(	|O
p	|O
<	|O
0.05	|O
)	|O
protein	|O
thiols	|O
following	|O
I	|O
-	|O
R	|O
compared	|O
to	|O
the	|O
CON	|O
animals	|O
.	|O

Grippers	|O
with	|O
integrated	|O
piezoresistive	|O
force	|O
sensors	|O
and	|O
with	|O
attached	|O
strain	|O
gauges	|O
have	|O
been	|O
reported	|O
.	|O

The	|O
child	|O
left	|O
behind	|O
.	|O

Transition	|O
between	|O
P	|O
-	|O
and	|O
H	|O
-	|O
BPPV	|O
was	|O
found	|O
in	|O
6	|O
cases	|O
.	|O

The	|O
contrasting	|O
effects	|O
of	|O
dopaminergic	|O
stimulation	|O
on	|O
the	|O
motor	|O
performance	|O
and	|O
on	|O
some	|O
aspects	|O
of	|O
cognitive	|O
processing	|O
suggest	|O
the	|O
existence	|O
of	|O
complex	|O
interactions	|O
within	|O
pre	|O
-	|O
and	|O
postsynaptic	|O
brain	|O
dopamine	|B-PROTEIN
receptors	|I-PROTEIN
,	|O
and	|O
an	|O
intervention	|O
of	|O
segregated	|O
basal	|O
ganglia	|O
-	|O
prefrontal	|O
cortex	|O
loops	|O
in	|O
motor	|O
and	|O
cognitive	|O
behaviour	|O
.	|O

HexA71	|B-PROTEIN
negatively	|O
affects	|O
RpoS	|B-PROTEIN
,	|O
as	|O
the	|O
levels	|O
of	|O
this	|O
alternative	|O
sigma	|B-PROTEIN
factor	|I-PROTEIN
are	|O
higher	|O
in	|O
the	|O
HexA	|B-PROTEIN
-	|O
mutant	|O
than	|O
in	|O
the	|O
HexA+	|B-PROTEIN
strain	|O
.	|O

Multiple	|O
copies	|O
of	|O
rsmB+	|B-PROTEIN
DNA	|O
,	|O
on	|O
the	|O
other	|O
hand	|O
,	|O
stimulate	|O
exoenzyme	|O
production	|O
by	|O
relieving	|O
the	|O
negative	|O
effects	|O
of	|O
a	|O
chromosomal	|O
copy	|O
of	|O
hexA+	|B-PROTEIN
.	|O

0%	|O
)	|O
and	|O
IL	|B-PROTEIN
-	|I-PROTEIN
12	|I-PROTEIN
(	|O
42.6%	|O
vs.	|O

Systematic	|O
review	|O
of	|O
diagnostic	|O
tests	|O
for	|O
vaginal	|O
trichomoniasis	|O
.	|O

CHAP	|O
and	|O
the	|O
Department	|O
of	|O
Veterans	|O
Affairs	|O
.	|O

More	|O
importantly	|O
,	|O
this	|O
fusion	|O
converted	|O
a	|O
less	|O
effective	|O
vaccine	|O
into	|O
one	|O
with	|O
significant	|O
potency	|O
against	|O
established	|O
E7	|B-PROTEIN
-	|O
expressing	|O
metastatic	|O
tumors	|O
.	|O

We	|O
compared	|O
previously	|O
the	|O
methylation	|O
status	|O
between	|O
normal	|O
liver	|O
and	|O
liver	|O
tumors	|O
in	|O
SV40	|B-PROTEIN
T	|I-PROTEIN
/	|O
t	|B-PROTEIN
antigen	|I-PROTEIN
transgenic	|O
mice	|O
(	|O
MT	|O
-	|O
D2	|O
mice	|O
)	|O
using	|O
Restriction	|O
Landmark	|O
Genomic	|O
Scanning	|O
for	|O
Methylation	|O
(	|O
RLGS	|O
-	|O
M	|O
)	|O
and	|O
identified	|O
several	|O
loci	|O
/	|O
spots	|O
that	|O
appeared	|O
to	|O
be	|O
methylated	|O
frequently	|O
in	|O
liver	|O
tumors	|O
.	|O

The	|O
Genescan	|O
program	|O
predicted	|O
an	|O
open	|O
reading	|O
frame	|O
of	|O
a	|O
novel	|O
,	|O
intron	|O
-	|O
less	|O
gene	|O
adjacent	|O
to	|O
the	|O
B236	|O
spot	|O
that	|O
encodes	|O
a	|O
putative	|O
493	|O
-	|O
amino	|O
acid	|O
protein	|O
containing	|O
the	|O
SNAG	|O
repressor	|O
motif	|O
in	|O
the	|O
NH2	|O
-	|O
terminal	|O
region	|O
and	|O
five	|O
C2H2	|O
-	|O
type	|O
zinc	|O
finger	|O
motifs	|O
in	|O
the	|O
COOH	|O
-	|O
terminal	|O
half	|O
.	|O

Northern	|O
blot	|O
analysis	|O
revealed	|O
that	|O
mlt	|B-PROTEIN
1	|I-PROTEIN
is	|O
normally	|O
expressed	|O
in	|O
brain	|O
,	|O
spleen	|O
,	|O
stom	|O
ach	|O
,	|O
and	|O
liver	|O
.	|O

Treatment	|O
of	|O
N18TG	|O
-	|O
2	|O
cells	|O
with	|O
a	|O
demethylating	|O
agent	|O
,	|O
5	|O
-	|O
aza	|O
-	|O
deoxycytidine	|O
,	|O
resulted	|O
in	|O
an	|O
expression	|O
of	|O
mlt	|B-PROTEIN
1	|I-PROTEIN
,	|O
indicating	|O
that	|O
the	|O
repression	|O
of	|O
mlt	|B-PROTEIN
1	|I-PROTEIN
is	|O
attributable	|O
to	|O
methylation	|O
Thus	|O
,	|O
mlt	|B-PROTEIN
1	|I-PROTEIN
is	|O
a	|O
novel	|O
target	|O
gene	|O
that	|O
is	|O
silenced	|O
by	|O
methylation	|O
during	|O
liver	|O
tumorigenesis	|O
initiated	|O
by	|O
SV40	|B-PROTEIN
T	|I-PROTEIN
antigen	|I-PROTEIN
.	|O

As	|O
an	|O
oral	|O
,	|O
nontoxic	|O
compound	|O
with	|O
a	|O
mechanism	|O
of	|O
action	|O
distinct	|O
from	|O
that	|O
of	|O
ABL	|B-PROTEIN
tyrosine	|O
kinase	|O
inhibition	|O
,	|O
FTI	|O
SCH66336	|O
shows	|O
promise	|O
for	|O
the	|O
treatment	|O
of	|O
BCR	|B-PROTEIN
/	|O
ABL	|B-PROTEIN
-	|O
induced	|O
leukemia	|O
.	|O

These	|O
results	|O
suggested	|O
a	|O
critical	|O
role	|O
for	|O
tyrosine	|O
residue	|O
1229	|O
in	|O
the	|O
regulation	|O
of	|O
L1	|B-PROTEIN
endocytosis	|O
.	|O

We	|O
conclude	|O
that	|O
RPMS	|B-PROTEIN
acts	|O
as	|O
a	|O
negative	|O
regulator	|O
of	|O
EBNA2	|B-PROTEIN
and	|O
Notch	|B-PROTEIN
activity	|O
through	|O
its	|O
interactions	|O
with	|O
the	|O
CBF1	|B-PROTEIN
-	|O
associated	|O
corepressor	|O
complex	|O
.	|O

Folate	|O
metabolism	|O
in	|O
the	|O
human	|O
malaria	|O
parasite	|O
Plasmodium	|O
falciparum	|O
is	|O
an	|O
essential	|O
activity	|O
for	|O
cell	|O
growth	|O
and	|O
replication	|O
,	|O
and	|O
the	|O
target	|O
of	|O
an	|O
important	|O
class	|O
of	|O
therapeutic	|O
agents	|O
in	|O
widespread	|O
use	|O
.	|O

The	|O
BFA	|O
System	|O
reads	|O
a	|O
text	|O
file	|O
with	|O
flows	|O
,	|O
measured	|O
with	|O
fluorescent	|O
microsphere	|O
technique	|O
,	|O
and	|O
constructs	|O
the	|O
lung	|O
anatomy	|O
with	|O
volumetric	|O
pixels	|O
showing	|O
the	|O
flows	|O
with	|O
a	|O
color	|O
schema	|O
.	|O

Retinoids	|O
participate	|O
in	|O
the	|O
onset	|O
of	|O
differentiation	|O
,	|O
apoptosis	|O
and	|O
the	|O
inhibition	|O
of	|O
growth	|O
in	|O
a	|O
wide	|O
variety	|O
of	|O
normal	|O
and	|O
cancerous	|O
cells	|O
.	|O

Transactivation	|O
of	|O
oIFNtau	|B-PROTEIN
enhancer	|O
-	|O
reporter	|O
constructs	|O
was	|O
primarily	|O
regulated	|O
by	|O
three	|O
regions	|O
containing	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
site	|O
,	|O
GATA	|B-PROTEIN
like	|O
sequence	|O
and	|O
site	|O
(	|O
s	|O
)	|O
unidentified	|O
.	|O

These	|O
results	|O
indicate	|O
that	|O
evaluation	|O
of	|O
exposure	|O
to	|O
S.	|O
neurona	|O
by	|O
WB	|O
analysis	|O
of	|O
serum	|O
may	|O
be	|O
misleading	|O
in	|O
young	|O
horses	|O
.	|O

Drosophila	|O
Menin1	|B-PROTEIN
gene	|O
transcripts	|O
use	|O
alternative	|O
polyadenylation	|O
sites	|O
resulting	|O
in	|O
4.3	|O
and	|O
5	|O
-	|O
kb	|O
messages	|O
.	|O

Sequence	|O
analysis	|O
indicates	|O
that	|O
RBP21	|B-PROTEIN
shares	|O
homology	|O
with	|O
other	|O
retinoblastoma	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
proteins	|I-PROTEIN
in	|O
the	|O
pRb	|B-PROTEIN
-	|O
binding	|O
motif	|O
LxCxE	|O
at	|O
the	|O
C	|O
-	|O
terminal	|O
region	|O
.	|O

In	|O
addition	|O
,	|O
the	|O
consensus	|O
amino	|O
acid	|O
motif	|O
for	|O
serine	|B-PROTEIN
threonine	|I-PROTEIN
receptor	|I-PROTEIN
kinases	|I-PROTEIN
was	|O
also	|O
present	|O
.	|O

We	|O
have	|O
also	|O
isolated	|O
and	|O
analyzed	|O
the	|O
5'	|O
flanking	|O
region	|O
of	|O
the	|O
pea	|O
33RNP	|B-PROTEIN
gene	|O
.	|O

OsBBPI	|B-PROTEIN
was	|O
found	|O
to	|O
be	|O
rapidly	|O
induced	|O
in	|O
rice	|O
seedling	|O
leaf	|O
in	|O
response	|O
to	|O
cut	|B-PROTEIN
,	|O
exogenous	|O
jasmonic	|O
acid	|O
(	|O
JA	|O
)	|O
,	|O
and	|O
two	|O
potent	|O
protein	|B-PROTEIN
phosphatase	|I-PROTEIN
2A	|I-PROTEIN
(	|O
PP2A	|B-PROTEIN
)	|O
inhibitors	|O
,	|O
cantharidin	|O
(	|O
CN	|O
)	|O
and	|O
endothall	|O
(	|O
EN	|O
)	|O
,	|O
in	|O
a	|O
light	|O
/	|O
dark	|O
-	|O
,	|O
time	|O
-	|O
and	|O
dose	|O
-	|O
dependent	|O
manner	|O
;	|O
this	|O
induction	|O
was	|O
completely	|O
inhibited	|O
by	|O
cycloheximide	|O
(	|O
CHX	|O
)	|O
,	|O
indicating	|O
a	|O
requirement	|O
for	|O
de	|O
novo	|O
protein	|O
synthesis	|O
in	|O
its	|O
induction	|O
.	|O

Copyright	|O
2000	|O
John	|O
Wiley	|O
&	|O
Sons	|O
,	|O
Ltd	|O
.	|O

The	|O
effects	|O
of	|O
chlordiazepoxide	|O
(	|O
2.5-15.0	|O
mg	|O
/	|O
kg	|O
)	|O
,	|O
a	|O
full	|O
benzodiazepine	|B-PROTEIN
receptor	|I-PROTEIN
agonist	|O
,	|O
and	|O
bretazenil	|O
(	|O
5.0-30.0	|O
mg	|O
/	|O
kg	|O
)	|O
,	|O
a	|O
partial	|O
benzodiazepine	|B-PROTEIN
receptor	|I-PROTEIN
agonist	|O
,	|O
were	|O
examined	|O
in	|O
the	|O
murine	|O
elevated	|O
plus	|O
-	|O
maze	|O
paradigm	|O
.	|O

However	|O
,	|O
plasmids	|O
carrying	|O
the	|O
yeast	|O
TyrRS	|B-PROTEIN
gene	|O
could	|O
not	|O
be	|O
stably	|O
maintained	|O
in	|O
E.	|O
coli	|O
.	|O

In	|O
mammalian	|O
tissue	|O
culture	|O
cells	|O
,	|O
overexpression	|O
of	|O
any	|O
of	|O
the	|O
four	|O
mouse	|O
deltex	|O
homologs	|O
suppressed	|O
the	|O
transcriptional	|O
activity	|O
of	|O
E47	|B-PROTEIN
,	|O
a	|O
basic	|O
helix	|O
-	|O
loop	|O
-	|O
helix	|O
(	|B-PROTEIN
bHLH	|I-PROTEIN
)	|I-PROTEIN
protein	|I-PROTEIN
,	|O
in	|O
a	|O
manner	|O
similar	|O
to	|O
suppression	|O
by	|O
an	|O
activated	|O
form	|O
of	|O
human	|O
Notch1	|B-PROTEIN
or	|O
human	|O
DTX1	|B-PROTEIN
.	|O

Multiparous	|O
women	|O
presented	|O
higher	|O
BMI	|O
(	|O
P	|O
=	|O
0.01	|O
)	|O
and	|O
PBF	|O
(	|O
P	|O
=	|O
0.03	|O
)	|O
compared	|O
with	|O
primi	|O
-	|O
and	|O
nulliparous	|O
groups	|O
.	|O

The	|O
authors	|O
did	|O
not	|O
detect	|O
any	|O
significant	|O
correlations	|O
between	|O
parameters	|O
of	|O
the	|O
lipids	|O
of	|O
bone	|O
marrow	|O
and	|O
leptin	|B-PROTEIN
levels	|O
in	|O
serum	|O
and	|O
bone	|O
marrow	|O
.	|O

Fluorimetric	|O
determination	|O
of	|O
methylmercury	|O
as	|O
an	|O
ion	|O
-	|O
association	|O
complex	|O
with	|O
rhodamine	|O
B	|O
in	|O
the	|O
presence	|O
of	|O
iodide	|O
.	|O

The	|O
position	|O
of	|O
the	|O
analyst	|O
as	|O
expert	|O
:	|O
yesterday	|O
and	|O
today	|O
.	|O

Our	|O
results	|O
suggest	|O
that	|O
the	|O
central	|O
role	|O
of	|O
the	|O
Notch	|B-PROTEIN
-	|O
CBF1	|B-PROTEIN
/	|O
RBP	|B-PROTEIN
-	|I-PROTEIN
Jkappa	|I-PROTEIN
signaling	|O
pathway	|O
in	|O
cell	|O
fate	|O
decisions	|O
renders	|O
it	|O
susceptible	|O
to	|O
pathways	|O
of	|O
viral	|O
replication	|O
and	|O
oncogenic	|O
conversion	|O
.	|O

Using	|O
a	|O
novel	|O
method	|O
combining	|O
chromatin	|O
immunoprecipitation	|O
and	|O
genomic	|O
array	|O
hybridization	|O
,	|O
we	|O
have	|O
identified	|O
a	|O
460	|O
-	|O
kb	|O
CENP	|B-PROTEIN
-	|I-PROTEIN
A	|I-PROTEIN
-	|O
binding	|O
DNA	|O
domain	|O
of	|O
a	|O
neocentromere	|O
derived	|O
from	|O
the	|O
20p12	|O
region	|O
of	|O
an	|O
invdup	|O
(	|O
20p	|O
)	|O
human	|O
marker	|O
chromosome	|O
.	|O

We	|O
describe	|O
a	|O
total	|O
of	|O
39	|O
DEAH	|B-PROTEIN
helicases	|I-PROTEIN
in	|O
these	|O
four	|O
species	|O
.	|O

Two	|O
cases	|O
with	|O
marked	|O
chronic	|O
arm	|O
lymphoedema	|O
reported	|O
major	|O
and	|O
persistent	|O
improvements	|O
in	|O
arm	|O
volume	|O
for	|O
at	|O
least	|O
12	|O
months	|O
after	|O
treatment	|O
with	|O
HBO2	|O
.	|O

The	|O
sensitivity	|O
of	|O
human	|O
neuroblastoma	|O
cells	|O
SK	|O
-	|O
N	|O
-	|O
SH	|O
to	|O
undergo	|O
apoptosis	|O
induced	|O
by	|O
thapsigargin	|O
was	|O
examined	|O
.	|O

Prophylactic	|O
lymph	|O
node	|O
dissection	|O
or	|O
radiation	|O
therapy	|O
to	|O
the	|O
nodal	|O
chain	|O
may	|O
decrease	|O
local	|O
recurrence	|O
but	|O
does	|O
not	|O
consistently	|O
affect	|O
overall	|O
survival	|O
.	|O

Currently	|O
,	|O
the	|O
clinical	|O
use	|O
of	|O
5	|O
-	|O
aminolaevulinic	|O
acid	|O
(	|O
ALA	|O
)	|O
induced	|O
protoporphyrin	|B-PROTEIN
IX	|I-PROTEIN
(	|O
PPIX	|B-PROTEIN
)	|O
for	|O
photodynamic	|O
therapy	|O
(	|O
PDT	|O
)	|O
is	|O
limited	|O
by	|O
the	|O
maximum	|O
tolerated	|O
oral	|O
ALA	|O
dose	|O
(	|O
60	|O
mg	|O
/	|O
kg	|O
)	|O
.	|O

We	|O
can	|O
classify	|O
antibiotics	|O
into	|O
two	|O
groups	|O
based	|O
on	|O
initial	|O
bactericidal	|O
activity	|O
against	|O
P.	|O
aeruginosa	|O
;	|O
one	|O
class	|O
is	|O
antibiotics	|O
having	|O
rapid	|O
initial	|O
killing	|O
such	|O
as	|O
AMK	|O
,	|O
IPM	|O
and	|O
PAPM	|O
,	|O
the	|O
other	|O
is	|O
CAZ	|O
,	|O
MEPM	|O
showing	|O
slow	|O
initial	|O
killing	|O
.	|O

Managing	|O
HIV	|O
.	|O

In	|O
Klinefelter	|O
's	|O
syndrome	|O
(	|O
47XXY	|O
)	|O
,	|O
serum	|O
testosterone	|O
levels	|O
are	|O
at	|O
the	|O
lower	|O
end	|O
of	|O
the	|O
normal	|O
range	|O
and	|O
dihydrotestosterone	|O
levels	|O
are	|O
low	|O
.	|O

The	|O
histamine	|O
H1	|B-PROTEIN
receptor	|I-PROTEIN
antagonists	|O
(	|O
antihistamines	|O
)	|O
are	|O
an	|O
important	|O
class	|O
of	|O
medications	|O
used	|O
for	|O
the	|O
relief	|O
of	|O
common	|O
symptoms	|O
associated	|O
with	|O
hyperhistaminic	|O
conditions	|O
occurring	|O
in	|O
children	|O
and	|O
adults	|O
.	|O

Conclusion	|O
:	|O
The	|O
Lp	|B-PROTEIN
(	|I-PROTEIN
a	|I-PROTEIN
)	|I-PROTEIN
levels	|O
in	|O
these	|O
children	|O
were	|O
the	|O
lower	|O
ever	|O
reported	|O
.	|O

A	|O
subset	|O
of	|O
patients	|O
(	|O
n	|O
=	|O
30	|O
)	|O
underwent	|O
multichannel	|O
pressure	|O
flow	|O
studies	|O
,	|O
which	|O
demonstrated	|O
that	|O
transrectal	|O
HIFU	|O
reduces	|O
bladder	|O
outflow	|O
obstruction	|O
.	|O

AIMS	|O
:	|O
To	|O
establish	|O
a	|O
baseline	|O
and	|O
intraindividual	|O
fluctuations	|O
of	|O
the	|O
tumour	|O
markers	|O
CEA	|B-PROTEIN
,	|O
CA	|B-PROTEIN
50	|I-PROTEIN
and	|O
CA	|B-PROTEIN
242	|I-PROTEIN
in	|O
patients	|O
cured	|O
from	|O
colorectal	|O
cancer	|O
,	|O
and	|O
to	|O
test	|O
the	|O
hypothesis	|O
that	|O
serum	|O
concentrations	|O
and	|O
intraindividual	|O
fluctuations	|O
do	|O
not	|O
differ	|O
from	|O
the	|O
concentrations	|O
in	|O
cancer	|O
-	|O
free	|O
individuals	|O
.	|O

The	|O
homologous	|O
active	|O
-	|O
site	|O
framework	|O
of	|O
these	|O
enzymes	|O
with	|O
distinct	|O
structures	|O
suggests	|O
convergent	|O
evolution	|O
of	|O
a	|O
common	|O
catalytic	|O
mechanism	|O
.	|O

Cells	|O
containing	|O
alpha	|O
subunits	|O
that	|O
lacked	|O
a	|O
distal	|O
domain	|O
(	|O
term	|O
-	|O
3	|O
)	|O
or	|O
had	|O
the	|O
alternatively	|O
spliced	|O
alpha	|O
-	|O
2	|O
distal	|O
domain	|O
showed	|O
markedly	|O
decreased	|O
ability	|O
to	|O
support	|O
tyrosine	|O
phosphorylation	|O
of	|O
Jak	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
and	|O
its	|O
substrates	|O
or	|O
to	|O
up	|O
-	|O
regulate	|O
CD86	|B-PROTEIN
.	|O

We	|O
found	|O
that	|O
RhoA	|B-PROTEIN
can	|O
initiate	|O
a	|O
linear	|O
kinase	|O
cascade	|O
leading	|O
to	|O
the	|O
activation	|O
of	|O
ERK6	|B-PROTEIN
(	|O
p38	|B-PROTEIN
gamma	|I-PROTEIN
)	|O
,	|O
a	|O
recently	|O
identified	|O
member	|O
of	|O
the	|O
p38	|B-PROTEIN
family	|O
of	|O
MAPKs	|O
.	|O

We	|O
show	|O
that	|O
several	|O
heme	|O
-	|O
responsive	|O
mechanisms	|O
combine	|O
to	|O
regulate	|O
DAN	|B-PROTEIN
/	|O
TIR	|B-PROTEIN
gene	|O
expression	|O
.	|O

In	|O
strains	|O
lacking	|O
tup11	|B-PROTEIN
and	|O
tup12	|B-PROTEIN
,	|O
the	|O
atf1	|B-PROTEIN
-	|O
pcr1	|B-PROTEIN
transcriptional	|O
activator	|O
continues	|O
to	|O
play	|O
a	|O
central	|O
role	|O
in	|O
fbp1	|B-PROTEIN
-	|O
lacZ	|B-PROTEIN
expression	|O
;	|O
however	|O
,	|O
spc1	|B-PROTEIN
MAPK	|O
phosphorylation	|O
of	|O
atf1	|B-PROTEIN
is	|O
no	|O
longer	|O
essential	|O
for	|O
its	|O
activation	|O
.	|O

In	|O
vitro	|O
binding	|O
studies	|O
demonstrate	|O
that	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
5A	|I-PROTEIN
is	|O
required	|O
for	|O
efficient	|O
interaction	|O
of	|O
Rev	|B-PROTEIN
-	|O
NES	|B-PROTEIN
with	|O
CRM1	|B-PROTEIN
/	|O
exportin1	|B-PROTEIN
and	|O
that	|O
eIF	|B-PROTEIN
-	|I-PROTEIN
5A	|I-PROTEIN
interacts	|O
with	|O
the	|O
nucleoporins	|O
CAN	|B-PROTEIN
/	|O
nup214	|B-PROTEIN
,	|O
nup153	|B-PROTEIN
,	|O
nup98	|B-PROTEIN
,	|O
and	|O
nup62	|B-PROTEIN
.	|O

Structural	|O
studies	|O
have	|O
shown	|O
that	|O
class	|O
I	|O
major	|B-PROTEIN
histocompatibility	|I-PROTEIN
complex	|I-PROTEIN
(	|O
MHC	|B-PROTEIN
)	|O
-	|O
restricted	|O
peptide	|O
-	|O
specific	|O
T	|O
cell	|O
receptor	|O
(	|B-PROTEIN
TCR	|I-PROTEIN
)	|I-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
/	|I-PROTEIN
betas	|I-PROTEIN
make	|O
multiple	|O
contacts	|O
with	|O
the	|O
alpha1	|O
and	|O
alpha2	|O
helices	|O
of	|O
the	|O
MHC	|B-PROTEIN
,	|O
but	|O
it	|O
is	|O
unclear	|O
which	|O
or	|O
how	|O
many	|O
of	|O
these	|O
interactions	|O
contribute	|O
to	|O
functional	|O
binding	|O
.	|O

In	|O
Saccharomyces	|O
cerevisiae	|O
,	|O
eIF6	|B-PROTEIN
is	|O
encoded	|O
by	|O
a	|O
single	|O
-	|O
copy	|O
essential	|O
gene	|O
.	|O

Mice	|O
homozygous	|O
for	|O
the	|O
dlg	|B-PROTEIN
mutation	|O
exhibit	|O
growth	|O
retardation	|O
in	|O
utero	|O
,	|O
have	|O
hypoplasia	|O
of	|O
the	|O
premaxilla	|O
and	|O
mandible	|O
,	|O
have	|O
a	|O
cleft	|O
secondary	|O
palate	|O
,	|O
and	|O
die	|O
perinatally	|O
.	|O

Moreover	|O
,	|O
a	|O
complex	|O
containing	|O
PTP	|B-PROTEIN
phi	|I-PROTEIN
,	|O
paxillin	|B-PROTEIN
,	|O
and	|O
a	|O
paxillin	|O
-	|O
associated	|O
tyrosine	|B-PROTEIN
kinase	|I-PROTEIN
,	|O
Pyk2	|B-PROTEIN
,	|O
can	|O
be	|O
immunoprecipitated	|O
from	|O
macrophage	|O
lysates	|O
,	|O
and	|O
the	|O
catalytic	|O
domain	|O
of	|O
PTP	|B-PROTEIN
phi	|I-PROTEIN
selectively	|O
binds	|O
paxillin	|B-PROTEIN
and	|O
Pyk2	|B-PROTEIN
in	|O
vitro	|O
.	|O

A	|O
single	|O
base	|O
change	|O
(	|O
A8G	|O
)	|O
in	|O
either	|O
sequence	|O
reduces	|O
hnRNP	|O
A2	|B-PROTEIN
binding	|O
and	|O
,	|O
in	|O
the	|O
case	|O
of	|O
A2RE	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
,	|O
inhibits	|O
RNA	|O
transport	|O
.	|O

Baseline	|O
variables	|O
associated	|O
with	|O
CD	|O
included	|O
a	|O
less	|O
frequent	|O
use	|O
of	|O
prestroke	|O
aspirin	|O
and	|O
a	|O
higher	|O
incidence	|O
of	|O
early	|O
CT	|O
changes	|O
of	|O
edema	|O
or	|O
mass	|O
effect	|O
or	|O
dense	|O
middle	|O
cerebral	|O
artery	|O
sign	|O
.	|O

IL	|B-PROTEIN
-	|I-PROTEIN
1beta	|I-PROTEIN
was	|O
significantly	|O
higher	|O
in	|O
endometrioma	|O
than	|O
in	|O
lesions	|O
of	|O
other	|O
localizations	|O
.	|O

A	|O
complete	|O
drug	|O
history	|O
was	|O
compiled	|O
,	|O
specifying	|O
the	|O
amount	|O
and	|O
duration	|O
of	|O
VGB	|O
medication	|O
.	|O

TaqMan	|O
analysis	|O
of	|O
gene	|O
expression	|O
following	|O
chronic	|O
FA	|O
treatment	|O
showed	|O
neither	|O
a	|O
decrease	|O
in	|O
the	|O
amount	|O
of	|O
leptin	|B-PROTEIN
receptor	|I-PROTEIN
(	|O
Ob	|B-PROTEIN
-	|I-PROTEIN
R	|I-PROTEIN
)	|O
mRNA	|O
,	|O
nor	|O
an	|O
increase	|O
in	|O
the	|O
negative	|O
regulators	|O
of	|O
STAT	|B-PROTEIN
signalling	|O
,	|O
SOCS3	|B-PROTEIN
(	|O
suppressors	|B-PROTEIN
of	|I-PROTEIN
cytokine	|I-PROTEIN
signalling	|I-PROTEIN
)	|O
or	|O
cytokine	|B-PROTEIN
inducible	|I-PROTEIN
sequence	|I-PROTEIN
(	|O
CIS	|B-PROTEIN
)	|O
.	|O

The	|O
mutant	|O
receptors	|O
,	|O
as	|O
well	|O
as	|O
sBMPR	|B-PROTEIN
-	|I-PROTEIN
IA	|I-PROTEIN
,	|O
were	|O
expressed	|O
as	|O
fusion	|O
proteins	|O
with	|O
thioredoxin	|B-PROTEIN
in	|O
Escherichia	|O
coli	|O
,	|O
and	|O
purified	|O
using	|O
reverse	|O
phase	|O
high	|O
performance	|O
liquid	|O
chromatography	|O
(	|O
RP	|O
-	|O
HPLC	|O
)	|O
after	|O
digestion	|O
with	|O
enterokinase	|B-PROTEIN
.	|O

The	|O
authors	|O
undertook	|O
a	|O
retrospective	|O
analysis	|O
of	|O
pathology	|O
with	|O
quantification	|O
of	|O
the	|O
percentage	|O
of	|O
papillary	|O
serous	|O
component	|O
(	|O
%	|O
PSC	|O
)	|O
and	|O
p53	|B-PROTEIN
expression	|O
.	|O

For	|O
this	|O
purpose	|O
,	|O
the	|O
immediate	|O
and	|O
the	|O
final	|O
(	|O
after	|O
swelling	|O
)	|O
fixation	|O
strengths	|O
of	|O
two	|O
variations	|O
of	|O
the	|O
swellable	|O
bone	|O
anchor	|O
designs	|O
(	|O
a	|O
smooth	|O
anchor	|O
and	|O
a	|O
screw	|O
anchor	|O
)	|O
were	|O
measured	|O
in	|O
two	|O
different	|O
foams	|O
(	|O
used	|O
to	|O
simulate	|O
bone	|O
)	|O
with	|O
different	|O
densities	|O
.	|O

Constitutive	|O
phosphorylation	|O
and	|O
nuclear	|O
localization	|O
of	|O
Smad3	|B-PROTEIN
are	|O
correlated	|O
with	|O
increased	|O
collagen	|B-PROTEIN
gene	|O
transcription	|O
in	|O
activated	|O
hepatic	|O
stellate	|O
cells	|O
.	|O

Cloning	|O
and	|O
characterization	|O
of	|O
the	|O
murine	|O
beta	|B-PROTEIN
(	|I-PROTEIN
3	|I-PROTEIN
)	|I-PROTEIN
integrin	|I-PROTEIN
gene	|O
promoter	|O
:	|O
identification	|O
of	|O
an	|O
interleukin	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
responsive	|O
element	|O
and	|O
regulation	|O
by	|O
STAT	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
.	|O

CONCLUSIONS	|O
:	|O
Although	|O
the	|O
levels	|O
of	|O
oxLDL	|B-PROTEIN
antibodies	|O
might	|O
be	|O
modified	|O
in	|O
early	|O
hypertension	|O
,	|O
once	|O
advanced	|O
coronary	|O
artery	|O
disease	|O
has	|O
developed	|O
the	|O
presence	|O
of	|O
hypertension	|O
does	|O
not	|O
affect	|O
anti	|B-PROTEIN
-	|I-PROTEIN
oxLDL	|I-PROTEIN
levels	|O
.	|O

GafChromic	|O
(	|O
MD	|O
-	|O
55-2	|O
)	|O
radiochromic	|O
film	|O
has	|O
become	|O
increasingly	|O
popular	|O
for	|O
medical	|O
applications	|O
and	|O
has	|O
proven	|O
to	|O
be	|O
useful	|O
for	|O
brachytherapy	|O
dosimetry	|O
.	|O

RESULTS	|O
:	|O
Within	|O
7	|O
days	|O
,	|O
all	|O
groups	|O
re	|O
-	|O
acquired	|O
responding	|O
for	|O
heroin	|O
under	|O
CRF	|O
at	|O
rates	|O
similar	|O
to	|O
their	|O
pre	|O
-	|O
lesion	|O
performance	|O
.	|O

Cis	|O
-	|O
acting	|O
CCAAT	|O
elements	|O
are	|O
frequently	|O
found	|O
in	|O
eukaryotic	|O
promoter	|O
regions	|O
.	|O

Twenty	|O
-	|O
five	|O
patients	|O
also	|O
received	|O
PET	|O
examinations	|O
during	|O
the	|O
staging	|O
procedures	|O
.	|O

The	|O
Gap69C	|B-PROTEIN
is	|O
a	|O
single	|O
-	|O
copy	|O
gene	|O
producing	|O
a	|O
major	|O
2.1	|O
-	|O
kb	|O
mRNA	|O
throughout	|O
development	|O
,	|O
but	|O
its	|O
amount	|O
is	|O
decreased	|O
in	|O
larvae	|O
.	|O

Cases	|O
of	|O
lung	|O
cancer	|O
with	|O
intramedullary	|O
metastasis	|O
are	|O
rare	|O
,	|O
especially	|O
those	|O
diagnosed	|O
before	|O
death	|O
.	|O

A	|O
novel	|O
growth	|O
-	|O
related	|O
nuclear	|O
protein	|O
binds	|O
and	|O
inhibits	|O
rat	|O
aldolase	|B-PROTEIN
B	|I-PROTEIN
gene	|O
promoter	|O
.	|O

OBJECTIVE	|O
:	|O
To	|O
investigate	|O
the	|O
association	|O
between	|O
complete	|O
congenital	|O
heart	|O
block	|O
(	|O
CCHB	|O
)	|O
in	|O
the	|O
fetus	|O
and	|O
adult	|O
disease	|O
.	|O

This	|O
study	|O
examined	|O
the	|O
role	|O
of	|O
cholesteryl	|O
ester	|O
transfer	|O
(	|O
CET	|O
)	|O
,	|O
cholesteryl	|B-PROTEIN
ester	|I-PROTEIN
transfer	|I-PROTEIN
protein	|I-PROTEIN
(	|O
CETP	|B-PROTEIN
)	|O
activity	|O
,	|O
and	|O
phospholipid	|B-PROTEIN
transfer	|I-PROTEIN
protein	|I-PROTEIN
(	|O
PLTP	|B-PROTEIN
)	|O
activity	|O
in	|O
the	|O
increased	|O
prevalence	|O
of	|O
coronary	|O
artery	|O
calcification	|O
(	|O
CAC	|O
)	|O
in	|O
diabetic	|O
subjects	|O
compared	|O
with	|O
nondiabetic	|O
subjects	|O
and	|O
in	|O
the	|O
loss	|O
of	|O
the	|O
sex	|O
difference	|O
in	|O
CAC	|O
in	|O
diabetes	|O
.	|O

Two	|O
families	|O
with	|O
concordant	|O
inheritance	|O
of	|O
DNAH9	|B-PROTEIN
alleles	|O
in	|O
affected	|O
individuals	|O
were	|O
observed	|O
.	|O

The	|O
blood	|O
levels	|O
of	|O
lactate	|O
,	|O
pyruvate	|O
and	|O
amino	|O
acids	|O
were	|O
not	|O
elevated	|O
.	|O

Efficacy	|O
of	|O
first	|O
-	|O
generation	|O
Cavermap	|O
to	|O
verify	|O
location	|O
and	|O
function	|O
of	|O
cavernous	|O
nerves	|O
during	|O
radical	|O
prostatectomy	|O
:	|O
a	|O
multi	|O
-	|O
institutional	|O
evaluation	|O
by	|O
experienced	|O
surgeons	|O
.	|O

The	|O
(	|O
two	|O
-	|O
motif	|O
)	|O
domain	|O
fold	|O
contains	|O
a	|O
pair	|O
of	|O
calcium	|O
binding	|O
sites	|O
very	|O
similar	|O
to	|O
those	|O
found	|O
in	|O
a	|O
two	|O
-	|O
domain	|O
prokaryotic	|O
betagamma	|B-PROTEIN
-	|I-PROTEIN
crystallin	|I-PROTEIN
fold	|O
family	|O
member	|O
,	|O
Protein	|B-PROTEIN
S.	|I-PROTEIN

Deletional	|O
analyses	|O
of	|O
VDR	|B-PROTEIN
indicated	|O
that	|O
GRIP1	|B-PROTEIN
and	|O
RAC3	|B-PROTEIN
required	|O
an	|O
intact	|O
VDR	|B-PROTEIN
activation	|O
function	|O
(	|O
AF	|O
-	|O
2	|O
)	|O
domain	|O
for	|O
efficient	|O
interaction	|O
as	|O
well	|O
as	|O
additional	|O
but	|O
distinct	|O
regions	|O
of	|O
the	|O
VDR	|B-PROTEIN
.	|O

Mechanism	|O
in	|O
the	|O
sequential	|O
control	|O
of	|O
cell	|O
morphology	|O
and	|O
S	|O
phase	|O
entry	|O
by	|O
epidermal	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
involves	|O
distinct	|O
MEK	|B-PROTEIN
/	|O
ERK	|B-PROTEIN
activations	|O
.	|O

The	|O
expression	|O
of	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
amylase	|I-PROTEIN
can	|O
be	|O
transactivated	|O
by	|O
the	|O
transcription	|O
factor	|O
GAMyb	|B-PROTEIN
,	|O
which	|O
is	|O
itself	|O
induced	|O
by	|O
GA	|O
.	|O

3D	|O
image	|O
-	|O
processing	|O
permits	|O
to	|O
analyse	|O
ultrasound	|O
data	|O
interactively	|O
in	|O
three	|O
orthogonal	|O
planes	|O
(	|O
section	|O
mode	|O
)	|O
or	|O
in	|O
realistic	|O
3D	|O
views	|O
(	|O
rendering	|O
mode	|O
)	|O
.	|O

Only	|O
nine	|O
patients	|O
were	|O
offered	|O
surgery	|O
(	|O
six	|O
were	|O
resected	|O
and	|O
three	|O
were	|O
found	|O
inoperable	|O
)	|O
.	|O

Direct	|O
superoxide	|O
scavenging	|O
activity	|O
of	|O
nonsteroidal	|O
anti	|O
-	|O
inflammatory	|O
drugs	|O
:	|O
determination	|O
by	|O
electron	|O
spin	|O
resonance	|O
using	|O
the	|O
spin	|O
trap	|O
method	|O
.	|O

BACKGROUND	|O
:	|O
Dermoscopy	|O
is	|O
a	|O
noninvasive	|O
technique	|O
that	|O
increases	|O
the	|O
diagnostic	|O
accuracy	|O
of	|O
pigmented	|O
skin	|O
lesions	|O
,	|O
particularly	|O
improving	|O
the	|O
diagnosis	|O
of	|O
patients	|O
with	|O
cutaneous	|O
melanoma	|O
in	|O
situ	|O
(	|O
CMIS	|O
)	|O
and	|O
early	|O
invasive	|O
melanoma	|O
.	|O

Moreover	|O
,	|O
PTax	|B-PROTEIN
expressed	|O
higher	|O
background	|O
activities	|O
than	|O
PTF	|B-PROTEIN
,	|O
indicating	|O
that	|O
the	|O
sequence	|O
of	|O
the	|O
synthetic	|O
regulatory	|O
region	|O
can	|O
influence	|O
background	|O
levels	|O
.	|O

However	|O
,	|O
the	|O
promoter	|O
region	|O
contains	|O
several	|O
potential	|O
cis	|O
-	|O
regulatory	|O
elements	|O
such	|O
as	|O
Sp1	|B-PROTEIN
,	|O
early	|B-PROTEIN
growth	|I-PROTEIN
response	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
activator	|B-PROTEIN
protein	|I-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
,	|O
MyoD	|B-PROTEIN
,	|O
p300	|B-PROTEIN
,	|O
nuclear	|B-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
,	|O
myeloid	|B-PROTEIN
zinc	|I-PROTEIN
finger	|I-PROTEIN
protein	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
caudal	|O
-	|O
related	|O
homeobox	|O
(	|B-PROTEIN
Cdx	|I-PROTEIN
)	|I-PROTEIN
gene	|I-PROTEIN
A	|I-PROTEIN
,	|O
and	|O
Cdx	|B-PROTEIN
protein	|I-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
binding	|O
sites	|O
.	|O

Thus	|O
,	|O
the	|O
interaction	|O
of	|O
Tat	|B-PROTEIN
with	|O
the	|O
components	|O
of	|O
this	|O
rel	|B-PROTEIN
/	|O
AP1	|B-PROTEIN
cooperative	|O
complex	|O
seems	|O
to	|O
induce	|O
quantitative	|O
and	|O
qualitative	|O
alterations	|O
of	|O
this	|O
complex	|O
as	|O
activation	|O
progresses	|O
,	|O
resulting	|O
in	|O
a	|O
decrease	|O
of	|O
IL	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
gene	|O
transcription	|O
.	|O

2001	|O
.	|O

Adjuvant	|O
and	|O
neoadjuvant	|O
treatment	|O
of	|O
breast	|O
cancer	|O
.	|O

Unlike	|O
other	|O
progenitor	|O
cells	|O
of	|O
the	|O
brain	|O
,	|O
SVZa	|O
progenitor	|O
cells	|O
have	|O
the	|O
capacity	|O
to	|O
divide	|O
even	|O
though	|O
they	|O
express	|O
a	|O
neuronal	|O
phenotype	|O
.	|O

A	|O
minimal	|O
ER3	|O
sequence	|O
of	|O
DNA	|O
was	|O
further	|O
demonstrated	|O
to	|O
function	|O
as	|O
a	|O
FXR	|B-PROTEIN
HRE	|O
and	|O
was	|O
bound	|O
in	|O
vitro	|O
by	|O
FXR	|B-PROTEIN
-	|O
expressing	|O
yeast	|O
extracts	|O
.	|O

OBJECTIVE	|O
:	|O
To	|O
determine	|O
the	|O
association	|O
of	|O
depressive	|O
symptoms	|O
with	|O
HIV	|O
-	|O
related	|O
mortality	|O
and	|O
decline	|O
in	|O
CD4	|B-PROTEIN
lymphocyte	|O
counts	|O
among	|O
women	|O
with	|O
HIV	|O
.	|O

An	|O
economic	|O
analysis	|O
using	|O
West	|O
of	|O
Scotland	|O
Coronary	|O
Prevention	|O
Study	|O
(	|O
WOSCOPS	|O
)	|O
findings	|O
indicates	|O
that	|O
statin	|B-PROTEIN
treatment	|O
would	|O
have	|O
prevented	|O
318	|O
events	|O
per	|O
10,000	|O
patients	|O
in	|O
a	|O
population	|O
similar	|O
to	|O
that	|O
in	|O
WOSCOPS	|O
(	|O
average	|O
1.5%	|O
annual	|O
risk	|O
of	|O
a	|O
cardiovascular	|O
event	|O
)	|O
at	|O
a	|O
discounted	|O
cost	|O
per	|O
life	|O
-	|O
year	|O
gained	|O
of	|O
20,375	|O
pounds	|O
(	|O
$	|O
31,818	|O
)	|O
.	|O

Furthermore	|O
,	|O
the	|O
soluble	|O
forms	|O
of	|O
ATF6	|B-PROTEIN
and	|O
the	|O
G13	|B-PROTEIN
gene	|O
product	|O
are	|O
unable	|O
to	|O
bind	|O
to	|O
several	|O
point	|O
mutants	|O
of	|O
the	|O
cis	|O
-	|O
acting	|O
ER	|O
stress	|O
response	|O
element	|O
in	|O
vitro	|O
that	|O
hardly	|O
respond	|O
to	|O
ER	|O
stress	|O
in	|O
vivo	|O
.	|O

Sequence	|O
analysis	|O
revealed	|O
significant	|O
differences	|O
between	|O
the	|O
5'	|O
region	|O
of	|O
the	|O
beta	|O
subunit	|O
gene	|O
and	|O
the	|O
corresponding	|O
regions	|O
of	|O
the	|O
homologous	|O
GlyR	|B-PROTEIN
alpha	|I-PROTEIN
subunit	|O
genes	|O
;	|O
it	|O
also	|O
identified	|O
a	|O
novel	|O
exon	|O
(	|O
exon	|O
0	|O
)	|O
that	|O
encodes	|O
most	|O
of	|O
the	|O
5'	|O
-	|O
untranslated	|O
portion	|O
of	|O
the	|O
GlyR	|B-PROTEIN
beta	|I-PROTEIN
mRNA	|O
.	|O

The	|O
present	|O
study	|O
was	|O
initiated	|O
to	|O
explore	|O
the	|O
potential	|O
of	|O
a	|O
hybrid	|O
biological	|O
reactor	|O
,	|O
combining	|O
trickling	|O
filter	|O
(	|O
TF	|O
)	|O
and	|O
activated	|O
sludge	|O
process	|O
(	|O
ASP	|O
)	|O
,	|O
to	|O
treat	|O
wastewater	|O
containing	|O
trichloroethylene	|O
(	|O
TCE	|O
)	|O
at	|O
ambient	|O
temperature	|O
at	|O
different	|O
hydraulic	|O
retention	|O
time	|O
(	|O
HRT	|O
)	|O
.	|O

In	|O
DNA	|O
strand	|O
exchange	|O
reactions	|O
using	|O
oligonucleotides	|O
,	|O
we	|O
found	|O
that	|O
Rec2	|B-PROTEIN
exhibited	|O
a	|O
pairing	|O
bias	|O
that	|O
is	|O
opposite	|O
that	|O
of	|O
RecA	|B-PROTEIN
.	|O

Anecdotal	|O
observations	|O
scattered	|O
throughout	|O
the	|O
literature	|O
have	|O
often	|O
provided	|O
clues	|O
to	|O
underlying	|O
variations	|O
in	|O
humans	|O
'	|O
ability	|O
to	|O
handle	|O
dietary	|O
chemicals	|O
.	|O

Forskolin	|O
treatment	|O
(	|O
10	|O
microM	|O
)	|O
of	|O
the	|O
transfected	|O
cells	|O
for	|O
3	|O
-	|O
-	|O
6	|O
h	|O
maximally	|O
induced	|O
luciferase	|B-PROTEIN
threefold	|O
.	|O

Analysis	|O
of	|O
ace2Delta	|O
cells	|O
reveals	|O
that	|O
Ace2p	|B-PROTEIN
is	|O
required	|O
for	|O
cell	|O
separation	|O
but	|O
not	|O
for	|O
polarized	|O
growth	|O
.	|O

The	|O
results	|O
presented	|O
here	|O
show	|O
that	|O
AR1	|B-PROTEIN
of	|O
the	|O
promoter	|O
-	|O
proximal	|O
CAP	|B-PROTEIN
subunit	|O
was	|O
required	|O
for	|O
papBA	|B-PROTEIN
transcription	|O
even	|O
in	|O
the	|O
absence	|O
of	|O
the	|O
histone	|B-PROTEIN
-	|O
like	|O
protein	|O
H	|B-PROTEIN
-	|I-PROTEIN
NS	|I-PROTEIN
.	|O

A.	|O
,	|O
Slatkin	|O
,	|O
D.	|O

RESULTS	|O
:	|O
A	|O
significant	|O
correlation	|O
(	|O
p	|O
<	|O
0.001	|O
)	|O
was	|O
observed	|O
for	|O
mean	|O
wall	|O
thickness	|O
and	|O
vessel	|O
wall	|O
area	|O
between	|O
MRI	|O
and	|O
histopathology	|O
(	|O
r	|O
=	|O
0.87	|O
and	|O
r	|O
=	|O
0.85	|O
,	|O
respectively	|O
)	|O
.	|O

Our	|O
data	|O
indicate	|O
that	|O
SIP1	|B-PROTEIN
is	|O
required	|O
to	|O
confine	|O
XBra	|B-PROTEIN
gene	|O
expression	|O
to	|O
the	|O
mesoderm	|O
.	|O

SIP1	|B-PROTEIN
(	|O
Smad	|B-PROTEIN
interacting	|I-PROTEIN
protein	|I-PROTEIN
1	|I-PROTEIN
)	|O
and	|O
deltaEF1	|B-PROTEIN
(	|O
delta	|B-PROTEIN
-	|I-PROTEIN
crystallin	|I-PROTEIN
enhancer	|I-PROTEIN
binding	|I-PROTEIN
factor	|I-PROTEIN
)	|O
are	|O
structurally	|O
similar	|O
transcriptional	|O
repressors	|O
.	|O

B	|B-PROTEIN
-	|I-PROTEIN
myb	|I-PROTEIN
is	|O
essential	|O
for	|O
G1	|O
/	|O
S	|O
transition	|O
and	|O
has	|O
been	|O
shown	|O
to	|O
be	|O
phosphorylated	|O
by	|O
the	|O
cyclin	|B-PROTEIN
A2	|I-PROTEIN
/	|O
cdk2	|B-PROTEIN
complex	|O
.	|O

Nucleotide	|O
sequence	|O
,	|O
transcription	|O
map	|O
,	|O
and	|O
mutation	|O
analysis	|O
of	|O
the	|O
13q14	|O
chromosomal	|O
region	|O
deleted	|O
in	|O
B	|O
-	|O
cell	|O
chronic	|O
lymphocytic	|O
leukemia	|O
.	|O

Human	|O
T	|O
-	|O
cell	|O
leukemia	|O
virus	|O
type	|O
I	|O
(	|O
HTLV	|O
-	|O
I	|O
)	|O
Tax	|B-PROTEIN
is	|O
a	|O
potent	|O
transcriptional	|O
regulator	|O
that	|O
can	|O
activate	|O
or	|O
repress	|O
specific	|O
cellular	|O
genes	|O
and	|O
that	|O
has	|O
been	|O
proposed	|O
to	|O
contribute	|O
to	|O
leukemogenesis	|O
in	|O
adult	|O
T	|O
-	|O
cell	|O
leukemia	|O
.	|O

Requirements	|O
for	|O
the	|O
nuclear	|O
-	|O
cytoplasmic	|O
translocation	|O
of	|O
infected	|B-PROTEIN
-	|I-PROTEIN
cell	|I-PROTEIN
protein	|I-PROTEIN
0	|I-PROTEIN
of	|O
herpes	|O
simplex	|O
virus	|O
1	|O
.	|O

The	|O
human	|O
cytomegalovirus	|O
(	|O
HCMV	|O
)	|O
major	|O
immediate	|O
-	|O
early	|O
protein	|O
IE2	|B-PROTEIN
is	|O
a	|O
nuclear	|O
phosphoprotein	|O
that	|O
is	|O
believed	|O
to	|O
be	|O
a	|O
key	|O
regulator	|O
in	|O
both	|O
lytic	|O
and	|O
latent	|O
infections	|O
.	|O

OBJECTIVE	|O
:	|O
To	|O
determine	|O
whether	|O
RSTD	|O
predicts	|O
coronary	|O
anatomy	|O
during	|O
acute	|O
coronary	|O
occlusion	|O
.	|O

The	|O
Novacor	|O
Left	|O
Ventricular	|O
Assist	|O
System	|O
(	|O
LVAS	|O
)	|O
(	|O
Novacor	|O
Corp	|O
,	|O
Oakland	|O
,	|O
CA	|O
)	|O
was	|O
initially	|O
console	|O
-	|O
based	|O
and	|O
has	|O
been	|O
available	|O
since	|O
1993	|O
in	|O
a	|O
wearable	|O
configuration	|O
.	|O

Atheroma	|O
appears	|O
as	|O
a	|O
very	|O
low	|O
signal	|O
intensity	|O
area	|O
on	|O
2	|O
-	|O
dimensional	|O
time	|O
-	|O
of	|O
-	|O
flight	|O
(	|O
TOF	|O
)	|O
magnetic	|O
resonance	|O
(	|O
MR	|O
)	|O
images	|O
,	|O
and	|O
its	|O
components	|O
have	|O
various	|O
signal	|O
intensities	|O
on	|O
spin	|O
-	|O
echo	|O
(	|O
SE	|O
)	|O
images	|O
.	|O

Body	|O
fat	|O
distribution	|O
was	|O
determined	|O
by	|O
abdominal	|O
computed	|O
tomography	|O
.	|O

The	|O
flux	|O
rates	|O
of	|O
p	|O
-	|O
toluidine	|O
decreased	|O
as	|O
the	|O
pH	|O
value	|O
in	|O
the	|O
donor	|O
solution	|O
increased	|O
.	|O

We	|O
have	|O
now	|O
tested	|O
all	|O
known	|O
mammalian	|O
Groucho	|B-PROTEIN
family	|O
members	|O
for	|O
their	|O
ability	|O
to	|O
interact	|O
specifically	|O
with	|O
individual	|O
Tcf	|B-PROTEIN
/	|O
Lef	|B-PROTEIN
family	|O
members	|O
.	|O

We	|O
show	|O
here	|O
that	|O
the	|O
in	|O
vitro	|O
transcription	|O
extract	|O
contains	|O
a	|O
binding	|O
activity	|O
that	|O
is	|O
specific	|O
for	|O
the	|O
initiator	|O
element	|O
and	|O
thus	|O
may	|O
participate	|O
in	|O
recruiting	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
II	|I-PROTEIN
to	|O
the	|O
SL	|O
RNA	|O
gene	|O
promoter	|O
.	|O

The	|O
protein	|O
is	|O
composed	|O
of	|O
two	|O
major	|O
domains	|O
separated	|O
by	|O
a	|O
hydrophobic	|O
linker	|O
region	|O
of	|O
20	|O
amino	|O
acid	|O
residues	|O
.	|O

The	|O
438	|O
bp	|O
EcoRI	|B-PROTEIN
fragment	|O
,	|O
which	|O
was	|O
detected	|O
by	|O
Southern	|O
hybridization	|O
,	|O
reveals	|O
an	|O
open	|O
reading	|O
frame	|O
which	|O
encodes	|O
a	|O
protein	|O
of	|O
103	|O
amino	|O
acids	|O
.	|O

We	|O
performed	|O
the	|O
present	|O
study	|O
to	|O
clarify	|O
the	|O
relationship	|O
between	|O
the	|O
DOX	|O
binding	|O
ability	|O
(	|O
%	|O
DB	|O
)	|O
and	|O
the	|O
histologic	|O
response	|O
,	|O
rate	|O
of	|O
decrease	|O
in	|O
tumor	|O
volume	|O
of	|O
malignant	|O
soft	|O
tissue	|O
tumors	|O
after	|O
preoperative	|O
chemotherapy	|O
and	|O
prognosis	|O
.	|O

To	|O
avoid	|O
misinterpretations	|O
,	|O
special	|O
reference	|O
values	|O
should	|O
be	|O
applied	|O
for	|O
preadolescents	|O
,	|O
at	|O
least	|O
with	|O
regard	|O
to	|O
FVC	|O
and	|O
FEV1	|O
.	|O

Nephrotoxicity	|O
after	|O
orthotopic	|O
liver	|O
transplantation	|O
in	|O
cyclosporin	|O
A	|O
and	|O
FK	|O
506	|O
-	|O
treated	|O
patients	|O
.	|O

Compared	|O
with	|O
normal	|O
control	|O
subjects	|O
,	|O
all	|O
74	|O
TOF	|O
patients	|O
had	|O
decreased	|O
systolic	|O
and	|O
diastolic	|O
myocardial	|O
velocities	|O
and	|O
a	|O
longer	|O
isovolumic	|O
relaxation	|O
time	|O
.	|O

Acetoin	|O
can	|O
be	|O
reused	|O
by	|O
the	|O
bacteria	|O
during	|O
stationary	|O
phase	|O
when	|O
other	|O
carbon	|O
sources	|O
have	|O
been	|O
depleted	|O
.	|O

Mutational	|O
analysis	|O
showed	|O
that	|O
the	|O
U	|O
-	|O
box	|O
,	|O
like	|O
the	|O
RING	|O
finger	|O
in	|O
other	|O
proteins	|O
,	|O
forms	|O
the	|O
physical	|O
basis	|O
for	|O
the	|O
interaction	|O
with	|O
E2	|B-PROTEIN
enzymes	|O
.	|O

Thus	|O
,	|O
our	|O
studies	|O
define	|O
Rac	|B-PROTEIN
/	|O
Cdc42	|B-PROTEIN
/	|O
Pak	|B-PROTEIN
as	|O
a	|O
module	|O
upstream	|O
of	|O
Raf	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
during	|O
its	|O
activation	|O
by	|O
microtubule	|O
disruption	|O
.	|O

Nrf2	|B-PROTEIN
regulates	|O
expression	|O
of	|O
genes	|O
encoding	|O
enzymes	|O
with	|O
antioxidant	|O
(	|O
e.g.	|O
heme	|B-PROTEIN
oxygenase	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
(	|O
HO	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
)	|O
or	|O
xenobiotic	|O
detoxification	|O
(	|O
e.g.	|O

These	|O
results	|O
indicate	|O
that	|O
ATF4	|B-PROTEIN
regulates	|O
basal	|O
and	|O
CdCl	|O
(	|O
2	|O
)	|O
-	|O
induced	|O
expression	|O
of	|O
the	|O
ho	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
gene	|O
in	|O
a	|O
cell	|O
-	|O
specific	|O
manner	|O
and	|O
possibly	|O
in	|O
a	|O
complex	|O
with	|O
Nrf2	|B-PROTEIN
.	|O

On	|O
the	|O
other	|O
hand	|O
,	|O
forced	|O
overexpression	|O
of	|O
the	|O
wild	|O
type	|O
,	|O
but	|O
not	|O
the	|O
kinase	|O
-	|O
inactivated	|O
mutant	|O
of	|O
nm23H1	|B-PROTEIN
,	|O
converted	|O
the	|O
GDP	|O
-	|O
bound	|O
forms	|O
of	|O
Rac1	|B-PROTEIN
,	|O
Cdc42	|B-PROTEIN
,	|O
and	|O
RhoA	|B-PROTEIN
to	|O
their	|O
GTP	|O
-	|O
bound	|O
forms	|O
in	|O
vitro	|O
by	|O
its	|O
nucleoside	|B-PROTEIN
diphosphate	|I-PROTEIN
kinase	|I-PROTEIN
activity	|O
,	|O
but	|O
nm23H1	|B-PROTEIN
alone	|O
apparently	|O
did	|O
not	|O
produce	|O
the	|O
GTP	|O
-	|O
bound	|O
form	|O
of	|O
these	|O
GTPases	|B-PROTEIN
in	|O
vivo	|O
.	|O

This	|O
effect	|O
was	|O
observed	|O
in	|O
the	|O
absence	|O
of	|O
de	|O
novo	|O
protein	|O
synthesis	|O
and	|O
was	|O
independent	|O
of	|O
histone	|B-PROTEIN
deacetylase	|I-PROTEIN
activity	|O
.	|O

Deletion	|O
of	|O
the	|O
potential	|O
initiator	|O
element	|O
does	|O
not	|O
affect	|O
repression	|O
of	|O
the	|O
p21	|B-PROTEIN
promoter	|O
by	|O
c	|B-PROTEIN
-	|I-PROTEIN
Myc	|I-PROTEIN
.	|O

Fetal	|O
lung	|O
volume	|O
:	|O
estimation	|O
at	|O
MR	|O
imaging	|O
-	|O
initial	|O
results	|O
.	|O

Of	|O
its	|O
gene	|O
products	|O
,	|O
E6	|B-PROTEIN
binds	|O
to	|O
and	|O
inactivates	|O
p53	|B-PROTEIN
tumor	|O
suppressor	|O
protein	|O
by	|O
ubiquitin	|B-PROTEIN
/	|O
proteasome	|O
-	|O
dependent	|O
degradation	|O
.	|O

In	|O
mouse	|O
,	|O
Mmip1	|B-PROTEIN
(	|O
Mad	|B-PROTEIN
member	|I-PROTEIN
interacting	|I-PROTEIN
protein	|I-PROTEIN
1	|I-PROTEIN
)	|O
and	|O
Smc3	|B-PROTEIN
share	|O
99%	|O
sequence	|O
identity	|O
and	|O
are	|O
products	|O
of	|O
the	|O
same	|O
gene	|O
.	|O

An	|O
element	|O
within	|O
the	|O
5'	|O
untranslated	|O
region	|O
of	|O
human	|O
Hsp70	|B-PROTEIN
mRNA	|O
which	|O
acts	|O
as	|O
a	|O
general	|O
enhancer	|O
of	|O
mRNA	|O
translation	|O
.	|O

In	|O
SN	|O
-	|O
48	|O
neuronal	|O
cells	|O
that	|O
express	|O
MR	|B-PROTEIN
,	|O
GR	|B-PROTEIN
,	|O
and	|O
5	|B-PROTEIN
-	|I-PROTEIN
HT1A	|I-PROTEIN
receptors	|I-PROTEIN
,	|O
deletion	|O
or	|O
inactivation	|O
of	|O
the	|O
nGRE	|O
(	|O
negative	|O
GRE	|O
)	|O
eliminated	|O
negative	|O
regulation	|O
of	|O
the	|O
rat	|O
5	|B-PROTEIN
-	|I-PROTEIN
HT1A	|I-PROTEIN
or	|O
heterologous	|O
promoters	|O
by	|O
corticosteroids	|O
,	|O
whereas	|O
its	|O
inclusion	|O
conferred	|O
corticosteroid	|O
-	|O
induced	|O
inhibition	|O
to	|O
a	|O
heterologous	|O
promoter	|O
.	|O

Corticosteroid	|O
-	|O
mediated	|O
transcriptional	|O
inhibition	|O
was	|O
greater	|O
for	|O
MR	|B-PROTEIN
/	|O
GR	|B-PROTEIN
in	|O
combination	|O
than	|O
for	|O
MR	|B-PROTEIN
or	|O
GR	|B-PROTEIN
alone	|O
.	|O

Whereas	|O
Smad2	|B-PROTEIN
was	|O
rapidly	|O
phosphorylated	|O
by	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
and	|O
involved	|O
in	|O
the	|O
initial	|O
activation	|O
of	|O
Agc	|B-PROTEIN
expression	|O
in	|O
confluent	|O
cells	|O
,	|O
Smad2	|B-PROTEIN
activation	|O
was	|O
not	|O
required	|O
for	|O
maintaining	|O
the	|O
high	|O
level	|O
of	|O
Agc	|B-PROTEIN
expression	|O
.	|O

Furthermore	|O
,	|O
this	|O
kinase	|O
-	|O
deficient	|O
mutant	|O
inhibited	|O
2	|O
-	|O
MeSADP	|O
-	|O
induced	|O
caspase	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
stimulation	|O
and	|O
the	|O
associated	|O
decrease	|O
in	|O
cell	|O
number	|O
.	|O

Reverse	|B-PROTEIN
transcriptase	|I-PROTEIN
-	|O
polymerase	|O
chain	|O
reaction	|O
assays	|O
showed	|O
that	|O
PKRDeltaE7	|B-PROTEIN
is	|O
expressed	|O
in	|O
a	|O
broad	|O
range	|O
of	|O
human	|O
tissues	|O
at	|O
variable	|O
levels	|O
.	|O

Both	|O
pancreatic	|O
and	|O
intestinal	|O
cell	|O
lines	|O
were	|O
found	|O
to	|O
express	|O
a	|O
number	|O
of	|O
POU	|B-PROTEIN
(	|O
OCT	|B-PROTEIN
binding	|O
)	|O
homeodomain	|O
proteins	|O
examined	|O
by	|O
electrophoretic	|O
mobility	|O
shift	|O
assay	|O
.	|O

SV1	|B-PROTEIN
has	|O
a	|O
33	|O
-	|O
amino	|O
acid	|O
insert	|O
in	|O
the	|O
S1	|O
transmembrane	|O
domain	|O
that	|O
does	|O
not	|O
alter	|O
S1	|O
overall	|O
hydrophobicity	|O
,	|O
but	|O
makes	|O
the	|O
S0	|O
-	|O
S1	|O
linker	|O
longer	|O
.	|O

Polyclonal	|O
antibodies	|O
against	|O
the	|O
N	|O
-	|O
terminal	|O
part	|O
(	|O
amino	|O
acids	|O
12-363	|O
)	|O
and	|O
the	|O
C	|O
-	|O
terminal	|O
part	|O
(	|O
amino	|O
acids	|O
330-730	|O
)	|O
of	|O
rainbow	|O
trout	|O
HIF	|B-PROTEIN
-	|I-PROTEIN
1alpha	|I-PROTEIN
protein	|O
recognized	|O
rainbow	|O
trout	|O
and	|O
chinook	|O
salmon	|O
HIF	|B-PROTEIN
-	|I-PROTEIN
1alpha	|I-PROTEIN
protein	|O
in	|O
Western	|O
blot	|O
analysis	|O
.	|O

The	|O
v	|B-PROTEIN
-	|I-PROTEIN
Src	|I-PROTEIN
SH3	|O
domain	|O
facilitates	|O
a	|O
cell	|O
adhesion	|O
-	|O
independent	|O
association	|O
with	|O
focal	|B-PROTEIN
adhesion	|I-PROTEIN
kinase	|I-PROTEIN
.	|O

A	|O
20	|O
-	|O
base	|O
pair	|O
oligonucleotide	|O
containing	|O
this	|O
nonamer	|O
confers	|O
up	|O
-	|O
regulation	|O
by	|O
hypoxia	|O
and	|O
inhibition	|O
by	|O
unsaturated	|O
fatty	|O
acids	|O
when	|O
placed	|O
upstream	|O
of	|O
a	|O
heterologous	|O
promoter	|O
in	|O
a	|O
lacZ	|B-PROTEIN
reporter	|O
construct	|O
.	|O

Deletion	|O
analyses	|O
implicate	|O
the	|O
N	|O
-	|O
terminal	|O
110	|O
amino	|O
acids	|O
of	|O
Grb14	|B-PROTEIN
and	|O
ankyrin	|B-PROTEIN
repeats	|O
10-19	|O
of	|O
tankyrase	|B-PROTEIN
2	|I-PROTEIN
in	|O
mediating	|O
this	|O
interaction	|O
.	|O

Mutagenesis	|O
of	|O
SNT1	|B-PROTEIN
(	|O
IRS	|B-PROTEIN
)	|O
CX	|B-PROTEIN
identified	|O
three	|O
classes	|O
of	|O
effector	|O
motifs	|O
within	|O
SNT	|B-PROTEIN
critical	|O
for	|O
both	|O
sustained	|O
ERK	|B-PROTEIN
activation	|O
and	|O
neuronal	|O
differentiation	|O
:	|O
1	|O
)	|O
four	|O
phosphotyrosine	|O
motifs	|O
that	|O
mediate	|O
recruitment	|O
of	|O
Grb2	|B-PROTEIN
,	|O
2	|O
)	|O
two	|O
phosphotyrosine	|O
motifs	|O
that	|O
mediate	|O
recruitment	|O
of	|O
Shp2	|B-PROTEIN
,	|O
and	|O
3	|O
)	|O
a	|O
C	|O
-	|O
terminal	|O
motif	|O
that	|O
functions	|O
by	|O
helping	|O
to	|O
recruit	|O
Sos	|B-PROTEIN
.	|O

Exchanging	|O
the	|O
human	|O
propeptide	|O
in	|O
this	|O
chimera	|O
with	|O
either	|O
the	|O
murine	|O
MIC	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
or	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta1	|I-PROTEIN
propeptide	|O
resulted	|O
in	|O
secretion	|O
of	|O
the	|O
unprocessed	|O
,	|O
monomeric	|O
chimera	|O
,	|O
suggesting	|O
a	|O
specific	|O
interaction	|O
between	|O
the	|O
human	|O
MIC	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
propeptide	|O
and	|O
mature	|O
peptide	|O
.	|O

Radiolabeled	|O
biantennary	|O
N	|O
-	|O
glycans	|O
synthesized	|O
by	|O
Pro	|O
(	|O
-	|O
)	|O
5Lec20	|O
were	|O
proportionately	|O
less	|O
ricin	|O
-	|O
bound	|O
than	|O
similar	|O
species	|O
from	|O
parental	|O
CHO	|O
cells	|O
,	|O
and	|O
Lec20	|O
cell	|O
extracts	|O
had	|O
a	|O
markedly	|O
reduced	|O
ability	|O
to	|O
transfer	|O
Gal	|O
to	|O
GlcNAc	|O
-	|O
terminating	|O
acceptors	|O
.	|O

We	|O
found	|O
that	|O
the	|O
SOCS	|B-PROTEIN
box	|I-PROTEIN
interacted	|O
with	|O
Cullin	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
and	|O
promoted	|O
ubiquitination	|O
of	|O
TEL	|B-PROTEIN
-	|O
JAK2	|B-PROTEIN
.	|O

Neuron	|O
-	|O
specific	|O
Bcl	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
homology	|O
3	|O
domain	|O
-	|O
only	|O
splice	|O
variant	|O
of	|O
Bak	|B-PROTEIN
is	|O
anti	|O
-	|O
apoptotic	|O
in	|O
neurons	|O
,	|O
but	|O
pro	|O
-	|O
apoptotic	|O
in	|O
non	|O
-	|O
neuronal	|O
cells	|O
.	|O

Finally	|O
a	|O
10	|O
-	|O
nucleotide	|O
region	|O
flanking	|O
the	|O
exon	|O
4	|O
protein	|O
-	|O
binding	|O
site	|O
is	|O
homologous	|O
to	|O
instability	|O
elements	|O
within	|O
five	|O
other	|O
transcripts	|O
,	|O
suggesting	|O
that	|O
a	|O
common	|O
coding	|O
region	|O
determinant	|O
may	|O
exist	|O
.	|O

Sequence	|O
comparison	|O
and	|O
binding	|O
studies	|O
of	|O
the	|O
18	|O
-	|O
bp	|O
MOK2	|B-PROTEIN
-	|O
binding	|O
sites	|O
present	|O
in	|O
intron	|O
2	|O
of	|O
human	|O
,	|O
bovine	|O
,	|O
and	|O
mouse	|O
IRBP	|B-PROTEIN
genes	|O
show	|O
that	|O
the	|O
3'	|O
-	|O
half	|O
sequence	|O
is	|O
the	|O
essential	|O
core	|O
element	|O
for	|O
MOK2	|B-PROTEIN
binding	|O
.	|O

Furthermore	|O
,	|O
SB203580	|O
inhibited	|O
LPS	|O
-	|O
induced	|O
activation	|O
of	|O
Sp1	|B-PROTEIN
,	|O
as	|O
well	|O
as	|O
the	|O
promoter	|O
activity	|O
in	|O
cells	|O
transfected	|O
with	|O
a	|O
plasmid	|O
containing	|O
the	|O
Sp1	|B-PROTEIN
consensus	|O
sequence	|O
.	|O

We	|O
confirmed	|O
the	|O
interaction	|O
between	|O
TLS	|B-PROTEIN
and	|O
p65	|B-PROTEIN
by	|O
the	|O
pull	|O
-	|O
down	|O
assay	|O
in	|O
vitro	|O
and	|O
by	|O
a	|O
coimmunoprecipitation	|O
experiment	|O
followed	|O
by	|O
Western	|O
blot	|O
of	|O
the	|O
cultured	|O
cell	|O
in	|O
vivo	|O
.	|O

Analysis	|O
of	|O
regulatory	|O
regions	|O
in	|O
the	|O
promoter	|O
of	|O
the	|O
ctr4	|B-PROTEIN
(	|I-PROTEIN
+	|I-PROTEIN
)	|I-PROTEIN
copper	|I-PROTEIN
transporter	|I-PROTEIN
gene	|O
in	|O
fission	|O
yeast	|O
Schizosaccharomyces	|O
pombe	|O
reveals	|O
the	|O
identity	|O
of	|O
a	|O
conserved	|O
copper	|O
-	|O
signaling	|O
element	|O
(	|O
CuSE	|O
)	|O
,	|O
which	|O
is	|O
recognized	|O
by	|O
the	|O
transcription	|O
factor	|O
Cuf1	|B-PROTEIN
.	|O

Based	|O
on	|O
mutational	|O
data	|O
and	|O
possible	|O
mRNA	|O
structure	|O
,	|O
we	|O
hypothesized	|O
about	|O
the	|O
effect	|O
of	|O
mRNA	|O
structure	|O
on	|O
translation	|O
of	|O
the	|O
two	|O
major	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBPepsilon	|I-PROTEIN
isoforms	|O
:	|O
p32	|B-PROTEIN
and	|O
p30	|B-PROTEIN
.	|O

WRN	|B-PROTEIN
helicase	|I-PROTEIN
resolves	|O
alternate	|O
DNA	|O
structures	|O
including	|O
tetraplex	|O
and	|O
triplex	|O
DNA	|O
,	|O
and	|O
Holliday	|O
junctions	|O
.	|O

These	|O
data	|O
suggest	|O
that	|O
ADAM	|B-PROTEIN
-	|I-PROTEIN
TS12	|I-PROTEIN
may	|O
play	|O
roles	|O
in	|O
pulmonary	|O
cells	|O
during	|O
fetal	|O
development	|O
or	|O
in	|O
tumor	|O
processes	|O
through	|O
its	|O
proteolytic	|O
activity	|O
or	|O
as	|O
a	|O
molecule	|O
potentially	|O
involved	|O
in	|O
regulation	|O
of	|O
cell	|O
adhesion	|O
.	|O

Binding	|O
of	|O
serum	|B-PROTEIN
response	|I-PROTEIN
factor	|I-PROTEIN
to	|O
CArG	|O
box	|O
sequences	|O
is	|O
necessary	|O
but	|O
not	|O
sufficient	|O
to	|O
restrict	|O
gene	|O
expression	|O
to	|O
arterial	|O
smooth	|O
muscle	|O
cells	|O
.	|O

Together	|O
,	|O
these	|O
results	|O
identify	|O
HPK1	|B-PROTEIN
as	|O
a	|O
new	|O
component	|O
of	|O
TCR	|B-PROTEIN
signaling	|O
.	|O

Biol.	|O

The	|O
size	|O
of	|O
the	|O
infarct	|O
was	|O
determined	|O
using	|O
the	|O
creatine	|B-PROTEIN
kinase	|I-PROTEIN
integral	|O
method	|O
.	|O

A	|O
new	|O
echocardiographic	|O
technique	|O
is	|O
described	|O
with	|O
a	|O
conventional	|O
M	|O
mode	|O
,	|O
digitalised	|O
2D	|O
and	|O
tissular	|O
Doppler	|O
which	|O
has	|O
a	|O
comparable	|O
ability	|O
to	|O
identify	|O
the	|O
anomalous	|O
pathways	|O
of	|O
electric	|O
conduction	|O
using	|O
a	|O
non	|O
-	|O
invasive	|O
method	|O
.	|O

SELECTION	|O
CRITERIA	|O
:	|O
Randomised	|O
controlled	|O
trials	|O
of	|O
cabergoline	|O
versus	|O
placebo	|O
in	|O
patients	|O
with	|O
a	|O
clinical	|O
diagnosis	|O
of	|O
idiopathic	|O
Parkinson	|O
's	|O
disease	|O
and	|O
long	|O
-	|O
term	|O
complications	|O
of	|O
levodopa	|O
therapy	|O
.	|O

CONCLUSIONS	|O
:	|O
Using	|O
icodextrin	|O
-	|O
based	|O
instead	|O
of	|O
glucose	|O
-	|O
based	|O
PD	|O
fluids	|O
can	|O
largely	|O
reduce	|O
the	|O
formation	|O
of	|O
Amadori	|O
albumin	|B-PROTEIN
and	|O
AGEs	|O
.	|O

In	|O
contrast	|O
,	|O
exogenous	|O
PTHrP1	|B-PROTEIN
-	|I-PROTEIN
34	|I-PROTEIN
and	|O
1-86	|O
peptides	|O
did	|O
not	|O
significantly	|O
affect	|O
IL	|B-PROTEIN
-	|I-PROTEIN
8	|I-PROTEIN
production	|O
;	|O
moreover	|O
,	|O
PTHrP	|B-PROTEIN
-	|O
neutralizing	|O
antibodies	|O
did	|O
not	|O
inhibit	|O
the	|O
production	|O
of	|O
IL	|B-PROTEIN
-	|I-PROTEIN
8	|I-PROTEIN
by	|O
transfected	|O
PTHrP	|B-PROTEIN
.	|O

Deterministic	|O
effects	|O
.	|O

Unusual	|O
two	|O
-	|O
domain	|O
arginine	|B-PROTEIN
kinases	|I-PROTEIN
(	|O
AKs	|B-PROTEIN
)	|O
arose	|O
independently	|O
at	|O
least	|O
two	|O
times	|O
during	|O
molecular	|O
evolution	|O
of	|O
phosphagen	|B-PROTEIN
kinases	|I-PROTEIN
:	|O
AKs	|B-PROTEIN
from	|O
the	|O
primitive	|O
sea	|O
anemone	|O
Anthopleurura	|O
japonicus	|O
and	|O
from	|O
the	|O
clam	|O
Pseudocardium	|O
sachalinensis	|O
.	|O

The	|O
mouse	|O
platelet	|O
-	|O
derived	|O
growth	|O
factor	|O
(	|B-PROTEIN
PDGF	|I-PROTEIN
)	|I-PROTEIN
beta	|I-PROTEIN
-	|I-PROTEIN
receptor	|I-PROTEIN
promoter	|O
contains	|O
a	|O
CCAAT	|O
motif	|O
,	|O
and	|O
NF	|B-PROTEIN
-	|I-PROTEIN
Y	|I-PROTEIN
plays	|O
an	|O
essential	|O
role	|O
in	|O
its	|O
transcription	|O
.	|O

Baseline	|O
MBF	|O
in	|O
females	|O
was	|O
significantly	|O
(	|O
P	|O
<	|O
0.001	|O
)	|O
higher	|O
than	|O
in	|O
males	|O
.	|O

No	|O
preferential	|O
VH	|B-PROTEIN
/	|O
VL	|B-PROTEIN
-	|O
chains	|O
correlated	|O
with	|O
any	|O
of	|O
the	|O
12	|O
different	|O
antigen	|O
reactivities	|O
,	|O
even	|O
for	|O
mAbs	|O
with	|O
nearly	|O
identical	|O
cross	|O
-	|O
reactivities	|O
.	|O

Recently	|O
,	|O
it	|O
was	|O
shown	|O
that	|O
purified	|O
RAG1/2	|B-PROTEIN
proteins	|O
can	|O
cleave	|O
DNA	|O
hairpins	|O
in	|O
vitro	|O
,	|O
but	|O
the	|O
same	|O
activity	|O
was	|O
also	|O
described	|O
for	|O
a	|O
protein	|O
complex	|O
of	|O
the	|O
DNA	|O
repair	|O
proteins	|O
Nbs1	|B-PROTEIN
/	|O
Mre11	|B-PROTEIN
/	|O
Rad50	|B-PROTEIN
.	|O

In	|O
addition	|O
,	|O
we	|O
did	|O
not	|O
detect	|O
significant	|O
differences	|O
in	|O
CDR3	|B-PROTEIN
sequences	|O
of	|O
endogenous	|O
Ig	|B-PROTEIN
lambdaL	|I-PROTEIN
and	|O
kappaL	|B-PROTEIN
chain	|I-PROTEIN
gene	|O
loci	|O
cloned	|O
from	|O
peripheral	|O
blood	|O
lymphocytes	|O
of	|O
an	|O
NBS	|O
patient	|O
and	|O
of	|O
healthy	|O
individuals	|O
.	|O

Phase	|O
II	|O
study	|O
of	|O
paclitaxel	|O
and	|O
oral	|O
etoposide	|O
in	|O
patients	|O
with	|O
locally	|O
advanced	|O
or	|O
metastatic	|O
non	|O
-	|O
small	|O
cell	|O
lung	|O
cancer	|O
.	|O

Oral	|O
supplementation	|O
of	|O
L	|O
-	|O
arginine	|O
significantly	|O
increased	|O
plasma	|O
L	|O
-	|O
citrulline	|O
,	|O
which	|O
indicated	|O
enhancement	|O
of	|O
NO	|O
production	|O
.	|O

This	|O
activation	|O
was	|O
then	|O
blocked	|O
by	|O
CGS	|O
12066A	|O
.	|O

Our	|O
results	|O
suggest	|O
that	|O
WASP	|B-PROTEIN
activates	|O
transcription	|O
following	|O
TCR	|B-PROTEIN
stimulation	|O
in	|O
a	|O
manner	|O
that	|O
is	|O
independent	|O
of	|O
its	|O
role	|O
in	|O
Arp2/3	|B-PROTEIN
-	|O
directed	|O
actin	|B-PROTEIN
polymerization	|O
.	|O

Two	|O
independent	|O
transgenic	|O
lines	|O
were	|O
produced	|O
,	|O
and	|O
both	|O
showed	|O
expression	|O
of	|O
the	|O
Gus	|B-PROTEIN
gene	|O
specifically	|O
in	|O
the	|O
endosperm	|O
during	|O
mid	|O
-	|O
development	|O
(	|O
first	|O
detected	|O
10-12	|O
d	|O
after	|O
anthesis	|O
)	|O
.	|O

Here	|O
we	|O
demonstrate	|O
that	|O
native	|O
MRCK	|B-PROTEIN
exists	|O
in	|O
high	|O
-	|O
molecular	|O
-	|O
weight	|O
complexes	|O
.	|O

These	|O
data	|O
define	|O
a	|O
conserved	|O
pathway	|O
wherein	|O
sequential	|O
histone	|B-PROTEIN
modifications	|O
establish	|O
a	|O
"	|O
histone	|B-PROTEIN
code	|O
"	|O
essential	|O
for	|O
the	|O
epigenetic	|O
inheritance	|O
of	|O
heterochromatin	|O
assembly	|O
.	|O

Regression	|O
analyses	|O
showed	|O
that	|O
SOREMP	|O
dream	|O
occurrences	|O
were	|O
significantly	|O
related	|O
to	|O
the	|O
amount	|O
of	|O
REM	|O
sleep	|O
,	|O
while	|O
NREMP	|O
dream	|O
occurrences	|O
were	|O
related	|O
to	|O
arousals	|O
from	|O
NREM	|O
sleep	|O
.	|O

Instead	|O
,	|O
TRPS1	|B-PROTEIN
potently	|O
and	|O
specifically	|O
represses	|O
transcriptional	|O
activation	|O
mediated	|O
by	|O
other	|O
GATA	|B-PROTEIN
factors	|I-PROTEIN
.	|O

9.7	|O
(	|O
95%	|O
CI	|O
:	|O
9.6-9.7	|O
)	|O
micromol	|O
/	|O
L	|O
among	|O
women	|O
(	|O
P	|O
=	|O
0.003	|O
)	|O
.	|O

Three	|O
patients	|O
received	|O
additional	|O
cycles	|O
of	|O
5	|O
-	|O
fluorouracil	|O
+	|O
/	|O
-	|O
leucovorin	|O
as	|O
maintenance	|O
chemotherapy.R	|O
ESULTS	|O
:	|O
Thirty	|O
males	|O
and	|O
21	|O
females	|O
with	|O
a	|O
median	|O
age	|O
of	|O
55	|O
years	|O
(	|O
range	|O
31	|O
-	|O
-	|O
73	|O
years	|O
)	|O
were	|O
treated	|O
.	|O

The	|O
Delta6CCI	|O
virus	|O
was	|O
extremely	|O
attenuated	|O
in	|O
replication	|O
capacity	|O
yet	|O
retained	|O
infectiousness	|O
for	|O
CEMx174	|O
and	|O
MT4	|O
cells	|O
.	|O

Secretion	|O
of	|O
interleukin	|B-PROTEIN
-	|I-PROTEIN
8	|I-PROTEIN
,	|O
RANTES	|B-PROTEIN
,	|O
macrophage	|B-PROTEIN
inflammatory	|I-PROTEIN
protein	|I-PROTEIN
1alpha	|I-PROTEIN
,	|O
and	|O
10	|O
-	|O
kappaDa	|O
IFN	|B-PROTEIN
-	|I-PROTEIN
gamma	|I-PROTEIN
-	|O
inducible	|O
protein	|O
were	|O
increased	|O
in	|O
differentiating	|O
keratinocytes	|O
by	|O
E6	|B-PROTEIN
.	|O

Another	|O
mutant	|O
,	|O
T255A	|O
,	|O
lost	|O
the	|O
ability	|O
to	|O
bind	|O
E4orf6	|B-PROTEIN
,	|O
but	|O
unexpectedly	|O
,	|O
viral	|O
late	|O
-	|O
gene	|O
expression	|O
was	|O
not	|O
affected	|O
.	|O

Herein	|O
PPARgamma	|B-PROTEIN
,	|O
liganded	|O
by	|O
either	|O
natural	|O
(	|O
15d	|O
-	|O
PGJ	|O
(	|O
2	|O
)	|O
and	|O
PGD	|O
(	|O
2	|O
)	|O
)	|O
or	|O
synthetic	|O
ligands	|O
(	|O
BRL49653	|O
and	|O
troglitazone	|O
)	|O
,	|O
selectively	|O
inhibited	|O
expression	|O
of	|O
the	|O
cyclin	|B-PROTEIN
D1	|I-PROTEIN
gene	|O
.	|O

Here	|O
we	|O
demonstrate	|O
that	|O
the	|O
Ras	|B-PROTEIN
-	|O
activated	|O
Raf	|B-PROTEIN
-	|O
MEK	|B-PROTEIN
-	|O
extracellular	|B-PROTEIN
signal	|I-PROTEIN
-	|I-PROTEIN
regulated	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
ERK	|B-PROTEIN
)	|O
signaling	|O
pathway	|O
can	|O
specifically	|O
control	|O
the	|O
expression	|O
of	|O
individual	|O
integrin	|B-PROTEIN
subunits	|O
in	|O
a	|O
variety	|O
of	|O
human	|O
and	|O
mouse	|O
cell	|O
lines	|O
.	|O

PABP	|B-PROTEIN
is	|O
a	|O
modular	|O
protein	|O
,	|O
with	|O
four	|O
N	|O
-	|O
terminal	|O
RNA	|O
-	|O
binding	|O
domains	|O
and	|O
an	|O
extensive	|O
C	|O
terminus	|O
.	|O

Children	|O
who	|O
developed	|O
lower	|O
respiratory	|O
tract	|O
infections	|O
or	|O
PCP	|O
had	|O
increased	|O
rates	|O
of	|O
decline	|O
of	|O
CD4	|B-PROTEIN
cell	|O
counts	|O
during	|O
the	|O
first	|O
6	|O
months	|O
of	|O
life	|O
.	|O

The	|O
reproductive	|O
effects	|O
of	|O
the	|O
administration	|O
of	|O
4	|O
-	|O
chloro	|O
-	|O
2	|O
-	|O
methylphenoxyacetic	|O
acid	|O
(	|O
MCPA	|O
)	|O
to	|O
rats	|O
were	|O
evaluated	|O
through	|O
two	|O
generations	|O
,	|O
from	|O
prior	|O
to	|O
mating	|O
,	|O
throughout	|O
mating	|O
,	|O
to	|O
gestation	|O
and	|O
lactation	|O
.	|O

Coexposure	|O
to	|O
FP	|O
also	|O
resulted	|O
in	|O
a	|O
more	|O
pronounced	|O
and	|O
sustained	|O
activation	|O
of	|O
the	|O
mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
kinase	|I-PROTEIN
/	|O
extracellular	|B-PROTEIN
signal	|I-PROTEIN
-	|I-PROTEIN
regulated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
cascade	|O
after	|O
PMA	|O
treatment	|O
,	|O
although	|O
disruption	|O
of	|O
this	|O
pathway	|O
by	|O
the	|O
mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
kinase	|I-PROTEIN
1	|I-PROTEIN
inhibitor	|O
U0126	|O
did	|O
not	|O
prevent	|O
potentiation	|O
of	|O
apoptosis	|O
.	|O

Also	|O
,	|O
the	|O
EWS	|B-PROTEIN
protein	|O
stimulates	|O
transcription	|O
mediated	|O
by	|O
the	|O
COOH	|O
-	|O
terminal	|O
transactivation	|O
domain	|O
of	|O
the	|O
cofactor	|O
CREB	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
(	|O
CBP	|B-PROTEIN
)	|O
.	|O

In	|O
the	|O
present	|O
study	|O
,	|O
we	|O
have	|O
determined	|O
the	|O
ICBP90	|B-PROTEIN
gene	|O
structure	|O
by	|O
screening	|O
of	|O
a	|O
human	|O
placenta	|O
genomic	|O
library	|O
and	|O
PCR	|O
analysis	|O
.	|O

Tumor	|O
-	|O
like	|O
accumulation	|O
on	|O
Tl	|O
-	|O
201	|O
SPECT	|O
in	|O
subacute	|O
hemorrhagic	|O
cerebral	|O
infarction	|O
.	|O

METHODS	|O
:	|O
126	|O
patients	|O
with	|O
histologically	|O
confirmed	|O
MFH	|O
were	|O
analyzed	|O
.	|O

It	|O
is	|O
surprising	|O
that	|O
dnaE173	|O
,	|O
a	|O
potent	|O
mutator	|O
mutation	|O
specific	|O
for	|O
sequence	|O
substitution	|O
as	|O
well	|O
as	|O
single	|O
-	|O
base	|O
frameshift	|O
,	|O
did	|O
not	|O
enhance	|O
the	|O
frequency	|O
of	|O
the	|O
hot	|O
-	|O
spot	|O
frameshift	|O
mutation	|O
.	|O

Its	|O
transcription	|O
in	|O
vitro	|O
by	|O
pol	|B-PROTEIN
III	|I-PROTEIN
requires	|O
the	|O
same	|O
factors	|O
as	|O
the	|O
U6	|B-PROTEIN
gene	|O
with	|O
the	|O
major	|O
exception	|O
that	|O
the	|O
modified	|O
TATA	|O
-	|O
box	|O
of	|O
this	|O
construct	|O
only	|O
interacts	|O
with	|O
a	|O
TATA	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
(	|O
TBP	|B-PROTEIN
)	|O
mutant	|O
(	|O
TBP	|B-PROTEIN
-	|I-PROTEIN
DR2	|I-PROTEIN
)	|O
but	|O
not	|O
with	|O
TBP	|B-PROTEIN
wild	|O
-	|O
type	|O
(	|O
TBPwt	|B-PROTEIN
)	|O
.	|O

HSF	|B-PROTEIN
binds	|O
DNA	|O
as	|O
a	|O
trimer	|O
,	|O
and	|O
additional	|O
trimers	|O
can	|O
bind	|O
DNA	|O
co	|O
-	|O
operatively	|O
.	|O

We	|O
also	|O
demonstrate	|O
that	|O
the	|O
spo20	|B-PROTEIN
(	|O
+	|O
)	|O
gene	|O
product	|O
is	|O
structurally	|O
homologous	|O
to	|O
Saccharomyces	|O
cerevisiae	|O
Sec14	|B-PROTEIN
,	|O
the	|O
major	|O
phosphatidylinositol	|O
transfer	|O
protein	|O
of	|O
budding	|O
yeast	|O
.	|O

There	|O
was	|O
no	|O
evidence	|O
of	|O
linkage	|O
disequilibrium	|O
between	|O
the	|O
polymorphic	|O
site	|O
in	|O
the	|O
B	|O
cell	|O
specific	|O
promoter	|O
and	|O
those	|O
in	|O
the	|O
3'	|O
UTR	|O
.	|O

Their	|O
numbers	|O
have	|O
regularly	|O
increased	|O
since	|O
the	|O
mid	|O
-	|O
1970s	|O
.	|O

Specimen	|O
mass	|O
reduction	|O
increased	|O
with	|O
irradiance	|O
from	|O
19	|O
to	|O
72%	|O
of	|O
the	|O
initial	|O
mass	|O
for	|O
9	|O
-	|O
-	|O
31	|O
W	|O
/	|O
cm	|O
(	|O
2	|O
)	|O
,	|O
respectively	|O
.	|O

In	|O
addition	|O
,	|O
another	|O
derivative	|O
of	|O
pCMVJS21	|O
(	|O
pCMVJS21DeltaGP	|O
)	|O
in	|O
which	|O
the	|O
gag	|B-PROTEIN
,	|O
pol	|B-PROTEIN
(	|O
and	|O
orf	|B-PROTEIN
-	|I-PROTEIN
x	|I-PROTEIN
)	|O
coding	|O
sequences	|O
were	|O
deleted	|O
also	|O
gave	|O
transformed	|O
foci	|O
.	|O

In	|O
conclusion	|O
,	|O
tube	|O
size	|O
estimated	|O
by	|O
Cole	|O
's	|O
formula	|O
tends	|O
to	|O
be	|O
smaller	|O
than	|O
practically	|O
appropriate	|O
tube	|O
size	|O
for	|O
pediatric	|O
cardiac	|O
anesthesia	|O
,	|O
and	|O
therefore	|O
we	|O
suggest	|O
new	|O
formula	|O
to	|O
estimate	|O
the	|O
tube	|O
size	|O
.	|O

An	|O
F222W	|B-PROTEIN
:	|O
W21F	|B-PROTEIN
rGST	|I-PROTEIN
A1	|I-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
double	|O
mutant	|O
provides	|O
a	|O
direct	|O
fluorescence	|O
probe	|O
of	|O
changes	|O
in	|O
the	|O
environment	|O
of	|O
the	|O
C	|O
-	|O
terminal	|O
residue	|O
.	|O

The	|O
recessive	|O
hos1	|B-PROTEIN
mutation	|O
causes	|O
enhanced	|O
induction	|O
of	|O
the	|O
CBF	|B-PROTEIN
transcription	|O
factors	|O
by	|O
low	|O
temperature	|O
as	|O
well	|O
as	|O
of	|O
their	|O
downstream	|O
cold	|O
-	|O
responsive	|O
genes	|O
.	|O

Stable	|O
transfection	|O
of	|O
human	|O
CHOP	|B-PROTEIN
cDNA	|O
into	|O
mammary	|O
carcinoma	|O
cells	|O
demonstrated	|O
that	|O
CHOP	|B-PROTEIN
functioned	|O
not	|O
as	|O
a	|O
mediator	|O
of	|O
hGH	|B-PROTEIN
-	|O
stimulated	|O
mitogenesis	|O
but	|O
rather	|O
enhanced	|O
the	|O
protection	|O
from	|O
apoptosis	|O
afforded	|O
by	|O
hGH	|B-PROTEIN
in	|O
a	|O
p38	|B-PROTEIN
MAPK	|O
-	|O
dependent	|O
manner	|O
.	|O

In	|O
contrast	|O
,	|O
neither	|O
I.	|O
argentina	|O
nor	|O
I.	|O
theezans	|O
exerted	|O
any	|O
effect	|O
on	|O
BF	|O
or	|O
intestinal	|O
propulsion	|O
.	|O

A	|O
comparison	|O
of	|O
the	|O
duplicated	|O
Vkappa	|B-PROTEIN
genes	|O
suggests	|O
positive	|O
selection	|O
on	|O
the	|O
complementarity	|O
-	|O
determining	|O
regions	|O
of	|O
the	|O
duplicated	|O
genes	|O
by	|O
point	|O
mutations	|O
.	|O

In	|O
contrast	|O
,	|O
the	|O
ubiquitous	|O
expression	|O
of	|O
p19	|B-PROTEIN
(	|O
INK4d	|B-PROTEIN
)	|O
has	|O
not	|O
been	|O
previously	|O
described	|O
in	|O
human	|O
or	|O
murine	|O
B	|O
-	|O
lineage	|O
cells	|O
.	|O

The	|O
results	|O
show	|O
that	|O
cognitive	|O
stimulation	|O
enhanced	|O
performance	|O
on	|O
the	|O
Boston	|O
Naming	|O
Test	|O
and	|O
a	|O
Word	|O
List	|O
Recognition	|O
Task	|O
;	|O
physical	|O
intervention	|O
,	|O
however	|O
,	|O
did	|O
not	|O
reach	|O
statistical	|O
significance	|O
.	|O

Instead	|O
,	|O
affective	|O
flattening	|O
was	|O
associated	|O
with	|O
both	|O
dopamine	|B-PROTEIN
receptor	|I-PROTEIN
sensitivity	|O
and	|O
psychomotor	|O
slowing	|O
.	|O

Homo	|O
-	|O
oligomerisation	|O
and	|O
nuclear	|O
localisation	|O
of	|O
mouse	|O
histone	|B-PROTEIN
deacetylase	|I-PROTEIN
1	|I-PROTEIN
.	|O

These	|O
data	|O
reveal	|O
a	|O
complex	|O
network	|O
of	|O
interactions	|O
between	|O
GTPases	|B-PROTEIN
in	|O
the	|O
ARF	|B-PROTEIN
family	|O
and	|O
their	|O
effectors	|O
and	|O
reveal	|O
a	|O
potential	|O
for	|O
cross	|O
-	|O
talk	|O
not	|O
demonstrated	|O
previously	|O
.	|O

With	|O
NEU	|B-PROTEIN
overexpression	|O
,	|O
nodal	|O
control	|O
decreased	|O
from	|O
72%	|O
to	|O
34%	|O
(	|O
p	|O
=	|O
.008	|O
)	|O
.	|O

At	|O
the	|O
time	|O
of	|O
the	|O
blind	|O
therapeutic	|O
doses	|O
,	|O
Tg	|B-PROTEIN
-	|O
off	|O
values	|O
ranged	|O
from	|O
8	|O
to	|O
608	|O
microg	|O
/	|O
l	|O
.	|O

Effects	|O
of	|O
a	|O
booster	|O
dose	|O
of	|O
tetanus	|O
toxoid	|O
after	|O
different	|O
primary	|O
courses	|O
of	|O
vaccination	|O
:	|O
implications	|O
on	|O
the	|O
use	|O
of	|O
immune	|B-PROTEIN
globulin	|I-PROTEIN
.	|O

Using	|O
RACE	|O
techniques	|O
we	|O
have	|O
cloned	|O
and	|O
sequenced	|O
one	|O
of	|O
the	|O
hamster	|O
liver	|O
3	|B-PROTEIN
-	|I-PROTEIN
hydroxy	|I-PROTEIN
-	|I-PROTEIN
hexobarbital	|I-PROTEIN
dehydrogenases	|I-PROTEIN
which	|O
catalyze	|O
not	|O
only	|O
cyclic	|O
alcohols	|O
but	|O
also	|O
17beta	|O
-	|O
hydroxy	|O
-	|O
steroids	|O
and	|O
3alpha	|O
-	|O
hydroxysteroids	|O
.	|O

A	|O
mutation	|O
in	|O
the	|O
C	|O
domain	|O
of	|O
Rb	|B-PROTEIN
,	|O
L901Q	|O
,	|O
has	|O
been	|O
identified	|O
that	|O
completely	|O
abolishes	|O
cdk4	|B-PROTEIN
/	|O
D1	|B-PROTEIN
phosphorylation	|O
of	|O
the	|O
isolated	|O
C	|O
domain	|O
.	|O

An	|O
association	|O
was	|O
demonstrated	|O
between	|O
the	|O
expression	|O
of	|O
aberrantly	|O
and	|O
/	|O
or	|O
alternatively	|O
spliced	|O
mdm2	|B-PROTEIN
mRNAs	|O
and	|O
a	|O
lack	|O
of	|O
progesterone	|B-PROTEIN
receptor	|I-PROTEIN
.	|O

Histological	|O
examination	|O
showed	|O
lichenoid	|O
changes	|O
,	|O
acantholytic	|O
blister	|O
formation	|O
and	|O
apoptotic	|O
keratinocytes	|O
.	|O

We	|O
find	|O
that	|O
our	|O
response	|O
function	|O
is	|O
well	|O
approximated	|O
by	|O
the	|O
GSER	|O
only	|O
within	|O
a	|O
particular	|O
frequency	|O
range	|O
determined	|O
by	|O
the	|O
material	|O
parameters	|O
of	|O
both	|O
the	|O
bead	|O
and	|O
the	|O
network	|O
.	|O

It	|O
is	|O
shown	|O
that	|O
,	|O
for	|O
any	|O
periodic	|O
input	|O
,	|O
the	|O
map	|O
representing	|O
the	|O
relation	|O
between	|O
input	|O
phases	|O
at	|O
consecutive	|O
discharge	|O
times	|O
can	|O
be	|O
restricted	|O
to	|O
a	|O
piecewise	|O
continuous	|O
,	|O
orientation	|O
preserving	|O
circle	|O
map	|O
.	|O

Nine	|O
strains	|O
were	|O
subtyped	|O
as	|O
Camp	|O
.	|O
jejuni	|O
subsp	|O
.	|O
jejuni	|O
biotype	|O
II	|O
and	|O
the	|O
remaining	|O
ones	|O
as	|O
biotype	|O
I.	|O

Analysis	|O
of	|O
mCTR	|B-PROTEIN
mRNAs	|O
has	|O
revealed	|O
that	|O
the	|O
three	|O
alternative	|O
promoters	|O
give	|O
rise	|O
to	|O
at	|O
least	|O
seven	|O
mCTR	|B-PROTEIN
isoforms	|O
in	|O
the	|O
5'	|O
region	|O
of	|O
the	|O
gene	|O
and	|O
generate	|O
5'	|O
-	|O
untranslated	|O
regions	|O
of	|O
very	|O
different	|O
lengths	|O
.	|O

We	|O
previously	|O
showed	|O
that	|O
this	|O
proteolysis	|O
1	|O
)	|O
can	|O
be	|O
acutely	|O
promoted	|O
by	|O
the	|O
phorbol	|O
ester	|O
phorbol	|O
12	|O
-	|O
myristate	|O
13	|O
-	|O
acetate	|O
(	|O
PMA	|O
)	|O
,	|O
2	|O
)	|O
requires	|O
a	|O
metalloprotease	|B-PROTEIN
activity	|O
,	|O
3	|O
)	|O
generates	|O
both	|O
shed	|O
GHBP	|B-PROTEIN
and	|O
a	|O
membrane	|O
-	|O
associated	|O
GHR	|B-PROTEIN
transmembrane	|O
/	|O
cytoplasmic	|O
domain	|O
remnant	|O
,	|O
and	|O
4	|O
)	|O
results	|O
in	|O
down	|O
-	|O
regulation	|O
of	|O
GHR	|B-PROTEIN
abundance	|O
and	|O
GH	|B-PROTEIN
signaling	|O
.	|O

Effects	|O
of	|O
3'	|O
terminus	|O
modifications	|O
on	|O
mRNA	|O
functional	|O
decay	|O
during	|O
in	|O
vitro	|O
protein	|O
synthesis	|O
.	|O

A	|O
comprehensive	|O
neuropsychological	|O
battery	|O
was	|O
administered	|O
to	|O
48	|O
veterans	|O
with	|O
Gulf	|O
War	|O
Illness	|O
(	|O
GWI	|O
)	|O
characterized	|O
by	|O
severe	|O
fatigue	|O
(	|O
GV	|O
-	|O
F	|O
)	|O
and	|O
39	|O
healthy	|O
veterans	|O
(	|O
GV	|O
-	|O
H	|O
)	|O
.	|O

Reverse	|O
transcription	|O
-	|O
PCR	|O
analysis	|O
of	|O
mRNA	|O
from	|O
patients	|O
shows	|O
that	|O
each	|O
of	|O
these	|O
five	|O
mutations	|O
results	|O
in	|O
aberrant	|O
splicing	|O
.	|O

RESULTS	|O
:	|O
Coronary	|O
mortality	|O
during	|O
the	|O
median	|O
follow	|O
-	|O
up	|O
time	|O
of	|O
17	|O
months	|O
was	|O
6	|O
-	|O
fold	|O
higher	|O
in	|O
the	|O
highest	|O
tertile	|O
for	|O
CRP	|B-PROTEIN
and	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
and	|O
3.5	|O
-	|O
fold	|O
higher	|O
in	|O
the	|O
highest	|O
tertile	|O
for	|O
fibrinogen	|B-PROTEIN
and	|O
TNF	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
than	|O
in	|O
the	|O
respective	|O
combined	|O
lower	|O
tertiles	|O
.	|O

The	|O
relationship	|O
of	|O
the	|O
factor	|B-PROTEIN
V	|I-PROTEIN
Leiden	|O
mutation	|O
or	|O
the	|O
deletion	|O
-	|O
deletion	|O
polymorphism	|O
of	|O
the	|O
angiotensin	|B-PROTEIN
converting	|I-PROTEIN
enzyme	|I-PROTEIN
to	|O
postoperative	|O
thromboembolic	|O
events	|O
following	|O
total	|O
joint	|O
arthroplasty	|O
.	|O

These	|O
disorders	|O
include	|O
low	|O
-	|O
back	|O
pain	|O
,	|O
saddle	|O
anesthesia	|O
,	|O
bilateral	|O
sciatica	|O
,	|O
then	|O
motor	|O
weakness	|O
of	|O
the	|O
lower	|O
extremities	|O
or	|O
chronic	|O
paraplegia	|O
and	|O
,	|O
bladder	|O
dysfunction	|O
.	|O

Sural	|O
nerve	|O
biopsy	|O
showed	|O
mild	|O
thickening	|O
of	|O
the	|O
perineurium	|O
,	|O
vascular	|O
alterations	|O
with	|O
inflammatory	|O
cell	|O
infiltration	|O
in	|O
the	|O
perineurium	|O
,	|O
and	|O
remarkable	|O
loss	|O
of	|O
large	|O
and	|O
small	|O
myelinated	|O
fibers	|O
.	|O

To	|O
examine	|O
transcriptional	|O
regulation	|O
of	|O
the	|O
rat	|O
eIF4E	|B-PROTEIN
gene	|O
,	|O
2.1	|O
kB	|O
of	|O
the	|O
rat	|O
eIF4E	|B-PROTEIN
promoter	|O
region	|O
was	|O
cloned	|O
and	|O
the	|O
contribution	|O
of	|O
specific	|O
elements	|O
in	|O
regulating	|O
transcription	|O
was	|O
determined	|O
in	|O
primary	|O
cultures	|O
of	|O
rat	|O
cardiocytes	|O
and	|O
in	|O
a	|O
murine	|O
C	|O
(	|O
2	|O
)	|O
C	|O
(	|O
12	|O
)	|O
myoblast	|O
cell	|O
line	|O
.	|O

When	|O
this	|O
CCAAT	|O
box	|O
was	|O
inserted	|O
into	|O
a	|O
heterologous	|O
promoter	|O
construct	|O
,	|O
OA	|O
induction	|O
was	|O
dependent	|O
on	|O
an	|O
intact	|O
CCAAT	|O
box	|O
.	|O

The	|O
JHRLSS	|O
has	|O
been	|O
used	|O
in	|O
prior	|O
studies	|O
to	|O
assess	|O
RLS	|O
severity	|O
,	|O
but	|O
has	|O
not	|O
previously	|O
been	|O
validated	|O
in	|O
relation	|O
to	|O
direct	|O
measures	|O
of	|O
the	|O
morbidity	|O
associated	|O
with	|O
RLS	|O
.	|O

In	|O
the	|O
remaining	|O
case	|O
,	|O
the	|O
aneurysm	|O
originated	|O
from	|O
the	|O
proximal	|O
end	|O
of	|O
the	|O
associated	|O
A1	|O
fenestration	|O
.	|O

GABA	|B-PROTEIN
(	|I-PROTEIN
B	|I-PROTEIN
)	|I-PROTEIN
R1g	|I-PROTEIN
was	|O
expressed	|O
in	|O
both	|O
brain	|O
and	|O
peripheral	|O
tissues	|O
.	|O

Raes	|O
,	|O
P.	|O

NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
pathway	|O
activation	|O
occurs	|O
during	|O
transformation	|O
induced	|O
by	|O
a	|O
number	|O
of	|O
classical	|O
oncogenes	|O
,	|O
including	|O
Bcr	|B-PROTEIN
/	|O
Abl	|B-PROTEIN
,	|O
Ras	|B-PROTEIN
and	|O
Rac	|B-PROTEIN
,	|O
and	|O
is	|O
necessary	|O
for	|O
full	|O
transforming	|O
potential	|O
.	|O

We	|O
used	|O
a	|O
rev	|B-PROTEIN
-	|O
and	|O
RRE	|B-PROTEIN
-	|O
defective	|O
HIV	|O
type	|O
1	|O
(	|O
HIV	|O
-	|O
1	|O
)	|O
molecular	|O
clone	|O
in	|O
complementation	|O
experiments	|O
to	|O
establish	|O
a	|O
method	|O
for	|O
the	|O
rapid	|O
isolation	|O
of	|O
posttranscriptional	|O
regulatory	|O
elements	|O
from	|O
the	|O
mammalian	|O
genome	|O
by	|O
selecting	|O
for	|O
rescue	|O
of	|O
virus	|O
replication	|O
.	|O

Copyright	|O
2001	|O
Academic	|O
Press	|O
.	|O

A	|O
novel	|O
myeloid	|O
-	|O
restricted	|O
zebrafish	|O
CCAAT	|B-PROTEIN
/	|I-PROTEIN
enhancer	|I-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
with	|O
a	|O
potent	|O
transcriptional	|O
activation	|O
domain	|O
.	|O

Recently	|O
,	|O
we	|O
discovered	|O
that	|O
alanine	|O
substitutions	|O
of	|O
the	|O
active	|O
center	|O
cleft	|O
residues	|O
significantly	|O
impair	|O
the	|O
depurinating	|O
and	|O
ribosome	|O
inhibitory	|O
activity	|O
of	|O
PAP	|B-PROTEIN
.	|O

SH2D1A	|B-PROTEIN
protein	|O
levels	|O
are	|O
up	|O
-	|O
regulated	|O
by	|O
CD40	|B-PROTEIN
cross	|O
-	|O
linking	|O
and	|O
down	|O
-	|O
regulated	|O
by	|O
B	|B-PROTEIN
cell	|I-PROTEIN
receptor	|I-PROTEIN
ligation	|O
.	|O

Cross	|O
-	|O
linking	|O
FcalphaR	|B-PROTEIN
on	|O
wt	|B-PROTEIN
-	|I-PROTEIN
ITAM	|I-PROTEIN
or	|O
IIA	|B-PROTEIN
-	|I-PROTEIN
ITAM	|I-PROTEIN
cells	|O
triggered	|O
equivalent	|O
PI	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
-	|O
dependent	|O
activation	|O
of	|O
PKBalpha	|B-PROTEIN
.	|O

RPM	|B-PROTEIN
/	|O
RGL3	|B-PROTEIN
resembled	|O
AF	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
and	|O
Nore1	|B-PROTEIN
in	|O
interacting	|O
strongly	|O
with	|O
constitutively	|O
active	|O
M	|B-PROTEIN
-	|I-PROTEIN
Ras	|I-PROTEIN
and	|O
p21	|B-PROTEIN
Ras	|I-PROTEIN
.	|O

A	|O
novel	|O
potential	|O
effector	|O
of	|O
M	|B-PROTEIN
-	|I-PROTEIN
Ras	|I-PROTEIN
and	|O
p21	|B-PROTEIN
Ras	|I-PROTEIN
negatively	|O
regulates	|O
p21	|B-PROTEIN
Ras	|I-PROTEIN
-	|O
mediated	|O
gene	|O
induction	|O
and	|O
cell	|O
growth	|O
.	|O

The	|O
mice	|O
are	|O
phenotypically	|O
normal	|O
and	|O
do	|O
not	|O
develop	|O
spontaneous	|O
tumors	|O
at	|O
an	|O
early	|O
age	|O
,	|O
in	|O
contrast	|O
to	|O
knock	|O
-	|O
out	|O
(	|O
p53	|B-PROTEIN
(	|O
-	|O
/	|O
-	|O
)	|O
)	|O
strains	|O
with	|O
a	|O
defective	|O
p53	|B-PROTEIN
gene	|O
.	|O

Our	|O
results	|O
suggest	|O
that	|O
the	|O
C	|O
-	|O
terminal	|O
region	|O
of	|O
Crk	|B-PROTEIN
contains	|O
negative	|O
regulatory	|O
elements	|O
important	|O
for	|O
both	|O
Abl	|B-PROTEIN
and	|O
FAK	|B-PROTEIN
dependent	|O
signal	|O
pathways	|O
,	|O
and	|O
offers	|O
a	|O
paradigm	|O
for	|O
an	|O
autoinhibitory	|O
region	|O
in	|O
the	|O
SH3	|B-PROTEIN
linker	|O
/	|O
C	|O
-	|O
terminal	|O
SH3	|B-PROTEIN
domain	|O
.	|O

Cyclins	|B-PROTEIN
are	|O
one	|O
of	|O
the	|O
pivotal	|O
determinants	|O
regulating	|O
cell	|O
cycle	|O
progression	|O
.	|O

Evidence	|O
-	|O
based	|O
care	|O
:	|O
a	|O
new	|O
formula	|O
for	|O
an	|O
old	|O
problem	|O
?	|O

Further	|O
,	|O
the	|O
osteo	|O
-	|O
retentive	|O
ability	|O
of	|O
the	|O
hydroxyapatite	|O
in	|O
the	|O
sockets	|O
was	|O
seen	|O
to	|O
be	|O
close	|O
to	|O
significance	|O
(	|O
after	|O
six	|O
months	|O
width	|O
differences	|O
,	|O
in	|O
the	|O
canine	|O
region	|O
:	|O
P	|O
=	|O
0.059	|O
,	|O
LHS	|O
,	|O
and	|O
P	|O
=	|O
0.065	|O
,	|O
RHS	|O
)	|O
.	|O

The	|O
cleavage	|O
site	|O
between	|O
VPg	|B-PROTEIN
and	|O
RNA	|O
dependent	|O
RNA	|B-PROTEIN
polymerase	|I-PROTEIN
was	|O
predicted	|O
to	|O
be	|O
E445	|O
-	|O
T446	|O
based	|O
on	|O
the	|O
amino	|O
acid	|O
sequence	|O
analysis	|O
of	|O
the	|O
polyprotein	|O
from	|O
different	|O
sobemoviruses	|O
.	|O

The	|O
%	|O
SVend	|O
of	|O
HCM	|O
-	|O
I	|O
was	|O
significantly	|O
lower	|O
than	|O
the	|O
respective	|O
values	|O
of	|O
the	|O
HCM	|O
-	|O
II	|O
and	|O
Control	|O
groups	|O
.	|O

Nearly	|O
all	|O
isolates	|O
of	|O
S.	|O
intermedius	|O
and	|O
most	|O
isolates	|O
of	|O
S.	|O
constellatus	|O
,	|O
but	|O
only	|O
19%	|O
of	|O
those	|O
of	|O
S.	|O
anginosus	|O
,	|O
were	|O
associated	|O
with	|O
abscess	|O
.	|O

DESIGN	|O
:	|O
Retrospective	|O
study	|O
.	|O

Human	|O
brain	|O
cDNA	|O
library	|O
screening	|O
and	|O
5'	|O
rapid	|O
amplification	|O
of	|O
cDNA	|O
ends	|O
yielded	|O
full	|O
-	|O
length	|O
DENTT	|B-PROTEIN
cDNA	|O
containing	|O
an	|O
1899	|O
-	|O
bp	|O
open	|O
reading	|O
frame	|O
encoding	|O
a	|O
predicted	|O
633	|O
-	|O
amino	|O
-	|O
acid	|O
protein	|O
with	|O
four	|O
potential	|O
nuclear	|O
localization	|O
signals	|O
(	|O
NLSs	|O
)	|O
and	|O
two	|O
coiled	|O
-	|O
coil	|O
regions	|O
.	|O

Transfection	|O
of	|O
EGFP	|O
-	|O
tagged	|O
DENTT	|B-PROTEIN
NLS	|O
deletion	|O
constructs	|O
lacking	|O
the	|O
bipartite	|O
NLS	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
were	|O
excluded	|O
from	|O
the	|O
nucleolus	|O
.	|O

These	|O
genes	|O
encode	|O
a	|O
tryptophanyl	|B-PROTEIN
tRNA	|I-PROTEIN
,	|O
the	|O
protein	|B-PROTEIN
translocase	|I-PROTEIN
component	|O
SecE	|B-PROTEIN
,	|O
the	|O
antiterminator	|O
protein	|O
NusG	|B-PROTEIN
,	|O
and	|O
the	|O
ribosomal	|O
proteins	|O
L11	|B-PROTEIN
and	|O
L1	|B-PROTEIN
in	|O
addition	|O
to	|O
PkwR	|B-PROTEIN
,	|O
a	|O
putative	|O
regulatory	|O
protein	|O
of	|O
the	|O
LacI	|B-PROTEIN
-	|O
GalR	|B-PROTEIN
family	|O
.	|O

Rapamycin	|O
(	|O
FRAP	|B-PROTEIN
/	|O
mTOR	|B-PROTEIN
inhibitor	|O
)	|O
blocked	|O
4E	|B-PROTEIN
-	|I-PROTEIN
BP1	|I-PROTEIN
phosphorylation	|O
causing	|O
a	|O
predominance	|O
of	|O
the	|O
alpha	|O
(	|O
hypophosphorylated	|O
)	|O
band	|O
.	|O

Sixteen	|O
out	|O
of	|O
52	|O
seropositive	|O
MS	|O
patients	|O
(	|O
30.8%	|O
)	|O
showed	|O
intrathecal	|O
synthesis	|O
of	|O
C.	|O
pneumoniae	|O
-	|O
specific	|O
IgG	|B-PROTEIN
but	|O
only	|O
one	|O
of	|O
43	|O
seropositive	|O
controls	|O
(	|O
2.3%	|O
)	|O
.	|O

Far	|O
Western	|O
blot	|O
analysis	|O
suggested	|O
that	|O
the	|O
tandem	|O
SH2	|B-PROTEIN
domains	|O
of	|O
SHP2	|B-PROTEIN
bind	|O
to	|O
Gab1	|B-PROTEIN
in	|O
a	|O
specific	|O
orientation	|O
,	|O
in	|O
which	|O
the	|O
N	|B-PROTEIN
-	|I-PROTEIN
SH2	|I-PROTEIN
domain	|O
binds	|O
to	|O
phosphotyrosine	|O
(	|O
Tyr	|O
(	|O
P	|O
)	|O
)	|O
-	|O
627	|O
and	|O
the	|O
C	|B-PROTEIN
-	|I-PROTEIN
SH2	|I-PROTEIN
domain	|O
binds	|O
to	|O
Tyr	|O
(	|O
P	|O
)	|O
-	|O
659	|O
.	|O

Molecular	|O
cloning	|O
,	|O
genomic	|O
mapping	|O
,	|O
and	|O
expression	|O
of	|O
two	|O
secretor	|O
blood	|O
group	|O
alpha	|B-PROTEIN
(	|I-PROTEIN
1,2	|I-PROTEIN
)	|I-PROTEIN
fucosyltransferase	|I-PROTEIN
genes	|O
differentially	|O
regulated	|O
in	|O
mouse	|O
uterine	|O
epithelium	|O
and	|O
gastrointestinal	|O
tract	|O
.	|O

The	|O
UBA	|B-PROTEIN
domains	|O
of	|O
RAD23	|B-PROTEIN
and	|O
DDI1	|B-PROTEIN
are	|O
required	|O
for	|O
these	|O
interactions	|O
.	|O

It	|O
was	|O
found	|O
that	|O
intrathecal	|O
administration	|O
(	|O
i.t	|O
.	|O
)	|O
of	|O
D2	|B-PROTEIN
receptor	|I-PROTEIN
agonist	|O
LY171555	|O
or	|O
D1	|B-PROTEIN
/	|I-PROTEIN
D2	|I-PROTEIN
receptor	|I-PROTEIN
agonist	|O
apomorphine	|O
increased	|O
pain	|O
threshold	|O
and	|O
had	|O
a	|O
potentiating	|O
effect	|O
on	|O
AA	|O
.	|O

The	|O
R2	|O
between	|O
MFI	|O
of	|O
fresh	|O
and	|O
frozen	|O
muscle	|O
was	|O
0.94	|O
and	|O
0.92	|O
for	|O
lamb	|O
and	|O
pork	|O
longissimus	|O
,	|O
respectively	|O
.	|O

After	|O
all	|O
doses	|O
of	|O
d	|O
-	|O
amphetamine	|O
,	|O
responding	|O
occurred	|O
largely	|O
on	|O
the	|O
saline	|O
key	|O
under	|O
both	|O
schedules	|O
.	|O

Intravenous	|O
L	|O
-	|O
carnitine	|O
treatment	|O
increased	|O
plasma	|O
carnitine	|O
concentrations	|O
,	|O
improved	|O
patient	|O
-	|O
assessed	|O
fatigue	|O
,	|O
and	|O
may	|O
prevent	|O
the	|O
decline	|O
in	|O
peak	|O
exercise	|O
capacity	|O
in	|O
hemodialysis	|O
patients	|O
.	|O

Elevated	|O
expression	|O
of	|O
full	|O
-	|O
length	|O
UhpB	|B-PROTEIN
or	|O
of	|O
a	|O
soluble	|O
hybrid	|O
protein	|O
,	|O
GST	|B-PROTEIN
-	|O
Bc	|B-PROTEIN
,	|O
which	|O
is	|O
glutathione	|B-PROTEIN
S	|I-PROTEIN
-	|I-PROTEIN
transferase	|I-PROTEIN
(	|O
GST	|B-PROTEIN
)	|O
fused	|O
to	|O
the	|O
cytoplasmic	|O
C	|O
-	|O
terminal	|O
portion	|O
of	|O
UhpB	|B-PROTEIN
,	|O
results	|O
in	|O
complete	|O
blockage	|O
of	|O
uhpT	|B-PROTEIN
expression	|O
in	|O
a	|O
uhp	|B-PROTEIN
(	|O
+	|O
)	|O
strain	|O
.	|O

This	|O
unique	|O
location	|O
of	|O
cavernous	|O
malformation	|O
is	|O
associated	|O
with	|O
a	|O
risk	|O
of	|O
permanent	|O
loss	|O
of	|O
the	|O
vision	|O
.	|O

Here	|O
we	|O
show	|O
that	|O
PKC	|B-PROTEIN
and	|O
p44	|B-PROTEIN
/	|O
p42MAPK	|B-PROTEIN
signalings	|O
are	|O
required	|O
for	|O
the	|O
HBx	|B-PROTEIN
-	|O
induced	|O
Sp1	|B-PROTEIN
-	|O
mediated	|O
IGF	|B-PROTEIN
-	|I-PROTEIN
II	|I-PROTEIN
P4	|O
transcriptional	|O
activity	|O
since	|O
(	|O
i	|O
)	|O
PKC	|B-PROTEIN
activation	|O
by	|O
PMA	|O
or	|O
PKC	|B-PROTEIN
expression	|O
vector	|O
increases	|O
Sp1	|B-PROTEIN
phosphorylation	|O
and	|O
P4	|B-PROTEIN
activity	|O
in	|O
HBx	|B-PROTEIN
-	|O
transfected	|O
HepG2	|O
cells	|O
;	|O
(	|O
ii	|O
)	|O
PKC	|B-PROTEIN
inhibition	|O
by	|O
PKC	|B-PROTEIN
inhibitor	|O
Go6976	|O
reduces	|O
Sp1	|B-PROTEIN
phosphorylation	|O
,	|O
P4	|B-PROTEIN
activity	|O
,	|O
and	|O
IGF	|B-PROTEIN
-	|I-PROTEIN
II	|I-PROTEIN
mRNA	|O
in	|O
HBx	|B-PROTEIN
-	|O
transfected	|O
HepG2	|O
cells	|O
;	|O
and	|O
(	|O
iii	|O
)	|O
the	|O
inhibition	|O
of	|O
MEK	|B-PROTEIN
activation	|O
by	|O
U0126	|O
reduces	|O
Sp1	|B-PROTEIN
phosphorylation	|O
,	|O
P4	|B-PROTEIN
activity	|O
and	|O
IGF	|B-PROTEIN
-	|I-PROTEIN
II	|I-PROTEIN
mRNA	|O
in	|O
HBx	|B-PROTEIN
-	|O
transfected	|O
HepG2	|O
cells	|O
.	|O

Through	|O
two	|O
novel	|O
mechanisms	|O
,	|O
Arf	|B-PROTEIN
inhibits	|O
the	|O
oncoprotein	|O
Hdm2	|B-PROTEIN
,	|O
a	|O
negative	|O
regulator	|O
of	|O
p53	|B-PROTEIN
.	|O

In	|O
the	|O
free	|O
-	|O
swimming	|O
rotatory	|O
test	|O
mice	|O
spend	|O
most	|O
of	|O
the	|O
time	|O
swimming	|O
close	|O
to	|O
the	|O
wall	|O
of	|O
the	|O
container	|O
attempting	|O
to	|O
escape	|O
from	|O
an	|O
aversive	|O
test	|O
situation	|O
.	|O

Examination	|O
of	|O
various	|O
promoter	|O
deletion	|O
mutants	|O
indicated	|O
that	|O
SF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
acts	|O
through	|O
the	|O
proximal	|O
promoter	|O
region	|O
and	|O
upstream	|O
promoter	|O
sequences	|O
.	|O

The	|O
MSL	|B-PROTEIN
complex	|O
is	|O
specifically	|O
localized	|O
on	|O
the	|O
male	|O
X	|O
chromosome	|O
to	|O
increase	|O
its	|O
expression	|O
approximately	|O
2	|O
-	|O
fold	|O
.	|O

Prrp	|B-PROTEIN
can	|O
also	|O
associate	|O
with	|O
the	|O
EVH1	|B-PROTEIN
domain	|O
of	|O
Mena	|B-PROTEIN
,	|O
another	|O
microfilament	|O
-	|O
associated	|O
protein	|O
.	|O

Srb10	|B-PROTEIN
is	|O
a	|O
physiological	|O
regulator	|O
of	|O
Gcn4	|B-PROTEIN
stability	|O
because	|O
both	|O
phosphorylation	|O
and	|O
turnover	|O
of	|O
Gcn4	|B-PROTEIN
are	|O
diminished	|O
in	|O
srb10	|B-PROTEIN
mutants	|O
.	|O

Consistent	|O
effects	|O
on	|O
pVHL	|B-PROTEIN
function	|O
were	|O
observed	|O
for	|O
all	|O
mutations	|O
within	|O
each	|O
subclass	|O
.	|O

A	|O
new	|O
intron	|O
of	|O
476	|O
base	|O
pairs	|O
was	|O
found	|O
in	|O
the	|O
middle	|O
of	|O
the	|O
5'	|O
-	|O
untranslated	|O
leader	|O
sequence	|O
and	|O
was	|O
shown	|O
to	|O
robustly	|O
enhance	|O
the	|O
promoter	|O
activity	|O
.	|O

Based	|O
on	|O
this	|O
analysis	|O
,	|O
we	|O
propose	|O
that	|O
the	|O
interactions	|O
of	|O
Sos	|B-PROTEIN
with	|O
the	|O
switch	|O
1	|O
and	|O
switch	|O
2	|O
regions	|O
of	|O
Ras	|B-PROTEIN
have	|O
distinct	|O
functional	|O
consequences	|O
:	|O
the	|O
interaction	|O
with	|O
switch	|O
2	|O
mediates	|O
the	|O
anchoring	|O
of	|O
Ras	|B-PROTEIN
to	|O
Sos	|B-PROTEIN
,	|O
whereas	|O
the	|O
interaction	|O
with	|O
switch	|O
1	|O
leads	|O
to	|O
disruption	|O
of	|O
the	|O
nucleotide	|O
-	|O
binding	|O
site	|O
and	|O
GDP	|O
dissociation	|O
.	|O

A	|O
log	|O
-	|O
linear	|O
dose	|O
-	|O
response	|O
was	|O
obtained	|O
for	|O
the	|O
average	|O
increase	|O
in	|O
FEV1	|O
up	|O
to	|O
6	|O
h	|O
(	|O
AUC0	|O
-	|O
6	|O
h	|O
)	|O
and	|O
peak	|O
FEV1	|O
across	|O
the	|O
dose	|O
range	|O
administered	|O
by	|O
Respimat	|O
.	|O

Bandshift	|O
experiments	|O
demonstrate	|O
that	|O
BmHR3A	|B-PROTEIN
binds	|O
specifically	|O
to	|O
RORE	|B-PROTEIN
(	|O
Retinoic	|B-PROTEIN
acid	|I-PROTEIN
-	|I-PROTEIN
related	|I-PROTEIN
Orphan	|I-PROTEIN
receptor	|I-PROTEIN
Response	|I-PROTEIN
Element	|I-PROTEIN
)	|O
-	|O
like	|O
sequences	|O
in	|O
the	|O
promoters	|O
of	|O
both	|O
genes	|O
,	|O
thus	|O
suggesting	|O
a	|O
direct	|O
role	|O
for	|O
BmHR3A	|B-PROTEIN
in	|O
regulating	|O
the	|O
expression	|O
of	|O
BmGATAbeta	|B-PROTEIN
and	|O
ESP	|B-PROTEIN
genes	|O
during	|O
vitellogenesis	|O
.	|O

This	|O
was	|O
most	|O
pronounced	|O
during	|O
the	|O
initial	|O
phase	|O
of	|O
Erk	|B-PROTEIN
activation	|O
.	|O

The	|O
iterative	|O
method	|O
proposed	|O
by	|O
Bengtsson	|O
[	|O
Appl	|O
.	|O

Here	|O
,	|O
we	|O
identify	|O
Rsc3	|B-PROTEIN
and	|O
Rsc30	|B-PROTEIN
as	|O
novel	|O
components	|O
of	|O
the	|O
essential	|O
yeast	|O
remodeler	|O
RSC	|B-PROTEIN
complex	|O
.	|O

The	|O
COD	|O
and	|O
color	|O
removals	|O
were	|O
both	|O
more	|O
than	|O
90%	|O
when	|O
FeCl3	|O
was	|O
used	|O
as	|O
the	|O
coagulation	|O
(	|O
dosages	|O
of	|O
two	|O
-	|O
step	|O
coagulation	|O
were	|O
0.031	|O
and	|O
0.012	|O
mol	|O
/	|O
L	|O
respectively	|O
)	|O
after	|O
a	|O
ferrous	|O
hydrogen	|O
peroxide	|O
oxidation	|O
pretreatment	|O
at	|O
a	|O
H2O2	|O
dosage	|O
of	|O
0.06	|O
mol	|O
/	|O
L.	|O

Although	|O
there	|O
was	|O
a	|O
high	|O
correlation	|O
between	|O
sap	|O
flux	|O
densities	|O
registered	|O
by	|O
the	|O
old	|O
and	|O
new	|O
sensors	|O
,	|O
significant	|O
differences	|O
in	|O
sap	|O
flux	|O
densities	|O
between	|O
the	|O
duplicated	|O
sensors	|O
were	|O
detected	|O
.	|O

Three	|O
of	|O
the	|O
proteins	|O
involved	|O
in	|O
checkpoint	|O
signaling	|O
,	|O
Rad1	|B-PROTEIN
,	|O
Hus1	|B-PROTEIN
,	|O
and	|O
Rad9	|B-PROTEIN
,	|O
have	|O
been	|O
shown	|O
to	|O
interact	|O
by	|O
immunoprecipitation	|O
and	|O
yeast	|O
two	|O
-	|O
hybrid	|O
studies	|O
.	|O

Based	|O
on	|O
the	|O
hypothesis	|O
that	|O
evolutionarily	|O
conserved	|O
regions	|O
are	|O
functionally	|O
important	|O
and	|O
likely	|O
to	|O
interact	|O
with	|O
coactivators	|O
,	|O
we	|O
compared	|O
the	|O
amino	|O
acid	|O
sequence	|O
of	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBPalpha	|I-PROTEIN
from	|O
different	|O
species	|O
(	|O
frog	|O
to	|O
human	|O
)	|O
and	|O
identified	|O
four	|O
highly	|O
conserved	|O
regions	|O
(	|O
CR1	|O
-	|O
CR4	|O
)	|O
within	|O
the	|O
transactivation	|O
domain	|O
.	|O

Tolerance	|O
to	|O
ADAL	|O
-	|O
2	|O
was	|O
similar	|O
to	|O
that	|O
of	|O
Vicryl	|O
suture	|O
and	|O
tolerance	|O
to	|O
ADAL	|O
-	|O
2	|O
was	|O
superior	|O
to	|O
that	|O
to	|O
Tisuacryl	|O
.	|O

Of	|O
the	|O
patients	|O
in	|O
each	|O
regimen	|O
who	|O
reached	|O
study	|O
end	|O
points	|O
,	|O
17	|O
of	|O
29	|O
(	|O
59%	|O
)	|O
were	|O
in	|O
regimen	|O
A	|O
,	|O
11	|O
of	|O
20	|O
(	|O
55%	|O
)	|O
were	|O
in	|O
regimen	|O
B	|O
,	|O
and	|O
28	|O
of	|O
43	|O
(	|O
65%	|O
)	|O
were	|O
in	|O
regimen	|O
C	|O
met	|O
the	|O
treatment	|O
success	|O
criterion	|O
.	|O

Early	|O
indicators	|O
of	|O
the	|O
effect	|O
of	|O
a	|O
breast	|O
cancer	|O
screening	|O
program	|O
for	|O
low	|O
-	|O
income	|O
women	|O
.	|O

SAMPLE	|O
POPULATION	|O
:	|O
MCB	|O
from	|O
7	|O
racing	|O
Greyhounds	|O
euthanatized	|O
for	|O
reasons	|O
unrelated	|O
to	|O
MCB	|O
abnormalities	|O
.	|O

CONCLUSIONS	|O
AND	|O
CLINICAL	|O
RELEVANCE	|O
:	|O
Increased	|O
cortical	|O
thickness	|O
and	|O
geometric	|O
properties	|O
of	|O
left	|O
MCB	|O
-	|O
IV	|O
and	|O
-	|O
V	|O
of	|O
Greyhounds	|O
,	|O
together	|O
with	|O
altered	|O
turnover	|O
and	|O
orientation	|O
of	|O
osteons	|O
in	|O
the	|O
dorsal	|O
quadrants	|O
of	|O
left	|O
MCB	|O
,	|O
are	|O
site	|O
-	|O
specific	|O
adaptive	|O
responses	|O
associated	|O
with	|O
asymmetric	|O
cyclic	|O
loading	|O
as	|O
a	|O
result	|O
of	|O
racing	|O
on	|O
circular	|O
tracks	|O
.	|O

Linear	|O
eight	|O
-	|O
or	|O
nine	|O
-	|O
residue	|O
D	|O
-	|O
peptides	|O
derived	|O
from	|O
the	|O
pocket	|O
-	|O
binding	|O
domain	|O
of	|O
the	|O
cyclic	|O
molecules	|O
also	|O
bind	|O
specifically	|O
.	|O

METHODS	|O
AND	|O
RESULTS	|O
:	|O
Palmaz	|O
-	|O
Schatz	|O
stents	|O
were	|O
dip	|O
-	|O
coated	|O
with	|O
paclitaxel	|O
(	|O
0	|O
,	|O
0.2	|O
,	|O
15	|O
,	|O
or	|O
187	|O
microgram	|O
/	|O
stent	|O
)	|O
by	|O
immersion	|O
in	|O
ethanolic	|O
paclitaxel	|O
and	|O
evaporation	|O
of	|O
the	|O
solvent	|O
.	|O

Percentages	|O
of	|O
recovery	|O
for	|O
overload	|O
and	|O
dilution	|O
tests	|O
were	|O
between	|O
87	|O
and	|O
120%	|O
.	|O

One	|O
of	|O
the	|O
conserved	|O
RNA	|O
subdomains	|O
,	|O
designated	|O
P3	|B-PROTEIN
,	|O
has	|O
previously	|O
been	|O
shown	|O
to	|O
be	|O
required	|O
for	|O
nucleolar	|O
localization	|O
.	|O

In	|O
Cd	|O
-	|O
spiked	|O
OECD	|O
soil	|O
,	|O
internal	|O
Cd	|O
levels	|O
were	|O
linearly	|O
related	|O
to	|O
external	|O
Cd	|O
concentrations	|O
,	|O
whereas	|O
the	|O
springtails	|O
maintained	|O
fixed	|O
internal	|O
levels	|O
of	|O
Cu	|O
and	|O
Zn	|O
regardless	|O
of	|O
spiked	|O
concentrations	|O
.	|O

Nutritional	|O
status	|O
in	|O
adults	|O
on	|O
an	|O
alternative	|O
or	|O
traditional	|O
diet	|O
]	|O
BACKGROUND	|O
:	|O
Plant	|O
food	|O
lacks	|O
vitamin	|O
B12	|O
,	|O
vitamin	|O
D	|O
and	|O
higher	|O
n	|O
-	|O
3	|O
polyunsaturated	|O
fatty	|O
acids	|O
.	|O

It	|O
is	|O
useful	|O
as	|O
an	|O
adjunct	|O
to	|O
mammography	|O
in	|O
those	|O
patients	|O
with	|O
radiographically	|O
dense	|O
breasts	|O
for	|O
the	|O
characterization	|O
of	|O
palpable	|O
masses	|O
.	|O

Measurements	|O
were	|O
obtained	|O
:	|O
(	|O
i	|O
)	|O
just	|O
after	|O
the	|O
traumatic	|O
exposure	|O
(	|O
D0	|O
)	|O
;	|O
(	|O
ii	|O
)	|O
3	|O
days	|O
after	|O
this	|O
first	|O
measurement	|O
(	|O
D3	|O
)	|O
;	|O
and	|O
(	|O
iii	|O
)	|O
30	|O
days	|O
after	|O
(	|O
D30	|O
)	|O
.	|O

Here	|O
we	|O
present	|O
evidence	|O
that	|O
the	|O
distal	|O
half	|O
(	|O
Stem	|O
2	|O
)	|O
of	|O
the	|O
conserved	|O
base	|O
-	|O
paired	|O
stem	|O
structure	|O
found	|O
in	|O
all	|O
hY	|B-PROTEIN
RNAs	|O
also	|O
plays	|O
a	|O
critical	|O
role	|O
in	|O
the	|O
export	|O
process	|O
.	|O

Changes	|O
of	|O
the	|O
DB	|O
sequence	|O
without	|O
affecting	|O
the	|O
postulated	|O
stem	|O
structure	|O
led	|O
to	|O
drastic	|O
losses	|O
of	|O
translation	|O
efficiency	|O
.	|O

It	|O
has	|O
been	|O
suggested	|O
that	|O
members	|O
of	|O
this	|O
protein	|O
family	|O
exhibit	|O
both	|O
prolyl	|B-PROTEIN
isomerase	|I-PROTEIN
and	|O
chaperone	|O
activity	|O
.	|O

Inhibition	|O
of	|O
the	|O
Raf	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
target	|O
ERK	|B-PROTEIN
kinase	|O
(	|O
MEK	|B-PROTEIN
)	|O
either	|O
attenuated	|O
or	|O
abolished	|O
Rp	|O
-	|O
cAMPS	|O
-	|O
and	|O
PKI	|B-PROTEIN
-	|O
induced	|O
ERK	|B-PROTEIN
activation	|O
,	|O
caldesmon	|B-PROTEIN
phosphorylation	|O
,	|O
and	|O
stress	|O
fiber	|O
formation	|O
.	|O

PACAP	|B-PROTEIN
mRNA	|O
was	|O
widely	|O
expressed	|O
in	|O
most	|O
human	|O
tissues	|O
;	|O
in	|O
transfected	|O
cells	|O
,	|O
PACAP	|B-PROTEIN
was	|O
diffusely	|O
expressed	|O
in	|O
the	|O
cytoplasm	|O
.	|O

Here	|O
we	|O
provide	|O
the	|O
first	|O
evidence	|O
for	|O
the	|O
involvement	|O
of	|O
GCN1	|B-PROTEIN
-	|O
GCN2	|B-PROTEIN
interaction	|O
in	|O
activation	|O
of	|O
GCN2	|B-PROTEIN
per	|O
se	|O
.	|O

The	|O
radial	|O
forearm	|O
flap	|O
is	|O
used	|O
most	|O
commonly	|O
,	|O
however	|O
the	|O
lateral	|O
arm	|O
flap	|O
may	|O
be	|O
the	|O
flap	|O
of	|O
choice	|O
in	|O
certain	|O
situations	|O
.	|O

By	|O
comparison	|O
,	|O
in	|O
nontumorigenic	|O
Ad5	|O
cells	|O
,	|O
class	|O
I	|O
expression	|O
is	|O
high	|O
due	|O
to	|O
negligible	|O
binding	|O
of	|O
COUP	|B-PROTEIN
-	|I-PROTEIN
TF	|I-PROTEIN
and	|O
strong	|O
binding	|O
of	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
.	|O

As	|O
an	|O
application	|O
of	|O
reverse	|O
genetics	|O
,	|O
we	|O
introduced	|O
one	|O
nucleotide	|O
change	|O
(	|O
UCU	|O
to	|O
ACU	|O
)	|O
to	|O
immediate	|O
downstream	|O
of	|O
the	|O
RNA	|O
-	|O
editing	|O
site	|O
of	|O
the	|O
V	|B-PROTEIN
gene	|O
in	|O
the	|O
full	|O
-	|O
length	|O
hPIV2	|O
cDNA	|O
and	|O
were	|O
able	|O
to	|O
obtain	|O
infectious	|O
viruses	|O
[	|O
rPIV2V	|O
(	|O
-	|O
)	|O
]	|O
from	|O
the	|O
cDNA	|O
.	|O

The	|O
frameshift	|O
initiated	|O
by	|O
ADEx2	|O
is	|O
believed	|O
to	|O
alter	|O
the	|O
regular	|O
coding	|O
sequence	|O
,	|O
acting	|O
as	|O
a	|O
loss	|O
-	|O
of	|O
-	|O
function	|O
ASIP	|B-PROTEIN
mutation	|O
.	|O

In	|O
regards	|O
to	|O
the	|O
latter	|O
activity	|O
,	|O
it	|O
has	|O
been	|O
shown	|O
that	|O
S3	|B-PROTEIN
contains	|O
vigorous	|O
N	|B-PROTEIN
-	|I-PROTEIN
glycosylase	|I-PROTEIN
activity	|O
for	|O
the	|O
removal	|O
of	|O
8	|O
-	|O
oxoguanine	|O
residues	|O
in	|O
DNA	|O
that	|O
leaves	|O
baseless	|O
sites	|O
in	|O
their	|O
places	|O
.	|O

Here	|O
we	|O
report	|O
the	|O
isolation	|O
and	|O
characterization	|O
of	|O
the	|O
forkhead	|B-PROTEIN
homologue	|O
in	|O
rhabdomyosarcoma	|O
(	|O
FKHR	|B-PROTEIN
)	|O
,	|O
a	|O
recently	|O
described	|O
member	|O
of	|O
the	|O
hepatocyte	|B-PROTEIN
nuclear	|I-PROTEIN
factor	|I-PROTEIN
3	|I-PROTEIN
/	|O
forkhead	|B-PROTEIN
homeotic	|O
gene	|O
family	|O
,	|O
as	|O
a	|O
nuclear	|B-PROTEIN
hormone	|I-PROTEIN
receptor	|I-PROTEIN
(	|O
NR	|B-PROTEIN
)	|O
intermediary	|O
protein	|O
.	|O

The	|O
improved	|O
CSF	|O
outflow	|O
conductance	|O
may	|O
increase	|O
the	|O
intracranial	|O
compliance	|O
and	|O
thereby	|O
dampen	|O
a	|O
pathological	|O
ICP	|O
waveform	|O
.	|O

A	|O
new	|O
species	|O
of	|O
Euspondylus	|O
is	|O
described	|O
based	|O
on	|O
a	|O
female	|O
(	|O
taken	|O
within	|O
a	|O
bromeliad	|O
)	|O
from	|O
Cerro	|O
El	|O
Humo	|O
,	|O
Sucre	|O
,	|O
northeastern	|O
Venezuela	|O
.	|O

The	|O
cyclins	|B-PROTEIN
bind	|O
to	|O
and	|O
activate	|O
the	|O
CDK	|B-PROTEIN
,	|O
which	|O
leads	|O
to	|O
phosphorylation	|O
(	|O
and	|O
then	|O
inhibition	|O
)	|O
of	|O
the	|O
tumor	|O
suppressor	|O
protein	|O
,	|O
pRb	|B-PROTEIN
.	|O
pRb	|B-PROTEIN
controls	|O
commitment	|O
to	|O
progress	|O
from	|O
the	|O
G1	|O
to	|O
S	|O
phase	|O
,	|O
at	|O
least	|O
in	|O
part	|O
by	|O
repressing	|O
the	|O
activity	|O
of	|O
the	|O
E2F	|B-PROTEIN
transcription	|O
factors	|O
known	|O
to	|O
promote	|O
cell	|O
proliferation	|O
.	|O

Additional	|O
education	|O
and	|O
research	|O
is	|O
needed	|O
to	|O
provide	|O
further	|O
direction	|O
for	|O
intervention	|O
and	|O
incorporation	|O
into	|O
practice	|O
.	|O

Proliferative	|O
vasculopathy	|O
and	|O
cutaneous	|O
hemorrhages	|O
in	|O
porcine	|O
neonates	|O
infected	|O
with	|O
the	|O
porcine	|O
reproductive	|O
and	|O
respiratory	|O
syndrome	|O
virus	|O
.	|O

The	|O
difference	|O
of	|O
hardness	|O
over	|O
time	|O
of	|O
composite	|O
specimens	|O
was	|O
measured	|O
using	|O
Knoop	|O
hardness	|O
measurements	|O
taken	|O
at	|O
the	|O
top	|O
and	|O
bottom	|O
surfaces	|O
of	|O
resin	|O
specimens	|O
made	|O
in	|O
a	|O
Teflon	|O
mold	|O
the	|O
same	|O
dimensions	|O
as	|O
the	|O
cavity	|O
prepared	|O
in	|O
dentin	|O
.	|O

An	|O
18	|O
-	|O
kb	|O
genomic	|O
clone	|O
including	|O
sequences	|O
encoding	|O
for	|O
the	|O
two	|O
GHS	|B-PROTEIN
-	|I-PROTEIN
R	|I-PROTEIN
variants	|O
was	|O
isolated	|O
.	|O

Saccharomyces	|O
cerevisiae	|O
activates	|O
a	|O
regulatory	|O
network	|O
called	|O
"	|O
general	|O
control	|O
"	|O
that	|O
provides	|O
the	|O
cell	|O
with	|O
sufficient	|O
amounts	|O
of	|O
protein	|O
precursors	|O
during	|O
amino	|O
acid	|O
starvation	|O
.	|O

In	|O
Ka13	|O
cells	|O
,	|O
CoCl	|O
(	|O
2	|O
)	|O
stimulated	|O
expression	|O
of	|O
a	|O
luciferase	|B-PROTEIN
reporter	|O
gene	|O
under	|O
the	|O
control	|O
of	|O
a	|O
15	|O
-	|O
kilobase	|O
pair	|O
mouse	|O
ho	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
promoter	|O
(	|O
pHO15luc	|B-PROTEIN
)	|O
.	|O

Mutation	|O
analyses	|O
identified	|O
the	|O
cobalt	|O
-	|O
responsive	|O
sequences	|O
as	|O
the	|O
stress	|O
-	|O
response	|O
elements	|O
(	|O
StREs	|O
)	|O
.	|O

Members	|O
of	|O
the	|O
AP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
superfamily	|O
of	|O
basic	|B-PROTEIN
-	|I-PROTEIN
leucine	|I-PROTEIN
zipper	|I-PROTEIN
factors	|I-PROTEIN
bind	|O
to	|O
the	|O
StRE	|O
.	|O

Descriptions	|O
of	|O
this	|O
locus	|O
would	|O
allow	|O
comparison	|O
with	|O
functionally	|O
relevant	|O
molecular	|O
genetic	|O
features	|O
of	|O
other	|O
species	|O
'	|O
homologous	|O
loci	|O
including	|O
the	|O
single	|O
-	|O
copy	|O
equid	|O
LH	|B-PROTEIN
/	|O
CGbeta	|B-PROTEIN
gene	|O
and	|O
the	|O
primate	|O
LHbeta	|B-PROTEIN
-	|O
CGbeta	|B-PROTEIN
gene	|O
cluster	|O
locus	|O
.	|O

Like	|O
the	|O
consensus	|O
mammalian	|O
LHbeta	|B-PROTEIN
gene	|O
,	|O
the	|O
5'	|O
-	|O
flanking	|O
region	|O
of	|O
the	|O
gpLH	|B-PROTEIN
/	|O
CGbeta	|B-PROTEIN
gene	|O
contains	|O
a	|O
single	|O
TATA	|O
sequence	|O
37	|O
bp	|O
upstream	|O
of	|O
the	|O
translation	|O
start	|O
codon	|O
.	|O

This	|O
shows	|O
that	|O
in	|O
situations	|O
of	|O
separated	|O
breaks	|O
,	|O
NHEJ	|O
deficiency	|O
leads	|O
to	|O
genomic	|O
rearrangements	|O
,	|O
in	|O
agreement	|O
with	|O
chromosomal	|O
studies	|O
.	|O

Expression	|O
of	|O
human	|O
RACK1	|B-PROTEIN
efficiently	|O
relieves	|O
E1A	|B-PROTEIN
-	|O
mediated	|O
growth	|O
inhibition	|O
in	|O
HF7c	|O
and	|O
protects	|O
human	|O
tumor	|O
cells	|O
from	|O
E1A	|B-PROTEIN
-	|O
induced	|O
apoptosis	|O
.	|O

Foxp1	|B-PROTEIN
and	|O
Foxp2	|B-PROTEIN
are	|O
expressed	|O
at	|O
high	|O
levels	|O
in	|O
the	|O
lung	|O
as	|O
early	|O
as	|O
E12.5	|O
of	|O
mouse	|O
development	|O
with	|O
Foxp2	|B-PROTEIN
expression	|O
restricted	|O
to	|O
the	|O
airway	|O
epithelium	|O
.	|O

Molecular	|O
analysis	|O
of	|O
the	|O
pRA2	|O
partitioning	|O
region	|O
:	|O
ParB	|B-PROTEIN
autoregulates	|O
parAB	|B-PROTEIN
transcription	|O
and	|O
forms	|O
a	|O
nucleoprotein	|O
complex	|O
with	|O
the	|O
plasmid	|O
partition	|O
site	|O
,	|O
parS	|B-PROTEIN
.	|O

Immunological	|O
and	|O
biochemical	|O
characterization	|O
of	|O
streptococcal	|B-PROTEIN
pyrogenic	|I-PROTEIN
exotoxins	|I-PROTEIN
I	|I-PROTEIN
and	|I-PROTEIN
J	|I-PROTEIN
(	|O
SPE	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
and	|O
SPE	|B-PROTEIN
-	|I-PROTEIN
J	|I-PROTEIN
)	|O
from	|O
Streptococcus	|O
pyogenes	|O
.	|O

Several	|O
dozen	|O
HIF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
targets	|O
are	|O
known	|O
,	|O
including	|O
the	|O
gene	|O
encoding	|O
vascular	|B-PROTEIN
endothelial	|I-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
(	|O
VEGF	|B-PROTEIN
)	|O
.	|O

We	|O
previously	|O
reported	|O
that	|O
Tax	|B-PROTEIN
induced	|O
cell	|O
cycle	|O
progression	|O
from	|O
G0	|O
/	|O
G1	|O
phase	|O
to	|O
S	|O
and	|O
G2	|O
/	|O
M	|O
phases	|O
in	|O
human	|O
T	|O
-	|O
cell	|O
line	|O
Kit	|O
225	|O
cells	|O
.	|O

Most	|O
yeast	|O
peroxisomal	|B-PROTEIN
matrix	|I-PROTEIN
proteins	|I-PROTEIN
contain	|O
a	|O
type	|O
1C	|O
-	|O
terminal	|O
peroxisomal	|O
targeting	|O
signal	|O
(	|O
PTS1	|O
)	|O
consisting	|O
of	|O
the	|O
tripeptide	|O
SKL	|O
or	|O
a	|O
conservative	|O
variant	|O
thereof	|O
.	|O

Here	|O
,	|O
the	|O
PEX5	|B-PROTEIN
-	|O
TPR	|B-PROTEIN
domains	|I-PROTEIN
from	|O
human	|O
,	|O
tobacco	|O
,	|O
and	|O
nematode	|O
were	|O
inserted	|O
into	|O
a	|O
TPR	|O
-	|O
less	|O
yeast	|O
Pex5p	|B-PROTEIN
construct	|O
to	|O
generate	|O
Pex5p	|B-PROTEIN
chimaeras	|O
.	|O

HIV	|O
-	|O
1	|O
and	|O
hepatitis	|O
B	|O
virus	|O
infections	|O
in	|O
adolescents	|O
lodged	|O
in	|O
security	|O
institutes	|O
of	|O
Buenos	|O
Aires	|O
.	|O

Immunofixation	|O
experiments	|O
of	|O
C4A	|B-PROTEIN
and	|O
C4B	|B-PROTEIN
demonstrate	|O
>	|O
41	|O
allotypes	|O
in	|O
the	|O
two	|O
classes	|O
of	|O
proteins	|O
.	|O

However	|O
,	|O
C4B	|B-PROTEIN
proteins	|O
encoded	|O
by	|O
monomodular	|O
short	|O
genes	|O
may	|O
have	|O
relatively	|O
higher	|O
concentrations	|O
than	|O
those	|O
from	|O
long	|O
C4A	|B-PROTEIN
genes	|O
.	|O

In	|O
the	|O
course	|O
of	|O
screening	|O
for	|O
transcription	|O
factors	|O
which	|O
interact	|O
with	|O
the	|O
human	|O
myeloperoxidase	|B-PROTEIN
(	|O
MPO	|B-PROTEIN
)	|O
promoter	|O
we	|O
,	|O
for	|O
the	|O
first	|O
time	|O
,	|O
identified	|O
and	|O
cloned	|O
the	|O
cDNA	|O
and	|O
genomic	|O
DNA	|O
for	|O
human	|O
HBP1	|B-PROTEIN
(	|O
HMG	|B-PROTEIN
-	|I-PROTEIN
Box	|I-PROTEIN
containing	|I-PROTEIN
protein	|I-PROTEIN
1	|I-PROTEIN
)	|O
,	|O
a	|O
member	|O
of	|O
the	|O
high	|B-PROTEIN
mobility	|I-PROTEIN
group	|I-PROTEIN
of	|O
non	|O
-	|O
histone	|O
chromosomal	|O
proteins	|O
.	|O

The	|O
human	|O
protein	|O
sequence	|O
exhibits	|O
a	|O
putative	|O
DNA	|O
-	|O
binding	|O
domain	|O
similar	|O
to	|O
that	|O
seen	|O
in	|O
rat	|O
HBP1	|B-PROTEIN
and	|O
shows	|O
homology	|O
with	|O
the	|O
activation	|O
and	|O
repressor	|O
domains	|O
previously	|O
demonstrated	|O
in	|O
the	|O
rat	|O
protein	|O
.	|O

Promoter	|O
transcriptional	|O
activity	|O
was	|O
determined	|O
for	|O
a	|O
wide	|O
5'	|O
portion	|O
of	|O
the	|O
human	|O
annexin	|B-PROTEIN
A5	|I-PROTEIN
gene	|O
,	|O
from	|O
bp	|O
-	|O
1275	|O
to	|O
+	|O
79	|O
relative	|O
to	|O
the	|O
most	|O
5'	|O
of	|O
several	|O
discrete	|O
transcription	|O
start	|O
points	|O
.	|O

In	|O
contrast	|O
the	|O
human	|O
and	|O
mouse	|O
BCNT	|B-PROTEIN
proteins	|O
contain	|O
one	|O
repeat	|O
unit	|O
and	|O
lack	|O
the	|O
RTE	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
-	|O
derived	|O
portion	|O
.	|O

Molecular	|O
identification	|O
of	|O
smg	|B-PROTEIN
-	|I-PROTEIN
4	|I-PROTEIN
,	|O
required	|O
for	|O
mRNA	|O
surveillance	|O
in	|O
C.	|O
elegans	|O
.	|O

Two	|O
remotely	|O
situated	|O
exons	|O
within	|O
the	|O
complement	|O
C3	|B-PROTEIN
gene	|O
locus	|O
encode	|O
an	|O
alternate	|O
5'	|O
end	|O
and	|O
proximal	|O
ORF	|O
under	|O
the	|O
control	|O
of	|O
a	|O
bidirectional	|O
promoter	|O
.	|O

CONCLUSIONS	|O
:	|O
Adding	|O
MMF	|O
,	|O
a	|O
potent	|O
topical	|O
corticosteroid	|O
,	|O
to	|O
an	|O
emollient	|O
cream	|O
is	|O
statistically	|O
significantly	|O
more	|O
effective	|O
than	|O
emollient	|O
cream	|O
alone	|O
in	|O
reducing	|O
acute	|O
radiation	|O
dermatitis	|O
.	|O

Recent	|O
advances	|O
have	|O
shown	|O
that	|O
volatile	|O
sulfur	|O
is	|O
a	|O
result	|O
of	|O
ecological	|O
interactions	|O
and	|O
transformation	|O
processes	|O
through	|O
planktonic	|O
food	|O
webs	|O
.	|O

The	|O
first	|O
hypothesis	|O
was	|O
supported	|O
in	|O
the	|O
sense	|O
that	|O
stimulus	|O
differences	|O
might	|O
affect	|O
behaviour	|O
even	|O
without	|O
their	|O
successful	|O
attentive	|O
processing	|O
in	|O
normal	|O
participants	|O
.	|O

There	|O
was	|O
an	|O
increase	|O
in	|O
protein	|O
binding	|O
onto	|O
this	|O
element	|O
only	|O
after	|O
peptide	|O
treatment	|O
.	|O

CSR	|O
is	|O
directed	|O
to	|O
specific	|O
heavy	|O
chain	|O
isotypes	|O
by	|O
cytokines	|O
and	|O
B	|O
cell	|O
activators	|O
that	|O
induce	|O
transcription	|O
from	|O
the	|O
unrearranged	|O
,	|O
or	|O
germline	|O
(	|O
GL	|O
)	|O
,	|O
C	|B-PROTEIN
(	|I-PROTEIN
H	|I-PROTEIN
)	|I-PROTEIN
region	|O
genes	|O
.	|O

In	|O
this	|O
manuscript	|O
we	|O
demonstrate	|O
that	|O
two	|O
tandem	|O
Ets	|B-PROTEIN
sites	|O
in	|O
the	|O
mouse	|O
GL	|B-PROTEIN
alpha	|I-PROTEIN
promoter	|O
bind	|O
the	|O
transcription	|O
factors	|O
Elf	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
and	|O
PU.1	|B-PROTEIN
,	|O
and	|O
that	|O
the	|O
3'	|O
site	|O
is	|O
essential	|O
for	|O
expression	|O
of	|O
a	|O
luciferase	|B-PROTEIN
reporter	|O
gene	|O
driven	|O
by	|O
the	|O
GL	|B-PROTEIN
alpha	|I-PROTEIN
promoter	|O
.	|O

Cell.	|O

The	|O
mean	|O
serum	|O
creatinine	|O
level	|O
did	|O
not	|O
change	|O
during	|O
the	|O
first	|O
6	|O
months	|O
after	|O
withdrawal	|O
of	|O
MMF	|O
.	|O

The	|O
proportion	|O
of	|O
the	|O
biopsies	|O
found	|O
to	|O
be	|O
seropositive	|O
for	|O
HBs	|B-PROTEIN
antigen	|I-PROTEIN
was	|O
27.9%	|O
,	|O
and	|O
these	|O
showed	|O
either	|O
MGN	|O
or	|O
MPGN	|O
pattern	|O
.	|O

They	|O
correspond	|O
to	|O
nucleotides	|O
equivalent	|O
to	|O
base	|O
-	|O
pair	|O
C1	|O
-	|O
G72	|O
and	|O
discriminator	|O
base	|O
A73	|O
in	|O
the	|O
amino	|O
acid	|O
-	|O
acceptor	|O
branch	|O
of	|O
the	|O
molecule	|O
.	|O

This	|O
domain	|O
without	|O
the	|O
canonical	|O
anticodon	|O
loop	|O
or	|O
the	|O
tyrosine	|O
anticodon	|O
acts	|O
as	|O
an	|O
anchor	|O
for	|O
TyrRS	|B-PROTEIN
interaction	|O
leading	|O
to	|O
a	|O
better	|O
efficiency	|O
of	|O
tyrosylation	|O
.	|O

During	|O
most	|O
of	|O
the	|O
cell	|O
cycle	|O
,	|O
separase	|B-PROTEIN
is	|O
kept	|O
inactive	|O
by	|O
binding	|O
to	|O
an	|O
inhibitory	|O
protein	|O
called	|O
securin	|B-PROTEIN
.	|O

Mechanical	|O
ventilation	|O
in	|O
control	|O
lungs	|O
produced	|O
a	|O
47%	|O
decrease	|O
in	|O
chord	|O
compliance	|O
,	|O
an	|O
increase	|O
in	|O
lung	|O
lavage	|O
levels	|O
of	|O
tumor	|O
necrosis	|O
factor	|O
(	|B-PROTEIN
TNF	|I-PROTEIN
)	|I-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
(	|O
722	|O
+	|O
/	|O
-	|O
306	|O
pg	|O
/	|O
ml	|O
)	|O
,	|O
interleukin	|O
(	|B-PROTEIN
IL	|I-PROTEIN
)	|I-PROTEIN
-	|I-PROTEIN
1beta	|I-PROTEIN
(	|O
902	|O
+	|O
/	|O
-	|O
322	|O
pg	|O
/	|O
ml	|O
)	|O
,	|O
and	|O
macrophage	|B-PROTEIN
inflammatory	|I-PROTEIN
protein	|I-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
(	|O
MIP	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
)	|O
(	|O
363	|O
+	|O
/	|O
-	|O
104	|O
pg	|O
/	|O
ml	|O
)	|O
as	|O
compared	|O
with	|O
low	|O
levels	|O
of	|O
cytokines	|O
detected	|O
in	|O
preventilation	|O
data	|O
,	|O
and	|O
no	|O
change	|O
in	|O
percentage	|O
of	|O
surfactant	|O
large	|O
aggregates	|O
(	|O
LA	|O
)	|O
.	|O

Maternal	|O
p	|O
,	|O
p	|O
'	|O
DDE	|O
and	|O
beta	|O
-	|O
HCH	|O
levels	|O
were	|O
also	|O
associated	|O
with	|O
newborn	|O
levels	|O
,	|O
but	|O
levels	|O
of	|O
PCBs	|O
were	|O
not	|O
.	|O

Multiple	|O
regression	|O
analysis	|O
performed	|O
between	|O
these	|O
long	|O
-	|O
term	|O
abiotic	|O
factors	|O
and	|O
nymphal	|O
abundance	|O
in	|O
positive	|O
sites	|O
showed	|O
high	|O
relationship	|O
(	|O
R2	|O
coefficients	|O
)	|O
for	|O
every	|O
habitat	|O
category	|O
and	|O
explained	|O
>	|O
50%	|O
of	|O
the	|O
variation	|O
in	|O
tick	|O
abundance	|O
.	|O

In	|O
summary	|O
,	|O
we	|O
conclude	|O
that	|O
the	|O
adenoviral	|O
oncoprotein	|O
E1A	|B-PROTEIN
activates	|O
transcription	|O
from	|O
the	|O
endogenous	|O
AP	|B-PROTEIN
-	|I-PROTEIN
2alpha	|I-PROTEIN
gene	|O
,	|O
an	|O
effect	|O
that	|O
involves	|O
transcriptional	|O
derepression	|O
of	|O
the	|O
AP	|B-PROTEIN
-	|I-PROTEIN
2alpha	|I-PROTEIN
promoter	|O
by	|O
interaction	|O
of	|O
E1A	|B-PROTEIN
with	|O
the	|O
AP	|B-PROTEIN
-	|I-PROTEIN
2rep	|I-PROTEIN
corepressor	|O
CtBP1	|B-PROTEIN
.	|O

Additional	|O
factors	|O
such	|O
as	|O
advanced	|O
age	|O
,	|O
concomitant	|O
use	|O
of	|O
corticosteroids	|O
or	|O
anticoagulants	|O
,	|O
prior	|O
ulcer	|O
complications	|O
and	|O
co	|O
-	|O
morbid	|O
diseases	|O
may	|O
further	|O
increase	|O
the	|O
risk	|O
of	|O
bleeding	|O
.	|O

SERS	|O
spectra	|O
were	|O
obtained	|O
by	|O
vacuum	|O
evaporation	|O
and	|O
casting	|O
of	|O
p	|O
-	|O
NTP	|O
onto	|O
silver	|O
island	|O
films	|O
,	|O
and	|O
also	|O
from	|O
colloidal	|O
silver	|O
solutions	|O
.	|O

Copyright	|O
2001	|O
Academic	|O
Press	|O
.	|O

The	|O
core	|O
promoter	|O
of	|O
human	|O
thioredoxin	|B-PROTEIN
reductase	|I-PROTEIN
1	|I-PROTEIN
:	|O
cloning	|O
,	|O
transcriptional	|O
activity	|O
,	|O
and	|O
Oct	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
Sp1	|B-PROTEIN
,	|O
and	|O
Sp3	|B-PROTEIN
binding	|O
reveal	|O
a	|O
housekeeping	|O
-	|O
type	|O
promoter	|O
for	|O
the	|O
AU	|O
-	|O
rich	|O
element	|O
-	|O
regulated	|O
gene	|O
.	|O

Here	|O
we	|O
show	|O
that	|O
phosphorylation	|O
-	|O
induced	|O
loss	|O
of	|O
the	|O
protein	|O
kinase	|O
activity	|O
of	|O
DNA	|B-PROTEIN
-	|I-PROTEIN
PK	|I-PROTEIN
is	|O
restored	|O
by	|O
the	|O
addition	|O
of	|O
the	|O
purified	|O
catalytic	|O
subunit	|O
of	|O
either	|O
protein	|B-PROTEIN
phosphatase	|I-PROTEIN
1	|I-PROTEIN
or	|O
protein	|B-PROTEIN
phosphatase	|I-PROTEIN
2A	|I-PROTEIN
(	|O
PP2A	|B-PROTEIN
)	|O
and	|O
that	|O
this	|O
reactivation	|O
is	|O
blocked	|O
by	|O
the	|O
potent	|O
protein	|O
phosphatase	|O
inhibitor	|O
,	|O
microcystin	|O
.	|O

The	|O
first	|O
exon	|O
(	|O
exon	|O
1A	|O
)	|O
that	|O
corresponded	|O
to	|O
the	|O
5'	|O
-	|O
untranslated	|O
region	|O
of	|O
the	|O
GHR	|B-PROTEIN
1A	|O
mRNA	|O
was	|O
15,250	|O
bp	|O
upstream	|O
from	|O
exon	|O
2	|O
in	|O
the	|O
GHR	|B-PROTEIN
gene	|O
.	|O

These	|O
corrections	|O
do	|O
not	|O
involve	|O
sequences	|O
predicted	|O
to	|O
function	|O
as	|O
transcription	|O
factor	|O
binding	|O
sites	|O
.	|O

FLP	|B-PROTEIN
and	|O
Cre	|B-PROTEIN
recombinase	|O
function	|O
in	|O
Xenopus	|O
embryos	|O
.	|O

A	|O
method	|O
of	|O
three	|O
-	|O
station	|O
three	|O
-	|O
dimensional	|O
magnetic	|O
resonance	|O
(	|O
MR	|O
)	|O
angiography	|O
of	|O
the	|O
lower	|O
extremities	|O
with	|O
segmented	|O
volume	|O
acquisition	|O
is	|O
presented	|O
.	|O

A	|O
single	|O
nucleotide	|O
polymorphism	|O
(	|O
SNP	|O
)	|O
in	|O
exon	|O
2	|O
,	|O
which	|O
is	|O
tightly	|O
liked	|O
to	|O
another	|O
SNP	|O
(	|O
GTG83	|O
/	|O
ATG83	|O
)	|O
,	|O
creates	|O
an	|O
additional	|O
alternative	|O
in	|O
-	|O
frame	|O
AUG	|O
in	|O
B	|O
-	|O
type	|O
MTH1	|B-PROTEIN
mRNAs	|O
yielding	|O
the	|O
fourth	|O
MTH1	|B-PROTEIN
polypeptide	|O
,	|O
p26	|B-PROTEIN
that	|O
possesses	|O
an	|O
additional	|O
mitochondrial	|O
targeting	|O
signal	|O
.	|O

Our	|O
previous	|O
studies	|O
have	|O
shown	|O
that	|O
SHP	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
a	|O
SH2	|B-PROTEIN
domain	|O
-	|O
containing	|O
protein	|O
-	|O
tyrosine	|O
phosphatase	|O
,	|O
is	|O
expressed	|O
not	|O
only	|O
in	|O
cells	|O
of	|O
hematopoietic	|O
lineages	|O
,	|O
but	|O
also	|O
in	|O
many	|O
non	|O
-	|O
hematopoietic	|O
cells	|O
under	|O
the	|O
control	|O
of	|O
an	|O
alternative	|O
tissue	|O
-	|O
specific	|O
promoter	|O
,	|O
P1	|O
.	|O

Unexpectedly	|O
,	|O
Arg1	|B-PROTEIN
-	|O
expressing	|O
COS1	|O
cells	|O
showed	|O
no	|O
significant	|O
proteinase	|O
activity	|O
to	|O
various	|O
synthesized	|O
substrates	|O
under	|O
neutral	|O
or	|O
acidic	|O
conditions	|O
in	|O
this	|O
study	|O
.	|O

ORF1	|O
(	|O
1029	|O
bp	|O
;	|O
EMBL	|O
databank	|O
,	|O
Accession	|O
No	|O
.	|O

In	|O
the	|O
meantime	|O
,	|O
one	|O
has	|O
succeeded	|O
to	|O
establish	|O
the	|O
deammonification	|O
processes	|O
in	|O
a	|O
continuous	|O
flow	|O
moving	|O
-	|O
bed	|O
pilot	|O
plant	|O
.	|O

The	|O
purpose	|O
of	|O
this	|O
study	|O
was	|O
to	|O
evaluate	|O
simplified	|O
methods	|O
for	|O
estimation	|O
of	|O
Technetium	|O
Tc	|O
99m	|O
(	|O
99mTc	|O
)	|O
-	|O
pentetate	|O
and	|O
orthoiodohippurate	|O
I	|O
131	|O
(	|O
131I	|O
-	|O
OIH	|O
)	|O
plasma	|O
clearance	|O
in	|O
dogs	|O
and	|O
cats	|O
with	|O
1	|O
and	|O
2	|O
blood	|O
samples	|O
.	|O

A	|O
patient	|O
is	|O
described	|O
with	|O
skin	|O
lesions	|O
resembling	|O
Kaposi	|O
's	|O
sarcoma	|O
(	|O
KS	|O
)	|O
.	|O

Interventions	|O
aimed	|O
at	|O
these	|O
specific	|O
mediators	|O
and	|O
processes	|O
may	|O
be	|O
successful	|O
in	|O
reducing	|O
the	|O
very	|O
significant	|O
human	|O
and	|O
economic	|O
costs	|O
of	|O
vascular	|O
access	|O
dysfunction	|O
.	|O

In	|O
addition	|O
,	|O
stonin	|B-PROTEIN
2	|I-PROTEIN
binds	|O
to	|O
the	|O
C2B	|O
domains	|O
of	|O
synaptotagmins	|B-PROTEIN
I	|I-PROTEIN
and	|I-PROTEIN
II	|I-PROTEIN
.	|O

This	|O
partial	|O
transection	|O
could	|O
permit	|O
vasopressin	|B-PROTEIN
to	|O
be	|O
secreted	|O
in	|O
response	|O
to	|O
a	|O
larger	|O
rise	|O
in	|O
plasma	|O
sodium	|O
concentration	|O
.	|O

In	|O
conclusion	|O
,	|O
USPIO	|O
-	|O
enhanced	|O
MRI	|O
data	|O
were	|O
capable	|O
to	|O
characterize	|O
tumor	|O
microvessel	|O
properties	|O
in	|O
this	|O
breast	|O
cancer	|O
model	|O
:	|O
microvascular	|O
permeability	|O
(	|O
determined	|O
using	|O
USPIO	|O
)	|O
correlated	|O
significantly	|O
with	|O
tumor	|O
grade	|O
.	|O

The	|O
images	|O
showed	|O
rapid	|O
,	|O
predominantly	|O
urinary	|O
excretion	|O
of	|O
99mTc	|O
ciprofloxacin	|O
,	|O
with	|O
low	|O
to	|O
absent	|O
brain	|O
,	|O
lung	|O
and	|O
bone	|O
marrow	|O
uptake	|O
and	|O
low	|O
liver	|O
uptake	|O
and	|O
excretion	|O
.	|O

To	|O
this	|O
end	|O
,	|O
an	|O
expression	|O
cassette	|O
consisting	|O
of	|O
the	|O
gene	|O
for	|O
a	|O
green	|B-PROTEIN
fluorescent	|I-PROTEIN
protein	|I-PROTEIN
(	|O
GFP	|B-PROTEIN
)	|O
flanked	|O
at	|O
its	|O
3'	|O
end	|O
by	|O
EAV	|O
-	|O
specific	|O
transcription	|O
-	|O
regulating	|O
sequences	|O
was	|O
constructed	|O
.	|O

However	|O
,	|O
the	|O
N63S	|O
mutation	|O
in	|O
the	|O
wild	|O
-	|O
type	|O
VP5	|B-PROTEIN
background	|O
increased	|O
the	|O
interaction	|O
,	|O
as	|O
judged	|O
by	|O
the	|O
beta	|B-PROTEIN
-	|I-PROTEIN
galactosidase	|I-PROTEIN
activity	|O
,	|O
by	|O
a	|O
factor	|O
of	|O
9	|O
relative	|O
to	|O
when	|O
the	|O
PR7	|O
mutation	|O
was	|O
present	|O
.	|O

In	|O
addition	|O
,	|O
severe	|O
vision	|O
loss	|O
can	|O
be	|O
seen	|O
with	|O
interferon	|B-PROTEIN
alfa	|I-PROTEIN
-	|I-PROTEIN
2b	|I-PROTEIN
-	|O
associated	|O
retinopathy	|O
.	|O

The	|O
mechanism	|O
of	|O
the	|O
induction	|O
of	|O
3beta	|B-PROTEIN
-	|I-PROTEIN
HSD	|I-PROTEIN
type	|I-PROTEIN
1	|I-PROTEIN
gene	|O
expression	|O
was	|O
further	|O
characterized	|O
in	|O
ZR	|O
-	|O
75-1	|O
human	|O
breast	|O
cancer	|O
cells	|O
.	|O

An	|O
integrated	|O
RTC	|O
algorithm	|O
for	|O
the	|O
urban	|O
wastewater	|O
system	|O
is	|O
formulated	|O
,	|O
the	|O
parameters	|O
of	|O
which	|O
are	|O
optimized	|O
using	|O
various	|O
global	|O
optimization	|O
routines	|O
.	|O

SKP1	|B-PROTEIN
-	|O
SnRK	|B-PROTEIN
protein	|O
kinase	|O
interactions	|O
mediate	|O
proteasomal	|O
binding	|O
of	|O
a	|O
plant	|O
SCF	|B-PROTEIN
ubiquitin	|I-PROTEIN
ligase	|I-PROTEIN
.	|O

PATIENTS	|O
AND	|O
METHODS	|O
:	|O
Between	|O
June	|O
1991	|O
and	|O
December	|O
1996	|O
,	|O
we	|O
administered	|O
the	|O
nucleoside	|O
analog	|O
2	|O
-	|O
chlorodeoxyadenosine	|O
(	|O
2	|O
-	|O
CDA	|O
)	|O
to	|O
73	|O
children	|O
with	|O
primary	|O
AML	|O
and	|O
20	|O
children	|O
with	|O
secondary	|O
AML	|O
or	|O
myelodysplastic	|O
syndrome	|O
(	|O
MDS	|O
)	|O
.	|O

The	|O
severity	|O
of	|O
pathologic	|O
changes	|O
increased	|O
with	|O
the	|O
magnitude	|O
of	|O
percussion	|O
.	|O

Experimental	|O
study	|O
of	|O
ta	|O
chengchi	|O
tang	|O
decoction	|O
for	|O
relieving	|O
lung	|O
injury	|O
during	|O
acute	|O
necrotizing	|O
pancreatitis	|O
]	|O
The	|O
objectives	|O
of	|O
the	|O
study	|O
were	|O
to	|O
investigate	|O
the	|O
changes	|O
of	|O
leukocyte	|O
adhesiveness	|O
and	|O
tumor	|B-PROTEIN
necrosis	|I-PROTEIN
factor	|I-PROTEIN
(	|O
TNF	|B-PROTEIN
)	|O
in	|O
the	|O
early	|O
stage	|O
of	|O
acute	|O
necrotizing	|O
pancreatitis	|O
(	|O
ANP	|O
)	|O
,	|O
to	|O
go	|O
further	|O
into	|O
the	|O
relation	|O
of	|O
those	|O
changes	|O
to	|O
lung	|O
injury	|O
of	|O
ANP	|O
,	|O
and	|O
to	|O
evaluate	|O
the	|O
prohibitive	|O
effect	|O
of	|O
ta	|O
chengchi	|O
tang	|O
Decoction	|O
on	|O
leukocyte	|O
adhesion	|O
and	|O
TNF	|B-PROTEIN
secretion	|O
.	|O

A	|O
variety	|O
of	|O
receptor	|O
-	|O
mediated	|O
signaling	|O
pathways	|O
are	|O
controlled	|O
by	|O
both	|O
positive	|O
and	|O
negative	|O
extracellular	|O
regulators	|O
.	|O

TT	|O
cells	|O
,	|O
a	|O
human	|O
MTC	|O
cell	|O
line	|O
expressing	|O
MEN	|O
2A	|O
type	|O
RET	|B-PROTEIN
,	|O
display	|O
transcriptionally	|O
active	|O
RelA	|B-PROTEIN
(	|I-PROTEIN
p65	|I-PROTEIN
)	|I-PROTEIN
in	|O
the	|O
nucleus	|O
.	|O

Inhibition	|O
of	|O
constitutive	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
activity	|O
results	|O
in	|O
cell	|O
death	|O
of	|O
TT	|O
cells	|O
and	|O
blocks	|O
focus	|O
formation	|O
induced	|O
by	|O
oncogenic	|O
forms	|O
of	|O
RET	|B-PROTEIN
in	|O
NIH	|O
3T3	|O
cells	|O
.	|O

Reciprocally	|O
,	|O
HMGI	|B-PROTEIN
-	|I-PROTEIN
C	|I-PROTEIN
expression	|O
also	|O
coordinately	|O
enhances	|O
PIAS3	|B-PROTEIN
-	|O
mediated	|O
repression	|O
of	|O
STAT3	|B-PROTEIN
-	|O
dependent	|O
transactivation	|O
.	|O

A	|O
central	|O
finding	|O
is	|O
the	|O
identification	|O
of	|O
a	|O
GC	|O
-	|O
rich	|O
sequence	|O
in	|O
the	|O
-	|O
99	|O
/	|O
-	|O
91	|O
Cp	|B-PROTEIN
region	|O
that	|O
is	|O
essential	|O
for	|O
oriPI	|O
-	|O
EBNA1	|B-PROTEIN
-	|O
independent	|O
as	|O
well	|O
as	|O
oriPI	|O
-	|O
EBNA1	|B-PROTEIN
-	|O
dependent	|O
activity	|O
of	|O
the	|O
promoter	|O
.	|O

Additional	|O
deletion	|O
mutations	|O
revealed	|O
a	|O
new	|O
,	|O
67	|O
-	|O
amino	|O
-	|O
acid	|O
functional	|O
domain	|O
within	|O
the	|O
proline	|O
-	|O
rich	|O
region	|O
of	|O
SLP	|B-PROTEIN
-	|I-PROTEIN
76	|I-PROTEIN
,	|O
which	|O
we	|O
have	|O
termed	|O
the	|O
P	|O
-	|O
1	|O
domain	|O
.	|O

Finally	|O
,	|O
profiling	|O
of	|O
a	|O
gcn4Delta	|B-PROTEIN
mutant	|O
uncovered	|O
an	|O
alternative	|O
induction	|O
pathway	|O
operating	|O
at	|O
many	|O
Gcn4p	|B-PROTEIN
target	|O
genes	|O
in	|O
histidine	|O
-	|O
starved	|O
cells	|O
.	|O

Evidence	|O
from	|O
a	|O
Northern	|O
hybridization	|O
indicated	|O
that	|O
jadM	|B-PROTEIN
expression	|O
is	|O
correlated	|O
with	|O
jadomycin	|B-PROTEIN
B	|I-PROTEIN
synthesis	|O
.	|O

Right	|O
LHR	|O
(	|O
R	|O
-	|O
LHR	|O
)	|O
provided	|O
the	|O
best	|O
interobserver	|O
and	|O
intraobserver	|O
reproducibility	|O
.	|O

CONCLUSIONS	|O
:	|O
The	|O
methodology	|O
of	|O
LHR	|O
measurement	|O
significantly	|O
influences	|O
the	|O
clinical	|O
contribution	|O
of	|O
Tl	|O
-	|O
201	|O
lung	|O
uptake	|O
evaluation	|O
.	|O

Mutation	|O
of	|O
the	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
site	|O
in	|O
the	|O
Mdr1b	|B-PROTEIN
promoter	|O
prevents	|O
its	|O
induction	|O
by	|O
TNF	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
.	|O

To	|O
determine	|O
the	|O
genomic	|O
complexity	|O
of	|O
the	|O
deleted	|O
region	|O
shared	|O
among	|O
tumors	|O
,	|O
we	|O
assembled	|O
a	|O
physical	|O
map	|O
of	|O
the	|O
I	|O
Mbp	|O
SRO	|O
consisting	|O
predominantly	|O
of	|O
bacteriophage	|O
P1	|O
-	|O
derived	|O
artificial	|O
chromosome	|O
(	|O
PAC	|O
)	|O
clones	|O
.	|O

Online	|O
teaching	|O
:	|O
design	|O
and	|O
techniques	|O
.	|O

The	|O
application	|O
of	|O
the	|O
biotechnology	|O
at	|O
the	|O
plants	|O
for	|O
treatment	|O
of	|O
the	|O
surface	|O
storm	|O
waters	|O
from	|O
the	|O
industrial	|O
zone	|O
Telychka	|O
of	|O
the	|O
city	|O
of	|O
Kyiv	|O
has	|O
allowed	|O
the	|O
content	|O
of	|O
petroleum	|O
in	|O
water	|O
dropped	|O
to	|O
the	|O
Dnieper	|O
to	|O
be	|O
constantly	|O
reduced	|O
50-100	|O
times	|O
.	|O

Data	|O
were	|O
obtained	|O
from	|O
2	|O
undergraduate	|O
student	|O
samples	|O
,	|O
a	|O
self	|O
-	|O
report	|O
group	|O
(	|O
n	|O
=	|O
132	|O
)	|O
who	|O
provided	|O
NEO	|O
-	|O
PI	|O
-	|O
R	|O
self	|O
-	|O
ratings	|O
on	|O
2	|O
occasions	|O
separated	|O
by	|O
a	|O
7	|O
-	|O
to	|O
14	|O
-	|O
day	|O
interval	|O
and	|O
an	|O
informant	|O
group	|O
(	|O
n	|O
=	|O
109	|O
)	|O
who	|O
provided	|O
ratings	|O
of	|O
well	|O
-	|O
known	|O
friends	|O
or	|O
relatives	|O
on	|O
2	|O
occasions	|O
separated	|O
by	|O
a	|O
6	|O
month	|O
interval	|O
.	|O

Northern	|O
blot	|O
analysis	|O
of	|O
RNAs	|O
from	|O
a	|O
number	|O
of	|O
mouse	|O
tissues	|O
reveals	|O
that	|O
Atp6i	|B-PROTEIN
is	|O
expressed	|O
predominantly	|O
in	|O
osteoclasts	|O
,	|O
and	|O
this	|O
predominant	|O
expression	|O
was	|O
confirmed	|O
by	|O
reverse	|O
-	|O
transcription	|O
polymerase	|O
chain	|O
reaction	|O
(	|O
RT	|O
-	|O
PCR	|O
)	|O
assay	|O
and	|O
immunohistochemical	|O
analysis	|O
.	|O

Indeed	|O
,	|O
mutation	|O
of	|O
two	|O
of	|O
these	|O
motifs	|O
,	|O
known	|O
to	|O
be	|O
important	|O
to	|O
regulation	|O
of	|O
sid1	|B-PROTEIN
,	|O
altered	|O
the	|O
differential	|O
regulation	|O
of	|O
sid2	|B-PROTEIN
by	|O
iron	|O
.	|O

The	|O
described	|O
results	|O
show	|O
that	|O
DTD	|O
is	|O
fast	|O
,	|O
simple	|O
,	|O
and	|O
easy	|O
to	|O
automate	|O
;	|O
requires	|O
only	|O
a	|O
small	|O
amount	|O
of	|O
sample	|O
(	|O
approximately	|O
50	|O
mg	|O
)	|O
;	|O
and	|O
affords	|O
quantitative	|O
information	|O
about	|O
the	|O
main	|O
groups	|O
of	|O
compounds	|O
present	|O
in	|O
cheeses	|O
.	|O

Guidelines	|O
for	|O
performing	|O
a	|O
routine	|O
spiral	|O
assay	|O
are	|O
presented	|O
,	|O
and	|O
alternative	|O
test	|O
methods	|O
intended	|O
to	|O
overcome	|O
a	|O
variety	|O
of	|O
technical	|O
difficulties	|O
(	|O
such	|O
as	|O
restricted	|O
sample	|O
availability	|O
,	|O
sample	|O
viscosity	|O
or	|O
volatility	|O
,	|O
etc	|O
.	|O
)	|O
are	|O
recommended	|O
.	|O

In	|O
conclusion	|O
,	|O
obesity	|O
,	|O
alcohol	|O
intake	|O
,	|O
and	|O
multimetabolic	|O
disorders	|O
were	|O
determined	|O
to	|O
be	|O
independent	|O
predictors	|O
for	|O
the	|O
development	|O
of	|O
hyperuricemia	|O
.	|O

Fans	|O
in	|O
tunnels	|O
and	|O
open	|O
windows	|O
at	|O
aboveground	|O
locations	|O
appeared	|O
to	|O
greatly	|O
reduce	|O
the	|O
likelihood	|O
of	|O
high	|O
PH3	|O
concentrations	|O
in	|O
enclosed	|O
areas	|O
.	|O

Autoregulation	|O
enables	|O
different	|O
pathways	|O
to	|O
control	|O
CCAAT	|B-PROTEIN
/	|I-PROTEIN
enhancer	|I-PROTEIN
binding	|I-PROTEIN
protein	|I-PROTEIN
beta	|I-PROTEIN
(	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
beta	|I-PROTEIN
)	|O
transcription	|O
.	|O

The	|O
first	|O
case	|O
of	|O
HCV	|O
seroconversion	|O
in	|O
Portugal	|O
after	|O
the	|O
introduction	|O
of	|O
HCV	|O
NAT	|O
screening	|O
.	|O

As	|O
a	|O
reflection	|O
of	|O
uncertainties	|O
in	|O
the	|O
estimates	|O
for	|O
individual	|O
sources	|O
,	|O
the	|O
90th	|O
percentiles	|O
of	|O
PCDD	|O
/	|O
F	|O
releases	|O
for	|O
1999	|O
ranged	|O
up	|O
to	|O
4.1	|O
g	|O
I	|O
-	|O
TEQ	|O
/	|O
y	|O
.	|O

Gabapentin	|O
for	|O
opiod	|O
-	|O
related	|O
myoclonus	|O
in	|O
cancer	|O
patients	|O
.	|O

CONCLUSIONS	|O
:	|O
Our	|O
meta	|O
-	|O
analysis	|O
of	|O
randomized	|O
controlled	|O
trials	|O
of	|O
HRT	|O
noted	|O
a	|O
statistically	|O
significant	|O
reduction	|O
in	|O
nonvertebral	|O
fractures	|O
.	|O

Newcastle	|B-PROTEIN
disease	|I-PROTEIN
antibody	|I-PROTEIN
titre	|O
is	|O
dependent	|O
on	|O
serum	|O
calcium	|O
concentration	|O
.	|O

A	|O
total	|O
of	|O
25	|O
patients	|O
with	|O
malignant	|O
brain	|O
tumours	|O
were	|O
investigated	|O
.	|O

Net	|O
lift	|O
and	|O
combined	|O
drag	|O
from	|O
all	|O
8	|O
bearings	|O
of	|O
the	|O
4	|O
-	|O
bladed	|O
impeller	|O
are	|O
compared	|O
with	|O
predictions	|O
based	|O
on	|O
2	|O
-	|O
D	|O
theory	|O
.	|O

Our	|O
results	|O
indicate	|O
that	|O
Gab1	|B-PROTEIN
is	|O
involved	|O
in	|O
the	|O
control	|O
of	|O
egr	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
expression	|O
regulated	|O
by	|O
insulin	|B-PROTEIN
.	|O

The	|O
observed	|O
triplexes	|O
depend	|O
on	|O
the	|O
length	|O
of	|O
the	|O
repeat	|O
.	|O

The	|O
co	|O
-	|O
existence	|O
of	|O
TE	|B-PROTEIN
domains	|O
within	|O
modular	|O
PKSs	|B-PROTEIN
along	|O
with	|O
physically	|O
separated	|O
,	|O
monofunctional	|O
TEs	|B-PROTEIN
(	|O
TE	|B-PROTEIN
IIs	|O
)	|O
has	|O
been	|O
reported	|O
for	|O
a	|O
number	|O
of	|O
modular	|O
polyketide	|O
and	|O
non	|B-PROTEIN
-	|I-PROTEIN
ribosomal	|I-PROTEIN
peptide	|I-PROTEIN
synthases	|I-PROTEIN
(	|O
NRPS	|B-PROTEIN
)	|O
.	|O

To	|O
gain	|O
an	|O
understanding	|O
of	|O
the	|O
mGSTM2	|B-PROTEIN
regulation	|O
,	|O
we	|O
have	|O
also	|O
cloned	|O
and	|O
analyzed	|O
its	|O
promoter	|O
region	|O
.	|O

10.0	|O
+	|O
/	|O
-	|O
2.0	|O
pmol	|O
/	|O
24	|O
h	|O
,	|O
P	|O
<	|O
0.01	|O
)	|O
and	|O
remained	|O
elevated	|O
.	|O

SELECTION	|O
CRITERIA	|O
:	|O
All	|O
randomised	|O
controlled	|O
trials	|O
comparing	|O
IUSs	|O
with	|O
other	|O
forms	|O
of	|O
reversible	|O
contraceptives	|O
and	|O
reporting	|O
on	|O
pre	|O
-	|O
determined	|O
outcomes	|O
in	|O
women	|O
of	|O
reproductive	|O
years	|O
.	|O

OBJECTIVES	|O
:	|O
The	|O
objective	|O
of	|O
this	|O
review	|O
was	|O
to	|O
compare	|O
the	|O
effectiveness	|O
,	|O
safety	|O
and	|O
acceptability	|O
of	|O
the	|O
diaphragm	|O
with	|O
and	|O
without	|O
spermicide	|O
.	|O

To	|O
test	|O
the	|O
hypothesis	|O
that	|O
these	|O
elements	|O
are	|O
required	|O
for	|O
promoter	|O
activity	|O
,	|O
we	|O
compared	|O
the	|O
reporter	|O
expression	|O
activity	|O
of	|O
segments	|O
containing	|O
mutations	|O
of	|O
these	|O
elements	|O
with	|O
activity	|O
of	|O
the	|O
parent	|O
Hlx	|B-PROTEIN
promoter	|O
sequence	|O
.	|O

In	|O
all	|O
of	|O
these	|O
cases	|O
,	|O
expression	|O
of	|O
the	|O
implicated	|O
genes	|O
was	|O
absent	|O
.	|O

CONCLUSIONS	|O
:	|O
Ketamine	|O
-	|O
induced	|O
dissociative	|O
anesthesia	|O
produces	|O
persistently	|O
elevated	|O
BIS	|O
index	|O
which	|O
is	|O
different	|O
from	|O
thiamylal	|O
and	|O
those	|O
reported	|O
with	|O
other	|O
conventional	|O
anesthetic	|O
agents	|O
.	|O

Our	|O
results	|O
are	|O
reassuring	|O
and	|O
we	|O
therefore	|O
advise	|O
that	|O
in	|O
patients	|O
undergoing	|O
free	|O
jejunum	|O
flap	|O
reconstruction	|O
of	|O
the	|O
hypopharyngo	|O
-	|O
esophageal	|O
tract	|O
voice	|O
restoration	|O
should	|O
be	|O
attempted	|O
by	|O
placing	|O
a	|O
voice	|O
prosthesis	|O
through	|O
a	|O
secondary	|O
tracheo	|O
-	|O
esophageal	|O
puncture	|O
and	|O
providing	|O
intensive	|O
speech	|O
training	|O
.	|O

Hypercalcemia	|O
associated	|O
with	|O
elevated	|O
serum	|O
PTH	|B-PROTEIN
concentration	|O
indicating	|O
primary	|O
hyperparathyroidism	|O
was	|O
found	|O
in	|O
7	|O
BC	|O
patients	|O
(	|O
7%	|O
)	|O
and	|O
in	|O
none	|O
of	|O
healthy	|O
women	|O
or	|O
patients	|O
with	|O
thyroid	|O
cancer	|O
.	|O

Positive	|O
and	|O
significant	|O
correlations	|O
were	|O
found	|O
between	|O
the	|O
weeks	|O
of	|O
pregnancy	|O
and	|O
Se	|O
levels	|O
in	|O
kidney	|O
(	|O
r	|O
=	|O
0.433	|O
,	|O
P	|O
=	|O
0.023	|O
)	|O
and	|O
heart	|O
(	|O
r	|O
=	|O
0.313	|O
,	|O
P	|O
=	|O
0.030	|O
)	|O
.	|O

This	|O
study	|O
suggests	|O
that	|O
PSP	|O
is	|O
more	|O
common	|O
than	|O
previously	|O
considered	|O
,	|O
is	|O
commonly	|O
misdiagnosed	|O
and	|O
that	|O
the	|O
majority	|O
of	|O
cases	|O
are	|O
not	|O
initially	|O
referred	|O
to	|O
neurologists	|O
.	|O

In	|O
Saccharomyces	|O
cerevisiae	|O
,	|O
entry	|O
into	|O
mitosis	|O
requires	|O
activation	|O
of	|O
the	|O
cyclin	|B-PROTEIN
-	|I-PROTEIN
dependent	|I-PROTEIN
kinase	|I-PROTEIN
Cdc28	|O
in	|O
its	|O
cyclin	|B-PROTEIN
B	|I-PROTEIN
(	|O
Clb	|B-PROTEIN
)	|O
-	|O
associated	|O
form	|O
.	|O

We	|O
investigated	|O
the	|O
production	|O
of	|O
hyaluronan	|O
(	|O
HA	|O
)	|O
and	|O
its	|O
effect	|O
on	|O
cell	|O
motility	|O
in	|O
cells	|O
expressing	|O
the	|O
v	|B-PROTEIN
-	|I-PROTEIN
src	|I-PROTEIN
mutants	|O
.	|O

Our	|O
results	|O
indicate	|O
that	|O
D	|B-PROTEIN
(	|I-PROTEIN
4	|I-PROTEIN
)	|I-PROTEIN
and	|I-PROTEIN
D	|I-PROTEIN
(	|I-PROTEIN
2L	|I-PROTEIN
)	|I-PROTEIN
receptors	|I-PROTEIN
activate	|O
the	|O
ERK	|B-PROTEIN
kinase	|I-PROTEIN
cascade	|O
by	|O
first	|O
mobilizing	|O
signaling	|O
by	|O
the	|O
PDGF	|B-PROTEIN
receptor	|I-PROTEIN
,	|O
followed	|O
by	|O
the	|O
subsequent	|O
activation	|O
of	|O
ERK1/2	|B-PROTEIN
by	|O
pathways	|O
associated	|O
with	|O
this	|O
receptor	|B-PROTEIN
tyrosine	|I-PROTEIN
kinase	|I-PROTEIN
.	|O

Karger	|O
AG	|O
,	|O
Basel	|O

We	|O
used	|O
stored	|O
plasma	|O
samples	|O
from	|O
409	|O
patients	|O
in	|O
the	|O
National	|O
Institute	|O
of	|O
Neurological	|O
Diseases	|O
and	|O
Stroke	|O
(	|O
NINDS	|O
)	|O
tissue	|B-PROTEIN
plasminogen	|I-PROTEIN
activator	|I-PROTEIN
(	|O
t	|B-PROTEIN
-	|I-PROTEIN
PA	|I-PROTEIN
)	|O
Stroke	|O
Trial	|O
to	|O
examine	|O
the	|O
relationship	|O
between	|O
an	|O
apolipoprotein	|O
(	|B-PROTEIN
Apo	|I-PROTEIN
)	|I-PROTEIN
E2	|I-PROTEIN
or	|O
an	|O
Apo	|B-PROTEIN
E4	|I-PROTEIN
phenotype	|O
and	|O
a	|O
favorable	|O
outcome	|O
3	|O
months	|O
after	|O
stroke	|O
,	|O
the	|O
risk	|O
of	|O
intracerebral	|O
hemorrhage	|O
,	|O
and	|O
the	|O
response	|O
to	|O
intravenous	|O
t	|B-PROTEIN
-	|I-PROTEIN
PA	|I-PROTEIN
therapy	|O
.	|O

NIRS	|O
was	|O
used	|O
for	|O
the	|O
quantitative	|O
measurement	|O
of	|O
muscle	|O
O	|O
(	|O
2	|O
)	|O
consumption	|O
(	|O
mV.O	|O
(	|O
2	|O
)	|O
)	|O
and	|O
forearm	|O
blood	|O
flow	|O
(	|O
FBF	|O
)	|O
in	|O
78	|O
healthy	|O
subjects	|O
.	|O

No	|O
dominant	|O
clinical	|O
factor	|O
of	|O
risk	|O
was	|O
found	|O
,	|O
but	|O
multiple	|O
regression	|O
analysis	|O
identified	|O
age	|O
,	|O
body	|O
surface	|O
area	|O
,	|O
valve	|O
size	|O
,	|O
shop	|O
order	|O
fracture	|O
rate	|O
,	|O
and	|O
manufacturing	|O
period	|O
as	|O
risk	|O
factors	|O
for	|O
OSF	|O
.	|O

In	|O
this	|O
report	|O
this	|O
technique	|O
was	|O
applied	|O
to	|O
human	|O
breast	|O
carcinoma	|O
MDA	|O
-	|O
MB231	|O
cells	|O
overexpressing	|O
human	|O
MPG	|B-PROTEIN
in	|O
order	|O
to	|O
assess	|O
whether	|O
up	|O
-	|O
regulation	|O
of	|O
the	|O
initial	|O
step	|O
in	|O
BER	|O
alters	|O
the	|O
activity	|O
of	|O
selected	|O
other	|O
BER	|O
(	|O
hOGG1	|B-PROTEIN
and	|O
APE	|B-PROTEIN
/	|O
ref	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
)	|O
or	|O
direct	|O
reversal	|O
(	|O
MGMT	|B-PROTEIN
)	|O
repair	|O
activities	|O
.	|O

The	|O
selective	|O
alteration	|O
of	|O
the	|O
genome	|O
using	|O
Cre	|B-PROTEIN
recombinase	|O
to	|O
target	|O
the	|O
rearrangement	|O
of	|O
genes	|O
flanked	|O
by	|O
LOX	|B-PROTEIN
recognition	|O
sequences	|O
has	|O
required	|O
the	|O
use	|O
of	|O
two	|O
separate	|O
genetic	|O
constructs	|O
in	|O
trans	|O
,	|O
one	|O
containing	|O
cre	|O
and	|O
the	|O
other	|O
containing	|O
the	|O
gene	|O
of	|O
interest	|O
flanked	|O
by	|O
LOX	|B-PROTEIN
sites	|O
.	|O

Colorectal	|O
cancer	|O
was	|O
shown	|O
to	|O
disproportionately	|O
overburden	|O
Ashkenazi	|O
Jews	|O
,	|O
who	|O
may	|O
also	|O
be	|O
at	|O
increased	|O
risk	|O
for	|O
ovarian	|O
,	|O
pancreatic	|O
and	|O
stomach	|O
cancer	|O
,	|O
and	|O
non	|O
-	|O
Hodgkin	|O
's	|O
lymphoma	|O
.	|O

Influence	|O
of	|O
compression	|O
therapy	|O
on	|O
symptoms	|O
following	|O
soft	|O
tissue	|O
injury	|O
from	|O
maximal	|O
eccentric	|O
exercise	|O
.	|O

Keratoconjunctivitis	|O
sicca	|O
appears	|O
to	|O
be	|O
a	|O
common	|O
ocular	|O
complication	|O
and	|O
all	|O
children	|O
with	|O
JRA	|O
should	|O
be	|O
screened	|O
for	|O
it	|O
with	|O
a	|O
comprehensive	|O
battery	|O
of	|O
tests	|O
.	|O

STAT5A	|B-PROTEIN
mutations	|O
in	|O
the	|O
Src	|B-PROTEIN
homology	|I-PROTEIN
2	|I-PROTEIN
(	|O
SH2	|B-PROTEIN
)	|O
and	|O
SH3	|B-PROTEIN
domains	|O
did	|O
not	|O
alter	|O
the	|O
BTK	|B-PROTEIN
-	|O
mediated	|O
tyrosine	|O
phosphorylation	|O
.	|O

In	|O
conclusion	|O
,	|O
primary	|O
chemotherapy	|O
based	|O
on	|O
high	|O
dose	|O
MTX	|O
and	|O
ara	|O
-	|O
C	|O
is	|O
highly	|O
efficient	|O
in	|O
PCNSL	|O
.	|O

RANTES	|B-PROTEIN
(	|O
regulated	|B-PROTEIN
upon	|I-PROTEIN
activation	|I-PROTEIN
,	|I-PROTEIN
normally	|I-PROTEIN
T	|I-PROTEIN
-	|I-PROTEIN
cell	|I-PROTEIN
expressed	|I-PROTEIN
and	|I-PROTEIN
presumably	|I-PROTEIN
secreted	|I-PROTEIN
)	|O
is	|O
a	|O
CC	|O
chemokine	|O
which	|O
recruits	|O
and	|O
activates	|O
monocytes	|O
,	|O
lymphocytes	|O
,	|O
and	|O
eosinophils	|O
,	|O
all	|O
cell	|O
types	|O
present	|O
in	|O
the	|O
lung	|O
inflammatory	|O
infiltrate	|O
induced	|O
by	|O
RSV	|O
infection	|O
.	|O

Reovirus	|O
mRNAs	|O
are	|O
efficiently	|O
translated	|O
within	|O
host	|O
cells	|O
despite	|O
the	|O
absence	|O
of	|O
3'	|O
polyadenylated	|O
tails	|O
.	|O

Analyses	|O
revealed	|O
that	|O
scale	|O
matters	|O
above	|O
and	|O
beyond	|O
the	|O
effect	|O
of	|O
quadrat	|O
area	|O
.	|O

Myasthenia	|O
gravis	|O
is	|O
an	|O
autoimmune	|O
disease	|O
resulting	|O
from	|O
the	|O
production	|O
of	|O
antibodies	|O
against	|O
the	|O
ACh	|B-PROTEIN
receptors	|I-PROTEIN
of	|O
the	|O
neuromuscular	|O
synapse	|O
.	|O

Copyright	|O
2001	|O
Academic	|O
Press	|O
.	|O

Using	|O
the	|O
postural	|O
and	|O
force	|O
data	|O
as	|O
input	|O
to	|O
a	|O
3	|O
-	|O
D	|O
biomechanical	|O
model	|O
,	|O
the	|O
lumbosacral	|O
spinal	|O
compression	|O
was	|O
calculated	|O
.	|O

Angina	|O
(	|O
Q	|O
)	|O
persistence	|O
showed	|O
marked	|O
associations	|O
with	|O
previous	|O
myocardial	|O
infarction	|O
,	|O
diagnosed	|O
angina	|O
,	|O
electrocardiogram	|O
ischemia	|O
,	|O
and	|O
subsequent	|O
major	|O
ischemic	|O
heart	|O
disease	|O
events	|O
from	|O
Q5	|O
onward	|O
.	|O

In	|O
the	|O
past	|O
decade	|O
,	|O
there	|O
have	|O
been	|O
enormous	|O
advances	|O
in	|O
the	|O
use	|O
of	|O
Bayesian	|O
methodology	|O
for	|O
analysis	|O
of	|O
epidemiologic	|O
data	|O
,	|O
and	|O
there	|O
are	|O
now	|O
many	|O
practical	|O
advantages	|O
to	|O
the	|O
Bayesian	|O
approach	|O
.	|O

To	|O
assess	|O
more	|O
specific	|O
PKA	|B-PROTEIN
-	|O
dependent	|O
mediation	|O
of	|O
LH	|B-PROTEIN
's	|O
contribution	|O
to	|O
combined	|O
hormonal	|O
drive	|O
,	|O
the	|O
LDL	|B-PROTEIN
receptor	|I-PROTEIN
(	|O
-	|O
1076	|O
to	|O
+	|O
11	|O
bp	|O
)	|O
reporter	|O
plasmid	|O
was	|O
cotransfected	|O
with	|O
a	|O
full	|B-PROTEIN
-	|I-PROTEIN
sequence	|I-PROTEIN
rabbit	|I-PROTEIN
muscle	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
inhibitor	|I-PROTEIN
(	|O
PKI	|B-PROTEIN
)	|O
minigene	|O
driven	|O
constitutively	|O
by	|O
a	|O
Rous	|B-PROTEIN
sarcoma	|I-PROTEIN
virus	|I-PROTEIN
promoter	|I-PROTEIN
.	|O

To	|O
investigate	|O
the	|O
convergent	|O
role	|O
of	|O
the	|O
insulin	|B-PROTEIN
/	|O
IGF	|B-PROTEIN
-	|I-PROTEIN
I	|I-PROTEIN
effector	|O
pathway	|O
mediating	|O
bihormonal	|O
stimulation	|O
of	|O
LDL	|B-PROTEIN
receptor	|I-PROTEIN
promoter	|O
expression	|O
,	|O
transfected	|O
granulosa	|O
-	|O
luteal	|O
cells	|O
were	|O
pretreated	|O
for	|O
30	|O
min	|O
with	|O
two	|O
specific	|O
inhibitors	|O
of	|O
phophatidylinositol	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
,	|O
wortmannin	|O
(	|O
100	|O
nM	|O
)	|O
and	|O
LY	|O
294002	|O
(	|O
10	|O
microM	|O
)	|O
,	|O
or	|O
of	|O
mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
kinase	|I-PROTEIN
,	|O
PD	|O
98059	|O
(	|O
50	|O
microM	|O
)	|O
,	|O
U0126	|O
(	|O
10	|O
microM	|O
)	|O
,	|O
or	|O
the	|O
latter	|O
's	|O
inactive	|O
derivative	|O
,	|O
U0124	|O
(	|O
10	|O
microM	|O
)	|O
.	|O

Concerted	|O
transcriptional	|O
activation	|O
of	|O
the	|O
low	|B-PROTEIN
density	|I-PROTEIN
lipoprotein	|I-PROTEIN
receptor	|I-PROTEIN
gene	|O
by	|O
insulin	|B-PROTEIN
and	|O
luteinizing	|B-PROTEIN
hormone	|I-PROTEIN
in	|O
cultured	|O
porcine	|O
granulosa	|O
-	|O
luteal	|O
cells	|O
:	|O
possible	|O
convergence	|O
of	|O
protein	|B-PROTEIN
kinase	|I-PROTEIN
a	|I-PROTEIN
,	|O
phosphatidylinositol	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
,	|O
and	|O
mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
signaling	|O
pathways	|O
.	|O

These	|O
studies	|O
demonstrate	|O
that	|O
site	|O
-	|O
specific	|O
recognition	|O
of	|O
the	|O
bxd	|B-PROTEIN
PRE	|O
by	|O
d	|O
(	|O
GA	|O
)	|O
(	|O
n	|O
)	|O
repeat	|O
binding	|O
activities	|O
mediates	|O
PcG	|B-PROTEIN
-	|O
dependent	|O
silencing	|O
.	|O

Our	|O
findings	|O
further	|O
our	|O
understanding	|O
of	|O
how	|O
ZBP	|B-PROTEIN
-	|I-PROTEIN
89	|I-PROTEIN
modulates	|O
cell	|O
proliferation	|O
and	|O
reveals	|O
a	|O
novel	|O
mechanism	|O
by	|O
which	|O
the	|O
p53	|B-PROTEIN
protein	|O
is	|O
stabilized	|O
.	|O

A	|O
computerized	|O
method	|O
of	|O
determining	|O
the	|O
focal	|O
point	|O
of	|O
electrical	|O
activity	|O
in	|O
the	|O
pallidum	|O
of	|O
parkinsonian	|O
patients	|O
was	|O
developed	|O
using	|O
on	|O
-	|O
line	|O
quantitative	|O
physiological	|O
data	|O
analysis	|O
.	|O

Five	|O
modalities	|O
of	|O
nonpharmacologic	|O
approaches	|O
are	|O
recommended	|O
at	|O
present	|O
for	|O
lifestyle	|O
modification	|O
and	|O
control	|O
of	|O
arterial	|O
blood	|O
pressure	|O
elevation	|O
:	|O
1	|O
)	|O
weight	|O
reduction	|O
to	|O
ideal	|O
body	|O
weight	|O
,	|O
since	|O
it	|O
reduces	|O
risk	|O
of	|O
hypertension	|O
as	|O
well	|O
as	|O
overall	|O
cardiovascular	|O
morbidity	|O
and	|O
mortality	|O
;	|O
2	|O
)	|O
dietary	|O
sodium	|O
restriction	|O
to	|O
less	|O
than	|O
2	|O
g	|O
a	|O
day	|O
,	|O
without	|O
assurance	|O
that	|O
it	|O
will	|O
normalize	|O
arterial	|O
pressure	|O
although	|O
it	|O
may	|O
help	|O
reduce	|O
dosage	|O
and	|O
numbers	|O
of	|O
prescribed	|O
antihypertensive	|O
drugs	|O
;	|O
3	|O
)	|O
moderation	|O
of	|O
alcohol	|O
consumption	|O
to	|O
less	|O
than	|O
1	|O
ounce	|O
a	|O
day	|O
;	|O
4	|O
)	|O
a	|O
regular	|O
isotonic	|O
exercise	|O
program	|O
;	|O
and	|O
5	|O
)	|O
cessation	|O
of	|O
tobacco	|O
consumption	|O
.	|O

Isolated	|O
Systolic	|O
Hypertension	|O
:	|O
An	|O
Update	|O
.	|O

Ga	|O
-	|O
67	|O
and	|O
Tl	|O
-	|O
201	|O
scintigraphy	|O
in	|O
extramedullary	|O
plasmacytoma	|O
:	|O
a	|O
case	|O
report	|O
.	|O

Arterial	|O
blood	|O
gas	|O
tensions	|O
were	|O
similar	|O
across	|O
all	|O
ventilation	|O
modes	|O
.	|O

As	|O
expected	|O
,	|O
homologous	|O
loxP	|B-PROTEIN
sequences	|O
efficiently	|O
underwent	|O
Cre	|B-PROTEIN
-	|O
mediated	|O
recombination	|O
.	|O

The	|O
N	|O
-	|O
terminal	|O
portion	|O
of	|O
Notch	|B-PROTEIN
(	|I-PROTEIN
IC	|I-PROTEIN
)	|I-PROTEIN
inhibited	|O
p50	|B-PROTEIN
DNA	|O
binding	|O
and	|O
interacted	|O
specifically	|O
with	|O
p50	|B-PROTEIN
subunit	|O
,	|O
not	|O
p65	|B-PROTEIN
of	|O
NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
.	|O

Conformational	|O
changes	|O
of	|O
the	|O
ferric	|B-PROTEIN
uptake	|I-PROTEIN
regulation	|I-PROTEIN
protein	|O
upon	|O
metal	|O
activation	|O
and	|O
DNA	|O
binding	|O
;	|O
first	|O
evidence	|O
of	|O
structural	|O
homologies	|O
with	|O
the	|O
diphtheria	|B-PROTEIN
toxin	|I-PROTEIN
repressor	|I-PROTEIN
.	|O

As	|O
a	|O
complement	|O
to	|O
genome	|O
-	|O
wide	|O
mapping	|O
and	|O
sequencing	|O
efforts	|O
,	|O
it	|O
is	|O
often	|O
important	|O
to	|O
generate	|O
detailed	|O
maps	|O
and	|O
sequence	|O
data	|O
for	|O
specific	|O
regions	|O
of	|O
interest	|O
.	|O

Granulocyte	|B-PROTEIN
colony	|I-PROTEIN
-	|I-PROTEIN
stimulating	|I-PROTEIN
factor	|I-PROTEIN
(	|O
G	|B-PROTEIN
-	|I-PROTEIN
CSF	|I-PROTEIN
)	|O
administration	|O
in	|O
vivo	|O
has	|O
been	|O
shown	|O
to	|O
improve	|O
the	|O
defence	|O
mechanisms	|O
against	|O
infection	|O
by	|O
different	|O
microbes	|O
.	|O

Among	|O
individuals	|O
,	|O
however	|O
,	|O
changes	|O
were	|O
strongly	|O
correlated	|O
with	|O
ACR	|O
levels	|O
at	|O
baseline	|O
.	|O

Thus	|O
,	|O
the	|O
screen	|O
for	|O
toxic	|O
p53	|B-PROTEIN
mutants	|O
in	|O
yeast	|O
can	|O
identify	|O
novel	|O
p53	|B-PROTEIN
variants	|O
that	|O
may	|O
be	|O
useful	|O
in	|O
dissecting	|O
p53	|B-PROTEIN
regulated	|O
cellular	|O
responses	|O
and	|O
in	|O
developing	|O
p53	|B-PROTEIN
-	|O
based	|O
cancer	|O
therapies	|O
.	|O

This	|O
is	|O
necessary	|O
if	|O
psychiatric	|O
diagnoses	|O
are	|O
ultimately	|O
going	|O
to	|O
be	|O
refined	|O
and	|O
validated	|O
against	|O
biological	|O
criteria	|O
.	|O

Since	|O
the	|O
latter	|O
is	|O
very	|O
small	|O
for	|O
physiological	|O
flows	|O
,	|O
the	|O
result	|O
is	|O
that	|O
alpha	|O
<	|O
1	|O
even	|O
at	|O
relatively	|O
high	|O
values	|O
of	|O
the	|O
Reynolds	|O
number	|O
(	|O
i.e.	|O
,	|O
for	|O
non	|O
-	|O
negligible	|O
inertia	|O
)	|O
and	|O
we	|O
validate	|O
our	|O
perturbation	|O
theory	|O
results	|O
by	|O
comparison	|O
with	|O
a	|O
numerical	|O
integration	|O
of	|O
the	|O
full	|O
model	|O
.	|O

Cells	|O
lacking	|O
p116	|B-PROTEIN
exhibit	|O
a	|O
striking	|O
defect	|O
in	|O
the	|O
formation	|O
of	|O
these	|O
macropinocytic	|O
structures	|O
,	|O
a	|O
concomitant	|O
reduction	|O
in	|O
the	|O
rate	|O
of	|O
fluid	|O
phase	|O
pinocytosis	|O
,	|O
a	|O
significant	|O
decrease	|O
in	|O
the	|O
efficiency	|O
of	|O
chemotactic	|O
aggregation	|O
,	|O
and	|O
a	|O
decrease	|O
in	|O
cellular	|O
F	|B-PROTEIN
-	|I-PROTEIN
actin	|I-PROTEIN
content	|O
.	|O

The	|O
validity	|O
of	|O
the	|O
FPS	|O
-	|O
R	|O
was	|O
further	|O
supported	|O
by	|O
strong	|O
positive	|O
correlations	|O
with	|O
the	|O
VAS	|O
(	|O
r	|O
=	|O
0.92	|O
,	|O
N	|O
=	|O
45	|O
)	|O
and	|O
the	|O
CAS	|O
(	|O
r	|O
=	|O
0.84	|O
,	|O
N	|O
=	|O
45	|O
)	|O
in	|O
this	|O
clinical	|O
sample	|O
.	|O

The	|O
susceptibility	|O
of	|O
Aspergillus	|O
fumigatus	|O
to	|O
mulundocandin	|O
,	|O
an	|O
echinocandin	|O
-	|O
like	|O
compound	|O
,	|O
and	|O
other	|O
antifungal	|O
agents	|O
was	|O
assessed	|O
by	|O
the	|O
National	|O
Committee	|O
for	|O
Clinical	|O
Laboratory	|O
Standards	|O
(	|O
NCCLS	|O
)	|O
M38	|O
-	|O
P	|O
method	|O
,	|O
a	|O
2,3	|O
-	|O
bis	|O
(	|O
2	|O
-	|O
methoxy	|O
-	|O
4	|O
-	|O
nitro	|O
-	|O
5	|O
-	|O
sulfophenyl	|O
)	|O
-	|O
5	|O
-	|O
[	|O
(	|O
phenyl	|O
-	|O
amino	|O
)	|O
carbonyl	|O
]	|O
-	|O
2H	|O
-	|O
tetrazolium	|O
hydroxide	|O
(	|O
XTT	|O
)	|O
-	|O
based	|O
colorimetric	|O
assay	|O
,	|O
and	|O
determination	|O
of	|O
morphologic	|O
alterations	|O
by	|O
microscopy	|O
.	|O

The	|O
Van	|O
der	|O
Hoeve	|O
's	|O
syndrome	|O
lesions	|O
as	|O
poorly	|O
mineralized	|O
,	|O
with	|O
low	|O
calcium	|O
salt	|O
and	|O
apparent	|O
increase	|O
of	|O
phosphates	|O
.	|O

A	|O
5	|O
-	|O
month	|O
-	|O
old	|O
infant	|O
with	|O
persistent	|O
congenital	|O
stridor	|O
and	|O
acute	|O
respiratory	|O
distress	|O
is	|O
presented	|O
.	|O

DESIGN	|O
:	|O
A	|O
retrospective	|O
chart	|O
review	|O
of	|O
9,322	|O
patients	|O
undergoing	|O
surgical	|O
procedures	|O
in	|O
the	|O
period	|O
January	|O
1993	|O
to	|O
December	|O
1998	|O
.	|O

Pulmonary	|O
vein	|O
varix	|O
in	|O
association	|O
with	|O
bilateral	|O
pulmonary	|O
vein	|O
stenosis	|O
.	|O

Biochemical	|O
experiments	|O
have	|O
shown	|O
that	|O
CopG	|B-PROTEIN
co	|O
-	|O
operatively	|O
associates	|O
to	|O
its	|O
target	|O
DNA	|O
at	|O
low	|O
protein	|O
:	|O
DNA	|O
ratios	|O
,	|O
completely	|O
protecting	|O
four	|O
helical	|O
turns	|O
on	|O
the	|O
same	|O
face	|O
of	|O
the	|O
double	|O
helix	|O
in	|O
both	|O
directions	|O
from	|O
the	|O
inverted	|O
repeat	|O
that	|O
constitutes	|O
the	|O
CopG	|B-PROTEIN
primary	|O
target	|O
.	|O

We	|O
demonstrated	|O
that	|O
,	|O
under	|O
serum	|O
-	|O
starved	|O
conditions	|O
,	|O
KMS	|O
-	|O
11	|O
and	|O
OPM	|O
-	|O
2	|O
cells	|O
express	|O
appreciable	|O
levels	|O
of	|O
phosphorylated	|O
FGFR3	|B-PROTEIN
mutants	|O
indicating	|O
a	|O
constitutive	|O
activation	|O
of	|O
the	|O
Y373C	|B-PROTEIN
and	|I-PROTEIN
K650E	|I-PROTEIN
receptors	|I-PROTEIN
;	|O
the	|O
addition	|O
of	|O
the	|O
aFGF	|B-PROTEIN
ligand	|O
further	|O
increased	|O
the	|O
level	|O
of	|O
receptor	|O
phosphorylation	|O
.	|O

[	|O
figure	|O
:	|O
see	|O
text	|O
]	|O
The	|O
Stille	|O
coupling	|O
reaction	|O
has	|O
been	|O
performed	|O
in	|O
1	|O
-	|O
butyl	|O
-	|O
3	|O
-	|O
methylimidazolium	|O
tetrafluoroborate	|O
(	|O
BMIM	|O
BF4	|O
)	|O
,	|O
a	|O
room	|O
-	|O
temperature	|O
ionic	|O
liquid	|O
(	|O
RTIL	|O
)	|O
.	|O

Special	|O
issues	|O
devoted	|O
to	|O
the	|O
biosynthesis	|O
of	|O
woody	|O
plant	|O
biopolymers	|O
and	|O
related	|O
substances	|O
.	|O

Interactions	|O
between	|O
the	|O
checkpoint	|O
abrogator	|O
UCN	|O
-	|O
01	|O
and	|O
several	|O
pharmacological	|O
inhibitors	|O
of	|O
the	|O
mitogen	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinase	|I-PROTEIN
(	|I-PROTEIN
MAPK	|I-PROTEIN
)	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
MEK	|B-PROTEIN
)	|O
/	|O
MAPK	|B-PROTEIN
pathway	|O
have	|O
been	|O
examined	|O
in	|O
a	|O
variety	|O
of	|O
human	|O
leukemia	|O
cell	|O
lines	|O
.	|O

Low	|O
affinity	|O
binding	|O
of	|O
Rab6A	|B-PROTEIN
-	|O
GTP	|O
was	|O
also	|O
observed	|O
(	|O
K	|O
(	|O
d	|O
)	|O
=	|O
16	|O
microm	|O
)	|O
,	|O
whereas	|O
Rab1B	|B-PROTEIN
,	|I-PROTEIN
-	|I-PROTEIN
5	|I-PROTEIN
,	|I-PROTEIN
-	|I-PROTEIN
7	|I-PROTEIN
,	|I-PROTEIN
-	|I-PROTEIN
8	|I-PROTEIN
,	|I-PROTEIN
or	|I-PROTEIN
-	|I-PROTEIN
11A	|I-PROTEIN
did	|O
not	|O
bind	|O
.	|O

The	|O
students	|O
who	|O
had	|O
abnormal	|O
urine	|O
screening	|O
results	|O
at	|O
the	|O
first	|O
time	|O
received	|O
a	|O
second	|O
urine	|O
analysis	|O
10	|O
to	|O
15	|O
days	|O
later	|O
to	|O
confirm	|O
the	|O
abnormal	|O
urine	|O
analysis	|O
.	|O

PURPOSE	|O
:	|O
The	|O
objective	|O
of	|O
this	|O
study	|O
was	|O
to	|O
assess	|O
first	|O
embryo	|O
cleavage	|O
(	|O
FEC	|O
)	|O
25-27	|O
h	|O
after	|O
intracytoplasmic	|O
sperm	|O
injection	|O
(	|O
ICSI	|O
)	|O
as	|O
a	|O
parameter	|O
for	|O
the	|O
embryo	|O
selection	|O
process	|O
.	|O

Regulation	|O
of	|O
laminin	|B-PROTEIN
beta2	|I-PROTEIN
chain	|O
gene	|O
expression	|O
in	|O
human	|O
cancer	|O
cell	|O
lines	|O
.	|O

Northern	|O
and	|O
Western	|O
blot	|O
analyses	|O
demonstrated	|O
that	|O
Graf2	|B-PROTEIN
is	|O
expressed	|O
in	|O
several	|O
tissues	|O
,	|O
with	|O
the	|O
highest	|O
expression	|O
in	|O
skeletal	|O
muscle	|O
.	|O

However	|O
,	|O
when	|O
directed	|O
to	|O
the	|O
nucleosome	|O
by	|O
fusion	|O
to	|O
core	|O
histone	|O
H2A	|B-PROTEIN
or	|O
H2B	|B-PROTEIN
,	|O
the	|O
non	|O
-	|O
histone	|B-PROTEIN
tail	|O
forms	|O
an	|O
MCB	|O
that	|O
appears	|O
identical	|O
to	|O
that	|O
of	|O
the	|O
endogenous	|O
protein	|O
.	|O

These	|O
data	|O
suggest	|O
that	|O
proper	|O
direct	|O
binding	|O
of	|O
Nhp2p	|B-PROTEIN
to	|O
H	|B-PROTEIN
/	|I-PROTEIN
ACA	|I-PROTEIN
snoRNAs	|O
is	|O
required	|O
for	|O
the	|O
assembly	|O
of	|O
H	|B-PROTEIN
/	|I-PROTEIN
ACA	|I-PROTEIN
snoRNPs	|O
and	|O
hence	|O
for	|O
the	|O
stability	|O
of	|O
some	|O
of	|O
their	|O
components	|O
.	|O

Telomerase	|B-PROTEIN
is	|O
a	|O
ribonucleoprotein	|O
complex	|O
that	|O
synthesizes	|O
telomeric	|O
DNA	|O
onto	|O
chromosomes	|O
using	|O
its	|O
RNA	|O
component	|O
as	|O
template	|O
.	|O

SIT	|B-PROTEIN
(	|O
SHP2	|B-PROTEIN
-	|I-PROTEIN
interacting	|I-PROTEIN
transmembrane	|I-PROTEIN
adaptor	|I-PROTEIN
protein	|I-PROTEIN
)	|O
is	|O
a	|O
recently	|O
identified	|O
transmembrane	|O
adaptor	|O
protein	|O
,	|O
which	|O
is	|O
expressed	|O
in	|O
lymphocytes	|O
.	|O

In	|O
35	|O
of	|O
those	|O
patients	|O
DD	|O
was	|O
measured	|O
also	|O
with	|O
microlatex	|O
tests	|O
-	|O
-	|O
Tinaquant	|O
and	|O
BC	|O
d	|O
-	|O
dimer	|O
.	|O

Cytosolic	|O
acetyl	|B-PROTEIN
-	|I-PROTEIN
CoA	|I-PROTEIN
synthetase	|I-PROTEIN
(	|O
AceCS1	|B-PROTEIN
)	|O
activates	|O
acetate	|O
to	|O
supply	|O
the	|O
cells	|O
with	|O
acetyl	|O
-	|O
CoA	|O
for	|O
lipid	|O
synthesis	|O
.	|O

Ileal	|O
digestibilities	|O
of	|O
DM	|O
,	|O
OM	|O
,	|O
CP	|O
,	|O
total	|O
dietary	|O
fiber	|O
(	|O
TDF	|O
)	|O
,	|O
fat	|O
and	|O
gross	|O
energy	|O
(	|O
GE	|O
)	|O
were	|O
lower	|O
(	|O
P	|O
<	|O
0.05	|O
)	|O
for	|O
dogs	|O
fed	|O
diets	|O
containing	|O
supplemental	|O
fiber	|O
compared	|O
with	|O
dogs	|O
fed	|O
the	|O
control	|O
diet	|O
.	|O

Together	|O
these	|O
data	|O
imply	|O
that	|O
the	|O
HFV	|B-PROTEIN
R	|O
region	|O
acts	|O
in	|O
the	|O
nucleus	|O
to	|O
modify	|O
the	|O
cytoplasmic	|O
fate	|O
of	|O
target	|O
HFV	|O
mRNA	|O
.	|O

These	|O
TxRE	|B-PROTEIN
contain	|O
cyclic	|O
AMP	|O
-	|O
responsive	|O
elements	|O
(	|O
CRE	|O
)	|O
,	|O
but	|O
,	|O
remarkably	|O
,	|O
the	|O
"	|O
TGACGTCA	|O
"	|O
consensus	|O
is	|O
never	|O
strictly	|O
conserved	|O
in	|O
any	|O
viral	|O
strain	|O
(	|O
e.g.	|O
,	|O
AGACGTCA	|O
,	|O
TGACGGCA	|O
,	|O
TGACCTCA	|O
)	|O
.	|O

And	|O
,	|O
most	|O
importantly	|O
,	|O
reconstitution	|O
of	|O
a	|O
consensus	|O
CRE	|O
,	|O
within	|O
the	|O
21	|O
-	|O
bp	|O
enhancers	|O
increases	|O
binding	|O
of	|O
CREB	|B-PROTEIN
/	|O
ATF	|B-PROTEIN
proteins	|O
but	|O
abrogates	|O
basal	|O
repression	|O
of	|O
LTR	|O
-	|O
directed	|O
transcription	|O
in	|O
vitro	|O
.	|O

Site	|O
-	|O
directed	|O
mutagenesis	|O
of	|O
CAR	|B-PROTEIN
revealed	|O
that	|O
CAR	|B-PROTEIN
residues	|O
Leu73	|O
and	|O
Lys121	|O
and	|O
/	|O
or	|O
Lys123	|O
are	|O
critical	|O
contact	|O
residues	|O
,	|O
with	|O
Tyr80	|O
and	|O
Tyr83	|O
being	|O
peripherally	|O
involved	|O
in	|O
the	|O
binding	|O
interaction	|O
with	|O
the	|O
Ad5	|B-PROTEIN
,	|I-PROTEIN
Ad9	|I-PROTEIN
,	|I-PROTEIN
Ad12	|I-PROTEIN
,	|I-PROTEIN
and	|I-PROTEIN
Ad41L	|I-PROTEIN
fiber	|I-PROTEIN
knobs	|I-PROTEIN
.	|O

This	|O
subfamily	|O
of	|O
genes	|O
all	|O
have	|O
a	|O
single	|O
ATP	|O
-	|O
binding	|O
domain	|O
at	|O
the	|O
N	|O
-	|O
terminus	|O
and	|O
a	|O
single	|O
C	|O
-	|O
terminal	|O
set	|O
of	|O
transmembrane	|O
segments	|O
.	|O

Tolerance	|O
in	|O
renal	|O
transplantation	|O
after	|O
allogeneic	|O
bone	|O
marrow	|O
transplantation	|O
-	|O
6	|O
-	|O
year	|O
follow	|O
-	|O
up	|O
.	|O

The	|O
promoter	|O
activity	|O
of	|O
the	|O
proximal	|O
region	|O
was	|O
found	|O
to	|O
be	|O
restricted	|O
to	|O
a	|O
subset	|O
of	|O
prestalk	|O
cells	|O
.	|O

Substitution	|O
of	|O
serine	|O
residues	|O
at	|O
the	|O
C	|O
-	|O
terminus	|O
indicated	|O
that	|O
loss	|O
of	|O
phosphorylation	|O
sites	|O
did	|O
not	|O
appear	|O
to	|O
have	|O
any	|O
effect	|O
on	|O
transcription	|O
and	|O
replication	|O
.	|O

Thus	|O
,	|O
replication	|O
fork	|O
movement	|O
near	|O
HML	|B-PROTEIN
pauses	|O
at	|O
a	|O
silent	|O
origin	|O
which	|O
is	|O
competent	|O
for	|O
replication	|O
initiation	|O
but	|O
kept	|O
silent	|O
through	|O
Orc2p	|B-PROTEIN
,	|O
a	|O
component	|O
of	|O
the	|O
replication	|O
initiator	|O
.	|O

These	|O
findings	|O
suggest	|O
that	|O
the	|O
adapter	|O
Gab1	|B-PROTEIN
may	|O
redirect	|O
c	|B-PROTEIN
-	|I-PROTEIN
Met	|I-PROTEIN
signaling	|O
through	|O
PI3K	|B-PROTEIN
away	|O
from	|O
a	|O
c	|B-PROTEIN
-	|I-PROTEIN
Akt	|I-PROTEIN
/	|O
Pak1	|B-PROTEIN
cell	|O
survival	|O
pathway	|O
.	|O

We	|O
have	|O
cloned	|O
a	|O
novel	|O
mouse	|O
protein	|O
,	|O
TAF	|B-PROTEIN
(	|I-PROTEIN
II	|I-PROTEIN
)	|I-PROTEIN
140	|I-PROTEIN
,	|O
containing	|O
an	|O
HFD	|B-PROTEIN
and	|O
a	|O
plant	|B-PROTEIN
homeodomain	|I-PROTEIN
(	|O
PHD	|B-PROTEIN
)	|O
finger	|O
,	|O
which	|O
we	|O
demonstrated	|O
by	|O
immunoprecipitation	|O
to	|O
be	|O
a	|O
mammalian	|O
TFIID	|B-PROTEIN
component	|O
.	|O

The	|O
other	|O
inhibitor	|O
was	|O
a	|O
single	|O
TAR	|B-PROTEIN
decoy	|O
,	|O
driven	|O
by	|O
the	|O
U6	|B-PROTEIN
small	|I-PROTEIN
nuclear	|I-PROTEIN
RNA	|I-PROTEIN
promoter	|O
(	|O
U6	|B-PROTEIN
-	|I-PROTEIN
P	|I-PROTEIN
)	|O
.	|O

In	|O
contrast	|O
to	|O
MPc3	|B-PROTEIN
,	|O
data	|O
indicate	|O
that	|O
the	|O
Pc	|B-PROTEIN
protein	|O
M33	|B-PROTEIN
does	|O
not	|O
interact	|O
with	|O
AF9	|B-PROTEIN
.	|O

Foreigners	|O
return	|O
.	|O

Long	|O
-	|O
term	|O
results	|O
with	|O
MACOP	|O
-	|O
B	|O
and	|O
radiation	|O
therapy	|O
for	|O
aggressive	|O
lymphomas	|O
]	|O
BACKGROUND	|O
:	|O
Long	|O
-	|O
term	|O
results	|O
are	|O
needed	|O
to	|O
evaluate	|O
chemotherapy	|O
regimens	|O
and	|O
prognostic	|O
factors	|O
in	|O
non	|O
-	|O
Hodgkin	|O
's	|O
lymphomas	|O
(	|O
NHL	|O
)	|O
.	|O

At	|O
20	|O
days	|O
(	|O
D	|O
)	|O
and	|O
at	|O
3	|O
months	|O
post	|O
-	|O
TBI	|O
,	|O
irradiated	|O
rats	|O
had	|O
a	|O
significantly	|O
lower	|O
percentage	|O
of	|O
avoidance	|O
than	|O
controls	|O
but	|O
no	|O
statistical	|O
difference	|O
was	|O
found	|O
at	|O
5	|O
months	|O
post	|O
-	|O
TBI	|O
.	|O
b	|O
/	|O
Two	|O
-	|O
way	|O
avoidance	|O
test	|O
:	|O
this	|O
test	|O
was	|O
performed	|O
only	|O
after	|O
TBI	|O
.	|O

At	|O
the	|O
end	|O
of	|O
each	|O
day	|O
of	|O
migration	|O
the	|O
pulmonary	|O
hemolymph	|O
PO2	|O
decreased	|O
by	|O
1-2.5	|O
kPa	|O
,	|O
but	|O
the	|O
hemocyanin	|O
remained	|O
saturated	|O
with	|O
O2	|O
and	|O
the	|O
venous	|O
reserve	|O
was	|O
largely	|O
unchanged	|O
(	|O
O2	|O
>	|O
0.4	|O
mmol	|O
x	|O
l	|O
(	|O
-	|O
1	|O
)	|O
)	|O
.	|O

DESIGN	|O
:	|O
Prospective	|O
cohort	|O
study	|O
with	|O
a	|O
20	|O
y	|O
follow	|O
-	|O
up	|O
period	|O
,	|O
the	|O
First	|O
National	|O
Health	|O
and	|O
Examination	|O
Survey	|O
(	|O
NHANES	|O
1	|O
)	|O
Epidemiologic	|O
Follow	|O
-	|O
up	|O
Study	|O
(	|O
NHEFS	|O
)	|O
.	|O

Mean	|O
Hg	|O
concentrations	|O
in	|O
the	|O
livers	|O
of	|O
mice	|O
at	|O
some	|O
sites	|O
in	|O
Isle	|O
Royale	|O
are	|O
not	|O
significantly	|O
lower	|O
(	|O
P	|O
=	|O
0.62	|O
)	|O
than	|O
Hg	|O
concentrations	|O
considered	|O
by	|O
some	|O
government	|O
agencies	|O
to	|O
be	|O
unhealthy	|O
for	|O
human	|O
consumption	|O
.	|O

There	|O
are	|O
many	|O
different	|O
proposals	|O
for	|O
the	|O
statistical	|O
analysis	|O
of	|O
data	|O
to	|O
determine	|O
early	|O
onset	|O
of	|O
action	|O
.	|O

The	|O
assay	|O
herein	|O
described	|O
allows	|O
the	|O
comparison	|O
of	|O
relative	|O
FGFR	|B-PROTEIN
expression	|O
levels	|O
,	|O
both	|O
within	|O
a	|O
single	|O
RNA	|O
pool	|O
and	|O
among	|O
multiple	|O
RNA	|O
pool	|O
samples	|O
.	|O

The	|O
amount	|O
of	|O
drained	|O
effusion	|O
was	|O
measured	|O
,	|O
and	|O
fluid	|O
was	|O
sent	|O
for	|O
diagnostic	|O
assessment	|O
.	|O

The	|O
system	|O
,	|O
designed	|O
to	|O
exploit	|O
the	|O
relatively	|O
constant	|O
small	|O
intestine	|O
transit	|O
time	|O
,	|O
consists	|O
of	|O
a	|O
drug	|O
-	|O
containing	|O
core	|O
coated	|O
with	|O
a	|O
polymeric	|O
matrix	|O
formed	|O
by	|O
a	|O
channeling	|O
agent	|O
(	|O
NaCl	|O
,	|O
mannitol	|O
,	|O
and	|O
Emdex	|O
)	|O
and	|O
an	|O
inert	|O
polymer	|O
(	|O
Eudragit	|O
RS100	|O
)	|O
.	|O

STUDY	|O
OBJECTIVE	|O
:	|O
This	|O
study	|O
assessed	|O
several	|O
methodological	|O
aspects	|O
related	|O
to	|O
the	|O
quality	|O
of	|O
published	|O
controlled	|O
clinical	|O
trials	|O
(	|O
CCTs	|O
)	|O
in	|O
relation	|O
to	|O
the	|O
participation	|O
of	|O
an	|O
epidemiologist	|O
/	|O
biostatistician	|O
(	|O
E	|O
/	|O
B	|O
)	|O
.	|O

The	|O
median	|O
preoperative	|O
best	|O
-	|O
corrected	|O
visual	|O
acuity	|O
of	|O
0.08	|O
(	|O
range	|O
hand	|O
motions	|O
/	|O
0.003	|O
to	|O
0.4	|O
)	|O
,	|O
improved	|O
by	|O
5	|O
lines	|O
to	|O
a	|O
median	|O
final	|O
postoperative	|O
best	|O
-	|O
corrected	|O
visual	|O
acuity	|O
of	|O
0.25	|O
(	|O
range	|O
0.025-0.5	|O
)	|O
(	|O
P	|O
=	|O
0.001	|O
)	|O
.	|O

A	|O
rare	|O
case	|O
of	|O
primary	|O
group	|O
A	|O
streptococcal	|O
peritonitis	|O
.	|O

Gimpl	|O
,	|O
F.	|O

The	|O
present	|O
chemotherapy	|O
of	|O
AE	|O
is	|O
based	|O
on	|O
the	|O
administration	|O
of	|O
benzimidazole	|O
carbamate	|O
derivatives	|O
,	|O
such	|O
as	|O
mebendazole	|O
and	|O
albendazole	|O
.	|O

Topological	|O
and	|O
mutational	|O
analysis	|O
of	|O
Saccharomyces	|O
cerevisiae	|O
Ste14p	|B-PROTEIN
,	|O
founding	|O
member	|O
of	|O
the	|O
isoprenylcysteine	|B-PROTEIN
carboxyl	|I-PROTEIN
methyltransferase	|I-PROTEIN
family	|O
.	|O

Hormonal	|O
regulation	|O
of	|O
multiple	|O
promoters	|O
of	|O
the	|O
rat	|O
mitochondrial	|O
glycerol	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
phosphate	|I-PROTEIN
dehydrogenase	|I-PROTEIN
gene	|O
:	|O
identification	|O
of	|O
a	|O
complex	|O
hormone	|O
-	|O
response	|O
element	|O
in	|O
the	|O
ubiquitous	|O
promoter	|O
B.	|O

BACKGROUND	|O
/	|O
AIMS	|O
:	|O
Hepatitis	|O
C	|O
and	|O
nonalcoholic	|O
fatty	|O
liver	|O
disease	|O
(	|O
NAFL	|O
)	|O
are	|O
the	|O
two	|O
most	|O
common	|O
forms	|O
of	|O
liver	|O
disease	|O
in	|O
the	|O
United	|O
States	|O
.	|O

Statistical	|O
Analysis	|O
included	|O
ANOVA	|O
,	|O
the	|O
Pearson	|O
Product	|O
Moment	|O
Correlation	|O
Coefficient	|O
,	|O
Principal	|O
Components	|O
Analysis	|O
and	|O
Discriminant	|O
Function	|O
Analysis	|O
and	|O
the	|O
calculation	|O
of	|O
Cronbach	|O
's	|O
alpha	|O
(	|O
alpha	|O
)	|O
RESULTS	|O
:	|O
Both	|O
Sensitivity	|O
and	|O
specificity	|O
exceed	|O
90.00	|O
at	|O
23/24	|O
,	|O
Chronbach	|O
's	|O
alpha	|O
for	|O
the	|O
total	|O
scale	|O
was	|O
equal	|O
to	|O
0.95	|O
.	|O

The	|O
telomerase	|B-PROTEIN
RNA	|O
-	|O
protein	|O
complex	|O
responsible	|O
for	|O
maintenance	|O
of	|O
telomeric	|O
DNA	|O
at	|O
chromosome	|O
ends	|O
,	|O
is	|O
usually	|O
inactive	|O
in	|O
most	|O
primary	|O
somatic	|O
human	|O
cells	|O
,	|O
but	|O
is	|O
specifically	|O
activated	|O
with	|O
in	|O
vitro	|O
immortalization	|O
and	|O
during	|O
tumorigenesis	|O
.	|O

The	|O
titer	|O
of	|O
TSH	|B-PROTEIN
binding	|I-PROTEIN
inhibitor	|I-PROTEIN
immunoglobulin	|I-PROTEIN
(	|O
TBII	|B-PROTEIN
)	|O
,	|O
which	|O
had	|O
been	|O
8.6%	|O
at	|O
initial	|O
presentation	|O
,	|O
rose	|O
to	|O
14.9%	|O
in	|O
2	|O
weeks	|O
.	|O

Our	|O
results	|O
show	|O
that	|O
CVN	|B-PROTEIN
specifically	|O
recognizes	|O
with	|O
nanomolar	|O
affinity	|O
Man	|O
(	|O
9	|O
)	|O
GlcNAc	|O
(	|O
2	|O
)	|O
and	|O
the	|O
D1D3	|O
isomer	|O
of	|O
Man	|O
(	|O
8	|O
)	|O
GlcNAc	|O
(	|O
2	|O
)	|O
.	|O

Here	|O
we	|O
show	|O
that	|O
independent	|O
of	|O
uncertainties	|O
in	|O
the	|O
models	|O
,	|O
terrestrial	|O
planets	|O
with	|O
dense	|O
atmosphere	|O
like	|O
Venus	|O
can	|O
evolve	|O
into	|O
one	|O
of	|O
only	|O
four	|O
possible	|O
rotation	|O
states	|O
.	|O

Enantiomer	|O
separation	|O
of	|O
venlafaxine	|O
and	|O
O	|O
-	|O
desmethylvenlafaxine	|O
in	|O
human	|O
plasma	|O
.	|O

TE	|O
-	|O
671	|O
cells	|O
that	|O
were	|O
transfected	|O
with	|O
cAMP	|O
response	|O
element	|O
mutant	|O
constructs	|O
demonstrated	|O
a	|O
diminished	|O
basal	|O
activity	|O
of	|O
the	|O
GnRH	|B-PROTEIN
-	|I-PROTEIN
II	|I-PROTEIN
promoter	|O
.	|O

They	|O
consist	|O
of	|O
at	|O
least	|O
two	|O
separable	|O
components	|O
,	|O
one	|O
heat	|O
stable	|O
and	|O
the	|O
other	|O
heat	|O
labile	|O
.	|O

Altogether	|O
,	|O
we	|O
confirm	|O
that	|O
all	|O
genes	|O
of	|O
the	|O
Rad52	|B-PROTEIN
recombinational	|O
repair	|O
pathway	|O
are	|O
required	|O
for	|O
the	|O
survival	|O
of	|O
rad27	|B-PROTEIN
Delta	|I-PROTEIN
strains	|O
at	|O
both	|O
permissive	|O
(	|O
23	|O
degrees	|O
C	|O
)	|O
and	|O
semipermissive	|O
(	|O
30	|O
degrees	|O
C	|O
)	|O
temperatures	|O
for	|O
growth	|O
.	|O

In	|O
the	|O
last	|O
case	|O
,	|O
both	|O
hydroxychloroquine	|O
,	|O
carbamazepine	|O
and	|O
fluvoxamine	|O
had	|O
a	|O
common	|O
imputability	|O
which	|O
was	|O
plausible	|O
.	|O

We	|O
investigate	|O
the	|O
reaction	|O
kinetics	|O
of	|O
small	|O
spherical	|O
particles	|O
with	|O
inertia	|O
,	|O
obeying	|O
coalescence	|O
type	|O
of	|O
reaction	|O
,	|O
B+	|O
B	|O
-	|O
-	|O
>	|O
B	|O
,	|O
and	|O
being	|O
advected	|O
by	|O
hydrodynamical	|O
flows	|O
with	|O
time	|O
-	|O
periodic	|O
forcing	|O
.	|O

The	|O
role	|O
of	|O
the	|O
Vp1	|B-PROTEIN
DBD	|O
during	|O
infection	|O
was	|O
investigated	|O
by	|O
taking	|O
advantage	|O
of	|O
NLS	|O
phenotypic	|O
complementation	|O
(	|O
N.	|O

2	|O
were	|O
nonviable	|O
,	|O
and	|O
the	|O
mutant	|O
Vp1s	|B-PROTEIN
unexpectedly	|O
failed	|O
to	|O
localize	|O
to	|O
the	|O
nucleus	|O
though	|O
Vp2	|B-PROTEIN
and	|O
Vp3	|B-PROTEIN
did	|O
,	|O
suggesting	|O
that	|O
the	|O
mutated	|O
NLS1	|B-PROTEIN
acted	|O
as	|O
a	|O
dominant	|O
signal	|O
for	|O
the	|O
cytoplasmic	|O
localization	|O
of	|O
Vp1	|B-PROTEIN
.	|O

Zhu	|O
,	|O
V.	|O

Fasting	|O
gastrin	|B-PROTEIN
levels	|O
(	|O
normal	|O
range	|O
:	|O
25-110	|O
mU	|O
/	|O
L	|O
)	|O
varied	|O
from	|O
48.78	|O
mU	|O
/	|O
L	|O
-	|O
168.20	|O
(	|O
mean	|O
:	|O
85.23	|O
mU	|O
/	|O
L	|O
)	|O
.	|O

Here	|O
,	|O
we	|O
show	|O
that	|O
the	|O
phorbol	|O
ester	|O
PMA	|O
decreases	|O
both	|O
basal	|O
and	|O
dexamethasone	|O
/	|O
cAMP	|O
-	|O
induced	|O
expression	|O
of	|O
a	|O
luciferase	|B-PROTEIN
gene	|O
under	|O
the	|O
control	|O
of	|O
the	|O
G6Pase	|B-PROTEIN
promoter	|O
in	|O
transiently	|O
transfected	|O
H4IIE	|O
hepatoma	|O
cells	|O
.	|O

Through	|O
deletion	|O
mutagenesis	|O
,	|O
we	|O
identify	|O
amino	|O
acids	|O
2003	|O
to	|O
2212	|O
of	|O
CBP	|B-PROTEIN
,	|O
which	|O
we	|O
call	|O
carboxy	|O
-	|O
terminal	|O
region	|O
2	|O
(	|O
CR2	|O
)	|O
,	|O
as	|O
the	|O
minimal	|O
region	|O
for	|O
Tax	|B-PROTEIN
interaction	|O
.	|O

Such	|O
knowledge	|O
could	|O
advance	|O
diagnosis	|O
and	|O
treatment	|O
of	|O
the	|O
patient	|O
and	|O
counseling	|O
of	|O
the	|O
affected	|O
family	|O
.	|O

BACKGROUND	|O
:	|O
There	|O
is	|O
increasing	|O
interest	|O
on	|O
the	|O
part	|O
of	|O
investigators	|O
and	|O
the	|O
public	|O
at	|O
large	|O
in	|O
finding	|O
ways	|O
to	|O
study	|O
and	|O
improve	|O
treatments	|O
for	|O
the	|O
seriously	|O
mentally	|O
ill	|O
without	|O
exposing	|O
such	|O
individuals	|O
to	|O
unnecessary	|O
risks	|O
.	|O

In	|O
the	|O
next	|O
week	|O
,	|O
the	|O
beta	|O
-	|O
adrenergic	|O
antagonist	|O
atenolol	|O
was	|O
added	|O
at	|O
an	|O
initial	|O
dose	|O
of	|O
25	|O
mg	|O
/	|O
day	|O
and	|O
titrated	|O
to	|O
50	|O
mg	|O
/	|O
day	|O
within	|O
1	|O
week	|O
.	|O

Lack	|O
of	|O
association	|O
between	|O
Kawasaki	|O
syndrome	|O
and	|O
infection	|O
with	|O
Rickettsia	|O
conorii	|O
,	|O
Rickettsia	|O
typhi	|O
,	|O
Coxiella	|O
burnetii	|O
or	|O
Ehrlichia	|O
phagocytophila	|O
group	|O
.	|O

The	|O
presence	|O
of	|O
AS	|O
-	|O
oligo	|O
had	|O
no	|O
further	|O
effect	|O
on	|O
the	|O
FSH	|B-PROTEIN
-	|O
mediated	|O
activation	|O
of	|O
the	|O
EB	|O
*	|O
-	|O
mTf	|B-PROTEIN
-	|O
CAT	|B-PROTEIN
construct	|O
but	|O
reduced	|O
cAMP	|O
-	|O
mediated	|O
activation	|O
.	|O

This	|O
is	|O
a	|O
challenging	|O
task	|O
insofar	|O
as	|O
direct	|O
measures	|O
of	|O
ISF	|O
glucose	|O
are	|O
not	|O
readily	|O
available	|O
.	|O

We	|O
report	|O
the	|O
results	|O
of	|O
a	|O
detailed	|O
policy	|O
analysis	|O
comparing	|O
2	|O
CJD	|O
-	|O
related	|O
decisions	|O
:	|O
a	|O
1995	|O
recall	|O
of	|O
blood	|O
from	|O
a	|O
donor	|O
with	|O
classic	|O
CJD	|O
and	|O
the	|O
1999	|O
decision	|O
to	|O
defer	|O
donations	|O
from	|O
individuals	|O
with	|O
a	|O
6	|O
-	|O
month	|O
travel	|O
history	|O
to	|O
the	|O
UK	|O
between	|O
1980	|O
and	|O
1996	|O
due	|O
to	|O
concerns	|O
related	|O
to	|O
variant	|O
CJD	|O
.	|O

The	|O
novel	|O
approach	|O
to	|O
insulin	|B-PROTEIN
administration	|O
known	|O
as	|O
chronic	|O
intermittent	|O
intravenous	|O
insulin	|B-PROTEIN
therapy	|O
(	|O
CIIIT	|O
)	|O
delivers	|O
insulin	|B-PROTEIN
in	|O
a	|O
pulsatile	|O
fashion	|O
and	|O
achieves	|O
physiological	|O
insulin	|B-PROTEIN
concentration	|O
in	|O
the	|O
portal	|O
vein	|O
.	|O

At	|O
visit	|O
5	|O
,	|O
the	|O
isokinetic	|O
test	|O
showed	|O
impaired	|O
muscle	|O
function	|O
recovery	|O
from	|O
23%	|O
to	|O
32%	|O
,	|O
while	|O
the	|O
manual	|O
test	|O
showed	|O
almost	|O
full	|O
recovery	|O
.	|O

We	|O
developed	|O
a	|O
system	|O
for	|O
domain	|O
shuffling	|O
to	|O
establish	|O
the	|O
function	|O
of	|O
C1	|B-PROTEIN
domains	|O
from	|O
human	|O
Raf	|B-PROTEIN
kinase	|I-PROTEIN
and	|O
rat	|O
PKC	|B-PROTEIN
eta	|I-PROTEIN
in	|O
yeast	|O
.	|O

We	|O
interpret	|O
these	|O
data	|O
as	|O
further	|O
evidence	|O
that	|O
interaction	|O
with	|O
a	|O
small	|B-PROTEIN
GTPase	|I-PROTEIN
is	|O
the	|O
main	|O
regulatory	|O
function	|O
of	|O
the	|O
C1	|B-PROTEIN
domain	|O
in	|O
yeast	|O
.	|O

Breast	|O
cancer	|O
risk	|O
assessment	|O
:	|O
Who	|O
holds	|O
the	|O
magic	|O
crystal	|O
ball	|O
?	|O

Patients	|O
with	|O
type	|O
III	|O
SOD	|O
may	|O
have	|O
visceral	|O
hyperalgesia	|O
;	|O
a	|O
trial	|O
of	|O
antidepressants	|O
or	|O
a	|O
therapeutic	|O
trial	|O
with	|O
botulinum	|B-PROTEIN
toxin	|I-PROTEIN
injection	|O
into	|O
the	|O
ampulla	|O
should	|O
be	|O
considered	|O
prior	|O
to	|O
more	|O
invasive	|O
endoscopic	|O
therapy	|O
.	|O

The	|O
activity	|O
of	|O
Rac1	|B-PROTEIN
leads	|O
to	|O
STAT3	|B-PROTEIN
translocation	|O
to	|O
the	|O
nucleus	|O
coincident	|O
with	|O
STAT3	|B-PROTEIN
-	|O
dependent	|O
gene	|O
expression	|O
.	|O

RESULTS	|O
:	|O
There	|O
is	|O
a	|O
considerable	|O
amount	|O
of	|O
variation	|O
between	|O
the	|O
results	|O
of	|O
TRA1	|O
and	|O
TRA2	|O
and	|O
between	|O
the	|O
results	|O
of	|O
both	|O
TRA	|O
's	|O
and	|O
the	|O
door	|O
-	|O
to	|O
-	|O
door	|O
survey	|O
.	|O

In	|O
addition	|O
,	|O
these	|O
patients	|O
show	|O
both	|O
quantitative	|O
and	|O
qualitative	|O
differences	|O
in	|O
their	|O
infectious	|O
microbiological	|O
spectrum	|O
,	|O
mainly	|O
in	|O
clean	|O
-	|O
contaminated	|O
,	|O
contaminated	|O
and	|O
dirty	|O
surgical	|O
procedures	|O
.	|O

CONCLUSION	|O
:	|O
Extrusion	|O
cooking	|O
is	|O
effective	|O
for	|O
the	|O
inactivation	|O
of	|O
DON	|O
but	|O
is	|O
of	|O
limited	|O
value	|O
for	|O
AFB1	|B-PROTEIN
,	|O
even	|O
if	|O
metabisulphite	|O
is	|O
added	|O
.	|O

The	|O
differences	|O
in	|O
the	|O
CPIgG	|B-PROTEIN
,	|O
CRP	|B-PROTEIN
,	|O
and	|O
fibrinogen	|B-PROTEIN
levels	|O
in	|O
patients	|O
who	|O
were	|O
diagnosed	|O
with	|O
ACS	|O
versus	|O
those	|O
who	|O
were	|O
not	|O
(	|O
non	|O
-	|O
ACS	|O
)	|O
were	|O
evaluated	|O
.	|O

NaeI	|B-PROTEIN
,	|O
a	|O
novel	|O
DNA	|B-PROTEIN
endonuclease	|I-PROTEIN
,	|O
shows	|O
topoisomerase	|B-PROTEIN
and	|O
recombinase	|B-PROTEIN
activities	|O
when	|O
a	|O
Lys	|O
residue	|O
is	|O
substituted	|O
for	|O
Leu	|O
43	|O
.	|O

Mss4	|B-PROTEIN
also	|O
acts	|O
as	|O
a	|O
relatively	|O
inefficient	|O
guanine	|B-PROTEIN
nucleotide	|I-PROTEIN
exchange	|I-PROTEIN
factor	|I-PROTEIN
(	|O
GEF	|B-PROTEIN
)	|O
.	|O

The	|O
decrements	|O
in	|O
cerebrovascular	|O
resistance	|O
induced	|O
by	|O
hexamethonium	|O
,	|O
in	|O
mm	|O
Hg	|O
ml	|O
(	|O
-	|O
1	|O
)	|O
.	|O
min	|O
(	|O
-	|O
1	|O
)	|O
,	|O
were	|O
:	|O
under	|O
control	|O
.	|O

The	|O
desirability	|O
function	|O
is	|O
based	|O
on	|O
the	|O
search	|O
for	|O
a	|O
global	|O
optimum	|O
[	|O
D	|O
=	|O
f	|O
(	|O
Y1	|O
,	|O
Y2	|O
,	|O
...	|O
,	|O
Yn	|O
)	|O
]	|O
by	|O
the	|O
transformation	|O
of	|O
the	|O
measured	|O
property	|O
to	|O
a	|O
dimensionless	|O
scale	|O
for	|O
each	|O
criterion	|O
.	|O

She	|O
has	|O
since	|O
developed	|O
a	|O
positive	|O
anti	|O
-	|O
cardiolipin	|B-PROTEIN
antibody	|I-PROTEIN
but	|O
does	|O
not	|O
meet	|O
diagnostic	|O
criteria	|O
for	|O
systemic	|O
lupus	|O
erythematosis	|O
.	|O
CONCLUSION	|O
:	|O
The	|O
presence	|O
of	|O
known	|O
autoimmune	|O
disease	|O
in	|O
a	|O
woman	|O
with	|O
POF	|O
should	|O
not	|O
dissuade	|O
the	|O
clinician	|O
from	|O
evaluating	|O
for	|O
a	|O
potential	|O
genetic	|O
cause	|O
.	|O

RESULTS	|O
:	|O
In	|O
vivo	|O
,	|O
there	|O
was	|O
a	|O
wide	|O
distribution	|O
with	|O
the	|O
coefficient	|O
of	|O
variation	|O
(	|O
SD	|O
/	|O
mean	|O
x	|O
100%	|O
)	|O
for	|O
different	|O
valve	|O
sizes	|O
ranging	|O
from	|O
21%	|O
to	|O
39%	|O
in	|O
the	|O
St	|O
Jude	|O
Medical	|O
valve	|O
and	|O
from	|O
25%	|O
to	|O
33%	|O
in	|O
the	|O
Omnicarbon	|O
valve	|O
.	|O

Even	|O
if	|O
the	|O
electrocardiographic	|O
signs	|O
are	|O
subdued	|O
,	|O
the	|O
underlying	|O
blockade	|O
of	|O
I	|O
(	|O
Kr	|O
)	|O
current	|O
may	|O
precipitate	|O
the	|O
occurrence	|O
of	|O
arrhythmia	|O
.	|O

Effects	|O
of	|O
aerosol	|O
-	|O
vapor	|O
JP	|O
-	|O
8	|O
jet	|O
fuel	|O
on	|O
the	|O
functional	|O
observational	|O
battery	|O
,	|O
and	|O
learning	|O
and	|O
memory	|O
in	|O
the	|O
rat	|O
.	|O

The	|O
production	|O
of	|O
ceramide	|O
is	|O
emerging	|O
as	|O
a	|O
fixture	|O
of	|O
programmed	|O
cell	|O
death	|O
.	|O

We	|O
randomly	|O
assigned	|O
1,219	|O
subjects	|O
to	|O
receive	|O
either	|O
the	|O
standard	|O
three	|O
-	|O
times	|O
-	|O
weekly	|O
(	|O
TIW	|O
)	|O
interferon	|B-PROTEIN
alfa	|I-PROTEIN
-	|I-PROTEIN
2b	|I-PROTEIN
dose	|O
(	|O
3	|O
MIU	|O
)	|O
or	|O
the	|O
once	|O
-	|O
weekly	|O
(	|O
QW	|O
)	|O
peginterferon	|B-PROTEIN
alfa	|I-PROTEIN
-	|I-PROTEIN
2b	|I-PROTEIN
(	|O
0.5	|O
,	|O
1.0	|O
,	|O
or	|O
1.5	|O
microg	|O
/	|O
kg	|O
)	|O
.	|O

At	|O
cross	|O
purposes	|O
.	|O

CONCLUSION	|O
:	|O
There	|O
are	|O
no	|O
differences	|O
in	|O
the	|O
measurement	|O
data	|O
derived	|O
from	|O
this	|O
method	|O
and	|O
actual	|O
measurement	|O
data	|O
from	|O
an	|O
object	|O
created	|O
by	|O
the	|O
computer	|O
-	|O
aided	|O
dental	|O
design	|O
program	|O
.	|O

Among	|O
the	|O
transcription	|O
factors	|O
known	|O
to	|O
interact	|O
with	|O
Groucho	|B-PROTEIN
-	|O
related	|O
protein	|O
,	|O
only	|O
RUNX1	|B-PROTEIN
was	|O
appreciably	|O
downregulated	|O
by	|O
E2A	|B-PROTEIN
-	|O
HLF	|B-PROTEIN
.	|O

Many	|O
factors	|O
do	|O
influence	|O
the	|O
educational	|O
outcome	|O
in	|O
students	|O
and	|O
large	|O
statistical	|O
power	|O
(	|O
such	|O
as	|O
meta	|O
analysis	|O
)	|O
should	|O
be	|O
helpful	|O
to	|O
eliminate	|O
many	|O
sources	|O
of	|O
error	|O
.	|O

The	|O
combination	|O
of	|O
ifosfamide	|O
,	|O
epirubicin	|O
and	|O
etoposide	|O
(	|O
IEV	|O
)	|O
is	|O
an	|O
effective	|O
salvage	|O
regimen	|O
for	|O
lymphoproliferative	|O
disease	|O
.	|O

A	|O
prospective	|O
trial	|O
was	|O
undertaken	|O
to	|O
determine	|O
(	|O
1	|O
)	|O
clinical	|O
characteristics	|O
of	|O
patients	|O
with	|O
chest	|O
pain	|O
;	|O
(	|O
2	|O
)	|O
value	|O
of	|O
cardiac	|O
markers	|O
troponin	|B-PROTEIN
T	|I-PROTEIN
,	|O
myoglobin	|B-PROTEIN
and	|O
CK	|B-PROTEIN
-	|O
MB	|B-PROTEIN
mass	|O
in	|O
differentiating	|O
cardiac	|O
and	|O
noncardiac	|O
chest	|O
pain	|O
;	|O
(	|O
3	|O
)	|O
the	|O
proportion	|O
of	|O
patients	|O
with	|O
ACS	|O
in	|O
whom	|O
these	|O
markers	|O
provided	|O
helpful	|O
additional	|O
information	|O
on	|O
admission	|O
and	|O
afterwards	|O
.	|O

Cardiac	|O
markers	|O
troponin	|B-PROTEIN
T	|I-PROTEIN
,	|O
CK	|B-PROTEIN
-	|O
MB	|B-PROTEIN
mass	|O
and	|O
myoglobin	|B-PROTEIN
were	|O
helpful	|O
in	|O
the	|O
differential	|O
diagnosis	|O
of	|O
chest	|O
pain	|O
,	|O
even	|O
when	|O
the	|O
ECG	|O
was	|O
unremarkable	|O
or	|O
nonspecific	|O
.	|O

At	|O
termination	|O
(	|O
gd	|O
20	|O
)	|O
,	|O
confirmed	|O
-	|O
pregnant	|O
females	|O
(	|O
21	|O
to	|O
25	|O
per	|O
group	|O
)	|O
were	|O
evaluated	|O
for	|O
clinical	|O
status	|O
and	|O
gestational	|O
outcome	|O
;	|O
live	|O
fetuses	|O
were	|O
examined	|O
for	|O
external	|O
,	|O
visceral	|O
,	|O
and	|O
skeletal	|O
malformations	|O
.	|O

One	|O
maternal	|O
death	|O
,	|O
reduced	|O
body	|O
weight	|O
,	|O
and	|O
reduced	|O
weight	|O
gain	|O
were	|O
noted	|O
at	|O
the	|O
high	|O
dose	|O
;	|O
confirmed	|O
pregnancy	|O
rates	|O
were	|O
84	|O
to	|O
100%	|O
for	|O
each	|O
group	|O
.	|O

In	|O
the	|O
further	|O
development	|O
of	|O
bladder	|O
neck	|O
suspension	|O
according	|O
to	|O
Stamey	|O
-	|O
Pereyra	|O
,	|O
the	|O
use	|O
of	|O
miniature	|O
bone	|O
anchors	|O
received	|O
considerable	|O
support	|O
.	|O

Our	|O
results	|O
demonstrated	|O
that	|O
50%	|O
of	|O
the	|O
hepatic	|O
artery	|O
-	|O
alone	|O
ALT	|O
graft	|O
showed	|O
almost	|O
normal	|O
structure	|O
histologically	|O
at	|O
1	|O
month	|O
after	|O
grafting	|O
,	|O
with	|O
bile	|O
secretion	|O
preserved	|O
.	|O

Simulating	|O
the	|O
impact	|O
during	|O
human	|O
jumping	|O
by	|O
means	|O
of	|O
a	|O
4	|O
-	|O
degrees	|O
-	|O
of	|O
-	|O
freedom	|O
model	|O
with	|O
time	|O
-	|O
dependent	|O
properties	|O
.	|O

A	|O
1	|O
-	|O
base	|O
pair	|O
mismatch	|O
within	|O
the	|O
corresponding	|O
region	|O
of	|O
the	|O
CYP3A4	|B-PROTEIN
gene	|O
was	|O
sufficient	|O
for	|O
a	|O
differential	|O
enhancer	|O
activity	|O
.	|O

The	|O
authors	|O
made	|O
an	|O
analysis	|O
of	|O
social	|O
-	|O
economical	|O
conditions	|O
limiting	|O
the	|O
possibilities	|O
of	|O
rendering	|O
cardiosurgical	|O
care	|O
to	|O
children	|O
.	|O

METHODS	|O
:	|O
93	|O
female	|O
and	|O
43	|O
male	|O
patients	|O
undergoing	|O
thyroid	|O
surgery	|O
were	|O
stratified	|O
according	|O
to	|O
gender	|O
and	|O
then	|O
randomised	|O
to	|O
receive	|O
double	|O
-	|O
blind	|O
one	|O
of	|O
four	|O
antiemetic	|O
regimes	|O
:	|O
50	|O
mg	|O
dolasetron	|O
given	|O
orally	|O
45	|O
minutes	|O
prior	|O
to	|O
induction	|O
of	|O
anaesthesia	|O
(	|O
group	|O
I	|O
)	|O
,	|O
12.5	|O
mg	|O
dolasetron	|O
given	|O
intravenously	|O
during	|O
induction	|O
of	|O
anaesthesia	|O
(	|O
group	|O
II	|O
)	|O
,	|O
1.25	|O
mg	|O
DHB	|B-PROTEIN
given	|O
intravenously	|O
during	|O
induction	|O
of	|O
anaesthesia	|O
(	|O
group	|O
III	|O
)	|O
or	|O
placebo	|O
(	|O
group	|O
IV	|O
)	|O
.	|O

This	|O
slow	|O
progression	|O
through	|O
the	|O
early	|O
G1	|O
-	|O
phase	|O
resulted	|O
in	|O
decreased	|O
phosphorylation	|O
of	|O
the	|O
RB	|B-PROTEIN
protein	|O
and	|O
subsequent	|O
delay	|O
into	|O
the	|O
S	|O
phase	|O
transition	|O
.	|O

In	|O
mammals	|O
,	|O
the	|O
transcriptional	|O
repressors	|O
in	|O
the	|O
Wnt	|B-PROTEIN
pathway	|O
are	|O
not	|O
well	|O
defined	|O
.	|O

The	|O
human	|O
ABCG1	|B-PROTEIN
gene	|O
encodes	|O
a	|O
member	|O
of	|O
the	|O
ATP	|B-PROTEIN
-	|I-PROTEIN
binding	|I-PROTEIN
cassette	|I-PROTEIN
(	|O
ABC	|B-PROTEIN
)	|O
superfamily	|O
of	|O
transporter	|B-PROTEIN
proteins	|I-PROTEIN
and	|O
is	|O
highly	|O
induced	|O
when	|O
macrophages	|O
are	|O
incubated	|O
with	|O
oxysterols	|O
.	|O

Despite	|O
abundant	|O
expression	|O
of	|O
NtmybAS	|B-PROTEIN
transcripts	|O
in	|O
mature	|O
pollen	|O
,	|O
gPAL1	|B-PROTEIN
transcripts	|O
were	|O
not	|O
detectable	|O
in	|O
pollen	|O
.	|O

C	|B-PROTEIN
/	|I-PROTEIN
EBPbeta	|I-PROTEIN
LIP	|I-PROTEIN
overexpressing	|O
HC11	|O
cells	|O
did	|O
not	|O
express	|O
beta	|B-PROTEIN
-	|I-PROTEIN
casein	|I-PROTEIN
mRNA	|O
(	|O
mammary	|O
epithelial	|O
cell	|O
differentiation	|O
marker	|O
)	|O
in	|O
response	|O
to	|O
lactogenic	|O
hormones	|O
.	|O

Identical	|O
effects	|O
were	|O
obtained	|O
when	|O
inhibitors	|O
and	|O
dominant	|O
negative	|O
mutants	|O
were	|O
tested	|O
on	|O
the	|O
-	|O
29	|O
to	|O
+	|O
139	|O
bp	|O
region	|O
of	|O
the	|O
cyclin	|B-PROTEIN
D1	|I-PROTEIN
promoter	|O
.	|O

These	|O
findings	|O
suggest	|O
a	|O
novel	|O
ankyrin	|B-PROTEIN
-	|O
independent	|O
role	|O
for	|O
LAD	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
related	|O
to	|O
FGFR	|B-PROTEIN
signaling	|O
.	|O

Moreover	|O
,	|O
elderly	|O
men	|O
with	|O
bioavailable	|O
estradiol	|O
levels	|O
below	|O
the	|O
median	|O
[	|O
40	|O
pmol	|O
/	|O
liter	|O
(	|O
11	|O
pg	|O
/	|O
ml	|O
)	|O
]	|O
had	|O
significantly	|O
higher	|O
rates	|O
of	|O
bone	|O
loss	|O
and	|O
levels	|O
of	|O
bone	|O
resorption	|O
markers	|O
than	|O
men	|O
with	|O
bioavailable	|O
estradiol	|O
levels	|O
above	|O
40	|O
pmol	|O
/	|O
liter	|O
.	|O

Competition	|O
electrophoretic	|O
mobility	|O
shift	|O
and	|O
immunoshift	|O
assays	|O
confirmed	|O
that	|O
NF1	|B-PROTEIN
factors	|I-PROTEIN
present	|O
in	|O
nuclear	|O
extracts	|O
of	|O
HeLa	|O
and	|O
CV	|O
-	|O
1	|O
cells	|O
bind	|O
to	|O
the	|O
BKV	|O
-	|O
MLP	|B-PROTEIN
.	|O

This	|O
study	|O
demonstrates	|O
that	|O
inducible	|O
expression	|O
in	|O
response	|O
to	|O
either	|O
PMA	|O
or	|O
TPO	|B-PROTEIN
is	|O
mediated	|O
through	|O
the	|O
Ets	|B-PROTEIN
site	|O
in	|O
the	|O
proximal	|O
promoter	|O
of	|O
GPIX	|B-PROTEIN
and	|O
is	|O
dependent	|O
upon	|O
the	|O
upstream	|O
activation	|O
of	|O
MAPK	|B-PROTEIN
/	|O
extracellular	|B-PROTEIN
signal	|I-PROTEIN
-	|I-PROTEIN
regulated	|I-PROTEIN
kinase	|I-PROTEIN
.	|O

RESULTS	|O
:	|O
The	|O
analyzed	|O
fragment	|O
has	|O
significant	|O
activity	|O
in	|O
EpCAM	|B-PROTEIN
positive	|O
cells	|O
,	|O
and	|O
it	|O
is	|O
regulated	|O
negatively	|O
by	|O
tumor	|B-PROTEIN
necrosis	|I-PROTEIN
factor	|I-PROTEIN
alpha	|I-PROTEIN
(	|O
TNFalpha	|B-PROTEIN
)	|O
.	|O

On	|O
Cox	|O
proportional	|O
hazards	|O
regression	|O
adenocarcinoma	|O
(	|O
P	|O
=	|O
0.006	|O
)	|O
,	|O
the	|O
development	|O
of	|O
BPF	|O
(	|O
P	|O
=	|O
0.003	|O
)	|O
,	|O
older	|O
age	|O
(	|O
P	|O
=	|O
0.03	|O
)	|O
and	|O
higher	|O
pathological	|O
stage	|O
(	|O
P	|O
=	|O
0.02	|O
)	|O
were	|O
independent	|O
adverse	|O
predictors	|O
of	|O
survival	|O
.	|O

Phosphatidylinositol	|B-PROTEIN
3	|I-PROTEIN
-	|I-PROTEIN
kinase	|I-PROTEIN
potentiates	|O
,	|O
but	|O
does	|O
not	|O
trigger	|O
,	|O
T	|O
cell	|O
proliferation	|O
mediated	|O
by	|O
the	|O
IL	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
receptor	|I-PROTEIN
.	|O

In	|O
the	|O
stable	|O
transfectants	|O
(	|O
BM3	|O
cells	|O
)	|O
expressing	|O
a	|O
mutant	|O
bacterial	|O
P450	|B-PROTEIN
AA	|I-PROTEIN
epoxygenase	|I-PROTEIN
,	|O
F87V	|O
BM3	|O
,	|O
which	|O
was	|O
genetically	|O
engineered	|O
to	|O
metabolize	|O
arachidonic	|O
acid	|O
only	|O
to	|O
14,15	|O
-	|O
EET	|O
,	|O
AA	|O
did	|O
not	|O
induce	|O
apoptosis	|O
and	|O
protected	|O
against	|O
agonist	|O
-	|O
induced	|O
apoptosis	|O
.	|O

The	|O
loop	|O
domain	|O
of	|O
heat	|B-PROTEIN
shock	|I-PROTEIN
transcription	|I-PROTEIN
factor	|I-PROTEIN
1	|I-PROTEIN
dictates	|O
DNA	|O
-	|O
binding	|O
specificity	|O
and	|O
responses	|O
to	|O
heat	|O
stress	|O
.	|O

EXAFS	|O
measurements	|O
around	|O
the	|O
Ge	|O
-	|O
K	|O
edge	|O
have	|O
been	|O
carried	|O
out	|O
for	|O
liquid	|O
Ge	|O
-	|O
Si	|O
alloys	|O
for	|O
the	|O
first	|O
time	|O
to	|O
investigate	|O
the	|O
local	|O
structure	|O
around	|O
a	|O
Ge	|O
atom	|O
.	|O

Progressive	|O
study	|O
and	|O
robustness	|O
test	|O
of	|O
QSAR	|O
model	|O
based	|O
on	|O
quantum	|O
chemical	|O
parameters	|O
for	|O
predicting	|O
BCF	|O
of	|O
selected	|O
polychlorinated	|O
organic	|O
compounds	|O
(	|O
PCOCs	|O
)	|O
.	|O

Of	|O
the	|O
six	|O
cases	|O
of	|O
malignant	|O
polyposis	|O
,	|O
none	|O
were	|O
identified	|O
using	|O
CT	|O
,	|O
and	|O
only	|O
two	|O
were	|O
diagnosed	|O
by	|O
small	|O
bowel	|O
follow	|O
-	|O
through	|O
.	|O

Using	|O
the	|O
two	|O
-	|O
hybrid	|O
system	|O
,	|O
we	|O
show	|O
that	|O
nonprenylated	|O
Rac1	|B-PROTEIN
interacts	|O
very	|O
weakly	|O
with	|O
Rho	|B-PROTEIN
-	|I-PROTEIN
GDI	|I-PROTEIN
,	|O
pointing	|O
to	|O
the	|O
predominant	|O
role	|O
of	|O
protein	|O
-	|O
isoprene	|O
interaction	|O
in	|O
complex	|O
formation	|O
.	|O

Although	|O
metabolized	|O
by	|O
the	|O
cytochrome	|B-PROTEIN
P	|I-PROTEIN
-	|I-PROTEIN
450	|I-PROTEIN
(	|O
CYP	|B-PROTEIN
)	|O
system	|O
,	|O
venlafaxine	|O
inhibits	|O
CYP	|B-PROTEIN
2D6	|I-PROTEIN
and	|I-PROTEIN
3A4	|I-PROTEIN
to	|O
a	|O
far	|O
lesser	|O
extent	|O
than	|O
do	|O
the	|O
SSRIs	|O
.	|O

Analysis	|O
of	|O
the	|O
promoter	|O
sequence	|O
revealed	|O
the	|O
presence	|O
of	|O
a	|O
major	|O
transcriptional	|O
start	|O
site	|O
,	|O
a	|O
canonical	|O
TATA	|O
box	|O
and	|O
putative	|O
cis	|O
regulatory	|O
elements	|O
for	|O
pituitary	|O
specific	|O
expression	|O
as	|O
well	|O
as	|O
an	|O
E	|O
-	|O
responsive	|O
element	|O
.	|O

Novel	|O
intronic	|O
promoter	|O
in	|O
the	|O
rat	|O
ER	|B-PROTEIN
alpha	|I-PROTEIN
gene	|O
responsible	|O
for	|O
the	|O
transient	|O
transcription	|O
of	|O
a	|O
variant	|O
receptor	|O
.	|O

Pitx2	|B-PROTEIN
rescues	|O
the	|O
GABAergic	|O
differentiation	|O
defect	|O
and	|O
partially	|O
rescues	|O
the	|O
axon	|O
guidance	|O
and	|O
behavioral	|O
phenotypes	|O
of	|O
unc	|B-PROTEIN
-	|I-PROTEIN
30	|I-PROTEIN
mutants	|O
,	|O
indicating	|O
a	|O
high	|O
degree	|O
of	|O
functional	|O
conservation	|O
between	|O
these	|O
evolutionarily	|O
related	|O
genes	|O
.	|O

The	|O
patterns	|O
of	|O
early	|O
mRNA	|O
and	|O
protein	|O
expression	|O
in	|O
these	|O
seven	|O
mutants	|O
were	|O
examined	|O
,	|O
and	|O
it	|O
was	|O
found	|O
that	|O
mutation	|O
of	|O
the	|O
T'	|B-PROTEIN
(	|I-PROTEIN
135	|I-PROTEIN
)	|I-PROTEIN
acceptor	|O
site	|O
resulted	|O
in	|O
the	|O
utilization	|O
of	|O
cryptic	|O
splice	|O
sites	|O
and	|O
the	|O
generation	|O
of	|O
new	|O
T'	|B-PROTEIN
species	|O
.	|O

Sixty	|O
-	|O
one	|O
cases	|O
of	|O
cholera	|O
,	|O
all	|O
caused	|O
by	|O
V.	|O
cholerae	|O
O1	|O
,	|O
were	|O
reported	|O
.	|O

Subsequently	|O
,	|O
these	|O
coordinates	|O
must	|O
be	|O
interpreted	|O
to	|O
define	|O
particular	|O
tissues	|O
and	|O
organs	|O
.	|O

Testing	|O
was	|O
associated	|O
with	|O
a	|O
history	|O
of	|O
nonsexual	|O
risk	|O
behavior	|O
,	|O
increased	|O
knowledge	|O
of	|O
the	|O
hepatitis	|O
C	|O
virus	|O
,	|O
and	|O
healthcare	|O
provider	|O
communication	|O
.	|O

Low	|O
-	|O
selenium	|O
diet	|O
has	|O
a	|O
human	|O
unfavourable	|O
impact	|O
.	|O

Thus	|O
,	|O
BALB	|O
/	|O
c	|O
mice	|O
appear	|O
to	|O
be	|O
the	|O
most	|O
appropriate	|O
strain	|O
of	|O
mice	|O
to	|O
perform	|O
studies	|O
on	|O
the	|O
possible	|O
connection	|O
between	|O
infection	|O
with	|O
T.	|O
canis	|O
and	|O
allergic	|O
asthma	|O
.	|O

We	|O
have	|O
previously	|O
shown	|O
that	|O
the	|O
adenoviral	|O
12S	|O
E1A	|B-PROTEIN
protein	|O
modulates	|O
the	|O
phosphorylation	|O
status	|O
of	|O
p130	|B-PROTEIN
and	|O
p107	|B-PROTEIN
without	|O
apparent	|O
changes	|O
in	|O
the	|O
cell	|O
cycle	|O
dependent	|O
phosphorylation	|O
of	|O
the	|O
retinoblastoma	|B-PROTEIN
protein	|I-PROTEIN
.	|O

The	|O
prevalence	|O
of	|O
tobacco	|O
dependence	|O
diagnosed	|O
according	|O
to	|O
the	|O
ICD	|O
-	|O
10	|O
criteria	|O
was	|O
higher	|O
in	|O
alcohol	|O
-	|O
dependent	|O
individuals	|O
(	|O
58.1%	|O
)	|O
than	|O
in	|O
nondrinkers	|O
or	|O
social	|O
drinkers	|O
(	|O
12.8%	|O
)	|O
.	|O

Diffuse	|O
myalgias	|O
were	|O
more	|O
frequent	|O
in	|O
patients	|O
with	|O
than	|O
without	|O
an	|O
MMF	|O
lesion	|O
at	|O
deltoid	|O
muscle	|O
biopsy	|O
(	|O
P	|O
<	|O
0.0001	|O
)	|O
.	|O

Furthermore	|O
,	|O
hormonal	|O
regulation	|O
of	|O
G	|O
(	|O
1	|O
)	|O
gene	|O
transcription	|O
can	|O
occur	|O
even	|O
without	|O
additional	|O
activation	|O
of	|O
the	|O
Mek	|B-PROTEIN
-	|O
Erk1/2	|B-PROTEIN
pathway	|O
by	|O
estrogen	|B-PROTEIN
receptors	|I-PROTEIN
.	|O

Therefore	|O
,	|O
to	|O
understand	|O
how	|O
ErbB1	|B-PROTEIN
/	|O
ErbB2	|B-PROTEIN
signaling	|O
contributes	|O
to	|O
this	|O
process	|O
,	|O
we	|O
used	|O
the	|O
ErbB	|B-PROTEIN
kinase	|I-PROTEIN
inhibitor	|O
AG1478in	|O
ErbB2	|B-PROTEIN
-	|O
dependent	|O
BT	|O
-	|O
474	|O
and	|O
SKBR	|O
-	|O
3	|O
human	|O
breast	|O
cancer	|O
cells	|O
.	|O

This	|O
plus	|O
the	|O
reduced	|O
phosphorylation	|O
of	|O
p27	|B-PROTEIN
by	|O
MAPK	|B-PROTEIN
enhanced	|O
the	|O
stability	|O
of	|O
p27	|B-PROTEIN
that	|O
associated	|O
with	|O
nuclear	|O
Cdk2	|B-PROTEIN
at	|O
high	|O
stoichiometry	|O
and	|O
inhibited	|O
its	|O
kinase	|O
activity	|O
.	|O

ICA	|O
in	|O
the	|O
reference	|O
solution	|O
was	|O
characterised	|O
by	|O
LC	|O
and	|O
time	|O
-	|O
of	|O
-	|O
flight	|O
(	|O
TOF	|O
)	|O
MS	|O
and	|O
quantified	|O
by	|O
LC	|O
chemiluminescent	|O
nitrogen	|O
detection	|O
(	|O
LC	|O
-	|O
CLND	|O
)	|O
.	|O

Forced	|O
expression	|O
of	|O
BZAP45	|B-PROTEIN
strongly	|O
stimulates	|O
H4	|B-PROTEIN
promoter	|O
(	|O
nt	|O
-	|O
215	|O
to	|O
-	|O
1	|O
)	|O
/	|O
CAT	|B-PROTEIN
reporter	|O
gene	|O
activity	|O
.	|O

Local	|O
control	|O
rates	|O
were	|O
91%	|O
for	|O
metastatic	|O
lung	|O
cancer	|O
,	|O
89%	|O
for	|O
primary	|O
lung	|O
cancer	|O
and	|O
85%	|O
for	|O
T1	|O
,	|O
2N0M0	|O
cases	|O
.	|O

Utility	|O
of	|O
OAE	|O
screener	|O
(	|O
GSI	|O
70	|O
)	|O
for	|O
the	|O
evaluation	|O
of	|O
distortion	|O
product	|O
otoacoustic	|O
emissions	|O
]	|O
The	|O
purpose	|O
of	|O
this	|O
study	|O
was	|O
to	|O
investigate	|O
the	|O
ability	|O
of	|O
the	|O
OAE	|O
screener	|O
GSI	|O
70	|O
to	|O
evaluate	|O
of	|O
cochlea	|O
function	|O
in	|O
neonates	|O
,	|O
infants	|O
and	|O
adults	|O
.	|O

For	|O
the	|O
sample	|O
of	|O
systematic	|O
reviews	|O
drawn	|O
from	|O
ACP	|O
Journal	|O
Club	|O
(	|O
n	|O
=	|O
103	|O
)	|O
,	|O
the	|O
PubMed	|O
strategy	|O
achieved	|O
a	|O
sensitivity	|O
of	|O
97%	|O
(	|O
CI	|O
,	|O
91%	|O
to	|O
99%	|O
)	|O
.	|O

Additionally	|O
,	|O
a	|O
CaCO3	|O
-	|O
CO2	|O
/	|O
N2	|O
buffered	|O
solution	|O
was	|O
necessary	|O
to	|O
maintain	|O
a	|O
pH	|O
of	|O
8	|O
.	|O

Inhibition	|O
of	|O
JNK1	|B-PROTEIN
and	|O
ERK	|B-PROTEIN
kinase	|O
activities	|O
either	|O
by	|O
expression	|O
of	|O
the	|O
dominant	|O
negative	|O
mutant	|O
JNK1	|B-PROTEIN
or	|O
by	|O
treatment	|O
with	|O
a	|O
selective	|O
chemical	|O
inhibitor	|O
of	|O
ERK	|B-PROTEIN
(	|O
PD098059	|O
)	|O
substantially	|O
abrogates	|O
the	|O
UV	|O
induction	|O
of	|O
the	|O
GADD45	|B-PROTEIN
promoter	|O
.	|O

With	|O
a	|O
GC	|O
content	|O
of	|O
45%	|O
the	|O
one	|O
segment	|O
would	|O
correspond	|O
to	|O
"	|O
isochore	|O
H1	|B-PROTEIN
"	|O
and	|O
the	|O
other	|O
segment	|O
(	|O
39%	|O
GC	|O
in	|O
human	|O
,	|O
40%	|O
GC	|O
in	|O
mouse	|O
)	|O
to	|O
"	|O
isochore	|O
L1	|B-PROTEIN
/	|O
L2	|B-PROTEIN
"	|O
.	|O

Copyright	|O
2001	|O
S.	|O

No	|O
mutation	|O
of	|O
the	|O
NRL	|B-PROTEIN
gene	|O
was	|O
found	|O
in	|O
any	|O
of	|O
the	|O
two	|O
families	|O
.	|O

NF	|B-PROTEIN
-	|I-PROTEIN
kappaB	|I-PROTEIN
is	|O
involved	|O
in	|O
the	|O
regulation	|O
of	|O
CD154	|B-PROTEIN
(	|O
CD40	|B-PROTEIN
ligand	|O
)	|O
expression	|O
in	|O
primary	|O
human	|O
T	|O
cells	|O
.	|O

After	|O
nerve	|O
injury	|O
,	|O
the	|O
nociceptive	|O
responses	|O
through	|O
type	|O
I	|O
neurons	|O
,	|O
which	|O
are	|O
polymodal	|O
C	|O
-	|O
fibers	|O
and	|O
drive	|O
NK1	|B-PROTEIN
-	|I-PROTEIN
receptor	|I-PROTEIN
mechanisms	|O
in	|O
spinal	|O
pain	|O
transmission	|O
,	|O
were	|O
completely	|O
lost	|O
,	|O
but	|O
without	|O
changes	|O
in	|O
type	|O
II	|O
ones	|O
,	|O
which	|O
are	|O
polymodal	|O
C	|O
-	|O
fibers	|O
and	|O
drive	|O
NMDA	|B-PROTEIN
receptor	|I-PROTEIN
-	|O
mechanisms	|O
,	|O
while	|O
type	|O
III	|O
ones	|O
,	|O
which	|O
are	|O
capsaicin	|O
-	|O
insensitive	|O
(	|O
possibly	|O
A	|O
-	|O
fibers	|O
)	|O
and	|O
drive	|O
NMDA	|B-PROTEIN
-	|I-PROTEIN
receptor	|I-PROTEIN
mechanisms	|O
,	|O
were	|O
markedly	|O
enhanced	|O
.	|O

This	|O
article	|O
reports	|O
the	|O
design	|O
and	|O
development	|O
of	|O
an	|O
ECG	|O
simulator	|O
intended	|O
for	|O
use	|O
in	|O
the	|O
testing	|O
,	|O
calibration	|O
and	|O
maintenance	|O
of	|O
electrocardiographic	|O
equipment	|O
.	|O

Subacute	|O
diencephalic	|O
angioencephalopathy	|O
(	|O
SDAE	|O
)	|O
is	|O
a	|O
rare	|O
and	|O
fatal	|O
disease	|O
of	|O
unknown	|O
etiology	|O
that	|O
involves	|O
the	|O
thalami	|O
bilaterally	|O
.	|O

Third	|O
,	|O
consistent	|O
with	|O
these	|O
data	|O
,	|O
N	|O
-	|O
acetylcysteine	|O
reduced	|O
the	|O
stimulatory	|O
effect	|O
of	|O
HGF	|B-PROTEIN
on	|O
stress	|B-PROTEIN
kinase	|I-PROTEIN
activities	|O
,	|O
while	|O
p42/44	|B-PROTEIN
mitogen	|O
activated	|O
kinase	|O
(	|O
MAPK	|O
)	|O
was	|O
unmodified	|O
,	|O
suggesting	|O
an	|O
involvement	|O
of	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
-	|I-PROTEIN
N	|I-PROTEIN
-	|I-PROTEIN
terminal	|I-PROTEIN
kinase	|I-PROTEIN
(	|O
JNK	|B-PROTEIN
)	|O
and	|O
p38	|B-PROTEIN
MAPK	|O
in	|O
HIF	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
activation	|O
.	|O

Mutation	|O
of	|O
the	|O
octamer	|O
element	|O
also	|O
significantly	|O
reduced	|O
the	|O
ability	|O
of	|O
HDAC1	|B-PROTEIN
to	|O
confer	|O
repression	|O
of	|O
inducible	|O
HLA	|B-PROTEIN
-	|I-PROTEIN
DRA	|I-PROTEIN
promoter	|O
activation	|O
.	|O

There	|O
was	|O
no	|O
significant	|O
difference	|O
in	|O
developmental	|O
scores	|O
at	|O
9	|O
or	|O
18	|O
months	|O
,	|O
although	|O
PDF	|O
infants	|O
had	|O
a	|O
2.8	|O
(	|O
-	|O
1.3-6.8	|O
)	|O
point	|O
advantage	|O
in	|O
Bayley	|O
motor	|O
score	|O
scales	|O
.	|O

In	|O
the	|O
single	|O
case	|O
the	|O
restoration	|O
of	|O
a	|O
structured	|O
daily	|O
routine	|O
represents	|O
the	|O
presupposition	|O
for	|O
a	|O
cognitive	|O
therapy	|O
.	|O

However	|O
these	|O
search	|O
engines	|O
respond	|O
with	|O
such	|O
cumbersome	|O
results	|O
that	|O
domain	|O
specific	|O
experts	|O
can	|O
not	|O
tolerate	|O
.	|O

The	|O
binary	|O
and	|O
tertiary	|O
combinations	|O
of	|O
plant	|O
-	|O
derived	|O
molluscicides	|O
Azadirachta	|O
indica	|O
and	|O
Cedrus	|O
deodara	|O
oil	|O
with	|O
synergists	|O
MGK	|O
-	|O
264	|O
,	|O
piperonyl	|O
butoxide	|O
(	|O
PB	|O
)	|O
and	|O
fruit	|O
powder	|O
of	|O
Embelia	|O
ribes	|O
were	|O
used	|O
against	|O
the	|O
Lymnaea	|O
acuminata	|O
.	|O

From	|O
the	|O
above	|O
results	|O
,	|O
we	|O
might	|O
infer	|O
that	|O
the	|O
seizure	|O
type	|O
of	|O
TLE	|O
and	|O
a	|O
high	|O
frequency	|O
of	|O
seizure	|O
are	|O
two	|O
major	|O
independent	|O
precipitate	|O
factors	|O
for	|O
abnormal	|O
latencies	|O
of	|O
P300	|O
in	|O
the	|O
epileptic	|O
patients	|O
.	|O

Audiological	|O
findings	|O
in	|O
pregnancy	|O
.	|O

The	|O
deubiquitinating	|O
enzyme	|O
DUB	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
is	|O
induced	|O
in	|O
response	|O
to	|O
IL	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
but	|O
as	|O
yet	|O
its	|O
function	|O
has	|O
not	|O
been	|O
determined	|O
.	|O

The	|O
isoform	|O
,	|O
designated	|O
HDAC9a	|B-PROTEIN
,	|O
is	|O
132	|O
aa	|O
shorter	|O
at	|O
the	|O
C	|O
terminus	|O
than	|O
HDAC9	|B-PROTEIN
.	|O

Pulmonary	|O
embolectomy	|O
and	|O
lung	|O
transplantation	|O
are	|O
the	|O
main	|O
indications	|O
for	|O
the	|O
use	|O
of	|O
heart	|O
-	|O
lung	|O
-	|O
machine	|O
.	|O

In	|O
such	|O
conditions	|O
,	|O
the	|O
following	|O
kinetic	|O
reactions	|O
have	|O
been	|O
studied	|O
:	|O
N2	|O
(	|O
A	|O
)	|O
+	|O
N2	|O
(	|O
A	|O
)	|O
-	|O
-	|O
>	|O
N2	|O
(	|O
C	|O
,	|O
B	|O
,	|O
V'	|O
)	|O
+	|O
N2	|O
(	|O
X	|O
)	|O
,	|O
N2	|O
(	|O
A	|O
)	|O
+	|O
N2	|O
(	|O
X	|O
,	|O
V	|O
>	|O
5	|O
)	|O
-	|O
-	|O
>	|O
N2	|O
(	|O
X	|O
)	|O
+	|O
N2	|O
(	|O
B	|O
,	|O
V'	|O
)	|O
in	|O
pure	|O
N2	|O
post	|O
-	|O
discharges	|O
and	|O
N2	|O
(	|O
A	|O
)	|O
+	|O
CH4	|O
-	|O
-	|O
>	|O
products	|O
,	|O
C	|O
+	|O
N	|O
+	|O
M2	|O
-	|O
-	|O
>	|O
CN	|O
(	|O
B	|O
,	|O
V'	|O
)	|O
+	|O
M2	|O
,	|O
N2	|O
(	|O
X	|O
,	|O
V	|O
>	|O
4	|O
)	|O
+	|O
CN	|O
-	|O
-	|O
>	|O
N2	|O
(	|O
X	|O
)	|O
+	|O
CN	|O
(	|O
B	|O
,	|O
A	|O
,	|O
V'	|O
)	|O
,	|O
in	|O
N2	|O
-	|O
1%	|O
CH4	|O
post	|O
-	|O
discharges	|O
.	|O

The	|O
NAUSICAA	|O
system	|O
gives	|O
a	|O
good	|O
knowledge	|O
of	|O
LET	|O
spectra	|O
for	|O
the	|O
first	|O
time	|O
in	|O
space	|O
dosimetry	|O
.	|O

In	|O
order	|O
to	|O
quantify	|O
these	|O
effects	|O
,	|O
tests	|O
were	|O
conducted	|O
in	|O
the	|O
NASA	|O
MSFC	|O
Neutral	|O
Buoyancy	|O
Simulator	|O
,	|O
in	|O
the	|O
NASA	|O
KC	|O
-	|O
135	|O
in	|O
parabolic	|O
flight	|O
,	|O
and	|O
in	|O
space	|O
with	|O
the	|O
EASE	|O
program	|O
during	|O
the	|O
Shuttle	|O
Atlantis	|O
mission	|O
61	|O
-	|O
B	|O
.	|O

This	|O
article	|O
comparatively	|O
evaluates	|O
five	|O
Generic	|O
Systems	|O
that	|O
describe	|O
the	|O
basic	|O
alternatives	|O
to	|O
composting	|O
facility	|O
design	|O
and	|O
control	|O
.	|O

Different	|O
thermoluminescent	|O
detectors	|O
(	|O
TLD	|O
)	|O
have	|O
been	|O
used	|O
to	|O
measure	|O
the	|O
contribution	|O
of	|O
the	|O
low	|O
linear	|O
energy	|O
transfer	|O
component	|O
(	|O
LET	|O
<	|O
10	|O
keV	|O
/	|O
micrometer	|O
)	|O
and	|O
plastic	|O
nuclear	|O
track	|O
detectors	|O
(	|O
PNTD	|O
)	|O
for	|O
the	|O
high	|O
linear	|O
energy	|O
tranfer	|O
(	|O
LET	|O
)	|O
component	|O
.	|O

Responses	|O
of	|O
TLD	|O
Mg2SiO4	|O
:	|O
Tb	|O
and	|O
radiophotoluminescent	|O
glass	|O
to	|O
heavy	|O
charged	|O
particles	|O
and	|O
space	|O
radiation	|O
.	|O

The	|O
absorbed	|O
dose	|O
was	|O
measured	|O
by	|O
combination	|O
of	|O
two	|O
integrating	|O
detectors	|O
:	|O
thermo	|O
-	|O
luminescent	|O
dosemeter	|O
of	|O
Mg2SiO4	|O
:	|O
Tb	|O
(	|O
TDMS	|O
)	|O
and	|O
plastic	|O
nuclear	|O
track	|O
detector	|O
(	|O
PNTD	|O
)	|O
.	|O

Six	|O
of	|O
the	|O
gstC	|B-PROTEIN
'	|I-PROTEIN
mutants	|O
,	|O
primarily	|O
in	|O
the	|O
C	|O
-	|O
terminal	|O
half	|O
of	|O
C'	|B-PROTEIN
,	|O
exhibited	|O
a	|O
defect	|O
in	|O
the	|O
ability	|O
to	|O
bind	|O
L	|B-PROTEIN
protein	|O
.	|O

Thus	|O
,	|O
while	|O
the	|O
folds	|O
of	|O
all	|O
Myb	|B-PROTEIN
domains	|O
resemble	|O
each	|O
other	|O
closely	|O
,	|O
the	|O
function	|O
of	|O
each	|O
Myb	|B-PROTEIN
domain	|O
depends	|O
on	|O
the	|O
amino	|O
acid	|O
residues	|O
that	|O
are	|O
located	|O
on	|O
the	|O
surface	|O
of	|O
each	|O
protein	|O
.	|O

METHODS	|O
:	|O
Experiments	|O
testing	|O
the	|O
new	|O
catheter	|O
and	|O
comparing	|O
it	|O
to	|O
the	|O
existing	|O
catheter	|O
included	|O
:	|O
(	|O
1	|O
)	|O
measurement	|O
of	|O
the	|O
laser	|O
output	|O
beam	|O
sizes	|O
and	|O
divergences	|O
;	|O
(	|O
2	|O
)	|O
evaluation	|O
of	|O
particulate	|O
matter	|O
generation	|O
during	|O
ablation	|O
of	|O
atherosclerotic	|O
tissue	|O
;	|O
(	|O
3	|O
)	|O
measurement	|O
of	|O
ablation	|O
hole	|O
sizes	|O
and	|O
tissue	|O
penetration	|O
rates	|O
;	|O
(	|O
4	|O
)	|O
histopathologic	|O
examination	|O
of	|O
laser	|O
-	|O
induced	|O
in	|O
vivo	|O
vessel	|O
wall	|O
injury	|O
.	|O

A	|O
proposal	|O
of	|O
50	|O
performance	|O
indicators	|O
divided	|O
into	|O
five	|O
different	|O
groups	|O
is	|O
presented	|O
here	|O
,	|O
namely	|O
structural	|O
indicators	|O
,	|O
operational	|O
indicators	|O
,	|O
water	|O
and	|O
service	|O
quality	|O
indicators	|O
,	|O
personnel	|O
indicators	|O
and	|O
economic	|O
indicators	|O
.	|O

Overexpression	|O
of	|O
RORgamma	|B-PROTEIN
has	|O
been	|O
shown	|O
to	|O
inhibit	|O
T	|B-PROTEIN
cell	|I-PROTEIN
receptor	|I-PROTEIN
-	|O
mediated	|O
apoptosis	|O
in	|O
T	|O
cell	|O
hybridomas	|O
and	|O
to	|O
repress	|O
the	|O
induction	|O
of	|O
Fas	|B-PROTEIN
-	|I-PROTEIN
ligand	|I-PROTEIN
and	|O
interleukin	|B-PROTEIN
2	|I-PROTEIN
.	|O

Once	|O
ICP	|O
reaches	|O
critical	|O
values	|O
(	|O
>	|O
30	|O
mm	|O
Hg	|O
)	|O
herniation	|O
occurs	|O
,	|O
usually	|O
within	|O
2	|O
to	|O
5	|O
days	|O
.	|O

Other	|O
therapies	|O
are	|O
also	|O
available	|O
,	|O
including	|O
hypertonic	|O
saline	|O
solution	|O
,	|O
THAM	|O
(	|O
Tris	|O
-	|O
hydroxy	|O
-	|O
methyl	|O
-	|O
aminomethane	|O
)	|O
buffer	|O
,	|O
and	|O
high	|O
-	|O
dose	|O
barbiturates	|O
.	|O

CONCLUSIONS	|O
:	|O
ChromaFlo	|O
-	|O
enhanced	|O
IVUS	|O
demonstrates	|O
colorized	|O
blood	|O
flow	|O
inside	|O
the	|O
vessel	|O
lumen	|O
,	|O
which	|O
is	|O
helpful	|O
in	|O
distinguishing	|O
echolucent	|O
disease	|O
from	|O
luminal	|O
blood	|O
flow	|O
and	|O
can	|O
also	|O
be	|O
used	|O
to	|O
perform	|O
peripheral	|O
interventions	|O
in	|O
patients	|O
with	|O
renal	|O
failure	|O
or	|O
allergy	|O
,	|O
avoiding	|O
the	|O
use	|O
of	|O
contrast	|O
media	|O
.	|O

CYP2C19	|B-PROTEIN
genotype	|O
was	|O
determined	|O
by	|O
the	|O
polymerase	|O
chain	|O
reaction	|O
-	|O
restriction	|O
fragment	|O
length	|O
polymorphism	|O
method	|O
.	|O

The	|O
results	|O
indicate	|O
that	|O
a	|O
more	|O
differentiated	|O
diagnosis	|O
of	|O
the	|O
molar	|O
relationship	|O
will	|O
allow	|O
for	|O
a	|O
more	|O
causally	|O
directed	|O
correction	|O
of	|O
Class	|O
II	|O
molar	|O
relationship	|O
.	|O

Similar	|O
data	|O
were	|O
also	|O
obtained	|O
when	|O
either	|O
dominant	|O
negative	|O
EGFR	|B-PROTEIN
-	|O
CD533	|B-PROTEIN
or	|O
dominant	|O
negative	|O
Ras	|B-PROTEIN
N17	|O
were	|O
used	|O
to	|O
block	|O
MAPK	|B-PROTEIN
activation	|O
.	|O

These	|O
analyses	|O
re	|O
-	|O
open	|O
the	|O
question	|O
whether	|O
all	|O
the	|O
CesA	|B-PROTEIN
genes	|O
encode	|O
cellulose	|B-PROTEIN
synthases	|I-PROTEIN
or	|O
whether	|O
some	|O
of	|O
the	|O
sub	|O
-	|O
class	|O
members	|O
may	|O
encode	|O
other	|O
non	|O
-	|O
cellulosic	|O
(	|B-PROTEIN
1	|I-PROTEIN
-	|I-PROTEIN
-	|I-PROTEIN
>	|I-PROTEIN
4	|I-PROTEIN
)	|I-PROTEIN
beta	|I-PROTEIN
-	|I-PROTEIN
glycan	|I-PROTEIN
synthases	|I-PROTEIN
in	|O
plants	|O
.	|O

The	|O
hatcher	|O
incubators	|O
of	|O
both	|O
companies	|O
were	|O
also	|O
persistently	|O
contaminated	|O
with	|O
Salmonella	|O
livingstone	|O
and	|O
Salmonella	|O
thomasville	|O
in	|O
company	|O
A	|O
and	|O
with	|O
Salmonella	|O
senftenberg	|O
in	|O
company	|O
B.	|O

At	|O
both	|O
companies	|O
sites	|O
Salmonella	|O
enteritidis	|O
and	|O
Salmonella	|O
typhimurium	|O
Tr104	|O
were	|O
also	|O
isolated	|O
occasionally	|O
from	|O
various	|O
locations	|O
.	|O

The	|O
mutation	|O
experiments	|O
showed	|O
that	|O
the	|O
most	|O
critical	|O
sequence	|O
for	|O
the	|O
repression	|O
of	|O
PTH	|B-PROTEIN
was	|O
5'	|O
-	|O
GGGGGAGGGGAG	|O
-	|O
3'	|O
(	|O
+	|O
1	|O
to	|O
+	|O
12	|O
)	|O
of	|O
PTHSR	|B-PROTEIN
.	|O

Cardiac	|O
output	|O
at	|O
anaerobic	|O
threshold	|O
(	|O
COAT	|O
)	|O
<	|O
or	|O
=	|O
7.3	|O
L	|O
/	|O
min	|O
was	|O
the	|O
best	|O
cutoff	|O
value	|O
for	|O
identifying	|O
multivessel	|O
coronary	|O
artery	|O
disease	|O
(	|O
relative	|O
risk	|O
,	|O
3.1	|O
)	|O
.	|O

Experience	|O
with	|O
xylene	|O
-	|O
free	|O
sections	|O
since	|O
1995	|O
at	|O
the	|O
Vrinnevi	|O
Hospital	|O
is	|O
favorable	|O
.	|O

A	|O
randomized	|O
mix	|O
of	|O
180	|O
sections	|O
(	|O
10	|O
samples	|O
x	|O
3	|O
tissues	|O
x	|O
3	|O
stains	|O
x	|O
2	|O
)	|O
gave	|O
90	|O
matched	|O
pairs	|O
.	|O

Interestingly	|O
,	|O
the	|O
CYP71D20	|B-PROTEIN
-	|O
encoded	|O
enzyme	|O
activity	|O
was	|O
capable	|O
of	|O
converting	|O
both	|O
5	|O
-	|O
epi	|O
-	|O
aristolochene	|O
and	|O
1	|O
-	|O
deoxycapsidiol	|O
to	|O
capsidiol	|O
in	|O
vitro	|O
,	|O
consistent	|O
with	|O
the	|O
notion	|O
that	|O
this	|O
P450	|B-PROTEIN
enzyme	|O
catalyzes	|O
both	|O
hydroxylations	|O
of	|O
its	|O
hydrocarbon	|O
substrate	|O
.	|O

In	|O
conclusion	|O
,	|O
NF	|B-PROTEIN
-	|I-PROTEIN
Y	|I-PROTEIN
and	|O
Sp1	|B-PROTEIN
binding	|O
sites	|O
play	|O
a	|O
decisive	|O
role	|O
in	|O
the	|O
basal	|O
expression	|O
of	|O
the	|O
rat	|O
mrp2	|B-PROTEIN
gene	|O
,	|O
while	|O
the	|O
human	|O
MRP2	|B-PROTEIN
gene	|O
is	|O
regulated	|O
differently	|O
.	|O

E2F1	|B-PROTEIN
-	|O
mediated	|O
transcriptional	|O
inhibition	|O
of	|O
the	|O
plasminogen	|B-PROTEIN
activator	|I-PROTEIN
inhibitor	|I-PROTEIN
type	|I-PROTEIN
1	|I-PROTEIN
gene	|O
.	|O

Transcriptional	|O
regulation	|O
of	|O
the	|O
estrogen	|O
-	|O
inducible	|O
pS2	|B-PROTEIN
breast	|O
cancer	|O
marker	|O
gene	|O
by	|O
the	|O
ERR	|B-PROTEIN
family	|O
of	|O
orphan	|B-PROTEIN
nuclear	|I-PROTEIN
receptors	|I-PROTEIN
.	|O

NB	|O
-	|O
506	|O
completely	|O
inhibits	|O
the	|O
capacity	|O
of	|O
topoisomerase	|B-PROTEIN
I	|I-PROTEIN
to	|O
phosphorylate	|O
,	|O
in	|O
vitro	|O
,	|O
the	|O
human	|O
splicing	|B-PROTEIN
factor	|I-PROTEIN
2	|I-PROTEIN
/	|O
alternative	|B-PROTEIN
splicing	|I-PROTEIN
factor	|I-PROTEIN
(	|O
SF2	|B-PROTEIN
/	|O
ASF	|B-PROTEIN
)	|O
.	|O

However	|O
,	|O
during	|O
our	|O
work	|O
with	|O
a	|O
replication	|O
-	|O
deficient	|O
virus	|O
expressing	|O
the	|O
ASF	|B-PROTEIN
/	|O
SF2	|B-PROTEIN
splicing	|O
factor	|O
from	|O
a	|O
progesterone	|O
antagonist	|O
-	|O
inducible	|O
gene	|O
cassette	|O
,	|O
we	|O
discovered	|O
that	|O
ASF	|B-PROTEIN
/	|O
SF2	|B-PROTEIN
was	|O
expressed	|O
at	|O
a	|O
significant	|O
level	|O
in	|O
the	|O
293	|O
producer	|O
cell	|O
line	|O
,	|O
even	|O
in	|O
the	|O
absence	|O
of	|O
inducer	|O
.	|O

DNA	|O
binding	|O
assays	|O
confirmed	|O
the	|O
interference	|O
of	|O
p30	|B-PROTEIN
(	|I-PROTEIN
II	|I-PROTEIN
)	|I-PROTEIN
with	|O
the	|O
assembly	|O
of	|O
CREB	|B-PROTEIN
-	|O
Tax	|B-PROTEIN
-	|O
p300	|B-PROTEIN
/	|O
CBP	|B-PROTEIN
multiprotein	|O
complexes	|O
on	|O
21	|O
-	|O
bp	|O
repeat	|O
oligonucleotides	|O
in	|O
vitro	|O
.	|O

Using	|O
the	|O
presented	|O
categorical	|O
structure	|O
as	|O
domain	|O
model	|O
a	|O
prototype	|O
DSS	|O
for	|O
dipslide	|O
urine	|O
cultures	|O
has	|O
been	|O
developed	|O
.	|O

DNA	|O
recognition	|O
by	|O
F	|B-PROTEIN
factor	|I-PROTEIN
TraI36	|O
:	|O
highly	|O
sequence	|O
-	|O
specific	|O
binding	|O
of	|O
single	|O
-	|O
stranded	|O
DNA	|O
.	|O

E47	|B-PROTEIN
protein	|O
levels	|O
remain	|O
high	|O
until	|O
the	|O
double	|O
positive	|O
developmental	|O
stage	|O
,	|O
at	|O
which	|O
point	|O
they	|O
drop	|O
to	|O
relatively	|O
moderate	|O
levels	|O
,	|O
and	|O
are	|O
further	|O
downregulated	|O
upon	|O
transition	|O
to	|O
the	|O
single	|O
positive	|O
stage	|O
.	|O

The	|O
dual	|O
specificity	|O
kinases	|O
mitogen	|O
-	|O
activated	|O
protein	|O
kinase	|O
(	|O
MAPK	|O
)	|O
kinase	|O
(	|B-PROTEIN
MKK	|I-PROTEIN
)	|I-PROTEIN
7	|I-PROTEIN
and	|O
MKK4	|B-PROTEIN
are	|O
the	|O
only	|O
molecules	|O
known	|O
to	|O
directly	|O
activate	|O
the	|O
stress	|O
kinases	|O
stress	|B-PROTEIN
-	|I-PROTEIN
activated	|I-PROTEIN
protein	|I-PROTEIN
kinases	|I-PROTEIN
(	|O
SAPKs	|B-PROTEIN
)	|O
/	|O
c	|B-PROTEIN
-	|I-PROTEIN
Jun	|I-PROTEIN
N	|I-PROTEIN
-	|I-PROTEIN
terminal	|I-PROTEIN
kinases	|I-PROTEIN
(	|O
JNKs	|B-PROTEIN
)	|O
in	|O
response	|O
to	|O
environmental	|O
or	|O
mitogenic	|O
stimuli	|O
.	|O

SAPK	|B-PROTEIN
/	|O
JNK	|B-PROTEIN
activation	|O
was	|O
completely	|O
abolished	|O
in	|O
the	|O
absence	|O
of	|O
MKK7	|B-PROTEIN
,	|O
even	|O
though	|O
expression	|O
of	|O
MKK4	|B-PROTEIN
was	|O
strongly	|O
upregulated	|O
in	|O
mkk7	|B-PROTEIN
(	|O
-	|O
/	|O
-	|O
)	|O
mast	|O
cell	|O
lines	|O
,	|O
and	|O
phosphorylation	|O
of	|O
MKK4	|B-PROTEIN
occurred	|O
normally	|O
in	|O
response	|O
to	|O
multiple	|O
stress	|O
stimuli	|O
.	|O

Thus	|O
,	|O
MKK7	|B-PROTEIN
is	|O
an	|O
essential	|O
and	|O
specific	|O
regulator	|O
of	|O
stress	|O
-	|O
induced	|O
SAPK	|B-PROTEIN
/	|O
JNK	|B-PROTEIN
activation	|O
in	|O
mast	|O
cells	|O
and	|O
MKK7	|B-PROTEIN
negatively	|O
regulates	|O
growth	|O
factor	|O
and	|O
antigen	|O
receptor	|O
-	|O
driven	|O
proliferation	|O
in	|O
hematopoietic	|O
cells	|O
.	|O

The	|O
small	|O
copepod	|O
Pseudonychocamptus	|O
proximus	|O
progressively	|O
replaced	|O
the	|O
large	|O
Tisbe	|O
furcata	|O
in	|O
sand	|O
filters	|O
during	|O
the	|O
fall	|O
of	|O
1995	|O
and	|O
was	|O
responsible	|O
for	|O
the	|O
large	|O
increase	|O
in	|O
meiofaunal	|O
biomass	|O
observed	|O
after	|O
spring	|O
1996	|O
.	|O

When	|O
mixed	|O
with	|O
aqueous	|O
solutions	|O
of	|O
TMT	|O
-	|O
55	|O
,	|O
aqueous	|O
solutions	|O
of	|O
either	|O
reagent	|O
-	|O
grade	|O
zinc	|O
,	|O
cadmium	|O
,	|O
or	|O
lead	|O
salts	|O
precipitate	|O
crystalline	|O
"	|O
Zn	|O
-	|O
TMT	|O
"	|O
,	|O
amorphous	|O
or	|O
crystalline	|O
"	|O
Cd	|O
-	|O
TMT	|O
"	|O
or	|O
amorphous	|O
"	|O
Pb	|O
-	|O
TMT	|O
"	|O
(	|O
M3	|O
[	|O
S3C3N3	|O
]	|O
2.n	|O
H2O	|O
,	|O
where	|O
M	|O
=	|O
Cd2+	|O
,	|O
Pb2+	|O
,	|O
and	|O
Zn2+	|O
and	|O
n	|O
>	|O
or	|O
=	|O
0	|O
)	|O
that	|O
may	|O
eventually	|O
crystallize	|O
if	|O
stored	|O
in	|O
air	|O
.	|O

Many	|O
of	|O
the	|O
important	|O
genes	|O
associated	|O
with	|O
G1	|O
regulation	|O
have	|O
been	|O
shown	|O
to	|O
play	|O
a	|O
key	|O
role	|O
in	|O
proliferation	|O
,	|O
differentiation	|O
and	|O
oncogenic	|O
transformation	|O
and	|O
programmed	|O
cell	|O
death	|O
(	|O
apoptosis	|O
)	|O
.	|O

The	|O
probability	|O
of	|O
treatment	|O
with	|O
lamotrigine	|O
being	|O
maintained	|O
for	|O
six	|O
months	|O
was	|O
86%	|O
,	|O
for	|O
twelve	|O
months	|O
61%	|O
and	|O
for	|O
three	|O
years	|O
31%	|O
.	|O

These	|O
results	|O
indicate	|O
the	|O
presence	|O
of	|O
TATA	|O
-	|O
unified	|O
transcription	|O
systems	|O
in	|O
contemporary	|O
eukaryotes	|O
and	|O
provide	|O
insight	|O
into	|O
the	|O
residual	|O
need	|O
for	|O
TBP	|B-PROTEIN
by	|O
all	|O
three	|O
Pols	|B-PROTEIN
in	|O
other	|O
eukaryotes	|O
despite	|O
a	|O
lack	|O
of	|O
TATA	|O
elements	|O
in	|O
their	|O
promoters	|O
.	|O

Thus	|O
,	|O
through	|O
a	|O
change	|O
in	|O
conformation	|O
upon	|O
repair	|O
of	|O
the	|O
6RG	|O
lesion	|O
,	|O
MGMT	|B-PROTEIN
switches	|O
from	|O
a	|O
DNA	|O
repair	|O
factor	|O
to	|O
a	|O
transcription	|O
regulator	|O
(	|O
R	|B-PROTEIN
-	|I-PROTEIN
MGMT	|I-PROTEIN
)	|O
,	|O
enabling	|O
the	|O
cell	|O
to	|O
sense	|O
as	|O
well	|O
as	|O
respond	|O
to	|O
mutagens	|O
.	|O

Data	|O
from	|O
in	|O
vitro	|O
splicing	|O
assays	|O
,	|O
UV	|O
crosslinking	|O
and	|O
RNA	|O
-	|O
binding	|O
competition	|O
experiments	|O
indicates	|O
a	|O
strong	|O
correlation	|O
between	|O
the	|O
binding	|O
affinities	|O
of	|O
PSI	|B-PROTEIN
for	|O
the	|O
SELEX	|O
sequences	|O
and	|O
their	|O
ability	|O
to	|O
modulate	|O
splicing	|O
of	|O
P	|B-PROTEIN
element	|I-PROTEIN
IVS3	|O
in	|O
vitro	|O
.	|O

A	|O
split	|O
motor	|O
domain	|O
in	|O
a	|O
cytoplasmic	|O
dynein	|B-PROTEIN
.	|O

In	|O
hypertensive	|O
nephrosclerosis	|O
,	|O
therapy	|O
containing	|O
an	|O
ACEI	|O
alone	|O
or	|O
in	|O
combination	|O
significantly	|O
reduces	|O
the	|O
incidence	|O
of	|O
renal	|O
events	|O
.	|O

Body	|O
weight	|O
reduction	|O
increases	|O
insulin	|B-PROTEIN
sensitivity	|O
and	|O
improves	|O
both	|O
blood	|O
glucose	|O
and	|O
blood	|O
pressure	|O
control	|O
.	|O

Here	|O
we	|O
suggest	|O
that	|O
uvrA	|B-PROTEIN
and	|O
the	|O
nucleotide	|O
excision	|O
repair	|O
pathway	|O
are	|O
involved	|O
in	|O
the	|O
repair	|O
of	|O
acid	|O
-	|O
induced	|O
DNA	|O
damage	|O
and	|O
are	|O
associated	|O
with	|O
successful	|O
adaptation	|O
of	|O
S.	|O
mutans	|O
to	|O
low	|O
pH	|O
.	|O

The	|O
best	|O
regression	|O
model	|O
for	|O
predicting	|O
changes	|O
in	|O
the	|O
WCXR	|O
included	|O
time	|O
to	|O
first	|O
positive	|O
culture	|O
and	|O
antibody	|O
titer	|O
for	|O
Pa	|O
elastase	|B-PROTEIN
.	|O

Temperature	|O
measurement	|O
in	|O
microfluidic	|O
systems	|O
using	|O
a	|O
temperature	|O
-	|O
dependent	|O
fluorescent	|O
dye	|O
.	|O

APC	|B-PROTEIN
-	|O
resistance	|O
was	|O
determined	|O
with	|O
a	|O
functional	|O
method	|O
with	|O
high	|O
sensitivity	|O
and	|O
specificity	|O
for	|O
the	|O
factor	|B-PROTEIN
V	|I-PROTEIN
Leiden	|O
mutation	|O
.	|O

Zarix	|O
expected	|O
patient	|O
enrollment	|O
in	|O
Canadian	|O
clinical	|O
sites	|O
to	|O
begin	|O
in	|O
Spring	|O
2001	|O
[	|O
397955	|O
]	|O
,	|O
[	|O
405928	|O
]	|O
.	|O

RESULTS	|O
:	|O
The	|O
subjects	|O
in	|O
the	|O
augmented	|O
feedback	|O
group	|O
significantly	|O
reduced	|O
their	|O
peak	|O
vertical	|O
ground	|O
reaction	|O
force	|O
in	|O
both	|O
post	|O
-	|O
test	|O
conditions	|O
(	|O
2	|O
-	|O
minute	|O
post	|O
-	|O
test	|O
reduction	|O
,	|O
0.85	|O
+	|O
/	|O
-	|O
0.62	|O
;	|O
1	|O
-	|O
week	|O
post	|O
-	|O
test	|O
reduction	|O
,	|O
0.74	|O
+	|O
/	|O
-	|O
0.58	|O
)	|O
as	|O
compared	|O
to	|O
the	|O
sensory	|O
,	|O
control	|O
I	|O
,	|O
and	|O
control	|O
II	|O
feedback	|O
groups	|O
.	|O

Four	|O
casein	|B-PROTEIN
kinase	|I-PROTEIN
I	|I-PROTEIN
isoforms	|O
are	|O
differentially	|O
partitioned	|O
between	|O
nucleus	|O
and	|O
cytoplasm	|O
.	|O

Use	|O
of	|O
a	|O
dual	|O
-	|O
pulse	|O
lithotripter	|O
to	|O
generate	|O
a	|O
localized	|O
and	|O
intensified	|O
cavitation	|O
field	|O
.	|O

This	|O
paper	|O
describes	|O
the	|O
results	|O
of	|O
an	|O
initial	|O
study	|O
on	|O
the	|O
application	|O
of	|O
linear	|O
solvation	|O
energy	|O
relationships	|O
(	|O
LSERs	|O
)	|O
to	|O
the	|O
prediction	|O
of	|O
internal	|O
standard	|O
compounds	|O
in	|O
reversed	|O
-	|O
phase	|O
liquid	|O
chromatographic	|O
(	|O
RPLC	|O
)	|O
method	|O
development	|O
.	|O

When	|O
the	|O
blood	|O
clot	|O
is	|O
formed	|O
in	|O
the	|O
vitreous	|O
cavity	|O
,	|O
intravitreal	|O
injection	|O
of	|O
t	|B-PROTEIN
-	|I-PROTEIN
PA	|I-PROTEIN
can	|O
convert	|O
plasminogen	|B-PROTEIN
to	|O
plasmin	|B-PROTEIN
and	|O
remove	|O
the	|O
clot	|O
.	|O

Management	|O
of	|O
postvitrectomy	|O
diabetic	|O
vitreous	|O
hemorrhage	|O
with	|O
tissue	|B-PROTEIN
plasminogen	|I-PROTEIN
activator	|I-PROTEIN
(	|O
t	|B-PROTEIN
-	|I-PROTEIN
PA	|I-PROTEIN
)	|O
and	|O
volume	|O
homeostatic	|O
fluid	|O
-	|O
fluid	|O
exchanger	|O
.	|O

Effect	|O
of	|O
heat	|O
treatments	|O
on	|O
the	|O
meltability	|O
of	|O
cheeses	|O
.	|O

RESULTS	|O
:	|O
Sixty	|O
per	|O
cent	|O
of	|O
African	|O
Americans	|O
exposed	|O
in	|O
26	|O
community	|O
outbreaks	|O
were	|O
TST	|O
positive	|O
compared	|O
to	|O
only	|O
40%	|O
of	|O
whites	|O
following	|O
comparable	|O
exposures	|O
.	|O

The	|O
mean	|O
waiting	|O
time	|O
to	|O
receive	|O
the	|O
pancreas	|O
transplant	|O
was	|O
244	|O
days	|O
for	|O
SPK	|O
and	|O
167	|O
days	|O
for	|O
PAK	|O
recipients	|O
(	|O
P	|O
=	|O
0.001	|O
)	|O
.	|O

Patients	|O
with	|O
antibody	|O
peaks	|O
,	|O
defined	|O
as	|O
fivefold	|O
or	|O
higher	|O
increase	|O
in	|O
antibody	|O
titer	|O
compared	|O
to	|O
the	|O
lowest	|O
antibody	|O
titer	|O
over	|O
the	|O
course	|O
of	|O
GBS	|O
,	|O
had	|O
higher	|O
disability	|O
scores	|O
during	|O
the	|O
first	|O
two	|O
weeks	|O
of	|O
GBS	|O
and	|O
a	|O
worse	|O
clinical	|O
outcome	|O
(	|O
anti	|B-PROTEIN
-	|I-PROTEIN
GM1	|I-PROTEIN
IgG	|I-PROTEIN
and	|O
anti	|B-PROTEIN
-	|I-PROTEIN
GD1a	|I-PROTEIN
IgM	|I-PROTEIN
antibody	|O
peaks	|O
)	|O
and	|O
axonal	|O
damage	|O
(	|O
anti	|B-PROTEIN
-	|I-PROTEIN
GD1a	|I-PROTEIN
IgM	|I-PROTEIN
antibody	|O
peaks	|O
)	|O
,	|O
compared	|O
to	|O
patients	|O
without	|O
peak	|O
antibody	|O
titers	|O
.	|O

Following	|O
baseline	|O
clinical	|O
examination	|O
and	|O
initial	|O
periodontal	|O
therapy	|O
,	|O
32	|O
patients	|O
received	|O
mucogingival	|O
surgery	|O
with	|O
free	|O
gingival	|O
grafts	|O
for	|O
treatment	|O
of	|O
insufficient	|O
attached	|O
gingiva	|O
.	|O

However	|O
,	|O
patients	|O
with	|O
isolated	|O
office	|O
hypertension	|O
had	|O
fewer	|O
previous	|O
cardiovascular	|O
complications	|O
.	|O

In	|O
the	|O
TVD	|O
-	|O
patients	|O
decreases	|O
in	|O
skin	|O
blood	|O
flow	|O
were	|O
similar	|O
compared	|O
with	|O
the	|O
healthy	|O
controls	|O
.	|O

2	|O
:	|O
The	|O
dynamic	|O
moduli	|O
of	|O
microcrystalline	|O
cellulose	|O
.	|O

These	|O
findings	|O
suggest	|O
that	|O
an	|O
intracellular	|O
WT	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
/	|O
HSAL2	|B-PROTEIN
pathway	|O
may	|O
play	|O
a	|O
role	|O
in	|O
development	|O
and	|O
hematopoiesis	|O
.	|O

ICAM	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
has	|O
been	|O
suggested	|O
a	|O
predictor	|O
of	|O
the	|O
onset	|O
of	|O
GO	|O
.	|O

Phosphotyrosyl	|O
peptides	|O
block	|O
Stat3	|B-PROTEIN
-	|O
mediated	|O
DNA	|O
binding	|O
activity	|O
,	|O
gene	|O
regulation	|O
,	|O
and	|O
cell	|O
transformation	|O
.	|O

Plane	|O
wave	|O
geometry	|O
is	|O
impractical	|O
for	|O
clinical	|O
use	|O
but	|O
the	|O
results	|O
of	|O
this	|O
work	|O
encouraged	|O
us	|O
to	|O
further	|O
develop	|O
the	|O
P3	|O
approximation	|O
for	|O
a	|O
spherical	|O
geometry	|O
,	|O
described	|O
in	|O
this	|O
paper	|O
.	|O

The	|O
diagnosis	|O
of	|O
HCV	|O
arthritis	|O
in	|O
patients	|O
with	|O
positive	|O
rheumatoid	|B-PROTEIN
factor	|I-PROTEIN
and	|O
chronic	|O
inflammatory	|O
polyarthritis	|O
may	|O
be	|O
difficult	|O
.	|O

METHODS	|O
:	|O
We	|O
retrospectively	|O
selected	|O
13	|O
TFCD	|O
patients	|O
who	|O
underwent	|O
surgery	|O
for	|O
intractable	|O
epilepsy	|O
with	|O
the	|O
aim	|O
of	|O
removing	|O
the	|O
magnetic	|O
resonance	|O
(	|O
MR	|O
)	|O
-	|O
detectable	|O
lesion	|O
and	|O
/	|O
or	|O
the	|O
epileptogenic	|O
zone	|O
defined	|O
by	|O
stereoelectroencephalographic	|O
recordings	|O
.	|O

RESULTS	|O
:	|O
At	|O
latest	|O
examination	|O
,	|O
mean	|O
UPDRS	|O
II	|O
and	|O
III	|O
scores	|O
had	|O
improved	|O
by	|O
30%	|O
(	|O
on	|O
stimulation	|O
,	|O
off	|O
therapy	|O
)	|O
with	|O
mean	|O
50%	|O
reduction	|O
in	|O
daily	|O
off	|O
time	|O
.	|O

In	|O
Exp.	|O

Several	|O
distinct	|O
apoptotic	|O
stimuli	|O
induce	|O
the	|O
expression	|O
and	|O
caspase	|B-PROTEIN
-	|O
dependent	|O
cleavage	|O
of	|O
hTAF	|B-PROTEIN
(	|I-PROTEIN
II	|I-PROTEIN
)	|I-PROTEIN
80	|I-PROTEIN
delta	|I-PROTEIN
.	|O
hTAF	|B-PROTEIN
(	|I-PROTEIN
II	|I-PROTEIN
)	|I-PROTEIN
80	|I-PROTEIN
delta	|I-PROTEIN
,	|O
unlike	|O
hTAF	|B-PROTEIN
(	|I-PROTEIN
II	|I-PROTEIN
)	|I-PROTEIN
80	|I-PROTEIN
,	|O
forms	|O
a	|O
TFIID	|B-PROTEIN
-	|O
like	|O
complex	|O
lacking	|O
hTAF	|B-PROTEIN
(	|I-PROTEIN
II	|I-PROTEIN
)	|I-PROTEIN
31	|I-PROTEIN
.	|O

Endovascular	|O
aneurysm	|O
repair	|O
with	|O
the	|O
AneuRx	|O
stent	|O
-	|O
graft	|O
is	|O
safe	|O
,	|O
but	|O
is	|O
it	|O
effective	|O
?	|O

Chronic	|O
nutritional	|O
diseases	|O
of	|O
infectious	|O
origin	|O
:	|O
an	|O
assessment	|O
of	|O
a	|O
nascent	|O
field	|O
.	|O

Drug	|O
interactions	|O
have	|O
been	|O
found	|O
with	|O
drugs	|O
that	|O
compete	|O
for	|O
the	|O
same	|O
CYP450	|B-PROTEIN
isoenzymes	|O
as	|O
statins	|O
.	|O

METHODS	|O
:	|O
We	|O
studied	|O
the	|O
clinical	|O
benefit	|O
of	|O
depth	|O
-	|O
dependent	|O
RR	|O
,	|O
nonuniform	|O
AC	|O
using	|O
a	|O
scanning	|O
line	|O
source	|O
,	|O
and	|O
scatter	|O
correction	|O
(	|O
photon	|O
energy	|O
recovery	|O
[	|O
PER	|O
]	|O
)	|O
compared	|O
with	|O
filtered	|O
backprojection	|O
alone	|O
.	|O

Because	|O
of	|O
differences	|O
in	|O
patient	|O
characteristics	|O
,	|O
control	|O
measurements	|O
were	|O
obtained	|O
from	|O
normal	|O
muscle	|O
in	|O
all	|O
patients	|O
.	|O

However	|O
,	|O
the	|O
abi1	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
gene	|O
product	|O
has	|O
no	|O
effect	|O
on	|O
the	|O
ABA	|O
suppression	|O
of	|O
a	|O
GA	|O
-	|O
responsive	|O
alpha	|B-PROTEIN
-	|I-PROTEIN
amylase	|I-PROTEIN
gene	|O
.	|O

In	|O
children	|O
unable	|O
to	|O
perform	|O
forced	|O
expiratory	|O
maneuvers	|O
(	|O
n	|O
=	|O
25	|O
)	|O
,	|O
FOT	|O
,	|O
contrary	|O
to	|O
the	|O
interrupter	|O
technique	|O
,	|O
clearly	|O
identified	|O
a	|O
subgroup	|O
of	|O
young	|O
children	|O
with	|O
high	|O
resistance	|O
values	|O
at	|O
baseline	|O
,	|O
which	|O
returned	|O
to	|O
normal	|O
after	|O
bronchodilation	|O
.	|O

In	|O
budding	|O
yeast	|O
,	|O
this	|O
latter	|O
checkpoint	|O
response	|O
involves	|O
the	|O
proteins	|O
Mad1	|B-PROTEIN
,	|I-PROTEIN
2	|I-PROTEIN
,	|I-PROTEIN
3	|I-PROTEIN
,	|O
Bub1	|B-PROTEIN
and	|O
Bub3	|B-PROTEIN
,	|O
whose	|O
vertebrate	|O
counterparts	|O
localize	|O
to	|O
unattached	|O
kinetochores	|O
.	|O

HTLV	|O
-	|O
1	|O
decreases	|O
Th2	|O
type	|O
of	|O
immune	|O
response	|O
in	|O
patients	|O
with	|O
strongyloidiasis	|O
.	|O

However	|O
,	|O
the	|O
beta5L	|O
splice	|O
variant	|O
was	|O
found	|O
only	|O
in	|O
the	|O
retina	|O
.	|O

PROCEDURE	|O
:	|O
Cannulas	|O
were	|O
surgically	|O
positioned	|O
in	|O
the	|O
abomasal	|O
body	|O
and	|O
pyloric	|O
antrum	|O
of	|O
each	|O
calf	|O
.	|O

METHODS	|O
:	|O
Humphrey	|O
Field	|O
Analyzer	|O
model	|O
630	|O
(	|O
HFA	|O
I	|O
,	|O
program	|O
30-2	|O
with	|O
a	|O
rectangular	|O
6	|O
degrees	|O
x	|O
6	|O
degrees	|O
grid	|O
)	|O
was	|O
used	|O
as	|O
the	|O
conventional	|O
perimetric	|O
method	|O
.	|O

Transforming	|B-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
(	|O
TGF	|B-PROTEIN
-	|I-PROTEIN
beta	|I-PROTEIN
)	|O
induced	|O
growth	|O
arrest	|O
of	|O
cells	|O
involves	|O
regulation	|O
of	|O
the	|O
activities	|O
of	|O
both	|O
D	|B-PROTEIN
-	|I-PROTEIN
and	|I-PROTEIN
E	|I-PROTEIN
-	|I-PROTEIN
type	|I-PROTEIN
cyclin	|I-PROTEIN
kinase	|I-PROTEIN
complexes	|O
thought	|O
to	|O
be	|O
mediated	|O
primarily	|O
by	|O
the	|O
regulation	|O
of	|O
p15	|B-PROTEIN
(	|O
Ink4b	|B-PROTEIN
)	|O
and	|O
p27	|B-PROTEIN
(	|O
Kip1	|B-PROTEIN
)	|O
cyclin	|O
kinase	|O
inhibitors	|O
.	|O

Alignment	|O
of	|O
different	|O
cDNAs	|O
of	|O
the	|O
NR5A2	|B-PROTEIN
(	|O
hB1F	|B-PROTEIN
)	|O
gene	|O
with	|O
the	|O
genomic	|O
sequence	|O
facilitated	|O
the	|O
delineation	|O
of	|O
its	|O
structural	|O
organization	|O
,	|O
which	|O
spans	|O
over	|O
150	|O
kb	|O
and	|O
consists	|O
of	|O
eight	|O
exons	|O
interrupted	|O
by	|O
seven	|O
introns	|O
.	|O

The	|O
genomic	|O
structure	|O
of	|O
the	|O
human	|O
SPEC1	|B-PROTEIN
gene	|O
reveals	|O
complex	|O
splicing	|O
and	|O
close	|O
promoter	|O
proximity	|O
to	|O
the	|O
AF1q	|B-PROTEIN
translocation	|O
gene	|O
.	|O

Hp	|O
positive	|O
relatives	|O
of	|O
gastric	|O
cancer	|O
had	|O
a	|O
markedly	|O
higher	|O
prevalence	|O
of	|O
atrophy	|O
than	|O
those	|O
with	|O
Hp	|O
negativity	|O
without	|O
cancer	|O
relatives	|O
(	|O
29	|O
vs.	|O

Peripheral	|O
metabolism	|O
of	|O
androgens	|O
takes	|O
place	|O
in	|O
various	|O
areas	|O
within	|O
the	|O
pilosebaceous	|O
unit	|O
,	|O
as	|O
indicated	|O
by	|O
local	|O
differences	|O
in	|O
the	|O
activities	|O
of	|O
aromatase	|B-PROTEIN
,	|O
5alpha	|B-PROTEIN
-	|I-PROTEIN
reductase	|I-PROTEIN
as	|O
well	|O
as	|O
of	|O
the	|O
presence	|O
of	|O
the	|O
androgen	|B-PROTEIN
receptors	|I-PROTEIN
.	|O

The	|O
uptake	|O
of	|O
fluorine	|O
-	|O
18	|O
fluorodeoxyglucose	|O
(	|O
F	|O
-	|O
18	|O
FDG	|O
)	|O
by	|O
a	|O
malignant	|O
tumor	|O
depends	|O
on	|O
the	|O
blood	|O
glucose	|O
level	|O
.	|O

Northern	|O
blot	|O
analysis	|O
with	|O
one	|O
of	|O
the	|O
PARNAs	|B-PROTEIN
revealed	|O
a	|O
highly	|O
abundant	|O
signal	|O
of	|O
approximately	|O
2.0	|O
kilobases	|O
(	|O
kb	|O
)	|O
present	|O
in	|O
all	|O
cell	|O
lines	|O
tested	|O
.	|O

This	|O
analysis	|O
supports	|O
the	|O
use	|O
of	|O
fluticasone	|O
propionate	|O
88	|O
microg	|O
twice	|O
daily	|O
as	|O
first	|O
-	|O
line	|O
treatment	|O
in	|O
patients	|O
with	|O
persistent	|O
asthma	|O
previously	|O
treated	|O
with	|O
short	|O
-	|O
acting	|O
beta2	|B-PROTEIN
-	|O
agonist	|O
alone	|O
.	|O

By	|O
using	|O
space	|O
-	|O
discrete	|O
/	|O
continuous	|O
metapopulation	|O
dynamic	|O
models	|O
and	|O
computer	|O
simulations	|O
,	|O
we	|O
show	|O
that	|O
there	|O
can	|O
be	|O
two	|O
principally	|O
different	|O
regimes	|O
of	|O
metapopulation	|O
dynamics	|O
.	|O

Eight	|O
CAD	|O
patients	|O
who	|O
were	|O
matched	|O
to	|O
the	|O
treated	|O
patients	|O
for	|O
age	|O
(	|O
+	|O
/	|O
-	|O
3	|O
years	|O
)	|O
,	|O
baseline	|O
low	|B-PROTEIN
density	|I-PROTEIN
lipoprotein	|I-PROTEIN
(	|O
+	|O
/	|O
-	|O
5	|O
mg	|O
/	|O
dL	|O
)	|O
,	|O
and	|O
triglycerides	|O
(	|O
+	|O
/	|O
-	|O
50	|O
mg	|O
/	|O
dL	|O
)	|O
but	|O
who	|O
had	|O
never	|O
been	|O
treated	|O
with	|O
lipid	|O
-	|O
lowering	|O
drugs	|O
were	|O
selected	|O
as	|O
controls	|O
.	|O

The	|O
corresponding	|O
orifice	|O
voltages	|O
for	|O
the	|O
three	|O
instruments	|O
were	|O
20/50/80	|O
V	|O
(	|O
API	|O
365	|O
)	|O
,	|O
30/90/130	|O
V	|O
(	|O
API	|O
2000	|O
)	|O
and	|O
40/80/120	|O
V	|O
(	|O
API	|O
3000	|O
)	|O
.	|O

RESULTS	|O
:	|O
A	|O
novel	|O
gene	|O
was	|O
cloned	|O
.	|O

The	|O
moduli	|O
of	|O
elasticity	|O
of	|O
the	|O
gray	|O
and	|O
white	|O
matter	|O
were	|O
3.4	|O
+	|O
/	|O
-	|O
1.4	|O
kPa	|O
(	|O
mean	|O
+	|O
/	|O
-	|O
standard	|O
deviation	|O
)	|O
and	|O
3.4	|O
+	|O
/	|O
-	|O
0.9	|O
kPa	|O
in	|O
the	|O
axial	|O
section	|O
,	|O
3+	|O
/	|O
-	|O
0.3	|O
kPa	|O
and	|O
3.5	|O
+	|O
/	|O
-	|O
0.5	|O
kPa	|O
in	|O
the	|O
frontal	|O
section	|O
,	|O
and	|O
3.5	|O
+	|O
/	|O
-	|O
0.9	|O
kPa	|O
and	|O
2.8	|O
+	|O
/	|O
-	|O
0.4	|O
kPa	|O
in	|O
the	|O
sagittal	|O
section	|O
,	|O
respectively	|O
.	|O

The	|O
LA	|O
50s	|O
derived	|O
from	|O
this	|O
combined	|O
data	|O
when	|O
compared	|O
with	|O
our	|O
earlier	|O
series	|O
from	|O
1965	|O
to	|O
1970	|O
also	|O
did	|O
not	|O
show	|O
a	|O
significant	|O
change	|O
in	|O
mortality	|O
.	|O

Direct	|O
current	|O
polarography	|O
and	|O
differential	|O
pulse	|O
polarographic	|O
methods	|O
have	|O
been	|O
developed	|O
for	|O
the	|O
qualitative	|O
as	|O
well	|O
as	|O
quantitative	|O
analysis	|O
of	|O
vitamin	|O
B1	|O
,	|O
B2	|O
and	|O
B6	|O
.	|O

Against	|O
gram	|O
-	|O
positive	|O
organisms	|O
,	|O
E	|O
-	|O
4767	|O
and	|O
E	|O
-	|O
5065	|O
were	|O
,	|O
in	|O
general	|O
,	|O
eight	|O
-	|O
and	|O
fourfold	|O
more	|O
active	|O
than	|O
tosufloxacin	|O
,	|O
which	|O
is	|O
the	|O
most	|O
potent	|O
of	|O
the	|O
reference	|O
compounds	|O
.	|O

However	|O
,	|O
most	|O
produced	|O
significant	|O
alteration	|O
of	|O
small	|O
intestinal	|O
permeability	|O
.	|O

These	|O
included	|O
HNF	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
beta	|I-PROTEIN
,	|O
HFH	|B-PROTEIN
-	|I-PROTEIN
1	|I-PROTEIN
,	|O
HFH	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
,	|O
HFH	|B-PROTEIN
-	|I-PROTEIN
3	|I-PROTEIN
,	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
,	|O
and	|O
C	|B-PROTEIN
/	|I-PROTEIN
EBP	|I-PROTEIN
beta	|I-PROTEIN
,	|O
all	|O
of	|O
which	|O
are	|O
consistent	|O
with	|O
the	|O
tissue	|O
-	|O
specific	|O
expression	|O
profiles	|O
of	|O
the	|O
gene	|O
.	|O

Managing	|O
vertigo	|O
and	|O
vertigo	|O
syndromes	|O
in	|O
the	|O
elderly	|O

The	|O
MABP	|O
and	|O
MCBFV	|O
signals	|O
were	|O
bandpass	|O
filtered	|O
in	|O
the	|O
very	|O
low	|O
-	|O
frequency	|O
range	|O
(	|O
VLF	|O
,	|O
0.015-0.07	|O
Hz	|O
)	|O
,	|O
low	|O
-	|O
frequency	|O
range	|O
(	|O
LF	|O
,	|O
0.07-0.15	|O
Hz	|O
)	|O
and	|O
high	|O
-	|O
frequency	|O
range	|O
(	|O
HF	|O
,	|O
0.15-0.40	|O
Hz	|O
)	|O
before	|O
applying	|O
CCF	|O
for	|O
the	|O
purpose	|O
of	|O
studying	|O
the	|O
effect	|O
of	|O
different	|O
bandwidths	|O
on	|O
the	|O
resulting	|O
mean	|O
CCFs	|O
.	|O

Treatment	|O
of	|O
ischemic	|O
heart	|O
disease	|O
in	|O
the	|O
elderly	|O

Hepatitis	|O
B	|O
and	|O
C	|O
seroprevalence	|O
rates	|O
among	|O
high	|O
-	|O
risk	|O
adolescents	|O
are	|O
lower	|O
in	|O
El	|O
Paso	|O
than	|O
in	|O
other	|O
similar	|O
US	|O
populations	|O
,	|O
presenting	|O
an	|O
ideal	|O
climate	|O
for	|O
prevention	|O
programs	|O
.	|O

A	|O
twelfth	|O
insertion	|O
disrupts	|O
two	|O
genes	|O
,	|O
Nrk	|B-PROTEIN
,	|O
a	|O
"	|O
neurospecific	|O
"	|O
receptor	|B-PROTEIN
tyrosine	|I-PROTEIN
kinase	|I-PROTEIN
,	|O
and	|O
Tpp	|B-PROTEIN
,	|O
which	|O
encodes	|O
a	|O
neuropeptidase	|B-PROTEIN
.	|O

A	|O
peculiar	|O
people	|O
:	|O
"	|O
the	|O
physiological	|O
aspects	|O
of	|O
Mormonism	|O
1850-1975	|O
.	|O
"	|O

Not	|O
Available	|O

This	|O
unique	|O
work	|O
needs	|O
to	|O
be	|O
edited	|O
critically	|O
and	|O
afterwards	|O
translated	|O
into	|O
Urdu	|O
and	|O
other	|O
languages	|O
for	|O
the	|O
benefit	|O
of	|O
the	|O
present	|O
day	|O
students	|O
and	|O
scholars	|O
.	|O

Comparison	|O
of	|O
German	|O
language	|O
versions	|O
of	|O
the	|O
QWB	|O
-	|O
SA	|O
and	|O
SF	|O
-	|O
36	|O
evaluating	|O
outcomes	|O
for	|O
patients	|O
with	|O
prostate	|O
disease	|O
.	|O

Disciplinary	|O
action	|O
for	|O
DNA	|O
violation	|O
.	|O

Epithelial	|O
cytotoxicity	|O
of	|O
combined	|O
antibiotics	|O
was	|O
additive	|O
,	|O
with	|O
no	|O
evidence	|O
of	|O
competition	|O
or	|O
synergism	|O
.	|O

Pro	|O
-	|O
inflammatory	|O
cytokine	|O
,	|O
tumor	|B-PROTEIN
necrosis	|I-PROTEIN
factor	|I-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
(	|O
TNF	|B-PROTEIN
-	|I-PROTEIN
alpha	|I-PROTEIN
)	|O
,	|O
produced	|O
from	|O
adipose	|O
tissues	|O
in	|O
obese	|O
subjects	|O
,	|O
is	|O
known	|O
to	|O
play	|O
a	|O
predominant	|O
role	|O
in	|O
inducing	|O
insulin	|B-PROTEIN
resistance	|O
.	|O

She	|O
drank	|O
alcohol	|O
once	|O
or	|O
twice	|O
a	|O
week	|O
and	|O
regularly	|O
took	|O
an	|O
analgesic	|O
preparation	|O
,	|O
containing	|O
aspirin	|O
and	|O
acetaminophen	|O
,	|O
for	|O
alleviation	|O
of	|O
headaches	|O
.	|O

The	|O
most	|O
important	|O
risk	|O
factors	|O
are	|O
:	|O
1	|O
)	|O
genetic	|O
;	|O
2	|O
)	|O
Epstein	|O
-	|O
Barr	|O
virus	|O
(	|O
infectious	|O
mononucleosis	|O
)	|O
;	|O
3	|O
)	|O
congenital	|O
and	|O
acquired	|O
immunodeficiency	|O
;	|O
4	|O
)	|O
occupational	|O
exposure	|O
(	|O
the	|O
wood	|O
industry	|O
)	|O
.	|O

The	|O
most	|O
important	|O
finding	|O
,	|O
however	|O
,	|O
was	|O
that	|O
IMT	|O
values	|O
were	|O
related	|O
with	|O
24	|O
h	|O
SBP	|O
or	|O
PP	|O
standard	|O
deviation	|O
(	|O
P	|O
<	|O
0.001	|O
)	|O
,	|O
a	|O
measure	|O
of	|O
overall	|O
SBP	|O
or	|O
PP	|O
variability	|O
.	|O

The	|O
difference	|O
between	|O
the	|O
patients	|O
and	|O
the	|O
controls	|O
was	|O
statistically	|O
significant	|O
(	|O
p	|O
=	|O
0.03	|O
)	|O
.	|O

The	|O
effect	|O
of	|O
crude	|O
oil	|O
spillage	|O
on	|O
growth	|O
,	|O
productivity	|O
and	|O
nutrient	|O
uptake	|O
of	|O
maize	|O
(	|O
Zea	|O
mays	|O
L.	|O
)	|O
was	|O
assessed	|O
in	|O
a	|O
pot	|O
experiment	|O
using	|O
an	|O
Evwreni	|O
manifold	|O
sample	|O
of	|O
a	|O
petroleum	|O
development	|O
company	|O
,	|O
which	|O
had	|O
a	|O
specific	|O
gravity	|O
of	|O
0.8778	|O
.	|O

NO	|O
metabolites	|O
were	|O
determined	|O
by	|O
the	|O
measurement	|O
of	|O
nitrate	|O
/	|O
nitrite	|O
(	|O
NOx	|O
,	|O
micromol	|O
/	|O
mmol	|O
creatinine	|O
)	|O
and	|O
cyclic	|O
guanosine	|O
monophosphate	|O
(	|O
cGMP	|O
,	|O
nmol	|O
/	|O
mmol	|O
creatinine	|O
)	|O
in	|O
plasma	|O
and	|O
urine	|O
.	|O

In	|O
the	|O
base	|O
-	|O
case	|O
analysis	|O
,	|O
total	|O
direct	|O
costs	|O
per	|O
patient	|O
were	|O
$	|O
728	|O
for	|O
zoledronic	|O
acid	|O
and	|O
$	|O
776	|O
for	|O
pamidronate	|O
.	|O

The	|O
diet	|O
of	|O
migrants	|O
showed	|O
both	|O
positive	|O
(	|O
macronutrients	|O
)	|O
and	|O
negative	|O
(	|O
micronutrients	|O
)	|O
differences	|O
with	|O
the	|O
general	|O
Dutch	|O
diet	|O
.	|O

C.	|O
elegans	|O
embryogenesis	|O
begins	|O
with	|O
a	|O
stereotyped	|O
sequence	|O
of	|O
asymmetric	|O
cell	|O
divisions	|O
that	|O
are	|O
largely	|O
responsible	|O
for	|O
establishing	|O
the	|O
nematode	|O
body	|O
plan	|O
.	|O

Finally	|O
,	|O
a	|O
chromogenic	|O
method	|O
was	|O
used	|O
,	|O
based	|O
on	|O
thrombin	|B-PROTEIN
inhibition	|O
and	|O
the	|O
substrate	|O
S	|O
-	|O
2238	|O
.	|O

[	|O
Diabetologia	|O
(	|O
2001	|O
)	|O
44	|O
[	|O
Suppl	|O
3	|O
]	|O
:	|O
B37	|O
-	|O
B44	|O
]	|O

The	|O
5'	|O
flanking	|O
sequence	|O
of	|O
the	|O
3B	|B-PROTEIN
gene	|I-PROTEIN
is	|O
extremely	|O
A	|O
+	|O
T	|O
rich	|O
but	|O
contains	|O
five	|O
G	|O
/	|O
C	|O
rich	|O
stretches	|O
,	|O
each	|O
approximately	|O
7bp	|O
long	|O
,	|O
which	|O
have	|O
strong	|O
sequence	|O
similarity	|O
to	|O
the	|O
G	|O
boxes	|O
found	|O
upstream	|O
of	|O
other	|O
developmentally	|O
regulated	|O
Dictyostelium	|O
genes	|O
.	|O

Considering	|O
that	|O
the	|O
reactor	|O
is	|O
thoroughly	|O
mixed	|O
during	|O
each	|O
discharge	|O
and	|O
that	|O
LD50	|O
=	|O
0.9	|O
values	|O
are	|O
nearly	|O
independent	|O
of	|O
E.	|O
coli	|O
concentrations	|O
in	|O
the	|O
range	|O
of	|O
2	|O
x	|O
10	|O
(	|O
3	|O
)	|O
<	|O
or	|O
=	|O
E	|O
coli	|O
/	|O
cfu	|O
mL	|O
(	|O
-	|O
1	|O
)	|O
<	|O
or	|O
=	|O
3	|O
x	|O
10	|O
(	|O
6	|O
)	|O
,	|O
we	|O
ascribe	|O
the	|O
nonexponential	|O
Pn	|O
decay	|O
of	|O
single	|O
-	|O
strain	|O
E.	|O
coli	|O
colonies	|O
to	|O
a	|O
shielding	|O
phenomenon	|O
where	|O
inactive	|O
cells	|O
protect	|O
the	|O
successively	|O
smaller	|O
numbers	|O
of	|O
viable	|O
cells	|O
in	|O
the	|O
EHD	|O
.	|O

OBJECTIVES	|O
:	|O
The	|O
objective	|O
of	|O
this	|O
review	|O
was	|O
to	|O
assess	|O
the	|O
effects	|O
of	|O
prophylactic	|O
prostaglandin	|O
use	|O
in	|O
the	|O
third	|O
stage	|O
of	|O
labour	|O
.	|O

In	|O
the	|O
long	|O
term	|O
,	|O
questions	|O
still	|O
remain	|O
about	|O
whether	|O
pre	|O
-	|O
dialysis	|O
rHu	|O
EPO	|B-PROTEIN
either	|O
speeds	|O
up	|O
or	|O
delays	|O
the	|O
onset	|O
of	|O
dialysis	|O
.	|O

METHODS	|O
:	|O
This	|O
retrospective	|O
review	|O
comprised	|O
2711	|O
eyes	|O
that	|O
had	|O
LASIK	|O
between	|O
September	|O
1996	|O
and	|O
September	|O
1999	|O
.	|O

No	|O
ISREs	|B-PROTEIN
could	|O
be	|O
identified	|O
in	|O
the	|O
mouse	|O
promoter	|O
.	|O

BACKGROUND	|O
:	|O
Ischemic	|O
heart	|O
disease	|O
is	|O
the	|O
primary	|O
cause	|O
of	|O
morbidity	|O
and	|O
mortality	|O
among	|O
diabetics	|O
,	|O
especially	|O
those	|O
who	|O
became	|O
ill	|O
at	|O
a	|O
young	|O
age	|O
.	|O

A	|O
38	|O
-	|O
year	|O
-	|O
old	|O
woman	|O
with	|O
ulcerative	|O
colitis	|O
subsequently	|O
developed	|O
sarcoidosis	|O
.	|O

Cholesteryl	|B-PROTEIN
ester	|I-PROTEIN
transfer	|I-PROTEIN
protein	|I-PROTEIN
and	|O
atherosclerosis	|O
in	|O
Japanese	|O
subjects	|O
:	|O
a	|O
study	|O
based	|O
on	|O
coronary	|O
angiography	|O
.	|O

Electrophoretic	|O
mobility	|O
shift	|O
assays	|O
and	|O
coimmunoprecipitation	|O
studies	|O
suggest	|O
that	|O
homo	|O
-	|O
and	|O
heterodimerization	|O
occurs	|O
between	|O
cKrox	|B-PROTEIN
family	|O
members	|O
.	|O

The	|O
hcKrox	|B-PROTEIN
gene	|O
family	|O
regulates	|O
multiple	|O
extracellular	|O
matrix	|O
genes	|O
.	|O

A	|O
review	|O
of	|O
the	|O
literature	|O
identified	|O
8	|O
comprehensive	|O
clinical	|O
studies	|O
,	|O
all	|O
of	|O
which	|O
failed	|O
to	|O
document	|O
any	|O
relationship	|O
between	|O
NF1	|B-PROTEIN
and	|O
intracranial	|O
aneurysms	|O
.	|O

These	|O
utilisation	|O
data	|O
imply	|O
annual	|O
drug	|O
costs	|O
in	|O
the	|O
range	|O
of	|O
$	|O
US	|O
480,000	|O
to	|O
$	|O
US	|O
3,600,000	|O
for	|O
TNF	|B-PROTEIN
antagonists	|O
for	|O
RA	|O
per	|O
1	|O
million	|O
population	|O
.	|O

Under	|O
our	|O
conditions	|O
,	|O
the	|O
combination	|O
O3	|O
/	|O
UV	|O
did	|O
not	|O
improve	|O
the	|O
degradation	|O
rate	|O
obtained	|O
by	|O
ozonation	|O
.	|O

This	|O
study	|O
investigated	|O
whether	|O
boron	|O
would	|O
enhance	|O
the	|O
ability	|O
of	|O
17beta	|O
-	|O
estradiol	|O
(	|O
E2	|O
)	|O
or	|O
parathyroid	|B-PROTEIN
hormone	|I-PROTEIN
(	|O
PTH	|B-PROTEIN
)	|O
to	|O
improve	|O
bone	|O
quality	|O
in	|O
ovariectomized	|O
OVX	|O
rats	|O
.	|O

We	|O
found	|O
in	|O
the	|O
control	|O
subjects	|O
rCBF	|O
increases	|O
in	|O
regions	|O
associated	|O
with	|O
the	|O
meso	|O
-	|O
striatal	|O
and	|O
meso	|O
-	|O
corticolimbic	|O
circuits	|O
in	|O
response	|O
to	|O
both	|O
monetary	|O
reward	|O
and	|O
nonmonetary	|O
reinforcement	|O
.	|O

Doxorubicin	|O
(	|O
DOX	|O
)	|O
is	|O
commonly	|O
used	|O
for	|O
the	|O
treatment	|O
of	|O
hematological	|O
and	|O
solid	|O
tumors	|O
.	|O

The	|O
event	|O
rate	|O
in	|O
patients	|O
with	|O
chronic	|O
Irr	|O
-	|O
rMFP	|O
or	|O
Un	|O
-	|O
nrMFP	|O
was	|O
markedly	|O
higher	|O
than	|O
it	|O
was	|O
in	|O
those	|O
with	|O
Rev	|O
-	|O
rMFP	|O
or	|O
Sta	|O
-	|O
nrMFP	|O
.	|O

Subtraction	|O
hybridization	|O
identified	|O
melanoma	|B-PROTEIN
differentiation	|I-PROTEIN
associated	|I-PROTEIN
gene	|I-PROTEIN
-	|I-PROTEIN
7	|I-PROTEIN
(	|O
mda	|B-PROTEIN
-	|I-PROTEIN
7	|I-PROTEIN
)	|O
,	|O
as	|O
a	|O
gene	|O
induced	|O
during	|O
these	|O
physiological	|O
changes	|O
in	|O
human	|O
melanoma	|O
cells	|O
.	|O

Therefore	|O
,	|O
vitamin	|O
D3	|O
analogues	|O
have	|O
a	|O
substantial	|O
antipsoriatic	|O
effect	|O
.	|O

Hydrocoele	|O
is	|O
common	|O
in	|O
men	|O
in	|O
Wuchereria	|O
bancrofti	|O
-	|O
endemic	|O
areas	|O
,	|O
the	|O
treatment	|O
for	|O
which	|O
is	|O
currently	|O
surgical	|O
intervention	|O
.	|O

Growth	|B-PROTEIN
hormone	|I-PROTEIN
and	|O
insulin	|B-PROTEIN
-	|I-PROTEIN
like	|I-PROTEIN
growth	|I-PROTEIN
factor	|I-PROTEIN
I	|I-PROTEIN
receptors	|I-PROTEIN
in	|O
the	|O
temporomandibular	|O
joint	|O
of	|O
the	|O
rat	|O
.	|O

On	|O
the	|O
other	|O
hand	|O
,	|O
hepatic	|O
arterial	|O
infusion	|O
therapy	|O
prolongs	|O
the	|O
survival	|O
of	|O
H3	|O
patients	|O
only	|O
.	|O

In	|O
addition	|O
to	|O
that	|O
,	|O
she	|O
received	|O
hepatic	|O
intra	|O
-	|O
arterial	|O
infusion	|O
of	|O
levoforinate	|O
(	|O
l	|O
-	|O
LV	|O
)	|O
250	|O
mg	|O
and	|O
5	|O
-	|O
fluorouracil	|O
(	|O
5	|O
-	|O
FU	|O
)	|O
500	|O
mg	|O
for	|O
combined	|O
multiple	|O
hepatic	|O
metastases	|O
starting	|O
on	|O
postoperative	|O
day	|O
14	|O
,	|O
and	|O
these	|O
medications	|O
were	|O
administered	|O
over	|O
48	|O
hours	|O
once	|O
weekly	|O
by	|O
infuser	|O
pump	|O
.	|O

The	|O
astronaut	|O
crew	|O
operates	|O
the	|O
payload	|O
and	|O
documents	|O
its	|O
operation	|O
.	|O

For	|O
these	|O
patients	|O
the	|O
introduction	|O
of	|O
a	|O
separate	|O
category	|O
"	|O
extended	|O
oligoarthritis	|O
at	|O
onset	|O
"	|O
should	|O
be	|O
considered	|O
to	|O
establish	|O
comparable	|O
patient	|O
groups	|O
.	|O

Finally	|O
,	|O
there	|O
are	|O
a	|O
growing	|O
number	|O
of	|O
arguments	|O
favouring	|O
the	|O
use	|O
of	|O
ACE	|B-PROTEIN
inhibitors	|O
very	|O
early	|O
in	|O
patients	|O
with	|O
diabetes	|O
mellitus	|O
.	|O

Phase	|O
II	|O
trial	|O
of	|O
the	|O
anti	|O
-	|O
G	|O
(	|O
D2	|O
)	|O
monoclonal	|O
antibody	|O
3F8	|B-PROTEIN
and	|O
granulocyte	|B-PROTEIN
-	|I-PROTEIN
macrophage	|I-PROTEIN
colony	|I-PROTEIN
-	|I-PROTEIN
stimulating	|I-PROTEIN
factor	|I-PROTEIN
for	|O
neuroblastoma	|O
.	|O

Hepatitis	|O
A	|O
infected	|O
food	|O
handler	|O
at	|O
an	|O
Edmonton	|O
,	|O
Alberta	|O
retail	|O
food	|O
facility	|O
:	|O
public	|O
health	|O
protection	|O
strategies	|O
.	|O

Hydrogels	|O
for	|O
tissue	|O
engineering	|O
.	|O

Eliminating	|O
any	|O
subset	|O
of	|O
ASCUS	|O
reduces	|O
the	|O
ASCUS	|O
/	|O
SIL	|O
ratio	|O
but	|O
also	|O
significantly	|O
diminishes	|O
the	|O
sensitivity	|O
of	|O
the	|O
Papanicolaou	|O
test	|O
.	|O

Eliminating	|O
any	|O
subset	|O
of	|O
ASCUS	|O
reduces	|O
the	|O
ASCUS	|O
/	|O
SIL	|O
ratio	|O
but	|O
also	|O
significantly	|O
diminishes	|O
the	|O
sensitivity	|O
of	|O
the	|O
Papanicolaou	|O
test	|O
.	|O

Two	|O
nuclear	|O
medicine	|O
physicians	|O
blinded	|O
to	|O
the	|O
surgical	|O
findings	|O
interpreted	|O
all	|O
available	|O
images	|O
and	|O
various	|O
Tc	|O
-	|O
99m	|O
MIBI	|O
image	|O
combinations	|O
at	|O
15	|O
minutes	|O
alone	|O
;	|O
15	|O
minutes	|O
and	|O
2	|O
hours	|O
,	|O
15	|O
minutes	|O
and	|O
4	|O
hours	|O
;	|O
and	|O
15	|O
minutes	|O
and	|O
2	|O
and	|O
4	|O
hours	|O
each	|O
with	|O
and	|O
without	|O
correlative	|O
pertechnetate	|O
thyroid	|O
imaging	|O
.	|O

Is	|O
clopidogrel	|O
superior	|O
to	|O
aspirin	|O
in	|O
secondary	|O
prevention	|O
of	|O
vascular	|O
disease	|O
?	|O
The	|O
cornerstone	|O
in	|O
clinical	|O
evidence	|O
of	|O
the	|O
relative	|O
efficacy	|O
of	|O
thienopyridines	|O
(	|O
clopidogrel	|O
,	|O
ticlopidine	|O
)	|O
versus	|O
aspirin	|O
in	|O
the	|O
secondary	|O
prevention	|O
of	|O
vascular	|O
disease	|O
is	|O
the	|O
Clopidogrel	|O
versus	|O
Aspirin	|O
in	|O
Patients	|O
at	|O
Risk	|O
of	|O
Ischaemic	|O
Events	|O
trial	|O
.	|O

We	|O
hypothesize	|O
that	|O
proprioception	|O
may	|O
be	|O
used	|O
to	|O
calibrate	|O
the	|O
efference	|O
copy	|O
during	|O
development	|O
and	|O
in	|O
response	|O
to	|O
perturbations	|O
by	|O
signaling	|O
potential	|O
mismatches	|O
between	|O
eye	|O
movement	|O
information	|O
derived	|O
from	|O
the	|O
efferent	|O
command	|O
and	|O
the	|O
actual	|O
motion	|O
of	|O
the	|O
eye	|O
transduced	|O
by	|O
the	|O
proprioceptive	|O
organs	|O
.	|O

Between	|O
1967	|O
and	|O
1994	|O
,	|O
495	|O
patients	|O
underwent	|O
surgery	|O
for	|O
primary	|O
PTC	|O
at	|O
the	|O
Department	|O
of	|O
Surgery	|O
,	|O
Helsinki	|O
University	|O
Central	|O
Hospital	|O
.	|O

ISS	|O
and	|O
the	|O
acute	|O
physiology	|O
and	|O
chronic	|O
health	|O
evaluation	|O
(	|O
APACHE	|O
II	|O
)	|O
calculated	|O
on	|O
admission	|O
.	|O

The	|O
procedure	|O
is	|O
less	|O
aggressive	|O
and	|O
painful	|O
than	|O
sternotomy	|O
.	|O

Paul	|O
Monagle	|O
addresses	|O
the	|O
epidemiology	|O
of	|O
neonatal	|O
thrombosis	|O
outside	|O
of	|O
the	|O
central	|O
nervous	|O
system	|O
in	|O
both	|O
arterial	|O
and	|O
venous	|O
locations	|O
,	|O
and	|O
those	|O
that	|O
occur	|O
in	|O
utero	|O
.	|O

[	|O
Clinical	|O
and	|O
epidemiological	|O
characteristics	|O
of	|O
squamous	|O
cell	|O
carcinoma	|O
of	|O
the	|O
oral	|O
cavity	|O
in	|O
women	|O
]	|O
BACKGROUND	|O
:	|O
Squamous	|O
cell	|O
carcinoma	|O
(	|O
SCC	|O
)	|O
of	|O
the	|O
oral	|O
cavity	|O
occurs	|O
mainly	|O
in	|O
the	|O
male	|O
population	|O
.	|O

Regarding	|O
gestational	|O
risk	|O
,	|O
3,243	|O
drugs	|O
used	|O
(	|O
34%	|O
)	|O
belonged	|O
to	|O
category	|O
A	|O
risk	|O
,	|O
1,923	|O
(	|O
22.6%	|O
)	|O
to	|O
category	|O
B	|O
,	|O
3,798	|O
(	|O
39.7%	|O
)	|O
to	|O
category	|O
C	|O
,	|O
289	|O
(	|O
3.0%	|O
)	|O
to	|O
category	|O
D	|O
,	|O
and	|O
55	|O
(	|O
0.6%	|O
)	|O
to	|O
category	|O
X.	|O

The	|O
severity	|O
of	|O
clinical	|O
course	|O
was	|O
expressed	|O
by	|O
means	|O
of	|O
SOFA	|O
score	|O
(	|O
group	|O
A	|O
0.3-1-1.3	|O
point	|O
,	|O
group	|O
B	|O
2.2-2.9-2.6	|O
point	|O
,	|O
group	|O
C	|O
7.4-8.3-7.7	|O
point	|O
)	|O
and	|O
APACHE	|O
II	|O
score	|O
(	|O
group	|O
A	|O
3.7-7.6-8.1	|O
point	|O
,	|O
group	|O
B	|O
8.6-11.1-10.5	|O
point	|O
,	|O
group	|O
C	|O
16.3-15.2-14.3	|O
point	|O
)	|O
.	|O

The	|O
process	|O
has	|O
been	|O
applied	|O
to	|O
the	|O
river	|O
reclamation	|O
in	|O
Yangpu	|O
District	|O
of	|O
Shanghai	|O
City	|O
,	|O
China	|O
.	|O

Physical	|O
principles	|O
in	|O
therapeutic	|O
apheresis	|O
.	|O

These	|O
results	|O
were	|O
compared	|O
with	|O
the	|O
estimates	|O
of	|O
penetration	|O
from	|O
steady	|O
-	|O
state	|O
calculations	|O
,	|O
square	|O
root	|O
of	|O
time	|O
calculations	|O
,	|O
and	|O
a	|O
biologically	|O
based	|O
mathematical	|O
model	|O
.	|O

Rind	|O
et	|O
al.	|O
's	|O
study	|O
's	|O
main	|O
conclusions	|O
were	|O
not	|O
supported	|O
by	|O
the	|O
original	|O
data	|O
.	|O

Of	|O
major	|O
concern	|O
to	|O
food	|O
processors	|O
is	|O
the	|O
inadvertent	|O
cross	|O
-	|O
contact	|O
of	|O
food	|O
products	|O
with	|O
allergenic	|O
residues	|O
,	|O
which	|O
could	|O
result	|O
in	|O
potentially	|O
life	|O
-	|O
threatening	|O
reactions	|O
in	|O
those	|O
with	|O
a	|O
food	|O
allergy	|O
.	|O

Lactate	|O
accumulation	|O
peak	|O
was	|O
unaffected	|O
by	|O
supplementation	|O
(	|O
HMB	|O
,	|O
8.1	|O
+	|O
/	|O
-	|O
1.1	|O
mM	|O
;	|O
LEU	|O
,	|O
6.2	|O
+	|O
/	|O
-	|O
0.8	|O
mM	|O
;	|O
CON	|O
,	|O
7.5	|O
+	|O
/	|O
-	|O
1.3	|O
mM	|O
)	|O
.	|O

The	|O
increased	|O
clearance	|O
observed	|O
in	|O
young	|O
infants	|O
is	|O
in	|O
contrast	|O
to	|O
other	|O
opioids	|O
.	|O

These	|O
results	|O
were	|O
robust	|O
to	|O
changes	|O
in	|O
the	|O
baseline	|O
assumptions	|O
of	|O
the	|O
model	|O
.	|O

CONCLUSION	|O
:	|O
The	|O
training	|O
of	|O
novices	|O
using	|O
MIST	|O
-	|O
VR	|O
yields	|O
quantifiable	|O
changes	|O
in	|O
skill	|O
that	|O
are	|O
transferable	|O
to	|O
a	|O
simple	|O
real	|O
task	|O
and	|O
are	|O
similar	|O
to	|O
the	|O
results	|O
achieved	|O
with	|O
conventional	|O
training	|O
.	|O

The	|O
patients	|O
and	|O
their	|O
families	|O
were	|O
closely	|O
questioned	|O
,	|O
and	|O
full	|O
clinical	|O
examination	|O
included	|O
a	|O
test	|O
for	|O
orthostasia	|O
.	|O

They	|O
have	|O
not	|O
been	|O
previously	|O
reported	|O
as	|O
a	|O
reaction	|O
to	|O
i.v	|O
.	|O
contrast	|O
material	|O
.	|O

There	|O
was	|O
a	|O
statistically	|O
significant	|O
correlation	|O
between	|O
simultaneous	|O
weekly	|O
average	|O
pollen	|O
levels	|O
in	|O
Philadelphia	|O
and	|O
in	|O
Cherry	|O
Hill	|O
(	|O
Acer	|O
,	|O
r	|O
(	|O
p	|O
)	|O
=	|O
0.987	|O
,	|O
Quercus	|O
,	|O
r	|O
(	|O
p	|O
)	|O
=	|O
0.645	|O
,	|O
Betula	|O
,	|O
r	|O
(	|O
p	|O
)	|O
=	|O
0.896	|O
,	|O
Pinus	|O
,	|O
r	|O
(	|O
p	|O
)	|O
=	|O
0.732	|O
,	|O
Cupressaceae	|O
,	|O
r	|O
(	|O
p	|O
)	|O
=	|O
0.695	|O
,	|O
Poaceae	|O
,	|O
r	|O
(	|O
p	|O
)	|O
=	|O
0.950	|O
,	|O
Ambrosia	|O
,	|O
r	|O
(	|O
p	|O
)	|O
=	|O
0.903	|O
,	|O
and	|O
Rumex	|O
,	|O
r	|O
(	|O
p	|O
)	|O
=	|O
0.572	|O
,	|O
P	|O
<	|O
0.001	|O
)	|O
.	|O

Encouraged	|O
by	|O
a	|O
Dutch	|O
study	|O
using	|O
etidronate	|O
/	|O
fluoride	|O
in	|O
corticoid	|O
-	|O
induced	|O
osteoporosis	|O
,	|O
we	|O
performed	|O
a	|O
pilot	|O
study	|O
in	|O
33	|O
men	|O
with	|O
severe	|O
established	|O
primary	|O
osteoporosis	|O
giving	|O
cyclically	|O
etidronate	|O
for	|O
14	|O
days	|O
followed	|O
by	|O
fluoride	|O
plus	|O
calcium	|O
/	|O
vitamin	|O
D	|O
for	|O
76	|O
days	|O
.	|O

Treadmill	|O
training	|O
at	|O
least	|O
for	|O
2	|O
weeks	|O
can	|O
reduce	|O
the	|O
infarction	|O
size	|O
and	|O
edema	|O
caused	|O
by	|O
MCA	|O
occlusion	|O
(	|O
P	|O
<	|O
0.01	|O
)	|O
.	|O

In	|O
order	|O
to	|O
overcome	|O
the	|O
false	|O
positive	|O
readings	|O
that	|O
are	|O
possible	|O
in	|O
sphincter	|O
manometry	|O
,	|O
we	|O
proposed	|O
to	|O
use	|O
secretin	|B-PROTEIN
stimulated	|O
endoscopic	|O
ultrasound	|O
(	|O
SSEUS	|O
)	|O
to	|O
measure	|O
pancreatic	|O
ductal	|O
response	|O
as	|O
an	|O
adjunctive	|O
method	|O
to	|O
aid	|O
and	|O
supplement	|O
the	|O
diagnosis	|O
.	|O

The	|O
cut	|O
-	|O
off	|O
percentage	|O
positivity	|O
value	|O
was	|O
established	|O
using	|O
500	|O
brucellosis	|O
-	|O
positive	|O
and	|O
500	|O
brucellosis	|O
-	|O
negative	|O
serum	|O
samples	|O
,	|O
confirmed	|O
with	|O
reference	|O
to	|O
the	|O
sample	|O
data	|O
using	|O
the	|O
indirect	|O
ELISA	|O
kit	|O
.	|O

An	|O
analysis	|O
of	|O
the	|O
dynamics	|O
is	|O
performed	|O
of	|O
exactly	|O
solvable	|O
models	|O
for	|O
fragile	|O
and	|O
strong	|O
glasses	|O
,	|O
exploiting	|O
the	|O
partitioning	|O
of	|O
the	|O
free	|O
-	|O
energy	|O
landscape	|O
in	|O
inherent	|O
structures	|O
.	|O

Fifty	|O
-	|O
six	|O
semen	|O
samples	|O
were	|O
included	|O
in	|O
this	|O
study	|O
;	|O
18	|O
were	|O
subnormal	|O
(	|O
G1	|O
)	|O
and	|O
38	|O
were	|O
normal	|O
(	|O
G2	|O
)	|O
based	|O
on	|O
World	|O
Health	|O
Organization	|O
criteria	|O
,	|O
except	|O
for	|O
morphology	|O
,	|O
which	|O
was	|O
evaluated	|O
according	|O
to	|O
strict	|O
criteria	|O
.	|O

At	|O
this	|O
timepoint	|O
,	|O
many	|O
leucocytes	|O
in	|O
the	|O
ME	|O
and	|O
ET	|O
mucosa	|O
had	|O
incorporated	|O
BrdU	|O
(	|O
between	|O
15	|O
and	|O
25%	|O
within	|O
the	|O
subsets	|O
)	|O
.	|O

Modality	|O
-	|O
specific	|O
areas	|O
(	|O
e.g.	|O
,	|O
right	|O
Wernicke	|O
,	|O
left	|O
fusiform	|O
gyrus	|O
,	|O
Broca	|O
BA44	|O
,	|O
supramarginal	|O
gyrus	|O
)	|O
,	|O
appear	|O
to	|O
cope	|O
with	|O
the	|O
computations	|O
relevant	|O
to	|O
making	|O
contact	|O
with	|O
these	|O
more	|O
abstract	|O
dimensions	|O
.	|O

We	|O
found	|O
no	|O
correlation	|O
between	|O
plasma	|O
COP	|O
and	|O
body	|O
weight	|O
at	|O
the	|O
same	|O
age	|O
(	|O
r2	|O
=	|O
0.05	|O
,	|O
P	|O
=	|O
0.155	|O
)	|O
.	|O

Their	|O
chemical	|O
structures	|O
were	|O
elucidated	|O
as	|O
1	|O
alpha	|O
,	|O
2	|O
alpha	|O
-	|O
diacetoxy	|O
-	|O
8	|O
beta	|O
-	|O
isobutanoyloxy	|O
-	|O
9	|O
alpha	|O
-	|O
benzoyloxy	|O
-	|O
13	|O
-	|O
(	|O
alpha	|O
-	|O
methyl	|O
)	|O
butanoyloxy	|O
-	|O
4	|O
beta	|O
,	|O
6	|O
beta	|O
-	|O
dihydroxy	|O
-	|O
beta	|O
-	|O
dihydroagarofuran	|O
(	|O
1	|O
)	|O
,	|O
1	|O
alpha	|O
,	|O
2	|O
alpha	|O
-	|O
diacetoxy	|O
-	|O
8	|O
beta	|O
-	|O
(	|O
beta	|O
-	|O
furancarbonyloxy	|O
)	|O
-	|O
9	|O
alpha	|O
-	|O
benzoyloxy	|O
-	|O
13	|O
-	|O
isobutanoyloxy	|O
-	|O
4	|O
beta	|O
,	|O
6	|O
beta	|O
-	|O
dihydroxy	|O
-	|O
beta	|O
-	|O
dihydroagarofuran	|O
(	|O
2	|O
)	|O
and	|O
1	|O
alpha	|O
,	|O
6	|O
beta	|O
,	|O
8	|O
alpha	|O
,	|O
13	|O
-	|O
tetraacetoxy	|O
-	|O
9	|O
alpha	|O
-	|O
benzoyloxy	|O
-	|O
2	|O
alpha	|O
-	|O
hydroxy	|O
-	|O
beta	|O
-	|O
dihydroagarofuran	|O
(	|O
3	|O
)	|O
mainly	|O
by	|O
analyses	|O
NMR	|O
and	|O
MS	|O
spectral	|O
data	|O
.	|O

Both	|O
toxins	|O
in	|O
a	|O
dose	|O
10	|O
-	|O
fold	|O
surpassing	|O
the	|O
maximum	|O
permissible	|O
concentration	|O
increased	|O
activity	|O
of	|O
glutathione	|B-PROTEIN
peroxidase	|I-PROTEIN
in	|O
brain	|O
tissue	|O
;	|O
moreover	|O
,	|O
toluene	|O
increased	|O
chemiluminescence	|O
intensity	|O
,	|O
which	|O
attested	|O
to	|O
activation	|O
of	|O
free	|O
radical	|O
processes	|O
.	|O

Saunders	|O
Company	|O
.	|O

The	|O
performance	|O
of	|O
pH	|O
-	|O
sensitive	|O
particles	|O
is	|O
attributed	|O
to	|O
their	|O
ability	|O
to	|O
release	|O
the	|O
drug	|O
selectively	|O
in	|O
the	|O
upper	|O
part	|O
of	|O
the	|O
intestine	|O
in	|O
a	|O
molecular	|O
or	|O
amorphous	|O
form	|O
.	|O

Comparison	|O
of	|O
remnant	|O
-	|O
like	|O
lipoprotein	|O
particles	|O
in	|O
postmenopausal	|O
women	|O
with	|O
and	|O
without	|O
coronary	|O
artery	|O
disease	|O
and	|O
in	|O
men	|O
with	|O
coronary	|O
artery	|O
disease	|O
.	|O

Because	|O
results	|O
of	|O
recent	|O
randomized	|O
trials	|O
indicate	|O
minimal	|O
efficacy	|O
of	|O
continuing	|O
MAC	|O
prophylaxis	|O
in	|O
patients	|O
who	|O
respond	|O
to	|O
potent	|O
combination	|O
antiretroviral	|O
therapy	|O
,	|O
the	|O
observed	|O
high	|O
incidence	|O
of	|O
macrolide	|O
-	|O
resistant	|O
bacterial	|O
colonization	|O
of	|O
the	|O
respiratory	|O
tract	|O
in	|O
this	|O
trial	|O
supports	|O
the	|O
discontinuation	|O
of	|O
macrolide	|O
prophylaxis	|O
in	|O
all	|O
AIDS	|O
patients	|O
whose	|O
CD4	|B-PROTEIN
counts	|O
have	|O
risen	|O
above	|O
100	|O
cells	|O
/	|O
microL	|O
.	|O

Acute	|O
stress	|O
in	|O
7	|O
rats	|O
also	|O
increased	|O
the	|O
mean	|O
amount	|O
of	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
released	|O
in	|O
the	|O
urine	|O
by	|O
31.5%	|O
from	|O
775.9	|O
+	|O
/	|O
-	|O
69.2	|O
to	|O
1,021.1	|O
+	|O
/	|O
-	|O
93.3	|O
pg	|O
.	|O
/	|O
ml	|O
.	|O

Patients	|O
with	|O
CF	|O
and	|O
meconium	|O
ileus	|O
presented	|O
a	|O
poor	|O
nutritional	|O
status	|O
at	|O
diagnosis	|O
and	|O
a	|O
lower	|O
survival	|O
rate	|O
compared	|O
to	|O
the	|O
general	|O
CF	|O
population	|O
.	|O

(	|O
Cactaceae	|O
)	|O
waste	|O
matter	|O
.	|O

Skin	|O
cancers	|O
,	|O
followed	|O
by	|O
gastrointestinal	|O
tract	|O
and	|O
male	|O
genital	|O
system	|O
affected	|O
mostly	|O
older	|O
age	|O
patients	|O
.	|O

CONCLUSION	|O
:	|O
MMF	|O
(	|O
2-3	|O
g	|O
/	|O
day	|O
)	|O
is	|O
unable	|O
to	|O
control	|O
the	|O
signs	|O
of	|O
mucocutaneous	|O
Adamantiades	|O
-	|O
Behcet	|O
's	|O
disease	|O
.	|O

In	|O
the	|O
treatment	|O
of	|O
opioid	|O
naive	|O
patients	|O
who	|O
underwent	|O
surgery	|O
and	|O
received	|O
opioids	|O
for	|O
acute	|O
pain	|O
,	|O
oral	|O
ADL	|O
8-2698	|O
(	|O
6.0	|O
mg	|O
)	|O
improved	|O
the	|O
management	|O
of	|O
postoperative	|O
ileus	|O
(	|O
POI	|O
)	|O
by	|O
shortening	|O
the	|O
time	|O
to	|O
achieve	|O
normal	|O
bowel	|O
function	|O
and	|O
,	|O
ultimately	|O
,	|O
hospital	|O
stay	|O
.	|O

METHODS	|O
:	|O
302	|O
consecutive	|O
patients	|O
with	|O
BS	|O
and	|O
438	|O
patients	|O
with	|O
other	|O
rheumatological	|O
conditions	|O
were	|O
surveyed	|O
for	|O
the	|O
presence	|O
or	|O
absence	|O
of	|O
the	|O
features	|O
of	|O
BS	|O
by	|O
means	|O
of	|O
a	|O
standard	|O
form	|O
which	|O
had	|O
been	|O
prepared	|O
according	|O
to	|O
ISG	|O
criteria	|O
.	|O

Evidence	|O
suggests	|O
that	|O
PHACES	|O
syndrome	|O
is	|O
not	|O
a	|O
random	|O
association	|O
but	|O
a	|O
true	|O
phakomatosis	|O
;	|O
further	|O
studies	|O
are	|O
awaited	|O
to	|O
shed	|O
light	|O
on	|O
a	|O
possible	|O
genetic	|O
background	|O
.	|O

A	|O
computer	|O
program	|O
,	|O
ACCESS	|O
-	|O
IAQ	|O
,	|O
is	|O
developed	|O
to	|O
simulate	|O
the	|O
airflow	|O
pattern	|O
,	|O
the	|O
time	|O
history	|O
of	|O
the	|O
contaminant	|O
concentrations	|O
in	|O
the	|O
occupied	|O
zone	|O
,	|O
and	|O
the	|O
inhalation	|O
exposures	|O
.	|O

Moreover	|O
,	|O
a	|O
severe	|O
decrease	|O
of	|O
antithrombin	|B-PROTEIN
activity	|O
became	|O
evident	|O
during	|O
both	|O
experiments	|O
(	|O
eg	|O
,	|O
in	|O
experiment	|O
2	|O
from	|O
95.6	|O
+	|O
/	|O
-	|O
4.8	|O
to	|O
59.2	|O
+	|O
/	|O
-	|O
6.6%	|O
)	|O
.	|O

The	|O
Penn	|O
State	|O
Worry	|O
Questionnaire	|O
for	|O
Children	|O
(	|O
PSWQ	|O
-	|O
C	|O
)	|O
is	|O
a	|O
14	|O
-	|O
item	|O
self	|O
-	|O
report	|O
questionnaire	|O
that	|O
intends	|O
to	|O
measure	|O
the	|O
tendency	|O
of	|O
children	|O
to	|O
engage	|O
in	|O
excessive	|O
,	|O
generalized	|O
,	|O
and	|O
uncontrollable	|O
worry	|O
(	|O
Chorpita	|O
et	|O
al.	|O
,	|O
Behav	|O
.	|O

Classification	|O
according	|O
to	|O
the	|O
ILAR	|O
criteria	|O
was	|O
possible	|O
in	|O
321	|O
patients	|O
;	|O
290	|O
patients	|O
had	|O
a	|O
disease	|O
duration	|O
>	|O
or	|O
=	|O
3	|O
months	|O
and	|O
were	|O
classified	|O
according	|O
to	|O
the	|O
EULAR	|O
criteria	|O
.	|O

Described	|O
X	|O
-	|O
ray	|O
projection	|O
were	|O
performed	|O
in	|O
70	|O
patients	|O
.	|O

We	|O
conducted	|O
a	|O
clinical	|O
and	|O
pathologic	|O
review	|O
of	|O
nine	|O
patients	|O
with	|O
immature	|O
ovarian	|O
teratoma	|O
.	|O

Pyrethroid	|O
insecticides	|O
are	|O
widely	|O
used	|O
in	|O
agriculture	|O
and	|O
private	|O
households	|O
.	|O

The	|O
sorption	|O
mechanisms	|O
changed	|O
from	|O
adsorption	|O
to	|O
partition	|O
in	|O
the	|O
process	|O
of	|O
repetitious	|O
sorption	|O
.	|O

Although	|O
the	|O
spatial	|O
and	|O
temporal	|O
variability	|O
of	|O
LDF	|O
signals	|O
evoked	|O
by	|O
cerebrocortical	|O
microflow	|O
is	|O
in	|O
the	|O
same	|O
range	|O
as	|O
with	|O
other	|O
methods	|O
and	|O
in	|O
other	|O
organs	|O
,	|O
LDF	|O
cerebrocortical	|O
mapping	|O
is	|O
restricted	|O
by	|O
the	|O
large	|O
temporal	|O
and	|O
spatial	|O
heterogeneity	|O
of	|O
the	|O
cerebrocortical	|O
vasculature	|O
.	|O

The	|O
5	|O
-	|O
year	|O
overall	|O
survival	|O
(	|O
OS	|O
)	|O
and	|O
progression	|O
-	|O
free	|O
survival	|O
(	|O
PFS	|O
)	|O
rates	|O
were	|O
58.9%	|O
and	|O
55.4%	|O
for	|O
arm	|O
A	|O
and	|O
44.5%	|O
and	|O
41.3%	|O
for	|O
arm	|O
B	|O
(	|O
P	|O
=	|O
.007	|O
and	|O
P	|O
=	|O
.02	|O
)	|O
,	|O
respectively	|O
.	|O

METHODS	|O
:	|O
P	|B-PROTEIN
-	|I-PROTEIN
selectin	|I-PROTEIN
expression	|O
of	|O
nonstimulated	|O
and	|O
ADP	|O
-	|O
stimulated	|O
platelets	|O
was	|O
flow	|O
cytometrically	|O
measured	|O
before	|O
the	|O
clopidogrel	|O
loading	|O
dose	|O
and	|O
on	|O
3	|O
consecutive	|O
days	|O
in	|O
52	|O
patients	|O
with	|O
coronary	|O
artery	|O
disease	|O
:	|O
21	|O
patients	|O
in	|O
group	|O
1	|O
received	|O
300	|O
mg	|O
of	|O
clopidogrel	|O
after	|O
stent	|O
implantation	|O
and	|O
11	|O
patients	|O
in	|O
group	|O
2	|O
received	|O
the	|O
higher	|O
450	|O
-	|O
mg	|O
clopidogrel	|O
loading	|O
dose	|O
followed	|O
by	|O
a	|O
daily	|O
dose	|O
of	|O
75	|O
mg	|O
of	|O
clopidogrel	|O
for	|O
both	|O
groups	|O
.	|O

Traditional	|O
surgical	|O
exploration	|O
was	|O
followed	|O
by	|O
survey	|O
with	|O
a	|O
gamma	|O
-	|O
detecting	|O
probe	|O
.	|O

No	|O
effect	|O
of	|O
the	|O
intervention	|O
on	|O
depression	|O
scores	|O
was	|O
found	|O
.	|O

IV	|O
.	|O
combined	|O
sclerosis	|O
and	|O
resorption	|O
of	|O
the	|O
skull	|O
base	|O
(	|O
6	|O
cases	|O
,	|O
2	|O
group	|O
I	|O
lesions	|O
and	|O
4	|O
group	|O
II	|O
lesions	|O
)	|O
.	|O

The	|O
quantity	|O
of	|O
each	|O
population	|O
(	|O
L.	|O
bulgaricus	|O
,	|O
S.	|O
thermophilus	|O
)	|O
was	|O
then	|O
estimated	|O
in	|O
the	|O
pellet	|O
by	|O
PyMS	|O
,	|O
and	|O
the	|O
data	|O
were	|O
analysed	|O
by	|O
artificial	|O
neural	|O
networks	|O
(	|O
ANNs	|O
)	|O
.	|O

AF	|B-PROTEIN
showed	|O
a	|O
mixed	|O
nuclear	|O
/	|O
cytoplasmic	|O
pattern	|O
of	|O
expression	|O
in	|O
the	|O
epithelial	|O
,	|O
endothelial	|O
,	|O
and	|O
stromal	|O
component	|O
of	|O
the	|O
normal	|O
breast	|O
and	|O
benign	|O
lesions	|O
,	|O
whereas	|O
an	|O
impressive	|O
loss	|O
of	|O
AF	|B-PROTEIN
expression	|O
was	|O
noted	|O
in	|O
in	|O
situ	|O
and	|O
invasive	|O
breast	|O
cancer	|O
and	|O
tumoral	|O
stroma	|O
.	|O

We	|O
derive	|O
joint	|O
probability	|O
density	|O
distributions	|O
for	|O
three	|O
key	|O
uncertain	|O
properties	|O
of	|O
the	|O
climate	|O
system	|O
,	|O
using	|O
an	|O
optimal	|O
fingerprinting	|O
approach	|O
to	|O
compare	|O
simulations	|O
of	|O
an	|O
intermediate	|O
complexity	|O
climate	|O
model	|O
with	|O
three	|O
distinct	|O
diagnostics	|O
of	|O
recent	|O
climate	|O
observations	|O
.	|O

Frequency	|O
of	|O
seeing	|O
curves	|O
were	|O
examined	|O
for	|O
the	|O
method	|O
most	|O
similar	|O
to	|O
FDT	|O
.	|O

Chronic	|O
graft	|O
-	|O
versus	|O
-	|O
host	|O
disease	|O
(	|O
cGVHD	|O
)	|O
is	|O
a	|O
major	|O
complication	|O
of	|O
allogeneic	|O
hematopoietic	|O
cell	|O
transplantation	|O
.	|O

Compared	|O
to	|O
white	|O
-	|O
on	|O
-	|O
white	|O
(	|O
W	|O
-	|O
W	|O
)	|O
perimetry	|O
,	|O
SWAP	|O
is	|O
limited	|O
clinically	|O
by	|O
:	|O
greater	|O
variability	|O
associated	|O
with	|O
the	|O
estimation	|O
of	|O
threshold	|O
,	|O
ocular	|O
media	|O
absorption	|O
,	|O
increased	|O
examination	|O
duration	|O
and	|O
an	|O
additional	|O
learning	|O
effect	|O
.	|O

Preservatives	|O
are	|O
an	|O
important	|O
component	|O
of	|O
ophthalmic	|O
preparations	|O
,	|O
providing	|O
antimicrobial	|O
activity	|O
in	|O
the	|O
bottle	|O
and	|O
preventing	|O
decomposition	|O
of	|O
active	|O
drug	|O
.	|O

Comparative	|O
analysis	|O
of	|O
various	|O
techniques	|O
of	|O
prostatic	|O
drainage	|O
in	|O
patients	|O
with	|O
chronic	|O
obstructive	|O
prostatitis	|O
]	|O
The	|O
efficacy	|O
of	|O
prostatic	|O
drainage	|O
using	|O
transurethral	|O
vacuum	|O
aspiration	|O
(	|O
Introl	|O
-	|O
4	|O
unit	|O
)	|O
and	|O
transrectal	|O
pneumovibromassage	|O
(	|O
PVM	|O
-	|O
R	|O
-	|O
01	|O
)	|O
was	|O
compared	|O
in	|O
1511	|O
patients	|O
with	|O
chronic	|O
obstructive	|O
prostatitis	|O
.	|O

The	|O
results	|O
are	|O
discussed	|O
in	|O
relation	|O
to	|O
acoustical	|O
models	|O
of	|O
sound	|O
propagation	|O
and	|O
physiology	|O
,	|O
and	|O
it	|O
is	|O
suggested	|O
that	|O
height	|O
-	|O
dependent	|O
degradation	|O
within	|O
a	|O
forest	|O
is	|O
an	|O
important	|O
selection	|O
pressure	|O
for	|O
transmissibility	|O
in	|O
avian	|O
communication	|O
.	|O

Consumption	|O
of	|O
4%	|O
sucrose	|O
was	|O
not	|O
affected	|O
by	|O
excitotoxic	|O
lesions	|O
of	|O
the	|O
PPTg	|O
,	|O
but	|O
PPTg	|O
lesioned	|O
rats	|O
consumed	|O
significantly	|O
more	|O
12%	|O
and	|O
20%	|O
sucrose	|O
than	|O
sham	|O
controls	|O
.	|O

Actuarial	|O
freedom	|O
from	|O
ventricular	|O
arrhythmias	|O
at	|O
4	|O
-	|O
year	|O
follow	|O
-	|O
up	|O
was	|O
74.1	|O
+	|O
/	|O
-	|O
6.0%	|O
in	|O
group	|O
A	|O
vs.	|O

Mental	|O
development	|O
is	|O
generally	|O
normal	|O
.	|O

Influence	|O
of	|O
different	|O
methods	|O
of	|O
chemical	|O
disinfection	|O
on	|O
the	|O
physical	|O
properties	|O
of	|O
type	|O
IV	|O
and	|O
V	|O
gypsum	|O
dies	|O
]	|O
Several	|O
instruments	|O
and	|O
materials	|O
frequently	|O
used	|O
in	|O
prosthodontics	|O
-	|O
-	|O
such	|O
as	|O
stone	|O
casts	|O
,	|O
dental	|O
impressions	|O
,	|O
interocclusal	|O
records	|O
-	|O
-	|O
are	|O
classified	|O
,	|O
by	|O
the	|O
dental	|O
literature	|O
,	|O
as	|O
vehicles	|O
of	|O
transmission	|O
of	|O
infectious	|O
diseases	|O
to	|O
those	|O
who	|O
handle	|O
them	|O
.	|O

In	|O
sterilized	|O
milk	|O
there	|O
was	|O
a	|O
slight	|O
decrease	|O
of	|O
linoleic	|O
acid	|O
(	|O
C18	|O
:	|O
2n6	|O
;	|O
-	|O
0.7%	|O
vs.	|O
fresh	|O
;	|O
P	|O
=	|O
0.006	|O
)	|O
and	|O
arachidonic	|O
acid	|O
(	|O
C20	|O
:	|O
4n6	|O
;	|O
-	|O
2.5%	|O
;	|O
P	|O
=	|O
0.045	|O
)	|O
.	|O

Vitrectomy	|O
and	|O
removal	|O
of	|O
retained	|O
lens	|O
fragments	|O
restores	|O
good	|O
visual	|O
acuity	|O
and	|O
reduces	|O
secondary	|O
glaucoma	|O
in	|O
the	|O
majority	|O
of	|O
patients	|O
.	|O

CONCLUSIONS	|O
:	|O
The	|O
mechanism	|O
of	|O
MIRI	|O
is	|O
Qi	|O
deficiency	|O
and	|O
blood	|O
stasis	|O
in	|O
TCM	|O
,	|O
its	|O
treating	|O
principles	|O
should	|O
be	|O
promoting	|O
Qi	|O
and	|O
removing	|O
the	|O
blood	|O
stasis	|O
.	|O

Effects	|O
of	|O
activating	|O
blood	|O
circulation	|O
to	|O
remove	|O
blood	|O
stasis	|O
on	|O
barrier	|O
action	|O
of	|O
gastric	|O
wall	|O
in	|O
chronic	|O
atrophic	|O
gastritis	|O

Proteomic	|O
patterns	|O
of	|O
nipple	|O
aspirate	|O
fluids	|O
obtained	|O
by	|O
SELDI	|O
-	|O
TOF	|O
:	|O
potential	|O
for	|O
new	|O
biomarkers	|O
to	|O
aid	|O
in	|O
the	|O
diagnosis	|O
of	|O
breast	|O
cancer	|O
.	|O

According	|O
to	|O
the	|O
laboratory	|O
results	|O
,	|O
the	|O
application	|O
of	|O
neural	|O
network	|O
can	|O
solve	|O
the	|O
problem	|O
successfully	|O
.	|O

A	|O
high	|O
-	|O
efficiency	|O
cross	|O
-	|O
flow	|O
micronebulizer	|O
interface	|O
for	|O
capillary	|O
electrophoresis	|O
and	|O
inductively	|O
coupled	|O
plasma	|O
mass	|O
spectrometry	|O
.	|O

The	|O
electrodes	|O
themselves	|O
do	|O
not	|O
need	|O
to	|O
be	|O
polished	|O
prior	|O
to	|O
their	|O
use	|O
but	|O
are	|O
observed	|O
to	|O
be	|O
slightly	|O
recessed	|O
from	|O
the	|O
surrounding	|O
insulating	|O
surface	|O
.	|O

The	|O
experimental	|O
results	|O
showed	|O
that	|O
the	|O
coagulation	|O
-	|O
electrooxidation	|O
process	|O
could	|O
efficiently	|O
remove	|O
the	|O
color	|O
and	|O
the	|O
COD	|O
from	|O
the	|O
simulated	|O
dye	|O
wastewater	|O
.	|O

Cyclic	|O
loading	|O
of	|O
bone	|O
during	|O
normal	|O
daily	|O
activity	|O
leads	|O
to	|O
the	|O
formation	|O
of	|O
microcracks	|O
within	|O
the	|O
tissue	|O
matrix	|O
of	|O
compact	|O
bone	|O
.	|O

The	|O
weight	|O
-	|O
bearing	|O
surface	|O
of	|O
the	|O
PE	|O
head	|O
became	|O
smoother	|O
with	|O
time	|O
after	|O
THA	|O
,	|O
and	|O
the	|O
friction	|O
coefficient	|O
did	|O
not	|O
differ	|O
significantly	|O
from	|O
that	|O
of	|O
an	|O
unused	|O
PE	|O
head	|O
.	|O

OBJECTIVE	|O
:	|O
To	|O
demonstrate	|O
a	|O
lack	|O
of	|O
effect	|O
of	|O
steady	|O
-	|O
state	|O
concentrations	|O
of	|O
cilomilast	|O
,	|O
a	|O
new	|O
oral	|O
phosphodiesterase	|B-PROTEIN
4	|I-PROTEIN
inhibitor	|O
for	|O
the	|O
treatment	|O
of	|O
chronic	|O
obstructive	|O
pulmonary	|O
disease	|O
,	|O
on	|O
warfarin	|O
-	|O
induced	|O
anticoagulation	|O
.	|O

Postdocs	|O
face	|O
hardship	|O
across	|O
mainland	|O
Europe	|O
.	|O

The	|O
design	|O
principle	|O
based	|O
on	|O
a	|O
uniform	|O
vibration	|O
mode	|O
is	|O
presented	|O
.	|O

Because	|O
the	|O
DPPD	|B-PROTEIN
gene	|O
is	|O
not	|O
present	|O
in	|O
non	|O
-	|O
tuberculous	|O
bacilli	|O
,	|O
these	|O
results	|O
suggest	|O
that	|O
this	|O
molecule	|O
can	|O
be	|O
an	|O
additional	|O
tool	|O
for	|O
a	|O
more	|O
specific	|O
diagnosis	|O
of	|O
tuberculosis	|O
.	|O

Dynamic	|O
imaging	|O
of	|O
nuclear	|O
wave	|O
functions	|O
with	|O
ultrashort	|O
UV	|O
laser	|O
pulses	|O
.	|O

Efficacy	|O
and	|O
safety	|O
of	|O
aspirin	|O
in	|O
the	|O
long	|O
-	|O
term	|O
management	|O
of	|O
atherothrombosis	|O
.	|O

The	|O
General	|O
Practice	|O
Research	|O
Database	|O
(	|O
GPRD	|O
)	|O
is	|O
the	|O
world	|O
's	|O
largest	|O
computerized	|O
database	|O
of	|O
anonymized	|O
longitudinal	|O
patient	|O
records	|O
from	|O
general	|O
practice	|O
and	|O
is	|O
a	|O
unique	|O
public	|O
health	|O
research	|O
tool	|O
.	|O

This	|O
paper	|O
reports	|O
the	|O
results	|O
of	|O
a	|O
laboratory	|O
study	|O
on	|O
aldicarb	|O
and	|O
its	|O
main	|O
metabolites	|O
,	|O
aldicarb	|O
sulfone	|O
and	|O
aldicarb	|O
sulfoxide	|O
.	|O

Only	|O
one	|O
DC	|O
cardioversion	|O
was	|O
required	|O
in	|O
the	|O
HBS	|O
group	|O
,	|O
whereas	|O
2	|O
DC	|O
in	|O
the	|O
CBC	|O
group	|O
and	|O
total	|O
7	|O
DC	|O
in	|O
the	|O
GIK	|O
group	|O
.	|O

Since	|O
August	|O
1994	|O
,	|O
the	|O
ENRP	|O
has	|O
retained	|O
70.3	|O
metric	|O
tons	|O
of	|O
TP	|O
that	|O
otherwise	|O
would	|O
have	|O
entered	|O
the	|O
Everglades	|O
.	|O

It	|O
was	|O
found	|O
that	|O
the	|O
disappearance	|O
of	|O
BOD5	|O
and	|O
NH3	|O
-	|O
N	|O
could	|O
be	|O
approximated	|O
using	|O
first	|O
-	|O
order	|O
kinetics	|O
,	|O
but	|O
the	|O
kinetics	|O
of	|O
TP	|O
removal	|O
were	|O
unclear	|O
.	|O

It	|O
was	|O
found	|O
that	|O
the	|O
disappearance	|O
of	|O
BOD5	|O
and	|O
NH3	|O
-	|O
N	|O
could	|O
be	|O
approximated	|O
using	|O
first	|O
-	|O
order	|O
kinetics	|O
,	|O
but	|O
the	|O
kinetics	|O
of	|O
TP	|O
removal	|O
were	|O
unclear	|O
.	|O

Losses	|O
of	|O
dichlofluanid	|O
(	|O
54%	|O
)	|O
,	|O
chlozolinate	|O
(	|O
22%	|O
)	|O
,	|O
and	|O
etridiazole	|O
(	|O
40%	|O
)	|O
,	|O
previously	|O
reported	|O
to	|O
occur	|O
during	|O
ambient	|O
processing	|O
of	|O
apples	|O
,	|O
were	|O
reduced	|O
to	|O
barely	|O
significant	|O
levels	|O
(	|O
10	|O
,	|O
17	|O
,	|O
and	|O
14%	|O
,	|O
respectively	|O
)	|O
by	|O
cryogenic	|O
processing	|O
.	|O

The	|O
TB	|O
incidence	|O
in	|O
the	|O
"	|O
AIRIN	|O
"	|O
area	|O
,	|O
where	|O
about	|O
20%	|O
TB	|O
patients	|O
are	|O
homeless	|O
,	|O
shows	|O
highest	|O
rate	|O
of	|O
above	|O
1,000/100,000	|O
.	|O

It	|O
is	|O
shown	|O
that	|O
the	|O
displacement	|O
distribution	|O
measured	|O
by	|O
q	|O
-	|O
space	|O
MRI	|O
in	|O
both	|O
the	|O
large	|O
displacement	|O
(	|O
i.e.	|O
,	|O
large	|O
r	|O
)	|O
and	|O
the	|O
long	|O
-	|O
wavelength	|O
(	|O
i.e.	|O
,	|O
small	|O
q	|O
)	|O
limits	|O
is	|O
the	|O
same	|O
3D	|O
Gaussian	|O
displacement	|O
distribution	|O
assumed	|O
in	|O
DT	|O
-	|O
MRI	|O
.	|O

The	|O
procedure	|O
facilitated	|O
the	|O
retention	|O
of	|O
a	|O
mandibular	|O
molar	|O
with	|O
a	|O
Class	|O
III	|O
FI	|O
in	|O
a	|O
manner	|O
acceptable	|O
to	|O
both	|O
the	|O
patient	|O
and	|O
the	|O
clinician	|O
.	|O

The	|O
results	|O
of	|O
our	|O
ten	|O
-	|O
fold	|O
cross	|O
-	|O
validation	|O
experiments	|O
show	|O
that	|O
,	|O
on	|O
the	|O
average	|O
,	|O
the	|O
system	|O
increases	|O
the	|O
specificity	|O
from	|O
0.19	|O
(	|O
0.35	|O
)	|O
to	|O
0.69	|O
(	|O
0.74	|O
)	|O
at	|O
a	|O
sensitivity	|O
level	|O
of	|O
1.0	|O
(	|O
0.95	|O
)	|O
.	|O

The	|O
physical	|O
characteristics	|O
of	|O
these	|O
calls	|O
vary	|O
among	|O
species	|O
of	|O
bat	|O
,	|O
and	|O
variations	|O
also	|O
exist	|O
in	|O
the	|O
timing	|O
and	|O
patterns	|O
of	|O
respiratory	|O
muscle	|O
recruitment	|O
during	|O
echolocation	|O
.	|O

Clicking	|O
on	|O
"	|O
Examples	|O
and	|O
Explanations	|O
of	|O
APA	|O
Form	|O
"	|O
provides	|O
a	|O
help	|O
system	|O
with	|O
examples	|O
of	|O
the	|O
various	|O
sections	|O
of	|O
a	|O
review	|O
article	|O
,	|O
journal	|O
article	|O
that	|O
has	|O
one	|O
experiment	|O
,	|O
or	|O
journal	|O
article	|O
that	|O
has	|O
two	|O
or	|O
more	|O
experiments	|O
.	|O

The	|O
drug	|O
packets	|O
contained	|O
acetyl	|O
aspirin	|O
,	|O
acetaminophen	|O
and	|O
chloramphenicol	|O
.	|O

Karger	|O
AG	|O
,	|O
Basel	|O

AIM	|O
:	|O
To	|O
understand	|O
the	|O
role	|O
of	|O
nutritional	|O
status	|O
in	|O
cirrhotic	|O
patients	|O
without	|O
clinical	|O
porto	|O
-	|O
systemic	|O
encephalopathy	|O
(	|O
PSE	|O
)	|O
.	|O
METHODS	|O
:	|O
Fifty	|O
-	|O
one	|O
non	|O
-	|O
alcoholic	|O
patients	|O
with	|O
cirrhosis	|O
without	|O
PSE	|O
were	|O
studied	|O
prospectively	|O
and	|O
compared	|O
with	|O
20	|O
healthy	|O
volunteers	|O
.	|O

MAIN	|O
OUTCOME	|O
MEASURE	|O
(	|O
S	|O
)	|O
:	|O
Serum	|O
levels	|O
of	|O
FSH	|B-PROTEIN
,	|O
LH	|B-PROTEIN
,	|O
and	|O
inhibin	|B-PROTEIN
A	|I-PROTEIN
and	|I-PROTEIN
B.	|I-PROTEIN

For	|O
instance	|O
,	|O
a	|O
total	|O
SIP	|O
score	|O
of	|O
an	|O
individual	|O
patient	|O
of	|O
28.3%	|O
(	|O
which	|O
is	|O
taken	|O
as	|O
an	|O
example	|O
,	|O
being	|O
the	|O
mean	|O
score	|O
in	|O
the	|O
study	|O
population	|O
)	|O
should	|O
decrease	|O
by	|O
at	|O
least	|O
9.26%	|O
or	|O
approximately	|O
13	|O
items	|O
,	|O
before	|O
any	|O
improvement	|O
beyond	|O
reproducibility	|O
noise	|O
can	|O
be	|O
detected	|O
.	|O

Group	|O
I	|O
comprised	|O
5	|O
adult	|O
Collies	|O
that	|O
received	|O
at	|O
least	|O
400	|O
microg	|O
/	|O
kg	|O
ivermectin	|O
p.o	|O
.	|O
and	|O
were	|O
presented	|O
to	|O
the	|O
VMTH	|O
3	|O
hours	|O
after	|O
intoxication	|O
.	|O

Patients	|O
with	|O
a	|O
secondary	|O
cardiac	|O
event	|O
had	|O
more	|O
common	|O
Type	|O
A	|O
behavior	|O
patterns	|O
and	|O
higher	|O
Bortner	|O
scores	|O
than	|O
patients	|O
without	|O
a	|O
secondary	|O
cardiac	|O
event	|O
.	|O

Interestingly	|O
,	|O
continuation	|O
of	|O
the	|O
interferon	|B-PROTEIN
therapy	|O
in	|O
the	|O
presence	|O
of	|O
a	|O
mild	|O
-	|O
to	|O
-	|O
moderate	|O
exacerbation	|O
of	|O
sarcoidosis	|O
may	|O
be	|O
safe	|O
in	|O
a	|O
minority	|O
of	|O
patients	|O
with	|O
noncritical	|O
organ	|O
involvement	|O
.	|O

No	|O
increased	|O
tumor	|O
-	|O
related	|O
mortality	|O
was	|O
observed	|O
after	|O
a	|O
mean	|O
follow	|O
-	|O
up	|O
of	|O
44	|O
months	|O
.	|O

Dissociable	|O
effects	|O
of	|O
lidocaine	|O
inactivation	|O
of	|O
the	|O
rostral	|O
and	|O
caudal	|O
basolateral	|O
amygdala	|O
on	|O
the	|O
maintenance	|O
and	|O
reinstatement	|O
of	|O
cocaine	|O
-	|O
seeking	|O
behavior	|O
in	|O
rats	|O
.	|O

The	|O
population	|O
studied	|O
comprised	|O
4472	|O
men	|O
and	|O
5212	|O
women	|O
aged	|O
30-74	|O
years	|O
,	|O
without	|O
coronary	|O
heart	|O
disease	|O
,	|O
who	|O
had	|O
CRP	|B-PROTEIN
measurements	|O
in	|O
the	|O
Third	|O
National	|O
Health	|O
and	|O
Nutrition	|O
Examination	|O
Survey	|O
(	|O
NHANES	|O
III	|O
)	|O
.	|O

Herceptin	|O
,	|O
which	|O
recognizes	|O
the	|O
HER	|B-PROTEIN
-	|I-PROTEIN
2	|I-PROTEIN
/	|O
neu	|B-PROTEIN
antigen	|O
and	|O
has	|O
similar	|O
size	|O
(	|O
10	|O
nm	|O
)	|O
to	|O
G6	|O
-	|O
(	|O
1B4M	|O
-	|O
Gd	|O
)	|O
(	|O
256	|O
)	|O
,	|O
accumulated	|O
and	|O
internalized	|O
in	|O
the	|O
WIBC	|O
-	|O
9	|O
tumors	|O
more	|O
quickly	|O
than	|O
in	|O
the	|O
control	|O
MC	|O
-	|O
5	|O
tumors	|O
that	|O
progress	|O
with	|O
normal	|O
angiogenesis	|O
.	|O

Forty	|O
-	|O
eight	|O
pigs	|O
were	|O
removed	|O
from	|O
sows	|O
at	|O
1	|O
d	|O
of	|O
age	|O
and	|O
randomly	|O
assigned	|O
to	|O
one	|O
of	|O
three	|O
treatments	|O
:	|O
1	|O
)	|O
control	|O
with	|O
lactose	|O
as	|O
the	|O
carbohydrate	|O
source	|O
,	|O
2	|O
)	|O
lactose	|O
replaced	|O
(	|O
gram	|O
for	|O
gram	|O
)	|O
with	|O
CSS	|O
(	|O
dextrose	|O
equivalent	|O
[	|O
DE	|O
]	|O
-	|O
20	|O
)	|O
,	|O
and	|O
3	|O
)	|O
lactose	|O
replaced	|O
with	|O
DE	|O
-	|O
42	|O
.	|O

CONCLUSIONS	|O
:	|O
AMVT	|O
is	|O
rare	|O
but	|O
a	|O
potentially	|O
lethal	|O
emergency	|O
disease	|O
.	|O

There	|O
was	|O
no	|O
difference	|O
in	|O
apnea	|O
duration	|O
between	|O
the	|O
supine	|O
and	|O
prone	|O
positions	|O
.	|O

Therefore	|O
,	|O
in	|O
a	|O
large	|O
animal	|O
model	|O
of	|O
permanent	|O
focal	|O
ischemia	|O
in	|O
which	|O
transfusion	|O
starts	|O
30	|O
min	|O
after	|O
ischemia	|O
,	|O
tetrameric	|O
cross	|O
-	|O
linked	|O
hemoglobin	|B-PROTEIN
transfusion	|O
can	|O
augment	|O
oxygen	|O
transport	|O
to	|O
the	|O
ischemic	|O
cortex	|O
,	|O
but	|O
the	|O
increase	|O
can	|O
be	|O
delayed	|O
and	|O
not	|O
necessarily	|O
provide	|O
protection	|O
.	|O

Since	|O
the	|O
early	|O
1980s	|O
there	|O
has	|O
been	|O
increasing	|O
awareness	|O
of	|O
the	|O
importance	|O
of	|O
quantifying	|O
health	|O
-	|O
related	|O
quality	|O
of	|O
life	|O
(	|O
HRQL	|O
)	|O
in	|O
patients	|O
with	|O
chronic	|O
respiratory	|O
disorders	|O
included	|O
in	|O
clinical	|O
trials	|O
.	|O

They	|O
were	|O
randomly	|O
allocated	|O
to	|O
receive	|O
either	|O
625	|O
mg	|O
of	|O
calcium	|O
carbonate	|O
(	|O
250	|O
mg	|O
of	|O
elemental	|O
calcium	|O
)	|O
at	|O
the	|O
end	|O
of	|O
a	|O
meal	|O
three	|O
times	|O
a	|O
day	|O
(	|O
group	|O
A	|O
,	|O
n	|O
=	|O
26	|O
)	|O
or	|O
calcium	|O
carbonate	|O
in	|O
the	|O
same	|O
manner	|O
plus	|O
0.625	|O
mg	|O
/	|O
day	|O
of	|O
conjugated	|O
equine	|O
estrogen	|O
and	|O
5	|O
mg	|O
medrogestone	|O
acetate	|O
from	|O
day	|O
1-12	|O
each	|O
month	|O
(	|O
group	|O
B	|O
,	|O
n	|O
=	|O
30	|O
)	|O
.	|O

TNFalpha	|B-PROTEIN
and	|O
IL	|B-PROTEIN
-	|I-PROTEIN
6	|I-PROTEIN
levels	|O
were	|O
determined	|O
in	|O
the	|O
culture	|O
supernatants	|O
.	|O

Therefore	|O
,	|O
this	|O
study	|O
has	|O
demonstrated	|O
that	|O
prenatal	|O
disturbance	|O
can	|O
induce	|O
a	|O
lasting	|O
change	|O
in	|O
cytokine	|O
biology	|O
,	|O
which	|O
persists	|O
well	|O
beyond	|O
the	|O
fetal	|O
and	|O
infant	|O
stage	|O
.	|O

The	|O
two	|O
-	|O
wave	|O
,	|O
1995-1996	|O
National	|O
Longitudinal	|O
Study	|O
of	|O
Adolescent	|O
Health	|O
uses	|O
a	|O
measure	|O
of	|O
depressive	|O
symptomatology	|O
across	|O
a	|O
12	|O
-	|O
month	|O
interval	|O
.	|O

METHODS	|O
:	|O
9	|O
cases	|O
of	|O
conventional	|O
intermittent	|O
tissue	|O
expansion	|O
(	|O
CITE	|O
)	|O
and	|O
9	|O
cases	|O
of	|O
continuous	|O
pressure	|O
-	|O
controlled	|O
tissue	|O
expansion	|O
(	|O
CPTE	|O
)	|O
were	|O
chosen	|O
for	|O
the	|O
study	|O
.	|O

Wegener	|O
's	|O
granulomatosis	|O

There	|O
was	|O
a	|O
significant	|O
effect	|O
of	|O
hematocrit	|O
on	|O
the	|O
General	|O
Health	|O
scale	|O
on	|O
the	|O
SF	|O
-	|O
36	|O
(	|O
P	|O
=	|O
0.03	|O
)	|O
.	|O

Based	|O
on	|O
analytic	|O
precisions	|O
,	|O
a	|O
+	|O
/	|O
-	|O
2%	|O
urine	|O
-	|O
plasma	|O
difference	|O
was	|O
set	|O
as	|O
the	|O
cut	|O
-	|O
off	|O
value	|O
.	|O

Schistosoma	|O
mansoni	|O
schistosomiasis	|O
]	|O
Schistosomosis	|O
are	|O
parasitic	|O
diseases	|O
caused	|O
by	|O
blood	|O
flukes	|O
of	|O
the	|O
Schistosoma	|O
genus	|O
.	|O

A	|O
global	|O
response	|O
rate	|O
was	|O
17%	|O
(	|O
95%	|O
confidence	|O
interval	|O
(	|O
95%	|O
CI	|O
)	|O
:	|O
2%	|O
-	|O
32%	|O
)	|O
and	|O
the	|O
median	|O
overall	|O
survival	|O
was	|O
12	|O
months	|O
.	|O

We	|O
also	|O
studied	|O
a	|O
new	|O
parameter	|O
:	|O
the	|O
angle	|O
to	|O
maximal	|O
peak	|O
torque	|O
(	|O
APT	|O
)	|O
.	|O

For	|O
the	|O
2.5	|O
to	|O
4	|O
ng	|O
/	|O
mL	|O
model	|O
,	|O
the	|O
AUC	|O
of	|O
the	|O
ANN	|O
ROC	|O
curve	|O
was	|O
significantly	|O
higher	|O
than	|O
the	|O
AUCs	|O
for	|O
percentage	|O
of	|O
free	|O
PSA	|B-PROTEIN
(	|O
P	|O
=	|O
.0239	|O
)	|O
,	|O
PSA	|O
-	|O
TZ	|O
(	|O
P	|O
=	|O
.0204	|O
)	|O
,	|O
and	|O
PSA	|B-PROTEIN
density	|O
and	|O
total	|O
prostate	|O
volume	|O
(	|O
P	|O
<	|O
.01	|O
for	|O
both	|O
)	|O
.	|O

Potential	|O
treatments	|O
include	|O
dobutamine	|O
,	|O
KATP	|O
channel	|O
activators	|O
,	|O
and	|O
21	|O
-	|O
aminosteroids	|O
.	|O

Selenium	|O
is	|O
an	|O
essential	|O
element	|O
for	|O
humans	|O
,	|O
animals	|O
and	|O
some	|O
species	|O
of	|O
microorganisms	|O
.	|O

The	|O
GT	|O
-	|O
foreign	|O
-	|O
pictures	|O
showed	|O
that	|O
the	|O
judgment	|O
of	|O
other	|O
subjects	|O
changed	|O
toward	|O
hedonic	|O
and	|O
permeability	|O
directions	|O
.	|O

Emphysematous	|O
cholecystitis	|O
:	|O
sonographic	|O
findings	|O
.	|O

Age	|O
was	|O
categorized	|O
into	|O
four	|O
groups	|O
:	|O
20-44	|O
,	|O
45-64	|O
,	|O
65-74	|O
,	|O
and	|O
75	|O
+	|O
.	|O
RESULTS	|O
:	|O
At	|O
the	|O
initiation	|O
of	|O
dialysis	|O
PD	|O
patients	|O
were	|O
approximately	|O
6	|O
years	|O
younger	|O
(	|O
P	|O
<	|O
0.0001	|O
)	|O
than	|O
HD	|O
patients	|O
.	|O

RESULTS	|O
:	|O
The	|O
target	|O
dose	|O
was	|O
comparable	|O
in	|O
the	|O
3D	|O
-	|O
CRT	|O
and	|O
IMRT	|O
plans	|O
,	|O
although	|O
improvements	|O
were	|O
seen	|O
when	|O
seven	|O
and	|O
nine	|O
IMRT	|O
fields	|O
were	|O
used	|O
.	|O

We	|O
therefore	|O
applied	|O
a	|O
radiolabelled	|O
serumalbumin	|B-PROTEIN
method	|O
to	|O
determine	|O
blood	|O
volume	|O
after	|O
haemodilution	|O
with	|O
crosslinked	|O
or	|O
conjugated	|O
haemoglobin	|B-PROTEIN
,	|O
in	|O
comparison	|O
with	|O
a	|O
reference	|O
solution	|O
of	|O
hydroxyethyl	|O
starch	|O
(	|O
HES	|O
)	|O
.	|O

The	|O
equilibrium	|O
phosphorus	|O
content	|O
(	|O
EPC0	|O
)	|O
of	|O
surface	|O
soil	|O
was	|O
generally	|O
higher	|O
than	|O
the	|O
SRP	|O
content	|O
of	|O
drainage	|O
water	|O
,	|O
at	|O
one	|O
farm	|O
by	|O
1	|O
order	|O
of	|O
magnitude	|O
.	|O

The	|O
long	|O
-	|O
term	|O
prediction	|O
is	|O
based	|O
on	|O
an	|O
algorithm	|O
for	|O
R	|O
-	|O
R	|O
interval	|O
estimation	|O
.	|O

Despite	|O
considerable	|O
research	|O
,	|O
an	|O
explanation	|O
of	|O
this	|O
effect	|O
has	|O
been	|O
elusive	|O
.	|O

The	|O
structure	|O
has	|O
been	|O
established	|O
by	|O
a	|O
study	|O
of	|O
its	|O
mono	|O
-	|O
and	|O
bidimensional	|O
NMR	|O
spectra	|O
and	|O
mass	|O
spectrometry	|O
.	|O

We	|O
argue	|O
that	|O
this	|O
is	|O
the	|O
general	|O
property	|O
of	|O
QSAR	|O
models	|O
developed	|O
using	|O
LOO	|O
cross	|O
-	|O
validation	|O
.	|O

We	|O
compared	|O
the	|O
efficacy	|O
and	|O
costs	|O
of	|O
valacyclovir	|O
in	|O
preventing	|O
HSV	|O
reactivation	|O
among	|O
HSV	|O
seropositive	|O
autologous	|O
progenitor	|O
cell	|O
transplantation	|O
(	|O
APCT	|O
)	|O
patients	|O
with	|O
historical	|O
controls	|O
in	|O
whom	|O
intravenous	|O
acyclovir	|O
or	|O
no	|O
HSV	|O
prophylaxis	|O
were	|O
used	|O
.	|O

All	|O
adults	|O
attending	|O
the	|O
outpatient	|O
clinics	|O
of	|O
a	|O
dermatological	|O
hospital	|O
on	|O
predetermined	|O
days	|O
were	|O
given	|O
the	|O
12	|O
-	|O
item	|O
General	|O
Health	|O
Questionnaire	|O
.	|O

Data	|O
on	|O
prosthesis	|O
use	|O
are	|O
encouraging	|O
,	|O
although	|O
a	|O
follow	|O
-	|O
up	|O
study	|O
is	|O
required	|O
to	|O
determine	|O
the	|O
functional	|O
outcome	|O
for	|O
prosthesis	|O
users	|O
and	|O
non	|O
-	|O
users	|O
.	|O

A	|O
mail	|O
survey	|O
of	|O
Georgia	|O
members	|O
of	|O
the	|O
American	|O
College	|O
of	|O
Obstetricians	|O
and	|O
Gynecologists	|O
was	|O
conducted	|O
.	|O

HIV	|O
-	|O
1	|O
C	|O
subtype	|O
in	|O
IDUs	|O
accounted	|O
for	|O
61.3%	|O
.	|O

When	|O
a	|O
plateau	|O
of	|O
enhancement	|O
was	|O
reached	|O
,	|O
a	|O
single	|O
lesion	|O
in	|O
each	|O
patient	|O
was	|O
imaged	|O
using	|O
five	|O
different	|O
continuous	|O
scanning	|O
modes	|O
,	|O
fundamental	|O
grey	|O
scale	|O
(	|O
FGS	|O
)	|O
;	|O
fundamental	|O
colour	|O
Doppler	|O
(	|O
FCD	|O
)	|O
;	|O
fundamental	|O
power	|O
Doppler	|O
(	|O
FPD	|O
)	|O
;	|O
second	|O
harmonic	|O
grey	|O
scale	|O
(	|O
HGS	|O
)	|O
;	|O
and	|O
pulse	|O
inversion	|O
mode	|O
(	|O
Pim	|O
)	|O
using	|O
an	|O
HDI5000	|O
scanner	|O
and	|O
C5	|O
-	|O
2	|O
probe	|O
(	|O
ATL	|O
,	|O
Bothell	|O
,	|O
WA	|O
)	|O
.	|O

A	|O
comparative	|O
study	|O
of	|O
the	|O
effects	|O
of	|O
carbamazepine	|O
and	|O
the	|O
NMDA	|B-PROTEIN
receptor	|I-PROTEIN
antagonist	|O
remacemide	|O
on	|O
road	|O
tracking	|O
and	|O
car	|O
-	|O
following	|O
performance	|O
in	|O
actual	|O
traffic	|O
.	|O

We	|O
find	|O
that	|O
the	|O
measured	|O
Nusselt	|O
number	|O
decreased	|O
about	|O
20%	|O
over	|O
the	|O
range	|O
of	|O
Pr	|O
spanned	|O
in	|O
the	|O
experiment	|O
.	|O

Viral	|O
and	|O
atypical	|O
pathogens	|O
as	|O
causes	|O
of	|O
type	|O
1	|O
acute	|O
exacerbations	|O
of	|O
chronic	|O
bronchitis	|O
.	|O

Treatment	|O
for	|O
this	|O
condition	|O
often	|O
involves	|O
use	|O
of	|O
a	|O
wax	|O
softening	|O
or	|O
dispersing	|O
agent	|O
(	|O
cerumenolytic	|O
)	|O
before	|O
syringing	|O
.	|O

In	|O
addition	|O
,	|O
benzocaine	|O
and	|O
2	|O
-	|O
phenoxyethanol	|O
depressed	|O
complement	|O
activity	|O
and	|O
phagocytosis	|O
,	|O
while	|O
MS222	|O
and	|O
quinaldine	|O
sulphate	|O
did	|O
not	|O
.	|O

The	|O
EC	|O
(	|O
50	|O
)	|O
for	|O
suppression	|O
of	|O
long	|O
-	|O
term	|O
memory	|O
(	|O
the	|O
concentration	|O
decreasing	|O
memory	|O
by	|O
50%	|O
)	|O
of	|O
fear	|O
conditioning	|O
to	|O
context	|O
was	|O
2.00%	|O
plus	|O
/	|O
minus	|O
0.01%	|O
(	|O
mean	|O
plus	|O
/	|O
minus	|O
SEM	|O
)	|O
,	|O
and	|O
for	|O
fear	|O
conditioning	|O
to	|O
tone	|O
was	|O
3.45%	|O
plus	|O
/	|O
minus	|O
0.26%	|O
,	|O
(	|O
P	|O
<	|O
0.05	|O
)	|O
.	|O

The	|O
utility	|O
of	|O
such	|O
analyses	|O
in	|O
the	|O
design	|O
of	|O
ceramic	|O
/	|O
substrate	|O
bilayer	|O
systems	|O
for	|O
optimal	|O
resistance	|O
to	|O
lifetime	|O
-	|O
threatening	|O
damage	|O
is	|O
discussed	|O
.	|O

It	|O
has	|O
been	|O
proposed	|O
that	|O
insulin	|B-PROTEIN
resistance	|O
(	|O
IR	|O
)	|O
underlies	|O
a	|O
cluster	|O
of	|O
cardiovascular	|O
disease	|O
(	|O
CVD	|O
)	|O
risk	|O
factors	|O
constituting	|O
a	|O
"	|O
metabolic	|O
syndrome	|O
.	|O
"	|O
CVD	|O
is	|O
a	|O
leading	|O
cause	|O
of	|O
premature	|O
mortality	|O
among	|O
indigenous	|O
Australians	|O
.	|O

Dementia	|O
is	|O
being	|O
avoided	|O
in	|O
NHS	|O
and	|O
social	|O
care	|O
.	|O

HIV	|O
-	|O
1	|O
infection	|O
in	|O
rural	|O
Africa	|O
:	|O
is	|O
there	|O
a	|O
difference	|O
in	|O
median	|O
time	|O
to	|O
AIDS	|O
and	|O
survival	|O
compared	|O
with	|O
that	|O
in	|O
industrialized	|O
countries	|O
?	|O
OBJECTIVES	|O
:	|O
To	|O
describe	|O
the	|O
progression	|O
times	|O
of	|O
HIV	|O
-	|O
1	|O
infection	|O
from	|O
seroconversion	|O
to	|O
AIDS	|O
and	|O
to	|O
death	|O
,	|O
and	|O
time	|O
from	|O
first	|O
developing	|O
AIDS	|O
to	|O
death	|O
in	|O
rural	|O
Uganda	|O
.	|O

The	|O
use	|O
of	|O
highly	|O
active	|O
antiretroviral	|O
therapy	|O
(	|O
HAART	|O
)	|O
has	|O
resulted	|O
in	|O
significant	|O
improvements	|O
in	|O
the	|O
treatment	|O
of	|O
HIV	|O
infection	|O
,	|O
including	|O
a	|O
decrease	|O
in	|O
the	|O
incidence	|O
and	|O
severity	|O
of	|O
several	|O
acquired	|O
immune	|O
deficiency	|O
syndrome	|O
(	|O
AIDS	|O
)	|O
-	|O
related	|O
malignancies	|O
.	|O

Time	|O
to	|O
progression	|O
was	|O
6	|O
months	|O
(	|O
5-7	|O
months	|O
)	|O
with	|O
a	|O
median	|O
survival	|O
from	|O
registration	|O
of	|O
9.6	|O
months	|O
(	|O
95%	|O
CI	|O
8-12	|O
months	|O
)	|O
.	|O

Heparin	|O
(	|O
100	|O
U	|O
.	|O
kg	|O
(	|O
-	|O
1	|O
)	|O
.	|O
day	|O
(	|O
-	|O
1	|O
)	|O
)	|O
was	|O
injected	|O
subcutaneously	|O
to	|O
the	|O
rats	|O
in	|O
H	|O
group	|O
while	|O
normal	|O
saline	|O
to	|O
those	|O
in	|O
N	|O
group	|O
once	|O
a	|O
day	|O
.	|O

MAIN	|O
OUTCOME	|O
MEASURE	|O
:	|O
A	|O
positive	|O
test	|O
result	|O
for	|O
gonococcal	|O
or	|O
chlamydial	|O
infection	|O
by	|O
the	|O
ligase	|B-PROTEIN
chain	|O
reaction	|O
assay	|O
;	|O
secondary	|O
outcome	|O
measure	|O
was	|O
a	|O
positive	|O
test	|O
result	|O
for	|O
human	|O
immunodeficiency	|O
virus	|O
(	|O
HIV	|O
)	|O
.	|O

The	|O
purpose	|O
of	|O
this	|O
study	|O
was	|O
to	|O
develop	|O
a	|O
reliable	|O
and	|O
culturally	|O
meaningful	|O
exercise	|O
self	|O
-	|O
efficacy	|O
questionnaire	|O
for	|O
older	|O
Mexican	|O
American	|O
women	|O
.	|O

Neutrophil	|O
:	|O
lymphocyte	|O
ratio	|O
,	|O
plasma	|O
haptoglobin	|B-PROTEIN
,	|O
and	|O
CBG	|B-PROTEIN
levels	|O
were	|O
greater	|O
(	|O
P	|O
<	|O
0.01	|O
)	|O
during	|O
the	|O
INITIAL	|O
period	|O
than	|O
during	|O
the	|O
PRE	|O
or	|O
POST	|O
periods	|O
but	|O
did	|O
not	|O
differ	|O
between	|O
treatments	|O
.	|O

Adjacent	|O
to	|O
those	|O
lesions	|O
,	|O
and	|O
in	|O
homologous	|O
contralateral	|O
structures	|O
,	|O
FMZ	|O
binding	|O
was	|O
analysed	|O
in	|O
four	|O
pairs	|O
of	|O
cortical	|O
9	|O
x	|O
9	|O
-	|O
mm	|O
regions	|O
of	|O
interest	|O
(	|O
ROIs	|O
)	|O
placed	|O
on	|O
transaxial	|O
and	|O
coronal	|O
slices	|O
,	|O
respectively	|O
,	|O
as	|O
well	|O
as	|O
in	|O
the	|O
lesion	|O
volume	|O
and	|O
its	|O
mirror	|O
region	|O
.	|O

Because	|O
a	|O
close	|O
correlation	|O
between	|O
regional	|O
decreases	|O
in	|O
FMZ	|O
binding	|O
and	|O
spiking	|O
activity	|O
was	|O
recently	|O
demonstrated	|O
in	|O
neocortical	|O
epilepsies	|O
,	|O
abnormal	|O
peri	|O
-	|O
lesional	|O
FMZ	|O
binding	|O
may	|O
bear	|O
some	|O
relation	|O
to	|O
the	|O
mechanisms	|O
of	|O
epileptogenesis	|O
in	|O
symptomatic	|O
epilepsies	|O
.	|O

CD	|O
was	|O
determined	|O
using	|O
the	|O
Farnsworth	|O
D	|O
-	|O
15	|O
method	|O
.	|O

Here	|O
is	|O
presented	|O
the	|O
monitoring	|O
of	|O
the	|O
accidental	|O
spill	|O
on	|O
vertical	|O
distribution	|O
of	|O
heavy	|O
metals	|O
in	|O
the	|O
estuarine	|O
sediments	|O
.	|O

The	|O
large	|O
fluxes	|O
of	|O
239	|O
+	|O
240Pu	|O
might	|O
be	|O
attributed	|O
to	|O
episodic	|O
lateral	|O
transport	|O
of	|O
particles	|O
that	|O
flow	|O
down	|O
the	|O
continental	|O
slope	|O
with	|O
the	|O
nepheloid	|O
layer	|O
which	|O
was	|O
considered	|O
to	|O
be	|O
significant	|O
for	|O
239	|O
+	|O
240Pu	|O
transport	|O
on	|O
the	|O
continental	|O
slope	|O
in	|O
the	|O
East	|O
China	|O
Sea	|O
.	|O

Rigorous	|O
treatment	|O
protocols	|O
for	|O
diet	|O
delivery	|O
and	|O
EEN	|O
-	|O
related	|O
GI	|O
adverse	|O
effects	|O
were	|O
applied	|O
.	|O

We	|O
found	|O
three	|O
out	|O
of	|O
four	|O
original	|O
(	|O
Volkan	|O
's	|O
)	|O
groups	|O
of	|O
linking	|O
objects	|O
,	|O
but	|O
also	|O
an	|O
additional	|O
one	|O
,	|O
hitherto	|O
undescribed	|O
,	|O
comprising	|O
objects	|O
used	|O
for	|O
designing	|O
a	|O
memorial	|O
shrine	|O
to	|O
the	|O
deceased	|O
.	|O

The	|O
range	|O
of	|O
200	|O
000-300	|O
000	|O
spermatozoa	|O
/	|O
microl	|O
appeared	|O
to	|O
be	|O
a	|O
reasonable	|O
compromise	|O
for	|O
both	|O
criteria	|O
.	|O

Gastritis	|O
score	|O
was	|O
significantly	|O
lower	|O
in	|O
nod	|O
-	|O
/	|O
CagA	|B-PROTEIN
-	|O
children	|O
than	|O
in	|O
nod+	|O
/	|O
CagA	|B-PROTEIN
-	|O
(	|O
p	|O
=	|O
.004	|O
)	|O
,	|O
nod	|O
-	|O
/	|O
CagA+	|B-PROTEIN
(	|O
p	|O
=	|O
.002	|O
)	|O
and	|O
nod+	|O
/	|O
CagA+	|B-PROTEIN
(	|O
p	|O
<	|O
.001	|O
)	|O
,	|O
both	|O
in	|O
the	|O
antrum	|O
and	|O
corpus	|O
.	|O

The	|O
mean	|O
thickness	|O
of	|O
the	|O
visceral	|O
peritoneum	|O
was	|O
comparable	|O
in	|O
both	|O
groups	|O
of	|O
animals	|O
,	|O
but	|O
,	|O
macroscopically	|O
,	|O
more	|O
severe	|O
fibrosis	|O
was	|O
found	|O
in	|O
the	|O
peritoneum	|O
of	|O
rats	|O
exposed	|O
to	|O
CAPD	|O
3	|O
as	|O
compared	|O
with	|O
animals	|O
treated	|O
with	|O
CAPD	|O
3	|O
Balance	|O
(	|O
p	|O
<	|O
0.05	|O
)	|O
.	|O

A	|O
further	|O
analysis	|O
has	|O
been	|O
performed	|O
using	|O
the	|O
series	|O
of	|O
maximum	|O
intensity	|O
for	|O
fixed	|O
duration	|O
(	|O
1	|O
,	|O
3	|O
,	|O
6	|O
,	|O
12	|O
,	|O
24	|O
hrs	|O
)	|O
and	|O
annual	|O
daily	|O
maxima	|O
.	|O

BACKGROUND	|O
:	|O
We	|O
hypothesized	|O
that	|O
the	|O
postoperative	|O
serum	|O
level	|O
of	|O
TA90	|B-PROTEIN
-	|I-PROTEIN
IC	|I-PROTEIN
,	|O
an	|O
immune	|O
complex	|O
of	|O
a	|O
90	|O
-	|O
kDa	|O
tumor	|O
-	|O
associated	|O
antigen	|O
and	|O
its	|O
antibody	|O
,	|O
might	|O
have	|O
a	|O
significant	|O
correlation	|O
with	|O
recurrence	|O
and	|O
survival	|O
in	|O
patients	|O
with	|O
thick	|O
primary	|O
melanomas	|O
.	|O

Genetics	|O
Institute	|O
has	|O
developed	|O
and	|O
launched	|O
oprelvekin	|B-PROTEIN
(	|O
rhIL	|B-PROTEIN
-	|I-PROTEIN
11	|I-PROTEIN
;	|O
Neumega	|O
)	|O
,	|O
a	|O
recombinant	|O
form	|O
of	|O
human	|O
IL	|B-PROTEIN
-	|I-PROTEIN
11	|I-PROTEIN
.	|O

Patients	|O
subsequently	|O
returned	|O
to	|O
the	|O
clinic	|O
every	|O
3	|O
days	|O
to	|O
have	|O
the	|O
wounds	|O
checked	|O
and	|O
dressings	|O
changed	|O
.	|O

Elements	|O
that	|O
are	|O
fundamental	|O
to	|O
the	|O
safety	|O
evaluation	|O
of	|O
flavor	|O
ingredients	|O
include	|O
exposure	|O
,	|O
structural	|O
analogy	|O
,	|O
metabolism	|O
,	|O
pharmacokinetics	|O
and	|O
toxicology	|O
.	|O

The	|O
mass	|O
-	|O
specific	|O
resting	|O
minute	|O
ventilation	|O
(	|O
E	|O
)	|O
and	|O
the	|O
ventilatory	|O
equivalent	|O
(	|O
VE	|O
/	|O
(	|O
O	|O
(	|O
2	|O
)	|O
)	|O
)	|O
were	|O
approximately	|O
the	|O
same	|O
at	|O
the	|O
two	|O
ages	|O
,	|O
with	|O
a	|O
breathing	|O
pattern	|O
significantly	|O
deeper	|O
and	|O
slower	|O
at	|O
day	|O
1	|O
.	|O

INTERPRETATION	|O
:	|O
It	|O
is	|O
probable	|O
that	|O
the	|O
cognitive	|O
dissonance	|O
created	|O
by	|O
more	|O
health	|O
information	|O
on	|O
smoking	|O
after	|O
1964	|O
,	|O
i.e.	|O
the	|O
necessary	|O
motivation	|O
to	|O
quit	|O
,	|O
was	|O
reduced	|O
as	|O
a	|O
result	|O
of	|O
strategic	|O
changes	|O
in	|O
the	|O
amount	|O
and	|O
content	|O
of	|O
advertising	|O
.	|O

Nine	|O
cases	|O
of	|O
GBS	|O
and	|O
five	|O
of	|O
TM	|O
reported	|O
to	|O
the	|O
active	|O
AFP	|O
surveillance	|O
were	|O
not	|O
found	|O
in	|O
the	|O
hospital	|O
searches	|O
.	|O

The	|O
ability	|O
of	|O
rats	|O
with	|O
control	|O
or	|O
hippocampal	|O
lesions	|O
to	|O
learn	|O
an	|O
object	|O
-	|O
place	|O
,	|O
odor	|O
-	|O
place	|O
,	|O
or	|O
object	|O
-	|O
odor	|O
paired	|O
-	|O
associate	|O
task	|O
was	|O
assessed	|O
in	|O
a	|O
cheeseboard	|O
maze	|O
apparatus	|O
.	|O

The	|O
shift	|O
in	|O
the	|O
earliest	|O
activation	|O
site	|O
after	|O
administration	|O
of	|O
esmolol	|O
was	|O
compared	|O
with	|O
the	|O
shift	|O
after	|O
RFA	|O
.	|O
RESULTS	|O
:	|O
The	|O
heart	|O
rate	|O
at	|O
rest	|O
and	|O
in	|O
drug	|O
-	|O
free	|O
state	|O
ranged	|O
between	|O
95	|O
and	|O
125	|O
beats	|O
/	|O
min	|O
(	|O
mean	|O
99	|O
+	|O
/	|O
-	|O
14	|O
beats	|O
/	|O
min	|O
)	|O
.	|O

Urine	|O
samples	|O
collected	|O
after	|O
the	|O
administration	|O
of	|O
these	|O
supplements	|O
can	|O
test	|O
positive	|O
.	|O

CONCLUSIONS	|O
:	|O
Lymphoscintigraphy	|O
of	|O
the	|O
cynomolgus	|O
monkey	|O
eyelids	|O
reveals	|O
discrete	|O
lymphatic	|O
drainage	|O
pathways	|O
for	|O
the	|O
upper	|O
and	|O
lower	|O
eyelids	|O
and	|O
a	|O
dual	|O
pathway	|O
for	|O
the	|O
central	|O
upper	|O
eyelid	|O
.	|O

Data	|O
management	|O
in	|O
practice	|O
-	|O
based	|O
research	|O
.	|O

We	|O
have	|O
previously	|O
reported	|O
reduced	|O
levels	|O
of	|O
choline	|B-PROTEIN
acetyltransferase	|I-PROTEIN
activity	|O
in	|O
the	|O
cerebral	|O
cortex	|O
of	|O
patients	|O
who	|O
died	|O
after	|O
a	|O
head	|O
injury	|O
,	|O
demonstrating	|O
that	|O
there	|O
is	|O
a	|O
loss	|O
of	|O
cortical	|O
cholinergic	|O
innervation	|O
.	|O

After	|O
taking	|O
smears	|O
from	|O
lesions	|O
of	|O
the	|O
oral	|O
mucosa	|O
(	|O
tongue	|O
,	|O
cheeks	|O
,	|O
palate	|O
)	|O
and	|O
the	|O
contiguous	|O
denture	|O
surface	|O
by	|O
cotton	|O
wool	|O
swabs	|O
and	|O
inoculating	|O
them	|O
onto	|O
Sabouraud	|O
glucose	|O
agar	|O
and	|O
CHROMagar	|O
Candida	|O
,	|O
individual	|O
yeast	|O
species	|O
were	|O
identified	|O
by	|O
a	|O
germ	|O
tube	|O
,	|O
filamentous	|O
,	|O
and	|O
assimilation	|O
tests	|O
employing	|O
the	|O
commercial	|O
kit	|O
AuxaColor	|O
.	|O

The	|O
effects	|O
of	|O
pharmacological	|O
treatment	|O
and	|O
professional	|O
care	|O
and	|O
support	|O
may	|O
improve	|O
when	|O
dementia	|O
is	|O
detected	|O
in	|O
an	|O
early	|O
stage	|O
.	|O

Sexually	|O
conditioned	|O
incentives	|O
:	|O
attenuation	|O
of	|O
motivational	|O
impact	|O
during	|O
dopamine	|B-PROTEIN
receptor	|I-PROTEIN
antagonism	|O
.	|O

One	|O
CKD	|O
patient	|O
's	|O
journey	|O
.	|O

PATIENTS	|O
AND	|O
METHODS	|O
:	|O
This	|O
study	|O
is	|O
a	|O
retrospective	|O
cohort	|O
study	|O
of	|O
all	|O
children	|O
with	|O
cancer	|O
admitted	|O
to	|O
a	|O
single	|O
institution	|O
with	|O
fever	|O
and	|O
neutropenia	|O
(	|O
defined	|O
as	|O
an	|O
absolute	|O
neutrophil	|O
count	|O
<	|O
500	|O
cells	|O
/	|O
mm3	|O
)	|O
in	|O
a	|O
1	|O
-	|O
year	|O
period	|O
.	|O

Concentrations	|O
of	|O
N	|O
(	|O
O3	|O
-	|O
)	|O
-	|O
N	|O
and	|O
N	|O
(	|O
H3	|O
-	|O
)	|O
-	|O
N	|O
at	|O
Deoprayag	|O
varied	|O
from	|O
0.30	|O
to	|O
0.50	|O
and	|O
0.02	|O
to	|O
0.12	|O
mg	|O
/	|O
L	|O
,	|O
respectively	|O
,	|O
depending	|O
on	|O
season	|O
.	|O

Steal	|O
is	|O
a	|O
pathophysiological	|O
process	|O
in	|O
which	|O
increased	|O
blood	|O
flow	|O
through	|O
a	|O
low	|O
-	|O
resistance	|O
vascular	|O
bed	|O
is	|O
sufficient	|O
to	|O
divert	|O
flow	|O
away	|O
from	|O
a	|O
region	|O
of	|O
the	|O
central	|O
nervous	|O
system	|O
.	|O

The	|O
orientations	|O
of	|O
the	|O
contact	|O
surfaces	|O
and	|O
their	|O
locations	|O
relative	|O
to	|O
the	|O
object	|O
's	|O
center	|O
of	|O
mass	|O
were	|O
varied	|O
.	|O

The	|O
results	|O
are	|O
given	|O
as	|O
:	|O
flux	|O
,	|O
number	|O
of	|O
stars	|O
per	|O
cm3	|O
,	|O
charge	|O
of	|O
the	|O
ions	|O
,	|O
comparison	|O
with	|O
other	|O
detectors	|O
(	|O
plastics	|O
,	|O
AgCl	|O
crystals	|O
,	|O
LiF	|O
)	|O
,	|O
energy	|O
loss	|O
,	|O
hit	|O
region	|O
in	|O
the	|O
biological	|O
objects	|O
.	|O

Nodal	|O
domains	|O
are	|O
regions	|O
where	|O
a	|O
function	|O
has	|O
definite	|O
sign	|O
.	|O

DESIGN	|O
:	|O
Prospective	|O
,	|O
randomized	|O
,	|O
double	|O
-	|O
blind	|O
,	|O
controlled	|O
trial	|O
.	|O

CONCLUSIONS	|O
:	|O
This	|O
retrospective	|O
uncontrolled	|O
study	|O
shows	|O
that	|O
in	|O
patients	|O
with	|O
type	|O
1	|O
HRS	|O
,	|O
terlipressin	|O
-	|O
induced	|O
improved	|O
renal	|O
function	|O
is	|O
associated	|O
with	|O
an	|O
increase	|O
in	|O
survival	|O
.	|O

In	|O
patients	|O
who	|O
respond	|O
to	|O
quetiapine	|O
,	|O
therapy	|O
should	|O
be	|O
continued	|O
at	|O
the	|O
optimal	|O
dose	|O
that	|O
maintains	|O
remission	|O
,	|O
within	|O
the	|O
range	|O
of	|O
150	|O
to	|O
750	|O
mg	|O
/	|O
d	|O
.	|O

Calcimimetic	|O
agents	|O
directly	|O
inhibit	|O
PTH	|B-PROTEIN
secretion	|O
by	|O
activating	|O
the	|O
calcium	|O
-	|O
sensing	|O
receptor	|O
in	|O
the	|O
parathyroid	|O
glands	|O
,	|O
but	|O
clinical	|O
experience	|O
with	|O
them	|O
is	|O
limited	|O
.	|O

With	|O
such	|O
analysis	|O
,	|O
one	|O
can	|O
test	|O
hypotheses	|O
about	|O
the	|O
structure	|O
of	|O
latent	|O
variability	|O
within	|O
a	|O
given	|O
data	|O
set	|O
.	|O

The	|O
subjects	|O
were	|O
shown	|O
to	|O
be	|O
capable	|O
of	|O
assessing	|O
integrally	|O
the	|O
value	|O
of	|O
accelerations	|O
and	|O
estimating	|O
it	|O
with	|O
an	|O
error	|O
of	|O
0.1-0.12	|O
g	|O
.	|O

The	|O
observed	|O
incidence	|O
rates	|O
were	|O
compared	|O
to	|O
expected	|O
rates	|O
in	|O
the	|O
general	|O
population	|O
.	|O

The	|O
only	|O
predictor	|O
of	|O
response	|O
to	|O
tacrolimus	|O
was	|O
a	|O
previous	|O
response	|O
to	|O
cyclosporin	|O
and	|O
prednisone	|O
,	|O
either	|O
as	|O
a	|O
complete	|O
or	|O
partial	|O
remission	|O
(	|O
remission	|O
rate	|O
75%	|O
vs	|O
15.3	|O
;	|O
P	|O
=	|O
0.036	|O
)	|O
.	|O

Based	|O
on	|O
a	|O
morphological	|O
study	|O
of	|O
the	|O
resin	|O
-	|O
dentine	|O
interface	|O
,	|O
a	|O
broad	|O
selection	|O
of	|O
dentine	|O
adhesive	|O
systems	|O
was	|O
classified	|O
following	|O
their	|O
adhesion	|O
-	|O
strategy	|O
.	|O

Copyright	|O
2002	|O
American	|O
Cancer	|O
Society.D	|O
OI	|O
10.1002	|O
/	|O
cncr.1	|O
0318	|O

In	|O
this	|O
study	|O
we	|O
wanted	|O
to	|O
assess	|O
the	|O
DR	|O
using	|O
the	|O
'	|O
combined	|O
test	|O
'	|O
in	|O
an	|O
unselected	|O
population	|O
of	|O
self	|O
-	|O
referred	|O
pregnant	|O
women	|O
at	|O
a	|O
false	|O
-	|O
positive	|O
rate	|O
(	|O
FPR	|O
)	|O
of	|O
about	|O
5%	|O
.	|O

As	|O
measured	|O
by	|O
the	|O
PDQ	|O
-	|O
39	|O
,	|O
STN	|O
-	|O
DBS	|O
significantly	|O
improves	|O
important	|O
aspects	|O
of	|O
QoL	|O
in	|O
patients	|O
with	|O
advanced	|O
PD	|O
.	|O

